<SEC-DOCUMENT>0001125376-25-000021.txt : 20250205
<SEC-HEADER>0001125376-25-000021.hdr.sgml : 20250205
<ACCEPTANCE-DATETIME>20250205160346
ACCESSION NUMBER:		0001125376-25-000021
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		129
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250205
DATE AS OF CHANGE:		20250205

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ENSIGN GROUP, INC
		CENTRAL INDEX KEY:			0001125376
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-SKILLED NURSING CARE FACILITIES [8051]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				330861263
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33757
		FILM NUMBER:		25593191

	BUSINESS ADDRESS:	
		STREET 1:		29222 RANCHO VIEJO RD.
		STREET 2:		SUITE 127
		CITY:			SAN JUAN CAPISTRANO
		STATE:			CA
		ZIP:			92675
		BUSINESS PHONE:		(949) 487-9500

	MAIL ADDRESS:	
		STREET 1:		29222 RANCHO VIEJO RD.
		STREET 2:		SUITE 127
		CITY:			SAN JUAN CAPISTRANO
		STATE:			CA
		ZIP:			92675

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ENSIGN GROUP INC
		DATE OF NAME CHANGE:	20000930
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>ensg-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9fad20ba-6b95-4b5d-8a1b-0cd604b824d6,g:826a027b-6e82-45d1-b4d8-5465cc4138ed,d:ec37f02aeb9544da81ef9669e1252f6f-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:ensg="http://www.ensigngroup.net/20241231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ensg-20241231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-32">0001125376</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-33">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-34">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-35">false</ix:nonNumeric><ix:nonNumeric contextRef="c-55" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-501">P3Y0M0D</ix:nonNumeric><ix:nonNumeric contextRef="c-55" name="us-gaap:LesseeOperatingLeaseRenewalTerm" id="f-507">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="c-57" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="f-511">P4M0D</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-975">http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold</ix:nonNumeric><ix:nonNumeric contextRef="c-417" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="f-1458">P3Y0M</ix:nonNumeric><ix:nonNumeric contextRef="c-13" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1530">http://fasb.org/us-gaap/2024#RevenueFromContractWithCustomerExcludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1531">http://fasb.org/us-gaap/2024#RevenueFromContractWithCustomerExcludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="c-12" name="us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList" id="f-1532">http://fasb.org/us-gaap/2024#RevenueFromContractWithCustomerExcludingAssessedTax</ix:nonNumeric><ix:nonNumeric contextRef="c-478" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1627">273</ix:nonNumeric><ix:nonNumeric contextRef="c-481" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1628">160</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ensg-20241231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="facility"><xbrli:measure>ensg:facility</xbrli:measure></xbrli:unit><xbrli:unit id="bed"><xbrli:measure>ensg:bed</xbrli:measure></xbrli:unit><xbrli:unit id="unit"><xbrli:measure>ensg:unit</xbrli:measure></xbrli:unit><xbrli:unit id="property"><xbrli:measure>ensg:property</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>ensg:lease</xbrli:measure></xbrli:unit><xbrli:unit id="option"><xbrli:measure>ensg:option</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="subsidiary"><xbrli:measure>ensg:subsidiary</xbrli:measure></xbrli:unit><xbrli:unit id="renewal"><xbrli:measure>ensg:renewal</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>ensg:segment</xbrli:measure></xbrli:unit><xbrli:unit id="plan"><xbrli:measure>ensg:plan</xbrli:measure></xbrli:unit><xbrli:unit id="installment"><xbrli:measure>ensg:installment</xbrli:measure></xbrli:unit><xbrli:unit id="agreement"><xbrli:measure>ensg:agreement</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CombinedRealEstateAndLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">ensg:ThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">ensg:ThirdPartyOperatorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateDeductibleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateDeductibleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:AllStatesExcludingColoradoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:PerOccurenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:AllStatesExcludingColoradoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:PerFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:AllStatesExcludingColoradoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CO</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:PerOccurenceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CO</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:PerFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateDeductibleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateDeductibleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:AllStatesExcludingCaliforniaTexasAndWashingtonMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:LossSensitiveLimitPerClaimMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:StopLossInsuranceLimitPerClaimMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:HealthLiabilityInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ensg:InsuranceSubsidiaryLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ensg:InsuranceSubsidiaryLongTermInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">ensg:ThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">ensg:PreviousSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceBaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceIncentiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:ManagementServiceTotalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceBaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceBaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:DepreciationAndAmortizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:DepreciationAndAmortizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:DepreciationAndAmortizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:TwentyThreeSubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PrepaymentFeePeriodAxis">ensg:FirstThreeYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PrepaymentFeePeriodAxis">ensg:InTheFourthYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PrepaymentFeePeriodAxis">ensg:YearsFiveThroughTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:PrepaymentFeePeriodAxis">ensg:AfterYearTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:A53PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:A53PromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-349"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2022PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-352"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-353"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-354"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-355"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-356"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-357"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-358"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-359"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-360"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeFiveMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-361"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-362"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-363"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-364"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeSevenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-365"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-366"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeEightMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-367"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-368"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeNineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-369"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-370"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeTenMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-371"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-372"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-373"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-374"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-375"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-376"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-377"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-378"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-379"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-380"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-381"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-382"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-383"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-384"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-385"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-386"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-387"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-388"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-389"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-390"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2019LTIPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-391"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2019LTIPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-392"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2019LTIPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-393"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2019LTIPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpinoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-394"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ensg:OtherStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-395"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ensg:OtherStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-396"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ensg:OtherStockAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-397"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-398"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:MasterLeaseAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:TripleNetLeaseArrangementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-400"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:TripleNetLeaseArrangementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:TripleNetLeaseArrangementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-402"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:TripleNetLeaseArrangementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-403"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-404"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:OperationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-405"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-406"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-407"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-408"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:PurchaseOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-409"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-410"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-411"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-412"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-413"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-418"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-419"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:CostofSalesandGeneralandAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:CostofSalesandGeneralandAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-421"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:CostofSalesandGeneralandAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-422"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-423"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-424"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-425"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewMasterLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-426"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewMasterLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewAndAmendedMasterLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-429"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-431"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-432"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-433"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-434"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewMasterLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2025-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-435"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewMasterLeaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-01-01</xbrli:startDate><xbrli:endDate>2025-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-436"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThePennantGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-437"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-438"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-439"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-440"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-441"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:SubleaseToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-442"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:SubleaseToThirdPartyOperatorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-443"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-444"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-445"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThePennantGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-446"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThePennantGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-447"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThePennantGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-448"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThirdPartyTenantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThirdPartyTenantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-450"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThirdPartyTenantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-451"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-452"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-454"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-455"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-456"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-457"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-458"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-459"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-460"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-461"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-462"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-463"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-464"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-465"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-466"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-467"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-468"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-469"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:May2024RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-05-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-470"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:May2024RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-16</xbrli:startDate><xbrli:endDate>2024-05-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-471"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:May2024RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-472"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:August2023RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-473"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:August2023RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-29</xbrli:startDate><xbrli:endDate>2023-08-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-474"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:August2023RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-475"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:July2022RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-476"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:July2022RepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-28</xbrli:startDate><xbrli:endDate>2022-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-477"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-478"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:Dr.AnnS.BlouinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-479"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:Dr.AnnS.BlouinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-480"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:Dr.AnnS.BlouinMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-481"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:SuzanneD.SnapperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-482"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:SuzanneD.SnapperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001125376</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:SuzanneD.SnapperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iec37f02aeb9544da81ef9669e1252f6f_7"></div><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:13pt;font-weight:700;line-height:120%">                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:13pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">_____________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:5.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-3">December&#160;31</ix:nonNumeric>, 2024</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:5.342%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:92.458%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the transition period from </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"> to</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;.</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">001-33757</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">_____________________________</span></div><div style="margin-top:3pt;text-align:center"><img src="ensg-20241231_g1.jpg" alt="ensignlogoofficiala01.jpg" style="height:40px;margin-bottom:5pt;vertical-align:text-bottom;width:64px"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:22pt;font-weight:700;line-height:120%">THE <ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">ENSIGN GROUP, INC</ix:nonNumeric>.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:47.726%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.074%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">33-0861263</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">29222 Rancho Viejo Road, Suite 127</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">San Juan Capistrano</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">CA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">92675</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices and Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">949</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">487-9500</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:35.953%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.657%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">ENSG</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.970%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.227%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.847%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.269%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #566b39;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indicate by check mark:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #566b39;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act.</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">Yes</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric></span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#226600;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">whether the registrant has submitted electronically, every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#226600;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">whether the registrant is a large accelerated filer, an accelerated filer, non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act:</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-right:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If an emerging growth company, indicate if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section-404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-26">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Yes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">No</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">If securities are registered pursuant to Section 12(b) of the Act, whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#226600;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-27">&#254;</ix:nonNumeric></span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#226600;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#254;</span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#3d6702;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Yes</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#226600;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">&#254;</ix:nonNumeric></span></td><td colspan="3" style="border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">No</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="42" style="border-bottom:1pt solid #3d6702;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">As of June 30, 2024, the aggregate market value of the Registrant's Common Stock held by non-affiliates was: </span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="30" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="12" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-3" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="f-29">4,196,977,000</ix:nonFraction></span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The aggregate market value of Common Stock was computed by reference to the closing price as of the last business day of the registrant's most recently completed second fiscal quarter. Shares of Common Stock held by each executive officer, director and each person owning more than 10% of the outstanding Common Stock of the registrant have been excluded (in the amount of $2,620,517,000)</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">in that such persons may be deemed to be affiliates of the registrant. This determination of affiliate status is not necessarily a conclusive determination for other purposes.</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of January&#160;31, 2025, <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-30">57,455,374</ix:nonFraction> shares of the registrant&#8217;s common stock, $0.001 par value, were outstanding.</span></div><div style="margin-top:10pt"><span><br/></span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE:</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-31" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Part III of this Form 10-K incorporates information by reference from the Registrant's definitive proxy statement for the Registrant's 2025 Annual Meeting of Stockholders to be filed within 120 days after the close of the fiscal year covered by this annual report.</span></div></ix:nonNumeric><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_22"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THE ENSIGN GROUP, INC.</span></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">INDEX TO ANNUAL REPORT ON FORM 10-K</span></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 </span></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.972%"><tr><td style="width:0.1%"/><td style="width:0.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.236%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.820%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.103%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART I</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_406">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_406">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_406">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_367">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_367">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_367">33</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_424">Item 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_424">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_424">63</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_427">Item 1C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_427">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_424">63</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_430">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_430">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_430">65</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_364">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_364">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_364">67</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_382">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_382">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_382">70</a></span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART II.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_439">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_439">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_439">70</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_445">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_445">[RESERVED]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_445">71</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_304">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_304">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_304">71</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_352">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_352">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_352">90</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_31">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_31">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_31">91</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_451">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_451">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_451">127</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_454">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_454">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_454">127</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_385">Item 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_385">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_385">129</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_457">Item 9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_457">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_457">129</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART III.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_463">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_463">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_463">129</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_466">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_466">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_466">129</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_469">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_469">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_469">129</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_472">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_472">Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_472">129</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_475">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_475">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_475">129</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PART IV.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_481">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_481">Exhibits</a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_481"> and</a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_481"> Financial Statement</a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_481"> Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_481">130</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_487">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_487">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_487">132</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_400">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_400">133</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE&#160;REGARDING FORWARD-LOOKING STATEMENTS</span><span style="color:#3d6702;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form&#160;10-K contains forward-looking statements, which include, but are not limited to our expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities and plans and objectives of management. Forward-looking statements can often be identified by words such as &#8220;anticipates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;predicts,&#8221; &#8220;believes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;ongoing,&#8221; similar expressions, and variations or negatives of these words. These statements are subject to the safe harbors under Private Securities Litigation Reform Act of 1995.  These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors, some of which are listed under the section &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;1A of this Annual Report on Form&#160;10-K. Accordingly, you should not rely upon forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this Annual Report on Form 10-K, and are based on our current expectations, estimates and projections about our industry and business, management's beliefs, and certain assumptions made by us, all of which are subject to change. We undertake no obligation to revise or update publicly any forward-looking statement for any reason, except as otherwise required by law. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Annual Report on Form&#160;10-K, the words, "Ensign," "Company," &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refer to The Ensign Group, Inc. and its consolidated subsidiaries. All of our independent subsidiaries, the Service Center (defined below) and our wholly-owned captive insurance subsidiary (the Captive Insurance) and captive real estate investment trust called Standard Bearer Healthcare REIT, Inc. (Standard Bearer) are operated by separate, wholly-owned, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated &#8220;Company&#8221; and &#8220;its&#8221; assets and activities, as well as the use of the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar terms in this Annual Report  on Form 10-K are not meant to imply, nor should it be construed as meaning, that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by The Ensign Group. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ensign Group, Inc. is a holding company with no direct operating assets, employees or revenues. In addition, certain of our wholly-owned independent subsidiaries, collectively referred to as the Service Center, provide centralized accounting, payroll, human resources, information technology, legal, risk management and other centralized services to the other independent subsidiaries through contractual relationships with such subsidiaries. The Captive Insurance provides some claims-made coverage to our independent subsidiaries for general and professional liability, as well as for certain workers' compensation insurance liabilities. Standard Bearer owns and manages our real estate business. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Service Center address is 29222 Rancho Viejo Rd Suite 127, San Juan Capistrano, CA 92675, and our telephone number is (949)&#160;487-9500. Our corporate website is located at </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">www.ensigngroup.net. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 10-K. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensign</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is our United States trademark. All other trademarks and trade names appearing in this annual report are the property of their respective owners. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:justify"><span><br/></span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART I. </span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_406"></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Founded in 1999, The Ensign Group, Inc. (Ensign) is a holding company with independent subsidiaries that provide skilled nursing, senior living and rehabilitative services, as well as other ancillary businesses (including mobile diagnostics and medical transportation), in 15 states. As part of our investment strategy, we also acquire, lease and own healthcare real estate to service the post-acute care continuum through acquisition and investment opportunities in healthcare properties. For the year ended December&#160;31, 2024, we generated approximately 95.7% of our revenue from our skilled nursing facilities. The remainder of our revenue is primarily generated from our real estate properties, senior living services and other ancillary services.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OPERATIONS</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2024, we offered skilled nursing, senior living and rehabilitative care services through 327 skilled nursing and senior living facilities. Of the 327 facilities, we operated 231 facilities under long-term lease arrangements and have options to purchase 12 of those 231 facilities. Our real estate portfolio consists of 129 owned real estate properties, which included 96</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">facilities operated and managed by us, 33 operations leased to and operated by third-party operators, and the Service Center's California location. Of the 33 third-party operations, one senior living operation is located on the same real estate property as a skilled nursing operation that we own and operate.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Unique Approach and Structure</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The name "Ensign" is synonymous with a "flag" or a "standard" and refers to our goal of setting the standard by which all others in our industry are measured. We believe that through our efforts and leadership, we can foster a new level of patient care and professional competence at our independent subsidiaries and set a new industry standard for each patient we service. We view healthcare services primarily as a local business. We believe our success is largely driven by our proven ability to build strong relationships with key stakeholders in local healthcare communities, in part, by leveraging our reputation for providing superior care. Accordingly, our brand strategy and organizational structure promotes the empowerment of local leadership and staff to make their facility the &#8220;operation of choice&#8221; in their community. This is accomplished by allowing local leadership to discern and address the unique needs and priorities of healthcare professionals, customers and other stakeholders in the local community or market, and then work to create a superior service offering for, and reputation in, their particular community. This local empowerment is unique within the healthcare services industry. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our localized approach encourages prospective patients and referral sources to choose or recommend our local operations. In addition, our leaders share real-time operating data, clinical benchmark and operational performance metrics with their peers in order to improve clinical care, enhance patient satisfaction and augment operational efficiencies, promoting the sharing of best practices.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We organize our independent subsidiaries into portfolio companies, which we believe has enabled us to maintain a local, field-driven organizational structure, attract additional qualified leadership talent, and to identify, acquire, and improve operations at a generally faster rate. Each of our portfolio companies has its own leader. These leaders, who are generally taken from the ranks of operational CEOs, serve as leadership resources within their own portfolio companies, and have the primary responsibility for recruiting qualified talent, finding potential acquisition targets, and identifying other internal and external growth opportunities. We believe this organizational structure has improved the quality of our recruiting and will continue to facilitate successful acquisitions. </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate investments are part of our strategies to further our mission of dignifying post-acute care in the eyes of the world through thoughtful acquisitions of property and leases that promote healthy long-term operations. In the past, we have spun-off our owned real estate properties into a public real estate investment trust (REIT). Currently, we plan to continue to expand our real estate portfolio. We own 129 real estate properties, including 33 real estate properties that are leased to third parties under triple-net long-term leases. We manage and operate the remaining real estate properties, including the Service Center's California location. We are committed to growing our real estate portfolio, which we believe will further enhance our earnings and maximize long-term shareholder value.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To continue with our growth strategy on our real estate portfolio, in January 2022, we formed Standard Bearer. Standard Bearer owns and manages our real estate business. The REIT structure allows us to better demonstrate the growing value of our owned real estate and provides us with an efficient vehicle for future acquisitions of properties that could be operated by our independent subsidiaries or other third parties. We believe this structure gives us new pathways to growth with transactions we would not have considered in the past. Standard Bearer elected to be taxed as a REIT, for U.S. federal income tax purposes, commencing with its taxable year ended December 31, 2022. The real estate portfolio in Standard Bearer consists of 124 of our 129 owned real estate properties. During the </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2024,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Standard Bearer acquired the real estate of 11 stand-alone skilled nursing facilities, three stand-alone senior living facilities, and three campus operations. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of these additions, the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11 skilled nursing facilities and three campus operations acquired are </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operated by the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The senior living</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> operations are leased to a third-party operator. For further details on the Standard Bearer REIT, refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in Notes to the Consolidated Financial Statements of this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SEGMENTS</span><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two reportable segments: (1) skilled services, which includes the operation of skilled nursing facilities and rehabilitation therapy services and (2) Standard Bearer, which is comprised of select properties owned by us through our captive REIT and leased to skilled nursing and senior living operations, including our own independent subsidiaries and third-party operators. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also report an &#8220;all other&#8221; category that includes operating results from our senior living operations, mobile diagnostics, transportation, other real estate and other ancillary operations. These businesses are neither significant individually, nor in aggregate, and therefore do not constitute a reportable segment. Our Chief Executive Officer, who is our chief operating decision maker, or CODM, reviews financial information at the operating segment level. We have presented our segment results in this Annual Report on Form 10-K on a comparative basis to conform to the segment structure. For more information about our operating segments, as well as financial information, see Part II, Item 7. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 8, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Notes to the Consolidated Financial Statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skilled Services</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, our skilled nursing companies provided skilled nursing care at 316 operations, with 33,547 operational beds, in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. We provide short and long-term nursing care services for patients with chronic conditions, prolonged illness, and the elderly. Our residents are often high-acuity patients that come to our facilities to recover from strokes, cardiovascular and respiratory conditions, neurological conditions, joint replacements, and other muscular or skeletal disorders. We use interdisciplinary teams of experienced medical professionals to provide services prescribed by physicians. These medical professionals provide individualized comprehensive nursing care to our short-stay and long-stay patients. Many of our skilled nursing facilities are equipped to provide specialty care, such as on-site dialysis, ventilator care, cardiac and pulmonary management. We also provide standard services such as room and board, special nutritional programs, social services, recreational activities, entertainment, and other services. We are dedicated to ensuring our residents are happy, comfortable, and motivated to achieve their health goals through the provision of quality care. We generate our skilled services revenue from Medicaid, Medicare, managed care, commercial insurance, and private pay. During the year ended December&#160;31, 2024, approximately</span><span style="color:#242424;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 46.9% and 25.9% </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our skilled services revenue was derived from Medicaid and Medicare programs, respectively. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standard Bearer</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We engage in the acquisition and leasing of skilled nursing and senior living properties. We generate rental revenue primarily by leasing post-acute care properties we acquired to healthcare operators under triple-net lease arrangements, whereby the tenant is solely responsible for the costs related to the property, including property taxes, insurance and maintenance and repair costs, subject to certain exceptions. As of December&#160;31, 2024, our real estate portfolio within Standard Bearer is comprised of 124 real estate properties located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. Of these properties, 92 are leased to our independent subsidiaries and 33 are leased to operations wholly-owned and managed by third-party operators. Of the 33 third-party operations, one senior living operation is located on the same real estate property as a skilled nursing operation that we own and operate. During the year ended December 31, 2024, we generated rental revenues of $95.1 million, of which $78.1 million was derived from our independent subsidiaries, and therefore eliminated in consolidation.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from our senior living operations, mobile diagnostics, transportation, other real estate and other ancillary operations comprise approximately 4.5% of our annual revenue. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Living &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2024, we had an aggregate of 3,088 senior living units across 41 operations, of which 30 were located on the same site location as our skilled nursing care operations. Our senior living communities located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Texas, Utah and Washington, provide residential accommodations, activities, meals, housekeeping and assistance in the activities of daily living to seniors who are independent or who require some support, but not the level of nursing care provided in a skilled nursing operation. Our independent living units are non-licensed independent living apartments in which residents are independent and require no support with the activities of daily living.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior living operations comprise approximately 2.1% of our annual revenue. We generate revenue at these operations primarily from private pay sources, Medicaid and other state-specific programs. Specifically, during the year ended December&#160;31, 2024, approximately 60% of our senior living revenue was derived from private pay sources.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ancillary &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> our independent subsidiaries operate ancillary services located in Arizona, California, Colorado, Idaho, Texas, Utah and Washington. We have invested in and are exploring new business lines that are complementary to our existing skilled services and senior living services. These new business lines consist of mobile ancillary services, including digital x-ray, ultrasound, electrocardiograms, sub-acute services, dialysis, respiratory, long-term care pharmacy and patient transportation to people in their homes or at long-term care facilities. To date, these businesses were not meaningful contributors to our operating results.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GROWTH</span><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an established track record of successful acquisitions. Much of our historical growth can be attributed to implementing our expertise in acquiring real estate or leasing both under-performing and performing post-acute care operations and transforming them into market leaders in clinical quality, staff competency, employee loyalty and financial performance. With each acquisition, we apply our core operating expertise to improve these operations, both clinically and financially. In years where pricing has been high, we have focused on the integration and improvement of our existing independent subsidiaries while limiting our acquisitions to strategically situated properties.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From January 1, 2020 through December&#160;31, 2024, we acquired 99 facilities, which added 10,375 operational skilled nursing beds and 834 senior living units to our independent subsidiaries. The following table summarizes cumulative skilled nursing and senior living operations, operational skilled nursing beds and senior living unit counts for each of the last five years to reflect our growth over a five-year period as a result of the acquisition of these facilities:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.478%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.948%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative number of skilled nursing and senior living operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative number of operational skilled nursing beds</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,172&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,032&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,130&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,602&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,547&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cumulative number of senior living units</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,254&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,237&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,021&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,121&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,088&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Number of operational beds and number of operations for 2020-2023 include operational beds and operations that we no longer operate. The number of operations and operational beds do not include the closed facilities beginning in the year of their closures.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also invested in new business lines that are complementary to our existing businesses, such as ancillary services. We plan to continue to grow our revenue and earnings by: </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:8.52pt">continuing to grow our talent base and develop future leaders;</span></div><div style="padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:8.52pt">increasing the overall percentage or &#8220;mix&#8221; of higher acuity patients;</span></div><div style="padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:8.52pt">focusing on organic growth and internal operating efficiencies;</span></div><div style="padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:8.52pt">continuing to acquire additional operations in existing and new markets; </span></div><div style="padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:8.52pt">expanding and renovating our existing operations, and</span></div><div style="padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:8.52pt">strategically investing in and integrating other post-acute care healthcare businesses.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Market CEO and New Ventures Programs &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to broaden our reach into new markets, and in an effort to provide existing leaders in our company with the entrepreneurial opportunity and challenge of entering a new market and starting a new business, we established our New Market CEO program in 2006. Supported by our Service Center and other resources, a New Market CEO evaluates a target market, develops a comprehensive business plan, and relocates to the target market to find talent and connect with other providers, regulators and the healthcare community in that market, with the goal of ultimately acquiring businesses and establishing an operating platform for future growth. In addition, this program includes other lines of business that are closely related to the skilled nursing industry. The New Ventures program encourages our local leaders to evaluate service offerings with the goal of establishing an operating platform in new markets and new businesses. We believe that this program will not only continue to drive growth, but will also provide a valuable training ground for our next generation of leaders, who will have experienced the challenges of growing and operating a new business.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OPERATION EXPANSIONS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2024, we expanded through a combination of long-term leases and real estate purchases, with the addition of 28 stand-alone skilled nursing operations and three campus operations. Of these additions, Standard Bearer acquired the real estate of 11 of the stand-alone skilled nursing operations and three campus operations, which were leased back to Ensign's independent subsidiaries. These new operations added a total of 3,030 operational skilled nursing beds and 218 operational senior living units to be operated by our independent subsidiaries. Additionally, we invested in new ancillary services that are complementary to our existing businesses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, we expanded through a combination of a long-term lease and a real estate purchase, with the addition of seven stand-alone skilled nursing operations totaling 682 operational skilled nursing beds to be operated by our independent subsidiaries, including one in a new state, Alabama. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further discussion of our acquisitions, see Note 7, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operation Expansions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Notes to the Consolidated Financial Statements.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUALITY OF CARE MEASURES </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Improvement in Acquired Facilities </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Five-Star Quality Rating System introduced by the Centers for Medicare and Medicaid Services (CMS) intends to help consumers, their families and caregivers compare nursing homes more easily. The Five-Star Quality Rating System gives each skilled nursing operation a rating between one and five stars in various categories including health inspections, staffing and quality measures (QM). We have a strong history of quickly improving the quality of care in the facilities we acquire. Thus, as new assessments are conducted post-acquisition, the star ratings see consistent improvement. At the time of acquisition, the majority of our facilities have 1 and 2-Star ratings. </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Over the last few years, CMS has modified the star rating requirements. These changes have been significant and made it more difficult to achieve a 4 or 5-Star rating, resulting in certain skilled nursing operations losing stars in their "Quality" and "Staffing" ratings, which negatively impacted the "Overall" ratings. Nevertheless, we continue to demonstrate strong performance in the Five-Star Quality Rating System. We believe compliance and quality outcomes are precursors to outstanding financial performance. Thus, we strive to aggressively increase quality and compliance in every facility we acquire, and to adjust our overall policies to adapt to CMS&#8217;s changing criteria for the Five-Star Quality Rating System. </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 1, 2023, a significant change impacting the QM category was a shift in focus from a resident's functional status to their functional abilities and goals, commonly referred to as the Minimum Data Set (MDS) Section G to Section GG. The transition resulted in numerous QM modifications and changes which impacted the Five-Star rating. As part of this change, in April 2024, CMS froze the associated new and modified quality measures as part of the transition on the Nursing Home Compare website. Starting in October 2024, CMS replaced the short-stay functionality QM with the new cross-setting functionality QM, which is used in the SNF Quality Reporting Program (QRP). The remaining three measures will continue to be frozen until January 2025 while the data for the equivalent measures are collected. Additionally, beginning in April of 2024, CMS revised the staffing rating methodology to give the lowest possible score for staffing turnover measures to providers who fail to submit staffing data or submit erroneous data. Therefore, the predictability and movement in the QM ratings will not necessarily be consistent with our current quality performance. In addition, what and how we are measuring the QM will not be consistent with the historical practice and accordingly will not be comparable. Therefore, depending on the changes, we may experience periods of time where the number of facilities with 4 or 5-Star ratings decline. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the number of our facilities with 4 and 5-Star ratings since 2020:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"/><td style="width:64.181%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:5.279%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.279%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.279%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.279%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.393%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.287%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 and 5-Star Quality Rated skilled nursing facilities</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Above-Average Ratings </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 2024, despite the fact that Ensign&#8217;s acquisition of facilities with 1 or 2-Star ratings skews our company-wide ratings, our mean score on the Five-Star Quality Rating System is 62.5%, which exceeds the national average score of 56.9%. Our average cycle 1 health inspections for all of our facilities, which is based on the latest inspections, is 8.1% better than the national average. </span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_409"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">INDUSTRY TRENDS</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The post-acute care industry has evolved to meet the growing demand for post-acute and custodial healthcare services generated by an aging population, increasing life expectancies and the trend toward shifting patient care to lower cost settings. The industry has evolved in recent years, which we believe has led to a number of favorable improvements in the industry, as described below:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Shift of Patient Care to Lower Cost Alternatives </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth of the senior population in the U.S. continues to increase healthcare costs, often faster than the available funding from government-sponsored healthcare programs. In response, federal and state governments have adopted cost-containment measures that encourage the treatment of patients in more cost-effective settings such as skilled nursing facilities, for which the staffing requirements and associated costs are often significantly lower than acute care hospitals and other post-acute care settings. As a result, skilled nursing facilities are generally serving a larger population of higher acuity patients than in the past.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Significant Acquisition and Consolidation Opportunities </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The skilled nursing industry is large and highly fragmented, characterized predominantly by numerous local and regional providers. Due to the increasing demands from hospitals and insurance carriers to implement sophisticated and expensive reporting systems, we believe this fragmentation provides us with significant acquisition and consolidation opportunities.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Improving Supply and Demand Balance </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The number of skilled nursing facilities has declined modestly over the past several years. We expect that the supply and demand balance in the skilled nursing industry will continue to improve due to the shift of patient care to lower cost settings, an aging population and increasing life expectancies.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Increased Demand Driven by Aging Populations </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As seniors account for an increasing percentage of the total U.S. population, we believe the demand for skilled nursing and senior living services will continue to increase. According to the census projection released by the U.S. Census Bureau in early 2020, between 2016 and 2030, the number of individuals over 65 years old is projected to be one of the fastest growing segments of the United States population, growing from 15% to 21%. The Bureau expects this segment to increase nearly 50% to 73&#160;million, as compared to the total U.S. population which is projected to increase by 10% over that time period. Furthermore, the generation currently retiring has accumulated less savings than prior generations, creating demand for more affordable senior housing and skilled nursing services. As a high-quality provider in lower cost settings, we believe we are well-positioned to benefit from this trend.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Value-based Care and Reimbursement Reform </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In response to rising healthcare spending in the United States, commercial, government and other payors are generally shifting away from fee-for-service (FFS) payment models towards value-based models, including risk-based payment models that tie financial incentives to quality, efficiency and coordination of care. We believe that patient-centered outcomes driven reimbursement models will continue to grow in prominence. Many of our operations already receive value-based payments, and as valued-based payment systems continue to increase in prominence, it is our view that our strong clinical outcomes will be increasingly rewarded.</span></div><div style="margin-top:4pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:4pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant goal of U.S. federal health care reform is to transform the delivery of health care by changing reimbursement to reflect and support a focus on equity, payment for value and efficacious delivery of person-centered care. Reimbursement models and demonstrations that increase accountability and provide financial incentives to encourage efficiency, affordability and high-quality care, have been developed and implemented by government and commercial third-party payers. Special focus is placed on increasing the number of beneficiaries in care relationships with accountability for quality and total cost of care, improvements in care coordination, reducing inequities at the population level and supporting care innovation to close care gaps and increase access. The most prominent value-based models designed to accomplish these aims include Accountable Care Models (e.g., MSSP ACOs, ACO REACH) and Disease-Specific &amp; Episode-Based Models (e.g., BPCI Advanced, GUIDE Model, CJR). These models, alongside State &amp; Community, Statutory and Health Plan Models, are aimed at alignment across payers and care settings, leveraging effective clinical tools, outcomes-focused payment approaches and stakeholder-led policy development. Reimbursement methodology reform includes Value-Based Purchasing (VBP), in which a portion of provider reimbursement is redistributed based on relative performance, or improvement on designated economic, clinical quality and patient satisfaction metrics. These reimbursement methodologies and similar programs are likely to continue and expand, both in government and commercial health plans. Many of our operations already participate in value-based initiatives and models. With our focus on quality care and strong clinical outcomes, we are well-positioned to benefit from these outcome-based payment models. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the post-acute industry has been and will continue to be impacted by several other trends. The use of long-term care insurance is increasing among seniors as a means of planning for the costs of skilled nursing services. In addition, as a result of increased mobility in society, reduction of average family size and the increased number of two-wage earner couples, more residents are looking for alternatives outside the family for their care.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_412"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">REVENUE SOURCES  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive revenue primarily from the Medicaid and Medicare programs, managed care and commercial insurance payors and private pay patients. The majority of our revenue is derived from skilled nursing, which is highly dependent upon the Medicaid and Medicare programs. Thus, any changes to payment models, reimbursements and budgets impact our revenue, some positively and some negatively. A detailed discussion of the regulatory framework impacting our business is found in the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> section below. See also, Item 1A., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A brief overview of each of our revenue sources is as follows:</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicaid </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Medicaid is a program financed by state funds and matching federal funds administered by the states and their political subdivisions, and often go by state-specific names, such as Medi-Cal in California and the Arizona Healthcare Cost Containment System in Arizona. Medicaid programs generally provide health benefits for qualifying individuals and may supplement Medicare benefits for the disabled and for persons aged 65 and older meeting financial eligibility requirements. Medicaid reimbursement formulas are established by each state with the approval of the federal government in accordance with federal guidelines. Seniors who enter skilled nursing facilities as private pay clients can become eligible for Medicaid once they have substantially depleted their assets. Medicaid is generally the largest source of funding for most skilled nursing facilities. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid reimbursement varies from state to state and is based upon a number of different systems, including cost-based, prospective payment; case mixed adjusted payments and negotiated rate systems. Rates are subject to a state&#8217;s annual budgetary requirements and funding, statutory and regulatory changes and interpretations and rulings by individual state agencies and State Plan Amendments approved by CMS.  However, given that most states are required to have balanced budgets and Medicaid is frequently their largest program, many states have implemented or might consider implementing various strategies to manage Medicaid expenses. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Medicaid typically covers patients that require standard room and board services and provides reimbursement rates that are generally lower than rates earned from other sources. We monitor our payor mix to measure the level received from each payor across each of our business units. We intend to continue to focus on enhancing our care offerings to accommodate more high acuity patients.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received revenues from Medicaid in all the states in which we operate, with approximately 90% coming from Arizona, California, Colorado, Idaho, Texas, Utah and Washington. As a result, we are sensitive to potential changes in state-based revenue programs, such as Medicaid, as well as regulatory, economic, environmental, and competitive changes in those states. While the Medicaid spending of each state reflects its own population size, trends and public health challenges, the broad trend across our largest states in 2024 was either stable or increasing rate growth. With some states even electing to make the temporary Covid funding part of their long term budgets. Over the long term, Medicaid spending is expected to increase across all states as a result of the increases in costs of care and the increase in population eligible for Medicaid benefits. For example, California projected its Medicaid spending to increase from current levels through the state&#8217;s 2028-2029 budget period. However, the increased Medicaid spending may not directly translate into rate increases for care. Additionally, we have seen that some state budgets continue to be pressured by budget shortfalls.  For example, in Colorado, recent budget shortfalls have caused the state to propose provider compensation that is stagnant despite increases in costs for the 2025-2026 budget period.  This is an area we monitor closely and will continue to follow as it affects the success of our independent facilities and overall business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Medicare is a federal program that provides healthcare benefits to individuals who are 65&#160;years of age or older or are disabled. To achieve and maintain Medicare certification, a skilled nursing facility must sign a Medicare provider agreement and meet the CMS &#8220;Conditions of Participation&#8221; on an ongoing basis, as determined in periodic facility inspections or &#8220;surveys&#8221; conducted primarily by the state licensing agency in the state where the facility is located. Medicare pays for inpatient skilled nursing facility services under the prospective payment system (PPS). Under PPS, facilities are paid a predetermined amount per patient, per day, for certain services. Medicare Part A skilled nursing facility coverage is limited to 100&#160;days per episode of illness for those beneficiaries who require daily care following discharge from an acute care hospital.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Medicare beneficiaries who qualify for the Medicare Part A coverage, rehabilitation services are included in the per diem payment. For beneficiaries who do not meet the coverage criteria for Part A services, rehabilitation services may qualify for the services to be provided under Medicare Part B. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed Care and Private Insurance </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Managed care patients consist of individuals who are insured by certain third-party entities, or who are Medicare beneficiaries who have assigned their Medicare benefits to a managed care organization plan. Another type of insurance, long-term care insurance, is also becoming more available to consumers, but is not expected to contribute significantly to industry revenues in the near term.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Private and Other Payors </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Private and other payors consist primarily of individuals, family members or other third parties who directly pay for the services we provide. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rental Revenue </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real estate rental revenue is generated by leasing post-acute care properties that we acquired to healthcare operators under triple-net lease arrangements, whereby the tenant is solely responsible for the costs related to the property, including property taxes, insurance and maintenance and repair costs, subject to certain exceptions.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following charts sets forth our total service revenue by payor source generated by our consolidated operations and skilled services segment as a percentage of total revenue for the years ended December 31, 2024 and 2023, respectively:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CONSOLIDATED SERVICE REVENUE BY PAYOR</span></div><div style="margin-top:10pt;text-align:center"><img src="ensg-20241231_g2.jpg" alt="6420" style="height:305px;margin-bottom:5pt;vertical-align:text-bottom;width:340px"/><img src="ensg-20241231_g3.jpg" alt="6421" style="height:305px;margin-bottom:5pt;vertical-align:text-bottom;width:340px"/></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SKILLED SERVICES REVENUE BY PAYOR</span></div><div style="margin-top:10pt;text-align:center"><img src="ensg-20241231_g4.jpg" alt="6458" style="height:305px;margin-bottom:5pt;vertical-align:text-bottom;width:340px"/><img src="ensg-20241231_g5.jpg" alt="6459" style="height:305px;margin-bottom:5pt;vertical-align:text-bottom;width:340px"/></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payor Sources as a Percentage of Skilled Services </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The following table sets forth our percentage of skilled nursing patient days by payor source:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:72.106%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.930%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.932%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percentage of Skilled Nursing Days:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other skilled</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SKILLED MIX</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29.9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30.4</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other payors</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SKILLED NURSING</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">REIMBURSEMENT FOR SPECIFIC SERVICES  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement for Skilled Services </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Skilled nursing facility revenue is primarily derived from Medicaid, Medicare, managed care and private payors. Our skilled nursing operations provide Medicaid-covered services to eligible individuals consisting of nursing care, room and board and social services. In addition, states may, at their option, cover other services such as physical, occupational and speech therapies.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, adjustments to reimbursement under Medicare and Medicaid have had a significant effect on our revenue and results of operations.&#160;Recently enacted, pending and proposed legislation and administrative rulemaking at the federal and state levels could have similar effects on our business.&#160;Efforts to impose reduced reimbursement rates, greater discounts and more stringent cost controls by government and other payors are expected to continue for the foreseeable future and could adversely affect our business, financial condition and results of operations.&#160;Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement for Rehabilitation Therapy Services </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Rehabilitation therapy revenue is primarily received from private pay, managed care and Medicare for services provided at skilled nursing operations and senior living operations. The payments are based on negotiated patient per diem rates or a negotiated fee schedule based on the type of service rendered. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement for Senior Living </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Senior living facility revenue is primarily derived from private pay patients at rates we established, with the secondary source of  revenue derived from state-specific programs such as Medicaid.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement for Other Ancillary Services </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Other ancillary revenue, such as mobile diagnostics and medical transportation, is primarily derived from Medicare Part B, Medicaid, managed care and private payors at rates we establish based upon the services we provide and market conditions in the area of operation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">RENTAL REVENUE</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rental revenue from third-party rental property tenants </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Standard Bearer's owned properties are leased pursuant to non-cancelable operating leases, generally with an initial term of 10 to 20 years. All of the leases for post-acute care healthcare properties contain renewal options. The leases provide for fixed minimum base rent during the initial and renewal periods. Standard Bearer's leases contain provisions for specified annual increases over the rents of the prior year and those increases are generally calculated based on the Consumer Price Index. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each lease is a triple net lease which requires the lessee to pay all taxes, insurance, maintenance and repairs, capital and non-capital expenditures and other costs necessary in the operations of the facilities. In addition, Standard Bearer's leases with third-parties are typically structured as master leases. The master leases consist of multiple leases, each with its own pool of properties, that have varying maturities and diversity in property geography. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a lessee makes payments for taxes and insurance directly to a third-party on our behalf, we are required to exclude these payments from variable payments and from revenue recognition in our consolidated statements of income. Otherwise, tenant reimbursements paid to us for taxes and insurance are classified as additional rental revenue recognized by us on a gross basis.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rental revenue from our independent subsidiaries </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Rental revenue from our independent subsidiaries is based on mutually agreed-upon base rents that are subject to change from time to time. Intercompany revenue is eliminated in consolidation, along with the corresponding intercompany rent expenses of the related healthcare facilities. </span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_415"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COMPETITION</span><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#3d6702;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The post-acute care industry is highly competitive, and we expect that the industry will become increasingly competitive in the future. The industry is highly fragmented and characterized by numerous local and regional providers, in addition to large national providers that have achieved geographic diversity and economies of scale. Our independent subsidiaries also compete with inpatient rehabilitation facilities and long-term acute care hospitals. Increasingly, we are competing with home health and community-based providers who have developed programs designed to provide services to seniors outside a facility-based setting, potentially decreasing the time they need the higher level of care provided in a skilled nursing facility.&#160;Competitiveness may vary significantly from location to location, depending upon factors such as the number of competing facilities, availability of services, expertise of staff, and the physical appearance and amenities of each location. We believe that the primary competitive factors in the post-acute care industry are: </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:13.02pt">ability to attract and to retain qualified management and caregivers;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:13.02pt">reputation and achievements of quality healthcare outcomes;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:13.02pt">attractiveness and location of facilities;</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:13.02pt">the expertise and commitment of the management team and employees; and</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:80%;padding-left:13.02pt">community value, including amenities and ancillary services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to compete effectively in each market by establishing a reputation within the local community as the &#8220;operation of choice.&#8221; This means that the operation leaders are generally free to discern and address the unique needs and priorities of healthcare professionals, customers and other stakeholders in the local community or market, and then create a superior service offering and reputation for that particular community or market that is calculated to encourage prospective customers and referral sources to choose or recommend the operation. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased competition could limit our ability to attract and retain patients, maintain or increase rates or to expand our business. Some of our competitors have greater financial and other resources than we have, may have greater brand recognition and may be more established in their respective communities than we are. Competing companies may also offer newer facilities or different programs or services than we offer, and may therefore, attract individuals who are currently patients of our facilities, potential patients of our facilities, or who are otherwise receiving our healthcare services. Other competitors may have lower expenses or other competitive advantages than us and, therefore, provide services at lower prices than we offer. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other services, such as senior living facilities and other ancillary services, also compete with local, regional, and national companies. The primary competitive factors in these businesses are similar to those for our skilled nursing facilities and include reputation, cost of services, quality of clinical services, responsiveness to patient/resident needs, location and the ability to provide support in other areas such as third-party reimbursement, information management and patient recordkeeping.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Standard Bearer segment competes for real property investments with healthcare providers, healthcare-related REITs, real estate partnerships, banks, private equity funds, venture capital funds and other investors. Some of these competitors are significantly larger and have greater financial resources and lower costs of capital than us. Our ability to compete successfully for real property investments will be determined by numerous factors, including our ability to identify suitable acquisition targets, our ability to negotiate acceptable terms for any such acquisition and our cost of capital in the event an acquisition requires debt or equity financing.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OUR COMPETITIVE STRENGTHS</span><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are well positioned to benefit from the ongoing changes within our industry. We believe that our ability to acquire, integrate and improve our facilities is a direct result of the following key competitive strengths: </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Experienced and Dedicated Employees </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We believe that our independent subsidiaries' employees are among the best in their respective industries. We believe each of our independent subsidiaries is led by an experienced and caring leadership team, including dedicated front-line care staff, who participates daily in the clinical and operational improvement of their individual operations. We have been successful in attracting, training, incentivizing and retaining a core group of outstanding business and clinical leaders to spearhead our independent subsidiaries. These leaders operate as separate local businesses. With broad local control, these talented leaders and their care staffs are able to quickly meet the needs of their patients and residents, employees and local communities, without waiting for permission to act or being bound to a &#8220;one-size-fits-all&#8221; corporate strategy. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unique Incentive Programs </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We believe that our employee compensation programs are unique within the industry.  Employee stock options and performance bonuses, based on achieving target clinical quality, cultural, compliance and financial benchmarks, represent a significant component of total compensation for our operational leaders. We believe that these compensation programs assist us in encouraging our leaders and key employees to act with a shared ownership mentality. Furthermore, our leaders are motivated to help local operations within a defined &#8220;cluster&#8221; and "market," which is a group of geographically proximate operations that share clinical best practices, real-time financial data and other resources and information. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Staff and Leadership Development </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a culture that believes ongoing education, training and professional development is essential. Accordingly, our operational leaders participate in regular training. Most participate in training sessions at Ensign University, our in-house educational system. Other training opportunities are generally offered via on-demand training tools, including podcasts. In addition, we offer weekly cultural and interactive educational topics including leadership development, our values, updates on Medicaid and Medicare billing requirements, updates on new regulations or legislation, infection control, emerging healthcare service alternatives and other relevant clinical, business and industry specific coursework. We also encourage and provide ongoing education classes for our clinical staff to maintain licensing and increase the breadth of their knowledge and expertise. We believe that our commitment to, and substantial investment in, ongoing education will further strengthen the quality of our operational leaders and staff, and the quality of the care they provide to our patients and residents.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Innovative Service Center Approach </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We do not maintain a corporate headquarters; rather, we operate service centers to support the efforts of each operation. Our Service Center is a dedicated service organization that acts as a resource and provides centralized information technology, human resources, accounting, payroll, legal, risk management, educational and other back-office support services, so that local leaders can focus on delivering top-quality care and efficient business operations. Our Service Center approach allows individual operations to function with the strength, synergies and economies of scale found in larger organizations, but without what we believe are the disadvantages of a top-down management structure or corporate hierarchy. We believe our Service Center approach is unique within the industry, and allows us to preserve the &#8220;one-operation-at-a-time&#8221; focus and culture that has contributed to our success. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proven Track Record of Successful Acquisitions </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We have established a disciplined acquisition strategy that is focused on selectively acquiring operations within our target markets. Our acquisition strategy is driven by our operations team. Prospective leaders are included in the decision-making process and compensated as these acquired operations reach pre-established clinical quality and financial benchmarks, helping to ensure that we only undertake acquisitions that key leaders believe can become clinically sound and contribute to our financial performance. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024,</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we have expanded to 327 facilities with an aggregate of 33,547 operational skilled nursing beds and 3,088 senior living units, through both long-term leases and real estate purchases. We believe our experience in acquiring these operations and our demonstrated success in significantly improving their operations enables us to consider a broad range of acquisition targets. In addition, we believe we have developed expertise in transitioning newly acquired operations to our unique organizational culture and systems, which enables us to acquire operations with limited disruption to patients, residents and operating staff, while significantly improving quality of care. We have also constructed new facilities to target demand, which exists for high-end healthcare facilities when we determine that market conditions justify the cost of new construction in some of our markets. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Successful Real Estate Investment Strategy </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our Standard Bearer segment, we maintain a real estate portfolio of long-term healthcare facilities diversified by geographic location and operated by a diverse group of established healthcare providers. We are focused on selectively acquiring real estate properties based on our industry experience and opportunistic strategy, which we believe provides us with greater investment and purchasing opportunities. Due to our credit strength, we have the ability to acquire large portfolios of real estate properties; a portion of which can be managed and operated by our independent subsidiaries and their established healthcare leaders and a portion of which can be leased to third parties. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, our real estate portfolio consists of 129 owned facilities, which include properties leased to and operated by third parties and properties we managed and operated. We believe our real estate investment strategy has allowed us to accumulate a portfolio that aids our healthcare operators in improving performance and generating additional returns through leases with third parties.   </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reputation for Quality Care </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We believe that we have achieved a reputation for high-quality and cost-effective care and services to our patients and residents within the communities we serve. We believe that our achievement of quality outcomes enhances our reputation for quality, that when coupled with the integrated services that we offer, allows us to attract patients that require more intensive and medically complex care and generally result in higher reimbursement rates than lower acuity patients. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Community Focused Approach </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We view our services primarily as a local, community-based business. Our local leadership-centered management culture enables each operation's nursing support staff and leaders to meet the unique needs of their patients and local communities. We believe that our commitment to this &#8220;one-operation-at-a-time&#8221; philosophy helps to ensure that each operation, its patients, their family members and the community will receive the individualized attention they need. By serving our patients, their families, the community and our fellow healthcare professionals, we strive to make each individual business the operation of choice in its local community. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We further believe that when choosing a healthcare provider, consumers usually choose a person or people they know and trust, rather than a corporation or business. Therefore, rather than pursuing a traditional organization-wide branding strategy, we actively seek to develop the operations brand at the local level, serving and marketing one-on-one to caregivers, our patients, their families, the community and our fellow healthcare professionals in the local market. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment in Information Technology </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We utilize information technology that enables our operational leaders to access, and to share with their peers, both clinical and financial performance data in real time. Armed with relevant and current information, our operation leaders and their management teams are able to share best practices and the latest information, adjust to challenges and opportunities on a timely basis, improve quality of care, mitigate risk and improve both clinical outcomes and financial performance. We have also invested in specialized healthcare technology systems to assist our nursing and support staff. We have installed software and touch-screen interface systems in each operation to enable our clinical staff to more efficiently monitor and deliver patient care and record patient information. We believe these systems have improved the quality of our medical and billing records, while improving the productivity of our staff. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OUR GROWTH STRATEGY </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the following strategies are primarily responsible for our growth to date, and will continue to drive the growth of our business: </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grow Talent Base and Develop Future Leaders </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Our primary growth strategy is to expand our talent base and develop future leaders. A key component of our organizational culture is our belief that strong local leadership is a primary key to the success of each operation. While we believe that significant acquisition opportunities exist, we have generally followed a disciplined approach to growth that permits us to acquire an operation only when we believe, among other things, that we will have qualified leadership for that operation. To develop these leaders, we have a rigorous &#8220;CEO-in-Training Program&#8221; that attracts proven business leaders from various industries and backgrounds, and provides them the knowledge and hands-on training they need to successfully lead one of our independent subsidiaries. We generally have between 55 and 65 prospective administrators progressing through the various stages of this training program, which is generally much more rigorous, hands-on and intensive than the minimum 1,000&#160;hours of training mandated by the licensing requirements of most states where we do business. Once administrators are licensed and assigned to an operation, they continue to learn and develop in our operational Chief Executive Officer Program (CEO Program), which facilitates the continued development of these talented business leaders into outstanding operational chief executive officers, through regular peer review, our leadership development tools and on-the-job training. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our Chief Operating Officer Program (COO Program) recruits and trains highly qualified Directors of Nursing to lead the clinical programs in our operations. Working together with their operational CEO and/or administrator, other key operational leaders and front-line staff, these experienced nurses manage delivery of care and other clinical personnel and programs to optimize both clinical outcomes and employee and patient satisfaction. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increase Mix of High Acuity Patients </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Many skilled nursing facilities are serving an increasingly larger population of patients who require a high level of skilled nursing and rehabilitative care, whom we refer to as high acuity patients, as a result of government and other payors seeking lower-cost alternatives to traditional acute-care hospitals. We generally receive higher reimbursement rates for providing care for these medically complex patients. In addition, many of these patients require therapy and other rehabilitative services, which we are able to provide as part of our integrated service offerings. Where higher complex services are medically necessary and prescribed by a patient's physician or other appropriate healthcare professional, we generally receive additional revenue in connection with the provision of those services. By making these integrated services available to such patients and maintaining established clinical standards in the delivery of those services, we are able to increase our overall revenues. We believe that we can continue to attract high acuity patients to our operations by maintaining and enhancing our reputation for quality care and continuing our community focused approach. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focus on Organic Growth and Internal Operating Efficiencies </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We plan to continue to grow organically by focusing on increasing patient occupancy within our existing operations.  Although some of the facilities we have acquired were in good physical and operating condition, the majority have been clinically and financially troubled, with some facilities having had occupancy rates as low as 30% at the time of acquisition.  Additionally, we believe that incremental operating margins on the last 20% of our beds/units are significantly higher than on the first 80%, offering opportunities to improve financial performance within our existing facilities.  </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our overall occupancy is impacted significantly by the number of facilities acquired and the operational occupancy on the acquisition date. We historically have acquired operations with lower occupancy and skilled mix. Therefore, consolidated occupancy will vary significantly based on these factors. Our average consolidated occupancy rates for our skilled nursing facilities were 80.5% and 78.5% for the years ended December 31, 2024 and 2023, respectively. Throughout most of our history, our business is affected by seasonal fluctuations in occupancy and acuity, which are most prominent when comparing the summer and winter months of the calendar year. For skilled nursing occupancy and skilled mix, our historic seasonal trend tends to show stronger occupancy and acuity during the first and fourth quarters and softening in the second and third quarters. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also believe we can generate organic growth by improving operating efficiencies and the quality of care at the patient level. By focusing on staff development, clinical systems and the efficient delivery of quality patient care, we believe we are able to deliver higher quality care at lower costs than many of our competitors. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have achieved incremental occupancy and revenue growth by creating or expanding clinical service offerings in existing operations. For example, by expanding clinical programs to provide outpatient therapy services in many markets, we are able to increase revenue while spreading the fixed costs of maintaining these programs over a larger patient base. Outpatient therapy has also proven to be an effective marketing tool, raising the visibility of our facilities in their local communities and enhancing the reputation of our facilities with short-stay rehabilitation patients. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Add New Facilities and Expand Existing Facilities </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;One of our growth strategies includes the acquisition of new and existing facilities from third parties and the expansion and upgrade of current facilities. In the near term, we plan to take advantage of the fragmented skilled nursing industry by acquiring operations within select geographic markets and may consider the construction of new facilities. In addition, we have targeted facilities that we believed were performing and operations that were underperforming, where we believed we could improve service delivery, occupancy rates and cash flow. With experienced leaders in place at the community level and demonstrated success in significantly improving operating conditions at acquired facilities, we believe that we are well positioned for continued growth. While the integration of underperforming facilities generally has a negative short-term effect on overall operating margins, these facilities are typically accretive to earnings within 12 to 18&#160;months following their acquisition. For the facilities that we acquired from 2002 through 2024, the aggregate EBITDAR as a percentage of revenue improved from 13.3% during the first full three months of operations to 16.5% during the thirteenth through fifteenth months of operation and to 18.6% during the 45th quarter of operation. </span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standard Bearer Portfolio Growth </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> An important part of our business strategy is to continue to expand and diversify our real estate portfolio through accretive acquisition and investment opportunities in healthcare properties. Our execution of this strategy hinges on our ability to successfully identify, secure and consummate beneficial transactions. We have a proven track record of acquiring properties that we have determined are investment opportunities and develop these into thriving properties that are well-suited for operational purposes. We then use these properties for our skilled nursing or senior living operations, or we lease the properties to other long-term care facility operators. We expect that our REIT structure will allow us to expand our real estate footprint while bringing the best operational practices to our own and other operators in the industry. </span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HUMAN CAPITAL</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2024, we had approximately 39,300 full-time equivalent employees who were employed by our Service Center and our independent subsidiaries. For the year ended December&#160;31, 2024, approximately 60.0% of our total expenses were payroll related. Periodically, market forces, which vary by region, require that we increase wages in excess of general inflation or in excess of increases in reimbursement rates we receive. We believe that we staff appropriately, focusing primarily on the acuity level and day-to-day needs of our patients and residents. In most of the states where we operate, our skilled nursing facilities are subject to state mandated minimum staffing ratios, so our ability to reduce costs by decreasing staff, notwithstanding decreases in acuity or need, is limited and subject to government audits and penalties in some states. We seek to manage our labor costs by improving staff retention, improving operating efficiencies, maintaining competitive wage rates and benefits and reducing reliance on overtime compensation and temporary nursing agency services. The Service Center's Chief Human Capital Officer, together with the Unity Committee, oversee the following human capital initiatives:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Culture </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operation of our skilled nursing and senior living facilities requires a large number of highly skilled healthcare professionals and support staff. Our employees are at the heart of our Company and we are committed to their health, professional development and workplace satisfaction. Our core values, which focus on developing our employees, fostering an ownership mentality and allowing for intelligent risk taking, guide us in our decision making and inspire us to be better people, both professionally and personally.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Benefits </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry as a whole has been experiencing shortages of qualified professional clinical staff. We believe that our ability to attract and retain qualified professional clinical staff stems from our ability to offer attractive wage and benefits packages, a high level of employee training, an empowered culture that provides incentives for individual efforts and a quality work environment. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unity </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commitment to inclusion is deeply rooted in our core values, including </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Love One Another</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, where we foster a welcoming and supportive environment for residents and their families and ensure that every individual&#8212;whether resident, family member, or team member&#8212;feels valued, informed, and comfortable to work together. Our commitment is to provide equal opportunity and fair treatment to all individuals based on merit and without discrimination. Our teams enable us to be a more relevant, competitive, and resilient organization. These efforts are supported by our Unity Committee, a multidisciplinary group led by our Chief Executive Officer. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Training and Development </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide training and development to all employees. We have many training programs at all levels such as our CEO in Training, Director of Nursing in Training, Director of Rehab in Training, nursing certified assistant schools, weekly culture trainings, boot camps and annual meetings, where we focus on both career and professional development. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Social Sustainability </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We continuously work towards bridging the gap between what the healthcare system currently provides and the basic needs of individuals. We aim to have an enduring impact on the communities in which we live and work. We partner with Elevate Charities, a non-profit organization that is dedicated to elevating the condition and quality of life for members of the senior healthcare community, employees, caregivers, family members, patients and residents. Elevate Charities has three unique funds: Heritage Fund, Heritage Scholarship Fund and the Emergency Fund. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Heritage Fund and the Heritage Scholarship Fund engage in a mission to enhance the quality of life for seniors in our communities through caring service, fulfilling essential needs and providing education to caregivers. The Heritage Fund helps the caregiver identify specific and practical ways to meet the needs of those under their care. This can help provide a better life, improved experience and greater satisfaction for our aging population. The financial support provided by the Heritage Fund benefits seniors directly. In addition, the Heritage Scholarship Fund helps qualified clinical professionals who may not be able to afford to advance in the field of long-term care. Through grants and scholarships, the fund helps these qualified professionals gain the education needed to advance in the field of senior-focused healthcare. Since 2018, we have partnered with public charities who have  awarded 244 scholarships to employees in our workforce. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lastly, the Emergency Fund is a way of passing the hat to help long term care staff whose lives are affected by tragedy. This program is funded for our team members by our team members. All team members are encouraged to  contribute to the fund either through a one-time donation or by recurring payroll deduction. In 2024, approximately 90% of those employed by our independent subsidiaries contributed to Elevate Charities Emergency Fund. In 2024, the public charity distributed approximately $4.8 million in grants to members of our independent subsidiaries. To date, the Emergency Fund has distributed over 19,400 grants totaling almost $20.6 million to members of our independent subsidiaries in their time of need. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on human capital matters, please see our most recent proxy statement or ESG report, each of which is available on our website at www.ensigngroup.net. For additional information on Elevate Charities, please visit www.elevatecharities.org. The information contained in, or that can be accessed through, either of the foregoing websites does not constitute a part of this Annual Report on Form 10-K.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_307"></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOVERNMENT REGULATION</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</span><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare is an area of extensive and frequent regulatory change. Changes in the law or new interpretations of existing laws may have a significant impact on our revenue, costs and business operations. Our independent subsidiaries that provide healthcare services are subject to federal, state and local laws relating to, among other things, licensure, quality and adequacy of care, physical plant requirements, life safety, personnel and operating policies. In addition, these same subsidiaries are subject to federal and state laws that govern billing and reimbursement, relationships with vendors, business relationships with physicians and workplace protection for healthcare staff. Such laws include (but are not limited to) the Anti-Kickback Statute (AKS), the federal False Claims Act (FCA), the Stark Law and state corporate practice of medicine statutes. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental and other authorities periodically inspect our independent subsidiaries to verify continued compliance with applicable regulations and standards. The operations must pass these inspections to remain licensed under state laws and to comply with Medicare and Medicaid provider agreements and applicable Conditions of Participation. The operations can only participate in these third-party payment programs if unannounced inspections by regulatory authorities reveal that the operations are in substantial compliance with applicable state and federal requirements. In the ordinary course of business, federal or state regulatory authorities may issue notices to the operations alleging deficiencies in certain regulatory practices, which may require corrective action to regain and maintain compliance. In some cases, federal or state regulators may impose other remedies including imposition of directed in-service training, state monitoring, civil monetary penalties, temporary admission and/or payment bans, loss of certification as a provider in the Medicare or Medicaid program, or revocation of a state operating license. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the regulatory environment surrounding the healthcare industry subjects providers to intense scrutiny. In the ordinary course of business, providers are subject to inquiries, investigations and audits by federal and state agencies related to compliance with participation and payment rules under government payment programs. These inquiries may originate from the Department of Health and Human Services (HHS), Office of the Inspector General (OIG), state Medicaid agencies, state Attorney Generals, local and state ombudsman offices and Centers for Medicare and Medicaid Services (CMS) Recovery Audit Contractors, among other agencies. In response to the inquiries, investigations and audits, federal and state agencies continue to impose citations for regulatory deficiencies and other regulatory penalties, including demands for refund of overpayments, expanded civil monetary penalties that extend over long periods of time and date back to incidents prior to surveyor visits, Medicare and Medicaid payment bans and terminations from those programs, which may be temporary or permanent in nature. We vigorously contest each such regulatory outcome when appropriate; however, there are significant legal and other expenses involved that consume our financial and personnel resources. Expansion of enforcement activity could adversely affect our business, financial condition or the results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proposed, Anticipated and Recently Issued Rulemaking and Administrative Actions</span></div><div style="margin-bottom:9pt;margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal government, through CMS rulemaking, Presidential executive actions or Congressional legislation, and state and local governments have recently released the following proposed rulemaking or administrative actions that may have an impact on our independent Skilled Nursing Facilities (SNFs) or Assisted Living Facilities (ALFs):</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biden-Harris Administration's Nursing Home Care Priorities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Biden-Harris Administration sought reform around reimbursement, staffing levels, standards of care, increased transparency and public disclosure of ownership, and enhanced civil remedies as a means of enforcement against those facilities that do not satisfy CMS&#8217;s standards. Through rules that were proposed and finalized beginning 2023, including those highlighted below, the Biden-Harris Administration directed the government to exercise greater oversight of SNFs and ALFs receiving federal reimbursement. For example, the SNF PPS FY 2025 Final Rule grants CMS greater sanctioning authority for ongoing or persistent deficiencies in Medicare-participating SNFs. These increased sanctioning authorities will take effect in the 2025 federal fiscal year, beginning October 1, 2024. With the new administration, it currently is unknown whether any of these rules will be reduced in their scope or application, or whether they will be increased in any respects.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The individuals anticipated to be nominated to serve as the Secretary of HHS and Director of CMS, respectively, have not yet provided any indication what their priorities of anticipated future actions would be in this area. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ownership Transparency Final Rule </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS' final rule published in November 2023 requires SNFs to publicly disclose certain additional information regarding their ownership and managerial relationships, including the identity of any person or legal entity that: (1) exercises financial, operational, or managerial control over any facility or part of a facility, or provides services to a facility that include its policies and procedures or cash management services; (2) leases or subleases real property to the facility, or owns 5% or more of the real property&#8217;s total value; and (3) provides any management or administrative services (or consults regarding the same), or provides accounting or financial services to SNFs. The rule also expands ownership and control interest disclosures to include information about each member of the facilities governing body, individuals or entities serving as officers, directors, members, partners or managing employees, and a comprehensive breakdown of the organizational structure of any additional disclosable party that is not a natural person along with a description of their relationships with the facility. This rule&#8217;s disclosure requirements came into effect throughout 2024, with all SNFs required to comply by November of 2024.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states have adopted laws reflecting their concerns regarding ownership transparency. For example, Iowa adopted laws requiring disclosure of ownership information not previously required for licensure to promote transparency in 2023. Additionally, in March 2024, the California Department of Health Care Access and Information of the California Health and Human Services Agency issued its notice of approval of regulatory action establishing policies and procedures that implement financial and ownership transparency requirements for California-licensed SNFs that are required by California law passed in 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Legislation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Home and Community-Based Services</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(HCBS) Access Act (Access Act) was introduced in 2023 to expand access to and resources available for HCBS. The Access Act ensures that Medicaid funding is made available to individuals who provide direct home- and community-based care to adults over the age of 60 or people who have disabilities. This bill also provides financial resources for the training of these direct care providers, who are intended to provide services to the elderly or disabled that range from advocacy and community integration to transportation and daily assistance tasks ranging from bathing and laundry to meal preparation and housekeeping. As of the date of filing, no further action has been taken on the HCBS Access Act since its introduction and referral to the House of Representatives committees.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the HCBS Relief Act introduced in 2023, provides additional funds to states to stabilize their HCBS service delivery networks, recruit and retain HCBS direct care workers, and meet long-term service and support needs of people eligible for Medicaid home and community-based services. To qualify for the enhanced rate, a state must commit to initiatives aimed at improving the provision of services. As of the date of this filing, no action has been taken on the HCBS Relief Act since its introduction and referral to the Senate Committee on Finance.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Legislation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Many states in which our independent subsidiaries operate have introduced or passed legislation that would create or change laws and regulations related to our business and industry. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, California had discussed issuing proposed regulations on direct care spending requirements that may have affected our business and SNFs operating within that state. These proposals have included requirements for healthcare facilities certified by CMS, including SNFs, to report all annual revenues to the State of California and certify that a stated percentage of all revenues should be used for direct patient-related services, including staffing and operational costs. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California has also signed into law a bill that impacts the minimum wages of healthcare workers. Effective October 16,  2024, the law raised the minimum wage for California healthcare employees and set a new wage threshold for those who are considered exempt healthcare employees. The bill only becomes effective for SNFs if a direct care minimum spending requirement bill is also passed. While the existing requirement bill has not seen any traction, we anticipate a minimum spending bill could be proposed in the future, including the next California legislative session that begins in 2025.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 24, 2024, the California Department of Health Care Access and Information (HCAI) announced that the Office of Health Care Affordability&#8217;s Board approved a statewide healthcare spending target of 3%, which represents a long-term reduction of current levels of statewide healthcare spending. The spending target will be phased in over time, initially starting at 3.5% for 2025 and 2026, the target will be lowered to 3.2% for 2027 and 2028 before ultimately reaching 3% for 2029 and beyond.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Final Rule Fiscal Year 2025 Skilled Nursing Facility Prospective Payment System (SNF PPS)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; CMS released the final rule for the SNF PPS for FY 2025 (SNF PPS FY 2025 Final Rule) in July 2024 to update the Medicare payment rates within the SNF PPS and provide significant enhancements to CMS&#8217;s enforcement capabilities within nursing homes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This final rule results in a net 4.2% increase in SNF payments under Medicare Part A in fiscal year 2025, which started on October 1, 2024 and will run through September 30, 2025. The net increase is based on the SNF market basket of 3.0%, plus a 1.7% market basket forecast error adjustment, and a negative 0.5% productivity adjustment. This increase does not include the SNF VBP reductions for certain SNFs subject to the net reduction in payments under the SNF VBP. CMS also revised the SNF market basket base year from the 2018 base year to the current 2022 base year and updated the payment rates used under the SNF PPS based on the FY 2025 market basket increase factor, which is adjusted by both the productivity adjustment and forecast error correction. Within this rule, CMS also updated the SNF PPS wage index using core-based statistical areas (CBSAs) to reflect regional wage costs.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF PPS FY 2025 Final Rule also includes significant enhancements to CMS&#8217;s enforcement capabilities within nursing homes, aiming to reinforce the safety and quality of care. The rule broadens CMS&#8217;s ability to use financial penalties to ensure sustained remediation of health and safety infractions, thereby motivating facilities to quickly comply with CMS regulations. The rule eliminates the restrictions of per instance (PI) for isolated violations or per day (PD) for ongoing non-compliance restrictions, allowing for more flexible imposition of both PD and PI penalties, which would not exceed statutory daily limits. This change is intended to provide CMS with enhanced tools to address violations more effectively and reflect the severity of the impact on residents&#8217; health and safety. Additionally, the SNF PPS FY 2025 includes updates to the QRP to better account for social determinants of health, adding items to be reported regarding these social determinants of health&#8212;living situation, food, and utilities&#8212;in the minimum data set each SNF is required to report to CMS.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF PPS FY 2025 also contains an update to the SNF Value-Based Purchasing (VBP) Program, including how its measurements are retained or removed from use in evaluating quality of care, updates to technical measures so that measures can be updated using a sub-regulatory process, and administrative policies for updating and correcting data CMS relies on in calculating its measurements.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2025 Home Health and Hospice Payment Rules Affecting SNFs</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CMS&#8217;s final payment rules for other modalities of care delivery also affect the operations of SNFs.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 Home Health PPS Final Rule requires long-term care facilities, including SNFs, to make at least weekly reports to CMS regarding respiratory illnesses, including facility census, resident vaccination status for specified respiratory illnesses, confirmed resident cases and residents hospitalized from such illnesses.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Final Rule Fiscal Year 2024 SNF PPS</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SNF PPS FY 2024 Final Rule, which was effective October 1, 2023, updated the Medicare payment rates and modified the SNF QRP and the SNF VBP Program. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SNF PPS FY 2024 Final Rule finalized the rates to be paid in fiscal year 2024, which started on October 1, 2023 and ran through September 30, 2024. The net effect of these changes was an overall 4.0% increase in payments to SNFs in FY 2024. The increase included a 6.4% net market basket update to the payment rates of 3.0%, plus a 3.6% market basket forecast error adjustment, less a 0.2% productivity adjustment, as well as a negative 2.3% in the FY 2024 SNF PPS rates due to the second phase of the Patient Driven Payment Model (PDPM) parity adjustment recalibration. In addition, this final rule also updates the SNF QRP for FY 2024 and future years, including the adoption of two new quality reporting measures, modification of one measure and removal of three measures resulting in public reporting of four QRP measures. Additionally, the SNF PPS FY 2024 Final Rule made changes to the SNF VBP Program, specifically adopting four new measures: the nursing staff turnover measure, the discharge function score measure, the long stay hospitalization measure per 1,000 resident days and the percent of residents experiencing one or more falls with a major injury (long stay); the existing SNF 30-day all-cause readmission measure (SNFRM) is replaced with the SNF within stay potentially preventable readmissions measure beginning in FY 2028.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNF PPS FY 2024 Final Rule adopted the Nursing Staff Turnover (NST) measure for the SNF VBP program beginning with the FY 2026 program year. This is a structural measure that has been collected and publicly reported on Care Compare, and the measure assesses the stability of the staffing within a SNF using nursing staff turnover. The NST measure uses facility-reported, electronic data from CMS&#8217; Payroll-Based Journal (PBJ) system to calculate annual turnover rates for nursing staff, including RNs, LPNs, and nurse assistants. Facilities would begin reporting this measure in FY 2024, with payment effects beginning in FY 2026. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NST measure looks at six consecutive quarters of data. It starts with a baseline quarter and the first two quarters of the performance period to identify eligible employees. Then, uses the next four quarters to find the number of employment cycles that ended in turnover. Finally, the data from the sixth quarter is validated to identify gaps in days worked that began in the last 60 days of the fifth quarter used for the measure. The measure score is then calculated by comparing the total number of eligible employees with 60-day gaps in working during the specified periods. After submission, CMS may audit the data and if discrepancies are found, the consequences may include penalties, decreased ratings and suppression of metrics for the trailing 6 quarters. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CMS Minimum Staffing Standards Final Rule </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; CMS issued its final rule establishing minimum staffing standards for skilled nursing facilities (Staffing Rule) in April 2024. The Staffing Rule contains three primary staffing requirements and provides for a staggered and phase implementation over the next several years following the Staffing Rule&#8217;s publication. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial phase, effective 90 days from the Staffing Rule's publication, which is August 8, 2024, requires facility self-assessment, which enhances the current assessment that all SNFs must perform and document annually and on an as-needed basis. The Staffing Rule&#8217;s requirement for enhanced self-assessments requires the following: 1) facilities must use evidence-based methods when planning for resident care, including accommodation of behavioral health needs; 2) facilities to use their self-assessment to assess the specific needs of each resident, with adjustments made for changes in the resident population; 3) facilities include the input of staff, including leadership, management, nurse staff and other direct care providers who render other services to residents; and 4) the facility&#8217;s staffing plan maximizes recruitment and retention of staff in a manner consistent with the President Biden&#8217;s April 2023 Executive Order on increasing access to high-quality care and supporting caregivers. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The second phase, effective within two years of the Staffing Rule's publication, which is May 2026 for non-rural facilities, requires that all SNFs have a registered nurse (RN) available to provide direct resident care onsite 24 hours per day, seven days per week (24/7). The rule states that administrative nurses may satisfy this requirement, provided that the nurse is available to provide direct resident care. In addition to the 24/7 RN, the Staffing Rule requires facilities to provide a minimum of 3.48 hours per resident per day (HPRD) of direct nursing care to residents. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The third phase, effective within three years of the Staffing Rule's publication, which is May 2027 for non-rural facilities, requires that the HPRD are satisfied through RNs providing 0.55 HPRD, nurse aides (NAs) providing 2.45 HPRD, and any combination of RNs, licensed practical nurses (LPNs), licensed vocational nurses (LVNs), or NAs to account for the final 0.48 HPRD. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Staffing Rule finalized the hardship exemption for the HPRD requirements. A facility can qualify for a temporary hardship exemption from the new minimum staffing ratios and 24/7 RN onsite staffing requirement (the self-assessment standards must still be satisfied) if it is in an area where the supply of RN, NA, or total nursing staff is insufficient to meet the needs of that area. This exemption is based on the provider-to-population ratio for the nursing workforce, which must be at least 20% below the national average as calculated by CMS. Additionally, the Staffing Rule provides a one year extension of deadlines to rural facilities on Phases 2 and 3.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Staffing Rule also enhances transparency for the use of Medicaid payments for facility services, referenced as Medicaid Institutional Payment Transparency Reporting provisions (MIPTR). The MIPTR provisions within the Staffing Rule require States to report to CMS the percentage of Medicaid payments for nursing facility services spent on direct care workers and support staff, regardless of whether such payments are made under a fee-for-service or managed care model. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the publication of the Staffing Rule, two bills, named the Protecting America&#8217;s Seniors&#8217; Access to Care Act and Protecting Rural Seniors&#8217; Access to Care Act (one in the House and a companion bill in the Senate) were introduced to block the Staffing Rule from taking effect. Both bills have been referred to committee and are pending further action.  These bills reason that the minimum staffing standard would endanger rural nursing facilities, subjecting them to potential fines and closures for failure to comply and might require them to discharge residents or limit the number of residents they accept in an effort to meet the requirements of the bill. It is uncertain if any of these bills or other legislative action will pass as well as their potential impact on the Staffing Rule.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Staffing Rule has been met with further opposition and proposed legislation to halt its implementation. On May 23, 2024, the American Health Care Association (AHCA) filed a lawsuit in the Northern District of Texas against HHS and CMS, alleging that the Staffing Rule exceeds the scope of CMS&#8217;s statutory authority and violates the Administrative Procedure Act.  The State of Texas brought suit and was granted consolidation of its lawsuit with AHCA's in the same venue arguing the rule is &#8220;arbitrary and capricious&#8221; and in violation of the Administrative Procedure Act. Subsequently, over 20 additional states have filed similar suits in opposition to the rule, as well as industry groups including Leading Age and the South Dakota Association of Healthcare Organizations.  On May 10, 2024, a joint resolution was introduced in the House of Representatives under the Congressional Review Act to overturn the Staffing Rule, which was referred to the House Ways and Means committee and its Subcommittee on Health on May 17, 2024, with no further action taken on the joint resolution since then. Related to the pending proposed legislation regarding the Staffing Rule, the Long-Term Care Workforce Support Act was introduced in both the Senate and House of Representatives in April of 2024 and both versions of the bill were subsequently referred to the Senate Committee on Finance and the House Ways and Means committee and its Subcommittee on Health, respectively, by April 19, 2024, with no action taken on either bill since then.  These companion bills were introduced in order to increase the direct care workforce and improve pay, by increasing the federal match for Medicaid by up to 10% for each state across 10 years. The recent Supreme Court decision in </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loper Bright Enterprises v. Raimondo</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("Chevron" decision) gives courts greater authority to challenge federal agencies' statutory interpretations. As such, the Staffing Rule may see increased legal challenges under the new doctrine. (For further discussion of the Chevron case and its implications see "United States Supreme Court Decisions" section below.)</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare presently accounts for approximately 25.9% of our skilled nursing services revenue year-to-date, being our second-largest revenue payor. The Medicare program and its reimbursement rates and rules are subject to frequent change. These include statutory and regulatory changes, rate adjustments, administrative or executive orders and government funding restrictions, all of which may materially adversely affect the rates at which Medicare reimburses us for our services. Budget pressures often lead the federal government to reduce or place limits on reimbursement rates under Medicare. Implementation of these and other types of measures has in the past, and could in the future, result in substantial reductions in our revenue and operating margins. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient-Driven Payment Model (PDPM)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The SNF PPS Rule included a case mix model called PDPM that focuses on the patient&#8217;s condition (clinically relevant factors) and resulting care needs to determine Medicare reimbursement. PDPM utilizes clinically relevant factors for determining Medicare payment by using diagnosis codes and other patient characteristics as the basis for patient classification. PDPM makes effective use of five case-mix adjusted payment components: physician therapy, occupational therapy, speech language pathology, nursing and social services and non-therapy ancillary services. It also uses a sixth non-case mix component to cover utilization of SNFs' resources that do not vary depending on resident characteristics. PDPM is intended to achieve a more value-based, unified post-acute care payment system. For example, PDPM adjusts Medicare payments based on each aspect of a resident&#8217;s care. Under the SNF PPS PDPM system, the payment to SNFs and nursing homes is based heavily on the patient&#8217;s condition rather than the specific services provided by each SNF.  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skilled Nursing Facility - Quality Reporting Program (SNF QRP) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Improving Medicare Post-Acute Care Transformation Act of 2014 (IMPACT Act) provided data reporting requirements for certain Post-Acute-Care (PAC) providers. If a SNF does not submit required quality data as required by the IMPACT Act, its payment rates are reduced by 2.0% for each such fiscal year, which may result in payment rates for a fiscal year being less than the preceding fiscal year.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF QRP standardized patient assessment data elements. The SNF QRP applies to freestanding SNFs, SNFs affiliated with acute care facilities and all non-critical access hospital swing-bed rural hospitals. These data elements are the subject of frequent change and adjustment. CMS's rulemaking often identifies new data elements to be reported. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS revised the calculation of its five-star ratings for the Nursing Home Compare website.  Under this methodology, points are assigned to a SNF based on its performance across six measures: (1) case-mix adjusted total nurse staffing levels (including registered nurses, licensed practical nurses, and nursing aides), measured by hours per resident per day; (2) case-mix adjusted registered nurse staffing levels, measured by hours per resident per day; (3) case-mix adjusted total nurse staffing levels (including registered nurses, licensed practical nurses, and nursing aides), measured by hours per resident day on the weekend; (4) total nurse turnover, defined as the percentage of nursing staff that left the nursing home over a 12-month period; (5) registered nurse turnover, defined as the percentage of registered nursing staff that left the nursing home over a 12-month period; and (6) administrator turnover, defined as the percentage of administrators that left the nursing home over a 12-month period. These six measures will be measured on a quarterly basis. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These six new measures were included in the five-star rating starting in October 2022. In addition, CMS also implemented a planned increase to the quality measure reporting thresholds, increasing each threshold by one-half of the average improvement of quality measure scores since CMS last set quality measure thresholds. Going forward, CMS plans to implement similar rating threshold increases every six months.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has continued to refine the QRP including various measurements such as the adoption of a process measure for influenza vaccination coverage among healthcare personnel within SNFs and a Discharge Function Score (DC Function) measure, which determines the functional condition of residents by examining the proportion of SNF residents who achieve or surpass a projected discharge functionality score. The assessment includes consideration of mobility and self-care, utilizing data from the Minimum Data Set (MDS). The DC Function will replace the current process and is scheduled to go into effect for the FY 2025 SNF QRP. The SNF PPS FY 2024 Final Rule also modified the SNF QRP&#8217;s Healthcare Professional (HCP) Covid Vaccine Measure. The measure will track the proportion of healthcare staff vaccinated for COVID-19 and have kept their vaccination status current per the CDC recommendations. The SNF PPS FY 2024 Final Rule also removed the Application of Functional Assessment/Care Plan measures from the SNF QRP.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the SNF PPS FY 2024 Final Rule, CMS will adopt two measures for the SNF QRP starting in FY 2026. First, CMS will raise the Data Completion Thresholds for the MDS. SNFs must report required quality measure data and standardized resident assessment data gathered using the MDS for at least 90% of the assessments they submit to CMS. SNFs who fail to meet this requirement will be subject to a 2.0% reduction on their applicable fiscal year payment starting in FY 2026. Second, CMS will adopt the Patient/Resident COVID-19 Vaccine metric. This metric highlights the number of patient stays in which SNF patients received the COVID-19 vaccine.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS&#8217;s SNF PPS FY 2025 Final Rule adopts several updates to the SNF QRP aimed at enhancing the integration of social determinants of health (SDOH) into patient assessments and ensuring the accuracy of reported data. Starting in fiscal year 2027, CMS will introduce four new SDOH items related to living situation, food security, and utility access, and modify an existing item on transportation availability in the MDS. Additionally, CMS requires that SNFs participating in the SNF QRP undergo a data validation process similar to that already implemented in the SNF VBP Program. Also beginning in fiscal year 2027, SNFs participating in the SNF QRP program must participate in a validation program similar to that used for SNFs participating in the SNF VBP Program.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Annual Payment Rule </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS is required to calculate an annual Medicare market-basket update to the payment rates. The SNF PPS FY 2025 Final Rule, issued on July 31, 2024 increased the Medicare payment rates to SNFs in fiscal year 2025 by 4.2%, which is based on a market basket of 3.0% plus a 1.7% market basket forecast error adjustment and a  negative 0.5% productivity adjustment.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 31, 2023, CMS issued the SNF PPS FY 2024 Final Rule that increased Medicare payment rates by 4.0% to SNFs in fiscal year 2024. This increase results from the 6.4% net market basket update to the payment rates, which is based on a 3.0% SNF market basket increase plus a 3.6% market basket forecast error adjustment, less a 0.2% productivity adjustment and a negative 2.3% adjustment as a result of the recalibrated parity adjustment.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 29, 2022, CMS issued a final rule for fiscal year 2023 that increased the Medicare payment rates to aggregate net market basket by 2.7%. The increase results from the 5.1% update to the market basket, which is based on a 3.9% current year market basket increase plus a 1.5% market basket error adjustment, less a 0.3% productivity adjustment and a negative 2.3% adjustment as a result of the recalibrated parity adjustment. The recalibrated parity adjustment is being phased in at a rate of 2.3% per year on both the SNF PPS FY 2024 and FY 2023 Final Rules. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sequestration of Medicare Rates</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  &#8212;The Budget Control Act of 2011 requires a mandatory, across the board reduction in federal spending, called  sequestration. Medicare FFS claims with dates of service or dates of discharge on or after April 1, 2013 incur a 2.0% reduction in Medicare payments through at least 2023, unless Congress takes further action. Under the CAA 2023, a further 4.0% cut to Medicare spending that would have been required under the Statutory Pay-As-You-Go Act of 2010 (PAYGO) was waived for fiscal years 2023 and 2024. Instead, the CAA 2023 deferred any further Medicare sequestration under PAYGO until fiscal year 2025. The CAA 2023 also offset planned Medicare sequestrations that would have been as high as 4.0% and instead maintained fee schedule cuts of approximately 2.0%. Absent a further act by Congress, such as a consolidated appropriations act for 2025 or other bill addressing spending in fiscal year 2025 (including retroactively), the sequestration of Medicare FFS claims is expected to take effect in fiscal year 2025. On October 29, 2024, the Medicare Patient Access and Stabilization Act of 2024 (MPASA) was introduced in the House of Representatives, seeking to increase the amount paid to physicians under Medicare by 4.73%. MPASA was referred to the House Ways and Means Committee and House Committee on Energy and Commerce on October 29, 2024,  referred to the Subcommittee on Health on December 17, 2024 and no further action has been taken on this bill.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skilled Nursing Facility Value-Based Purchasing (SNF-VBP) Program </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF-VBP Program rewards SNFs with incentive payments based on the quality of care they provide to Medicare beneficiaries, as measured by a hospital readmissions measure. CMS annually adjusts its payment rules for SNFs using the SNF-VBP Program. The program also introduced quality measures to assess how health information is shared and adopted several standardized patient assessment data elements that assess factors such as cognitive function and mental status, special services and social determinants of health. CMS uses regulations to specify how it measures the performance for SNFs as well as the data that SNFs are to report to CMS. The deadlines for baseline period quality measure quarterly reporting and performance periods and standards began in the 2023 program year. The final rule for the fiscal year 2023 SNF PPS also provided for SNF-VBP program expansion beyond the use of its single, all-cause hospital readmission measure to determine payment, with the inclusion of measures in fiscal year 2026 for SNF healthcare associated infections requiring hospitalization (SNF HAI) and total nursing hours per resident day measures and in fiscal year 2027, the discharge to community post-acute care measure for SNFs, which assess the rate of successful discharges to the community from a SNF setting.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF PPS FY 2024 Final Rule elected to replace the SNFRM measure with the SNF within-stay (WS) potentially preventable readmission (PPR) measure beginning in the FY 2028 program year. The PPR measure assesses the risk-standardized rate of unplanned and potentially avoidable readmissions during SNF stays for Medicare fee-for-service beneficiaries. The new SNF WS PPR measure refines the original Skilled Nursing Facility 30-Day Potentially Preventable Readmission (SNFPPR) measure, which followed the requirements of the Protecting Access to Medicare Act (PAMA) of 2014. The refinement in the SNF WS PPR measure shifts the observation window from a fixed 30-day post-hospital discharge to the duration of the SNF stay. Moreover, the time gap allowed between the prior inpatient discharge and the SNF admission has been extended from one day to 30 days. These changes, based on feedback from expert panels and a 2015 partnership, better align the measure with the IMPACT Act's provisions and enhance the reliability of tracking preventable readmissions. Additionally, the SNF WS PPR measure's calculations use two years of Medicare claims data to generate a provider-specific risk-standardized readmission rate.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SNF PPS FY 2025 Final Rule adopted several operational and administrative updates to the SNF VBP Program. The SNF rule adopted a policy to select, retain and remove measurements to ensure the VBP Program&#8217;s evaluation metrics remain relevant and effective for assessing care quality, as well as policies for updating technical measures and policies for reviewing and correcting data CMS relies upon to calculate its measures. The rule allows CMS to update the case-mix methodology for the Total Nurse Staffing measure, and its policies to allow the review and revise measures, as well as review and correct data, allow SNFs to review and correct Payroll-Based Journal (PBJ) data from fiscal year 2026 and MDS data from fiscal year 2027, allowing CMS to fashion more accurate measures based on updated data.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Part B Rehabilitation Requirements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; A portion of our revenue is paid by the Medicare Part B program under a fee schedule. Part B services are limited with a payment cap by combined speech-language pathology services (SLP), physical therapy (PT) services and a separate annual cap for occupational therapy (OT) services. Part B services are limited by a payment cap as there is one amount for physical therapy (PT) services and speech-language pathology (SLP) services combined and a separate amount for occupational therapy (OT) services. On November 1, 2024, CMS issued the Calendar Year (CY) 2025 Physician Fee Schedule (PFS) Final Rule (2025 PFS Final Rule).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Bipartisan Budget Act of 2018 (BBA) establishes coding modifier requirements to obtain payments beyond certain payment thresholds, discussed below and reaffirms the specific $3,000 claim audit threshold requirements for Medicare Administrative Contractors. For PT and SLP combined the threshold for coding modifier requirements was $2,330 for CY 2024 with the same threshold for OT services. The KX modifier is added to medical claims to indicate the providing clinician attests that the services corresponding to that claim were medically necessary and that the justification for those services is contained within the patient&#8217;s medical records. This modifier is intended for use where the services will exceed the threshold for those services set by the BBA and updated by annual fee schedule rules, yet are still appropriate and medically necessary, and thus should be compensated by Medicare.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with CMS&#8217;s &#8220;Patients over Paperwork&#8221; initiative, the agency has also been moving toward eliminating burdensome claims-based functional reporting requirements. Beginning in 2021, CMS rescinded 21 problematic National Correct Coding Initiative edits impacting outpatient therapy services, including services furnished under Medicare Part B primarily related to PT and OT services, removing a coding burden caused by requirements for additional documentation and claim modifier coding. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Multiple Procedure Payment Reduction (MPPR) continues at a 50.0% reduction, which is applied to therapy procedures by reducing payments for practice expense of the second and subsequent procedures when services provided beyond one unit of one procedure are provided on the same day. The implementation of MPPR includes (1) facilities that provide Medicare Part B speech-language pathology, occupational therapy and physical therapy services and bill under the same provider number; and (2) providers in private practice, including speech-language pathologists, who perform and bill for multiple services in a single day.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through the end of CY 2024, certain of our Part B services provided through telehealth would qualify for Medicare reimbursement based on flexibility first provided under the Emergency Waivers, which added physical therapy, occupational therapy and speech-language pathology to the list of approved telehealth Providers for the Medicare Part B programs provided by a SNF. During the Public Health Emergency (PHE), CMS added certain PT and OT services to the list of Medicare-covered telehealth services on a temporary basis, some of which were made permanent for use and new codes were added for PT, OT, or SLP telehealth services&#8212;including some &#8220;sometimes therapy&#8221; codes that were not subject to MPPR. The CAA 2023 extended certain, but not all, telehealth flexibilities until December 31, 2024, allowing certain telehealth flexibilities to continue after the PHE's expiration. The American Relief Act, 2025 extended some but not all telehealth flexibilities for an additional 3 months.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2025 PFS Final Rule, the 2.93% increase to the CY 2024 PFS Conversion Factor (CF) expired and CMS seeks to impose an estimated 0.05% adjustment based on changes in work relative value units (RVUs) for certain services. As a result, the 2025 PFS Final Rule implements a reimbursement reduction of 2.83%, with a CF of $32.35, which is a reduction from the CY 2024 CF of $33.29. The 2025 PFS Final Rule adopts a 3.6% increase to the threshold for coding modifier requirements for PT and SLP combined, totaling $2,410 for CY 2025 with the same threshold for OT services. The threshold for targeted medical review for PT and OT (combined) and SLP is expected to remain at $3,000 through CY 2027.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2025 PFS Final Rule also adopts a regulatory change that allows physical therapy assistants and occupational therapy assistants to be generally supervised by physical therapists and occupational therapists, respectively, in private practice, non-institutional settings, allowing greater flexibility in billing for those assistants&#8217; services. Additionally, the 2025 PFS Final Rule excepts a therapist-established initial plan of care (POC) for PT, OT, or SLT services from requiring a physician or non-physician provider&#8217;s (NPP&#8217;s) signature, provided that (1) the patient&#8217;s physician or NPP referred the patient to the therapist and (2) the therapist has evidence that the POC was transmitted to the patient&#8217;s physician or NPP within 30 days of the patient&#8217;s initial evaluation. This flexibility applies only to the initial certification.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the 2025 PFS Final Rule reduces COVID-19 PHE-era telehealth flexibilities beginning on January 1, 2025.  Under this final rule, certain restrictions on telehealth that existed prior to the COVID-19 PHE will go back into effect: most geographic and site-of-service restrictions to telehealth will return, while physicians can still provide telehealth from home, and can provide audio-only telehealth communication in specific circumstances where the patient is unable to use video technology. CMS is also establishing new coding and payment for caregiver training services, including training services provided through eligible telehealth means.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2024, MPASA was introduced in the House of Representatives, seeking to increase the amount paid to physicians under Medicare by 4.73%. MPASA was referred to the House Ways and Means Committee and House Committee on Energy and Commerce on October 29, 2024, and no further action has been taken on this bill. On March 9, 2024, President Biden signed the Consolidated Appropriations Act, 2024, which included a 2.93% update to the CY 2024 PFS CF for dates of service March 9, 2024 through December 31, 2024. This replaced the 1.25% update provided by the Consolidated Appropriations Act, 2023. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 PFS Final Rule was finalized in November 2023, which changed Medicare payments under the PFS and other Medicare Part B components. The CY 2024 PFS Final Rule contained a conversion factor of $32.74, which was a decrease of $1.15 from the CY 2023 PFS conversion factor of $33.89. This CY 2024 conversion factor was 3.4% lower than the CY 2023 conversion factor. The billing period started on January 1, 2024 and ran through December 31, 2024. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 PFS Final Rule made payments when physicians and NPPs, involve caregivers in implementing an individualized plan of treatment or therapy. These provisions incentivize the training of caregivers and provide additional funds to offset the costs of training these caregivers. For PT and SLP combined, the threshold for coding modifier requirements increases to $2,330 for CY 2024 with the same threshold for OT services. The KX modifier is added to medical claims to indicate the providing clinician attests that the services corresponding to that claim were medically necessary and that the justification for those services is contained within the patient&#8217;s medical records. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 PFS Final Rule allowed for general supervision of therapy assistants by PTs and OTs for remote therapeutic monitoring (RTM) services. This change may affect the rate of reimbursement for PT and OT services in the future. Additionally, the 2024 PFS Final Rule added certain health and well-being coaching services that Medicare reimbursed on a temporary basis for 2024. The final rule also added risk assessments for social determinants of health to the list of telehealth services Medicare would reimburse.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Programs of All-Inclusive Care for the Elderly</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The requirements under the Programs of All-Inclusive Care for the Elderly (PACE) provide greater operational flexibility and update information under the Medicare and Medicaid programs, including leniency in compliance with program requirements during and after a 3-year trial period and relieving restrictions placed on the team that assesses and provides for the needs of each PACE participant. Further, non-physician primary care providers can provide certain services in place of primary care physicians. The final rule, which went into effect on April 3, 2023, requires the collection of data by Medicare Advantage organizations and their service providers and the submission of data to CMS for risk adjustment data validation (RADV) audits. The purpose of these RADV audits is to maintain the accuracy of risk-adjusted payments made to Medicare Advantage organizations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, CMS issued a new prescription drug event (PDE) reporting requirements for PACE organizations to receive manufacturer discounts for drugs provided through Medicare Part D as provided for in the Inflation Reduction Act of 2022 (IRA). The additional PDE information must be submitted beginning January 1, 2025. In June of 2024, CMS also updated its statement of rights for PACE participants. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Decisions Regarding Skilled Nursing Facility Payment</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reimbursement rates and rules are subject to frequent change that historically, have had a significant effect on our revenue. The federal government and state governments continue to focus on efforts to curb spending on healthcare programs such as Medicare and Medicaid. We are not able to predict the outcome of the legislative process. We also cannot predict the extent to which proposals will be adopted or, if adopted and implemented, what effect, if any, such proposals and existing new legislation will have on us. Efforts to impose reduced allowances, greater discounts and more stringent cost controls by government and other payors are expected to continue and could adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These include statutory and regulatory changes, rate adjustments (including retroactive adjustments), administrative or executive orders and government funding restrictions influenced by budgetary or political pressures, may materially adversely affect the rates at which Medicare reimburses us for our services. Implementation of these and other types of measures has in the past, and could in the future, result in substantial reductions in our revenue and operating margins. For a discussion of historic adjustments and recent changes to the Medicare program and other reimbursement rates, see Part I, Item 1A </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> under the headings Risks Related to Our Business and Industry.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient Protection and Affordable Care Act</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various healthcare reform provisions became law upon enactment of the Patient Protection and Affordable Care Act (ACA). The reforms contained in the ACA have affected our independent subsidiaries in some manner and are directed in large part at increased quality and cost reductions.&#160;Several of the reforms are very significant and could ultimately change the nature of our services, the methods of payment for our services and the underlying regulatory environment. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IRA, which continued and expanded certain provisions of the ACA, extended the premium subsidies paid by the federal government, until the end of 2024, resulting in subsidies being available to offset or reduce the costs of private health insurance policies for qualifying individuals. This may aid older patients in obtaining or keeping their health insurance in order to pay for long-term care services. The CAA 2023 revised the funds available to fund Medicare in 2023 and deferred the PAYGO sequestration of Medicare expenses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the presidential administration may significantly alter the current health care regulatory framework, payment activity, and impact our business and the health care industry, including any repeals, curtailments, extensions or expansions of certain ACA provisions, included, but not limited to recent rulemaking activity regarding ACA Section 1557's anti-discrimination provisions. We continually monitor these developments so we can respond to the changing regulatory environment impacting our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements of Participation</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has requirements that providers, including SNFs, must meet in order to participate in the Medicare and Medicaid Programs. Some of these requirements can be burdensome and costly. One such requirement of participation in the Medicare and Medicaid programs involves limitations around the use of pre-dispute, binding arbitration agreements by SNFs. CMS has issued guidance and direction around arbitration that must be satisfied for any agreement to be enforceable and which may result in adverse consequences for our business if not followed. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phase 2 and 3 of the Requirements of Participation focuses on: (1) resident abuse and neglect; (2) admission, transfer and discharge; (3) mental health and substance abuse disorders; (4) staffing sufficiency; (5) residents&#8217; rights; (6) potential inaccurate diagnoses or assessments; (7) prescription and use of pharmaceuticals; (8) infection prevention and control; (9) arbitration of disputes between facilities and residents; (10) psychosocial outcomes and related severity; and (11) the timeliness and completion of state investigations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, CMS updated the Medicare Requirements of Participation for SNFs, to modify the requirements associated with a facility's physical environment to minimize unnecessary renovation expenses and avoid closure of SNFs due to the related expense. CMS "grandfathered" certain facilities and will allow SNFs that were participating in Medicare before July 5, 2016 and that previously used the Fire Safety Evaluation System (FSES) to continue using the 2001 FSES mandatory values when determining compliance with applicable standards. CMS also updated the Requirements of Participation to revise existing qualification requirements for directors of food and nutrition services in SNFs, while "grandfathering" in directors with two or more years of experience and certain minimum training in food safety so they may continue in that role without satisfying further educational requirements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, CMS revised the survey resources that CMS and state surveyors use in evaluating SNFs&#8217; compliance with federal Requirements for Participation. This revision incorporated changes to CMS&#8217;s focused infection control survey item, which CMS had removed in favor of standard infection control survey measures. These updates provided more information for state surveyors to utilize when evaluating SNFs&#8217; compliance with the Medicare Requirements of Participation, as well as included guidance for facilities on operationalizing compliance with these requirements based on how surveyors would measure and evaluate facility performance. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Civil and Criminal Fraud and Abuse Laws and Enforcement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various complex federal and state laws exist which govern a wide array of referrals, relationships and arrangements, and prohibit fraud by healthcare providers. Governmental agencies are devoting increasing attention and resources to such anti-fraud efforts. The Balanced Budget Act of 1997 expanded the penalties for healthcare fraud. Additionally, the government or those acting on its behalf may bring an action under the FCA, alleging that a healthcare provider has defrauded the government by submitting a claim for items or services not rendered as claimed, which may include coding errors, billing for services not provided and submitting false or erroneous cost reports. The FCA clarifies that if an item or service is provided in violation of the AKS, the claim submitted for those items or services is a false claim that may be prosecuted under the FCA as a false claim. Under the qui tam or &#8220;whistleblower&#8221; provisions of the FCA, a private individual with knowledge of fraud may bring a claim on behalf of the federal government and receive a percentage of the federal government&#8217;s recovery. The Biden-Harris Administration had also signaled an increasing focus on nursing home performance and the reimbursement nursing homes receive from federal healthcare payment programs. The change in the presidency following the 2024 presidential elections may result in a change to this focus, in whole or in part. There has not yet been public disclosure of the priorities of the new Presidential Administration, in addition to those of the anticipated new leaders of HHS and CMS, as they relate to SNFs and long-term care facilities. Many states also have a false claim prohibition that mirrors or closely tracks the federal FCA.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal law also provides that the OIG has the authority to exclude individuals and entities from federally funded health care programs on a number of grounds, including, but not limited to, certain types of criminal offenses, licensure revocations or suspensions and exclusion from state or other federal healthcare programs. CMS can recover overpayments from health care providers up to six years following the year in which payment was made. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2021, the OIG released the result of an audit finding that Medicare overpaid millions of dollars for chronic care management (CCM) services. The OIG's 2021 report found that in calendar years 2017 and 2018, Medicare overpaid millions of dollars in CCM claims. In 2022, the OIG released an audit revealing that CMS had not collected $226 million, or 45%, of identified overpayments within that period, potentially affecting SNFs. These investigatory actions by OIG demonstrate its increased scrutiny into post-hospital SNF care provided to beneficiaries and may encourage additional oversight or stricter compliance standards. In 2023, representatives of the DOJ speaking at certain industry events, including the American Health Law Association&#8217;s Fraud and Compliance Forum, have indicated that its healthcare enforcement trends would emphasize opioid prescribing, Medicare Advantage and managed care plan fraud, and COVID-19 related fraud, including under various relief programs available during and in conjunction with the pandemic. In November of 2023, OIG added to its work plan an audit of nursing homes' nurse staffing hours reported in CMS's payroll-based journal, for which OIG expects to issue a report in FY 2025. In addition, the OIG identified the following areas as its "key goals" for oversight: (1) protecting residents from fraud, abuse, neglect, and promoting quality of care; (2) promoting emergency preparedness and emergency response efforts: (3) strengthening frontline oversight; and (4) supporting federal monitoring of nursing homes to mitigate risks to residents. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February of 2024, the OIG added to its work plan a study regarding the use of the National Background Check Program (NBCP) in conducting background checks of prospective long-term care provider employees. The purpose of this study will be to prepare a report regarding the cost of background checks, number of applicants who received background checks, and disqualification of employees during and after NBCP participation. This report will also include information regarding the cost of background checks and any unintended consequences experienced as a result of using this program. In April of 2024, the OIG updated its work plan to study and determine whether and how states used Medicaid supplemental payments for use in satisfying the state&#8217;s obligations to pay nursing facilities any amounts due under the state&#8217;s nursing facility upper payment limit. The OIG further updated its work plan in June 2024 to study and assess the implementation of the Special Focus Facility Program for nursing facilities based on facilities that participated in the program from 2013 through 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model, is based in part on serving higher acuity patients. Over time our overall patient mix has consistently shifted to higher acuity in most facilities we operate. We also use specialized care-delivery software that assists our caregivers in more accurately capturing and recording services in order to, among other things, increase reimbursement to levels appropriate for the care actually delivered. These efforts may place us under greater scrutiny with the OIG, CMS, our fiscal intermediaries, recovery audit contractors and others. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal Healthcare Reform</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Five-Star Quality Reporting Metrics </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Quality Payment Program (QPP) was created under the Medicare Access and Children's Health Insurance Program (CHIP) Reauthorization Act of 2015. This program was based on the Merit-based Incentive Payment System (MIPS) or the use of Alternative Payment Models (APM), which relied on quality data CMS gathered and evaluated using the Five-Star Quality Rating system, which includes a rating of one to five in various categories. These categories include (but are not limited to) the results of surveys conducted by state inspectors, other health inspection outcomes, staffing, spending, readmissions and stay durations; the data collected and its weighting in determining a rating on a scale of one to five stars is subject to periodic and ongoing revision, re-balancing and adjustment by CMS to reflect market conditions and CMS&#8217;s priorities in patient care. Since 2020, CMS&#8217;s measurement of the data reported by providers, including SNFs, has become more competitive and resulted in a reduction of four- and five-star rankings available under CMS&#8217;s Five-Star Quality Rating system. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Five-Star Quality reporting system for nursing homes is displayed on CMS's consumer-based Nursing Home Compare website, along with a consumer alert icon next to nursing homes that have been cited for incidents of abuse, neglect, or exploitation on the Nursing Home Compare website. The Nursing Home Compare website is updated monthly with CMS&#8217;s refresh of survey inspection results on that website. Additionally, in 2022, the Nursing Home Compare website began publishing the ownership information for Medicare-enrolled nursing facilities based on disclosures made to CMS from 2016 through 2022 due to mergers, acquisitions, or other changes in ownership, to allow for the identification of common ownership of nursing facilities. In addition, the Five Star Quality Ratings incorporated staffing data such as staff tenure and SNF weekend staffing beginning with the October 2022 refresh of the Nursing Home Compare website. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July of 2024, CMS updated the Nursing Home Five-Star Quality Rating System&#8217;s Technical Users&#8217; Guide to identify and explain a change in staffing case-mix methodology to adopt a model based on PDPM, changing the measures that CMS previously froze in April of 2024. This update to the Technical Users&#8217; Guide also extended the gap period (during which no work hours are reported) for defining nurse staffing turnover from 60 days to 90 days. As a result of this update, for the three staffing turnover measures, individuals who no longer work in the nursing home are defined as eligible individuals who have a period of at least 90 consecutive days in which they do not work at all, increased from 60 days. CMS also updated the risk-adjustment models for the four claims-based measures to reflect measures of functional abilities and goals, rather than residents&#8217; functional status. Finally, CMS revised the thresholds for the staffing measures and claims-based quality measures to maintain the same distribution by points for affected staffing and quality measures, maintaining the same proportions of available five- and four-star ratings for facilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April of 2024, CMS updated its Nursing Home Five-Star Quality Rating System&#8217;s Technical Users&#8217; Guide in several respects. First, CMS froze four of the quality measures from any changes: (1) percentage of residents who made improvements in function (short stay); (2) percentage of residents whose need for help with activities of daily living has increased (long stay); (3) percentage of residents whose ability to move independently worsened (long stay); and (4) percentage of high-risk residents with pressure ulcers (long stay). All of these measures will be frozen until January 2025, while the short-stay functional improvement measure is replaced in October of 2024 with a new cross-setting function measure used in the SNF QRP. CMS also updated the staffing level case-mix adjustment methodology and froze three staffing level measures until July of 2024: (1) adjusted RN staffing (HPRD); (2) adjusted total nurse staffing (HPRD); and (3) adjusted total nurse staffing on weekends (HPRD). These frozen measures will not affect staff turnover measures.  Additionally, beginning in April of 2024, CMS revised the staffing rating methodology to give the lowest possible score for staffing turnover measures to providers who fail to submit staffing data or submit erroneous data.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, CMS revised the nursing-home level exclusion criteria used on the administrator turnover measure, adding information regarding the staff turnover measure and an updated ratings table, which identifies the points needed for each nursing facility to obtain certain star ratings. Under these guidelines, only 10% of nursing facilities can receive a five-star rating in the state where it operates, with the bottom 20% receiving a one-star rating and the remaining 70% receiving a distribution of two-, three-, and four-star ratings.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State Legislation Concerning Nursing Home Supervision</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> California passed into law a bill which changes the limitations, or &#8220;caps,&#8221; on non-economic damages that can be awarded in medical negligence cases filed against healthcare providers (including skilled nursing and long-term care facilities). Beginning on January 1, 2023, non-economic damages (i.e., pain and suffering) available to plaintiffs suing healthcare providers in medical malpractice and professional negligence cases increased from $0.25 million to $0.35 million, and will then increase over the following ten years up to a $0.75 million cap. Once the limit reaches $0.75 million, a 2% annual inflationary adjustment will attach beginning on January 1, 2034. In wrongful death cases that arise from claims of medical malpractice and professional negligence, the cap on non-economic damages increased from $0.25 million to $0.50 million on January 1, 2023, and increase every year thereafter for ten years until the cap on non-economic damages in such cases is $1.0 million; thereafter, this cap will also be subject to an annual 2.0% increase. The caps are separate as to each claim, meaning that there is one cap for negligence and one cap for wrongful death. The new limits on non-economic damages apply prospectively to lawsuits filed on and after January 1, 2023.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, California&#8217;s Governor signed into law the Skilled Nursing Facility Ownership and Management Reform Act of 2022. This law increases the oversight authority of the California Department of Public Health, and changes several provisions regarding SNF licensing in the State of California. This includes eliminating previous regulatory provisions that permitted SNFs to operate in advance of receiving their formal license from the State. This law also requires SNF license applicants to disclose additional information in connection with a license application and evaluates more data regarding the applicant&#8217;s prior operations, including prior citations, CMS sanctions and legal proceedings against the applicant or other facilities owned or managed by the applicant before issuing a license.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States Supreme Court Decisions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; On June 28, 2024, the United States Supreme Court issued its opinion in</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Loper Bright Enterprises v. Raimondo</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, deciding to vacate and remand decisions by the United States Courts of Appeals that relied on the Supreme Court&#8217;s own 1984 precedent in </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chevron U.S.A. Inc. v. Natural Resources Defense Council, Inc.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which sometimes required courts to defer to &#8220;permissible&#8221; agency interpretations of the statutes those agencies administered and enforced&#8212;a legal doctrine known as the &#8220;Chevron doctrine.&#8221; In </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Loper</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Supreme Court had to decide whether it should overrule or clarify the Chevron doctrine based on its application more than 40 years after its creation, and the Supreme Court chose to overrule it.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Chevron doctrine required courts to use a two-step process to interpret statutes administered by federal agencies. After determining that the Chevron doctrine may apply to a dispute before it, a federal court must assess whether Congress has directly spoken to the precise question at issue. If (and only if) the congressional intent of the statute is clear, that is the end of the inquiry as to the statute&#8217;s meaning. If the court determines that the statute is silent or ambiguous regarding the issue at hand, then the Chevron doctrine requires the court to defer to the agency&#8217;s interpretation if it &#8220;is based on a permissible construction of the statute.&#8221;</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Supreme Court&#8217;s Loper decision found that the Chevron doctrine is incompatible with the federal Administrative Procedure Act&#8217;s requirement for courts to exercise their independent judgment in deciding whether a federal agency has acted within its statutory authority. It further held that courts may not defer to an agency interpretation of a statute merely because the statute is ambiguous, as it is the responsibility of the court, rather than an agency that administers or acts under a statute, to discern the statute&#8217;s meaning. The Supreme Court reasoned that allowing agencies to interpret the laws they enforce or act under, rather than reserving that activity for the courts, was an impermissible delegation of an activity reserved to the courts.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the decisions at issue in Loper pertained to fishing regulations promulgated by the Department of Commerce, the Chevron doctrine&#8217;s significance to the highly regulated field of healthcare is profound. The Chevron doctrine is frequently implicated in litigation over healthcare regulation, ranging from rules concerning staffing requirements and the validity of arbitration provisions, to requirements for healthcare workers to be vaccinated. Subsequent analysis has focused on the limits of the Loper decision, including any deference that courts may still afford to administrative agencies when based on agency fact-finding and policy-making, particularly where such power is expressly delegated to the agency by statute. The Loper decision likely will have significant and lasting consequences for the promulgation and enforcement of federal regulations by HHS and CMS, and may bear on the depth and detail of future legislation that is passed and enacted as statutes by Congress so that such laws can be enforced without administrative rulemaking or agency enforcement mechanisms.</span></div><div style="margin-top:9pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Monitoring Compliance in Our Independent Subsidiaries</span><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:115%">&#160;</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental agencies and other authorities periodically inspect our independent subsidiaries to assess compliance with various standards, rules and regulations, with potential fines, sanctions and other penalties for noncompliance. Unannounced surveys or inspections generally occur at least annually and may also follow a government agency's receipt of a complaint about a facility. Facilities must pass these inspections to maintain licensure under state law, to obtain or maintain certification under the Medicare and Medicaid programs, to continue participation in the Veterans Administration program at some facilities, and to comply with provider contracts with managed care clients at many facilities. From time to time, our independent subsidiaries, like others in the healthcare industry, may receive notices from federal and state regulatory agencies of an alleged failure to substantially comply with applicable standards, rules or regulations. These notices may require corrective action, may impose civil monetary penalties for noncompliance, and may threaten or impose other operating restrictions on SNFs such as admission holds, provisional skilled nursing license, or increased staffing requirements. If our independent subsidiaries fail to comply with these directives or otherwise fail to comply substantially with licensure and certification laws, rules and regulations, the facility could lose its certification as a Medicare or Medicaid provider, or lose its license permitting operation in the State.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Facilities with otherwise acceptable regulatory histories generally are given an opportunity to correct deficiencies and continue their participation in the Medicare and Medicaid programs by a certain date, usually within six months of inspection; however, although where denial of payment remedies are asserted, such interim remedies go into effect much sooner. Facilities with deficiencies that immediately jeopardize patient health and safety and those that are classified as poor performing facilities, however, may not be given an opportunity to correct their deficiencies prior to the imposition of remedies and other enforcement actions. Moreover, facilities with poor regulatory histories continue to be classified by CMS as poor performing facilities notwithstanding any intervening change in ownership, unless the new owner obtains a new Medicare provider agreement instead of assuming the facility's existing agreement. However, new owners nearly always assume the existing Medicare provider agreement due to the difficulty and time delays generally associated with obtaining new Medicare certifications, especially in previously certified locations with sub-par operating histories. Accordingly, facilities that have poor regulatory histories before acquisition by our independent subsidiaries and that develop new deficiencies after acquisition are more likely to have sanctions imposed upon them by CMS or state regulators.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, CMS has increased its focus on facilities with a history of serious or sustained quality of care problems through the Special Focus Facility (SFF) program. SFFs receive heightened scrutiny and more frequent regulatory surveys. Failure to improve the quality of care can result in fines and termination from participation in Medicare and Medicaid. A facility &#8220;graduates&#8221; from the SFF program once it demonstrates significant improvements in quality of care that are continued over a defined period of time. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, CMS increased penalties for SFFs that fail to improve their performance upon further inspection by CMS, increasing the standards SFFs must meet to graduate from the SFF program, maintaining heightened oversight of any SFF for a period of three years after it graduates and increasing the technical assistance CMS provides to SFFs. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanctions such as denial of payment for new admissions often are scheduled to go into effect before surveyors return to verify compliance. Generally, if the surveyors confirm that the facility is in compliance upon their re-evaluation, the sanctions never take effect. However, if they determine that the facility is not in compliance, the denial of payment goes into effect retroactive to the date given in the original notice, leaving operators with the task of deciding whether to continue accepting patients after the potential denial of payment date--risking the retroactive denial of revenue. Some of our independent subsidiaries have been or will be in denial of payment status due to findings of continued regulatory deficiencies, resulting in an actual loss of revenue associated with patients admitted after the denial of payment date. Additional sanctions could ensue and, if imposed, could include various remedies up to and including decertification.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has undertaken several initiatives to increase or intensify Medicaid and Medicare survey and enforcement activities, including federal oversight of state surveyors. CMS is taking steps to focus more survey and enforcement efforts on facilities with findings of substandard care or repeat violations of Medicaid and Medicare standards and to identify multi-facility providers with patterns of noncompliance. CMS is also increasing its oversight of state survey agencies and requiring state agencies to use enforcement sanctions and remedies more promptly when substandard care or repeat violations are identified, to investigate complaints more promptly, and to survey facilities more consistently. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations Regarding Financial Arrangements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to federal and state laws that regulate financial arrangement by and between healthcare providers, such as the federal and state anti-kickback laws, the Stark laws, and various state anti-referral laws.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Social Security Act prohibits the knowing and willful offer, payment, solicitation, or receipt of any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce the referral of an individual, in return for recommending, or to arrange for, the referral of an individual for any item or service payable under any federal healthcare program, including Medicare or Medicaid. The OIG has issued regulations that create &#8220;safe harbors&#8221; for certain conduct and business relationships that are deemed protected under the Social Security Act. In order to receive safe harbor protection, all of the requirements of a safe harbor must be met. The fact that a given business arrangement does not fall within one of these safe harbors does not render the arrangement per se illegal. Business arrangements of healthcare service providers that fail to satisfy the applicable safe harbor criteria, if investigated, will be evaluated on a case-by-case basis based upon all facts and circumstances and risk increased scrutiny and possible sanctions by enforcement authorities. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the Social Security Act can result in inflation-adjusted criminal penalties of more than $0.1 million and ten years imprisonment. It can also result in inflation-adjusted civil monetary penalties of more than $0.1 million per violation and an assessment of up to three times the total amount of remuneration offered, paid, solicited, or received. It may also result in an individual's or organization's exclusion from future participation in federal healthcare programs. State Medicaid programs are required to enact an anti-kickback statute. Many states in which our independent subsidiaries operate have adopted or are considering similar legislative proposals, some of which extend beyond that state's Medicaid program, to prohibit the payment or receipt of remuneration for the referral of patients regardless of the source of payment for the care. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the "Stark Law" of the Social Security Act provides that a physician may not refer a Medicare or Medicaid patient for a &#8220;designated health service&#8221; to an entity with which the physician or an immediate family member has a financial relationship unless the financial arrangement meets an exception under the Stark Law or its regulations. Designated health services include, in relevant part, inpatient and outpatient hospital services, PT, OT, SLP, durable medical equipment, prosthetics, orthotics and supplies, diagnostic imaging, and home health services. Under the Stark Law, a &#8220;financial relationship&#8221; is defined as an ownership or investment interest or a compensation arrangement. If such a financial relationship exists and does not meet a Stark Law exception, the entity is disallowed from seeking payment under the Medicare or Medicaid programs or from collecting from the patient or other payor. Statutory and regulatory exceptions and exemptions to this exist and have specific rules that must be followed to qualify for such exception or exemption. Any funds collected for an item or service resulting from a referral that violates the Stark Law are not eligible for payment by federal healthcare programs and must be repaid. Violations of the Stark Law may result in the imposition of civil monetary penalties, including, treble damages. Individuals and organizations may also be excluded from participation in federal healthcare programs for Stark Law violations. Many states have enacted healthcare provider referral laws that go beyond physician self-referrals or apply to a greater range of services than just the designated health services under the Stark Law. </span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations Regarding Patient Record Confidentiality</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health care providers are also subject to laws and regulations enacted to protect the confidentiality of patient health information and patients' right to access such information. For example, HHS has issued rules pursuant to HIPAA, including the Health Information Technology for Economic and Clinical Health (HITECH) Act which governs our use and disclosure of protected health information of patients. We and our independent subsidiaries have established policies and procedures to comply with HIPAA privacy and security requirements and our independent subsidiaries have adopted and implemented HIPAA compliance plans, which we believe comply with the HIPAA privacy and security regulations, which impose significant costs for ongoing compliance activities. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous other laws and legislative and regulatory initiatives at the federal and state levels addressing privacy and security concerns. Our independent subsidiaries are also subject to any federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 17, 2024, CMS published the CMS Interoperability and Prior Authorization Final Rule (Interoperability Final Rule), which affects the data standards and application programming interfaces (APIs) used by entities that are payors for our services, including but not limited to Medicare Advantage organizations, Medicaid fee-for-service providers, and managed care organizations. This new rule requires these payor entities to adopt new patient access APIs beginning January 1, 2026, and to complete implementation of both patient and provider access APIs by January 1, 2027, to facilitate the sharing of payor information with payors and providers. While the purpose of this final rule is predominantly oriented to sharing information in the clinical setting and expediting the exchange of prior authorization data, this new rule may have implications for our business and how information is shared among our independent subsidiaries that participate in these programs, the payors, residents, and residents&#8217; families involved in their care.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Antitrust Laws&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to federal and state antitrust laws. Enforcement of the antitrust laws against healthcare providers is common, and antitrust liability may arise in a wide variety of circumstances, including third party contracting, physician relations, joint venture, merger, affiliation and acquisition activities. On February 3, 2023, the DOJ&#8217;s Antitrust Division withdrew its support for three policies that had been jointly created by the DOJ and the Federal Trade Commission (FTC) in 1993, 1996, and 2011, announcing instead, without providing further alternative guidance, that the DOJ would take a case-by-case enforcement approach to evaluate conduct in the healthcare industry, citing that the previous policies were outdated and overly permissive. Similarly, on July 14, 2023, the FTC withdrew two antitrust policy statements related to enforcement in healthcare markets. Moving forward, the FTC will evaluate mergers and conduct in healthcare markets on a case-by-case basis using principles of antitrust enforcement and competition policy. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 19, 2023, the DOJ and FTC released a draft joint statement of antitrust policy that outlines 13 guidelines to be used when determining if a merger is unlawfully anticompetitive under antitrust laws. These guidelines cover various aspects of antitrust enforcement relevant to SNF and senior living facilities, such as market concentration, competition between firms, risk of coordination, elimination of potential entrants, control of products or services, vertical mergers, dominant positions, trends toward concentration, series of multiple acquisitions, multi-sided platforms, competing buyers, partial ownership or minority interests and overall impact on competition. The draft joint statement also includes detailed sections on the application of the guidelines, defining relevant markets and approaches to rebuttal evidence. These proposed statements are not exhaustive and the DOJ and FTC may focus on one or multiple guidelines depending on the specific circumstances of each merger. These proposed general statements of antitrust policy, once finalized, may be a prelude to a new joint statement of healthcare antitrust policy of the DOJ and FTC, with the agencies&#8217; finalized general statements providing insight into whether healthcare-specific statements will be issued. This development and potential new guidance regarding DOJ and FTC antitrust policy increases risk and uncertainty regarding transactions that may be subject to criminal and civil enforcement by federal and state agencies, as well as by private litigants. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further change is expected with respect to the DOJ and FTC&#8217;s antitrust policies due to the outcome of the 2024 presidential election, including as to how they relate to healthcare. As a result, these changes to the DOJ and FTC&#8217;s antitrust policies may be changed materially, not implemented, or reverted to prior statements that were withdrawn in February of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Americans with Disabilities Act (ADA)</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent subsidiaries must also comply with the ADA, and similar state and local laws to the extent that the facilities are "public accommodations" as defined in those laws. The obligation to comply with the ADA and other similar laws is an ongoing obligation, and the independent subsidiaries continue to assess their facilities relative to ADA compliance and make appropriate modifications as needed.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Civil Rights </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 25, 2024, the Office for Civil Rights (OCR) for HHS issued guidance to hospitals and long-term care facilities, emphasizing their obligation under CMS regulations to ensure non-discriminatory visitation policies, especially during public health emergencies. This guidance, part of the U.S. National Strategy to Counter Antisemitism, clarifies that these facilities cannot discriminate based on religion or other classes or characteristics protected against discrimination under federal civil rights laws. The guidance includes examples where non-compliance occurred, such as unequal treatment based on religious affiliation or dietary restrictions, and stricter screening processes for certain religious groups. OCR offers assistance to facilities to obtain compliance with these standards and encourages residents and other affected individuals to file complaints with OCR for potential administrative or civil action in cases of civil rights violations. OCR has been increasingly involved in the monitoring and enforcement of patient and resident rights, particularly under ongoing rulemaking under Section 1557 of the ACA.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Real Estate Investment Trust (REIT) Qualification</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected for Standard Bearer to be taxed as a REIT for U.S. federal income tax purposes. Standard Bearer's qualification as a REIT will depend upon its ability to meet, on a continuing basis, various complex requirements under the Internal Revenue Code, relating to, among other things, the sources of its gross income, the composition and value of its assets, distribution levels to its shareholders and the concentration of ownership of its capital stock. We believe that Standard Bearer is organized in conformity with the requirements for qualification and taxation as a REIT under the Code and that its manner of operation has and will enable it to continue to meet the requirements for qualification and taxation as a REIT. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGULATIONS SPECIFIC TO SENIOR LIVING COMMUNITIES AND ANCILLARY SERVICES </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously mentioned, senior living services revenue, which accounted for 2.1% of total revenue, is primarily derived from private pay residents and senior living revenue derived from Medicaid funds. Thus, some of the regulations discussed above applicable to Medicaid providers, also apply to senior living.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of states provide, or are approved to provide, Medicaid payments for personal care and medical services to some residents in licensed senior living communities. As rates paid to senior living community operators are generally lower than rates paid to SNF operators, some states use Medicaid funding of senior living services as a means of lowering the cost of services for residents who may not need the higher level of health services provided in SNFs. States that administer Medicaid programs for services in senior living communities are responsible for monitoring the participating communities and, as a result of the growth of senior living in recent years, these states have adopted licensing standards applicable to senior living communities. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has continued to commence a series of actions to increase its oversight of state quality assurance programs for senior living communities and has provided guidance and technical assistance to states to improve their ability to monitor and improve the quality of services paid through Medicaid waiver programs. CMS is encouraging state Medicaid programs to expand their use of home and community-based services as alternatives to facility-based services, pursuant to provisions of the ACA, and other authorities, through the use of several programs. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The types of laws and statutes affecting the regulatory landscape of the post-acute industry continue to expand and the pressure to enforce those laws by federal and state authorities continues to grow as well. In order to operate our businesses, we and our independent subsidiaries must comply with federal, state and local laws from healthcare including provisions regarding patient safety, staffing, and prescription drugs to environmental issues. Changes in the law or new interpretations of existing laws may have an adverse impact on our methods and costs of doing business.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_418"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL MATTERS </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strive to reduce our environmental impact through initiatives to modernize our facilities, conserve water, optimize waste, work towards a paperless office and partner with green vendors. Our ongoing and planned facility modernization initiatives include solar projects, heating, ventilation and air condition (HVAC) upgrades, water systems updates, lighting retrofits and utility upgrades. Additionally, we track and evaluate the utilities used by our facilities to drive our initiatives. For the year ended December 31, 2024, we spent $158.2 million on purchases of property improvements and equipment which included facility modernization initiatives. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management and Strategy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identify and assess environmental risk to the organization by: </span></div><div style="margin-bottom:3pt;margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Conducting assessments of transition risks, which are risks related to the transition to a lower-carbon economy, and physical risks, which are risks related to the physical impacts of climate change.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Identifying climate-related opportunities, which includes programs to reduce electricity usage and carbon emissions at our independent subsidiaries. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Identifying the potential financial impact of transition risks, physical risks and climate-related opportunities.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Developing and implementing our strategy, which focuses on monitoring environmental policy and on-going developments, ensuring community resiliency, evaluating usage of energy management systems, building operational and emergency response systems, performing hazard vulnerability assessments and tracking and responding to developing natural disasters. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governance</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensign's environmental management team (EMT) is part of our ESG Committee. The EMT is led by the Service Center's leadership team members including Construction and Asset Development as well as its Executive Management. The EMT is responsible for:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Implementation and continuous execution of our environment management system and policy.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Development of the Company's environmental management policy.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Identification of climate related risks under the Task Force on Climate-Related Financial Disclosures framework.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Providing structure and support to our independent subsidiaries that are led by local operators to make decisions on their capital expenditure projects at their facilities. The team advises our local field operators on best practices and identifies opportunities for them to assess priorities of projects. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Overseeing environmental programs which include the evaluation and installation of LED lighting, solar panel, improved doors and insulation, automated HVAC controls and thermal efficiency projects related to micro-turbine, and demand control ventilation to name a few.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Development of targets for reduction of carbon emissions, and increase ENERGY STAR scores.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Tracking and monitoring of currently available environmental metrics such as utility usage and development of an energy management system that tracks greenhouse gas emissions and more. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Preparing for applicable environmental audits in the future. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to a variety of federal, state and local environmental laws and regulations. As a healthcare provider, we face regulatory requirements in areas of air and water quality control, medical and low-level radioactive waste management and disposal, asbestos management, response to mold and lead-based paint in our facilities and employee safety.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an owner or operator of our facilities, we also may be required to investigate and remediate hazardous substances that are located on and/or under the property, including any such substances that may have migrated off, or may have been discharged or transported from the property. Part of our operations involves the handling, use, storage, transportation, disposal and discharge of medical, biological, infectious, toxic, flammable and other hazardous materials, wastes, pollutants or contaminants. In addition, we are sometimes unable to determine with certainty whether prior uses of our facilities and properties or surrounding properties may have produced continuing environmental contamination or noncompliance, particularly where the timing or cost of making such determinations is not deemed cost-effective. These activities, as well as the possible presence of such materials in, on and under our properties, may result in damage to individuals, property or the environment; may interrupt operations or increase costs; may result in legal liability, damages, injunctions or fines; may result in investigations, administrative proceedings, penalties or other governmental agency actions; and may not be covered by insurance.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are in material compliance with applicable environmental and occupational health and safety requirements. However, we cannot assure you that we will not encounter liabilities with respect to these regulations in the future, and such liabilities may result in material adverse consequences to our operations or financial condition.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on the EMT and our environmental sustainability efforts, please see our ESG report, which is available on our website at www.ensigngroup.net. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AVAILABLE INFORMATION </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the reporting requirements under the Securities Exchange Act of 1934, as amended (the Exchange Act). Consequently, we are required to file reports and information with the Securities and Exchange Commission (SEC), including reports on the following forms: annual reports on Form&#160;10-K, quarterly reports on Form&#160;10-Q, current reports on Form&#160;8-K, and amendments to those reports filed or furnished pursuant to Section&#160;13(a) or 15(d) of the Exchange Act. These reports, proxy and information statements and other information concerning our company may be accessed through the SEC's website at http://www.sec.gov.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may also find on our website at www.ensigngroup.net, electronic copies of our annual reports on Form&#160;10-K, quarterly reports on Form&#160;10-Q, current reports on Form&#160;8-K and amendments to those reports filed or furnished pursuant to Section&#160;13(a) or 15(d) of the Exchange Act. Such filings are placed on our website as soon as reasonably possible after they are filed with the SEC. All such filings are available free of charge. The information contained in, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 10-K.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_367"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. RISK FACTORS </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are providing the following summary of the risk factors contained in our Form 10-K to enhance the readability and accessibility of our risk factor disclosures. We encourage our stockholders to carefully review the risk factors contained in this Form 10-K in their entirety for additional information regarding the risks and uncertainties that could cause our actual results to vary materially from recent results or from our anticipated future results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to our Business and Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:10.2pt">The rules of Medicare and Medicaid, including reductions of reimbursement rates, changes to spending requirements, data reporting, measurement and evaluation standards could have a material, adverse effect on our revenues, financial condition and results of operations.</span></div><div style="padding-left:12.67pt;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:9.42pt">State-level direct spending requirements could negatively impact our results of operations.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Changes to the U.S. healthcare system, including changes to the ACA or its regulations, new transparency and disclosure requirements, and federal and state standards for minimum nurse staffing levels, continue to impose new requirements upon us that could materially impact our business.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Anticipated changes in the U.S. political environment, including those as a result of the change in Presidential administration and control of Congress, and to regulatory agencies, particularly HHS, may result in significant changes to the regulatory framework, enforcement, and reimbursements in our industry.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">We are subject to various government reviews, audits and investigations that could adversely affect our business, including an obligation to refund amounts previously paid to us, potential criminal charges, loss of licensure, the imposition of fines and sanctions.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">We are subject to extensive and complex laws and government regulations. If we are not operating in compliance with these laws and regulations or if these laws and regulations change, we could be required to make significant expenditures or change our operations in order to bring our facilities and operations into compliance. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Public and government calls for increased enforcement efforts toward SNFs, past and potential rulemaking that results in enhanced enforcement and penalties, and new guidance for surveyors regarding the review of SNFs and enforcement of their Requirements of Participation, could result in increased scrutiny by state and federal survey agencies, including sanctions that could negatively affect our financial condition and results of operations.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">CMS&#8217;s changes to the SFF program and its look-back period may create greater risk of our facilities being subject to this program and subject to potential fines and sanctions, even after graduating from the SFF program.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Federal minimum staffing mandates may adversely affect our labor costs, ability to maintain desired levels of patient or resident capacity, and profitability.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Future cost containment initiatives undertaken by payors may limit our revenue and profitability.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Reductions in Medicare reimbursements for physician and non-physician services could impact reimbursement for medical professionals.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">We may be subject to increased investigation and enforcement activities related to HIPAA violations.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Security breaches and other cyber-security incidents could violate security laws and subject us to significant liability.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">If our independent subsidiaries are not fully reimbursed for all services for which each facility bills through consolidated billing, our revenue, financial condition and results of operations could be adversely affected. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Increased competition for, or a shortage of, nurses and other skilled personnel, could increase our staffing and labor costs and subject us to monetary fines resulting from a failure to maintain minimum staffing requirements, or may affect reimbursement.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Annual caps, uncertainty regarding reimbursement and other cost-reductions for outpatient therapy services may reduce our future revenue and profitability or cause us to incur losses.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Increased scrutiny of our activities and billing practices by the OIG or other regulatory authorities may result in an increase in regulatory monitoring and oversight, decreased reimbursement rates, or otherwise adversely affect our business, financial condition and results of operations. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">State efforts to regulate or deregulate the healthcare services industry or the construction or expansion of healthcare facilities could impair our ability to expand our operations, or could result in increased competition.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Newly enacted legislation in the States where our independent subsidiaries are located may impact the volume and exposure in claims filed and the overall cost of those cases from a defense and indemnity standpoint. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Changes to federal and state employment-related laws and regulations could increase our cost of doing business.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Required regulatory approvals could delay or prohibit transfers of our healthcare operations, which could result in periods in which we are unable to receive reimbursement for such properties.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Compliance with federal and state fair housing, fire, safety, staffing, and other regulations may require us to incur unexpected expenses, which could be costly to us.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Our revenue, financial condition and results of operations could be negatively impacted by any changes in the acuity mix of patients in our independent subsidiaries as well as payor mix and payment methodologies.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">We are subject to litigation that could result in significant legal costs and large settlement amounts or damage awards. Similarly, a change in the enforceability of arbitration provisions between SNFs and senior living facilities and residents and patients may affect the risks we face from claims and potential litigation. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">If our regular internal investigations into the care delivery, recordkeeping and billing processes of our independent subsidiaries detect instances of noncompliance, efforts to correct such non-compliance could materially decrease our revenue.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">We may be unable to complete future facility or business acquisitions at attractive prices or at all, or may elect to dispose of underperforming or non-strategic independent subsidiaries, either of which could decrease our revenue. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">We may not be able to successfully integrate acquired facilities and businesses into our operations, or we may be exposed to costs, liabilities and regulatory issues that may adversely affect our operations. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">In undertaking acquisitions, we may be adversely impacted by costs, liabilities and regulatory issues that may adversely affect our operations.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">If we do not achieve or maintain competitive quality of care ratings from CMS or private organizations engaged in similar monitoring activities, our business may be negatively affected. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">If we are unable to obtain insurance, or if insurance becomes more costly for us to obtain, our business may be adversely affected, and our self-insurance programs may expose us to significant and unexpected costs and losses. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">The geographic concentration of our independent subsidiaries could leave us vulnerable to economic downturn, regulatory changes or acts of nature in those areas. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">The actions of a national labor union that has pursued a negative publicity campaign criticizing our business in the past may adversely affect our revenue and our profitability. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">The risks associated with leased property where our independent subsidiaries operate could adversely affect our business, financial position or results of operations. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Failure to generate sufficient cash flow to cover required payments or meet operating covenants under our long-term debt, mortgages and long-term operating leases could result in defaults under such agreements and cross-defaults under other debt, mortgage or operating lease arrangements, which could harm our independent subsidiaries and cause us to lose facilities or experience foreclosures. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">A continued housing slowdown or housing downturn could decrease demand for senior living services. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">As we continue to acquire and lease real estate assets, we may not be successful in identifying and consummating these transactions. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">As we expand our presence in other relevant healthcare industries, we would become subject to risks in a market in which we have limited experience. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">If our referral sources fail to view us as an attractive skilled nursing provider, or if our referral sources otherwise refer fewer patients, our patient base may decrease. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">We may need additional capital to fund our independent subsidiaries and finance our growth, and we may not be able to obtain it on terms acceptable to us, or at all, which may limit our ability to grow. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">The condition of the financial markets could limit the availability of debt and equity financing sources to fund the capital and liquidity requirements of our business.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Delays in reimbursement may cause liquidity problems. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">The utilization and expansion of managed care organizations may contribute to delays or reductions in our reimbursement, including Managed Medicaid.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Compliance with the regulations of the Department of Housing and Urban Development may require us to make unanticipated expenditures which could increase our costs. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Failure to safeguard our patient trust funds may subject us to citations, fines and penalties. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">We are a holding company with no operations and rely upon our multiple independent subsidiaries.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Certain directors who serve on our Board of Directors also serve as directors of Pennant, and ownership of shares of Pennant common stock by our directors and executive officers may create, or appear to create, conflicts of interest.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Standard Bearer's failure to qualify as a REIT may cause it to be subject to U.S. federal income tax. Additionally, legislative or other actions affecting REITs could have a negative effect on Standard Bearer.</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:9.42pt">Failure to comply with existing environmental laws could result in increased expenditures, litigation and potential loss to our business and in our asset value. </span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:3.6pt"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Ownership of our Common Stock</span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:9.42pt">We may not be able to pay or maintain dividends and the failure to do so would adversely affect our stock price. </span></div><div style="margin-bottom:3pt;padding-left:12.67pt;text-align:justify;text-indent:-14.4pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:9.42pt">Our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law contain provisions that could discourage transactions resulting in a change in control, which may negatively affect the market price of our common stock. </span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:3.6pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should carefully consider each of the following risk factors. The risk factors generally have been separated into two categories: risks relating to our business and our industry and risks relating to our common stock. Based on the information currently known to us, we believe that the following information identifies the most significant risk factors affecting our company in each of these categories of risks. However, the risks and uncertainties we face are not limited to those set forth in the risk factors described below. Additional risks and uncertainties not presently known to us or that we currently believe to be immaterial may also adversely affect our business. In addition, past financial performance may not be a reliable indicator of future performance and historical trends should not be used to anticipate results or trends in future periods.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">If any of the following risks and uncertainties develops into actual events, these events could have a material adverse effect on our business, financial condition or results of operations. In such case, the trading price of our common stock could decline. You should carefully read the following risk factors, together with the financial statements, related notes and other information contained in this Annual Report on Form 10-K. This Annual Report on Form 10-K contains forward-looking statements that contain risks and uncertainties. Please refer to the section entitled "Cautionary Note Regarding Forward-Looking Statements" on page [1] of this Annual Report on Form 10-K in connection with your consideration of the risk factors and other important factors that may affect future results described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">The rules of Medicare and Medicaid, including reductions of reimbursement rates, changes to spending requirements, data reporting, measurement and evaluation standards could have a material, adverse effect on our revenues, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derived 24.9% and 26.6% of our service revenue from the Medicare programs for the years ended December 31, 2024 and 2023, respectively. In addition, many other payors may use published Medicare rates as a basis for reimbursements. Accordingly, if Medicare reimbursement rates are reduced or fail to increase as quickly as our costs, if there are changes in the rules governing the Medicare program that are disadvantageous to our business or industry, or if there are delays in Medicare payments, our business and results of operations will be adversely affected. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicare program and its reimbursement rates and rules are subject to frequent change, including statutory and regulatory changes, rate adjustments (including retroactive adjustments), annual caps that limit the amount that can be paid (including deductible and coinsurance amounts), administrative or executive orders and government funding restrictions, all of which may materially adversely affect the rates at which Medicare reimburses us for our services.&#160;See Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sequestration of Medicare Rates, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further information</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Implementation of these and other types of measures has in the past and could in the future result in substantial reductions in our revenue and operating margins. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, payments can be delayed or declined due to determinations that certain costs are not reimbursable or reasonable because either adequate or additional documentation was not provided or because certain services were not covered or considered medically necessary. Additionally, revenue from these payors can be retroactively adjusted after a new examination during the claims settlement process or as a result of post-payment audits. New legislation and regulatory proposals could impose further limitations on government payments to healthcare providers.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS often changes the rules governing the Medicare program, including those governing reimbursement. Changes to the Medicare program that could adversely affect our business could include, but are not limited to the following: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">administrative or legislative changes to base rates or the bases for payment, including changes to the rates at which Medicare will reimburse services; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">limits on the services or types of providers for which Medicare will provide reimbursement; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">changes in methodology for patient assessment and/or determination of payment levels; </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">changes in staff requirements as a condition of payment or eligibility for Medicare reimbursement (See also, Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">the reduction or elimination of annual rate increases, implementation of reimbursement decreases, or the end of the reduced payments deferment (See also, Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">); and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">an increase in co-payments or deductibles payable by beneficiaries. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among the changes being implemented by CMS are provisions of the IMPACT Act, which imposes a stringent timeline for implementing benchmark quality measures and data metrics across facilities that include SNFs. The enactment mandates specific actions to design a unified payment methodology for post-acute providers, which CMS implements through ongoing regulations. The costs of final implementation may be significant, with potential fines and payment reductions resulting from a failure to meet CMS's implementation requirements.&#160; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions in reimbursement rates or the scope of services being reimbursed could have a material, adverse effect on our revenue, financial condition and results of operations or even result in reimbursement rates that are insufficient to cover our operating costs. In addition, CMS may make future adjustments to reimbursement levels and underlying reimbursement formulae as it continues to monitor the impact of current payments system on patient outcomes and budget neutrality. The Biden-Harris Administration focused on studying the nursing home industry and directed HHS to issue proposed rules based on those studies, including changes to SNF facility reimbursement and specifically, the SNF-VBP Program, which may also adversely affect our reimbursement. The change in presidency following the 2024 presidential election may result in different focuses with respect to the nursing home industry. The new Presidential Administration's policy directives and priorities regarding the nursing home industry and SNFs in particular are not yet known. These metrics potentially affecting our revenues and expenses in future government fiscal years include the SNF healthcare-associated infections (HAI) measurement, total nursing hours per resident day measures, and discharge to community - post acute care measure. The Interoperability Final Rule&#8217;s implementation beginning in 2026, and to be completed by January 1, 2027, may also adversely affect our reimbursement paid through Medicare, specifically including Medicare Advantage.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss of Medicare reimbursement, or a delay or default by the government in making Medicare payments, would also have a material adverse effect on our revenue. Non-compliance with Medicare regulations exist, and any penalty, suspension, termination, or other sanction under any state&#8217;s Medicaid program could lead to reciprocal and commensurate penalties being imposed under the Medicare program, up to termination or rescission of our Medicare participation and payor agreements as noted above. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of reimbursement for skilled nursing services comes from Medicaid. In fact, Medicaid is our largest source of revenue, accounting for 46.0%  of our revenue for both the years ended December 31, 2024 and 2023, respectively. Medicaid is a state-administered program financed by both state funds and matching federal funds. Medicaid spending has increased rapidly in recent years, becoming a significant component of state budgets, which has led both the federal government and many states to institute measures aimed at controlling the growth of Medicaid spending, and in some instances reducing aggregate Medicaid spending. Since a significant portion of our revenue is generated from our skilled nursing independent subsidiaries in California, Texas and Arizona, any budget reductions or delays in these states could adversely affect our net patient service revenue and profitability. Due to recent fluctuations in state budgets many of the states in which we operate (including those with current budget surpluses), are seeking to contain costs on Medicaid outlays for SNFs, and any such decline could adversely affect our financial condition and results of operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Medicaid program and its reimbursement rates and rules are subject to frequent change at both the federal and state level, including through changes in laws, regulations, rate adjustments (including retroactive adjustments), administrative or executive orders and government funding restrictions, all of which may materially adversely affect the rates at which our services are reimbursed by state Medicaid plans or the amount of expense we incur. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To generate funds to pay for the increasing costs of the Medicaid program, many states utilize financial arrangements commonly referred to as provider taxes. Under provider tax arrangements, states collect taxes from healthcare providers and then use the revenue to pay the providers as a Medicaid expenditure, which allows the states to then claim additional federal matching funds on the additional reimbursements. Current federal law provides for a cap on the maximum allowable provider tax as a percentage of the providers' total revenue. There can be no assurance that federal law will continue to provide matching federal funds on state Medicaid expenditures funded through provider taxes, or that the current caps on provider taxes will not be reduced. Any discontinuance or reduction in federal matching of provider tax-related Medicaid expenditures could have a significant and adverse effect on states' Medicaid expenditures, and as a result could have a material and adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State-level direct spending requirements could negatively impact our results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain states where the Company operates have implemented direct spending requirements requiring SNFs to spend a portion of their revenue, particularly including Medicaid-derived revenue, on expenses directly relating to care. These spending requirements could affect our operational results and place the Company at higher risk of suffering non-compliance consequences, such as penalties, pay-backs, restrict admissions and/or operational/financial penalties. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, Washington state incorporates the costs of direct care, indirect care, and capital expenditures for SNF services in computing the State&#8217;s Medicaid payments to nursing facilities. Using periodically updated calculations that account for factors including case acuity, fair market value of capital expenditures, inflation, and facility performance, Washington sets facility compensation so that the majority of Medicaid reimbursement paid to a skilled nursing facility is used for care-related activities, with limitations on how much a facility&#8217;s reimbursement may increase from year to year. Washington state first adopted this care-based payment model in 2015 and has periodically updated it since, including in 2020, 2022, and 2023; it is expected that Washington will continue to amend this law in the future. For state fiscal year 2024, Texas requires all nursing facilities must show that a portion of funds paid to SNFs by Texas&#8217;s Medicaid program, including both fee-for-service and managed care reimbursement, were expended for direct care activities, including direct care staff wages and benefits. In addition, California in the past has proposed bills that, if passed, would require nursing facilities to spend a stated percentage of revenue on direct patient-related services. While the most recent attempt by the California Assembly (Bill 1537) to impose direct spending requirements on SNFs has been placed in suspense with no action being taken, similar legislation in the future may seek to impose identical or analogous funding requirements for SNFs operating in California or other states.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reforms to the U.S. healthcare system, including new regulations under the ACA, continue to impose new requirements upon us that could materially impact our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in greater detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the ACA has resulted in significant changes to our operations and reimbursement models for services we provide. CMS continues to issue rules to implement the ACA, including most recently, new rules regarding the implementation of the anti-discrimination provisions and proposed rules requiring the disclosure of SNF ownership, organization, management and the identity of the real property owners from which the SNF leases or subleases its operating space. With the passage of the IRA in 2022, Congress continues to expand and supplement the ACA, including through the continuation of federally funded insurance premium subsidies. This modification of the ACA by the IRA indicates that Congress may continue to change and expand the ACA in the future. The outcome of the 2024 presidential election, which saw a change in control of both the Presidency and Senate to the Republican party, may signal further changes to the ACA, including reversing regulatory changes made under the Biden-Harris Administration.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The efficacy of the ACA is the subject of much debate among members of Congress and the public and it has been the subject of extensive litigation before numerous courts, including the United States Supreme Court, with varying outcomes &#8212; some expanding and others limiting the ACA. If the ACA is repealed or any elements of the ACA that are beneficial to our business are materially amended or changed, such as provisions regarding the health insurance industry, reimbursement and insurance coverage by payers, our business, operating results and financial condition could be harmed. Thus, the future impact of the ACA on our business is difficult to predict and its continued uncertain future may negatively impact our business.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is not possible to predict whether and when any such changes will occur, specific proposals discussed leading up to the 2024 presidential election, including a repeal or material amendment of the ACA, could harm our business, operating results and financial condition. The ACA continues to be a salient political topic and proposed changes to it may become the subject of campaign promises, litigation, administrative action, or legislation following the 2024 presidential election. In addition, even if the ACA is not amended or repealed, the President and the executive branch of the federal government, as well as CMS and HHS, have a significant impact on the implementation of the provisions of the ACA. It is expected that the incoming Presidential Administration will make changes impacting the implementation and enforcement of the ACA, which could harm our business, operating results and financial condition. We have already seen such changes with the Biden-Harris Administration's regulatory activity promulgating rules regarding anti-discrimination under Section 1557 of the ACA and recent rulemaking requiring SNFs to disclose their ownership and the ownership of service providers under Section 6101 of the ACA. It is not possible to know whether, when, or how any or all of these regulations or their implementation will be changed, the manner in which any change may be effected, and the ultimate effects of such changes on our business. If we are slow or unable to adapt to any such changes, our business, operating results and financial condition could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, CMS issued a final rule requiring SNFs to disclose certain information regarding their ownership and managerial relationships which was fully implemented in November of 2024. This final rule is more invasive and comprehensive than the ownership information already disclosed through Medicare's Nursing Home Compare website. Refer to Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. The breadth of disclosure required by this new rule may be adverse to our business interests and detrimental to our operations, revenue, and profitability and may have a chilling effect on investment due to the depth of the new reporting and transparency requirements. Similarly, California passed a comparable law requiring the disclosure of certain ownership and financial information for SNFs in 2021. On March 6, 2024, California&#8217;s regulations implementing this law took effect, which may invite further scrutiny and potential legal action, whether by the state agencies or private parties, within California based on the information disclosed as required by this law and its enabling regulations.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what effect future reforms to the U.S. healthcare system will have on our business, including the demand for our services or the amount of reimbursement available for those services. However, it is possible these new laws may lower reimbursement or increase the cost of doing business and adversely affect our business.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anticipated changes in the U.S. political environment, including those as a result of the change in Presidential administration and control of Congress, and to regulatory agencies, particularly HHS, may result in significant changes to regulatory framework, enforcements and reimbursements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the 2024 presidential election, changes in the Presidency and both houses of Congress may result in significant changes in, and have resulted in uncertainty with respect to, legislation, regulation, implementation or repeal of laws and rules related to government health programs, including Medicare and Medicaid.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, proposals regarding HHS and certain programs and regulation concerning health care, including Medicare, Medicaid, and the ACA, have indicated that the incoming Presidential Administration seeks to make changes to these programs and laws, as well as their implementation. Other pending legislation, such as the Protecting America&#8217;s Seniors&#8217; Access to Care Act and Protecting America's Rural Seniors' Access Act, which seek to halt HHS and CMS from finalizing and enforcing its proposed rule for staffing requirements, indicates a bipartisan interest in restraining HHS&#8217;s ability to finalize, implement and enforce regulations that may be burdensome on our independent subsidiaries, creating still more uncertainty and unpredictability in the legislative process.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to existing policies and rules regarding nursing facilities, including those recently instituted, in addition to anticipated new rule proposals, may result in significant regulatory changes, increased survey frequency and scope, and increased penalties for non-compliance. With the changes in the presidential administration, we anticipate that there may be changes in legislative control and legislative priorities. As a result, future legislation may be proposed or passed that may adversely affect our business, operating results and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually monitor these developments in order to respond to the changing regulatory environment impacting our business. While it is not possible to predict whether and when any such changes will occur, specific proposals discussed during and after the election, including a repeal or material amendment of the ACA or other laws affecting the provision of healthcare services, could harm our business, operating results and financial condition. If we are slow or unable to adapt to any such changes, our business, operating results and financial condition could be adversely affected.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to various government reviews, audits and investigations that could adversely affect our business, including an obligation to refund amounts previously paid to us, potential criminal charges, the imposition of fines, and/or the loss of our right to participate in Medicare and Medicaid programs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of our participation in the Medicaid and Medicare programs, we are subject to various governmental reviews, audits and investigations to verify our compliance with the rules associated with these programs and related applicable laws and regulations, including our claims for payments submitted to those programs, which are subject to reviews by Recovery Audit Contractors, Zone Program Integrity Contractors, Program Safeguard Contractors, Unified Program Integrity Contractors, Supplemental Medical Review Contractors and Medicaid Integrity Contractors programs (collectively referred to as Reviews). In these Reviews, third-party firms engaged by CMS conduct extensive analysis of claims data and medical and other records to identify potential improper payments under the federal and state programs. As discussed above, the Biden-Harris Administration has called for HHS and CMS to increase the level of scrutiny of SNF facilities and requested those agencies to adopt rules that would impose greater penalties upon non-compliant SNF operators, and this scrutiny may not change due to a change of Presidential Administration, including changes to the leadership of HHS and CMS. The SNF PPS FY 2025 Final Rule implemented increased penalties that surveyors may impose on SNFs for perceived non-compliance with CMS&#8217;s requirements for SNF participation in Medicare. In addition, in 2023, CMS updated the survey resources that CMS and state surveyors use in evaluating our SNFs&#8217; compliance with federal Requirements for Participation, incorporating recent changes to CMS&#8217;s methods for surveying infection control procedures. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, CMS updated guidance for Phase 2 and 3 of the requirements of participation, discussed in greater detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The application of CMS&#8217;s new guidance could result in more aggressive and stringent surveys, and potential fines, penalties, sanctions, or administrative actions taken against our independent subsidiaries. Also described in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Interoperability Final Rule and its changes intended to facilitate data exchange between and among patients, providers, and payors, will be implemented beginning in 2026 and must be fully implemented by January 1, 2027. This rule and the greater access to and use of data between and among payors transmitting funds for state and federal healthcare programs, may also trigger additional scrutiny or review of facilities such as ours, and may adversely affect our reimbursement paid through state and federal programs including Medicaid.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS announced a new nationwide audit the &#8220;SNF 5-Claim Probe &amp; Educate Review,&#8221; in which the Medicare Administrative Contractors will review five claims from each of the facilities to check for compliance with PDPM billings, which could result in individual claim payment denials if errors are identified. All facilities that are not undergoing Targeted Probe and Educate (TPE) reviews, or have not recently passed a TPE review, will be subject to the nationwide audit.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private payors also reserve the right to conduct audits. We believe that billing and reimbursement errors and disagreements are common in our industry, and thus we are regularly engaged in reviews, audits and appeals of our claims for reimbursement due to the subjectivities inherent in the process related to patient diagnosis and care, record keeping, claims processing and other aspects of the patient service and reimbursement processes, and the errors and disagreements those subjectivities can produce. An adverse review, audit or investigation could result in:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-11.25pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.27pt">an obligation to refund amounts previously paid to us pursuant to the Medicare or Medicaid programs or from private payors, in amounts that could be material to our business;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-11.25pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.27pt">state or federal agencies imposing fines, penalties or other sanctions on us;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-11.25pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.27pt">temporary or permanent loss of our right to participate in the Medicare or Medicaid programs or one or more private payor networks;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-11.25pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.27pt">an increase in private litigation against us; and</span></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-11.25pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.27pt">damage to our reputation in the geographies served by our independent subsidiaries.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have always been subject to post-payment audits and reviews, more intensive &#8220;probe reviews&#8221; performed by Medicare administrative contractors in recent years appear to be a regular procedure with our fiscal intermediaries. All findings of overpayment from CMS contractors are eligible for appeal. With the exception of rare findings of overpayment related to objective errors in Medicare payment methodology or claims processing, we utilize all defenses reasonably available to us to demonstrate that the services provided meet all clinical and regulatory requirements for reimbursement.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where claim and documentation review by a CMS contractor results in repeated unsatisfactory results, an operation can be subjected to protracted regulatory oversight. This CMS oversight may include education and sampling of claims, extended pre-payment review, referral of the operating business to recovery audit or integrity contractors, or extrapolation of an error rate to other reimbursement made outside of specifically reviewed claims. Ongoing failure to demonstrate improvement towards meeting all claim filing and documentation requirements could ultimately lead to Medicare decertification. As of December&#160;31, 2024 and through the filing date of this report, 18 of our independent subsidiaries had multi-claim reviews scheduled or in process, either pre- or post-payment. We anticipate that these reviews could increase in frequency in the future.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, both federal and state government agencies have heightened and coordinated civil and criminal enforcement efforts as part of numerous ongoing investigations of healthcare companies and, in particular, SNFs. The focus of these investigations includes, among other things, billing and cost reporting practices; quality of care provided; financial relationships with referral sources; and the medical necessity of rendered services. For example, refer to the matter discussed in Part I, Item 3., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we should agree to a settlement of claims or obligations under Medicare statutes, the FCA, or similar federal or state statutes and related regulations, our business, financial condition and results of operations and cash flows could be materially and adversely affected, and our stock price could be adversely impacted. Among other things, any settlement or litigation could involve the payment of substantial sums to settle any alleged civil violations and may also include our assumption of specific procedural and financial obligations going forward under a corporate integrity agreement or other arrangement with the government.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the government or a court were to conclude that errors and deficiencies constitute criminal violations and/or that such errors and deficiencies resulted in the submission of false claims to federal healthcare programs, or were to discover other problems in addition to the ones identified by the probe reviews that rose to actionable levels, we and certain of our officers might face potential criminal charges and civil claims, administrative sanctions and penalties for amounts that could be material to our business, results of operations and financial condition. In addition, we or some of the key personnel of our independent subsidiaries could be temporarily or permanently excluded from future participation in state and federal healthcare reimbursement programs such as Medicaid and Medicare. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our independent subsidiaries is decertified or loses its licenses, our revenue, financial condition or results of operations would be adversely affected. In addition, the report of such issues at any of our independent subsidiaries could harm our reputation for quality care and lead to a reduction in the patient referrals to and ultimately a reduction in occupancy at these facilities. Also, responding to auditing and enforcement efforts diverts material time, resources and attention away from our management team and our staff, and could have a materially detrimental impact on our results of operations during and after any such investigation or proceedings, regardless of whether we prevail on the underlying claim.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to extensive and complex laws and government regulations. If we are not operating in compliance with these laws and regulations or if these laws and regulations change, we could be required to make significant expenditures or change our operations in order to bring our facilities and operations into compliance. </span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, along with other companies in the healthcare industry, are required to comply with extensive and complex laws and regulations at the federal, state and local government levels relating to, among other things:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">licensure and certification; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">disclosure of ownership and affiliated parties;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">adequacy and quality of healthcare services; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">qualifications of healthcare and support personnel; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">state-specified and potential federal mandates for specific nurse staffing levels;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">quality and maintenance of medical equipment and facilities; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">confidentiality, maintenance and security issues associated with medical records and claims processing; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">relationships with physicians and other referral sources and recipients; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">constraints on protective contractual provisions with patients and third-party payors; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">operating policies and procedures; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">addition of facilities and services; and</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">billing for services. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and regulations governing our operations, along with the terms of participation in various government programs, regulate how we conduct our business, the services we offer, and our interactions with patients and other healthcare providers. These laws and regulations are subject to frequent change. As noted above, the Biden-Harris Administration called upon HHS and CMS to study and propose new rules regarding staffing requirements and reimbursement for the nursing home industry, including tying reimbursement to staffing levels, salary, benefits, and retention. The change in Presidential Administration, including changes to the leadership of HHS and CMS, may not result in any change, abatement, or reduction in the enforcement of these policies, and instead could lead to even greater scrutiny. CMS's recently finalized ownership transparency rule, and similar state disclosure requirements such as California&#8217;s, discussed in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, may provide an additional basis for further investigation, administrative action and ultimately fines, penalties, or sanctions if finalized, and may dissuade parties from working with us or our independent subsidiaries due to the reporting and disclosure obligations of being an Additional Disclosable Party under that final rule. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that such regulations that may adversely affect our business, operation and profitability. The quantity and scope of these regulations may increase in the future, and we cannot predict the ultimate content, timing or impact on us of any healthcare reform legislation. If we fail to comply with these applicable laws and regulations, or their interpretations as determined by courts or enforced by regulators, we could suffer civil or criminal penalties and other detrimental consequences, including denial of reimbursement, imposition of fines, temporary suspension of admission of new patients, suspension or decertification from the Medicaid and Medicare programs, restrictions on our ability to acquire new facilities or expand or operate existing facilities, the loss of our licenses to operate and the loss of our ability to participate in federal and state reimbursement programs. Additionally, in the future, different interpretations or enforcement of these laws and regulations could subject our current or past practices to allegations of impropriety or illegality or could require us to make changes in our facilities, equipment, personnel, services, capital expenditure programs and operating expenses. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in greater detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, we are subject to federal and state laws intended to prevent healthcare fraud and abuse. Possible sanctions for violation of any of these laws and regulations include loss of eligibility to participate in federal and state reimbursement programs and civil and criminal penalties. If we fail to comply, even inadvertently, with any of these requirements, we could be required to alter our operations, refund payments to the government, enter into a corporate integrity agreement, deferred prosecution or similar agreements with state or federal government agencies, and become subject to significant civil and criminal penalties. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These anti-fraud and abuse laws and regulations are complex, and we do not always have the benefit of significant regulatory or judicial interpretation of these laws and regulations. While we do not believe we are in violation of these prohibitions, we cannot assure you that governmental officials charged with the responsibility for enforcing these prohibitions will not assert that we are violating the provisions of such laws and regulations. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are unable to predict the future course of federal, state and local regulation or legislation, including as it pertains to Medicare, Medicaid, or fraud and abuse laws, and how they are enforced. Changes in the regulatory framework, our failure to obtain or renew required regulatory approvals, credentials, qualifications, or licenses or to comply with applicable regulatory requirements, or the imposition of other enforcement sanctions, fines or penalties could have a material adverse effect upon our business, financial condition or results of operations. Furthermore, should we lose licenses or certifications for a number of our facilities or other businesses as a result of regulatory action or legal proceedings, we could be deemed to be in default under some of our agreements, including agreements governing outstanding indebtedness. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public and government calls for increased survey and enforcement efforts toward SNFs, past and potential rulemaking that results in enhanced enforcement and penalties, could result in increased scrutiny by state and federal survey agencies. In addition, potential sanctions and remedies based upon alleged regulatory deficiencies could negatively affect our financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS's efforts to enhance its enforcement powers and increase enforcement activities towards SNFs, as discussed in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, result in state survey agencies having more accountability for their survey and enforcement efforts. Within the SNF PPS FY 2025 Final Rule, CMS obtained greater ability to impose monetary penalties upon SNFs for incident-based and day-based violations of CMS&#8217;s conditions of participation. Further, the enhanced penalties against SFFs under the Biden-Harris Administration represented further federal calls for transparency, oversight and penalties for low-ranked and underperforming SNFs. These policies may prove to be popular, effective, or otherwise desirable and might not change with a new Presidential Administration, including under new leadership of HHS and CMS. These enhanced penalties and enforcement activities precedes greater focus by CMS in obtaining oversight over SFFs, and continuing that oversight even after those SFFs improve, and subjecting them to more exacting and routine oversight. The likely result may be more frequent surveys of our independent subsidiaries, with more substantial penalties, fines and other consequences if they do not perform well. For low-performing facilities in the SFF program, the standards for successfully emerging from that program and not being subject to ongoing and enhanced government oversight will be higher and measured over a longer period of time, prolonging the risks of monetary penalties, fines and potential suspension or exclusion from the Medicare and Medicaid programs.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the ordinary course of business, we receive deficiency reports from state and federal regulatory bodies resulting from such inspections or surveys. CMS's updated guidance to these surveyors incorporate recent changes to CMS&#8217;s methods for surveying infection control procedures. Additionally, CMS's recently finalized rule requiring disclosure of ownership and financial relationships between nursing facilities and property owners or management entities, as well as other state rules over ownership transparency, may provide an additional basis for further investigation, administrative action, and ultimately fines, penalties, or sanctions and could dissuade individuals and businesses from doing business with us or our independent subsidiaries. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although most inspection deficiencies are resolved through an agreed-upon plan of corrective action, the reviewing agency typically has the authority to take further action against a licensed or certified facility. These remedial actions could result in the imposition of fines, imposition of a license to a conditional or provisional status, suspension or revocation of a license, suspension or denial of payment for new admissions, loss of certification as a provider under state or federal healthcare programs, or imposition of other sanctions, including criminal penalties. In the past, we have experienced inspection deficiencies that have resulted in the imposition of a provisional license and could experience these results in the future. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, in some states, citation of one independent subsidiary could negatively impact other independent subsidiaries in the same state. Revocation of a license at a given facility could therefore impair our ability to obtain new licenses or to renew, or maintain, existing licenses at other facilities, which may also trigger defaults or cross-defaults under our leases and our credit arrangements, or adversely affect our ability to operate or obtain financing in the future. CMS&#8217;s rules requiring disclosure of ownership, management and the owners of real property lessors or sublessors, which are greater and more intrusive than existing disclosure requirements heighten this risk. Our failure to comply with applicable legal and regulatory requirements in any single facility could negatively impact our financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we have opted to voluntarily stop accepting new patients pending completion of a revisit survey, in order to avoid possible denial of payment for new admissions during the deficiency cure period, or simply to avoid straining staff and other resources while retraining staff, upgrading operating systems or making other operational improvements. If we elect to voluntarily close any operations in the future or to opt to stop accepting new patients pending completion of a state or federal survey, it could negatively impact our financial condition and results of operation.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received notices of potential sanctions and remedies based upon alleged regulatory deficiencies from time to time, and such sanctions have been imposed on some of our independent subsidiaries. We have had independent subsidiaries placed on SFF status in the past and other independent subsidiaries may be identified for such status in the future. We currently have no facilities placed on SFF status.  </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CMS&#8217;s changes to the SFF program and its look-back period may create greater risk of our facilities being subject to this program and subject to potential fines and sanctions, even after graduating from the SFF program.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in greater detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in 2022 CMS updated the SFF program with the intent to reduce the amount of time a SNF spends as an SFF and increase the number of nursing homes that progress through the SFF program. The OIG has been studying the SFF program, including its 2022 updates, to understand the program&#8217;s outcomes, identify factors that aided SFFs that successfully graduated the SFF program with sustained quality improvements, and make further changes based on the data obtained in this study. In June of 2024, the OIG added the SFF program to ts Work Plan for continued attention. CMS clarified certain details of the SFF program updates in 2023 and how they are to be implemented by each state survey agency (SA). As part of the revisions to the SFF program, a priority in revising the SFF program was to address &#8220;yo-yo&#8221; noncompliance of SNFs that would graduate from the SFF program only to later see their compliance and quality measures regress after graduation, potentially requiring readmission to the SFF program. Among the measures implemented to avoid this issue of &#8220;yo-yo&#8221; noncompliance was a three-year look-back period for facilities that graduate from the SFF program to ensure that the quality and compliance improvements achieved through the SFF program were sustained. Facilities that graduate from the SFF program but continue to demonstrate poor compliance as evidenced by any SA&#8217;s survey, such as for actual harm, substandard quality of care, or immediate jeopardy deficiencies, may be subject to enhanced enforcement by CMS, up to and including termination from the Medicare and/or Medicaid programs.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This three-year look-back for sustained improvements by facilities that graduate the SFF program poses risk for our independent subsidiaries, specifically those that may be subject to the SFF program or that have been subject to the SFF program in the past. As of December&#160;31, 2024, we have three facilities that graduated from the SFF program within the past three years. First, for SNFs that are selected by CMS for participation in the SFF program, or which currently are in the SFF program, even graduation from the program is no longer an assurance that the SNF will be able to continue its operations. Even one survey with a significant compliance deficiency, such as actual harm or an immediate jeopardy deficiency, may result in CMS&#8212;acting solely within its discretion&#8212;terminating the SNF&#8217;s Medicare or Medicaid participation, likely triggering the termination of other payor contracts and rendering the facility economically unviable. Second, for SNFs that have graduated from the SFF program, they are subject to a three-year period of enhanced scrutiny where adverse findings by a SA and a single survey&#8217;s finding of poor compliance may result in CMS discretionally terminating that facility&#8217;s Medicare and/or Medicaid participation, which would likely cause other payors to terminate their agreements with the facility as well. As a result, the financial and manpower resources needed for graduation from the SFF program may be for nothing if, in the three years following graduation from the SFF program, a SNF receives a poor survey result and CMS imposes fines and penalties up to the termination of the facility&#8217;s Medicare and Medicaid participation.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, Medicare and Medicaid represent significant sources of payment for our independent subsidiaries. Any of our facilities&#8217; loss of a Medicare or Medicaid contract would significantly harm the financial performance of that facility. Additionally, if CMS perceived there to be common upstream ownership of multiple facilities that were participants in or graduates of the SFF program, CMS may seek to take enforcement actions against those other facilities due to their common ownership based on another facility&#8217;s deficiencies after graduating the SFF program, with CMS imposing penalties up to and potentially including termination of those SNFs&#8217; participation in the Medicare and/or Medicaid programs.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Federal minimum staffing mandates may adversely affect our labor costs, ability to maintain desired levels of patient or resident capacity, and profitability.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 22, 2024, CMS issued the Staffing Rule, establishing minimum staffing standards for SNFs. As discussed in more detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Staffing Rule contains three primary staffing requirements which are phased in over the next several years. Due to pending legislation in both the House of Representatives and the Senate, industry litigation filed to dispute the Staffing Rule's validity and enforceability, as well as the long phase-in of the Staffing Rule's requirements, the exact effects of the Staffing Rule cannot yet be ascertained. Given the pending legislation before both houses of Congress, change in control of the Presidency, changes in leadership of HHS and CMS, and change in control of the Senate following the 2024 presidential election, future developments may significantly alter or even halt the implementation of the Staffing Rule. However, we expect that the Staffing Rule in its current form will have adverse financial consequences upon our business unless or until it is repealed, enjoined, or otherwise prevented from taking effect.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to hire substantially more staff members, particularly nurse practitioners, registered nurses, and nursing aides than currently staffed. Additionally, the Staffing Rule would place similar pressure on our competitors and result in sudden, expanded demand for nursing staff across the SNF industry. This sudden demand across the SNF industry may exacerbate an already difficult labor market, with demand for nursing staff far outstripping the supply of qualified individuals, and the salary requirements of both current and prospective staff increasing markedly to increase the likelihood of recruiting and retaining skilled caregivers.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future cost containment initiatives undertaken by private third-party payors may limit our revenue and profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-Medicare and non-Medicaid revenue and profitability are affected by continuing efforts of third-party payors to maintain or reduce costs of healthcare, such as by lowering payment rates, narrowing the scope of covered services, increasing case management review of services and negotiating pricing. In addition, sustained unfavorable economic conditions may affect the number of patients enrolled in managed care programs and the profitability of managed care companies, which could result in reduced payment rates. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party payors may not make timely payments for our services, and we may be unable to maintain our current payor or revenue mix. We are continuing our efforts to develop our non-Medicare and non-Medicaid sources of revenue and any changes in payment levels from current or future third-party payors could have a material adverse effect on our business and consolidated financial condition, results of operations and cash flows.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reductions in Medicare reimbursements for physician and non-physician services could impact reimbursement for medical professionals. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in greater detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, MACRA revised the payment system for physician and non-physician services. The changes to the therapy caps imposed on Medicare Part B outpatient therapy from this law have been changed by the BBA, and are subject to future budgetary changes through rulemaking and legislation, resulting in ongoing uncertainty regarding payment for these Medicare Part B services. Under both the 2024 and 2025 PFS Final Rules, reductions in conversion factor, payments to providers and conditions imposed in exchange for higher payments may impose operational requirements and working conditions that further detract from and reduce our financial performance. Similarly, new final rules concerning the PACE program and the information it will collect from our independent subsidiaries may adversely affect the risk-adjusted reimbursement.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to increased investigation and enforcement activities related to HIPAA violations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA, as amended by the HITECH Act, requires us to adopt and maintain business procedures and systems designed to protect the privacy, security and integrity of patients' individual health information, in addition to state laws governing the privacy of patient information.&#160;We must comply with these state privacy laws to the extent that they are more protective of healthcare information or provide additional protections not afforded by HIPAA. The regulations enacting HIPAA periodically change and the last proposed change was issued in late 2022. In 2024, CMS published the Interoperability Final Rule, which affects the data standards and APIs that entities may use. Additionally, CMS issued its final rule updating the separate confidentiality requirements for Substance Use Disorder (SUD) records maintained. Changes to these regulations may require our independent subsidiaries to modify certain policies, procedures and practices regarding the disclosure of residents&#8217; information. If we fail to comply with these state and federal laws, we could be subject to criminal penalties, civil sanctions, litigation, and be forced to modify our policies and procedures, in addition to undertaking costly breach notification and remediation efforts, as well as sustaining reputational harm. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to breaches of protected patient information, under HIPAA and the 21st Century Cures Act (Cures Act) and other federal regulations, healthcare entities are also required to afford patients with certain rights of access to their health information and to promote sharing of patient data between and among healthcare providers involved in the same patient's course of care. Recently, the Office for Civil Rights, the agency responsible for HIPAA enforcement, has targeted investigative and enforcement efforts on violations of patients&#8217; rights of access, imposing significant fines for violations largely initiated from patient complaints. If we fail to comply with our obligations under HIPAA, we could face significant fines. Likewise, if we fail to comply with our obligations under the Cures Act, we could face fines from the Office of the National Coordinator for Health Information Technology, the agency responsible for Cures Act enforcement.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches and other cyber-security incidents could violate security laws and subject us to significant liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare businesses are increasingly the target of cyberattacks whereby hackers disrupt business operations or obtain protected health information, often demanding large ransoms. In 2024, healthcare was among the most-breached sector of the economy based on publicly disclosed information. The frequency of this activity has increased precipitously.  Our business is dependent on the proper functioning and availability of our computer systems and networks. We cannot assure you that our safety and security measures and disaster recovery plan will prevent damage, interruption or breach of our information systems and operations. Additionally, we cannot control the safety and security of our information held by third-party vendors with whom we contract. The techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may be difficult to detect, and as such we (or third-party vendors) may be unable to anticipate these techniques or implement adequate preventive measures. In addition, hardware, software or applications we (or third-party vendors) develop or procure from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise the security of information systems. Unauthorized parties may attempt to gain access to our systems or facilities, or those of third parties with whom we do business, through fraud or other forms of deception. Additionally, the rapid ongoing evolution and increased adoption of emerging technologies such as artificial intelligence and machine learning may make it more difficult to anticipate and implement protective measures to recognize, detect and prevent the occurrence of data breaches, including but not limited to cybersecurity breaches.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On occasion, we have acquired additional information systems through our business acquisitions, and these acquired systems may expose us to risk. We also license certain third-party software to support our operations and information systems. Our inability, or the inability of third-party vendors, to continue to maintain and upgrade information systems and software could disrupt or reduce the efficiency of our operations. In addition, costs and potential problems and interruptions associated with the implementation of new or upgraded systems and technology or with maintenance or adequate support of existing systems also could disrupt or reduce the efficiency of our operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A cyber-attack or other incident that bypasses the security measures of our information systems could cause a security breach, which may lead to a material disruption to our information systems infrastructure or business, significant costs to remediate (e.g., data recovery) and may involve a significant loss of business or patient health information. If a cyber-attack or other unauthorized attempt to access our systems or facilities were successful, it could also result in the theft, destruction, loss, misappropriation or release of confidential information or intellectual property, and could cause operational or business delays that may materially impact our ability to provide various healthcare services. Any successful cyber-attack or other unauthorized attempt to access our systems or facilities also could result in negative publicity which could damage our reputation or brand with our patients, referral sources, payors or other third parties and could subject us to a number of adverse consequences, the vast majority of which are not insurable, including but not limited to, disruptions in our operations, regulatory and other civil and criminal penalties, fines, investigations and enforcement actions (including, but not limited to, those arising from the SEC, FTC, OCR, the OIG or state attorneys general), fines, private litigation with those affected by the data breach (including class action litigation), loss of customers, disputes with payors and increased operating expense, which either individually or in the aggregate could have a material adverse effect on our business, financial position, results of operations, liquidity, and stock price.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be fully reimbursed for all services for which each facility bills through consolidated billing, which could adversely affect our revenue, financial condition and results of operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SNFs are required to perform consolidated billing for certain items and services furnished to patients and residents. The consolidated billing requirement requires the SNF to effectively bill for the entire package of care that its patients receive in these situations.  If more payments are required to be bundled in the future, this trend may continue, with our SNFs not receiving full reimbursement for all the services they provide, and have a further adverse effect on SNF utilization and revenue. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased competition for, or a shortage of, nurses and other skilled personnel could increase our staffing and labor costs and subject us to monetary fines.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends upon our ability to retain and attract nurses and other skilled personnel, such as Certified Nurse Assistants, social workers and speech, physical and occupational therapists, as well as skilled management personnel responsible for day-to-day facility operation. Each facility has a facility leader responsible for the overall day-to-day operations of the facility, including quality of care, social services and financial performance. Depending upon the size of the facility, each facility leader is supported by facility staff who are directly responsible for day-to-day care of the patients, marketing and community outreach programs. Other key positions supporting each facility may include individuals responsible for physical, occupational and speech therapy, food service and maintenance. We compete with various healthcare service providers, including other skilled nursing providers, in retaining and attracting qualified and skilled personnel.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent SNFs are located in the states of Alabama, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. All states follow the current federal regulation relative to staffing, which establishes that SNFs are required to staff to meet the needs of the residents present in the facility. In addition, several states have established minimum staffing requirements for facilities operating in those states.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with these requirements can, among other things, jeopardize a facility's compliance with the conditions of participation under relevant state and federal healthcare programs. If a facility is determined to be out of compliance with these requirements, it may be subject to a notice of deficiency, a citation, or a significant fine or litigation risk, with penalties including the suspension of patient admissions and the termination of Medicaid participation, or the suspension, revocation or non-renewal of the SNF's license. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonetheless, for the federal government or any state government to materially change the way compliance with the minimum staffing standard is calculated or enforced, our labor costs could increase and the current shortage of healthcare workers could impact us more significantly. The broader labor market where we compete is in a state of disequilibrium where the needs of businesses such as ours outstrip the supply of available and willing workers. There is additional upward pressure on wages from different industries and more generally due to the current rate of inflation. Some of these industries compete with us for labor and others that do not, which makes it difficult to make significant hourly wage and salary increases due to the fixed nature of our reimbursement under insurance contracts as well as Medicare and Medicaid, in addition to our increasing variable costs. Due to the limited supply of qualified applicants who seek or are willing to accept employment, these broader concerns, may increase our labor costs or lead to potential staffing shortages, reduced operations to comply with applicable laws and regulations, or difficulty complying with those laws and regulations at current operational levels. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal laws and regulations, such as the Staffing Rule, may increase our costs of maintaining qualified nursing and skilled personnel, or make it more difficult for us to attract or retain qualified nurses and skilled staff members. Proposed legislation, such as the previously proposed Nursing Home Improvement Act and the proposed HCBS Access Act, may make it more expensive to compete for, hire, and retain nursing staff, if passed into law in substantially the same form as previously introduced to Congress. The Biden-Harris Administration sought to increase staffing level requirements for the nursing home industry and to tie reimbursement to the salary, benefits, and retention of staff, which may increase our labor costs. The change in Presidential Administration  may not result in a change in this policy, and instead it is possible that HHS and CMS, under new leadership, could impose more stringent requirements for staffing. CMS has published guidance to surveyors addressing topics that specifically include nurse staffing and collection of payroll data to evaluate appropriate staffing levels, which may lead to future regulations that increase our staffing requirements and labor costs or lower revenues.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar state-level requirements in the states where our independent SNFs operate, whether such requirements are passed by statute, regulation, or executive order, may result in a shortage or inability to obtain nurses and skilled staff. Prior concerns about the COVID-19 vaccination IFR may be abated by the Omnibus Final Rule&#8217;s withdrawal of that IFR.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The withdrawal of the COVID-19 vaccination IFR may allow for nursing and other personnel unwilling to receive the COVID-19 vaccination to re-enter the workforce for Medicare-certified facilities and increase the pool of hirable talent.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increased competition for, or a shortage of, nurses or other trained personnel, or general ongoing inflationary pressures may require that we enhance our pay and benefits packages to compete effectively for such personnel. Turnover rates and the magnitude of the shortage of nurses or other trained personnel vary substantially from operation to operation and may adversely affect those operations' quality ratings based on data reported to CMS. In addition, state laws regarding minimum wage increases, such as California&#8217;s minimum wage increases for both healthcare and fast-food workers, may intensify competition for unskilled labor in both skilled and unskilled settings. For skilled workers within the skilled care market where we operate, the costs of skilled labor, which are already greater than unskilled labor, could increase further. Similarly, the increased minimum wage of unskilled labor will not only increase the cost of unskilled labor but may also have effects that dissuade workers from training to join the skilled workforce to earn higher wage growth, resulting in a smaller pool of available skilled workers and further increased competition&#8212;and higher wages&#8212;for them. If we fail to attract and retain qualified and skilled personnel, our ability to conduct our business operations could be harmed. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Annual caps and other cost-reductions for outpatient therapy services may reduce our future revenue and profitability or cause us to incur losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, sub-heading </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Part B Rehabilitation Requirements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, several government actions have been taken in recent years to try and contain the costs of rehabilitation therapy services provided under Medicare Part B, including the MPPR, institution of annual caps, mandatory medical reviews for annual claims beyond a certain monetary threshold, and a reduction in reimbursement rates. Of specific concern has been CMS efforts to lower Medicare Part B reimbursement rates for outpatient therapy services, which are reduced by 2.83% in the 2025 PFS Final Rule. Such cost-containment measures and ongoing payment changes could have an adverse effect on our revenue. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Office of the Inspector General or other regulatory authorities may choose to more closely scrutinize billing practices in areas where we operate or propose to expand, which could result in an increase in regulatory monitoring and oversight, decreased reimbursement rates, or otherwise adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in greater detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Civil and Criminal Fraud and Abuse Laws and Enforcement, the OIG regularly conducts investigations regarding certain payment or compliance issues within the healthcare industry. The OIG identified SNF compliance as an issue of concern in its 2021, 2022, 2023 and  2024 semi-annual reports to Congress. In June 2024, the OIG continued to focus on SNFs, adding the SFF Program to its Work Plan. The OIG's January 2023 study regarding SNF emergency preparedness identified the need for further oversight and addition of SNF emergency readiness to the OIG's fall 2023 work plan. In November of 2023, OIG added to its work plan an audit of nursing homes' nurse staffing hours reported in CMS's payroll-based journal, for which OIG expects to issue a report in FY 2025. Nursing homes were also a topic of discussion in the OIG&#8217;s 2023 semiannual report to Congress, which emphasized the continued protection and oversight of care that nursing facilities provide to residents. Among other things, the OIG recommended attention to the rate of reimbursement for professional services rendered within facilities.  The OIG&#8217;s reports to Congress have also recommended a reduction in the use of psychotropic drugs in nursing homes and urged CMS to evaluate the appropriateness of psychotropic drug use among residents, including the use of data to identify nursing homes with higher rates of use for potential further scrutiny and action. Based on this information, SNFs in particular are potential targets for more robust scrutiny and examination by regulators. Prior publications and statements by the Biden-Harris Administration have also called for greater scrutiny of SNF facilities. Following the 2024 presidential election, it is not yet known whether the new Presidential Administration will follow the same policies and seek further or escalating scrutiny of SNFs, or whether it will retain any or all of the Biden-Harris Administration&#8217;s priorities regarding SNFs.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To respond to the local community needs and the shifting of higher acuity patients from the acute care setting to the SNF setting, over time our overall patient mix has consistently shifted to higher acuity and higher-resource utilization patients in most facilities we operate. We also use specialized care-delivery software that assists our caregivers in more accurately capturing and recording activities of daily living services, among other things. These efforts may place us under greater scrutiny with the OIG, CMS, our fiscal intermediaries, recovery audit contractors and others.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State efforts to regulate or deregulate the healthcare services industry or the construction or expansion of healthcare facilities could impair our ability to expand our operations, or could result in increased competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states require healthcare providers, including SNFs, to obtain prior approval, known as a certificate of need, for: (1) the purchase, construction or expansion of healthcare facilities; (2) capital expenditures exceeding a prescribed amount; or (3) changes in services or bed capacity.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other states that do not require certificates of need have effectively barred the expansion of existing facilities and the establishment of new ones by placing partial or complete moratoria on the number of new Medicaid beds those states will certify in certain areas or throughout the entire state. Still other states have established such stringent development standards and approval procedures for constructing new healthcare facilities that the construction of new facilities, or the expansion or renovation of existing facilities, may become cost-prohibitive or extremely time-consuming. In addition, some states require the approval of the state Attorney General for acquisition of a facility being operated by a non-profit organization.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to acquire or construct new facilities or expand or provide new services at existing facilities would be adversely affected if we are unable to obtain the necessary approvals, if there are changes in the standards applicable to those approvals, or if we experience delays and increased expenses associated with obtaining those approvals. We may not be able to obtain licensure, certificate of need approval, Medicaid certification, state Attorney General approval or other necessary approvals for future expansion projects. Conversely, the elimination or reduction of state regulations that limit the construction, expansion or renovation of new or existing facilities could result in increased competition to us or result in overbuilding of facilities in some of our markets. If overbuilding in the skilled nursing industry in the markets in which we operate were to occur, it could reduce the occupancy rates of existing facilities and, in some cases, might reduce the private rates that we charge for our services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Newly enacted and proposed legislation in the States where our independent subsidiaries are located may affect our operations in terms of individual litigation and the broader regulatory environment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A bill in the State of California was signed into law which increases the cap of non-economic damages awarded to plaintiffs who are successful in medical malpractice litigation. The cap increases from $0.25 million to $0.35 million beginning on January 1, 2023, then increases over the following 10 years until the cap reaches a maximum of $0.75 million, with further adjustments for inflation. In wrongful death cases, the cap increases from $0.25 million to $0.5 million on January 1, 2023, with incremental increases over the following 10 years until the cap reaches a maximum of $1.0 million, with adjustments for inflation. Due to California's influence on other states, other jurisdictions where we operate have enacted and may enact similar laws in the future. Similar to the potential incentive of increased damages caps, recent Supreme Court decisions may increase public interest in potential claims against SNFs and senior living facilities, particularly pertaining to specific civil rights claims against governmental actors rather than general liability claims against privately owned SNFs such as those operated by our independent subsidiaries. While there may be additional claims and litigation that arise from the Supreme Court's decision that have an adverse impact on our cash flow, it is not expected that the decision will have a significant impact on our business.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Another example, California&#8217;s adoption of the Skilled Nursing Facility Ownership and Management Reform Act of 2022, discussed in Item 1., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, imposes new requirements for obtaining licenses to operate SNFs. These new requirements may delay or limit the ability to obtain new SNF licenses within that state, whether through acquisition of existing facilities or opening a new facility. This new law's obligations may increase the costs of obtaining licensure, make applications more time-consuming and complex, and may result in civil penalties and other sanctions against our independent subsidiaries in the event they are not compliant with these new licensure application requirements. As a result, this new law may delay or impede growth within California. As with the bill that increases the cap of non-economic damages for medical malpractice litigation, California&#8217;s influence on other states may result in this legislation becoming a model for other states and having similar, potentially adverse effects within those jurisdictions as well.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective October 2024, California law SB525 increased the minimum wage for healthcare workers. However, the law will only impact SNFs upon passage of a companion bill imposing minimum direct spending requirements upon SNFs. For the 2023-2024 California legislative session, this minimum spending bill took the form of AB1537 and, as of October 2024 has been placed in suspense without further action. A future bill may still be passed that would trigger SB525's requirements for healthcare workers in SNFs to receive higher minimum wages. As discussed in Item 1., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, these proposed bills would create new and costly obligations on our independent subsidiaries if they became law and if enacted, would adversely affect our business, operations, and profitability.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As another example, Texas passed a bill which partially restored Medicaid state relief funding for SNFs through August 31, 2023, while it also considered legislation that contained direct care spending requirements and ownership, similar to proposed federal rulemaking discussed in Item 1., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. While this bill provided financial relief to our independent subsidiaries in Texas, other proposed bills may impose the same regulatory requirements and limitations inherent in both the proposed legislation in other states and the federally proposed rule requiring disclosure of such information in applications and change-of-ownership disclosures, which may adversely affect our business, operations, and profitability.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to federal and state employment-related laws and regulations could increase our cost of doing business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent subsidiaries are subject to a variety of federal and state employment-related laws and regulations, including, but not limited to, the U.S. Fair Labor Standards Act that governs such matters as minimum wages, overtime and other working conditions, the ADA and similar state laws that provide civil rights protections to individuals with disabilities in the context of employment, public accommodations and other areas, the National Labor Relations Act, regulations of the EEOC, regulations of the Office of Civil Rights, regulations of state attorney generals, family leave mandates and a variety of similar laws enacted by the federal and state governments that govern these and other employment law matters.  Changes to federal and state regulations and laws are discussed in more detail in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Biden-Harris Administration requested that HHS and CMS study and issue proposed rules regarding care-based careers, including improving access to training, increasing the attractiveness of compensation in care-based positions, and improving the retention and career progression of care workers. The incoming Presidential Administration, as well as new leadership of HHS or CMS, may discontinue these studies, discontinue ongoing rulemaking activity, and may pursue significantly different policy-setting and rulemaking priorities that do not include any of the Biden-Harris Administration&#8217;s priorities. Simultaneously, certain actions taken under the Biden-Harris Administration, such as increased enforcement authority by HHS and CMS, may be retained and utilized by the incoming Presidential Administration and its new leaders of HHS and CMS. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other pending legislation, such as the HCBS Access Act, indicated a legislative priority of providing funding for care-based careers that may affect our pool of desired workers. Due to a change of political party control of both houses of Congress, though, such legislation may have a lower likelihood of passing, even if reintroduced in a subsequent congress.  Rising operating costs due to labor shortages, greater compensation and incentives required to attract and retain qualified personnel and higher-than-usual inflation on items including energy, utilities, food and other goods used in our facilities and the costs for transporting these items could increase our cost and decrease our profits.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compliance costs associated with these laws and evolving regulations could be substantial. By way of example, all of our independent subsidiaries are required to comply with the ADA, which has separate compliance requirements for &#8220;public accommodations&#8221; and &#8220;commercial properties,&#8221; but generally requires that buildings be made accessible to people with disabilities. Compliance with ADA requirements could require removal of access barriers and non-compliance could result in imposition of government fines or an award of damages to private litigants. Further legislation may impose additional burdens or restrictions with respect to access by disabled persons. In addition, federal proposals to introduce a system of mandated health insurance and flexible work time and other similar initiatives could, if implemented, adversely affect our operations. We also may be subject to employee-related claims such as wrongful discharge, discrimination or violation of equal employment law. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Required regulatory approvals could delay or prohibit transfers of our healthcare operations, which could result in periods in which we are unable to receive reimbursement for such properties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operations of our independent subsidiaries must be licensed under applicable state law and, depending upon the type of operation, certified or approved as providers under the Medicare and/or Medicaid programs. In the process of acquiring or transferring operating assets, our operations must receive change of ownership approvals from state licensing agencies, Medicare and Medicaid as well as third-party payors.&#160;Proposed rules regarding the disclosure of SNF facility ownership, if made effective, may increase the scrutiny placed on companies that operate, directly or indirectly, multiple SNFs, and may subject our licensing and approval process to additional scrutiny or delays. If there are any delays in receiving regulatory approvals from the applicable federal, state or local government agencies, or the inability to receive such approvals, such delays or denials could result in delayed or lost reimbursement related to periods of service prior to the receipt of such approvals, which could negatively impact our cash position. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with federal and state fair housing, fire, safety and other regulations may require us to make unanticipated expenditures, which could be costly to us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must comply with the federal Fair Housing Act and similar state laws, which prohibit us from discriminating against individuals if it would cause such individuals to face barriers in gaining residency in any of our independent subsidiaries. Additionally, the Fair Housing Act and other similar state laws require that we do not advertise our services in a way that may be discriminatory. We may be required, among other things, to change our marketing techniques to comply with these requirements.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our independent subsidiaries are required to operate in compliance with applicable fire and safety regulations, building codes and other land use regulations and food licensing or certification requirements as they may be adopted by governmental agencies and bodies from time to time. Like other healthcare facilities, our independent SNFs are subject to periodic surveys or inspections by governmental authorities to assess and assure compliance with regulatory requirements. Surveys occur on a regular (often annual or biannual) schedule, and special surveys may result from a specific complaint filed by a patient, a family member or one of our competitors. We may be required to make substantial capital expenditures to comply with these requirements. In some cases, we may be unable to comply with new regulations prior to their effective date exposing us to potential fines or regulatory action.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend largely upon reimbursement from third-party payors, and our revenue, financial condition and results of operations could be negatively impacted by any changes in the acuity mix of patients in our independent subsidiaries as well as payor mix and payment methodologies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is affected by the percentage of the patients of our independent subsidiaries who require a high level of skilled nursing and rehabilitative care, whom we refer to as high acuity patients, and by our mix of payment sources. Changes in the acuity level of patients we attract, as well as our payor mix among Medicaid, Medicare, private payors and managed care companies, significantly affect our profitability. We generally receive higher reimbursement rates for high acuity patients, and payors reimburse us at different rates. For the years ended December 31, 2024 and 2023, 70.9% and 72.6% of our revenue was provided by government payors that reimburse us at predetermined rates, respectively. If our labor or other operating costs increase, we will be unable to recover such increased costs from government payors. Accordingly, if we fail to maintain our proportion of high acuity patients or if there is any significant increase in the percentage of the patients of our independent subsidiaries for whom we receive Medicaid reimbursement, our results of operations may be adversely affected.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Initiatives undertaken by major insurers and managed care companies to contain healthcare costs may adversely affect our business. These tactics include contracting with healthcare providers to obtain services on a discounted basis. We believe that this trend will continue and may limit reimbursements for healthcare services. If insurers or managed care companies from whom we receive substantial payments were to reduce the amounts they pay for services and we did not wish to accept such reductions, we may lose patients if we choose not to renew our contracts with these insurers at lower rates. Additionally, trade publications within the healthcare industry have reported on the trend of payors using the No Surprises Act as a means to force re-negotiation of reimbursement rates for providers and facilities, leading to litigation between these providers and/or facilities against payors and it may adversely affect us as well.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed under Item 1., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Biden-Harris Administration requested HHS and CMS conduct studies to evaluate potential staffing, data reporting, employee compensation and retention, and resident experience regulations that may result in a reduction of our revenue from Medicare and Medicaid. CMS first requested information regarding these priorities in 2022 and subsequently published further requests for information from the public in the Federal Register to aid in studies and anticipated rulemaking. The change in Presidential Administration, including new leadership of HHS and CMS, may result in a change in these priorities, and this prior research and rulemaking may be materially altered or abandoned.  Certain results of the Biden-Harris Administration&#8217;s rulemaking, including enhanced enforcement ability, may be retained under the new Presidential Administration.  We continue to monitor this area and look for public disclosures from the incoming Presidential Administration and expected heads of HHS and CMS to better anticipate what policy priorities and changes we can expect regarding Medicare and Medicaid reimbursement, including payment models and factors affecting our independent subsidiaries&#8217; reimbursement for the services they provide.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to litigation that could result in significant legal costs and large settlement amounts or damage awards.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The skilled nursing business involves a significant risk of liability given the age and health of the patients and residents of our independent subsidiaries and the services we provide. The industry has experienced an increased trend in the number and severity of litigation claims, due in part to the number of large verdicts, including large punitive damage awards. These claims are filed based upon a wide variety of claims and theories, including deficiencies under conditions of participation under certain state and federal healthcare programs. Plaintiffs' attorneys have become increasingly more aggressive in their pursuit of claims against healthcare providers, including skilled nursing providers, employing a wide variety of advertising and solicitation activities to generate more claims. The increased caps on damages awarded in such actions, as discussed above, may trigger a larger number of these lawsuits against our independent subsidiaries in California and other states that adopt similar legislation. The defense of lawsuits has in the past, and may in the future, result in significant legal costs, regardless of the outcome. Additionally, increases to the frequency and/or severity of losses from such claims and suits may result in increased liability insurance premiums or a decline in available insurance coverage levels, which could materially and adversely affect our business, financial condition and results of operations. In addition to carrying third-party liability insurance, our captive insurance subsidiary provides professional liability and general liability insurance to various </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries. See the risk factor titled &#8220;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our self-insurance programs may expose us to significant and unexpected costs and losses.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past been subject to class action litigation involving claims of violations of various regulatory requirements and been able to settle these claims without an ongoing material adverse effect on our business. Future claims could be brought that may materially affect our business, financial condition and results of operations. Other claims and suits, including class actions, continue to be filed against us and other companies in our industry. For example, there has been a general increase in the number of wage and hour class action claims filed in several of the jurisdictions where we operate, typically based on alleged failures to permit or properly compensate for meal and rest periods, or failure to pay for time worked. If there were a significant increase in the number of these claims against us or an increase in amounts owing should plaintiffs be successful in their claims, this could have a material adverse effect on our business, financial condition, results of operations and cash flows. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to potential lawsuits under the FCA and comparable state laws alleging submission of fraudulent claims for services to any healthcare program (such as Medicare or Medicaid) or other payor. Under the qui tam or "whistleblower" provisions of the FCA, a private individual with knowledge of fraud or potential fraud may bring a claim on behalf of the federal government and receive a percentage of the federal government's recovery. Due to these whistleblower incentives, qui tam lawsuits have become more frequent. For example,</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> d</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">espite the decision of the DOJ to decline to participate in litigation based on the subject matter of its issued CID, the involved qui tam relator moved forward with the complaint in December 2020. Refer to Part I, Item 3., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on this case. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beyond our skilled nursing business, we engage in numerous ancillary businesses through one or more of our subsidiaries. These ancillary businesses generally support and provide services complementary to our operations, including but not limited to non-emergent ground transportation for patients and residents. Our ancillary businesses may also be the subject of claims, lawsuits, and regulatory oversight that are specific to the particular services they offer. Noncompliance with the laws and regulations that may apply to our ancillary businesses may result in fines, penalties, and civil claims paid by our affected independent subsidiaries. Specific to our non-emergent ground transportation business, the drivers employed by this business may be subject to additional state-specific regulations regarding working time allowed to be spent driving, waiting time, and break or rest periods, and violations of these rules may lead to regulatory fines, penalties, or claims to be paid to individual drivers, in addition to the general employment risks described above.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ancillary businesses also are susceptible to general liability claims based on facts and circumstances that are specific to their activities and operations</span><span style="color:#ff0090;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> such as claims for automobile-involved accidents against our non-emergent ground transportation business. The defense of claims and lawsuits relating to our ancillary businesses in the past, and may in the future, result in significant legal costs, regardless of the outcome. As our ancillary businesses grow, the independent subsidiaries may be subject to increased frequency and/or severity of losses from such claims and suits which may result in increased liability insurance premiums and decline in available coverage as described above, which could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we contract with a variety of landlords, lenders, vendors, suppliers, consultants and other individuals and businesses. These contracts typically contain covenants and default provisions. If the other party to one or more of our contracts were to allege that we have violated the contract terms, we could be subject to civil liabilities which could have a material adverse effect on our financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If litigation is instituted against one or more of our subsidiaries, a plaintiff might attempt to hold us or another subsidiary liable for the alleged wrongdoing of the subsidiary principally targeted by the litigation. If a court in such litigation decided to disregard the corporate form, the resulting judgment could increase our liability and adversely affect our financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Congress has repeatedly considered, without passage, a bill that would require, among other things, that agreements to arbitrate nursing home disputes be made after the dispute has arisen rather than before prospective patients move in, to prevent nursing home operators and prospective patients from mutually entering into a pre-admission, pre-dispute arbitration agreement. This bill, known as the Fairness in Nursing Home Arbitration Act, was introduced in the House of Representatives in 2021; the bill and its analogue introduced in the Senate have never made it out of the committees to which they were referred for discussion. The Fairness in Nursing Home Arbitration Act was re-introduced in the House of Representatives on January 29, 2024 and was referred to the Committee on Ways and Means and the Committee on Energy and Commerce. No action has been taken since these referrals of the bill to these committees.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent subsidiaries use arbitration agreements, which have generally been favored by the courts, to streamline the dispute resolution process and reduce our exposure to legal fees and excessive jury awards. CMS has identified these arbitration agreements as an area of focus and issued guidance to state surveyors regarding federal requirements for the use of arbitration agreements in nursing home care, with non-compliance potentially resulting in fines and other sanctions. If we are not able to secure pre-admission arbitration agreements, our litigation exposure and costs of defense in patient liability actions could increase, our liability insurance premiums could increase, and our business may be adversely affected.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcomes of any of these litigation matters are difficult to predict and litigation and other legal claims are subject to inherent uncertainties. Those uncertainties include, but are not limited to, litigation costs and attorneys&#8217; fees, unpredictable judicial or jury decisions and the differing laws and judicial proclivities regarding damage awards among the states in which we operate. A further complication is that even where the possibility of an adverse outcome is remote under traditional legal analysis, juries sometimes substitute their subjective views in place of facts and established legal principles. Unexpected outcomes in such legal proceedings, or changes in management&#8217;s evaluation or predictions of the likely outcomes of such proceedings (possibly resulting in changes in established reserves) could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct regular internal investigations into the care delivery, recordkeeping and billing processes of our independent subsidiaries. These reviews sometimes detect instances of noncompliance which we attempt to correct, which can decrease our revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an operator of healthcare facilities through our independent subsidiaries, we have a program to aid them in complying with various requirements of federal and private healthcare programs.&#160;Our compliance program includes, among other things, (1) policies and procedures modeled after applicable laws, regulations, sub-regulatory guidance and industry practices and customs that govern the clinical, reimbursement and operational aspects of our subsidiaries; (2) training about our compliance process for all of the employees of our independent subsidiaries, our directors and officers, and training about Medicare and Medicaid laws, fraud and abuse prevention, clinical standards and practices, and claim submission and reimbursement policies and procedures for appropriate employees; and (3) internal controls that monitor, among other things, the accuracy of claims, reimbursement submissions, cost reports and source documents, provision of patient care, services, and supplies as required by applicable standards and laws, accuracy of clinical assessment and treatment documentation, and implementation of judicial and regulatory requirements (i.e., background checks, licensing and training).</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time our systems and controls highlight potential compliance issues, which we investigate as they arise. Historically, we have initiated, and will continue to do so in the future, internal inquiries into possible recordkeeping and related irregularities at our independent subsidiaries, which were detected by our internal compliance team in the course of its ongoing reviews.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through these internal inquiries, we have identified potential deficiencies in the assessment of and recordkeeping for small subsets of patients. We have assisted in implementing, targeted improvements in the assessment and recordkeeping practices to make them consistent with the existing standards and policies applicable to our independent subsidiaries. We continue to monitor the measures implemented for effectiveness and perform follow-up reviews to ensure compliance. Consistent with healthcare industry accounting practices, we record any charge for refunded payments against revenue in the period in which the claim adjustment becomes known.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If additional reviews result in identification and quantification of additional amounts to be refunded, we will accrue additional liabilities for claim costs and interest, and repay any amounts due in normal course and within the time permitted by law. Failure to refund overpayments within required time frames (as described in greater detail above) could result in FCA liability and our business, financial condition and results of operations could be materially and adversely affected and our stock price could decline.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to complete future asset or business acquisitions at attractive prices or at all, which may adversely affect our revenue; we may also elect to dispose of underperforming or non-strategic independent subsidiaries, which would also decrease our revenue. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, our revenue growth has been significantly impacted by our acquisition of new facilities and businesses. Subject to general market conditions and the availability of essential resources and leadership within our company, we continue to seek both single-and multi-facility acquisition and business acquisition opportunities that are consistent with our geographic, financial and operating objectives.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face competition for the acquisition of facilities and businesses and expect this competition to increase. Based upon factors such as our ability to identify suitable acquisition candidates, future regulations affecting our ability to purchase facilities, the purchase price of the facilities, increasing interest rates for debt-financed purchases, prevailing market conditions, the availability of leadership to manage new facilities and our own willingness to take on new operations, the rate at which we have historically acquired facilities has fluctuated significantly. In the future, we anticipate the rate at which we may acquire facilities will continue to fluctuate, which may affect our revenue.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also previously acquired a few operations, which were or have proven to be non-strategic or less desirable, and we may consider disposing of such operations or exchanging them for operations that are more desirable, either because they were included in larger, indivisible groups of operations or under other circumstances. To the extent we dispose of such an operation without simultaneously acquiring an operation in exchange, our revenue may decrease.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully integrate acquired assets and businesses into our operations, and we may not achieve the benefits we expect from any of our acquisitions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to successfully or efficiently integrate new acquisitions of assets and businesses with our existing independent subsidiaries, culture and systems. The process of integrating acquisitions into our existing operations may result in unforeseen operating difficulties, divert management's attention from existing operations, or require an unexpected commitment of staff and financial resources, and may ultimately be unsuccessful. Existing operations available for acquisition frequently serve or target different markets than those that we currently serve. We also may determine that renovations of acquired facilities and changes in staff and operating management personnel are necessary to successfully integrate those acquisitions into our existing operations. We may not be able to recover the costs incurred to reposition or renovate newly independent subsidiaries. The financial benefits we expect to realize from many of our acquisitions are largely dependent upon our ability to improve clinical performance, overcome regulatory deficiencies, rehabilitate or improve the reputation of the operations in the community, increase and maintain occupancy, control costs, and in some cases change the patient acuity mix. If we are unable to accomplish any of these objectives at the independent subsidiaries we acquire, we will not realize the anticipated benefits and we may experience lower than anticipated profits, or even losses.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, we expanded our operations through a combination of long-term leases and real estate purchases, with the addition of 28 stand-alone skilled nursing operations and three campus operations. This growth has placed and will continue to place significant demands on our current management resources. Our ability to manage our growth effectively and to successfully integrate new acquisitions into our existing business will require us to continue to expand our operational, financial and management information systems and to continue to retain, attract, train, motivate and manage key employees, including facility-level leaders and our local directors of nursing. We may not be successful in attracting qualified individuals necessary for future acquisitions to be successful, and our management team may expend significant time and energy working to attract qualified personnel to manage operations we may acquire in the future. Also, the newly acquired operations may require us to spend significant time improving services that have historically been substandard, and if we are unable to improve such operations quickly enough, we may be subject to litigation and/or loss of licensure or certification. If we are not able to successfully overcome these and other integration challenges, we may not achieve the benefits we expect from any of our acquisitions, and our business may suffer. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In undertaking acquisitions, we may be adversely impacted by costs, liabilities and regulatory issues that may adversely affect our operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In undertaking acquisitions, we also may be adversely impacted by unforeseen liabilities attributable to the prior providers who operated those businesses, against whom we may have little or no recourse. Many operations we have historically acquired were underperforming financially and had clinical and regulatory issues prior to and at the time of acquisition. Even where we have improved independent subsidiaries and patient care, we still may face post-acquisition regulatory issues related to pre-acquisition events. These may include, without limitation, payment recoupment related to our predecessors' prior noncompliance, the imposition of fines, penalties, operational restrictions or special regulatory status. Further, we may incur post-acquisition compliance risk due to the difficulty or impossibility of immediately or quickly bringing non-compliant operations into full compliance. Diligence materials pertaining to acquisition targets, especially the underperforming facilities that often represent the greatest opportunity for return, are often inadequate, inaccurate or impossible to obtain, sometimes requiring us to make acquisition decisions with incomplete information. Despite our due diligence procedures, operations that we have acquired or may acquire in the future may generate unexpectedly low returns, may cause us to incur substantial losses, may require unexpected levels of management time, expenditures or other resources, or may otherwise not meet a risk profile that our investors find acceptable. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we might encounter unanticipated difficulties and expenditures relating to any of the acquired operations, including contingent liabilities. For example, when we acquire operations, we generally assume the operation's existing Medicare provider number for purposes of billing Medicare for services. If CMS later determines that the prior owner of the operation had received overpayments from Medicare for the period of time during which it ran the operation, or had incurred fines, CMS could hold us liable for repayment of the overpayments or fines. We may be unable to improve every operation that we acquire. In addition, operation of these newly acquired operations may divert management time and attention from other operations and priorities, negatively impact cash flows, result in adverse or unanticipated accounting charges, or otherwise damage other areas of our company if they are not timely and adequately improved.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also incur regulatory risk in acquiring certain facilities due to the licensing, certification and other regulatory requirements affecting our right to operate the acquired facilities. For example, in order to acquire facilities on a predictable schedule, or to acquire declining operations quickly to prevent further pre-acquisition declines, we frequently acquire such facilities prior to receiving license approval or provider certification. We operate such facilities as the interim manager for the outgoing licensee, assuming financial responsibility, among other obligations for the facility. To the extent that we may be unable or delayed in obtaining a license, we may need to operate the facility under a management agreement from the prior operator. Any inability in obtaining consent from the prior operator of a target acquisition to utilizing its license in this manner could impact our ability to acquire additional facilities. Further, anticipated future regulations may cause delays in acquiring the required licenses and certifications, if it is possible to do so at all. If we were subsequently denied licensure or certification for any reason, we might not realize the expected benefits of the acquisition and would likely incur unanticipated costs and other challenges which could cause our business to suffer.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not achieve or maintain competitive quality of care ratings from CMS or private organizations engaged in similar monitoring activities, our business may be negatively affected. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Item 1., under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS provides comparative public data, rating every SNF operating in each state based upon quality-of-care indicators. Certain private organizations engage in similar monitoring and ranking activities. CMS&#8217;s system is the Five-Star Quality Rating System which gives each nursing home a rating of between one and five stars in various categories, with five-star ratings harder to obtain over time. The ratings are available on a consumer-facing website, Nursing Home Compare. In cases of acquisitions, the previous operator's clinical ratings are included in our overall Five-Star Quality Rating and the rating may not reflect the improvements we were able to make until it is recalculated. Based on CMS's guidance and regulations, we expect more data to be collected by CMS and reported on the Nursing Home Compare website in the future. Additionally, CMS's ownership transparency final rule, which requires the disclosure of SNF ownership and affiliated parties, will ultimately provide for the public disclosure of information reported to CMS under that rule. Other states, including Iowa and California, have adopted similar statutes and regulations requiring the disclosure of this information. The publicly available information disclosed as a result of these laws and rules may result in potential residents perceiving our highly rated facilities to be less desirable if they share ownership with lower rated facilities, even if the lower rated facility is a new acquisition or has a lower score for reasons beyond our control. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS continues to increase quality measure thresholds, which are regularly increased every six months, making it more difficult to achieve upward and five-star ratings. CMS increased its quality measure thresholds in 2022, making it more difficult for facilities to obtain or maintain four- and five-star ratings. Some facilities may see a decline in their overall five-star rating absent any new inspection information, and as a result the five-star ratings of our independent subsidiaries may decline even as their quality measures remain unchanged or improve. Additionally, on the Nursing Home Compare website, CMS recently began displaying a consumer alert icon next to nursing homes that have been cited on inspection reports for incidents of abuse, neglect, or exploitation. In 2022, CMS updated the scoring measures used for SNFs to include six dimensions of staffing and turnover. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2023, CMS revised the nursing-home level exclusion criteria used on the administrator turnover measure, adding information regarding its calculation of the staff turnover measure and publishing an updated ratings table, which identifies the points needed for each nursing facility to obtain certain star ratings within its state. This change made it more competitive to obtain a five-star rating, and more difficult to maintain such a rating once achieved. Only 10% of nursing facilities can receive a five-star rating in the state where they operate. These changes also increase the pressure on our independent subsidiaries to obtain a smaller number of available five-star ratings, as lower ratings may make it more difficult to attract prospective residents to receive our services.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2023, CMS announced that it will update the staffing level case-mix adjustment methodology and freeze four of the quality measures used in the Nursing Home Five-Star Quality Rating System beginning with the April 2024 refresh of the Nursing Home Compare website data.  In April 2024, CMS announced the freezing of four quality measures, with one short-stay measure updated effective October 2024 with the new Discharge Function Score Measure and the other three measures unfrozen in January 2025. CMS has unfrozen its staffing level measures with changes to the time period needed to constitute the cessation of employment for the purposes of turnover measurement. CMS announced that it is changing its staffing rating methodology to give the lowest possible score to and penalize providers that fail to provide staffing data or provide erroneous staffing data. These changes risk our independent subsidiaries&#8217; facilities being incorrectly awarded a lower star rating, or prevented from attaining a deserved higher ranking due to favorable data not being reflected in CMS&#8217;s five-star ratings due to the freeze or replacement of certain measures. These lower ratings may cause potential residents to evaluate these independent  subsidiaries&#8217; facilities as less desirable, and result in fewer admissions and thus reduced revenue.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, CMS changed the staffing case-mix adjustment methodology to a model based on PDPM. The Nursing Home Compare website has begun posting staffing level measures that use this methodology. CMS will revise the staffing rating thresholds to maintain the same distribution of points for staffing measures that will be affected by this freeze and replacement. Further, CMS will penalize SNFs that submit erroneous data, or fail to submit data, by awarding them the lowest possible rating on that measure. We may be significantly affected if any of our independent subsidiaries fail to submit information for the MDS in 2024, or if CMS deems their MDS submissions to be erroneous. In addition to the uncertainty created by future changes to CMS&#8217;s five-star ratings that currently are unknown, the potential negative consequences of freezing unfavorable data may adversely affect our star rating and negatively impact our ability to attract residents.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Providing quality patient care is the cornerstone of our business. We believe that hospitals, physicians and other referral sources refer patients to us in large part because of our reputation for delivering quality care. If we should fail to achieve our internal rating goals or fail to exceed the national average rating on the Five-Star Quality Rating System, including due to nursing and administrative staffing and turnover, or have facilities displaying a consumer alert icon for incidents of abuse, neglect, or exploitation, it may affect our ability to generate referrals, which could have a material adverse effect upon our business and consolidated financial condition, results of operations and cash flows.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain insurance, or if insurance becomes more costly for us to obtain, our business may be adversely affected. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It may become more difficult and costly for us to obtain coverage for resident care liabilities and other risks, including property, automobile and casualty insurance. For example, the following circumstances may adversely affect our ability to obtain insurance at favorable rates: </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">we experience higher-than-expected professional liability, property and casualty, or other types of claims or losses;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">we receive survey deficiencies or citations of higher-than-normal scope or severity;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">we acquire especially troubled operations or facilities that present unattractive risks to current or prospective insurers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">insurers choose to stop operating or offering policies in certain states due to changes in economic conditions or laws;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">insurers tighten underwriting standards applicable to us or our industry; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">insurers or reinsurers are unable or unwilling to insure us or the industry at historical premiums and coverage levels.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of these potential circumstances were to occur, our insurance carriers may cancel or not renew our policies, or require us to significantly increase our self-insured retention levels or pay substantially higher premiums for the same or reduced coverage for insurance, including workers compensation, property and casualty, automobile, employment practices liability, directors and officers liability, employee healthcare and general and professional liability coverages.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some states, the law prohibits or limits insurance coverage for the risk of punitive damages arising from professional liability and general liability claims or litigation. Other states where we operate have experienced a withdrawal of insurers from the marketplace due to prior losses, or are at risk of insurers leaving the market due to changes in the law that make it difficult for those insurers to operate within the state. Coverage for punitive damages is also excluded under some insurance policies. As a result, we may be liable for punitive damage awards in these states that either are not covered or are in excess of our insurance policy limits. Claims against us, regardless of their merit or eventual outcome, could also inhibit our ability to attract patients or expand our business and could require our management to devote time to matters unrelated to the day-to-day operation of our business.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With few exceptions, general and professional, workers compensation and employee health insurance costs have also increased markedly in recent years and are expected to increase in the future. To partially offset these increases, we have increased the amounts of our self-insured retention and deductibles in connection with general and professional liability claims. We also have implemented a self-insurance program for workers compensation in all states, and elected non-subscriber status for workers compensation in Texas. Due to the nature of our business and the residents we serve, including the risk of claims from residents as well as potential governmental action, it may be difficult to complete the underwriting process and obtain insurance at commercially reasonable rates. If we are unable to obtain insurance, or if insurance becomes more costly for us to obtain, or if the coverage levels we can economically obtain decline, our business may be adversely affected.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our self-insurance programs may expose us to significant and unexpected costs and losses. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain general and professional liability insurance and workers compensation insurance through a wholly-owned captive insurance subsidiary to insure our self-insurance reimbursements and deductibles as part of a continually evolving overall risk management strategy. We establish the insurance loss reserves based on an estimation process that uses information obtained from both company-specific and industry data. The estimation process requires us to continuously monitor and evaluate the life cycle of the claims. Using data obtained from this monitoring and our assumptions about emerging trends, we, along with an independent actuary, develop information about the size of ultimate claims based on our historical experience and other available industry information. The most significant assumptions used in the estimation process include determining the trend in costs, the expected cost of claims incurred but not reported and the expected costs to settle or pay damages with respect to unpaid claims. It is possible, however, that the actual liabilities may exceed our estimates of loss. We may also experience an unexpectedly large number of successful claims or claims that result in costs or liability significantly in excess of our projections. For these and other reasons, our self-insurance reserves could prove to be inadequate, resulting in liabilities in excess of our available insurance and self-insurance. If a successful claim is made against us and it is not covered by our insurance or exceeds the insurance policy limits, our business may be negatively and materially impacted.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, because our self-insurance reimbursements under our general and professional liability and workers compensation programs applies on a per claim basis, there is no limit to the maximum number of claims or the total amount for which we could incur liability in any policy period.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also self-insure our employee health benefits. With respect to our health benefits self-insurance, our reserves and premiums are computed based on a mix of company specific and general industry data that is not specific to our own company. Even with a combination of limited company-specific loss data and general industry data, our loss reserves are based on actuarial estimates that may not correlate to actual loss experience in the future. Therefore, our reserves may prove to be insufficient and we may be exposed to significant and unexpected losses.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The geographic concentration of our independent subsidiaries could leave us vulnerable to an economic downturn, regulatory changes or acts of nature in those areas. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent subsidiaries located in Arizona, California, and Texas account for the majority of our total revenue. As a result of this concentration, the conditions of local economies and real estate markets, changes in governmental rules, presence and participation of insurers, regulations and reimbursement rates or criteria, changes in demographics, state funding, acts of nature and other factors that may result in a decrease in demand and/or reimbursement for skilled nursing services in these states could have a disproportionately adverse effect on our revenue, costs and results of operations. Moreover, since over 21% of our independent subsidiaries are located in California, we are particularly susceptible to revenue loss, cost increase or damage caused by natural disasters such as electrical power shortages, fires, earthquakes or mudslides, or increased liabilities that may arise from regulations as discussed within Item 1.,<a style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_307"> under </a></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our independent subsidiaries in certain states are more susceptible to revenue loss, cost increases or damage caused by natural disasters including hurricanes, tornadoes and flooding. These acts of nature may cause disruption to us, the employees of our independent subsidiaries, which could have an adverse impact on the patients of our independent subsidiaries and our business. In order to provide care for the patients of our independent subsidiaries, we are dependent on consistent and reliable delivery of food, pharmaceuticals, utilities and other goods to our independent subsidiaries, and the availability of employees to provide services. If the delivery of goods or the ability of employees to reach our independent subsidiaries were interrupted in any material respect due to a natural disaster or other reasons, it would have a significant impact on our independent subsidiaries and our business. Furthermore, the impact, or impending threat, of a natural disaster may require that we evacuate one or more facilities, which would be costly and would involve risks, including potentially fatal risks, for the patients. The impact of disasters and similar events is inherently uncertain. Such events could harm the patients and employees of our independent subsidiaries, severely damage or destroy one or more of our independent subsidiaries, harm our business, reputation and financial performance, or otherwise cause our business to suffer in ways that we currently cannot predict.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The actions of a national labor union that has pursued a negative publicity campaign criticizing our business in the past may adversely affect our revenue and our profitability. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to maintain our right to inform the employees of our independent subsidiaries about our views of the potential impact of unionization upon the workplace generally and upon individual employees. Historically, the staff at our independent subsidiaries that have been approached to unionize have uniformly rejected union organizing efforts. We previously indicated there may be forthcoming proposed rules from CMS, based on the Biden-Harris Administration's executive orders discussed under </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Item 1., as well as potential legislation such as the HCBS Access Act aimed toward providing more resources to those considering care-based careers, may increase the likelihood of employee unionization due to increased emphasis on care-based careers in SNF facilities. The outcome of the 2024 presidential election, including change in control of the Senate and Presidency from the Democratic to the Republican party, may result in a reversal of these orders, significant changes in HHS and CMS policy and rulemaking, and a reduced likelihood of successful legislation that seeks to provide more resources to creating pathways to care-based careers.  This change in Presidential Administration may also affect the favorability of unionization efforts before the Department of Labor. If employees successfully decide to unionize, our cost of doing business could increase, and we could experience contract delays, difficulty in adapting to a changing regulatory and economic environment, cultural conflicts between unionized and non-unionized employees, strikes and work stoppages, and we may conclude that affected facilities or operations would be uneconomical to continue operating.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we lease the majority of the facilities operated by our independent subsidiaries, we are subject to risks associated with leased real property, including risks relating to lease termination, lease extensions and special charges, any of which could adversely affect our business, financial position or results of operations.   </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, our independent subsidiaries operated 231 of our 327 facilities under long term lease arrangements. Most of our leases are triple-net leases, which means that, in addition to rent, we are required to pay for the costs related to the property (including property taxes, insurance, and maintenance and repair costs). We are responsible for paying these costs notwithstanding the fact that some of the benefits associated with paying these costs accrue to the landlords as owners of the associated facilities.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each lease provides that the landlord may terminate the lease for a variety of reasons, including the default in any payment of rent, taxes or other payment obligations or the breach of any other covenant or agreement in the lease. Termination of a lease could result in a default under our debt agreements and could adversely affect our business, financial position or results of operations. There can be no assurance that we will be able to comply with all of our obligations under the leases in the future.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to generate sufficient cash flow to cover required payments or meet operating covenants under our long-term debt, mortgages and long-term operating leases could result in defaults under such agreements and cross-defaults under other debt, mortgage or operating lease arrangements, which could harm our independent subsidiaries and cause us to lose facilities or experience foreclosures. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our Credit Facility has a borrowing capacity of up to $600.0 million in aggregate principal amount. As of December&#160;31, 2024 and through the filing date of this report, we had no outstanding borrowings under our Credit Facility. Twenty-three of our subsidiaries have mortgage loans insured with the Department of Housing and Urban Development (HUD) for an aggregate amount of $146.9 million, which subjects these subsidiaries to HUD oversight and periodic inspections. The terms of the mortgage loans range from 25- to 35-years.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We also have one outstanding promissory note with an aggregate principal amount of approximately $1.5 million as of December&#160;31, 2024. The term of the note is 12 years. Because this promissory note is insured with HUD, our borrower subsidiary under the note is subject to HUD oversight and periodic inspections. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we had $2.8 billion of future operating lease obligations as of December&#160;31, 2024. We intend to continue financing our independent subsidiaries through mortgage financing, long-term operating leases and other types of financing, including borrowings under our lines of credit and future credit facilities we may obtain. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not generate sufficient cash flow from operations to cover required interest, principal and lease payments. In addition, our outstanding Credit Facility and mortgage loans contain restrictive covenants and require us to maintain or satisfy specified coverage tests on a consolidated basis and on a facility or facilities basis. These restrictions and operating covenants include, among other things, requirements with respect to occupancy, debt service coverage, project yield, net leverage ratios, minimum interest coverage ratios and minimum asset coverage ratios. These restrictions may interfere with our ability to obtain additional advances under our Credit Facility or to obtain new financing or to engage in other business activities, which may inhibit our ability to grow our business and increase revenue.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the financial performance of one or more of our mortgaged facilities may not comply with the required operating covenants under the terms of the mortgage. Any non-payment, noncompliance or other default under our financing arrangements could, subject to cure provisions, cause the lender to foreclose upon the facility or facilities securing such indebtedness or, in the case of a lease, cause the lessor to terminate the lease, each with a consequent loss of revenue and asset value to us or a loss of property. Furthermore, in many cases, indebtedness is secured by both a mortgage on one or more facilities, and a guaranty by us. In the event of a default under one of these scenarios, the lender could avoid judicial procedures required to foreclose on real property by declaring all amounts outstanding under the guaranty immediately due and payable, and requiring us to fulfill our obligations to make such payments. If any of these scenarios were to occur, our financial condition would be adversely affected. For tax purposes, a foreclosure on any of our properties would be treated as a sale of the property for a price equal to the outstanding balance of the debt secured by the mortgage. If the outstanding balance of the debt secured by the mortgage exceeds our tax basis in the property, we would recognize taxable income on foreclosure, but would not receive any cash proceeds, which would negatively impact our earnings and cash position. Further, because our mortgages and operating leases generally contain cross-default and cross-collateralization provisions, a default by us related to one facility could affect a significant number of other facilities and their corresponding financing arrangements and operating leases.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our term loans, promissory note, bonds, mortgages and lease obligations are fixed expenses and secured by specific assets, and because our revolving loan obligations are secured by virtually all of our assets, if reimbursement rates, patient acuity mix or occupancy levels decline, or if for any reason we are unable to meet our loan or lease obligations, we may not be able to cover our costs and some or all of our assets may become at risk. Our ability to make payments of principal and interest on our indebtedness and to make lease payments on our operating leases depends upon our future performance, which will be subject to general economic conditions, industry cycles and financial, business and other factors affecting our independent subsidiaries, many of which are beyond our control. If we are unable to generate sufficient cash flow from operations in the future to service our debt or to make lease payments on our operating leases, we may be required, among other things, to seek additional financing in the debt or equity markets, refinance or restructure all or a portion of our indebtedness, sell selected assets, reduce or delay planned capital expenditures or delay or abandon desirable acquisitions. Such measures might not be sufficient to enable us to service our debt or to make lease payments on our operating leases. The failure to make required payments on our debt or operating leases or the delay or abandonment of our planned growth strategy could result in an adverse effect on our future ability to generate revenue and sustain profitability. In addition, any such financing, refinancing or sale of assets might not be available on terms that are economically favorable to us, or at all. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A housing downturn could decrease demand for senior living services. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Seniors often use the proceeds of home sales to fund their admission to senior living facilities. A downturn in the housing markets, including reductions in sales prices caused by increasing mortgage interest rates, economic uncertainty, recession, or a reduction in activity in the market for residential real estate, could adversely affect seniors&#8217; ability to afford our resident fees and entrance fees. If national or local housing markets enter a persistent decline, our occupancy rates, revenues, results of operations and cash flow could be negatively impacted. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As we continue to acquire and lease real estate assets, we may not be successful in identifying and consummating these transactions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we lease 33 of our properties to third-party operators.&#160;In the future, we might expand our leasing property portfolio to additional tenants. We have very limited control over the success or failure of our tenants&#8217; and operators&#8217; businesses and, at any time, a tenant or operator may experience a downturn in its business that weakens its financial condition. If that happens, the tenant or operator may fail to make its payments to us when due. Although our lease agreements give us the right to exercise certain remedies in the event of default on the obligations owing to us, we may determine not to do so if we believe that enforcement of our rights would be more detrimental to our business than seeking alternative approaches.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An important part of our business strategy is to continue to expand and diversify our real estate portfolio through accretive acquisition and investment opportunities in healthcare properties. Our execution of this strategy by successfully identifying, securing and consummating beneficial transactions is made more challenging by increased competition and can be affected by many factors, including our relationships with current and prospective tenants, our ability to obtain debt and equity capital at costs comparable to or better than our competitors and our ability to negotiate favorable terms with property owners seeking to sell and other contractual counterparties. Our competitors for these opportunities include healthcare REITs, real estate partnerships, healthcare providers, healthcare lenders and other investors, including developers, banks, insurance companies, pension funds, government-sponsored entities and private equity firms, some of whom may have greater financial resources and lower costs of capital than we do. Potential regulations may affect the ability of these entities, as well as ourselves, to compete for these opportunities or enter into transactions for real estate related to our business. If we are unsuccessful at identifying and capitalizing on investment or acquisition opportunities, our growth and profitability in our real estate investment portfolio may be adversely affected.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investments in and acquisitions of healthcare properties entail risks associated with real estate investments generally, including risks that the investment will not achieve expected returns, that the cost estimates for necessary property improvements will prove inaccurate or that the tenant or operator will fail to meet performance expectations.&#160;Income from properties and yields from investments in our properties may be affected by many factors, including changes in governmental regulation (such as licensing and government payment), general or local economic conditions (such as fluctuations in interest rates, senior savings, and employment conditions), the available local supply of and demand for improved real estate, a reduction in rental income as the result of an inability to maintain occupancy levels, natural disasters (such as hurricanes, earthquakes and floods) or similar factors. Furthermore, healthcare properties are often highly customized, and the development or redevelopment of such properties may require costly tenant-specific improvements. As a result, we cannot assure you that we will achieve the economic benefit we expect from acquisition or investment opportunities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As we expand our presence in other relevant healthcare industries, we would become subject to risks in a market in which we have limited experience. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our independent subsidiaries have historically been SNFs. As we expand our presence in other relevant healthcare industries, our existing overall business model will continue to change and expose our company to risks in markets in which we have limited experience, such as the Eliminating Kickbacks in Recovery Act and other state laws that are not as well-developed in regulation and decisional authority as their federal equivalents. We expect that we will have to adjust certain elements of our existing business model, which could have an adverse effect on our business.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our referral sources fail to view us as an attractive skilled nursing provider, or if our referral sources otherwise refer fewer patients, our patient base may decrease. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely significantly on appropriate referrals from hospitals, physicians, and other healthcare providers in the communities in which we deliver our services to attract appropriate residents and patients to our independent subsidiaries. Our referral sources are not obligated to refer business to us and may refer business to other healthcare providers. We believe many of our referral sources refer business to us as a result of the quality of our patient care and our efforts to establish and build a relationship with our referral sources. If we lose, or fail to maintain, existing relationships with our referral resources, fail to develop new relationships, or if we are perceived by our referral sources as not providing high quality patient care, our occupancy rate and the quality of our patient mix could suffer. In addition, if any of our referral sources have a reduction in patients whom they can refer due to a decrease in their business, our occupancy rate and the quality of our patient mix could suffer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need additional capital to fund our independent subsidiaries and finance our growth, and we may not be able to obtain it on terms acceptable to us, or at all, which may limit our ability to grow. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to maintain and enhance our independent subsidiaries and equipment in a suitable condition to meet regulatory standards, operate efficiently and remain competitive in our markets requires us to commit substantial resources to continued investment in our independent subsidiaries and equipment. We are sometimes more aggressive than our competitors in capital spending to address issues that arise in connection with aging and obsolete facilities and equipment. In addition, continued expansion of our business through the acquisition of existing facilities, expansion of our existing facilities and construction of new facilities may require additional capital, particularly if we were to accelerate our acquisition and expansion plans. Financing may not be available to us or may be available to us only on terms that are not favorable, including being subject to interest rates that are higher than those incurred in the recent past. In addition, some of our outstanding indebtedness and long-term leases restrict, among other things, our ability to incur additional debt. If we are unable to raise additional funds or obtain additional funds on terms acceptable to us, we may have to delay or abandon some or all of our growth strategies. Further, if additional funds are raised through the issuance of additional equity securities, the percentage ownership of our stockholders would be diluted. Any newly issued equity securities may have rights, preferences or privileges senior to those of our common stock.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The condition of the financial markets, including volatility and deterioration in the capital and credit markets, could limit the availability of debt and equity financing sources to fund the capital and liquidity requirements of our business, as well as negatively impact or impair the value of our current portfolio of cash, cash equivalents and investments, including U.S. Treasury securities and U.S.-backed investments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents and investments are held in a variety of interest-bearing instruments, including U.S. treasury securities. As a result of the uncertain domestic and global political, economic, credit and financial market conditions, including the increases in the federal funds rate since 2021, with limited decreases in 2024, and Consumer Price Index increases above historical norms for 2024, investments in these types of financial instruments pose risks arising from liquidity and credit concerns. Given that future deterioration in the U.S. and global credit and financial markets is a possibility, no assurance can be made that losses or significant deterioration in the fair value of our cash, cash equivalents, or investments will not occur. Uncertainty surrounding the trading market for U.S. government securities or impairment of the U.S. government's ability to satisfy its obligations under such treasury securities could impact the liquidity or valuation of our current portfolio of cash, cash equivalents, and investments, a substantial portion of which were invested in U.S. treasury securities. Further, continued domestic and international political uncertainty, along with credit, and financial market uncertainty, may make it difficult for us to liquidate our investments prior to their maturity without incurring a loss, which would have a material adverse effect on our consolidated financial position, results of operations or cash flows.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need additional capital if a substantial acquisition or other growth opportunity becomes available or if unexpected events occur or opportunities arise. U.S. capital markets can be volatile. We cannot assure you that additional capital will be available or available on terms acceptable to us. If capital is not available, we may not be able to fund internal or external business expansion or respond to competitive pressures or other market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delays in reimbursement may cause liquidity problems. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we experience problems with our billing information systems or if issues arise with Medicare, Medicaid or other payors, we may encounter delays in our payment cycle. From time to time, we have experienced such delays as a result of government payors instituting planned reimbursement delays for budget balancing purposes or as a result of prepayment reviews. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some states in which we operate are operating with budget deficits or could have budget deficits in the future, which may delay reimbursement in a manner that would adversely affect our liquidity. In addition, from time to time, procedural issues require us to resubmit or appeal claims before payment is remitted, which contributes to our aged receivables. Unanticipated delays in receiving reimbursement from state programs or commercial payors due to changes in their policies or billing or audit procedures may adversely impact our liquidity and working capital.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The continued use and growth of managed care organizations (MCOs) may contribute to delays or reductions in our reimbursement, including Managed Medicaid.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In forty-one states, including some of the largest where we operate, state Medicaid benefits are administered through MCOs. Typically, these MCOs manage commercial health and federal Medicare Advantage benefits under a managed care contract. Nationally, more than two-thirds of all Medicaid beneficiaries receive most or all of their care from MCOs. MCOs may be more aggressive than state Medicaid and federal Medicare agencies in denying claims or seeking recoupment of payments so that their services under these managed contracts are profitable. The additional steps created by the use of MCOs in disbursement of funds creates more risk of delayed, reduced, or recouped payments for our independent subsidiaries, and additional avenues for risks that include fines and other sanctions, including suspension or exclusion from participation in various governmental programs.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with the regulations of the Department of Housing and Urban Development may require us to make unanticipated expenditures which could increase our costs.</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Twenty-three of our independent subsidiaries are currently subject to regulatory agreements with HUD that give the Commissioner of HUD broad authority to require us to be replaced as the operator of those facilities in the event that the Commissioner determines there are operational deficiencies at such facilities under HUD regulations. Compliance with HUD's requirements can often be difficult because these requirements are not always consistent with the requirements of other federal and state agencies. Appealing a failed inspection can be costly and time-consuming and, if we do not successfully remediate the failed inspection, we could be precluded from obtaining HUD financing in the future or we may encounter limitations or prohibitions on our operation of HUD-insured facilities. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to safeguard the monies held in our patient trust funds, we will be required to reimburse such monies, and we may be subject to citations, fines and penalties. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our independent subsidiaries is required by federal law to maintain a patient trust fund to safeguard certain assets of their residents and patients. If any money held in a patient trust fund is misappropriated, we are required to reimburse the patient trust fund for the amount of money that was misappropriated. If any monies held in our patient trust funds are misappropriated in the future and are unrecoverable, we will be required to reimburse such monies, and we may be subject to citations, fines and penalties pursuant to federal and state laws.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a holding company with no operations and rely upon our multiple independent subsidiaries to provide us with the funds necessary to meet our financial obligations. Liabilities of any one or more of our subsidiaries could be imposed upon us or our other subsidiaries.</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a holding company with no direct operating assets, employees or revenue. Each of our independent subsidiaries is operated through a separate, wholly-owned, independent subsidiary, which has its own management, employees and assets. Our principal assets are the equity interests we directly or indirectly hold in our multiple operating and real estate holding subsidiaries. As a result, we are dependent upon distributions from our subsidiaries to generate the funds necessary to meet our financial obligations and pay dividends. Our subsidiaries are legally distinct from us and have no obligation to make funds available to us. The ability of our subsidiaries to make distributions to us will depend substantially on their respective operating results and will be subject to restrictions under, among other things, the laws of their jurisdiction of organization, which may limit the amount of funds available for distribution to investors or stockholders, agreements of those subsidiaries, the terms of our financing arrangements and the terms of any future financing arrangements of our subsidiaries.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain directors who serve on our Board of Directors also serve as directors of Pennant, and ownership of shares of Pennant common stock by our directors and executive officers may create, or appear to create, conflicts of interest.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our directors who serve on our Board of Directors also serve on the board of directors of Pennant. This may create, or appear to create, conflicts of interest when our, or Pennant's management and directors face decisions that could have different implications for us and Pennant, including the resolution of any dispute regarding the terms of the agreements governing the spin-off transaction and the relationship between us and Pennant after the spin-off transaction or any other commercial agreements entered into in the future between us and Pennant and the allocation of such directors&#8217; time between us and Pennant.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our executive officers and some of our non-employee directors own shares of the common stock of Pennant. The continued ownership of such common stock by our directors and executive officers following the spin-off creates, or may create, the appearance of a conflict of interest when these directors and executive officers are faced with decisions that could have different implications for us and Pennant.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If Standard Bearer fails to remain qualified as a REIT, it will be subject to U.S. federal income tax as a regular corporation and could face substantial tax liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer currently operates, and intends to continue to operate, in a manner that allows it to qualify to be taxed as a REIT for U.S. federal income tax purposes. If Standard Bearer fails to remain qualified to be taxed as a REIT in any year, it would be subject to U.S. federal income tax, including any applicable alternative minimum tax, on our taxable income at regular corporate rates, and dividends paid to its shareholders would not be deductible by it in computing its taxable income. Any resulting corporate liability could be substantial and would reduce the amount of cash available for distribution to its shareholders. Unless it was entitled to relief under certain Code provisions, it also would be disqualified from re-electing to be taxed as a REIT for the four taxable years following the year in which it failed to qualify to be taxed as a REIT.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legislative or other actions affecting REITs could have a negative effect on Standard Bearer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the IRS and the U.S. Department of the Treasury (Treasury). Changes to the tax laws or interpretations thereof, with or without retroactive application, could materially and adversely affect Standard Bearer's investors or Standard Bearer. We cannot predict how changes in the tax laws, including any tax reform called for by the current presidential administration, might affect Standard Bearer or its investors. New legislation, Treasury regulations, administrative interpretations or court decisions could significantly and negatively affect its ability to qualify to be taxed as a REIT or the U.S. federal income tax consequences to Standard Bearer or its investors of such qualification. Changes to the U.S. federal tax laws and interpretations thereof, whether under the TCJA or otherwise, could adversely affect an investment in our stock. Additionally, REIT's that are related to our operation will likely be subject to the disclosure requirements of CMS's ownership transparency final rule (and analogous state rules), and may subject these REITs to additional public scrutiny. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No prediction can be made regarding whether new legislation or regulation (including new tax measures) will be enacted by legislative bodies or governmental agencies, nor can we predict what consequences would result from this legislation or regulation. Accordingly, no assurance can be given that the currently anticipated tax treatment of an investment will not be modified by legislative, judicial or administrative changes, possibly with retroactive effect.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standard Bearer could fail to qualify to be taxed as a REIT if income it receives from our tenants is not treated as qualifying income.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under applicable provisions of the Code, Standard Bearer will not be treated as a REIT unless it satisfies various requirements, including requirements relating to the sources of its gross income. Rents received or accrued by it from its tenants will not be treated as qualifying rent for purposes of these requirements if the leases are not respected as true leases for U.S. federal income tax purposes and are instead treated as service contracts, joint ventures or other arrangements. If the leases are not respected as true leases for U.S. federal income tax purposes, Standard Bearer will likely fail to qualify to be taxed as a REIT.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if Standard Bearer remains qualified as a REIT, it may face other tax liabilities that reduce its cash flow.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if Standard Bearer remain qualified for taxation as a REIT, it may be subject to certain U.S. federal, state, and local taxes on its income and assets, including taxes on any undistributed income and state or local income, property and transfer taxes. For example, Standard Bearer may hold some of its assets or conduct certain of its activities through one or more taxable REIT subsidiaries (each, a TRS) or other subsidiary corporations that will be subject to U.S. federal, state, and local corporate-level income taxes as regular C corporations. In addition, it may incur a 100% excise tax on transactions with a TRS if they are not conducted on an arm&#8217;s-length basis. Any of these taxes would decrease cash available for distribution to its shareholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with existing environmental laws could result in increased expenditures, litigation and potential loss to our business and in our asset value. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent subsidiaries are subject to regulations under various federal, state and local environmental laws, primarily those relating to the handling, storage, transportation, treatment and disposal of medical waste; the identification and warning of the presence of asbestos-containing materials in buildings, as well as the encapsulation or removal of such materials; and the presence of other substances in the indoor environment.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent subsidiaries generate infectious or other hazardous medical waste due to the illness or physical condition of the patients. Each of our independent subsidiaries has an agreement with a waste management company for the proper disposal of all infectious medical waste, but the use of a waste management company does not immunize us from alleged violations of such laws even if carried out by a third party, nor does it immunize us from third-party claims for the cost to cleanup disposal sites at which such wastes have been disposed.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the independently operated facilities we lease, own or may acquire may have asbestos-containing materials. Federal regulations require building owners and those exercising control over a building's management to identify and warn their employees and other employers operating in the building of potential hazards posed by workplace exposure to installed asbestos-containing materials and known or suspected asbestos-containing materials in their buildings. Significant fines can be assessed for violation of these regulations. Building owners and those exercising control over a building's management may be subject to an increased risk of personal injury lawsuits. Federal, state and local laws and regulations also govern the removal, encapsulation, disturbance, handling and disposal of asbestos-containing materials and potential asbestos-containing materials when such materials are in poor condition or in the event of construction, remodeling, renovation or demolition of a building. Such laws may impose liability for improper handling or a release into the environment of asbestos containing materials and potential asbestos-containing materials and may provide for fines to, and for third parties to seek recovery from, owners or operators of real properties for personal injury or improper work exposure associated with asbestos-containing materials and potential asbestos-containing materials.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The presence of mold, lead-based paint, underground storage tanks, contaminants in drinking water, radon and/or other substances at our independent subsidiaries may lead to the incurrence of costs for remediation, mitigation or the implementation of an operations and maintenance plan and may result in third party litigation for personal injury or property damage. If we fail to comply with applicable environmental laws, we would face increased expenditures in terms of fines and remediation of the underlying problems, potential litigation relating to exposure to such materials, and a potential decrease in value to our business and in the value of our underlying assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risks Related to Ownership of our Common Stock</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to pay or maintain dividends and the failure to do so would adversely affect our stock price. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to pay and maintain cash dividends is based on many factors, including our ability to make and finance acquisitions, our ability to negotiate favorable lease and other contractual terms, anticipated operating cost levels, the level of demand for occupancy at our facilities, the rates we charge and actual results that may vary substantially from estimates. Some of the factors are beyond our control and a change in any such factor could affect our ability to pay or maintain dividends. The Credit Facility restricts our ability to pay dividends to stockholders if we receive notice that we are in default under the agreement. The failure to pay or maintain dividends could adversely affect our stock price.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law contain provisions that could discourage transactions resulting in a change in control, which may negatively affect the market price of our common stock. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that may enable our Board of Directors to resist a change in control. These provisions may discourage, delay or prevent a change in the ownership of our company or a change in our management, even if doing so might be beneficial to our stockholders. In addition, these provisions could limit the price that investors would be willing to pay in the future for shares of our common stock. Such provisions set forth in our amended and restated certificate of incorporation or our amended and restated bylaws include: </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">our Board of Directors is authorized, without prior stockholder approval, to create and issue preferred stock, commonly referred to as &#8220;blank check&#8221; preferred stock, with rights senior to those of common stock;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">advance notice requirements for stockholders to nominate individuals to serve on our Board of Directors or to submit proposals that can be acted upon at stockholder meetings;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">our Board of Directors is classified so not all members of our board are elected at one time, which may make it more difficult for a person who acquires control of a majority of our outstanding voting stock to replace our directors;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">stockholder action by written consent is limited;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">special meetings of the stockholders are permitted to be called only by the chairman of our Board of Directors, our chief executive officer or by a majority of our Board of Directors;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">stockholders are not permitted to cumulate their votes for the election of directors;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">newly created directorships resulting from an increase in the authorized number of directors or vacancies on our Board of Directors are filled only by majority vote of the remaining directors;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">our Board of Directors is expressly authorized to make, alter or repeal our bylaws; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-13.5pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8.52pt">stockholders are permitted to amend our bylaws only upon receiving the affirmative vote of at least a majority of our outstanding common stock.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to the anti-takeover provisions of Section 203 of the General Corporation Law of the State of Delaware. Under these provisions, if anyone becomes an &#8220;interested stockholder,&#8221; we may not enter into a &#8220;business combination&#8221; with that person for three years without special approval, which could discourage a third-party from making a takeover offer and could delay or prevent a change of control. For purposes of Section 203, &#8220;interested stockholder&#8221; means, generally, someone owning more than 15% or more of our outstanding voting stock or an affiliate of ours that owned 15% or more of our outstanding voting stock during the past three years, subject to certain exceptions as described in Section 203.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and other provisions in our amended and restated certificate of incorporation, amended and restated bylaws and Delaware law could discourage acquisition proposals and make it more difficult or expensive for stockholders or potential acquirers to obtain control of our Board of Directors or initiate actions that are opposed by our then-current Board of Directors, including delaying or impeding a merger, tender offer or proxy contest involving us. Any delay or prevention of a change of control transaction or changes in our Board of Directors could cause the market price of our common stock to decline.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_424"></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. UNRESOLVED STAFF COMMENTS </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_427"></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1C. CYBERSECURITY</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-36" continuedAt="f-36-1" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-37" escape="true">We utilize information technology that enables our operational leaders to access and share with their peers, both clinical and financial performance data in real time. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-38">Armed with relevant and current information, our operation leaders and their management teams can share best practices and the latest information, adjust to challenges and opportunities on a timely basis, improve quality of care, mitigate risk and improve both clinical outcomes and financial performance.</ix:nonNumeric> We have also invested in specialized healthcare technology systems to assist our nursing and support staff. We have installed software and touch-screen interface systems in each operation to enable our clinical staff to monitor and deliver patient care and record patient information more efficiently. We believe these systems have improved the quality of our medical and billing records, while improving the productivity of our staff. Such uses of information systems give rise to cybersecurity risks, including system disruption, security breach, ransomware, theft, espionage and inadvertent release of information.</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK MANAGEMENT AND STRATEGY </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess and identify security risk to the organization by: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">conducting risk assessments to determine the likelihood and magnitude of an attack from unauthorized access, use, disclosure, disruption, modification or destruction of information systems and the related information processes, stored, or transmitted;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">performing penetration testing assessments annually and producing security assessment reports that document the results of the assessment for use and review by information technology (IT) senior leadership, including the Service Center's Chief Information Officer;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">ensuring security controls are assessed for effectiveness, are implemented correctly, operating as intended and producing the desired outcome;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">continuously scanning for vulnerabilities and remediating vulnerabilities within their service level agreements in accordance with the associated risk level; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-39">reviewing third party and vendor risks to our organization through an internal interdisciplinary Technology Advisory Committee that includes members from our IT, Information Security Office (ISO), legal, compliance, clinical, finance and billing departments.</ix:nonNumeric> </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><ix:continuation id="f-36-1" continuedAt="f-36-2"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Monitoring</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a continuous monitoring strategy and program, which includes: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">a set of defined security metrics to be monitored;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">performance of security control assessments on an ongoing basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">addressing results of analysis and reporting security status to the executive team;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">monitoring information systems to detect attacks and indicators of potential attacks or compromises;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">identification of unauthorized use of the information system resources;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">deployment of monitoring systems and agents strategically within the information system environment; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-40">require that third party service providers who store, process or transmit data with access to electronic Protected Health Information (ePHI) undergo an independent third-party audit to achieve system organization controls certification annually.</ix:nonNumeric> </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Protection </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented an Information Security Management System Program to secure sensitive data protected by us. This program includes: </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">establishing policies governing data security;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">monitoring data access throughout the organization&#8217;s independent subsidiaries;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">providing continuous security training and awareness;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">establishing controls over devices on the network which are actively tracked, monitored and evaluated for new, missing, or updated software needed to strengthen security on the device, patch known vulnerabilities, or stabilize software or operating system issues;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">protecting sensitive data through encryption techniques; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">designing and implementing systems to include backup and recoverability principles, such as periodic data backups and safeguards in the case of a disaster. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incident Management Plan </span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-41" continuedAt="f-41-1" escape="true"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity incident management plan comprises the following six-step process: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The Service Center's Chief Information Officer and Director of Information Security lead its ISO team in the development, documentation, review and testing of security procedures and incident management procedures. Beyond initial creation, procedures are continually re-assessed, updated and tested on an ongoing basis. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The ISO team works with the Executive Team on the identification, assessment, verification and classification of incidents to determine affected stakeholders and appropriate parties for contact. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-42" escape="true">The Service Center's Chief Information Officer and Director of Information Security are responsible for launching the Incident Response Team (IRT) if necessary and for notification to the Executive Team, who in turn will contact the Board of Directors and the Audit Committee to validate that the response is being addressed appropriately.</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The IRT, in consultation with outside experts if needed, is responsible for the following: </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Initial containment by making tactical changes to the computing environment to mitigate active threats based on currently known information. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Analysis to establish the root cause of incidents, identification and evidence collection from all affected machines and log sources, threat intelligence and other information sources. Once all appropriate information has been collected, we perform a careful analysis using forensically-sound tools and methods to prevent any contamination of evidence. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Incident containment by further analyzing additional information and further identifying any additional compromised machines or resources not previously identified. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Incident eradication by re-assessing the root cause of incidents where solutions are then implemented to solve underlying problems and prevent re-occurrence. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Recovery and restoring normal business functionality, which includes the reversal of any damage caused by the incident and responding as necessary. </span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><ix:continuation id="f-41-1" continuedAt="f-41-2"><ix:continuation id="f-36-2" continuedAt="f-36-3"><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:13.27pt">Review after closure of each incident and conducting a lessons learned analysis to improve prevention and help to make incident response processes more efficient and effective. Also, the IRT evaluates competency and any additional training requirements needed. A final incident report will then be provided to key stakeholders and IRT members, which includes, but is not limited to the summary of the incident and its impact, a timeline of events, a detailed description of the incident, an evaluation of the organizational response and an assessment of the damages. </span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><ix:continuation id="f-41-2" continuedAt="f-41-3"><ix:continuation id="f-36-3" continuedAt="f-36-4"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-43">We have not experienced a material cybersecurity breach in the past five years and, as a result, there have been no charges related to a breach in the past five years.</ix:nonNumeric> Moreover, risks from cybersecurity threats have not materially affected our business strategy, results of operations, or financial condition. While we have implemented processes and procedures that we believe are tailored to address and mitigate the cybersecurity threats that our company faces, there can be no assurances that such an incident will not occur despite our efforts, as more fully described in Item 1A. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risk Factors</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:continuation id="f-41-3"><ix:continuation id="f-36-4">.</ix:continuation></ix:continuation>   </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNANCE </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-44" continuedAt="f-44-1" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-45" escape="true">Our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-46"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-47">Audit Committee</ix:nonNumeric></ix:nonNumeric> receives quarterly reports on our information security and cyber fraud prevention programs from the <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-48" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-49" escape="true">Service Center's Chief Information Officer and Director of Information Security</ix:nonNumeric>, who each have over 24 years of experience in IT, including various leadership roles at other large corporations.</ix:nonNumeric> One of the three members of our Audit Committee is a cybersecurity expert.</ix:nonNumeric>  </span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-50" escape="true"><ix:continuation id="f-44-1">The ISO has been established by the Service Center's Chief Information Officer, with dedicated cyber security staff focusing on security monitoring, vulnerability management, incident response, risk assessments, employee training, security engineering and management of cyber security policies, standards and regulatory compliance. Like many organizations, we align to a Cyber Security Framework and take a risk-based approach during control assessment and implementation. We align to the National Institute of Standards and Technology (NIST) Special Publication 800-53 Revision 4, a globally recognized cyber security framework of Policies, Standards and Controls is comprised of five categories of defense &#8211; Identify, Protect, Detect, Respond and Recover. We are committed to the protection of our data, systems, network and continually invest in enhancements to mitigate or reduce the impact from a cyber security threat. We conduct periodic tests to maintain readiness and resiliency while regularly reviewing policies in the interest of protecting data security. External companies or agencies may be called upon to provide consulting, guidance, assistance, or some other form of support in response to a cybersecurity incident. The regular training of employees, at least annually, on the ever-present threat of cybersecurity helps maintain data security.</ix:continuation></ix:nonNumeric> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_430"></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160; PROPERTIES</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Center </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;Our primary Service Center is located at our San Juan Capistrano, California campus, which we acquired for a purchase price of $31.0 million to accommodate our growing Service Center team. The property consists of approximately 108,058 square feet of usable office space. In addition, we lease a portion of the space within the campus to third-party tenants. We also have service centers located in Tempe, Arizona; San Antonio, Texas; Dallas, Texas and Salt Lake City, Utah.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Facilities </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate 327 independent subsidiaries in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin, with the operational capacity to serve approximately 37,000 patients as of December&#160;31, 2024. Of the 327 facilities, we operate 231 facilities under long-term lease arrangements and have options to purchase 12 of those 231 facilities. The results of our independent subsidiaries are reflected in our skilled services segment for our skilled nursing operations and in the "All Other" category for our senior living operations. For more information about our subsequent acquisitions, see Part II, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides summary information regarding the location of our facilities, operational beds and units by property type as of December&#160;31, 2024:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.143%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operated Facilities </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leased without a Purchase Option </span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Leased with a Purchase Option</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned </span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Facilities </span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beds/Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Facilities </span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beds/Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Facilities </span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beds/Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Facilities</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Beds/Units</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,975</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,724</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,636</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,232</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,868</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,342</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,198</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,540</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,916</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington </span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">391</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,129</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,443</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11,063</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36,635</span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the location of our facilities and the number of operational beds and units located at our skilled nursing, senior living and campus facilities as of December&#160;31, 2024:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:14.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.599%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Facility Counts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Bed / Unit Counts </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Nursing Operations</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Communities </span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Campus Operations</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Nursing Beds </span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Units </span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Beds / Units</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,120</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">604</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,724</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,671</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,868</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,649</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">891</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,540</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,379</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,012</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,071</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington </span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,378</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,476</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,079</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">286</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">11</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">327</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33,547</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,088</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36,635</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Real Estate Properties </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> As of December&#160;31, 2024, we owned 129 real estate properties in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin, which include 96</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">of the 327 facilities that we operate and manage. Of our 129 real estate properties, 33 operations are leased to and operated by third-party operators. One senior living facility is located on the same real estate property as a skilled nursing facility that we own and operate. We further own the real estate property of our Service Center's California location and continue to lease a portion of the office space to third-party tenants. Our Standard Bearer segment reflects the results of operations for 124 of the 129 owned real estate properties. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides summary information regarding the location of our owned real estate properties as of December&#160;31, 2024: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.291%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.613%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.618%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned and Operated by Ensign</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Owned and Leased to Third-Party Operators</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Service Center</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Properties</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah </span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kansas</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho </span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Carolina</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nebraska</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tennessee</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa </span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">96</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">33</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">129</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) One senior living operation in Texas, which is owned by an independent subsidiary of Ensign and leased to a third-party operator, is located on the same real estate property as a skilled nursing facility that we own and operate. In this situation, the senior living operation is included in the total under "Owned and Leased to Third Party Operators" and the skilled nursing operation is included in the total under "Owned and Operated by Ensign", however, the amount reflected under "Total Properties" only recognizes the operation as a single property.</span></div><div style="text-align:justify"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_364"></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160; LEGAL PROCEEDINGS </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we enter into contracts that contingently require us to indemnify parties against third-party claims. These contracts primarily include (i) certain real estate leases, under which we may be required to indemnify property owners or prior facility operators for post-transfer environmental or other liabilities and other claims arising from our use of the applicable premises, (ii) operations transfer agreements, in which we agree to indemnify past operators of facilities we acquire against certain liabilities arising from the transfer of the operation and/or the operation thereof after the transfer to our independent subsidiary, (iii) certain lending agreements, under which we may be required to indemnify the lender against various claims and liabilities, and (iv) certain agreements with our officers, directors and others, under which we may be required to indemnify such persons for liabilities based on the nature of their relationship to us. The terms of such obligations vary by contract and, in most instances, do not expressly state or include a specific or maximum dollar amount. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Consequently, because no claims have been asserted, no liabilities have been recorded for these obligations on our balance sheets for any of the periods presented.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Matters</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws and regulations governing Medicare and Medicaid programs are complex and subject to review and interpretation. Compliance with such laws and regulations is evaluated regularly, the results of which can be subject to future governmental review and interpretation and can include significant regulatory action with the possibility of fines, penalties, and exclusion from certain governmental programs. Included in these laws and regulations is the Health Insurance Portability and Accountability Act of 1996 (monitored and enforced by the Office of Civil Rights), the terms of which require healthcare providers (among other things) to safeguard the privacy and security of certain patient protected health information.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our independent subsidiaries are party to various legal actions and administrative proceedings and are subject to various claims arising in the ordinary course of business, including claims that services provided to patients by our independent subsidiaries have resulted in injury or death, and claims related to employment and commercial matters. For example, in a four-week medical negligence trial in the State of Arizona, the jury returned a verdict against one of our independent subsidiaries in late November 2023. We are in the process of appealing the jury verdict. We have in the past appealed similar decisions and have, in some circumstances, received decisions in our favor. Although we intend to vigorously defend against these claims and in general these types of claims and cases, there can be no assurance that the outcomes of these matters will not have a material adverse effect on operational results and financial condition. Additionally, in certain states in which we have or have had independent subsidiaries, insurance coverage for the risk of punitive damages arising from general and professional liability litigation may not be available due to state law and/or public policy prohibitions. There can be no assurance that we and or our independent subsidiaries will not be liable for punitive damages awarded in litigation arising in states for which punitive damage insurance coverage is not available. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The skilled nursing and post-acute care industry is heavily regulated. As such, we and our independent subsidiaries are continuously subject to state and federal regulatory scrutiny, supervision and intervention in the ordinary course of business. Such regulatory scrutiny often includes inquiries, investigations, examinations, audits, site visits and surveys, some of which are non-routine. In addition to being subject to regulatory oversight from state and federal agencies, the skilled nursing and post-acute care industry is also subject to regulatory requirements which, if noncompliance is identified, could result in civil, administrative or criminal fines, penalties or restitutionary relief, and/or reimbursement; authorities could also seek the suspension or exclusion of a provider or individual from participation in State and Federal healthcare programs. We believe that there has been, and will continue to be, an increase in governmental investigations of post-acute providers, particularly in alleged Medicare/Medicaid false claims, as well as an increase in enforcement actions resulting from these investigations. Adverse determinations in civil legal proceedings or governmental investigations, whether currently asserted or arising in the future, could have a material adverse effect on our financial position, results of operations, and cash flows. Additionally, such proceedings and/or investigation can be a distraction to the business of our independent subsidiaries.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, on behalf of our independent subsidiaries, received a Civil Investigative Demand (CID) from the U.S. Department of Justice (DOJ) in January of 2024 indicating that the DOJ is investigating the Company to determine whether claims have been submitted to Medicare and Texas Medicaid for services which were unnecessary or otherwise not consistent with existing reimbursement requirements. The CID covers the period from January 1, 2016 to the present. As a general matter, our independent subsidiaries maintain policies and procedures to promote compliance with all applicable Medicare and Medicaid requirements, including, but not limited to those relating to the presentation of claims for reimbursement for services provided. We are fully cooperating with the DOJ in response to the CID. However, we cannot predict the outcome of the investigation or its potential impact to the consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the potential lawsuits and claims described above, we and our independent subsidiaries are also subject to potential lawsuits under the FCA and comparable state laws alleging submission of fraudulent claims for services to any Federal and State healthcare program (such as Medicare or Medicaid). A violation may provide the basis for exclusion from federally funded healthcare programs. Such exclusions could have a correlative negative impact on our financial performance. In addition, and pursuant to the qui tam or "whistleblower" provisions of the FCA, a private individual with knowledge of fraud or potential fraud may bring a claim on behalf of the Federal government, and receive a percentage of any recovery obtained. Due to these whistleblower incentives, qui tam lawsuits have become more frequent. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, on May 31, 2018, we, on behalf of our independent subsidiaries, received a CID from the DOJ stating that it was investigating to determine whether there had been a violation of the FCA and/or the Anti-Kickback Statute (AKS) with respect to the relationships between certain of our independent subsidiaries and persons who serve or have served as medical directors. We fully cooperated with the DOJ and promptly responded to its requests for information. In April 2020, we were advised that the DOJ declined to intervene in any subsequent action filed in connection with the subject matter of this investigation. Despite the decision of the DOJ to decline to participate in litigation based on the subject matter of its previously issued CID, the involved qui tam relator moved forward with the complaint in December 2020. From that time until December 2023, and notwithstanding our success in early pre-trial motions, we continued to incur legal defense costs and fees, including significant amounts related to the mandatory exchange of information between the parties in the fourth quarter of 2023. In 2024, we entered into mediation with the involved parties and agreed to settle the civil case for $48.0 million. Following the finalization of the settlement documents and payment of the settlement funds, the qui tam complaint was dismissed and the matter was resolved. The settlement does not include admissions on the part of the Company or our independent subsidiaries, and we maintain that we have consistently complied with and continue to comply with all applicable State and Federal statutes (including but not limited to the FCA and the AKS). </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the FCA, some states, including California, Arizona and Texas, have enacted similar whistleblower and false claims laws and regulations. Further, the Deficit Reduction Act of 2005 created incentives for states to enact anti-fraud legislation modeled on the FCA. As such, we and our independent subsidiaries could face increased scrutiny, potential liability and legal expenses and costs based on claims under state false claims acts in markets where our independent subsidiaries do business.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Fraud Enforcement and Recovery Act of 2009 (FERA), health care providers face significant penalties for the knowing retention of government overpayments, even if no false claim was involved. Health care providers can now be liable for knowingly and improperly avoiding or decreasing an obligation to pay money or property to the government. This includes the retention of any government overpayment. The government can argue, therefore, that an FCA violation can occur without any affirmative fraudulent action or statement, if the action or statement is knowingly improper. In addition, FERA extended protections against retaliation for whistleblowers, including protections not only for employees, but also contractors and agents. Thus, an employment relationship is generally not required in order to qualify for protection against retaliation for whistleblowing.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare litigation (including class action litigation) is common and is filed based upon a wide variety of claims and theories. We and our independent subsidiaries have been subjected to, and/or are currently involved in, class action litigation alleging violations (alone or in combination) of state and federal wage and hour law related to the alleged failure to pay wages, to timely provide and authorize meal and rest breaks, and other such similar causes of action. Additionally, in July of 2024, two of our independent subsidiaries received a subpoena to produce documents related to alleged environmental matters from the United States&#8217; Attorney&#8217;s office for the Western District of Washington. Our independent subsidiaries are fully cooperating with the United States' Attorney&#8217;s office in response to the subpoena. We do not believe that the ultimate resolution of this matter will have a material adverse effect on our business, cash flows, financial condition or results of operations. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our independent subsidiaries have been, and continue to be, subject to claims, findings and legal actions that arise in the ordinary course of the various businesses, including in connection with the delivery of healthcare and non-healthcare services. These claims include but are not limited to potential claims related to patient care and treatment (professional negligence claims) as well as employment related claims. While we have been able to settle or otherwise resolve many of these types of claims without an ongoing material adverse effect on our business, a significant increase in the number of these claims, or an increase in the amounts owing should plaintiffs be successful in their prosecution of remaining or future claims, could materially adversely affect our business, financial condition, results of operations and cash flows. In addition, these claims could impact our ability to procure insurance to cover our exposure related to the various services provided by our independent subsidiaries to their residents, customers and patients.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both government and private pay sources have instituted cost-containment measures designed to limit payments made to providers of healthcare services, and there can be no assurance that future measures designed to limit payments made to providers will not adversely affect us.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Revenue Recoupments</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our independent subsidiaries are subject to regulatory reviews relating to the provision of Medicare services, billings and potential overpayments resulting from reviews conducted via RAC, various Program Safeguard Contractors and Medicaid Integrity Contractors (collectively referred to as Reviews). Reviews vary in claim selection size and processes, ranging from a single episode/claim to larger, multi-claim batches; and from single rounds of review to reviews of multiple rounds with pass/fail criteria. If an operation has a significant error or fails a Review and/or subsequent Reviews, the operation could then be subject to extended review or an extrapolation of the identified error rate to billings in the same time period. We anticipate that these Reviews could increase in frequency in the future. As of December&#160;31, 2024 and through the filing date of this report, 18 of our independent subsidiaries had multi-claim Reviews scheduled or in process. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, CMS announced a new nationwide audit, the &#8220;SNF 5-Claim Probe &amp; Educate Review,&#8221; in which the Medicare Administrative Contractors will review five claims from each SNF to evaluate for claims compliance. In implementing this SNF 5-Claim Probe &amp; Educate Review, CMS acknowledged that the increase in observed improper payments from 2021 to 2022 may have arisen from a &#8220;misunderstanding&#8221; by SNFs about how to appropriately bill for claims of service after October 1, 2019. All facilities that are not undergoing TPE reviews, or have not recently passed a TPE review, will be subject to the nationwide audit. MACs will complete only one round of probe-and-educate for each SNF, rather than the three rounds that typically occur in the TPE Program. Additionally, CMS&#8217;s education for each SNF will be individualized and based on observed claim review errors, with rationales for denial explained to the SNF on a claim-by-claim basis. This program will apply only to claims submitted after October 1, 2019, and will exclude claims containing a COVID-19 diagnosis.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_382"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160; MINE SAFETY DISCLOSURES </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_361"></div><div style="text-align:center"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART II.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_439"></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160; MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES </span></div><div style="margin-top:9pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market Information </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded under the symbol &#8220;ENSG&#8221; on the NASDAQ Global Select Market. As of January&#160;31, 2025, there were approximately 359 holders of record of our common stock. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Notwithstanding anything to the contrary set forth in any of our filings under the Securities Act or the Exchange Act that might incorporate future filings, including the Annual Report on Form 10-K, in whole or in part, the Stock Performance Graph and supporting data which follows shall not be deemed to be incorporated by reference into any such filings except to the extent that we specifically incorporate any such information into any such future filings.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below shows the cumulative total stockholder return of investment of $100 (and the reinvestment of any dividends thereafter) on December 31, 2019 in (i) our common stock, (ii) the Skilled Nursing Facilities Peer Group 1 and (iii) the NASDAQ Market Index. Our stock price performance shown in the graph below is not indicative of future stock price performance.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPARISON OF 60 MONTH CUMULATIVE TOTAL RETURN*</span></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Among Ensign Group, the NASDAQ Composite Index and Our Peer Group</span></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December 2024 </span></div><div style="text-align:center;text-indent:24.75pt"><img src="ensg-20241231_g6.jpg" alt="2248" style="height:350px;margin-bottom:5pt;vertical-align:text-bottom;width:750px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*Assumes $100 invested on December 31, 2019 in stock in index, including reinvestment of dividends.</span></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fiscal year ended December 31.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:34.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.887%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Ensign Group, Inc.</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.37&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186.25&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">210.40&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.09&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.63&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NASDAQ Market Index</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144.92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172.77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223.87&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peer Group</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.80&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The current composition of our Peer Group is as follows: Amedysis, Inc., CareTrust REIT Inc., Encompass Healthcare Corp., LTC Properties, Inc., National Healthcare Corporation, National Health Investors, Inc., Omega Healthcare Investors, Inc., PACS Group, Inc., Select Medical Holdings Corp. and Welltower Inc. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Policy </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not have a formal dividend policy, but we currently intend to continue to pay regular quarterly dividends to the holders of our common stock. We have been a dividend-paying company since 2002 and have increased our dividend every year for the last 22 years.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer Repurchases of Equity Securities</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Programs </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2024, the Board of Directors approved a stock repurchase program pursuant to which we may repurchase up to $20.0 million of our common stock under the program for a period of approximately 12 months from September&#160;1, 2024.  We did not purchase any shares pursuant to this stock repurchase program during the year ended December 31, 2024. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 29, 2023, the Board of Directors approved a stock repurchase program pursuant to which we may repurchase up to $20.0 million of our common stock under the program for a period of approximately 12 months from September&#160;1, 2023. The program terminated by its terms on August 31, 2024 and is no longer in effect. We did not purchase any shares pursuant to this stock repurchase program. </span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these repurchase programs, we are authorized to repurchase our issued and outstanding common shares from time to time in open-market and privately negotiated transactions, tender offers, pursuant to contractual provisions, and block trades, or otherwise in accordance with federal securities laws. The share repurchase program does not obligate us to acquire any specific number of shares. Any such repurchases will depend on our business strategy, prevailing market conditions, our liquidity requirements, contractual restrictions or covenants, compliance with securities laws, and other factors. The amounts involved in any such transaction may be material.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_445"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160; [RESERVED]</span></div><div style="text-align:justify"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_304"></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.&#160;&#160;&#160;&#160; MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the consolidated financial statements and accompanying notes, which appear elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Annual Report on Form 10-K. See Part I. Item 1A. Risk Factors and Cautionary Note Regarding Forward-Looking Statements. </span></div><div style="margin-bottom:5pt;margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For discussion of 2022 items and year-over-year comparisons between 2023 and 2022 that are not included in this 2024 Form 10-K, refer to &#8220;Item 7. &#8211; Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; found in our Form 10-K for the year ended December&#160;31, 2023, that was filed with the Securities and Exchange Commission on February&#160;1, 2024.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a provider of health care services across the post-acute care continuum. We engage in the operation, ownership, acquisition, development and leasing of skilled nursing, senior living and other healthcare related properties and ancillary businesses located in Alabama, Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. Our independent subsidiaries, each of which strive to be the operation of choice in the communities they serve, provide a broad spectrum of services. As of December&#160;31, 2024, we offered skilled nursing, long term acute care, senior living and rehabilitative care services through 327 skilled nursing and senior living facilities. Our real estate portfolio includes 129 owned real estate properties, which includes 96</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">facilities operated and managed by us, 33 operations leased to and operated by third-party operators and the Service Center location. Of the 33 third-party operations, one senior living operation is located on the same real estate property as a skilled nursing operation that we own and operate.</span></div><div style="text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"/><td style="width:54.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.450%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.454%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ensign Group, Inc. is a holding company with no direct operating assets, employees or revenues. Our subsidiaries are operated by separate, independent entities, each of which has its own management, employees and assets. In addition, certain of our wholly-owned subsidiaries including Ensign Services, Inc. and Cornet Limited, Inc., referred to collectively as the Service Center, provide centralized accounting, payroll, human resources, information technology, legal, risk management and other centralized services to the other independent subsidiaries. We also have a wholly-owned captive insurance subsidiary that provides some claims-made coverage to our independent subsidiaries for general and professional liability, as well as coverage for certain workers&#8217; compensation insurance liabilities and our captive real estate trust owns and operates our real estate portfolio. Our captive real estate investment trust, Standard Bearer, owns and manages our real estate business. References herein to the consolidated &#8220;Company&#8221; and &#8220;its&#8221; assets and activities, as well as the use of the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar terms in this Annual Report, are not meant to imply, nor should they be construed as meaning that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by The Ensign Group, Inc.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Activities</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we exist to dignify and transform post-acute care. We set out a strategy to achieve our goal of ensuring our patients are receiving the best possible care through our ability to acquire, integrate and improve our operations. Our results serve as a strong indicator that our strategy is working and our transformation is underway. Our dedication to our cultural and operational fundamentals continues to deliver strong results. Refer to </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operational Update</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our combined Same Facilities and Transitioning Facilities occupancy increased by 2.9% compared to the same period in 2023.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the first quarter of 2024, Same Facilities skilled nursing occupancy has surpassed pre-pandemic occupancy. Our focus on rebuilding census resulted in Same Facilities occupancy of 81.3% during the year ended December 31, 2024 compared to 79.2% in the same period in 2023. These results were possible due to the innovative approaches and strategic partnerships which supported our multiple year growth in occupancy improvements and continue to enable us to gain additional market share. These key initiatives together with our dedication to our cultural and operational fundamentals resulted in strong 2024 results.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operational and New State Expansions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, we expanded our operations with the addition of 28 stand-alone skilled nursing operations and three campus operations, which added a total of 3,030 operational skilled nursing beds and 218 operational senior living units to be operated by our independent subsidiaries. Subsequent to December&#160;31, 2024, we added seven stand-alone skilled nursing operations, which added 682 operational skilled nursing beds to be operated by our independent subsidiary. We also invested in new ancillary services that are complementary to our existing businesses.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Twelve of the operations mentioned above are located in Tennessee and Alabama, which are new states for us.  The expansion into the two new states are part of our strategic vision to further strengthen our growing national presence in both existing and new attractive markets. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standard Bearer Update</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer Healthcare REIT, Inc. (Standard Bearer), our captive REIT, is a holding company with subsidiaries that own a majority of our real estate portfolio. We expect the REIT structure to allow us to better demonstrate the growing value of our owned real estate and provide us with an efficient vehicle for future acquisitions of properties that could be operated by our independent subsidiaries or other third parties. This structure gives us new pathways to growth with transactions we would not have considered in the past.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, Standard Bearer added $131.9 million of real estate associated with 11 stand-alone skilled nursing operations, three stand-alone senior living operations and three campus operations.</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Of these additions, the stand-alone skilled nursing and campus operations are</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operated by </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three stand-alone senior living operations are leased to a third-party operator. Our existing relationships with third-party operators within our industry have allowed us to expand our growing REIT structure to operators outside of our organization. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the fair value of Standard Bearer's real estate portfolio is approximately $1.3 billion. The fair value was determined by a third-party independent valuation specialist and incorporated each property's rental income, capitalization rate, rental yield rate and discount rate. </span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, Standard Bearer added $50.9 million of real estate associated with four stand-alone skilled nursing operations and one campus operation. Four of the acquisitions were related to exercising purchase options from CareTrust REIT, Inc. (CareTrust) lease arrangements, which the operations are currently operated and managed by our independent subsidiaries. The remaining real estate acquisition was leased back to our independent subsidiaries.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insignia Pathway </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2024, we funded $35.0 million to the formation of Insignia Pathway, an independent public charity, with a mission to empower, support and expand the post acute care workforce through recruiting talent, providing resources, education, housing and advocacy to enhance professional growth, job satisfaction and community impact. Insignia Pathway is dedicated to addressing workforce challenges, fostering equity and inspiring the current and next generation to join the essential field of post acute care. Insignia Pathway is currently in the process of applying for recognition of exemption as an organization under Section 501(c)(3) of the Internal Revenue Code.  </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Repurchase Program</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2024, the Board of Directors approved a stock repurchase program pursuant to which we may repurchase up to $20.0&#160;million of our common stock under the program for a period of approximately 12 months from September&#160;1, 2024. We did not repurchase any shares during the fiscal year 2024.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_3845"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Key Performance Indicators</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage the fiscal aspects of our business by monitoring key performance indicators that affect our financial performance. Revenue associated with these metrics is generated based on contractually agreed-upon amounts or rate, excluding the estimates of variable consideration under the revenue recognition standard, Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606. These indicators and their definitions include the following:</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skilled Services</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Routine revenue </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Routine revenue is generated by the contracted daily rate charged for all contractually inclusive skilled nursing services. The inclusion of therapy and other ancillary treatments varies by payor source and by contract. Services provided outside of the routine contractual agreement are recorded separately as ancillary revenue, including Medicare Part&#160;B therapy services, and are not included in the routine revenue definition.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Skilled revenue </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of routine revenue generated from patients in the skilled nursing facilities who are receiving higher levels of care under Medicare, managed care, Medicaid, or other skilled reimbursement programs. The other skilled patients who are included in this population represent very high acuity patients who are receiving high levels of nursing and ancillary services which are reimbursed by payors other than Medicare or managed care. Skilled revenue excludes any revenue generated from our senior living services.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Skilled mix </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The amount of our skilled revenue as a percentage of our total skilled nursing routine revenue. Skilled mix (in days) represents the number of days our Medicare, managed care, or other skilled patients are receiving skilled nursing services at the skilled nursing facilities divided by the total number of days patients from all payor sources are receiving skilled nursing services at the skilled nursing facilities for any given period.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Average daily rates </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The routine revenue by payor source for a period at the skilled nursing facilities divided by actual patient days for that revenue source for that given period. These rates exclude additional state relief funding, which includes the American Rescue Plan Act (ARPA), the Family First Coronavirus Response Act (FFCRA) and other state specific relief programs.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Occupancy percentage (operational beds) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total number of patients occupying a bed in a skilled nursing facility as a percentage of the beds in a facility which are available for occupancy during the measurement period.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:13.02pt">Number of facilities and operational beds </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total number of skilled nursing facilities that we own or operate and the total number of operational beds associated with these facilities.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skilled Mix </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Like most skilled nursing providers, we measure both patient days and revenue by payor. Medicare, managed care and other skilled patients, whom we refer to as high acuity patients, typically require a higher level of skilled nursing and rehabilitative care. Accordingly, Medicare and managed care reimbursement rates are typically higher than from other payors. In most states, Medicaid reimbursement rates are generally the lowest of all payor types. Changes in the payor mix can significantly affect our revenue and profitability.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our overall skilled mix from our skilled nursing services for the periods indicated as a percentage of our total skilled nursing routine revenue and as a percentage of total skilled nursing patient days:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:62.882%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.176%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.178%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Mix:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Days</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.2&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Occupancy </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We define occupancy derived from our skilled services as the ratio of actual patient days (one patient day equals one patient occupying one bed for one day) during any measurement period to the number of beds in facilities which are available for occupancy during the measurement period. The number of beds in a skilled nursing facility that are actually operational and available for occupancy may be less than the total official licensed bed capacity. This sometimes occurs due to the permanent dedication of bed space to alternative purposes, such as enhanced therapy treatment space or other desirable uses calculated to improve service offerings and/or operational efficiencies in a facility. In some cases, three- and four-bed wards have been reduced to two-bed rooms for resident comfort, and larger wards have been reduced to conform to changes in Medicare requirements. These beds are seldom expected to be placed back into service. We believe that reporting occupancy based on operational beds is consistent with industry practices and provides a more useful measure of actual occupancy performance from period to period.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our overall occupancy statistics for skilled nursing operations for the periods indicated:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.301%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Occupancy for skilled services:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operational beds at end of period</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,547&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,602&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available patient days</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,710,297&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,940,320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual patient days</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,431,825&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,590,995&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy percentage (based on operational beds)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="border-bottom:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two reportable segments: (1) skilled services, which includes the operation of skilled nursing facilities and rehabilitation therapy services and (2) Standard Bearer, which is comprised of select properties owned by us through our captive REIT and leased to skilled nursing and senior living operations, including our own independent subsidiaries and third-party operators. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also reported an &#8220;all other&#8221; category that includes operating results from our senior living operations, mobile diagnostics, transportation, other real estate and other ancillary operations. These businesses are neither significant individually, nor in aggregate and therefore do not constitute a reportable segment. Our Chief Executive Officer, who is our chief operating decision maker, or CODM, reviews financial information at the operating segment level. </span></div><div style="text-align:justify"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_3787"></div><div style="margin-top:3pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Sources</span></div><div style="margin-top:1pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:1pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Skilled Services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Within our skilled nursing operations, we generate revenue from Medicaid, private pay, managed care and Medicare payors.&#160;We believe that our skilled mix, which we define as the number of days Medicare, managed care and other skilled patients are receiving services at our skilled nursing operations divided by the total number of days patients are receiving services at our skilled nursing operations, from all payor sources (less days from senior living services) for any given period, is an important indicator of our success in attracting high-acuity patients because it represents the percentage of our patients who are reimbursed by Medicare, managed care and other skilled payors, for whom we receive higher reimbursement rates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:1pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in supplemental payment programs and quality improvement programs in various states that provide supplemental Medicaid payments for skilled nursing facilities that are licensed to non-state government-owned entities such as city and county hospital districts. A number of our independent subsidiaries have entered into transactions with various hospital districts providing for the transfer of the licenses for those skilled nursing facilities to the hospital districts. Each affected independent subsidiary agreement between the hospital district and our subsidiary is terminable by either party to fully restore the prior license status. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standard Bearer</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate rental revenue primarily by leasing post-acute care properties that we acquired to healthcare operators under triple-net lease arrangements, whereby the tenants are solely responsible for the costs related to the property, including property taxes, insurance and maintenance and repair costs, subject to certain exceptions. As of December&#160;31, 2024, our real estate portfolio within Standard Bearer is comprised of 124 real estate properties. Of these properties, 92 are leased to our independent subsidiaries and 33 are leased to facilities wholly-owned and managed by third-party operators. Of those 33 operations, one senior living operation is located on the same real estate property as a skilled nursing operation that an independent subsidiary operates. During the year ended December 31, 2024, we generated rental revenues of $95.1 million, of which $78.1 million was derived from our independent subsidiaries and therefore eliminated in consolidation. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our senior living operations, we generate revenue primarily from private pay sources, with a portion earned from Medicaid payors or through other state-specific programs. Payment for these services varies and is based upon the service provided. The payment is adjusted for an inability to obtain appropriate billing documentation or authorizations acceptable to the payor and other reasons unrelated to credit risk.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Primary Components of Expense</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(exclusive of rent and depreciation and amortization shown separately) </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our cost of services represents the costs of operating our operating subsidiaries, which primarily consists of payroll and related benefits, supplies, purchased services, and ancillary expenses such as the cost of pharmacy and therapy services provided to patients. Cost of services also includes the cost of general and professional liability insurance, rent expenses related to leasing our operational facilities that are not included in facility rent - cost of services, and other general cost of services with respect to our operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Facility Rent - Cost of Services </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Rent - cost of services consists solely of base minimum rent amounts payable under lease agreements to third-party real estate owners. Our independent subsidiaries lease and operate but do not own the underlying real estate and these amounts do not include taxes, insurance, impounds, capital reserves or other charges payable under the applicable lease agreements.  Expenses related to leasing our operations are included in cost of services. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expense </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense consists primarily of payroll and related benefits and travel expenses for our Service Center personnel, including training and other operational support. General and administrative expense also includes professional fees (including accounting and legal fees), costs relating to our information systems and stock-based compensation related to our Service Center employees.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Property and equipment are recorded at their original historical cost. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets. The following is a summary of the depreciable lives of our depreciable assets:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.502%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:66.298%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Minimum of three years to a maximum of 59 years, generally 45&#160;years</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of the lease term or estimated useful life, generally 5 to 15&#160;years</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 to 10&#160;years</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP). The preparation of these financial statements and related disclosures requires us to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. We believe that the application of the following accounting policies, which are important to our financial position and results of operations, require significant judgments and estimates on the part of management. For a summary of our significant accounting policies, including the accounting policies discussed below, see Note 2, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of the Notes to the Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable consideration within revenue recognition</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. We determine the transaction price based on contractually agreed-upon amounts or rates, adjusted for estimates of variable consideration. We use the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from our estimates, we adjust these estimates, which would affect net service revenue in the period such variances become known. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-insurance for general and professional liability</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The self-insured retention and deductible limits for general and professional liability for all states, except Kansas, are self-insured through our wholly owned captive insurance subsidiary (the Captive Insurance), the related assets and liabilities of which are included in the accompanying consolidated balance sheets.  Our general and professional liability as of the years ended December 31, 2024 and 2023 was $160.1 million and $117.7 million, respectively. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is to accrue amounts equal to the actuarially estimated costs to settle open claims of insureds, as well as an estimate of the cost of insured claims that have been incurred but not reported. We develop information about the size of the ultimate claims based on historical experience, current industry information and actuarial analysis and evaluate the estimates for claim loss exposure on a quarterly basis. We use actuarial valuations to estimate the liability based on historical experience and industry information.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_319"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we exist to dignify and transform post-acute care. We set out a strategy to achieve our goal of ensuring our patients are receiving the best possible care through our ability to acquire, integrate and improve our operations. Our results serve as a strong indicator that our strategy is working and our transformation is underway. Over the last five years, our total revenue increased by $2.2 billion, or 109.2%, representing a 15.9% compound annual growth rate (CAGR) while our diluted GAAP earning per share (EPS) from continuing operations grew by $3.48 from 2019 to 2024, representing a 25.6% CAGR. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total revenue for the year ended December 31, 2024 increased $531.1 million, or 14.2%, compared to the year ended December 31, 2023. Throughout 2024, we continued to make progress on targeted initiatives related to increasing occupancy and the level of acuity and complexity of the patients we serve in our facilities, attracting and developing our people and acquiring underperforming skilled nursing operations and integrating them with our proven cultural and operational principles.  During the year ended December 31, 2024, we added 31 new operations. We consistently experience healthy growth in both revenue and overall results as we continue to work diligently with existing and recently acquired operations so that each can reach its full clinical and financial potential. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our combined Same Facilities and Transitioning Facilities occupancy increased by 2.9% compared to the same period in 2023.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the first quarter of 2024, Same Facilities skilled nursing occupancy has surpassed pre-pandemic occupancy. Our focus on rebuilding census resulted in Same Facilities occupancy of 81.3% during the year ended December 31, 2024 compared to 79.2% in the same period in 2023, demonstrating our ability to gain additional market share even at our more mature operations. Further, our Transitioning Facilities occupancy increased by 4.1% to 76.0% compared to the same period in 2023, highlighting our organic growth ability that results from transforming underperforming operations that we have acquired.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout most of our history, our business is affected by seasonal fluctuations in occupancy and acuity, which are most prominent when comparing the summer and winter months of the calendar year. For skilled nursing occupancy and skilled mix, our historic seasonal trend tends to show stronger occupancy and acuity during the first and fourth quarters and softening in the second and third quarters. Additionally, we historically have acquired operations with lower occupancy and skilled mix. As these operations become "operations of choice" in each of their respective healthcare markets, we typically see both occupancy and skilled mix increase. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our strength remains in our operating model, which empowers each operator to form their own market-specific strategy and adjust to the needs of their local medical communities, including methods for attracting new healthcare professionals into our workforce and retaining and developing existing staff. Despite continued labor pressures, there are positive trends on both turnover and agency usage across our operations. During 2024, we added over 4,000 full-time equivalent team members, or 11%, to our independent subsidiaries and the Service Center.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth details of operating results for our revenue, expenses and earnings, and their respective components, as a percentage of total revenue for the periods indicated:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.806%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">REVENUE:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.5&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.4&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL REVENUE</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL EXPENSES</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">91.6</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">93.2</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INCOME (EXPENSE), NET</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">0.5</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET INCOME</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.6</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income attributable to noncontrolling interests </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;Net income attributable to The Ensign Group, Inc.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.6</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.394%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.998%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.001%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SEGMENT INCOME</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">518,463&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">464,925&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Standard Bearer</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2) </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,065&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NON-GAAP&#160;FINANCIAL MEASURES:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PERFORMANCE METRICS </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBT</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427,976&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">365,310&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3) </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449,284&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333,569&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490,392&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FFO for Standard Bearer</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,632&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">VALUATION METRICS</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDAR</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">706,408&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Segment income represents operating results of the reportable segments excluding gain and loss on sale of assets, real estate insurance recoveries and losses, impairment charges and provision for income taxes. Included in segment income for Standard Bearer are expenses for intercompany management fees between Standard Bearer and the Service Center and intercompany interest expense. Segment income is reconciled to the Consolidated Statement of Income in Note 8, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Business Segments </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">in Notes to Financial Statements of this Annual Report on Form 10-K.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Standard Bearer segment income includes rental revenue and expenses from our independent subsidiaries.</span></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) EBITDA includes litigation related to specific proceedings arising outside of the ordinary course of business as discussed in Item 3. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion includes references to Adjusted EBT, EBITDA, Adjusted EBITDA, Adjusted EBITDAR and Funds from Operations (FFO) which are non-GAAP financial measures (collectively, the Non-GAAP Financial Measures). Regulation G, Conditions for Use of Non-GAAP Financial Measures, and other provisions of the Securities Exchange Act of 1934, as amended (the Exchange Act), define and prescribe the conditions for use of certain non-GAAP financial information. These Non-GAAP Financial Measures are used in addition to and in conjunction with results presented in accordance with GAAP. These Non-GAAP Financial Measures should not be relied upon to the exclusion of GAAP financial measures. These Non-GAAP Financial Measures reflect an additional way of viewing aspects of our operations that, when viewed with our GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting our business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the presentation of certain Non-GAAP Financial Measures are useful to investors and other external users of our financial statements regarding our results of operations because:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">they are widely used by investors and analysts in our industry as a supplemental measure to evaluate the overall performance of companies in our industry without regard to items such as interest income, interest expense and depreciation and amortization, which can vary substantially from company to company depending on the book value of assets, capital structure and the method by which assets were acquired; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">they help investors evaluate and compare the results of our operations from period to period by removing the impact of our capital structure and asset base from our operating results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the Non-GAAP Financial Measures:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">as measurements of our operating performance to assist us in comparing our operating performance on a consistent basis;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%;padding-left:13.02pt">to allocate resources to enhance the financial performance of our business;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%;padding-left:13.02pt">to assess the value of a potential acquisition;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%;padding-left:13.02pt">to assess the value of a transformed operation's performance;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%;padding-left:13.02pt">to evaluate the effectiveness of our operational strategies; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:90%;padding-left:13.02pt">to compare our operating performance to that of our competitors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use certain Non-GAAP Financial Measures to compare the operating performance of each operation. These measures are useful in this regard because they do not include such costs as other expense, income taxes, depreciation and amortization expense, which may vary from period-to-period depending upon various factors, including the method used to finance operations, the amount of debt that we have incurred, whether an operation is owned or leased, the date of acquisition of a facility or business, and the tax law of the state in which a business unit operates.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also establish compensation programs and bonuses for our leaders that are partially based upon the achievement of certain Non-GAAP Financial Measures.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the importance of these measures in analyzing our underlying business, designing incentive compensation and for our goal setting, the Non-GAAP Financial Measures have no standardized meaning defined by GAAP. Therefore, certain of our Non-GAAP Financial Measures have limitations as analytical tools, and they should not be considered in isolation, or as a substitute for analysis of our results as reported in accordance with GAAP. Some of these limitations are:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">they do not reflect our current or future cash requirements for capital expenditures or contractual commitments;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">they</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">do not reflect changes in, or cash requirements for, our working capital needs;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">they</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">do not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">they do not reflect rent expenses, which are necessary to operate our leased operations, in the case of Adjusted EBITDAR;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">they</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">do not reflect any income tax payments we may be required to make;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">although</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and do not reflect any cash requirements for such replacements; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">other</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies in our industry may calculate these measures differently than we do, which may limit their usefulness as comparative measures.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compensate for these limitations by using them only to supplement net income on a basis prepared in accordance with GAAP in order to provide a more complete understanding of the factors and trends affecting our business. Management strongly encourages investors to review our consolidated financial statements in their entirety and to not rely on any single financial measure. Because these Non-GAAP Financial Measures are not standardized, it may not be possible to compare these financial measures with other companies&#8217; Non-GAAP financial measures having the same or similar names. These Non-GAAP Financial Measures should not be considered a substitute for, nor superior to, financial results and measures determined or calculated in accordance with GAAP. We strongly urge you to review the reconciliation of income from operations to the Non-GAAP Financial Measures in the table below, along with our Financial Statements and related notes included elsewhere in this document. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the following Non-GAAP financial measures that we believe are useful to investors as key valuation and operating performance measures:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PERFORMANCE MEASURES</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBT</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adjust income before provision for income taxes (Adjusted EBT) when evaluating our performance because we believe that the exclusion of certain additional items described below provides useful supplemental information to investors regarding our ongoing operating performance. We believe that the presentation of Adjusted EBT, when combined with income before provision for income taxes and GAAP net income attributable to The Ensign Group, Inc., is beneficial to an investor&#8217;s complete understanding of our operating performance. We use this performance measure as an indicator of business performance, as well as for operational planning, decision-making purposes and to determine compensation in our executive compensation plan.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBT is income before provision for income taxes adjusted for non-core business items, which for the reported periods includes, to the extent applicable: </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">stock-based compensation expense;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">litigation;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">loss (gain) on long-lived assets and gain on business interruption recoveries;</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">acquisition related costs; </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">costs incurred related to system implementations; </span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">write off of deferred financing fees; and</span></div><div style="margin-bottom:5pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">amortization of patient base intangible assets.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">EBITDA</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe EBITDA is useful to investors in evaluating our operating performance because it helps investors evaluate and compare the results of our operations from period to period by removing the impact of our asset base (depreciation and amortization expense) from our operating results.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate EBITDA as net income, adjusted for net losses attributable to noncontrolling interest, before (a) interest income, (b) provision for income taxes, (c) depreciation and amortization, and (d) interest expense. EBITDA in the prior period has been recast to conform to the current period presentation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adjust EBITDA when evaluating our performance because we believe that the exclusion of certain additional items described below provides useful supplemental information to investors regarding our ongoing operating performance, in the case of Adjusted EBITDA. We believe that the presentation of Adjusted EBITDA, when combined with EBITDA and GAAP net income attributable to The Ensign Group, Inc., is beneficial to an investor&#8217;s complete understanding of our operating performance. &#160;</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is EBITDA adjusted for the same non-core business items as listed in Adjusted EBT, except for write off of deferred financing fees and amortization of patient base intangible assets.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funds from Operations (FFO)</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider FFO to be a useful supplemental measure of the operating performance of Standard Bearer. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many real estate investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (NAREIT) created FFO as a supplemental measure of operating performance for REITs, which excludes historical cost depreciation from net income. We define (in accordance with the definition used by NAREIT) FFO to consist of Standard Bearer segment income, excluding depreciation and amortization related to real estate, gains or losses from the sale of real estate, insurance recoveries related to real estate and impairment of long-lived assets.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VALUATION MEASURE</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDAR</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;We use Adjusted EBITDAR as one measure in determining the value of prospective acquisitions. It is also a commonly used measure by our management, research analysts and investors, to compare the enterprise value of different companies in the healthcare industry, without regard to differences in capital structures and leasing arrangements. Adjusted EBITDAR is a financial valuation measure that is not specified in GAAP. This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense, and is therefore presented only for the current period.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjustments made and previously described in the computation of Adjusted EBITDA are also made when computing Adjusted EBITDAR. We calculate Adjusted EBITDAR by excluding rent-cost of services from Adjusted EBITDA.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the use of Adjusted EBITDAR allows the investor to compare operational results of companies who have operating and capital leases. A significant portion of capital lease expenditures are recorded in interest, whereas operating lease expenditures are recorded in rent expense.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles income before provision for income taxes to Adjusted EBT for the periods presented:</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.952%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated statements of income data:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,094&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,762&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,226&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,425)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,781&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on long-lived assets and gain on business interruption recoveries </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,335&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred related to system implementations</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization - patient base</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense - write off deferred financing fees</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ADJUSTED EBT</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">427,976</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">365,310</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Represents specific proceedings and adjustments arising outside of the ordinary course of business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Represents costs incurred to acquire operations that are not capitalizable. </span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Represents amortization expenses related to patient base intangible assets at newly acquired skilled nursing and senior living facilities.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4) Represents the write off of deferred financing fees associated with mortgage loans.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles net income to EBITDA, Adjusted EBITDA and Adjusted EBITDAR for the periods presented:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.952%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated statements of income data:</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,458&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,850&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:  Net income attributable to noncontrolling interests</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">28,749&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">19,216&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add:  Provision for income taxes</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">87,636&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">62,912&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Depreciation and amortization</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">84,138&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">72,387&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,286&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">8,087&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBITDA</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">449,284</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">333,569</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to EBITDA:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,226&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,767&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1) </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,425)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss (gain) on long-lived assets and gain on business interruption recoveries </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,335&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,132)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs incurred related to system implementations</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">963&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ADJUSTED EBITDA</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">490,392</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">425,762</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,016&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,358&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ADJUSTED EBITDAR </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">706,408</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:9pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Litigation relates to specific proceedings and adjustments arising outside of the ordinary course of business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Costs incurred to acquire operations that are not capitalizable. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_331"></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December&#160;31, 2024 Compared to the Year Ended December&#160;31, 2023</span></div><div style="margin-top:12pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth details of operating results for our revenue and earnings, and their respective components, by our reportable segment for the periods indicated.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.905%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.871%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">All Other</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Eliminations</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue </span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,076,825&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">95,086&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">192,881&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(104,307)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">4,260,485&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses, including other income, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,558,362&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">65,751&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">352,250&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(104,307)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,872,056&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment income (loss)</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">518,463&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(159,369)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">388,429&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on long-lived assets </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,335)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision for income taxes </span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">386,094</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;padding-right:-9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:42.823%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.888%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">All Other</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Eliminations</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue </span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,578,855&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">82,486&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">155,804&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(87,790)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,729,355&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses, including other income, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,113,930&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">53,421&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">377,055&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(87,790)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">3,456,616&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment income (loss)</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">464,925&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">29,065&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(221,251)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">272,739&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of assets and insurance recoveries from real estate, net</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">272,762</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.164%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total revenue increased by $531.1 million, or 14.2%, compared to the year ended December 31, 2023. The increase in revenue was primarily driven by an increase in occupancy of 2.7% and 4.1% from our skilled services in Same Facilities and Transitioning Facilities, respectively, coupled with increasing daily revenue rates and the impact of acquisitions. Additionally, our skilled services in Recently Acquired Facilities increased total revenue by $271.7 million, when compared to the same period in 2023.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skilled Services Segment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the skilled services revenue and key performance metrics by category during the years ended December 31, 2024 and 2023:</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL FACILITY RESULTS:</span></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled services revenue</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076,825&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,578,855&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">497,970&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of facilities at period end</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of campuses at period end</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual patient days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,431,825&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,590,995&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840,830&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy percentage &#8212; Operational beds</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.5&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.5&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing revenue</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #697f57;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #697f57;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.2&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SAME FACILITY RESULTS:</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled services revenue</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018,601&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823,314&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195,287&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of facilities at period end</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of campuses at period end</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual patient days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902,006&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,704,689&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy percentage &#8212; Operational beds</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.2&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.7&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing revenue</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.2&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.993%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITIONING FACILITY RESULTS:</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled services revenue</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507,143&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472,808&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,335&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of facilities at period end</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of campuses at period end</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual patient days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,336,074&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302,680&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy percentage &#8212; Operational beds</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.0&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.0&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.8&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing revenue</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RECENTLY ACQUIRED FACILITY RESULTS:</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled services revenue</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550,507&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,791&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271,716&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of facilities at period end</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of campuses at period end</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual patient days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,191,663&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625,265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy percentage &#8212; Operational beds</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.6&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.4&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled mix by nursing revenue</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.9&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.7&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.139%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FACILITY CLOSED RESULTS:</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skilled services revenue</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">574&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,942&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,368)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actual patient days</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,228&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,146)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy percentage &#8212; Operational beds</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.6&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.8&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Campus represents a facility that offers both skilled nursing and senior living services. Revenue and expenses related to skilled nursing and senior living services have been allocated and recorded in the respective operating segment. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Same Facility results represent all facilities purchased prior to January&#160;1, 2021. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Transitioning Facility results represent all facilities purchased from January&#160;1, 2021 to December&#160;31, 2022.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Recently Acquired Facility (Acquisitions) results represent all facilities purchased on or subsequent to January&#160;1, 2023. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Facility Closed results represent a closed operation during the year ended December 31, 2024 due to the transitioning of an intermediate care facility program to a group home setting, which is included in the All Other category. The skilled services revenue was excluded from Same Facility results for the years ended December 31, 2024 and 2023 for comparison purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skilled services revenue increased $498.0 million, or 13.9%, compared to the year ended December 31, 2023. The increases in skilled services revenue were across all payer types including increases in Medicaid revenue of $238.0 million, or 14.2%, Medicare revenue of $69.4 million, or 7.0%, managed care revenue of $123.6 million, or 18.6% and private revenue of $67.0 million, or 26.6%.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in skilled services revenue was primarily driven by strong occupancy performance across our skilled services operations. Our consolidated occupancy increased by 2.5% to 80.5% during the year ended December 31, 2024 compared to the same period in 2023, as a result of an increase in long-term care Medicaid patients and an increase in managed care skilled days. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue in our Same Facilities increased $195.3 million, or 6.9%, compared to the same period in 2023, due to increased occupancy from long-term care patients, strong skilled days and revenue per patient day. Our diligent efforts to strengthen our partnerships with various managed care organizations, hospitals and local communities, increased our managed care revenue by 12.1%, mainly due to increases in managed care days of 6.5% and revenue per patient day of 3.6%. We continued to see a shift in our patient population from Medicare to managed care as Medicare Advantage enrollment continues to account for a larger portion of the overall Medicare eligible population. In addition, Medicaid revenue increased by $89.8 million or 6.8%, mainly from the increases in Medicaid days and revenue per patient day. Our skilled mix days and revenue percentage decline was due to our non-skilled days and revenue growing at a faster pace than our skilled days and revenue.  Both skilled and non-skilled days and revenue increased from the prior year.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue generated by our Transitioning Facilities increased $34.3 million, or 7.3%,</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily due to improved occupancy growth, increases in skilled mix days and revenue per patient day. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The increases in revenue were derived from managed care revenue of 25.5%, Medicare revenue of 2.1%, Medicaid revenue of 3.9% and private revenue of 16.5%. These increases demonstrate our ability to focus on increasing occupancy across payer types. Included in the year ended December 31, 2023 is the revenue related to a facility that was not operating at full capacity starting in the first quarter of 2024 due to flooding.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skilled services revenue generated by </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recently Acquired Facilities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> increased by approximately $271.7 million compared to the year ended December 31, 2023. The increases were primarily due to 31 operational expansions between January 1, 2024 and December&#160;31, 2024 across ten states. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have generally experienced lower occupancy rates and lower skilled mix at Recently Acquired Facilities and therefore, we anticipate lower overall occupancy during years of growth. Included in our metrics for Recently Acquired Facilities are 17 facilities we acquired in California in 2023 that were more mature and accordingly, had higher occupancy rates, higher skilled mix days and higher skilled mix revenue than our typical acquisitions. In the future, if we acquire additional turnaround or start-up operations, we expect to see lower occupancy rates and skilled mix and these metrics are expected to vary from period to period based upon the type of the facilities and operations that we acquire.</span></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reflects the change in skilled nursing average daily revenue rates by payor source, excluding services that are not covered by the daily rate </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.955%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="45" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Same Facility</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transitioning</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="48" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SKILLED NURSING AVERAGE DAILY REVENUE RATES </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">757.99&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721.04&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">705.71&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.71&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">846.60&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">865.81&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">767.72&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733.47&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555.11&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526.01&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">590.50&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">555.37&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other skilled</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628.01&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595.57&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537.30&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494.43&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">627.85&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">424.56&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620.42&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">575.34&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total skilled revenue</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">638.61&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615.59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605.32&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">593.46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738.31&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743.60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">647.28&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296.64&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275.47&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.24&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251.18&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309.90&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.73&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294.78&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272.14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other payors</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278.20&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246.18&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.92&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347.70&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280.24&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.93&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total skilled nursing revenue</span></div></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">403.02&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382.15&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.94&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320.41&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436.43&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.18&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398.66&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">378.02&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) The rates are based on contractually agreed-upon amounts or rates, excluding the estimates of variable consideration under the revenue recognition standard, Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606 and state relief funding during the year</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> ended December 31, 2023</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare daily rates at Same Facilities and Transitioning Facilities increased by 5.1% and 4.1%, respectively, compared to the year ended December 31, 2023. The increase is attributable to the 4.0% and 4.2% net market basket increase that became effective in October 2023 and October 2024, respectively, and a shift toward higher acuity patients. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our average Medicaid rates increased 8.3% due to state reimbursement increases, our participation in supplemental Medicaid payment programs and quality improvement programs in various states and changes in Medicaid mix. For example, we continue to have an increase in Medicaid days in states with higher rates, such as California. In addition, during the COVID periods from 2020 through 2023, we received state relief funding through Medicaid programs from various states such as California. These funds have been excluded from our average daily rates from 2020-2023. Starting in 2024, several of the states we operate in have incorporated the state relief funding as part of the state per diem rates or enhanced their supplemental programs. As results, these revenue are included in the 2024 average daily revenue rate. As such, the increase in Medicaid rates from 2023 to 2024 is not a lateral comparison.  </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Payor Sources as a Percentage of Skilled Nursing Services </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We use our skilled mix as a measure of the quality of reimbursements we receive at our independent skilled nursing facilities over various periods. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our percentage of skilled nursing patient revenue and days by payor source:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.955%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="45" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Same Facility</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Transitioning</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PERCENTAGE OF SKILLED NURSING REVENUE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.8&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.8&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other skilled</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled mix</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.2</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51.2</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38.4</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">38.4</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">59.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">48.6</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">50.2</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other payors</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.6&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53.0&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SKILLED NURSING</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.455%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.955%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="45" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Same Facility</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Transitioning</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Acquisitions</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PERCENTAGE OF SKILLED NURSING DAYS</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.9&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.4&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other skilled</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled mix</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">31.8</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21.8</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">28.9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">37.4</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29.9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30.4</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other payors</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.1&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.2&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.4&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SKILLED NURSING</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total cost of services for our skilled services segment for the periods indicated (dollars in thousands): </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service</span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,242,737&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,832,012&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410,725&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue percentage</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.5&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.1&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services related to our skilled services segment increased by $410.7 million, or 14.5%, from the same period in 2023. Cost of services as a percentage of revenue increased to 79.5% from 79.1%, due to increased labor costs as a result of new acquisitions in the turnaround stage, increased insurance expenses and increased expense related to the deferred compensation investment program. Our cost of services as a percentage of revenue varies depending on the volume of acquisitions during the period, which typically have higher costs during the transition period.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Standard Bearer</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.747%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Dollars in thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue generated from third-party tenants</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,976&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,774&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue generated from Ensign's independent subsidiaries</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,110&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,712&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL RENTAL REVENUE</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95,086</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,600</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">15.3</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment income</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,335&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,065&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,297&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,092&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FFO</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,632</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">54,270</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,362</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rental revenue </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our rental revenue, including revenue generated from our independent subsidiaries, increased by $12.6 million, or 15.3%, to $95.1 million, compared to the year ended December 31, 2023. The increase in revenue is primarily attributable to 17 real estate purchases as well as annual rent increases since the year ended December 31, 2023. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FFO </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our FFO increased by $4.4 million, or 8.0%, to $58.6 million, compared to the year ended December 31, 2023. The increase in rental revenue of $12.6 million is offset by increases in interest expense of $7.4 million associated with the intercompany debt arrangements as Standard Bearer continues to grow its real estate portfolio.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">All Other Revenue </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our other revenue increased by $37.1 million, or 23.8%, to $192.9 million, compared to the year ended December 31, 2023. Other revenue for the year ended December 31, 2024 includes senior living revenue of $90.0 million, revenue from other ancillary services of $91.1 million and rental income of $11.8 million. The increase in other revenue is primarily attributable to our senior living and other ancillary services.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated Financial Expenses</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rent-cost of services </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our rent-cost of services as a percentage of revenue decreased by 0.2% to 5.1%, as our operational expansions included a higher mix of real estate purchases.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and administrative expense </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense decreased by $37.9 million or 14.4%, to $225.1 million. General and administrative expense as a percentage of revenue decreased by 1.8% to 5.3%. This reduction is attributable to a settlement that was outside the ordinary course of business and finalized in 2023. Excluding the impact of the proceeding in 2023, general and administrative expense as a percentage of revenue would be at 5.4%. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and amortization </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense increased by $11.8 million, or 16.2%, to $84.1 million. This increase was primarily related to the additional depreciation and amortization incurred as a result of our newly acquired operations and capital expenditures. Depreciation and amortization expense as a percentage of revenue remained consistent at 1.9%.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income (expense), net </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Other income (expense), net as a percentage of revenue increased by 0.2%. Other income primarily includes interest income from our investments, interest expense related to our debt and deferred compensation gains and losses. Other income (expense), net increased by $10.4 million due to increases in interest income from our investments and gains in our deferred compensation plan which incurs gains or losses depending on market performance. During the years ended December&#160;31, 2024 and 2023, the deferred compensation plan had gains of $5.2 million and $4.6 million, respectively. We also recorded an offsetting expense allocated between cost of services and general and administrative expenses. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for income taxes </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our effective tax rate was 22.7% for the year ended December 31, 2024, compared to 23.1% for the same period in 2023. The effective tax rate for both periods was driven by the impact of excess tax benefits from stock-based compensation, partially offset by non-deductible expenses, including non-deductible compensation. See Note 13, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, in the Financial Statements for further discussion. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_343"></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity have historically been derived from our cash flows from operations and long-term debt secured by our real property and our Credit Facility (defined below). Our liquidity as of December&#160;31, 2024 is impacted by cash generated from strong operational performance offset by investments made for our operational expansions and ancillary businesses as well as capital expenditures to improve the quality of care at our existing operations.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have primarily financed the majority of our acquisitions through mortgages on our properties, our Credit Facility and cash generated from operations. Cash paid to fund acquisitions was $156.5 million for the year ended December 31, 2024 compared to cash paid of $69.0 million for the year ended December 31, 2023. Total capital expenditures for property and equipment were $158.2 million and $106.2 million for the years ended December 31, 2024 and 2023, respectively. We currently have approximately $150.0 million budgeted for renovation projects in 2025. We believe our current cash balances, our cash flow from operations and the amounts available for borrowing under our Credit Facility will be sufficient to cover our operating needs for at least the next 12 months.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, in the future, seek to raise additional capital to fund growth, capital renovations, operations and other business activities, but such additional capital may not be available on acceptable terms, on a timely basis, or at all.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents as of December&#160;31, 2024 consisted of bank term deposits, money market funds and U.S. Treasury bill related investments. In addition, as of December&#160;31, 2024, we held investments of approximately $203.5 million. We believe our investments that were in an unrealized loss position as of December&#160;31, 2024 do not require an allowance for expected credit losses, nor has any event occurred subsequent to that date that would indicate so.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As mentioned above, our primary source of cash is from our ongoing operations. Our positive cash flows have supported our business and have allowed us to pay regular dividends to our stockholders. We currently anticipate that existing cash and total investments as of December&#160;31, 2024, along with projected operating cash flows and available financing, will support our normal business operations for the foreseeable future. </span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2024, the Board of Directors approved a stock repurchase program pursuant to which we may repurchase up to $20.0&#160;million of our common stock under the program for a period of approximately 12 months from September&#160;1, 2024. On August 29, 2023, the Board of Directors previously approved a stock repurchase program pursuant to which we could repurchase up to $20.0&#160;million of our common stock under the program for a period of approximately 12 months from September&#160;1, 2023, which the program terminated by its terms on August 31, 2024 and is no longer in effect. We did not purchase any shares pursuant to the stock repurchase programs during the year ended December 31, 2024.</span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these repurchase programs, we are authorized to repurchase our issued and outstanding common shares from time to time in open-market and privately negotiated transactions, tender offers, pursuant to contractual provisions, and block trades, or otherwise in accordance with federal securities laws. The stock repurchase programs do not obligate us to acquire any specific number of shares. Any such repurchases will depend on our business strategy, prevailing market conditions, our liquidity requirements, contractual restrictions or covenants, compliance with securities laws, and other factors. The amounts involved in any such transaction may be material.</span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents selected data from our consolidated statement of cash flows for the periods presented:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.253%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">NET CASH PROVIDED BY/(USED IN):</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">347,186&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">376,666&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(390,052)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(182,698)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(2,162)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(612)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></div></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(45,028)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">193,356</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents beginning of period</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">509,626&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">316,270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">464,598</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">509,626</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities is net income adjusted for certain non-cash items and changes in operating assets and liabilities. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $29.5 million decrease in cash provided by operating activities for the year ended December 31, 2024 compared to the same period in 2023 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> due to payment of the $48.0 million related to the litigation matter discussed in Item 3., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and we funded $35.0 million to Insignia Pathway, which is discussed in </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Activities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This cash outflow was partially offset </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by an increase in operational performance. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing cash flows consist primarily of capital expenditures, investment activities, insurance proceeds and cash used for acquisitions. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $207.4 million increase in cash used in investing activities for the year ended December 31, 2024 compared to the same period in 2023 was primarily used for operational expansions and capital expenditures as well as increased investment activity as part of our capital strategy. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows consist primarily of cash provided by the issuance of common stock upon exercise of stock options, payment of dividends to stockholders, issuance and repayment of short-term and long-term debt, payment for share repurchases and the noncontrolling interest activity. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $1.6 million increase in cash provided by financing activities for the year ended December 31, 2024 compared to the same period in 2023, was primarily due to stock option exercises offset by the purchase of non-controlling interest in one of our ancillary businesses. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A discussion of our cash flows for the year ended December 31, 2022 is included in Part II, Item 7, Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations - Liquidity and Capital Resources, included in our Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission on February 1, 2024.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material cash requirements from known contractual and other obligations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-term debt obligations, net of debt discount, outstanding as of the end of each fiscal year were as follows: </span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans and promissory note</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,438&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,388&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,271&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">159,967&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,806&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148,438</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">152,388</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">156,271</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">159,967</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">117,806</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant contractual obligations as of December 31, 2024 were as follows, including the future periods in which payments are expected:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.309%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.439%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2029</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,909&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,696&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,002&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,994&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,144&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776,571&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,792,316&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,227&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,779&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,896&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,553&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,438&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payments on long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,487&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,346&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,207&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,091&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,974&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,463&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,568&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213,482</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">213,269</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">212,106</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">210,864</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">207,014</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,955,587</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,012,322</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not included in the table above are our actuarially determined self-insured general and professional malpractice liability, workers' compensation and medical (including prescription drugs) and dental healthcare obligations which are broken out between current and long-term liabilities in our financial statements included in this Annual Report on Form 10-K.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the proceeding discussed in Item 3., </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal Proceedings</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parties agreed to settle the litigation for $48.0 million. The settlement funds were fully paid during the year ended December 31, 2024.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility with a Lending Consortium Arranged by Truist </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a revolving credit facility with Truist Securities (Truist) (the Credit Facility) with availability of up to $600.0 million in aggregate principal. The maturity date of the Credit Facility is April&#160;8, 2027. Borrowings are supported by a lending consortium arranged by Truist. The interest rates applicable to loans under the Credit Facility are, at our option, equal to either a base rate plus a margin ranging from 0.25% to 1.25% per annum or SOFR plus a margin ranging from 1.25% to 2.25% per annum, based on the Consolidated Total Net Debt to Consolidated EBITDA ratio (as defined in the Credit Facility). In addition, there is a commitment fee on the unused portion of the commitments that ranges from 0.20% to 0.40% per annum, depending on the Consolidated Total Net Debt to Consolidated EBITDA ratio.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans and Promissory Note</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, 23 of our subsidiaries had mortgage loans insured with HUD for an aggregate amount of $146.9 million, which subjects these subsidiaries to HUD oversight and periodic inspections. The mortgage loans bear effective interest rates at a range of 3.1% to 4.2%, including fixed interest rates at a range of 2.4% to 3.3% per annum. In addition to the interest rate, we incur other fees for HUD placement, including but not limited to audit fees. Amounts borrowed under the mortgage loans may be prepaid, subject to prepayment fees of the principal balance on the date of prepayment. For the majority of the loans, during the first three years, the prepayment fee is 10.0%, and is reduced by 3.0% in the fourth year of the loan, and reduced by 1.0%</span><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per year for years five through ten of the loan. There is no prepayment penalty after year ten. The terms for all the mortgage loans are 25 to 35 years. </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the HUD mortgage loans, one of our subsidiaries has a promissory note that bears a fixed interest rate of 5.3% per annum and has a term of 12 years. The note, which was used for an acquisition, is secured by the real property comprising the facility and the rent, issues and profits thereof, as well as all personal property used in the operation of the facility.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-top:12pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2024, 231 of our facilities are under long-term lease arrangements, of which 99 of the operations are under nine triple-net Master Leases and one stand-alone lease with CareTrust. The Master Leases consist of multiple leases, each with its own pool of properties, that have varying maturities and diversity in property geography. Under each master lease, our individual subsidiaries that operate those properties are the tenants and CareTrust's individual subsidiaries that own the properties subject to the Master Leases are the landlords. The rent structure under the Master Leases includes a fixed component, subject to annual escalation equal to the lesser of the percentage change in the Consumer Price Index (but not less than zero) or 2.5%. At our option, we can extend the Master Leases for two or three five-year renewal terms beyond the initial term, on the same terms and conditions. If we elect to renew the term of a Master Lease, the renewal will be effective as to all, but not less than all, of the leased property then subject to the Master Lease. Additionally, four of the 100 facilities leased from CareTrust include an option to purchase that we can exercise starting on December 1, 2024. Subsequent to December&#160;31, 2024, we, through Standard Bearer, exercised the option to purchase the real estate of the four facilities from CareTrust for $44.6 million.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease certain facilities and our administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from five to 20 years and are subject to annual escalation equal to the percentage change in the Consumer Price Index with a stated cap percentage. In addition, we lease certain of our equipment under non-cancelable operating leases with initial terms ranging from three to five years. Most of these leases contain renewal options, certain of which involve rent increases. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ninety of our independent subsidiaries, excluding the subsidiaries that are operated under the Master Leases from CareTrust, are operated under 14 separate master lease arrangements. Under these master leases, a default at a single facility could subject one or more of the other independent subsidiaries covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of our leases, master lease agreements and debt financing instruments. In addition, other potential defaults related to an individual facility may cause a default of an entire master lease portfolio and could trigger cross-default provisions in our outstanding debt arrangements and other leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the lease without the consent of the landlord.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inflation</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically derived a substantial portion of our revenue from the Medicare program. We also derive revenue from state Medicaid and similar reimbursement programs. Payments under these programs generally provide for reimbursement levels that are adjusted for inflation annually based upon the state&#8217;s fiscal year for the Medicaid programs and in each October for the Medicare program. These adjustments may not continue in the future, and even if received, such adjustments may not reflect the actual increase in our costs for providing healthcare services.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Labor, supply expenses and capital expenditures make up a substantial portion of our cost of services. Those expenses can be subject to increase in periods of rising inflation and when labor shortages occur in the marketplace. To date, we have generally been able to implement cost control measures or obtain increases in reimbursement sufficient to offset increases in these expenses. There can be no assurance that we will be able to anticipate fully or otherwise respond to any future inflationary pressures. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_352"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of </a><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:107%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Contents</a></span></div></div><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to risks associated with market changes in interest rates through our borrowing arrangements and investments. In particular, our Credit Facility exposes us to variability in interest payments due to changes in SOFR interest rates. We manage our exposure to this market risk by monitoring available financing alternatives. Our mortgages and promissory note require principal and interest payments through maturity pursuant to amortization schedules. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mortgages generally contain provisions that allow us to make repayments earlier than the stated maturity date. In some cases, we are not allowed to make early repayment prior to a cutoff date. Where prepayment is permitted, we are generally allowed to make prepayments only at a premium which is often designed to preserve a stated yield to the note holder. These prepayment rights may afford us opportunities to mitigate the risk of refinancing our debts at maturity at higher rates by refinancing prior to maturity.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a Credit Facility with Truist of up to $600.0 million in aggregate principal. We have no outstanding borrowings under our Credit Facility as of December&#160;31, 2024 and through the filing date of this report. In addition, we have outstanding indebtedness under mortgage loans insured with HUD and a promissory note payable to a third party of $148.4 million, all of which are at fixed interest rates.</span><span style="color:#ff0090;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents as of December&#160;31, 2024 consisted of bank term deposits, money market funds and U.S. Treasury bill related investments. In addition, as of December&#160;31, 2024, we held investments of approximately $203.5 million. We believe our investments that were in an unrealized loss position as of December&#160;31, 2024 do not require an allowance for expected credit losses, nor has any event occurred subsequent to that date that would indicate so. Our market risk exposure is interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates. The primary objective of our investment activities is to preserve principal, while at the same time maximizing the income we receive from our investments without significantly increasing risk. Due to the low risk profile of our investment portfolio, an immediate 10.0% change in interest rates would not have a material effect on the fair market value of our portfolio. Accordingly, we would not expect our operating results or cash flows to be affected to any significant degree by the effect of a sudden change in market interest rates on our securities portfolio.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above only incorporates those exposures that exist as of December&#160;31, 2024 and does not consider those exposures or positions which could arise after that date. If we diversify our investment portfolio into securities and other investment alternatives, we may face increased risk and exposures as a result of interest risk and the securities markets in general.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_31"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="text-align:justify"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_496"></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">THE ENSIGN GROUP, INC. </span></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">AND FINANCIAL STATEMENT SCHEDULE</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:86.436%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.364%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_499">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_499">92</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Consolidated Financial Statements:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_34">Consolidated Balance Sheets as of December 31, 202</a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_34">4</a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_34"> and 202</a>3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_34">93</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_43">Consolidated Statements of Income for the Years Ended December&#160;31, </a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_43">2024, </a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_43">2023, </a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_43">and </a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_43">2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_43">94</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_52">Consolidated Statements of Stockholders' Equity for the Years Ended December&#160;31, </a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_43">2024, 2023, and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_52">95</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_55">Consolidated Statements of Cash Flows for the Years Ended December&#160;31, </a><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_43">2024, 2023, and 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_55">96</a></span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_67">Notes to the Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_67">98</a></span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_499"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ensign Group, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Juan Capistrano, California </span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of The Ensign Group Inc. and subsidiaries (the "Company") as of December 31, 2024, and 2023, the related consolidated statements of income, stockholders' equity, and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024, and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 5, 2025, expressed  an unqualified opinion on the Company's internal control over financial reporting.</span><span style="color:#000000;font-family:'Calibri Light',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance Liabilities (General and Professional Liability Claims) - Refer to Notes 2 and 18 to the financial statements </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's self-insurance liabilities for general and professional liability claims totaled $160.1 million at December 31, 2024. The Company develops information about the size of the ultimate claims based on historical experience, current industry information, and actuarial analysis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of reserves for general and professional liability claims is highly subjective. Given the significant judgments in estimating the general and professional liability claims, we have determined this to be a critical audit matter. This required a high degree of auditor judgment and an increased extent of effort when performing audit procedures to evaluate the reasonableness of management estimates of reserves for open claims as well as for claims that are incurred but not reported (IBNR).</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to management&#8217;s judgment regarding the estimation of the reserve for general and professional liability claims included the following, among others:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">We tested the effectiveness of controls over the reserve for general and professional liabilities, including those related to both the determination of reserves for open claims and estimation of the IBNR claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">We obtained an understanding of the factors considered and assumptions made by management and its external actuarial specialists in developing the estimate of the general and professional liability reserves, including the sources of data relevant to these factors and assumptions. We tested underlying claims data, including testing the completeness and accuracy of open cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">We involved our actuarial specialists to assist in our evaluation of the methodologies applied by management's specialist and to develop an independent range of expected reserves.  We compared the recorded reserves to the estimated independent range. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">We performed a retrospective review in which we compared the prior-year recorded amounts for ultimate losses and current liabilities to the subsequent claim emergence.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-51">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-52">Costa Mesa, California</ix:nonNumeric></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;5, 2025</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 1999.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_34"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%"> THE ENSIGN GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In thousands, except par values)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:65.225%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current assets: </span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-53">464,598</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-54">509,626</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts receivable&#8212;less allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-55">8,435</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">9,348</ix:nonFraction> at December&#160;31, 2024 and 2023, respectively</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">569,897</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">485,039</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Investments&#8212;current</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-59">62,255</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-60">17,229</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-61">60,882</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">35,036</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total current assets</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">1,157,632</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">1,046,930</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-65">1,291,354</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-66">1,090,771</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Right-of-use assets </span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-67">1,861,071</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-68">1,756,430</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Insurance subsidiary deposits and investments </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:InsuranceSubsidiaryDepositsAndInvestments" format="ixt:num-dot-decimal" scale="3" id="f-69">141,246</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:InsuranceSubsidiaryDepositsAndInvestments" format="ixt:num-dot-decimal" scale="3" id="f-70">92,687</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-71">66,281</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-72">67,124</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Restricted and other assets </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:RestrictedAndOtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">46,499</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:RestrictedAndOtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">40,205</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Intangible assets, net </span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-75">7,292</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-76">6,525</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-77">97,981</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-78">76,869</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">TOTAL ASSETS</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-79">4,669,356</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-80">4,177,541</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">LIABILITIES AND EQUITY</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">98,947</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">92,811</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued wages and related liabilities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">347,532</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-84">332,568</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Lease liabilities&#8212;current </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-85">93,475</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-86">82,526</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued self-insurance liabilities&#8212;current</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SelfInsuranceReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">67,331</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SelfInsuranceReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="f-88">54,664</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-89">132,057</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-90">168,228</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Current maturities of long-term debt</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-91">4,086</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-92">3,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 43.75pt;text-align:left;text-indent:-13.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-93">743,428</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-94">734,747</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term debt&#8212;less current maturities</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" format="ixt:num-dot-decimal" scale="3" id="f-95">141,585</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" format="ixt:num-dot-decimal" scale="3" id="f-96">145,497</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Long-term lease liabilities&#8212;less current portion </span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">1,735,325</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-98">1,639,326</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Accrued self-insurance liabilities&#8212;less current portion</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SelfInsuranceReserveNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-99">144,421</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SelfInsuranceReserveNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">111,246</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:DeferredRentAndOtherLongTermLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-101">64,169</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:DeferredRentAndOtherLongTermLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-102">49,408</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">TOTAL LIABILITIES</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-103">2,828,928</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-104">2,680,224</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Commitments and contingencies (Notes 14 and 19)</span></div></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-105"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-106"></ix:nonFraction></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Ensign Group, Inc. stockholders' equity:</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock: $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-107"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-108">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-109"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-110">150,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-111">60,838</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-112">57,438</ix:nonFraction> shares issued and shares outstanding at December&#160;31, 2024, respectively, and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-113">59,987</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-114">56,597</ix:nonFraction> shares issued and shares outstanding at December 31, 2023, respectively </span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-115">61</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-116">60</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-117">528,052</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-118">465,707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-119">1,426,762</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-120">1,142,653</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Common stock in treasury, at cost, <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="f-121">3,400</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="f-122">3,390</ix:nonFraction> shares at December&#160;31, 2024 and 2023, respectively</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-123">117,764</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="f-124">116,555</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total Ensign Group, Inc. stockholders' equity</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-125">1,837,111</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-126">1,491,865</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 41.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-127">3,317</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-128">5,452</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 55pt;text-align:left;text-indent:-22.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Total equity</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-129">1,840,428</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-130">1,497,317</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 66.25pt;text-align:left;text-indent:-36pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">TOTAL LIABILITIES AND EQUITY</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-131">4,669,356</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-132">4,177,541</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_43"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">  THE ENSIGN GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:56.001%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.811%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except per share data)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">REVENUE</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Service revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-133">4,237,525</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-134">3,708,071</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-135">3,008,711</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rental revenue</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-136">22,960</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-137">21,284</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-138">16,757</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">TOTAL REVENUE</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-139">4,260,485</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-140">3,729,355</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-141">3,025,468</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Expense:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-142">3,376,884</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-143">2,941,238</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-144">2,354,434</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Rent&#8212;cost of services </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ensg:RentCostOfServices" format="ixt:num-dot-decimal" scale="3" id="f-145">216,016</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:RentCostOfServices" format="ixt:num-dot-decimal" scale="3" id="f-146">197,358</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:RentCostOfServices" format="ixt:num-dot-decimal" scale="3" id="f-147">153,049</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-148">225,143</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-149">263,005</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-150">158,805</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-151">84,138</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-152">72,387</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-153">62,355</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">TOTAL EXPENSES</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-154">3,902,181</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-155">3,473,988</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-156">2,728,643</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-157">358,304</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-158">255,367</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-159">296,825</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-160">8,286</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-161">8,087</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-162">8,931</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-163">28,749</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-164">19,216</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InvestmentIncomeInterest" format="ixt:num-dot-decimal" scale="3" id="f-165">5,035</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Other income (expense)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-166">7,327</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-167">6,266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-168">3,840</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">OTHER INCOME (EXPENSE), NET</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-169">27,790</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-170">17,395</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-171">7,736</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-172">386,094</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-173">272,762</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-174">289,089</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-175">87,636</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-176">62,912</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-177">64,437</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">NET INCOME</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-178">298,458</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-179">209,850</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-180">224,652</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Less: </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-181">485</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-182">451</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-183">29</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">NET INCOME ATTRIBUTABLE TO THE ENSIGN GROUP, INC. </span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-184">297,973</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-185">209,399</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-186">224,681</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">NET INCOME PER SHARE ATTRIBUTABLE TO THE ENSIGN GROUP INC.</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 1.75pt;text-align:left;text-indent:4.49pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-187">5.26</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-188">3.76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-189">4.09</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 1.75pt;text-align:left;text-indent:4.49pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-190">5.12</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-191">3.65</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-192">3.95</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">WEIGHTED AVERAGE COMMON SHARES OUTSTANDING </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-193">56,655</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-194">55,708</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-195">54,887</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-196">58,240</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-197">57,323</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-198">56,871</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_52"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%"> THE ENSIGN GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.863%"><tr><td style="width:1.0%"/><td style="width:35.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.782%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.423%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.560%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.013%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.150%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:6.697%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.982%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-Controlling Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE&#160;- JANUARY&#160;1, 2022</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-199">55,190</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-200">58</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-201">369,760</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-202">733,992</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="f-203">2,944</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-204">83,042</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-205">946</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-206">1,021,714</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock to employees and directors resulting from the exercise of stock options</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-207">688</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-208">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-209">12,676</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-210">12,677</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of forfeitures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="f-211">207</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-212">5,241</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-213">5,241</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares of common stock used to satisfy tax withholding obligations</span></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-214">20</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-215">20</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-216">1,702</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-217">1,702</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-218">0.2225</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="f-219">12,334</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="f-220">12,334</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock award compensation</span></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-221">22,720</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-222">22,720</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock (Note 20)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="f-223">404</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-22" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="f-224">404</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-225">29,882</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-226">29,882</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of noncontrolling interest shares</span></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-227">1,539</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-228">835</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-229">704</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of noncontrolling interests through subsidiary equity plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" format="ixt:num-dot-decimal" scale="3" id="f-230">6,693</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" format="ixt:num-dot-decimal" scale="3" id="f-231">6,693</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></div></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-232">29</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-233">29</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interest attributable to subsidiary equity plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-234">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-235">284</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-236">275</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to the Ensign Group, Inc.</span></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-237">224,681</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-238">224,681</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE&#160;- DECEMBER&#160;31, 2022</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-25" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-239">55,661</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-240">59</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-241">415,560</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-242">946,339</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-28" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="f-243">3,368</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-244">114,626</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-245">1,468</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-246">1,248,800</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock to employees and directors resulting from the exercise of stock options</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-247">759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-248">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-249">18,368</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-250">18,369</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of forfeitures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="f-251">199</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-252">5,068</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-253">5,068</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares of common stock used to satisfy tax withholding obligations</span></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-254">22</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-255">22</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-256">1,929</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-257">1,929</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-258">0.2325</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="f-259">13,085</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="f-260">13,085</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock award compensation</span></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-261">30,754</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-262">30,754</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of noncontrolling interest shares</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-263">256</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-264">256</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></div></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-265">451</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-266">451</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interest attributable to subsidiary equity plan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="f-267">3,787</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" format="ixt:num-dot-decimal" scale="3" id="f-268">3,533</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-269">254</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to the Ensign Group, Inc.</span></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-270">209,399</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-271">209,399</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE&#160;- DECEMBER&#160;31, 2023</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-272">56,597</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-273">60</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-274">465,707</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-275">1,142,653</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="f-276">3,390</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-277">116,555</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-278">5,452</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-279">1,497,317</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock to employees and directors resulting from the exercise of stock options</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-280">632</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-281">1</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-282">22,285</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-283">22,286</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of restricted stock, net of forfeitures</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="f-284">219</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-285">6,165</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="3" id="f-286">6,165</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares of common stock used to satisfy tax withholding obligations</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-287">10</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-43" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="f-288">10</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-289">1,209</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-290">1,209</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-291">0.2425</ix:nonFraction> per share)</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="f-292">13,864</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Dividends" format="ixt:num-dot-decimal" scale="3" id="f-293">13,864</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Employee stock award compensation</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-294">36,183</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-295">36,183</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of noncontrolling interest shares</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-296">2,426</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-297">2,024</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:num-dot-decimal" scale="3" id="f-298">4,450</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-299">485</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-300">485</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interest attributable to subsidiary equity plan</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-301">138</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-302">596</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="3" id="f-303">458</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income attributable to the Ensign Group, Inc.</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-304">297,973</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-305">297,973</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">BALANCE&#160;- DECEMBER&#160;31, 2024</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-306">57,438</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="f-307">61</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-308">528,052</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-309">1,426,762</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-49" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="f-310">3,400</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-311">117,764</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-312">3,317</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-313">1,840,428</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_55"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">THE ENSIGN GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.722%"><tr><td style="width:1.0%"/><td style="width:65.891%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.484%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.484%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.488%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net income </span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-314">298,458</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-315">209,850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-316">224,652</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-317">84,138</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-318">72,387</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-319">62,355</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of deferred financing fees</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-320">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-321">1,067</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-322">1,036</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash leasing arrangement </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ensg:NonCashLeaseExpense" scale="3" id="f-323">808</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:NonCashLeaseExpense" scale="3" id="f-324">870</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:NonCashLeaseExpense" scale="3" id="f-325">493</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:num-dot-decimal" scale="3" id="f-326">1,849</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-327">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="3" id="f-328">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Write-off of deferred financing fees</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="3" id="f-329">200</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" format="ixt:fixed-zero" scale="3" id="f-330">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:WriteOffOfDeferredDebtIssuanceCost" scale="3" id="f-331">566</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes </span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-332">635</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-333">27,481</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-334">6,496</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for doubtful accounts </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-335">1,739</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-336">3,408</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-337">2,390</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-338">36,226</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-339">30,767</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-340">22,720</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash received from insurance proceeds</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromInsuranceSettlementOperatingActivities" scale="3" id="f-341">199</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProceedsFromInsuranceSettlementOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-342">1,396</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProceedsFromInsuranceSettlementOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-343">1,282</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on sale of assets </span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="f-344">486</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" scale="3" id="f-345">123</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets1" format="ixt:num-dot-decimal" scale="3" id="f-346">3,467</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on insurance claims and asset disposals</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets" scale="3" id="f-347">833</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets" scale="3" id="f-348">550</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets" scale="3" id="f-349">627</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Litigation </span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="3" id="f-350">4,289</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="3" id="f-351">47,182</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:GainLossRelatedToLitigationSettlement" format="ixt:num-dot-decimal" scale="3" id="f-352">4,553</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in operating assets and liabilities</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable </span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-353">84,397</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-354">79,818</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-355">82,426</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" format="ixt:num-dot-decimal" scale="3" id="f-356">9,227</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="f-357">814</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="3" id="f-358">809</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-359">19,055</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-360">6,993</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-361">9,141</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:29.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred employer portion of social security taxes (Note 3)</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" format="ixt:fixed-zero" scale="3" id="f-362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" format="ixt:fixed-zero" scale="3" id="f-363">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" format="ixt:num-dot-decimal" scale="3" id="f-364">24,155</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policy premiums</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue" format="ixt:num-dot-decimal" scale="3" id="f-365">14,833</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue" format="ixt:num-dot-decimal" scale="3" id="f-366">16,072</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue" format="ixt:num-dot-decimal" scale="3" id="f-367">7,614</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredCompensation" format="ixt:num-dot-decimal" scale="3" id="f-368">14,986</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredCompensation" format="ixt:num-dot-decimal" scale="3" id="f-369">16,044</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredCompensation" format="ixt:num-dot-decimal" scale="3" id="f-370">7,637</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-371">287</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-372">6,564</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="f-373">345</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-374">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-375">15,924</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-376">17,870</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued wages and related liabilities</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-377">19,992</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-378">47,967</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-379">38,982</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-380">30,670</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-381">23,828</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-382">3,010</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued self-insurance liabilities</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInSelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-383">44,014</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncreaseDecreaseInSelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-384">28,827</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncreaseDecreaseInSelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-385">17,785</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="3" id="f-386">911</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="3" id="f-387">50</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="3" id="f-388">46</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET CASH PROVIDED BY OPERATING ACTIVITIES</span></div></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-389">347,186</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-390">376,666</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-391">272,513</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ensg:PaymentsToAcquirePropertyAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-392">158,240</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:PaymentsToAcquirePropertyAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-393">106,180</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:PaymentsToAcquirePropertyAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-394">87,545</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash payments for acquisitions</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-395">156,547</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-396">69,014</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-397">101,136</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash from insurance proceeds</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromInsuranceSettlementInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-398">3,334</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProceedsFromInsuranceSettlementInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-399">2,029</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProceedsFromInsuranceSettlementInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-400">1,339</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash proceeds from the sale of assets </span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-401">2,818</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="3" id="f-402">248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProceedsFromSaleOfProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-403">8,630</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="f-404">105,149</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="f-405">29,603</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="f-406">21,975</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Maturities of investments</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:num-dot-decimal" scale="3" id="f-407">26,397</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:num-dot-decimal" scale="3" id="f-408">18,852</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" format="ixt:num-dot-decimal" scale="3" id="f-409">14,356</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other restricted assets</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-410">2,665</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="f-411">970</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="f-412">149</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET CASH USED IN INVESTING ACTIVITIES </span></div></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-413">390,052</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-414">182,698</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-415">186,182</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt (Note 14)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="f-416">400</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="f-417">150</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="3" id="f-418">411</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on debt </span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-419">4,350</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-420">4,033</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-421">4,106</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of options</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-422">22,286</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-423">18,369</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-424">12,677</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of shares of common stock to satisfy tax withholding obligations</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-425">1,209</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-426">1,929</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-427">1,702</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of shares of common stock (Note 20)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-429">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-430">29,882</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-431">13,671</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-432">12,890</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="f-433">12,168</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiary shares (Note 6)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" format="ixt:fixed-zero" scale="3" id="f-435">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" format="ixt:num-dot-decimal" scale="3" id="f-436">6,693</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-controlling interest distribution</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="f-437">543</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="f-438">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="f-439">284</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ensg:PurchasesOfNonControllingInterest" format="ixt:num-dot-decimal" scale="3" id="f-440">4,450</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:PurchasesOfNonControllingInterest" scale="3" id="f-441">256</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:PurchasesOfNonControllingInterest" scale="3" id="f-442">704</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payment of contingent consideration</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="3" id="f-443">625</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-444">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="3" id="f-445">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments of deferred financing costs</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:fixed-zero" scale="3" id="f-446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="f-447">19</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-448">3,197</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">NET CASH USED IN FINANCING ACTIVITIES</span></div></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-449">2,162</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-450">612</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-451">32,262</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net (decrease) increase in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-452">45,028</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-453">193,356</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-454">54,069</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents beginning of period</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-455">509,626</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-456">316,270</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-457">262,201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash and cash equivalents end of period</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-458">464,598</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-459">509,626</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-460">316,270</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_61"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash paid during the period for:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-461">7,063</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-462">7,025</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-463">7,604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-464">96,337</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-465">89,730</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="f-466">70,055</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-467">215,677</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-468">196,942</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-469">151,870</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-cash financing and investing activity</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued capital expenditures</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-470">7,900</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-471">4,600</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #edfee2;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-472">4,800</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued dividends declared</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-473">3,589</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-474">3,396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-475">3,201</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new and modified operating lease obligations</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-476">232,918</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-477">376,550</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-478">370,753</ix:nonFraction>&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">See accompanying notes to consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_67"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:120%">THE ENSIGN GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Dollars, shares and options in thousands, except per share data)</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_70"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-479" continuedAt="f-479-1" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="f-479-1"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ensign Group, Inc. (collectively, Ensign or the Company), is a holding company with no direct operating assets, employees or revenue. The Company's independent subsidiaries provide health care services across the post-acute care continuum and engage in the ownership, acquisition, development and leasing of skilled nursing, senior living and other healthcare-related properties and ancillary businesses. As of December&#160;31, 2024, the Company's independent subsidiaries operated <ix:nonFraction unitRef="facility" contextRef="c-51" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-480">327</ix:nonFraction> facilities and other ancillary operations located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The Company's independent subsidiaries have a collective capacity of approximately <ix:nonFraction unitRef="bed" contextRef="c-52" decimals="-2" name="ensg:NumberOfSkilledNursingBeds" format="ixt:num-dot-decimal" scale="0" id="f-481">33,500</ix:nonFraction> operational skilled nursing beds and <ix:nonFraction unitRef="unit" contextRef="c-52" decimals="-2" name="ensg:NumberOfSeniorLivingUnits" format="ixt:num-dot-decimal" scale="0" id="f-482">3,100</ix:nonFraction> senior living units. As of December&#160;31, 2024, the Company's independent subsidiaries operated <ix:nonFraction unitRef="facility" contextRef="c-52" decimals="INF" name="ensg:NumberOfFacilitiesUnderLongTermLeaseArrangements" scale="0" id="f-483">231</ix:nonFraction> facilities under long-term lease arrangements and had options to purchase <ix:nonFraction unitRef="facility" contextRef="c-52" decimals="INF" name="ensg:NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" scale="0" id="f-484">12</ix:nonFraction> of those <ix:nonFraction unitRef="facility" contextRef="c-52" decimals="INF" name="ensg:NumberOfFacilitiesUnderLongTermLeaseArrangements" scale="0" id="f-485">231</ix:nonFraction> facilities. The Company's real estate portfolio consists of <ix:nonFraction unitRef="property" contextRef="c-4" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-486">129</ix:nonFraction> owned real estate properties, which includes <ix:nonFraction unitRef="property" contextRef="c-52" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-487">96</ix:nonFraction> facilities operated and managed by the Company's independent subsidiaries, <ix:nonFraction unitRef="property" contextRef="c-53" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-488">33</ix:nonFraction> operations leased to and operated by third-party operators and the Service Center (defined below) location. Of those <ix:nonFraction unitRef="property" contextRef="c-53" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-489">33</ix:nonFraction> third-party operations, <ix:nonFraction unitRef="property" contextRef="c-54" decimals="INF" name="ensg:NumberOfRealEstatePropertiesSharingLocations" format="ixt-sec:numwordsen" scale="0" id="f-490">one</ix:nonFraction> senior living operation is located on the same real estate property as a skilled nursing operation that an independent subsidiary operates. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s wholly-owned independent subsidiaries, collectively referred to as the Service Center, provide specific accounting, payroll, human resources, information technology, legal, risk management and other centralized services to the other independent subsidiaries. The Company also has a wholly-owned captive insurance subsidiary that provides some claims-made coverage to the Company&#8217;s independent subsidiaries for general and professional liabilities, as well as coverage for certain workers&#8217; compensation insurance liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's captive real estate investment trust (REIT), Standard Bearer Healthcare REIT, Inc. (Standard Bearer), owns and manages its real estate business. The REIT structure provides the Company with an efficient vehicle for future acquisitions of properties that could be operated by Ensign's independent subsidiaries or other third parties. Standard Bearer has elected to be taxed as a REIT for U.S. federal income tax purposes. Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on Standard Bearer. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company's independent subsidiaries are operated by wholly-owned subsidiaries that have their own management, employees and assets. References herein to the consolidated &#8220;Company&#8221; and &#8220;its&#8221; assets and activities in this Annual Report are not meant to imply, nor should it be construed as meaning that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by The Ensign Group, Inc.</span></div></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_94"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="f-491" continuedAt="f-491-1" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="f-491-1" continuedAt="f-491-2"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-492" continuedAt="f-492-1" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span></ix:nonNumeric><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-492-1"> The accompanying consolidated financial statements (the Financial Statements) have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The Company is the sole member or stockholder of various consolidated limited liability companies and corporations established to operate various acquired skilled nursing operations, senior living operations and related ancillary services. All intercompany transactions and balances have been eliminated in consolidation. The Company presents noncontrolling interests within the equity section of its consolidated balance sheets and the amount of consolidated net income that is attributable to The Ensign Group, Inc. and the noncontrolling interests in its consolidated statements of income. The Financial Statements include the accounts of all independent subsidiaries controlled by the Company through its ownership of a majority voting interest.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="f-493" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period statements of income and statements of cash flows have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net income.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-494" continuedAt="f-494-1" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span></ix:nonNumeric><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-494-1"> The preparation of the Financial Statements in conformity with GAAP&#160;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company&#8217;s Financial Statements relate to revenue, acquired property and equipment, intangible assets and goodwill, right-of-use assets and lease liabilities, impairment of long-lived assets, as well as general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities. Actual results could differ from those estimates</ix:continuation>.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-491-2" continuedAt="f-491-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="f-495" continuedAt="f-495-1" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Considerations</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist principally of cash and cash equivalents, debt security investments, accounts receivable, insurance subsidiary deposits, deferred compensation investment funds, equity investments, accounts payable and borrowings. The Company believes all of the financial instruments&#8217; recorded values approximate fair values because of their nature or respective short durations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. See Note 5, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-495-1">The Company's non-financial assets, which includes goodwill, intangible assets, property and equipment and right-of-use assets, are not required to be measured at fair value on a recurring basis. However, on a periodic basis, or whenever events or changes in circumstances indicate that their carrying value may not be recoverable, the Company assesses its long-lived assets for impairment. When impairment has occurred, such long-lived assets are written down to fair value.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-496" continuedAt="f-496-1" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue Recognition</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 606).</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's service revenue is derived primarily from providing healthcare services to its patients. Revenue is recognized when services are provided to patients at the amount that reflects the consideration that the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. The healthcare services provided pursuant to skilled patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct. Additionally, there may be ancillary services that are not included in the daily rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rates on a per day basis, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration that is included in the transaction price may be constrained and is included in net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net revenue in the period such variances become known.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company&#8217;s contracts with its patients have an original duration of one year or less, the Company uses the practical expedient applicable to its contracts and does not consider the time value of money. Further, because of the short duration of these contracts, the Company has not disclosed the transaction price for the remaining performance obligations as of the end of each reporting period or when the Company expects to recognize this revenue. In addition, the Company has applied the practical expedient provided by FASB ASC Topic 340, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and all incremental customer contract acquisition costs are expensed as they are incurred because the amortization period would have been one year or less.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rental Revenue Recognition</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's rental revenues are primarily generated by leasing healthcare-related properties through triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Revenue for operating leases is recognized on a straight-line basis over the lease term when collectability of all minimum lease payments is probable in accordance with FASB ASC Topic 842, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 842). The Company has elected the single component practical expedient, which allows a lessor, by class of underlying asset, not to allocate the total consideration to the lease and non-lease components based on their relative stand-alone selling prices where certain criteria are met. </span></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-496-1">Tenant reimbursements related to property taxes and insurance are neither considered lease nor non-lease components under ASC 842. Lessee payments for taxes and insurance paid directly to a third party, on behalf of the Company, are excluded from variable lease payments and rental revenue in the Company&#8217;s consolidated statements of income. Otherwise, tenant reimbursements for taxes and insurance that are paid by the Company directly to a third party are classified as additional rental revenue and expense and recognized by the Company on a gross basis.</ix:continuation> </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-491-3" continuedAt="f-491-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="f-497" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-498" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of bank term deposits, money market funds and treasury bill related investments with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of money market funds is determined based on &#8220;Level&#160;1&#8221; inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentPolicyTextBlock" id="f-499" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Subsidiary Deposits and Other Investments &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's captive insurance subsidiary cash and cash equivalents, deposits and investments are designated to support long-term insurance subsidiary liabilities and have been classified as short-term and long-term assets based on the timing of expected future payments of the Company's captive insurance liabilities. The majority of these deposits and investments are currently held in AA, A and BBB rated debt security investments and the remainder is held in a bank account with a high credit quality financial institution. Investments classified as held-to-maturity are financial instruments that the Company has the intent and ability to hold to maturity and are reported net of any related amortization and are not remeasured to fair value on a recurring basis.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's non-qualified deferred compensation plan's (the DCP) contracts insuring the lives of certain employees who are eligible to participate in the DCP are held in a rabbi trust. Cash surrender value of the contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating an investment for its current expected credit losses, the Company reviews factors such as historical experience with defaults, losses, credit ratings, term, market sector and macroeconomic trends, including current conditions and forecasts to the extent they are reasonable and supportable.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-500" continuedAt="f-500-1" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span></ix:nonNumeric><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-500-1"> Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from <span style="-sec-ix-hidden:f-501">three</span> to <ix:nonNumeric contextRef="c-56" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-502">59</ix:nonNumeric> years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-503" continuedAt="f-503-1" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases skilled nursing facilities, senior living facilities and commercial office space.</span><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease and performs an evaluation to determine whether the lease should be classified as an operating or finance lease at the inception of the lease. As of December&#160;31, 2024, the Company has <ix:nonFraction unitRef="lease" contextRef="c-4" decimals="INF" name="ensg:NumberOfFinancingLeases" format="ixt-sec:numwordsen" scale="0" id="f-504">three</ix:nonFraction> financing lease that are not material to the consolidated balance sheet. Rights and obligations of the operating leases are included as right-of-use assets and current and long-term lease liabilities on the Company's consolidated balance sheets. As the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of future lease payments. The Company utilizes a third-party credit specialist to assist in estimating the incremental borrowing rate.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records rent expense for operating leases on a straight-line basis over the term of the lease. The lease term used for straight-line rent expense is calculated from the date the Company is given control of the leased premises through the end of the lease term. Renewals are not assumed in the determination of the lease term unless they are deemed to be reasonably assured at the inception of the lease. The lease term used for this evaluation also provides the basis for establishing depreciable lives for buildings subject to lease and leasehold improvements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's real estate leases generally have initial lease terms of <ix:nonNumeric contextRef="c-55" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-505">ten years</ix:nonNumeric> or more and typically include <ix:nonFraction unitRef="option" contextRef="c-1" decimals="INF" name="ensg:LesseeOperatingLeaseNumberOfRenewalOptions" format="ixt-sec:numwordsen" scale="0" id="f-506">one</ix:nonFraction> or more options to renew, with renewal terms that generally extend the lease term for an additional <span style="-sec-ix-hidden:f-507">ten</span> to <ix:nonNumeric contextRef="c-56" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:duryear" id="f-508">15</ix:nonNumeric> years. Exercise of the renewal options is generally subject to the satisfaction of certain conditions which vary by contract and generally follow payment terms that are consistent with those in place during the initial term. The Company reassesses the renewal option using a "reasonably certain" threshold, which is understood to be a high threshold. For leases where the Company is reasonably certain to exercise its renewal option, the option periods are included within the lease term and, therefore, the measurement of the right-of-use asset and lease liability. The Company's leases generally contain annual escalation clauses that are either fixed or variable in nature, some of which are dependent upon published indices. The Company recognizes lease expense for leases with an initial term of 12 months or less on a straight-line basis over the lease term. These leases are not recorded on the consolidated balance sheets. Certain of the Company's lease agreements include rental payments that are adjusted periodically for inflation. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. </span></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-491-4" continuedAt="f-491-5"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-503-1">The Company subleases skilled nursing facilities to third-party operators and considers the subleases to be separate contracts as the Company is not relieved of its primary obligation under its operating lease. The rental income from third-parties related to these subleases is presented on a gross basis from the rent expense associated with the Company's lease obligations and is not material to the consolidated statements of income.</ix:continuation> </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-509" continuedAt="f-509-1" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span></ix:nonNumeric><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-509-1">The Company reviews the carrying value of long-lived assets that are held and used in the Company&#8217;s independent subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the independent subsidiaries to which the assets relate, utilizing management&#8217;s best estimate, appropriate assumptions and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="f-510" continuedAt="f-510-1" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Goodwill</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Definite-lived intangible assets consist primarily of patient base, facility trade names and customer relationships. Patient base is amortized over a period of <span style="-sec-ix-hidden:f-511">four</span> to <ix:nonNumeric contextRef="c-58" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-512">eight months</ix:nonNumeric>, depending on the classification of the patients and the level of occupancy in a new acquisition on the acquisition date. Trade names at independent subsidiaries are amortized over <ix:nonNumeric contextRef="c-59" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-513">30</ix:nonNumeric> years&#160;and customer relationships are amortized over a period of up to <ix:nonNumeric contextRef="c-60" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-514">20</ix:nonNumeric> years.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. </span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><ix:continuation id="f-510-1" continuedAt="f-510-2"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. The Company tests goodwill during the fourth quarter of each year or more often if events or circumstances indicate there may be impairment. The Company performs its analysis for each reporting unit that constitutes a business for which discrete financial information is produced and reviewed by operating segment management and provides services that are distinct from the other components of the operating segment, in accordance with the provisions of FASB ASC Topic 350,&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#160;</span></ix:continuation><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-510-2">(ASC 350). This guidance provides the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company performs a goodwill impairment test by comparing the carrying value of each reporting unit to its respective fair value. The Company determines the estimated fair value of each reporting unit using a discounted cash flow analysis. The fair value of the reporting unit is the implied fair value of goodwill. In the event a reporting unit's carrying value exceeds its fair value, an impairment loss will be recognized. An impairment loss is measured by the difference between the carrying value of the reporting unit and its fair value. The Company anticipates that the majority of goodwill recognized will be fully deductible for tax purposes as of December&#160;31, 2024.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SelfInsuranceReservePolicyTextBlock" id="f-515" continuedAt="f-515-1" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Insurance</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is partially self-insured for general and professional liability claims up to a base amount per claim (the self-insured retention) with an aggregate, one-time deductible above this limit. Losses beyond these amounts are insured through third-party policies with coverage limits per claim, per location and on an aggregate basis for the Company. The combined self-insured retention is $<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-516">750</ix:nonFraction> per claim, subject to an additional one-time deductible of $<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-517">1,500</ix:nonFraction> for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-518">650</ix:nonFraction> per claim, subject to an additional one-time, deductible of $<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-519">1,400</ix:nonFraction>. For all independent subsidiaries, except those located in Colorado, the third-party coverage above these limits is $<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-520">1,000</ix:nonFraction> per claim, $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-521">3,000</ix:nonFraction> per operation, with a $<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-522">10,000</ix:nonFraction> aggregate limit and an additional state-specific aggregate where required by state law. In Colorado, the third-party coverage above these limits is $<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-523">1,000</ix:nonFraction> per claim and $<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-524">3,000</ix:nonFraction> per operation, which is independent of the aforementioned aggregate limits that apply outside of Colorado. Subsequent to December&#160;31, 2024, the combined self-insured retention is $<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-525">1,000</ix:nonFraction> per claim ($<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-526">750</ix:nonFraction> if an enforceable arbitration agreement applies), subject to an additional one-time deductible of $<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-527">2,950</ix:nonFraction> for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-528">750</ix:nonFraction> per claim ($<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-529">650</ix:nonFraction> if an enforceable arbitration agreement applies), subject to an additional one-time, deductible of $<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-530">4,500</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the self-insured retention and deductible limits for general and professional liabilities and workers' compensation liabilities are self-insured through the captive insurance subsidiary, the related assets and liabilities of which are included in the accompanying consolidated balance sheets. The captive insurance subsidiary is subject to certain statutory requirements as an insurance provider. </span></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-491-5" continuedAt="f-491-6"><ix:continuation id="f-515-1"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy is to accrue amounts equal to the actuarial estimated costs to settle open claims of insureds, as well as an estimate of the cost of insured claims that have been incurred but not reported. The Company develops information about the size of the ultimate claims based on historical experience, current industry information and actuarial analysis, and evaluates the estimates for claim loss exposure on a quarterly basis. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent subsidiaries are self-insured for workers&#8217; compensation liabilities in California. To protect itself against loss exposure in California with this policy, the Company has purchased individual specific excess insurance coverage that insures individual claims that exceed $<ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-531">625</ix:nonFraction> per occurrence. In Texas, the independent subsidiaries have elected non-subscriber status for workers&#8217; compensation claims and the Company has purchased individual stop-loss coverage that insures individual claims that exceed $<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-532">750</ix:nonFraction> per occurrence. The Company&#8217;s independent subsidiaries in all other states, with the exception of Washington, are under a loss sensitive plan that insures individual claims that exceed $<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-533">350</ix:nonFraction> per occurrence. In the state of Washington, the Company is self-insured and has purchased individual specific excess insurance coverage that insures individual claims that exceed $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-534">500</ix:nonFraction> per occurrence. For all of the self-insured plans and retention, the Company accrues amounts equal to the estimated costs to settle open claims, as well as an estimate of the cost of claims that have been incurred but not reported. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company self-funds medical (including prescription drugs) and dental healthcare benefits to the majority of its employees. The Company is fully liable for all financial and legal aspects of these benefit plans. To protect itself against loss exposure with this policy, the Company has purchased individual stop-loss insurance coverage that insures individual claims that exceed $<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:SelfInsuranceReserve" scale="3" id="f-535">525</ix:nonFraction> for each covered person.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that adequate provision has been made in the Financial Statements for liabilities that may arise out of patient care, workers&#8217; compensation, healthcare benefits and related services provided to date. The amount of the Company&#8217;s reserves was determined based on an estimation process that uses information obtained from both company-specific and industry data. This estimation process requires the Company to continuously monitor and evaluate the life cycle of the claims. Using data obtained from this monitoring and the Company&#8217;s assumptions about emerging trends, the Company, with the assistance of an independent actuary, develops information about the size of ultimate claims based on the Company&#8217;s historical experience and other available industry information. The most significant assumptions used in the estimation process include determining the trend in costs, the expected cost of claims incurred but not reported and the expected costs to settle or pay damage awards with respect to unpaid claims. The self-insured liabilities are based upon estimates, and while management believes that the estimates of loss are reasonable, the ultimate liability may be in excess of or less than the recorded amounts. Due to the inherent volatility of actuarially determined loss estimates, it is reasonably possible that the Company could experience changes in estimated losses that could be material to net income. If the Company&#8217;s actual liabilities exceed its estimates of losses, its future earnings, cash flows and financial condition would be adversely affected.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-536" continuedAt="f-536-1" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#8217;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#8217;s estimates and assumptions, actual results could differ.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-536-1">Standard Bearer was organized, has operated and intends to continue to operate in a manner to qualify for taxation as a REIT. In order to qualify as a REIT, Standard Bearer must meet certain organizational and operational requirements, including a requirement to distribute to its shareholders, which in this case is the Company, at least 90% of its annual taxable income. As a REIT, Standard Bearer generally will not be subject to federal income tax to the extent it distributes as qualifying dividends, all of its REIT taxable income to its shareholders. If Standard Bearer fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions.</ix:continuation> </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-491-6"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><ix:nonNumeric contextRef="c-1" name="ensg:NoncontrollingInterestPolicyTextBlock" id="f-537" continuedAt="f-537-1" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span></ix:nonNumeric><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-537-1">The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income attributable to The Ensign Group, Inc. in its consolidated statements of income. Net income per share is calculated based on net income attributable to The Ensign Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-538" escape="true"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based payment awards made to employees and directors including employee stock options and restricted stock awards based on estimated fair values, ratably over the requisite service period of the award. Net income has been reduced as a result of the recognition of the fair value of all stock options and restricted stock awards issued, the amount of which is based upon the number of grants and other variables. As stock-based compensation expense recognized in the Company&#8217;s consolidated statements of income was based on awards expected to vest, it has been reduced for estimated forfeitures. The Company estimates forfeitures at the time of grant and, if necessary, revises the estimate in subsequent periods if actual forfeitures differ.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-539" continuedAt="f-539-1" escape="true"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span></ix:nonNumeric><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-539-1"> The Company does not have any components of other comprehensive income recorded within its Financial Statements and, therefore, does not separately present a statement of comprehensive income in its Financial Statements.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-540" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except for rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws and a limited number of grandfathered standards, the FASB ASC is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements announced, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company's reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company's financial management and certain standards are under consideration.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Standards Adopted by the Company &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2023, the FASB issued Accounting Standards Update (ASU) 2023-07 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to expand the breadth and frequency of segment disclosures to include additional information about significant segment expenses, the chief operating decision maker (CODM) and other items, and also require the annual disclosures on an interim basis. This guidance was effective for annual periods beginning with the Company's fiscal year 2024, and in interim periods within the Company's fiscal year 2025. The Company adopted the requirements of this ASU in Note 8, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of this Annual Report.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In October 2023, the FASB issued ASU 2023-06</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Codification Amendments in Response to the SEC&#8217;s Disclosure Update and Simplification Initiative," </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which amends U.S. GAAP to include 14 disclosure requirements that are currently required under SEC Regulation S-X or Regulation S-K. Each amendment will be effective on the date on which the SEC removes the related disclosure requirement from SEC Regulation S-X or Regulation S-K. The adoption is not expected to have a material impact on the Company's Financial Statements as these requirements were previously incorporated under the SEC Regulations. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to disclose disaggregated jurisdictional and categorical information for the tax rate reconciliation, income taxes paid and other income tax related amounts. ASU 2023-09 is effective for annual periods beginning with the Company's fiscal year 2025, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to disaggregate key expense categories such as employee compensation, depreciation and intangible asset amortization within its financial statements. ASU 2024-03 is effective for annuals periods beginning with the Company's fiscal year 2027, and interim periods within the Company's fiscal year 2028, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_97"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-541" continuedAt="f-541-1" escape="true">REVENUE AND ACCOUNTS RECEIVABLE</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-541-1" continuedAt="f-541-2"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's service revenue is derived primarily from providing healthcare services to its patients. Revenue is recognized when services are provided to patients at the amount that reflects the consideration that the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates revenue from contracts with its patients by payors. The Company has determined that disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Payor</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is derived primarily from providing healthcare services to patients and is recognized on the date services are provided at amounts billable to individual patients, adjusted for estimates for variable consideration. For patients under reimbursement arrangements with third-party payors, including Medicaid, Medicare and private insurers, revenue is recorded based on contractually agreed-upon amounts or rates, adjusted for estimates for variable consideration, on a per patient, daily basis or as services are performed.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from the Medicare and Medicaid programs accounted for <ix:nonFraction unitRef="number" contextRef="c-81" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-542">70.9</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-82" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-543">72.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-544">73.7</ix:nonFraction>% for the years ended December 31, 2024, 2023 and 2022, respectively. Settlements with Medicare and Medicaid payors for retroactive adjustments due to audits and reviews are considered variable consideration and are included in the determination of the estimated transaction price. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and the Company&#8217;s historical settlement activity. Consistent with healthcare industry practices, any changes to these revenue estimates are recorded in the period the change or adjustment becomes known based on the final settlement. The Company recorded adjustments to revenue which were not material to the Company's revenue for the years ended December 31, 2024, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-545" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue for the years ended December 31, 2024, 2023 and 2022 is summarized in the following tables:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.086%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.312%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-546">1,682,344</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-85" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-547">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-548">1,459,449</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-87" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-549">39.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-550">1,183,156</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-551">39.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-552">1,055,226</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-91" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-553">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-554">985,749</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-555">26.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-556">832,160</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-95" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-557">27.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid &#8212; skilled</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-558">266,738</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-97" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-559">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-560">245,663</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-99" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-561">6.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-562">200,878</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-101" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-563">6.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicaid and Medicare</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-564">3,004,308</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-81" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-565">70.9</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-566">2,690,861</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-82" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-567">72.6</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-568">2,216,194</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-569">73.7</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-570">789,643</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-106" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-571">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-572">666,129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-108" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-573">18.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-574">525,710</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-110" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-575">17.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-576">443,574</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-112" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-577">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-578">351,081</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-114" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-579">9.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-580">266,807</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-116" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-581">8.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SERVICE REVENUE</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-582">4,237,525</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-117" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-583">100.0</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-584">3,708,071</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-118" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-585">100.0</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-586">3,008,711</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-119" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-587">100.0</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Medicaid payor includes revenue for senior living operations.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Medicaid payor includes revenue related to state relief funding during the year ended December 31, 2023 and 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Private and other also includes revenue from senior living operations and all revenue generated in other an</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">cillary services.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the service revenue above, the Company's rental revenue derived from triple-net lease arrangements with third parties is $<ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-588">22,960</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-589">21,284</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-590">16,757</ix:nonFraction> for the years ended December 31, 2024, 2023 and 2022.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State relief funding</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received state relief funding through Medicaid programs from various states, including healthcare relief funding under the American Rescue Plan Act (ARPA), increases in the Federal Medical Assistance Percentage (FMAP) under the Families First Coronavirus Response Act (FFCRA) and other state specific relief programs. The funding generally incorporates specific use requirements primarily for direct patient care including labor related expenses that are attributable to the COVID-19 pandemic or are associated with providing patient care. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-541-2"><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the expiration of the COVID-19 Public Health Emergency in May 2023, the Company did <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="ensg:FamilyFirstCoronavirusResponseActPaymentsReceived" format="ixt:fixed-zero" scale="3" id="f-591">not</ix:nonFraction> receive additional funding during the year ended December 31, 2024. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from these additional payments are recognized in accordance with ASC 606, subject to variable consideration constraints. In certain operations where the Company received additional payments that exceeded expenses incurred related to specific qualifiers, the Company recorded deferred revenue for the excess amount until additional expenses are incurred for recognition. Accordingly, the amount of state relief revenue recognized is limited to the actual related expenses incurred. As of years ended December 31, 2023 and 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:AccruedLiabilitiesStateReliefContractLiabilities" scale="3" id="f-592">486</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="ensg:AccruedLiabilitiesStateReliefContractLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-593">1,001</ix:nonFraction> in unapplied state relief funds, respectively. During the years ended December 31, 2023 and 2022, the Company received an additional $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:FamilyFirstCoronavirusResponseActPaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="f-594">64,238</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:FamilyFirstCoronavirusResponseActPaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="f-595">81,057</ix:nonFraction> in state relief funding and recognized $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="f-596">64,753</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="f-597">81,837</ix:nonFraction>, respectively, as revenue.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal relief funding </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of the Coronavirus Aid, Relief, and Economic Security Act of 2020 (CARES Act), the Company deferred payment of the employer portion of social security taxes related to 2020. For the year ended December 31, 2022, the Company paid $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:MedicareAcceleratedAndAdvancePaymentCARESACT" format="ixt:num-dot-decimal" scale="3" id="f-598">24,155</ix:nonFraction>, which was the second and final payment associated with the deferred amount from 2020. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Balance Sheet Impact</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s consolidated balance sheets are contract balances, comprised of billed accounts receivable and unbilled receivables, which are the result of the timing of revenue recognition, billings and cash collections, as well as contract liabilities, which primarily represent payments the Company receives in advance of services provided. The Company had no material contract liabilities and contract assets as of December 31, 2024 and 2023, or activity during the years ended December 31, 2024, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration and doubtful accounts. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-599" continuedAt="f-599-1" escape="true">Accounts receivable as of December&#160;31, 2024 and 2023, is summarized in the following table:</ix:nonNumeric></span></div><ix:continuation id="f-599-1"><div style="margin-top:9.75pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.861%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-600">228,872</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-601">178,285</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-602">139,711</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-603">125,907</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-604">77,056</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-605">85,512</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other payors</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-606">132,693</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-607">104,683</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-608">578,332</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-609">494,387</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-610">8,435</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-611">9,348</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ACCOUNTS RECEIVABLE, NET</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-612">569,897</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-613">485,039</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_106"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-614" continuedAt="f-614-1" escape="true">COMPUTATION OF NET INCOME PER COMMON SHARE</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="f-614-1" continuedAt="f-614-2"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share is computed by dividing income from operations attributable to stockholders of The Ensign Group, Inc. by the weighted average number of outstanding common shares for the period. The computation of diluted net income per share is similar to the computation of basic net income per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-614-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" id="f-615" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator used in the calculation of basic net income per common share follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NUMERATOR:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-616">298,458</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-617">209,850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-618">224,652</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income (loss) attributable to noncontrolling interests </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="f-619">485</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="f-620">451</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="f-621">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to The Ensign Group, Inc. </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-622">297,973</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-623">209,399</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-624">224,681</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DENOMINATOR:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic net income per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-625">56,655</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-626">55,708</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-627">54,887</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-628">5.26</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-629">3.76</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-630">4.09</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" id="f-631" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator used in the calculation of diluted net income per common share follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.818%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NUMERATOR:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-632">298,458</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-633">209,850</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-634">224,652</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="f-635">485</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="f-636">451</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" scale="3" id="f-637">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to The Ensign Group, Inc. </span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-638">297,973</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-639">209,399</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-640">224,681</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DENOMINATOR:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-641">56,655</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-642">55,708</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-643">54,887</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: incremental shares from assumed conversion</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="f-644">1,585</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="f-645">1,615</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="f-646">1,984</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted weighted average common shares outstanding</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-647">58,240</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-648">57,323</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-649">56,871</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-650">5.12</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-651">3.65</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-652">3.95</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-653">914</ix:nonFraction>, </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="f-654">1,429</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="f-655">780</ix:nonFraction> for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div></ix:nonNumeric></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_115"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-656" continuedAt="f-656-1" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-656-1" continuedAt="f-656-2"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial assets include held-to-maturity investments carried at amortized cost basis of $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-657">138,600</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-658">59,530</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-659">65,831</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-660">59,530</ix:nonFraction> are designated to support long-term insurance subsidiary liabilities, both as of December&#160;31, 2024 and 2023, respectively. As of December&#160;31, 2024 and 2023, the amortized cost basis of these financial assets are considered to approximate fair value and are derived using Level 2 inputs. The Company believes its amortized cost basis investments that were in an unrealized loss position as of December&#160;31, 2024 and 2023 do not require an allowance for expected credit losses, nor has any event occurred through the filing date of this report that would indicate differently.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial assets also include the contracts insuring the lives of certain employees who are eligible to participate in non-qualified deferred compensation plans that are held in a rabbi trust. The cash surrender value of these contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan and are held at fair value. As of December&#160;31, 2024 and 2023, the fair value of the investment funds was $<ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-661">56,049</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-662">41,216</ix:nonFraction>, respectively, which are derived using Level 2 inputs.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-656-2">Additionally, the Company has other investments held at historical cost basis, which are not material, for which the fair value is derived using Level 3 inputs.</ix:continuation> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_121"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="c-1" name="ensg:StandardBearerTextBlock" id="f-663" continuedAt="f-663-1" escape="true">STANDARD BEARER</ix:nonNumeric></span></div><ix:continuation id="f-663-1" continuedAt="f-663-2"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Standard Bearer's real estate portfolio consists of <ix:nonFraction unitRef="property" contextRef="c-132" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-664">124</ix:nonFraction> of the Company's <ix:nonFraction unitRef="property" contextRef="c-4" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-665">129</ix:nonFraction> owned real estate properties, of which <ix:nonFraction unitRef="property" contextRef="c-133" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-666">92</ix:nonFraction> are operated and managed by the Company's independent subsidiaries and <ix:nonFraction unitRef="property" contextRef="c-53" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-667">33</ix:nonFraction> are leased to and operated by third-party operators. Of those <ix:nonFraction unitRef="property" contextRef="c-53" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-668">33</ix:nonFraction> operations, <ix:nonFraction unitRef="property" contextRef="c-54" decimals="INF" name="ensg:NumberOfRealEstatePropertiesSharingLocations" format="ixt-sec:numwordsen" scale="0" id="f-669">one</ix:nonFraction> senior living operation is located on the same real estate property as a skilled nursing operation that an independent subsidiary operates. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2024,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Standard Bearer added $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-670">131,927</ix:nonFraction> of real estate assets associated with <ix:nonFraction unitRef="property" contextRef="c-135" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-671">11</ix:nonFraction> stand-alone skilled nursing operations, <ix:nonFraction unitRef="property" contextRef="c-136" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-672">three</ix:nonFraction> stand-alone senior living operations and <ix:nonFraction unitRef="property" contextRef="c-137" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-673">three</ix:nonFraction> campus operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These new additions for the stand-alone skilled nursing and campus operations are</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operated by </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="subsidiary" contextRef="c-138" decimals="INF" name="ensg:NumberOfOperatingSubsidiaries" scale="0" id="f-674">14</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsidiaries and the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="property" contextRef="c-136" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-675">three</ix:nonFraction> stand-alone senior living operations are leased to a third-party operator. Refer to Note 7, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operation Expansions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, Standard Bearer added $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-676">50,853</ix:nonFraction> of real estate assets associated with <ix:nonFraction unitRef="property" contextRef="c-140" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-677">four</ix:nonFraction> stand-alone skilled nursing operations and <ix:nonFraction unitRef="property" contextRef="c-141" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-678">one</ix:nonFraction> campus operation. <ix:nonFraction unitRef="property" contextRef="c-142" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-679">Four</ix:nonFraction> of the acquisitions were related to exercising purchase options under an existing lease arrangement from CareTrust REIT, Inc. (CareTrust). These locations are currently operated by the Company's independent subsidiaries. The remaining <ix:nonFraction unitRef="property" contextRef="c-143" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-680">one</ix:nonFraction> real estate acquisition was leased back to the Company's independent subsidiaries. Refer to Note 7, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operation Expansions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. </span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, Standard Bearer added $<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-681">65,899</ix:nonFraction> of real estate assets associated with <ix:nonFraction unitRef="property" contextRef="c-145" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-682">three</ix:nonFraction> stand-alone skilled nursing facilities and <ix:nonFraction unitRef="property" contextRef="c-146" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-683">two</ix:nonFraction> campus operations. Of these additions, the <ix:nonFraction unitRef="property" contextRef="c-147" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-684">three</ix:nonFraction> skilled nursing facilities and <ix:nonFraction unitRef="property" contextRef="c-148" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-685">one</ix:nonFraction> campus operation acquired are operated by the Company's independent subsidiaries and the other campus operation is leased to a third-party operator. </span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, Standard Bearer added $<ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-686">84,656</ix:nonFraction> of real estate assets associated with <ix:nonFraction unitRef="property" contextRef="c-150" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-687">ten</ix:nonFraction> skilled nursing facilities, <ix:nonFraction unitRef="property" contextRef="c-151" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-688">three</ix:nonFraction> of which were previously operated and managed by the Company's independent subsidiaries. Refer to Note 7, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operation Expansions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the formation of Standard Bearer, certain of the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Standard Bearer and Standard Bearer's independent real estate subsidiaries entered into several agreements that include leasing, management services and debt arrangements between the operations</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All intercompany transactions have been eliminated in consolidation. Refer to Note 8, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information related to these intercompany eliminations as well as Standard Bearer as a reportable segment. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intercompany master lease agreements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's independent subsidiaries and <ix:nonFraction unitRef="property" contextRef="c-133" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-689">92</ix:nonFraction> Standard Bearer independent real estate subsidiaries have entered into <ix:nonFraction unitRef="lease" contextRef="c-1" decimals="INF" name="ensg:NumberOfLeaseArrangements" format="ixt-sec:numwordsen" scale="0" id="f-690">six</ix:nonFraction> triple-net master lease agreements (collectively, the Standard Bearer Master Leases). The lease periods range from <ix:nonNumeric contextRef="c-152" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-691">15</ix:nonNumeric> to <ix:nonNumeric contextRef="c-153" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-692">19</ix:nonNumeric> years with <ix:nonFraction unitRef="renewal" contextRef="c-154" decimals="INF" name="ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" format="ixt-sec:numwordsen" scale="0" id="f-693">three</ix:nonFraction> <ix:nonNumeric contextRef="c-154" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-694">five-year</ix:nonNumeric> renewal options beyond the initial term, on the same terms and conditions. The rent structure under the Standard Bearer Master Leases includes a fixed component, subject to annual escalation equal to the lesser of (1) the percentage change in the Consumer Price Index (but not less than <ix:nonFraction unitRef="number" contextRef="c-152" decimals="INF" name="us-gaap:LesseeOperatingLeaseDiscountRate" format="ixt:fixed-zero" scale="0" id="f-695">zero</ix:nonFraction>) or (2) <ix:nonFraction unitRef="number" contextRef="c-154" decimals="3" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="f-696">2.5</ix:nonFraction>%. In addition to rent, the independent subsidiaries are required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties; (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. Intercompany rental revenue generated from Ensign affiliated operations was $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-697">78,110</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-698">66,712</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-699">57,967</ix:nonFraction> for the years ended December 31, 2024, 2023 and 2022, respectively, which has been eliminated in consolidation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intercompany management agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer has no employees. The Service Center provides personnel and services to Standard Bearer pursuant to the management agreement between Standard Bearer and the Service Center. The management agreement provides for a base management fee that is equal to <ix:nonFraction unitRef="number" contextRef="c-158" decimals="3" name="ensg:PropertyManagementFeePercentFeeOfTotalRevenues" scale="-2" id="f-700">5.0</ix:nonFraction>% of total rental revenue and an incentive management fee that is equal to <ix:nonFraction unitRef="number" contextRef="c-159" decimals="3" name="ensg:PropertyManagementFeePercentFeeOfFundsFromOperations" scale="-2" id="f-701">5.0</ix:nonFraction>% of funds from operations (FFO) and is capped at <ix:nonFraction unitRef="number" contextRef="c-159" decimals="3" name="ensg:PropertyManagementFeePercentFeeOfTotalRevenues" scale="-2" id="f-702">1.0</ix:nonFraction>% of total rental revenue, for a total of <ix:nonFraction unitRef="number" contextRef="c-160" decimals="3" name="ensg:PropertyManagementFeePercentFeeOfTotalRevenues" scale="-2" id="f-703">6.0</ix:nonFraction>%. Management fee generated between Standard Bearer and the Service Center for the years ended December 31, 2024, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-704">5,707</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-705">4,948</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:ManagementFeeExpense" format="ixt:num-dot-decimal" scale="3" id="f-706">4,367</ix:nonFraction>, respectively, which has been eliminated in consolidation. </span></div></ix:continuation><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-663-2"><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intercompany debt arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer obtains its funding through various sources including operating cash flows, access to debt arrangements and intercompany loans. The intercompany debt arrangements include mortgage loans and a credit facility to fund acquisitions and working capital needs. The interest rate under the credit facility is a base rate plus a margin ranging from <ix:nonFraction unitRef="number" contextRef="c-163" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-707">0.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-164" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-708">1.25</ix:nonFraction>% per annum or SOFR plus a margin ranging from <ix:nonFraction unitRef="number" contextRef="c-165" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-709">1.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-166" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-710">2.25</ix:nonFraction>% per annum. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as the Department of Housing and Urban Development (HUD) mortgage loans and promissory note are entered into by real estate subsidiaries of Standard Bearer, the interest expense incurred from these debts are included in Standard Bearer's segment income. Refer to Note 14, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information related to these debts. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Instrument Denominated in the Shares of a Subsidiary</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the formation of Standard Bearer in 2022, the Company established the Standard Bearer Healthcare REIT, Inc. 2022 Omnibus Incentive Plan (Standard Bearer Equity Plan). The Company may grant stock options and restricted stock awards under the Standard Bearer Equity Plan to employees and management of Ensign's independent subsidiaries. These awards generally vest over a period of <ix:nonNumeric contextRef="c-167" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-711">five years</ix:nonNumeric> or upon the occurrence of certain prescribed events. The value of the stock options and restricted stock awards is tied to the value of the common stock of Standard Bearer, which is determined based on an independent valuation of Standard Bearer. The Company can also call the awards, generally upon employee termination. The Company granted <ix:nonFraction unitRef="shares" contextRef="c-168" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-712">39</ix:nonFraction> restricted stock awards during the year ended December 31, 2024. During the years ended December&#160;31, 2023 and 2022, the Company did <ix:nonFraction unitRef="shares" contextRef="c-169" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-713"><ix:nonFraction unitRef="shares" contextRef="c-170" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-714"><ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-715"><ix:nonFraction unitRef="shares" contextRef="c-172" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-716">not</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> grant any stock options or restricted shares under the Standard Bearer Equity Plan. During the years ended December 31, 2024, 2023 and 2022, there were <ix:nonFraction unitRef="shares" contextRef="c-168" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="f-717"><ix:nonFraction unitRef="shares" contextRef="c-170" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="f-718"><ix:nonFraction unitRef="shares" contextRef="c-171" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="f-719">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> restricted stock awards vested for the periods. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of the awards is recognized as compensation expense over the relevant vesting periods, with a corresponding adjustment to noncontrolling interests. The grant value was determined based on an independent valuation of the subsidiary shares.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2024, the Standard Bearer Equity Plan's share-based compensation expense was not material. There was <ix:nonFraction unitRef="usd" contextRef="c-169" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-720"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="INF" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="0" id="f-721">no</ix:nonFraction></ix:nonFraction> expense during the years ended December&#160;31, 2023 and 2022.</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, Standard Bearer sold fully vested common shares from the Standard Bearer Equity Plan to shareholders for cash of $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-722">6,544</ix:nonFraction>. Also, during the year ended December 31, 2022, Standard Bearer established shareholders of its preferred shares through contributions of cash of $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" scale="3" id="f-723">149</ix:nonFraction>. These preferred shares were fully vested at the time of the contributions by the shareholders. The value of Standard Bearer common and preferred shares held by the Company are eliminated in consolidation and the value held by other shareholders are classified as noncontrolling interests on the Company's consolidated balance sheets.</span></div></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_130"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-724" continuedAt="f-724-1" escape="true">OPERATION EXPANSIONS</ix:nonNumeric></span></div><ix:continuation id="f-724-1" continuedAt="f-724-2"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expansion focus of the Company's independent subsidiaries is to purchase or lease operations that are complementary to the current operations, accretive to the business, or otherwise advance the Company's strategy. The results of all independent subsidiaries are included in the Financial Statements subsequent to the date of acquisition. Acquisitions are accounted for using the acquisition method of accounting. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the new operations obtained through long-term leases, the Company did not acquire any material assets or assume any liabilities other than the tenant's post-assumption rights and obligations under the long-term lease. The Company also entered into a separate operations transfer agreement with each prior operator as part of each transaction. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's independent subsidiaries also enter into long-term leases that may include options to purchase the facilities. As a result, from time to time, an independent real estate subsidiary may acquire the property of facilities that have previously been operated under third-party leases. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2024 Expansions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, the Company expanded its operations through a combination of long-term leases and real estate purchases</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with the addition of <ix:nonFraction unitRef="property" contextRef="c-173" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-725">28</ix:nonFraction> stand-alone skilled nursing operations, including a long-term acute care hospital and</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="property" contextRef="c-174" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-726">three</ix:nonFraction> campus operations. Of these additions, Standard Bearer acquired the real estate of <ix:nonFraction unitRef="property" contextRef="c-175" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-727">14</ix:nonFraction> of these operations, all of which were leased back to the Company's independent subsidiaries.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on the purchase of real estate properties. These new operations added a total of <ix:nonFraction unitRef="bed" contextRef="c-176" decimals="INF" name="ensg:NumberOfSkilledNursingBeds" format="ixt:num-dot-decimal" scale="0" id="f-728">3,030</ix:nonFraction> operational skilled nursing beds, including <ix:nonFraction unitRef="bed" contextRef="c-176" decimals="INF" name="ensg:NumberOfLongTermAcuteCareBeds" scale="0" id="f-729">43</ix:nonFraction> long-term acute care beds and <ix:nonFraction unitRef="unit" contextRef="c-176" decimals="INF" name="ensg:NumberOfSeniorLivingUnits" scale="0" id="f-730">218</ix:nonFraction> operational senior living units to be operated by the Company's independent subsidiaries. The Company also invested in new ancillary services that are complementary to its existing businesses. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-724-2"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, the Company expanded its operations with the addition of <ix:nonFraction unitRef="property" contextRef="c-177" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-731">seven</ix:nonFraction> stand-alone skilled nursing operations. Of these additions, Standard Bearer acquired the real estate of <ix:nonFraction unitRef="property" contextRef="c-178" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-732">one</ix:nonFraction> of these operations, which was leased back to the Company's independent subsidiary.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on the purchase of the real estate property. The new operations added <ix:nonFraction unitRef="bed" contextRef="c-143" decimals="INF" name="ensg:NumberOfSkilledNursingBeds" scale="0" id="f-733">682</ix:nonFraction> operational skilled nursing beds to be operated by the Company's independent subsidiaries.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Expansions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, the Company expanded its operations through a combination of long-term leases and real estate purchases</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with the addition of <ix:nonFraction unitRef="property" contextRef="c-179" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-734">25</ix:nonFraction> stand-alone skilled nursing operations and <ix:nonFraction unitRef="property" contextRef="c-180" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-735">one</ix:nonFraction> campus operation. Of these additions, Standard Bearer acquired the real estate of <ix:nonFraction unitRef="property" contextRef="c-147" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-736">three</ix:nonFraction> of the stand-alone skilled nursing operations and <ix:nonFraction unitRef="property" contextRef="c-148" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-737">one</ix:nonFraction> campus operation, which were leased back to the Company's independent subsidiaries.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on the purchase of real estate properties. These new operations added a total of <ix:nonFraction unitRef="bed" contextRef="c-181" decimals="INF" name="ensg:NumberOfSkilledNursingBeds" format="ixt:num-dot-decimal" scale="0" id="f-738">2,483</ix:nonFraction> operational skilled nursing beds and <ix:nonFraction unitRef="unit" contextRef="c-181" decimals="INF" name="ensg:NumberOfSeniorLivingUnits" scale="0" id="f-739">94</ix:nonFraction> operational senior living units to be operated by the Company's independent subsidiaries. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Expansions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company expanded its operations and real estate portfolio through a combination of long-term leases and real estate purchases</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, with the addition of </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="property" contextRef="c-182" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-740">23</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stand-alone skilled nursing operations and </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="property" contextRef="c-183" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-741">one</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> campus operation. Of these additions, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer acquired the real estate of <ix:nonFraction unitRef="property" contextRef="c-184" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-742">seven</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the stand-alone skilled nursing operations, which were leased back to Ensign's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsidiaries.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on the purchases of real estate properties. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company added </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="property" contextRef="c-185" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-743">five</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> senior living operations that were transferred from The Pennant Group, Inc. (Pennant), </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="property" contextRef="c-186" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-744">three</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of which are part of campuses operated by the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsidiaries. These new operations added a total of </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="bed" contextRef="c-187" decimals="INF" name="ensg:NumberOfSkilledNursingBeds" format="ixt:num-dot-decimal" scale="0" id="f-745">3,058</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> operational skilled nursing beds and </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="unit" contextRef="c-187" decimals="INF" name="ensg:NumberOfSeniorLivingUnits" scale="0" id="f-746">674</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> operational senior living units to be operated by the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsidiaries. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also invested in new ancillary services that are complementary to its existing businesses. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="f-747" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the allocation of the purchase price for the operations acquired during the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">years ended December 31, 2024, 2023 and 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.449%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-748">20,547</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-749">7,794</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-750">15,527</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-751">108,709</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-752">57,488</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-753">65,070</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture, and fixtures</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-754">2,937</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-755">1,840</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-756">1,618</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assembled occupancy</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" format="ixt:num-dot-decimal" scale="3" id="f-757">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="f-758">346</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="f-759">367</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-760">21,112</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="f-761">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-762">16,400</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased asset</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="ensg:LeasedAssetsAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="f-763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="ensg:LeasedAssetsAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="f-764">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="ensg:LeasedAssetsAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-765">1,909</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="f-766">364</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="f-767">330</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="f-768">245</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL ACQUISITIONS</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-769">154,879</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-770">67,798</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-771">101,136</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquisition strategy has been focused on identifying both opportunistic and strategic acquisitions within its target markets that offer strong opportunities for return. The operations added by the Company are frequently underperforming financially and can have regulatory and clinical challenges to overcome. Financial information, especially with underperforming operations, is often inadequate, inaccurate or unavailable. Consequently, the Company believes that prior operating results are not a meaningful representation of the Company&#8217;s current operating results or indicative of the integration potential of its newly acquired </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The operations added during the&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were not material to the Company individually or in the aggregate. Accordingly, pro forma financial information is not presented. These additions have been included in the&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> balance sheets of the Company, and the operating results have been included in the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> statements of income of the Company since the date the Company gained effective control.</span></div></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_139"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 8. <ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-772" continuedAt="f-772-1" escape="true">BUSINESS SEGMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-772-1" continuedAt="f-772-2"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-773">two</ix:nonFraction> reportable segments: (1) skilled services, which includes the operation of skilled nursing facilities and rehabilitation therapy services and (2) Standard Bearer, which is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. </span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-772-2" continuedAt="f-772-3"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the skilled services segment includes <ix:nonFraction unitRef="property" contextRef="c-203" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-774">286</ix:nonFraction> skilled nursing and <ix:nonFraction unitRef="property" contextRef="c-204" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-775">30</ix:nonFraction> campus operations that provide both skilled nursing and rehabilitative care services and senior living services. The Company's Standard Bearer segment consists of <ix:nonFraction unitRef="property" contextRef="c-205" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-776">124</ix:nonFraction> owned real estate properties. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also reports an &#8220;All Other&#8221; category that includes results from its senior living operations, which includes <ix:nonFraction unitRef="property" contextRef="c-206" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-777">11</ix:nonFraction> stand-alone senior living operations and the senior living operations at <ix:nonFraction unitRef="property" contextRef="c-207" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-778">30</ix:nonFraction> campus operations that provide both skilled nursing and rehabilitative care services and senior living services. In addition, the "All Other" category includes mobile diagnostics, medical transportation, other real estate, other ancillary operations and the Service Center. Services included in the &#8220;All Other&#8221; category are insignificant individually, and therefore do not constitute a reportable segment.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments are significant operating segments that offer differentiated services. The segment structure reflects the Company's current operational and financial management and provides the best structure to maximize the quality of care and investment strategy provided, while maintaining financial discipline.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income (loss) is defined as income or loss before provision for income taxes, excluding gain or loss from sale of real estate, real estate insurance recoveries and impairment of long-lived assets. The Company's CODM, who is the Chief Executive Officer, reviews segment income or loss for each operating segment to evaluate performance and allocate capital resources. The CODM uses segment income or loss to analyze actual results as part of operational planning and to decide whether to reinvest profits into the segments or into other parts of the Company, such as through acquisitions, to pay dividends or to recommend a stock repurchase program. The Company's CODM does not review assets by segment in his resource allocation and therefore assets by segment are not disclosed below.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intercompany revenue is eliminated in consolidation, along with corresponding intercompany expenses. Included in segment income for Standard Bearer is expense for intercompany services provided by the Service Center as described in Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as it is part of the CODM financial information. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="f-779" continuedAt="f-779-1" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth financial information for the segments:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.603%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-780">4,076,825</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-781">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-782">4,076,825</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-783">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-784">95,086</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-785">95,086</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-786">4,076,825</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-787">95,086</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-788">4,171,911</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-789">192,881</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-790">104,307</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-791">4,260,485</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-792">3,513,167</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-793">9,152</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-794">45,195</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-795">29,297</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:fixed-zero" scale="3" id="f-796">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-797">27,302</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-798">518,463</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-799">29,335</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-800">547,798</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" sign="-" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-801">161,704</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-802">386,094</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All other revenue includes $<ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-803">181,066</ix:nonFraction> of service revenue and $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-804">11,815</ix:nonFraction> of rental revenue for the year ended December 31, 2024, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-805">83,941</ix:nonFraction> and intercompany service revenue of $<ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-806">20,366</ix:nonFraction> for the year ended December 31, 2024.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-779-1" continuedAt="f-779-2"><ix:continuation id="f-772-3" continuedAt="f-772-4"><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" sign="-" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-807">104,307</ix:nonFraction> during the year ended December 31, 2024, which are eliminated in consolidation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" sign="-" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-808">20,285</ix:nonFraction> during the year ended December 31, 2024, which is eliminated in consolidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:59.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.363%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.386%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.366%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-809">3,578,855</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-810">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-811">3,578,855</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-812">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-813">82,486</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-814">82,486</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-815">3,578,855</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-816">82,486</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-817">3,661,341</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-818">155,804</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-819">87,790</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-820">3,729,355</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-821">3,075,164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-822">8,455</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-823">38,766</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-824">25,205</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:fixed-zero" scale="3" id="f-825">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-826">19,761</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-827">464,925</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-828">29,065</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-829">493,990</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" sign="-" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-830">221,228</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-831">272,762</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All Other revenue includes $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-832">144,667</ix:nonFraction> of service revenue and $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-833">11,137</ix:nonFraction> of rental revenue for the year ended December 31, 2023, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination intercompany rental revenue of $<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-834">72,339</ix:nonFraction> and intercompany service revenue of $<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-835">15,451</ix:nonFraction> for the year ended December 31, 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" sign="-" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-836">87,790</ix:nonFraction> during the year ended December 31, 2023, which is eliminated in consolidation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" sign="-" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-837">12,902</ix:nonFraction> during the year ended December 31, 2023, which is eliminated in consolidation.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-772-4" continuedAt="f-772-5"><ix:continuation id="f-779-2" continuedAt="f-779-3"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.332%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-838">2,906,215</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-839">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-840">2,906,215</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-841">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-842">72,937</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-843">72,937</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-844">2,906,215</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-845">72,937</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-846">2,979,152</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-847">122,610</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-848">76,294</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-849">3,025,468</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-850">2,464,259</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-851">7,746</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-852">33,224</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-853">21,613</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:fixed-zero" scale="3" id="f-854">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-855">15,707</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-856">408,732</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-857">27,871</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-858">436,603</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" sign="-" name="ensg:SegmentIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-859">147,514</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-860">289,089</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All Other revenue includes $<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-861">115,214</ix:nonFraction> of service revenue and $<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-862">7,396</ix:nonFraction> of rental revenue for the year ended December 31, 2022, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-863">63,576</ix:nonFraction> and intercompany service revenue of $<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-864">12,718</ix:nonFraction> for the year ended December 31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment.  Additionally, there are intercompany expenses of $<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" sign="-" name="us-gaap:SegmentReportingOtherItemAmount" format="ixt:num-dot-decimal" scale="3" id="f-865">76,294</ix:nonFraction> during the year ended December 31, 2022, which is eliminated in consolidation. </span></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"><ix:continuation id="f-779-3">(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" sign="-" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-866">8,646</ix:nonFraction> during the year ended December 31, 2022, which is eliminated in consolidation.</ix:continuation> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" id="f-867" continuedAt="f-867-1" escape="true"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue by major payor source were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.397%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-868">1,646,422</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-869">35,922</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-870">1,682,344</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-85" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-871">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-872">1,055,226</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-874">1,055,226</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-91" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-875">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-876">266,738</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-877">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-878">266,738</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-97" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-879">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-880">2,968,386</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-881">35,922</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-882">3,004,308</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-81" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-883">70.9</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-884">789,643</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-885">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-886">789,643</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-106" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-887">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-888">318,796</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-889">124,778</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-890">443,574</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-112" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-891">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-892">4,076,825</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-893">160,700</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-894">4,237,525</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-117" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-895">100.0</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-867-1"><ix:continuation id="f-772-5"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-896">1,429,473</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-897">29,976</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-898">1,459,449</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-87" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-899">39.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-900">985,749</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-901">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-92" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-902">985,749</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-93" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-903">26.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-904">245,663</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-905">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-906">245,663</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-99" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-907">6.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-908">2,660,885</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-909">29,976</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-910">2,690,861</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-82" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-911">72.6</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-912">666,129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-913">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-914">666,129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-108" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-915">18.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-916">251,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-917">99,240</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-918">351,081</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-114" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-919">9.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-920">3,578,855</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-921">129,216</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-922">3,708,071</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-118" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-923">100.0</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.355%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-924">1,158,309</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-925">24,847</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-926">1,183,156</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-927">39.3</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-928">832,160</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-929">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-930">832,160</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-95" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-931">27.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-932">200,878</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-933">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-934">200,878</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-101" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-935">6.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-936">2,191,347</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-937">24,847</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-938">2,216,194</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-939">73.7</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-940">525,710</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-288" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-941">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-942">525,710</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-110" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-943">17.5</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-289" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-944">189,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-290" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-945">77,649</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-946">266,807</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-116" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-947">8.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-948">2,906,215</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-291" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-949">102,496</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-950">3,008,711</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-119" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-951">100.0</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all payors generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div></ix:continuation></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_151"></div><div style="margin-top:12pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-952" continuedAt="f-952-1" escape="true">PROPERTY AND EQUIPMENT - NET</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-953" escape="true"><ix:continuation id="f-952-1" continuedAt="f-952-2"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.958%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.715%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-292" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-954">162,873</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-293" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-955">142,656</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-294" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-956">933,790</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-295" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-957">803,155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-296" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-958">212,603</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-959">172,064</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-960">396,018</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-961">339,383</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-962">4,349</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-963">4,192</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-964">41,209</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-965">25,563</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-966">1,750,842</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-967">1,487,013</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-968">459,488</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-969">396,242</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY AND EQUIPMENT, NET</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-970">1,291,354</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-971">1,090,771</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify;text-indent:22.5pt"><ix:continuation id="f-952-2" continuedAt="f-952-3"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed the sale of assets for a sale price of $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-972">8,607</ix:nonFraction> and recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:num-dot-decimal" scale="3" id="f-973">3,467</ix:nonFraction> within the Company's consolidated statement of income as cost of services during the year ended December 31, 2022. The Company recorded gain and losses related to sale of assets, which were not material during the years ended December 31, 2024 and 2023. Management evaluated its long-lived assets and recorded an impairment charge of</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="f-974">1,849</ix:nonFraction> within the Company's consolidated statement of income as <span style="-sec-ix-hidden:f-975">cost of services</span> during the year ended December 31, 2024.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></ix:continuation><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-952-3">The Company determined there was <ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-976"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="INF" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-977">no</ix:nonFraction></ix:nonFraction> impairment during the year ended December 31, 2023 and 2022.</ix:continuation> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_160"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="f-978" continuedAt="f-978-1" escape="true">INTANGIBLE ASSETS - NET</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-978-1" continuedAt="f-978-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-979" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.806%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.303%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.682%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="5" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assembled occupancy</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-304" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-980">0.4</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-981">1,991</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-982">1,316</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-983">675</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-984">781</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-985">742</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-986">39</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility trade name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-307" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-987">30.0</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-988">733</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-989">462</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-990">271</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-991">733</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="f-992">439</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="f-993">294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-309" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="f-994">18.4</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-995">4,582</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-996">2,902</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-997">1,680</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-998">4,582</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-999">2,692</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1000">1,890</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1001">7,306</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1002">4,680</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1003">2,626</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1004">6,096</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1005">3,873</ix:nonFraction>)</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1006">2,223</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2024, 2023 and 2022, amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1007">2,019</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1008">1,790</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-1009">1,714</ix:nonFraction>, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1010">1,212</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1011">1,202</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1012">1,160</ix:nonFraction> was related to the amortization of right-of-use assets, respectively. The Company did <ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-1013"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-1014"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="INF" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="3" id="f-1015">not</ix:nonFraction></ix:nonFraction></ix:nonFraction> record any impairment charge to intangible assets during the years ended December 31, 2024, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-1016" escape="true"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated amortization expense for each of the years ending December&#160;31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.382%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.381%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="f-1017">911</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="f-1018">234</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="f-1019">234</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="f-1020">234</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="f-1021">234</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="3" id="f-1022">779</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1023">2,626</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" id="f-1024" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other indefinite-lived intangible assets consist of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="f-1025">889</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="f-1026">889</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicaid licenses</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1027">3,777</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1028">3,413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1029">4,666</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-1030">4,302</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-978-2">During the year ended December 31, 2024, the Company acquired $<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="f-1031">364</ix:nonFraction> in Medicare and Medicaid licenses compared to $<ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="f-1032">330</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="us-gaap:IndefinitelivedIntangibleAssetsAcquired" scale="3" id="f-1033">245</ix:nonFraction> in the fiscal years 2023 and 2022, respectively.</ix:continuation> </span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_172"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillDisclosureTextBlock" id="f-1034" continuedAt="f-1034-1" escape="true">GOODWILL </ix:nonNumeric></span></div><ix:continuation id="f-1034-1"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Provided that goodwill corresponds to the acquisition of a business and not merely the acquisition of real estate property, the Company's Standard Bearer segment appropriately does not carry a goodwill balance. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfGoodwillTextBlock" id="f-1035" continuedAt="f-1035-1" escape="true">The following table represents activity in goodwill by skilled service segment and "all other" category as of December&#160;31, 2024, 2023 and 2022:</ix:nonNumeric></span></div><div style="margin-top:3pt;text-align:justify"><ix:continuation id="f-1035-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-321" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1036">51,486</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-322" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1037">8,983</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1038">60,469</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1039">16,400</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-323" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="f-1040">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1041">16,400</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-324" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1042">67,886</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-325" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1043">8,983</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1044">76,869</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-326" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1045">67,886</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-327" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1046">8,983</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1047">76,869</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1048">20,740</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-328" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="f-1049">372</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1050">21,112</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-329" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1051">88,626</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-330" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1052">9,355</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-1053">97,981</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:continuation><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has evaluated its goodwill and intangible assets and determined there was <ix:nonFraction unitRef="usd" contextRef="c-12" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="f-1054"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="f-1055"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="f-1056">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment during the years ended December 31, 2024, 2023 and 2022. The Company has recognized cumulative goodwill impairment losses of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:GoodwillImpairedAccumulatedImpairmentLoss" format="ixt:num-dot-decimal" scale="3" id="f-1057">7,410</ix:nonFraction>, since inception in 1999. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div id="iec37f02aeb9544da81ef9669e1252f6f_190"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-1058" continuedAt="f-1058-1" escape="true">OTHER ACCRUED LIABILITIES</ix:nonNumeric></span></div><div style="text-indent:24.75pt"><span><br/></span></div><ix:continuation id="f-1058-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-1059" escape="true"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality assurance fee</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:QualityAssuranceFee" format="ixt:num-dot-decimal" scale="3" id="f-1060">12,667</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:QualityAssuranceFee" format="ixt:num-dot-decimal" scale="3" id="f-1061">14,035</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refunds payable</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:ResidentRefundsPayable" format="ixt:num-dot-decimal" scale="3" id="f-1062">56,755</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:ResidentRefundsPayable" format="ixt:num-dot-decimal" scale="3" id="f-1063">51,248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resident advances</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1064">18,818</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1065">10,834</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash held in trust for patients</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:CashHeldInTrustForResidents" format="ixt:num-dot-decimal" scale="3" id="f-1066">6,370</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:CashHeldInTrustForResidents" format="ixt:num-dot-decimal" scale="3" id="f-1067">6,215</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1068">3,589</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DividendsPayableCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1069">3,396</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property taxes</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1070">15,400</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1071">12,875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued litigation (Note 19)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LitigationReserveCurrent" format="ixt:fixed-zero" scale="3" id="f-1072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LitigationReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1073">51,734</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1074">18,458</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1075">17,891</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ACCRUED LIABILITIES</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1076">132,057</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1077">168,228</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality assurance fee represents the aggregate of amounts payable to Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Tennessee, Utah, Washington and Wisconsin as a result of a mandated fee based on patient days or licensed beds. Refunds payable includes payables related to overpayments, duplicate payments and credit balances from various payor sources. Resident advances occur when the Company receives payments in advance of services provided. Cash held in trust for patients reflects monies received from or on behalf of patients. Maintaining a trust account for patients is a regulatory requirement and, while the trust assets offset the liabilities, the Company assumes a fiduciary responsibility for these funds. The cash balance related to this liability is included in other current assets in the consolidated balance sheets.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_202"></div><div><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1078" continuedAt="f-1078-1" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1079" escape="true"><ix:continuation id="f-1078-1" continuedAt="f-1078-2"><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the years ended December 31, 2024, 2023 and 2022 is summarized as follows: </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1080">70,144</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1081">73,092</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1082">56,717</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1083">16,857</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1084">17,301</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1085">14,216</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1086">87,001</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1087">90,393</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1088">70,933</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="f-1089">582</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1090">22,280</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1091">5,158</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="f-1092">53</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1093">5,201</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1094">1,338</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" scale="3" id="f-1095">635</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1096">27,481</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1097">6,496</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;TOTAL</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1098">87,636</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1099">62,912</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1100">64,437</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1078-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1101" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory rate to the effective tax rate for net income for the years ended December 31, 2024, 2023 and 2022, respectively, is comprised as follows: </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1102">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1103">21.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="f-1104">21.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes&#160;- net of federal benefit</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1105">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1106">3.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="f-1107">3.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="f-1108">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="f-1109">3.4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" scale="-2" id="f-1110">2.0</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="f-1111">3.3</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="f-1112">4.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" scale="-2" id="f-1113">3.6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1114">0.3</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1115">0.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="f-1116">0.6</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL INCOME TAX PROVISION</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1117">22.7</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1118">23.1</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1119">22.3</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate was <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1120">22.7</ix:nonFraction>% for the year ended December 31, 2024, compared to <ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1121">23.1</ix:nonFraction>% for the same period in 2023 and <ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1122">22.3</ix:nonFraction>% in 2022. The lower effective tax rate is due to lower non-deductible expenses included but not limited to tax benefits from stock based compensation.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1123" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's deferred tax assets and liabilities as of December&#160;31, 2024 and 2023 are summarized below. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1124">76,419</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1125">81,502</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related reserves</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-1126">27,023</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="f-1127">23,714</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="f-1128">597</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1129">1,192</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" format="ixt:num-dot-decimal" scale="3" id="f-1130">24,817</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" format="ixt:num-dot-decimal" scale="3" id="f-1131">16,864</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1132">470,313</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1133">444,590</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1134">599,169</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1135">567,862</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-1136">93</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-1137">789</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DEFERRED TAX ASSETS</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1138">599,076</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1139">567,073</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:DeferredTaxLiabilitiesStateTaxes" scale="3" id="f-1140">197</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:DeferredTaxLiabilitiesStateTaxes" scale="3" id="f-1141">280</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1142">57,253</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-1143">52,334</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1144">6,390</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" format="ixt:num-dot-decimal" scale="3" id="f-1145">4,113</ix:nonFraction>)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset </span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:DeferredTaxLiabilitiesRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1146">468,955</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:DeferredTaxLiabilitiesRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1147">443,222</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DEFERRED TAX LIABILITIES</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1148">532,795</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1149">499,949</ix:nonFraction>)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET DEFERRED TAX ASSETS</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-1150">66,281</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="f-1151">67,124</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had state credit carryforwards as of December 31, 2024 and 2023 of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="3" id="f-1152">597</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1153">1,192</ix:nonFraction>, respectively. These carryforwards almost entirely relate to state limitations on the application of Enterprise Zone employment-related tax credits. Unless the Company uses the Enterprise Zone credits beforehand, the carryforward began to expire in 2023. The remainder of these carryforwards relate to credits against the Texas margin tax and is expected to carryforward until 2027. As of December 31, 2024 and 2023, the valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-1154">93</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="f-1155">789</ix:nonFraction>, respectively, was primarily recorded against the Enterprise Zone credits as the Company believes it is more likely than not that some of the benefit of the credits will not be realized. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operating loss carry forwards for states were not material during the years ended December 31, 2024 and 2023. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2024, 2023 and 2022, the Company did not have any unrecognized tax benefits, net of its state benefits that would affect the Company's effective tax rate. The Company classifies interest and/or penalties on income tax liabilities or refunds as additional income tax expense or income. Such amounts are not material.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal statutes of limitations on the Company's 2020, 2019, and 2018 income tax years lapsed during the third quarter of 2024, 2023, and 2022, respectively. During the fourth quarter of each year, various state statutes of limitations also lapsed. The lapses during the years ended December 31, 2024 and 2023 had no impact on the Company's unrecognized tax benefits.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_208"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-1156" continuedAt="f-1156-1" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="f-1156-1" continuedAt="f-1156-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-1157" escape="true"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.592%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans and promissory note</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1158">148,438</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-332" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1159">152,388</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1160">4,086</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1161">3,950</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs, net</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1162">2,767</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-1163">2,941</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM DEBT LESS CURRENT MATURITIES</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1164">141,585</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1165">145,497</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility with a Lending Consortium Arranged by Truist </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a revolving credit facility between the Company and its independent subsidiaries, including Standard Bearer as co-borrowers, and Truist Securities (Truist) (the Credit Facility) with a revolving line of credit of up to $<ix:nonFraction unitRef="usd" contextRef="c-333" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="f-1166">600,000</ix:nonFraction> in aggregate principal amount with a maturity date of April&#160;8, 2027. Borrowings are supported by a lending consortium arranged by Truist. The interest rates applicable to loans under the Credit Facility are, at the Company's option, equal to either a base rate plus a margin ranging from <ix:nonFraction unitRef="number" contextRef="c-163" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1167">0.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-164" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1168">1.25</ix:nonFraction>% per annum or SOFR plus a margin ranging from <ix:nonFraction unitRef="number" contextRef="c-165" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1169">1.25</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-166" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-1170">2.25</ix:nonFraction>% per annum, based on the Consolidated Total Net Debt to Consolidated EBITDA ratio (as defined in the Credit Facility). In addition, there is a commitment fee on the unused portion of the commitments that ranges from <ix:nonFraction unitRef="number" contextRef="c-334" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-1171">0.20</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-335" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-1172">0.40</ix:nonFraction>% per annum, depending on the Consolidated Total Net Debt to Consolidated EBITDA ratio. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings made under the Credit Facility are guaranteed, jointly and severally, by certain of the Company&#8217;s wholly-owned subsidiaries, and are secured by a pledge of stock of the Company's material independent subsidiaries as well as a first lien on substantially all of such independent subsidiaries' personal property. The Credit Facility contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. Under the terms of the Credit Facility, the Company must comply with financial maintenance covenants to be tested quarterly, consisting of (i) a maximum consolidated total net debt to consolidated EBITDA ratio (which shall not be greater than <ix:nonFraction unitRef="number" contextRef="c-333" decimals="INF" name="ensg:TotalNetDebtRatioMaximum" scale="0" id="f-1173">3.75</ix:nonFraction>:1.00; provided that if the aggregate consideration for approved acquisitions in a <ix:nonNumeric contextRef="c-333" name="ensg:LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" format="ixt-sec:durwordsen" id="f-1174">six month</ix:nonNumeric> period is greater than $<ix:nonFraction unitRef="usd" contextRef="c-333" decimals="-6" name="ensg:LongTermDebtThresholdForEBITDARatioIncreaseElection" format="ixt:num-dot-decimal" scale="3" id="f-1175">50,000</ix:nonFraction>, then the ratio can be increased at the election of the Company with notice to the administrative agent to <ix:nonFraction unitRef="number" contextRef="c-333" decimals="INF" name="ensg:TotalNetDebtRatioMaximumAfterIncreaseElection" scale="0" id="f-1176">4.25</ix:nonFraction>:1.00 for the first fiscal quarter and the immediately following three fiscal quarters), and (ii) a minimum interest/rent coverage ratio (which cannot be less than <ix:nonFraction unitRef="number" contextRef="c-333" decimals="INF" name="ensg:TotalNetDebtRatioMinimum" scale="0" id="f-1177">1.50</ix:nonFraction>:1.00). As of December&#160;31, 2024, there was <ix:nonFraction unitRef="usd" contextRef="c-333" decimals="INF" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:fixed-zero" scale="3" id="f-1178">no</ix:nonFraction> outstanding debt under the Credit Facility. The Company was in compliance with all loan covenants as of December&#160;31, 2024.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans and Promissory Note</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company has <ix:nonFraction unitRef="subsidiary" contextRef="c-336" decimals="INF" name="ensg:NumberOfOperatingSubsidiaries" scale="0" id="f-1179">23</ix:nonFraction> subsidiaries that have mortgage loans insured with HUD in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-336" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1180">146,898</ix:nonFraction>, which subjects these subsidiaries to HUD oversight and periodic inspections. The mortgage loans bear effective interest rates in a range of <ix:nonFraction unitRef="number" contextRef="c-337" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1181">3.1</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-338" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1182">4.2</ix:nonFraction>%, including fixed interest rates in a range of <ix:nonFraction unitRef="number" contextRef="c-337" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1183">2.4</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-338" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1184">3.3</ix:nonFraction>% per annum. In addition to the interest rate, the Company incurs other fees for HUD placement, including, but not limited to audit fees. Amounts borrowed under the mortgage loans may be prepaid, subject to prepayment fees based on the principal balance on the date of prepayment. For the majority of the loans, during the first three years, the prepayment fee is <ix:nonFraction unitRef="number" contextRef="c-339" decimals="3" name="ensg:PrepaymentPenalty" scale="-2" id="f-1185">10.0</ix:nonFraction>% and is reduced by <ix:nonFraction unitRef="number" contextRef="c-340" decimals="3" name="ensg:ReductionInPrepaymentPenalty" scale="-2" id="f-1186">3.0</ix:nonFraction>% in the fourth year of the loan and reduced by <ix:nonFraction unitRef="number" contextRef="c-341" decimals="3" name="ensg:ReductionInPrepaymentPenalty" scale="-2" id="f-1187">1.0</ix:nonFraction>%</span><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per year for years five through ten of the loan. There is <ix:nonFraction unitRef="number" contextRef="c-342" decimals="INF" name="ensg:PrepaymentPenalty" format="ixt:fixed-zero" scale="0" id="f-1188">no</ix:nonFraction> prepayment penalty after year ten. The terms for all the mortgage loans are <ix:nonNumeric contextRef="c-343" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="f-1189">25</ix:nonNumeric> to <ix:nonNumeric contextRef="c-344" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="f-1190">35</ix:nonNumeric> years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the HUD mortgage loans above, the Company has a promissory note of $<ix:nonFraction unitRef="usd" contextRef="c-345" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1191">1,540</ix:nonFraction> that bears a fixed interest rate of <ix:nonFraction unitRef="number" contextRef="c-345" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-1192">5.3</ix:nonFraction>% per annum and has a term of <ix:nonNumeric contextRef="c-346" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="f-1193">12</ix:nonNumeric> years. The note, which was assumed as part of an acquisition, is secured by the real property comprising the facility and the rent, issues and profits thereof, as well as all personal property used in the operation of the facility. </span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1156-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-1194" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future principal payments due under the long-term debt arrangements discussed above are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.057%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.013%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1195">4,086</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1196">4,227</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1197">3,897</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1198">3,779</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1199">3,896</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1200">128,553</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1201">148,438</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on Level 2 inputs, the carrying value of the Company's long-term debt is considered to approximate the fair value of such debt for all periods presented based upon the interest rates that the Company believes it can currently obtain for similar debt.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2024, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="3" id="f-1202">27,893</ix:nonFraction> of borrowing capacity under the Credit Facility pledged as collateral to secure outstanding letters of credit, which increased by $<ix:nonFraction unitRef="usd" contextRef="c-347" decimals="-3" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" format="ixt:num-dot-decimal" scale="3" id="f-1203">21,638</ix:nonFraction> from December&#160;31, 2023. The Company believes that its outstanding letters of credit as of December&#160;31, 2024 do not require an allowance for expected credit losses, nor has any event occurred through the filing date of this report that would indicate differently.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_223"></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-1204" continuedAt="f-1204-1" escape="true">OPTIONS AND AWARDS</ix:nonNumeric></span></div><ix:continuation id="f-1204-1" continuedAt="f-1204-2"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Omnibus Incentive Plan (2022 Plan)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has <ix:nonFraction unitRef="plan" contextRef="c-4" decimals="INF" name="ensg:NumberOfStockIncentivePlans" format="ixt-sec:numwordsen" scale="0" id="f-1205">one</ix:nonFraction> stock incentive plan, the 2022 Omnibus Incentive Plan (the 2022 Plan), pursuant to which grants of the Company's securities may currently be made. Including the shares rolled over from the 2017 Omnibus Incentive Plan, the 2022 Plan provides for the issuance of <ix:nonFraction unitRef="shares" contextRef="c-348" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-1206">3,452</ix:nonFraction> shares of common stock. The number of shares available to be issued under the 2022 Plan will be reduced by (i) <ix:nonFraction unitRef="number" contextRef="c-349" decimals="INF" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" format="ixt-sec:numwordsen" scale="0" id="f-1207">one</ix:nonFraction> share for each share that relates to an option or stock appreciation right award and (ii) <ix:nonFraction unitRef="number" contextRef="c-349" decimals="INF" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" format="ixt-sec:numwordsen" scale="0" id="f-1208">two</ix:nonFraction> shares for each share which relates to an award other than a stock option or stock appreciation right award (a full-value award). Non-employee director options, to the extent granted, will vest and become exercisable in <ix:nonFraction unitRef="installment" contextRef="c-350" decimals="INF" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" format="ixt-sec:numwordsen" scale="0" id="f-1209">three</ix:nonFraction> equal annual installments, or the length of the term if less than <ix:nonNumeric contextRef="c-350" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" format="ixt-sec:durwordsen" id="f-1210">three years</ix:nonNumeric>, on the completion of each year of service measured from the grant date. All other options generally vest over <ix:nonNumeric contextRef="c-349" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1211">five years</ix:nonNumeric> at <ix:nonFraction unitRef="number" contextRef="c-349" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-1212">20</ix:nonFraction>% per year on the anniversary of the grant date. Options expire <ix:nonNumeric contextRef="c-349" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-1213">ten years</ix:nonNumeric> from the date of grant. At December&#160;31, 2024, the total number of shares available for issuance under the 2022 Plan was <ix:nonFraction unitRef="shares" contextRef="c-348" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="3" id="f-1214">346</ix:nonFraction>.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option-pricing model to recognize the value of stock-based compensation expense for stock option awards. Determining the appropriate fair-value model and calculating the fair value of stock option awards at the grant date requires judgment, including estimating stock price volatility, expected option life, and forfeiture rates. The fair-value of the restricted stock awards at the grant date is based on the market price on the grant date, adjusted for forfeiture rates. The Company develops estimates based on historical data and market information, which can change significantly over time. The Black-Scholes model required the Company to make several key judgments including: </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">The expected option term is calculated by the average of the contractual term of the options and the weighted average vesting period for all options. The calculation of the expected option term is based on the Company's experience due to sufficient history.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">The Company utilizes its own experience to calculate estimated volatility for options granted. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">The dividend yield is based on the Company's historical pattern of dividends as well as expected dividend patterns.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">The risk-free rate is based on the implied yield of U.S.&#160;Treasury notes as of the grant date with a remaining term approximately equal to the expected term.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Estimated forfeiture rate of approximately <ix:nonFraction unitRef="number" contextRef="c-4" decimals="4" name="ensg:ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" scale="-2" id="f-1215">4.86</ix:nonFraction>% per year is based on the Company's historical forfeiture activity of unvested stock options.</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1204-2" continuedAt="f-1204-3"><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-1216" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1217">704</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="f-1218">1,008</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1219">581</ix:nonFraction> stock options during the years ended December 31, 2024, 2023 and 2022, respectively. The Company used the following assumptions for stock options granted during the years ended December 31, 2024, 2023 and 2022:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.490%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.428%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Risk-Free Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Dividend Yield</span></td></tr><tr><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1220">704</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1221">4.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1222">6.2</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="f-1223">40.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-1224">0.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="f-1225">1,008</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1226">4.3</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-12" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1227">6.2</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="f-1228">41.3</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-12" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-1229">0.2</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1230">581</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1231">2.8</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-13" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1232">6.2</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="f-1233">42.1</ix:nonFraction>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-13" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-1234">0.3</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" id="f-1235" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2024, 2023 and 2022, the following represents the exercise price and fair value displayed at grant date for stock option grants:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.245%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.687%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Fair Value of Options</span></td></tr><tr><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1236">704</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1237">132.46</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1238">60.37</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="f-1239">1,008</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1240">95.05</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1241">43.85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1242">581</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1243">85.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1244">37.83</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average exercise price equaled the weighted average fair value of common stock on the grant date for all options granted during the periods ended December 31, 2024, 2023 and 2022 and therefore, the intrinsic value was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="f-1245"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="f-1246"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" scale="0" id="f-1247">0</ix:nonFraction></ix:nonFraction></ix:nonFraction> at the date of grant.  </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="f-1248" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the years ended December 31, 2024, 2023 and 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.981%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Options Vested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Exercise Price of Options Vested</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1249">4,038</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-19" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1250">36.60</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1251">2,183</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-19" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1252">21.02</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1253">581</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1254">85.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="f-1255">98</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1256">59.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-1257">688</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1258">18.43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1259">3,833</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-30" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1260">46.72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1261">2,069</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-30" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1262">28.87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="f-1263">1,008</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1264">95.05</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="f-1265">91</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1266">71.44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-1267">759</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1268">24.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31. 2023</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1269">3,991</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1270">62.65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1271">1,887</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1272">39.58</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="f-1273">704</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1274">132.46</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="f-1275">76</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1276">86.92</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-1277">632</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-1278">35.28</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1279">3,987</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1280">78.84</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1281">1,895</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-1282">52.64</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1204-3" continuedAt="f-1204-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="f-1283" escape="true"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the year ended December 31, 2024:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.891%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options Vested</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Black-Scholes Fair Value</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and Exercisable</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year of Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-351" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1284">18.20</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-351" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1285">21.39</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-352" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1286">69</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-352" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" scale="3" id="f-1287">537</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-351" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1288">1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-352" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1289">69</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-353" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1290">15.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-353" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1291">16.86</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-354" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1292">112</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-354" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" scale="3" id="f-1293">667</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-353" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1294">2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-354" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1295">112</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-355" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1296">15.80</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-355" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1297">19.41</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-356" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1298">148</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-356" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" scale="3" id="f-1299">867</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-355" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1300">3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-356" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1301">148</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-357" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1302">22.49</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-357" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1303">32.71</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-358" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1304">241</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-358" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1305">2,557</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-357" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1306">4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-358" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1307">241</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-359" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1308">41.07</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-359" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1309">45.76</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-360" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1310">417</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-360" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1311">6,557</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-359" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1312">5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-360" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1313">417</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-361" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1314">44.84</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-361" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1315">59.49</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-362" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1316">406</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-362" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1317">8,020</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-361" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1318">6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-362" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1319">301</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-363" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1320">73.47</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-363" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1321">83.64</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-364" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1322">458</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-364" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1323">15,041</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-363" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1324">7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-364" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1325">251</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-365" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1326">79.79</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-365" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1327">94.88</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-366" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1328">489</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-366" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1329">18,601</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-365" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1330">8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-366" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1331">176</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-367" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1332">89.83</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-367" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1333">98.83</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-368" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1334">951</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-368" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1335">41,753</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-367" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1336">9</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-368" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="f-1337">180</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-369" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="f-1338">119.19</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-369" decimals="INF" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="f-1339">146.37</ix:nonFraction></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-370" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="f-1340">696</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-370" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1341">42,024</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-369" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1342">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-370" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:fixed-zero" scale="0" id="f-1343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" format="ixt:num-dot-decimal" scale="3" id="f-1344">3,987</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" format="ixt:num-dot-decimal" scale="3" id="f-1345">136,624</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" format="ixt:num-dot-decimal" scale="3" id="f-1346">1,895</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" id="f-1347" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options outstanding, vested and expected to vest as of December 31, 2024, 2023 and 2022 is as follows:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.349%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1348">219,309</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1349">197,819</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1350">183,593</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-1351">152,011</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-1352">137,048</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-1353">136,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1354">63,243</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1355">56,759</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1356">43,232</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the options</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024, 2023 and 2022, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he aggregate intrinsic value of options that vested </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the years ended December&#160;31, 2024, 2023 and 2022 was</span><span style="color:#ff0090;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="f-1357">37,700</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="f-1358">31,658</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" format="ixt:num-dot-decimal" scale="3" id="f-1359">27,955</ix:nonFraction>, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the years ended December&#160;31, 2024, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1360">60,358</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1361">56,186</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-1362">47,441</ix:nonFraction>, respectively. </span><span style="color:#ff0090;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="c-374" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1363">232</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="c-375" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1364">219</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and <ix:nonFraction unitRef="shares" contextRef="c-376" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1365">233</ix:nonFraction> restricted stock awards during the years ended </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively. All awards were granted at an issue price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="0" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" scale="0" id="f-1366">0</ix:nonFraction> and generally vest over <ix:nonNumeric contextRef="c-374" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1367">five years</ix:nonNumeric>. The fair value per share of restricted awards granted during the years ended </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ranged from</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usdPerShare" contextRef="c-377" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1368">116.65</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-378" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1369">149.12</ix:nonFraction>,</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usdPerShare" contextRef="c-379" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1370">89.83</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-380" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1371">98.31</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-381" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1372">73.17</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-382" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1373">94.88</ix:nonFraction>, respectively. The fair value per share includes quarterly stock awards to non-employee directors. Included in the restricted stock award grants are </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-3" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1374">6,165</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-3" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-1375">5,068</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of annual bonuses that were settled in vested restricted stock awards during the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">years ended December 31, 2024 and 2023, respectively.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1204-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="f-1376" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company's non-vested restricted stock awards as of December&#160;31, 2024 and changes during the years ended December&#160;31, 2024, 2023 and 2022 is presented below:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.859%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.954%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested Restricted Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at January 1, 2022</span></div></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-383" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1377">549</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-383" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1378">52.16</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-376" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1379">233</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-376" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1380">81.57</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-376" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-1381">269</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-376" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1382">54.06</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-376" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1383">26</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-376" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1384">57.29</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December 31, 2022</span></div></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-384" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1385">487</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-384" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1386">64.92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-375" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1387">219</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-375" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1388">92.04</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-375" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-1389">255</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-375" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1390">64.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-375" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1391">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-375" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1392">71.53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-385" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1393">431</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-385" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1394">78.91</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-374" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1395">232</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-374" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1396">131.26</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-374" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-1397">215</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-374" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1398">86.97</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-374" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-1399">13</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-374" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1400">83.12</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-386" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="f-1401">435</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-386" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1402">102.71</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, the Company granted</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonFraction unitRef="shares" contextRef="c-387" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="f-1403">16</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> quarterly stock awards to non-employee directors for their service on the Company's board of directors. The fair value per share of these stock awards ranged from </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-388" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1404">116.65</ix:nonFraction> to $<ix:nonFraction unitRef="usdPerShare" contextRef="c-389" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1405">149.12</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> based on the market price on the grant date. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Incentive Plan</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 27, 2019, the Board approved the Long-Term Incentive Plan (the 2019 LTI Plan). The 2019 LTI Plan provides that certain employees of the Company who assisted in the consummation of the spin-off of Pennant from the Company in 2019 were granted shares of restricted stock upon successful completion of the spin-off. The 2019 LTI Plan provides for the issuance of <ix:nonFraction unitRef="shares" contextRef="c-390" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="3" id="f-1406">500</ix:nonFraction> shares of Pennant restricted stock. As of December&#160;31, 2024, the 2019 LTI Plan was fully vested. The total stock-based compensation related to the 2019 LTI Plan was $<ix:nonFraction unitRef="usd" contextRef="c-391" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-1407">546</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-392" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-1408">827</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-393" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-1409">836</ix:nonFraction> for the years ended December&#160;31, 2024, 2023 and 2022, respectively. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation expense</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-1410" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the years ended December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022 was as follows:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.915%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to stock options</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-371" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1411">22,439</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-372" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1412">17,221</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-373" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1413">11,361</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to restricted stock awards</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-374" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1414">11,662</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-375" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1415">11,845</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-376" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1416">9,920</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to restricted stock awards to non-employee directors</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-394" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1417">2,082</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-395" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1418">1,688</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-396" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1419">1,439</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1420">36,183</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1421">30,754</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1422">22,720</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In future periods, the Company expects to recognize approximately</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-397" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="3" id="f-1423">84,914</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-386" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="3" id="f-1424">38,434</ix:nonFraction> in stock-based compensation expense for unvested options and unvested restricted stock awards, respectively, that were outstanding as of December&#160;31, 2024. Future stock-based compensation expense will be recognized over <ix:nonNumeric contextRef="c-371" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1425">3.8</ix:nonNumeric> and <ix:nonNumeric contextRef="c-374" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1426">3.7</ix:nonNumeric> weighted average years for unvested options and restricted stock awards, respectively. There were <ix:nonFraction unitRef="shares" contextRef="c-397" decimals="-3" name="ensg:EmployeeServiceShareBasedCompensationNonvestedAwards" format="ixt:num-dot-decimal" scale="3" id="f-1427">2,092</ix:nonFraction> unvested and outstanding options as of December&#160;31, 2024, of which <ix:nonFraction unitRef="shares" contextRef="c-397" decimals="-3" name="ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" format="ixt:num-dot-decimal" scale="3" id="f-1428">1,925</ix:nonFraction> shares are expected to vest. The weighted average contractual life for options outstanding, vested and expected to vest as of December&#160;31, 2024 was&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-1429">6.7</ix:nonNumeric> years.</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_238"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="c-1" name="us-gaap:OperatingLeasesOfLessorDisclosureTextBlock" id="f-1431" continuedAt="f-1431-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-1430" continuedAt="f-1430-1" escape="true">LEASES</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="f-1431-1" continuedAt="f-1431-2"><ix:continuation id="f-1430-1" continuedAt="f-1430-2"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases from CareTrust REIT, Inc. (CareTrust) real property associated with <ix:nonFraction unitRef="property" contextRef="c-398" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-1432">100</ix:nonFraction> independent skilled nursing and senior living facilities used in the Company&#8217;s operations, <ix:nonFraction unitRef="property" contextRef="c-399" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-1433">99</ix:nonFraction> of which are under <ix:nonFraction unitRef="agreement" contextRef="c-400" decimals="INF" name="ensg:NumberOfMasterLeaseAgreements" format="ixt-sec:numwordsen" scale="0" id="f-1434">nine</ix:nonFraction> &#8220;triple-net&#8221; master lease agreements (collectively, the Master Leases), which range in terms from <ix:nonNumeric contextRef="c-401" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1435">13</ix:nonNumeric> to <ix:nonNumeric contextRef="c-402" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1436">20</ix:nonNumeric> years. At the Company&#8217;s option, the Master Leases may be extended for <ix:nonFraction unitRef="renewal" contextRef="c-401" decimals="INF" name="ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" format="ixt-sec:numwordsen" scale="0" id="f-1437">two</ix:nonFraction> or <ix:nonFraction unitRef="renewal" contextRef="c-402" decimals="INF" name="ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" format="ixt-sec:numwordsen" scale="0" id="f-1438">three</ix:nonFraction> <ix:nonNumeric contextRef="c-400" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-1439">five-year</ix:nonNumeric> renewal terms beyond the initial term, on the same terms and conditions. The extension of the term of any of the Master Leases is subject to the following conditions: (1) no event of default under any of the Master Leases having occurred and continuing; and (2) the tenants providing timely notice of their intent to renew. The term of the Master Leases is subject to termination prior to the expiration of the current term upon default by the tenants in their obligations, if not cured within any applicable cure periods set forth in the Master Leases. If the Company elects to renew the term of a Master Lease, the renewal will be effective to all, but not less than all, of the leased property then subject to the Master Lease. During the year ended December&#160;31, 2024, the Company amended <ix:nonFraction unitRef="agreement" contextRef="c-403" decimals="INF" name="ensg:NumberOfMasterLeaseAgreements" format="ixt-sec:numwordsen" scale="0" id="f-1440">two</ix:nonFraction> of the Master Leases by adding <ix:nonFraction unitRef="property" contextRef="c-404" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1441">three</ix:nonFraction> operations and extending the terms to <ix:nonNumeric contextRef="c-405" name="ensg:LesseeOperatingLeaseTermExtension" format="ixt-sec:duryear" id="f-1442">15</ix:nonNumeric> and <ix:nonNumeric contextRef="c-406" name="ensg:LesseeOperatingLeaseTermExtension" format="ixt-sec:duryear" id="f-1443">20</ix:nonNumeric> years, respectively. These amendments increased the lease liabilities and right-of-use assets by $<ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1444"><ix:nonFraction unitRef="usd" contextRef="c-407" decimals="-3" name="ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1445">72,503</ix:nonFraction></ix:nonFraction> to reflect the new lease obligations. Additionally, <ix:nonFraction unitRef="property" contextRef="c-408" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1446">four</ix:nonFraction> of the <ix:nonFraction unitRef="property" contextRef="c-398" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-1447">100</ix:nonFraction> facilities leased from CareTrust include an option to purchase that the Company can exercise starting on December 1, 2024. Subsequent to December&#160;31, 2024, the Company purchased the real estate of the <ix:nonFraction unitRef="property" contextRef="c-409" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1448">four</ix:nonFraction> facilities from CareTrust for $<ix:nonFraction unitRef="usd" contextRef="c-410" decimals="-3" name="us-gaap:AssetAcquisitionConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-1449">44,575</ix:nonFraction>.</span></div><div style="margin-top:10.05pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have the ability to terminate the obligations under a Master Lease prior to its expiration without CareTrust&#8217;s consent. If a Master Lease is terminated prior to its expiration other than with CareTrust&#8217;s consent, the Company may be liable for damages and incur charges such as continued payment of rent through the end of the lease term as well as maintenance and repair costs for the leased property.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rent structure under the Master Leases includes a fixed component, subject to annual escalation equal to the lesser of (1) the percentage change in the Consumer Price Index (but not less than <ix:nonFraction unitRef="number" contextRef="c-411" decimals="INF" name="ensg:LesseeOperatingLeaseConsumerPriceIndex" format="ixt:fixed-zero" scale="0" id="f-1450">zero</ix:nonFraction>) or (2) <ix:nonFraction unitRef="number" contextRef="c-411" decimals="3" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="f-1451">2.5</ix:nonFraction>%. In addition to rent, the Company is required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The terms and conditions of the <ix:nonFraction unitRef="lease" contextRef="c-412" decimals="INF" name="ensg:LesseeOperatingLeaseNumberOfLeases" format="ixt-sec:numwordsen" scale="0" id="f-1452">one</ix:nonFraction> stand-alone lease are substantially the same as those for the master leases described above. Total rent expense under the Master Leases was approximately $<ix:nonFraction unitRef="usd" contextRef="c-412" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1453">69,399</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-413" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1454">66,439</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-414" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1455">64,178</ix:nonFraction> for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, under the Master Leases, the Company must maintain compliance with specified financial covenants measured on a quarterly basis, including a portfolio coverage ratio and a minimum rent coverage ratio. The Master Leases also include certain reporting, legal and authorization requirements. The Company is in compliance with requirements of the Master Leases as of December&#160;31, 2024. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities where its independent subsidiaries operate and certain administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from <ix:nonNumeric contextRef="c-415" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1456">15</ix:nonNumeric> to <ix:nonNumeric contextRef="c-416" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1457">20</ix:nonNumeric> years. In addition, the Company leases certain of its equipment under non-cancelable operating leases with initial terms ranging from <span style="-sec-ix-hidden:f-1458">three</span> to <ix:nonNumeric contextRef="c-418" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="f-1459">five years</ix:nonNumeric>. Most of these leases contain renewal options, certain of which involve rent increases. Total rent expense for continuing operations inclusive of straight-line rent adjustments and rent associated with the Master Leases noted above, was $<ix:nonFraction unitRef="usd" contextRef="c-419" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1460">216,716</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-420" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1461">197,856</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-421" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="f-1462">153,174</ix:nonFraction> for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="subsidiary" contextRef="c-422" decimals="INF" name="ensg:SubsidiariesUnderMasterLeaseArrangement" format="ixt-sec:numwordsen" scale="0" id="f-1463">Ninety</ix:nonFraction> of the Company&#8217;s independent subsidiaries, excluding the subsidiaries that are operated under the Master Leases with CareTrust, are operated under <ix:nonFraction unitRef="agreement" contextRef="c-422" decimals="INF" name="ensg:NumberOfMasterLeaseAgreements" scale="0" id="f-1464">14</ix:nonFraction> separate master lease arrangements. During the year ended December&#160;31, 2024, the Company amended <ix:nonFraction unitRef="agreement" contextRef="c-423" decimals="INF" name="ensg:NumberOfMasterLeaseAgreements" format="ixt-sec:numwordsen" scale="0" id="f-1465">one</ix:nonFraction> of the separate master lease arrangements to add <ix:nonFraction unitRef="property" contextRef="c-424" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1466">two</ix:nonFraction> stand-alone skilled nursing operations operated by the Company's independent subsidiaries and extended the term to <ix:nonNumeric contextRef="c-423" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1467">20</ix:nonNumeric> years. In addition, the Company entered into <ix:nonFraction unitRef="agreement" contextRef="c-425" decimals="INF" name="ensg:NumberOfMasterLeaseAgreements" format="ixt-sec:numwordsen" scale="0" id="f-1468">one</ix:nonFraction> new master lease arrangement to add <ix:nonFraction unitRef="property" contextRef="c-426" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1469">six</ix:nonFraction> stand-alone skilled nursing operations operated by the Company's independent subsidiaries with an initial term of <ix:nonNumeric contextRef="c-425" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1470">15</ix:nonNumeric> years. The amended and new master lease arrangements increased the lease liabilities and right-of-use assets by $<ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1471"><ix:nonFraction unitRef="usd" contextRef="c-427" decimals="-3" name="ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1472">71,616</ix:nonFraction></ix:nonFraction> to reflect the new lease obligations. Under the master leases, a default at a single facility could subject one or more of the other facilities covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of the Company&#8217;s leases, master lease agreements and debt financing instruments. In addition, other potential defaults related to an individual facility may cause a default of an entire master lease portfolio and could trigger cross-default provisions in the Company&#8217;s outstanding debt arrangements and other leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the lease without the consent of the landlord. <ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1473" continuedAt="f-1473-1" escape="true">The components of operating lease expense are as follows:</ix:nonNumeric></span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1431-2" continuedAt="f-1431-3"><ix:continuation id="f-1430-2" continuedAt="f-1430-3"><ix:continuation id="f-1473-1"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.326%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1474">216,016</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1475">197,358</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1476">153,049</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1477">24,297</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1478">20,454</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1479">16,938</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-431" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-1480">700</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-432" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-1481">498</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-433" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-1482">125</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1483">1,212</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1484">1,202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1485">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1486">242,225</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1487">219,512</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1488">171,272</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Rent- cost of services includes accrued rent expense adju</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">stments of</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ensg:AccruedRentAdjustment" scale="3" id="f-1489">808</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:AccruedRentAdjustment" scale="3" id="f-1490">870</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="ensg:AccruedRentAdjustment" scale="3" id="f-1491">493</ix:nonFraction> for the years ended December 31, 2024, 2023 and 2022, respectively. Additionally, rent- cost of services includes other variable lease costs such as consumer price index increases and short-term leases of $<ix:nonFraction unitRef="usd" contextRef="c-428" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1492">14,013</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-429" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1493">10,259</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-430" decimals="-3" name="us-gaap:ShortTermLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1494">5,878</ix:nonFraction> for the years ended December 31, 2024,  2023, and 2022 respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Cost of services includes variable lease costs, which consists of property taxes and insurance. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Depreciation and amortization is related to the amortization of favorable and direct lease costs.</span></div></ix:continuation><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-1495" escape="true"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for all third-party leases as of December&#160;31, 2024 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.718%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1496">204,909</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-1497">204,696</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-1498">204,002</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1499">202,994</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1500">199,144</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-1501">1,776,571</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL LEASE PAYMENTS</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1502">2,792,316</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment </span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-1503">963,516</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PRESENT VALUE OF TOTAL LEASE LIABILITIES</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1504">1,828,800</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current lease liabilities</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1505">93,475</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM OPERATING LEASE LIABILITIES</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1506">1,735,325</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the lease commencement date. As of&#160;December&#160;31, 2024 and 2023, the weighted average remaining lease term is&#160;<ix:nonNumeric contextRef="c-4" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1507">14.5</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1508">14.9</ix:nonNumeric> years, respectively, and the weighted average discount rate used to determine the operating lease liabilities is&#160;<ix:nonFraction unitRef="number" contextRef="c-4" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1509">6.3</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1510">6.5</ix:nonFraction>%, respectively. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, the Company expanded its operations through a new master lease with the addition of <ix:nonFraction unitRef="property" contextRef="c-434" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1511">six</ix:nonFraction> standalone skilled nursing operations. The aggregate impact to the carrying value of lease liabilities and right-of-use assets related to the long-term leases is estimated to be approximately $<ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-3" name="ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-1512"><ix:nonFraction unitRef="usd" contextRef="c-435" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1513">67,572</ix:nonFraction></ix:nonFraction>.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its owned real estate properties to third-party operators, of which <ix:nonFraction unitRef="property" contextRef="c-436" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-1514">32</ix:nonFraction> senior living operations are operated by Pennant. All of these properties are triple-net leases, whereby the respective tenants are responsible for all costs at the properties including: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The initial terms range from <ix:nonNumeric contextRef="c-437" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1515">14</ix:nonNumeric> to <ix:nonNumeric contextRef="c-438" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1516">16</ix:nonNumeric> years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024, the Company expanded its operations through a separate master lease arrangement for <ix:nonFraction unitRef="property" contextRef="c-439" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1517">three</ix:nonFraction> stand-alone senior living operations with a third-party operator for an initial lease term of <ix:nonNumeric contextRef="c-440" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1518">15</ix:nonNumeric> years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company entered into a sublease agreement for <ix:nonFraction unitRef="property" contextRef="c-441" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1519">three</ix:nonFraction> stand-alone skilled nursing operations with a third-party operator with an initial lease term of <ix:nonNumeric contextRef="c-442" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1520">18</ix:nonNumeric> years. Additionally, during the year, the Company entered into a lease agreement with a third-party operator for <ix:nonFraction unitRef="property" contextRef="c-443" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-1521">one</ix:nonFraction> campus operation with an initial lease term of <ix:nonNumeric contextRef="c-444" name="us-gaap:LessorOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-1522">15</ix:nonNumeric> years.</span></div></ix:continuation></ix:continuation><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1431-3" continuedAt="f-1431-4"><ix:continuation id="f-1430-3" continuedAt="f-1430-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:OperatingLeaseLeaseIncomeTableTextBlock" id="f-1523" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rental income from all third-party sources for the years ended December 31, 2024, 2023 and 2022 is as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.157%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennant</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1524">15,480</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1525">15,048</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1526">14,915</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third-party</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-448" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1527">7,480</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-449" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1528">6,236</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-450" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1529">1,842</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1530"><span style="-sec-ix-hidden:f-1531"><span style="-sec-ix-hidden:f-1532">TOTAL</span></span></span></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-451" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1533">22,960</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-452" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1534">21,284</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-453" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1535">16,757</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Pennant rental income includes variable rent such as property taxes of $<ix:nonFraction unitRef="usd" contextRef="c-445" decimals="-3" name="us-gaap:OperatingLeaseVariableLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1536">1,235</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-446" decimals="-3" name="us-gaap:OperatingLeaseVariableLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1537">1,296</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-447" decimals="-3" name="us-gaap:OperatingLeaseVariableLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1538">1,318</ix:nonFraction> during the year ended December 31, 2024, 2023, and 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Other third-party includes rental revenue associated with the Company's subleases to third parties of $<ix:nonFraction unitRef="usd" contextRef="c-454" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1539">4,347</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-455" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1540">3,897</ix:nonFraction> for the years ended December 31, 2024 and 2023. There was <ix:nonFraction unitRef="usd" contextRef="c-456" decimals="INF" name="us-gaap:SubleaseIncome" format="ixt:fixed-zero" scale="0" id="f-1541">no</ix:nonFraction> sublease rental revenue for the year ended December 31, 2022.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="f-1542" continuedAt="f-1542-1" escape="true"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual rental income for all third-party leases as of December&#160;31, 2024 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-1543">23,664</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" format="ixt:num-dot-decimal" scale="3" id="f-1544">23,179</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears" format="ixt:num-dot-decimal" scale="3" id="f-1545">22,736</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears" format="ixt:num-dot-decimal" scale="3" id="f-1546">22,535</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears" format="ixt:num-dot-decimal" scale="3" id="f-1547">22,511</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThereafter" format="ixt:num-dot-decimal" scale="3" id="f-1548">119,811</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="f-1549">234,436</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="f-1542-1"><ix:continuation id="f-1431-4"><ix:continuation id="f-1430-4">(1) Annual rental income includes base rents and variable rental income pursuant to existing leases as of December&#160;31, 2024.</ix:continuation></ix:continuation></ix:continuation> </span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_247"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 17. <ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="f-1550" continuedAt="f-1550-1" escape="true">DEFINED CONTRIBUTION PLANS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="f-1550-1"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) defined contribution plan (the 401(k) Plan), whereby eligible employees may contribute up to <ix:nonFraction unitRef="number" contextRef="c-457" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-1551">90</ix:nonFraction>% of their annual basic earnings, subject to applicable annual Internal Revenue Code limits. Additionally, the 401(k) Plan provides for discretionary matching contributions (as defined in the 401(k) Plan) by the Company. The Company expensed matching contributions to the 401(k) Plan of $<ix:nonFraction unitRef="usd" contextRef="c-457" decimals="-3" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="3" id="f-1552">3,532</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="c-458" decimals="-3" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="3" id="f-1553">2,836</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="c-459" decimals="-3" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="3" id="f-1554">2,418</ix:nonFraction> during the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a non-qualified deferred compensation plan (DCP), whereby certain highly compensated employees who are otherwise ineligible to participate in the Company's 401(k) plan, may defer the receipt of a portion of their base compensation and, for certain employees, up to&#160;<ix:nonFraction unitRef="number" contextRef="c-460" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-1555">100</ix:nonFraction>% of their eligible bonuses. Additionally, the DCP allows for the employee deferrals to be deposited into a rabbi trust and the funds are generally invested in individual variable life insurance contracts owned by the Company that are specifically designed to fund savings plans of this nature. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company accrued $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1556">63,051</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1557">49,201</ix:nonFraction>, respectively, as long term deferred compensation in other long term liabilities&#160;on the consolidated balance sheets. Cash surrender value of the contracts is based on investment funds that shadow the investment allocations specified by participants in the deferred compensation plan. Refer to Note 5, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information on the funds.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2024 and 2023, the Company recorded gains related to its DCP of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1558">5,157</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1559">4,634</ix:nonFraction>, respectively, which are included in other income (expense), and recorded offsetting expenses of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="ensg:InvestmentExpenseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1560">5,559</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="ensg:InvestmentExpenseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1561">4,887</ix:nonFraction>, which are allocated between cost of services and general and administrative expenses. For the year ended December 31, 2022, the Company recorded a loss related to its DCP of $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:GainLossOnInvestments" format="ixt:num-dot-decimal" scale="3" id="f-1562">4,188</ix:nonFraction>, which is included in other income (expense), and recorded an offsetting reduction in expense of $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="ensg:InvestmentExpenseIncome" format="ixt:num-dot-decimal" scale="3" id="f-1563">4,051</ix:nonFraction>, which is allocated between cost of services and general and administrative expenses.</span></div></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_256"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18. <ix:nonNumeric contextRef="c-1" name="us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" id="f-1564" continuedAt="f-1564-1" escape="true">SELF INSURANCE LIABILITIES</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock" id="f-1565" continuedAt="f-1565-1" escape="true"><ix:continuation id="f-1564-1" continuedAt="f-1564-2"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company's self-insurance insurance liabilities, on an undiscounted basis, inclusive of anticipated insurance recoveries, as of December 31, 2024 and 2023: </span></div></ix:continuation></ix:nonNumeric><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1564-2"><ix:continuation id="f-1565-1"><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.206%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued general liability and professional malpractice liabilities</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-461" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-1566">160,149</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-462" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-1567">117,744</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued workers&#8217; compensation liabilities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-463" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-1568">37,291</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-464" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-1569">33,352</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued health benefits</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-465" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-1570">14,312</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-466" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-1571">14,814</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SELF-INSURANCE LIABILITIES</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-1572">211,752</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SelfInsuranceReserve" format="ixt:num-dot-decimal" scale="3" id="f-1573">165,910</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current self-insurance liabilities</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SelfInsuranceReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1574">67,331</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SelfInsuranceReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="f-1575">54,664</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM SELF-INSURANCE LIABILITIES</span></div></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:SelfInsuranceReserveNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1576">144,421</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SelfInsuranceReserveNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-1577">111,246</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock" id="f-1578" escape="true"><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents activity in the Company's self-insurance liabilities as of and for the years ended December 31, 2024 and 2023: </span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.011%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January&#160;1, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1579">131,682</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year provisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1580">164,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims paid and direct expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1581">135,799</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in long-term insurance losses recoverable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1582">5,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance December&#160;31, 2023</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"/><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1583">165,910</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year provisions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1584">217,631</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims paid and direct expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1585">173,617</ix:nonFraction>)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in long-term insurance losses recoverable</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"/><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-1586">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance December&#160;31, 2024</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"/><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilityForFuturePolicyBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1587">211,752</ix:nonFraction></span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The anticipated insurance recoveries included in the self-insurance liabilities are presented gross rather than net with the corresponding asset of $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EstimatedInsuranceRecoveries" format="ixt:num-dot-decimal" scale="3" id="f-1588">17,741</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:EstimatedInsuranceRecoveries" format="ixt:num-dot-decimal" scale="3" id="f-1589">15,913</ix:nonFraction> as of December 31, 2024 and 2023, respectively, included in Restricted and other assets on the consolidated balance sheets.</span></div></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_265"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1590" continuedAt="f-1590-1" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="f-1590-1" continuedAt="f-1590-2"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. The terms of such obligations vary by contract and, in most instances, do not expressly state or include a specific or maximum dollar amount. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Consequently, because no claims have been asserted, no liabilities have been recorded for these obligations on the Company&#8217;s </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> balance sheets for any of the periods presented.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Matters</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company and its independent subsidiaries are party to various legal actions and administrative proceedings and are subject to various claims arising in the ordinary course of business. Such claims may be related to, but are not limited to, the Health Insurance Portability and Accountability Act of 1996, alleged Medicare or Medicaid false claims, qui tam or "whistleblower" provisions of the False Claims Act and/or the Anti-Kickback Statute, alleged violations of state and federal wage and hour laws, environmental matters, investigations, examinations, audits, site visits and surveys or other claims in connection with the delivery of healthcare and non-healthcare services. Refer to </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Part I. Item 3. Legal Proceedings</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on litigation and regulatory matters. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, the Company, on behalf of its independent subsidiaries, received a </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Civil Investigative Demand (CID)</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Department of Justice (DOJ) </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indicating that the DOJ is investigating the Company to determine whether claims have been submitted to Medicare and Texas Medicaid for services which were unnecessary or otherwise not consistent with existing reimbursement requirements. The CID covers the period from January 1, 2016, to the present. As a general matter, the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> maintain policies and procedures to promote compliance with all applicable Medicare and Medicaid requirements, including but not limited to those relating to the presentation of claims for reimbursement for services provided</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is fully cooperating with the DOJ in response to the CID. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the Company cannot predict the outcome of the investigation or its potential impact on the consolidated financial statements.</span></div></ix:continuation><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1590-2"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, in a four-week medical negligence trial in the State of Arizona, the jury returned a verdict against one of the Company&#8217;s independent subsidiaries. The Company is in the process of appealing the jury verdict. The Company has in the past appealed similar decisions and has, in some circumstances, received decisions in its favor. Although the Company intends to vigorously defend against these claims and in general these types of claims and cases, there can be no assurance that the outcomes of these matters will not have a material adverse effect on operational results and financial condition.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, the Company, on behalf of its independent subsidiaries, received a CID from the DOJ stating that it was investigating to determine whether there had been a violation of the False Claims Act (FCA) and/or the Anti-Kickback Statute (AKS) with respect to the relationships between certain of the Company&#8217;s independent subsidiaries and persons who serve or have served as medical directors. In 2020, the Company was advised that the DOJ declined to intervene in any subsequent action filed in connection with the subject matter of this investigation. Despite the decision of the DOJ to decline to participate in litigation based on the subject matter of its previously issued CID, the involved qui tam relator moved forward with the complaint in 2020. In 2024, the Company mediated with the involved parties and agreed to settle the civil case for $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedToOtherParty" format="ixt:num-dot-decimal" scale="3" id="f-1591">48,000</ix:nonFraction> and recorded the accrual as of December 31, 2023. Following the finalization of the settlement documents and payment of the settlement funds during the year ended December&#160;31, 2024, the qui tam complaint was dismissed and the matter was resolved. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Revenue Recoupments</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's independent subsidiaries are subject to regulatory reviews relating to the provision of Medicare services, billings and potential overpayments as a result of Recovery Audit Contractors (RAC), various Program Safeguard Contractors, and Medicaid Integrity Contractor programs (collectively referred to as Reviews). Reviews vary in claim selection size and processes, ranging from a single episode/claim month to larger, multi-claim batches; and from single rounds of review to reviews of multiple rounds with pass/fail criteria. If an operation has a significant error rate or fails a Review and/or subsequent Reviews, the operation could then be subject to extended review or an extrapolation of the identified error rate to billings in the same time period. The Company anticipates that these Reviews could increase in frequency in the future. As of December&#160;31, 2024 and through the filing date of this report, <ix:nonFraction unitRef="subsidiary" contextRef="c-4" decimals="INF" name="ensg:IndependentOperatingSubsidiariesUnderMedicareProbeReviews" scale="0" id="f-1592">18</ix:nonFraction> of the Company's independent subsidiaries had multi-claim Reviews scheduled or in process.  </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company has significant accounts receivable balances, the collectability of which is dependent on the availability of funds from certain governmental programs, primarily Medicare and Medicaid. These receivables represent the only significant concentration of credit risk for the Company. The Company does not believe there are significant credit risks associated with these governmental programs. The Company believes that an appropriate allowance has been recorded for the possibility of these receivables proving uncollectible and continually monitors and adjusts these allowances as necessary. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables from Medicare and Medicaid payor programs accounted for <ix:nonFraction unitRef="number" contextRef="c-467" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1593">52.9</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-468" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1594">53.4</ix:nonFraction>% of its total accounts receivable as of December&#160;31, 2024 and 2023, respectively. Revenue from reimbursement under the Medicare and Medicaid programs accounted for <ix:nonFraction unitRef="number" contextRef="c-81" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1595">70.9</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="c-82" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1596">72.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-83" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-1597">73.7</ix:nonFraction>% of the Company's revenue for the years ended December&#160;31, 2024, 2023 and 2022, respectively.</span></div></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_274"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-1598" continuedAt="f-1598-1" escape="true">COMMON STOCK REPURCHASE PROGRAM</ix:nonNumeric></span></div><ix:continuation id="f-1598-1" continuedAt="f-1598-2"><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2024, the Board of Directors approved a stock repurchase program pursuant to which the Company may repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-469" decimals="INF" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="3" id="f-1599">20,000</ix:nonFraction> of its common stock under the program for a period of approximately <ix:nonNumeric contextRef="c-470" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durmonth" id="f-1600">12</ix:nonNumeric> months from September&#160;1, 2024. The Company did <ix:nonFraction unitRef="shares" contextRef="c-471" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="f-1601">not</ix:nonFraction> purchase any shares pursuant to this stock repurchase program during the year ended December 31, 2024.</span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 29, 2023, the Board of Directors approved a stock repurchase program pursuant to which the Company could repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-472" decimals="INF" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="3" id="f-1602">20,000</ix:nonFraction> of its common stock under the program for a period of approximately <ix:nonNumeric contextRef="c-473" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durmonth" id="f-1603">12</ix:nonNumeric> months from September&#160;1, 2023. The stock repurchase program expired on August 31, 2024 and is no longer in effect. The Company did <ix:nonFraction unitRef="shares" contextRef="c-474" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="f-1604">not</ix:nonFraction> purchase any shares pursuant to this stock repurchase program.</span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, the Board of Directors approved a stock repurchase program pursuant to which the Company could repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-475" decimals="INF" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="3" id="f-1605">20,000</ix:nonFraction> of its common stock under the program for a period of approximately <ix:nonNumeric contextRef="c-476" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durmonth" id="f-1606">12</ix:nonNumeric> months from August&#160;2, 2022. The stock repurchase program expired on August 2, 2023 and is no longer in effect. The Company did <ix:nonFraction unitRef="shares" contextRef="c-476" decimals="INF" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="0" id="f-1607">not</ix:nonFraction> purchase any shares pursuant to this stock repurchase program. </span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="c-13" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="f-1608">404</ix:nonFraction> shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-1609">29,882</ix:nonFraction> during the year ended December 31, 2022, related to two separate stock repurchase programs that are no longer in effect. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="margin-bottom:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">&#160;&#160;&#160;&#160;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:14pt;font-weight:700;line-height:100%">THE ENSIGN GROUP, INC.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:100%">NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - (Continued)</span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div></div><ix:continuation id="f-1598-2"><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these repurchase programs, the Company is authorized to repurchase its issued and outstanding common shares from time to time in open-market and privately negotiated transactions, tender offers, pursuant to contractual provisions, and block trades, or otherwise in accordance with federal securities laws. The share repurchase program does not obligate the Company to acquire any specific number of shares. Any such repurchases will depend on the Company's business strategy, prevailing market conditions, the Company's liquidity requirements, contractual restrictions or covenants, compliance with securities laws, and other factors. The amounts involved in any such transaction may be material.</span></div></ix:continuation><div id="iec37f02aeb9544da81ef9669e1252f6f_451"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.&#160;&#160;&#160;&#160; CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;None.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_454"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. CONTROLS AND PROCEDURES </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a)  Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains disclosure controls and procedures that are designed to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to its management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, our management recognized that any system of controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the preparation of this Annual Report on Form 10-K our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of our disclosure controls and procedures, as such term is defined under Rule&#160;13a-15(e) promulgated under the Exchange Act. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this Annual Report on Form&#160;10-K. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(b)  Management's Report on Internal Control over Financial Reporting</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as defined in Rule&#160;13a-15(f) promulgated under the Exchange Act. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, evaluated the effectiveness of our internal control over financial reporting using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control&#160;- Integrated Framework (2013).</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As a result of this assessment, management concluded that, as of December&#160;31, 2024, our internal control over financial reporting was effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm, Deloitte&#160;&amp; Touche LLP, has audited the consolidated financial statements included in this Annual Report on Form&#160;10-K and, as part of their audit, has issued an audit report, included herein, on the effectiveness of our internal control over financial reporting. Their report is set forth below. </span></div><div style="margin-top:9pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(c)  Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:3pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting, as defined in Rule&#160;13a-15(f) promulgated under the Exchange Act, that occurred during the fourth quarter of fiscal 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(d)  Report of Independent Registered Public Accounting Firm</span></div><div style="padding-left:72pt;text-indent:-72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of The Ensign Group, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:111%">We have audited the internal control over financial reporting of The Ensign Group, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2024, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control &#8212; Integrated Framework (2013) issued by COSO.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:111%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2024, of the Company and our report dated February 5, 2025, expressed an unqualified opinion on those financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:111%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:111%">/s/ DELOITTE &amp; TOUCHE LLP </span></div><div style="padding-left:4.5pt;padding-right:391.5pt"><span><br/></span></div><div style="padding-left:4.5pt;padding-right:391.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costa Mesa, California February&#160;5, 2025</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_385"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. OTHER INFORMATION</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-477" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1610"><ix:nonNumeric contextRef="c-477" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1611"><ix:nonNumeric contextRef="c-477" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1612">Rule 10b5-1 Plan Elections</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-479" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1614" escape="true"><ix:nonNumeric contextRef="c-478" name="ecd:TrdArrIndName" id="f-1613">Dr. Ann S. Blouin</ix:nonNumeric>, <ix:nonNumeric contextRef="c-478" name="ecd:TrdArrIndTitle" id="f-1615">a member of our Board of Directors</ix:nonNumeric>, <ix:nonNumeric contextRef="c-478" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1616">entered into</ix:nonNumeric> a Rule 10b5-1 trading arrangement on <ix:nonNumeric contextRef="c-478" name="ecd:TrdArrAdoptionDate" id="f-1617">November 12, 2024</ix:nonNumeric>. Dr. Blouin's 10b5-1 Plan provides for the sale of up to <ix:nonFraction unitRef="shares" contextRef="c-480" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" scale="0" id="f-1618">450</ix:nonFraction> shares of the Company's common stock between February 11, 2025 and <ix:nonNumeric contextRef="c-478" name="ecd:TrdArrExpirationDate" id="f-1619">November 11, 2025</ix:nonNumeric>.</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-482" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1621" escape="true"><ix:nonNumeric contextRef="c-481" name="ecd:TrdArrIndName" id="f-1620">Suzanne D. Snapper</ix:nonNumeric>, <ix:nonNumeric contextRef="c-481" name="ecd:TrdArrIndTitle" id="f-1622">Chief Financial Officer, Executive Vice President, and Director</ix:nonNumeric>, <ix:nonNumeric contextRef="c-481" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1623">entered into</ix:nonNumeric> a Rule 10b5-1 trading arrangement on <ix:nonNumeric contextRef="c-481" name="ecd:TrdArrAdoptionDate" id="f-1624">November 15, 2024</ix:nonNumeric>. Ms. Snapper's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to <ix:nonFraction unitRef="shares" contextRef="c-483" decimals="INF" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" scale="0" id="f-1625">10,618</ix:nonFraction> shares of the Company's common stock between February 18, 2025 and <ix:nonNumeric contextRef="c-481" name="ecd:TrdArrExpirationDate" id="f-1626">July 28, 2025</ix:nonNumeric>.</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These Rule 10b5-1 trading arrangements were entered into during open trading windows and are intended to satisfy the affirmative defense conditions of Rule 10b5-1 (c) under the Securities Exchange Act of 1934, as amended, and the Company's policies regarding transactions in Company securities.</span></div><div style="text-align:justify"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_457"></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Not applicable.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_460"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PART III.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_463"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement for the 2025 Annual Meeting of Stockholders.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a code of ethics and business conduct that applies to all employees, including our Chief Executive Officer (our principal executive officer) and Chief Financial Officer (our principal financial officer), and employees of our subsidiaries, as well as each member of our Board of Directors. The code of ethics and business conduct is available on our website at www.ensigngroup.net under the Investor Relations section. The information contained in, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 10-K. We intend to satisfy any disclosure requirement under Item 5.05 of Form 8-K regarding an amendment to, or waiver from, a provision of the code of ethics by posting such information on our website, at the address specified above.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_466"></div><div style="margin-top:12pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. EXECUTIVE COMPENSATION</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement for the 2025 Annual Meeting of Stockholders.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_469"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement for the 2025 Annual Meeting of Stockholders.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_472"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement for the 2025 Annual Meeting of Stockholders.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_475"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement for the 2025 Annual Meeting of Stockholders. Our principal accountant is Deloitte &amp; Touche LLP (PCAOB ID No.<ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-1629">34</ix:nonNumeric>).</span></div><div style="text-align:justify"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_478"></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PART IV.</span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_481"></div><div style="-sec-extract:summary;margin-top:12pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as a part of this report: </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) (1)&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements:</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Financial Statements described in Part II. Item&#160;8 and beginning on page <a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_496">91</a> are filed as part of this Annual Report on Form 10-K.</span></div></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) (3)&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exhibits:</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;The following exhibits are filed or furnished with or incorporated by reference this Annual Report on Form 10-K.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">File</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Filing</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Filed</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit Description*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Herewith</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537624000135/ensgq22024ex31.htm">3.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fifth Amended and Restated Certificate of Incorporation of the Corporation, filed with the Delaware Secretary of State on November 15, 2007, and all Certificates of Amendment thereto filed with the Delaware Secretary of State through May 23, 2024.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/25/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000110465907090660/a07-31302_1ex3d2.htm">3.2</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Bylaws of The Ensign Group, Inc.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/21/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537614000082/exhit32.htm">3.3</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to the Amended and Restated Bylaws, dated August 5, 2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/8/2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537620000018/ensg123119ex41.htm">4.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Description of the Common stock of The Ensign Group, Inc.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/5/2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007452/a2179557zex-4_1.htm">4.2</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specimen common stock certificate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007452/a2179557zex-10_3.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Ensign Group, Inc. 2007 Omnibus Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000095012309026413/c88415exv99w2.htm">10.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to The Ensign Group, Inc. 2007 Omnibus Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/28/2009</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007452/a2179557zex-10_4.htm">10.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2007 Omnibus Incentive Plan Notice of Grant of Stock Options; and form of Non-Incentive Stock Option Award Terms and Conditions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142797</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007452/a2179557zex-10_5.htm">10.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2007 Omnibus Incentive Plan Restricted Stock Agreement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007452/a2179557zex-10_6.htm">10.5</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Indemnification Agreement entered into between The Ensign Group, Inc. and its directors, officers and certain key employees</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/5/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907004101/a2175777zex-10_41.htm">10.6</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Independent Consulting and Centralized Services Agreement between Ensign Facility Services, Inc. and certain of its subsidiaries</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.41&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/14/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007770/a2180032zex-10_48.htm">10.7</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Health Insurance Benefit Agreement pursuant to which certain subsidiaries of The Ensign Group, Inc. participate in the Medicare program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007770/a2180032zex-10_49.htm">10.8</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Medi-Cal Provider Agreement pursuant to which certain subsidiaries of The Ensign Group, Inc. participate in the California Medicaid program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.49&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007770/a2180032zex-10_50.htm">10.9</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Provider Participation Agreement pursuant to which certain subsidiaries of The Ensign Group, Inc. participate in the Arizona Medicaid program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007770/a2180032zex-10_51.htm">10.10</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Contract to Provide Nursing Facility Services under the Texas Medical Assistance Program pursuant to which certain subsidiaries of The Ensign Group, Inc. participate in the Texas Medicaid program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007770/a2180032zex-10_52.htm">10.11</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Client Service Contract pursuant to which certain subsidiaries of The Ensign Group, Inc. participate in the Washington Medicaid program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">File</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Filing</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Filed</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit Description*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007770/a2180032zex-10_53.htm">10.12</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Provider Agreement for Medicaid and UMAP pursuant to which certain subsidiaries of The Ensign Group, Inc. participate in the Utah Medicaid program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000104746907007770/a2180032zex-10_54.htm">10.13</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Medicaid Provider Agreement pursuant to which a subsidiary of The Ensign Group, Inc. participates in the Idaho Medicaid program</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S-1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333-142897</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.54&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/19/2007</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537614000008/ensg123113ex1074.htm">10.14</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate Integrity Agreement between the Office of Inspector General of the Department of Health and Human Services and The Ensign Group, Inc. dated October 1, 2013.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/13/2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537614000031/ensg33114ex1075.htm">10.15</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement agreement dated October 1, 2013, entered into among the United States of America, acting through the United States Department of Justice and on behalf of the Office of Inspector General (OIG-HHS) of the Department of Health and Human Services (HHS) (collectively the "United States") and the Company.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5/8/2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000119312514226138/d737181dex101.htm">10.16</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Master Lease by and among certain subsidiaries of The Ensign Group, Inc. and certain subsidiaries of CareTrust REIT, Inc.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/5/2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000119312514226138/d737181dex102.htm">10.17</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Guaranty of Master Lease by The Ensign Group, Inc. in favor of certain subsidiaries of CareTrust REIT, Inc., as landlords under the Master Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/5/2014</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537616000139/amendedandrestatedsuntrust.htm">10.18</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Credit Agreement as of February 5, 2016, by and among The Ensign Group, Inc., SunTrust Bank, now known as Truist, as administrative agent, and the lenders party thereto</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/8/2016</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537616000214/secondarcreditagreementv57.htm">10.19</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amended Credit Agreement as of July 19, 2016, by and among The Ensign Group, Inc., SunTrust Bank, now known as Truist, as administrative agent, and the lenders party thereto</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/25/2016</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537617000035/a2016proxystatement.htm#s79c1f29a0e9c477ca771e6b5687c20a1">10.20</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Ensign Group, Inc. 2017 Omnibus Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEF 14A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/13/2017</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537618000028/ensgex1087.htm">10.21</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2017 Omnibus Incentive Plan Notice of Grant of Stock Options; and form of Non-Incentive Stock Option Award Terms and Conditions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/8/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537618000028/ensgex1088.htm">10.22</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2017 Omnibus Incentive Plan Restricted Stock Agreement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.88&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/8/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537618000006/exhibit101hudnote.htm">10.23</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of U.S. Department of Housing and Urban Development Healthcare Facility Note and schedule of individual subsidiary loans, by and among The Ensign Group, Inc.'s subsidiaries listed therein and U.S. Department of Housing and Urban Development</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/3/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537618000006/exhibit102securityinstrume.htm">10.24</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of U.S. Department of Housing and Urban Development Security Instrument/Mortgage/Deed of Trust</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/3/2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537619000134/exhibit104.htm">10.25</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Third Amended and Restated Credit Agreement, dated as of October 1, 2019, by and among The Ensign Group, Inc., SunTrust Bank, now known as Truist, as administrative agent, and the lenders party thereto</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537619000134/exhibit105.htm">10.26</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease Agreement, dated as of October 1, 2019, by and between The Ensign Group, Inc. and The Pennant Group, Inc.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/1/2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537621000020/ensg123120ex1096.htm">10.27</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Ensign Services, Inc. Deferred Compensation Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/3/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537621000020/ensg123120ex1097.htm">10.28</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to The Ensign Services, Inc. Deferred Compensation Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/3/2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="-sec-extract:summary;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:none" href="#iec37f02aeb9544da81ef9669e1252f6f_22">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.902%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.142%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:47.948%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.170%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.588%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.789%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">File</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Filing</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Filed</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Exhibit Description*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537622000019/ensg123121ex101.htm">10.29</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment to Third Amended and Restated Credit Agreement, dated as of February 8, 2022, by and among The Ensign Group, Inc., Standard Bearer Healthcare REIT, Inc., Truist Bank (as successor by merger to SunTrust Bank), as administrative agent, and the lenders party thereto</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/9/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537622000060/ex101.htm">10.30</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Second Amendment to Third Amended and Restated Credit Agreement, dated as of April 8, 2022, by and among The Ensign Group, Inc. and Truist Bank, as administrative agent, and the lenders party thereto. </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/12/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537622000062/a2021proxystatement.htm#i175cebcaa24a45a3a49df6587d41941e_112">10.31</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Ensign Group, Inc. 2022 Omnibus Incentive Plan</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEF 14A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/14/2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537623000018/ensg123122ex102.htm">10.32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2022 Omnibus Incentive Plan Notice of Grant of Stock Options; and form of Non-Incentive Stock Option Award Terms and Conditions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/2/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537623000018/ensg123122ex103.htm">10.33</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of 2022 Omnibus Incentive Plan Restricted Stock Agreement</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/2/2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537624000047/0001125376-24-000047-index.htm">13.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Report to Security Holders</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARS</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ARS</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/5/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="ensgq42024ex191.htm">19.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-1630">Statement of Company Policy Regarding Insider Trading</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="ensgq42024ex192.htm">19.2</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum to Statement of Company Policy Regarding Insider Trading</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="ensg123124ex211.htm">21.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subsidiaries of The Ensign Group, Inc., as amended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="ensg123124ex231.htm">23.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of Deloitte &amp; Touche LLP</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="ensgq42024ex311.htm">31.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="ensgq42024ex312.htm">31.2</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="ensgq42024ex321.htm">32.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="ensgq42024ex322.htm">32.2</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="-sec-extract:exhibit;color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="https://www.sec.gov/Archives/edgar/data/1125376/000112537624000018/ensg123123ex97.htm">97.</a>1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Policy for Recovery of Erroneously Awarded Incentive-Based Compensation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">001-33757</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2/1/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interactive data file (furnished electronically herewith pursuant to Rule 406T of Regulations S-T)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">104</span><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indicates management contract or compensatory plan.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Documents not filed herewith are incorporated by reference to the prior filings identified in the table above.</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div id="iec37f02aeb9544da81ef9669e1252f6f_487"></div><div style="text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;FORM 10-K SUMMARY </span></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><div id="iec37f02aeb9544da81ef9669e1252f6f_400"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div style="text-align:justify"><span><br/></span></div></div><div style="text-align:center"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:48.680%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.927%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.093%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">THE ENSIGN GROUP, INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY:&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SUZANNE D. SNAPPER &#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suzanne D. Snapper&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer, Executive Vice President and Director (Principal Financial Officer and Principal Accounting Officer)&#160;</span></div></td></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated. </span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:36.436%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.207%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.591%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ BARRY R. PORT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director (principal executive officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barry R. Port</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;SUZANNE D. SNAPPER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer, Executive Vice President and Director (principal financial officer and principal accounting officer)&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suzanne D. Snapper</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHRISTOPHER R. CHRISTENSEN</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Chairman and Chairman of the Board</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher R. Christensen</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;ANN S. BLOUIN</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ann S. Blouin</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;SWATI B. ABBOTT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Swati B. Abbott</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;DAREN J. SHAW</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daren J. Shaw</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;JOHN O. AGWUNOBI</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John O. Agwunobi</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;BARRY M. SMITH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barry M. Smith</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ MARK V. PARKINSON</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 5, 2025</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark V. Parkinson</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>2
<FILENAME>ensgq42024ex191.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i96cc4bb46134496892b646f2d843f43f_36"></div><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 19.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Statement of Company Policy  </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">REGARDING INSIDER TRADING</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted August 14, 2007</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Amended as of October 29, 2008, May 18, 2023 and </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">November 6, 2024</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">This Policy Statement applies to all officers, directors and employees of  The Ensign Group, Inc. and its subsidiaries (collectively the &#8220;Company&#8221;) and supersedes all prior insider trading policies.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:28.34pt">THE NEED FOR A POLICY STATEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Under the federal securities laws, it is illegal to trade in the Company&#8217;s securities (collectively referred to in this Policy Statement as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) while in the possession of material nonpublic information about the Company. It is also illegal to disclose or give material nonpublic information to others who may trade on the basis of that information or to advise others how to trade while in possession of material nonpublic information. Any person who possesses material nonpublic information about the Company is deemed to be an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">insider</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.&#8221; The category of insiders is NOT limited to officers and directors.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Insider trading violations are pursued vigorously by the U.S. Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and such violations are punished severely. While regulatory authorities often concentrate their efforts on the individuals who trade, or who tip material nonpublic information to others who trade, the federal securities laws also impose potential liability on companies and other controlling persons if they fail to take reasonable steps to prevent insider trading by Company personnel. Both the SEC and the Nasdaq Stock Market, on which Company  Securities are traded, are very effective at detecting and pursuing insider trading violations. The SEC has successfully prosecuted cases against employees trading through foreign accounts, trading by family members and friends, and trading involving only a small number of shares. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company has adopted this Statement of Company Policy Regarding Insider Trading (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) to provide guidelines with respect to transactions in Company Securities and the handling of confidential information about the Company and the companies with which the Company does business.  This Policy Statement is intended to promote compliance with federal, state and foreign securities laws that prohibit certain persons who are aware of material nonpublic information about a company from&#58; (i) trading in securities of that company&#59; or (ii) providing material nonpublic information to other persons who may trade on the basis of that information. This Policy Statement is also intended to prevent the appearance of improper conduct, which can cause reputational harm to the Company, on the part of any persons subject to this Policy Statement.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:23.68pt">THE PENALTIES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The consequences of an insider trading violation can be extremely serious and severe&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Traders and Tippers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Company personnel (or their tippees) who trade on material nonpublic information (or tip material nonpublic information to others) are subject to the following penalties, among other things&#58; </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A civil penalty of up to three times the profit gained or loss avoided&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A criminal fine of up to $5,000,000 (no matter how small the profit from the trade)&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A jail term of up to twenty years. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">A person who tips information to a person who then trades is subject to the same penalties as the tippee, even if the person did not trade and did not profit from the tippee&#8217;s trading. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Control Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Company and its supervisory personnel, if they fail to take appropriate steps to prevent illegal insider trading, can be subject to the following penalties&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A civil penalty of up to $1,000,000 or, if greater, three times the profit gained or loss avoided as a result of the employee&#8217;s violation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A criminal penalty of up to $25,000,000. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Company-Imposed Sanctions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Compliance with the policies of the Company is a condition of continued employment or service with the Company of each employee, officer and director. The failure of an employee, officer and director to comply with this Policy Statement will subject such person to Company-imposed sanctions, which may include dismissal for cause, whether or not the person&#8217;s failure to comply results in a violation of law. The Company reserves the right to determine, in its own discretion and on the basis of the information available to it, whether this Policy Statement has been violated. The Company may also determine that specific conduct violates this Policy Statement whether or not the conduct also violates the law. It is not necessary for the Company to wait for the filing or conclusion of a civil or criminal action against the alleged violator before taking disciplinary action. </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:19.02pt"> PERSONS SUBJECT TO THIS POLICY STATEMENT</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Persons Subject to this Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement applies to all officers of the Company and its subsidiaries, all members of the Company&#8217;s Board of Directors and all employees of the Company and its subsidiaries. The Company may also determine that other persons should be subject to this Policy Statement, such as contractors or consultants who have access to material nonpublic information, as described below. This Policy Statement also applies to family members, other members of a person&#8217;s household and entities controlled by a person covered by this Policy Statement, as described below.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Contract Personnel (Non-Employees)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Company sometimes utilizes the services of contract personnel who are not employees of the Company. As such, non-employee personnel may have access to material nonpublic information about the Company. The Company expects all such contract personnel to comply with its policies on the trading of Company Securities to the same extent as employees are required to comply with such policies. The Company will take appropriate action against any such personnel and the organizations for which they are employed if there is a failure to comply with the policies of the Company.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Transactions by Family Members and Others</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement applies to your family members who reside with you (including a spouse, a child, a child away at college, stepchildren, grandchildren, parents, stepparents, grandparents, siblings and in-laws), anyone else who lives in your household, and any family members who do not live in your household but </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">whose transactions in Company Securities are directed by you or are subject to your influence or control, such as parents or children who consult with you before they trade in Company Securities (collectively referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Family Members</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). You are responsible for the transactions of these other persons and therefore should make them aware of the need to confer with you before they trade in Company Securities, and you should treat all such transactions for the purposes of this Policy Statement and applicable securities laws as if the transactions were for your own account. This Policy Statement does not, however, apply to personal securities transactions of Family Members where the purchase or sale decision is made by a third party not controlled by, influenced by or related to you or your Family Members.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Transactions by Entities that You Influence or Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement applies to any entities that you influence or control, including any corporations, partnerships or trusts (collectively referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Controlled Entities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and transactions by these Controlled Entities should be treated for the purposes of this Policy Statement and applicable securities laws as if they were for your own account.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Individual Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Persons subject to this Policy Statement have ethical and legal obligations to maintain the confidentiality of information about the Company and to not engage in transactions in Company Securities while in possession of material nonpublic information. Persons subject to this Policy Statement must not engage in illegal trading and must avoid the appearance of improper trading. Each individual is responsible for making sure that he or she complies with this Policy Statement, and that any Family Member or Controlled Entities whose transactions are subject to this Policy Statement, as discussed above, also comply with this Policy Statement. In all cases, the responsibility for determining whether an individual is in possession of material nonpublic information rests with that individual. You could be subject to severe legal penalties and disciplinary action by the Company for any conduct prohibited by this Policy Statement or applicable securities laws, as described in more detail under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">The Penalties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:19.68pt">STATEMENT OF POLICY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Policy Statement applies to transactions in Company Securities, including the Company&#8217;s common stock, options to purchase common stock, or any other type of securities that the Company may issue, including (but not limited to) preferred stock, convertible debentures and warrants, as well as derivative securities that are not issued by the Company, such as exchange-traded put or call options or swaps relating to the Company&#8217;s securities.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">It is the policy of the Company that no director, officer or employee of the Company or person subject to this Policy Statement (as described in more detail under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Persons Subject to this Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) who is aware of material nonpublic information relating to the Company may, directly or indirectly through Family Members or Controlled Entities&#58; </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Engage in transactions in Company Securities, except as otherwise specified in this Policy Statement under the headings &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transactions Under Company Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">,&#8221; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transactions Not Involving a Purchase or Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Rule 10b5-1 Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#59;&#8221;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Recommend the purchase or sale of any Company Securities&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Disclose material nonpublic information to persons within the Company whose jobs do not require them to have that information, or outside of the Company to other persons, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">including, but not limited to, family, friends, business associates, investors and expert consulting firms, unless any such disclosure is made in accordance with the Company&#8217;s policies regarding the protection or authorized external disclosure of information regarding the Company&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Assist anyone engaged in the foregoing activities.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In addition, it is the policy of the Company that no director, officer or other employee of the Company (or any other person designated as subject to this Policy Statement) who, in the course of working for the Company, learns of material nonpublic information about a company with which the Company does business, including a customer or supplier of the Company, may trade in that company&#8217;s securities until the information becomes public or is no longer material.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company itself must comply with U.S. securities laws applicable to its own securities trading activities, and will not effect transactions in Company Securities, or adopt any securities repurchase plans, when it is in possession of material nonpublic information concerning the Company, other than in compliance with applicable law, subject to the policies and procedures adopted by the Company.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">There are no exceptions to this Policy Statement, except as specifically noted herein. Transactions that may be necessary or justifiable for independent reasons (such as the need to raise money for an emergency expenditure), or small transactions, are not excepted from this Policy Statement. The securities laws do not recognize any mitigating circumstances, and, in any event, even the appearance of an improper transaction must be avoided to preserve the Company&#8217;s reputation for adhering to the highest standards of conduct.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:24.34pt">DEFINITION OF MATERIAL NONPUBLIC INFORMATION</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Material Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Information is considered &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">material</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; if a reasonable investor would consider that information important in making a decision to buy, hold or sell securities. Any information that could be expected to affect a company&#8217;s stock price, whether it is positive or negative, should be considered material. There is no bright-line standard for assessing materiality&#59; rather, materiality is based on an assessment of all of the facts and circumstances, and is often evaluated by enforcement authorities with the benefit of hindsight. While it is not possible to define all categories of material information, some examples of information that ordinarily would be regarded as material are&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Financial information, including, but not limited to, revenue results, operating income or loss, or net income or loss&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Projections of future earnings or losses, or other earnings guidance&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Changes to previously announced earnings guidance, or the decision to suspend earnings guidance&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A pending or proposed merger, acquisition, joint venture or tender offer&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A pending or proposed acquisition or disposition of a significant asset or facility&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A Company restructuring&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Significant related party transactions&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A public or private offering of additional securities, borrowings, credit facilities or other financing transactions&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A change in dividend policy or the declaration of a stock split&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Bank borrowings or other financing transactions out of the ordinary course&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">The establishment of a repurchase program for Company Securities&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A change in the Company&#8217;s pricing or cost structure&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">News about a significant contract or cancellation of an existing significant contract&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">News about significant new services or lines of business&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">The gain or loss of a significant supplier&#59; </font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A change in the Board of Directors, senior management or any other major personnel changes&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A change in auditors or notification that the auditor&#8217;s reports may no longer be relied upon&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Pending or threatened significant litigation, or the resolution of such litigation&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">Impending bankruptcy or the existence of severe liquidity problems&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">A significant cybersecurity incident, such as a data breach, or any other significant disruption in the company&#8217;s operations or loss, potential loss, breach or unauthorized access of its property or assets, whether at its facilities or through its information technology infrastructure&#59; or</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">The imposition of an event-specific restriction on trading in Company Securities or the securities of another company or the extension or termination of such restriction.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Twenty-Twenty Hindsight</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Remember, anyone scrutinizing a transaction will be doing so after the fact, with the benefit of 20&#47;20 hindsight. As a practical matter, before engaging in any transaction, you should carefully consider how enforcement authorities and others might view the transaction in hindsight. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">When Information is Considered &#8220;Public&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. If you are aware of material nonpublic information, you may not trade until the information has been widely disseminated to the marketplace and the investing public has had time to absorb the information fully.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Information that has not been disclosed to the public is generally considered to be nonpublic information. In order to establish that the information has been disclosed to the public, it may be necessary to demonstrate that the information has been widely disseminated. Information generally would be considered widely disseminated if it has been disclosed through press releases on newswire services, a broadcast on widely available radio or television programs, publication in a widely available newspaper, magazine or news website, or public disclosure documents filed with the SEC that are available on the SEC&#8217;s website. By contrast, information would likely not be considered widely disseminated if it is available only to the Company&#8217;s employees, or if it is only available to a select group of analysts, brokers and institutional investors.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Once information is widely disseminated, it is still necessary to provide the investing public with sufficient time to absorb the information. As a general rule, information should not be considered fully absorbed by the marketplace until after the second business day after the day on which the information is released. If, for example, the Company were to make an announcement on a Monday, you should not trade in Company Securities until Thursday. Depending on the particular circumstances, the Company may determine that a longer or shorter period should apply to the release of specific material nonpublic information.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">VI.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:19.68pt">EXCLUDED TRANSACTIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Transactions Under Company Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement does not apply in the case of the following transactions, except as specifically noted&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Stock Option Exercises</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement does not apply to the exercise of an employee stock option acquired pursuant to the Company&#8217;s equity incentive plans, or to the exercise of a tax withholding right pursuant to which a person has elected to have the Company withhold shares subject to an option to satisfy tax withholding requirements. This Policy Statement does apply, however, to any sale of stock as part of a broker-assisted cashless exercise of an option, or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Restricted Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement does not apply to the vesting of restricted stock, or the exercise of a tax withholding right pursuant to which you elect to have the Company withhold shares of stock to satisfy tax withholding requirements upon the vesting of any restricted stock. This Policy Statement does apply, however, to any market sale of restricted stock.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Transactions Not Involving a Purchase or Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement does not apply to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> gifts of Company Securities, unless (1) the person making the gift has reason to believe that the recipient intends to sell the Company Securities while the person making the gift is aware of material nonpublic information, or (2) the person making the gift is subject to the restrictions specified in the Addendum to this Policy Statement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Addendum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). A </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> gift described in (2) of the preceding sentence may be permitted, but is subject to the restrictions specified in the Addendum. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Rule 10b5-1 Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) provides a defense from insider trading liability under Rule 10b-5. In order to be eligible to rely on this defense, a person subject to this Policy Statement must enter into a Rule 10b5-1 plan for transactions in Company Securities that meets certain conditions specified in the Rule (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Rule 10b5-1 Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). If the plan meets the requirements of Rule 10b5-1, Company Securities may be purchased or sold without regard to certain insider trading restrictions. To comply with this Policy Statement, a Rule 10b5-1 Plan must be approved by the General Counsel or its designee and meet the requirements of Rule 10b5-1. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In general, a Rule 10b5-1 Plan must&#58; (i) be entered into at a time when the person entering into the plan is not aware of material nonpublic information&#59; (ii) contain a minimum &#8220;cooling-off period&#8221; between the date an approved Rule 10b-5 Plan is adopted or modified and when trading under the plan commences&#59; (iii) include a written certification of the person entering into the plan certifying that he or she (a) is not aware of material nonpublic information about the Company or Company Securities and (b) is adopting or modifying the plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b-5&#59; and (iv) persons are generally prohibited from having more than one Rule 10b-5 Plan with respect to Company Securities. Once the plan is adopted, the person must not exercise any influence over the amount of securities to be traded, the price at which they are to be traded or the date of the trade. The Rule 10b5-1 Plan must either specify the amount, pricing and timing of transactions in advance or delegate discretion on these matters to an independent third party.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Any Rule 10b5-1 Plan must be submitted for approval two days prior to the entry into the Rule 10b5-1 Plan. No further pre-approval of transactions conducted pursuant to the Rule 10b5-1 Plan will be required.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">VII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:15.02pt">ADDITIONAL PROHIBITED TRANSACTIONS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company has determined that there is a heightened legal risk and&#47;or the appearance of improper or inappropriate conduct if the persons subject to this Policy Statement engage in certain types of transactions, namely short-term or speculative transactions in Company Securities. It therefore is the Company&#8217;s policy that directors, officers and other employees may </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">NOT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> engage in any of the following transactions&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Short Sales</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Short sales of Company Securities (i.e., the sale of a security that the seller does not own) may evidence an expectation on the part of the seller that the securities will decline in value, and therefore have the potential to signal to the market that the seller lacks confidence in the Company or its prospects. In addition, short sales may reduce a seller&#8217;s incentive to improve the Company&#8217;s performance. For these reasons, short sales of Company Securities are prohibited by this Policy Statement. In addition, Section 16(c) of the Exchange Act prohibits officers and directors from engaging in short sales.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Publicly Traded Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. A transaction in options is, in effect, a bet on the short-term movement of the Company&#8217;s stock, and therefore may create the appearance that the director, officer or employee is trading based on material nonpublic information. Transactions in options also may focus the director&#8217;s, officer&#8217;s or employee&#8217;s attention on short-term performance at the expense of the Company&#8217;s long-term objectives. Accordingly, transactions in puts, calls or other derivative securities involving the Company, on an exchange or in any other organized market, are prohibited by this Policy Statement. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Margin Accounts and Pledged Securities</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Securities held in a margin account may be sold by the broker without the customer&#8217;s consent if the customer fails to meet a margin call. Similarly, securities pledged (or hypothecated) as collateral for a loan may be sold in foreclosure if the borrower defaults on the loan. Because a margin sale or foreclosure sale may occur at a time when the pledgor is aware of material nonpublic information or otherwise is not permitted to trade in Company Securities, directors, officers and other employees are prohibited from holding Company Securities in a margin account or pledging Company Securities as collateral for a loan. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Hedging Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Hedging or monetization transactions can be accomplished through a number of possible mechanisms, including through the use of financial instruments such as prepaid variable forwards, equity swaps, collars and exchange funds. Such transactions may permit a director, officer or employee to continue to own Company Securities obtained through employee benefit plans or otherwise, but without the full risks and rewards of ownership. When that occurs, the director, officer or employee may no longer have the same objectives as the Company&#8217;s other shareholders. Therefore, the Company prohibits you from engaging in such transactions. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Standing and Limit Orders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Standing and limit orders (except standing and limit orders under approved Rule 10b5-1 Plans) create heightened risks for insider trading violations similar </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">to the use of margin accounts. There is no control over the timing of purchases or sales that result from standing instructions to a broker, and as a result the broker could execute a transaction when a director, officer or other employee is in possession of material nonpublic information. The Company therefore discourages placing standing or limit orders on Company Securities. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">VIII.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:10.36pt">ADDITIONAL PROCEDURES</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Administration of this Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Company&#8217;s General Counsel or other legal officer designated by the General Counsel shall serve as the administrator of this Policy Statement. All determinations and interpretations by the General Counsel or its designee shall be final and not subject to further review.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Event-Specific Trading Restriction Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. From time to time, an event may occur that is material to the Company and is known by only a few directors, officers and&#47;or employees. The Company reserves the right to enforce an event-specific trading restriction period, and the persons designated by the General Counsel will be prohibited from trading in Company Securities during such transaction or event. As a result of an event-specific restriction, the Company may require you to cancel existing orders (including good until cancelled orders) and also may instruct your broker to cancel any such orders. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The existence of an event-specific trading restriction period will not be announced to the Company as a whole, and should not be communicated to any other person. Even if the General Counsel has not designated you as a person who should not trade due to an event-specific restriction, you should not trade while aware of material nonpublic information. Exceptions will not be granted during an event-specific trading restriction period.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Post-Termination Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement continues to apply to transactions in Company Securities even after termination of service to the Company. If an individual is in possession of material nonpublic information when his or her service terminates, that individual may not trade in Company Securities until that information has become public or is no longer material.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Company Assistance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Any person who has a question about this Policy Statement or its application to any proposed transaction may obtain additional guidance from the Company&#8217;s General Counsel or the Company&#8217;s Associate General Counsel - Corporate &#38; Securities, who can be reached by telephone at (949) 487-9500. If you have any doubt as to whether you are in possession of material nonpublic information or whether a trade may otherwise violate this Policy Statement, you should contact the General Counsel before trading in any Company Securities. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Other Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Company may change these procedures or adopt such other procedures in the future as the Company considers appropriate or advisable in order to carry out the purposes of this Policy Statement or to comply with the federal securities laws. Wherever this Policy Statement refers to or calls for action by or involving the Company&#8217;s General Counsel, such reference shall include the Company&#8217;s Associate General Counsel - Corporate &#38; Securities or such other person as the General Counsel may designate from time to time.</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Third-Party Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. This Policy Statement is not intended to create any rights in third parties with respect to any violation of its terms and is also not intended to create any legal liability for the Company or any employee, officer or director beyond those for which they are already responsible under applicable securities laws.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Personal Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The ultimate responsibility for adhering to this Policy Statement and avoiding improper trading rests with you.  Violation of this Policy Statement could result in the Company taking disciplinary action, including dismissal for cause.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Certification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. All employees, officers and directors must annually certify their understanding of, and intent to comply with, this Policy Statement. A copy of the certification that all persons subject to this Policy Statement (other than those who are subject to the additional restrictions and policies set forth in the Addendum) must sign is attached to this Policy Statement. Please return an executed copy of the attached certification to the General Counsel immediately. Directors, executive officers and certain key employees are also subject to additional restrictions on their transactions in Company Securities, which are described in a separate Addendum to this Policy Statement. Directors, executive officers and such key employees subject to the Addendum should instead sign the certification attached to the Addendum.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">CERTIFICATION</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">I hereby certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">I have read and understand the Statement of Company Policy Regarding Insider Trading, dated August 14, 2007, as subsequently amended on October 29, 2008, May 18, 2023 and November 6, 2024 (as so amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). I understand that the General Counsel and the outside legal counsel of The Ensign Group, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) are available to answer any questions I have regarding the Policy Statement.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">I agree that I will comply with the Policy Statement for as long as I am subject to the Policy Statement. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">I agree that the Company may at any time and in its sole discretion issue a prohibition on trading in Company Securities and that the Company shall have full power and authority to cancel any outstanding orders, including &#8220;good until cancelled&#8221; orders, that I may place, but that I have the sole responsibility for compliance with the Policy Statement. I further agree and represent that I will never trade in Company Securities while I am in possession of material nonpublic information regarding the Company.</font></div><div><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">This certification constitutes consent for the Company to issue any necessary stop-transfer orders to the Company&#8217;s transfer agent to enforce compliance with this Policy Statement. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Signature&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                                   </font></div><div style="text-align:justify;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Print Name&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                                </font></div><div style="text-align:justify;text-indent:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Date&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                                           </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-08-07&#59; Amended 10-29-08, 05-18-23 and 11-06-24</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.2
<SEQUENCE>3
<FILENAME>ensgq42024ex192.htm
<DESCRIPTION>EX-19.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ifdb8a7140e314ba69665dae2f1ec4c5a_36"></div><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibit 19.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:112%">ADDENDUM TO STATEMENT OF COMPANY POLICY REGARDING INSIDER TRADING</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted August 14, 2007</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Amended as of October 29, 2008, December 17, 2009, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">March 11, 2010, May 18, 2023 and November 6, 2024</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">This Addendum applies to all executive officers, directors and certain key employees of  The Ensign Group, Inc. and its subsidiaries (collectively the &#8220;Company&#8221;) </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company has adopted a Statement of Company Policy Regarding Insider Trading (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). The Company has also adopted this Addendum to the Policy Statement, which sets forth additional procedures in order to assist the Company in the administration of the Policy Statement, to facilitate compliance with laws prohibiting insider trading while in possession of material nonpublic information, and to avoid the appearance of any impropriety. This Addendum is in addition to and supplements the Policy Statement. Capitalized terms used but not defined in this Addendum shall have the respective meanings given to such terms in the Policy Statement.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This Addendum applies to members of the Board of Directors of the Company (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), executive officers of the Company, including those who are subject to Section 16 of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;, all such officers, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; and officers subject to Section 16, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Section 16 Officers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;), and certain designated employees and consultants of the Company and its subsidiaries who regularly become aware of earnings information or have access to material nonpublic information about the Company (collectively with Directors and Officers, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Covered Persons</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). The General Counsel of the Company shall maintain a list of the names and current positions of the Covered Persons. </font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">I.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;padding-left:37.34pt">PRE-CLEARANCE PROCEDURES </font></div><div style="padding-left:18pt;text-indent:-27pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To help prevent inadvertent violations of the federal securities laws and to avoid even the appearance of trading on the basis of material nonpublic information, Covered Persons, as well as the Family Members and Controlled Entities of such persons, may not engage in any transaction involving Company Securities without first obtaining pre-clearance of the transaction from the General Counsel. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">A request for pre-clearance should be submitted to the General Counsel at least two business days in advance of the proposed transaction, unless earlier notice is otherwise required by the Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The General Counsel is under no obligation to approve a trade submitted for pre-clearance, and may, in his or her sole discretion, determine not to permit the trade. If a person seeks pre-clearance and permission to engage in the transaction is denied, then he or she should refrain from initiating any transaction in Company Securities, and should not inform any other person of the restriction.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">When a request for pre-clearance is made, the requestor should carefully consider whether he or she may be aware of any material nonpublic information about the Company, and should describe fully any such circumstances to the General Counsel. The requestor should also indicate whether he or she has effected any non-exempt &#8220;opposite-way&#8221; transactions within the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">1</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-8-07&#59; Amended 10-29-08, 12-17-09&#59; 3-11-10&#59; 05-18-23&#59; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11-6-24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">past six months, and should be prepared to report the proposed transaction on an appropriate Form 4 or Form 5. The requestor should also be prepared to comply with SEC Rule 144 and file Form 144, if necessary, at the time of any sale.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:112%">Bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> gifts of securities may be approved so long as the person making the gift has no reason to believe that the recipient intends to sell the Company Securities while the person making the gift is aware of material nonpublic information.  </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The requirement for pre-clearance of trades set forth in this Addendum does not apply to transactions conducted pursuant to approved Rule 10b5-1 Plans, described in the Policy Statement under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Rule 10b5-1 Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.&#8221;  However, any person subject to the pre-clearance requirements who wishes to implement a trading plan under Rule 10b5-1 must first pre-clear the Rule 10b5-1 Plan with the General Counsel. As required by Rule 10b5-1, a Rule 10b5-1 Plan must&#58; (i) be entered into at a time when the person entering into the plan is not aware of material nonpublic information&#59; (ii) contain a minimum &#8220;cooling-off period&#8221; between the date an approved Rule 10b-5 Plan is adopted or modified and when trading under the plan commences&#59; (iii) include a written certification of the person entering into the plan certifying that he or she (a) is not aware of material nonpublic information about the Company or Company Securities and (b) is adopting or modifying the plan in good faith and not as part of a plan or scheme to evade the prohibitions of Rule 10b-5&#59; and (iv) persons are generally prohibited from having more than one Rule 10b-5 Plan with respect to Company Securities. Transactions effected pursuant to a pre-cleared Rule 10b-5 Plan will not require further pre-clearance at the time of the transaction if the Rule 10b-5 Plan specifies the dates, prices and amounts of the contemplated trades, or establishes a formula for determining the dates, prices and amounts. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">II.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:32.68pt">BROKER INTERFACE PROCEDURES</font></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The reporting obligations for Section 16 reports require tight interface with brokers handling transactions for our Directors and Section 16 Officers. In addition, the other Covered Persons designated by the General Counsel as being subject to the Company&#8217;s broker interface and notification procedures, together with their Family Members and Controlled Entities, must abide by these procedures at all times. We require that you provide a copy of this Addendum to your broker and such broker must agree that he, she or it&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;padding-left:9.68pt">Will not enter any orders for you (except for orders under pre-approved Rule 10b5-1 Plans) without first&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-24.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt">verifying with the Company that your transaction was pre-cleared&#59; and</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-27.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt">complying with the brokerage firm&#8217;s compliance procedures (e.g., Rule 144).</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:9pt">Report any transactions immediately to the General Counsel of the Company via&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-24.33pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt">telephone&#59; and</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-27.66pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:18pt">in writing via e-mail to legal&#64;ensigngroup.net, describing the details of every transaction involving Company Securities, including gifts, transfers, pledges, and all transactions pursuant to Rule 10b5-1 Plans.  </font></div><div><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-8-07&#59; Amended 10-29-08, 12-17-09&#59; 3-11-10&#59; 05-18-23&#59; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11-6-24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="padding-left:54pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">III.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:28.02pt">BLACKOUT PERIODS</font></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Quarterly Blackout Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The Company&#8217;s announcement of its quarterly and annual financial results has the potential to have a material effect on the market for Company Securities. Therefore, to avoid even the appearance of trading while aware of material nonpublic information, persons designated by the General Counsel as subject to this restriction, as well as their Family Members or Controlled Entities, may not conduct any transactions involving the Company&#8217;s Securities, during a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Quarterly Blackout Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; beginning on the fourteenth calendar day of the last month of each fiscal quarter and ending after the second full business day following the Company&#8217;s issuance of its quarterly earnings release. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Persons subject to these Quarterly Blackout Periods include&#58; Directors, Officers, the Controller of the Company, and all other persons who are informed by the General Counsel that they are subject to the Quarterly Blackout Periods. The General Counsel and the Chief Executive Officer shall meet at least annually or at such more frequent intervals as they deem advisable to establish those employees who are subject to Quarterly Blackout Periods, which will include persons who are or may be expected to be aware of the Company&#8217;s quarterly financial results. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Further, the Company may on occasion issue interim earnings guidance or other potentially material information by means of a press release, a Current Report on Form 8-K filed with the SEC or by other means designed to achieve widespread dissemination of the information. You should anticipate that trades are unlikely to be pre-cleared while the Company is in the process of assembling the information to be released and until the information has been released and fully absorbed by the market, notwithstanding that such event may occur outside of a Quarterly Blackout Period. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Event-Specific Blackout Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. From time to time, an event may occur that is material to the Company and is known by only a few directors, officers or employees. So long as the event remains material and nonpublic, the persons designated by the General Counsel may not trade in Company Securities. </font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">The existence of an event-specific blackout period will not be announced to the Company as a whole. If, however, a person whose trades are subject to pre-clearance requests permission to trade in Company Securities during an event-specific blackout, the General Counsel will inform the requester of the existence of the event-specific blackout period, without disclosing the reason for the blackout. Any person made aware of the existence of an event-specific blackout should not disclose the existence of the blackout to any other person. Even if the General Counsel has not designated you as a person who should not trade due to an event-specific restriction, you should not trade while aware of material nonpublic information. Exceptions will not be granted during an event-specific trading restriction period.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Exceptions Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The quarterly trading restrictions and event-specific trading restrictions do not apply to those transactions to which the Policy Statement does not apply, as described in the Policy Statement under the headings &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transactions Under Company Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221; or &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transactions Not Involving a Purchase or Sale</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.&#34;  </font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">3</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-8-07&#59; Amended 10-29-08, 12-17-09&#59; 3-11-10&#59; 05-18-23&#59; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11-6-24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Further, the requirement for pre-clearance, the quarterly trading restrictions and event-specific trading restrictions do not apply to transactions conducted pursuant to approved Rule 10b5-1 Plans, described in the Policy Statement under the heading &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Rule 10b5-1 Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.&#8221;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Hardship Exceptions to Quarterly Blackout Periods</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> A person who is subject to the Quarterly Blackout Periods and who has an unexpected and urgent need to sell Company Securities in order to generate cash may, in appropriate and very limited rare circumstances, be permitted to sell Company Securities even during the Quarterly Blackout Period. A hardship exception may be granted only by the Audit Committee, in its sole discretion, and such exception must be requested at least two business days in advance of the proposed trade. A hardship exception may be granted only if the Audit Committee concludes that the Company&#8217;s earnings information for the applicable quarter does not constitute material nonpublic information or if the Company does not have sufficient insight as to the Company&#8217;s earnings information as of that time. Under no circumstance will a hardship exception be granted during an event-specific blackout period. </font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">IV.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:28.68pt">PROHIBITION ON SHORT-SWING TRADES</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Short-term trading of Company Securities may be distracting to the person and may unduly focus the person on the Company&#8217;s short-term stock market performance instead of the Company&#8217;s long-term business objectives. For these reasons, any Covered Person (i) who purchases Company Securities in the open market may not sell any Company Securities of the same class during the six months following the purchase, and (ii) who sells Company Securities in the open market may not purchase any Company Securities of the same class during the six months following the sale.  This prohibition applies only to purchases or sales in the open market, and would not apply to stock option exercises or other employee benefit plan transactions as described in the Policy Statement under the heading &#34;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">Transactions under Company Plans</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#34;. </font></div><div><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">V.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;padding-left:33.34pt">ADDITIONAL PROCEDURES</font></div><div style="padding-left:18pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Post-Termination Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">.  This Addendum continues to apply to transactions in Company Securities even after termination of service to the Company. If you are aware of material nonpublic information when you terminate service as a Covered Person, you may not trade in Company Securities until that information has become public or is no longer material.  The pre-clearance procedures specified under the heading &#8220;Pre-Clearance Procedures&#8221; in this Addendum, however, will cease to apply to transactions in Company Securities upon the expiration of any Blackout Period or other Company-imposed trading restrictions applicable at the time of the termination of service.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Company Assistance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Any person who has a question about the Policy Statement or this Addendum or their respective application to any proposed transaction may obtain additional guidance from the Company&#8217;s General Counsel or the Company&#8217;s Associate General Counsel - Corporate &#38; Securities, who can be reached by telephone at (949) 487-9500 or ensign-investors&#64;ensignservices.net. If you have any doubt as to whether you are in possession of material nonpublic information or whether a trade may otherwise violate the Policy Statement or this Addendum, you should contact the General Counsel before trading in any Company Securities. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">4</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-8-07&#59; Amended 10-29-08, 12-17-09&#59; 3-11-10&#59; 05-18-23&#59; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11-6-24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Other Procedures</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The Company may change these procedures or adopt such other procedures in the future as the Company considers appropriate or advisable in order to carry out the purposes of the Policy Statement or this Addendum or to comply with the federal securities laws. Wherever this Policy Statement refers to or calls for action by or involving the Company&#8217;s General Counsel, such reference shall include the Company&#8217;s Associate General Counsel - Corporate &#38; Securities or such other person as the General Counsel may designate from time to time.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">No Third-Party Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. Neither the Policy Statement nor this Addendum is intended to create any rights in third parties with respect to any violation of its respective terms and neither is intended to create any legal liability for the Company or any employee, officer or director beyond those for which they are already responsible under applicable securities laws.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Personal Responsibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. The ultimate responsibility for adhering to the Policy Statement and this Addendum and avoiding improper trading rests with you.  Violation of the Policy Statement and this Addendum could result in the Company taking disciplinary action, including dismissal for cause.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Certifications</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">. All Covered Persons subject to the procedures set forth in this Addendum must annually certify their understanding of, and intent to comply with, the Policy Statement and this Addendum. Please return an executed copy of the attached certification to the General Counsel immediately. </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-27pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">5</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-8-07&#59; Amended 10-29-08, 12-17-09&#59; 3-11-10&#59; 05-18-23&#59; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11-6-24</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">CERTIFICATION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">(For Executive Officers, Directors and Certain Key Employees)</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">I hereby certify that&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">1.         I have read and understand the Statement of Company Policy Regarding Insider Trading dated August 14, 2007, as subsequently amended on October 29, 2008, May 18, 2023 and November 6, 2024 (as so amended, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Policy Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) and the Addendum to such Policy Statement dated August 14, 2007, as subsequently amended on October 29, 2008, December 17, 2009, March 11, 2010, May 18, 2023 and November 6, 2024 (as amended, the Addendum, and together with the Policy Statement, the  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Insider Trading Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;). I understand that the General Counsel and the outside legal counsel of The Ensign Group, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:112%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8221;) are available to answer any questions I have regarding the Insider Trading Policy.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">2.         I agree that I will comply with the Insider Trading Policy for as long as I am subject to the Insider Trading Policy.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">3.         </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">I understand that all of my trades must be pre-approved by the Company&#8217;s General Counsel or such other person as the Company may designate from time to time.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">4.         I agree that the Company may at any time and in its sole discretion issue a prohibition on trading in Company securities, and that the Company shall have full power and authority to cancel any outstanding orders, including good until cancelled orders, that I may place, but I understand that I have the sole responsibility for compliance with the Insider Trading Policy. I further agree and represent that I will never trade in Company securities while I am in possession of material nonpublic information regarding the Company.</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">5.         This certification constitutes consent for the Company to issue any necessary stop-transfer orders to the Company&#8217;s transfer agent to enforce compliance with the Insider Trading Policy. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%"> Signature&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                        </font></div><div style="text-align:justify;text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Print Name&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                     </font></div><div style="text-align:justify;text-indent:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Date&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;text-decoration:underline">                                                               </font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">6</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Adopted 8-14-07&#59; Effective 11-8-07&#59; Amended 10-29-08, 12-17-09&#59; 3-11-10&#59; 05-18-23&#59; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">11-6-24</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>ensg123124ex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib491ef9c63004e6cac70a56fd09ae78a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT 21.1</font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#b6b6b6;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Legal Name</font></td><td colspan="3" style="background-color:#b6b6b6;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">President Company&#47; Owner</font></td><td colspan="3" style="background-color:#b6b6b6;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Jurisdiction of Organization &#47; Formation</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">1645 Florence Rd TN LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2016 Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2020 Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">2410 Stillhouse Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">24th Street Healthcare Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">524 West Main Street TN LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">726 Kentucky Avenue S TN LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Abbot Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Adipiscor, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Agape Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Alice Branch Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Allen Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Alvarado Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Amelia Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">American Lake Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">American Pika Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">American Robin Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ann Arbor Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Anza Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Apache Trail Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Appaloosa Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ellis Pointe Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Apple Springs Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Armstrong Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Arris Health Services LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Covalence Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Arvada Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ascent Health Services LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridge Holding Company, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ash Creek Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Atlantic Memorial Healthcare Associates, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Avalanche Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Avenues Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Avocado Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Aztec Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bainbridge Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bakorp, L.L.C.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PMD Investments, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Arizona</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Banner Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bannock Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bardwell Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Baseline Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bayshore Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bayside Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Baywood Health Holdings LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Beacon Hill Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Beacon Purchasing LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Banner Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bear Creek Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bear Creek Senior Living, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bell Villa Care Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Belmont Ridge Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bennett Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bernardo Heights Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bertetti Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Best SW Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Big Blue Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Big Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bijou Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bijou Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bing Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Black Ridge Canyon Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Black Wolf Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Blackbird Senior Living, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bluebird Creek Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bluebird Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bluebonnet Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Boise Imaging Solutions LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bakorp L.L.C.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bouverie Healthcare Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Brackenridge Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bremer Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Brenwood Park Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridge Holding Company, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridge Resources LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridge Holding Company, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridger Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridgestone Living LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Brody Bay Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Broken Ridge Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Brownsville Care Associates, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bruce Neenah Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Buffalo Creek Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Burch Creek Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">C Street Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Calavaras Creek Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">California Nursing Academy, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Camarillo Community Care, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Canary Bend Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cane Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cane Island Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Canyon Springs Senior Living, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridgestone Living LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Resources, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cardiff Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cardinal Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Carolina Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Carrollton Heights Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Castle Pines Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Castle Rock Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cedar City Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cedar Ridge Transportation LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Woodland Transportation Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Central Avenue Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chaparral Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chateau Julia Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cherokee Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cherry Hills Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chickadee Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Chimney Rock Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Circle Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">City Heights Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Claremont Foothills Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Clark Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Claydelle Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Clear Skies Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Clear Sky Flights LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pioneer Transportation Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cleaver Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Clint Trail Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cloverleaf Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Clovis Point Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Coalescence Health Services, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridge Holding Company, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Coldwater Springs Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Columbia Respiratory Care, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Covalence Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Columbia River Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Concord Avenue Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Congaree Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Conrad Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Constitution Road Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Conway Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Copeland Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cornet Limited, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Arizona</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Costa Victoria Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cottontail Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Covalence Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cow Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Creed Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cress Creek Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Crown Hill Healthcare LLC </font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Crystal Lake Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cypress Creek Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">D3T Enterprise, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Woodland Transportation Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Texas</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Da Vinci Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Daffodil Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dark Sky Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Davis Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">De Moisy Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deer Creek Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deer Tail Senior Living, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Deergrass Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Desert Cove Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Desert Empire Behavioral Health, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Desert Lily Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Desert Mallow Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Design City Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dessau Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Devonshire Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dewey Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dexter Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Diamond Valley Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Discovery Trail Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dorothy Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dove Valley Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Downey Community Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dragonfly Senior Living, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Duck Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dusk Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Eagle Harbor Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Eagle Health Services LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridge Holding Company, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Earhart Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">East Mesa Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">East River Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Echo Canyon Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Eiffel Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Elati Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Turnberry Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Elevate Air Med LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Elkhorn Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ellis Pointe Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Empirecare Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensidium Investments, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Cloverdale LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Montgomery LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Palm I LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Panorama LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Pleasanton LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Sabino LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign San Dimas LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Santa Rosa LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Sonoma LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Whittier East LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Whittier West LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ensign Willits LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fawn Meadows Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">First Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flintrock Falls Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Floyde Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Forney Lake Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Forrest Hill Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fossil Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Founders Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Founders RX LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Founders Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fox Bay Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fox Hollow Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fox Sparrow Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Franklin Avenue Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Franklin Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">French Lake Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Fullerton Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Garwood Health Holdings II LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gate Three Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gem Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Getzendaner Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Glendale Healthcare Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Glimmer Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Golden Eagle Senior Living, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Golden Oaks Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Golden Ridge Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Golden Years Program, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Goldenstar Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Goldfield Mountain Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Good Hope Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gooding Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Graceland Senior Living, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Grand Avenue Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Grand Villa PHX, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Grassland Healthcare and Rehabilitation, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Green Bay Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Green Heron Senior Living, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Green Mountain Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Green Mountain Personalized Care, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Green Valley Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gypsum Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hamilton Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harbor Mesa Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harlan Heights Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harlingen Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harmony Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harmony Hill Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Harrison Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hartwell Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hawkins Spring Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">HB Healthcare Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Healthlift Medical Transportation, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Heartland Health Holdings II LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Highcross Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Highland Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Higley Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hill Country Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Holbrook Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Holford Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Holly Plains Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hollyleaf Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Holman Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Homedale Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hoquiam Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hub City Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hueneme Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Huntington Beach Convalescent Hospital Asset LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Longboard Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hutchins Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hyrum Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Immediate Clinic Seattle, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Immediate Clinic Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Iron Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Iron Horse Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Jack Finney Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">JARR Transportation Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Arizona</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Jefferson Healthcare LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Jordan Health Associates, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">JRT Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Juniper Springs Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keller Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Kenosha Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Kettle Creek Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Kingston Falls Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Klement Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Knight Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Korsin Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Krypton Health Services LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Covalence Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">La Jolla Skilled LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">La Veta Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lacefield Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lake Cassidy Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lake Island Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lake Morris Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lake Pleasant Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lake Pointe Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lake Washington Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lakewood Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lakewood Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Last Empire Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Latham River Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ledbetter Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Legend Lake Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lemon Grove Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lightning Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lil&#8217; Tots Day Program, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lilac City Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lilly Road Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lindahl Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Link Support Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cornet Limited, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Little Blue Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Little Mountain Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Little Village Day Care, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Littleton Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Livingston Care Associates, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lone Pine Ridge Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lone Star MTC, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Longboard Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Longs Peak Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lookout Mountain Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lost Cane Senior Living, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lowell Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lucky Peak Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ludden Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Luna Vega Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lynnwood Health Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Lynx Canyon Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Madison Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Madison Pointe Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Magic Valley Senior Living, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridgestone Living LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Magic Way Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Malcolm Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Manitowoc Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Manor Park Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Manzanita Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Maple Hills Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Marble City Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Marguerite Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mariano Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Marion Health Associates, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Market Bayou Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Marshall Lake Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mason Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mason Park Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">MavStar Medical Transportation, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">McAllen Care Associates, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">McAllen Community Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">McCall Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">McFarland Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">MedStar Medical Transportation, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">JARR Transporation Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Arizona</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Menomonee Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Meridian Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Midland Nampa Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Midland Nampa Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Midnight Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Millcreek Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mission Trails Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Misty Willow Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mockingbird Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Monroe Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Montebella Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Moon Cove Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC owned&#59;<br>Milestone Healthcare LLC operated</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Moonflower Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Moonrise Healthcare, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Morning Glory Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mount Lemmon Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mountain View Retirement, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mountain Violet Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Muriel Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Murphy Health Holdings II LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mussel Rock Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Mustang Ridge Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Myracle Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Myrtle Springs Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ellis Pointe Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nautilus Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">NB Brown Rock Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">New England Medical Transportation, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nightfall Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nobel Health Properties LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nordic Valley Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">North Fork Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">North Mountain Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">North Parkway Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">North Parkway Healthcare LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">North Silver Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Northern Oaks Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Oak Point Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Oak Prairie Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Oceanview Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ocotillo Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Old Pueblo Medical Transportation, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Olmstead Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Olympic Marmot Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Olympus Health, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">One Hope Senior Living LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Orange Grove Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Orange Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Orchard Bay Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Orman Ridge Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Osage Valley Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ottawa Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pacific Mobile Diagnostics Holdings (CA), LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PMD Investments, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Padua Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Palm Valley Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Panorama Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Park Waverly Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Parker Creek Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Parkside Healthcare, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Peoria Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Percheron Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ellis Pointe Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Permunitum LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Perris Hills Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pikes Peak Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pine Forest Healthcare, Inc.  </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Piney Lufkin Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pioneer Transportation Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pleasant Run Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PMD Investments, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PMD X-Ray Services, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bakorp L.L.C.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PMDAZ, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bakorp L.L.C.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PMDCO, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bakorp L.L.C.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PMDTC, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bakorp L.L.C.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">PMDUT, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bakorp L.L.C.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pocatello Health Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pointe Meadow Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pomerado Ranch Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ponderosa Pine Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Portside Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">POST Rio Grande Valley LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Woodlands Therapy Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Post Therapy LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Woodlands Therapy Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Poudre Creek Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Powderhorn Mountain Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Powers Park Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prairie Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prairie Ridge Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Prairie Waters Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Presidio Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Price Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Primrose Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Primrose Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Quail Creek Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Queenston Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Quorum Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Quorum Ventures, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Racine Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Radiant Hills Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Railroad Crossing Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ramon Healthcare Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Randolph Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Raven Lake Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Ravenscroft Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Red Cliffs Healthcare, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Red Mountain Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Redbrook Healthcare Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">RenewCare of Scottsdale, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Respire Health Services LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Covalence Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rex Road Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Richmond Senior Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rigby Creek Senior Living, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rio Hondo Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rio Mesa Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">River Bluff Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">River Hawk Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">River Otter Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Riverside Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Riverview Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Riverview Village Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Riverwalk Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Roadrunner Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rock Canyon Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rock Hill Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Mountain Medical Transportation<br>&#160;Company, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rose Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rose Park Healthcare Associates, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rosemead Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rowlett Creek Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Royal View Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sage Meadow Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sage Terrace Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sagebrush Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Salado Creek Senior Care, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Saltwater Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sand Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Southstone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sand Hollow Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sandpiper Senior Living LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Santa Catalina Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Santa Maria Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Santiago Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Santiago Personal Care, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Savoy Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sawtooth Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Scandinavian Court Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Seaboard Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Seagull Lane Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Second West Health Holdings LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sedgewood Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sentinel Peak Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sheboygan Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sherman Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sherwood Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Shoshone Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sidewinder Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Siena Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Silver Falls Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Skywalk Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Smoky Mountain Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Somers Kenosha Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Songbird Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">South C Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">South Valley Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Southern Charm Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Southern Oaks Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Southland Management LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Southside Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Southstone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Spring Creek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Spring Trail Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Squak Valley Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stagecoach Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare Merger Sub, LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Maryland</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP GP, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare REIT, Inc.    </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare REIT, Inc.&#59;<br>Standard Bearer Healthcare OP GP, LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare REIT, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Maryland</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standardbearer Insurance Company, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Arizona</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stanton Lake Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stapleton Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Starburst Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Starling Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Statler Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Steel City Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Steelhead Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stevens Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stevens Point Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stoney Hill Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Hopewell Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Storm Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Stoughton Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Strawberry Pond Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Streetcar Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Strong Creek Health Holdings LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Subacute Facility Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Successor Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Summit Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Summit Trail Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sun Mountain Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sunflower Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sungazer Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sunland Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sunny Acres Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sunny Acres Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sunrise Mountain Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Sweet Bay Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Terrace Court Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Terrace Hill Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">N&#47;A</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Delaware</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">TheraTroopers CA, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Theratroopers Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Theratroopers Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">TheraTroopers, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Theratroopers Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Thompson Peak Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Thorntree Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Thunder Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Thunderbird Health Holdings LLC </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Toluca Way Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Top City Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Tortolita Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Towers Park Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Towers Park Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Towers Park Personal Care, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Town East Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Tracy Ridge Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Tradewind Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Treasure Hills Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Treasure Valley Senior Living, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bridgestone Living LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Treaty Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Tree City Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Truckee Meadows Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Tulip Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Turnberry Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Turner Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Rocky Top Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Tustin Hills Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Twinflower Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Two Rivers Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Two Trails Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Union Hill Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Upland Community Care, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Val Verda Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Valley Ranch Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Valley View Health Services, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Velda Rose Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Victoria Ventura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare Central LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Victory Medical Transportation, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Viewpoint Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Vintage Court Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Vista Woods Health Associates LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Wallsville Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Washington Heights Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Waterfall Canyon Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Watson Woods Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Wellington Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West 5600 Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West 5600 Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Ashby Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Broad Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Court Lane Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare North LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Escondido Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Meadow Health Holdings II LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Olive Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Owyhee Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Pine Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Star Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Flagstone Healthcare South LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">West Van Buren Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Western Canal Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Western Edge Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Turnberry Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Whispering Pines Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Whitewater Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Wildcreek Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Wildwood Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Willard Peak Group Home, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Willow Canyon Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Willow Springs Creek Healthcare, Inc. </font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Windsor Lake Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Endura Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Wisconsin Rapids Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Wolf Point Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Wolf River Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Gateway Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Wood Bayou Healthcare, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Woodard Creek Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Pennant Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Woodland Transportation Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Capstone Transportation Investments, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Woodlands Therapy Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Woodson Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Yellow Ridge Healthcare LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.845%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.010%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Yellow Rose Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Ensign Group, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Yellowstar Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Keystone Care LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Youngtown Health, Inc.</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Bandera Healthcare LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Yucca Flats Health Holdings LLC</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Standard Bearer Healthcare OP, LP</font></td><td colspan="3" style="border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr><tr><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Zion Healthcare, Inc.</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Milestone Healthcare LLC</font></td><td colspan="3" style="border-bottom:1.5pt solid #000000;border-left:1.5pt solid #000000;border-right:1.5pt solid #000000;border-top:1.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Nevada</font></td></tr></table></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:8pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>ensg123124ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id98b6ace02794241b94039b16b3b141b_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">EXHIBIT 23.1</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in Registration Statement No. 333&#8208;268018 on Form S&#8208;8 of our reports dated February 5, 2025, relating to the financial statements of The Ensign Group, Inc. and the effectiveness of The Ensign Group, Inc.&#8217;s internal control over financial reporting, appearing in this Annual Report on Form 10&#8208;K for the year ended December 31, 2024.</font></div><div style="text-align:justify;text-indent:22.5pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; DELOITTE &#38; TOUCHE LLP </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costa Mesa, California </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 5, 2025</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>ensgq42024ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i3cf2b231d1a741f98e4e94fb6b03a068_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1 </font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Barry R. Port, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of The Ensign Group, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;5, 2025</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Barry R. Port &#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barry R. Port</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Director (principal executive officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>ensgq42024ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i0b60f4d3e25e4737978215e7c909adc8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2 </font></div><div style="text-align:right"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Suzanne D. Snapper, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this  Annual Report on Form 10-K of The Ensign Group, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules&#160;13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;5, 2025</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.256%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Suzanne D. Snapper &#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suzanne D. Snapper&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer, Executive Vice President and Director (principal financial officer and principal accounting officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>ensgq42024ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1395d1091bd44f0c8baaf0d444f746d4_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. &#167;1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of The Ensign Group, Inc. (the Company) on Form 10-K for the period ended December&#160;31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Barry R. Port, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.275%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.952%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)))&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Barry R. Port</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barry R. Port&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Director (principal executive officer)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160; </font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;5, 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by 18 U.S.C. Section&#160;1350 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>ensgq42024ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if7372d73390e4b8b9106e22eddb1d5ea_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. &#167;1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of The Ensign Group, Inc. (the Company) on Form 10-K for the period ended December&#160;31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Suzanne D. Snapper, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:0.1%"></td><td style="width:2.585%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.953%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)))&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Suzanne D. Snapper &#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suzanne D. Snapper&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer, Executive Vice President and Director (principal financial officer and principal accounting officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February&#160;5, 2025</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by 18 U.S.C. Section&#160;1350 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. </font></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160; </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>ensg-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9fad20ba-6b95-4b5d-8a1b-0cd604b824d6,g:826a027b-6e82-45d1-b4d8-5465cc4138ed-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ensg="http://www.ensigngroup.net/20241231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ensigngroup.net/20241231">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ensg-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ensg-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ensg-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ensg-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.ensigngroup.net/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.ensigngroup.net/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>9952153 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical">
        <link:definition>9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESS">
        <link:definition>9952157 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>9952158 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLE" roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLE">
        <link:definition>9952159 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPUTATIONOFNETINCOMEPERCOMMONSHARE" roleURI="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE">
        <link:definition>9952160 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTS">
        <link:definition>9952161 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STANDARDBEARER" roleURI="http://www.ensigngroup.net/role/STANDARDBEARER">
        <link:definition>9952162 - Disclosure - STANDARD BEARER</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATIONEXPANSIONS" roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONS">
        <link:definition>9952163 - Disclosure - OPERATION EXPANSIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTS" roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTS">
        <link:definition>9952164 - Disclosure - BUSINESS SEGMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNET" roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNET">
        <link:definition>9952165 - Disclosure - PROPERTY AND EQUIPMENT&#8212; NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSNET" roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNET">
        <link:definition>9952166 - Disclosure - INTANGIBLE ASSETS &#8212; NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILL" roleURI="http://www.ensigngroup.net/role/GOODWILL">
        <link:definition>9952167 - Disclosure - GOODWILL</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERACCRUEDLIABILITIES" roleURI="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIES">
        <link:definition>9952168 - Disclosure - OTHER ACCRUED LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.ensigngroup.net/role/INCOMETAXES">
        <link:definition>9952169 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.ensigngroup.net/role/DEBT">
        <link:definition>9952170 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDS" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDS">
        <link:definition>9952171 - Disclosure - OPTIONS AND AWARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.ensigngroup.net/role/LEASES">
        <link:definition>9952172 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEFINEDCONTRIBUTIONPLANS" roleURI="http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANS">
        <link:definition>9952173 - Disclosure - DEFINED CONTRIBUTION PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SELFINSURANCELIABILITIES" roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIES">
        <link:definition>9952174 - Disclosure - SELF INSURANCE LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>9952175 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMONSTOCKREPURCHASEPROGRAM" roleURI="http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAM">
        <link:definition>9952176 - Disclosure - COMMON STOCK REPURCHASE PROGRAM</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>9955511 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLETables" roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLETables">
        <link:definition>9955512 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPUTATIONOFNETINCOMEPERCOMMONSHARETables" roleURI="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables">
        <link:definition>9955513 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATIONEXPANSIONSTables" roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSTables">
        <link:definition>9955514 - Disclosure - OPERATION EXPANSIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTSTables" roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSTables">
        <link:definition>9955515 - Disclosure - BUSINESS SEGMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNETTables" roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETTables">
        <link:definition>9955516 - Disclosure - PROPERTY AND EQUIPMENT&#8212; NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSNETTables" roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETTables">
        <link:definition>9955517 - Disclosure - INTANGIBLE ASSETS &#8212; NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLTables" roleURI="http://www.ensigngroup.net/role/GOODWILLTables">
        <link:definition>9955518 - Disclosure - GOODWILL (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERACCRUEDLIABILITIESTables" roleURI="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESTables">
        <link:definition>9955519 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.ensigngroup.net/role/INCOMETAXESTables">
        <link:definition>9955520 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.ensigngroup.net/role/DEBTTables">
        <link:definition>9955521 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSTables" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables">
        <link:definition>9955522 - Disclosure - OPTIONS AND AWARDS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.ensigngroup.net/role/LEASESTables">
        <link:definition>9955523 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SELFINSURANCELIABILITIESTables" roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESTables">
        <link:definition>9955524 - Disclosure - SELF INSURANCE LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSDetails" roleURI="http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails">
        <link:definition>9955525 - Disclosure - DESCRIPTION OF BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails" roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails">
        <link:definition>9955526 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails" roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails">
        <link:definition>9955527 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails" roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails">
        <link:definition>9955528 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails" roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails">
        <link:definition>9955529 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-Insurance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLENarrativeDetails" roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails">
        <link:definition>9955530 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails" roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails">
        <link:definition>9955531 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails" roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails">
        <link:definition>9955532 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails" roleURI="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails">
        <link:definition>9955533 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSDetails" roleURI="http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails">
        <link:definition>9955534 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STANDARDBEARERDetails" roleURI="http://www.ensigngroup.net/role/STANDARDBEARERDetails">
        <link:definition>9955535 - Disclosure - STANDARD BEARER (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATIONEXPANSIONSNarrativeDetails" roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails">
        <link:definition>9955536 - Disclosure - OPERATION EXPANSIONS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPERATIONEXPANSIONSPurchasePriceAllocationDetails" roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails">
        <link:definition>9955537 - Disclosure - OPERATION EXPANSIONS - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTSNarrativeDetails" roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails">
        <link:definition>9955538 - Disclosure - BUSINESS SEGMENTS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails" roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails">
        <link:definition>9955539 - Disclosure - BUSINESS SEGMENTS - Schedule of Segment Financial Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails" roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails">
        <link:definition>9955540 - Disclosure - BUSINESS SEGMENTS - Schedule of Service Revenue by Major Payor Source (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails" roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails">
        <link:definition>9955541 - Disclosure - PROPERTY AND EQUIPMENT&#8212; NET - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNETNarrativeDetails" roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails">
        <link:definition>9955542 - Disclosure - PROPERTY AND EQUIPMENT&#8212; NET - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails" roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails">
        <link:definition>9955543 - Disclosure - INTANGIBLE ASSETS &#8212; NET - Schedule of Finite Lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSNETNarrativeDetails" roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails">
        <link:definition>9955544 - Disclosure - INTANGIBLE ASSETS &#8212; NET - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails" roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails">
        <link:definition>9955545 - Disclosure - INTANGIBLE ASSETS &#8212; NET - Schedule of Estimated Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails" roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails">
        <link:definition>9955546 - Disclosure - INTANGIBLE ASSETS &#8212; NET - Schedule of Indefinite-lived Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLScheduleofGoodwillDetails" roleURI="http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails">
        <link:definition>9955547 - Disclosure - GOODWILL - Schedule of Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLNarrativeDetails" roleURI="http://www.ensigngroup.net/role/GOODWILLNarrativeDetails">
        <link:definition>9955548 - Disclosure - GOODWILL - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERACCRUEDLIABILITIESDetails" roleURI="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails">
        <link:definition>9955549 - Disclosure - OTHER ACCRUED LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESExpenseDetails" roleURI="http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails">
        <link:definition>9955550 - Disclosure - INCOME TAXES - Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTaxRateDetails" roleURI="http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails">
        <link:definition>9955551 - Disclosure - INCOME TAXES - Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.ensigngroup.net/role/INCOMETAXESNarrativeDetails">
        <link:definition>9955552 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955553 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofLongtermDebtDetails" roleURI="http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails">
        <link:definition>9955554 - Disclosure - DEBT - Schedule of Long-term Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails" roleURI="http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails">
        <link:definition>9955555 - Disclosure - DEBT - Credit Facility with a Lending Consortium Arranged by Truist (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails" roleURI="http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails">
        <link:definition>9955556 - Disclosure - DEBT - Mortgage Loans and Promissory Notes and Off-Balance Sheet Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTLongtermDebtArrangementsDetails" roleURI="http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails">
        <link:definition>9955557 - Disclosure - DEBT - Long-term Debt Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSStockOptionsNarrativeDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails">
        <link:definition>9955558 - Disclosure - OPTIONS AND AWARDS - Stock Options, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails">
        <link:definition>9955559 - Disclosure - OPTIONS AND AWARDS - Schedule of Assumptions for Stock Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails">
        <link:definition>9955560 - Disclosure - OPTIONS AND AWARDS - Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails">
        <link:definition>9955561 - Disclosure - OPTIONS AND AWARDS - Schedule of Employee Stock Option Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails">
        <link:definition>9955562 - Disclosure - OPTIONS AND AWARDS - Options Outstanding by Exercise Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails">
        <link:definition>9955563 - Disclosure - OPTIONS AND AWARDS - Schedule of Aggregate Intrinsic Value of Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails">
        <link:definition>9955564 - Disclosure - OPTIONS AND AWARDS - Restricted Stock Awards, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails">
        <link:definition>9955565 - Disclosure - OPTIONS AND AWARDS - Schedule of Nonvested Restricted Stock Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails">
        <link:definition>9955566 - Disclosure - OPTIONS AND AWARDS - Long-Term Incentive Plan, Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails" roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails">
        <link:definition>9955567 - Disclosure - OPTIONS AND AWARDS - Schedule of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLesseeNarrativeDetails" roleURI="http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails">
        <link:definition>9955568 - Disclosure - LEASES - Lessee Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofOperatingLeaseExpensesDetails" roleURI="http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails">
        <link:definition>9955569 - Disclosure - LEASES - Schedule of Operating Lease Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofFutureMinimumLeasePaymentsDetails" roleURI="http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails">
        <link:definition>9955570 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofFutureMinimumLeasePaymentsDetails_1" roleURI="http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1">
        <link:definition>9955570 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESLessorNarrativeDetails" roleURI="http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails">
        <link:definition>9955571 - Disclosure - LEASES - Lessor Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofRentalIncomefromThirdPartySourcesDetails" roleURI="http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails">
        <link:definition>9955572 - Disclosure - LEASES - Schedule of Rental Income from Third-Party Sources (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESScheduleofAnnualRentalIncomeDetails" roleURI="http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails">
        <link:definition>9955573 - Disclosure - LEASES - Schedule of Annual Rental Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEFINEDCONTRIBUTIONPLANSDetails" roleURI="http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails">
        <link:definition>9955574 - Disclosure - DEFINED CONTRIBUTION PLANS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails" roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails">
        <link:definition>9955575 - Disclosure - SELF INSURANCE LIABILITIES - Schedule of Future Self Insurance Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails" roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails">
        <link:definition>9955576 - Disclosure - SELF INSURANCE LIABILITIES - Schedule of Insurance Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SELFINSURANCELIABILITIESNarrativeDetails" roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESNarrativeDetails">
        <link:definition>9955577 - Disclosure - SELF INSURANCE LIABILITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>9955578 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMONSTOCKREPURCHASEPROGRAMDetails" roleURI="http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails">
        <link:definition>9955579 - Disclosure - COMMON STOCK REPURCHASE PROGRAM (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ensg_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="ensg_InsuranceSubsidiaryDepositsAndInvestments" abstract="false" name="InsuranceSubsidiaryDepositsAndInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_RestrictedAndOtherAssetsNoncurrent" abstract="false" name="RestrictedAndOtherAssetsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" abstract="false" name="LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_DeferredRentAndOtherLongTermLiabilities" abstract="false" name="DeferredRentAndOtherLongTermLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_RentalMember" abstract="true" name="RentalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_RentCostOfServices" abstract="false" name="RentCostOfServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_NonCashLeaseExpense" abstract="false" name="NonCashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets" abstract="false" name="GainLossOnInsuranceClaimsAndDispositionOfAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" abstract="false" name="IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_PaymentsToAcquirePropertyAndEquipment" abstract="false" name="PaymentsToAcquirePropertyAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" abstract="false" name="ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_PurchasesOfNonControllingInterest" abstract="false" name="PurchasesOfNonControllingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_StandardBearerTextBlock" abstract="false" name="StandardBearerTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="ensg_NoncontrollingInterestPolicyTextBlock" abstract="false" name="NoncontrollingInterestPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ensg_RealEstateAndLeaseArrangementsAxis" abstract="true" name="RealEstateAndLeaseArrangementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ensg_RealEstateAndLeaseArrangementsDomain" abstract="true" name="RealEstateAndLeaseArrangementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_CombinedRealEstateAndLeasesMember" abstract="true" name="CombinedRealEstateAndLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_OperatingEntityAxis" abstract="true" name="OperatingEntityAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ensg_OperatingEntityDomain" abstract="true" name="OperatingEntityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ThirdPartyOperatorsMember" abstract="true" name="ThirdPartyOperatorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_StandardBearerHealthcareREITIncMember" abstract="true" name="StandardBearerHealthcareREITIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_SeniorLivingOperationsMember" abstract="true" name="SeniorLivingOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_NumberOfSkilledNursingBeds" abstract="false" name="NumberOfSkilledNursingBeds" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_NumberOfSeniorLivingUnits" abstract="false" name="NumberOfSeniorLivingUnits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements" abstract="false" name="NumberOfFacilitiesUnderLongTermLeaseArrangements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" abstract="false" name="NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_NumberOfRealEstatePropertiesSharingLocations" abstract="false" name="NumberOfRealEstatePropertiesSharingLocations" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_NumberOfFinancingLeases" abstract="false" name="NumberOfFinancingLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_LesseeOperatingLeaseNumberOfRenewalOptions" abstract="false" name="LesseeOperatingLeaseNumberOfRenewalOptions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_AssembledOccupancyAcquiredMember" abstract="true" name="AssembledOccupancyAcquiredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_InsuranceCoverageLimitTypeAxis" abstract="true" name="InsuranceCoverageLimitTypeAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ensg_InsuranceCoverageLimitTypeDomain" abstract="true" name="InsuranceCoverageLimitTypeDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_SelfInsuranceRetentionPerClaimMember" abstract="true" name="SelfInsuranceRetentionPerClaimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember" abstract="true" name="SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_AggregateDeductibleMember" abstract="true" name="AggregateDeductibleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_PerOccurenceMember" abstract="true" name="PerOccurenceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_PerFacilityMember" abstract="true" name="PerFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_AggregateMember" abstract="true" name="AggregateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_LossSensitiveLimitPerClaimMember" abstract="true" name="LossSensitiveLimitPerClaimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_StopLossInsuranceLimitPerClaimMember" abstract="true" name="StopLossInsuranceLimitPerClaimMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_PayorAxis" abstract="true" name="PayorAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ensg_PayorDomain" abstract="true" name="PayorDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_HealthLiabilityInsuranceMember" abstract="true" name="HealthLiabilityInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_NonCaliforniaMember" abstract="true" name="NonCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_AllStatesExcludingColoradoMember" abstract="true" name="AllStatesExcludingColoradoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember" abstract="true" name="AllStatesExcludingCaliforniaTexasAndWashingtonMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_MedicaidAndMedicareMember" abstract="true" name="MedicaidAndMedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_FamilyFirstCoronavirusResponseActPaymentsReceived" abstract="false" name="FamilyFirstCoronavirusResponseActPaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_AccruedLiabilitiesStateReliefContractLiabilities" abstract="false" name="AccruedLiabilitiesStateReliefContractLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" abstract="false" name="RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_MedicareAcceleratedAndAdvancePaymentCARESACT" abstract="false" name="MedicareAcceleratedAndAdvancePaymentCARESACT" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_MedicaidMember" abstract="true" name="MedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_MedicaidSkilledMember" abstract="true" name="MedicaidSkilledMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ManagedCareMember" abstract="true" name="ManagedCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_PrivatePayAndOtherMember" abstract="true" name="PrivatePayAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_InsuranceSubsidiaryLongTermInvestmentsMember" abstract="true" name="InsuranceSubsidiaryLongTermInvestmentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_PreviousSubsidiariesMember" abstract="true" name="PreviousSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_SkilledNursingOperationsMember" abstract="true" name="SkilledNursingOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_CampusOperationsMember" abstract="true" name="CampusOperationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_A2024AcquiredPropertiesMember" abstract="true" name="A2024AcquiredPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_A2025AcquiredPropertiesMember" abstract="true" name="A2025AcquiredPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_A2023AcquiredPropertiesMember" abstract="true" name="A2023AcquiredPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_A2022AcquiredPropertiesMember" abstract="true" name="A2022AcquiredPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_CareTrustREITMember" abstract="true" name="CareTrustREITMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_LeaseArrangementAxis" abstract="true" name="LeaseArrangementAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ensg_LeaseArrangementDomain" abstract="true" name="LeaseArrangementDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_StandardBearerMasterLeasesMember" abstract="true" name="StandardBearerMasterLeasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ManagementServiceTotalMember" abstract="true" name="ManagementServiceTotalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_TruistBankMember" abstract="true" name="TruistBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_StandardBearerEquityPlanMember" abstract="true" name="StandardBearerEquityPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_NumberOfOperatingSubsidiaries" abstract="false" name="NumberOfOperatingSubsidiaries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_NumberOfLeaseArrangements" abstract="false" name="NumberOfLeaseArrangements" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" abstract="false" name="LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_PropertyManagementFeePercentFeeOfTotalRevenues" abstract="false" name="PropertyManagementFeePercentFeeOfTotalRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ensg_PropertyManagementFeePercentFeeOfFundsFromOperations" abstract="false" name="PropertyManagementFeePercentFeeOfFundsFromOperations" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ensg_NumberOfLongTermAcuteCareBeds" abstract="false" name="NumberOfLongTermAcuteCareBeds" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_BusinessAndAssetAcquisitionsAxis" abstract="true" name="BusinessAndAssetAcquisitionsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ensg_BusinessAndAssetAcquisitionsDomain" abstract="true" name="BusinessAndAssetAcquisitionsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_AcquiredPropertiesMember" abstract="true" name="AcquiredPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_LeasedAssetsAcquiredDuringPeriod" abstract="false" name="LeasedAssetsAcquiredDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" abstract="false" name="BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_SkilledServicesSegmentMember" abstract="true" name="SkilledServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_StandardBearerSegmentMember" abstract="true" name="StandardBearerSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_SegmentIncomeLoss" abstract="false" name="SegmentIncomeLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_EliminationsAndReconcilingItemsMember" abstract="true" name="EliminationsAndReconcilingItemsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_DepreciationAndAmortizationMember" abstract="true" name="DepreciationAndAmortizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_MedicareAndMedicaidLicensesMember" abstract="true" name="MedicareAndMedicaidLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_QualityAssuranceFee" abstract="false" name="QualityAssuranceFee" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_ResidentRefundsPayable" abstract="false" name="ResidentRefundsPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_CashHeldInTrustForResidents" abstract="false" name="CashHeldInTrustForResidents" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_DeferredTaxLiabilitiesStateTaxes" abstract="false" name="DeferredTaxLiabilitiesStateTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_DeferredTaxLiabilitiesRightOfUseAsset" abstract="false" name="DeferredTaxLiabilitiesRightOfUseAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_TotalNetDebtRatioMaximum" abstract="false" name="TotalNetDebtRatioMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" abstract="false" name="LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection" abstract="false" name="LongTermDebtThresholdForEBITDARatioIncreaseElection" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_TotalNetDebtRatioMaximumAfterIncreaseElection" abstract="false" name="TotalNetDebtRatioMaximumAfterIncreaseElection" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ensg_TotalNetDebtRatioMinimum" abstract="false" name="TotalNetDebtRatioMinimum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ensg_HUDInsuredMortgagesMember" abstract="true" name="HUDInsuredMortgagesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_A53PromissoryNoteMember" abstract="true" name="A53PromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_TwentyThreeSubsidiariesMember" abstract="true" name="TwentyThreeSubsidiariesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_PrepaymentFeePeriodAxis" abstract="true" name="PrepaymentFeePeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ensg_PrepaymentFeePeriodDomain" abstract="true" name="PrepaymentFeePeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_FirstThreeYearsMember" abstract="true" name="FirstThreeYearsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_InTheFourthYearMember" abstract="true" name="InTheFourthYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_YearsFiveThroughTenMember" abstract="true" name="YearsFiveThroughTenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_AfterYearTenMember" abstract="true" name="AfterYearTenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_PrepaymentPenalty" abstract="false" name="PrepaymentPenalty" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ensg_ReductionInPrepaymentPenalty" abstract="false" name="ReductionInPrepaymentPenalty" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ensg_A2022PlanMember" abstract="true" name="A2022PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_NumberOfStockIncentivePlans" abstract="false" name="NumberOfStockIncentivePlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" abstract="false" name="ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ensg_ExercisePriceRangeOneMember" abstract="true" name="ExercisePriceRangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeTwoMember" abstract="true" name="ExercisePriceRangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeThreeMember" abstract="true" name="ExercisePriceRangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeFourMember" abstract="true" name="ExercisePriceRangeFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeFiveMember" abstract="true" name="ExercisePriceRangeFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeSixMember" abstract="true" name="ExercisePriceRangeSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeSevenMember" abstract="true" name="ExercisePriceRangeSevenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeEightMember" abstract="true" name="ExercisePriceRangeEightMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeNineMember" abstract="true" name="ExercisePriceRangeNineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ExercisePriceRangeTenMember" abstract="true" name="ExercisePriceRangeTenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" abstract="false" name="ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_A2019LTIPlanMember" abstract="true" name="A2019LTIPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_OtherStockAwardsMember" abstract="true" name="OtherStockAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_EmployeeServiceShareBasedCompensationNonvestedAwards" abstract="false" name="EmployeeServiceShareBasedCompensationNonvestedAwards" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ensg_MasterLeaseAgreementsMember" abstract="true" name="MasterLeaseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_NewAndAmendedMasterLeaseAgreementMember" abstract="true" name="NewAndAmendedMasterLeaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_AmendedMasterLeaseAgreementMember" abstract="true" name="AmendedMasterLeaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_AmendedMasterLeaseAgreementOneMember" abstract="true" name="AmendedMasterLeaseAgreementOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_AmendedMasterLeaseAgreementTwoMember" abstract="true" name="AmendedMasterLeaseAgreementTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_NewMasterLeaseAgreementMember" abstract="true" name="NewMasterLeaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_TripleNetLeaseArrangementsMember" abstract="true" name="TripleNetLeaseArrangementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_PurchaseOptionMember" abstract="true" name="PurchaseOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_VariousLandlordsMember" abstract="true" name="VariousLandlordsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember" abstract="true" name="SkilledNursingOperationsAndSeniorLivingFacilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_OperationMember" abstract="true" name="OperationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_CostofSalesandGeneralandAdministrativeExpenseMember" abstract="true" name="CostofSalesandGeneralandAdministrativeExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_NumberOfMasterLeaseAgreements" abstract="false" name="NumberOfMasterLeaseAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_LesseeOperatingLeaseTermExtension" abstract="false" name="LesseeOperatingLeaseTermExtension" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" abstract="false" name="IncreaseDecreaseInOperatingLeaseRightOfUseAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_LesseeOperatingLeaseConsumerPriceIndex" abstract="false" name="LesseeOperatingLeaseConsumerPriceIndex" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="ensg_LesseeOperatingLeaseNumberOfLeases" abstract="false" name="LesseeOperatingLeaseNumberOfLeases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_SubsidiariesUnderMasterLeaseArrangement" abstract="false" name="SubsidiariesUnderMasterLeaseArrangement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_AccruedRentAdjustment" abstract="false" name="AccruedRentAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_LeasesToThirdPartyOperatorsMember" abstract="true" name="LeasesToThirdPartyOperatorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_SubleaseToThirdPartyOperatorsMember" abstract="true" name="SubleaseToThirdPartyOperatorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_ThePennantGroupInc.Member" abstract="true" name="ThePennantGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_ThirdPartyTenantsMember" abstract="true" name="ThirdPartyTenantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_InvestmentExpenseIncome" abstract="false" name="InvestmentExpenseIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember" abstract="true" name="GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews" abstract="false" name="IndependentOperatingSubsidiariesUnderMedicareProbeReviews" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ensg_May2024RepurchaseProgramMember" abstract="true" name="May2024RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_August2023RepurchaseProgramMember" abstract="true" name="August2023RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_July2022RepurchaseProgramMember" abstract="true" name="July2022RepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="ensg_Dr.AnnS.BlouinMember" abstract="true" name="Dr.AnnS.BlouinMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ensg_SuzanneD.SnapperMember" abstract="true" name="SuzanneD.SnapperMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>ensg-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9fad20ba-6b95-4b5d-8a1b-0cd604b824d6,g:826a027b-6e82-45d1-b4d8-5465cc4138ed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d0999c0b-3970-470a-8794-85c394753210" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9cee8368-7f06-40b1-b7dc-ca2d864bfbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d0999c0b-3970-470a-8794-85c394753210" xlink:to="loc_us-gaap_LiabilitiesCurrent_9cee8368-7f06-40b1-b7dc-ca2d864bfbdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount_bec3e7a3-15be-406f-a5c7-975c326a2c1d" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d0999c0b-3970-470a-8794-85c394753210" xlink:to="loc_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount_bec3e7a3-15be-406f-a5c7-975c326a2c1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e663d9ba-9d79-4e7c-bad6-f03ea1681f92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d0999c0b-3970-470a-8794-85c394753210" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e663d9ba-9d79-4e7c-bad6-f03ea1681f92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent_8bf5d253-473a-4308-8c64-4c5f515219f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d0999c0b-3970-470a-8794-85c394753210" xlink:to="loc_us-gaap_SelfInsuranceReserveNoncurrent_8bf5d253-473a-4308-8c64-4c5f515219f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredRentAndOtherLongTermLiabilities_6d29552c-5b9f-4b27-a3b4-ee670e8e068d" xlink:href="ensg-20241231.xsd#ensg_DeferredRentAndOtherLongTermLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_d0999c0b-3970-470a-8794-85c394753210" xlink:to="loc_ensg_DeferredRentAndOtherLongTermLiabilities_6d29552c-5b9f-4b27-a3b4-ee670e8e068d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RestrictedAndOtherAssetsNoncurrent_f5680688-a9c4-4c94-bc86-de812d12445a" xlink:href="ensg-20241231.xsd#ensg_RestrictedAndOtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:to="loc_ensg_RestrictedAndOtherAssetsNoncurrent_f5680688-a9c4-4c94-bc86-de812d12445a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_fa4b491b-15a1-4c99-9178-b8b4aafac4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_fa4b491b-15a1-4c99-9178-b8b4aafac4ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b4d190c-7519-41c6-9a94-b5017c7034d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_0b4d190c-7519-41c6-9a94-b5017c7034d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8201281d-178d-41e5-bce8-377a24e0d359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:to="loc_us-gaap_AssetsCurrent_8201281d-178d-41e5-bce8-377a24e0d359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceSubsidiaryDepositsAndInvestments_51444124-94dc-40f9-ac1f-0d2929eaa26f" xlink:href="ensg-20241231.xsd#ensg_InsuranceSubsidiaryDepositsAndInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:to="loc_ensg_InsuranceSubsidiaryDepositsAndInvestments_51444124-94dc-40f9-ac1f-0d2929eaa26f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3707d2ff-7dd2-48a1-bacd-7948c5a62340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:to="loc_us-gaap_Goodwill_3707d2ff-7dd2-48a1-bacd-7948c5a62340" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_327b9c11-d091-4d31-be80-a1f101719a78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_327b9c11-d091-4d31-be80-a1f101719a78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ec4ea278-2818-4efe-b6a1-72c2a6806876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_23e0ae3d-463b-417f-8e63-67137e56227e" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ec4ea278-2818-4efe-b6a1-72c2a6806876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_65a0d17c-b857-4940-ace8-87883b137eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_20631433-5253-45dd-8228-296f5be0d3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_65a0d17c-b857-4940-ace8-87883b137eb0" xlink:to="loc_us-gaap_StockholdersEquity_20631433-5253-45dd-8228-296f5be0d3c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_21a3e4db-6502-4dcf-addf-651e880a7f94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_65a0d17c-b857-4940-ace8-87883b137eb0" xlink:to="loc_us-gaap_MinorityInterest_21a3e4db-6502-4dcf-addf-651e880a7f94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_f7b6f896-9410-401b-a587-548e72edf63d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3a351b42-a918-4748-8574-fe9ee8713f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f7b6f896-9410-401b-a587-548e72edf63d" xlink:to="loc_us-gaap_Liabilities_3a351b42-a918-4748-8574-fe9ee8713f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_517bfbdd-91ed-40fd-8f89-b34442a052eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f7b6f896-9410-401b-a587-548e72edf63d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_517bfbdd-91ed-40fd-8f89-b34442a052eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6422139-be0e-45d1-b737-e80545f444d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_f7b6f896-9410-401b-a587-548e72edf63d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f6422139-be0e-45d1-b737-e80545f444d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_60acf363-2d9d-42f1-96f3-c6e0e32cfc8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_36b1f3f8-3986-42ff-88f0-08db78de03e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_60acf363-2d9d-42f1-96f3-c6e0e32cfc8b" xlink:to="loc_us-gaap_AccountsPayableCurrent_36b1f3f8-3986-42ff-88f0-08db78de03e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_513b7c2e-bbf2-477c-a100-8974ef0eadf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_60acf363-2d9d-42f1-96f3-c6e0e32cfc8b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_513b7c2e-bbf2-477c-a100-8974ef0eadf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f69e2c6e-7bda-405c-8433-dc7cced15d16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_60acf363-2d9d-42f1-96f3-c6e0e32cfc8b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f69e2c6e-7bda-405c-8433-dc7cced15d16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_6eb36e3a-33d5-46da-be01-86acff0e9cd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_60acf363-2d9d-42f1-96f3-c6e0e32cfc8b" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_6eb36e3a-33d5-46da-be01-86acff0e9cd8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5aef8d96-f312-4916-a2e2-063cc6a4ed76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_60acf363-2d9d-42f1-96f3-c6e0e32cfc8b" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_5aef8d96-f312-4916-a2e2-063cc6a4ed76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_16248558-cfb7-4026-a543-935dd675b601" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_60acf363-2d9d-42f1-96f3-c6e0e32cfc8b" xlink:to="loc_us-gaap_LongTermDebtCurrent_16248558-cfb7-4026-a543-935dd675b601" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_5257365e-c352-490f-b50e-9a675a43fefa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_fcdb59a1-0567-4c70-95b6-9458f2c3f159" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5257365e-c352-490f-b50e-9a675a43fefa" xlink:to="loc_us-gaap_ShortTermInvestments_fcdb59a1-0567-4c70-95b6-9458f2c3f159" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16b671fa-99f8-42ea-b241-ddb1e993ee63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5257365e-c352-490f-b50e-9a675a43fefa" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_16b671fa-99f8-42ea-b241-ddb1e993ee63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1176b496-5b72-4bad-87ad-1119ab8aae27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5257365e-c352-490f-b50e-9a675a43fefa" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1176b496-5b72-4bad-87ad-1119ab8aae27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_1aebd8c5-25ef-48aa-b1ca-dfd134aa0850" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_5257365e-c352-490f-b50e-9a675a43fefa" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_1aebd8c5-25ef-48aa-b1ca-dfd134aa0850" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7cfcb376-b1b4-4b70-861d-4d7a0339f51c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7eff5953-ab3d-4bb0-9989-71e7e9bd6a31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7cfcb376-b1b4-4b70-861d-4d7a0339f51c" xlink:to="loc_us-gaap_CommonStockValue_7eff5953-ab3d-4bb0-9989-71e7e9bd6a31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_96b35f6c-75f4-4a46-ade0-0ef3d3a1902d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7cfcb376-b1b4-4b70-861d-4d7a0339f51c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_96b35f6c-75f4-4a46-ade0-0ef3d3a1902d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_38b5d9bc-3e67-4079-b19d-2143269b6981" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7cfcb376-b1b4-4b70-861d-4d7a0339f51c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_38b5d9bc-3e67-4079-b19d-2143269b6981" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_cf92e035-5a3b-4515-be5b-1ae33f8fb326" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7cfcb376-b1b4-4b70-861d-4d7a0339f51c" xlink:to="loc_us-gaap_TreasuryStockCommonValue_cf92e035-5a3b-4515-be5b-1ae33f8fb326" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a8d20f9a-3c1b-49d2-a74a-fd75a9c33d81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_747d32ce-4c17-47d1-9822-6f54ef79da43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a8d20f9a-3c1b-49d2-a74a-fd75a9c33d81" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_747d32ce-4c17-47d1-9822-6f54ef79da43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0bb53d34-9cd7-47c1-b74b-8dd8c0b6e082" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a8d20f9a-3c1b-49d2-a74a-fd75a9c33d81" xlink:to="loc_us-gaap_OperatingIncomeLoss_0bb53d34-9cd7-47c1-b74b-8dd8c0b6e082" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_85b63573-a507-4675-ba47-db92c1ffe3dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3ea67af8-ea5e-4079-a513-7b1457bb8e88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_85b63573-a507-4675-ba47-db92c1ffe3dd" xlink:to="loc_us-gaap_ProfitLoss_3ea67af8-ea5e-4079-a513-7b1457bb8e88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_08f7959c-74e7-4ce6-991b-d3d8c4dc1b03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_85b63573-a507-4675-ba47-db92c1ffe3dd" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_08f7959c-74e7-4ce6-991b-d3d8c4dc1b03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_dd1a00f6-f089-4574-8692-ab4dd14b4cf7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_d762f64b-be8b-43e0-80ba-0689d62a57df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dd1a00f6-f089-4574-8692-ab4dd14b4cf7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_d762f64b-be8b-43e0-80ba-0689d62a57df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentCostOfServices_44077570-4662-45f5-ad6c-1aef13111d28" xlink:href="ensg-20241231.xsd#ensg_RentCostOfServices"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dd1a00f6-f089-4574-8692-ab4dd14b4cf7" xlink:to="loc_ensg_RentCostOfServices_44077570-4662-45f5-ad6c-1aef13111d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_d7a1872b-ff1d-409b-b6e8-44e962665c5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dd1a00f6-f089-4574-8692-ab4dd14b4cf7" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_d7a1872b-ff1d-409b-b6e8-44e962665c5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_ceba8c84-7978-4091-96ff-b1cf5ef2a08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_dd1a00f6-f089-4574-8692-ab4dd14b4cf7" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_ceba8c84-7978-4091-96ff-b1cf5ef2a08a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cdd5cb39-3059-4ce9-b333-d18c73f23979" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_108f763f-c492-4038-81c4-2381c0c8ef57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_cdd5cb39-3059-4ce9-b333-d18c73f23979" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_108f763f-c492-4038-81c4-2381c0c8ef57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a588ce4c-b5ea-479a-ba86-cd64e90b7cda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_cdd5cb39-3059-4ce9-b333-d18c73f23979" xlink:to="loc_us-gaap_CostsAndExpenses_a588ce4c-b5ea-479a-ba86-cd64e90b7cda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_3aed4b37-bcf9-43d4-bee4-c2ff62bceefa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_4e848ea4-531c-458a-b016-51f668eaf873" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3aed4b37-bcf9-43d4-bee4-c2ff62bceefa" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_4e848ea4-531c-458a-b016-51f668eaf873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_6c334fc3-b484-438d-9595-0559ecd079a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3aed4b37-bcf9-43d4-bee4-c2ff62bceefa" xlink:to="loc_us-gaap_InterestExpenseNonoperating_6c334fc3-b484-438d-9595-0559ecd079a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_b164df3d-7411-4c25-8706-a8e973cceab8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_3aed4b37-bcf9-43d4-bee4-c2ff62bceefa" xlink:to="loc_us-gaap_InvestmentIncomeInterest_b164df3d-7411-4c25-8706-a8e973cceab8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_2d1abf12-163c-48e1-a079-6342abc1fb5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c822bf48-282d-4ff7-8032-421c3a07a6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_2d1abf12-163c-48e1-a079-6342abc1fb5a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c822bf48-282d-4ff7-8032-421c3a07a6d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ad97d0f-6d7d-4124-81ca-605ca3d6b4e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_2d1abf12-163c-48e1-a079-6342abc1fb5a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8ad97d0f-6d7d-4124-81ca-605ca3d6b4e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_217b6797-bf56-44f3-b8c2-a5c2fd775e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PaymentsToAcquirePropertyAndEquipment_161ef1a1-f6c5-4f35-98cc-404653b2c19f" xlink:href="ensg-20241231.xsd#ensg_PaymentsToAcquirePropertyAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_217b6797-bf56-44f3-b8c2-a5c2fd775e1e" xlink:to="loc_ensg_PaymentsToAcquirePropertyAndEquipment_161ef1a1-f6c5-4f35-98cc-404653b2c19f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_843f3771-431e-4b90-ab6a-5f82c7501cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_217b6797-bf56-44f3-b8c2-a5c2fd775e1e" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_843f3771-431e-4b90-ab6a-5f82c7501cc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_5c79c7a8-606b-4772-a14f-dcf57f002fcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_217b6797-bf56-44f3-b8c2-a5c2fd775e1e" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_5c79c7a8-606b-4772-a14f-dcf57f002fcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_58504fb6-29f1-4e2a-af3a-f0d9b23a1337" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_217b6797-bf56-44f3-b8c2-a5c2fd775e1e" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_58504fb6-29f1-4e2a-af3a-f0d9b23a1337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_968ae3fd-88f8-4546-ace0-b5b0d2ad5767" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_217b6797-bf56-44f3-b8c2-a5c2fd775e1e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_968ae3fd-88f8-4546-ace0-b5b0d2ad5767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_a42be007-b304-45d9-a736-8c495990991c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_217b6797-bf56-44f3-b8c2-a5c2fd775e1e" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_a42be007-b304-45d9-a736-8c495990991c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_587cf2b2-4211-446c-a40e-e26e02cc7052" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromInsuranceSettlementInvestingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_217b6797-bf56-44f3-b8c2-a5c2fd775e1e" xlink:to="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_587cf2b2-4211-446c-a40e-e26e02cc7052" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_80f47a6d-5cfa-4b48-93b8-dd03bb4a3857" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_80f47a6d-5cfa-4b48-93b8-dd03bb4a3857" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_edc6aba5-031c-4674-a81f-59e71da600a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_edc6aba5-031c-4674-a81f-59e71da600a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_6f2a0be9-4849-4135-810c-638afe483e45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_PaymentsOfDividends_6f2a0be9-4849-4135-810c-638afe483e45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_a6c25b84-b898-4ed3-8a3e-4105efe0a922" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_a6c25b84-b898-4ed3-8a3e-4105efe0a922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c25e3da7-9bd7-4540-8338-90b7bb74e00a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_c25e3da7-9bd7-4540-8338-90b7bb74e00a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_502cc333-1a1d-43b3-8d1e-9f6e18a7d224" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_502cc333-1a1d-43b3-8d1e-9f6e18a7d224" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PurchasesOfNonControllingInterest_2d264c51-cdeb-430e-9c2a-f60451dab194" xlink:href="ensg-20241231.xsd#ensg_PurchasesOfNonControllingInterest"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_ensg_PurchasesOfNonControllingInterest_2d264c51-cdeb-430e-9c2a-f60451dab194" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a1e71c2d-7cbb-4409-9f30-c0c90b4f4f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a1e71c2d-7cbb-4409-9f30-c0c90b4f4f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans_79d5c5de-5a17-4be4-a166-ae4f494c94e2" xlink:href="ensg-20241231.xsd#ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans_79d5c5de-5a17-4be4-a166-ae4f494c94e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0d8c1cc0-fb2d-44aa-badf-122b8bdb62c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0d8c1cc0-fb2d-44aa-badf-122b8bdb62c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d39e9ba1-4aeb-4e0e-85ac-08538d4ab3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_98665b2d-61f6-4708-b757-e48bec75b062" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_d39e9ba1-4aeb-4e0e-85ac-08538d4ab3c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ec46250-4e04-4b00-9239-2a815e64a82a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e4b3f33-05ba-49f9-a654-b86693e28597" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ec46250-4e04-4b00-9239-2a815e64a82a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4e4b3f33-05ba-49f9-a654-b86693e28597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4cdd0f8-2d75-496f-8a5f-1454f122373f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ec46250-4e04-4b00-9239-2a815e64a82a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4cdd0f8-2d75-496f-8a5f-1454f122373f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90c7630b-9da3-41df-b23f-629c9202e7b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_7ec46250-4e04-4b00-9239-2a815e64a82a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90c7630b-9da3-41df-b23f-629c9202e7b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_6e93f67d-ef85-46d4-aae9-e9ff364a74af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_6e93f67d-ef85-46d4-aae9-e9ff364a74af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_fe405f99-a345-4d70-a997-2b84478a9359" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_fe405f99-a345-4d70-a997-2b84478a9359" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_26b5beda-36fb-4355-98fb-3cdbc89d2344" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_26b5beda-36fb-4355-98fb-3cdbc89d2344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_a99c5930-d4ef-48e7-b5ae-e7be1106cea3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_a99c5930-d4ef-48e7-b5ae-e7be1106cea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_6b66d55c-8879-4003-bc0a-a4b88fabb2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_6b66d55c-8879-4003-bc0a-a4b88fabb2d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4514d626-ed18-4797-987f-763b09c10a61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4514d626-ed18-4797-987f-763b09c10a61" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_4df2c551-40d1-4b49-a4b0-5bf349945191" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromInsuranceSettlementOperatingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_4df2c551-40d1-4b49-a4b0-5bf349945191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_da9cffe3-cfa1-4d6f-851c-0a46a05bb310" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_ProfitLoss_da9cffe3-cfa1-4d6f-851c-0a46a05bb310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets_947c0311-7c4f-4614-870f-ad1a1c648f12" xlink:href="ensg-20241231.xsd#ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets_947c0311-7c4f-4614-870f-ad1a1c648f12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ba39c345-ea14-4785-af97-dba3a2fb18fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ba39c345-ea14-4785-af97-dba3a2fb18fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_95ea18ea-eb4d-409d-a79c-6f6918b1ebfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_95ea18ea-eb4d-409d-a79c-6f6918b1ebfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_be86b164-77f3-4fa2-a52d-05efd09b1dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_be86b164-77f3-4fa2-a52d-05efd09b1dfc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d5985e9f-5e45-468b-a8f8-ec733a3c95ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d5985e9f-5e45-468b-a8f8-ec733a3c95ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NonCashLeaseExpense_845e70e1-2990-443f-8bef-63852e08be53" xlink:href="ensg-20241231.xsd#ensg_NonCashLeaseExpense"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_ensg_NonCashLeaseExpense_845e70e1-2990-443f-8bef-63852e08be53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_51483f3b-b29a-45a3-a652-8ea305e13fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_51483f3b-b29a-45a3-a652-8ea305e13fc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_fbcb071e-40eb-4db1-804a-c1e1de21dd37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_fbcb071e-40eb-4db1-804a-c1e1de21dd37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue_e2bf8211-a3c9-46a7-b0ac-bb5772485d68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue"/>
    <link:calculationArc order="17" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue_e2bf8211-a3c9-46a7-b0ac-bb5772485d68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2899beec-9cd1-47fc-ae9e-1b927397bd95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2899beec-9cd1-47fc-ae9e-1b927397bd95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInSelfInsuranceReserve_95ebe38e-e8e5-44c3-894e-a91e08f198f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSelfInsuranceReserve"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInSelfInsuranceReserve_95ebe38e-e8e5-44c3-894e-a91e08f198f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_13e8dfb2-fe80-46b9-b956-7a7784a273f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="20" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_13e8dfb2-fe80-46b9-b956-7a7784a273f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4db18355-06a5-4251-b857-b032170a2816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_ShareBasedCompensation_4db18355-06a5-4251-b857-b032170a2816" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_136e3e66-860e-4cc3-b72f-c010e48e0d74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_AssetImpairmentCharges_136e3e66-860e-4cc3-b72f-c010e48e0d74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_ac1280e4-3bbe-4540-9cce-00b3fdbeaeee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:calculationArc order="23" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_ac1280e4-3bbe-4540-9cce-00b3fdbeaeee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b8f02517-7937-42bd-98e2-7e97fc46cc12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:calculationArc order="24" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_b8f02517-7937-42bd-98e2-7e97fc46cc12" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct_3386c3c9-58bd-4f50-b3e6-3e822a55fd3f" xlink:href="ensg-20241231.xsd#ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct"/>
    <link:calculationArc order="25" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_19fc2336-0985-4f1d-9d81-af3869706904" xlink:to="loc_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct_3386c3c9-58bd-4f50-b3e6-3e822a55fd3f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e7b3ca6f-e334-4ced-8696-78dce55ea16c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_5bb37631-c52b-438b-b87f-7323db03dbe4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_e7b3ca6f-e334-4ced-8696-78dce55ea16c" xlink:to="loc_us-gaap_AccountsReceivableGross_5bb37631-c52b-438b-b87f-7323db03dbe4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_adc4dd5e-0dac-42c9-b6d4-4d0f2f9ac358" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_e7b3ca6f-e334-4ced-8696-78dce55ea16c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_adc4dd5e-0dac-42c9-b6d4-4d0f2f9ac358" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d155b854-9624-4f1c-8fb1-6357c6c92cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5d4ae62f-8695-4e59-9c7b-7ff19f18d891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d155b854-9624-4f1c-8fb1-6357c6c92cbe" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5d4ae62f-8695-4e59-9c7b-7ff19f18d891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c6a69112-6986-4988-97e1-a2881953a26d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d155b854-9624-4f1c-8fb1-6357c6c92cbe" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c6a69112-6986-4988-97e1-a2881953a26d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_72e61287-1807-4bd9-8f37-8b1833bdbe45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_64b018d1-9eda-42d7-8a7a-7c12cef6638f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_72e61287-1807-4bd9-8f37-8b1833bdbe45" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_64b018d1-9eda-42d7-8a7a-7c12cef6638f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c1c667a8-2ddb-4b4b-823a-678baa6d1d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_72e61287-1807-4bd9-8f37-8b1833bdbe45" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_c1c667a8-2ddb-4b4b-823a-678baa6d1d1c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPERATIONEXPANSIONSPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_c8234b02-20f6-4e0f-a441-a5d61cec8d87" xlink:href="ensg-20241231.xsd#ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_e2cb8613-596f-4e12-be81-a215b909f29b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_c8234b02-20f6-4e0f-a441-a5d61cec8d87" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_e2cb8613-596f-4e12-be81-a215b909f29b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_920e4acd-075f-4e95-af68-311672b31e66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_c8234b02-20f6-4e0f-a441-a5d61cec8d87" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_920e4acd-075f-4e95-af68-311672b31e66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_308b9e7a-5171-4d1c-ac3e-c3600b7b4ca7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_c8234b02-20f6-4e0f-a441-a5d61cec8d87" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_308b9e7a-5171-4d1c-ac3e-c3600b7b4ca7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasedAssetsAcquiredDuringPeriod_1e46d449-d3e1-46d7-bdcb-674c2ff3ca43" xlink:href="ensg-20241231.xsd#ensg_LeasedAssetsAcquiredDuringPeriod"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_c8234b02-20f6-4e0f-a441-a5d61cec8d87" xlink:to="loc_ensg_LeasedAssetsAcquiredDuringPeriod_1e46d449-d3e1-46d7-bdcb-674c2ff3ca43" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_440efe20-2578-4eda-8521-267f8686d4a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SegmentIncomeLoss_628d2a32-75ee-42fc-a63e-8cc1aa46a507" xlink:href="ensg-20241231.xsd#ensg_SegmentIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_440efe20-2578-4eda-8521-267f8686d4a4" xlink:to="loc_ensg_SegmentIncomeLoss_628d2a32-75ee-42fc-a63e-8cc1aa46a507" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ca988157-9ba2-4a1e-b1c5-5eaa14f1df70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_a86e2f8a-cb17-4462-8238-e6a5b5e5b46c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ca988157-9ba2-4a1e-b1c5-5eaa14f1df70" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_a86e2f8a-cb17-4462-8238-e6a5b5e5b46c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_07858bf2-0e52-49bc-9a8e-82612abca019" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_ca988157-9ba2-4a1e-b1c5-5eaa14f1df70" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_07858bf2-0e52-49bc-9a8e-82612abca019" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44e7a657-2913-4ee7-857f-b8bcf7593c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fc973e83-9ba0-480d-a21b-4618e2c9b826" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44e7a657-2913-4ee7-857f-b8bcf7593c7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_fc973e83-9ba0-480d-a21b-4618e2c9b826" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ccbacd93-67c1-4949-ab73-d947564de5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_44e7a657-2913-4ee7-857f-b8bcf7593c7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_ccbacd93-67c1-4949-ab73-d947564de5d8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7ca13410-0beb-4848-bbdf-dd628dbcd0c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_10a8a309-7f01-43c0-b160-2648a6b3da83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7ca13410-0beb-4848-bbdf-dd628dbcd0c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_10a8a309-7f01-43c0-b160-2648a6b3da83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3d36105e-b576-4e1d-87a2-70dff743fc88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7ca13410-0beb-4848-bbdf-dd628dbcd0c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3d36105e-b576-4e1d-87a2-70dff743fc88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0b50e3b0-9c35-4040-b406-5f3311f46643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7ca13410-0beb-4848-bbdf-dd628dbcd0c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_0b50e3b0-9c35-4040-b406-5f3311f46643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9d72a98b-a2f5-4ab7-bc65-01dcd3f84d56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7ca13410-0beb-4848-bbdf-dd628dbcd0c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_9d72a98b-a2f5-4ab7-bc65-01dcd3f84d56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_52c1b59b-5107-49e4-b26d-ebdfed0c038b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7ca13410-0beb-4848-bbdf-dd628dbcd0c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_52c1b59b-5107-49e4-b26d-ebdfed0c038b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_70a62a83-2d78-4f70-a542-39da31a7c26a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7ca13410-0beb-4848-bbdf-dd628dbcd0c0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_70a62a83-2d78-4f70-a542-39da31a7c26a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OTHERACCRUEDLIABILITIESDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_83c2430c-8fa0-4e0a-966d-d39dbcb5e495" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_83c2430c-8fa0-4e0a-966d-d39dbcb5e495" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_fcc44905-eac7-458a-9559-a7b9e35968ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_fcc44905-eac7-458a-9559-a7b9e35968ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ResidentRefundsPayable_ae27e7dc-a4d7-4eaf-b661-16375cf70b99" xlink:href="ensg-20241231.xsd#ensg_ResidentRefundsPayable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:to="loc_ensg_ResidentRefundsPayable_ae27e7dc-a4d7-4eaf-b661-16375cf70b99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_QualityAssuranceFee_e3f69a6d-4a31-4705-b33f-70d592eb9f28" xlink:href="ensg-20241231.xsd#ensg_QualityAssuranceFee"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:to="loc_ensg_QualityAssuranceFee_e3f69a6d-4a31-4705-b33f-70d592eb9f28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_22d136d2-3ce0-4e5b-8435-e561158b3f45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:to="loc_us-gaap_LitigationReserveCurrent_22d136d2-3ce0-4e5b-8435-e561158b3f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_7c51af74-5074-49a6-8147-f587a04d3150" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_7c51af74-5074-49a6-8147-f587a04d3150" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5cfd240c-1252-43de-9a4d-9684b18a3496" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5cfd240c-1252-43de-9a4d-9684b18a3496" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CashHeldInTrustForResidents_6f3b1c44-b57c-411a-b95c-e9e215cb37b3" xlink:href="ensg-20241231.xsd#ensg_CashHeldInTrustForResidents"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_08d9446b-90fd-4336-ada0-84e8866ef5de" xlink:to="loc_ensg_CashHeldInTrustForResidents_6f3b1c44-b57c-411a-b95c-e9e215cb37b3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXESExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5e3ab739-1d59-4ae4-b9ad-ae82762e30d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_78d32d40-9b61-47de-9117-7d48af8c4ece" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5e3ab739-1d59-4ae4-b9ad-ae82762e30d1" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_78d32d40-9b61-47de-9117-7d48af8c4ece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_0ad7cf5b-c74f-4cf5-85bb-357b867c6166" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_5e3ab739-1d59-4ae4-b9ad-ae82762e30d1" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_0ad7cf5b-c74f-4cf5-85bb-357b867c6166" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_bf8697a4-bb8c-4259-a782-6ddae2837174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a1f78ac5-ffc3-4ea6-bd9d-acb4130e8d95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_bf8697a4-bb8c-4259-a782-6ddae2837174" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_a1f78ac5-ffc3-4ea6-bd9d-acb4130e8d95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_95be13c6-967b-4fe5-91e9-95d0e0d6a205" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_bf8697a4-bb8c-4259-a782-6ddae2837174" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_95be13c6-967b-4fe5-91e9-95d0e0d6a205" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77fec051-bc09-40cb-8852-959a1faffc38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ae653c11-d71a-482b-88c1-5df83d57a24f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77fec051-bc09-40cb-8852-959a1faffc38" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_ae653c11-d71a-482b-88c1-5df83d57a24f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0438349c-d2b6-4c4b-b668-f5a015e9ff0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_77fec051-bc09-40cb-8852-959a1faffc38" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_0438349c-d2b6-4c4b-b668-f5a015e9ff0c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXESTaxRateDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb2ed9d-b968-4413-a32e-1396b17a0210" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_48324596-0fbb-45a5-b9cd-6069fafaa06b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb2ed9d-b968-4413-a32e-1396b17a0210" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_48324596-0fbb-45a5-b9cd-6069fafaa06b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f62bd8a0-d613-4e8b-a463-59c2a1562292" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb2ed9d-b968-4413-a32e-1396b17a0210" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f62bd8a0-d613-4e8b-a463-59c2a1562292" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_6e271758-47ca-498d-a0f2-2cc8d7b5adf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb2ed9d-b968-4413-a32e-1396b17a0210" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_6e271758-47ca-498d-a0f2-2cc8d7b5adf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_fd859705-403b-4018-83f4-750e02982e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb2ed9d-b968-4413-a32e-1396b17a0210" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_fd859705-403b-4018-83f4-750e02982e8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cf5c19a9-9045-488d-9e61-b53fc020b3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_7cb2ed9d-b968-4413-a32e-1396b17a0210" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cf5c19a9-9045-488d-9e61-b53fc020b3b9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b65d42a0-2403-4e7e-93bf-e66a975986e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_a3d24c81-95cf-4254-b4d2-0b9987e1869d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b65d42a0-2403-4e7e-93bf-e66a975986e5" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_a3d24c81-95cf-4254-b4d2-0b9987e1869d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_3995291a-1898-4b2c-8d51-51dc6fd51035" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_b65d42a0-2403-4e7e-93bf-e66a975986e5" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_3995291a-1898-4b2c-8d51-51dc6fd51035" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5c205842-9ca8-4d9c-bc14-27d20085e541" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_561f7e4f-3602-409c-8cfc-25455424911a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5c205842-9ca8-4d9c-bc14-27d20085e541" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_561f7e4f-3602-409c-8cfc-25455424911a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxLiabilitiesStateTaxes_9a7296bb-a8a6-434b-b075-cea0138ba111" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxLiabilitiesStateTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5c205842-9ca8-4d9c-bc14-27d20085e541" xlink:to="loc_ensg_DeferredTaxLiabilitiesStateTaxes_9a7296bb-a8a6-434b-b075-cea0138ba111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxLiabilitiesRightOfUseAsset_2084c681-a29f-48d4-9d2b-0109cc26b3aa" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5c205842-9ca8-4d9c-bc14-27d20085e541" xlink:to="loc_ensg_DeferredTaxLiabilitiesRightOfUseAsset_2084c681-a29f-48d4-9d2b-0109cc26b3aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_554c6027-7c57-4da2-85b2-00dff915c9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_5c205842-9ca8-4d9c-bc14-27d20085e541" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_554c6027-7c57-4da2-85b2-00dff915c9d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e881ca3c-c9e7-4b6e-ad97-73da95a457b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b27c1402-8bc0-4042-bdad-eb00c2832106" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e881ca3c-c9e7-4b6e-ad97-73da95a457b5" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_b27c1402-8bc0-4042-bdad-eb00c2832106" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_634dfc64-3225-45d3-9e97-9c11b053f95c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e881ca3c-c9e7-4b6e-ad97-73da95a457b5" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_634dfc64-3225-45d3-9e97-9c11b053f95c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_07eeb560-1d90-48b6-be2f-e28a5b7c6881" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0ca5b695-a1c8-4f84-93a7-c3ed0fbb94da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_07eeb560-1d90-48b6-be2f-e28a5b7c6881" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_0ca5b695-a1c8-4f84-93a7-c3ed0fbb94da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_a4fb3747-31ca-405b-b135-6b4a2e802ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_07eeb560-1d90-48b6-be2f-e28a5b7c6881" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_a4fb3747-31ca-405b-b135-6b4a2e802ed1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_4b3734c2-ed6c-4771-8d2f-e69e2bb3dbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_07eeb560-1d90-48b6-be2f-e28a5b7c6881" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_4b3734c2-ed6c-4771-8d2f-e69e2bb3dbf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_ca299c80-0a86-458c-8b30-ae6b57cc3458" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_07eeb560-1d90-48b6-be2f-e28a5b7c6881" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_ca299c80-0a86-458c-8b30-ae6b57cc3458" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability_6f2bceb8-f3c3-48d0-a684-6c24a85c6218" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_07eeb560-1d90-48b6-be2f-e28a5b7c6881" xlink:to="loc_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability_6f2bceb8-f3c3-48d0-a684-6c24a85c6218" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTScheduleofLongtermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_74ba23b0-44eb-42e8-a6f1-72634e80b995" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_96a53d59-c7b4-4c8a-88de-7f01d766c55a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_74ba23b0-44eb-42e8-a6f1-72634e80b995" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_96a53d59-c7b4-4c8a-88de-7f01d766c55a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d037b86f-b094-4ef2-a5f3-4c363a38e27f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_74ba23b0-44eb-42e8-a6f1-72634e80b995" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d037b86f-b094-4ef2-a5f3-4c363a38e27f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5e3662ff-2fc0-4c53-a932-e1c571651989" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_74ba23b0-44eb-42e8-a6f1-72634e80b995" xlink:to="loc_us-gaap_LongTermDebtCurrent_5e3662ff-2fc0-4c53-a932-e1c571651989" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTLongtermDebtArrangementsDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_c6de1ed9-8b3b-4e30-8981-3bf7d071d194" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4099a66e-d922-4139-b592-c1fe0874484f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c6de1ed9-8b3b-4e30-8981-3bf7d071d194" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_4099a66e-d922-4139-b592-c1fe0874484f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_eb1b0093-54a5-4902-83d0-d0ec1175fd6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c6de1ed9-8b3b-4e30-8981-3bf7d071d194" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_eb1b0093-54a5-4902-83d0-d0ec1175fd6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1a59c899-da11-49e4-968b-9a5ae8a57e0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c6de1ed9-8b3b-4e30-8981-3bf7d071d194" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_1a59c899-da11-49e4-968b-9a5ae8a57e0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a9b4d6cc-2ce0-48d6-9779-10fb6a587e37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c6de1ed9-8b3b-4e30-8981-3bf7d071d194" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a9b4d6cc-2ce0-48d6-9779-10fb6a587e37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_aece6e76-3876-46dd-9c8b-6e02e722612f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c6de1ed9-8b3b-4e30-8981-3bf7d071d194" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_aece6e76-3876-46dd-9c8b-6e02e722612f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_307388f9-5e52-447d-927b-94c175f21efe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_c6de1ed9-8b3b-4e30-8981-3bf7d071d194" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_307388f9-5e52-447d-927b-94c175f21efe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofOperatingLeaseExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_2382d00f-be0a-4bd1-b6c7-21b55692fc37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_79f3daf8-87db-4967-93c4-b0080bbf06fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2382d00f-be0a-4bd1-b6c7-21b55692fc37" xlink:to="loc_us-gaap_OperatingLeaseCost_79f3daf8-87db-4967-93c4-b0080bbf06fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_ee8e6573-a13e-40b8-957a-ccd3abc4919c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_2382d00f-be0a-4bd1-b6c7-21b55692fc37" xlink:to="loc_us-gaap_VariableLeaseCost_ee8e6573-a13e-40b8-957a-ccd3abc4919c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6f40a1fe-ebb3-47eb-81f3-c89b062c4ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_4d0a3e21-1a35-4cb1-b962-f4e31bac660c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6f40a1fe-ebb3-47eb-81f3-c89b062c4ee1" xlink:to="loc_us-gaap_OperatingLeaseLiability_4d0a3e21-1a35-4cb1-b962-f4e31bac660c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_73fd9669-c127-4874-9447-a3530ce63c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6f40a1fe-ebb3-47eb-81f3-c89b062c4ee1" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_73fd9669-c127-4874-9447-a3530ce63c5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_06eddad6-341c-4678-a6f0-b600ba452378" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_562e55bf-bfb2-42bc-847a-79c25be8ea31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_06eddad6-341c-4678-a6f0-b600ba452378" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_562e55bf-bfb2-42bc-847a-79c25be8ea31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d71c051e-8241-4296-9652-3395c22f6d46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_06eddad6-341c-4678-a6f0-b600ba452378" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d71c051e-8241-4296-9652-3395c22f6d46" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ed5ecfe9-0dd3-4752-9e9f-7e1431fc37b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_594a2a3c-5af1-4a50-adbc-57524af48db0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ed5ecfe9-0dd3-4752-9e9f-7e1431fc37b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_594a2a3c-5af1-4a50-adbc-57524af48db0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f9fabd7a-58ae-40c0-a816-2b255c863dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ed5ecfe9-0dd3-4752-9e9f-7e1431fc37b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f9fabd7a-58ae-40c0-a816-2b255c863dd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_212d1d4b-3129-422c-9118-1fab58d42ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ed5ecfe9-0dd3-4752-9e9f-7e1431fc37b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_212d1d4b-3129-422c-9118-1fab58d42ee1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_258c1496-3e54-4485-afdb-5432ccd5a4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ed5ecfe9-0dd3-4752-9e9f-7e1431fc37b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_258c1496-3e54-4485-afdb-5432ccd5a4dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e2c97aa0-bd1b-4632-bb1d-67184ba0461f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ed5ecfe9-0dd3-4752-9e9f-7e1431fc37b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_e2c97aa0-bd1b-4632-bb1d-67184ba0461f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_639991e3-8df3-478d-b756-3d9a8bd72dce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ed5ecfe9-0dd3-4752-9e9f-7e1431fc37b5" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_639991e3-8df3-478d-b756-3d9a8bd72dce" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofAnnualRentalIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_7833e2e6-a54e-4d2c-a1d2-0debddd2618e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_15f078ef-7e96-4bfb-b67a-f8b7146dc6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_7833e2e6-a54e-4d2c-a1d2-0debddd2618e" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_15f078ef-7e96-4bfb-b67a-f8b7146dc6bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_ae53e12a-24fc-4af4-b0ec-b8e589842e74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_7833e2e6-a54e-4d2c-a1d2-0debddd2618e" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_ae53e12a-24fc-4af4-b0ec-b8e589842e74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_3e65e90c-8c08-40fa-80e8-dc490f6367c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_7833e2e6-a54e-4d2c-a1d2-0debddd2618e" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_3e65e90c-8c08-40fa-80e8-dc490f6367c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_77b31203-c53f-4971-9e77-cb08a462a9d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_7833e2e6-a54e-4d2c-a1d2-0debddd2618e" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_77b31203-c53f-4971-9e77-cb08a462a9d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_4966602a-7e0d-4c0d-8c6a-dd12cba52852" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_7833e2e6-a54e-4d2c-a1d2-0debddd2618e" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_4966602a-7e0d-4c0d-8c6a-dd12cba52852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_a1929470-c853-421c-8a28-fd85ef22588d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_7833e2e6-a54e-4d2c-a1d2-0debddd2618e" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_a1929470-c853-421c-8a28-fd85ef22588d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_f240ea33-c7b5-4c78-adbd-878be7a4ca93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_a2ce441a-319e-4179-98cd-1f146eb5af41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SelfInsuranceReserve_f240ea33-c7b5-4c78-adbd-878be7a4ca93" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_a2ce441a-319e-4179-98cd-1f146eb5af41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent_f60b107e-e8fb-4543-b827-5c369a187b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_SelfInsuranceReserve_f240ea33-c7b5-4c78-adbd-878be7a4ca93" xlink:to="loc_us-gaap_SelfInsuranceReserveNoncurrent_f60b107e-e8fb-4543-b827-5c369a187b8d" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>ensg-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9fad20ba-6b95-4b5d-8a1b-0cd604b824d6,g:826a027b-6e82-45d1-b4d8-5465cc4138ed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e2e6da21-0456-47c2-be62-60857812e0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_StatementTable_e2e6da21-0456-47c2-be62-60857812e0aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a715f7d4-3700-41b3-a695-302f1b7fdf2e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e2e6da21-0456-47c2-be62-60857812e0aa" xlink:to="loc_srt_ProductOrServiceAxis_a715f7d4-3700-41b3-a695-302f1b7fdf2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a715f7d4-3700-41b3-a695-302f1b7fdf2e_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a715f7d4-3700-41b3-a695-302f1b7fdf2e" xlink:to="loc_srt_ProductsAndServicesDomain_a715f7d4-3700-41b3-a695-302f1b7fdf2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee07e19a-c055-4702-9f99-c5ff8960849d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a715f7d4-3700-41b3-a695-302f1b7fdf2e" xlink:to="loc_srt_ProductsAndServicesDomain_ee07e19a-c055-4702-9f99-c5ff8960849d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_cc040d00-5c85-49b8-8e27-2c834901bae8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ee07e19a-c055-4702-9f99-c5ff8960849d" xlink:to="loc_us-gaap_ServiceMember_cc040d00-5c85-49b8-8e27-2c834901bae8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember_1351064d-b1d2-48ff-a920-1982bc9cff81" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ee07e19a-c055-4702-9f99-c5ff8960849d" xlink:to="loc_ensg_RentalMember_1351064d-b1d2-48ff-a920-1982bc9cff81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0b163921-5bb7-41c8-9057-ee14903c4dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0b163921-5bb7-41c8-9057-ee14903c4dbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_054a0329-d83e-4e38-abf0-2ab59da647aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_054a0329-d83e-4e38-abf0-2ab59da647aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentCostOfServices_612d0dfb-8f4b-4a2d-85f9-15b9d59b493a" xlink:href="ensg-20241231.xsd#ensg_RentCostOfServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_ensg_RentCostOfServices_612d0dfb-8f4b-4a2d-85f9-15b9d59b493a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c6ec9527-3cb5-4b01-a2c3-b4d9bb60ac9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c6ec9527-3cb5-4b01-a2c3-b4d9bb60ac9a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2de5ecd0-f054-413c-8ded-acbe8c6e64ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2de5ecd0-f054-413c-8ded-acbe8c6e64ba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6bbab5a1-d75e-4bcc-b1a7-7932cf653e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_us-gaap_CostsAndExpenses_6bbab5a1-d75e-4bcc-b1a7-7932cf653e2d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_252c2436-4f49-42d8-9aca-ae224689d0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_OperatingIncomeLoss_252c2436-4f49-42d8-9aca-ae224689d0d8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_17fb9617-28a1-449c-a1f6-42008650aba5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:to="loc_us-gaap_InterestExpenseNonoperating_17fb9617-28a1-449c-a1f6-42008650aba5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e64d0fc3-97ba-4e1e-95e8-79f9df5240f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e64d0fc3-97ba-4e1e-95e8-79f9df5240f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b8b42fc5-7239-42fe-a9c2-d28c7df17aca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b8b42fc5-7239-42fe-a9c2-d28c7df17aca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b4d02be6-0cef-4912-ae41-7df500562e22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b4d02be6-0cef-4912-ae41-7df500562e22" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6d07d318-6ed3-4a93-bb8f-0a89df0b9519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6d07d318-6ed3-4a93-bb8f-0a89df0b9519" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bea9b8d3-2249-40c8-98fd-e4d5cd9e1391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bea9b8d3-2249-40c8-98fd-e4d5cd9e1391" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c9e0ba6d-9c49-4c6b-871b-e325cdbaa51b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_ProfitLoss_c9e0ba6d-9c49-4c6b-871b-e325cdbaa51b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_72ce64ab-178f-4e39-b641-904dddf2755a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_72ce64ab-178f-4e39-b641-904dddf2755a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3ebd5726-b8a5-4478-9caa-69b7df79ddc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_72ce64ab-178f-4e39-b641-904dddf2755a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3ebd5726-b8a5-4478-9caa-69b7df79ddc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bf209a92-0357-43c7-b350-c3196bae88f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_NetIncomeLoss_bf209a92-0357-43c7-b350-c3196bae88f7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_880d7bc0-1014-47e4-af3d-5c983826cadd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_EarningsPerShareAbstract_880d7bc0-1014-47e4-af3d-5c983826cadd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b4a89c4d-fff0-4dc2-9442-48561c4e7768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_880d7bc0-1014-47e4-af3d-5c983826cadd" xlink:to="loc_us-gaap_EarningsPerShareBasic_b4a89c4d-fff0-4dc2-9442-48561c4e7768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7d2c5762-f6dc-4da2-8e18-b26fd8dbd125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareAbstract_880d7bc0-1014-47e4-af3d-5c983826cadd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7d2c5762-f6dc-4da2-8e18-b26fd8dbd125" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bdc6cfb-1724-4116-8a64-fee7673b12a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bdc6cfb-1724-4116-8a64-fee7673b12a7" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ad571f5-151a-4b25-b9bb-293874ceded2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bdc6cfb-1724-4116-8a64-fee7673b12a7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ad571f5-151a-4b25-b9bb-293874ceded2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_720058b9-ae29-4f0a-ba35-57e6ecd1f5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bdc6cfb-1724-4116-8a64-fee7673b12a7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_720058b9-ae29-4f0a-ba35-57e6ecd1f5d7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_703634c7-f8eb-423a-8d48-708a0e93324a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_185aa575-0e97-453d-b2cf-f5eafb2316c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_703634c7-f8eb-423a-8d48-708a0e93324a" xlink:to="loc_us-gaap_StatementTable_185aa575-0e97-453d-b2cf-f5eafb2316c8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9c693aee-d70c-4b6c-90ac-07556746d7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_185aa575-0e97-453d-b2cf-f5eafb2316c8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9c693aee-d70c-4b6c-90ac-07556746d7ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9c693aee-d70c-4b6c-90ac-07556746d7ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9c693aee-d70c-4b6c-90ac-07556746d7ba" xlink:to="loc_us-gaap_EquityComponentDomain_9c693aee-d70c-4b6c-90ac-07556746d7ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9c693aee-d70c-4b6c-90ac-07556746d7ba" xlink:to="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a7ae7978-d856-4efe-a415-1e86e75106c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_CommonStockMember_a7ae7978-d856-4efe-a415-1e86e75106c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_dad88cf6-ee17-40a3-bc54-88cbe5161123" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_dad88cf6-ee17-40a3-bc54-88cbe5161123" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b23bb92d-92c3-41c1-93d2-5fa2a23962cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_RetainedEarningsMember_b23bb92d-92c3-41c1-93d2-5fa2a23962cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_f3b0698c-0d9a-4366-a4f8-4631bbfd4538" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_TreasuryStockCommonMember_f3b0698c-0d9a-4366-a4f8-4631bbfd4538" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ada2f7bd-3731-4f6e-a59d-3e689fc7902c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ada2f7bd-3731-4f6e-a59d-3e689fc7902c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_703634c7-f8eb-423a-8d48-708a0e93324a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d0015506-851d-4752-b28d-54494b3bb18b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d0015506-851d-4752-b28d-54494b3bb18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e933ce3b-bc37-44f3-9eaf-cd21780f964b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e933ce3b-bc37-44f3-9eaf-cd21780f964b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_45dcdf23-5e44-4db4-ab94-2a063b3dde52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_TreasuryStockCommonShares_45dcdf23-5e44-4db4-ab94-2a063b3dde52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b19b0867-02f0-445e-836d-2a638d0098de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b19b0867-02f0-445e-836d-2a638d0098de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c13cf20-65c0-46e2-baf7-2f12ddc6341d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c13cf20-65c0-46e2-baf7-2f12ddc6341d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_bf6bd992-c3a7-40cf-8f6b-bdbaefe8e15a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_bf6bd992-c3a7-40cf-8f6b-bdbaefe8e15a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d06d1c72-30b9-4f57-83eb-63b65f0faf88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d06d1c72-30b9-4f57-83eb-63b65f0faf88" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c6d96820-bdb0-4d96-a0f5-3b4bf22a2dea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c6d96820-bdb0-4d96-a0f5-3b4bf22a2dea" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23a24b2f-2dc6-45a9-8cb5-f1eeb1688791" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23a24b2f-2dc6-45a9-8cb5-f1eeb1688791" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_96ce1cdc-cf79-4fd5-8817-21dc0b60e7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Dividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_Dividends_96ce1cdc-cf79-4fd5-8817-21dc0b60e7d6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_44c635c0-bfbf-4d50-be11-53ee06b5460b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_44c635c0-bfbf-4d50-be11-53ee06b5460b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ee20efd3-f26d-4b7e-bcbc-e510b24c1e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ee20efd3-f26d-4b7e-bcbc-e510b24c1e5b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_79e4b8b0-7ad6-433f-b638-a8b44dfbb6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_79e4b8b0-7ad6-433f-b638-a8b44dfbb6ed" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_7199efa6-6301-4ada-ad20-8968269c2ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_7199efa6-6301-4ada-ad20-8968269c2ae0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_5a15cf4b-ae53-4883-8498-580025792edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_5a15cf4b-ae53-4883-8498-580025792edf" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec91d5b5-66a8-4a7a-9d88-9e047bdf116c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec91d5b5-66a8-4a7a-9d88-9e047bdf116c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cd73ec3a-8acd-447a-9fa7-1f4b5941d4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cd73ec3a-8acd-447a-9fa7-1f4b5941d4ab" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c6afdeb7-5602-4b9b-994c-190faf000618" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_NetIncomeLoss_c6afdeb7-5602-4b9b-994c-190faf000618" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e95e8cb6-8842-48f8-b95a-69fa945e6006" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6c93e1b0-79ac-4d52-8609-8dd0d20e8579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_2a992279-bc13-4a77-8b6c-5920fdf2915a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsAxis_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsAxis_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00_default" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_598d0ce1-ae50-423e-b642-21c039a45aac" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_598d0ce1-ae50-423e-b642-21c039a45aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CombinedRealEstateAndLeasesMember_19bdf1c4-d1ba-460c-a24e-79c3a74d7bbf" xlink:href="ensg-20241231.xsd#ensg_CombinedRealEstateAndLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_598d0ce1-ae50-423e-b642-21c039a45aac" xlink:to="loc_ensg_CombinedRealEstateAndLeasesMember_19bdf1c4-d1ba-460c-a24e-79c3a74d7bbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_ensg_OperatingEntityAxis_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a_default" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_OperatingEntityAxis_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a" xlink:to="loc_ensg_OperatingEntityDomain_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_f9abc105-f01c-4984-b3f1-53b39b80297c" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_OperatingEntityAxis_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a" xlink:to="loc_ensg_OperatingEntityDomain_f9abc105-f01c-4984-b3f1-53b39b80297c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_4bc9d53c-d4ae-4fe5-a71d-21f25d1f6e03" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_OperatingEntityDomain_f9abc105-f01c-4984-b3f1-53b39b80297c" xlink:to="loc_srt_SubsidiariesMember_4bc9d53c-d4ae-4fe5-a71d-21f25d1f6e03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThirdPartyOperatorsMember_ada78d8f-59b0-4a00-ae90-509180a62d7c" xlink:href="ensg-20241231.xsd#ensg_ThirdPartyOperatorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_OperatingEntityDomain_f9abc105-f01c-4984-b3f1-53b39b80297c" xlink:to="loc_ensg_ThirdPartyOperatorsMember_ada78d8f-59b0-4a00-ae90-509180a62d7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ea8afa1b-a052-4136-8b06-62ec420cf4f1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_dei_LegalEntityAxis_ea8afa1b-a052-4136-8b06-62ec420cf4f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ea8afa1b-a052-4136-8b06-62ec420cf4f1_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ea8afa1b-a052-4136-8b06-62ec420cf4f1" xlink:to="loc_dei_EntityDomain_ea8afa1b-a052-4136-8b06-62ec420cf4f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_00a181b7-1f2d-49ef-b24c-48dbcbe76e44" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ea8afa1b-a052-4136-8b06-62ec420cf4f1" xlink:to="loc_dei_EntityDomain_00a181b7-1f2d-49ef-b24c-48dbcbe76e44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember_f2ccbdb9-62c8-4fe5-82b2-b3e624337fb3" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_00a181b7-1f2d-49ef-b24c-48dbcbe76e44" xlink:to="loc_ensg_StandardBearerHealthcareREITIncMember_f2ccbdb9-62c8-4fe5-82b2-b3e624337fb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e000272b-280e-45a3-9270-d8d122f84d45" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e000272b-280e-45a3-9270-d8d122f84d45" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_e000272b-280e-45a3-9270-d8d122f84d45_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e000272b-280e-45a3-9270-d8d122f84d45" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_e000272b-280e-45a3-9270-d8d122f84d45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_21015ed5-b640-4ede-bcf9-36d9fba4729d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e000272b-280e-45a3-9270-d8d122f84d45" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_21015ed5-b640-4ede-bcf9-36d9fba4729d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_ea2db800-a42c-42fb-bf38-8afcf75b24c5" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_21015ed5-b640-4ede-bcf9-36d9fba4729d" xlink:to="loc_ensg_SeniorLivingOperationsMember_ea2db800-a42c-42fb-bf38-8afcf75b24c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_ad742b1f-d35a-4f4c-b729-52deb8777d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_ad742b1f-d35a-4f4c-b729-52deb8777d0f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSkilledNursingBeds_77edd111-3a2b-44db-b589-2fe138bebc73" xlink:href="ensg-20241231.xsd#ensg_NumberOfSkilledNursingBeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfSkilledNursingBeds_77edd111-3a2b-44db-b589-2fe138bebc73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSeniorLivingUnits_ddc19c9c-8278-49a4-9497-c28a204c4b36" xlink:href="ensg-20241231.xsd#ensg_NumberOfSeniorLivingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfSeniorLivingUnits_ddc19c9c-8278-49a4-9497-c28a204c4b36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements_7b50b33f-e5b1-4f08-ba95-2cbd6c2ad97b" xlink:href="ensg-20241231.xsd#ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements_7b50b33f-e5b1-4f08-ba95-2cbd6c2ad97b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase_06e5a340-cea5-4d20-8e7c-42dcc00e5c76" xlink:href="ensg-20241231.xsd#ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase_06e5a340-cea5-4d20-8e7c-42dcc00e5c76" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfRealEstatePropertiesSharingLocations_7003c0f2-45d2-4b15-8925-7fefe800c5fc" xlink:href="ensg-20241231.xsd#ensg_NumberOfRealEstatePropertiesSharingLocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfRealEstatePropertiesSharingLocations_7003c0f2-45d2-4b15-8925-7fefe800c5fc" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1a525316-8142-4157-a45f-f8f981bdb395" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6ceb4e5-0022-4d99-942d-8a51169fa6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1a525316-8142-4157-a45f-f8f981bdb395" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6ceb4e5-0022-4d99-942d-8a51169fa6a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cedb8b74-75b7-42c2-8eab-f63076a5e0de" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6ceb4e5-0022-4d99-942d-8a51169fa6a1" xlink:to="loc_srt_RangeAxis_cedb8b74-75b7-42c2-8eab-f63076a5e0de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cedb8b74-75b7-42c2-8eab-f63076a5e0de_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cedb8b74-75b7-42c2-8eab-f63076a5e0de" xlink:to="loc_srt_RangeMember_cedb8b74-75b7-42c2-8eab-f63076a5e0de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bac91d7b-3a30-4e06-bd1d-40fbca42004a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cedb8b74-75b7-42c2-8eab-f63076a5e0de" xlink:to="loc_srt_RangeMember_bac91d7b-3a30-4e06-bd1d-40fbca42004a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9d5dc7b-7abb-46ba-be75-2889eae1eed2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bac91d7b-3a30-4e06-bd1d-40fbca42004a" xlink:to="loc_srt_MinimumMember_c9d5dc7b-7abb-46ba-be75-2889eae1eed2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dcd5979c-4ad8-445d-a999-aae649fac6a6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_bac91d7b-3a30-4e06-bd1d-40fbca42004a" xlink:to="loc_srt_MaximumMember_dcd5979c-4ad8-445d-a999-aae649fac6a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_60e716e3-68c9-4187-b3b8-1ab4439e5a82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1a525316-8142-4157-a45f-f8f981bdb395" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_60e716e3-68c9-4187-b3b8-1ab4439e5a82" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_d67ce46a-997d-47ed-865c-8c1f76ca3087" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_d67ce46a-997d-47ed-865c-8c1f76ca3087" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc28803e-1abf-453d-9cb8-9d14baccf242" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_d67ce46a-997d-47ed-865c-8c1f76ca3087" xlink:to="loc_srt_RangeAxis_fc28803e-1abf-453d-9cb8-9d14baccf242" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc28803e-1abf-453d-9cb8-9d14baccf242_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fc28803e-1abf-453d-9cb8-9d14baccf242" xlink:to="loc_srt_RangeMember_fc28803e-1abf-453d-9cb8-9d14baccf242_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b66932e-9c5d-424c-b727-c1ef59139c9b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fc28803e-1abf-453d-9cb8-9d14baccf242" xlink:to="loc_srt_RangeMember_3b66932e-9c5d-424c-b727-c1ef59139c9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_555226b3-f804-4e54-9bd7-44927ea65ceb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3b66932e-9c5d-424c-b727-c1ef59139c9b" xlink:to="loc_srt_MinimumMember_555226b3-f804-4e54-9bd7-44927ea65ceb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2beaf68d-8bf0-4256-a003-ec823f205f1f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3b66932e-9c5d-424c-b727-c1ef59139c9b" xlink:to="loc_srt_MaximumMember_2beaf68d-8bf0-4256-a003-ec823f205f1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFinancingLeases_367d79d5-4bb8-4cd2-b1f7-a9ce75b3d382" xlink:href="ensg-20241231.xsd#ensg_NumberOfFinancingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_ensg_NumberOfFinancingLeases_367d79d5-4bb8-4cd2-b1f7-a9ce75b3d382" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_2883fe35-ec6e-4561-bfd1-7b8952180f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_2883fe35-ec6e-4561-bfd1-7b8952180f6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseNumberOfRenewalOptions_87e79571-d3f5-4228-a819-8a5551639138" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_ensg_LesseeOperatingLeaseNumberOfRenewalOptions_87e79571-d3f5-4228-a819-8a5551639138" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_dcecc8f9-52af-43b0-8e14-081d0cd46598" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_dcecc8f9-52af-43b0-8e14-081d0cd46598" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9bec6b49-b6c3-4bb4-9dcb-3db1421e7234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9bec6b49-b6c3-4bb4-9dcb-3db1421e7234" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c639ee96-1ae8-41f1-ab08-04f8263f6916" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c639ee96-1ae8-41f1-ab08-04f8263f6916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c639ee96-1ae8-41f1-ab08-04f8263f6916_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c639ee96-1ae8-41f1-ab08-04f8263f6916" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c639ee96-1ae8-41f1-ab08-04f8263f6916_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c639ee96-1ae8-41f1-ab08-04f8263f6916" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AssembledOccupancyAcquiredMember_503a6a61-2d30-432a-9bf6-d321e01b6d0d" xlink:href="ensg-20241231.xsd#ensg_AssembledOccupancyAcquiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:to="loc_ensg_AssembledOccupancyAcquiredMember_503a6a61-2d30-432a-9bf6-d321e01b6d0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_25399392-2285-4839-937e-94ddfcc14f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:to="loc_us-gaap_TradeNamesMember_25399392-2285-4839-937e-94ddfcc14f1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0d40223b-518a-405f-87bf-3dd9d5da81e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0d40223b-518a-405f-87bf-3dd9d5da81e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_de74d035-00a0-43c1-9bf8-90b868fa9d75" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:to="loc_srt_RangeAxis_de74d035-00a0-43c1-9bf8-90b868fa9d75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de74d035-00a0-43c1-9bf8-90b868fa9d75_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_de74d035-00a0-43c1-9bf8-90b868fa9d75" xlink:to="loc_srt_RangeMember_de74d035-00a0-43c1-9bf8-90b868fa9d75_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c5b26098-f60a-4e33-9069-c29ce1abecc3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_de74d035-00a0-43c1-9bf8-90b868fa9d75" xlink:to="loc_srt_RangeMember_c5b26098-f60a-4e33-9069-c29ce1abecc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a4fca424-75d9-4ab6-960f-4b782963904b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c5b26098-f60a-4e33-9069-c29ce1abecc3" xlink:to="loc_srt_MinimumMember_a4fca424-75d9-4ab6-960f-4b782963904b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d095b38f-bd3b-428f-b168-3a8c8ebedd1c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c5b26098-f60a-4e33-9069-c29ce1abecc3" xlink:to="loc_srt_MaximumMember_d095b38f-bd3b-428f-b168-3a8c8ebedd1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e2a4fbbf-9c61-4271-a497-4e64e89b7046" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9bec6b49-b6c3-4bb4-9dcb-3db1421e7234" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e2a4fbbf-9c61-4271-a497-4e64e89b7046" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_716aa36d-6146-4439-9c7c-db41cc4e7f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_716aa36d-6146-4439-9c7c-db41cc4e7f2e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceCoverageLimitTypeAxis_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd" xlink:href="ensg-20241231.xsd#ensg_InsuranceCoverageLimitTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_ensg_InsuranceCoverageLimitTypeAxis_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceCoverageLimitTypeDomain_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd_default" xlink:href="ensg-20241231.xsd#ensg_InsuranceCoverageLimitTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_InsuranceCoverageLimitTypeAxis_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd" xlink:to="loc_ensg_InsuranceCoverageLimitTypeDomain_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:href="ensg-20241231.xsd#ensg_InsuranceCoverageLimitTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_InsuranceCoverageLimitTypeAxis_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd" xlink:to="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SelfInsuranceRetentionPerClaimMember_fe21c93f-666d-41cd-ac8b-b5b967dc716a" xlink:href="ensg-20241231.xsd#ensg_SelfInsuranceRetentionPerClaimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_SelfInsuranceRetentionPerClaimMember_fe21c93f-666d-41cd-ac8b-b5b967dc716a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember_10109caa-e3fd-4ffe-b9c0-ef3c5a768886" xlink:href="ensg-20241231.xsd#ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_SelfInsuranceRetentionPerClaimMember_fe21c93f-666d-41cd-ac8b-b5b967dc716a" xlink:to="loc_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember_10109caa-e3fd-4ffe-b9c0-ef3c5a768886" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AggregateDeductibleMember_c005e0ea-e711-447a-b6ba-314235fa687d" xlink:href="ensg-20241231.xsd#ensg_AggregateDeductibleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_AggregateDeductibleMember_c005e0ea-e711-447a-b6ba-314235fa687d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PerOccurenceMember_436554f5-5419-4662-b507-5d3e668336b1" xlink:href="ensg-20241231.xsd#ensg_PerOccurenceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_PerOccurenceMember_436554f5-5419-4662-b507-5d3e668336b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PerFacilityMember_46e622a7-850c-47bf-ac28-90f69d276d90" xlink:href="ensg-20241231.xsd#ensg_PerFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_PerFacilityMember_46e622a7-850c-47bf-ac28-90f69d276d90" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AggregateMember_ea267014-63e4-471f-ad17-b776b2dd682e" xlink:href="ensg-20241231.xsd#ensg_AggregateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_AggregateMember_ea267014-63e4-471f-ad17-b776b2dd682e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LossSensitiveLimitPerClaimMember_26115396-fe46-4749-b87d-7ae80c4e2a65" xlink:href="ensg-20241231.xsd#ensg_LossSensitiveLimitPerClaimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_LossSensitiveLimitPerClaimMember_26115396-fe46-4749-b87d-7ae80c4e2a65" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StopLossInsuranceLimitPerClaimMember_52506c2a-0f8b-46e3-89fc-b7d8f04e7d02" xlink:href="ensg-20241231.xsd#ensg_StopLossInsuranceLimitPerClaimMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_StopLossInsuranceLimitPerClaimMember_52506c2a-0f8b-46e3-89fc-b7d8f04e7d02" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PayorAxis_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65" xlink:href="ensg-20241231.xsd#ensg_PayorAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_ensg_PayorAxis_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PayorDomain_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65_default" xlink:href="ensg-20241231.xsd#ensg_PayorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_PayorAxis_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65" xlink:to="loc_ensg_PayorDomain_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PayorDomain_baa815eb-8d6f-4cd3-b741-c790e1c28a06" xlink:href="ensg-20241231.xsd#ensg_PayorDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_PayorAxis_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65" xlink:to="loc_ensg_PayorDomain_baa815eb-8d6f-4cd3-b741-c790e1c28a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8ca475db-ae9f-4a83-9ca8-4f77fdb605e5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_PayorDomain_baa815eb-8d6f-4cd3-b741-c790e1c28a06" xlink:to="loc_srt_ParentCompanyMember_8ca475db-ae9f-4a83-9ca8-4f77fdb605e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_naics_ZZ524292_afb39939-6acf-4fe8-8dfc-ffe6b099f4cb" xlink:href="https://xbrl.sec.gov/naics/2024/naics-2024.xsd#naics_ZZ524292"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_PayorDomain_baa815eb-8d6f-4cd3-b741-c790e1c28a06" xlink:to="loc_naics_ZZ524292_afb39939-6acf-4fe8-8dfc-ffe6b099f4cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_srt_ProductOrServiceAxis_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb" xlink:to="loc_srt_ProductsAndServicesDomain_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb" xlink:to="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralLiabilityMember_38694ceb-b786-4114-9039-c65fa7af82b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:to="loc_us-gaap_GeneralLiabilityMember_38694ceb-b786-4114-9039-c65fa7af82b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationInsuranceMember_438776ac-0cb3-4382-9691-82f7fd408332" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:to="loc_us-gaap_WorkersCompensationInsuranceMember_438776ac-0cb3-4382-9691-82f7fd408332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_HealthLiabilityInsuranceMember_8e1b5e99-6274-4ede-b5cf-88feecee7944" xlink:href="ensg-20241231.xsd#ensg_HealthLiabilityInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:to="loc_ensg_HealthLiabilityInsuranceMember_8e1b5e99-6274-4ede-b5cf-88feecee7944" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_58e5946d-5afe-42f4-8ab3-610cab171240" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_srt_StatementGeographicalAxis_58e5946d-5afe-42f4-8ab3-610cab171240" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_58e5946d-5afe-42f4-8ab3-610cab171240_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_58e5946d-5afe-42f4-8ab3-610cab171240" xlink:to="loc_srt_SegmentGeographicalDomain_58e5946d-5afe-42f4-8ab3-610cab171240_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_58e5946d-5afe-42f4-8ab3-610cab171240" xlink:to="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_7cdc50e4-fcf0-4eb5-91b1-692aead59adb" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_stpr_CA_7cdc50e4-fcf0-4eb5-91b1-692aead59adb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NonCaliforniaMember_3bb670e0-3cc2-453d-a500-0c1f33bcf977" xlink:href="ensg-20241231.xsd#ensg_NonCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_ensg_NonCaliforniaMember_3bb670e0-3cc2-453d-a500-0c1f33bcf977" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AllStatesExcludingColoradoMember_9f501a8b-8efd-48bc-9f4d-0669380ff3d2" xlink:href="ensg-20241231.xsd#ensg_AllStatesExcludingColoradoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_ensg_AllStatesExcludingColoradoMember_9f501a8b-8efd-48bc-9f4d-0669380ff3d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO_28e31a1b-06c7-45b4-88f8-38cae6b6aa28" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_stpr_CO_28e31a1b-06c7-45b4-88f8-38cae6b6aa28" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_d88f868f-ad1f-4abe-8c6a-a3c242de009f" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_stpr_TX_d88f868f-ad1f-4abe-8c6a-a3c242de009f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember_a8c5643a-3a31-45f8-b820-083d62cafffb" xlink:href="ensg-20241231.xsd#ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember_a8c5643a-3a31-45f8-b820-083d62cafffb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA_625dfb7f-9fda-4169-a1ea-f5cb56d56a3f" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_WA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_stpr_WA_625dfb7f-9fda-4169-a1ea-f5cb56d56a3f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fdcd90dd-c6c2-420a-8553-696feffd3dab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fdcd90dd-c6c2-420a-8553-696feffd3dab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fdcd90dd-c6c2-420a-8553-696feffd3dab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdcd90dd-c6c2-420a-8553-696feffd3dab" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fdcd90dd-c6c2-420a-8553-696feffd3dab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2731e16e-5dd4-4e09-9346-9ac22848088c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdcd90dd-c6c2-420a-8553-696feffd3dab" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2731e16e-5dd4-4e09-9346-9ac22848088c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_098d0eaa-c0bb-4d37-9e74-b5f4ffb07198" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2731e16e-5dd4-4e09-9346-9ac22848088c" xlink:to="loc_us-gaap_SubsequentEventMember_098d0eaa-c0bb-4d37-9e74-b5f4ffb07198" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_323e729e-74c5-4d6f-876a-25ca587cf130" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_716aa36d-6146-4439-9c7c-db41cc4e7f2e" xlink:to="loc_us-gaap_SelfInsuranceReserve_323e729e-74c5-4d6f-876a-25ca587cf130" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eb64e9f5-3750-4576-b7f8-c0693ab2bd34" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_srt_ProductOrServiceAxis_eb64e9f5-3750-4576-b7f8-c0693ab2bd34" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eb64e9f5-3750-4576-b7f8-c0693ab2bd34_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_eb64e9f5-3750-4576-b7f8-c0693ab2bd34" xlink:to="loc_srt_ProductsAndServicesDomain_eb64e9f5-3750-4576-b7f8-c0693ab2bd34_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_306eed80-b71d-4fa8-b12b-ef8f280f3c70" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_eb64e9f5-3750-4576-b7f8-c0693ab2bd34" xlink:to="loc_srt_ProductsAndServicesDomain_306eed80-b71d-4fa8-b12b-ef8f280f3c70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_7b784bc2-6666-4bf6-9b66-7894357444d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_306eed80-b71d-4fa8-b12b-ef8f280f3c70" xlink:to="loc_us-gaap_ServiceMember_7b784bc2-6666-4bf6-9b66-7894357444d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember_b8804748-270d-4c82-aaf4-89300a1e895c" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_306eed80-b71d-4fa8-b12b-ef8f280f3c70" xlink:to="loc_ensg_RentalMember_b8804748-270d-4c82-aaf4-89300a1e895c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54f3c8bf-ba83-47d5-ad54-1189e0fbb5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54f3c8bf-ba83-47d5-ad54-1189e0fbb5d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_a7fa636b-c3d4-40a2-93f2-ea44c8165659" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54f3c8bf-ba83-47d5-ad54-1189e0fbb5d7" xlink:to="loc_us-gaap_SalesRevenueNetMember_a7fa636b-c3d4-40a2-93f2-ea44c8165659" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_777b9297-f806-4f5d-b84a-02c5734a9347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_777b9297-f806-4f5d-b84a-02c5734a9347" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_777b9297-f806-4f5d-b84a-02c5734a9347_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_777b9297-f806-4f5d-b84a-02c5734a9347" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_777b9297-f806-4f5d-b84a-02c5734a9347_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c2f63c7a-0da6-49ab-a4e5-9cfba018bc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_777b9297-f806-4f5d-b84a-02c5734a9347" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c2f63c7a-0da6-49ab-a4e5-9cfba018bc9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_9f655c26-18f0-4a11-9e7f-2e237eecd045" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c2f63c7a-0da6-49ab-a4e5-9cfba018bc9a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_9f655c26-18f0-4a11-9e7f-2e237eecd045" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_1f5b2f4c-016a-4a21-96b4-573a8a764d0a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_srt_MajorCustomersAxis_1f5b2f4c-016a-4a21-96b4-573a8a764d0a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1f5b2f4c-016a-4a21-96b4-573a8a764d0a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_1f5b2f4c-016a-4a21-96b4-573a8a764d0a" xlink:to="loc_srt_NameOfMajorCustomerDomain_1f5b2f4c-016a-4a21-96b4-573a8a764d0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_22da3340-ebae-47d8-8879-2fa19d5e8aac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_1f5b2f4c-016a-4a21-96b4-573a8a764d0a" xlink:to="loc_srt_NameOfMajorCustomerDomain_22da3340-ebae-47d8-8879-2fa19d5e8aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember_72e5efb1-a85a-47bf-b213-b5399ad44603" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_22da3340-ebae-47d8-8879-2fa19d5e8aac" xlink:to="loc_ensg_MedicaidAndMedicareMember_72e5efb1-a85a-47bf-b213-b5399ad44603" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8e11e220-6547-44b4-ba48-c7a6e7d7bc96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8e11e220-6547-44b4-ba48-c7a6e7d7bc96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c01fd1b-2880-4f50-a842-6e3d88a5f689" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c01fd1b-2880-4f50-a842-6e3d88a5f689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived_f886fc0c-6271-4b98-897b-7bb78952be21" xlink:href="ensg-20241231.xsd#ensg_FamilyFirstCoronavirusResponseActPaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived_f886fc0c-6271-4b98-897b-7bb78952be21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AccruedLiabilitiesStateReliefContractLiabilities_35458b66-6d4b-41d4-863f-00aae7885942" xlink:href="ensg-20241231.xsd#ensg_AccruedLiabilitiesStateReliefContractLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_ensg_AccruedLiabilitiesStateReliefContractLiabilities_35458b66-6d4b-41d4-863f-00aae7885942" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized_5afaca21-2cd2-4efe-9e49-dc0bf41dc2c4" xlink:href="ensg-20241231.xsd#ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized_5afaca21-2cd2-4efe-9e49-dc0bf41dc2c4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT_319c77f8-9a8d-4f61-9a1f-63fe11d6c730" xlink:href="ensg-20241231.xsd#ensg_MedicareAcceleratedAndAdvancePaymentCARESACT"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT_319c77f8-9a8d-4f61-9a1f-63fe11d6c730" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2a0b174e-019d-4444-842b-1d48cc96090e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2a0b174e-019d-4444-842b-1d48cc96090e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a51a2435-1dbc-406b-bb23-acdd93927a26" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_srt_ProductOrServiceAxis_a51a2435-1dbc-406b-bb23-acdd93927a26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a51a2435-1dbc-406b-bb23-acdd93927a26_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a51a2435-1dbc-406b-bb23-acdd93927a26" xlink:to="loc_srt_ProductsAndServicesDomain_a51a2435-1dbc-406b-bb23-acdd93927a26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a80a4ba0-2814-4e9c-878e-f87486b0069c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a51a2435-1dbc-406b-bb23-acdd93927a26" xlink:to="loc_srt_ProductsAndServicesDomain_a80a4ba0-2814-4e9c-878e-f87486b0069c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_260038cc-e72a-4b5b-b4bb-9cc3127f9771" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a80a4ba0-2814-4e9c-878e-f87486b0069c" xlink:to="loc_us-gaap_ServiceMember_260038cc-e72a-4b5b-b4bb-9cc3127f9771" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_27a5ec15-b1e2-4e85-a213-a48ac9f9c364" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_27a5ec15-b1e2-4e85-a213-a48ac9f9c364" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_27a5ec15-b1e2-4e85-a213-a48ac9f9c364_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_27a5ec15-b1e2-4e85-a213-a48ac9f9c364" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_27a5ec15-b1e2-4e85-a213-a48ac9f9c364_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c314b246-d046-4984-bae1-2981beb42a66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_27a5ec15-b1e2-4e85-a213-a48ac9f9c364" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c314b246-d046-4984-bae1-2981beb42a66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b36bbab1-7a4a-4e71-a567-3b24b4290ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c314b246-d046-4984-bae1-2981beb42a66" xlink:to="loc_us-gaap_SalesRevenueNetMember_b36bbab1-7a4a-4e71-a567-3b24b4290ca9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_132523ed-7352-4fc6-8808-174ff12f1ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_132523ed-7352-4fc6-8808-174ff12f1ed2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_132523ed-7352-4fc6-8808-174ff12f1ed2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_132523ed-7352-4fc6-8808-174ff12f1ed2" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_132523ed-7352-4fc6-8808-174ff12f1ed2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_526b21f3-9fd1-43e0-a1ea-b6d2d13d1258" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_132523ed-7352-4fc6-8808-174ff12f1ed2" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_526b21f3-9fd1-43e0-a1ea-b6d2d13d1258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4c9bbbe8-eeac-490b-baa3-678ff34ffb65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_526b21f3-9fd1-43e0-a1ea-b6d2d13d1258" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4c9bbbe8-eeac-490b-baa3-678ff34ffb65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_1eca37c1-3ec3-4570-8491-15bf98995c6c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_srt_MajorCustomersAxis_1eca37c1-3ec3-4570-8491-15bf98995c6c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1eca37c1-3ec3-4570-8491-15bf98995c6c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_1eca37c1-3ec3-4570-8491-15bf98995c6c" xlink:to="loc_srt_NameOfMajorCustomerDomain_1eca37c1-3ec3-4570-8491-15bf98995c6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_1eca37c1-3ec3-4570-8491-15bf98995c6c" xlink:to="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:to="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidMember_457c8ba5-7bdc-4b30-8f66-e2766489c004" xlink:href="ensg-20241231.xsd#ensg_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:to="loc_ensg_MedicaidMember_457c8ba5-7bdc-4b30-8f66-e2766489c004" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareMember_ce252364-2d1a-4820-bddd-430c8696fe27" xlink:href="ensg-20241231.xsd#ensg_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:to="loc_ensg_MedicareMember_ce252364-2d1a-4820-bddd-430c8696fe27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidSkilledMember_e24555e8-4c13-4357-883d-5205b297e3ae" xlink:href="ensg-20241231.xsd#ensg_MedicaidSkilledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:to="loc_ensg_MedicaidSkilledMember_e24555e8-4c13-4357-883d-5205b297e3ae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagedCareMember_21240ea8-b2a8-49ce-8dc0-0ad2ceb8f0ea" xlink:href="ensg-20241231.xsd#ensg_ManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:to="loc_ensg_ManagedCareMember_21240ea8-b2a8-49ce-8dc0-0ad2ceb8f0ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrivatePayAndOtherMember_cc991ce9-7b19-4e62-8d4a-32172dfcc805" xlink:href="ensg-20241231.xsd#ensg_PrivatePayAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:to="loc_ensg_PrivatePayAndOtherMember_cc991ce9-7b19-4e62-8d4a-32172dfcc805" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d444496-c221-4dd8-8eee-fae2ab9173b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2a0b174e-019d-4444-842b-1d48cc96090e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d444496-c221-4dd8-8eee-fae2ab9173b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ac1dff6c-68dd-407e-9ffb-e536336fcd65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2a0b174e-019d-4444-842b-1d48cc96090e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ac1dff6c-68dd-407e-9ffb-e536336fcd65" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_fd90695c-ec18-43f4-a3e3-fc26a73ac4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_fd90695c-ec18-43f4-a3e3-fc26a73ac4b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_fd90695c-ec18-43f4-a3e3-fc26a73ac4b8" xlink:to="loc_srt_MajorCustomersAxis_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a" xlink:to="loc_srt_NameOfMajorCustomerDomain_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a" xlink:to="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidMember_adc0914a-7b3b-4a40-a4ec-64f04a0134d0" xlink:href="ensg-20241231.xsd#ensg_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:to="loc_ensg_MedicaidMember_adc0914a-7b3b-4a40-a4ec-64f04a0134d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagedCareMember_33bb62e9-1b1d-485b-8f6c-31c4d8661127" xlink:href="ensg-20241231.xsd#ensg_ManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:to="loc_ensg_ManagedCareMember_33bb62e9-1b1d-485b-8f6c-31c4d8661127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareMember_84e0529b-e29f-4d6c-9565-cbce7e1cc3ce" xlink:href="ensg-20241231.xsd#ensg_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:to="loc_ensg_MedicareMember_84e0529b-e29f-4d6c-9565-cbce7e1cc3ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrivatePayAndOtherMember_792f981f-1fc5-4aaa-9f6f-91891a8c2b6f" xlink:href="ensg-20241231.xsd#ensg_PrivatePayAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:to="loc_ensg_PrivatePayAndOtherMember_792f981f-1fc5-4aaa-9f6f-91891a8c2b6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_8cd889fd-d08f-41c1-ac86-481f2f8a23b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:to="loc_us-gaap_AccountsReceivableGross_8cd889fd-d08f-41c1-ac86-481f2f8a23b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d9e200b1-6519-4872-a49a-ac49c85ad471" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d9e200b1-6519-4872-a49a-ac49c85ad471" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f899b2c2-50e8-4b4b-aacb-8054a0cc178f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f899b2c2-50e8-4b4b-aacb-8054a0cc178f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54105f19-0da5-4ea5-8d61-c316c14605d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54105f19-0da5-4ea5-8d61-c316c14605d8" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59f0693d-c141-4733-93c0-5b77f36b05d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59f0693d-c141-4733-93c0-5b77f36b05d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_59f0693d-c141-4733-93c0-5b77f36b05d2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59f0693d-c141-4733-93c0-5b77f36b05d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_59f0693d-c141-4733-93c0-5b77f36b05d2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776a9dc4-2b57-4538-8388-514a19503e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59f0693d-c141-4733-93c0-5b77f36b05d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776a9dc4-2b57-4538-8388-514a19503e9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_50941013-1949-41df-a26a-54b749b00f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776a9dc4-2b57-4538-8388-514a19503e9d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_50941013-1949-41df-a26a-54b749b00f2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0c5061b2-351f-4a71-8d9b-f4673b5ca29e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0c5061b2-351f-4a71-8d9b-f4673b5ca29e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c5061b2-351f-4a71-8d9b-f4673b5ca29e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0c5061b2-351f-4a71-8d9b-f4673b5ca29e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0c5061b2-351f-4a71-8d9b-f4673b5ca29e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_42fe4837-ceff-425b-9cd1-9e18d73ce889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0c5061b2-351f-4a71-8d9b-f4673b5ca29e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_42fe4837-ceff-425b-9cd1-9e18d73ce889" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceSubsidiaryLongTermInvestmentsMember_775b378a-1ef6-47a4-b8ed-0b17c2cec2ca" xlink:href="ensg-20241231.xsd#ensg_InsuranceSubsidiaryLongTermInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_42fe4837-ceff-425b-9cd1-9e18d73ce889" xlink:to="loc_ensg_InsuranceSubsidiaryLongTermInvestmentsMember_775b378a-1ef6-47a4-b8ed-0b17c2cec2ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_294e2e51-cf26-4dcf-8e2f-36e7d095455f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54105f19-0da5-4ea5-8d61-c316c14605d8" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_294e2e51-cf26-4dcf-8e2f-36e7d095455f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a824a882-d15e-4c62-aebf-d64a7844cb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54105f19-0da5-4ea5-8d61-c316c14605d8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a824a882-d15e-4c62-aebf-d64a7844cb4c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/STANDARDBEARERDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#STANDARDBEARERDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/STANDARDBEARERDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ad056d5e-9bd3-41a9-9320-070dd5861a8b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_dei_LegalEntityAxis_ad056d5e-9bd3-41a9-9320-070dd5861a8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ad056d5e-9bd3-41a9-9320-070dd5861a8b_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_ad056d5e-9bd3-41a9-9320-070dd5861a8b" xlink:to="loc_dei_EntityDomain_ad056d5e-9bd3-41a9-9320-070dd5861a8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_44b0534e-fd73-4749-b043-dcaf6de9bb08" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_ad056d5e-9bd3-41a9-9320-070dd5861a8b" xlink:to="loc_dei_EntityDomain_44b0534e-fd73-4749-b043-dcaf6de9bb08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember_d90a4aef-cd8a-4146-a7f6-805947e8f419" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_44b0534e-fd73-4749-b043-dcaf6de9bb08" xlink:to="loc_ensg_StandardBearerHealthcareREITIncMember_d90a4aef-cd8a-4146-a7f6-805947e8f419" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis_e47211af-6b0e-4202-88d0-5c962e938352" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_ensg_OperatingEntityAxis_e47211af-6b0e-4202-88d0-5c962e938352" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_e47211af-6b0e-4202-88d0-5c962e938352_default" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_OperatingEntityAxis_e47211af-6b0e-4202-88d0-5c962e938352" xlink:to="loc_ensg_OperatingEntityDomain_e47211af-6b0e-4202-88d0-5c962e938352_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_OperatingEntityAxis_e47211af-6b0e-4202-88d0-5c962e938352" xlink:to="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_03acc449-3796-4354-a402-2a14de1d1b72" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:to="loc_srt_SubsidiariesMember_03acc449-3796-4354-a402-2a14de1d1b72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThirdPartyOperatorsMember_d505e065-7145-44c6-b10e-cd16c7012932" xlink:href="ensg-20241231.xsd#ensg_ThirdPartyOperatorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:to="loc_ensg_ThirdPartyOperatorsMember_d505e065-7145-44c6-b10e-cd16c7012932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PreviousSubsidiariesMember_e64a3ac2-2da6-4f21-a381-f5f227e65b4b" xlink:href="ensg-20241231.xsd#ensg_PreviousSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:to="loc_ensg_PreviousSubsidiariesMember_e64a3ac2-2da6-4f21-a381-f5f227e65b4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_25b61b47-69b7-4e17-8695-62148cd6f522" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_25b61b47-69b7-4e17-8695-62148cd6f522" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_25b61b47-69b7-4e17-8695-62148cd6f522_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_25b61b47-69b7-4e17-8695-62148cd6f522" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_25b61b47-69b7-4e17-8695-62148cd6f522_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_25b61b47-69b7-4e17-8695-62148cd6f522" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_0a398726-17ed-4b72-b23f-1bc7dfaa0a9a" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:to="loc_ensg_SeniorLivingOperationsMember_0a398726-17ed-4b72-b23f-1bc7dfaa0a9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_d42999cd-9759-430c-b60b-9c1b51a935be" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:to="loc_ensg_SkilledNursingOperationsMember_d42999cd-9759-430c-b60b-9c1b51a935be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_c8c07244-5807-4b0a-aa09-dcc92a065a65" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:to="loc_ensg_CampusOperationsMember_c8c07244-5807-4b0a-aa09-dcc92a065a65" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_AssetAcquisitionAxis_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69" xlink:to="loc_us-gaap_AssetAcquisitionDomain_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69" xlink:to="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember_060c59ac-8099-4b64-a2cd-a061ab43faf2" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:to="loc_ensg_A2024AcquiredPropertiesMember_060c59ac-8099-4b64-a2cd-a061ab43faf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2025AcquiredPropertiesMember_0e93ac6a-7e5d-447f-b804-3f86c79c9bd6" xlink:href="ensg-20241231.xsd#ensg_A2025AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:to="loc_ensg_A2025AcquiredPropertiesMember_0e93ac6a-7e5d-447f-b804-3f86c79c9bd6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2023AcquiredPropertiesMember_cf5658d8-ebd7-4cf1-a7ef-51ade0b56d9c" xlink:href="ensg-20241231.xsd#ensg_A2023AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:to="loc_ensg_A2023AcquiredPropertiesMember_cf5658d8-ebd7-4cf1-a7ef-51ade0b56d9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2022AcquiredPropertiesMember_a4a92a3c-06cf-44c7-bd9b-ec8a604ab985" xlink:href="ensg-20241231.xsd#ensg_A2022AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:to="loc_ensg_A2022AcquiredPropertiesMember_a4a92a3c-06cf-44c7-bd9b-ec8a604ab985" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4224fcb4-835f-43b2-8a08-5c0452c2e93d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4224fcb4-835f-43b2-8a08-5c0452c2e93d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9b456a0f-c474-4c91-94c9-48f737f47ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4224fcb4-835f-43b2-8a08-5c0452c2e93d" xlink:to="loc_us-gaap_SubsequentEventMember_9b456a0f-c474-4c91-94c9-48f737f47ea7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_500a2e7b-0202-478a-9d0c-4f6804192113" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_srt_CounterpartyNameAxis_500a2e7b-0202-478a-9d0c-4f6804192113" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_500a2e7b-0202-478a-9d0c-4f6804192113_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_500a2e7b-0202-478a-9d0c-4f6804192113" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_500a2e7b-0202-478a-9d0c-4f6804192113_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a2580393-9a0c-4090-846f-4a0fffe16442" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_500a2e7b-0202-478a-9d0c-4f6804192113" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a2580393-9a0c-4090-846f-4a0fffe16442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CareTrustREITMember_0ab6a2bc-9503-413f-b4b6-cd75bb630b1a" xlink:href="ensg-20241231.xsd#ensg_CareTrustREITMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a2580393-9a0c-4090-846f-4a0fffe16442" xlink:to="loc_ensg_CareTrustREITMember_0ab6a2bc-9503-413f-b4b6-cd75bb630b1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis_036c08cc-acba-4dbc-86f2-69fe7b151a4e" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_ensg_LeaseArrangementAxis_036c08cc-acba-4dbc-86f2-69fe7b151a4e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_036c08cc-acba-4dbc-86f2-69fe7b151a4e_default" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_LeaseArrangementAxis_036c08cc-acba-4dbc-86f2-69fe7b151a4e" xlink:to="loc_ensg_LeaseArrangementDomain_036c08cc-acba-4dbc-86f2-69fe7b151a4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_432fb4d1-66db-4a85-9d9a-cc2e885d0d48" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_LeaseArrangementAxis_036c08cc-acba-4dbc-86f2-69fe7b151a4e" xlink:to="loc_ensg_LeaseArrangementDomain_432fb4d1-66db-4a85-9d9a-cc2e885d0d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerMasterLeasesMember_9ba46374-477f-4564-a8fe-b11a60c1e42d" xlink:href="ensg-20241231.xsd#ensg_StandardBearerMasterLeasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_LeaseArrangementDomain_432fb4d1-66db-4a85-9d9a-cc2e885d0d48" xlink:to="loc_ensg_StandardBearerMasterLeasesMember_9ba46374-477f-4564-a8fe-b11a60c1e42d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_96547f87-bd6c-4584-95df-753a9052c80e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_srt_RangeAxis_96547f87-bd6c-4584-95df-753a9052c80e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_96547f87-bd6c-4584-95df-753a9052c80e_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_96547f87-bd6c-4584-95df-753a9052c80e" xlink:to="loc_srt_RangeMember_96547f87-bd6c-4584-95df-753a9052c80e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_455772a6-be22-4028-84fa-3efd46a0303e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_96547f87-bd6c-4584-95df-753a9052c80e" xlink:to="loc_srt_RangeMember_455772a6-be22-4028-84fa-3efd46a0303e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ab91eeaa-19c4-40b0-b6d1-ce7e6b1d481a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_455772a6-be22-4028-84fa-3efd46a0303e" xlink:to="loc_srt_MinimumMember_ab91eeaa-19c4-40b0-b6d1-ce7e6b1d481a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_85aea215-6e49-48a7-8d06-69734ba5a12d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_455772a6-be22-4028-84fa-3efd46a0303e" xlink:to="loc_srt_MaximumMember_85aea215-6e49-48a7-8d06-69734ba5a12d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7fa7b5f0-6909-427f-b5f8-74fd350f395a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_srt_ProductOrServiceAxis_7fa7b5f0-6909-427f-b5f8-74fd350f395a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_7fa7b5f0-6909-427f-b5f8-74fd350f395a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_7fa7b5f0-6909-427f-b5f8-74fd350f395a" xlink:to="loc_srt_ProductsAndServicesDomain_7fa7b5f0-6909-427f-b5f8-74fd350f395a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_7fa7b5f0-6909-427f-b5f8-74fd350f395a" xlink:to="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceBaseMember_76c7bb27-6048-4632-9dea-462ddf3e8a93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceBaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:to="loc_us-gaap_ManagementServiceBaseMember_76c7bb27-6048-4632-9dea-462ddf3e8a93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceIncentiveMember_c2a22664-eb82-4139-899c-36de29eabbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceIncentiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:to="loc_us-gaap_ManagementServiceIncentiveMember_c2a22664-eb82-4139-899c-36de29eabbcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagementServiceTotalMember_a405d97d-f639-424d-8692-73aa3b64daa8" xlink:href="ensg-20241231.xsd#ensg_ManagementServiceTotalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:to="loc_ensg_ManagementServiceTotalMember_a405d97d-f639-424d-8692-73aa3b64daa8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2004aefc-33a7-4a3d-a7e6-d49074904aee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_CreditFacilityAxis_2004aefc-33a7-4a3d-a7e6-d49074904aee" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_2004aefc-33a7-4a3d-a7e6-d49074904aee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_2004aefc-33a7-4a3d-a7e6-d49074904aee" xlink:to="loc_us-gaap_CreditFacilityDomain_2004aefc-33a7-4a3d-a7e6-d49074904aee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_71be29c0-8262-499d-9db4-5afb500a036d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_2004aefc-33a7-4a3d-a7e6-d49074904aee" xlink:to="loc_us-gaap_CreditFacilityDomain_71be29c0-8262-499d-9db4-5afb500a036d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d650e79c-0c02-4d0a-bf70-d948fea8de3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_71be29c0-8262-499d-9db4-5afb500a036d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d650e79c-0c02-4d0a-bf70-d948fea8de3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e94b5aec-f54e-4ac5-a019-cae695df248e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e94b5aec-f54e-4ac5-a019-cae695df248e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e94b5aec-f54e-4ac5-a019-cae695df248e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e94b5aec-f54e-4ac5-a019-cae695df248e" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e94b5aec-f54e-4ac5-a019-cae695df248e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_71dc853c-6042-4129-86fb-bdb61d80f90a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e94b5aec-f54e-4ac5-a019-cae695df248e" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_71dc853c-6042-4129-86fb-bdb61d80f90a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TruistBankMember_daff692c-a7de-4586-9f42-7e1e25d882b1" xlink:href="ensg-20241231.xsd#ensg_TruistBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_71dc853c-6042-4129-86fb-bdb61d80f90a" xlink:to="loc_ensg_TruistBankMember_daff692c-a7de-4586-9f42-7e1e25d882b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_3c2cef19-407c-46ec-8b42-8bae436d9512" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_VariableRateAxis_3c2cef19-407c-46ec-8b42-8bae436d9512" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_3c2cef19-407c-46ec-8b42-8bae436d9512_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_3c2cef19-407c-46ec-8b42-8bae436d9512" xlink:to="loc_us-gaap_VariableRateDomain_3c2cef19-407c-46ec-8b42-8bae436d9512_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2022e09b-642d-4ecc-8894-b4b8085c06fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_3c2cef19-407c-46ec-8b42-8bae436d9512" xlink:to="loc_us-gaap_VariableRateDomain_2022e09b-642d-4ecc-8894-b4b8085c06fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_61c07db2-6657-4bb1-b795-76ccc05ab79d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_2022e09b-642d-4ecc-8894-b4b8085c06fb" xlink:to="loc_us-gaap_BaseRateMember_61c07db2-6657-4bb1-b795-76ccc05ab79d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_80a3b5eb-599f-4e5d-9962-77fabdea0ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_2022e09b-642d-4ecc-8894-b4b8085c06fb" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_80a3b5eb-599f-4e5d-9962-77fabdea0ccb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ac1465f8-197e-4cfa-bcec-600afee87030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_PlanNameAxis_ac1465f8-197e-4cfa-bcec-600afee87030" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_ac1465f8-197e-4cfa-bcec-600afee87030_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_ac1465f8-197e-4cfa-bcec-600afee87030" xlink:to="loc_us-gaap_PlanNameDomain_ac1465f8-197e-4cfa-bcec-600afee87030_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1f6259d6-3366-451b-b716-aede3801e995" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_ac1465f8-197e-4cfa-bcec-600afee87030" xlink:to="loc_us-gaap_PlanNameDomain_1f6259d6-3366-451b-b716-aede3801e995" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerEquityPlanMember_cce7ee60-f482-4531-9322-61cd899985f5" xlink:href="ensg-20241231.xsd#ensg_StandardBearerEquityPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_1f6259d6-3366-451b-b716-aede3801e995" xlink:to="loc_ensg_StandardBearerEquityPlanMember_cce7ee60-f482-4531-9322-61cd899985f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_af11a125-c5bf-4cdd-98a7-9c950256ff5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_AwardTypeAxis_af11a125-c5bf-4cdd-98a7-9c950256ff5a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af11a125-c5bf-4cdd-98a7-9c950256ff5a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_af11a125-c5bf-4cdd-98a7-9c950256ff5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_af11a125-c5bf-4cdd-98a7-9c950256ff5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_966779ee-5ac8-441a-867d-20356d9f55e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_af11a125-c5bf-4cdd-98a7-9c950256ff5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_966779ee-5ac8-441a-867d-20356d9f55e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e78fd9d0-936d-46bf-b81b-efdfb0c3f821" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_966779ee-5ac8-441a-867d-20356d9f55e6" xlink:to="loc_us-gaap_RestrictedStockMember_e78fd9d0-936d-46bf-b81b-efdfb0c3f821" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_fc389241-2c35-4505-bb76-daaeb666a1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_fc389241-2c35-4505-bb76-daaeb666a1fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfRealEstatePropertiesSharingLocations_0aa5b2b9-73dd-42ff-a9ce-c83d07939c56" xlink:href="ensg-20241231.xsd#ensg_NumberOfRealEstatePropertiesSharingLocations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_NumberOfRealEstatePropertiesSharingLocations_0aa5b2b9-73dd-42ff-a9ce-c83d07939c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_7ebf935c-887a-4efd-a389-256332a496c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_7ebf935c-887a-4efd-a389-256332a496c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfOperatingSubsidiaries_7ce0955d-256c-4efb-a449-1a84b14edb2f" xlink:href="ensg-20241231.xsd#ensg_NumberOfOperatingSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_NumberOfOperatingSubsidiaries_7ce0955d-256c-4efb-a449-1a84b14edb2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfLeaseArrangements_ce575f37-0238-460d-a260-c7b135fb3621" xlink:href="ensg-20241231.xsd#ensg_NumberOfLeaseArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_NumberOfLeaseArrangements_ce575f37-0238-460d-a260-c7b135fb3621" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_39e7b988-ba5e-472b-bfbd-d06f238c6b86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_39e7b988-ba5e-472b-bfbd-d06f238c6b86" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_450f4b1d-76a7-46d0-ac9c-ed22d8221a89" xlink:href="ensg-20241231.xsd#ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_450f4b1d-76a7-46d0-ac9c-ed22d8221a89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_2ee59ea8-9b9a-4caa-9eff-b9af30d1df2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_2ee59ea8-9b9a-4caa-9eff-b9af30d1df2b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_c8ba5aab-142f-4e34-8f13-55256232565c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_c8ba5aab-142f-4e34-8f13-55256232565c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_ddc14fbf-9052-4cad-ae35-7e80a4f2fcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_ddc14fbf-9052-4cad-ae35-7e80a4f2fcaf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PropertyManagementFeePercentFeeOfTotalRevenues_6cbadd97-8570-49e0-98dc-04c54fbdfffe" xlink:href="ensg-20241231.xsd#ensg_PropertyManagementFeePercentFeeOfTotalRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_PropertyManagementFeePercentFeeOfTotalRevenues_6cbadd97-8570-49e0-98dc-04c54fbdfffe" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations_df38d4b8-0d9c-4dd4-b9e5-1651e02c5e3a" xlink:href="ensg-20241231.xsd#ensg_PropertyManagementFeePercentFeeOfFundsFromOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations_df38d4b8-0d9c-4dd4-b9e5-1651e02c5e3a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_22755aa7-3609-4168-b496-f29a447f5127" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementFeeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ManagementFeeExpense_22755aa7-3609-4168-b496-f29a447f5127" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c32cfdb8-d7a0-4fa9-962a-2cccdb53a64c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c32cfdb8-d7a0-4fa9-962a-2cccdb53a64c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f862a469-39c9-479f-863d-7a3469afd712" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f862a469-39c9-479f-863d-7a3469afd712" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4f2fdc31-1ffc-4949-bd90-4ea8584c5034" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4f2fdc31-1ffc-4949-bd90-4ea8584c5034" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_580fbed0-3344-4fb0-9d54-ad23b55743de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_580fbed0-3344-4fb0-9d54-ad23b55743de" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_27ec8b04-041d-4eb1-8189-5352177feb41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_27ec8b04-041d-4eb1-8189-5352177feb41" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8c93710e-a59f-4a9b-b7e7-46166295584b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8c93710e-a59f-4a9b-b7e7-46166295584b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_7bfe1530-c578-403d-ba86-dbd5e61daebe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_7bfe1530-c578-403d-ba86-dbd5e61daebe" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_ac251f93-f3de-4eb3-bd60-348372ccd31f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_ac251f93-f3de-4eb3-bd60-348372ccd31f" xlink:type="arc" order="20"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPERATIONEXPANSIONSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_cce41af2-887e-46c8-adfc-005a28a06866" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_us-gaap_AssetAcquisitionAxis_cce41af2-887e-46c8-adfc-005a28a06866" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_cce41af2-887e-46c8-adfc-005a28a06866_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_cce41af2-887e-46c8-adfc-005a28a06866" xlink:to="loc_us-gaap_AssetAcquisitionDomain_cce41af2-887e-46c8-adfc-005a28a06866_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_cce41af2-887e-46c8-adfc-005a28a06866" xlink:to="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember_ebfa93e2-ed1e-4134-8b19-5332785ed822" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:to="loc_ensg_A2024AcquiredPropertiesMember_ebfa93e2-ed1e-4134-8b19-5332785ed822" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2025AcquiredPropertiesMember_2917c7dc-66e8-4a5c-8376-ffeab544752f" xlink:href="ensg-20241231.xsd#ensg_A2025AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:to="loc_ensg_A2025AcquiredPropertiesMember_2917c7dc-66e8-4a5c-8376-ffeab544752f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2023AcquiredPropertiesMember_3af559f1-044e-4a30-bfc9-3c88cc77a2a4" xlink:href="ensg-20241231.xsd#ensg_A2023AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:to="loc_ensg_A2023AcquiredPropertiesMember_3af559f1-044e-4a30-bfc9-3c88cc77a2a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2022AcquiredPropertiesMember_c670821b-2a23-4960-8866-7f02e56e6e75" xlink:href="ensg-20241231.xsd#ensg_A2022AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:to="loc_ensg_A2022AcquiredPropertiesMember_c670821b-2a23-4960-8866-7f02e56e6e75" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsAxis_c71b03da-1f1f-423f-9ee2-ebcee80a3fab" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsAxis_c71b03da-1f1f-423f-9ee2-ebcee80a3fab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_c71b03da-1f1f-423f-9ee2-ebcee80a3fab_default" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_c71b03da-1f1f-423f-9ee2-ebcee80a3fab" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_c71b03da-1f1f-423f-9ee2-ebcee80a3fab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_7fe19a64-afb9-4d5c-a457-99e7d900a53d" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_c71b03da-1f1f-423f-9ee2-ebcee80a3fab" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_7fe19a64-afb9-4d5c-a457-99e7d900a53d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_5f9abbf0-7c17-4777-9f8a-e933c95b81db" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_7fe19a64-afb9-4d5c-a457-99e7d900a53d" xlink:to="loc_ensg_SkilledNursingOperationsMember_5f9abbf0-7c17-4777-9f8a-e933c95b81db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_a3a91bb6-ba78-40ec-8010-ffec013b7428" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_7fe19a64-afb9-4d5c-a457-99e7d900a53d" xlink:to="loc_ensg_CampusOperationsMember_a3a91bb6-ba78-40ec-8010-ffec013b7428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_ebc8af85-c1bc-439b-9a79-54f614b26230" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:to="loc_ensg_SkilledNursingOperationsMember_ebc8af85-c1bc-439b-9a79-54f614b26230" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_beb2a13f-1b84-45ba-8ad3-788d8f399185" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:to="loc_ensg_CampusOperationsMember_beb2a13f-1b84-45ba-8ad3-788d8f399185" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_bb42c9b8-0ef5-41c8-8920-e5cf1ad495ff" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:to="loc_ensg_SeniorLivingOperationsMember_bb42c9b8-0ef5-41c8-8920-e5cf1ad495ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8ee8c078-b0f4-4228-b02a-b302cedf0c03" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_dei_LegalEntityAxis_8ee8c078-b0f4-4228-b02a-b302cedf0c03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_8ee8c078-b0f4-4228-b02a-b302cedf0c03_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_8ee8c078-b0f4-4228-b02a-b302cedf0c03" xlink:to="loc_dei_EntityDomain_8ee8c078-b0f4-4228-b02a-b302cedf0c03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c65fd1f7-6ab3-4e6b-ab0b-a318d6add4ea" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_8ee8c078-b0f4-4228-b02a-b302cedf0c03" xlink:to="loc_dei_EntityDomain_c65fd1f7-6ab3-4e6b-ab0b-a318d6add4ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember_ac1b3e48-92da-418b-b946-2825c9ac7968" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c65fd1f7-6ab3-4e6b-ab0b-a318d6add4ea" xlink:to="loc_ensg_StandardBearerHealthcareREITIncMember_ac1b3e48-92da-418b-b946-2825c9ac7968" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis_ce00fc42-ebd8-4cc3-aa11-9672b299a682" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_ensg_OperatingEntityAxis_ce00fc42-ebd8-4cc3-aa11-9672b299a682" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_ce00fc42-ebd8-4cc3-aa11-9672b299a682_default" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_OperatingEntityAxis_ce00fc42-ebd8-4cc3-aa11-9672b299a682" xlink:to="loc_ensg_OperatingEntityDomain_ce00fc42-ebd8-4cc3-aa11-9672b299a682_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_587e6622-c19a-4774-a8b0-4e70083bf7b6" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_OperatingEntityAxis_ce00fc42-ebd8-4cc3-aa11-9672b299a682" xlink:to="loc_ensg_OperatingEntityDomain_587e6622-c19a-4774-a8b0-4e70083bf7b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_e5d7bfa0-a38e-4f60-98ea-15e8d4213920" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_OperatingEntityDomain_587e6622-c19a-4774-a8b0-4e70083bf7b6" xlink:to="loc_srt_SubsidiariesMember_e5d7bfa0-a38e-4f60-98ea-15e8d4213920" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_031308b2-771a-4ab4-a94d-7afa46787c04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_031308b2-771a-4ab4-a94d-7afa46787c04" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_031308b2-771a-4ab4-a94d-7afa46787c04_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_031308b2-771a-4ab4-a94d-7afa46787c04" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_031308b2-771a-4ab4-a94d-7afa46787c04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_be768f98-775f-4545-bd6e-3d8fb81c6274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_031308b2-771a-4ab4-a94d-7afa46787c04" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_be768f98-775f-4545-bd6e-3d8fb81c6274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9e190040-ae4b-454a-9d17-ff3c958c5338" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_be768f98-775f-4545-bd6e-3d8fb81c6274" xlink:to="loc_us-gaap_SubsequentEventMember_9e190040-ae4b-454a-9d17-ff3c958c5338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_5f6409c9-5f04-48b5-906b-bcce4c5674ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_5f6409c9-5f04-48b5-906b-bcce4c5674ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSkilledNursingBeds_0dc7ee85-6187-4c94-a10d-98d53917b131" xlink:href="ensg-20241231.xsd#ensg_NumberOfSkilledNursingBeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_ensg_NumberOfSkilledNursingBeds_0dc7ee85-6187-4c94-a10d-98d53917b131" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfLongTermAcuteCareBeds_845ce62e-dd96-4d76-8981-08f8e2d86ff9" xlink:href="ensg-20241231.xsd#ensg_NumberOfLongTermAcuteCareBeds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_ensg_NumberOfLongTermAcuteCareBeds_845ce62e-dd96-4d76-8981-08f8e2d86ff9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSeniorLivingUnits_3480db64-1e6c-42c3-a589-24786640fc89" xlink:href="ensg-20241231.xsd#ensg_NumberOfSeniorLivingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_ensg_NumberOfSeniorLivingUnits_3480db64-1e6c-42c3-a589-24786640fc89" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPERATIONEXPANSIONSPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessAndAssetAcquisitionsAxis_e3a67622-8343-4cec-bd7f-8bcf538f9ee5" xlink:href="ensg-20241231.xsd#ensg_BusinessAndAssetAcquisitionsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:to="loc_ensg_BusinessAndAssetAcquisitionsAxis_e3a67622-8343-4cec-bd7f-8bcf538f9ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessAndAssetAcquisitionsDomain_e3a67622-8343-4cec-bd7f-8bcf538f9ee5_default" xlink:href="ensg-20241231.xsd#ensg_BusinessAndAssetAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_BusinessAndAssetAcquisitionsAxis_e3a67622-8343-4cec-bd7f-8bcf538f9ee5" xlink:to="loc_ensg_BusinessAndAssetAcquisitionsDomain_e3a67622-8343-4cec-bd7f-8bcf538f9ee5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessAndAssetAcquisitionsDomain_dd1d1a7e-94d6-4c46-a732-fc72f4d65420" xlink:href="ensg-20241231.xsd#ensg_BusinessAndAssetAcquisitionsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_BusinessAndAssetAcquisitionsAxis_e3a67622-8343-4cec-bd7f-8bcf538f9ee5" xlink:to="loc_ensg_BusinessAndAssetAcquisitionsDomain_dd1d1a7e-94d6-4c46-a732-fc72f4d65420" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AcquiredPropertiesMember_8235eba7-171c-480a-a187-1781dc8e27a6" xlink:href="ensg-20241231.xsd#ensg_AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_BusinessAndAssetAcquisitionsDomain_dd1d1a7e-94d6-4c46-a732-fc72f4d65420" xlink:to="loc_ensg_AcquiredPropertiesMember_8235eba7-171c-480a-a187-1781dc8e27a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10d77c51-fa8f-4082-b109-1d3beab57606" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10d77c51-fa8f-4082-b109-1d3beab57606" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_10d77c51-fa8f-4082-b109-1d3beab57606_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10d77c51-fa8f-4082-b109-1d3beab57606" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_10d77c51-fa8f-4082-b109-1d3beab57606_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10d77c51-fa8f-4082-b109-1d3beab57606" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_0a695db8-0a08-4b23-adce-808766568561" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:to="loc_us-gaap_LandMember_0a695db8-0a08-4b23-adce-808766568561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7a61bcc6-4601-4f42-a7ab-aabd88f95baf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7a61bcc6-4601-4f42-a7ab-aabd88f95baf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b6fd366e-d991-4860-8f46-d9058db4f55b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b6fd366e-d991-4860-8f46-d9058db4f55b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AssembledOccupancyAcquiredMember_c45e7ed3-ff37-4ed0-a625-9c7f27405ea7" xlink:href="ensg-20241231.xsd#ensg_AssembledOccupancyAcquiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:to="loc_ensg_AssembledOccupancyAcquiredMember_c45e7ed3-ff37-4ed0-a625-9c7f27405ea7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_b2efc07e-a8bd-4f7f-80b6-e995838a65df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_b2efc07e-a8bd-4f7f-80b6-e995838a65df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_716286cf-de83-4ef8-be67-2c096b9c2e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_716286cf-de83-4ef8-be67-2c096b9c2e9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasedAssetsAcquiredDuringPeriod_4a15bb37-97d9-4499-b86e-1c17f06eb57b" xlink:href="ensg-20241231.xsd#ensg_LeasedAssetsAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_ensg_LeasedAssetsAcquiredDuringPeriod_4a15bb37-97d9-4499-b86e-1c17f06eb57b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_b14213c9-f408-4847-b737-72a98592b425" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_b14213c9-f408-4847-b737-72a98592b425" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_e5a47990-82f7-490f-be72-6f344072b5cb" xlink:href="ensg-20241231.xsd#ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_e5a47990-82f7-490f-be72-6f344072b5cb" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d3864b84-8eea-46ae-808f-107fbe9cd3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d3864b84-8eea-46ae-808f-107fbe9cd3f2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_51370481-abaa-48b0-b564-c14741b9f8be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_51370481-abaa-48b0-b564-c14741b9f8be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_51370481-abaa-48b0-b564-c14741b9f8be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51370481-abaa-48b0-b564-c14741b9f8be" xlink:to="loc_us-gaap_SegmentDomain_51370481-abaa-48b0-b564-c14741b9f8be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51370481-abaa-48b0-b564-c14741b9f8be" xlink:to="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember_b85b8b5a-3e97-4d32-a3d5-7c313ee9298a" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:to="loc_ensg_SkilledServicesSegmentMember_b85b8b5a-3e97-4d32-a3d5-7c313ee9298a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerSegmentMember_2d9f72f0-bc15-481d-a5c4-ea07d945bcbf" xlink:href="ensg-20241231.xsd#ensg_StandardBearerSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:to="loc_ensg_StandardBearerSegmentMember_2d9f72f0-bc15-481d-a5c4-ea07d945bcbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_b05fd949-cf6a-48ad-8bd7-d2bcc448dc97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:to="loc_us-gaap_AllOtherSegmentsMember_b05fd949-cf6a-48ad-8bd7-d2bcc448dc97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsAxis_857e651a-d636-4a9d-8d10-f559482c1953" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsAxis_857e651a-d636-4a9d-8d10-f559482c1953" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_857e651a-d636-4a9d-8d10-f559482c1953_default" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_857e651a-d636-4a9d-8d10-f559482c1953" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_857e651a-d636-4a9d-8d10-f559482c1953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_857e651a-d636-4a9d-8d10-f559482c1953" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_55cf3818-4879-47a5-a11e-f1bfc3dda290" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:to="loc_ensg_SkilledNursingOperationsMember_55cf3818-4879-47a5-a11e-f1bfc3dda290" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_5a936b18-4368-4e9f-ada7-78b4a894f456" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:to="loc_ensg_CampusOperationsMember_5a936b18-4368-4e9f-ada7-78b4a894f456" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_7028f613-6306-425c-9e7b-8e4cb8f4bfbd" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:to="loc_ensg_SeniorLivingOperationsMember_7028f613-6306-425c-9e7b-8e4cb8f4bfbd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b27f9a72-30bd-4db3-9682-eadf21fcf73c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d3864b84-8eea-46ae-808f-107fbe9cd3f2" xlink:to="loc_us-gaap_NumberOfReportableSegments_b27f9a72-30bd-4db3-9682-eadf21fcf73c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_c218ea97-c83e-4deb-a86d-35fd9b56ec69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d3864b84-8eea-46ae-808f-107fbe9cd3f2" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_c218ea97-c83e-4deb-a86d-35fd9b56ec69" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:to="loc_srt_ConsolidationItemsAxis_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf" xlink:to="loc_srt_ConsolidationItemsDomain_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf" xlink:to="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d0577174-42f9-4bc8-b254-9f807996d52e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:to="loc_us-gaap_OperatingSegmentsMember_d0577174-42f9-4bc8-b254-9f807996d52e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember_6666de78-f0a7-4f06-8b6d-09c33ed0cbad" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:to="loc_srt_ConsolidationEliminationsMember_6666de78-f0a7-4f06-8b6d-09c33ed0cbad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_99d81389-4ac1-4ac3-8583-c58f1bec3b83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_99d81389-4ac1-4ac3-8583-c58f1bec3b83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2df7a3d7-c941-41e6-8f35-1356d025ba41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2df7a3d7-c941-41e6-8f35-1356d025ba41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2df7a3d7-c941-41e6-8f35-1356d025ba41_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2df7a3d7-c941-41e6-8f35-1356d025ba41" xlink:to="loc_us-gaap_SegmentDomain_2df7a3d7-c941-41e6-8f35-1356d025ba41_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9e8d5243-5c29-4393-a20b-edeeb712b250" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2df7a3d7-c941-41e6-8f35-1356d025ba41" xlink:to="loc_us-gaap_SegmentDomain_9e8d5243-5c29-4393-a20b-edeeb712b250" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember_8787b064-dc13-48bb-af8f-297b9001aacb" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9e8d5243-5c29-4393-a20b-edeeb712b250" xlink:to="loc_ensg_SkilledServicesSegmentMember_8787b064-dc13-48bb-af8f-297b9001aacb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerSegmentMember_9c8e1390-2737-46bb-9b20-2a53bb069c77" xlink:href="ensg-20241231.xsd#ensg_StandardBearerSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9e8d5243-5c29-4393-a20b-edeeb712b250" xlink:to="loc_ensg_StandardBearerSegmentMember_9c8e1390-2737-46bb-9b20-2a53bb069c77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_dd7621e0-736c-4759-9be7-b33deaf27601" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:to="loc_srt_ProductOrServiceAxis_dd7621e0-736c-4759-9be7-b33deaf27601" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_dd7621e0-736c-4759-9be7-b33deaf27601_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_dd7621e0-736c-4759-9be7-b33deaf27601" xlink:to="loc_srt_ProductsAndServicesDomain_dd7621e0-736c-4759-9be7-b33deaf27601_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_417dc442-0ed8-4bbb-ab22-1ca1acc84514" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_dd7621e0-736c-4759-9be7-b33deaf27601" xlink:to="loc_srt_ProductsAndServicesDomain_417dc442-0ed8-4bbb-ab22-1ca1acc84514" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_0a5ed7b7-816c-48f8-90dc-14284ef03967" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_417dc442-0ed8-4bbb-ab22-1ca1acc84514" xlink:to="loc_us-gaap_ServiceMember_0a5ed7b7-816c-48f8-90dc-14284ef03967" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember_8523770e-b771-4409-bae5-48bf5ae2d42b" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_417dc442-0ed8-4bbb-ab22-1ca1acc84514" xlink:to="loc_ensg_RentalMember_8523770e-b771-4409-bae5-48bf5ae2d42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac708f05-eab8-44f2-8f50-5c4b5ed40164" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac708f05-eab8-44f2-8f50-5c4b5ed40164" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_cf85eebe-23df-4208-8019-7991ea3081e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_cf85eebe-23df-4208-8019-7991ea3081e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2b4d6940-d19d-45e5-b82a-378165b7e1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2b4d6940-d19d-45e5-b82a-378165b7e1bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_ea003623-de14-4ba6-8029-8694f93444e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_InterestExpenseNonoperating_ea003623-de14-4ba6-8029-8694f93444e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SegmentIncomeLoss_9142e690-2a6e-4fec-bb71-7e7545f511ab" xlink:href="ensg-20241231.xsd#ensg_SegmentIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_ensg_SegmentIncomeLoss_9142e690-2a6e-4fec-bb71-7e7545f511ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8c28056c-5d22-47cd-9cd3-ade4a21f0917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8c28056c-5d22-47cd-9cd3-ade4a21f0917" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_d3d1a4a5-ecc4-448e-8d7d-0046137cc4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_d3d1a4a5-ecc4-448e-8d7d-0046137cc4cf" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_691171dc-73f6-46ad-b4a1-c07f532696cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_srt_ProductOrServiceAxis_691171dc-73f6-46ad-b4a1-c07f532696cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_691171dc-73f6-46ad-b4a1-c07f532696cd_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_691171dc-73f6-46ad-b4a1-c07f532696cd" xlink:to="loc_srt_ProductsAndServicesDomain_691171dc-73f6-46ad-b4a1-c07f532696cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_144f9833-cf05-47eb-a86f-a0bb954291e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_691171dc-73f6-46ad-b4a1-c07f532696cd" xlink:to="loc_srt_ProductsAndServicesDomain_144f9833-cf05-47eb-a86f-a0bb954291e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_bc3ddf41-cbe0-400c-b3a9-534b58ade1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_144f9833-cf05-47eb-a86f-a0bb954291e9" xlink:to="loc_us-gaap_ServiceMember_bc3ddf41-cbe0-400c-b3a9-534b58ade1cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_359cbd37-4f83-40af-be5c-a6e289966bea" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_srt_ConsolidationItemsAxis_359cbd37-4f83-40af-be5c-a6e289966bea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_359cbd37-4f83-40af-be5c-a6e289966bea_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_359cbd37-4f83-40af-be5c-a6e289966bea" xlink:to="loc_srt_ConsolidationItemsDomain_359cbd37-4f83-40af-be5c-a6e289966bea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d12ebdcb-0f64-4761-ad4c-9ff268d4951d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_359cbd37-4f83-40af-be5c-a6e289966bea" xlink:to="loc_srt_ConsolidationItemsDomain_d12ebdcb-0f64-4761-ad4c-9ff268d4951d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_48d63760-209b-4c3a-b7df-086f47f9c569" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d12ebdcb-0f64-4761-ad4c-9ff268d4951d" xlink:to="loc_us-gaap_OperatingSegmentsMember_48d63760-209b-4c3a-b7df-086f47f9c569" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_EliminationsAndReconcilingItemsMember_6df807c9-5b76-41f0-be3d-6de1e6975d4f" xlink:href="ensg-20241231.xsd#ensg_EliminationsAndReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_d12ebdcb-0f64-4761-ad4c-9ff268d4951d" xlink:to="loc_ensg_EliminationsAndReconcilingItemsMember_6df807c9-5b76-41f0-be3d-6de1e6975d4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f" xlink:to="loc_us-gaap_SegmentDomain_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f3f3f50d-b6a7-41a9-afb8-c4a974f5b6af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f" xlink:to="loc_us-gaap_SegmentDomain_f3f3f50d-b6a7-41a9-afb8-c4a974f5b6af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember_94566abc-9cf1-4704-9acb-77826db50e56" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_f3f3f50d-b6a7-41a9-afb8-c4a974f5b6af" xlink:to="loc_ensg_SkilledServicesSegmentMember_94566abc-9cf1-4704-9acb-77826db50e56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa6a274-da87-456b-8e44-3f053eb38ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa6a274-da87-456b-8e44-3f053eb38ce8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0aa6a274-da87-456b-8e44-3f053eb38ce8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa6a274-da87-456b-8e44-3f053eb38ce8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_0aa6a274-da87-456b-8e44-3f053eb38ce8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2fd2ee07-99e0-4fa1-bf90-8c62893880fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa6a274-da87-456b-8e44-3f053eb38ce8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2fd2ee07-99e0-4fa1-bf90-8c62893880fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_7a090855-7628-454e-aaa1-4d232416b139" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2fd2ee07-99e0-4fa1-bf90-8c62893880fc" xlink:to="loc_us-gaap_SalesRevenueNetMember_7a090855-7628-454e-aaa1-4d232416b139" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1f0097f6-db06-41b2-a902-9662c834a5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1f0097f6-db06-41b2-a902-9662c834a5c5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_1f0097f6-db06-41b2-a902-9662c834a5c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1f0097f6-db06-41b2-a902-9662c834a5c5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_1f0097f6-db06-41b2-a902-9662c834a5c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_68bdf378-246e-43af-bf87-f57c329fd194" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1f0097f6-db06-41b2-a902-9662c834a5c5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_68bdf378-246e-43af-bf87-f57c329fd194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_53832f92-5bb7-4364-bd26-77533210fd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_68bdf378-246e-43af-bf87-f57c329fd194" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_53832f92-5bb7-4364-bd26-77533210fd0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_22b44fda-cf73-4a86-9a82-64988c9aa7a5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_srt_MajorCustomersAxis_22b44fda-cf73-4a86-9a82-64988c9aa7a5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_22b44fda-cf73-4a86-9a82-64988c9aa7a5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_22b44fda-cf73-4a86-9a82-64988c9aa7a5" xlink:to="loc_srt_NameOfMajorCustomerDomain_22b44fda-cf73-4a86-9a82-64988c9aa7a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_22b44fda-cf73-4a86-9a82-64988c9aa7a5" xlink:to="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:to="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidMember_5b041afc-5c6e-4f52-ba49-2b2544db494c" xlink:href="ensg-20241231.xsd#ensg_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:to="loc_ensg_MedicaidMember_5b041afc-5c6e-4f52-ba49-2b2544db494c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareMember_7c46ef1a-262a-4a8a-a926-3bbff86204d4" xlink:href="ensg-20241231.xsd#ensg_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:to="loc_ensg_MedicareMember_7c46ef1a-262a-4a8a-a926-3bbff86204d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidSkilledMember_735e0733-df84-44bd-8330-e5307b1c14bf" xlink:href="ensg-20241231.xsd#ensg_MedicaidSkilledMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:to="loc_ensg_MedicaidSkilledMember_735e0733-df84-44bd-8330-e5307b1c14bf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagedCareMember_ed5d9c21-f9f6-4b1b-954a-051f8a341717" xlink:href="ensg-20241231.xsd#ensg_ManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:to="loc_ensg_ManagedCareMember_ed5d9c21-f9f6-4b1b-954a-051f8a341717" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrivatePayAndOtherMember_a3e3111f-0a50-43a2-88a8-e6bcad3f1632" xlink:href="ensg-20241231.xsd#ensg_PrivatePayAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:to="loc_ensg_PrivatePayAndOtherMember_a3e3111f-0a50-43a2-88a8-e6bcad3f1632" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c90a426-fd7f-4aeb-a1f6-7e2d3a913af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_d3d1a4a5-ecc4-448e-8d7d-0046137cc4cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c90a426-fd7f-4aeb-a1f6-7e2d3a913af0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d1714424-5388-4949-9efd-d14eabb2cde1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_d3d1a4a5-ecc4-448e-8d7d-0046137cc4cf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d1714424-5388-4949-9efd-d14eabb2cde1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d4ec5137-9552-4778-ac12-f6dad7cfadb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d4ec5137-9552-4778-ac12-f6dad7cfadb6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e4be7e71-d1b4-401d-ad06-368e5a1f8033" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d4ec5137-9552-4778-ac12-f6dad7cfadb6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e4be7e71-d1b4-401d-ad06-368e5a1f8033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4be7e71-d1b4-401d-ad06-368e5a1f8033_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e4be7e71-d1b4-401d-ad06-368e5a1f8033" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e4be7e71-d1b4-401d-ad06-368e5a1f8033_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e4be7e71-d1b4-401d-ad06-368e5a1f8033" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_8852380f-a9f3-4051-9d24-7c868683738a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_LandMember_8852380f-a9f3-4051-9d24-7c868683738a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7ee60de4-5b3c-4e9f-b0fa-f1946bfa6d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7ee60de4-5b3c-4e9f-b0fa-f1946bfa6d8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_9260bfad-1c92-42a9-9f0e-1f6c8feca243" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_9260bfad-1c92-42a9-9f0e-1f6c8feca243" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_59b84320-3f2c-4a07-8413-7e561a03bace" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_EquipmentMember_59b84320-3f2c-4a07-8413-7e561a03bace" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_af2c40cd-d4a6-46dd-873f-2df3de032b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_af2c40cd-d4a6-46dd-873f-2df3de032b8b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_a9f6067b-b8f0-48f7-87fb-9989104fb7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_ConstructionInProgressMember_a9f6067b-b8f0-48f7-87fb-9989104fb7f2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b1d6dcae-0b69-4044-96f3-ba7ab00da23d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b1d6dcae-0b69-4044-96f3-ba7ab00da23d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8da2fff8-0aec-44ef-af5a-7dd89e37bbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8da2fff8-0aec-44ef-af5a-7dd89e37bbcf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_816316fc-2868-458e-8ec5-6006eda30d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_816316fc-2868-458e-8ec5-6006eda30d2a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6f6cb6b7-27d0-4c73-83d1-4c144213cb43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6f6cb6b7-27d0-4c73-83d1-4c144213cb43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4918ec34-dc40-4c1a-803d-59a270de0c47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6f6cb6b7-27d0-4c73-83d1-4c144213cb43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4918ec34-dc40-4c1a-803d-59a270de0c47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4918ec34-dc40-4c1a-803d-59a270de0c47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4918ec34-dc40-4c1a-803d-59a270de0c47" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4918ec34-dc40-4c1a-803d-59a270de0c47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4918ec34-dc40-4c1a-803d-59a270de0c47" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AssembledOccupancyAcquiredMember_ab3f6ded-77e6-4ae0-91b5-44e36a49493c" xlink:href="ensg-20241231.xsd#ensg_AssembledOccupancyAcquiredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:to="loc_ensg_AssembledOccupancyAcquiredMember_ab3f6ded-77e6-4ae0-91b5-44e36a49493c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4cbae47d-7a42-40c5-9d28-d758b7578b72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:to="loc_us-gaap_TradeNamesMember_4cbae47d-7a42-40c5-9d28-d758b7578b72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_01f23dc6-6422-4c5d-8c18-d5fe51fc0eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_01f23dc6-6422-4c5d-8c18-d5fe51fc0eb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_77e322bf-9fbe-4b5a-bf10-2a13831a2e17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_77e322bf-9fbe-4b5a-bf10-2a13831a2e17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_253878c5-094f-4f9e-b6a8-8485b9bc1079" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_253878c5-094f-4f9e-b6a8-8485b9bc1079" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_eee84309-4fe0-4209-a905-e98ba73729cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_eee84309-4fe0-4209-a905-e98ba73729cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_97c714a0-12ee-4f6f-997c-e5b7edf5d220" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_97c714a0-12ee-4f6f-997c-e5b7edf5d220" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b887472b-2085-49cb-835a-84348bd4713b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b887472b-2085-49cb-835a-84348bd4713b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b887472b-2085-49cb-835a-84348bd4713b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b887472b-2085-49cb-835a-84348bd4713b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b887472b-2085-49cb-835a-84348bd4713b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7aaaafe0-f13f-4f53-ba68-97244dfb26a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b887472b-2085-49cb-835a-84348bd4713b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7aaaafe0-f13f-4f53-ba68-97244dfb26a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DepreciationAndAmortizationMember_8576f54e-18dc-49d1-a792-2d0f8e0328dc" xlink:href="ensg-20241231.xsd#ensg_DepreciationAndAmortizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7aaaafe0-f13f-4f53-ba68-97244dfb26a1" xlink:to="loc_ensg_DepreciationAndAmortizationMember_8576f54e-18dc-49d1-a792-2d0f8e0328dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3f570d98-8da2-4e45-aa9b-cebc4cd15741" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3f570d98-8da2-4e45-aa9b-cebc4cd15741" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3f570d98-8da2-4e45-aa9b-cebc4cd15741_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3f570d98-8da2-4e45-aa9b-cebc4cd15741" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3f570d98-8da2-4e45-aa9b-cebc4cd15741_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c688e363-f3c7-45f3-9a57-d7f88a08a187" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3f570d98-8da2-4e45-aa9b-cebc4cd15741" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c688e363-f3c7-45f3-9a57-d7f88a08a187" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareAndMedicaidLicensesMember_3800621b-cc91-42dc-831b-424bda4318ba" xlink:href="ensg-20241231.xsd#ensg_MedicareAndMedicaidLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c688e363-f3c7-45f3-9a57-d7f88a08a187" xlink:to="loc_ensg_MedicareAndMedicaidLicensesMember_3800621b-cc91-42dc-831b-424bda4318ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_87a0afae-5d01-4d41-be43-4b93949811eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_87a0afae-5d01-4d41-be43-4b93949811eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_eba92292-5b3a-4ab5-b519-e9e272038a00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_OperatingLeaseCost_eba92292-5b3a-4ab5-b519-e9e272038a00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8620ca76-cc6c-4d6b-9ba7-bc5d7932366c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8620ca76-cc6c-4d6b-9ba7-bc5d7932366c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_f6fb231f-b6b3-4ac1-98e7-050576a73620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_f6fb231f-b6b3-4ac1-98e7-050576a73620" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_297f29e4-987d-4cdb-a8eb-bcb7901c0b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_719079b8-4497-4b22-8d3f-9e9babb3c0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_297f29e4-987d-4cdb-a8eb-bcb7901c0b1f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_719079b8-4497-4b22-8d3f-9e9babb3c0b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d24448c9-5655-4978-aa8f-ca40489d36ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_719079b8-4497-4b22-8d3f-9e9babb3c0b5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d24448c9-5655-4978-aa8f-ca40489d36ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d24448c9-5655-4978-aa8f-ca40489d36ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d24448c9-5655-4978-aa8f-ca40489d36ca" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d24448c9-5655-4978-aa8f-ca40489d36ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b865d7b-500f-4276-8cd1-407ccc11675b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d24448c9-5655-4978-aa8f-ca40489d36ca" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b865d7b-500f-4276-8cd1-407ccc11675b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_68cf87f9-a626-4beb-b9d5-eb76607fc060" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b865d7b-500f-4276-8cd1-407ccc11675b" xlink:to="loc_us-gaap_TradeNamesMember_68cf87f9-a626-4beb-b9d5-eb76607fc060" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareAndMedicaidLicensesMember_fc4d688e-fd50-4e3d-95aa-1ae850b58758" xlink:href="ensg-20241231.xsd#ensg_MedicareAndMedicaidLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b865d7b-500f-4276-8cd1-407ccc11675b" xlink:to="loc_ensg_MedicareAndMedicaidLicensesMember_fc4d688e-fd50-4e3d-95aa-1ae850b58758" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7e6e01d0-0730-4603-bb1a-7df31d39ddce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_297f29e4-987d-4cdb-a8eb-bcb7901c0b1f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7e6e01d0-0730-4603-bb1a-7df31d39ddce" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#GOODWILLScheduleofGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_76a1ab14-3e76-458b-93dd-044a536f6fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_76a1ab14-3e76-458b-93dd-044a536f6fd8" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7d330116-7c7b-4e84-8a16-78174ee30e9a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:to="loc_srt_ConsolidationItemsAxis_7d330116-7c7b-4e84-8a16-78174ee30e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_7d330116-7c7b-4e84-8a16-78174ee30e9a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_7d330116-7c7b-4e84-8a16-78174ee30e9a" xlink:to="loc_srt_ConsolidationItemsDomain_7d330116-7c7b-4e84-8a16-78174ee30e9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_60f9b57f-2858-469a-8f7e-c8b9714f730c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_7d330116-7c7b-4e84-8a16-78174ee30e9a" xlink:to="loc_srt_ConsolidationItemsDomain_60f9b57f-2858-469a-8f7e-c8b9714f730c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_4d4b4817-63cc-4662-a44c-f2b2cbbb8f76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_60f9b57f-2858-469a-8f7e-c8b9714f730c" xlink:to="loc_us-gaap_OperatingSegmentsMember_4d4b4817-63cc-4662-a44c-f2b2cbbb8f76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_ff330848-52f0-43d4-b3fb-051aedc03c05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_60f9b57f-2858-469a-8f7e-c8b9714f730c" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_ff330848-52f0-43d4-b3fb-051aedc03c05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1bf4e971-3040-4537-9935-c7c8d10369ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1bf4e971-3040-4537-9935-c7c8d10369ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1bf4e971-3040-4537-9935-c7c8d10369ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1bf4e971-3040-4537-9935-c7c8d10369ed" xlink:to="loc_us-gaap_SegmentDomain_1bf4e971-3040-4537-9935-c7c8d10369ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83200256-cc56-43b0-9dcf-cc79aee39c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1bf4e971-3040-4537-9935-c7c8d10369ed" xlink:to="loc_us-gaap_SegmentDomain_83200256-cc56-43b0-9dcf-cc79aee39c5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember_db51d708-986a-428e-b03c-3def6f70ed0a" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_83200256-cc56-43b0-9dcf-cc79aee39c5a" xlink:to="loc_ensg_SkilledServicesSegmentMember_db51d708-986a-428e-b03c-3def6f70ed0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_76a1ab14-3e76-458b-93dd-044a536f6fd8" xlink:to="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_98f39c1f-1bd5-4512-8414-d7b702131479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:to="loc_us-gaap_Goodwill_98f39c1f-1bd5-4512-8414-d7b702131479" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_c0fecb10-5142-49be-b63e-bfdda4086301" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_c0fecb10-5142-49be-b63e-bfdda4086301" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cdbed418-d2dd-4b3a-8d63-942fb35a3e38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTScheduleofLongtermDebtDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fd6a4b1d-f9b4-4f21-be15-e13389f203e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_DebtInstrumentTable_fd6a4b1d-f9b4-4f21-be15-e13389f203e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_fd6a4b1d-f9b4-4f21-be15-e13389f203e6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc8df927-3c38-45ab-845d-6d9288bdc0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc8df927-3c38-45ab-845d-6d9288bdc0a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralizedDebtObligationsMember_0a54c2be-213c-4b7d-814d-e447fcc00029" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralizedDebtObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc8df927-3c38-45ab-845d-6d9288bdc0a6" xlink:to="loc_us-gaap_CollateralizedDebtObligationsMember_0a54c2be-213c-4b7d-814d-e447fcc00029" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_880d0b95-845a-4c7e-8c53-fae41191913f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_880d0b95-845a-4c7e-8c53-fae41191913f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_331dd3df-8bd5-44c4-bf79-6c13ebdcca3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_LongTermDebtCurrent_331dd3df-8bd5-44c4-bf79-6c13ebdcca3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_2088859c-076b-4d79-a5da-ee945b80e79b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_2088859c-076b-4d79-a5da-ee945b80e79b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_454752f5-5b9b-4284-ac87-dae2ca29093a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_454752f5-5b9b-4284-ac87-dae2ca29093a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a97a01f9-32b1-4a58-94a4-425845e7c84e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_us-gaap_CreditFacilityAxis_a97a01f9-32b1-4a58-94a4-425845e7c84e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a97a01f9-32b1-4a58-94a4-425845e7c84e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a97a01f9-32b1-4a58-94a4-425845e7c84e" xlink:to="loc_us-gaap_CreditFacilityDomain_a97a01f9-32b1-4a58-94a4-425845e7c84e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b540e3c9-fa5b-4e48-bd66-3b4bc7e45798" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a97a01f9-32b1-4a58-94a4-425845e7c84e" xlink:to="loc_us-gaap_CreditFacilityDomain_b540e3c9-fa5b-4e48-bd66-3b4bc7e45798" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c599cafa-792f-456e-91c2-8c3c0bfcda16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b540e3c9-fa5b-4e48-bd66-3b4bc7e45798" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c599cafa-792f-456e-91c2-8c3c0bfcda16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_74d3a0a8-a265-484b-ba9a-a5769ecc562f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_74d3a0a8-a265-484b-ba9a-a5769ecc562f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TruistBankMember_36533cb0-a6fb-4147-b9c5-356b19bea559" xlink:href="ensg-20241231.xsd#ensg_TruistBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_74d3a0a8-a265-484b-ba9a-a5769ecc562f" xlink:to="loc_ensg_TruistBankMember_36533cb0-a6fb-4147-b9c5-356b19bea559" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9c8b1f98-3c47-4a9b-8c6a-817199d3d449" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_us-gaap_VariableRateAxis_9c8b1f98-3c47-4a9b-8c6a-817199d3d449" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_9c8b1f98-3c47-4a9b-8c6a-817199d3d449_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_9c8b1f98-3c47-4a9b-8c6a-817199d3d449" xlink:to="loc_us-gaap_VariableRateDomain_9c8b1f98-3c47-4a9b-8c6a-817199d3d449_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_26ae6ce4-01f6-4602-9b56-8c501ebd54d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_9c8b1f98-3c47-4a9b-8c6a-817199d3d449" xlink:to="loc_us-gaap_VariableRateDomain_26ae6ce4-01f6-4602-9b56-8c501ebd54d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_9e50e487-686c-4fe0-9477-ca2da55c8aca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_26ae6ce4-01f6-4602-9b56-8c501ebd54d7" xlink:to="loc_us-gaap_BaseRateMember_9e50e487-686c-4fe0-9477-ca2da55c8aca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_0d36ab68-4c3a-46a4-8b65-68e1f9a01f74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_26ae6ce4-01f6-4602-9b56-8c501ebd54d7" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_0d36ab68-4c3a-46a4-8b65-68e1f9a01f74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_13d18ed1-ceec-4a6c-9772-f34a475a6208" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_srt_RangeAxis_13d18ed1-ceec-4a6c-9772-f34a475a6208" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_13d18ed1-ceec-4a6c-9772-f34a475a6208_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_13d18ed1-ceec-4a6c-9772-f34a475a6208" xlink:to="loc_srt_RangeMember_13d18ed1-ceec-4a6c-9772-f34a475a6208_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1848354a-e81c-4def-a636-764958868e6c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_13d18ed1-ceec-4a6c-9772-f34a475a6208" xlink:to="loc_srt_RangeMember_1848354a-e81c-4def-a636-764958868e6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_77b48906-aa51-4a07-a08e-be78719b0497" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1848354a-e81c-4def-a636-764958868e6c" xlink:to="loc_srt_MinimumMember_77b48906-aa51-4a07-a08e-be78719b0497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f2fa1ba-5666-48de-bbe8-48255abd07c4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1848354a-e81c-4def-a636-764958868e6c" xlink:to="loc_srt_MaximumMember_1f2fa1ba-5666-48de-bbe8-48255abd07c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a9c2305-2034-4129-97c2-b19b7a5c33fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a9c2305-2034-4129-97c2-b19b7a5c33fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d7304758-07db-4e27-a993-e1a4e021660f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d7304758-07db-4e27-a993-e1a4e021660f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5f77c0e9-78b5-415f-b5a7-f50964b3c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5f77c0e9-78b5-415f-b5a7-f50964b3c12e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMaximum_2f6dffd9-e18a-48bd-901d-9afc67f6bc6c" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_TotalNetDebtRatioMaximum_2f6dffd9-e18a-48bd-901d-9afc67f6bc6c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod_b9d4caca-b0e7-4020-a96d-8d10380d0c77" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod_b9d4caca-b0e7-4020-a96d-8d10380d0c77" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection_ec2d2547-f2ed-4c82-b7a1-43f4f8d5046f" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection_ec2d2547-f2ed-4c82-b7a1-43f4f8d5046f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection_98e55214-36ec-4211-bd0b-d189f20ace53" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMaximumAfterIncreaseElection"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection_98e55214-36ec-4211-bd0b-d189f20ace53" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMinimum_6112d8f1-dd9d-4a52-98a2-f54b3c66c449" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_TotalNetDebtRatioMinimum_6112d8f1-dd9d-4a52-98a2-f54b3c66c449" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bc9f2537-b8e9-4836-bd06-76b7e733db53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bc9f2537-b8e9-4836-bd06-76b7e733db53" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_873aaeb0-53d2-4a2a-9284-c7a985331a16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_873aaeb0-53d2-4a2a-9284-c7a985331a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_873aaeb0-53d2-4a2a-9284-c7a985331a16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_873aaeb0-53d2-4a2a-9284-c7a985331a16" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_873aaeb0-53d2-4a2a-9284-c7a985331a16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_19c3a8e1-df22-4201-9cfe-f0a016a5d089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_873aaeb0-53d2-4a2a-9284-c7a985331a16" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_19c3a8e1-df22-4201-9cfe-f0a016a5d089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralizedDebtObligationsMember_fd11cee5-46a7-4b59-b40c-c39562f3632a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralizedDebtObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19c3a8e1-df22-4201-9cfe-f0a016a5d089" xlink:to="loc_us-gaap_CollateralizedDebtObligationsMember_fd11cee5-46a7-4b59-b40c-c39562f3632a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_us-gaap_DebtInstrumentAxis_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9392d29-5513-4a4e-bfda-e1b409c173e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9392d29-5513-4a4e-bfda-e1b409c173e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_HUDInsuredMortgagesMember_5f152cf9-81ff-4180-9194-14c08d492f42" xlink:href="ensg-20241231.xsd#ensg_HUDInsuredMortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9392d29-5513-4a4e-bfda-e1b409c173e7" xlink:to="loc_ensg_HUDInsuredMortgagesMember_5f152cf9-81ff-4180-9194-14c08d492f42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A53PromissoryNoteMember_f21fc064-3971-4434-ba26-f83a163fb104" xlink:href="ensg-20241231.xsd#ensg_A53PromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9392d29-5513-4a4e-bfda-e1b409c173e7" xlink:to="loc_ensg_A53PromissoryNoteMember_f21fc064-3971-4434-ba26-f83a163fb104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_52760252-1302-43a9-8786-fd7136101877" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_dei_LegalEntityAxis_52760252-1302-43a9-8786-fd7136101877" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_52760252-1302-43a9-8786-fd7136101877_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_52760252-1302-43a9-8786-fd7136101877" xlink:to="loc_dei_EntityDomain_52760252-1302-43a9-8786-fd7136101877_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c9f6513b-0419-425d-889d-767f9ca98bcc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_52760252-1302-43a9-8786-fd7136101877" xlink:to="loc_dei_EntityDomain_c9f6513b-0419-425d-889d-767f9ca98bcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TwentyThreeSubsidiariesMember_0231325f-90f6-4540-b76e-67a629bece63" xlink:href="ensg-20241231.xsd#ensg_TwentyThreeSubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_c9f6513b-0419-425d-889d-767f9ca98bcc" xlink:to="loc_ensg_TwentyThreeSubsidiariesMember_0231325f-90f6-4540-b76e-67a629bece63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3d8a4fc4-3c39-410a-ba81-53c663cabb60" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_srt_RangeAxis_3d8a4fc4-3c39-410a-ba81-53c663cabb60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3d8a4fc4-3c39-410a-ba81-53c663cabb60_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3d8a4fc4-3c39-410a-ba81-53c663cabb60" xlink:to="loc_srt_RangeMember_3d8a4fc4-3c39-410a-ba81-53c663cabb60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_91dbd22d-b0d8-4be6-8013-8828815730ab" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3d8a4fc4-3c39-410a-ba81-53c663cabb60" xlink:to="loc_srt_RangeMember_91dbd22d-b0d8-4be6-8013-8828815730ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a97ac2c-c14f-4401-876d-4a3b9bbe9edb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_91dbd22d-b0d8-4be6-8013-8828815730ab" xlink:to="loc_srt_MinimumMember_4a97ac2c-c14f-4401-876d-4a3b9bbe9edb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1d0f37d2-fac2-4064-a41d-c405bf8d4e81" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_91dbd22d-b0d8-4be6-8013-8828815730ab" xlink:to="loc_srt_MaximumMember_1d0f37d2-fac2-4064-a41d-c405bf8d4e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentFeePeriodAxis_8fd7ae35-6f55-461c-9ce4-edf6578affab" xlink:href="ensg-20241231.xsd#ensg_PrepaymentFeePeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_ensg_PrepaymentFeePeriodAxis_8fd7ae35-6f55-461c-9ce4-edf6578affab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentFeePeriodDomain_8fd7ae35-6f55-461c-9ce4-edf6578affab_default" xlink:href="ensg-20241231.xsd#ensg_PrepaymentFeePeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_PrepaymentFeePeriodAxis_8fd7ae35-6f55-461c-9ce4-edf6578affab" xlink:to="loc_ensg_PrepaymentFeePeriodDomain_8fd7ae35-6f55-461c-9ce4-edf6578affab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:href="ensg-20241231.xsd#ensg_PrepaymentFeePeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_PrepaymentFeePeriodAxis_8fd7ae35-6f55-461c-9ce4-edf6578affab" xlink:to="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_FirstThreeYearsMember_9c0b25d7-9945-4302-84c8-54471f5b1016" xlink:href="ensg-20241231.xsd#ensg_FirstThreeYearsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:to="loc_ensg_FirstThreeYearsMember_9c0b25d7-9945-4302-84c8-54471f5b1016" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InTheFourthYearMember_35bc6954-8418-4282-850b-c97f6b036c89" xlink:href="ensg-20241231.xsd#ensg_InTheFourthYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:to="loc_ensg_InTheFourthYearMember_35bc6954-8418-4282-850b-c97f6b036c89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_YearsFiveThroughTenMember_3f304a67-a567-4e75-84fb-90ad60e5e6c9" xlink:href="ensg-20241231.xsd#ensg_YearsFiveThroughTenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:to="loc_ensg_YearsFiveThroughTenMember_3f304a67-a567-4e75-84fb-90ad60e5e6c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AfterYearTenMember_7682a320-0ac2-4a0c-8208-fbb60125c10d" xlink:href="ensg-20241231.xsd#ensg_AfterYearTenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:to="loc_ensg_AfterYearTenMember_7682a320-0ac2-4a0c-8208-fbb60125c10d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0b4a2c29-0993-469b-acf1-df6b31ddeb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_us-gaap_CreditFacilityAxis_0b4a2c29-0993-469b-acf1-df6b31ddeb1d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0b4a2c29-0993-469b-acf1-df6b31ddeb1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_0b4a2c29-0993-469b-acf1-df6b31ddeb1d" xlink:to="loc_us-gaap_CreditFacilityDomain_0b4a2c29-0993-469b-acf1-df6b31ddeb1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_17c93167-05ce-4098-abf1-0b86e073aec8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_0b4a2c29-0993-469b-acf1-df6b31ddeb1d" xlink:to="loc_us-gaap_CreditFacilityDomain_17c93167-05ce-4098-abf1-0b86e073aec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_bf65918d-462c-4e1b-ac1c-d21371d1feef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_17c93167-05ce-4098-abf1-0b86e073aec8" xlink:to="loc_us-gaap_LetterOfCreditMember_bf65918d-462c-4e1b-ac1c-d21371d1feef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfOperatingSubsidiaries_de735198-d955-4297-858d-5cacd22bb35e" xlink:href="ensg-20241231.xsd#ensg_NumberOfOperatingSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_ensg_NumberOfOperatingSubsidiaries_de735198-d955-4297-858d-5cacd22bb35e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_60c0a032-b206-41ec-86c3-644bc2bcef30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_60c0a032-b206-41ec-86c3-644bc2bcef30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f9967fac-fe42-4921-a6d7-69e6af9d0c79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f9967fac-fe42-4921-a6d7-69e6af9d0c79" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f7d8e8fa-072b-4a38-9ab0-2206ce02bcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f7d8e8fa-072b-4a38-9ab0-2206ce02bcf5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentPenalty_9f1b424a-a1ad-4467-a1a9-1fb52b2de950" xlink:href="ensg-20241231.xsd#ensg_PrepaymentPenalty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_ensg_PrepaymentPenalty_9f1b424a-a1ad-4467-a1a9-1fb52b2de950" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ReductionInPrepaymentPenalty_794fd7dd-9f48-4eb3-a6bf-7015f1271e54" xlink:href="ensg-20241231.xsd#ensg_ReductionInPrepaymentPenalty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_ensg_ReductionInPrepaymentPenalty_794fd7dd-9f48-4eb3-a6bf-7015f1271e54" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_58941b84-1064-4c02-bb2a-57434d0d3d52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentTerm_58941b84-1064-4c02-bb2a-57434d0d3d52" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4e5c58ee-0b0a-4186-b86a-8100262cdb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4e5c58ee-0b0a-4186-b86a-8100262cdb4b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_410c81e2-7d77-48a2-9b2d-d684865635a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_410c81e2-7d77-48a2-9b2d-d684865635a0" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSStockOptionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_366b8383-ce7f-489d-8c6f-53a7c7c2a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:to="loc_us-gaap_PlanNameAxis_366b8383-ce7f-489d-8c6f-53a7c7c2a02d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_366b8383-ce7f-489d-8c6f-53a7c7c2a02d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_366b8383-ce7f-489d-8c6f-53a7c7c2a02d" xlink:to="loc_us-gaap_PlanNameDomain_366b8383-ce7f-489d-8c6f-53a7c7c2a02d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_946864f1-bf11-472f-96c1-c907e7dd94a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_366b8383-ce7f-489d-8c6f-53a7c7c2a02d" xlink:to="loc_us-gaap_PlanNameDomain_946864f1-bf11-472f-96c1-c907e7dd94a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2022PlanMember_c5a129de-96ad-4d1f-8be7-e5c371bb67fb" xlink:href="ensg-20241231.xsd#ensg_A2022PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_946864f1-bf11-472f-96c1-c907e7dd94a7" xlink:to="loc_ensg_A2022PlanMember_c5a129de-96ad-4d1f-8be7-e5c371bb67fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_b17ce335-bb58-466e-9141-d18c75e9147b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:to="loc_us-gaap_GranteeStatusAxis_b17ce335-bb58-466e-9141-d18c75e9147b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_b17ce335-bb58-466e-9141-d18c75e9147b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_b17ce335-bb58-466e-9141-d18c75e9147b" xlink:to="loc_us-gaap_GranteeStatusDomain_b17ce335-bb58-466e-9141-d18c75e9147b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_e95f050a-3416-4cdd-ad10-7e27b591d916" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_b17ce335-bb58-466e-9141-d18c75e9147b" xlink:to="loc_us-gaap_GranteeStatusDomain_e95f050a-3416-4cdd-ad10-7e27b591d916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_925a384d-547e-47fb-a3e1-518abcbe2023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_e95f050a-3416-4cdd-ad10-7e27b591d916" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_925a384d-547e-47fb-a3e1-518abcbe2023" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a2729834-95a7-49c7-be55-0275224dd55c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:to="loc_us-gaap_AwardTypeAxis_a2729834-95a7-49c7-be55-0275224dd55c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2729834-95a7-49c7-be55-0275224dd55c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a2729834-95a7-49c7-be55-0275224dd55c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a2729834-95a7-49c7-be55-0275224dd55c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faeba213-7156-4bbe-95e5-6aa5f3409a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a2729834-95a7-49c7-be55-0275224dd55c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faeba213-7156-4bbe-95e5-6aa5f3409a44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3c50a116-f119-435d-940c-637475bc3671" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faeba213-7156-4bbe-95e5-6aa5f3409a44" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3c50a116-f119-435d-940c-637475bc3671" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfStockIncentivePlans_22203048-58ec-4285-874f-a2cf005690de" xlink:href="ensg-20241231.xsd#ensg_NumberOfStockIncentivePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_NumberOfStockIncentivePlans_22203048-58ec-4285-874f-a2cf005690de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c7661e9-5b2d-462b-952e-1bf38bb657d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c7661e9-5b2d-462b-952e-1bf38bb657d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability_a234f230-6129-40eb-8d5f-f329c66f1ac4" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability_a234f230-6129-40eb-8d5f-f329c66f1ac4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability_cfa8cf02-dae4-404b-8543-81a65e400526" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability_cfa8cf02-dae4-404b-8543-81a65e400526" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments_4ee7aa63-8bc8-45f4-9e51-53caf24ba1ce" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments_4ee7aa63-8bc8-45f4-9e51-53caf24ba1ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_fd796b48-59a0-4db8-8141-2b5c8ec345bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_fd796b48-59a0-4db8-8141-2b5c8ec345bd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47c6b1b3-74b5-495b-a269-dcce5139ad24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47c6b1b3-74b5-495b-a269-dcce5139ad24" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ebbaf5bf-2236-4dce-bebc-9cfc0d4aada8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ebbaf5bf-2236-4dce-bebc-9cfc0d4aada8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b90d185a-b327-4d05-883d-b18e090e2089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b90d185a-b327-4d05-883d-b18e090e2089" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_37e430c0-d930-456d-8ffc-dd7ac19ee81b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_37e430c0-d930-456d-8ffc-dd7ac19ee81b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate_6d05b250-28fd-485e-87bc-467e33a02253" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate_6d05b250-28fd-485e-87bc-467e33a02253" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_94bce7be-c4a4-4fed-bc8a-85bfc62fbc73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_94bce7be-c4a4-4fed-bc8a-85bfc62fbc73" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_a098f351-84b5-49f2-8c8b-caa26439231c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_a098f351-84b5-49f2-8c8b-caa26439231c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3d48ab98-0d92-470e-b502-9b12053ac267" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3d48ab98-0d92-470e-b502-9b12053ac267" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_5fa42c5d-a759-45f6-a2b3-508ec0fab99f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_5fa42c5d-a759-45f6-a2b3-508ec0fab99f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_829ebd26-9e46-478f-ad12-812f20dd8725" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_5fa42c5d-a759-45f6-a2b3-508ec0fab99f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_829ebd26-9e46-478f-ad12-812f20dd8725" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_829ebd26-9e46-478f-ad12-812f20dd8725_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_829ebd26-9e46-478f-ad12-812f20dd8725" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_829ebd26-9e46-478f-ad12-812f20dd8725_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_829ebd26-9e46-478f-ad12-812f20dd8725" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeOneMember_f70593b0-67ff-4e40-a2cf-2ba19453f45c" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeOneMember_f70593b0-67ff-4e40-a2cf-2ba19453f45c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeTwoMember_6ceefd46-d2c7-4161-9845-80a42771e0f3" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeTwoMember_6ceefd46-d2c7-4161-9845-80a42771e0f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeThreeMember_8dfeb6b0-7661-4319-bc8c-c4adc4d52f22" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeThreeMember_8dfeb6b0-7661-4319-bc8c-c4adc4d52f22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeFourMember_6ba3f21e-e9da-41a7-a562-c5b5fc089d12" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeFourMember_6ba3f21e-e9da-41a7-a562-c5b5fc089d12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeFiveMember_7ec65dc4-81a5-4f3c-a1de-a47484309950" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeFiveMember_7ec65dc4-81a5-4f3c-a1de-a47484309950" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeSixMember_ee2304b2-e52f-4aa1-b9cc-40deead23af4" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeSixMember_ee2304b2-e52f-4aa1-b9cc-40deead23af4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeSevenMember_271dc412-3d58-494b-84fc-857e79f880fb" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeSevenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeSevenMember_271dc412-3d58-494b-84fc-857e79f880fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeEightMember_08d9db3d-60a8-4314-9740-8976236a8c34" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeEightMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeEightMember_08d9db3d-60a8-4314-9740-8976236a8c34" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeNineMember_e55b7835-3a37-420b-a6ce-0b1d79a6eaad" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeNineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeNineMember_e55b7835-3a37-420b-a6ce-0b1d79a6eaad" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeTenMember_88a3daae-9d23-46b9-9969-ec804f8035cd" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeTenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeTenMember_88a3daae-9d23-46b9-9969-ec804f8035cd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_51b1a984-99d3-4ef8-93a6-058c5ce58e56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_51b1a984-99d3-4ef8-93a6-058c5ce58e56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_204ff60a-831f-47f0-ad99-7c5e511d413a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_204ff60a-831f-47f0-ad99-7c5e511d413a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0ba4c5ba-3731-494d-aa14-414de99cf128" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0ba4c5ba-3731-494d-aa14-414de99cf128" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue_a7913b1e-7b47-4422-9658-3a60f4ec0ab3" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue_a7913b1e-7b47-4422-9658-3a60f4ec0ab3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_18896f2c-34e2-41ba-83d2-8e0095fb9c68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_18896f2c-34e2-41ba-83d2-8e0095fb9c68" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d7d2e636-c3b2-4c9f-b220-8326e848e949" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d7d2e636-c3b2-4c9f-b220-8326e848e949" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:to="loc_us-gaap_AwardTypeAxis_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7009b67-0093-4473-b189-de33ce7399cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7009b67-0093-4473-b189-de33ce7399cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a82bae5f-fcf5-43d2-ab2c-e9ba821dafc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7009b67-0093-4473-b189-de33ce7399cb" xlink:to="loc_us-gaap_RestrictedStockMember_a82bae5f-fcf5-43d2-ab2c-e9ba821dafc0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1efb2f16-31d2-4378-bfab-721b8b299205" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:to="loc_srt_RangeAxis_1efb2f16-31d2-4378-bfab-721b8b299205" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1efb2f16-31d2-4378-bfab-721b8b299205_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1efb2f16-31d2-4378-bfab-721b8b299205" xlink:to="loc_srt_RangeMember_1efb2f16-31d2-4378-bfab-721b8b299205_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_946f150c-bca0-48bf-9d98-075561dea98d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1efb2f16-31d2-4378-bfab-721b8b299205" xlink:to="loc_srt_RangeMember_946f150c-bca0-48bf-9d98-075561dea98d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7d249a5d-5502-4e13-a9a4-bcfcb5b50421" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_946f150c-bca0-48bf-9d98-075561dea98d" xlink:to="loc_srt_MinimumMember_7d249a5d-5502-4e13-a9a4-bcfcb5b50421" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_71a37494-4de5-4a6b-af80-46545ad36325" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_946f150c-bca0-48bf-9d98-075561dea98d" xlink:to="loc_srt_MaximumMember_71a37494-4de5-4a6b-af80-46545ad36325" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_87419702-ac53-4a9b-b3ff-763a8a57788a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:to="loc_us-gaap_GranteeStatusAxis_87419702-ac53-4a9b-b3ff-763a8a57788a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_87419702-ac53-4a9b-b3ff-763a8a57788a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_87419702-ac53-4a9b-b3ff-763a8a57788a" xlink:to="loc_us-gaap_GranteeStatusDomain_87419702-ac53-4a9b-b3ff-763a8a57788a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_911c3027-efc6-45e2-8ea4-6de53ad5ed81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_87419702-ac53-4a9b-b3ff-763a8a57788a" xlink:to="loc_us-gaap_GranteeStatusDomain_911c3027-efc6-45e2-8ea4-6de53ad5ed81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_4f0fb930-c059-4a7f-8a88-10d80c815f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_911c3027-efc6-45e2-8ea4-6de53ad5ed81" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_4f0fb930-c059-4a7f-8a88-10d80c815f1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7e462e4e-5875-480b-97e9-bcb0ce3691d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7e462e4e-5875-480b-97e9-bcb0ce3691d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice_dda37e63-17f0-45e0-b1e4-482ec0c71eff" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice_dda37e63-17f0-45e0-b1e4-482ec0c71eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7f61c8ff-2ef7-4415-a0cf-91de40852459" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7f61c8ff-2ef7-4415-a0cf-91de40852459" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b5739262-143c-4480-ba29-c631b24704e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b5739262-143c-4480-ba29-c631b24704e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod_94b37c47-c49e-4bc4-b695-2827a638a26b" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod_94b37c47-c49e-4bc4-b695-2827a638a26b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b59a220-0f29-44ee-b3d5-1f787c19607c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_631dd9e1-7026-49e9-9fa2-50d147c849f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b59a220-0f29-44ee-b3d5-1f787c19607c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_631dd9e1-7026-49e9-9fa2-50d147c849f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6f629045-f6ec-4315-8b5d-01a701e3dcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_631dd9e1-7026-49e9-9fa2-50d147c849f3" xlink:to="loc_us-gaap_AwardTypeAxis_6f629045-f6ec-4315-8b5d-01a701e3dcb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f629045-f6ec-4315-8b5d-01a701e3dcb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6f629045-f6ec-4315-8b5d-01a701e3dcb8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f629045-f6ec-4315-8b5d-01a701e3dcb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd0ea857-0651-4801-8dc6-7979adec31e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6f629045-f6ec-4315-8b5d-01a701e3dcb8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd0ea857-0651-4801-8dc6-7979adec31e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_eab0d6d8-e0d0-420c-b765-7eb299f1e2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd0ea857-0651-4801-8dc6-7979adec31e2" xlink:to="loc_us-gaap_RestrictedStockMember_eab0d6d8-e0d0-420c-b765-7eb299f1e2c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b59a220-0f29-44ee-b3d5-1f787c19607c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_36aac8d2-c6f9-46df-9629-1dd26dccc7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_36aac8d2-c6f9-46df-9629-1dd26dccc7b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6e9213a-b145-4a42-a1b7-ceb3f3084484" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6e9213a-b145-4a42-a1b7-ceb3f3084484" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94341e63-e60d-41a0-81f5-dde78912f61e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94341e63-e60d-41a0-81f5-dde78912f61e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1728bb17-4bc2-4fad-b942-61eddb1c59fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1728bb17-4bc2-4fad-b942-61eddb1c59fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638313ed-806b-4150-a447-ec8b980cbe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b59a220-0f29-44ee-b3d5-1f787c19607c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_121aa51d-1bee-40ff-a112-d286e6871b02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_121aa51d-1bee-40ff-a112-d286e6871b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a69b2fd8-2034-4105-8018-9ea02bf6bf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a69b2fd8-2034-4105-8018-9ea02bf6bf6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1e2fc200-ff79-4d1b-b438-2bebf7cc45ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1e2fc200-ff79-4d1b-b438-2bebf7cc45ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_cecae181-f0c3-4f40-bc42-d6ea2b95fe26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_cecae181-f0c3-4f40-bc42-d6ea2b95fe26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_299c3c27-bbef-4af3-b7e5-8d85893c3e21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_367a532a-eeef-46e9-a807-48c16cbff9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_367a532a-eeef-46e9-a807-48c16cbff9b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_367a532a-eeef-46e9-a807-48c16cbff9b7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_367a532a-eeef-46e9-a807-48c16cbff9b7" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_367a532a-eeef-46e9-a807-48c16cbff9b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d7eebbc7-c9bb-4e84-a05a-c89a1ed01b37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_367a532a-eeef-46e9-a807-48c16cbff9b7" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d7eebbc7-c9bb-4e84-a05a-c89a1ed01b37" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpinoffMember_cecbc3ea-d24f-4772-9d87-724bca3e71b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SpinoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d7eebbc7-c9bb-4e84-a05a-c89a1ed01b37" xlink:to="loc_us-gaap_SpinoffMember_cecbc3ea-d24f-4772-9d87-724bca3e71b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5704fa8a-4418-4b12-88f4-3960c55a7657" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:to="loc_us-gaap_PlanNameAxis_5704fa8a-4418-4b12-88f4-3960c55a7657" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5704fa8a-4418-4b12-88f4-3960c55a7657_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5704fa8a-4418-4b12-88f4-3960c55a7657" xlink:to="loc_us-gaap_PlanNameDomain_5704fa8a-4418-4b12-88f4-3960c55a7657_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a5651a97-1c5c-432c-afe6-be6807a5b2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5704fa8a-4418-4b12-88f4-3960c55a7657" xlink:to="loc_us-gaap_PlanNameDomain_a5651a97-1c5c-432c-afe6-be6807a5b2a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2019LTIPlanMember_7751a7f3-b041-4c8f-bdcd-d90538449026" xlink:href="ensg-20241231.xsd#ensg_A2019LTIPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a5651a97-1c5c-432c-afe6-be6807a5b2a3" xlink:to="loc_ensg_A2019LTIPlanMember_7751a7f3-b041-4c8f-bdcd-d90538449026" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0c8b1cad-2c00-4a07-b067-3954a7650dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0c8b1cad-2c00-4a07-b067-3954a7650dd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9132faeb-60fe-4743-9256-7333ff3b4510" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9132faeb-60fe-4743-9256-7333ff3b4510" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_60792ec6-1215-4db0-aa92-cbc43023641a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_60792ec6-1215-4db0-aa92-cbc43023641a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a79b5152-db5d-444a-9455-6b2d629528a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a79b5152-db5d-444a-9455-6b2d629528a3" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_162aff1d-18ee-4ec7-84f2-f0d2970d5163" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_162aff1d-18ee-4ec7-84f2-f0d2970d5163" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_636026e4-e61e-46f6-a570-c320453e9699" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_162aff1d-18ee-4ec7-84f2-f0d2970d5163" xlink:to="loc_us-gaap_AwardTypeAxis_636026e4-e61e-46f6-a570-c320453e9699" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636026e4-e61e-46f6-a570-c320453e9699_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_636026e4-e61e-46f6-a570-c320453e9699" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636026e4-e61e-46f6-a570-c320453e9699_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_636026e4-e61e-46f6-a570-c320453e9699" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_698e7d4e-9539-437e-b2e0-fe6b74a3c26d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:to="loc_us-gaap_EmployeeStockOptionMember_698e7d4e-9539-437e-b2e0-fe6b74a3c26d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_685b3a76-1db4-40a8-8e54-61c71519c5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:to="loc_us-gaap_RestrictedStockMember_685b3a76-1db4-40a8-8e54-61c71519c5f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OtherStockAwardsMember_97d0b01f-d5a3-42bf-a4b2-2058c8770713" xlink:href="ensg-20241231.xsd#ensg_OtherStockAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:to="loc_ensg_OtherStockAwardsMember_97d0b01f-d5a3-42bf-a4b2-2058c8770713" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_663bc3a5-54d5-4caf-8c1c-9f42448bee2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_663bc3a5-54d5-4caf-8c1c-9f42448bee2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6946fac6-9f95-48ab-a221-35a93eff4089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6946fac6-9f95-48ab-a221-35a93eff4089" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e2e5236d-1c12-44e0-a3ea-c65d19885d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e2e5236d-1c12-44e0-a3ea-c65d19885d7c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards_6b3f2f93-c0d0-46e9-a559-2e219b94e470" xlink:href="ensg-20241231.xsd#ensg_EmployeeServiceShareBasedCompensationNonvestedAwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards_6b3f2f93-c0d0-46e9-a559-2e219b94e470" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber_dddb3928-d5b8-4341-a127-fa0478bcf23f" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber_dddb3928-d5b8-4341-a127-fa0478bcf23f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6cb0c2d5-3ec6-48a2-8492-21ac522e699e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6cb0c2d5-3ec6-48a2-8492-21ac522e699e" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESLesseeNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis_5fc8d43f-36f5-45d6-b829-91213036361e" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_ensg_LeaseArrangementAxis_5fc8d43f-36f5-45d6-b829-91213036361e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_5fc8d43f-36f5-45d6-b829-91213036361e_default" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_LeaseArrangementAxis_5fc8d43f-36f5-45d6-b829-91213036361e" xlink:to="loc_ensg_LeaseArrangementDomain_5fc8d43f-36f5-45d6-b829-91213036361e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_LeaseArrangementAxis_5fc8d43f-36f5-45d6-b829-91213036361e" xlink:to="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MasterLeaseAgreementsMember_640bab9a-b2ee-41a8-8a84-ef15c7470bd2" xlink:href="ensg-20241231.xsd#ensg_MasterLeaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:to="loc_ensg_MasterLeaseAgreementsMember_640bab9a-b2ee-41a8-8a84-ef15c7470bd2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NewAndAmendedMasterLeaseAgreementMember_cc6249c7-d9d8-409b-9070-193b6179e437" xlink:href="ensg-20241231.xsd#ensg_NewAndAmendedMasterLeaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_MasterLeaseAgreementsMember_640bab9a-b2ee-41a8-8a84-ef15c7470bd2" xlink:to="loc_ensg_NewAndAmendedMasterLeaseAgreementMember_cc6249c7-d9d8-409b-9070-193b6179e437" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementMember_b87d7d8c-893e-4d77-88c1-fe80b475e353" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_NewAndAmendedMasterLeaseAgreementMember_cc6249c7-d9d8-409b-9070-193b6179e437" xlink:to="loc_ensg_AmendedMasterLeaseAgreementMember_b87d7d8c-893e-4d77-88c1-fe80b475e353" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementOneMember_75c312aa-a226-4151-b1af-f61be05f051a" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_AmendedMasterLeaseAgreementMember_b87d7d8c-893e-4d77-88c1-fe80b475e353" xlink:to="loc_ensg_AmendedMasterLeaseAgreementOneMember_75c312aa-a226-4151-b1af-f61be05f051a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementTwoMember_91660fdc-f051-4f36-90b8-2d2c19b36c47" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_AmendedMasterLeaseAgreementMember_b87d7d8c-893e-4d77-88c1-fe80b475e353" xlink:to="loc_ensg_AmendedMasterLeaseAgreementTwoMember_91660fdc-f051-4f36-90b8-2d2c19b36c47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NewMasterLeaseAgreementMember_64625939-2563-44dd-afb5-61ce9dcf33e6" xlink:href="ensg-20241231.xsd#ensg_NewMasterLeaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_NewAndAmendedMasterLeaseAgreementMember_cc6249c7-d9d8-409b-9070-193b6179e437" xlink:to="loc_ensg_NewMasterLeaseAgreementMember_64625939-2563-44dd-afb5-61ce9dcf33e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TripleNetLeaseArrangementsMember_c2ba1657-4c68-4a61-9f45-6b940e45b4d0" xlink:href="ensg-20241231.xsd#ensg_TripleNetLeaseArrangementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:to="loc_ensg_TripleNetLeaseArrangementsMember_c2ba1657-4c68-4a61-9f45-6b940e45b4d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PurchaseOptionMember_e1a54f4e-738a-4cb5-9c8c-03aa64f09542" xlink:href="ensg-20241231.xsd#ensg_PurchaseOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:to="loc_ensg_PurchaseOptionMember_e1a54f4e-738a-4cb5-9c8c-03aa64f09542" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_00305b48-af55-4d68-8ad9-d1f4aeb48363" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_srt_CounterpartyNameAxis_00305b48-af55-4d68-8ad9-d1f4aeb48363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_00305b48-af55-4d68-8ad9-d1f4aeb48363_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_00305b48-af55-4d68-8ad9-d1f4aeb48363" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_00305b48-af55-4d68-8ad9-d1f4aeb48363_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4ddf3c5-de09-4357-8f4a-f751c1a30db2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_00305b48-af55-4d68-8ad9-d1f4aeb48363" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4ddf3c5-de09-4357-8f4a-f751c1a30db2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CareTrustREITMember_134a411c-b8d0-4867-946b-e14a7abc0bda" xlink:href="ensg-20241231.xsd#ensg_CareTrustREITMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4ddf3c5-de09-4357-8f4a-f751c1a30db2" xlink:to="loc_ensg_CareTrustREITMember_134a411c-b8d0-4867-946b-e14a7abc0bda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_VariousLandlordsMember_522aaa4b-b7b4-4db4-af3c-63cdd6150018" xlink:href="ensg-20241231.xsd#ensg_VariousLandlordsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4ddf3c5-de09-4357-8f4a-f751c1a30db2" xlink:to="loc_ensg_VariousLandlordsMember_522aaa4b-b7b4-4db4-af3c-63cdd6150018" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_054b18b4-0ebb-4ecd-85a4-97146c3fd955" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_054b18b4-0ebb-4ecd-85a4-97146c3fd955" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_054b18b4-0ebb-4ecd-85a4-97146c3fd955_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_054b18b4-0ebb-4ecd-85a4-97146c3fd955" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_054b18b4-0ebb-4ecd-85a4-97146c3fd955_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_054b18b4-0ebb-4ecd-85a4-97146c3fd955" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember_1a45af17-7967-489f-b4a5-71ff80011f9b" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:to="loc_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember_1a45af17-7967-489f-b4a5-71ff80011f9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperationMember_f6835328-532d-4491-9acb-64c29e196c61" xlink:href="ensg-20241231.xsd#ensg_OperationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:to="loc_ensg_OperationMember_f6835328-532d-4491-9acb-64c29e196c61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_a4e70a0c-1cea-4fd8-83c5-29df8d4c9504" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:to="loc_ensg_SkilledNursingOperationsMember_a4e70a0c-1cea-4fd8-83c5-29df8d4c9504" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f7b551c-5732-48be-88b3-3460182a11ef" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_srt_RangeAxis_6f7b551c-5732-48be-88b3-3460182a11ef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f7b551c-5732-48be-88b3-3460182a11ef_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6f7b551c-5732-48be-88b3-3460182a11ef" xlink:to="loc_srt_RangeMember_6f7b551c-5732-48be-88b3-3460182a11ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f9bb446c-174d-4997-a9bb-700333af5ee8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6f7b551c-5732-48be-88b3-3460182a11ef" xlink:to="loc_srt_RangeMember_f9bb446c-174d-4997-a9bb-700333af5ee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dbef945b-1f03-4639-ab2b-de354eb11d5b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f9bb446c-174d-4997-a9bb-700333af5ee8" xlink:to="loc_srt_MinimumMember_dbef945b-1f03-4639-ab2b-de354eb11d5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df13aca8-bb92-45c5-8260-eef4590bb718" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f9bb446c-174d-4997-a9bb-700333af5ee8" xlink:to="loc_srt_MaximumMember_df13aca8-bb92-45c5-8260-eef4590bb718" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_dbe06a47-209b-4150-a3dc-1cf5f3932a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_AssetAcquisitionAxis_dbe06a47-209b-4150-a3dc-1cf5f3932a1e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_dbe06a47-209b-4150-a3dc-1cf5f3932a1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_dbe06a47-209b-4150-a3dc-1cf5f3932a1e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_dbe06a47-209b-4150-a3dc-1cf5f3932a1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_32d1f263-5999-46de-858e-5dbf436c53af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_dbe06a47-209b-4150-a3dc-1cf5f3932a1e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_32d1f263-5999-46de-858e-5dbf436c53af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember_a638ec94-f0db-4cd3-be27-cf96bdd4887e" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_32d1f263-5999-46de-858e-5dbf436c53af" xlink:to="loc_ensg_A2024AcquiredPropertiesMember_a638ec94-f0db-4cd3-be27-cf96bdd4887e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2025AcquiredPropertiesMember_0372cc36-de4b-416f-b7cd-e03ae2e7b996" xlink:href="ensg-20241231.xsd#ensg_A2025AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_32d1f263-5999-46de-858e-5dbf436c53af" xlink:to="loc_ensg_A2025AcquiredPropertiesMember_0372cc36-de4b-416f-b7cd-e03ae2e7b996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d54e29aa-3dea-436a-8245-cac751c3ed5c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_dei_LegalEntityAxis_d54e29aa-3dea-436a-8245-cac751c3ed5c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d54e29aa-3dea-436a-8245-cac751c3ed5c_default" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d54e29aa-3dea-436a-8245-cac751c3ed5c" xlink:to="loc_dei_EntityDomain_d54e29aa-3dea-436a-8245-cac751c3ed5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_86e99c5c-911e-4b2d-9e7a-6f024505e12e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d54e29aa-3dea-436a-8245-cac751c3ed5c" xlink:to="loc_dei_EntityDomain_86e99c5c-911e-4b2d-9e7a-6f024505e12e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember_17139864-c384-46db-b176-6e9653f1fe22" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_86e99c5c-911e-4b2d-9e7a-6f024505e12e" xlink:to="loc_ensg_StandardBearerHealthcareREITIncMember_17139864-c384-46db-b176-6e9653f1fe22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fcfdc668-81b3-4fad-8479-7dd99ada4b02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fcfdc668-81b3-4fad-8479-7dd99ada4b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6e3c80ff-410b-4b59-8fae-e7816d0c55e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_fcfdc668-81b3-4fad-8479-7dd99ada4b02" xlink:to="loc_us-gaap_SubsequentEventMember_6e3c80ff-410b-4b59-8fae-e7816d0c55e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6d244fae-95d1-4b13-ad51-69e545b32413" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6d244fae-95d1-4b13-ad51-69e545b32413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_599ad1ce-96f5-412d-82e2-5900d6d9ccb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6d244fae-95d1-4b13-ad51-69e545b32413" xlink:to="loc_us-gaap_EquipmentMember_599ad1ce-96f5-412d-82e2-5900d6d9ccb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_10e72bdf-3a28-4b95-bde1-d223ecab295f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_10e72bdf-3a28-4b95-bde1-d223ecab295f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_10e72bdf-3a28-4b95-bde1-d223ecab295f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10e72bdf-3a28-4b95-bde1-d223ecab295f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_10e72bdf-3a28-4b95-bde1-d223ecab295f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5bd49c5e-8d5f-46c9-ba21-cd3e3d894e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10e72bdf-3a28-4b95-bde1-d223ecab295f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5bd49c5e-8d5f-46c9-ba21-cd3e3d894e4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CostofSalesandGeneralandAdministrativeExpenseMember_a7675bc6-4a7c-4ad0-b5f6-cc66a6288124" xlink:href="ensg-20241231.xsd#ensg_CostofSalesandGeneralandAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5bd49c5e-8d5f-46c9-ba21-cd3e3d894e4d" xlink:to="loc_ensg_CostofSalesandGeneralandAdministrativeExpenseMember_a7675bc6-4a7c-4ad0-b5f6-cc66a6288124" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis_9922cfcc-28e0-4783-986a-c77eb8a0fd07" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_ensg_OperatingEntityAxis_9922cfcc-28e0-4783-986a-c77eb8a0fd07" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_9922cfcc-28e0-4783-986a-c77eb8a0fd07_default" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_OperatingEntityAxis_9922cfcc-28e0-4783-986a-c77eb8a0fd07" xlink:to="loc_ensg_OperatingEntityDomain_9922cfcc-28e0-4783-986a-c77eb8a0fd07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_e00d4ed9-c6ce-4f53-8c7f-5c2c17fee098" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_OperatingEntityAxis_9922cfcc-28e0-4783-986a-c77eb8a0fd07" xlink:to="loc_ensg_OperatingEntityDomain_e00d4ed9-c6ce-4f53-8c7f-5c2c17fee098" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_5d98c8d1-9196-406a-81d3-d3a91ed50053" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_OperatingEntityDomain_e00d4ed9-c6ce-4f53-8c7f-5c2c17fee098" xlink:to="loc_srt_SubsidiariesMember_5d98c8d1-9196-406a-81d3-d3a91ed50053" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_23e2bdb4-3b64-4a43-9682-3a432190fd72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_23e2bdb4-3b64-4a43-9682-3a432190fd72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfMasterLeaseAgreements_9b2c5604-4212-4403-a1e6-295567224543" xlink:href="ensg-20241231.xsd#ensg_NumberOfMasterLeaseAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_NumberOfMasterLeaseAgreements_9b2c5604-4212-4403-a1e6-295567224543" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_5627902c-1157-492e-9f32-2df0c6479c40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_5627902c-1157-492e-9f32-2df0c6479c40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_9260db84-1ac0-4083-8c66-22782312eb9c" xlink:href="ensg-20241231.xsd#ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_9260db84-1ac0-4083-8c66-22782312eb9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a5c7a1b1-dc33-4eb6-9614-3a39ee64fb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a5c7a1b1-dc33-4eb6-9614-3a39ee64fb7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseTermExtension_726c838d-166c-4591-9410-b71211bef175" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseTermExtension"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_LesseeOperatingLeaseTermExtension_726c838d-166c-4591-9410-b71211bef175" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_1e6e1690-91d8-4718-8921-dcaef98b80c9" xlink:href="ensg-20241231.xsd#ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_1e6e1690-91d8-4718-8921-dcaef98b80c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_814a11cd-0849-4134-9b16-6143efe5d432" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_814a11cd-0849-4134-9b16-6143efe5d432" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_159bfff9-a932-43e9-bd04-8fc84e18e240" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_159bfff9-a932-43e9-bd04-8fc84e18e240" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseConsumerPriceIndex_7aa6f11e-03b8-4e51-b864-7d5a0900f8cd" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseConsumerPriceIndex"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_LesseeOperatingLeaseConsumerPriceIndex_7aa6f11e-03b8-4e51-b864-7d5a0900f8cd" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_a10c69e6-04e1-49c5-8d09-cb59da3c5627" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_a10c69e6-04e1-49c5-8d09-cb59da3c5627" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseNumberOfLeases_cbf467d8-f067-4dfe-a085-c9bb1d63a8a3" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseNumberOfLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_LesseeOperatingLeaseNumberOfLeases_cbf467d8-f067-4dfe-a085-c9bb1d63a8a3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_1095e428-1f8e-4380-9728-80a1625cfb53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_OperatingLeaseExpense_1095e428-1f8e-4380-9728-80a1625cfb53" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SubsidiariesUnderMasterLeaseArrangement_08aaf78f-8822-40e4-9922-f46c9cb2753d" xlink:href="ensg-20241231.xsd#ensg_SubsidiariesUnderMasterLeaseArrangement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_SubsidiariesUnderMasterLeaseArrangement_08aaf78f-8822-40e4-9922-f46c9cb2753d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_e426141b-0b82-4f23-8c9c-a122829f5c60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_e426141b-0b82-4f23-8c9c-a122829f5c60" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ee33783c-fc3c-48c0-9db5-854335a95aff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ee33783c-fc3c-48c0-9db5-854335a95aff" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6237283f-6ce9-4bd6-b8d1-9bb770bf0171" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6237283f-6ce9-4bd6-b8d1-9bb770bf0171" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofOperatingLeaseExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_9ebd1345-1010-41d6-b888-cfdca7a2959f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_9ebd1345-1010-41d6-b888-cfdca7a2959f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9ebd1345-1010-41d6-b888-cfdca7a2959f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e7017c0d-9d18-4841-ba85-ad12e684088e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:to="loc_us-gaap_CostOfSalesMember_e7017c0d-9d18-4841-ba85-ad12e684088e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cfab102b-8fe5-4c21-ac4a-c8f0455404f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cfab102b-8fe5-4c21-ac4a-c8f0455404f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DepreciationAndAmortizationMember_a97f460b-2720-45a2-875e-4f3285f46e1b" xlink:href="ensg-20241231.xsd#ensg_DepreciationAndAmortizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:to="loc_ensg_DepreciationAndAmortizationMember_a97f460b-2720-45a2-875e-4f3285f46e1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_dedfad1d-be0d-4dcf-a4f5-6306526d76b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_OperatingLeaseCost_dedfad1d-be0d-4dcf-a4f5-6306526d76b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_4ad41bb9-0148-4473-96ba-30a33232f51d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_VariableLeaseCost_4ad41bb9-0148-4473-96ba-30a33232f51d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9e5f23d1-e9f2-4f12-b6d7-82d8678dc944" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_LeaseCost_9e5f23d1-e9f2-4f12-b6d7-82d8678dc944" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AccruedRentAdjustment_2cb62167-a6b6-4cf1-a0de-3a320b61d023" xlink:href="ensg-20241231.xsd#ensg_AccruedRentAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_ensg_AccruedRentAdjustment_2cb62167-a6b6-4cf1-a0de-3a320b61d023" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_554dae8a-eb91-431b-bcc9-789ca30f9ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_ShortTermLeaseCost_554dae8a-eb91-431b-bcc9-789ca30f9ff7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESLessorNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems_a3767501-2e0d-4e12-a385-9b9621764470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_a3767501-2e0d-4e12-a385-9b9621764470" xlink:to="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis_9052abd9-4264-46f7-99f0-362f5aa18226" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_ensg_LeaseArrangementAxis_9052abd9-4264-46f7-99f0-362f5aa18226" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_9052abd9-4264-46f7-99f0-362f5aa18226_default" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_LeaseArrangementAxis_9052abd9-4264-46f7-99f0-362f5aa18226" xlink:to="loc_ensg_LeaseArrangementDomain_9052abd9-4264-46f7-99f0-362f5aa18226_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_29643f6e-c326-46d5-bddf-aec78ed50519" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_LeaseArrangementAxis_9052abd9-4264-46f7-99f0-362f5aa18226" xlink:to="loc_ensg_LeaseArrangementDomain_29643f6e-c326-46d5-bddf-aec78ed50519" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasesToThirdPartyOperatorsMember_74447115-63a3-417e-b0d8-f9b6df384275" xlink:href="ensg-20241231.xsd#ensg_LeasesToThirdPartyOperatorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_LeaseArrangementDomain_29643f6e-c326-46d5-bddf-aec78ed50519" xlink:to="loc_ensg_LeasesToThirdPartyOperatorsMember_74447115-63a3-417e-b0d8-f9b6df384275" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SubleaseToThirdPartyOperatorsMember_36cc4df9-2714-4c9d-b1a3-40ef7e0836f3" xlink:href="ensg-20241231.xsd#ensg_SubleaseToThirdPartyOperatorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_LeaseArrangementDomain_29643f6e-c326-46d5-bddf-aec78ed50519" xlink:to="loc_ensg_SubleaseToThirdPartyOperatorsMember_36cc4df9-2714-4c9d-b1a3-40ef7e0836f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_37736f9e-8f33-4011-8ee3-d2a432ee1637" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_srt_CounterpartyNameAxis_37736f9e-8f33-4011-8ee3-d2a432ee1637" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37736f9e-8f33-4011-8ee3-d2a432ee1637_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_37736f9e-8f33-4011-8ee3-d2a432ee1637" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_37736f9e-8f33-4011-8ee3-d2a432ee1637_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_86ec0257-3aa7-460b-b564-c23e2d345083" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_37736f9e-8f33-4011-8ee3-d2a432ee1637" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_86ec0257-3aa7-460b-b564-c23e2d345083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThePennantGroupInc.Member_4382270d-dc40-4407-8f65-2ec429d3e402" xlink:href="ensg-20241231.xsd#ensg_ThePennantGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_86ec0257-3aa7-460b-b564-c23e2d345083" xlink:to="loc_ensg_ThePennantGroupInc.Member_4382270d-dc40-4407-8f65-2ec429d3e402" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d6034954-5966-458c-9e92-d20265f37301" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_srt_RangeAxis_d6034954-5966-458c-9e92-d20265f37301" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d6034954-5966-458c-9e92-d20265f37301_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d6034954-5966-458c-9e92-d20265f37301" xlink:to="loc_srt_RangeMember_d6034954-5966-458c-9e92-d20265f37301_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c8395550-f5c4-42a9-8486-60d9c11d5265" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d6034954-5966-458c-9e92-d20265f37301" xlink:to="loc_srt_RangeMember_c8395550-f5c4-42a9-8486-60d9c11d5265" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_69c63e5b-7af9-4b8d-a8b7-d69c6396c534" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c8395550-f5c4-42a9-8486-60d9c11d5265" xlink:to="loc_srt_MinimumMember_69c63e5b-7af9-4b8d-a8b7-d69c6396c534" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8fce12e7-3ccc-4c2c-aa40-72636079bd1a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c8395550-f5c4-42a9-8486-60d9c11d5265" xlink:to="loc_srt_MaximumMember_8fce12e7-3ccc-4c2c-aa40-72636079bd1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_4c7d7ad4-7753-4df3-af75-1136fe9267e3" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:to="loc_ensg_SeniorLivingOperationsMember_4c7d7ad4-7753-4df3-af75-1136fe9267e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_d45d4093-46a0-4a95-a4e2-5f72748f393a" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:to="loc_ensg_SkilledNursingOperationsMember_d45d4093-46a0-4a95-a4e2-5f72748f393a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_932e3755-5e7b-4c5c-8c76-55c10f8bfb8b" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:to="loc_ensg_CampusOperationsMember_932e3755-5e7b-4c5c-8c76-55c10f8bfb8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_aea1f6df-fb8a-46ab-82e9-3629069f156d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_us-gaap_AssetAcquisitionAxis_aea1f6df-fb8a-46ab-82e9-3629069f156d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_aea1f6df-fb8a-46ab-82e9-3629069f156d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_aea1f6df-fb8a-46ab-82e9-3629069f156d" xlink:to="loc_us-gaap_AssetAcquisitionDomain_aea1f6df-fb8a-46ab-82e9-3629069f156d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_91de662f-63a0-468f-a181-9fcbeadbc7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_aea1f6df-fb8a-46ab-82e9-3629069f156d" xlink:to="loc_us-gaap_AssetAcquisitionDomain_91de662f-63a0-468f-a181-9fcbeadbc7bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2023AcquiredPropertiesMember_d79c5f76-3a6c-4e1d-860a-97e0c1fa65b1" xlink:href="ensg-20241231.xsd#ensg_A2023AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_91de662f-63a0-468f-a181-9fcbeadbc7bd" xlink:to="loc_ensg_A2023AcquiredPropertiesMember_d79c5f76-3a6c-4e1d-860a-97e0c1fa65b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember_38908fc4-4b31-4742-9c37-faadb4b9ad7c" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_91de662f-63a0-468f-a181-9fcbeadbc7bd" xlink:to="loc_ensg_A2024AcquiredPropertiesMember_38908fc4-4b31-4742-9c37-faadb4b9ad7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_078fda41-2b9e-4a67-bfcc-f6f5dbf89513" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_a3767501-2e0d-4e12-a385-9b9621764470" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_078fda41-2b9e-4a67-bfcc-f6f5dbf89513" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_ea797b26-d953-4245-b232-32b023bccdac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_a3767501-2e0d-4e12-a385-9b9621764470" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_ea797b26-d953-4245-b232-32b023bccdac" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:to="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis_a3111e9f-dedf-4441-9f9f-8c6d61efffce" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_ensg_LeaseArrangementAxis_a3111e9f-dedf-4441-9f9f-8c6d61efffce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_a3111e9f-dedf-4441-9f9f-8c6d61efffce_default" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ensg_LeaseArrangementAxis_a3111e9f-dedf-4441-9f9f-8c6d61efffce" xlink:to="loc_ensg_LeaseArrangementDomain_a3111e9f-dedf-4441-9f9f-8c6d61efffce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_8c22a331-feca-4cb6-a06e-8dcd8ded25bc" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ensg_LeaseArrangementAxis_a3111e9f-dedf-4441-9f9f-8c6d61efffce" xlink:to="loc_ensg_LeaseArrangementDomain_8c22a331-feca-4cb6-a06e-8dcd8ded25bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasesToThirdPartyOperatorsMember_ff19b46f-3ff9-492d-bf74-625c677f0989" xlink:href="ensg-20241231.xsd#ensg_LeasesToThirdPartyOperatorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ensg_LeaseArrangementDomain_8c22a331-feca-4cb6-a06e-8dcd8ded25bc" xlink:to="loc_ensg_LeasesToThirdPartyOperatorsMember_ff19b46f-3ff9-492d-bf74-625c677f0989" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1d215db4-5794-463e-a0dc-cd840e5db26d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_srt_CounterpartyNameAxis_1d215db4-5794-463e-a0dc-cd840e5db26d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d215db4-5794-463e-a0dc-cd840e5db26d_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1d215db4-5794-463e-a0dc-cd840e5db26d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1d215db4-5794-463e-a0dc-cd840e5db26d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4737e79c-fb4f-4a7b-8344-f7431cbaabf6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1d215db4-5794-463e-a0dc-cd840e5db26d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4737e79c-fb4f-4a7b-8344-f7431cbaabf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThePennantGroupInc.Member_2f582bbf-83d6-4a35-9081-8dbd2ba17182" xlink:href="ensg-20241231.xsd#ensg_ThePennantGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4737e79c-fb4f-4a7b-8344-f7431cbaabf6" xlink:to="loc_ensg_ThePennantGroupInc.Member_2f582bbf-83d6-4a35-9081-8dbd2ba17182" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThirdPartyTenantsMember_1ceec55e-c4f7-4854-9e5d-078a3dc6c8bc" xlink:href="ensg-20241231.xsd#ensg_ThirdPartyTenantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4737e79c-fb4f-4a7b-8344-f7431cbaabf6" xlink:to="loc_ensg_ThirdPartyTenantsMember_1ceec55e-c4f7-4854-9e5d-078a3dc6c8bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_srt_ConsolidationItemsAxis_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac" xlink:to="loc_srt_ConsolidationItemsDomain_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_662b0800-0f63-4c8c-b5c3-8213929b4900" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac" xlink:to="loc_srt_ConsolidationItemsDomain_662b0800-0f63-4c8c-b5c3-8213929b4900" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_08c91ac5-6f86-462c-b59f-5751ce798369" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_662b0800-0f63-4c8c-b5c3-8213929b4900" xlink:to="loc_us-gaap_OperatingSegmentsMember_08c91ac5-6f86-462c-b59f-5751ce798369" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9abc7da2-4897-49e7-8c25-b0623974d59e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_srt_ProductOrServiceAxis_9abc7da2-4897-49e7-8c25-b0623974d59e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9abc7da2-4897-49e7-8c25-b0623974d59e_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9abc7da2-4897-49e7-8c25-b0623974d59e" xlink:to="loc_srt_ProductsAndServicesDomain_9abc7da2-4897-49e7-8c25-b0623974d59e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e83c3420-f643-49dd-a90f-e92d6561afee" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9abc7da2-4897-49e7-8c25-b0623974d59e" xlink:to="loc_srt_ProductsAndServicesDomain_e83c3420-f643-49dd-a90f-e92d6561afee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember_266cfd62-860a-41a8-a065-63ab4a50e8ee" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e83c3420-f643-49dd-a90f-e92d6561afee" xlink:to="loc_ensg_RentalMember_266cfd62-860a-41a8-a065-63ab4a50e8ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b8642113-1240-445f-8206-54e2ab2dbaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b8642113-1240-445f-8206-54e2ab2dbaf8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b8642113-1240-445f-8206-54e2ab2dbaf8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8642113-1240-445f-8206-54e2ab2dbaf8" xlink:to="loc_us-gaap_SegmentDomain_b8642113-1240-445f-8206-54e2ab2dbaf8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5ee8b5aa-e905-46c2-8288-cf73e2e45e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8642113-1240-445f-8206-54e2ab2dbaf8" xlink:to="loc_us-gaap_SegmentDomain_5ee8b5aa-e905-46c2-8288-cf73e2e45e9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_462d5466-d5b3-4d86-ad9e-a72a3ea4836e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_5ee8b5aa-e905-46c2-8288-cf73e2e45e9f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_462d5466-d5b3-4d86-ad9e-a72a3ea4836e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_dd8821c5-aa74-4697-ad63-82c6aa2d7bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_dd8821c5-aa74-4697-ad63-82c6aa2d7bbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_37d3ed80-66f4-41e8-99d5-ca0b8b968c04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome_dd8821c5-aa74-4697-ad63-82c6aa2d7bbf" xlink:to="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_37d3ed80-66f4-41e8-99d5-ca0b8b968c04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseVariableLeaseIncome_722af248-4611-42e2-94ad-d2480fd78ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseVariableLeaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:to="loc_us-gaap_OperatingLeaseVariableLeaseIncome_722af248-4611-42e2-94ad-d2480fd78ffc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_62c18ded-1aa6-448d-995b-a1074721d489" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:to="loc_us-gaap_SubleaseIncome_62c18ded-1aa6-448d-995b-a1074721d489" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEFINEDCONTRIBUTIONPLANSDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable_e72f6752-15c7-46bd-ab24-69f8387d8b88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_DefinedContributionPlanTable_e72f6752-15c7-46bd-ab24-69f8387d8b88" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_92397b4c-1d86-474a-bd9d-4c58015257ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DefinedContributionPlanTable_e72f6752-15c7-46bd-ab24-69f8387d8b88" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_92397b4c-1d86-474a-bd9d-4c58015257ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_92397b4c-1d86-474a-bd9d-4c58015257ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_92397b4c-1d86-474a-bd9d-4c58015257ed" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_92397b4c-1d86-474a-bd9d-4c58015257ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_d132c53f-9f23-486d-b749-5a552e9d0fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_92397b4c-1d86-474a-bd9d-4c58015257ed" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_d132c53f-9f23-486d-b749-5a552e9d0fcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_decfd80a-5958-460f-8521-2bb8bd29edc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_d132c53f-9f23-486d-b749-5a552e9d0fcd" xlink:to="loc_us-gaap_QualifiedPlanMember_decfd80a-5958-460f-8521-2bb8bd29edc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember_88bf359f-6ce6-4cdd-93cc-7bdf7c3af7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_d132c53f-9f23-486d-b749-5a552e9d0fcd" xlink:to="loc_us-gaap_NonqualifiedPlanMember_88bf359f-6ce6-4cdd-93cc-7bdf7c3af7ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_a3be9bb8-0a74-4ce5-b0e1-4889ab31fc57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_a3be9bb8-0a74-4ce5-b0e1-4889ab31fc57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_196810f6-324a-4045-aa8e-aa0197755636" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_196810f6-324a-4045-aa8e-aa0197755636" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_bbb1d899-ccd7-4736-b96b-3e9791784404" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_bbb1d899-ccd7-4736-b96b-3e9791784404" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d276448a-5fb1-4ba7-8dff-c640c9d27d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_GainLossOnInvestments_d276448a-5fb1-4ba7-8dff-c640c9d27d9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InvestmentExpenseIncome_b59b74a5-ad75-4316-bba2-bc6d213cff6a" xlink:href="ensg-20241231.xsd#ensg_InvestmentExpenseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_ensg_InvestmentExpenseIncome_b59b74a5-ad75-4316-bba2-bc6d213cff6a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_5c60d6d6-3157-40ed-971f-407490277428" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_5c60d6d6-3157-40ed-971f-407490277428" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_05cf0ccb-b3e5-493f-aa66-e82559ba2258" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_5c60d6d6-3157-40ed-971f-407490277428" xlink:to="loc_srt_ProductOrServiceAxis_05cf0ccb-b3e5-493f-aa66-e82559ba2258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_05cf0ccb-b3e5-493f-aa66-e82559ba2258_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_05cf0ccb-b3e5-493f-aa66-e82559ba2258" xlink:to="loc_srt_ProductsAndServicesDomain_05cf0ccb-b3e5-493f-aa66-e82559ba2258_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_05cf0ccb-b3e5-493f-aa66-e82559ba2258" xlink:to="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember_f0591cc1-7fa5-4459-b164-18b8b20c5f8d" xlink:href="ensg-20241231.xsd#ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:to="loc_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember_f0591cc1-7fa5-4459-b164-18b8b20c5f8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationInsuranceMember_320743e1-c66f-4887-9c4d-8a5f6fe0c3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationInsuranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:to="loc_us-gaap_WorkersCompensationInsuranceMember_320743e1-c66f-4887-9c4d-8a5f6fe0c3f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_9c0fcc4c-84fd-4b33-b590-2fe34fd6a333" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_9c0fcc4c-84fd-4b33-b590-2fe34fd6a333" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_2b899cdc-907a-4af7-be79-9f26b7f33a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:to="loc_us-gaap_SelfInsuranceReserve_2b899cdc-907a-4af7-be79-9f26b7f33a8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_5417098c-e8f7-4112-91c2-111c3abe5526" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_5417098c-e8f7-4112-91c2-111c3abe5526" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent_94cc7c9a-0ad5-489a-bf84-857288ffc59c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:to="loc_us-gaap_SelfInsuranceReserveNoncurrent_94cc7c9a-0ad5-489a-bf84-857288ffc59c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:to="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51e2933d-cc55-4080-881f-4a589254d2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51e2933d-cc55-4080-881f-4a589254d2f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51e2933d-cc55-4080-881f-4a589254d2f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51e2933d-cc55-4080-881f-4a589254d2f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51e2933d-cc55-4080-881f-4a589254d2f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_923834b6-ef76-4204-94cd-9941051a0507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51e2933d-cc55-4080-881f-4a589254d2f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_923834b6-ef76-4204-94cd-9941051a0507" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_2c63db5a-fb49-4836-9610-58d8eda96b21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_923834b6-ef76-4204-94cd-9941051a0507" xlink:to="loc_us-gaap_AccountsReceivableMember_2c63db5a-fb49-4836-9610-58d8eda96b21" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_ba479659-b929-468d-89b9-5d557dfedf3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_923834b6-ef76-4204-94cd-9941051a0507" xlink:to="loc_us-gaap_SalesRevenueNetMember_ba479659-b929-468d-89b9-5d557dfedf3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a145caa8-c828-42cb-af42-b1ca6ed82dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a145caa8-c828-42cb-af42-b1ca6ed82dc8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c9c44d42-6a2f-4fd9-81c2-128717456cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a145caa8-c828-42cb-af42-b1ca6ed82dc8" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c9c44d42-6a2f-4fd9-81c2-128717456cb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_00b51848-49cf-4eb2-9301-27d7f6ba99f9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_srt_MajorCustomersAxis_00b51848-49cf-4eb2-9301-27d7f6ba99f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_00b51848-49cf-4eb2-9301-27d7f6ba99f9_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_00b51848-49cf-4eb2-9301-27d7f6ba99f9" xlink:to="loc_srt_NameOfMajorCustomerDomain_00b51848-49cf-4eb2-9301-27d7f6ba99f9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_5bfd469a-aea9-4325-ae8d-cc043d5b13a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_00b51848-49cf-4eb2-9301-27d7f6ba99f9" xlink:to="loc_srt_NameOfMajorCustomerDomain_5bfd469a-aea9-4325-ae8d-cc043d5b13a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember_7a2ec057-a9fa-4e48-bbfe-00dece542115" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_5bfd469a-aea9-4325-ae8d-cc043d5b13a7" xlink:to="loc_ensg_MedicaidAndMedicareMember_7a2ec057-a9fa-4e48-bbfe-00dece542115" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d33f1030-e852-4c6e-ac2c-6d34134109fa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_srt_ProductOrServiceAxis_d33f1030-e852-4c6e-ac2c-6d34134109fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d33f1030-e852-4c6e-ac2c-6d34134109fa_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d33f1030-e852-4c6e-ac2c-6d34134109fa" xlink:to="loc_srt_ProductsAndServicesDomain_d33f1030-e852-4c6e-ac2c-6d34134109fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47bee5c4-0be0-49fb-bb93-d166064b10cc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d33f1030-e852-4c6e-ac2c-6d34134109fa" xlink:to="loc_srt_ProductsAndServicesDomain_47bee5c4-0be0-49fb-bb93-d166064b10cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_b945c8b0-d568-4e01-9f0c-54f2b0178089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47bee5c4-0be0-49fb-bb93-d166064b10cc" xlink:to="loc_us-gaap_ServiceMember_b945c8b0-d568-4e01-9f0c-54f2b0178089" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_5a23c7d2-ac46-4e11-91f2-830ceebbc74e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_5a23c7d2-ac46-4e11-91f2-830ceebbc74e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews_df02d1bc-27cb-4839-a945-e723f100c413" xlink:href="ensg-20241231.xsd#ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:to="loc_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews_df02d1bc-27cb-4839-a945-e723f100c413" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1f7a7b2e-3d21-44eb-9473-ddb9d0529a43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1f7a7b2e-3d21-44eb-9473-ddb9d0529a43" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMMONSTOCKREPURCHASEPROGRAMDetails"/>
  <link:definitionLink xlink:role="http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_d169af50-b19f-4c80-bbb6-9d90b3633d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_d169af50-b19f-4c80-bbb6-9d90b3633d3e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_b3a4d9d0-b38e-40ba-a95d-babd42187f90" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d169af50-b19f-4c80-bbb6-9d90b3633d3e" xlink:to="loc_srt_ShareRepurchaseProgramAxis_b3a4d9d0-b38e-40ba-a95d-babd42187f90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_b3a4d9d0-b38e-40ba-a95d-babd42187f90_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ShareRepurchaseProgramAxis_b3a4d9d0-b38e-40ba-a95d-babd42187f90" xlink:to="loc_srt_ShareRepurchaseProgramDomain_b3a4d9d0-b38e-40ba-a95d-babd42187f90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ShareRepurchaseProgramAxis_b3a4d9d0-b38e-40ba-a95d-babd42187f90" xlink:to="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_May2024RepurchaseProgramMember_a5875a83-d837-4b25-80b4-17c33a2ea453" xlink:href="ensg-20241231.xsd#ensg_May2024RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:to="loc_ensg_May2024RepurchaseProgramMember_a5875a83-d837-4b25-80b4-17c33a2ea453" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_August2023RepurchaseProgramMember_c23122b8-44e1-4d11-bbd2-320f448e8416" xlink:href="ensg-20241231.xsd#ensg_August2023RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:to="loc_ensg_August2023RepurchaseProgramMember_c23122b8-44e1-4d11-bbd2-320f448e8416" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_July2022RepurchaseProgramMember_9687b096-a197-44cb-bf58-d1e75c102a34" xlink:href="ensg-20241231.xsd#ensg_July2022RepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:to="loc_ensg_July2022RepurchaseProgramMember_9687b096-a197-44cb-bf58-d1e75c102a34" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_ffac6f54-f50f-4ee6-a119-a23215f49e10" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_ffac6f54-f50f-4ee6-a119-a23215f49e10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_976b35de-214a-4131-a20a-a524b29124d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_976b35de-214a-4131-a20a-a524b29124d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9094e27a-2b49-4c49-a0db-f8dc2a2941c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9094e27a-2b49-4c49-a0db-f8dc2a2941c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_711b3745-0b61-47f9-b650-9780bba18531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_711b3745-0b61-47f9-b650-9780bba18531" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="691"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_Dr.AnnS.BlouinMember_a38bec9d-320f-489d-abd7-eedc0a717c2d" xlink:href="ensg-20241231.xsd#ensg_Dr.AnnS.BlouinMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ensg_Dr.AnnS.BlouinMember_a38bec9d-320f-489d-abd7-eedc0a717c2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SuzanneD.SnapperMember_7b8fdc47-8416-43e0-a9a5-563e7114464d" xlink:href="ensg-20241231.xsd#ensg_SuzanneD.SnapperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ensg_SuzanneD.SnapperMember_7b8fdc47-8416-43e0-a9a5-563e7114464d" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>ensg-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9fad20ba-6b95-4b5d-8a1b-0cd604b824d6,g:826a027b-6e82-45d1-b4d8-5465cc4138ed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_8937a65d-7268-4256-8337-b0e02d4c3816_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_1e760301-0e70-4957-91f5-c6a7e7d474a6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ThirdPartyTenantsMember_e70d3232-1020-4d5e-8271-3fa9cfebbfeb_terseLabel_en-US" xlink:label="lab_ensg_ThirdPartyTenantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other third-party</link:label>
    <link:label id="lab_ensg_ThirdPartyTenantsMember_label_en-US" xlink:label="lab_ensg_ThirdPartyTenantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Third Party Tenants [Member]</link:label>
    <link:label id="lab_ensg_ThirdPartyTenantsMember_documentation_en-US" xlink:label="lab_ensg_ThirdPartyTenantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Third Party Tenants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThirdPartyTenantsMember" xlink:href="ensg-20241231.xsd#ensg_ThirdPartyTenantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ThirdPartyTenantsMember" xlink:to="lab_ensg_ThirdPartyTenantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_3254e9e2-df7f-4588-829b-76ffce3e8ef4_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Payments on debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_CashHeldInTrustForResidents_f066e3c9-6036-4960-a4a0-ac4e7d9ae7ea_terseLabel_en-US" xlink:label="lab_ensg_CashHeldInTrustForResidents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash held in trust for patients</link:label>
    <link:label id="lab_ensg_CashHeldInTrustForResidents_label_en-US" xlink:label="lab_ensg_CashHeldInTrustForResidents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Held In Trust For Residents</link:label>
    <link:label id="lab_ensg_CashHeldInTrustForResidents_documentation_en-US" xlink:label="lab_ensg_CashHeldInTrustForResidents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash held in trust for residents reflects monies received from, or on behalf of, residents. Maintaining a trust account for residents is a regulatory requirement and, while the trust assets offset the liability, the Company assumes a fiduciary responsibility for these funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CashHeldInTrustForResidents" xlink:href="ensg-20241231.xsd#ensg_CashHeldInTrustForResidents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_CashHeldInTrustForResidents" xlink:to="lab_ensg_CashHeldInTrustForResidents" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeFiveMember_4875a9fb-ea89-4fb6-956c-9af50dd7e5d1_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeFiveMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeFiveMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeFiveMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeFiveMember" xlink:to="lab_ensg_ExercisePriceRangeFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_4c3dc2d1-9f44-43d4-8b5c-92a6454ed495_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f073ccae-c1ed-44ad-92e6-b645e74e7d22_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_257057b4-14a3-4e35-99c4-cd9654c2e70f_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_19d01253-fbe4-46c4-9b9c-6bc27e3e9b5d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Future Minimum Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_MasterLeaseAgreementsMember_211e6255-8a69-4c56-bb71-e4b3c6ffaf9c_terseLabel_en-US" xlink:label="lab_ensg_MasterLeaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Master Lease Agreements</link:label>
    <link:label id="lab_ensg_MasterLeaseAgreementsMember_label_en-US" xlink:label="lab_ensg_MasterLeaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Master Lease Agreements [Member]</link:label>
    <link:label id="lab_ensg_MasterLeaseAgreementsMember_documentation_en-US" xlink:label="lab_ensg_MasterLeaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Master Lease Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MasterLeaseAgreementsMember" xlink:href="ensg-20241231.xsd#ensg_MasterLeaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_MasterLeaseAgreementsMember" xlink:to="lab_ensg_MasterLeaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_a27e5def-b39c-4397-b1bc-a44ec1d6c3ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Indefinite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease_a30c74be-8e42-47c6-9c5f-8c0cf6f17a76_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current year provisions</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefits, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_b63e6128-a38d-4d28-b26e-ba61aaab765d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations_35408bc4-ee10-4f44-b239-591e945ad0ba_terseLabel_en-US" xlink:label="lab_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Management fees, as a percentage of funds from operations</link:label>
    <link:label id="lab_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations_label_en-US" xlink:label="lab_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Management Fee, Percent Fee of Funds from Operations</link:label>
    <link:label id="lab_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations_documentation_en-US" xlink:label="lab_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Property Management Fee, Percent Fee of Funds from Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations" xlink:href="ensg-20241231.xsd#ensg_PropertyManagementFeePercentFeeOfFundsFromOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations" xlink:to="lab_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_c13abb63-1ab0-4fdf-967d-07106498356d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_HealthLiabilityInsuranceMember_165d5418-f207-4127-b156-2e562ff156db_terseLabel_en-US" xlink:label="lab_ensg_HealthLiabilityInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Health Liability Insurance</link:label>
    <link:label id="lab_ensg_HealthLiabilityInsuranceMember_label_en-US" xlink:label="lab_ensg_HealthLiabilityInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Health Liability Insurance [Member]</link:label>
    <link:label id="lab_ensg_HealthLiabilityInsuranceMember_documentation_en-US" xlink:label="lab_ensg_HealthLiabilityInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Health Liability Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_HealthLiabilityInsuranceMember" xlink:href="ensg-20241231.xsd#ensg_HealthLiabilityInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_HealthLiabilityInsuranceMember" xlink:to="lab_ensg_HealthLiabilityInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_StandardBearerTextBlock_81e6c56f-4a5a-4b59-8764-59001b95c68c_terseLabel_en-US" xlink:label="lab_ensg_StandardBearerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">STANDARD BEARER</link:label>
    <link:label id="lab_ensg_StandardBearerTextBlock_label_en-US" xlink:label="lab_ensg_StandardBearerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Bearer [Text Block]</link:label>
    <link:label id="lab_ensg_StandardBearerTextBlock_documentation_en-US" xlink:label="lab_ensg_StandardBearerTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard Bearer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerTextBlock" xlink:href="ensg-20241231.xsd#ensg_StandardBearerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_StandardBearerTextBlock" xlink:to="lab_ensg_StandardBearerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e4e6d018-3de2-47a7-b061-d5b82cc4bfe1_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts on accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a2fe5466-5bd0-46b0-8614-e1a4a4ac47a9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_d9b35444-43f4-40a4-96bd-daaea624a65a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling interests attributable to subsidiary equity plan</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_70656afb-5c93-4a33-810f-bb7dbe88a112_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SkilledNursingOperationsMember_e083e857-438c-4b79-8f8b-c92b730abda3_terseLabel_en-US" xlink:label="lab_ensg_SkilledNursingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Skilled Nursing Operations</link:label>
    <link:label id="lab_ensg_SkilledNursingOperationsMember_label_en-US" xlink:label="lab_ensg_SkilledNursingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Skilled Nursing Operations [Member]</link:label>
    <link:label id="lab_ensg_SkilledNursingOperationsMember_documentation_en-US" xlink:label="lab_ensg_SkilledNursingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Skilled Nursing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SkilledNursingOperationsMember" xlink:to="lab_ensg_SkilledNursingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_b74d8723-43b1-470b-8043-5b7bfbfb759d_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a93ab26d-72da-48b1-b4ee-8ee2106f59b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfRealEstatePropertiesSharingLocations_b038074b-a808-4563-a4c5-eab305f5dad3_terseLabel_en-US" xlink:label="lab_ensg_NumberOfRealEstatePropertiesSharingLocations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of senior living operations sharing property with skilled nursing operations</link:label>
    <link:label id="lab_ensg_NumberOfRealEstatePropertiesSharingLocations_label_en-US" xlink:label="lab_ensg_NumberOfRealEstatePropertiesSharingLocations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Real Estate Properties Sharing Locations</link:label>
    <link:label id="lab_ensg_NumberOfRealEstatePropertiesSharingLocations_documentation_en-US" xlink:label="lab_ensg_NumberOfRealEstatePropertiesSharingLocations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Real Estate Properties Sharing Locations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfRealEstatePropertiesSharingLocations" xlink:href="ensg-20241231.xsd#ensg_NumberOfRealEstatePropertiesSharingLocations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfRealEstatePropertiesSharingLocations" xlink:to="lab_ensg_NumberOfRealEstatePropertiesSharingLocations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_316b32f7-639b-4356-8c89-97a59320fe10_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_92b3f7fb-3371-4d1e-9e8b-ff84c4366d1a_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_076ee267-a025-421e-891d-e485c4d37c0e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of restricted stock, net of forfeitures (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_491f679c-5f01-4883-9e11-5bf118362a49_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_d90af5fc-8f1b-48cf-8c7b-bcfe882f9c54_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock upon exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_2376e950-fa48-4cbb-aefa-71b45b30d918_verboseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_bf9c7815-2aac-44e7-bd93-1d761b9f2f3f_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LeasesToThirdPartyOperatorsMember_23a62379-2b34-4800-8d68-7b5cb74f70ff_terseLabel_en-US" xlink:label="lab_ensg_LeasesToThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases To Third Party Operators</link:label>
    <link:label id="lab_ensg_LeasesToThirdPartyOperatorsMember_label_en-US" xlink:label="lab_ensg_LeasesToThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases To Third Party Operators [Member]</link:label>
    <link:label id="lab_ensg_LeasesToThirdPartyOperatorsMember_documentation_en-US" xlink:label="lab_ensg_LeasesToThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leases To Third Party Operators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasesToThirdPartyOperatorsMember" xlink:href="ensg-20241231.xsd#ensg_LeasesToThirdPartyOperatorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LeasesToThirdPartyOperatorsMember" xlink:to="lab_ensg_LeasesToThirdPartyOperatorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_9d9b5be0-8a6c-42b4-a93d-fd26622844fe_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Tax Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis" xlink:to="lab_us-gaap_RetirementPlanTaxStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_f34bfb0d-c1ce-40d1-92fd-a179bb25b783_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_a29510b0-c7f3-42df-96e3-0dabd3c3b6a4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_7944368f-2fac-4523-9753-d87b716c4518_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_ce8d5d53-0e6e-43ca-b411-367b1a2f94e1_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_RestrictedAndOtherAssetsNoncurrent_40e8ef2a-aaaf-425d-a9f4-6f35902a4b6b_terseLabel_en-US" xlink:label="lab_ensg_RestrictedAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted and other assets</link:label>
    <link:label id="lab_ensg_RestrictedAndOtherAssetsNoncurrent_label_en-US" xlink:label="lab_ensg_RestrictedAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted And Other Assets, Noncurrent</link:label>
    <link:label id="lab_ensg_RestrictedAndOtherAssetsNoncurrent_documentation_en-US" xlink:label="lab_ensg_RestrictedAndOtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted And Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RestrictedAndOtherAssetsNoncurrent" xlink:href="ensg-20241231.xsd#ensg_RestrictedAndOtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_RestrictedAndOtherAssetsNoncurrent" xlink:to="lab_ensg_RestrictedAndOtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember_8fffab38-5deb-452c-b1b0-9eb983f032ea_terseLabel_en-US" xlink:label="lab_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Skilled Nursing Operations And Senior Living Facilities</link:label>
    <link:label id="lab_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember_label_en-US" xlink:label="lab_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Skilled Nursing Operations And Senior Living Facilities [Member]</link:label>
    <link:label id="lab_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember_documentation_en-US" xlink:label="lab_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Skilled Nursing Operations And Senior Living Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember" xlink:to="lab_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_ca6bef36-05d3-4697-ad30-f21a9f2adca3_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_2f111d3d-0503-468c-9616-04a0926c25a2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_CampusOperationsMember_4572cfcd-81c7-4ca0-b10c-c78352b16cc5_terseLabel_en-US" xlink:label="lab_ensg_CampusOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Campus Operations</link:label>
    <link:label id="lab_ensg_CampusOperationsMember_label_en-US" xlink:label="lab_ensg_CampusOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Campus Operations [Member]</link:label>
    <link:label id="lab_ensg_CampusOperationsMember_documentation_en-US" xlink:label="lab_ensg_CampusOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Campus Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_CampusOperationsMember" xlink:to="lab_ensg_CampusOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AssembledOccupancyAcquiredMember_c6887094-10e7-4d84-873b-39c77638c1e4_terseLabel_en-US" xlink:label="lab_ensg_AssembledOccupancyAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assembled occupancy</link:label>
    <link:label id="lab_ensg_AssembledOccupancyAcquiredMember_9a678fb9-e6e4-4f65-9d51-3b0630c13656_verboseLabel_en-US" xlink:label="lab_ensg_AssembledOccupancyAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Assembled occupancy</link:label>
    <link:label id="lab_ensg_AssembledOccupancyAcquiredMember_label_en-US" xlink:label="lab_ensg_AssembledOccupancyAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assembled Occupancy Acquired [Member]</link:label>
    <link:label id="lab_ensg_AssembledOccupancyAcquiredMember_documentation_en-US" xlink:label="lab_ensg_AssembledOccupancyAcquiredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assembled occupancy acquired [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AssembledOccupancyAcquiredMember" xlink:href="ensg-20241231.xsd#ensg_AssembledOccupancyAcquiredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AssembledOccupancyAcquiredMember" xlink:to="lab_ensg_AssembledOccupancyAcquiredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_a56043a6-915a-4692-87ea-f29646ffb434_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_02ede0f6-658c-4d4c-87f0-bb57f1ab6099_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_8cbc88d4-e700-4fa2-82c1-c55a665acdb4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">NET CASH PROVIDED BY OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_875de4a9-b5bf-4c08-8f6c-5fc5941cd9be_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_8355ec9c-d014-4fe4-b057-80146de644fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grant date intrinsic value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_cdee6b03-5108-42dc-9ce5-651ce2e3e3b8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_3ebce013-a155-427c-b6c4-4d7157e66d43_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_a0292b44-d847-403f-b364-1c6ecb8b2923_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseVariableLeaseIncome_e0f5a65e-fbc7-4daa-87ed-35958a85e020_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, variable lease income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseVariableLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Variable Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseVariableLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseVariableLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_4d2d2ff4-bbfe-4b8b-9c25-11cf9edf6e64_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_cc0c7bbb-2712-44e6-b633-11a9af40aacd_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimates and Assumptions</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e2d14811-668d-4ef6-bea2-78ca2bd78581_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_7c79c7d5-2c85-45b7-a9c6-0ce3b348b078_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_5dba51be-12c1-423e-80e5-1aa29025f89b_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_6cab9a1c-5379-4d0b-8f46-9d280256beda_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OTHER ACCRUED LIABILITIES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c035dc9a-dd2d-4d77-98e9-80c5ab6cd0d4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PrepaymentFeePeriodAxis_05261fac-d7dc-4637-9d08-196b3f0c8e0a_terseLabel_en-US" xlink:label="lab_ensg_PrepaymentFeePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayment Fee, Period [Axis]</link:label>
    <link:label id="lab_ensg_PrepaymentFeePeriodAxis_label_en-US" xlink:label="lab_ensg_PrepaymentFeePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayment Fee, Period [Axis]</link:label>
    <link:label id="lab_ensg_PrepaymentFeePeriodAxis_documentation_en-US" xlink:label="lab_ensg_PrepaymentFeePeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepayment Fee, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentFeePeriodAxis" xlink:href="ensg-20241231.xsd#ensg_PrepaymentFeePeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PrepaymentFeePeriodAxis" xlink:to="lab_ensg_PrepaymentFeePeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6001d3f4-a861-491d-9296-d430dac6089d_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_e84e45bc-98e1-4ee6-96bc-f4f3d03461d3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Rental Income from Third-Party Sources</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Lease Income [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NoncontrollingInterestPolicyTextBlock_6a0f936e-ad87-472c-baf0-c6bf1f46c07b_terseLabel_en-US" xlink:label="lab_ensg_NoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_ensg_NoncontrollingInterestPolicyTextBlock_label_en-US" xlink:label="lab_ensg_NoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Policy Text Block]</link:label>
    <link:label id="lab_ensg_NoncontrollingInterestPolicyTextBlock_documentation_en-US" xlink:label="lab_ensg_NoncontrollingInterestPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NoncontrollingInterestPolicyTextBlock" xlink:href="ensg-20241231.xsd#ensg_NoncontrollingInterestPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NoncontrollingInterestPolicyTextBlock" xlink:to="lab_ensg_NoncontrollingInterestPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_3d8f03b1-c6bf-4c74-9bc0-64f0f326d44e_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_fa56cfd2-865e-4a3e-b5d5-b48ad13d21c4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_a6cd1d54-b8e0-4b20-b2bf-82a872bfb860_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_19c648d9-c077-4a4f-97c1-9e0faf69ff95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_63a2c8eb-e4a9-43e2-9802-b65f1a68b1e5_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_e2dd2b35-35c5-41d4-81d9-f9d8e19c673c_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_d7326bc4-2e05-44f7-91c6-b4653c637710_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_30856e1b-a948-48a6-b967-f39f1867547d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Repurchase of shares of common stock to satisfy tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_a3adb2af-47bc-4bc4-9440-1dbc0941bfd8_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ReductionInPrepaymentPenalty_9226f6f6-53a4-42b8-a1fa-dc68bf936939_terseLabel_en-US" xlink:label="lab_ensg_ReductionInPrepaymentPenalty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reduction in prepayment penalty</link:label>
    <link:label id="lab_ensg_ReductionInPrepaymentPenalty_label_en-US" xlink:label="lab_ensg_ReductionInPrepaymentPenalty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reduction In Prepayment Penalty</link:label>
    <link:label id="lab_ensg_ReductionInPrepaymentPenalty_documentation_en-US" xlink:label="lab_ensg_ReductionInPrepaymentPenalty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage that the prepayment penalty percentage is reduced during the fourth year.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ReductionInPrepaymentPenalty" xlink:href="ensg-20241231.xsd#ensg_ReductionInPrepaymentPenalty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ReductionInPrepaymentPenalty" xlink:to="lab_ensg_ReductionInPrepaymentPenalty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9270bb3c-2fea-4681-ab43-696d43069770_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_768e8a9f-1cd8-4637-a5d9-22b073e39aba_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense related to stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_bd31c95d-fdbd-4ecb-829e-a84115303cb1_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:to="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_b13f5956-31fa-401d-bf2b-23e70d141e2b_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SelfInsuranceRetentionPerClaimMember_1326cf15-dd0a-4f47-85e1-b989d25cfcaa_terseLabel_en-US" xlink:label="lab_ensg_SelfInsuranceRetentionPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Self-Insurance Retention Per Claim</link:label>
    <link:label id="lab_ensg_SelfInsuranceRetentionPerClaimMember_label_en-US" xlink:label="lab_ensg_SelfInsuranceRetentionPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Self-Insurance Retention Per Claim [Member]</link:label>
    <link:label id="lab_ensg_SelfInsuranceRetentionPerClaimMember_documentation_en-US" xlink:label="lab_ensg_SelfInsuranceRetentionPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Self-insurance retention per claim [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SelfInsuranceRetentionPerClaimMember" xlink:href="ensg-20241231.xsd#ensg_SelfInsuranceRetentionPerClaimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SelfInsuranceRetentionPerClaimMember" xlink:to="lab_ensg_SelfInsuranceRetentionPerClaimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_c1490456-0807-4582-982e-19ce382bd854_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AfterYearTenMember_a77b7aee-1189-4509-9d60-e9b91ee8682c_terseLabel_en-US" xlink:label="lab_ensg_AfterYearTenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">After Year Ten</link:label>
    <link:label id="lab_ensg_AfterYearTenMember_label_en-US" xlink:label="lab_ensg_AfterYearTenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">After Year Ten [Member]</link:label>
    <link:label id="lab_ensg_AfterYearTenMember_documentation_en-US" xlink:label="lab_ensg_AfterYearTenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">After Year Ten</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AfterYearTenMember" xlink:href="ensg-20241231.xsd#ensg_AfterYearTenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AfterYearTenMember" xlink:to="lab_ensg_AfterYearTenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_0fdb605d-3ee2-41e8-a80e-11fcece4a87b_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_19631f01-cb31-4386-8831-b131c0b6d091_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_18f83a9a-88bb-4310-ab1b-6d3fc111a587_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options Outstanding, Vested and Related Details</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_CostofSalesandGeneralandAdministrativeExpenseMember_98e0cfa4-872c-44ae-9d39-066e8a7457d9_terseLabel_en-US" xlink:label="lab_ensg_CostofSalesandGeneralandAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of Sales and General and Administrative Expense</link:label>
    <link:label id="lab_ensg_CostofSalesandGeneralandAdministrativeExpenseMember_label_en-US" xlink:label="lab_ensg_CostofSalesandGeneralandAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales and General and Administrative Expense [Member]</link:label>
    <link:label id="lab_ensg_CostofSalesandGeneralandAdministrativeExpenseMember_documentation_en-US" xlink:label="lab_ensg_CostofSalesandGeneralandAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing cost of services and general and administrative expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CostofSalesandGeneralandAdministrativeExpenseMember" xlink:href="ensg-20241231.xsd#ensg_CostofSalesandGeneralandAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_CostofSalesandGeneralandAdministrativeExpenseMember" xlink:to="lab_ensg_CostofSalesandGeneralandAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_EliminationsAndReconcilingItemsMember_95363ed4-a999-4b8e-aa8f-5fa7df743314_verboseLabel_en-US" xlink:label="lab_ensg_EliminationsAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">All Other</link:label>
    <link:label id="lab_ensg_EliminationsAndReconcilingItemsMember_label_en-US" xlink:label="lab_ensg_EliminationsAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Eliminations And Reconciling Items [Member]</link:label>
    <link:label id="lab_ensg_EliminationsAndReconcilingItemsMember_documentation_en-US" xlink:label="lab_ensg_EliminationsAndReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Eliminations And Reconciling Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_EliminationsAndReconcilingItemsMember" xlink:href="ensg-20241231.xsd#ensg_EliminationsAndReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_EliminationsAndReconcilingItemsMember" xlink:to="lab_ensg_EliminationsAndReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_543ce007-72c2-4083-91fa-f09da8ca7368_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities for Guarantees on Long-Duration Contracts [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities for Guarantees on Long-Duration Contracts [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems" xlink:to="lab_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_d448178b-aa94-4004-9018-84751f19d43e_terseLabel_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Write-off of deferred financing fees</link:label>
    <link:label id="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost_label_en-US" xlink:label="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Debt Issuance Cost, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:to="lab_us-gaap_WriteOffOfDeferredDebtIssuanceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_b451744e-91c7-484e-ae17-f246817efd05_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Less:</link:label>
    <link:label id="lab_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_label_en-US" xlink:label="lab_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:to="lab_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_80e8d8ee-57ec-41f2-81f9-fada6544718e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_028a2271-e584-4df6-9904-49f9b718fa67_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_6b011e39-b88e-4b38-a298-028c2b887028_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_46c1e32f-3be7-4a2d-8824-5a00b06e6846_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL LIABILITIES</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_5a01c6b6-92cc-4d65-9ecd-d6eb1492f7f6_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_6be67d1a-d7dc-4e2a-a402-753cc49ebd6f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price of Options Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_1462e6a0-fe69-4f23-a568-ad0ed82c0c75_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e1e3e7ea-6410-4bd0-84dc-4b59d409760d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_5392726b-a9e5-4322-b1ca-34199b7db57a_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Life (Years)</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_58bbf6b5-82e2-4b66-9ddc-7a4e13c00330_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revolving credit facility with Truist</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_cebc934c-0736-4271-a36e-4135a1741650_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_A2023AcquiredPropertiesMember_4aff7650-4bba-4258-a3f6-822ba8d5774a_terseLabel_en-US" xlink:label="lab_ensg_A2023AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Acquired Properties</link:label>
    <link:label id="lab_ensg_A2023AcquiredPropertiesMember_label_en-US" xlink:label="lab_ensg_A2023AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023 Acquired Properties [Member]</link:label>
    <link:label id="lab_ensg_A2023AcquiredPropertiesMember_documentation_en-US" xlink:label="lab_ensg_A2023AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2023 Acquired Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2023AcquiredPropertiesMember" xlink:href="ensg-20241231.xsd#ensg_A2023AcquiredPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_A2023AcquiredPropertiesMember" xlink:to="lab_ensg_A2023AcquiredPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_4c22b118-753e-4d89-9d6b-83aa681af271_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of preferred shares</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_cdfc73a4-a9a4-4dda-8ea1-2af443abde32_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities&#8212;current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_56dbc9e7-bb0b-4dd7-af69-171be4003ace_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_73689569-1ef3-4065-ad89-16b65d83e4f7_verboseLabel_en-US" xlink:label="lab_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase in right-of-use asset</link:label>
    <link:label id="lab_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset</link:label>
    <link:label id="lab_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_documentation_en-US" xlink:label="lab_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Operating Lease, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:href="ensg-20241231.xsd#ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:to="lab_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements_d7c2ba4b-9eee-4fe2-990e-9d930ea6b224_terseLabel_en-US" xlink:label="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of facilities under long-term lease arrangements</link:label>
    <link:label id="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements_label_en-US" xlink:label="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Facilities Under Long-Term Lease Arrangements</link:label>
    <link:label id="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements_documentation_en-US" xlink:label="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Facilities Under Long-Term Lease Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements" xlink:href="ensg-20241231.xsd#ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements" xlink:to="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NewMasterLeaseAgreementMember_e733a994-64d9-44d4-bd08-7e16df59ed18_terseLabel_en-US" xlink:label="lab_ensg_NewMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Master Lease Agreeement</link:label>
    <link:label id="lab_ensg_NewMasterLeaseAgreementMember_label_en-US" xlink:label="lab_ensg_NewMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Master Lease Agreement [Member]</link:label>
    <link:label id="lab_ensg_NewMasterLeaseAgreementMember_documentation_en-US" xlink:label="lab_ensg_NewMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New Master Lease Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NewMasterLeaseAgreementMember" xlink:href="ensg-20241231.xsd#ensg_NewMasterLeaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NewMasterLeaseAgreementMember" xlink:to="lab_ensg_NewMasterLeaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_1994fe6f-645f-41ab-b886-53c455505b43_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_ef4cb620-840b-4787-b138-edb85353024b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_49c06b32-286d-44ca-80fb-f3eb6aba8540_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock to employees and directors resulting from the exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_795a2546-8157-4e67-9374-452206d7f695_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_b4e3adf5-96c9-4263-b603-4803f85d0230_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_ee866b64-69c4-4ecf-ae74-f0a741aba294_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_c9ba492c-9faa-4453-88ff-11b888f66694_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7344f920-c79b-469a-83cf-c8ce31839a96_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection_8a42cc5a-c9a6-4d30-b91c-a756383db6ab_terseLabel_en-US" xlink:label="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt, threshold for EBITDA ratio increase election</link:label>
    <link:label id="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection_label_en-US" xlink:label="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Threshold For EBITDA Ratio Increase Election</link:label>
    <link:label id="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection_documentation_en-US" xlink:label="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Threshold For EBITDA Ratio Increase Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection" xlink:to="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_85809b9c-157d-436f-9837-d9cca53fd7be_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_3183c225-30a3-4bb2-9e60-b35a9d72075b_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Adjusted weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct_b79bd366-b07f-4c97-86bf-033406f5eeb8_negatedLabel_en-US" xlink:label="lab_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Deferred employer portion of social security taxes</link:label>
    <link:label id="lab_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct_label_en-US" xlink:label="lab_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Due To Deferred Employer Taxes, CARES Act</link:label>
    <link:label id="lab_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct_documentation_en-US" xlink:label="lab_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) Due To Deferred Employer Taxes, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" xlink:href="ensg-20241231.xsd#ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" xlink:to="lab_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_cfc2db6f-a6b7-4ada-8c69-c07e7fd4c9ce_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total Ensign Group, Inc. stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_81ce83ec-3440-4fde-a839-11033287867c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_RentalMember_58ef3efc-526d-4c51-b815-924075bd8b97_terseLabel_en-US" xlink:label="lab_ensg_RentalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rental revenue</link:label>
    <link:label id="lab_ensg_RentalMember_label_en-US" xlink:label="lab_ensg_RentalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rental [Member]</link:label>
    <link:label id="lab_ensg_RentalMember_documentation_en-US" xlink:label="lab_ensg_RentalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rental</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_RentalMember" xlink:to="lab_ensg_RentalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_57c36fd0-1272-47c1-a029-f79ebd89690e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_01fbab00-ad80-47da-b844-712a2a95e952_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_e59f4739-c4d8-49b8-931b-7bc9dfbbf371_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letters of credit outstanding, pledged amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_2a2b73d2-bdbd-436c-8a5d-3ee61d5a01fa_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expensed matching contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_61a71377-adbc-4b6f-aa30-88bb12ef08e5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rent - cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_c6d9694b-201e-4e84-9a5b-467a6e10e4bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase_54f7b9ea-df77-492f-8004-3bb97b9ccabf_terseLabel_en-US" xlink:label="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options to purchase under long-term lease arrangements</link:label>
    <link:label id="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase_label_en-US" xlink:label="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Facilities Under Long-Term Lease Arrangements, Option To Purchase</link:label>
    <link:label id="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase_documentation_en-US" xlink:label="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Facilities Under Long-Term Lease Arrangements, Option To Purchase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" xlink:href="ensg-20241231.xsd#ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" xlink:to="lab_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_3eb05429-b40a-4dd9-bc2e-599d88f6a40e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_6f9249e7-bf7e-46b6-8b18-75ab32daf658_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_30a44ba5-2885-4761-b5a7-b23c94370952_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued litigation</link:label>
    <link:label id="lab_us-gaap_LitigationReserveCurrent_label_en-US" xlink:label="lab_us-gaap_LitigationReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Litigation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserveCurrent" xlink:to="lab_us-gaap_LitigationReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_VariousLandlordsMember_a12f7a94-b624-486e-a442-4f09d75e2510_terseLabel_en-US" xlink:label="lab_ensg_VariousLandlordsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Various Landlords</link:label>
    <link:label id="lab_ensg_VariousLandlordsMember_label_en-US" xlink:label="lab_ensg_VariousLandlordsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Various Landlords [Member]</link:label>
    <link:label id="lab_ensg_VariousLandlordsMember_documentation_en-US" xlink:label="lab_ensg_VariousLandlordsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Various Landlords[Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_VariousLandlordsMember" xlink:href="ensg-20241231.xsd#ensg_VariousLandlordsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_VariousLandlordsMember" xlink:to="lab_ensg_VariousLandlordsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_5b5e8d32-3549-4023-a734-cc98fcf9a25b_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plus: incremental shares from assumed conversion (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_c974afb2-27af-4193-869a-a48cf1534ad0_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTaxStatusDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Plan Tax Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain" xlink:to="lab_us-gaap_RetirementPlanTaxStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_614ba6b9-5fc6-469a-854e-7113820ed16f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_640fc664-5b1a-4c22-8961-168c8870d978_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, options outstanding, weighted average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized_0c9a75d7-f85e-434c-8afc-7f195c308ab3_verboseLabel_en-US" xlink:label="lab_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stat relief funding recognized as revenue</link:label>
    <link:label id="lab_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized_label_en-US" xlink:label="lab_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Family First Coronavirus Response Act, Revenue Recognized</link:label>
    <link:label id="lab_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized_documentation_en-US" xlink:label="lab_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue Recognition, Family First Coronavirus Response Act, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" xlink:href="ensg-20241231.xsd#ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" xlink:to="lab_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_457996e4-0fb6-45d3-89ba-e783e8a7c94a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2d625b57-06f2-4cd6-bebd-0269ffb37047_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Dividend Yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_83d1a469-8190-407d-8e9d-194d882fdcd3_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_fa24aa6c-282e-497e-8104-ed0feaf43715_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, interest rate, effective percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_f38a0b0e-9cba-4366-a42f-bc8f70fc3052_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum annual contributions per employee</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_67a38853-b8eb-41c2-acd3-f9b2724fe7df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Financial Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SubleaseToThirdPartyOperatorsMember_07bade6a-187d-41cb-bf7e-b8595be02492_terseLabel_en-US" xlink:label="lab_ensg_SubleaseToThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease To Third Party Operators</link:label>
    <link:label id="lab_ensg_SubleaseToThirdPartyOperatorsMember_label_en-US" xlink:label="lab_ensg_SubleaseToThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease To Third Party Operators [Member]</link:label>
    <link:label id="lab_ensg_SubleaseToThirdPartyOperatorsMember_documentation_en-US" xlink:label="lab_ensg_SubleaseToThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sublease To Third Party Operators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SubleaseToThirdPartyOperatorsMember" xlink:href="ensg-20241231.xsd#ensg_SubleaseToThirdPartyOperatorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SubleaseToThirdPartyOperatorsMember" xlink:to="lab_ensg_SubleaseToThirdPartyOperatorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_40f91dc3-3901-4b63-9f38-ac3943f26f83_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_f1b64057-ba1c-4770-b240-5d6cd08d3d6b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeNineMember_06367c43-76a8-40ef-ba6e-7f99d808bad8_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeNineMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Nine [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeNineMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeNineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Nine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeNineMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeNineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeNineMember" xlink:to="lab_ensg_ExercisePriceRangeNineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfFinancingLeases_f8940e2a-26f8-4050-865a-d79a3475de77_terseLabel_en-US" xlink:label="lab_ensg_NumberOfFinancingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of financing lease</link:label>
    <link:label id="lab_ensg_NumberOfFinancingLeases_label_en-US" xlink:label="lab_ensg_NumberOfFinancingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Financing Leases</link:label>
    <link:label id="lab_ensg_NumberOfFinancingLeases_documentation_en-US" xlink:label="lab_ensg_NumberOfFinancingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Financing Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFinancingLeases" xlink:href="ensg-20241231.xsd#ensg_NumberOfFinancingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfFinancingLeases" xlink:to="lab_ensg_NumberOfFinancingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b35a14e2-cf0d-45c6-9f26-2844683eaa87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_5257a4e7-0843-468b-9f40-729520c8b9c3_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Parent Company</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_b424f87c-011f-4c49-9c15-3bfaf014fab6_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_40657805-410a-42e7-b1cc-b1fbbdf51e38_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_f9a1a825-d3cd-4c69-bd2d-bdb82af8b7fa_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cumulative goodwill impairment losses</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impaired, Accumulated Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_a562b830-6762-407e-8e8d-21ae28e7f33e_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_a5a5e53b-2c5b-4be3-ab74-650af06b6925_verboseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Equipment, furniture, and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_de4a75d5-13fa-4b23-9d20-0ecefb181136_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_8afc6879-f3c6-41de-bafe-a137cef99b15_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_e01db058-3f09-4234-a040-72c0fd2fd829_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Litigation</link:label>
    <link:label id="lab_us-gaap_GainLossRelatedToLitigationSettlement_label_en-US" xlink:label="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) from Litigation Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossRelatedToLitigationSettlement" xlink:to="lab_us-gaap_GainLossRelatedToLitigationSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_61650dd1-eddd-43fd-947a-97903cb32587_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Assumptions for Stock Options Granted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_dc6fa5a5-bc3d-48a3-bea8-9ac7c60a4132_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortized cost basis of held-to-maturity investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_ec9fb38c-2a89-4a8f-94f3-9308641077ef_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Lease, cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_2f00d44e-eb73-4bc3-a768-1195c10e1083_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionLineItems_6bdc086e-2fb1-4639-9f45-906dfb8939ab_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessor, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LessorLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_36a53a1e-78fb-45ac-9dad-c4fe23b49201_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Non-controlling interest distribution</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6c34108a-19af-4606-a160-d8ec414ef8c8_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_addeb94f-0ee0-4134-8614-6b889047bf26_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_d8c4b2b7-af49-48ce-b29d-9e13747a3416_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_34a35eee-e549-4660-bd9a-d2d9ff5e0093_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_9529b643-06de-4ab6-866a-cbede13f4a7e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of service</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PaymentsToAcquirePropertyAndEquipment_4794ec00-5434-49af-8778-a1b699efa621_negatedLabel_en-US" xlink:label="lab_ensg_PaymentsToAcquirePropertyAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_ensg_PaymentsToAcquirePropertyAndEquipment_label_en-US" xlink:label="lab_ensg_PaymentsToAcquirePropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments To Acquire Property And Equipment</link:label>
    <link:label id="lab_ensg_PaymentsToAcquirePropertyAndEquipment_documentation_en-US" xlink:label="lab_ensg_PaymentsToAcquirePropertyAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments To Acquire Property And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PaymentsToAcquirePropertyAndEquipment" xlink:href="ensg-20241231.xsd#ensg_PaymentsToAcquirePropertyAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PaymentsToAcquirePropertyAndEquipment" xlink:to="lab_ensg_PaymentsToAcquirePropertyAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_512f7b6a-200d-4e28-8bf5-bf4e9f3f617b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_5210ab21-04c2-4ad8-9775-e8d01be4be9f_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_5c164102-a154-4594-92b7-4cb0c53b38de_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_fb48d433-3a95-478d-aa67-5d506481b7b8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Diluted net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_bc4a2e35-a38e-4cba-873f-964bdfc713a7_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e8f78e21-67f8-4de7-8ee8-387e7f14fd1f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service Revenue Recognition, Rental Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_71913cb9-8954-43b9-8a96-ba7e94800399_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SELF INSURANCE LIABILITIES</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_d429d0a4-1aae-4189-b38b-a4bc53e9b7e7_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_6b1320da-d15c-4094-aa57-89e4530af8db_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_c33cb0e6-20ec-4324-8171-951f23dad349_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_InsuranceSubsidiaryLongTermInvestmentsMember_da2a7984-8714-477e-a9ae-fc2187a735ef_terseLabel_en-US" xlink:label="lab_ensg_InsuranceSubsidiaryLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Insurance Subsidiary Liabilities</link:label>
    <link:label id="lab_ensg_InsuranceSubsidiaryLongTermInvestmentsMember_label_en-US" xlink:label="lab_ensg_InsuranceSubsidiaryLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Subsidiary Long-Term Investments [Member]</link:label>
    <link:label id="lab_ensg_InsuranceSubsidiaryLongTermInvestmentsMember_documentation_en-US" xlink:label="lab_ensg_InsuranceSubsidiaryLongTermInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long-Term Insurance Subsidiary Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceSubsidiaryLongTermInvestmentsMember" xlink:href="ensg-20241231.xsd#ensg_InsuranceSubsidiaryLongTermInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_InsuranceSubsidiaryLongTermInvestmentsMember" xlink:to="lab_ensg_InsuranceSubsidiaryLongTermInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_A2022AcquiredPropertiesMember_cb386676-0298-4b88-9b8b-5a83768a8627_terseLabel_en-US" xlink:label="lab_ensg_A2022AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Acquired Properties</link:label>
    <link:label id="lab_ensg_A2022AcquiredPropertiesMember_label_en-US" xlink:label="lab_ensg_A2022AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Acquired Properties [Member]</link:label>
    <link:label id="lab_ensg_A2022AcquiredPropertiesMember_documentation_en-US" xlink:label="lab_ensg_A2022AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Acquired Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2022AcquiredPropertiesMember" xlink:href="ensg-20241231.xsd#ensg_A2022AcquiredPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_A2022AcquiredPropertiesMember" xlink:to="lab_ensg_A2022AcquiredPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_c776876e-fe82-477a-bf8f-662756949f3b_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_74c07229-23f2-4e96-8293-8935edecb8ea_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_StandardBearerMasterLeasesMember_b726a92c-3d05-4c38-bb97-103c9eb36844_terseLabel_en-US" xlink:label="lab_ensg_StandardBearerMasterLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard Bearer Master Leases</link:label>
    <link:label id="lab_ensg_StandardBearerMasterLeasesMember_label_en-US" xlink:label="lab_ensg_StandardBearerMasterLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Bearer Master Leases [Member]</link:label>
    <link:label id="lab_ensg_StandardBearerMasterLeasesMember_documentation_en-US" xlink:label="lab_ensg_StandardBearerMasterLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard Bearer Master Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerMasterLeasesMember" xlink:href="ensg-20241231.xsd#ensg_StandardBearerMasterLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_StandardBearerMasterLeasesMember" xlink:to="lab_ensg_StandardBearerMasterLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ca7fc400-a150-4f14-a536-f19f74a2a342_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_35e5e60d-7e20-44d9-a230-b43b7de047ae_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Self-Insurance</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReservePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Self Insurance Reserve [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:to="lab_us-gaap_SelfInsuranceReservePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice_263eab83-32b6-454d-ad00-242fe8555cfc_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, restricted awards, exercise price (in dollars per share)</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Restricted Awards, Exercise Price</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Restricted Awards, Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" xlink:to="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_ffd26376-0206-490e-89e2-4360822da703_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">NET INCOME</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_aca6cc2d-1ce1-42df-a058-ebe29c63ae7a_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_2764d967-8ade-4c86-9e54-c0f661103bbe_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales price on sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_TotalNetDebtRatioMinimum_d9cc7d76-3240-471d-b61e-f249f20f6cc7_terseLabel_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net debt ratio, minimum</link:label>
    <link:label id="lab_ensg_TotalNetDebtRatioMinimum_label_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Net Debt Ratio, Minimum</link:label>
    <link:label id="lab_ensg_TotalNetDebtRatioMinimum_documentation_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Net Debt Ratio, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMinimum" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_TotalNetDebtRatioMinimum" xlink:to="lab_ensg_TotalNetDebtRatioMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_fd56d085-8350-4d11-9015-e6d0beb07df6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_ad1fa6a5-dbd4-4891-a815-83054888e91c_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_f643c8be-715f-496a-9b1c-e1a4e7984360_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c63b62bd-13e3-41b5-ae6f-93a225c7aefc_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, nonvested awards, cost not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_HUDInsuredMortgagesMember_8782a5ff-24c7-469d-b1b8-938603ef9efb_terseLabel_en-US" xlink:label="lab_ensg_HUDInsuredMortgagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">HUD Insured Mortgages</link:label>
    <link:label id="lab_ensg_HUDInsuredMortgagesMember_label_en-US" xlink:label="lab_ensg_HUDInsuredMortgagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">HUD Insured Mortgages [Member]</link:label>
    <link:label id="lab_ensg_HUDInsuredMortgagesMember_documentation_en-US" xlink:label="lab_ensg_HUDInsuredMortgagesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">HUD Insured Mortgages</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_HUDInsuredMortgagesMember" xlink:href="ensg-20241231.xsd#ensg_HUDInsuredMortgagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_HUDInsuredMortgagesMember" xlink:to="lab_ensg_HUDInsuredMortgagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_06243d27-b721-41b0-8ddb-e1bd54c1a02d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">TOTAL REVENUE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f8120aac-67d9-4e27-9829-9b84132ef024_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4968c7b7-f86c-4af8-afa5-65d6dac3e5d6_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total Service Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d846e899-20a7-47fb-a00e-c826dd5af177_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">NET CASH USED IN INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_49585d2e-03e4-48bc-b379-dc379d6a3477_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_73e0f452-4e87-43c8-965b-50031ace1f8c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages and related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ceffdd73-cdb3-45e1-8f48-0da7dbbd6955_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LesseeOperatingLeaseNumberOfLeases_4d3e8dac-fb43-4d69-85e2-611cef129d9b_terseLabel_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of stand-alone leases</link:label>
    <link:label id="lab_ensg_LesseeOperatingLeaseNumberOfLeases_label_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Leases</link:label>
    <link:label id="lab_ensg_LesseeOperatingLeaseNumberOfLeases_documentation_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseNumberOfLeases" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseNumberOfLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LesseeOperatingLeaseNumberOfLeases" xlink:to="lab_ensg_LesseeOperatingLeaseNumberOfLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8b1e58e6-a29b-4ffb-92e8-e5eda3018044_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_731552b6-784b-4186-99eb-8ab69bc75f48_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SegmentIncomeLoss_25372bae-6a43-4d88-8a4d-5032b082c86d_verboseLabel_en-US" xlink:label="lab_ensg_SegmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Segment income (loss)</link:label>
    <link:label id="lab_ensg_SegmentIncomeLoss_label_en-US" xlink:label="lab_ensg_SegmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Income (Loss)</link:label>
    <link:label id="lab_ensg_SegmentIncomeLoss_documentation_en-US" xlink:label="lab_ensg_SegmentIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Segment Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SegmentIncomeLoss" xlink:href="ensg-20241231.xsd#ensg_SegmentIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SegmentIncomeLoss" xlink:to="lab_ensg_SegmentIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_5eebbf1f-90c5-4535-b9cc-8a2129c5a3d1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Insurance Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_DeferredRentAndOtherLongTermLiabilities_eaae6b54-22e5-465e-b360-b5275ce4232a_verboseLabel_en-US" xlink:label="lab_ensg_DeferredRentAndOtherLongTermLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_ensg_DeferredRentAndOtherLongTermLiabilities_label_en-US" xlink:label="lab_ensg_DeferredRentAndOtherLongTermLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred rent and other long-term liabilities</link:label>
    <link:label id="lab_ensg_DeferredRentAndOtherLongTermLiabilities_documentation_en-US" xlink:label="lab_ensg_DeferredRentAndOtherLongTermLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rental expense in excess of actual rental payments and other long-term liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredRentAndOtherLongTermLiabilities" xlink:href="ensg-20241231.xsd#ensg_DeferredRentAndOtherLongTermLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_DeferredRentAndOtherLongTermLiabilities" xlink:to="lab_ensg_DeferredRentAndOtherLongTermLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosureLineItems_9e8b3da1-6d1d-4df9-ba5c-fc8dc6b21796_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedContributionPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_67642d7e-7f0d-4037-b43a-b8bb75c9dd51_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rental revenue</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_82ad5298-2a83-47e5-b4f2-06b8b38f802b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of restricted stock, net of forfeitures</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_0f48af80-b760-47d6-b920-9779c319e67a_totalLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_a484ea28-5a28-4c18-8beb-ea3296dbdc41_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_2ef97165-cb2b-4396-ad1a-9e2a63c01fd4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_469ad4b1-4cf5-494a-8eaa-febb15b152cc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c6afe99f-3bb4-4c99-b010-41b4d85c0917_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_e2784e8c-277b-408d-974e-5fb37fa1f07f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e89ee76a-9953-4487-b1c0-5aa31d05ddac_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3da6acfe-f5d2-4acc-94c9-99841cc514f4_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b22bdbfe-9875-42be-8dc9-f7c385a88b08_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets_f22e00df-2838-4dd6-b1f7-e37d96b31408_negatedLabel_en-US" xlink:label="lab_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss (gain) on insurance claims and asset disposals</link:label>
    <link:label id="lab_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets_label_en-US" xlink:label="lab_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Insurance Claims And Disposition Of Assets</link:label>
    <link:label id="lab_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets_documentation_en-US" xlink:label="lab_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Gain (Loss) On Disposal Of Assets And Insurance Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets" xlink:href="ensg-20241231.xsd#ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets" xlink:to="lab_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_dd02b4a3-adde-46a0-b1ca-6b6e8ed01ce0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Options Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_5f6cca82-38ca-40cf-87c1-736e78e4ff06_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue related reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_A2025AcquiredPropertiesMember_6d4afe7b-703d-4edb-b905-7571eb32fd55_terseLabel_en-US" xlink:label="lab_ensg_A2025AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025 Acquired Properties</link:label>
    <link:label id="lab_ensg_A2025AcquiredPropertiesMember_label_en-US" xlink:label="lab_ensg_A2025AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2025 Acquired Properties [Member]</link:label>
    <link:label id="lab_ensg_A2025AcquiredPropertiesMember_documentation_en-US" xlink:label="lab_ensg_A2025AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2025 Acquired Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2025AcquiredPropertiesMember" xlink:href="ensg-20241231.xsd#ensg_A2025AcquiredPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_A2025AcquiredPropertiesMember" xlink:to="lab_ensg_A2025AcquiredPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0fb0be79-b9b8-4e13-87b5-6ed9f54a94e6_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_1bc08955-51de-489d-936e-8e31dc3a30da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_1fd369d0-ca7c-4cf3-8605-2da5b99d9edc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_426e8185-4dfa-4f77-8600-f6b123a70a2b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_24dd1675-5470-48e0-aae7-08e94730a164_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_f6bda2a6-b202-429b-9889-6ddb94a979aa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CO_777f18a0-0f54-4946-8c5a-3d982f9d231d_terseLabel_en-US" xlink:label="lab_stpr_CO" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Colorado</link:label>
    <link:label id="lab_stpr_CO_label_en-US" xlink:label="lab_stpr_CO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">COLORADO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CO" xlink:to="lab_stpr_CO" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_276e7c6d-bb89-4ed3-9fa5-1e6d25701ba1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period, (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_36a01fc4-d4ed-4caa-acef-a061e9d6c21a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period, (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_e5cf5ee3-082c-4de0-9feb-43465a95bf9f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_f70dd3ff-71ed-439b-b5e7-3c0ca70bedb2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_0fecbb3f-f111-409e-9076-aa9295a65b55_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">California</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_354324ac-d125-4d16-a459-cfba929d4e45_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMPUTATION OF NET INCOME PER COMMON SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_33da1bf7-9b9b-4709-acf1-86e93ed71bb9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_430578bf-63cc-40db-be08-51c26788d7d7_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock to employees and directors resulting from the exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_de590674-df68-4a46-8030-c8d6835919c8_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expense:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestments_55452210-8282-49a8-9b54-4a278a8902e7_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss (gain) on deferral investment</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestments" xlink:to="lab_us-gaap_GainLossOnInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b6c74886-541f-48fe-a441-0268486d7f11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeFourMember_3c77d88b-3268-45c1-a034-f83a2f8e66ba_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2018</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeFourMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeFourMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeFourMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeFourMember" xlink:to="lab_ensg_ExercisePriceRangeFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_b02c577a-1d6a-44a8-b3cc-9f4fe9f03117_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_cc9ab944-7a25-48b0-9baa-42833085261d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_6f2ccbb0-1abc-4156-aa36-d375a616d9f3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating leases of lessee, contingent rentals, basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_InsuranceCoverageLimitTypeAxis_dc55c783-c28c-4048-9b09-dbd36941e757_terseLabel_en-US" xlink:label="lab_ensg_InsuranceCoverageLimitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance Coverage Limit Type [Axis]</link:label>
    <link:label id="lab_ensg_InsuranceCoverageLimitTypeAxis_label_en-US" xlink:label="lab_ensg_InsuranceCoverageLimitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Coverage Limit Type [Axis]</link:label>
    <link:label id="lab_ensg_InsuranceCoverageLimitTypeAxis_documentation_en-US" xlink:label="lab_ensg_InsuranceCoverageLimitTypeAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Coverage Limit Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceCoverageLimitTypeAxis" xlink:href="ensg-20241231.xsd#ensg_InsuranceCoverageLimitTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_InsuranceCoverageLimitTypeAxis" xlink:to="lab_ensg_InsuranceCoverageLimitTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PrepaymentPenalty_e5a7fe9a-510b-4d53-99ca-a46ee1b17c80_terseLabel_en-US" xlink:label="lab_ensg_PrepaymentPenalty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayment penalty</link:label>
    <link:label id="lab_ensg_PrepaymentPenalty_label_en-US" xlink:label="lab_ensg_PrepaymentPenalty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayment Penalty</link:label>
    <link:label id="lab_ensg_PrepaymentPenalty_documentation_en-US" xlink:label="lab_ensg_PrepaymentPenalty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Percentage that the prepayment penalty percentage is reduced during the first three years.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentPenalty" xlink:href="ensg-20241231.xsd#ensg_PrepaymentPenalty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PrepaymentPenalty" xlink:to="lab_ensg_PrepaymentPenalty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_06182492-c561-41d1-bf77-e6ba87744d2e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_949f99c1-976e-4e0d-80a2-96418e9c8d0c_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_a9fda04c-4aac-42e3-811f-c8a801cb1c73_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_259b8bfa-7a6a-4786-841a-a20799d4fbb6_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_8c4d4563-f558-4d61-924c-53eaf1d2e92c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Common stock in treasury, at cost, 3,400 and 3,390 shares at December&#160;31, 2024 and 2023, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_49a61b2b-8bd0-4517-a937-7066fc69b56f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit facility, unused capacity, commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_MedicaidMember_569ec666-eded-4888-8977-11c5f7467381_terseLabel_en-US" xlink:label="lab_ensg_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_ensg_MedicaidMember_label_en-US" xlink:label="lab_ensg_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:label id="lab_ensg_MedicaidMember_documentation_en-US" xlink:label="lab_ensg_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue from Medicaid for custodial services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidMember" xlink:href="ensg-20241231.xsd#ensg_MedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_MedicaidMember" xlink:to="lab_ensg_MedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_d142f7cd-7643-4f57-a9ac-472a67dc86f1_verboseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_7872d59e-cca1-430f-8ca8-d8790792956f_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_0cbb8617-8e52-490b-bfc9-896c6277f908_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_c00f55c5-7738-4acf-9777-8bbc349e9fa1_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Financial assets, investment funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards_caeb7c54-4c1e-464f-bd0a-3fecd480452e_terseLabel_en-US" xlink:label="lab_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, nonvested awards (in shares)</link:label>
    <link:label id="lab_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards_label_en-US" xlink:label="lab_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards</link:label>
    <link:label id="lab_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards_documentation_en-US" xlink:label="lab_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards" xlink:href="ensg-20241231.xsd#ensg_EmployeeServiceShareBasedCompensationNonvestedAwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards" xlink:to="lab_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4bc73447-b73f-4556-b431-c50187a2e31f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_7e45429a-9817-46d9-97f7-26aad3392a3b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_9f5e6b2e-9103-4762-bdc8-49f041475a83_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AccruedRentAdjustment_142e4839-8313-4588-b1dd-9dc90d81f4f7_terseLabel_en-US" xlink:label="lab_ensg_AccruedRentAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued rent expense adjustments</link:label>
    <link:label id="lab_ensg_AccruedRentAdjustment_label_en-US" xlink:label="lab_ensg_AccruedRentAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Rent Adjustment</link:label>
    <link:label id="lab_ensg_AccruedRentAdjustment_documentation_en-US" xlink:label="lab_ensg_AccruedRentAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustment to deferred rent arising from the difference between rent expense recognized and rental payments made in the current period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AccruedRentAdjustment" xlink:href="ensg-20241231.xsd#ensg_AccruedRentAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AccruedRentAdjustment" xlink:to="lab_ensg_AccruedRentAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SubsidiariesUnderMasterLeaseArrangement_6c961140-832e-4f0c-bceb-8425fd4beb82_terseLabel_en-US" xlink:label="lab_ensg_SubsidiariesUnderMasterLeaseArrangement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries under master lease arrangement</link:label>
    <link:label id="lab_ensg_SubsidiariesUnderMasterLeaseArrangement_label_en-US" xlink:label="lab_ensg_SubsidiariesUnderMasterLeaseArrangement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries Under Master Lease Arrangement</link:label>
    <link:label id="lab_ensg_SubsidiariesUnderMasterLeaseArrangement_documentation_en-US" xlink:label="lab_ensg_SubsidiariesUnderMasterLeaseArrangement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facilities operated under two separate three-facility master lease arrangements. Under these master leases, a breach at a single facility could subject one or more of the other facilities covered by the same master lease to the same default risk.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SubsidiariesUnderMasterLeaseArrangement" xlink:href="ensg-20241231.xsd#ensg_SubsidiariesUnderMasterLeaseArrangement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SubsidiariesUnderMasterLeaseArrangement" xlink:to="lab_ensg_SubsidiariesUnderMasterLeaseArrangement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_17adb69e-bbc4-4241-9c73-b094fedd790a_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Service Revenue by Major Payor Source</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Revenue from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_a803f6c1-1169-418b-9337-1e5884262e8e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in operating assets and liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_b15d4bd8-d53e-4354-b46f-8f79f443751f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of credit increase</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Increase (Decrease), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="lab_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrMember_53bc7867-4348-4b42-b8c7-c01b7d57b237_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NonCaliforniaMember_1c5af4b5-3ed1-4b96-aa63-1979cb2bd18f_terseLabel_en-US" xlink:label="lab_ensg_NonCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-california</link:label>
    <link:label id="lab_ensg_NonCaliforniaMember_label_en-US" xlink:label="lab_ensg_NonCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-California [Member]</link:label>
    <link:label id="lab_ensg_NonCaliforniaMember_documentation_en-US" xlink:label="lab_ensg_NonCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-California [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NonCaliforniaMember" xlink:href="ensg-20241231.xsd#ensg_NonCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NonCaliforniaMember" xlink:to="lab_ensg_NonCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_TotalNetDebtRatioMaximum_729b3e2a-9b84-413b-9da8-026c0f19d649_terseLabel_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net debt ratio, maximum</link:label>
    <link:label id="lab_ensg_TotalNetDebtRatioMaximum_label_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Net Debt Ratio, Maximum</link:label>
    <link:label id="lab_ensg_TotalNetDebtRatioMaximum_documentation_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Net Debt Ratio, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMaximum" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_TotalNetDebtRatioMaximum" xlink:to="lab_ensg_TotalNetDebtRatioMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue_0147f664-93b2-401b-b697-3af8767659aa_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Black-Scholes Fair Value</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Fair Value</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair value determined using a black-scholes model for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" xlink:to="lab_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionTable_9f13553b-1d8c-4d27-8e2d-52aaf0c3f3e4_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessor, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LessorLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LessorLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable" xlink:to="lab_us-gaap_LessorLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_0eb4327d-52e7-42d9-abf1-23ecde1a2eb3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfSeniorLivingUnits_725d6d94-5202-4aab-aab2-1b5b50f9103e_verboseLabel_en-US" xlink:label="lab_ensg_NumberOfSeniorLivingUnits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of senior living units</link:label>
    <link:label id="lab_ensg_NumberOfSeniorLivingUnits_label_en-US" xlink:label="lab_ensg_NumberOfSeniorLivingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Senior Living Units</link:label>
    <link:label id="lab_ensg_NumberOfSeniorLivingUnits_documentation_en-US" xlink:label="lab_ensg_NumberOfSeniorLivingUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operational Assisted Living and Independent Living Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSeniorLivingUnits" xlink:href="ensg-20241231.xsd#ensg_NumberOfSeniorLivingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfSeniorLivingUnits" xlink:to="lab_ensg_NumberOfSeniorLivingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_93795064-b32e-4134-961e-dfce7aea13be_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_081c6a06-2443-4c23-9f98-b69b82b02bee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_cb4d1b8f-c11e-49a7-9a5f-ed2a6b85b328_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_331b6906-15be-4277-9c09-a5868712e2e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_37b5bec0-c0f6-459b-9bd0-b09d1c88a524_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementServiceIncentiveMember_39183aca-c8b3-4369-8812-88fe162d30eb_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementServiceIncentiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Incentive Management Fee</link:label>
    <link:label id="lab_us-gaap_ManagementServiceIncentiveMember_label_en-US" xlink:label="lab_us-gaap_ManagementServiceIncentiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Service, Incentive [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceIncentiveMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceIncentiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementServiceIncentiveMember" xlink:to="lab_us-gaap_ManagementServiceIncentiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_676236a5-f682-4cba-b5e4-116a28a2cb2f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_33bc1815-13e8-4c0b-88e0-d0478791beb0_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock used to satisfy tax withholding obligations (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_c096c812-c8a1-4699-b7c2-d7abc39fd254_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeThreeMember_0bdeed2a-f4e5-4101-affe-36285af18aa9_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2017</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeThreeMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeThreeMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeThreeMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeThreeMember" xlink:to="lab_ensg_ExercisePriceRangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_545a2f5e-0418-40cb-bf09-9bbdd87e6321_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LeaseArrangementDomain_5af1a510-69a5-4b34-99af-a317cb0fa954_terseLabel_en-US" xlink:label="lab_ensg_LeaseArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Domain]</link:label>
    <link:label id="lab_ensg_LeaseArrangementDomain_label_en-US" xlink:label="lab_ensg_LeaseArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Domain]</link:label>
    <link:label id="lab_ensg_LeaseArrangementDomain_documentation_en-US" xlink:label="lab_ensg_LeaseArrangementDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lease Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LeaseArrangementDomain" xlink:to="lab_ensg_LeaseArrangementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_3733e942-475a-4430-b3b2-9086af898beb_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_1b20ddc6-fd8e-44fd-bf4c-e97c9cfd18e4_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">COMMON STOCK REPURCHASE PROGRAM</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AllStatesExcludingColoradoMember_6ac93ab0-42c7-4a89-945e-3454c7c6dde6_terseLabel_en-US" xlink:label="lab_ensg_AllStatesExcludingColoradoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All States Except Colorado</link:label>
    <link:label id="lab_ensg_AllStatesExcludingColoradoMember_label_en-US" xlink:label="lab_ensg_AllStatesExcludingColoradoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All States, Excluding Colorado [Member]</link:label>
    <link:label id="lab_ensg_AllStatesExcludingColoradoMember_documentation_en-US" xlink:label="lab_ensg_AllStatesExcludingColoradoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">All States Except Colorado [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AllStatesExcludingColoradoMember" xlink:href="ensg-20241231.xsd#ensg_AllStatesExcludingColoradoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AllStatesExcludingColoradoMember" xlink:to="lab_ensg_AllStatesExcludingColoradoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_e4eacfde-d4ee-40a1-ae26-e1d22f5bdc18_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_0ead6ea2-60c5-49c4-a88c-1b393a879e39_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BUSINESS SEGMENTS</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_7fb630c6-b013-41f3-8921-bd6225f5188f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current maturities of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_d57e4ad9-b1df-4764-acb1-7206d76653b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5bca43c8-39ac-42c9-8297-4b5d8b989302_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee stock award compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_f06bccfb-a0a2-4c33-874b-a8fa6e5570f2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_f95bf133-9e14-4355-aeeb-5dd69f4b5fe0_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense related to restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_OtherStockAwardsMember_5d16018f-2570-4b5d-ba30-0718613ebb43_terseLabel_en-US" xlink:label="lab_ensg_OtherStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense related to restricted stock awards to non-employee directors</link:label>
    <link:label id="lab_ensg_OtherStockAwardsMember_label_en-US" xlink:label="lab_ensg_OtherStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Stock Awards [Member]</link:label>
    <link:label id="lab_ensg_OtherStockAwardsMember_documentation_en-US" xlink:label="lab_ensg_OtherStockAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OtherStockAwardsMember" xlink:href="ensg-20241231.xsd#ensg_OtherStockAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_OtherStockAwardsMember" xlink:to="lab_ensg_OtherStockAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanTable_5e4dd2cc-40b7-4c1c-aa32-be4e2be63aa9_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan [Table]</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanTable_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanTable" xlink:to="lab_us-gaap_DefinedContributionPlanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate_8cd6d0cd-ce4b-4a63-935e-24dd829d6af1_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeiture rate</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Award, Options, Fair Value, Assumptions Forfeiture Rate</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Award, Options, Fair Value, Assumptions Forfeiture Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" xlink:to="lab_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_a3fd5208-3073-42d4-a463-4b73fd89c01d_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d1001cdd-283f-4e3b-9d16-8a25ce2bdf9d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_c5709706-88bb-44e0-9ea4-9fad10e43ef7_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_f517b94c-b71f-4401-9ef6-7f14eff94b28_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_6fba8a48-ba75-4bbc-b5e4-60292b173299_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Self insurance reserve</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_591f18e1-1b1c-4655-8125-604552f4ad96_totalLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL SELF-INSURANCE LIABILITIES</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserve" xlink:to="lab_us-gaap_SelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_bdf60c4e-cb45-4ebd-96ea-1140d9a6be04_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Loss (gain) on sale of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets1_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets1" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets1" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_MedicaidSkilledMember_e9907087-ee34-433c-a076-2ed22bf2c519_terseLabel_en-US" xlink:label="lab_ensg_MedicaidSkilledMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medicaid &#8212; skilled</link:label>
    <link:label id="lab_ensg_MedicaidSkilledMember_8c8ac54c-512c-4bc3-8eb5-fd5898f75bc6_verboseLabel_en-US" xlink:label="lab_ensg_MedicaidSkilledMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Medicaid-skilled</link:label>
    <link:label id="lab_ensg_MedicaidSkilledMember_label_en-US" xlink:label="lab_ensg_MedicaidSkilledMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medicaid-skilled [Member]</link:label>
    <link:label id="lab_ensg_MedicaidSkilledMember_documentation_en-US" xlink:label="lab_ensg_MedicaidSkilledMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue from Medicaid for skilled services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidSkilledMember" xlink:href="ensg-20241231.xsd#ensg_MedicaidSkilledMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_MedicaidSkilledMember" xlink:to="lab_ensg_MedicaidSkilledMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PurchaseOptionMember_87aec09b-99de-4d32-bc59-84a79e62364d_terseLabel_en-US" xlink:label="lab_ensg_PurchaseOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase Option</link:label>
    <link:label id="lab_ensg_PurchaseOptionMember_label_en-US" xlink:label="lab_ensg_PurchaseOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Option [Member]</link:label>
    <link:label id="lab_ensg_PurchaseOptionMember_documentation_en-US" xlink:label="lab_ensg_PurchaseOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchase Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PurchaseOptionMember" xlink:href="ensg-20241231.xsd#ensg_PurchaseOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PurchaseOptionMember" xlink:to="lab_ensg_PurchaseOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_b8b8a648-568a-4e0f-ab59-0ff4762024a0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of shares of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability_db507cf6-fafc-46b7-b52b-c4ea70bc2f64_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion to reduce shares availability</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Conversion To Reduce Shares Availability</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Conversion To Reduce Shares Availability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" xlink:to="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7292f9e8-2128-48d2-b1b1-e242106a53a7_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">LONG-TERM DEBT LESS CURRENT MATURITIES</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_073ae63d-f867-4450-b250-a39daf2a12f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_July2022RepurchaseProgramMember_97ffb825-aea9-4f2d-b5b2-36f10f849b0b_terseLabel_en-US" xlink:label="lab_ensg_July2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">July 2022 Repurchase Program</link:label>
    <link:label id="lab_ensg_July2022RepurchaseProgramMember_label_en-US" xlink:label="lab_ensg_July2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">July 2022 Repurchase Program [Member]</link:label>
    <link:label id="lab_ensg_July2022RepurchaseProgramMember_documentation_en-US" xlink:label="lab_ensg_July2022RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">July 2022 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_July2022RepurchaseProgramMember" xlink:href="ensg-20241231.xsd#ensg_July2022RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_July2022RepurchaseProgramMember" xlink:to="lab_ensg_July2022RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_6c4ccca4-c224-4e1f-9cac-ce0b26ca434b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease_c269a3f3-d28c-4b3a-a041-afebcb45e6e2_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in long-term insurance losses recoverable</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefits, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans_320c4bc6-9403-4523-a0e7-937e2417efe7_verboseLabel_en-US" xlink:label="lab_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of subsidiary shares</link:label>
    <link:label id="lab_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans_label_en-US" xlink:label="lab_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Sale Of Common Stock Associated With Subsidiary Equity Plans</link:label>
    <link:label id="lab_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans_documentation_en-US" xlink:label="lab_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Sale Of Common Stock Associated With Subsidiary Equity Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" xlink:href="ensg-20241231.xsd#ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" xlink:to="lab_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_356a6dd6-741e-4c56-862f-d623f58504fe_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3b59d97b-7dac-41af-b391-dcdf32cb0dce_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NET INCOME PER SHARE ATTRIBUTABLE TO THE ENSIGN GROUP INC.</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_265cfd40-eb7b-488f-898d-45dd432de895_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EQUITY</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_dd4a2058-dd27-4d66-a241-114ed6669f7f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less: net income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f98b5808-bf92-40a1-aa78-24437399a1f4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_501e4b3a-2557-4c8c-b77a-83da62dd7a3a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash from insurance proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Insurance Settlement, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromInsuranceSettlementInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:to="lab_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_cfdcf6cf-dd16-4c1d-9cee-6e888692cd50_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfLeaseArrangements_0809025c-ea30-4b9c-98b2-51fc7dd7c4db_terseLabel_en-US" xlink:label="lab_ensg_NumberOfLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of master lease arrangements</link:label>
    <link:label id="lab_ensg_NumberOfLeaseArrangements_label_en-US" xlink:label="lab_ensg_NumberOfLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Lease Arrangements</link:label>
    <link:label id="lab_ensg_NumberOfLeaseArrangements_documentation_en-US" xlink:label="lab_ensg_NumberOfLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Lease Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfLeaseArrangements" xlink:href="ensg-20241231.xsd#ensg_NumberOfLeaseArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfLeaseArrangements" xlink:to="lab_ensg_NumberOfLeaseArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_6f6c6907-da3b-4b90-8d32-c7838b88a57f_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserveNoncurrent_c243d486-f947-491a-b021-cf358722da8e_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued self-insurance liabilities&#8212;less current portion</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserveNoncurrent_13ae521e-b60b-47da-b489-c30234491441_verboseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LONG-TERM SELF-INSURANCE LIABILITIES</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserveNoncurrent_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Self Insurance Reserve, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserveNoncurrent" xlink:to="lab_us-gaap_SelfInsuranceReserveNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_4bef6349-9ee3-43f7-9ebe-b67eb905c81d_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation settlement, amount awarded to other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded to Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedToOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_97a02998-47e8-4a80-a1cc-66357dd30ddb_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_e110d3bf-070b-4dd4-ab88-143d2bdbce59_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">PRESENT VALUE OF TOTAL LEASE LIABILITIES</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeTwoMember_cb661fac-9e6f-443c-91dc-33ef8deadea5_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2016</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeTwoMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeTwoMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeTwoMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeTwoMember" xlink:to="lab_ensg_ExercisePriceRangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AggregateMember_3a5201c2-5a43-4469-8b85-ce7f56e861cc_terseLabel_en-US" xlink:label="lab_ensg_AggregateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate</link:label>
    <link:label id="lab_ensg_AggregateMember_label_en-US" xlink:label="lab_ensg_AggregateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate [Member]</link:label>
    <link:label id="lab_ensg_AggregateMember_documentation_en-US" xlink:label="lab_ensg_AggregateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Blanket Aggregate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AggregateMember" xlink:href="ensg-20241231.xsd#ensg_AggregateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AggregateMember" xlink:to="lab_ensg_AggregateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_TruistBankMember_bda51c77-fec7-4bd4-9c75-06c1fb8e41c4_terseLabel_en-US" xlink:label="lab_ensg_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Truist</link:label>
    <link:label id="lab_ensg_TruistBankMember_label_en-US" xlink:label="lab_ensg_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Truist Bank [Member]</link:label>
    <link:label id="lab_ensg_TruistBankMember_documentation_en-US" xlink:label="lab_ensg_TruistBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Truist Bank [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TruistBankMember" xlink:href="ensg-20241231.xsd#ensg_TruistBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_TruistBankMember" xlink:to="lab_ensg_TruistBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_89b5ec23-4339-423f-9e7b-5a6c411dbaf7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_65d67e40-c93a-487d-aafe-24db23470535_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on sale of assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_OperatingEntityDomain_8fb74ebd-bdbd-4d39-9367-3f35ce3566b6_terseLabel_en-US" xlink:label="lab_ensg_OperatingEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Entity [Domain]</link:label>
    <link:label id="lab_ensg_OperatingEntityDomain_label_en-US" xlink:label="lab_ensg_OperatingEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Entity [Domain]</link:label>
    <link:label id="lab_ensg_OperatingEntityDomain_documentation_en-US" xlink:label="lab_ensg_OperatingEntityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Operating Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_OperatingEntityDomain" xlink:to="lab_ensg_OperatingEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_35bd6da6-4380-4c56-9ee4-d9151b264710_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: debt issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_d060a1e0-4f23-4b7f-b721-f0bff76531fe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_feec6958-173f-4eee-8e70-84715f499ca1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_25010c41-9389-45a1-b6ff-8f3c54857a38_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue_855be073-f2c1-4a74-abf5-359e4acb25f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Cash surrender value of life insurance policy premiums</link:label>
    <link:label id="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue_label_en-US" xlink:label="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Life Insurance, Corporate or Bank Owned, Change in Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue" xlink:to="lab_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_InsuranceCoverageLimitTypeDomain_51776ec3-d4ee-40ce-bafd-e3eec5d8b529_terseLabel_en-US" xlink:label="lab_ensg_InsuranceCoverageLimitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance Coverage Limit Type [Domain]</link:label>
    <link:label id="lab_ensg_InsuranceCoverageLimitTypeDomain_label_en-US" xlink:label="lab_ensg_InsuranceCoverageLimitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Coverage Limit Type [Domain]</link:label>
    <link:label id="lab_ensg_InsuranceCoverageLimitTypeDomain_documentation_en-US" xlink:label="lab_ensg_InsuranceCoverageLimitTypeDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Insurance Coverage Limit Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceCoverageLimitTypeDomain" xlink:href="ensg-20241231.xsd#ensg_InsuranceCoverageLimitTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain" xlink:to="lab_ensg_InsuranceCoverageLimitTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount_333064c2-919e-4f47-ab63-ac159c3629ac_terseLabel_en-US" xlink:label="lab_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt&#8212;less current maturities</link:label>
    <link:label id="lab_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount_label_en-US" xlink:label="lab_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long Term Debt, net of Current Maturities and Debt Discount</link:label>
    <link:label id="lab_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount_documentation_en-US" xlink:label="lab_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long Term Debt, net of Current Maturities and Debt Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" xlink:to="lab_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PayorDomain_f1203a1c-d1ca-4f5b-b31a-70a82e1a2747_terseLabel_en-US" xlink:label="lab_ensg_PayorDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payor [Domain]</link:label>
    <link:label id="lab_ensg_PayorDomain_label_en-US" xlink:label="lab_ensg_PayorDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payor [Domain]</link:label>
    <link:label id="lab_ensg_PayorDomain_documentation_en-US" xlink:label="lab_ensg_PayorDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payor [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PayorDomain" xlink:href="ensg-20241231.xsd#ensg_PayorDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PayorDomain" xlink:to="lab_ensg_PayorDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_A2024AcquiredPropertiesMember_2aadf9d1-d120-469a-8386-a1473640ace1_terseLabel_en-US" xlink:label="lab_ensg_A2024AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Acquired Properties</link:label>
    <link:label id="lab_ensg_A2024AcquiredPropertiesMember_label_en-US" xlink:label="lab_ensg_A2024AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Acquired Properties [Member]</link:label>
    <link:label id="lab_ensg_A2024AcquiredPropertiesMember_documentation_en-US" xlink:label="lab_ensg_A2024AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Acquired Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_A2024AcquiredPropertiesMember" xlink:to="lab_ensg_A2024AcquiredPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_StopLossInsuranceLimitPerClaimMember_7b6e5d4a-b0ed-4135-b1b4-f830f9ca1bea_terseLabel_en-US" xlink:label="lab_ensg_StopLossInsuranceLimitPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stop-Loss Insurance Limit Per Claim</link:label>
    <link:label id="lab_ensg_StopLossInsuranceLimitPerClaimMember_label_en-US" xlink:label="lab_ensg_StopLossInsuranceLimitPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stop-Loss Insurance Limit Per Claim [Member]</link:label>
    <link:label id="lab_ensg_StopLossInsuranceLimitPerClaimMember_documentation_en-US" xlink:label="lab_ensg_StopLossInsuranceLimitPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stop-Loss Insurance limit per claim[Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StopLossInsuranceLimitPerClaimMember" xlink:href="ensg-20241231.xsd#ensg_StopLossInsuranceLimitPerClaimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_StopLossInsuranceLimitPerClaimMember" xlink:to="lab_ensg_StopLossInsuranceLimitPerClaimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_f412764f-d795-4449-8622-7e2f09de1a79_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_65bacb28-f5ca-42a5-ba7a-4cde49397761_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:to="lab_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_d0148997-2b8e-4de1-b51e-f260d4f4067c_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_87adaf40-b2a7-4e94-b80f-4ac9da4b2f5e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other restricted assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_e47be5f7-c0d6-493c-809e-6d681f1c53bc_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_August2023RepurchaseProgramMember_c19d7044-6907-464b-8e5c-30bcee7121b7_terseLabel_en-US" xlink:label="lab_ensg_August2023RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">August 2023 Repurchase Program</link:label>
    <link:label id="lab_ensg_August2023RepurchaseProgramMember_label_en-US" xlink:label="lab_ensg_August2023RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">August 2023 Repurchase Program [Member]</link:label>
    <link:label id="lab_ensg_August2023RepurchaseProgramMember_documentation_en-US" xlink:label="lab_ensg_August2023RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">August 2023 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_August2023RepurchaseProgramMember" xlink:href="ensg-20241231.xsd#ensg_August2023RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_August2023RepurchaseProgramMember" xlink:to="lab_ensg_August2023RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_6b0e359a-2bd0-4531-a0c3-b3720c952d54_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-employee Directors</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_d5635441-2c3a-4969-bc05-a7294f0664f3_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_d88dff50-4197-41b5-b562-9a5b8352f68a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_A2019LTIPlanMember_11575301-7c68-4246-bd90-4a0cde7608e6_terseLabel_en-US" xlink:label="lab_ensg_A2019LTIPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2019 LTI Plan</link:label>
    <link:label id="lab_ensg_A2019LTIPlanMember_label_en-US" xlink:label="lab_ensg_A2019LTIPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2019 LTI Plan [Member]</link:label>
    <link:label id="lab_ensg_A2019LTIPlanMember_documentation_en-US" xlink:label="lab_ensg_A2019LTIPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2019 LTI Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2019LTIPlanMember" xlink:href="ensg-20241231.xsd#ensg_A2019LTIPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_A2019LTIPlanMember" xlink:to="lab_ensg_A2019LTIPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_9e39f57f-915e-4306-8334-9a2459918fc1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_3f3a0462-dc25-4ef3-bdb4-b54de79be9fb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_b9b6134b-7d18-474e-abd8-9b59aec0af9b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_b107bac1-cc5f-4b3f-bbca-b254172018b8_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementOneMember_a364238f-e7ab-4df4-b3fc-9415bb44e2bb_terseLabel_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement, One</link:label>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementOneMember_label_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement, One [Member]</link:label>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementOneMember_documentation_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement, One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementOneMember" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AmendedMasterLeaseAgreementOneMember" xlink:to="lab_ensg_AmendedMasterLeaseAgreementOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_682923b4-5fc6-4ec8-87e0-c8e3b4b012b1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">WEIGHTED AVERAGE COMMON SHARES OUTSTANDING</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_69cbce17-379f-401c-a8e1-31798c0856f5_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">DENOMINATOR:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_845977c2-b2c4-45cb-a968-164976e66c96_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL ASSETS</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_4e0163be-23fe-412b-bd40-e5c8245d33f4_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_3514cbc4-258b-4bcf-981c-df5803321145_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_20c78213-cd7f-47e1-9718-c2e4b32f08b1_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies (Notes 14 and 19)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b4a0bfd4-e454-4eaf-80b5-fe679e1f84eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeEightMember_a96adb2c-da1d-4878-bfd5-c67e70e1654b_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeEightMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Eight [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeEightMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeEightMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Eight [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeEightMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeEightMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeEightMember" xlink:to="lab_ensg_ExercisePriceRangeEightMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_fa000223-78ad-4ac0-9fc6-66de2e8d8214_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_264bebb0-c060-4323-9656-ad6385a5109d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_8604f7a4-fd2f-49d7-8efd-6910373ee29a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Claims paid and direct expenses</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_14073ff0-7714-4ff7-af64-4b391b6540a5_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_aa57bb91-0263-4ebc-af8e-2a8c86fc2040_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Purchase Price Allocation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_a7188d86-5d96-469e-8822-db957864811f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_CareTrustREITMember_541dd663-7446-4b69-8172-a922253d74fe_terseLabel_en-US" xlink:label="lab_ensg_CareTrustREITMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CareTrust REIT</link:label>
    <link:label id="lab_ensg_CareTrustREITMember_label_en-US" xlink:label="lab_ensg_CareTrustREITMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CareTrust REIT [Member]</link:label>
    <link:label id="lab_ensg_CareTrustREITMember_documentation_en-US" xlink:label="lab_ensg_CareTrustREITMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">CareTrust REIT [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CareTrustREITMember" xlink:href="ensg-20241231.xsd#ensg_CareTrustREITMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_CareTrustREITMember" xlink:to="lab_ensg_CareTrustREITMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_c58151e0-56dd-454b-9f27-5ebe3d2a8aa7_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">NET INCOME ATTRIBUTABLE TO THE ENSIGN GROUP, INC.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3d54a60b-0682-4a26-9bb4-3278f0a26b93_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Net income attributable to the Ensign Group, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability_ccdb0f48-71a1-47b6-8f0d-972a780a6de6_terseLabel_en-US" xlink:label="lab_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liability</link:label>
    <link:label id="lab_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability_label_en-US" xlink:label="lab_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax, Deferred Expense, Reserves And Accruals, Lease Liability</link:label>
    <link:label id="lab_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability_documentation_en-US" xlink:label="lab_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax, Deferred Expense, Reserves And Accruals, Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" xlink:to="lab_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a07cc863-5e6e-463f-a205-af2f2c3f6181_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PreviousSubsidiariesMember_1ab5581e-f428-4b26-9c2b-0edf48e3d0a1_terseLabel_en-US" xlink:label="lab_ensg_PreviousSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Previous Subsidiaries</link:label>
    <link:label id="lab_ensg_PreviousSubsidiariesMember_label_en-US" xlink:label="lab_ensg_PreviousSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previous Subsidiaries [Member]</link:label>
    <link:label id="lab_ensg_PreviousSubsidiariesMember_documentation_en-US" xlink:label="lab_ensg_PreviousSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Previous Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PreviousSubsidiariesMember" xlink:href="ensg-20241231.xsd#ensg_PreviousSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PreviousSubsidiariesMember" xlink:to="lab_ensg_PreviousSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfLongTermAcuteCareBeds_6377cd72-f1bd-433d-ae67-4e03e4b6ec65_terseLabel_en-US" xlink:label="lab_ensg_NumberOfLongTermAcuteCareBeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term acute care beds included within operational skilled nursing beds</link:label>
    <link:label id="lab_ensg_NumberOfLongTermAcuteCareBeds_label_en-US" xlink:label="lab_ensg_NumberOfLongTermAcuteCareBeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Long-Term Acute Care Beds</link:label>
    <link:label id="lab_ensg_NumberOfLongTermAcuteCareBeds_documentation_en-US" xlink:label="lab_ensg_NumberOfLongTermAcuteCareBeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Long-Term Acute Care Beds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfLongTermAcuteCareBeds" xlink:href="ensg-20241231.xsd#ensg_NumberOfLongTermAcuteCareBeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfLongTermAcuteCareBeds" xlink:to="lab_ensg_NumberOfLongTermAcuteCareBeds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_bbbf3326-c385-4aab-bb7a-0ebfff899997_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Controlling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_4ca8d797-d051-49fc-9227-8d042d7982cd_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4e6d7ff8-2ef9-4596-9f6c-977c7774b1c9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRealEstatePropertiesTable_7b88e98a-d6f0-42c2-87f1-daf1592597b8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Real Estate Properties [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRealEstatePropertiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Property, Ownership [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:to="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_5402c002-6e35-4924-a82a-7453e7de7de2_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeSevenMember_52965530-f151-482c-9153-a4622f462615_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeSevenMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Seven [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeSevenMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeSevenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Seven [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeSevenMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeSevenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeSevenMember" xlink:to="lab_ensg_ExercisePriceRangeSevenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_5ba20cb5-07eb-453f-8ca8-cf78acfb3144_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3c56c14e-6887-4299-a134-34cae41db04f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_671d6235-d110-4b9a-ad08-821b75ce733f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_84fc16d8-4dba-4ca7-9534-daae544fb1e6_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance Subsidiary Deposits and Other Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_QualifiedPlanMember_4b98861e-fada-4b8d-8790-26f8cbe0b480_terseLabel_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Qualified Plan</link:label>
    <link:label id="lab_us-gaap_QualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_QualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Qualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_QualifiedPlanMember" xlink:to="lab_us-gaap_QualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_3e686476-9413-49c9-8a57-40957b83fa3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Deferred Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_895ec258-a217-4da8-81da-7bf98ca7fa12_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_6ff8c1a9-7edd-4601-a98f-1da23998179f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_b5c22f98-44f9-4fe7-a297-cac91043d829_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income (loss) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SpinoffMember_6352a4e8-fbc0-4af0-ae8c-fe3002760562_terseLabel_en-US" xlink:label="lab_us-gaap_SpinoffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Spinoff</link:label>
    <link:label id="lab_us-gaap_SpinoffMember_label_en-US" xlink:label="lab_us-gaap_SpinoffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Spinoff [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpinoffMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SpinoffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SpinoffMember" xlink:to="lab_us-gaap_SpinoffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_067ec4a6-cc87-40dc-b458-ad75b4114412_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Self Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_DepreciationAndAmortizationMember_ab578b37-4027-4890-a75c-5209f25e898e_terseLabel_en-US" xlink:label="lab_ensg_DepreciationAndAmortizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and Amortization</link:label>
    <link:label id="lab_ensg_DepreciationAndAmortizationMember_9711896a-fab5-4c5f-ae05-1c6f1f8e57be_verboseLabel_en-US" xlink:label="lab_ensg_DepreciationAndAmortizationMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_ensg_DepreciationAndAmortizationMember_label_en-US" xlink:label="lab_ensg_DepreciationAndAmortizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation And Amortization [Member]</link:label>
    <link:label id="lab_ensg_DepreciationAndAmortizationMember_documentation_en-US" xlink:label="lab_ensg_DepreciationAndAmortizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Depreciation And Amortization [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DepreciationAndAmortizationMember" xlink:href="ensg-20241231.xsd#ensg_DepreciationAndAmortizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_DepreciationAndAmortizationMember" xlink:to="lab_ensg_DepreciationAndAmortizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AggregateDeductibleMember_97714762-9f43-46d6-908f-8269721d60cc_terseLabel_en-US" xlink:label="lab_ensg_AggregateDeductibleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Deductible</link:label>
    <link:label id="lab_ensg_AggregateDeductibleMember_label_en-US" xlink:label="lab_ensg_AggregateDeductibleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Deductible [Member]</link:label>
    <link:label id="lab_ensg_AggregateDeductibleMember_documentation_en-US" xlink:label="lab_ensg_AggregateDeductibleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Aggregate Deductible [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AggregateDeductibleMember" xlink:href="ensg-20241231.xsd#ensg_AggregateDeductibleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AggregateDeductibleMember" xlink:to="lab_ensg_AggregateDeductibleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_99229448-db52-4f6d-815c-3fe955403ae6_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f380b13e-6712-4e44-a82c-7ba2d9d442f3_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average shares outstanding for basic net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserveCurrent_0a2694b4-523d-4af2-92d2-a1e89833bff7_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued self-insurance liabilities&#8212;current</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserveCurrent_cf373035-422b-46a8-8ddc-8af04b1e3053_verboseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Less: current self-insurance liabilities</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserveCurrent_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Self Insurance Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserveCurrent" xlink:to="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_3f1924d4-7767-48b9-8763-d27516f43b8f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash proceeds from the sale of assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8620bb24-f736-4346-b5a4-b0dbe0951e88_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_790e0d17-820d-45a3-95cc-74526fe13b13_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8a62d36c-ff33-455c-a8b2-6b78a9713b9b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_d38d8ec8-3d47-43eb-bc4d-86c9d14c7b0a_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of deferred financing fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_82f0a78e-9242-45ab-988b-6183b6d5589c_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_9476683a-2826-4b61-96c0-11ec9a334e61_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_A2022PlanMember_7f0f7abf-c7d6-4a3d-a335-9b0a07fbfee4_terseLabel_en-US" xlink:label="lab_ensg_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Plan</link:label>
    <link:label id="lab_ensg_A2022PlanMember_label_en-US" xlink:label="lab_ensg_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Plan [Member]</link:label>
    <link:label id="lab_ensg_A2022PlanMember_documentation_en-US" xlink:label="lab_ensg_A2022PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2022PlanMember" xlink:href="ensg-20241231.xsd#ensg_A2022PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_A2022PlanMember" xlink:to="lab_ensg_A2022PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementFeeExpense_56a2fcf6-ea97-4f2c-8cf0-170ecceb25a9_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementFeeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Management fees</link:label>
    <link:label id="lab_us-gaap_ManagementFeeExpense_label_en-US" xlink:label="lab_us-gaap_ManagementFeeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Fee Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementFeeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementFeeExpense" xlink:to="lab_us-gaap_ManagementFeeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_d5df1b27-861c-4f62-b686-0f8bf3f4ab20_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_7c8517de-2394-4413-af51-094a3ee6ca92_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Annual Rental Income</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_06b50beb-d6e8-4f98-b9f2-919ec57ef33d_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the period for:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_BusinessAndAssetAcquisitionsDomain_ee87b05f-b1eb-41c3-badb-e6c4e9d8330d_terseLabel_en-US" xlink:label="lab_ensg_BusinessAndAssetAcquisitionsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business And Asset Acquisitions [Domain]</link:label>
    <link:label id="lab_ensg_BusinessAndAssetAcquisitionsDomain_label_en-US" xlink:label="lab_ensg_BusinessAndAssetAcquisitionsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business And Asset Acquisitions [Domain]</link:label>
    <link:label id="lab_ensg_BusinessAndAssetAcquisitionsDomain_documentation_en-US" xlink:label="lab_ensg_BusinessAndAssetAcquisitionsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business And Asset Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessAndAssetAcquisitionsDomain" xlink:href="ensg-20241231.xsd#ensg_BusinessAndAssetAcquisitionsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_BusinessAndAssetAcquisitionsDomain" xlink:to="lab_ensg_BusinessAndAssetAcquisitionsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_MedicaidAndMedicareMember_671364d8-9b54-433e-9af2-b1d2210a3a41_terseLabel_en-US" xlink:label="lab_ensg_MedicaidAndMedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Medicare and Medicaid</link:label>
    <link:label id="lab_ensg_MedicaidAndMedicareMember_2dfd1f35-17ae-4dc5-a78c-d18c067fd353_verboseLabel_en-US" xlink:label="lab_ensg_MedicaidAndMedicareMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total Medicaid and Medicare</link:label>
    <link:label id="lab_ensg_MedicaidAndMedicareMember_label_en-US" xlink:label="lab_ensg_MedicaidAndMedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medicaid And Medicare [Member]</link:label>
    <link:label id="lab_ensg_MedicaidAndMedicareMember_documentation_en-US" xlink:label="lab_ensg_MedicaidAndMedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total revenue from Medicaid and Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_MedicaidAndMedicareMember" xlink:to="lab_ensg_MedicaidAndMedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_09a6e198-3f30-4a3a-800f-bbcf9b901044_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_BusinessAndAssetAcquisitionsAxis_1ff61fd7-7621-4d6f-ac75-7885ebff54eb_terseLabel_en-US" xlink:label="lab_ensg_BusinessAndAssetAcquisitionsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business And Asset Acquisitions [Axis]</link:label>
    <link:label id="lab_ensg_BusinessAndAssetAcquisitionsAxis_label_en-US" xlink:label="lab_ensg_BusinessAndAssetAcquisitionsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business And Asset Acquisitions [Axis]</link:label>
    <link:label id="lab_ensg_BusinessAndAssetAcquisitionsAxis_documentation_en-US" xlink:label="lab_ensg_BusinessAndAssetAcquisitionsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business And Asset Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessAndAssetAcquisitionsAxis" xlink:href="ensg-20241231.xsd#ensg_BusinessAndAssetAcquisitionsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_BusinessAndAssetAcquisitionsAxis" xlink:to="lab_ensg_BusinessAndAssetAcquisitionsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_e1aa308c-9ee1-467b-861e-853a2ae047e6_netLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_45777d40-481f-423c-8848-a90f7373b119_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_8dc11952-8574-4265-b780-faa8fe82c7a5_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_c66f9b53-f5cf-41d6-9142-c9a2006852d6_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Operating Lease Expenses</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_68c3a806-b702-468c-b4a4-7957126023c8_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LesseeOperatingLeaseNumberOfRenewalOptions_f2a895ea-93d8-4614-904f-1b65ba729943_terseLabel_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of options to renew lease</link:label>
    <link:label id="lab_ensg_LesseeOperatingLeaseNumberOfRenewalOptions_label_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:label id="lab_ensg_LesseeOperatingLeaseNumberOfRenewalOptions_documentation_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Renewal Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:to="lab_ensg_LesseeOperatingLeaseNumberOfRenewalOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_830a4470-a4e3-4ebb-8357-99d464c6cc80_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e63a3f1b-f8b2-4185-a948-ba74b8cca564_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection_80a3114d-17ef-40a5-ae5f-a2792972d02c_terseLabel_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total net debt ratio, maximum after increase election</link:label>
    <link:label id="lab_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection_label_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Net Debt Ratio, Maximum After Increase Election</link:label>
    <link:label id="lab_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection_documentation_en-US" xlink:label="lab_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total Net Debt Ratio, Maximum After Increase Election</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMaximumAfterIncreaseElection"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection" xlink:to="lab_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments_faac2e06-a72c-4f44-b481-f83f42c28a75_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of installments</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Installments</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" xlink:to="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_a7cc6448-ab93-48e6-a503-e48242887ddf_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease obligations</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_a924d110-8ad1-4f24-b113-055f185cdb11_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in lease liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_d4c21488-8663-49f4-8d12-ddc804a9eeed_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash received from insurance proceeds</link:label>
    <link:label id="lab_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Insurance Settlement, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromInsuranceSettlementOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:to="lab_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_23a73f65-d396-41a2-b43a-a5ededf0c0d4_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_3f87189e-18ba-40ed-adf6-40490e7263d9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_fc6300d1-699a-452c-9571-46448b3d6771_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_c1a142ed-9cdb-4491-a0f3-21b2e5642da4_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_0b6f029a-8855-4fcb-9845-c06b0ce25bd1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c2958870-bfd4-49d5-91a3-0863d7b7f04f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_0868ee08-173b-4a45-9bdb-e4f6cb139ec3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Common stock, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e01528d8-1562-45dc-95de-5992af6983d5_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Common stock, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_f017d895-4549-4edd-8e7f-675baeca76d7_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_e5731d98-ee4e-4b37-b9a0-6ccf7a751124_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_09195294-0c8f-48f0-86cc-231388cce7f9_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_613cc5a4-94ef-4371-95ed-27817d920f65_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefits_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefit, before Reinsurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefits" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_43f6973b-6e45-4c3a-bf71-0ba915f1ef31_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_70e9f938-e467-43d7-8eb7-f1178001b587_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term lease liabilities&#8212;less current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_b2000241-dfd3-40c2-b370-2d4d8cebb150_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">LONG-TERM OPERATING LEASE LIABILITIES</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_6877cc62-f1ba-4aaf-9bb1-466f70d8da3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of noncontrolling interest shares</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralizedDebtObligationsMember_d60e6364-e3b7-4bc2-95ae-6718a2b0636f_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralizedDebtObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mortgage loans and promissory note</link:label>
    <link:label id="lab_us-gaap_CollateralizedDebtObligationsMember_label_en-US" xlink:label="lab_us-gaap_CollateralizedDebtObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collateralized Debt Obligations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralizedDebtObligationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralizedDebtObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralizedDebtObligationsMember" xlink:to="lab_us-gaap_CollateralizedDebtObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a7ada18f-82e5-4d17-990b-8b7b60553467_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Resident advances</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManagementServiceBaseMember_b2ae0fe9-fdfb-414b-bdf0-13ccf3fc6154_terseLabel_en-US" xlink:label="lab_us-gaap_ManagementServiceBaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base Management Fee</link:label>
    <link:label id="lab_us-gaap_ManagementServiceBaseMember_label_en-US" xlink:label="lab_us-gaap_ManagementServiceBaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Service, Base [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceBaseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceBaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManagementServiceBaseMember" xlink:to="lab_us-gaap_ManagementServiceBaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_04ba5b40-fe2a-4a38-a13b-1e7fcf65e981_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_72feaeeb-6803-4118-a39a-1eda783a4d39_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_83bf4b03-8efa-4e8e-bc01-6f7940a4c601_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f6a8ce69-657a-40e4-89c9-911cb49b97fa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_71ab30b3-8acf-4031-ae6b-9bf69c0e8fea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_0ec39676-0c53-445f-bb6b-1fc4cfd17cc2_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_ef8402dd-8a5c-4136-8666-41049d7fe823_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PayorAxis_0b9d24e7-efa4-4768-bc07-4457d77c3095_terseLabel_en-US" xlink:label="lab_ensg_PayorAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payor [Axis]</link:label>
    <link:label id="lab_ensg_PayorAxis_label_en-US" xlink:label="lab_ensg_PayorAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payor [Axis]</link:label>
    <link:label id="lab_ensg_PayorAxis_documentation_en-US" xlink:label="lab_ensg_PayorAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payor [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PayorAxis" xlink:href="ensg-20241231.xsd#ensg_PayorAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PayorAxis" xlink:to="lab_ensg_PayorAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_9568f857-fc3d-4a85-b333-48062d826f8b_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LeaseArrangementAxis_274afa58-0b76-474e-9b41-14361031f329_terseLabel_en-US" xlink:label="lab_ensg_LeaseArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Axis]</link:label>
    <link:label id="lab_ensg_LeaseArrangementAxis_label_en-US" xlink:label="lab_ensg_LeaseArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease Arrangement [Axis]</link:label>
    <link:label id="lab_ensg_LeaseArrangementAxis_documentation_en-US" xlink:label="lab_ensg_LeaseArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Information by group of related lease arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LeaseArrangementAxis" xlink:to="lab_ensg_LeaseArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_60e55047-9abd-47c7-8a13-591bd5f574d8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_188555e1-a1f0-4f78-8e65-ad02147a1c25_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_c2980d71-6d58-4be5-8d84-c9cf4deb194a_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_82b8bf23-8d5b-4cf0-a8df-662281ff4ef5_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Facility trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_56396e2f-40b5-46e1-a49d-78f327bdc46a_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL EXPENSES</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_OperatingEntityAxis_51fa4dd0-1ec3-4685-a6fe-967395e75af6_terseLabel_en-US" xlink:label="lab_ensg_OperatingEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Entity [Axis]</link:label>
    <link:label id="lab_ensg_OperatingEntityAxis_label_en-US" xlink:label="lab_ensg_OperatingEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Entity [Axis]</link:label>
    <link:label id="lab_ensg_OperatingEntityAxis_documentation_en-US" xlink:label="lab_ensg_OperatingEntityAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_OperatingEntityAxis" xlink:to="lab_ensg_OperatingEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_2a99c1d3-587b-4b7f-89d7-b55a9e73d3e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_519e2ef5-c580-42da-baa9-a22074acf46b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic Net Income Per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfMasterLeaseAgreements_90f3f3d1-44b1-418d-a53d-0c3354c0c923_terseLabel_en-US" xlink:label="lab_ensg_NumberOfMasterLeaseAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of master lease agreements</link:label>
    <link:label id="lab_ensg_NumberOfMasterLeaseAgreements_label_en-US" xlink:label="lab_ensg_NumberOfMasterLeaseAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Master Lease Agreements</link:label>
    <link:label id="lab_ensg_NumberOfMasterLeaseAgreements_documentation_en-US" xlink:label="lab_ensg_NumberOfMasterLeaseAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Master Lease agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfMasterLeaseAgreements" xlink:href="ensg-20241231.xsd#ensg_NumberOfMasterLeaseAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfMasterLeaseAgreements" xlink:to="lab_ensg_NumberOfMasterLeaseAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_YearsFiveThroughTenMember_a9fd7c73-680f-4eb7-96f3-b9b6658479b3_terseLabel_en-US" xlink:label="lab_ensg_YearsFiveThroughTenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Years Five Through Ten</link:label>
    <link:label id="lab_ensg_YearsFiveThroughTenMember_label_en-US" xlink:label="lab_ensg_YearsFiveThroughTenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Years Five Through Ten [Member]</link:label>
    <link:label id="lab_ensg_YearsFiveThroughTenMember_documentation_en-US" xlink:label="lab_ensg_YearsFiveThroughTenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Years Five Through Ten</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_YearsFiveThroughTenMember" xlink:href="ensg-20241231.xsd#ensg_YearsFiveThroughTenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_YearsFiveThroughTenMember" xlink:to="lab_ensg_YearsFiveThroughTenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_3228c4d9-46d7-47b7-a8d0-a0b566d7a2cd_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_c9b44797-aa85-4ef9-a4eb-5eed759e1666_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">NET DEFERRED TAX ASSETS</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_00c9abee-c9e3-4dea-b49a-7a1ad9754e29_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_801dd1f8-5de7-411b-856b-29577460f1ca_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_895e9c9d-cab1-4057-a6d4-0e85df8ab3f2_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">DEFINED CONTRIBUTION PLANS</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_3353fe7a-035c-42d5-a189-292a5f791bd6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rent expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ThePennantGroupInc.Member_70b192de-0f37-431a-8cf2-56da49edda0c_terseLabel_en-US" xlink:label="lab_ensg_ThePennantGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">The Pennant Group, Inc.</link:label>
    <link:label id="lab_ensg_ThePennantGroupInc.Member_6771c7a4-e9cb-47c9-a23e-61176a082c37_verboseLabel_en-US" xlink:label="lab_ensg_ThePennantGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Pennant</link:label>
    <link:label id="lab_ensg_ThePennantGroupInc.Member_label_en-US" xlink:label="lab_ensg_ThePennantGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">The Pennant Group, Inc. [Member]</link:label>
    <link:label id="lab_ensg_ThePennantGroupInc.Member_documentation_en-US" xlink:label="lab_ensg_ThePennantGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The Pennant Group, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThePennantGroupInc.Member" xlink:href="ensg-20241231.xsd#ensg_ThePennantGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ThePennantGroupInc.Member" xlink:to="lab_ensg_ThePennantGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AuditInformationAbstract_label_en-US" xlink:label="lab_ensg_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_ensg_AuditInformationAbstract_documentation_en-US" xlink:label="lab_ensg_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AuditInformationAbstract" xlink:href="ensg-20241231.xsd#ensg_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AuditInformationAbstract" xlink:to="lab_ensg_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_71cfab1a-96b1-4f7e-8edb-8d3a28517a86_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, nonvested awards, cost not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember_b825a98c-0149-441f-8100-555037746ee8_terseLabel_en-US" xlink:label="lab_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other States, Except California, Texas and Washington</link:label>
    <link:label id="lab_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember_label_en-US" xlink:label="lab_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All States, Excluding California, Texas And Washington [Member]</link:label>
    <link:label id="lab_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember_documentation_en-US" xlink:label="lab_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">All States, Excluding California, Texas And Washington</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember" xlink:href="ensg-20241231.xsd#ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember" xlink:to="lab_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_f243ad3e-040c-4a47-976c-62818647da3f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0572d163-7f6a-4ae5-b460-f70dfcd86965_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_9cf113e1-97aa-478f-82d1-0e26b4f758d7_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_4913ee97-c611-4e1f-b201-965388323048_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Considerations</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_8dfdff8e-94a5-4092-849c-e0c6e421e95c_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares in treasury, at cost (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_22dcd7e5-f507-44d8-9f8f-75580cbc51fd_periodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_4bac6029-906d-4aff-aea5-c9b03b37f5c0_periodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_d4b98a97-2d3b-45c2-950c-0dca89d58099_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_734f5488-d921-4cb7-9798-3aee589ba042_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">CPI increases and short term-lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_96a6beb6-fd40-4d9e-8f76-a8c7da283049_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_9014eddb-ce58-483e-8abd-d87549a176d3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e4932f7e-8a76-4efd-aec4-3c1bfdaf7f1b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8f186ac5-4fc0-4036-b9ff-85d63ca60765_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a1ad93df-f105-4444-93c1-cbdc6c1bdef6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_488e54c2-ef23-4fc1-8e9d-79c7c7465b92_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6e81ce7e-884e-4562-98f1-efb6a7eb3adb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Vested Restricted Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_ddac5f10-6953-430f-aca4-da1df9411497_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_404f2c2b-20cf-443b-89ac-55e0a54a3035_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Indefinite-lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_Dr.AnnS.BlouinMember_label_en-US" xlink:label="lab_ensg_Dr.AnnS.BlouinMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dr. Ann S. Blouin [Member]</link:label>
    <link:label id="lab_ensg_Dr.AnnS.BlouinMember_documentation_en-US" xlink:label="lab_ensg_Dr.AnnS.BlouinMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Dr. Ann S. Blouin</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_Dr.AnnS.BlouinMember" xlink:href="ensg-20241231.xsd#ensg_Dr.AnnS.BlouinMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_Dr.AnnS.BlouinMember" xlink:to="lab_ensg_Dr.AnnS.BlouinMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_83ededb7-3f10-429e-908a-2711ad38c886_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SkilledServicesSegmentMember_e06580a1-10e5-47ac-9754-af39b44d008c_terseLabel_en-US" xlink:label="lab_ensg_SkilledServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Skilled Services</link:label>
    <link:label id="lab_ensg_SkilledServicesSegmentMember_label_en-US" xlink:label="lab_ensg_SkilledServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Skilled Services Segment [Member]</link:label>
    <link:label id="lab_ensg_SkilledServicesSegmentMember_documentation_en-US" xlink:label="lab_ensg_SkilledServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Skilled Services Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SkilledServicesSegmentMember" xlink:to="lab_ensg_SkilledServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c44203d5-0769-4fd2-b36e-da24d0fbe249_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_aafdc490-d754-4bea-a87e-0f3fe40724e0_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_11dbbb81-ba87-437b-9296-b80867cd0082_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_74977dfd-c12f-48b0-8e34-82644ec4f329_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">% of Revenue</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_498d1155-1a33-4e76-b1bf-cf4d50115ec8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue %</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_9bcd7d55-cb64-4ca5-ab7d-bb06acd8e522_netLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Concentration percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_WA_6e680be3-b789-4336-8a01-473e1d40b8a3_terseLabel_en-US" xlink:label="lab_stpr_WA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">WASHINGTON</link:label>
    <link:label id="lab_stpr_WA_label_en-US" xlink:label="lab_stpr_WA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">WASHINGTON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_WA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_WA" xlink:to="lab_stpr_WA" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8a614423-7965-4aee-b7ec-ca7efc8d0126_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralLiabilityMember_5fd5c530-b327-4d6b-bc13-c33180a88427_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General Liability</link:label>
    <link:label id="lab_us-gaap_GeneralLiabilityMember_label_en-US" xlink:label="lab_us-gaap_GeneralLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralLiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralLiabilityMember" xlink:to="lab_us-gaap_GeneralLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_cd832135-ca42-4c72-b6d0-69c0ab2f522e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefit, by Product Segment [Table]</link:label>
    <link:label id="lab_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_label_en-US" xlink:label="lab_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Future Policy Benefit, by Product Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable" xlink:to="lab_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_3ecf456e-9f22-4ea6-86c4-33513c2ce38b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and intangible asset impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a7df9d62-1847-4b3f-b363-b86b6909795f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationEliminationsMember_6a4af837-6df4-4d90-83c9-e741558c4cc1_terseLabel_en-US" xlink:label="lab_srt_ConsolidationEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intercompany Elimination</link:label>
    <link:label id="lab_srt_ConsolidationEliminationsMember_label_en-US" xlink:label="lab_srt_ConsolidationEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationEliminationsMember" xlink:to="lab_srt_ConsolidationEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock_eaaa0779-7eb6-4f5b-a570-b20ce742a8d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Self-Insurance Insurance Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Liability for Future Policy Benefits, by Product Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_402ac50a-5890-4c9f-8bfa-262fb573684c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_4c0e458b-42b9-4f7c-b8f4-82321c62aed2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_f4cc0c9a-87a8-4f6f-94f2-63c93f0ab7ff_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_774d93fb-b322-432e-ac30-9e6d4930941a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Extended lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_253d26a3-57d5-4853-bee1-ea6f320a2186_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_0411f376-0973-4cc7-a188-41285f35056d_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_c224ae6c-d967-4224-b206-047936c5d61c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_7fc35113-5f45-43e4-be68-8834eaa7adaf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PROPERTY AND EQUIPMENT&#8212; NET</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_b7f8a2d1-0667-43da-8f69-900c47d1f4c9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payment of contingent consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3bb8d8e9-59b6-434f-b4cf-8b34355c5120_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable&#8212;less allowance for doubtful accounts of $8,435 and $9,348 at December&#160;31, 2024 and 2023, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_555932a3-b1c6-46a4-a672-eab7fbeaa311_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">ACCOUNTS RECEIVABLE, NET</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_502d9b58-65d3-40c9-bb5c-ff3086f44a09_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0e0ad9f8-4a72-47ea-b01e-317e15ec20a0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_e812ef43-afe1-4a5b-9ad2-a27f01224aef_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_d010820f-2b19-4ed0-9c3c-1a65d18c065a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_8451e6cf-dd85-480e-8c05-28795057c2d3_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0cffd91c-dfd0-4832-8c41-84325b1abdaa_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_naics_ZZ524292_dc986402-38d3-40fc-9edf-389e23fd2545_terseLabel_en-US" xlink:label="lab_naics_ZZ524292" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Third-Party Payor</link:label>
    <link:label id="lab_naics_ZZ524292_label_en-US" xlink:label="lab_naics_ZZ524292" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">524292 Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_naics_ZZ524292" xlink:href="https://xbrl.sec.gov/naics/2024/naics-2024.xsd#naics_ZZ524292"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_naics_ZZ524292" xlink:to="lab_naics_ZZ524292" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_RealEstateAndLeaseArrangementsAxis_1dd0e5a2-1cb3-40f2-af3e-93497bb179bc_terseLabel_en-US" xlink:label="lab_ensg_RealEstateAndLeaseArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate And Lease Arrangements [Axis]</link:label>
    <link:label id="lab_ensg_RealEstateAndLeaseArrangementsAxis_label_en-US" xlink:label="lab_ensg_RealEstateAndLeaseArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate And Lease Arrangements [Axis]</link:label>
    <link:label id="lab_ensg_RealEstateAndLeaseArrangementsAxis_documentation_en-US" xlink:label="lab_ensg_RealEstateAndLeaseArrangementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real Estate And Lease Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsAxis" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis" xlink:to="lab_ensg_RealEstateAndLeaseArrangementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SuzanneD.SnapperMember_label_en-US" xlink:label="lab_ensg_SuzanneD.SnapperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Suzanne D. Snapper [Member]</link:label>
    <link:label id="lab_ensg_SuzanneD.SnapperMember_documentation_en-US" xlink:label="lab_ensg_SuzanneD.SnapperMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Suzanne D. Snapper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SuzanneD.SnapperMember" xlink:href="ensg-20241231.xsd#ensg_SuzanneD.SnapperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SuzanneD.SnapperMember" xlink:to="lab_ensg_SuzanneD.SnapperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_e2986c72-856e-49d4-a7d6-3d738f153dee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_3095d1d4-bf61-44e2-9383-83b8d0ed9911_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_StandardBearerHealthcareREITIncMember_0f871e2e-2160-49be-8829-6eb37c9cff1e_terseLabel_en-US" xlink:label="lab_ensg_StandardBearerHealthcareREITIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard Bearer Healthcare REIT, Inc.</link:label>
    <link:label id="lab_ensg_StandardBearerHealthcareREITIncMember_label_en-US" xlink:label="lab_ensg_StandardBearerHealthcareREITIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Bearer Healthcare REIT, Inc. [Member]</link:label>
    <link:label id="lab_ensg_StandardBearerHealthcareREITIncMember_documentation_en-US" xlink:label="lab_ensg_StandardBearerHealthcareREITIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard Bearer Healthcare REIT, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_StandardBearerHealthcareREITIncMember" xlink:to="lab_ensg_StandardBearerHealthcareREITIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_c065ad51-f483-4e7a-864c-3debc08e428c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, lower range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_8d83a602-91c4-4f90-b268-da03a302da74_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Vested in the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c2a6194-fb90-4bca-bc23-94812af93358_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_118fb967-5230-4fc9-85de-b471a0f0a9f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Risk-Free Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LossSensitiveLimitPerClaimMember_d5f62f66-1007-4380-8c0e-363efa35bd1e_terseLabel_en-US" xlink:label="lab_ensg_LossSensitiveLimitPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss-Sensitive Limit Per Claim</link:label>
    <link:label id="lab_ensg_LossSensitiveLimitPerClaimMember_label_en-US" xlink:label="lab_ensg_LossSensitiveLimitPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss-Sensitive Limit Per Claim [Member]</link:label>
    <link:label id="lab_ensg_LossSensitiveLimitPerClaimMember_documentation_en-US" xlink:label="lab_ensg_LossSensitiveLimitPerClaimMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Loss-Sensitive limit per claim [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LossSensitiveLimitPerClaimMember" xlink:href="ensg-20241231.xsd#ensg_LossSensitiveLimitPerClaimMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LossSensitiveLimitPerClaimMember" xlink:to="lab_ensg_LossSensitiveLimitPerClaimMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_24716aea-3aef-4f42-adf0-dfa102e38925_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3df9db8d-1a1e-4090-a3ef-b30ceca4864e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other indefinite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9bae3fad-53d9-4bf3-8e56-c2027fe9163c_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_e1c67081-e583-49f1-934f-4ba784e813e4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments of deferred financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_65cd59a2-6e58-45ae-bc90-74ce564be686_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_TwentyThreeSubsidiariesMember_b7926e64-270b-45df-85ef-238ae57daf33_terseLabel_en-US" xlink:label="lab_ensg_TwentyThreeSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Twenty Three Subsidiaries</link:label>
    <link:label id="lab_ensg_TwentyThreeSubsidiariesMember_label_en-US" xlink:label="lab_ensg_TwentyThreeSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Twenty Three Subsidiaries [Member]</link:label>
    <link:label id="lab_ensg_TwentyThreeSubsidiariesMember_documentation_en-US" xlink:label="lab_ensg_TwentyThreeSubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Twenty Three Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TwentyThreeSubsidiariesMember" xlink:href="ensg-20241231.xsd#ensg_TwentyThreeSubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_TwentyThreeSubsidiariesMember" xlink:to="lab_ensg_TwentyThreeSubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_MedicareAndMedicaidLicensesMember_4a5bd4f7-16dd-42b6-8b2b-097905c2821c_terseLabel_en-US" xlink:label="lab_ensg_MedicareAndMedicaidLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medicare and Medicaid licenses</link:label>
    <link:label id="lab_ensg_MedicareAndMedicaidLicensesMember_label_en-US" xlink:label="lab_ensg_MedicareAndMedicaidLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medicare And Medicaid Licenses [Member]</link:label>
    <link:label id="lab_ensg_MedicareAndMedicaidLicensesMember_documentation_en-US" xlink:label="lab_ensg_MedicareAndMedicaidLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medicare licenses for home health and hospice segment and all other segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareAndMedicaidLicensesMember" xlink:href="ensg-20241231.xsd#ensg_MedicareAndMedicaidLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_MedicareAndMedicaidLicensesMember" xlink:to="lab_ensg_MedicareAndMedicaidLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_b2c76c6f-504e-4dee-9443-b5eaf072c674_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_afb09351-9ec0-46c4-85eb-63de429c34fd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OPERATION EXPANSIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3dae08ab-34f3-47f7-8477-322ebd15a0d4_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_82ef8be6-4645-4d0c-96a3-26a116bd8c1a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: present value adjustment</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_e65c61ce-0e14-4710-a016-7bc99bc2ad0f_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investments&#8212;current</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_44e7c1d4-19ed-4245-a83a-ed17ffa5f61b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_6d8cc5ee-1c10-4d80-8738-13a31ad4b8d6_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_MedicareMember_071341f4-9bd5-4952-a195-9d7ba1b7a4a1_terseLabel_en-US" xlink:label="lab_ensg_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_ensg_MedicareMember_d8401b8b-4c8b-42bd-a85c-f6381362923a_verboseLabel_en-US" xlink:label="lab_ensg_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_ensg_MedicareMember_7abff12d-3681-4c7b-93c2-32e1bb3abfca_netLabel_en-US" xlink:label="lab_ensg_MedicareMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_ensg_MedicareMember_label_en-US" xlink:label="lab_ensg_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_ensg_MedicareMember_documentation_en-US" xlink:label="lab_ensg_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue from Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareMember" xlink:href="ensg-20241231.xsd#ensg_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_MedicareMember" xlink:to="lab_ensg_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_ade60a37-1348-4ce9-858d-16e6bf2fe73f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_f0965642-2cd5-4c73-82fc-00401aae1024_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Definite-lived intangible asset useful life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_4d2bc112-6c97-4b3a-9829-3df478fd10fe_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d1abbe77-9086-43b7-8cc0-71d9ca5c118b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_6a7971fc-03e2-4524-9786-af28daaecdaa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_5723782a-b75c-4915-aa2c-ef698c29ec47_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">GOODWILL</link:label>
    <link:label id="lab_us-gaap_GoodwillDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PerOccurenceMember_9ae5db3b-e189-4f84-87e3-d3f15e128e2d_terseLabel_en-US" xlink:label="lab_ensg_PerOccurenceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Per Occurence</link:label>
    <link:label id="lab_ensg_PerOccurenceMember_label_en-US" xlink:label="lab_ensg_PerOccurenceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Per Occurence [Member]</link:label>
    <link:label id="lab_ensg_PerOccurenceMember_documentation_en-US" xlink:label="lab_ensg_PerOccurenceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Per Occurence [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PerOccurenceMember" xlink:href="ensg-20241231.xsd#ensg_PerOccurenceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PerOccurenceMember" xlink:to="lab_ensg_PerOccurenceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_68f09c0e-333c-4afc-90ba-80b4a46c2a71_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_d1edcd1a-04f0-4134-866b-7273b0d990a1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_19e0b8e1-7b43-4898-9eaf-897b42b5c718_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_85c16d8b-31e4-4f17-8077-ed2b8e13564a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_27479ae7-ebc8-4278-b5f3-a8fecbd7a6e2_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews_fc71737c-acb8-4ee3-8dbb-39e9dfb96737_terseLabel_en-US" xlink:label="lab_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Independent subsidiaries with multi-claim reviews scheduled or in process</link:label>
    <link:label id="lab_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews_label_en-US" xlink:label="lab_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Independent Operating Subsidiaries Under Medicare Probe Reviews</link:label>
    <link:label id="lab_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews_documentation_en-US" xlink:label="lab_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Facilities under Medicare Probe reviews relating to Medicare services, billings and potential overpayments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews" xlink:href="ensg-20241231.xsd#ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews" xlink:to="lab_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived_21052c82-aa91-47c1-a547-a0c8fbcbdeb7_verboseLabel_en-US" xlink:label="lab_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stat relief funding received</link:label>
    <link:label id="lab_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived_label_en-US" xlink:label="lab_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Family First Coronavirus Response Act, Payments Received</link:label>
    <link:label id="lab_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived_documentation_en-US" xlink:label="lab_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Family First Coronavirus Response Act, Payments Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived" xlink:href="ensg-20241231.xsd#ensg_FamilyFirstCoronavirusResponseActPaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived" xlink:to="lab_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_1a27cb55-d627-4d56-ac1c-865f0de308b9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NewAndAmendedMasterLeaseAgreementMember_94b3ecb2-1107-45ef-bd8d-fbcb3a9107f5_terseLabel_en-US" xlink:label="lab_ensg_NewAndAmendedMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New And Amended Master Lease Agreement</link:label>
    <link:label id="lab_ensg_NewAndAmendedMasterLeaseAgreementMember_label_en-US" xlink:label="lab_ensg_NewAndAmendedMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New And Amended Master Lease Agreement [Member]</link:label>
    <link:label id="lab_ensg_NewAndAmendedMasterLeaseAgreementMember_documentation_en-US" xlink:label="lab_ensg_NewAndAmendedMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New And Amended Master Lease Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NewAndAmendedMasterLeaseAgreementMember" xlink:href="ensg-20241231.xsd#ensg_NewAndAmendedMasterLeaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NewAndAmendedMasterLeaseAgreementMember" xlink:to="lab_ensg_NewAndAmendedMasterLeaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_e662e7aa-88fe-4836-8d1a-34e8f06ad8b1_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_0d0153b6-dadb-47b3-859d-5eeb1e5a47ef_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected to vest</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_7fde3a1c-3664-48bb-938c-ae07b2e08496_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_d49c2a59-89cc-4a09-a578-889c17e3e746_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL DEFERRED TAX ASSETS</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_a4b3476e-ee78-4111-9b11-7d81dfe764f3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, interest rate, stated percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeaseTermOfContract_b7cfa04f-8604-43b9-9a4c-99520a264fe4_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of operating lease</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LessorOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_85b95eda-e2e7-477d-804c-2917d9d59e66_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate intrinsic value of options that vested in period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_fc2cbe11-f141-4fc0-ac03-3dbc719160cf_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_6365edf7-4f52-4f6d-a543-cfe339c19b94_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber_ff66337d-3506-4518-b3f4-d66e000fb7d9_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation, options expected to vest, number (in shares)</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expected To Vest, Number</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">As of the balance sheet date, the number of shares which are expected to vest into stock options outstanding can be converted under the option plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" xlink:to="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_f7d48185-529b-4a85-99f9-447231c27951_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">OTHER INCOME (EXPENSE), NET</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_5a322674-40d5-470d-a8ad-368dc7fdc30a_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Service revenue</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_May2024RepurchaseProgramMember_b881bf25-e3ac-4921-8502-3ea7364077cb_terseLabel_en-US" xlink:label="lab_ensg_May2024RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">May 2024 Repurchase Program</link:label>
    <link:label id="lab_ensg_May2024RepurchaseProgramMember_label_en-US" xlink:label="lab_ensg_May2024RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">May 2024 Repurchase Program [Member]</link:label>
    <link:label id="lab_ensg_May2024RepurchaseProgramMember_documentation_en-US" xlink:label="lab_ensg_May2024RepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">May 2024 Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_May2024RepurchaseProgramMember" xlink:href="ensg-20241231.xsd#ensg_May2024RepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_May2024RepurchaseProgramMember" xlink:to="lab_ensg_May2024RepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_9a96fe20-4b1b-4378-ba0f-f7cd27642406_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PerFacilityMember_481b753f-3131-4f8b-9351-503faf882535_terseLabel_en-US" xlink:label="lab_ensg_PerFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Per Facility</link:label>
    <link:label id="lab_ensg_PerFacilityMember_label_en-US" xlink:label="lab_ensg_PerFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Per Facility [Member]</link:label>
    <link:label id="lab_ensg_PerFacilityMember_documentation_en-US" xlink:label="lab_ensg_PerFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Per Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PerFacilityMember" xlink:href="ensg-20241231.xsd#ensg_PerFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PerFacilityMember" xlink:to="lab_ensg_PerFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember_6816fe00-24f2-44d0-9908-df0a563985f4_terseLabel_en-US" xlink:label="lab_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Enforceable Arbitration Agreement</link:label>
    <link:label id="lab_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember_label_en-US" xlink:label="lab_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Self-Insurance Retention Per Claim, Enforceable Arbitration Agreement [Member]</link:label>
    <link:label id="lab_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember_documentation_en-US" xlink:label="lab_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Self-Insurance Retention Per Claim, Enforceable Arbitration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember" xlink:href="ensg-20241231.xsd#ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember" xlink:to="lab_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_f78bf7c6-b4a0-4f9a-ab66-fc4bbc3ca1a6_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_803fc7dc-f32f-478b-b05c-5067594b9b41_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL INCOME TAX PROVISION</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_49ee693d-1016-4667-b8c0-2e3cb9ed9991_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_b6eb638d-bbf9-4e88-8029-abdf2260d6a1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_dbc8b63f-f701-4c20-812a-a08274b659b2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_f2c74b16-05f0-4e5b-86c3-b8a8195901b3_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_ae295df5-8c35-4ff2-be95-40e33d490ea7_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL LIABILITIES AND EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_a9580065-7a1b-4588-80e1-a583edfcecdc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_710f4f22-680e-46f2-bf93-72ce8d062e9f_verboseLabel_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued health benefits</link:label>
    <link:label id="lab_us-gaap_HealthInsuranceProductLineMember_label_en-US" xlink:label="lab_us-gaap_HealthInsuranceProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Health Insurance Product Line [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthInsuranceProductLineMember" xlink:to="lab_us-gaap_HealthInsuranceProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_4c39a22d-94de-4343-85e5-31f79e0a48f2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining Contractual Life (Years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_2366604e-c038-4fe4-b3d1-0898f6c39c38_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_5d9376a5-69c3-4778-8d21-057d0336ff5a_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement in Liability for Future Policy Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in Liability for Future Policy Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward" xlink:to="lab_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_FirstThreeYearsMember_fb0d34de-4276-450d-97df-892b7f27f68f_terseLabel_en-US" xlink:label="lab_ensg_FirstThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First Three Years</link:label>
    <link:label id="lab_ensg_FirstThreeYearsMember_label_en-US" xlink:label="lab_ensg_FirstThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">First Three Years [Member]</link:label>
    <link:label id="lab_ensg_FirstThreeYearsMember_documentation_en-US" xlink:label="lab_ensg_FirstThreeYearsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">First Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_FirstThreeYearsMember" xlink:href="ensg-20241231.xsd#ensg_FirstThreeYearsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_FirstThreeYearsMember" xlink:to="lab_ensg_FirstThreeYearsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_7cd5ab30-04d2-4c64-9032-9e6b770528c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_d81c446e-8257-4a18-812c-fc9af16a7703_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b3a97a62-5c7e-419b-82fb-b504657a5142_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_638b31d5-6b8e-44db-b987-ba2b8d6e143f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_39459ed3-4b96-4d71-8b3a-d164639fd257_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for new and modified operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_9146a239-9d20-4d84-a098-76141a64e57b_verboseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_3eab09d6-c557-4876-a8d4-2852df3abf50_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingAndBuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building and Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingAndBuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingAndBuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_469a2240-2bfb-4ec6-af2f-6fcceec167c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock used to satisfy tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod_4cb3744d-5bf4-4f40-ae10-e51d987e2139_terseLabel_en-US" xlink:label="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term debt threshold for EBITDA ratio increase election period</link:label>
    <link:label id="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod_label_en-US" xlink:label="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long Term Debt Threshold For EBITDA Ratio Increase Election Period</link:label>
    <link:label id="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod_documentation_en-US" xlink:label="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long Term Debt Threshold For EBITDA Ratio Increase Election Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" xlink:to="lab_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_9eee1bab-25c2-4868-a09f-a13e56388161_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected Life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_5d48ca8a-a5e2-4bfc-a504-e8251fc674d6_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_fa5bd310-95ff-4675-9431-f4f09632a6af_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_92a06c42-6516-4e96-9209-2c39b2c3096d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_63accf78-2ccc-48f8-a264-71af526229d3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_16edab85-6c64-4427-b968-b985c2a8a41f_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1e5fba5c-2b3d-4644-a3a0-de4c6158eb54_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_ecbd716e-3fa6-4046-925f-fca20029add5_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_08391f61-6a3d-4324-a8f9-f0ed165a6f09_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_a4553c61-c6bd-41bb-a328-d436a5f7d85c_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_c81605c2-8fb4-47df-bc64-98bcf245fb53_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mortgage loans and promissory note</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_e2395e96-5cbe-466f-911a-9ff1b1352b49_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Outstanding debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4ececf1a-c4a7-478f-b432-3fd5c4a6161d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstatePropertiesLineItems_eae095a0-98ee-4ee7-97d8-8ab9dfd15e21_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstatePropertiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate Properties [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstatePropertiesLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstatePropertiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate Properties [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems" xlink:to="lab_us-gaap_RealEstatePropertiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_84f82557-eaa5-4264-ae75-1aea1d46b8b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages and related liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_4bb6f98c-1331-43d6-8661-5469eb8937ab_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Ensign Group, Inc. stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_cbc69e95-ecf5-41d8-b9c5-ebcc1219e9dd_verboseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Subsidiaries</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_cd8b58cb-7033-4234-ac44-dbeef2cace8b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_324019be-4678-455f-9707-ddf5fa27221e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d41f309f-992b-458c-bab7-c71e672ce541_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NonCashLeaseExpense_e1ea4d2d-934d-4c27-885d-6b302768acaf_terseLabel_en-US" xlink:label="lab_ensg_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash leasing arrangement</link:label>
    <link:label id="lab_ensg_NonCashLeaseExpense_label_en-US" xlink:label="lab_ensg_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Cash Lease Expense</link:label>
    <link:label id="lab_ensg_NonCashLeaseExpense_documentation_en-US" xlink:label="lab_ensg_NonCashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Cash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NonCashLeaseExpense" xlink:href="ensg-20241231.xsd#ensg_NonCashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NonCashLeaseExpense" xlink:to="lab_ensg_NonCashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_6bfdfe9a-bf70-4f00-b3c5-b27f69b3d9ab_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_f304c74c-2b30-44ba-a150-02e9c9ea9445_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_ff872c60-652f-481a-a934-cb95250b65d3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_c7b9a77c-5a48-468b-8a55-f5b5e0e6acb6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_d028b362-e5ca-45bd-a8cf-b90204504e9d_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AccruedLiabilitiesStateReliefContractLiabilities_871bb798-06a6-4cfa-bbde-62fb14d92944_terseLabel_en-US" xlink:label="lab_ensg_AccruedLiabilitiesStateReliefContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unapplied state relief funds</link:label>
    <link:label id="lab_ensg_AccruedLiabilitiesStateReliefContractLiabilities_label_en-US" xlink:label="lab_ensg_AccruedLiabilitiesStateReliefContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, State Relief Contract Liabilities</link:label>
    <link:label id="lab_ensg_AccruedLiabilitiesStateReliefContractLiabilities_documentation_en-US" xlink:label="lab_ensg_AccruedLiabilitiesStateReliefContractLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, State Relief Contract Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AccruedLiabilitiesStateReliefContractLiabilities" xlink:href="ensg-20241231.xsd#ensg_AccruedLiabilitiesStateReliefContractLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AccruedLiabilitiesStateReliefContractLiabilities" xlink:to="lab_ensg_AccruedLiabilitiesStateReliefContractLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_7f7bb2df-20e9-43f1-80e2-ef338f38b8fc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfStockIncentivePlans_7836f24c-906b-4548-8e58-6568e3878441_terseLabel_en-US" xlink:label="lab_ensg_NumberOfStockIncentivePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of stock incentive plans</link:label>
    <link:label id="lab_ensg_NumberOfStockIncentivePlans_label_en-US" xlink:label="lab_ensg_NumberOfStockIncentivePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Stock Incentive Plans</link:label>
    <link:label id="lab_ensg_NumberOfStockIncentivePlans_documentation_en-US" xlink:label="lab_ensg_NumberOfStockIncentivePlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Stock Incentive Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfStockIncentivePlans" xlink:href="ensg-20241231.xsd#ensg_NumberOfStockIncentivePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfStockIncentivePlans" xlink:to="lab_ensg_NumberOfStockIncentivePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_c8ba41e5-97af-45db-b75a-d32e301bc03d_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Other</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Operating Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_b1b4f6bd-9fdc-4a90-8af4-1e8f91e6a751_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_c52ffebf-50bc-4d95-8a4e-219c7bec1364_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_OperationMember_5161f5ce-e6a0-4007-b9c9-6602f7e483e6_terseLabel_en-US" xlink:label="lab_ensg_OperationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operation</link:label>
    <link:label id="lab_ensg_OperationMember_label_en-US" xlink:label="lab_ensg_OperationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operation [Member]</link:label>
    <link:label id="lab_ensg_OperationMember_documentation_en-US" xlink:label="lab_ensg_OperationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperationMember" xlink:href="ensg-20241231.xsd#ensg_OperationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_OperationMember" xlink:to="lab_ensg_OperationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_CombinedRealEstateAndLeasesMember_16ee3c08-b082-42a2-afe8-210e3e0acdb5_terseLabel_en-US" xlink:label="lab_ensg_CombinedRealEstateAndLeasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Combined Real Estate And Leases</link:label>
    <link:label id="lab_ensg_CombinedRealEstateAndLeasesMember_label_en-US" xlink:label="lab_ensg_CombinedRealEstateAndLeasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Combined Real Estate And Leases [Member]</link:label>
    <link:label id="lab_ensg_CombinedRealEstateAndLeasesMember_documentation_en-US" xlink:label="lab_ensg_CombinedRealEstateAndLeasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Combined Real Estate And Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CombinedRealEstateAndLeasesMember" xlink:href="ensg-20241231.xsd#ensg_CombinedRealEstateAndLeasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_CombinedRealEstateAndLeasesMember" xlink:to="lab_ensg_CombinedRealEstateAndLeasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_3ef1d5c1-c830-404c-8fe4-cfc8825de022_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_049b6836-2d85-4444-b1c9-a4e2f5eeec11_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award requisite service period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_07973cfc-3773-44e8-a612-25217a0fc517_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash financing and investing activity</link:label>
    <link:label id="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_a732e1ed-a9ab-4742-909f-21f2aa347a6f_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_0a85d4c0-6524-4e77-8018-7bc2abd2e99b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_231cd873-72ae-4efc-a73f-f992d4fd4ca1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_d091dd85-b770-4b72-90b1-43971fa46bc4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Diluted Net Income Per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_0fa4d47d-e3db-4405-964e-b0aada067e83_terseLabel_en-US" xlink:label="lab_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee leasing arrangements, operating leases, number of renewal terms</link:label>
    <link:label id="lab_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_label_en-US" xlink:label="lab_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms</link:label>
    <link:label id="lab_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_documentation_en-US" xlink:label="lab_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:href="ensg-20241231.xsd#ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:to="lab_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_a5f3c14c-e446-47c9-96ea-4969b306dcc9_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramDomain" xlink:to="lab_srt_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_00067d34-517b-495f-be9c-e2df29337175_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_A53PromissoryNoteMember_3829a40c-ed85-46f4-8358-baf0267a1edf_terseLabel_en-US" xlink:label="lab_ensg_A53PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.3% Promissory Note</link:label>
    <link:label id="lab_ensg_A53PromissoryNoteMember_label_en-US" xlink:label="lab_ensg_A53PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.3% Promissory Note [Member]</link:label>
    <link:label id="lab_ensg_A53PromissoryNoteMember_documentation_en-US" xlink:label="lab_ensg_A53PromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5.3% Promissory Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A53PromissoryNoteMember" xlink:href="ensg-20241231.xsd#ensg_A53PromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_A53PromissoryNoteMember" xlink:to="lab_ensg_A53PromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_d166a49e-d663-4d68-bbae-618638630020_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b54b9963-3f07-4dd6-80e6-8f82abeee844_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_f8b8686a-7056-4bdf-8e30-d7870f2b6870_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_414d4ea5-df13-40f7-beb3-a3c93efe7d7a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of long lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_StandardBearerEquityPlanMember_b2323f66-3ffe-4ddf-b767-d457b4eb40bc_terseLabel_en-US" xlink:label="lab_ensg_StandardBearerEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard Bearer Equity Plan</link:label>
    <link:label id="lab_ensg_StandardBearerEquityPlanMember_label_en-US" xlink:label="lab_ensg_StandardBearerEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Bearer Equity Plan [Member]</link:label>
    <link:label id="lab_ensg_StandardBearerEquityPlanMember_documentation_en-US" xlink:label="lab_ensg_StandardBearerEquityPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard Bearer Equity Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerEquityPlanMember" xlink:href="ensg-20241231.xsd#ensg_StandardBearerEquityPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_StandardBearerEquityPlanMember" xlink:to="lab_ensg_StandardBearerEquityPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_QualityAssuranceFee_480f1215-3cb6-415e-bcb3-4b1ab7f70ba5_terseLabel_en-US" xlink:label="lab_ensg_QualityAssuranceFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Quality assurance fee</link:label>
    <link:label id="lab_ensg_QualityAssuranceFee_label_en-US" xlink:label="lab_ensg_QualityAssuranceFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Quality Assurance Fee</link:label>
    <link:label id="lab_ensg_QualityAssuranceFee_documentation_en-US" xlink:label="lab_ensg_QualityAssuranceFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Quality assurance fee represents amounts payable to California, Utah, Idaho, Washington, Colorado, Iowa, and Nebraska in respect of a mandated fee based on resident days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_QualityAssuranceFee" xlink:href="ensg-20241231.xsd#ensg_QualityAssuranceFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_QualityAssuranceFee" xlink:to="lab_ensg_QualityAssuranceFee" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PrivatePayAndOtherMember_0279a4be-2870-4d6c-aca6-7a632f109dd1_verboseLabel_en-US" xlink:label="lab_ensg_PrivatePayAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Private and other</link:label>
    <link:label id="lab_ensg_PrivatePayAndOtherMember_e09998dd-6248-412f-b5a3-886c1647c900_terseLabel_en-US" xlink:label="lab_ensg_PrivatePayAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Private and other payors</link:label>
    <link:label id="lab_ensg_PrivatePayAndOtherMember_label_en-US" xlink:label="lab_ensg_PrivatePayAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Private Pay And Other [Member]</link:label>
    <link:label id="lab_ensg_PrivatePayAndOtherMember_documentation_en-US" xlink:label="lab_ensg_PrivatePayAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue from self-pay and Other payors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrivatePayAndOtherMember" xlink:href="ensg-20241231.xsd#ensg_PrivatePayAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PrivatePayAndOtherMember" xlink:to="lab_ensg_PrivatePayAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_979d6a0b-3f51-420d-949c-95c385d2cc6c_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4618716d-0869-4aa9-af1f-3db0de2449cb_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_58890843-f46f-48b0-8f6a-79b445d5843d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_fa0e7044-0875-495c-a327-69ea8139886a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_bf0a5786-f8ee-4558-8a16-2a487bc78128_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_5f91513f-eaea-4339-a2eb-3968957690df_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b57b3d06-3e46-4e65-8237-21f16082381b_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_InvestmentExpenseIncome_f0fa0210-9e0f-44f4-99cd-e723145e0be9_terseLabel_en-US" xlink:label="lab_ensg_InvestmentExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Offsetting expense (income)</link:label>
    <link:label id="lab_ensg_InvestmentExpenseIncome_label_en-US" xlink:label="lab_ensg_InvestmentExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Expense (Income)</link:label>
    <link:label id="lab_ensg_InvestmentExpenseIncome_documentation_en-US" xlink:label="lab_ensg_InvestmentExpenseIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Investment Expense (Income)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InvestmentExpenseIncome" xlink:href="ensg-20241231.xsd#ensg_InvestmentExpenseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_InvestmentExpenseIncome" xlink:to="lab_ensg_InvestmentExpenseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfOperatingSubsidiaries_d0a3da41-1551-4766-b97c-7c55ca1cadaf_terseLabel_en-US" xlink:label="lab_ensg_NumberOfOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating subsidiaries</link:label>
    <link:label id="lab_ensg_NumberOfOperatingSubsidiaries_label_en-US" xlink:label="lab_ensg_NumberOfOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Operating Subsidiaries</link:label>
    <link:label id="lab_ensg_NumberOfOperatingSubsidiaries_documentation_en-US" xlink:label="lab_ensg_NumberOfOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of operating subsidiaries entered into mortgage loans that are insured with HUD.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfOperatingSubsidiaries" xlink:href="ensg-20241231.xsd#ensg_NumberOfOperatingSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfOperatingSubsidiaries" xlink:to="lab_ensg_NumberOfOperatingSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5eedbde1-223e-43e8-b5f3-6c09bc78eb07_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_4edd542e-22ab-4f0f-8b55-b92bd2449dd8_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeTenMember_0d5954ca-adc8-42fc-83dc-25017664ddf9_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeTenMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Ten [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeTenMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeTenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Ten [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeTenMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeTenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeTenMember" xlink:to="lab_ensg_ExercisePriceRangeTenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimatedInsuranceRecoveries_c436e7ba-15a9-49a1-9a0f-983fbb7a0d11_verboseLabel_en-US" xlink:label="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Gross insurance recoveries</link:label>
    <link:label id="lab_us-gaap_EstimatedInsuranceRecoveries_label_en-US" xlink:label="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Estimated Insurance Recoveries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimatedInsuranceRecoveries" xlink:to="lab_us-gaap_EstimatedInsuranceRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_dd276597-ca0f-44c3-8702-f0531eb3321a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PropertyManagementFeePercentFeeOfTotalRevenues_10d25924-a1ce-4a61-a12b-c08a54f0a10c_terseLabel_en-US" xlink:label="lab_ensg_PropertyManagementFeePercentFeeOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Management fees, as a percentage of total revenues</link:label>
    <link:label id="lab_ensg_PropertyManagementFeePercentFeeOfTotalRevenues_label_en-US" xlink:label="lab_ensg_PropertyManagementFeePercentFeeOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property Management Fee, Percent Fee of Total Revenues</link:label>
    <link:label id="lab_ensg_PropertyManagementFeePercentFeeOfTotalRevenues_documentation_en-US" xlink:label="lab_ensg_PropertyManagementFeePercentFeeOfTotalRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Property Management Fee, Percent Fee of Total Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PropertyManagementFeePercentFeeOfTotalRevenues" xlink:href="ensg-20241231.xsd#ensg_PropertyManagementFeePercentFeeOfTotalRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PropertyManagementFeePercentFeeOfTotalRevenues" xlink:to="lab_ensg_PropertyManagementFeePercentFeeOfTotalRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LesseeOperatingLeaseConsumerPriceIndex_6ae78bd6-1245-4707-aa49-12cc823a31f0_terseLabel_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseConsumerPriceIndex" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consumer price index</link:label>
    <link:label id="lab_ensg_LesseeOperatingLeaseConsumerPriceIndex_label_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseConsumerPriceIndex" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Consumer Price Index</link:label>
    <link:label id="lab_ensg_LesseeOperatingLeaseConsumerPriceIndex_documentation_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseConsumerPriceIndex" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Consumer Price Index</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseConsumerPriceIndex" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseConsumerPriceIndex"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LesseeOperatingLeaseConsumerPriceIndex" xlink:to="lab_ensg_LesseeOperatingLeaseConsumerPriceIndex" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_DeferredTaxLiabilitiesRightOfUseAsset_7e8ccd8d-35da-4fbd-95f7-2a26a7a3519a_negatedLabel_en-US" xlink:label="lab_ensg_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Right-of-use asset</link:label>
    <link:label id="lab_ensg_DeferredTaxLiabilitiesRightOfUseAsset_label_en-US" xlink:label="lab_ensg_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Right-Of-Use Asset</link:label>
    <link:label id="lab_ensg_DeferredTaxLiabilitiesRightOfUseAsset_documentation_en-US" xlink:label="lab_ensg_DeferredTaxLiabilitiesRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Right-Of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxLiabilitiesRightOfUseAsset" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_DeferredTaxLiabilitiesRightOfUseAsset" xlink:to="lab_ensg_DeferredTaxLiabilitiesRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_5f2525c1-fea1-4f5e-a14b-3b66d6f71248_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_53bb9fd0-1b0d-467a-88e3-3fd082ac932a_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AcquiredPropertiesMember_8245b102-5152-48df-a565-35a340b347a3_terseLabel_en-US" xlink:label="lab_ensg_AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Properties</link:label>
    <link:label id="lab_ensg_AcquiredPropertiesMember_label_en-US" xlink:label="lab_ensg_AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Properties [Member]</link:label>
    <link:label id="lab_ensg_AcquiredPropertiesMember_documentation_en-US" xlink:label="lab_ensg_AcquiredPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquired Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AcquiredPropertiesMember" xlink:href="ensg-20241231.xsd#ensg_AcquiredPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AcquiredPropertiesMember" xlink:to="lab_ensg_AcquiredPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_415b5c73-c6dc-46ef-b1ff-55a4d80113e2_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, period in force</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_8b23285c-82d9-4d08-94aa-e70e5d41dd23_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_6c10efc0-42bb-42c1-8ec5-8d40a3a55b9c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_bb75caf1-9f91-43c5-90d2-546f5173ba54_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_252687cc-27dc-4c6e-a534-801b8c2d8685_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, gross</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_09e2c1cd-7f6d-4c3b-936a-c9913a871b23_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LeasedAssetsAcquiredDuringPeriod_3e85a828-da84-49ea-84d5-cacedccf372b_terseLabel_en-US" xlink:label="lab_ensg_LeasedAssetsAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leased asset</link:label>
    <link:label id="lab_ensg_LeasedAssetsAcquiredDuringPeriod_label_en-US" xlink:label="lab_ensg_LeasedAssetsAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leased Assets, Acquired During Period</link:label>
    <link:label id="lab_ensg_LeasedAssetsAcquiredDuringPeriod_documentation_en-US" xlink:label="lab_ensg_LeasedAssetsAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Leased Assets, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasedAssetsAcquiredDuringPeriod" xlink:href="ensg-20241231.xsd#ensg_LeasedAssetsAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LeasedAssetsAcquiredDuringPeriod" xlink:to="lab_ensg_LeasedAssetsAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_bb89dd6e-5f87-4694-bc1d-491e5d12e3f2_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_477b066f-ffc2-4417-9768-018db3640688_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT_c554fa33-2e49-44fa-a165-5e4e5c76242c_terseLabel_en-US" xlink:label="lab_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payment associated with deferred amount</link:label>
    <link:label id="lab_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT_label_en-US" xlink:label="lab_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Medicare Accelerated And Advance Payment, CARES ACT</link:label>
    <link:label id="lab_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT_documentation_en-US" xlink:label="lab_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Medicare Accelerated And Advance Payment, CARES ACT</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT" xlink:href="ensg-20241231.xsd#ensg_MedicareAcceleratedAndAdvancePaymentCARESACT"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT" xlink:to="lab_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_384cd7e8-cf9a-4889-acfc-e6e64edc807b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9ccecfd0-5484-423c-abf8-f2c11df35f9e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Fair Value of Options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ManagementServiceTotalMember_a31eafe5-9cfb-430c-973d-96b515504388_terseLabel_en-US" xlink:label="lab_ensg_ManagementServiceTotalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Management Fee</link:label>
    <link:label id="lab_ensg_ManagementServiceTotalMember_label_en-US" xlink:label="lab_ensg_ManagementServiceTotalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Management Service, Total [Member]</link:label>
    <link:label id="lab_ensg_ManagementServiceTotalMember_documentation_en-US" xlink:label="lab_ensg_ManagementServiceTotalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Management Service, Total</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagementServiceTotalMember" xlink:href="ensg-20241231.xsd#ensg_ManagementServiceTotalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ManagementServiceTotalMember" xlink:to="lab_ensg_ManagementServiceTotalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_8e46fb5f-3f65-4ef9-97bd-e85c29f8c90d_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b5710495-93a2-45f4-a9a1-4b4b6c9bac86_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_6aae3a1a-db06-40c8-ac32-13bdd78ccd84_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_cd6eb2cc-b4b6-4c63-9345-4c47ef0fd200_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NUMERATOR:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAbstract" xlink:to="lab_us-gaap_NetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_InsuranceSubsidiaryDepositsAndInvestments_8bd0f7e7-a43b-42c0-b933-04e8673c2f65_terseLabel_en-US" xlink:label="lab_ensg_InsuranceSubsidiaryDepositsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insurance subsidiary deposits and investments</link:label>
    <link:label id="lab_ensg_InsuranceSubsidiaryDepositsAndInvestments_label_en-US" xlink:label="lab_ensg_InsuranceSubsidiaryDepositsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insurance Subsidiary Deposits And Investments</link:label>
    <link:label id="lab_ensg_InsuranceSubsidiaryDepositsAndInvestments_documentation_en-US" xlink:label="lab_ensg_InsuranceSubsidiaryDepositsAndInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Captive insurance subsidiary cash and equivalents designated to support long-term insurance subsidiary liabilities and debt security investments held to maturity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceSubsidiaryDepositsAndInvestments" xlink:href="ensg-20241231.xsd#ensg_InsuranceSubsidiaryDepositsAndInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_InsuranceSubsidiaryDepositsAndInvestments" xlink:to="lab_ensg_InsuranceSubsidiaryDepositsAndInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_1a174bcb-6eed-40db-84d6-cde7fc13b513_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9e1c7071-a6a8-47bb-a280-b9e19fceed66_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_191c7eac-395c-4c4f-acb1-46862f0fa335_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease, weighted average discount rate, percent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_97338a4e-e3f1-416a-aec5-24e522531d70_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_335b8aa8-30f6-4fd1-a7ab-9f0ffa6f0b0a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">NET CASH USED IN FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationInsuranceMember_ae03b09f-53a9-43bf-8969-3110b18f8fe6_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Workers' Compensation</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationInsuranceMember_d60a0194-ec41-42e3-bf8e-b2314c2245fc_verboseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued workers&#8217; compensation liabilities</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationInsuranceMember_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Workers' Compensation Insurance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationInsuranceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationInsuranceMember" xlink:to="lab_us-gaap_WorkersCompensationInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_d40739d9-9e64-4884-9583-3655a038df31_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6b0e0ae0-bbe6-40d4-9788-0a7dc1346abb_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_b6180c9b-2096-4d5c-9790-4b3009e82edc_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Cash payments for acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_847ff8e0-338f-4b96-b94d-4bd6f65fed42_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_c306503c-8c93-4d4a-9a35-6fe6274a71e9_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_56b6146c-13d5-4cf7-9a8f-3bc60e4e3e9f_netLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_4f2386bb-2f3b-4baa-a863-696ba9c99b1a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">INTANGIBLE ASSETS &#8212; NET</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1c3fd5ad-ebb7-4437-baa9-fb951a3f2214_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_9eca50e7-9ffe-439c-97d3-6a94350c44a9_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_09943a8c-4c9c-4aa4-b76e-d481b8b3f220_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5f4cfd72-8511-4008-8938-6c9e2f42da91_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_802e5870-da3e-4685-bd8e-ae89cac9499f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PurchasesOfNonControllingInterest_f7d05423-6023-49bf-9e20-c11ce43cf698_negatedLabel_en-US" xlink:label="lab_ensg_PurchasesOfNonControllingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of non-controlling interest</link:label>
    <link:label id="lab_ensg_PurchasesOfNonControllingInterest_label_en-US" xlink:label="lab_ensg_PurchasesOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchases Of Non-Controlling Interest</link:label>
    <link:label id="lab_ensg_PurchasesOfNonControllingInterest_documentation_en-US" xlink:label="lab_ensg_PurchasesOfNonControllingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Purchases Of Non-Controlling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PurchasesOfNonControllingInterest" xlink:href="ensg-20241231.xsd#ensg_PurchasesOfNonControllingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PurchasesOfNonControllingInterest" xlink:to="lab_ensg_PurchasesOfNonControllingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_2d07553a-cf19-4cf3-ac62-5a26a9b3bbdc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_a369ecf8-48f4-4ee8-b4b9-82d020b5fcca_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_fea6974e-61f1-4f77-a5aa-18c54144f353_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_fb7ef786-aae4-45af-9df9-a6c8329f2c51_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock: $0.001 par value; 150,000 shares authorized; 60,838 and 57,438 shares issued and shares outstanding at December&#160;31, 2024, respectively, and 59,987 and 56,597 shares issued and shares outstanding at December 31, 2023, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ManagedCareMember_c943d5bd-68f3-4e00-9de6-a03d7d7a4fc9_terseLabel_en-US" xlink:label="lab_ensg_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Managed care</link:label>
    <link:label id="lab_ensg_ManagedCareMember_6d2d412c-8c70-4ceb-b0b5-e4c1ca2f6817_verboseLabel_en-US" xlink:label="lab_ensg_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Managed care</link:label>
    <link:label id="lab_ensg_ManagedCareMember_cd667132-3bfb-4549-892f-bb143d220f0c_netLabel_en-US" xlink:label="lab_ensg_ManagedCareMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Managed care</link:label>
    <link:label id="lab_ensg_ManagedCareMember_label_en-US" xlink:label="lab_ensg_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Managed Care [Member]</link:label>
    <link:label id="lab_ensg_ManagedCareMember_documentation_en-US" xlink:label="lab_ensg_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue from managed care payors [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagedCareMember" xlink:href="ensg-20241231.xsd#ensg_ManagedCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ManagedCareMember" xlink:to="lab_ensg_ManagedCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_bd40c34a-84a4-4302-bbdc-2e409fd359f8_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c890e94b-aff8-4c2f-8060-9cc8263401c2_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_28887dc0-5802-45eb-b6a7-282602ab90a2_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_19dccb78-e27e-475d-92e4-702b26726258_terseLabel_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived intangible assets acquired</link:label>
    <link:label id="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:to="lab_us-gaap_IndefinitelivedIntangibleAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_62fcc6ae-3a64-4f84-9e4f-b0e9d20a8e30_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State income taxes&#160;- net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementMember_44d0cfbf-f816-4848-b11e-8657a9e1a504_terseLabel_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement</link:label>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementMember_label_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement [Member]</link:label>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementMember_documentation_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementMember" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AmendedMasterLeaseAgreementMember" xlink:to="lab_ensg_AmendedMasterLeaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_7f94613f-8f6d-4cf1-b21e-6fa946d37ff0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_d0f255ee-8a3b-43d4-aafd-58d39049a227_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Employee Stock Option Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_23f15204-28f9-42dc-9702-82b035bd5a77_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_b78de307-473b-496f-a4e6-5f6b4b3005c0_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment charge to intangible assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f4ef9cee-9be5-4439-b70b-921d61a9f2c8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_8287a02d-ceb7-480f-aebc-b7a61897a7e0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_PrepaymentFeePeriodDomain_ad418be4-ef4c-4c61-982e-a4e029c00622_terseLabel_en-US" xlink:label="lab_ensg_PrepaymentFeePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepayment Fee, Period [Domain]</link:label>
    <link:label id="lab_ensg_PrepaymentFeePeriodDomain_label_en-US" xlink:label="lab_ensg_PrepaymentFeePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepayment Fee, Period [Domain]</link:label>
    <link:label id="lab_ensg_PrepaymentFeePeriodDomain_documentation_en-US" xlink:label="lab_ensg_PrepaymentFeePeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepayment Fee, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentFeePeriodDomain" xlink:href="ensg-20241231.xsd#ensg_PrepaymentFeePeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_PrepaymentFeePeriodDomain" xlink:to="lab_ensg_PrepaymentFeePeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_93c71e47-e05b-4b1d-8201-291b756b4a01_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">TOTAL DEFERRED TAX LIABILITIES</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_bd00fcea-71cc-4cbf-8c42-6b9c63e9b9d1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_38cad055-866f-4ee0-9a61-79921f10c2d8_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_94e6bffb-bc46-4588-a1df-ba0386ca2011_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_d5b6a848-1dde-4261-926e-cbb6ff02412b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_RentCostOfServices_be4734ab-0ccf-46a1-ad72-f554cea71173_terseLabel_en-US" xlink:label="lab_ensg_RentCostOfServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rent&#8212;cost of services</link:label>
    <link:label id="lab_ensg_RentCostOfServices_label_en-US" xlink:label="lab_ensg_RentCostOfServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rent Cost Of Services</link:label>
    <link:label id="lab_ensg_RentCostOfServices_documentation_en-US" xlink:label="lab_ensg_RentCostOfServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Rent cost of services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentCostOfServices" xlink:href="ensg-20241231.xsd#ensg_RentCostOfServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_RentCostOfServices" xlink:to="lab_ensg_RentCostOfServices" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ThirdPartyOperatorsMember_32588032-faef-4933-83b5-e4e74ea8951b_terseLabel_en-US" xlink:label="lab_ensg_ThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Third Party Operators</link:label>
    <link:label id="lab_ensg_ThirdPartyOperatorsMember_label_en-US" xlink:label="lab_ensg_ThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Third Party Operators [Member]</link:label>
    <link:label id="lab_ensg_ThirdPartyOperatorsMember_documentation_en-US" xlink:label="lab_ensg_ThirdPartyOperatorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Third Party Operators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThirdPartyOperatorsMember" xlink:href="ensg-20241231.xsd#ensg_ThirdPartyOperatorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ThirdPartyOperatorsMember" xlink:to="lab_ensg_ThirdPartyOperatorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_95c1d843-177b-42af-8636-049d6635a82f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonqualifiedPlanMember_161962c3-7cfb-459b-a227-026018269297_terseLabel_en-US" xlink:label="lab_us-gaap_NonqualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Nonqualified Plan</link:label>
    <link:label id="lab_us-gaap_NonqualifiedPlanMember_label_en-US" xlink:label="lab_us-gaap_NonqualifiedPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonqualified Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonqualifiedPlanMember" xlink:to="lab_us-gaap_NonqualifiedPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5226d9fb-d1d1-4853-8d62-e751842cd296_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_63d0cd3c-b0e7-42bf-8f10-9a1c0abce601_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_381c320b-2252-4e5b-b83b-1cdabdff0a5b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember_54c66468-7ccc-4bb8-9379-a5e902187bcf_terseLabel_en-US" xlink:label="lab_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued general liability and professional malpractice liabilities</link:label>
    <link:label id="lab_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember_label_en-US" xlink:label="lab_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General Liability And Professional Malpractice Liability Insurance [Member]</link:label>
    <link:label id="lab_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember_documentation_en-US" xlink:label="lab_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">General Liability And Professional Malpractice Liability Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember" xlink:href="ensg-20241231.xsd#ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember" xlink:to="lab_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_20f0c483-3056-4f51-8555-58ca4a9348c0_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_b9991e96-644f-4727-a47a-fa4036934bcb_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramAxis" xlink:to="lab_srt_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2a9622ae-22a5-4f50-b1a8-d072b2c9fd87_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e7fe3436-b330-41cb-bc3f-b07c3bca3516_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_9d035f48-c1fe-4b7b-9138-31b41e24e98e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock awards granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3cf7d48e-ff5a-4418-b6ad-40a63b840419_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_74f1dbeb-1d95-4361-bc08-8a94f3938d00_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of noncontrolling interests through subsidiary equity plan</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_7ecbda60-42e8-4d44-a1c5-a4d0eb5017a1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCompensation_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_InTheFourthYearMember_87a10cda-9d3e-4432-bbcb-bbc73976c0fd_terseLabel_en-US" xlink:label="lab_ensg_InTheFourthYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">In The Fourth Year</link:label>
    <link:label id="lab_ensg_InTheFourthYearMember_label_en-US" xlink:label="lab_ensg_InTheFourthYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">In The Fourth Year [Member]</link:label>
    <link:label id="lab_ensg_InTheFourthYearMember_documentation_en-US" xlink:label="lab_ensg_InTheFourthYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">In The Fourth Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InTheFourthYearMember" xlink:href="ensg-20241231.xsd#ensg_InTheFourthYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_InTheFourthYearMember" xlink:to="lab_ensg_InTheFourthYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_18f4ede2-3ae9-409b-a181-0dd011007828_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of real estate properties</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_d1de7ccd-2388-4a08-b6bc-0ef465c99b64_verboseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Number of real estate properties acquired</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_label_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Real Estate Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfRealEstateProperties" xlink:to="lab_us-gaap_NumberOfRealEstateProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_e979df0a-51e2-4cd1-84a5-c161706518cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Aggregate Intrinsic Value of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_e4340372-e5da-41b9-b7bb-0b3d85bed410_totalLabel_en-US" xlink:label="lab_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL ACQUISITIONS</link:label>
    <link:label id="lab_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Combination And Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</link:label>
    <link:label id="lab_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_documentation_en-US" xlink:label="lab_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Business Combination And Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="ensg-20241231.xsd#ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_0f2bd626-bb08-4142-8aea-08a1f09569eb_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">OPTIONS AND AWARDS</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_StandardBearerSegmentMember_55b24d93-27f5-41e9-839b-26fa488b4463_terseLabel_en-US" xlink:label="lab_ensg_StandardBearerSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Standard Bearer</link:label>
    <link:label id="lab_ensg_StandardBearerSegmentMember_label_en-US" xlink:label="lab_ensg_StandardBearerSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Bearer Segment [Member]</link:label>
    <link:label id="lab_ensg_StandardBearerSegmentMember_documentation_en-US" xlink:label="lab_ensg_StandardBearerSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard Bearer Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerSegmentMember" xlink:href="ensg-20241231.xsd#ensg_StandardBearerSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_StandardBearerSegmentMember" xlink:to="lab_ensg_StandardBearerSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_7eaf8b6c-c7fe-493e-ac27-41b69f3afe59_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset acquisition, purchase price</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionConsiderationTransferred_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:to="lab_us-gaap_AssetAcquisitionConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_SeniorLivingOperationsMember_82b28b05-d58e-4cc2-8801-112693213b94_terseLabel_en-US" xlink:label="lab_ensg_SeniorLivingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Living Operations</link:label>
    <link:label id="lab_ensg_SeniorLivingOperationsMember_label_en-US" xlink:label="lab_ensg_SeniorLivingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Living Operations [Member]</link:label>
    <link:label id="lab_ensg_SeniorLivingOperationsMember_documentation_en-US" xlink:label="lab_ensg_SeniorLivingOperationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Living Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_SeniorLivingOperationsMember" xlink:to="lab_ensg_SeniorLivingOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b293fba6-9c65-4634-87e3-ae94f2b9ecdc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_DeferredTaxLiabilitiesStateTaxes_f1bd5c16-5362-4f0f-a246-edb26d8520f2_negatedTerseLabel_en-US" xlink:label="lab_ensg_DeferredTaxLiabilitiesStateTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">State taxes</link:label>
    <link:label id="lab_ensg_DeferredTaxLiabilitiesStateTaxes_label_en-US" xlink:label="lab_ensg_DeferredTaxLiabilitiesStateTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, State Taxes</link:label>
    <link:label id="lab_ensg_DeferredTaxLiabilitiesStateTaxes_documentation_en-US" xlink:label="lab_ensg_DeferredTaxLiabilitiesStateTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, State Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxLiabilitiesStateTaxes" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxLiabilitiesStateTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_DeferredTaxLiabilitiesStateTaxes" xlink:to="lab_ensg_DeferredTaxLiabilitiesStateTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_04a3f583-750f-4050-8ad3-58ebda4d39e9_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_13424209-d813-4c92-aa0d-d1ef90ac3e6f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_ca8ee4d3-b32f-430a-9634-bc8dc3d87773_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intrinsic value of options exercised in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_de9e42d5-2043-4027-8e7b-af4bfa34dd00_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_9ef04de2-db66-4656-ad4e-6b10cc599adc_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense related to stock options</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_70970279-260d-4efd-b2c4-e8a920ac2f3e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Revenue Reconciling Item [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:to="lab_us-gaap_SegmentReportingRevenueReconcilingItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6afd279c-f0e4-4ef2-83f8-2b94fe1ace49_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_e5dc2783-387b-4437-9440-73fc0ca187b6_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_46e40623-9d10-41ff-bfdf-ceb4fac930d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_f2eb7737-8111-42af-91aa-ff4546d87b05_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_NumberOfSkilledNursingBeds_b8bc5da4-e103-460f-ad6f-cef4a0a7af64_terseLabel_en-US" xlink:label="lab_ensg_NumberOfSkilledNursingBeds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operational skilled nursing beds</link:label>
    <link:label id="lab_ensg_NumberOfSkilledNursingBeds_label_en-US" xlink:label="lab_ensg_NumberOfSkilledNursingBeds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Skilled Nursing Beds</link:label>
    <link:label id="lab_ensg_NumberOfSkilledNursingBeds_documentation_en-US" xlink:label="lab_ensg_NumberOfSkilledNursingBeds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of skilled nursing beds available for use at a skilled nursing facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSkilledNursingBeds" xlink:href="ensg-20241231.xsd#ensg_NumberOfSkilledNursingBeds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_NumberOfSkilledNursingBeds" xlink:to="lab_ensg_NumberOfSkilledNursingBeds" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_RealEstateAndLeaseArrangementsDomain_3664ec26-9e29-4031-bf9f-8e7ec8c43f34_terseLabel_en-US" xlink:label="lab_ensg_RealEstateAndLeaseArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate And Lease Arrangements [Domain]</link:label>
    <link:label id="lab_ensg_RealEstateAndLeaseArrangementsDomain_label_en-US" xlink:label="lab_ensg_RealEstateAndLeaseArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate And Lease Arrangements [Domain]</link:label>
    <link:label id="lab_ensg_RealEstateAndLeaseArrangementsDomain_documentation_en-US" xlink:label="lab_ensg_RealEstateAndLeaseArrangementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Real Estate And Lease Arrangements [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain" xlink:to="lab_ensg_RealEstateAndLeaseArrangementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_acf2aa96-7c51-40bf-9c95-7007fba53e81_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">REVENUE AND ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_c49237b6-f82b-4735-a157-09ea720bf9df_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_fe5fde11-9d3a-45cf-a6db-cea99ba44271_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_16237a45-f5a4-4637-be93-7c1ed7275ac0_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of common stock repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_8544ff14-b5fd-4866-ad1d-f68ca18c2c44_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ResidentRefundsPayable_1e36f5a8-b3a2-4359-9ce0-34928a12a07a_terseLabel_en-US" xlink:label="lab_ensg_ResidentRefundsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Refunds payable</link:label>
    <link:label id="lab_ensg_ResidentRefundsPayable_label_en-US" xlink:label="lab_ensg_ResidentRefundsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Resident Refunds Payable</link:label>
    <link:label id="lab_ensg_ResidentRefundsPayable_documentation_en-US" xlink:label="lab_ensg_ResidentRefundsPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Resident refunds payable includes amounts due to residents for overpayments and duplicate payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ResidentRefundsPayable" xlink:href="ensg-20241231.xsd#ensg_ResidentRefundsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ResidentRefundsPayable" xlink:to="lab_ensg_ResidentRefundsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_a804fc85-8a22-40b1-b711-9f8ca2a69e70_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_dff5b605-45fc-4bbc-953c-0b9f6927a921_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">OTHER ACCRUED LIABILITIES</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeSixMember_aa44a025-978d-4fbb-8fc6-efa0f4fc061d_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2020</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeSixMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range Six [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeSixMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range Six [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeSixMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeSixMember" xlink:to="lab_ensg_ExercisePriceRangeSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_868cfba3-ef5b-4b94-8919-2675456eb736_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_16540460-6347-4834-9131-57e0615fc2cc_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_e0873afc-853c-4ebc-8706-e043a87eeb8e_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_13134a0d-e7ae-4e37-abc1-4959a68e137e_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">TOTAL LEASE PAYMENTS</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0b761225-3531-4708-bbd5-f2ca475ebc22_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_43172ea6-39cc-4549-84e6-1fc12b425e78_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_LesseeOperatingLeaseTermExtension_253fb855-8039-464c-9c5f-f6ce855dc9df_terseLabel_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseTermExtension" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, operating lease, term extension</link:label>
    <link:label id="lab_ensg_LesseeOperatingLeaseTermExtension_label_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseTermExtension" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term, Extension</link:label>
    <link:label id="lab_ensg_LesseeOperatingLeaseTermExtension_documentation_en-US" xlink:label="lab_ensg_LesseeOperatingLeaseTermExtension" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Term, Extension</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseTermExtension" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseTermExtension"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_LesseeOperatingLeaseTermExtension" xlink:to="lab_ensg_LesseeOperatingLeaseTermExtension" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_75533037-98c9-4bcf-ba97-dbfeebb70963_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementTwoMember_fa1b7b5f-f24c-4785-b570-892fa2743607_terseLabel_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement, Two</link:label>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementTwoMember_label_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement, Two [Member]</link:label>
    <link:label id="lab_ensg_AmendedMasterLeaseAgreementTwoMember_documentation_en-US" xlink:label="lab_ensg_AmendedMasterLeaseAgreementTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended Master Lease Agreement, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementTwoMember" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_AmendedMasterLeaseAgreementTwoMember" xlink:to="lab_ensg_AmendedMasterLeaseAgreementTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_2b1af858-8fc1-46c5-a37e-4274a0ae266c_verboseLabel_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">All Other</link:label>
    <link:label id="lab_us-gaap_MaterialReconcilingItemsMember_label_en-US" xlink:label="lab_us-gaap_MaterialReconcilingItemsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaterialReconcilingItemsMember" xlink:to="lab_us-gaap_MaterialReconcilingItemsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_00556284-53f6-419f-b728-b506b7b36c0e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInSelfInsuranceReserve_2f2d831a-7711-4651-8f0c-b295bbdb8a75_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInSelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued self-insurance liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInSelfInsuranceReserve_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInSelfInsuranceReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Self Insurance Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInSelfInsuranceReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSelfInsuranceReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInSelfInsuranceReserve" xlink:to="lab_us-gaap_IncreaseDecreaseInSelfInsuranceReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability_1170c759-2d12-419f-b9e4-8a7b22644279_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other than options, conversion to reduce shares availability</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Conversion To Reduce Shares Availability</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Conversion To Reduce Shares Availability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" xlink:to="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9b802094-794f-46b1-b917-ae6db5efb93e_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_a2ca0238-7ce5-4ec6-bb59-dd5266f15ed8_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3bf0f9e8-328a-45b0-b832-967e39697ef9_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_TripleNetLeaseArrangementsMember_3d538bea-f11e-4c8e-9713-cf9ae8a9e242_terseLabel_en-US" xlink:label="lab_ensg_TripleNetLeaseArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Triple Net Lease Arrangements</link:label>
    <link:label id="lab_ensg_TripleNetLeaseArrangementsMember_label_en-US" xlink:label="lab_ensg_TripleNetLeaseArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Triple Net Lease Arrangements [Member]</link:label>
    <link:label id="lab_ensg_TripleNetLeaseArrangementsMember_documentation_en-US" xlink:label="lab_ensg_TripleNetLeaseArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Triple Net Lease Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TripleNetLeaseArrangementsMember" xlink:href="ensg-20241231.xsd#ensg_TripleNetLeaseArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_TripleNetLeaseArrangementsMember" xlink:to="lab_ensg_TripleNetLeaseArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_ab1236a4-04e2-45cd-a058-cd1ada5d89c1_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_51cc2589-da23-4a3f-ad22-29fa0afeeaba_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_6f80ee06-965c-4615-a8c6-5bdb931268e6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_2d303667-4323-44df-84f1-7a201e219ae7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_b71894bb-4035-4be5-bbcc-48ca382ca25d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price, upper range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_70bacff3-86d7-4843-a77d-33067c23d364_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ExercisePriceRangeOneMember_52ab1ade-4cbf-4cf5-abf8-137947568b11_terseLabel_en-US" xlink:label="lab_ensg_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2015</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeOneMember_label_en-US" xlink:label="lab_ensg_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:label id="lab_ensg_ExercisePriceRangeOneMember_documentation_en-US" xlink:label="lab_ensg_ExercisePriceRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Exercise Price Range One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeOneMember" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ExercisePriceRangeOneMember" xlink:to="lab_ensg_ExercisePriceRangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ba0feab9-54f6-44d5-b26c-7abb3055b54e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_9e21a6f8-5619-4240-a700-9c842de822b6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod_dcc934d6-3284-4b13-a686-48dbd37a3ea9_terseLabel_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Annual bonuses settled in vested awards</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Bonuses, Included In Equity Instruments Other Than Options, Grants In Period</link:label>
    <link:label id="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod_documentation_en-US" xlink:label="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Bonuses, Included In Equity Instruments Other Than Options, Grants In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_aba6c3fd-b92f-4c83-9439-5f513af6ea42_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_e47dd9cd-f4de-465f-ac76-13b52343b48d_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property taxes</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrual for Taxes Other than Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_8677d517-6046-40e0-9d28-c312438b3b3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_a33c5ef9-97e6-418e-8686-df4eee278d7d_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>ensg-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:9fad20ba-6b95-4b5d-8a1b-0cd604b824d6,g:826a027b-6e82-45d1-b4d8-5465cc4138ed-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ensigngroup.net/role/Cover" xlink:type="simple" xlink:href="ensg-20241231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_b992569c-e8c8-4bf9-8d13-240c5a4beaae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_DocumentType_b992569c-e8c8-4bf9-8d13-240c5a4beaae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_335b6e43-a798-4074-938b-144e8ebbd398" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_DocumentAnnualReport_335b6e43-a798-4074-938b-144e8ebbd398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_23151547-cd79-42f0-a5b0-34b0140136d9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_DocumentPeriodEndDate_23151547-cd79-42f0-a5b0-34b0140136d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_2de1c8ab-148a-4391-86b6-a439f3b9646a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_CurrentFiscalYearEndDate_2de1c8ab-148a-4391-86b6-a439f3b9646a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_ced83b2b-80c8-4b62-bbe3-e04cd47cb186" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_DocumentTransitionReport_ced83b2b-80c8-4b62-bbe3-e04cd47cb186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_d74564ac-a833-446b-b6c8-f0e6c370b9b7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityFileNumber_d74564ac-a833-446b-b6c8-f0e6c370b9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e34d80c7-40e7-49cc-916f-fcc5efcfa821" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityRegistrantName_e34d80c7-40e7-49cc-916f-fcc5efcfa821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6307efe7-b80f-4a56-9622-1db53da22b1d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6307efe7-b80f-4a56-9622-1db53da22b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_7d9fe1ba-d583-4423-9ca2-79928cf1e6a2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityTaxIdentificationNumber_7d9fe1ba-d583-4423-9ca2-79928cf1e6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_13429b7c-ab21-4e5f-85bb-20cade185cdb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityAddressAddressLine1_13429b7c-ab21-4e5f-85bb-20cade185cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ee211fbf-ffe5-4ccf-ac61-c616dbd893ca" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityAddressCityOrTown_ee211fbf-ffe5-4ccf-ac61-c616dbd893ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_91d153ae-49dd-4fca-8d8f-0ddb4b35ae19" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityAddressStateOrProvince_91d153ae-49dd-4fca-8d8f-0ddb4b35ae19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_58887d88-d0d0-47d3-af7d-2d0012b302f5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityAddressPostalZipCode_58887d88-d0d0-47d3-af7d-2d0012b302f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_d6691bd6-a817-45ec-86a7-a1caed4b9bd3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_CityAreaCode_d6691bd6-a817-45ec-86a7-a1caed4b9bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_e3d0cf27-778f-4d11-a866-c7d4aa38844f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_LocalPhoneNumber_e3d0cf27-778f-4d11-a866-c7d4aa38844f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_01897325-603a-4540-9e51-5a70e00561d6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_Security12bTitle_01897325-603a-4540-9e51-5a70e00561d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_5fccd217-c924-4195-8478-0b8ae137bfaa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_TradingSymbol_5fccd217-c924-4195-8478-0b8ae137bfaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b1b7bdac-1778-4aaf-9704-5099e3889d8f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_SecurityExchangeName_b1b7bdac-1778-4aaf-9704-5099e3889d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_7e2648c0-131f-46ad-a852-71a396e21214" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_7e2648c0-131f-46ad-a852-71a396e21214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_14056153-b99d-49a9-95b6-87517170b023" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityVoluntaryFilers_14056153-b99d-49a9-95b6-87517170b023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_65d85d0e-62f9-4e3a-baf4-3e25cd5221c2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityCurrentReportingStatus_65d85d0e-62f9-4e3a-baf4-3e25cd5221c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_1604867c-9c45-4818-b3d6-19ea49d1cbda" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityInteractiveDataCurrent_1604867c-9c45-4818-b3d6-19ea49d1cbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_20db19d9-edc5-410f-909a-9dde303c30da" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityFilerCategory_20db19d9-edc5-410f-909a-9dde303c30da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6905772e-1f72-47f8-9090-acaa4adeb39c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntitySmallBusiness_6905772e-1f72-47f8-9090-acaa4adeb39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3e1b2a33-c10e-4b6b-9a1e-527f473c9332" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityEmergingGrowthCompany_3e1b2a33-c10e-4b6b-9a1e-527f473c9332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_fb5787ff-3095-4cf2-86c3-65b3e0658d81" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_IcfrAuditorAttestationFlag_fb5787ff-3095-4cf2-86c3-65b3e0658d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_2b6cdb24-afe8-4d83-8b8e-e473e7148c0e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_2b6cdb24-afe8-4d83-8b8e-e473e7148c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_6cb207e1-c2ed-46e7-8a44-e54e8aa7fd89" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityShellCompany_6cb207e1-c2ed-46e7-8a44-e54e8aa7fd89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_7f5f1654-ddea-4012-827a-141b82e7145a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityPublicFloat_7f5f1654-ddea-4012-827a-141b82e7145a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_022711ca-7c74-4fae-b855-ad56d12913c7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_022711ca-7c74-4fae-b855-ad56d12913c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_ee093613-1a5a-4b9e-921f-f91b268ad1d2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_ee093613-1a5a-4b9e-921f-f91b268ad1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5cadc953-c8d5-4895-8706-2b74f0e06877" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_EntityCentralIndexKey_5cadc953-c8d5-4895-8706-2b74f0e06877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_cfe026e0-0dd4-4e01-975e-83899cfa1764" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_DocumentFiscalYearFocus_cfe026e0-0dd4-4e01-975e-83899cfa1764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_85e5a961-bf01-48be-b16d-8dfc73bf9314" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_DocumentFiscalPeriodFocus_85e5a961-bf01-48be-b16d-8dfc73bf9314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ba5702b5-179a-408c-a698-8d226b1295e7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_20290208-2405-480f-9fe1-cb11a877cea5" xlink:to="loc_dei_AmendmentFlag_ba5702b5-179a-408c-a698-8d226b1295e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/AuditInformation" xlink:type="simple" xlink:href="ensg-20241231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AuditInformationAbstract_f69f7b60-fae5-42cd-8de5-fc9914400d53" xlink:href="ensg-20241231.xsd#ensg_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_5d93ce01-0039-437a-896b-8d68b75cb590" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_AuditInformationAbstract_f69f7b60-fae5-42cd-8de5-fc9914400d53" xlink:to="loc_dei_AuditorName_5d93ce01-0039-437a-896b-8d68b75cb590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_cd3ec299-69e8-43e5-a549-5240fa50955f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_AuditInformationAbstract_f69f7b60-fae5-42cd-8de5-fc9914400d53" xlink:to="loc_dei_AuditorLocation_cd3ec299-69e8-43e5-a549-5240fa50955f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_2a6dd7f8-584e-4013-b2be-cc75faf90b6f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_AuditInformationAbstract_f69f7b60-fae5-42cd-8de5-fc9914400d53" xlink:to="loc_dei_AuditorFirmId_2a6dd7f8-584e-4013-b2be-cc75faf90b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d31a93c9-993b-46af-a2e6-0703091e7b20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d31a93c9-993b-46af-a2e6-0703091e7b20" xlink:to="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_f94ac90b-06c1-49e6-ac33-bfe98bf86ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_us-gaap_AssetsCurrentAbstract_f94ac90b-06c1-49e6-ac33-bfe98bf86ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_514d8334-f9e2-41ac-a9d9-5aba5144da55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f94ac90b-06c1-49e6-ac33-bfe98bf86ea5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_514d8334-f9e2-41ac-a9d9-5aba5144da55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_29136fce-f18c-4a16-aa70-ab86a0bcebd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f94ac90b-06c1-49e6-ac33-bfe98bf86ea5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_29136fce-f18c-4a16-aa70-ab86a0bcebd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_4d08c2eb-7ad4-453c-850a-7a425b03790d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f94ac90b-06c1-49e6-ac33-bfe98bf86ea5" xlink:to="loc_us-gaap_ShortTermInvestments_4d08c2eb-7ad4-453c-850a-7a425b03790d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0bf58972-2db2-4899-bef1-d22bbfa6b6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f94ac90b-06c1-49e6-ac33-bfe98bf86ea5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_0bf58972-2db2-4899-bef1-d22bbfa6b6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_400a7f5a-fc31-403f-be6f-858382a4e059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_f94ac90b-06c1-49e6-ac33-bfe98bf86ea5" xlink:to="loc_us-gaap_AssetsCurrent_400a7f5a-fc31-403f-be6f-858382a4e059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6e6af8e7-57cf-424b-96b8-25612731b8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6e6af8e7-57cf-424b-96b8-25612731b8ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_f6d4e7e9-10ad-42cc-9d73-d7f6a5021414" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_f6d4e7e9-10ad-42cc-9d73-d7f6a5021414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceSubsidiaryDepositsAndInvestments_8edf107e-c885-4b99-9929-8d8baf87d168" xlink:href="ensg-20241231.xsd#ensg_InsuranceSubsidiaryDepositsAndInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_ensg_InsuranceSubsidiaryDepositsAndInvestments_8edf107e-c885-4b99-9929-8d8baf87d168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4c83775d-f0e4-4dd8-88c1-8a690e5ce508" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4c83775d-f0e4-4dd8-88c1-8a690e5ce508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RestrictedAndOtherAssetsNoncurrent_a2a5c274-ea95-4e47-9624-d7572fb23f9d" xlink:href="ensg-20241231.xsd#ensg_RestrictedAndOtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_ensg_RestrictedAndOtherAssetsNoncurrent_a2a5c274-ea95-4e47-9624-d7572fb23f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a0847a38-899a-435b-ae13-262c9c7bf851" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_a0847a38-899a-435b-ae13-262c9c7bf851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_3ebcc5ee-3aa2-48bc-80b9-6b08df8bfb51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_us-gaap_Goodwill_3ebcc5ee-3aa2-48bc-80b9-6b08df8bfb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8d49b588-f4b5-4313-bc12-40ac589060c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_66a2ef71-6162-4fa2-a4f4-823d78586905" xlink:to="loc_us-gaap_Assets_8d49b588-f4b5-4313-bc12-40ac589060c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d31a93c9-993b-46af-a2e6-0703091e7b20" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_47b85d4a-adeb-49d6-a9e8-bea7205ce689" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:to="loc_us-gaap_AccountsPayableCurrent_47b85d4a-adeb-49d6-a9e8-bea7205ce689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7061f99d-487a-4bb6-97c9-ec02983de088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7061f99d-487a-4bb6-97c9-ec02983de088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_697186f7-4a54-4d0e-8ae3-434481564730" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_697186f7-4a54-4d0e-8ae3-434481564730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_949db20d-2603-47ad-9dca-d894456c8d31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_949db20d-2603-47ad-9dca-d894456c8d31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e80b931d-6a47-4a07-93b2-6383025b5544" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_e80b931d-6a47-4a07-93b2-6383025b5544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_153eca40-d2c5-4c36-a94c-0b6f239d347d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:to="loc_us-gaap_LongTermDebtCurrent_153eca40-d2c5-4c36-a94c-0b6f239d347d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_e4717d0f-c085-49fa-a6f3-4fa6a545a537" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_75d10ed7-2b41-48f3-bea3-ad897a7fb209" xlink:to="loc_us-gaap_LiabilitiesCurrent_e4717d0f-c085-49fa-a6f3-4fa6a545a537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount_5014e94e-bc88-4fcb-be34-49e5daa97683" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount_5014e94e-bc88-4fcb-be34-49e5daa97683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d350c0d8-73c6-4f3f-bed3-84c572e09719" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d350c0d8-73c6-4f3f-bed3-84c572e09719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent_ad1844d3-3847-4e61-b7ed-2024ac8c2b65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_us-gaap_SelfInsuranceReserveNoncurrent_ad1844d3-3847-4e61-b7ed-2024ac8c2b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredRentAndOtherLongTermLiabilities_5c6b0bfa-ee96-4499-a47d-4400daa72ed0" xlink:href="ensg-20241231.xsd#ensg_DeferredRentAndOtherLongTermLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_ensg_DeferredRentAndOtherLongTermLiabilities_5c6b0bfa-ee96-4499-a47d-4400daa72ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_33d2e33d-9d2d-456a-b6ea-f6db04ca2600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_us-gaap_Liabilities_33d2e33d-9d2d-456a-b6ea-f6db04ca2600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c18fcaae-3bf6-4d7c-8ec2-7f4a8e650e25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c18fcaae-3bf6-4d7c-8ec2-7f4a8e650e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f2594e1a-2f2c-4216-a590-0fdc572a5bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_us-gaap_EquityAbstract_f2594e1a-2f2c-4216-a590-0fdc572a5bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f84b7d8d-f202-4674-a46b-072e69b1d09c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f2594e1a-2f2c-4216-a590-0fdc572a5bc3" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f84b7d8d-f202-4674-a46b-072e69b1d09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7bebd9df-de77-4e65-a22f-bff767ee95e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f84b7d8d-f202-4674-a46b-072e69b1d09c" xlink:to="loc_us-gaap_CommonStockValue_7bebd9df-de77-4e65-a22f-bff767ee95e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_cb38a7bf-e453-44a5-8061-822f74b23eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f84b7d8d-f202-4674-a46b-072e69b1d09c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_cb38a7bf-e453-44a5-8061-822f74b23eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d2efd4f5-c1b6-4e62-9029-c7036addde98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f84b7d8d-f202-4674-a46b-072e69b1d09c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d2efd4f5-c1b6-4e62-9029-c7036addde98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_15c5dddd-8fd7-48b6-8666-6607ff1f3117" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f84b7d8d-f202-4674-a46b-072e69b1d09c" xlink:to="loc_us-gaap_TreasuryStockCommonValue_15c5dddd-8fd7-48b6-8666-6607ff1f3117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fe7b956e-33d9-419d-8d13-00a4d894a79b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f84b7d8d-f202-4674-a46b-072e69b1d09c" xlink:to="loc_us-gaap_StockholdersEquity_fe7b956e-33d9-419d-8d13-00a4d894a79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_78f8bf5e-56d8-47d7-bfab-29674883c44e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f2594e1a-2f2c-4216-a590-0fdc572a5bc3" xlink:to="loc_us-gaap_MinorityInterest_78f8bf5e-56d8-47d7-bfab-29674883c44e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1ee4c2ca-90c7-4cc2-8878-e18e5be5d017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f2594e1a-2f2c-4216-a590-0fdc572a5bc3" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1ee4c2ca-90c7-4cc2-8878-e18e5be5d017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_09a2c1ae-3106-433a-abc1-f03b3619ce37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_8b28b1a3-3be0-40b9-8c26-073074d64695" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_09a2c1ae-3106-433a-abc1-f03b3619ce37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_2b38bbc6-f895-42e2-b196-755732dd6b46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3db75a69-23cc-4882-a40c-26236cc09189" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b38bbc6-f895-42e2-b196-755732dd6b46" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3db75a69-23cc-4882-a40c-26236cc09189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_57bff603-912d-4cb6-a61d-4e00439b4066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b38bbc6-f895-42e2-b196-755732dd6b46" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_57bff603-912d-4cb6-a61d-4e00439b4066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_1ffcc2d6-63a9-475d-8b71-a7206fdeadd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b38bbc6-f895-42e2-b196-755732dd6b46" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_1ffcc2d6-63a9-475d-8b71-a7206fdeadd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_bc68c5e5-173c-4b0f-83c0-41eb26d88445" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b38bbc6-f895-42e2-b196-755732dd6b46" xlink:to="loc_us-gaap_CommonStockSharesIssued_bc68c5e5-173c-4b0f-83c0-41eb26d88445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_8584b0cb-750c-41ea-b0fb-c68d5f5bf965" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b38bbc6-f895-42e2-b196-755732dd6b46" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_8584b0cb-750c-41ea-b0fb-c68d5f5bf965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_381fc375-6b9e-4133-8ff7-78b1262de920" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_2b38bbc6-f895-42e2-b196-755732dd6b46" xlink:to="loc_us-gaap_TreasuryStockCommonShares_381fc375-6b9e-4133-8ff7-78b1262de920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_48911a19-c25c-4c9b-9cd7-bc61f5c5a960" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e2e6da21-0456-47c2-be62-60857812e0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_48911a19-c25c-4c9b-9cd7-bc61f5c5a960" xlink:to="loc_us-gaap_StatementTable_e2e6da21-0456-47c2-be62-60857812e0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a715f7d4-3700-41b3-a695-302f1b7fdf2e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e2e6da21-0456-47c2-be62-60857812e0aa" xlink:to="loc_srt_ProductOrServiceAxis_a715f7d4-3700-41b3-a695-302f1b7fdf2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ee07e19a-c055-4702-9f99-c5ff8960849d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a715f7d4-3700-41b3-a695-302f1b7fdf2e" xlink:to="loc_srt_ProductsAndServicesDomain_ee07e19a-c055-4702-9f99-c5ff8960849d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_cc040d00-5c85-49b8-8e27-2c834901bae8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ee07e19a-c055-4702-9f99-c5ff8960849d" xlink:to="loc_us-gaap_ServiceMember_cc040d00-5c85-49b8-8e27-2c834901bae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember_1351064d-b1d2-48ff-a920-1982bc9cff81" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ee07e19a-c055-4702-9f99-c5ff8960849d" xlink:to="loc_ensg_RentalMember_1351064d-b1d2-48ff-a920-1982bc9cff81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e2e6da21-0456-47c2-be62-60857812e0aa" xlink:to="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0b163921-5bb7-41c8-9057-ee14903c4dbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0b163921-5bb7-41c8-9057-ee14903c4dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_054a0329-d83e-4e38-abf0-2ab59da647aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_054a0329-d83e-4e38-abf0-2ab59da647aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentCostOfServices_612d0dfb-8f4b-4a2d-85f9-15b9d59b493a" xlink:href="ensg-20241231.xsd#ensg_RentCostOfServices"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_ensg_RentCostOfServices_612d0dfb-8f4b-4a2d-85f9-15b9d59b493a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c6ec9527-3cb5-4b01-a2c3-b4d9bb60ac9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c6ec9527-3cb5-4b01-a2c3-b4d9bb60ac9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2de5ecd0-f054-413c-8ded-acbe8c6e64ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2de5ecd0-f054-413c-8ded-acbe8c6e64ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6bbab5a1-d75e-4bcc-b1a7-7932cf653e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_39175b7b-28d1-4f24-8fb3-f830c94fa421" xlink:to="loc_us-gaap_CostsAndExpenses_6bbab5a1-d75e-4bcc-b1a7-7932cf653e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_252c2436-4f49-42d8-9aca-ae224689d0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_OperatingIncomeLoss_252c2436-4f49-42d8-9aca-ae224689d0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_17fb9617-28a1-449c-a1f6-42008650aba5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:to="loc_us-gaap_InterestExpenseNonoperating_17fb9617-28a1-449c-a1f6-42008650aba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e64d0fc3-97ba-4e1e-95e8-79f9df5240f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e64d0fc3-97ba-4e1e-95e8-79f9df5240f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b8b42fc5-7239-42fe-a9c2-d28c7df17aca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b8b42fc5-7239-42fe-a9c2-d28c7df17aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b4d02be6-0cef-4912-ae41-7df500562e22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseAbstract_ff2641e5-8e82-4aad-9bd9-d733815a5023" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b4d02be6-0cef-4912-ae41-7df500562e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6d07d318-6ed3-4a93-bb8f-0a89df0b9519" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6d07d318-6ed3-4a93-bb8f-0a89df0b9519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_bea9b8d3-2249-40c8-98fd-e4d5cd9e1391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_bea9b8d3-2249-40c8-98fd-e4d5cd9e1391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c9e0ba6d-9c49-4c6b-871b-e325cdbaa51b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_ProfitLoss_c9e0ba6d-9c49-4c6b-871b-e325cdbaa51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_72ce64ab-178f-4e39-b641-904dddf2755a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_72ce64ab-178f-4e39-b641-904dddf2755a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3ebd5726-b8a5-4478-9caa-69b7df79ddc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract_72ce64ab-178f-4e39-b641-904dddf2755a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3ebd5726-b8a5-4478-9caa-69b7df79ddc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bf209a92-0357-43c7-b350-c3196bae88f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_NetIncomeLoss_bf209a92-0357-43c7-b350-c3196bae88f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_880d7bc0-1014-47e4-af3d-5c983826cadd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_EarningsPerShareAbstract_880d7bc0-1014-47e4-af3d-5c983826cadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b4a89c4d-fff0-4dc2-9442-48561c4e7768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_880d7bc0-1014-47e4-af3d-5c983826cadd" xlink:to="loc_us-gaap_EarningsPerShareBasic_b4a89c4d-fff0-4dc2-9442-48561c4e7768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7d2c5762-f6dc-4da2-8e18-b26fd8dbd125" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_880d7bc0-1014-47e4-af3d-5c983826cadd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7d2c5762-f6dc-4da2-8e18-b26fd8dbd125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bdc6cfb-1724-4116-8a64-fee7673b12a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c8040fc3-8c4b-445a-a598-5b078599a6b1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bdc6cfb-1724-4116-8a64-fee7673b12a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ad571f5-151a-4b25-b9bb-293874ceded2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bdc6cfb-1724-4116-8a64-fee7673b12a7" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3ad571f5-151a-4b25-b9bb-293874ceded2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_720058b9-ae29-4f0a-ba35-57e6ecd1f5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2bdc6cfb-1724-4116-8a64-fee7673b12a7" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_720058b9-ae29-4f0a-ba35-57e6ecd1f5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5ac3df76-6064-4439-a876-cd442537a3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_185aa575-0e97-453d-b2cf-f5eafb2316c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5ac3df76-6064-4439-a876-cd442537a3e0" xlink:to="loc_us-gaap_StatementTable_185aa575-0e97-453d-b2cf-f5eafb2316c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9c693aee-d70c-4b6c-90ac-07556746d7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_185aa575-0e97-453d-b2cf-f5eafb2316c8" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9c693aee-d70c-4b6c-90ac-07556746d7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9c693aee-d70c-4b6c-90ac-07556746d7ba" xlink:to="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a7ae7978-d856-4efe-a415-1e86e75106c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_CommonStockMember_a7ae7978-d856-4efe-a415-1e86e75106c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_dad88cf6-ee17-40a3-bc54-88cbe5161123" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_dad88cf6-ee17-40a3-bc54-88cbe5161123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_b23bb92d-92c3-41c1-93d2-5fa2a23962cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_RetainedEarningsMember_b23bb92d-92c3-41c1-93d2-5fa2a23962cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_f3b0698c-0d9a-4366-a4f8-4631bbfd4538" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_TreasuryStockCommonMember_f3b0698c-0d9a-4366-a4f8-4631bbfd4538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ada2f7bd-3731-4f6e-a59d-3e689fc7902c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3eda3b5a-604f-4b93-bb59-362532679a15" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ada2f7bd-3731-4f6e-a59d-3e689fc7902c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_703634c7-f8eb-423a-8d48-708a0e93324a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_185aa575-0e97-453d-b2cf-f5eafb2316c8" xlink:to="loc_us-gaap_StatementLineItems_703634c7-f8eb-423a-8d48-708a0e93324a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_703634c7-f8eb-423a-8d48-708a0e93324a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d0015506-851d-4752-b28d-54494b3bb18b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d0015506-851d-4752-b28d-54494b3bb18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e933ce3b-bc37-44f3-9eaf-cd21780f964b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e933ce3b-bc37-44f3-9eaf-cd21780f964b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_45dcdf23-5e44-4db4-ab94-2a063b3dde52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_TreasuryStockCommonShares_45dcdf23-5e44-4db4-ab94-2a063b3dde52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b19b0867-02f0-445e-836d-2a638d0098de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b19b0867-02f0-445e-836d-2a638d0098de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c13cf20-65c0-46e2-baf7-2f12ddc6341d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c13cf20-65c0-46e2-baf7-2f12ddc6341d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_bf6bd992-c3a7-40cf-8f6b-bdbaefe8e15a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_bf6bd992-c3a7-40cf-8f6b-bdbaefe8e15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d06d1c72-30b9-4f57-83eb-63b65f0faf88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_d06d1c72-30b9-4f57-83eb-63b65f0faf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c6d96820-bdb0-4d96-a0f5-3b4bf22a2dea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_c6d96820-bdb0-4d96-a0f5-3b4bf22a2dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23a24b2f-2dc6-45a9-8cb5-f1eeb1688791" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_23a24b2f-2dc6-45a9-8cb5-f1eeb1688791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_96ce1cdc-cf79-4fd5-8817-21dc0b60e7d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_Dividends_96ce1cdc-cf79-4fd5-8817-21dc0b60e7d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_44c635c0-bfbf-4d50-be11-53ee06b5460b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_44c635c0-bfbf-4d50-be11-53ee06b5460b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_ee20efd3-f26d-4b7e-bcbc-e510b24c1e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_ee20efd3-f26d-4b7e-bcbc-e510b24c1e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_79e4b8b0-7ad6-433f-b638-a8b44dfbb6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_79e4b8b0-7ad6-433f-b638-a8b44dfbb6ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_7199efa6-6301-4ada-ad20-8968269c2ae0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_7199efa6-6301-4ada-ad20-8968269c2ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_5a15cf4b-ae53-4883-8498-580025792edf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_5a15cf4b-ae53-4883-8498-580025792edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec91d5b5-66a8-4a7a-9d88-9e047bdf116c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_ec91d5b5-66a8-4a7a-9d88-9e047bdf116c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cd73ec3a-8acd-447a-9fa7-1f4b5941d4ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_cd73ec3a-8acd-447a-9fa7-1f4b5941d4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c6afdeb7-5602-4b9b-994c-190faf000618" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_NetIncomeLoss_c6afdeb7-5602-4b9b-994c-190faf000618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e95e8cb6-8842-48f8-b95a-69fa945e6006" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e95e8cb6-8842-48f8-b95a-69fa945e6006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6c93e1b0-79ac-4d52-8609-8dd0d20e8579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6c93e1b0-79ac-4d52-8609-8dd0d20e8579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_2a992279-bc13-4a77-8b6c-5920fdf2915a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_7f363a5b-01ad-47d0-91a1-67aea73a8b08" xlink:to="loc_us-gaap_TreasuryStockCommonShares_2a992279-bc13-4a77-8b6c-5920fdf2915a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c2c7b468-8025-4e69-bfad-4c992f84e76f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_a3ce1a3c-eff6-477f-bc59-53b94d255d3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c2c7b468-8025-4e69-bfad-4c992f84e76f" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_a3ce1a3c-eff6-477f-bc59-53b94d255d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ensg-20241231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a90fcbb3-a3b2-48f4-b5c0-56280f35d1ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2420a5db-6601-4e41-a107-60c531211ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a90fcbb3-a3b2-48f4-b5c0-56280f35d1ab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2420a5db-6601-4e41-a107-60c531211ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_7d580631-560b-48a0-b99b-de628395910e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2420a5db-6601-4e41-a107-60c531211ba6" xlink:to="loc_us-gaap_ProfitLoss_7d580631-560b-48a0-b99b-de628395910e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2420a5db-6601-4e41-a107-60c531211ba6" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_210f5f28-6184-4594-84a7-d6210992ed25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_210f5f28-6184-4594-84a7-d6210992ed25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_038406dc-7edd-4264-af6b-3ccb7da30500" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_038406dc-7edd-4264-af6b-3ccb7da30500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NonCashLeaseExpense_decfbcf8-3e3a-4b1f-b98a-213f984ab26a" xlink:href="ensg-20241231.xsd#ensg_NonCashLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_ensg_NonCashLeaseExpense_decfbcf8-3e3a-4b1f-b98a-213f984ab26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_96b43b58-1fd6-4fda-9358-863d9d3893e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_AssetImpairmentCharges_96b43b58-1fd6-4fda-9358-863d9d3893e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_ff466cc1-0225-42b1-89ce-b18cfa52207c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WriteOffOfDeferredDebtIssuanceCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_WriteOffOfDeferredDebtIssuanceCost_ff466cc1-0225-42b1-89ce-b18cfa52207c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bd0ef313-7d76-4596-8a4c-edd2146898b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bd0ef313-7d76-4596-8a4c-edd2146898b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_caf1182c-b47f-41ce-9223-98c630487066" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_caf1182c-b47f-41ce-9223-98c630487066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f3781781-4b7f-4ac0-9271-4b2786f46090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_ShareBasedCompensation_f3781781-4b7f-4ac0-9271-4b2786f46090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_e9b44707-5a8e-407d-8ccc-b69bf5dea69e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromInsuranceSettlementOperatingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities_e9b44707-5a8e-407d-8ccc-b69bf5dea69e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets1_83865670-2dfe-4f8f-9149-6fd9ab7e186d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfAssets1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets1_83865670-2dfe-4f8f-9149-6fd9ab7e186d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets_92606ad2-84ba-4281-9774-62db06ee7e93" xlink:href="ensg-20241231.xsd#ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets_92606ad2-84ba-4281-9774-62db06ee7e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossRelatedToLitigationSettlement_d9acdd7f-995d-47c6-b82d-e208b170469d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossRelatedToLitigationSettlement"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_GainLossRelatedToLitigationSettlement_d9acdd7f-995d-47c6-b82d-e208b170469d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51cb7bf8-79b8-4756-a02b-caa6291d88a2" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7c0a98f1-bc83-446a-9edf-43d2bf7a385d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_7c0a98f1-bc83-446a-9edf-43d2bf7a385d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_01ca02e9-c99a-4c06-8077-3b01310099fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_01ca02e9-c99a-4c06-8077-3b01310099fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ceb243a2-0b85-402b-9d3f-2615834f64f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ceb243a2-0b85-402b-9d3f-2615834f64f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct_50983c3d-f2a1-45e5-9f5d-3e613c8b7349" xlink:href="ensg-20241231.xsd#ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct_50983c3d-f2a1-45e5-9f5d-3e613c8b7349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue_2dfc9da2-7ef6-4e41-b5ba-de9dab1b35cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue_2dfc9da2-7ef6-4e41-b5ba-de9dab1b35cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_75a25e4a-cba9-46f3-a598-3fcfe015feb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCompensation_75a25e4a-cba9-46f3-a598-3fcfe015feb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5db41eb6-bc80-40cf-b60b-9d0bcb6aa028" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_5db41eb6-bc80-40cf-b60b-9d0bcb6aa028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_bdf3195d-7b28-40e4-8ba1-1057817d0f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_bdf3195d-7b28-40e4-8ba1-1057817d0f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_5c1555f7-e229-476b-ad8e-268daa88ffd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_5c1555f7-e229-476b-ad8e-268daa88ffd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2acf4a13-b695-45a3-9c5d-a21bc9d66016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2acf4a13-b695-45a3-9c5d-a21bc9d66016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInSelfInsuranceReserve_e708029e-8ec3-4840-bfa2-3da2b05fb0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInSelfInsuranceReserve"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInSelfInsuranceReserve_e708029e-8ec3-4840-bfa2-3da2b05fb0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_b4befbb9-2f16-4221-a6a9-38cbfb9dde87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6ad167d3-69fd-49c7-a64e-21d26f7687e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_b4befbb9-2f16-4221-a6a9-38cbfb9dde87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_23c584f6-1a68-4eec-80de-a4c7209467e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2420a5db-6601-4e41-a107-60c531211ba6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_23c584f6-1a68-4eec-80de-a4c7209467e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a90fcbb3-a3b2-48f4-b5c0-56280f35d1ab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PaymentsToAcquirePropertyAndEquipment_d54677a1-5c27-42d5-97d8-04829b75f977" xlink:href="ensg-20241231.xsd#ensg_PaymentsToAcquirePropertyAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:to="loc_ensg_PaymentsToAcquirePropertyAndEquipment_d54677a1-5c27-42d5-97d8-04829b75f977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_d82ec18b-30a2-4654-b2a0-3c1536152393" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_d82ec18b-30a2-4654-b2a0-3c1536152393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_8e4082c3-e80c-46bd-bcca-ac4eb334458a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromInsuranceSettlementInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:to="loc_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities_8e4082c3-e80c-46bd-bcca-ac4eb334458a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_267e7fb0-e772-4b85-9593-c23ade517848" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_267e7fb0-e772-4b85-9593-c23ade517848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0081b0ed-39c8-4180-8b90-070a2adff7da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0081b0ed-39c8-4180-8b90-070a2adff7da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_bd02f74b-2b96-4fa1-b332-3d23097d7e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_bd02f74b-2b96-4fa1-b332-3d23097d7e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f334141d-8335-43b2-9038-37e4def98b66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_f334141d-8335-43b2-9038-37e4def98b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e4a68327-865b-4a85-80b2-58cf3f4eba51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bab8e98e-9802-4448-af25-d4a9ecf6ee0c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_e4a68327-865b-4a85-80b2-58cf3f4eba51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a90fcbb3-a3b2-48f4-b5c0-56280f35d1ab" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e72288f0-9b61-4c7f-a310-5ca2aadf4d85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_e72288f0-9b61-4c7f-a310-5ca2aadf4d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_c127173c-3738-4a69-8ec3-073f9af58f03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_c127173c-3738-4a69-8ec3-073f9af58f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_46f2bf4f-d576-406e-9534-3b0fcbbb97af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_46f2bf4f-d576-406e-9534-3b0fcbbb97af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_850b55ba-dd43-4a1e-9590-9f3ee87384d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_850b55ba-dd43-4a1e-9590-9f3ee87384d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7cdd4c84-5b6b-4ccf-a224-25432a64375d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_7cdd4c84-5b6b-4ccf-a224-25432a64375d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_b4ecde57-3988-4dee-ac06-891fcc4d552a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_PaymentsOfDividends_b4ecde57-3988-4dee-ac06-891fcc4d552a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans_05b88471-d491-466b-99b0-115b365a651c" xlink:href="ensg-20241231.xsd#ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans_05b88471-d491-466b-99b0-115b365a651c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_7611fa72-20c1-485f-9044-55c29b2d728b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_7611fa72-20c1-485f-9044-55c29b2d728b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PurchasesOfNonControllingInterest_67edba78-3ad5-482f-8e6b-ffb5cc17ff9a" xlink:href="ensg-20241231.xsd#ensg_PurchasesOfNonControllingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_ensg_PurchasesOfNonControllingInterest_67edba78-3ad5-482f-8e6b-ffb5cc17ff9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_e968511c-3a87-441b-9016-d4638a111b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_e968511c-3a87-441b-9016-d4638a111b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_fe536dee-d5fe-4d5e-95b8-f9ec187e91ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_fe536dee-d5fe-4d5e-95b8-f9ec187e91ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c1e5c87c-d805-4d75-baee-742159969620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_861c257f-5d52-41a2-a870-decc5de60afb" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c1e5c87c-d805-4d75-baee-742159969620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_04fc29a7-32c1-47ff-bf9e-67dad8f141fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a90fcbb3-a3b2-48f4-b5c0-56280f35d1ab" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_04fc29a7-32c1-47ff-bf9e-67dad8f141fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_99141887-5533-44d7-a32b-b19eca0ea50c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a90fcbb3-a3b2-48f4-b5c0-56280f35d1ab" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_99141887-5533-44d7-a32b-b19eca0ea50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3d101ecf-22a8-430d-a367-6b0b6f5a3f38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a90fcbb3-a3b2-48f4-b5c0-56280f35d1ab" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_3d101ecf-22a8-430d-a367-6b0b6f5a3f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_3b88bde2-a478-4081-9d79-24f30758f547" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a90fcbb3-a3b2-48f4-b5c0-56280f35d1ab" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_3b88bde2-a478-4081-9d79-24f30758f547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_2a315b69-6ebd-441e-848b-680089056938" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_3b88bde2-a478-4081-9d79-24f30758f547" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_2a315b69-6ebd-441e-848b-680089056938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_3d1ab48b-2d86-406d-8fa2-9e3b1e50f660" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_2a315b69-6ebd-441e-848b-680089056938" xlink:to="loc_us-gaap_InterestPaidNet_3d1ab48b-2d86-406d-8fa2-9e3b1e50f660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_72a317aa-1a1f-4cb3-a5b0-45e8c37db383" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_2a315b69-6ebd-441e-848b-680089056938" xlink:to="loc_us-gaap_IncomeTaxesPaid_72a317aa-1a1f-4cb3-a5b0-45e8c37db383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ca5d9e4b-c94c-411a-8dc7-545e4b3ee35c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_2a315b69-6ebd-441e-848b-680089056938" xlink:to="loc_us-gaap_OperatingLeasePayments_ca5d9e4b-c94c-411a-8dc7-545e4b3ee35c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_39e2b0c0-80e9-4f20-8ec0-d5d084fcf74b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_3b88bde2-a478-4081-9d79-24f30758f547" xlink:to="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_39e2b0c0-80e9-4f20-8ec0-d5d084fcf74b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b7dd111e-bf36-498c-8456-cf19eb7bd288" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_39e2b0c0-80e9-4f20-8ec0-d5d084fcf74b" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b7dd111e-bf36-498c-8456-cf19eb7bd288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_8b596895-3338-4b4b-9042-ccb113f8a2af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_39e2b0c0-80e9-4f20-8ec0-d5d084fcf74b" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_8b596895-3338-4b4b-9042-ccb113f8a2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8ac2e471-ef31-4197-846e-3339b32d58a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract_39e2b0c0-80e9-4f20-8ec0-d5d084fcf74b" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8ac2e471-ef31-4197-846e-3339b32d58a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="ensg-20241231.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68fab38f-3bb5-41f2-807d-7cd4c8fc7440" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b325ca68-2e7f-4bea-a9d4-81da371d4141" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_68fab38f-3bb5-41f2-807d-7cd4c8fc7440" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b325ca68-2e7f-4bea-a9d4-81da371d4141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cbca910f-1f0d-4328-a6db-4a047caa5368" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_b2c64338-7e31-4a7c-8afa-170750e3f729" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cbca910f-1f0d-4328-a6db-4a047caa5368" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_b2c64338-7e31-4a7c-8afa-170750e3f729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLE" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLE"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_76d8d22a-805b-40e0-9a6f-a778569df4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_d5ced188-f8c9-4a52-8aa1-faa8740b2f61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_76d8d22a-805b-40e0-9a6f-a778569df4a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_d5ced188-f8c9-4a52-8aa1-faa8740b2f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMPUTATIONOFNETINCOMEPERCOMMONSHARE"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ad8dfffd-1970-4664-9609-fa4f5acb4505" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_3ec1443a-7bdf-42ac-8e03-c73bf86cf11b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ad8dfffd-1970-4664-9609-fa4f5acb4505" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_3ec1443a-7bdf-42ac-8e03-c73bf86cf11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="ensg-20241231.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6059cfaa-8385-438d-891c-47873c78ef8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_38fedc0a-203c-4bd4-b6c9-1a326fe57cea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6059cfaa-8385-438d-891c-47873c78ef8d" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_38fedc0a-203c-4bd4-b6c9-1a326fe57cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/STANDARDBEARER" xlink:type="simple" xlink:href="ensg-20241231.xsd#STANDARDBEARER"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/STANDARDBEARER" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8b721818-cd8d-4559-996c-3c65f869c063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerTextBlock_eb4ef47c-210d-424c-aebb-3bc158a01f4a" xlink:href="ensg-20241231.xsd#ensg_StandardBearerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8b721818-cd8d-4559-996c-3c65f869c063" xlink:to="loc_ensg_StandardBearerTextBlock_eb4ef47c-210d-424c-aebb-3bc158a01f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONS" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPERATIONEXPANSIONS"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPERATIONEXPANSIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2aa4bdb3-9e2e-4af2-9a96-cd7b24a0ca28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_d7d9ff94-4af2-4c75-bdf9-4777e3acf977" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_2aa4bdb3-9e2e-4af2-9a96-cd7b24a0ca28" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_d7d9ff94-4af2-4c75-bdf9-4777e3acf977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTS" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTS"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0fa9d9a9-4b1e-4b51-a67d-3a9dbd688b05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_61d4fbc0-07c2-4678-8a84-025232d1e47d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0fa9d9a9-4b1e-4b51-a67d-3a9dbd688b05" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_61d4fbc0-07c2-4678-8a84-025232d1e47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNET" xlink:type="simple" xlink:href="ensg-20241231.xsd#PROPERTYANDEQUIPMENTNET"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0d7cd068-b2e4-4624-b766-81b8c508dd37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_43c55a15-47d2-41ca-9a4c-41fd81af1ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0d7cd068-b2e4-4624-b766-81b8c508dd37" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_43c55a15-47d2-41ca-9a4c-41fd81af1ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNET" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNET"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a0ec0869-33a6-4785-a500-a3d484d8732f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_ee692b87-a614-48e3-8c6b-b9e3eb1d91c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a0ec0869-33a6-4785-a500-a3d484d8732f" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_ee692b87-a614-48e3-8c6b-b9e3eb1d91c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/GOODWILL" xlink:type="simple" xlink:href="ensg-20241231.xsd#GOODWILL"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/GOODWILL" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_57fe2d34-04a7-4a3e-80bb-b489a350a6a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillDisclosureTextBlock_843bd9fa-148e-4959-8ac5-f0335c3d8f79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_57fe2d34-04a7-4a3e-80bb-b489a350a6a9" xlink:to="loc_us-gaap_GoodwillDisclosureTextBlock_843bd9fa-148e-4959-8ac5-f0335c3d8f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIES" xlink:type="simple" xlink:href="ensg-20241231.xsd#OTHERACCRUEDLIABILITIES"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_a56dd282-9b1a-4c8e-a711-c0146d575dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_8bba0ba1-d451-4cc1-8a93-466360d652bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_a56dd282-9b1a-4c8e-a711-c0146d575dbc" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_8bba0ba1-d451-4cc1-8a93-466360d652bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXES" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ced2fd90-1c75-4db6-a19e-2f4afd75ed3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_1bd28034-34e1-476d-a9e3-6462da571436" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ced2fd90-1c75-4db6-a19e-2f4afd75ed3f" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_1bd28034-34e1-476d-a9e3-6462da571436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBT" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_575f1654-299e-4e36-aef9-2a167e3f2928" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_62a1cdd5-7c38-4d3e-a0cf-b2aed4fb692f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_575f1654-299e-4e36-aef9-2a167e3f2928" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_62a1cdd5-7c38-4d3e-a0cf-b2aed4fb692f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDS" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDS"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6bf23124-634b-42c2-8b99-65c3d5fdcab0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9700eaae-c88b-4a45-9c6f-2ab48c5fa8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6bf23124-634b-42c2-8b99-65c3d5fdcab0" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_9700eaae-c88b-4a45-9c6f-2ab48c5fa8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASES" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_489b5d2b-1b26-430b-b70c-f036e463decd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_85697539-75a6-446a-9b11-4b25c5981f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasesOfLessorDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_489b5d2b-1b26-430b-b70c-f036e463decd" xlink:to="loc_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock_85697539-75a6-446a-9b11-4b25c5981f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_7ca4e135-5562-49bf-a55a-ec66bcfa52bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_489b5d2b-1b26-430b-b70c-f036e463decd" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_7ca4e135-5562-49bf-a55a-ec66bcfa52bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANS" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEFINEDCONTRIBUTIONPLANS"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4a4975ec-6c26-408f-8ada-66fc6fdc0ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_1aa5065a-8490-4a29-bde0-a651f0b1f077" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_4a4975ec-6c26-408f-8ada-66fc6fdc0ca6" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_1aa5065a-8490-4a29-bde0-a651f0b1f077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIES" xlink:type="simple" xlink:href="ensg-20241231.xsd#SELFINSURANCELIABILITIES"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_39034470-ac1f-4115-9f5b-af311da89dff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_5aa69a15-f9b3-4e98-997e-86b22299072c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_39034470-ac1f-4115-9f5b-af311da89dff" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock_5aa69a15-f9b3-4e98-997e-86b22299072c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5f66c293-e48e-4f3c-b7dc-bd0e7b5e52c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c9929895-d222-4d35-ab54-083f5e44ea75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5f66c293-e48e-4f3c-b7dc-bd0e7b5e52c1" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_c9929895-d222-4d35-ab54-083f5e44ea75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAM" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMMONSTOCKREPURCHASEPROGRAM"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAM" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7cd21cc2-7079-416c-beca-dcdc68e03525" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_97f221a6-a7f9-4242-b49f-cc272f4a2ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7cd21cc2-7079-416c-beca-dcdc68e03525" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_97f221a6-a7f9-4242-b49f-cc272f4a2ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_881979ac-95b7-4655-b1f9-635ebba992ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_881979ac-95b7-4655-b1f9-635ebba992ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3e874db3-4f4e-4de6-87f1-4c2de2e0c12a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3e874db3-4f4e-4de6-87f1-4c2de2e0c12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c54c0c14-f08f-4593-abe2-6b81c680edc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_UseOfEstimates_c54c0c14-f08f-4593-abe2-6b81c680edc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_0cdda84d-6f0f-4437-9333-e5e84df96098" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_0cdda84d-6f0f-4437-9333-e5e84df96098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_61f2d3e3-317a-4333-8769-65b6947239e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_61f2d3e3-317a-4333-8769-65b6947239e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_8b74148a-ef82-402b-8526-50268c61096a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_8b74148a-ef82-402b-8526-50268c61096a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2d6935fb-7283-4658-af1c-8c18b9096d0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2d6935fb-7283-4658-af1c-8c18b9096d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_19e83093-a6f3-4ba7-b97a-c9be60c97333" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_19e83093-a6f3-4ba7-b97a-c9be60c97333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_c0b5c20e-4ab5-40e1-9ebb-b9083ffb8428" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_c0b5c20e-4ab5-40e1-9ebb-b9083ffb8428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_b21f0b96-40da-41cf-a6c0-366c07011068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_b21f0b96-40da-41cf-a6c0-366c07011068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b8f7b82e-a3d1-4be0-b118-6c91b36c5090" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b8f7b82e-a3d1-4be0-b118-6c91b36c5090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_a44df874-0e18-4abd-9a9f-c470c4fb49a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_a44df874-0e18-4abd-9a9f-c470c4fb49a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_632f06c6-777a-4d1c-b7c3-87ec9f5deb22" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReservePolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_SelfInsuranceReservePolicyTextBlock_632f06c6-777a-4d1c-b7c3-87ec9f5deb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_e21b053f-38c5-42c7-a8d2-53e07aa35063" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_e21b053f-38c5-42c7-a8d2-53e07aa35063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NoncontrollingInterestPolicyTextBlock_d14aca95-b22c-4260-80b9-bcf5733b92e6" xlink:href="ensg-20241231.xsd#ensg_NoncontrollingInterestPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_ensg_NoncontrollingInterestPolicyTextBlock_d14aca95-b22c-4260-80b9-bcf5733b92e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_dd1f005d-d028-48df-a632-8880f230e116" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_dd1f005d-d028-48df-a632-8880f230e116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8323108c-099f-46bb-b912-e9afc6431c16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_8323108c-099f-46bb-b912-e9afc6431c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_84ddb73b-1ad4-4fef-b287-372f22e52399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4f840db1-7017-4c3c-a17d-8f323d138ff4" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_84ddb73b-1ad4-4fef-b287-372f22e52399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLETables" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLETables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_173df77c-8107-4f34-ac6c-ac70eb5ec8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_95438591-c8b7-4b98-a636-8d9eb34fc9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_173df77c-8107-4f34-ac6c-ac70eb5ec8f3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_95438591-c8b7-4b98-a636-8d9eb34fc9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b59bcee2-9d09-4cf8-8104-253d5f63d619" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_173df77c-8107-4f34-ac6c-ac70eb5ec8f3" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b59bcee2-9d09-4cf8-8104-253d5f63d619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMPUTATIONOFNETINCOMEPERCOMMONSHARETables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1db9ef34-c596-4c2b-a80c-b85548d99f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_19292ee0-d068-4b2e-bd34-7988de63a533" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1db9ef34-c596-4c2b-a80c-b85548d99f7d" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock_19292ee0-d068-4b2e-bd34-7988de63a533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_30810cec-b300-4e80-8059-2685f92e77e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1db9ef34-c596-4c2b-a80c-b85548d99f7d" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_30810cec-b300-4e80-8059-2685f92e77e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPERATIONEXPANSIONSTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c8623b55-1ad5-4647-99af-ab9996fcfc4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6a512452-813a-44a0-9d5b-55f9a26d2948" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c8623b55-1ad5-4647-99af-ab9996fcfc4b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6a512452-813a-44a0-9d5b-55f9a26d2948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTSTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c6c22b59-f76e-4fb0-b31d-d60e9b437db7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3a5daa51-f3b9-4131-9966-674a6855ef9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c6c22b59-f76e-4fb0-b31d-d60e9b437db7" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_3a5daa51-f3b9-4131-9966-674a6855ef9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_62b56889-279f-4fe4-ba77-26e46cf7899f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c6c22b59-f76e-4fb0-b31d-d60e9b437db7" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_62b56889-279f-4fe4-ba77-26e46cf7899f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#PROPERTYANDEQUIPMENTNETTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8a55641d-4f21-4fb3-afa6-80c89c78e355" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_56b356c4-51a9-447d-a1db-93997ac2a563" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8a55641d-4f21-4fb3-afa6-80c89c78e355" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_56b356c4-51a9-447d-a1db-93997ac2a563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66b36fdc-a734-4d05-a39b-54672cfb7f82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_876ae9be-fc9d-48e3-8805-c9a2a3cab016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66b36fdc-a734-4d05-a39b-54672cfb7f82" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_876ae9be-fc9d-48e3-8805-c9a2a3cab016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_366a7678-c9e5-47bf-bb01-dd63db3a24b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66b36fdc-a734-4d05-a39b-54672cfb7f82" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_366a7678-c9e5-47bf-bb01-dd63db3a24b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_8a355313-0d32-445f-8b5e-ff7430ac1615" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_66b36fdc-a734-4d05-a39b-54672cfb7f82" xlink:to="loc_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock_8a355313-0d32-445f-8b5e-ff7430ac1615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/GOODWILLTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#GOODWILLTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/GOODWILLTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4a48e266-3d59-4109-8ecd-c0573814c630" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_4b06e8fe-86ce-4ac8-a032-97dd8143a031" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4a48e266-3d59-4109-8ecd-c0573814c630" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_4b06e8fe-86ce-4ac8-a032-97dd8143a031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#OTHERACCRUEDLIABILITIESTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_db135398-0c57-4581-bf4f-a142481c493f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a1df1887-f7ba-423f-a6ab-5390976fe492" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_db135398-0c57-4581-bf4f-a142481c493f" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_a1df1887-f7ba-423f-a6ab-5390976fe492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXESTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5fca0d32-4b2f-4da5-a65d-684cafd6d579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0ef9e505-8fa3-44a0-8977-418cefcc5ee9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5fca0d32-4b2f-4da5-a65d-684cafd6d579" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0ef9e505-8fa3-44a0-8977-418cefcc5ee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_19539e1a-286f-48a9-b5e7-9e3a8b8766b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5fca0d32-4b2f-4da5-a65d-684cafd6d579" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_19539e1a-286f-48a9-b5e7-9e3a8b8766b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_10678e39-d871-4d03-859e-509a405e3171" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5fca0d32-4b2f-4da5-a65d-684cafd6d579" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_10678e39-d871-4d03-859e-509a405e3171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ab6e1295-df50-4410-9668-a43c89f03836" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_3722b7ac-cb53-4e10-858e-06fb0d3e71ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ab6e1295-df50-4410-9668-a43c89f03836" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_3722b7ac-cb53-4e10-858e-06fb0d3e71ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_6278b9a2-3428-41d9-9fb4-833e30f4f9bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ab6e1295-df50-4410-9668-a43c89f03836" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_6278b9a2-3428-41d9-9fb4-833e30f4f9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c657bcd-a2fa-413d-8378-ec80e1da53b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_64364bc5-b51d-461f-a805-15741b0e86a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c657bcd-a2fa-413d-8378-ec80e1da53b1" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_64364bc5-b51d-461f-a805-15741b0e86a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_d2553ee0-4062-4364-acfc-040affaaa7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c657bcd-a2fa-413d-8378-ec80e1da53b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock_d2553ee0-4062-4364-acfc-040affaaa7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_cdb3de3b-c48f-4031-87f6-dc05ebabe222" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c657bcd-a2fa-413d-8378-ec80e1da53b1" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_cdb3de3b-c48f-4031-87f6-dc05ebabe222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_9022a020-77cc-4d23-a123-bba74825fb4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c657bcd-a2fa-413d-8378-ec80e1da53b1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_9022a020-77cc-4d23-a123-bba74825fb4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_5632bcdf-a0c4-4c06-b85d-24a421a50f65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c657bcd-a2fa-413d-8378-ec80e1da53b1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock_5632bcdf-a0c4-4c06-b85d-24a421a50f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f0340516-f88a-45b9-8e1b-c4d1ab47b69d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c657bcd-a2fa-413d-8378-ec80e1da53b1" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_f0340516-f88a-45b9-8e1b-c4d1ab47b69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_72a13a15-7c63-4e4c-b4f6-e6cd8a8b4e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1c657bcd-a2fa-413d-8378-ec80e1da53b1" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_72a13a15-7c63-4e4c-b4f6-e6cd8a8b4e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_06886dbe-80d8-4d15-9339-24c9e06b22eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_136a5add-b674-4fc4-804a-a9ddf1932c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_06886dbe-80d8-4d15-9339-24c9e06b22eb" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_136a5add-b674-4fc4-804a-a9ddf1932c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_24ef7639-f3e8-4458-b4be-c882ae801f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_06886dbe-80d8-4d15-9339-24c9e06b22eb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_24ef7639-f3e8-4458-b4be-c882ae801f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_05961f86-4d37-4cec-ab31-c713a5f8daeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncomeTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_06886dbe-80d8-4d15-9339-24c9e06b22eb" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock_05961f86-4d37-4cec-ab31-c713a5f8daeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_06b972f0-0366-48b8-849c-a2d2212a4fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_06886dbe-80d8-4d15-9339-24c9e06b22eb" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_06b972f0-0366-48b8-849c-a2d2212a4fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESTables" xlink:type="simple" xlink:href="ensg-20241231.xsd#SELFINSURANCELIABILITIESTables"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_da2d5e14-f411-448d-80e9-31417098ef3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock_1375e00b-7406-45a6-8aba-6bd8432069ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_da2d5e14-f411-448d-80e9-31417098ef3c" xlink:to="loc_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock_1375e00b-7406-45a6-8aba-6bd8432069ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_90cc2813-46c5-4abc-94b5-27bbf22312b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_da2d5e14-f411-448d-80e9-31417098ef3c" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock_90cc2813-46c5-4abc-94b5-27bbf22312b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_470e5ebc-f0e2-423b-9c0c-70dc166c25aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_470e5ebc-f0e2-423b-9c0c-70dc166c25aa" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsAxis_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsAxis_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_598d0ce1-ae50-423e-b642-21c039a45aac" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_18a1b39a-a9cf-4b3e-8449-8f77b4dd0d00" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_598d0ce1-ae50-423e-b642-21c039a45aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CombinedRealEstateAndLeasesMember_19bdf1c4-d1ba-460c-a24e-79c3a74d7bbf" xlink:href="ensg-20241231.xsd#ensg_CombinedRealEstateAndLeasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_598d0ce1-ae50-423e-b642-21c039a45aac" xlink:to="loc_ensg_CombinedRealEstateAndLeasesMember_19bdf1c4-d1ba-460c-a24e-79c3a74d7bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_ensg_OperatingEntityAxis_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_f9abc105-f01c-4984-b3f1-53b39b80297c" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityAxis_a2df60f1-e6e7-4e68-850e-1e2de9c23c0a" xlink:to="loc_ensg_OperatingEntityDomain_f9abc105-f01c-4984-b3f1-53b39b80297c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_4bc9d53c-d4ae-4fe5-a71d-21f25d1f6e03" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityDomain_f9abc105-f01c-4984-b3f1-53b39b80297c" xlink:to="loc_srt_SubsidiariesMember_4bc9d53c-d4ae-4fe5-a71d-21f25d1f6e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThirdPartyOperatorsMember_ada78d8f-59b0-4a00-ae90-509180a62d7c" xlink:href="ensg-20241231.xsd#ensg_ThirdPartyOperatorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityDomain_f9abc105-f01c-4984-b3f1-53b39b80297c" xlink:to="loc_ensg_ThirdPartyOperatorsMember_ada78d8f-59b0-4a00-ae90-509180a62d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ea8afa1b-a052-4136-8b06-62ec420cf4f1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_dei_LegalEntityAxis_ea8afa1b-a052-4136-8b06-62ec420cf4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_00a181b7-1f2d-49ef-b24c-48dbcbe76e44" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ea8afa1b-a052-4136-8b06-62ec420cf4f1" xlink:to="loc_dei_EntityDomain_00a181b7-1f2d-49ef-b24c-48dbcbe76e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember_f2ccbdb9-62c8-4fe5-82b2-b3e624337fb3" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_00a181b7-1f2d-49ef-b24c-48dbcbe76e44" xlink:to="loc_ensg_StandardBearerHealthcareREITIncMember_f2ccbdb9-62c8-4fe5-82b2-b3e624337fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e000272b-280e-45a3-9270-d8d122f84d45" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e000272b-280e-45a3-9270-d8d122f84d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_21015ed5-b640-4ede-bcf9-36d9fba4729d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_e000272b-280e-45a3-9270-d8d122f84d45" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_21015ed5-b640-4ede-bcf9-36d9fba4729d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_ea2db800-a42c-42fb-bf38-8afcf75b24c5" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_21015ed5-b640-4ede-bcf9-36d9fba4729d" xlink:to="loc_ensg_SeniorLivingOperationsMember_ea2db800-a42c-42fb-bf38-8afcf75b24c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_6d698201-ef52-48d7-97d5-184d1742a95b" xlink:to="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_ad742b1f-d35a-4f4c-b729-52deb8777d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_ad742b1f-d35a-4f4c-b729-52deb8777d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSkilledNursingBeds_77edd111-3a2b-44db-b589-2fe138bebc73" xlink:href="ensg-20241231.xsd#ensg_NumberOfSkilledNursingBeds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfSkilledNursingBeds_77edd111-3a2b-44db-b589-2fe138bebc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSeniorLivingUnits_ddc19c9c-8278-49a4-9497-c28a204c4b36" xlink:href="ensg-20241231.xsd#ensg_NumberOfSeniorLivingUnits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfSeniorLivingUnits_ddc19c9c-8278-49a4-9497-c28a204c4b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements_7b50b33f-e5b1-4f08-ba95-2cbd6c2ad97b" xlink:href="ensg-20241231.xsd#ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements_7b50b33f-e5b1-4f08-ba95-2cbd6c2ad97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase_06e5a340-cea5-4d20-8e7c-42dcc00e5c76" xlink:href="ensg-20241231.xsd#ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase_06e5a340-cea5-4d20-8e7c-42dcc00e5c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfRealEstatePropertiesSharingLocations_7003c0f2-45d2-4b15-8925-7fefe800c5fc" xlink:href="ensg-20241231.xsd#ensg_NumberOfRealEstatePropertiesSharingLocations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_fa4cc5cd-90c5-4c96-ab34-e2dc381fe42b" xlink:to="loc_ensg_NumberOfRealEstatePropertiesSharingLocations_7003c0f2-45d2-4b15-8925-7fefe800c5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5e996d56-3c93-4e6a-8aa0-2a73e94562b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6ceb4e5-0022-4d99-942d-8a51169fa6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5e996d56-3c93-4e6a-8aa0-2a73e94562b4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6ceb4e5-0022-4d99-942d-8a51169fa6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cedb8b74-75b7-42c2-8eab-f63076a5e0de" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6ceb4e5-0022-4d99-942d-8a51169fa6a1" xlink:to="loc_srt_RangeAxis_cedb8b74-75b7-42c2-8eab-f63076a5e0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bac91d7b-3a30-4e06-bd1d-40fbca42004a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cedb8b74-75b7-42c2-8eab-f63076a5e0de" xlink:to="loc_srt_RangeMember_bac91d7b-3a30-4e06-bd1d-40fbca42004a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c9d5dc7b-7abb-46ba-be75-2889eae1eed2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bac91d7b-3a30-4e06-bd1d-40fbca42004a" xlink:to="loc_srt_MinimumMember_c9d5dc7b-7abb-46ba-be75-2889eae1eed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_dcd5979c-4ad8-445d-a999-aae649fac6a6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_bac91d7b-3a30-4e06-bd1d-40fbca42004a" xlink:to="loc_srt_MaximumMember_dcd5979c-4ad8-445d-a999-aae649fac6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1a525316-8142-4157-a45f-f8f981bdb395" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b6ceb4e5-0022-4d99-942d-8a51169fa6a1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1a525316-8142-4157-a45f-f8f981bdb395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_60e716e3-68c9-4187-b3b8-1ab4439e5a82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_1a525316-8142-4157-a45f-f8f981bdb395" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_60e716e3-68c9-4187-b3b8-1ab4439e5a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ebbb1b04-6754-426b-bd2d-d8851c9a64ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_d67ce46a-997d-47ed-865c-8c1f76ca3087" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ebbb1b04-6754-426b-bd2d-d8851c9a64ac" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_d67ce46a-997d-47ed-865c-8c1f76ca3087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fc28803e-1abf-453d-9cb8-9d14baccf242" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_d67ce46a-997d-47ed-865c-8c1f76ca3087" xlink:to="loc_srt_RangeAxis_fc28803e-1abf-453d-9cb8-9d14baccf242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3b66932e-9c5d-424c-b727-c1ef59139c9b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fc28803e-1abf-453d-9cb8-9d14baccf242" xlink:to="loc_srt_RangeMember_3b66932e-9c5d-424c-b727-c1ef59139c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_555226b3-f804-4e54-9bd7-44927ea65ceb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3b66932e-9c5d-424c-b727-c1ef59139c9b" xlink:to="loc_srt_MinimumMember_555226b3-f804-4e54-9bd7-44927ea65ceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_2beaf68d-8bf0-4256-a003-ec823f205f1f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3b66932e-9c5d-424c-b727-c1ef59139c9b" xlink:to="loc_srt_MaximumMember_2beaf68d-8bf0-4256-a003-ec823f205f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_d67ce46a-997d-47ed-865c-8c1f76ca3087" xlink:to="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfFinancingLeases_367d79d5-4bb8-4cd2-b1f7-a9ce75b3d382" xlink:href="ensg-20241231.xsd#ensg_NumberOfFinancingLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_ensg_NumberOfFinancingLeases_367d79d5-4bb8-4cd2-b1f7-a9ce75b3d382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_2883fe35-ec6e-4561-bfd1-7b8952180f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_2883fe35-ec6e-4561-bfd1-7b8952180f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseNumberOfRenewalOptions_87e79571-d3f5-4228-a819-8a5551639138" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseNumberOfRenewalOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_ensg_LesseeOperatingLeaseNumberOfRenewalOptions_87e79571-d3f5-4228-a819-8a5551639138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_dcecc8f9-52af-43b0-8e14-081d0cd46598" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_2240a735-33c0-4ee9-8076-a5c5e86a09b9" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_dcecc8f9-52af-43b0-8e14-081d0cd46598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4b599d8a-e729-441a-9d1d-62a9efd4826a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4b599d8a-e729-441a-9d1d-62a9efd4826a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c639ee96-1ae8-41f1-ab08-04f8263f6916" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c639ee96-1ae8-41f1-ab08-04f8263f6916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_c639ee96-1ae8-41f1-ab08-04f8263f6916" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AssembledOccupancyAcquiredMember_503a6a61-2d30-432a-9bf6-d321e01b6d0d" xlink:href="ensg-20241231.xsd#ensg_AssembledOccupancyAcquiredMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:to="loc_ensg_AssembledOccupancyAcquiredMember_503a6a61-2d30-432a-9bf6-d321e01b6d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_25399392-2285-4839-937e-94ddfcc14f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:to="loc_us-gaap_TradeNamesMember_25399392-2285-4839-937e-94ddfcc14f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_0d40223b-518a-405f-87bf-3dd9d5da81e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_50bf9962-ebea-4e9f-8652-59e9c1ebc5bc" xlink:to="loc_us-gaap_CustomerRelationshipsMember_0d40223b-518a-405f-87bf-3dd9d5da81e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_de74d035-00a0-43c1-9bf8-90b868fa9d75" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:to="loc_srt_RangeAxis_de74d035-00a0-43c1-9bf8-90b868fa9d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c5b26098-f60a-4e33-9069-c29ce1abecc3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_de74d035-00a0-43c1-9bf8-90b868fa9d75" xlink:to="loc_srt_RangeMember_c5b26098-f60a-4e33-9069-c29ce1abecc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a4fca424-75d9-4ab6-960f-4b782963904b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c5b26098-f60a-4e33-9069-c29ce1abecc3" xlink:to="loc_srt_MinimumMember_a4fca424-75d9-4ab6-960f-4b782963904b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d095b38f-bd3b-428f-b168-3a8c8ebedd1c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c5b26098-f60a-4e33-9069-c29ce1abecc3" xlink:to="loc_srt_MaximumMember_d095b38f-bd3b-428f-b168-3a8c8ebedd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9bec6b49-b6c3-4bb4-9dcb-3db1421e7234" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3165133d-b528-48e5-ae33-fae1621ff8ea" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9bec6b49-b6c3-4bb4-9dcb-3db1421e7234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e2a4fbbf-9c61-4271-a497-4e64e89b7046" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_9bec6b49-b6c3-4bb4-9dcb-3db1421e7234" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e2a4fbbf-9c61-4271-a497-4e64e89b7046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7c470bb9-693d-4929-bcce-82663e987a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7c470bb9-693d-4929-bcce-82663e987a6e" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceCoverageLimitTypeAxis_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd" xlink:href="ensg-20241231.xsd#ensg_InsuranceCoverageLimitTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_ensg_InsuranceCoverageLimitTypeAxis_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:href="ensg-20241231.xsd#ensg_InsuranceCoverageLimitTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_InsuranceCoverageLimitTypeAxis_a4df0bcc-6705-409e-a02a-8f07fe7ad9cd" xlink:to="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SelfInsuranceRetentionPerClaimMember_fe21c93f-666d-41cd-ac8b-b5b967dc716a" xlink:href="ensg-20241231.xsd#ensg_SelfInsuranceRetentionPerClaimMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_SelfInsuranceRetentionPerClaimMember_fe21c93f-666d-41cd-ac8b-b5b967dc716a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember_10109caa-e3fd-4ffe-b9c0-ef3c5a768886" xlink:href="ensg-20241231.xsd#ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_SelfInsuranceRetentionPerClaimMember_fe21c93f-666d-41cd-ac8b-b5b967dc716a" xlink:to="loc_ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember_10109caa-e3fd-4ffe-b9c0-ef3c5a768886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AggregateDeductibleMember_c005e0ea-e711-447a-b6ba-314235fa687d" xlink:href="ensg-20241231.xsd#ensg_AggregateDeductibleMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_AggregateDeductibleMember_c005e0ea-e711-447a-b6ba-314235fa687d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PerOccurenceMember_436554f5-5419-4662-b507-5d3e668336b1" xlink:href="ensg-20241231.xsd#ensg_PerOccurenceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_PerOccurenceMember_436554f5-5419-4662-b507-5d3e668336b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PerFacilityMember_46e622a7-850c-47bf-ac28-90f69d276d90" xlink:href="ensg-20241231.xsd#ensg_PerFacilityMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_PerFacilityMember_46e622a7-850c-47bf-ac28-90f69d276d90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AggregateMember_ea267014-63e4-471f-ad17-b776b2dd682e" xlink:href="ensg-20241231.xsd#ensg_AggregateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_AggregateMember_ea267014-63e4-471f-ad17-b776b2dd682e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LossSensitiveLimitPerClaimMember_26115396-fe46-4749-b87d-7ae80c4e2a65" xlink:href="ensg-20241231.xsd#ensg_LossSensitiveLimitPerClaimMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_LossSensitiveLimitPerClaimMember_26115396-fe46-4749-b87d-7ae80c4e2a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StopLossInsuranceLimitPerClaimMember_52506c2a-0f8b-46e3-89fc-b7d8f04e7d02" xlink:href="ensg-20241231.xsd#ensg_StopLossInsuranceLimitPerClaimMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_InsuranceCoverageLimitTypeDomain_13a7ef43-ca43-411f-b5fb-77da055437cf" xlink:to="loc_ensg_StopLossInsuranceLimitPerClaimMember_52506c2a-0f8b-46e3-89fc-b7d8f04e7d02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PayorAxis_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65" xlink:href="ensg-20241231.xsd#ensg_PayorAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_ensg_PayorAxis_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PayorDomain_baa815eb-8d6f-4cd3-b741-c790e1c28a06" xlink:href="ensg-20241231.xsd#ensg_PayorDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_PayorAxis_6fd5673f-2760-4e7a-ba9a-b7de52d1fb65" xlink:to="loc_ensg_PayorDomain_baa815eb-8d6f-4cd3-b741-c790e1c28a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_8ca475db-ae9f-4a83-9ca8-4f77fdb605e5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_PayorDomain_baa815eb-8d6f-4cd3-b741-c790e1c28a06" xlink:to="loc_srt_ParentCompanyMember_8ca475db-ae9f-4a83-9ca8-4f77fdb605e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_naics_ZZ524292_afb39939-6acf-4fe8-8dfc-ffe6b099f4cb" xlink:href="https://xbrl.sec.gov/naics/2024/naics-2024.xsd#naics_ZZ524292"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_PayorDomain_baa815eb-8d6f-4cd3-b741-c790e1c28a06" xlink:to="loc_naics_ZZ524292_afb39939-6acf-4fe8-8dfc-ffe6b099f4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_srt_ProductOrServiceAxis_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_f7b7aedd-d8d7-4b97-a4bb-77eb16dbb4bb" xlink:to="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralLiabilityMember_38694ceb-b786-4114-9039-c65fa7af82b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:to="loc_us-gaap_GeneralLiabilityMember_38694ceb-b786-4114-9039-c65fa7af82b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationInsuranceMember_438776ac-0cb3-4382-9691-82f7fd408332" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationInsuranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:to="loc_us-gaap_WorkersCompensationInsuranceMember_438776ac-0cb3-4382-9691-82f7fd408332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_HealthLiabilityInsuranceMember_8e1b5e99-6274-4ede-b5cf-88feecee7944" xlink:href="ensg-20241231.xsd#ensg_HealthLiabilityInsuranceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_6f8fdf81-42bd-4e45-bed4-e63a8f277ad3" xlink:to="loc_ensg_HealthLiabilityInsuranceMember_8e1b5e99-6274-4ede-b5cf-88feecee7944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_58e5946d-5afe-42f4-8ab3-610cab171240" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_srt_StatementGeographicalAxis_58e5946d-5afe-42f4-8ab3-610cab171240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_58e5946d-5afe-42f4-8ab3-610cab171240" xlink:to="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_7cdc50e4-fcf0-4eb5-91b1-692aead59adb" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_stpr_CA_7cdc50e4-fcf0-4eb5-91b1-692aead59adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NonCaliforniaMember_3bb670e0-3cc2-453d-a500-0c1f33bcf977" xlink:href="ensg-20241231.xsd#ensg_NonCaliforniaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_ensg_NonCaliforniaMember_3bb670e0-3cc2-453d-a500-0c1f33bcf977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AllStatesExcludingColoradoMember_9f501a8b-8efd-48bc-9f4d-0669380ff3d2" xlink:href="ensg-20241231.xsd#ensg_AllStatesExcludingColoradoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_ensg_AllStatesExcludingColoradoMember_9f501a8b-8efd-48bc-9f4d-0669380ff3d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO_28e31a1b-06c7-45b4-88f8-38cae6b6aa28" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CO"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_stpr_CO_28e31a1b-06c7-45b4-88f8-38cae6b6aa28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_d88f868f-ad1f-4abe-8c6a-a3c242de009f" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_TX"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_stpr_TX_d88f868f-ad1f-4abe-8c6a-a3c242de009f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember_a8c5643a-3a31-45f8-b820-083d62cafffb" xlink:href="ensg-20241231.xsd#ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember_a8c5643a-3a31-45f8-b820-083d62cafffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_WA_625dfb7f-9fda-4169-a1ea-f5cb56d56a3f" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_WA"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_69fb93b0-8165-4efa-b7d2-506115c09cb3" xlink:to="loc_stpr_WA_625dfb7f-9fda-4169-a1ea-f5cb56d56a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_fdcd90dd-c6c2-420a-8553-696feffd3dab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_fdcd90dd-c6c2-420a-8553-696feffd3dab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_2731e16e-5dd4-4e09-9346-9ac22848088c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_fdcd90dd-c6c2-420a-8553-696feffd3dab" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_2731e16e-5dd4-4e09-9346-9ac22848088c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_098d0eaa-c0bb-4d37-9e74-b5f4ffb07198" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_2731e16e-5dd4-4e09-9346-9ac22848088c" xlink:to="loc_us-gaap_SubsequentEventMember_098d0eaa-c0bb-4d37-9e74-b5f4ffb07198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_716aa36d-6146-4439-9c7c-db41cc4e7f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable_9969a007-e44a-4029-b19a-547c25067cd0" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_716aa36d-6146-4439-9c7c-db41cc4e7f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_323e729e-74c5-4d6f-876a-25ca587cf130" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems_716aa36d-6146-4439-9c7c-db41cc4e7f2e" xlink:to="loc_us-gaap_SelfInsuranceReserve_323e729e-74c5-4d6f-876a-25ca587cf130" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_57a48149-4f93-48a7-905b-2e4bf26aa4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_57a48149-4f93-48a7-905b-2e4bf26aa4a8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_eb64e9f5-3750-4576-b7f8-c0693ab2bd34" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_srt_ProductOrServiceAxis_eb64e9f5-3750-4576-b7f8-c0693ab2bd34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_306eed80-b71d-4fa8-b12b-ef8f280f3c70" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_eb64e9f5-3750-4576-b7f8-c0693ab2bd34" xlink:to="loc_srt_ProductsAndServicesDomain_306eed80-b71d-4fa8-b12b-ef8f280f3c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_7b784bc2-6666-4bf6-9b66-7894357444d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_306eed80-b71d-4fa8-b12b-ef8f280f3c70" xlink:to="loc_us-gaap_ServiceMember_7b784bc2-6666-4bf6-9b66-7894357444d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember_b8804748-270d-4c82-aaf4-89300a1e895c" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_306eed80-b71d-4fa8-b12b-ef8f280f3c70" xlink:to="loc_ensg_RentalMember_b8804748-270d-4c82-aaf4-89300a1e895c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54f3c8bf-ba83-47d5-ad54-1189e0fbb5d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_36d1218a-cc0d-4b5c-9205-7df11c4e8f4d" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54f3c8bf-ba83-47d5-ad54-1189e0fbb5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_a7fa636b-c3d4-40a2-93f2-ea44c8165659" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54f3c8bf-ba83-47d5-ad54-1189e0fbb5d7" xlink:to="loc_us-gaap_SalesRevenueNetMember_a7fa636b-c3d4-40a2-93f2-ea44c8165659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_777b9297-f806-4f5d-b84a-02c5734a9347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_777b9297-f806-4f5d-b84a-02c5734a9347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c2f63c7a-0da6-49ab-a4e5-9cfba018bc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_777b9297-f806-4f5d-b84a-02c5734a9347" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c2f63c7a-0da6-49ab-a4e5-9cfba018bc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_9f655c26-18f0-4a11-9e7f-2e237eecd045" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c2f63c7a-0da6-49ab-a4e5-9cfba018bc9a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_9f655c26-18f0-4a11-9e7f-2e237eecd045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_1f5b2f4c-016a-4a21-96b4-573a8a764d0a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_srt_MajorCustomersAxis_1f5b2f4c-016a-4a21-96b4-573a8a764d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_22da3340-ebae-47d8-8879-2fa19d5e8aac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_1f5b2f4c-016a-4a21-96b4-573a8a764d0a" xlink:to="loc_srt_NameOfMajorCustomerDomain_22da3340-ebae-47d8-8879-2fa19d5e8aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember_72e5efb1-a85a-47bf-b213-b5399ad44603" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_22da3340-ebae-47d8-8879-2fa19d5e8aac" xlink:to="loc_ensg_MedicaidAndMedicareMember_72e5efb1-a85a-47bf-b213-b5399ad44603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ae6226e5-6ed1-44ce-bdfc-d4f1fd001204" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8e11e220-6547-44b4-ba48-c7a6e7d7bc96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8e11e220-6547-44b4-ba48-c7a6e7d7bc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c01fd1b-2880-4f50-a842-6e3d88a5f689" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7c01fd1b-2880-4f50-a842-6e3d88a5f689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived_f886fc0c-6271-4b98-897b-7bb78952be21" xlink:href="ensg-20241231.xsd#ensg_FamilyFirstCoronavirusResponseActPaymentsReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived_f886fc0c-6271-4b98-897b-7bb78952be21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AccruedLiabilitiesStateReliefContractLiabilities_35458b66-6d4b-41d4-863f-00aae7885942" xlink:href="ensg-20241231.xsd#ensg_AccruedLiabilitiesStateReliefContractLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_ensg_AccruedLiabilitiesStateReliefContractLiabilities_35458b66-6d4b-41d4-863f-00aae7885942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized_5afaca21-2cd2-4efe-9e49-dc0bf41dc2c4" xlink:href="ensg-20241231.xsd#ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized_5afaca21-2cd2-4efe-9e49-dc0bf41dc2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT_319c77f8-9a8d-4f61-9a1f-63fe11d6c730" xlink:href="ensg-20241231.xsd#ensg_MedicareAcceleratedAndAdvancePaymentCARESACT"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_82ddef69-c29d-456d-a09a-474b2849d29e" xlink:to="loc_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT_319c77f8-9a8d-4f61-9a1f-63fe11d6c730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8607dfd-67b0-48ef-aceb-f87c64a15e90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e8607dfd-67b0-48ef-aceb-f87c64a15e90" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a51a2435-1dbc-406b-bb23-acdd93927a26" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_srt_ProductOrServiceAxis_a51a2435-1dbc-406b-bb23-acdd93927a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a80a4ba0-2814-4e9c-878e-f87486b0069c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a51a2435-1dbc-406b-bb23-acdd93927a26" xlink:to="loc_srt_ProductsAndServicesDomain_a80a4ba0-2814-4e9c-878e-f87486b0069c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_260038cc-e72a-4b5b-b4bb-9cc3127f9771" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a80a4ba0-2814-4e9c-878e-f87486b0069c" xlink:to="loc_us-gaap_ServiceMember_260038cc-e72a-4b5b-b4bb-9cc3127f9771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_27a5ec15-b1e2-4e85-a213-a48ac9f9c364" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_27a5ec15-b1e2-4e85-a213-a48ac9f9c364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c314b246-d046-4984-bae1-2981beb42a66" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_27a5ec15-b1e2-4e85-a213-a48ac9f9c364" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c314b246-d046-4984-bae1-2981beb42a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_b36bbab1-7a4a-4e71-a567-3b24b4290ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c314b246-d046-4984-bae1-2981beb42a66" xlink:to="loc_us-gaap_SalesRevenueNetMember_b36bbab1-7a4a-4e71-a567-3b24b4290ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_132523ed-7352-4fc6-8808-174ff12f1ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_132523ed-7352-4fc6-8808-174ff12f1ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_526b21f3-9fd1-43e0-a1ea-b6d2d13d1258" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_132523ed-7352-4fc6-8808-174ff12f1ed2" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_526b21f3-9fd1-43e0-a1ea-b6d2d13d1258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_4c9bbbe8-eeac-490b-baa3-678ff34ffb65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_526b21f3-9fd1-43e0-a1ea-b6d2d13d1258" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_4c9bbbe8-eeac-490b-baa3-678ff34ffb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_1eca37c1-3ec3-4570-8491-15bf98995c6c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_srt_MajorCustomersAxis_1eca37c1-3ec3-4570-8491-15bf98995c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_1eca37c1-3ec3-4570-8491-15bf98995c6c" xlink:to="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:to="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidMember_457c8ba5-7bdc-4b30-8f66-e2766489c004" xlink:href="ensg-20241231.xsd#ensg_MedicaidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:to="loc_ensg_MedicaidMember_457c8ba5-7bdc-4b30-8f66-e2766489c004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareMember_ce252364-2d1a-4820-bddd-430c8696fe27" xlink:href="ensg-20241231.xsd#ensg_MedicareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:to="loc_ensg_MedicareMember_ce252364-2d1a-4820-bddd-430c8696fe27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidSkilledMember_e24555e8-4c13-4357-883d-5205b297e3ae" xlink:href="ensg-20241231.xsd#ensg_MedicaidSkilledMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_MedicaidAndMedicareMember_20eda940-5dfe-49ea-8495-890942e814c1" xlink:to="loc_ensg_MedicaidSkilledMember_e24555e8-4c13-4357-883d-5205b297e3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagedCareMember_21240ea8-b2a8-49ce-8dc0-0ad2ceb8f0ea" xlink:href="ensg-20241231.xsd#ensg_ManagedCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:to="loc_ensg_ManagedCareMember_21240ea8-b2a8-49ce-8dc0-0ad2ceb8f0ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrivatePayAndOtherMember_cc991ce9-7b19-4e62-8d4a-32172dfcc805" xlink:href="ensg-20241231.xsd#ensg_PrivatePayAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ce120445-edc4-41e5-a878-2746b261a597" xlink:to="loc_ensg_PrivatePayAndOtherMember_cc991ce9-7b19-4e62-8d4a-32172dfcc805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2a0b174e-019d-4444-842b-1d48cc96090e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fc739028-6725-42ce-92ea-cb471c6e6e4f" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_2a0b174e-019d-4444-842b-1d48cc96090e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d444496-c221-4dd8-8eee-fae2ab9173b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2a0b174e-019d-4444-842b-1d48cc96090e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0d444496-c221-4dd8-8eee-fae2ab9173b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_ac1dff6c-68dd-407e-9ffb-e536336fcd65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2a0b174e-019d-4444-842b-1d48cc96090e" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_ac1dff6c-68dd-407e-9ffb-e536336fcd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_73b78ac6-e383-4b97-a102-bb982b8ed4c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_fd90695c-ec18-43f4-a3e3-fc26a73ac4b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_73b78ac6-e383-4b97-a102-bb982b8ed4c0" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_fd90695c-ec18-43f4-a3e3-fc26a73ac4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_fd90695c-ec18-43f4-a3e3-fc26a73ac4b8" xlink:to="loc_srt_MajorCustomersAxis_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_8b5ce40d-2673-4b7b-8d44-8ef5babeb26a" xlink:to="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidMember_adc0914a-7b3b-4a40-a4ec-64f04a0134d0" xlink:href="ensg-20241231.xsd#ensg_MedicaidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:to="loc_ensg_MedicaidMember_adc0914a-7b3b-4a40-a4ec-64f04a0134d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagedCareMember_33bb62e9-1b1d-485b-8f6c-31c4d8661127" xlink:href="ensg-20241231.xsd#ensg_ManagedCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:to="loc_ensg_ManagedCareMember_33bb62e9-1b1d-485b-8f6c-31c4d8661127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareMember_84e0529b-e29f-4d6c-9565-cbce7e1cc3ce" xlink:href="ensg-20241231.xsd#ensg_MedicareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:to="loc_ensg_MedicareMember_84e0529b-e29f-4d6c-9565-cbce7e1cc3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrivatePayAndOtherMember_792f981f-1fc5-4aaa-9f6f-91891a8c2b6f" xlink:href="ensg-20241231.xsd#ensg_PrivatePayAndOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_bad4e18d-a5d7-4800-85af-6ba868c39dc0" xlink:to="loc_ensg_PrivatePayAndOtherMember_792f981f-1fc5-4aaa-9f6f-91891a8c2b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_fd90695c-ec18-43f4-a3e3-fc26a73ac4b8" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_8cd889fd-d08f-41c1-ac86-481f2f8a23b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:to="loc_us-gaap_AccountsReceivableGross_8cd889fd-d08f-41c1-ac86-481f2f8a23b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d9e200b1-6519-4872-a49a-ac49c85ad471" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d9e200b1-6519-4872-a49a-ac49c85ad471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_f899b2c2-50e8-4b4b-aacb-8054a0cc178f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_7bafe265-a4be-41ef-822d-7acf36af787e" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_f899b2c2-50e8-4b4b-aacb-8054a0cc178f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7a165daf-633f-48b9-b5a9-96ccd0d2b4d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAbstract_e35c230a-9211-4082-8084-5fffaaa0eb30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a165daf-633f-48b9-b5a9-96ccd0d2b4d0" xlink:to="loc_us-gaap_NetIncomeLossAbstract_e35c230a-9211-4082-8084-5fffaaa0eb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_0a0d3708-7f53-4543-ab12-e2ad6c10674b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e35c230a-9211-4082-8084-5fffaaa0eb30" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_0a0d3708-7f53-4543-ab12-e2ad6c10674b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_c1d35cba-1671-4246-b042-1429cff481c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e35c230a-9211-4082-8084-5fffaaa0eb30" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity_c1d35cba-1671-4246-b042-1429cff481c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b27cbeb4-cd2e-419e-97b6-af4f9a20a308" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAbstract_e35c230a-9211-4082-8084-5fffaaa0eb30" xlink:to="loc_us-gaap_NetIncomeLoss_b27cbeb4-cd2e-419e-97b6-af4f9a20a308" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8a31cab5-a4cf-4d6c-afa7-97b28462fb59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a165daf-633f-48b9-b5a9-96ccd0d2b4d0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8a31cab5-a4cf-4d6c-afa7-97b28462fb59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_81f3cbb1-8424-4055-a9bf-677c1b1b90c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8a31cab5-a4cf-4d6c-afa7-97b28462fb59" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_81f3cbb1-8424-4055-a9bf-677c1b1b90c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ac6d52f3-872a-4012-a4ef-db98540cd7b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8a31cab5-a4cf-4d6c-afa7-97b28462fb59" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_ac6d52f3-872a-4012-a4ef-db98540cd7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_82c68023-4980-49e1-a69c-368fd82c692f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8a31cab5-a4cf-4d6c-afa7-97b28462fb59" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_82c68023-4980-49e1-a69c-368fd82c692f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_9808f2ef-9e84-4a2e-8523-c1d567fdb4ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a165daf-633f-48b9-b5a9-96ccd0d2b4d0" xlink:to="loc_us-gaap_EarningsPerShareBasic_9808f2ef-9e84-4a2e-8523-c1d567fdb4ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_b0e221aa-c20a-49b2-a900-315cd9af1f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a165daf-633f-48b9-b5a9-96ccd0d2b4d0" xlink:to="loc_us-gaap_EarningsPerShareDiluted_b0e221aa-c20a-49b2-a900-315cd9af1f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0de1a035-bab2-4fd0-8d92-01c6a45be637" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7a165daf-633f-48b9-b5a9-96ccd0d2b4d0" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_0de1a035-bab2-4fd0-8d92-01c6a45be637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#FAIRVALUEMEASUREMENTSDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b97473e1-5ce6-494a-9858-d82004995223" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b97473e1-5ce6-494a-9858-d82004995223" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59f0693d-c141-4733-93c0-5b77f36b05d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59f0693d-c141-4733-93c0-5b77f36b05d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776a9dc4-2b57-4538-8388-514a19503e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_59f0693d-c141-4733-93c0-5b77f36b05d2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776a9dc4-2b57-4538-8388-514a19503e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_50941013-1949-41df-a26a-54b749b00f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_776a9dc4-2b57-4538-8388-514a19503e9d" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_50941013-1949-41df-a26a-54b749b00f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0c5061b2-351f-4a71-8d9b-f4673b5ca29e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0c5061b2-351f-4a71-8d9b-f4673b5ca29e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_42fe4837-ceff-425b-9cd1-9e18d73ce889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0c5061b2-351f-4a71-8d9b-f4673b5ca29e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_42fe4837-ceff-425b-9cd1-9e18d73ce889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InsuranceSubsidiaryLongTermInvestmentsMember_775b378a-1ef6-47a4-b8ed-0b17c2cec2ca" xlink:href="ensg-20241231.xsd#ensg_InsuranceSubsidiaryLongTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_42fe4837-ceff-425b-9cd1-9e18d73ce889" xlink:to="loc_ensg_InsuranceSubsidiaryLongTermInvestmentsMember_775b378a-1ef6-47a4-b8ed-0b17c2cec2ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54105f19-0da5-4ea5-8d61-c316c14605d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_18f4f2e5-c520-44ec-9eaf-2812f76660ff" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54105f19-0da5-4ea5-8d61-c316c14605d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_294e2e51-cf26-4dcf-8e2f-36e7d095455f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54105f19-0da5-4ea5-8d61-c316c14605d8" xlink:to="loc_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss_294e2e51-cf26-4dcf-8e2f-36e7d095455f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a824a882-d15e-4c62-aebf-d64a7844cb4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_54105f19-0da5-4ea5-8d61-c316c14605d8" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_a824a882-d15e-4c62-aebf-d64a7844cb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/STANDARDBEARERDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#STANDARDBEARERDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/STANDARDBEARERDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_26adbe58-a96b-46bd-9714-2d67f4fbf0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_26adbe58-a96b-46bd-9714-2d67f4fbf0d0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_ad056d5e-9bd3-41a9-9320-070dd5861a8b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_dei_LegalEntityAxis_ad056d5e-9bd3-41a9-9320-070dd5861a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_44b0534e-fd73-4749-b043-dcaf6de9bb08" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_ad056d5e-9bd3-41a9-9320-070dd5861a8b" xlink:to="loc_dei_EntityDomain_44b0534e-fd73-4749-b043-dcaf6de9bb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember_d90a4aef-cd8a-4146-a7f6-805947e8f419" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_44b0534e-fd73-4749-b043-dcaf6de9bb08" xlink:to="loc_ensg_StandardBearerHealthcareREITIncMember_d90a4aef-cd8a-4146-a7f6-805947e8f419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis_e47211af-6b0e-4202-88d0-5c962e938352" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_ensg_OperatingEntityAxis_e47211af-6b0e-4202-88d0-5c962e938352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityAxis_e47211af-6b0e-4202-88d0-5c962e938352" xlink:to="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_03acc449-3796-4354-a402-2a14de1d1b72" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:to="loc_srt_SubsidiariesMember_03acc449-3796-4354-a402-2a14de1d1b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThirdPartyOperatorsMember_d505e065-7145-44c6-b10e-cd16c7012932" xlink:href="ensg-20241231.xsd#ensg_ThirdPartyOperatorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:to="loc_ensg_ThirdPartyOperatorsMember_d505e065-7145-44c6-b10e-cd16c7012932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PreviousSubsidiariesMember_e64a3ac2-2da6-4f21-a381-f5f227e65b4b" xlink:href="ensg-20241231.xsd#ensg_PreviousSubsidiariesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityDomain_5c60d79f-6eaa-49a4-a262-cf5020605867" xlink:to="loc_ensg_PreviousSubsidiariesMember_e64a3ac2-2da6-4f21-a381-f5f227e65b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_25b61b47-69b7-4e17-8695-62148cd6f522" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_25b61b47-69b7-4e17-8695-62148cd6f522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_25b61b47-69b7-4e17-8695-62148cd6f522" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_0a398726-17ed-4b72-b23f-1bc7dfaa0a9a" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:to="loc_ensg_SeniorLivingOperationsMember_0a398726-17ed-4b72-b23f-1bc7dfaa0a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_d42999cd-9759-430c-b60b-9c1b51a935be" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:to="loc_ensg_SkilledNursingOperationsMember_d42999cd-9759-430c-b60b-9c1b51a935be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_c8c07244-5807-4b0a-aa09-dcc92a065a65" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_ad798aef-f6f8-49bb-a3a9-1aaafe71144e" xlink:to="loc_ensg_CampusOperationsMember_c8c07244-5807-4b0a-aa09-dcc92a065a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_AssetAcquisitionAxis_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_1dfb7ad1-cd96-4a75-8784-b0ac81cf8d69" xlink:to="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember_060c59ac-8099-4b64-a2cd-a061ab43faf2" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:to="loc_ensg_A2024AcquiredPropertiesMember_060c59ac-8099-4b64-a2cd-a061ab43faf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2025AcquiredPropertiesMember_0e93ac6a-7e5d-447f-b804-3f86c79c9bd6" xlink:href="ensg-20241231.xsd#ensg_A2025AcquiredPropertiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:to="loc_ensg_A2025AcquiredPropertiesMember_0e93ac6a-7e5d-447f-b804-3f86c79c9bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2023AcquiredPropertiesMember_cf5658d8-ebd7-4cf1-a7ef-51ade0b56d9c" xlink:href="ensg-20241231.xsd#ensg_A2023AcquiredPropertiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:to="loc_ensg_A2023AcquiredPropertiesMember_cf5658d8-ebd7-4cf1-a7ef-51ade0b56d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2022AcquiredPropertiesMember_a4a92a3c-06cf-44c7-bd9b-ec8a604ab985" xlink:href="ensg-20241231.xsd#ensg_A2022AcquiredPropertiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_34b70f10-b71d-494e-ae56-3e9f3b4762fc" xlink:to="loc_ensg_A2022AcquiredPropertiesMember_a4a92a3c-06cf-44c7-bd9b-ec8a604ab985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4224fcb4-835f-43b2-8a08-5c0452c2e93d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_9d65e5ff-afc1-48e0-8d79-c6ac78b3fe08" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4224fcb4-835f-43b2-8a08-5c0452c2e93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9b456a0f-c474-4c91-94c9-48f737f47ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4224fcb4-835f-43b2-8a08-5c0452c2e93d" xlink:to="loc_us-gaap_SubsequentEventMember_9b456a0f-c474-4c91-94c9-48f737f47ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_500a2e7b-0202-478a-9d0c-4f6804192113" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_srt_CounterpartyNameAxis_500a2e7b-0202-478a-9d0c-4f6804192113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a2580393-9a0c-4090-846f-4a0fffe16442" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_500a2e7b-0202-478a-9d0c-4f6804192113" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a2580393-9a0c-4090-846f-4a0fffe16442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CareTrustREITMember_0ab6a2bc-9503-413f-b4b6-cd75bb630b1a" xlink:href="ensg-20241231.xsd#ensg_CareTrustREITMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a2580393-9a0c-4090-846f-4a0fffe16442" xlink:to="loc_ensg_CareTrustREITMember_0ab6a2bc-9503-413f-b4b6-cd75bb630b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis_036c08cc-acba-4dbc-86f2-69fe7b151a4e" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_ensg_LeaseArrangementAxis_036c08cc-acba-4dbc-86f2-69fe7b151a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_432fb4d1-66db-4a85-9d9a-cc2e885d0d48" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementAxis_036c08cc-acba-4dbc-86f2-69fe7b151a4e" xlink:to="loc_ensg_LeaseArrangementDomain_432fb4d1-66db-4a85-9d9a-cc2e885d0d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerMasterLeasesMember_9ba46374-477f-4564-a8fe-b11a60c1e42d" xlink:href="ensg-20241231.xsd#ensg_StandardBearerMasterLeasesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementDomain_432fb4d1-66db-4a85-9d9a-cc2e885d0d48" xlink:to="loc_ensg_StandardBearerMasterLeasesMember_9ba46374-477f-4564-a8fe-b11a60c1e42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_96547f87-bd6c-4584-95df-753a9052c80e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_srt_RangeAxis_96547f87-bd6c-4584-95df-753a9052c80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_455772a6-be22-4028-84fa-3efd46a0303e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_96547f87-bd6c-4584-95df-753a9052c80e" xlink:to="loc_srt_RangeMember_455772a6-be22-4028-84fa-3efd46a0303e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ab91eeaa-19c4-40b0-b6d1-ce7e6b1d481a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_455772a6-be22-4028-84fa-3efd46a0303e" xlink:to="loc_srt_MinimumMember_ab91eeaa-19c4-40b0-b6d1-ce7e6b1d481a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_85aea215-6e49-48a7-8d06-69734ba5a12d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_455772a6-be22-4028-84fa-3efd46a0303e" xlink:to="loc_srt_MaximumMember_85aea215-6e49-48a7-8d06-69734ba5a12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_7fa7b5f0-6909-427f-b5f8-74fd350f395a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_srt_ProductOrServiceAxis_7fa7b5f0-6909-427f-b5f8-74fd350f395a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_7fa7b5f0-6909-427f-b5f8-74fd350f395a" xlink:to="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceBaseMember_76c7bb27-6048-4632-9dea-462ddf3e8a93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceBaseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:to="loc_us-gaap_ManagementServiceBaseMember_76c7bb27-6048-4632-9dea-462ddf3e8a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementServiceIncentiveMember_c2a22664-eb82-4139-899c-36de29eabbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementServiceIncentiveMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:to="loc_us-gaap_ManagementServiceIncentiveMember_c2a22664-eb82-4139-899c-36de29eabbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagementServiceTotalMember_a405d97d-f639-424d-8692-73aa3b64daa8" xlink:href="ensg-20241231.xsd#ensg_ManagementServiceTotalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cbff66ff-fd47-484f-940b-d3fdf350ae41" xlink:to="loc_ensg_ManagementServiceTotalMember_a405d97d-f639-424d-8692-73aa3b64daa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_2004aefc-33a7-4a3d-a7e6-d49074904aee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_CreditFacilityAxis_2004aefc-33a7-4a3d-a7e6-d49074904aee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_71be29c0-8262-499d-9db4-5afb500a036d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_2004aefc-33a7-4a3d-a7e6-d49074904aee" xlink:to="loc_us-gaap_CreditFacilityDomain_71be29c0-8262-499d-9db4-5afb500a036d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_d650e79c-0c02-4d0a-bf70-d948fea8de3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_71be29c0-8262-499d-9db4-5afb500a036d" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_d650e79c-0c02-4d0a-bf70-d948fea8de3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e94b5aec-f54e-4ac5-a019-cae695df248e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e94b5aec-f54e-4ac5-a019-cae695df248e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_71dc853c-6042-4129-86fb-bdb61d80f90a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e94b5aec-f54e-4ac5-a019-cae695df248e" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_71dc853c-6042-4129-86fb-bdb61d80f90a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TruistBankMember_daff692c-a7de-4586-9f42-7e1e25d882b1" xlink:href="ensg-20241231.xsd#ensg_TruistBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_71dc853c-6042-4129-86fb-bdb61d80f90a" xlink:to="loc_ensg_TruistBankMember_daff692c-a7de-4586-9f42-7e1e25d882b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_3c2cef19-407c-46ec-8b42-8bae436d9512" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_VariableRateAxis_3c2cef19-407c-46ec-8b42-8bae436d9512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2022e09b-642d-4ecc-8894-b4b8085c06fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_3c2cef19-407c-46ec-8b42-8bae436d9512" xlink:to="loc_us-gaap_VariableRateDomain_2022e09b-642d-4ecc-8894-b4b8085c06fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_61c07db2-6657-4bb1-b795-76ccc05ab79d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_2022e09b-642d-4ecc-8894-b4b8085c06fb" xlink:to="loc_us-gaap_BaseRateMember_61c07db2-6657-4bb1-b795-76ccc05ab79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_80a3b5eb-599f-4e5d-9962-77fabdea0ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_2022e09b-642d-4ecc-8894-b4b8085c06fb" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_80a3b5eb-599f-4e5d-9962-77fabdea0ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_ac1465f8-197e-4cfa-bcec-600afee87030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_PlanNameAxis_ac1465f8-197e-4cfa-bcec-600afee87030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1f6259d6-3366-451b-b716-aede3801e995" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_ac1465f8-197e-4cfa-bcec-600afee87030" xlink:to="loc_us-gaap_PlanNameDomain_1f6259d6-3366-451b-b716-aede3801e995" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerEquityPlanMember_cce7ee60-f482-4531-9322-61cd899985f5" xlink:href="ensg-20241231.xsd#ensg_StandardBearerEquityPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_1f6259d6-3366-451b-b716-aede3801e995" xlink:to="loc_ensg_StandardBearerEquityPlanMember_cce7ee60-f482-4531-9322-61cd899985f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_af11a125-c5bf-4cdd-98a7-9c950256ff5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_AwardTypeAxis_af11a125-c5bf-4cdd-98a7-9c950256ff5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_966779ee-5ac8-441a-867d-20356d9f55e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_af11a125-c5bf-4cdd-98a7-9c950256ff5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_966779ee-5ac8-441a-867d-20356d9f55e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e78fd9d0-936d-46bf-b81b-efdfb0c3f821" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_966779ee-5ac8-441a-867d-20356d9f55e6" xlink:to="loc_us-gaap_RestrictedStockMember_e78fd9d0-936d-46bf-b81b-efdfb0c3f821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4ead3c3c-f79d-4e1f-8ca3-e4c7896f4744" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_fc389241-2c35-4505-bb76-daaeb666a1fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_fc389241-2c35-4505-bb76-daaeb666a1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfRealEstatePropertiesSharingLocations_0aa5b2b9-73dd-42ff-a9ce-c83d07939c56" xlink:href="ensg-20241231.xsd#ensg_NumberOfRealEstatePropertiesSharingLocations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_NumberOfRealEstatePropertiesSharingLocations_0aa5b2b9-73dd-42ff-a9ce-c83d07939c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_7ebf935c-887a-4efd-a389-256332a496c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_7ebf935c-887a-4efd-a389-256332a496c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfOperatingSubsidiaries_7ce0955d-256c-4efb-a449-1a84b14edb2f" xlink:href="ensg-20241231.xsd#ensg_NumberOfOperatingSubsidiaries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_NumberOfOperatingSubsidiaries_7ce0955d-256c-4efb-a449-1a84b14edb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfLeaseArrangements_ce575f37-0238-460d-a260-c7b135fb3621" xlink:href="ensg-20241231.xsd#ensg_NumberOfLeaseArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_NumberOfLeaseArrangements_ce575f37-0238-460d-a260-c7b135fb3621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_39e7b988-ba5e-472b-bfbd-d06f238c6b86" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_39e7b988-ba5e-472b-bfbd-d06f238c6b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_450f4b1d-76a7-46d0-ac9c-ed22d8221a89" xlink:href="ensg-20241231.xsd#ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_450f4b1d-76a7-46d0-ac9c-ed22d8221a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_2ee59ea8-9b9a-4caa-9eff-b9af30d1df2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_2ee59ea8-9b9a-4caa-9eff-b9af30d1df2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_c8ba5aab-142f-4e34-8f13-55256232565c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_c8ba5aab-142f-4e34-8f13-55256232565c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_ddc14fbf-9052-4cad-ae35-7e80a4f2fcaf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_ddc14fbf-9052-4cad-ae35-7e80a4f2fcaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PropertyManagementFeePercentFeeOfTotalRevenues_6cbadd97-8570-49e0-98dc-04c54fbdfffe" xlink:href="ensg-20241231.xsd#ensg_PropertyManagementFeePercentFeeOfTotalRevenues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_PropertyManagementFeePercentFeeOfTotalRevenues_6cbadd97-8570-49e0-98dc-04c54fbdfffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations_df38d4b8-0d9c-4dd4-b9e5-1651e02c5e3a" xlink:href="ensg-20241231.xsd#ensg_PropertyManagementFeePercentFeeOfFundsFromOperations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations_df38d4b8-0d9c-4dd4-b9e5-1651e02c5e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManagementFeeExpense_22755aa7-3609-4168-b496-f29a447f5127" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManagementFeeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ManagementFeeExpense_22755aa7-3609-4168-b496-f29a447f5127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c32cfdb8-d7a0-4fa9-962a-2cccdb53a64c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_c32cfdb8-d7a0-4fa9-962a-2cccdb53a64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f862a469-39c9-479f-863d-7a3469afd712" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f862a469-39c9-479f-863d-7a3469afd712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4f2fdc31-1ffc-4949-bd90-4ea8584c5034" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_4f2fdc31-1ffc-4949-bd90-4ea8584c5034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_580fbed0-3344-4fb0-9d54-ad23b55743de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_580fbed0-3344-4fb0-9d54-ad23b55743de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_27ec8b04-041d-4eb1-8189-5352177feb41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_27ec8b04-041d-4eb1-8189-5352177feb41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8c93710e-a59f-4a9b-b7e7-46166295584b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8c93710e-a59f-4a9b-b7e7-46166295584b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_7bfe1530-c578-403d-ba86-dbd5e61daebe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_7bfe1530-c578-403d-ba86-dbd5e61daebe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_ac251f93-f3de-4eb3-bd60-348372ccd31f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_61945719-e004-44e1-b638-e76afc7272e9" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_ac251f93-f3de-4eb3-bd60-348372ccd31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPERATIONEXPANSIONSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9678d16f-9f1a-448a-bd00-850ff867f579" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_9678d16f-9f1a-448a-bd00-850ff867f579" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_cce41af2-887e-46c8-adfc-005a28a06866" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_us-gaap_AssetAcquisitionAxis_cce41af2-887e-46c8-adfc-005a28a06866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_cce41af2-887e-46c8-adfc-005a28a06866" xlink:to="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember_ebfa93e2-ed1e-4134-8b19-5332785ed822" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:to="loc_ensg_A2024AcquiredPropertiesMember_ebfa93e2-ed1e-4134-8b19-5332785ed822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2025AcquiredPropertiesMember_2917c7dc-66e8-4a5c-8376-ffeab544752f" xlink:href="ensg-20241231.xsd#ensg_A2025AcquiredPropertiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:to="loc_ensg_A2025AcquiredPropertiesMember_2917c7dc-66e8-4a5c-8376-ffeab544752f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2023AcquiredPropertiesMember_3af559f1-044e-4a30-bfc9-3c88cc77a2a4" xlink:href="ensg-20241231.xsd#ensg_A2023AcquiredPropertiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:to="loc_ensg_A2023AcquiredPropertiesMember_3af559f1-044e-4a30-bfc9-3c88cc77a2a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2022AcquiredPropertiesMember_c670821b-2a23-4960-8866-7f02e56e6e75" xlink:href="ensg-20241231.xsd#ensg_A2022AcquiredPropertiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_66870533-7af0-436d-aef2-79f739f72f84" xlink:to="loc_ensg_A2022AcquiredPropertiesMember_c670821b-2a23-4960-8866-7f02e56e6e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsAxis_c71b03da-1f1f-423f-9ee2-ebcee80a3fab" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsAxis_c71b03da-1f1f-423f-9ee2-ebcee80a3fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_7fe19a64-afb9-4d5c-a457-99e7d900a53d" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_c71b03da-1f1f-423f-9ee2-ebcee80a3fab" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_7fe19a64-afb9-4d5c-a457-99e7d900a53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_5f9abbf0-7c17-4777-9f8a-e933c95b81db" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_7fe19a64-afb9-4d5c-a457-99e7d900a53d" xlink:to="loc_ensg_SkilledNursingOperationsMember_5f9abbf0-7c17-4777-9f8a-e933c95b81db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_a3a91bb6-ba78-40ec-8010-ffec013b7428" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_7fe19a64-afb9-4d5c-a457-99e7d900a53d" xlink:to="loc_ensg_CampusOperationsMember_a3a91bb6-ba78-40ec-8010-ffec013b7428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_1b681c0d-a64f-424f-9e0b-9df67d1d0cf2" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_ebc8af85-c1bc-439b-9a79-54f614b26230" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:to="loc_ensg_SkilledNursingOperationsMember_ebc8af85-c1bc-439b-9a79-54f614b26230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_beb2a13f-1b84-45ba-8ad3-788d8f399185" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:to="loc_ensg_CampusOperationsMember_beb2a13f-1b84-45ba-8ad3-788d8f399185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_bb42c9b8-0ef5-41c8-8920-e5cf1ad495ff" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e127baa-b8f7-41f5-b137-91a5e6e36543" xlink:to="loc_ensg_SeniorLivingOperationsMember_bb42c9b8-0ef5-41c8-8920-e5cf1ad495ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_8ee8c078-b0f4-4228-b02a-b302cedf0c03" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_dei_LegalEntityAxis_8ee8c078-b0f4-4228-b02a-b302cedf0c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c65fd1f7-6ab3-4e6b-ab0b-a318d6add4ea" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_8ee8c078-b0f4-4228-b02a-b302cedf0c03" xlink:to="loc_dei_EntityDomain_c65fd1f7-6ab3-4e6b-ab0b-a318d6add4ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember_ac1b3e48-92da-418b-b946-2825c9ac7968" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c65fd1f7-6ab3-4e6b-ab0b-a318d6add4ea" xlink:to="loc_ensg_StandardBearerHealthcareREITIncMember_ac1b3e48-92da-418b-b946-2825c9ac7968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis_ce00fc42-ebd8-4cc3-aa11-9672b299a682" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_ensg_OperatingEntityAxis_ce00fc42-ebd8-4cc3-aa11-9672b299a682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_587e6622-c19a-4774-a8b0-4e70083bf7b6" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityAxis_ce00fc42-ebd8-4cc3-aa11-9672b299a682" xlink:to="loc_ensg_OperatingEntityDomain_587e6622-c19a-4774-a8b0-4e70083bf7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_e5d7bfa0-a38e-4f60-98ea-15e8d4213920" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityDomain_587e6622-c19a-4774-a8b0-4e70083bf7b6" xlink:to="loc_srt_SubsidiariesMember_e5d7bfa0-a38e-4f60-98ea-15e8d4213920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_031308b2-771a-4ab4-a94d-7afa46787c04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_031308b2-771a-4ab4-a94d-7afa46787c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_be768f98-775f-4545-bd6e-3d8fb81c6274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_031308b2-771a-4ab4-a94d-7afa46787c04" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_be768f98-775f-4545-bd6e-3d8fb81c6274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_9e190040-ae4b-454a-9d17-ff3c958c5338" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_be768f98-775f-4545-bd6e-3d8fb81c6274" xlink:to="loc_us-gaap_SubsequentEventMember_9e190040-ae4b-454a-9d17-ff3c958c5338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c31c6f6b-3cb6-420f-8ca4-766fc924a521" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_5f6409c9-5f04-48b5-906b-bcce4c5674ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_5f6409c9-5f04-48b5-906b-bcce4c5674ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSkilledNursingBeds_0dc7ee85-6187-4c94-a10d-98d53917b131" xlink:href="ensg-20241231.xsd#ensg_NumberOfSkilledNursingBeds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_ensg_NumberOfSkilledNursingBeds_0dc7ee85-6187-4c94-a10d-98d53917b131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfLongTermAcuteCareBeds_845ce62e-dd96-4d76-8981-08f8e2d86ff9" xlink:href="ensg-20241231.xsd#ensg_NumberOfLongTermAcuteCareBeds"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_ensg_NumberOfLongTermAcuteCareBeds_845ce62e-dd96-4d76-8981-08f8e2d86ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfSeniorLivingUnits_3480db64-1e6c-42c3-a589-24786640fc89" xlink:href="ensg-20241231.xsd#ensg_NumberOfSeniorLivingUnits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_ce42ac00-2ad1-4267-b4bd-18887dbf54c4" xlink:to="loc_ensg_NumberOfSeniorLivingUnits_3480db64-1e6c-42c3-a589-24786640fc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPERATIONEXPANSIONSPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a1c40cfc-4ac0-4093-9790-c6138a882732" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_a1c40cfc-4ac0-4093-9790-c6138a882732" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessAndAssetAcquisitionsAxis_e3a67622-8343-4cec-bd7f-8bcf538f9ee5" xlink:href="ensg-20241231.xsd#ensg_BusinessAndAssetAcquisitionsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:to="loc_ensg_BusinessAndAssetAcquisitionsAxis_e3a67622-8343-4cec-bd7f-8bcf538f9ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessAndAssetAcquisitionsDomain_dd1d1a7e-94d6-4c46-a732-fc72f4d65420" xlink:href="ensg-20241231.xsd#ensg_BusinessAndAssetAcquisitionsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_BusinessAndAssetAcquisitionsAxis_e3a67622-8343-4cec-bd7f-8bcf538f9ee5" xlink:to="loc_ensg_BusinessAndAssetAcquisitionsDomain_dd1d1a7e-94d6-4c46-a732-fc72f4d65420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AcquiredPropertiesMember_8235eba7-171c-480a-a187-1781dc8e27a6" xlink:href="ensg-20241231.xsd#ensg_AcquiredPropertiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_BusinessAndAssetAcquisitionsDomain_dd1d1a7e-94d6-4c46-a732-fc72f4d65420" xlink:to="loc_ensg_AcquiredPropertiesMember_8235eba7-171c-480a-a187-1781dc8e27a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10d77c51-fa8f-4082-b109-1d3beab57606" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10d77c51-fa8f-4082-b109-1d3beab57606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10d77c51-fa8f-4082-b109-1d3beab57606" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_0a695db8-0a08-4b23-adce-808766568561" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:to="loc_us-gaap_LandMember_0a695db8-0a08-4b23-adce-808766568561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7a61bcc6-4601-4f42-a7ab-aabd88f95baf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7a61bcc6-4601-4f42-a7ab-aabd88f95baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_b6fd366e-d991-4860-8f46-d9058db4f55b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_b6fd366e-d991-4860-8f46-d9058db4f55b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AssembledOccupancyAcquiredMember_c45e7ed3-ff37-4ed0-a625-9c7f27405ea7" xlink:href="ensg-20241231.xsd#ensg_AssembledOccupancyAcquiredMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_017c47a3-1c20-4cae-ac8c-4662100b34af" xlink:to="loc_ensg_AssembledOccupancyAcquiredMember_c45e7ed3-ff37-4ed0-a625-9c7f27405ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_7c1c339e-87a0-499d-a767-0b0803d5e770" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_b2efc07e-a8bd-4f7f-80b6-e995838a65df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_b2efc07e-a8bd-4f7f-80b6-e995838a65df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_716286cf-de83-4ef8-be67-2c096b9c2e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_716286cf-de83-4ef8-be67-2c096b9c2e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasedAssetsAcquiredDuringPeriod_4a15bb37-97d9-4499-b86e-1c17f06eb57b" xlink:href="ensg-20241231.xsd#ensg_LeasedAssetsAcquiredDuringPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_ensg_LeasedAssetsAcquiredDuringPeriod_4a15bb37-97d9-4499-b86e-1c17f06eb57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_b14213c9-f408-4847-b737-72a98592b425" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_b14213c9-f408-4847-b737-72a98592b425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_e5a47990-82f7-490f-be72-6f344072b5cb" xlink:href="ensg-20241231.xsd#ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_63e74d16-6d5e-4a8d-b937-40c3e65f858c" xlink:to="loc_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet_e5a47990-82f7-490f-be72-6f344072b5cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8452c08e-ea8e-4e01-a686-af8b6e2e6780" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8452c08e-ea8e-4e01-a686-af8b6e2e6780" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_51370481-abaa-48b0-b564-c14741b9f8be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_51370481-abaa-48b0-b564-c14741b9f8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_51370481-abaa-48b0-b564-c14741b9f8be" xlink:to="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember_b85b8b5a-3e97-4d32-a3d5-7c313ee9298a" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:to="loc_ensg_SkilledServicesSegmentMember_b85b8b5a-3e97-4d32-a3d5-7c313ee9298a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerSegmentMember_2d9f72f0-bc15-481d-a5c4-ea07d945bcbf" xlink:href="ensg-20241231.xsd#ensg_StandardBearerSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:to="loc_ensg_StandardBearerSegmentMember_2d9f72f0-bc15-481d-a5c4-ea07d945bcbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_b05fd949-cf6a-48ad-8bd7-d2bcc448dc97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_21c28770-a4e5-4000-9e80-0dc967fdf2f8" xlink:to="loc_us-gaap_AllOtherSegmentsMember_b05fd949-cf6a-48ad-8bd7-d2bcc448dc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsAxis_857e651a-d636-4a9d-8d10-f559482c1953" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsAxis_857e651a-d636-4a9d-8d10-f559482c1953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:href="ensg-20241231.xsd#ensg_RealEstateAndLeaseArrangementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsAxis_857e651a-d636-4a9d-8d10-f559482c1953" xlink:to="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_55cf3818-4879-47a5-a11e-f1bfc3dda290" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:to="loc_ensg_SkilledNursingOperationsMember_55cf3818-4879-47a5-a11e-f1bfc3dda290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_5a936b18-4368-4e9f-ada7-78b4a894f456" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:to="loc_ensg_CampusOperationsMember_5a936b18-4368-4e9f-ada7-78b4a894f456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_7028f613-6306-425c-9e7b-8e4cb8f4bfbd" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_RealEstateAndLeaseArrangementsDomain_d75bc968-1820-499c-a437-d74562d8d563" xlink:to="loc_ensg_SeniorLivingOperationsMember_7028f613-6306-425c-9e7b-8e4cb8f4bfbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d3864b84-8eea-46ae-808f-107fbe9cd3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_ea5540d3-cedd-4361-a2f6-2b649a1ad203" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d3864b84-8eea-46ae-808f-107fbe9cd3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b27f9a72-30bd-4db3-9682-eadf21fcf73c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d3864b84-8eea-46ae-808f-107fbe9cd3f2" xlink:to="loc_us-gaap_NumberOfReportableSegments_b27f9a72-30bd-4db3-9682-eadf21fcf73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_c218ea97-c83e-4deb-a86d-35fd9b56ec69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d3864b84-8eea-46ae-808f-107fbe9cd3f2" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_c218ea97-c83e-4deb-a86d-35fd9b56ec69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a696eed2-8d4c-445f-9a3c-3933beb9b549" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a696eed2-8d4c-445f-9a3c-3933beb9b549" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:to="loc_srt_ConsolidationItemsAxis_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c2e6ec71-e728-4ce2-a097-e8cee6a2f1cf" xlink:to="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_d0577174-42f9-4bc8-b254-9f807996d52e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:to="loc_us-gaap_OperatingSegmentsMember_d0577174-42f9-4bc8-b254-9f807996d52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember_6666de78-f0a7-4f06-8b6d-09c33ed0cbad" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:to="loc_srt_ConsolidationEliminationsMember_6666de78-f0a7-4f06-8b6d-09c33ed0cbad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_99d81389-4ac1-4ac3-8583-c58f1bec3b83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b072c5c0-2377-4b3c-9ef3-cb69997343f5" xlink:to="loc_us-gaap_CorporateNonSegmentMember_99d81389-4ac1-4ac3-8583-c58f1bec3b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2df7a3d7-c941-41e6-8f35-1356d025ba41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2df7a3d7-c941-41e6-8f35-1356d025ba41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9e8d5243-5c29-4393-a20b-edeeb712b250" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2df7a3d7-c941-41e6-8f35-1356d025ba41" xlink:to="loc_us-gaap_SegmentDomain_9e8d5243-5c29-4393-a20b-edeeb712b250" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember_8787b064-dc13-48bb-af8f-297b9001aacb" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9e8d5243-5c29-4393-a20b-edeeb712b250" xlink:to="loc_ensg_SkilledServicesSegmentMember_8787b064-dc13-48bb-af8f-297b9001aacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerSegmentMember_9c8e1390-2737-46bb-9b20-2a53bb069c77" xlink:href="ensg-20241231.xsd#ensg_StandardBearerSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9e8d5243-5c29-4393-a20b-edeeb712b250" xlink:to="loc_ensg_StandardBearerSegmentMember_9c8e1390-2737-46bb-9b20-2a53bb069c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_dd7621e0-736c-4759-9be7-b33deaf27601" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:to="loc_srt_ProductOrServiceAxis_dd7621e0-736c-4759-9be7-b33deaf27601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_417dc442-0ed8-4bbb-ab22-1ca1acc84514" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_dd7621e0-736c-4759-9be7-b33deaf27601" xlink:to="loc_srt_ProductsAndServicesDomain_417dc442-0ed8-4bbb-ab22-1ca1acc84514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_0a5ed7b7-816c-48f8-90dc-14284ef03967" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_417dc442-0ed8-4bbb-ab22-1ca1acc84514" xlink:to="loc_us-gaap_ServiceMember_0a5ed7b7-816c-48f8-90dc-14284ef03967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember_8523770e-b771-4409-bae5-48bf5ae2d42b" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_417dc442-0ed8-4bbb-ab22-1ca1acc84514" xlink:to="loc_ensg_RentalMember_8523770e-b771-4409-bae5-48bf5ae2d42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_aacdd451-1982-462e-b56e-fece3c40a67c" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac708f05-eab8-44f2-8f50-5c4b5ed40164" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ac708f05-eab8-44f2-8f50-5c4b5ed40164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_cf85eebe-23df-4208-8019-7991ea3081e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_cf85eebe-23df-4208-8019-7991ea3081e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2b4d6940-d19d-45e5-b82a-378165b7e1bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2b4d6940-d19d-45e5-b82a-378165b7e1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_ea003623-de14-4ba6-8029-8694f93444e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_InterestExpenseNonoperating_ea003623-de14-4ba6-8029-8694f93444e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SegmentIncomeLoss_9142e690-2a6e-4fec-bb71-7e7545f511ab" xlink:href="ensg-20241231.xsd#ensg_SegmentIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_ensg_SegmentIncomeLoss_9142e690-2a6e-4fec-bb71-7e7545f511ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8c28056c-5d22-47cd-9cd3-ade4a21f0917" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_1106023a-0fd8-46df-b703-d6f959fbd371" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_8c28056c-5d22-47cd-9cd3-ade4a21f0917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_04a10abb-c2b1-4a31-930a-3755eedb354e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_04a10abb-c2b1-4a31-930a-3755eedb354e" xlink:to="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_691171dc-73f6-46ad-b4a1-c07f532696cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_srt_ProductOrServiceAxis_691171dc-73f6-46ad-b4a1-c07f532696cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_144f9833-cf05-47eb-a86f-a0bb954291e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_691171dc-73f6-46ad-b4a1-c07f532696cd" xlink:to="loc_srt_ProductsAndServicesDomain_144f9833-cf05-47eb-a86f-a0bb954291e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_bc3ddf41-cbe0-400c-b3a9-534b58ade1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_144f9833-cf05-47eb-a86f-a0bb954291e9" xlink:to="loc_us-gaap_ServiceMember_bc3ddf41-cbe0-400c-b3a9-534b58ade1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_359cbd37-4f83-40af-be5c-a6e289966bea" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_srt_ConsolidationItemsAxis_359cbd37-4f83-40af-be5c-a6e289966bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_d12ebdcb-0f64-4761-ad4c-9ff268d4951d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_359cbd37-4f83-40af-be5c-a6e289966bea" xlink:to="loc_srt_ConsolidationItemsDomain_d12ebdcb-0f64-4761-ad4c-9ff268d4951d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_48d63760-209b-4c3a-b7df-086f47f9c569" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d12ebdcb-0f64-4761-ad4c-9ff268d4951d" xlink:to="loc_us-gaap_OperatingSegmentsMember_48d63760-209b-4c3a-b7df-086f47f9c569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_EliminationsAndReconcilingItemsMember_6df807c9-5b76-41f0-be3d-6de1e6975d4f" xlink:href="ensg-20241231.xsd#ensg_EliminationsAndReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_d12ebdcb-0f64-4761-ad4c-9ff268d4951d" xlink:to="loc_ensg_EliminationsAndReconcilingItemsMember_6df807c9-5b76-41f0-be3d-6de1e6975d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_f3f3f50d-b6a7-41a9-afb8-c4a974f5b6af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1a019a2a-4f7a-4557-83c0-16cc79ef2b2f" xlink:to="loc_us-gaap_SegmentDomain_f3f3f50d-b6a7-41a9-afb8-c4a974f5b6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember_94566abc-9cf1-4704-9acb-77826db50e56" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_f3f3f50d-b6a7-41a9-afb8-c4a974f5b6af" xlink:to="loc_ensg_SkilledServicesSegmentMember_94566abc-9cf1-4704-9acb-77826db50e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa6a274-da87-456b-8e44-3f053eb38ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa6a274-da87-456b-8e44-3f053eb38ce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2fd2ee07-99e0-4fa1-bf90-8c62893880fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_0aa6a274-da87-456b-8e44-3f053eb38ce8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2fd2ee07-99e0-4fa1-bf90-8c62893880fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_7a090855-7628-454e-aaa1-4d232416b139" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2fd2ee07-99e0-4fa1-bf90-8c62893880fc" xlink:to="loc_us-gaap_SalesRevenueNetMember_7a090855-7628-454e-aaa1-4d232416b139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_1f0097f6-db06-41b2-a902-9662c834a5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_1f0097f6-db06-41b2-a902-9662c834a5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_68bdf378-246e-43af-bf87-f57c329fd194" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_1f0097f6-db06-41b2-a902-9662c834a5c5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_68bdf378-246e-43af-bf87-f57c329fd194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_53832f92-5bb7-4364-bd26-77533210fd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_68bdf378-246e-43af-bf87-f57c329fd194" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_53832f92-5bb7-4364-bd26-77533210fd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_22b44fda-cf73-4a86-9a82-64988c9aa7a5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_srt_MajorCustomersAxis_22b44fda-cf73-4a86-9a82-64988c9aa7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_22b44fda-cf73-4a86-9a82-64988c9aa7a5" xlink:to="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:to="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidMember_5b041afc-5c6e-4f52-ba49-2b2544db494c" xlink:href="ensg-20241231.xsd#ensg_MedicaidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:to="loc_ensg_MedicaidMember_5b041afc-5c6e-4f52-ba49-2b2544db494c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareMember_7c46ef1a-262a-4a8a-a926-3bbff86204d4" xlink:href="ensg-20241231.xsd#ensg_MedicareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:to="loc_ensg_MedicareMember_7c46ef1a-262a-4a8a-a926-3bbff86204d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidSkilledMember_735e0733-df84-44bd-8330-e5307b1c14bf" xlink:href="ensg-20241231.xsd#ensg_MedicaidSkilledMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_MedicaidAndMedicareMember_91317d67-fc06-42b7-895d-b6a8a9ea362a" xlink:to="loc_ensg_MedicaidSkilledMember_735e0733-df84-44bd-8330-e5307b1c14bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ManagedCareMember_ed5d9c21-f9f6-4b1b-954a-051f8a341717" xlink:href="ensg-20241231.xsd#ensg_ManagedCareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:to="loc_ensg_ManagedCareMember_ed5d9c21-f9f6-4b1b-954a-051f8a341717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrivatePayAndOtherMember_a3e3111f-0a50-43a2-88a8-e6bcad3f1632" xlink:href="ensg-20241231.xsd#ensg_PrivatePayAndOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_1ca83d46-fcde-4813-97d9-4c41a93aacb9" xlink:to="loc_ensg_PrivatePayAndOtherMember_a3e3111f-0a50-43a2-88a8-e6bcad3f1632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_d3d1a4a5-ecc4-448e-8d7d-0046137cc4cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingRevenueReconcilingItemLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable_284dca53-bbda-43d1-b6a7-8df29dfabd08" xlink:to="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_d3d1a4a5-ecc4-448e-8d7d-0046137cc4cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c90a426-fd7f-4aeb-a1f6-7e2d3a913af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_d3d1a4a5-ecc4-448e-8d7d-0046137cc4cf" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5c90a426-fd7f-4aeb-a1f6-7e2d3a913af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_d1714424-5388-4949-9efd-d14eabb2cde1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingRevenueReconcilingItemLineItems_d3d1a4a5-ecc4-448e-8d7d-0046137cc4cf" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_d1714424-5388-4949-9efd-d14eabb2cde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a11cb314-2523-474c-b5da-b05f82e2683a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d4ec5137-9552-4778-ac12-f6dad7cfadb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a11cb314-2523-474c-b5da-b05f82e2683a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d4ec5137-9552-4778-ac12-f6dad7cfadb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e4be7e71-d1b4-401d-ad06-368e5a1f8033" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d4ec5137-9552-4778-ac12-f6dad7cfadb6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e4be7e71-d1b4-401d-ad06-368e5a1f8033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_e4be7e71-d1b4-401d-ad06-368e5a1f8033" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_8852380f-a9f3-4051-9d24-7c868683738a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_LandMember_8852380f-a9f3-4051-9d24-7c868683738a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingAndBuildingImprovementsMember_7ee60de4-5b3c-4e9f-b0fa-f1946bfa6d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingAndBuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_BuildingAndBuildingImprovementsMember_7ee60de4-5b3c-4e9f-b0fa-f1946bfa6d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_9260bfad-1c92-42a9-9f0e-1f6c8feca243" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_9260bfad-1c92-42a9-9f0e-1f6c8feca243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_59b84320-3f2c-4a07-8413-7e561a03bace" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_EquipmentMember_59b84320-3f2c-4a07-8413-7e561a03bace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_af2c40cd-d4a6-46dd-873f-2df3de032b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_af2c40cd-d4a6-46dd-873f-2df3de032b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_a9f6067b-b8f0-48f7-87fb-9989104fb7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_1861e24a-5b2d-4c96-922c-9c5d1929653f" xlink:to="loc_us-gaap_ConstructionInProgressMember_a9f6067b-b8f0-48f7-87fb-9989104fb7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_d4ec5137-9552-4778-ac12-f6dad7cfadb6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b1d6dcae-0b69-4044-96f3-ba7ab00da23d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b1d6dcae-0b69-4044-96f3-ba7ab00da23d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8da2fff8-0aec-44ef-af5a-7dd89e37bbcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_8da2fff8-0aec-44ef-af5a-7dd89e37bbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_816316fc-2868-458e-8ec5-6006eda30d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_452ae261-5ff3-4e08-9f55-8a268577b9e5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_816316fc-2868-458e-8ec5-6006eda30d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#PROPERTYANDEQUIPMENTNETNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a2936839-0fdf-44e5-99d9-6526ed86c82e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_745b3371-1629-4c3c-8d8d-2702377e1808" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a2936839-0fdf-44e5-99d9-6526ed86c82e" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment_745b3371-1629-4c3c-8d8d-2702377e1808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_edf5cfa4-361b-4160-a6c8-4067e88fdf2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a2936839-0fdf-44e5-99d9-6526ed86c82e" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_edf5cfa4-361b-4160-a6c8-4067e88fdf2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3d0952c3-1e9e-41d0-af4b-0a25e2522763" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a2936839-0fdf-44e5-99d9-6526ed86c82e" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3d0952c3-1e9e-41d0-af4b-0a25e2522763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_34c2b39b-35fa-4223-914f-95d457342cea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_3d0952c3-1e9e-41d0-af4b-0a25e2522763" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_34c2b39b-35fa-4223-914f-95d457342cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dcb9901d-f169-46a8-8f75-c9cefec79db5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6f6cb6b7-27d0-4c73-83d1-4c144213cb43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_dcb9901d-f169-46a8-8f75-c9cefec79db5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6f6cb6b7-27d0-4c73-83d1-4c144213cb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4918ec34-dc40-4c1a-803d-59a270de0c47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6f6cb6b7-27d0-4c73-83d1-4c144213cb43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4918ec34-dc40-4c1a-803d-59a270de0c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4918ec34-dc40-4c1a-803d-59a270de0c47" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AssembledOccupancyAcquiredMember_ab3f6ded-77e6-4ae0-91b5-44e36a49493c" xlink:href="ensg-20241231.xsd#ensg_AssembledOccupancyAcquiredMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:to="loc_ensg_AssembledOccupancyAcquiredMember_ab3f6ded-77e6-4ae0-91b5-44e36a49493c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_4cbae47d-7a42-40c5-9d28-d758b7578b72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:to="loc_us-gaap_TradeNamesMember_4cbae47d-7a42-40c5-9d28-d758b7578b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_01f23dc6-6422-4c5d-8c18-d5fe51fc0eb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_38a7b9b0-a174-46db-885b-a5af7be1a5e0" xlink:to="loc_us-gaap_CustomerRelationshipsMember_01f23dc6-6422-4c5d-8c18-d5fe51fc0eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6f6cb6b7-27d0-4c73-83d1-4c144213cb43" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_77e322bf-9fbe-4b5a-bf10-2a13831a2e17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_77e322bf-9fbe-4b5a-bf10-2a13831a2e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_253878c5-094f-4f9e-b6a8-8485b9bc1079" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_253878c5-094f-4f9e-b6a8-8485b9bc1079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_eee84309-4fe0-4209-a905-e98ba73729cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_eee84309-4fe0-4209-a905-e98ba73729cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_97c714a0-12ee-4f6f-997c-e5b7edf5d220" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_423198f0-3e13-4317-be1a-accd4afba76a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_97c714a0-12ee-4f6f-997c-e5b7edf5d220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_336f389a-bf3b-4930-b55d-241a60fdf4b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_336f389a-bf3b-4930-b55d-241a60fdf4b9" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_b887472b-2085-49cb-835a-84348bd4713b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_b887472b-2085-49cb-835a-84348bd4713b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7aaaafe0-f13f-4f53-ba68-97244dfb26a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_b887472b-2085-49cb-835a-84348bd4713b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7aaaafe0-f13f-4f53-ba68-97244dfb26a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DepreciationAndAmortizationMember_8576f54e-18dc-49d1-a792-2d0f8e0328dc" xlink:href="ensg-20241231.xsd#ensg_DepreciationAndAmortizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_7aaaafe0-f13f-4f53-ba68-97244dfb26a1" xlink:to="loc_ensg_DepreciationAndAmortizationMember_8576f54e-18dc-49d1-a792-2d0f8e0328dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3f570d98-8da2-4e45-aa9b-cebc4cd15741" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3f570d98-8da2-4e45-aa9b-cebc4cd15741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c688e363-f3c7-45f3-9a57-d7f88a08a187" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_3f570d98-8da2-4e45-aa9b-cebc4cd15741" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c688e363-f3c7-45f3-9a57-d7f88a08a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareAndMedicaidLicensesMember_3800621b-cc91-42dc-831b-424bda4318ba" xlink:href="ensg-20241231.xsd#ensg_MedicareAndMedicaidLicensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c688e363-f3c7-45f3-9a57-d7f88a08a187" xlink:to="loc_ensg_MedicareAndMedicaidLicensesMember_3800621b-cc91-42dc-831b-424bda4318ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_edfa861e-3c61-40b7-816f-b5e495257b67" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_87a0afae-5d01-4d41-be43-4b93949811eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_87a0afae-5d01-4d41-be43-4b93949811eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_eba92292-5b3a-4ab5-b519-e9e272038a00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_OperatingLeaseCost_eba92292-5b3a-4ab5-b519-e9e272038a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8620ca76-cc6c-4d6b-9ba7-bc5d7932366c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_8620ca76-cc6c-4d6b-9ba7-bc5d7932366c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_f6fb231f-b6b3-4ac1-98e7-050576a73620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefinitelivedIntangibleAssetsAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_1fd74882-8915-41d4-92df-85132dfa6a14" xlink:to="loc_us-gaap_IndefinitelivedIntangibleAssetsAcquired_f6fb231f-b6b3-4ac1-98e7-050576a73620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa811820-bd10-4f87-8baa-6ef5b34be618" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0dc4128e-d327-40c4-aafa-b31b01892534" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa811820-bd10-4f87-8baa-6ef5b34be618" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0dc4128e-d327-40c4-aafa-b31b01892534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_940615fa-e8e9-4dff-b558-3baa2081a99b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa811820-bd10-4f87-8baa-6ef5b34be618" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_940615fa-e8e9-4dff-b558-3baa2081a99b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b89c0fdb-827c-47d0-87b5-8354a4aac503" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa811820-bd10-4f87-8baa-6ef5b34be618" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_b89c0fdb-827c-47d0-87b5-8354a4aac503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ececa4f2-6395-482c-802a-a3acb411cb81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa811820-bd10-4f87-8baa-6ef5b34be618" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ececa4f2-6395-482c-802a-a3acb411cb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4b8afafe-5f6f-4a0e-ad4a-73c4642d9044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa811820-bd10-4f87-8baa-6ef5b34be618" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_4b8afafe-5f6f-4a0e-ad4a-73c4642d9044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b2ea192b-e3d9-4cc0-879a-412f3a4b92da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa811820-bd10-4f87-8baa-6ef5b34be618" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b2ea192b-e3d9-4cc0-879a-412f3a4b92da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5e3e23d-c417-4f7d-aa20-7e48bc6e8a89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fa811820-bd10-4f87-8baa-6ef5b34be618" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b5e3e23d-c417-4f7d-aa20-7e48bc6e8a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_114dd11e-1538-4441-af86-8c3665d95d45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_719079b8-4497-4b22-8d3f-9e9babb3c0b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_114dd11e-1538-4441-af86-8c3665d95d45" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_719079b8-4497-4b22-8d3f-9e9babb3c0b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d24448c9-5655-4978-aa8f-ca40489d36ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_719079b8-4497-4b22-8d3f-9e9babb3c0b5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d24448c9-5655-4978-aa8f-ca40489d36ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b865d7b-500f-4276-8cd1-407ccc11675b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_d24448c9-5655-4978-aa8f-ca40489d36ca" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b865d7b-500f-4276-8cd1-407ccc11675b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_68cf87f9-a626-4beb-b9d5-eb76607fc060" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b865d7b-500f-4276-8cd1-407ccc11675b" xlink:to="loc_us-gaap_TradeNamesMember_68cf87f9-a626-4beb-b9d5-eb76607fc060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicareAndMedicaidLicensesMember_fc4d688e-fd50-4e3d-95aa-1ae850b58758" xlink:href="ensg-20241231.xsd#ensg_MedicareAndMedicaidLicensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1b865d7b-500f-4276-8cd1-407ccc11675b" xlink:to="loc_ensg_MedicareAndMedicaidLicensesMember_fc4d688e-fd50-4e3d-95aa-1ae850b58758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_297f29e4-987d-4cdb-a8eb-bcb7901c0b1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_719079b8-4497-4b22-8d3f-9e9babb3c0b5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_297f29e4-987d-4cdb-a8eb-bcb7901c0b1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7e6e01d0-0730-4603-bb1a-7df31d39ddce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_297f29e4-987d-4cdb-a8eb-bcb7901c0b1f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7e6e01d0-0730-4603-bb1a-7df31d39ddce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#GOODWILLScheduleofGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_84efae3f-cfe8-4e3e-9527-1cc1620a15b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_84efae3f-cfe8-4e3e-9527-1cc1620a15b4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_7d330116-7c7b-4e84-8a16-78174ee30e9a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:to="loc_srt_ConsolidationItemsAxis_7d330116-7c7b-4e84-8a16-78174ee30e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_60f9b57f-2858-469a-8f7e-c8b9714f730c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_7d330116-7c7b-4e84-8a16-78174ee30e9a" xlink:to="loc_srt_ConsolidationItemsDomain_60f9b57f-2858-469a-8f7e-c8b9714f730c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_4d4b4817-63cc-4662-a44c-f2b2cbbb8f76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_60f9b57f-2858-469a-8f7e-c8b9714f730c" xlink:to="loc_us-gaap_OperatingSegmentsMember_4d4b4817-63cc-4662-a44c-f2b2cbbb8f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaterialReconcilingItemsMember_ff330848-52f0-43d4-b3fb-051aedc03c05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MaterialReconcilingItemsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_60f9b57f-2858-469a-8f7e-c8b9714f730c" xlink:to="loc_us-gaap_MaterialReconcilingItemsMember_ff330848-52f0-43d4-b3fb-051aedc03c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1bf4e971-3040-4537-9935-c7c8d10369ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1bf4e971-3040-4537-9935-c7c8d10369ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_83200256-cc56-43b0-9dcf-cc79aee39c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1bf4e971-3040-4537-9935-c7c8d10369ed" xlink:to="loc_us-gaap_SegmentDomain_83200256-cc56-43b0-9dcf-cc79aee39c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledServicesSegmentMember_db51d708-986a-428e-b03c-3def6f70ed0a" xlink:href="ensg-20241231.xsd#ensg_SkilledServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_83200256-cc56-43b0-9dcf-cc79aee39c5a" xlink:to="loc_ensg_SkilledServicesSegmentMember_db51d708-986a-428e-b03c-3def6f70ed0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_76a1ab14-3e76-458b-93dd-044a536f6fd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_751d8dd0-e1a3-45ed-baeb-774cd260712e" xlink:to="loc_us-gaap_GoodwillLineItems_76a1ab14-3e76-458b-93dd-044a536f6fd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_76a1ab14-3e76-458b-93dd-044a536f6fd8" xlink:to="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_98f39c1f-1bd5-4512-8414-d7b702131479" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:to="loc_us-gaap_Goodwill_98f39c1f-1bd5-4512-8414-d7b702131479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_c0fecb10-5142-49be-b63e-bfdda4086301" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_c0fecb10-5142-49be-b63e-bfdda4086301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cdbed418-d2dd-4b3a-8d63-942fb35a3e38" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_5e517a2b-efe2-411c-89b8-4335f0157434" xlink:to="loc_us-gaap_Goodwill_cdbed418-d2dd-4b3a-8d63-942fb35a3e38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/GOODWILLNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#GOODWILLNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/GOODWILLNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d9570d66-8451-442d-9e41-0db76d88e097" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d4ba728b-94fb-45aa-b776-63d4e0ab6e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d9570d66-8451-442d-9e41-0db76d88e097" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_d4ba728b-94fb-45aa-b776-63d4e0ab6e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_b36d867b-ee6b-48a7-a0b1-7162c61b19d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairedAccumulatedImpairmentLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_d9570d66-8451-442d-9e41-0db76d88e097" xlink:to="loc_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss_b36d867b-ee6b-48a7-a0b1-7162c61b19d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OTHERACCRUEDLIABILITIESDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_QualityAssuranceFee_9922dbe1-fd63-47fd-9d98-bd5455c168df" xlink:href="ensg-20241231.xsd#ensg_QualityAssuranceFee"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_ensg_QualityAssuranceFee_9922dbe1-fd63-47fd-9d98-bd5455c168df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ResidentRefundsPayable_3f3fcff1-f900-4548-9f72-083174a530f8" xlink:href="ensg-20241231.xsd#ensg_ResidentRefundsPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_ensg_ResidentRefundsPayable_3f3fcff1-f900-4548-9f72-083174a530f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3c7b5f78-b1ef-41c5-87dc-b27d83d82d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_3c7b5f78-b1ef-41c5-87dc-b27d83d82d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CashHeldInTrustForResidents_6783baec-1c72-4f67-bcea-091d7e1230a8" xlink:href="ensg-20241231.xsd#ensg_CashHeldInTrustForResidents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_ensg_CashHeldInTrustForResidents_6783baec-1c72-4f67-bcea-091d7e1230a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_075cd689-1098-4c90-b1b1-2285378ddcb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_075cd689-1098-4c90-b1b1-2285378ddcb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_518af331-17a9-4c52-aeca-e6979bedb9e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent_518af331-17a9-4c52-aeca-e6979bedb9e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserveCurrent_0a5cb924-1c9d-4bd0-91b1-e5898bc9a7fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationReserveCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_us-gaap_LitigationReserveCurrent_0a5cb924-1c9d-4bd0-91b1-e5898bc9a7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_cd3dbd62-d0b8-496e-9da9-ab487240c379" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_cd3dbd62-d0b8-496e-9da9-ab487240c379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cd67cca7-ddc2-4e5f-ada0-82e38be8f95b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d6f00d07-b119-472a-be9d-e78fe640ec4f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cd67cca7-ddc2-4e5f-ada0-82e38be8f95b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXESExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e9811de3-11c0-479d-b741-ae96a603134e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_39130850-9ac2-4417-b2c6-9e7f13470a2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9811de3-11c0-479d-b741-ae96a603134e" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_39130850-9ac2-4417-b2c6-9e7f13470a2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_86c2842e-f4f8-4a75-9039-a04bba7af6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_39130850-9ac2-4417-b2c6-9e7f13470a2c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_86c2842e-f4f8-4a75-9039-a04bba7af6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a20872bf-28d2-4142-96d4-5020e86b1d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_39130850-9ac2-4417-b2c6-9e7f13470a2c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a20872bf-28d2-4142-96d4-5020e86b1d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bae5123c-3275-40e1-bffc-bad016112d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_39130850-9ac2-4417-b2c6-9e7f13470a2c" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_bae5123c-3275-40e1-bffc-bad016112d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_3a8eebbe-43e8-4e3d-8504-d372aa15921a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9811de3-11c0-479d-b741-ae96a603134e" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_3a8eebbe-43e8-4e3d-8504-d372aa15921a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_debd75be-6017-4673-bac5-896e1147a535" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_3a8eebbe-43e8-4e3d-8504-d372aa15921a" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_debd75be-6017-4673-bac5-896e1147a535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1f7c083e-d6ab-4692-8d3d-fcb79ab66c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_3a8eebbe-43e8-4e3d-8504-d372aa15921a" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1f7c083e-d6ab-4692-8d3d-fcb79ab66c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_7e4b379c-5cae-40bc-993a-3c74a19f4539" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_3a8eebbe-43e8-4e3d-8504-d372aa15921a" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_7e4b379c-5cae-40bc-993a-3c74a19f4539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d79e2b1f-210d-4938-8083-6ff6c644fd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e9811de3-11c0-479d-b741-ae96a603134e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d79e2b1f-210d-4938-8083-6ff6c644fd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXESTaxRateDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dd2e3b73-f4d3-4544-8376-072c2c61dc1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b16c6071-49ae-4cbe-acfd-373fd63e5801" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd2e3b73-f4d3-4544-8376-072c2c61dc1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b16c6071-49ae-4cbe-acfd-373fd63e5801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2b422c99-1a38-4f42-b8f2-03ca6a0b633f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd2e3b73-f4d3-4544-8376-072c2c61dc1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2b422c99-1a38-4f42-b8f2-03ca6a0b633f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_2ac706d0-664b-41f1-aa6c-75274b1b954b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd2e3b73-f4d3-4544-8376-072c2c61dc1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_2ac706d0-664b-41f1-aa6c-75274b1b954b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_4fd470d2-dec1-49ee-bc26-a5c67343b281" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd2e3b73-f4d3-4544-8376-072c2c61dc1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_4fd470d2-dec1-49ee-bc26-a5c67343b281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ef2068c1-f49f-4606-9a8f-9b2f239ad7e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd2e3b73-f4d3-4544-8376-072c2c61dc1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ef2068c1-f49f-4606-9a8f-9b2f239ad7e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cb7aa203-291b-4c37-8fd1-347702d2bc25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dd2e3b73-f4d3-4544-8376-072c2c61dc1a" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_cb7aa203-291b-4c37-8fd1-347702d2bc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2ef197ce-43d2-4201-96c7-fea18cbbd670" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9e9fc04c-fc43-47a5-9949-fcdc1df468a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2ef197ce-43d2-4201-96c7-fea18cbbd670" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_9e9fc04c-fc43-47a5-9949-fcdc1df468a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_564fb1fa-f64a-4b7a-a300-bce396e2f3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2ef197ce-43d2-4201-96c7-fea18cbbd670" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_564fb1fa-f64a-4b7a-a300-bce396e2f3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9bc0f541-baa2-4c2e-a447-0519372f3412" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2ef197ce-43d2-4201-96c7-fea18cbbd670" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_9bc0f541-baa2-4c2e-a447-0519372f3412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_4a91fe3c-0974-463a-b608-d1e14b208ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_4a91fe3c-0974-463a-b608-d1e14b208ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_b5297f38-b843-40c9-9c9e-2212cd77057c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_b5297f38-b843-40c9-9c9e-2212cd77057c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_6a58a603-9c75-4b37-94fb-0eda2d493db6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_6a58a603-9c75-4b37-94fb-0eda2d493db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_d1e48b9d-4e06-4772-82b8-1e5dae882631" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_d1e48b9d-4e06-4772-82b8-1e5dae882631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability_b4d4d2d6-34ac-435d-82a1-2a831852a254" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability_b4d4d2d6-34ac-435d-82a1-2a831852a254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_4701672b-205a-40ce-a1a2-edacf9c1e63a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_4701672b-205a-40ce-a1a2-edacf9c1e63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_73a79ec0-d00e-4b38-9277-2b0664dd3799" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_73a79ec0-d00e-4b38-9277-2b0664dd3799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1014af0a-2a1f-45d5-be96-ff6572f79c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1014af0a-2a1f-45d5-be96-ff6572f79c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxLiabilitiesStateTaxes_4e615598-0959-4ff5-9ed4-0763d8ca43d5" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxLiabilitiesStateTaxes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_ensg_DeferredTaxLiabilitiesStateTaxes_4e615598-0959-4ff5-9ed4-0763d8ca43d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0ec015d3-e54f-4f39-b7cb-1160c646b099" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0ec015d3-e54f-4f39-b7cb-1160c646b099" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_27de6c6a-c0ef-4aa4-bf97-4f5f9bb3aee0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_27de6c6a-c0ef-4aa4-bf97-4f5f9bb3aee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DeferredTaxLiabilitiesRightOfUseAsset_367a94e9-89d8-4401-8f64-35f622178186" xlink:href="ensg-20241231.xsd#ensg_DeferredTaxLiabilitiesRightOfUseAsset"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_ensg_DeferredTaxLiabilitiesRightOfUseAsset_367a94e9-89d8-4401-8f64-35f622178186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_e5249229-ac90-4d4e-9a00-e96f1e71718d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_e5249229-ac90-4d4e-9a00-e96f1e71718d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a098d911-a119-4937-a5fa-1a8c49d4196c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_129c6a53-e644-4e56-8d43-0376ceb43980" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_a098d911-a119-4937-a5fa-1a8c49d4196c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTScheduleofLongtermDebtDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fdc77e95-db50-4f5d-9a7f-7786cf317c72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_fd6a4b1d-f9b4-4f21-be15-e13389f203e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fdc77e95-db50-4f5d-9a7f-7786cf317c72" xlink:to="loc_us-gaap_DebtInstrumentTable_fd6a4b1d-f9b4-4f21-be15-e13389f203e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd6a4b1d-f9b4-4f21-be15-e13389f203e6" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc8df927-3c38-45ab-845d-6d9288bdc0a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_06a0fae6-73a3-4f87-9ec9-bf4888eed4fc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc8df927-3c38-45ab-845d-6d9288bdc0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralizedDebtObligationsMember_0a54c2be-213c-4b7d-814d-e447fcc00029" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralizedDebtObligationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dc8df927-3c38-45ab-845d-6d9288bdc0a6" xlink:to="loc_us-gaap_CollateralizedDebtObligationsMember_0a54c2be-213c-4b7d-814d-e447fcc00029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_fd6a4b1d-f9b4-4f21-be15-e13389f203e6" xlink:to="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_880d0b95-845a-4c7e-8c53-fae41191913f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_880d0b95-845a-4c7e-8c53-fae41191913f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_331dd3df-8bd5-44c4-bf79-6c13ebdcca3c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_LongTermDebtCurrent_331dd3df-8bd5-44c4-bf79-6c13ebdcca3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_2088859c-076b-4d79-a5da-ee945b80e79b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_2088859c-076b-4d79-a5da-ee945b80e79b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_454752f5-5b9b-4284-ac87-dae2ca29093a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_9d37b563-f398-492d-be51-c84869a0e228" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_454752f5-5b9b-4284-ac87-dae2ca29093a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ce39a319-82c0-44cd-ad73-78a23ac07e42" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ce39a319-82c0-44cd-ad73-78a23ac07e42" xlink:to="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a97a01f9-32b1-4a58-94a4-425845e7c84e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_us-gaap_CreditFacilityAxis_a97a01f9-32b1-4a58-94a4-425845e7c84e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b540e3c9-fa5b-4e48-bd66-3b4bc7e45798" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a97a01f9-32b1-4a58-94a4-425845e7c84e" xlink:to="loc_us-gaap_CreditFacilityDomain_b540e3c9-fa5b-4e48-bd66-3b4bc7e45798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_c599cafa-792f-456e-91c2-8c3c0bfcda16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b540e3c9-fa5b-4e48-bd66-3b4bc7e45798" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_c599cafa-792f-456e-91c2-8c3c0bfcda16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_74d3a0a8-a265-484b-ba9a-a5769ecc562f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_0eb2f669-8c4a-44e2-9c23-9cdc93d851ae" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_74d3a0a8-a265-484b-ba9a-a5769ecc562f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TruistBankMember_36533cb0-a6fb-4147-b9c5-356b19bea559" xlink:href="ensg-20241231.xsd#ensg_TruistBankMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_74d3a0a8-a265-484b-ba9a-a5769ecc562f" xlink:to="loc_ensg_TruistBankMember_36533cb0-a6fb-4147-b9c5-356b19bea559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_9c8b1f98-3c47-4a9b-8c6a-817199d3d449" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_us-gaap_VariableRateAxis_9c8b1f98-3c47-4a9b-8c6a-817199d3d449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_26ae6ce4-01f6-4602-9b56-8c501ebd54d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_9c8b1f98-3c47-4a9b-8c6a-817199d3d449" xlink:to="loc_us-gaap_VariableRateDomain_26ae6ce4-01f6-4602-9b56-8c501ebd54d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_9e50e487-686c-4fe0-9477-ca2da55c8aca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_26ae6ce4-01f6-4602-9b56-8c501ebd54d7" xlink:to="loc_us-gaap_BaseRateMember_9e50e487-686c-4fe0-9477-ca2da55c8aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_0d36ab68-4c3a-46a4-8b65-68e1f9a01f74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SecuredOvernightFinancingRateSofrMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_26ae6ce4-01f6-4602-9b56-8c501ebd54d7" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrMember_0d36ab68-4c3a-46a4-8b65-68e1f9a01f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_13d18ed1-ceec-4a6c-9772-f34a475a6208" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_srt_RangeAxis_13d18ed1-ceec-4a6c-9772-f34a475a6208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1848354a-e81c-4def-a636-764958868e6c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_13d18ed1-ceec-4a6c-9772-f34a475a6208" xlink:to="loc_srt_RangeMember_1848354a-e81c-4def-a636-764958868e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_77b48906-aa51-4a07-a08e-be78719b0497" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1848354a-e81c-4def-a636-764958868e6c" xlink:to="loc_srt_MinimumMember_77b48906-aa51-4a07-a08e-be78719b0497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1f2fa1ba-5666-48de-bbe8-48255abd07c4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1848354a-e81c-4def-a636-764958868e6c" xlink:to="loc_srt_MaximumMember_1f2fa1ba-5666-48de-bbe8-48255abd07c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_d4801d4b-cfac-4ca5-b7c7-adae34f414b5" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a9c2305-2034-4129-97c2-b19b7a5c33fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_1a9c2305-2034-4129-97c2-b19b7a5c33fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d7304758-07db-4e27-a993-e1a4e021660f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d7304758-07db-4e27-a993-e1a4e021660f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5f77c0e9-78b5-415f-b5a7-f50964b3c12e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_5f77c0e9-78b5-415f-b5a7-f50964b3c12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMaximum_2f6dffd9-e18a-48bd-901d-9afc67f6bc6c" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_TotalNetDebtRatioMaximum_2f6dffd9-e18a-48bd-901d-9afc67f6bc6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod_b9d4caca-b0e7-4020-a96d-8d10380d0c77" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod_b9d4caca-b0e7-4020-a96d-8d10380d0c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection_ec2d2547-f2ed-4c82-b7a1-43f4f8d5046f" xlink:href="ensg-20241231.xsd#ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection_ec2d2547-f2ed-4c82-b7a1-43f4f8d5046f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection_98e55214-36ec-4211-bd0b-d189f20ace53" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMaximumAfterIncreaseElection"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection_98e55214-36ec-4211-bd0b-d189f20ace53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TotalNetDebtRatioMinimum_6112d8f1-dd9d-4a52-98a2-f54b3c66c449" xlink:href="ensg-20241231.xsd#ensg_TotalNetDebtRatioMinimum"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_ensg_TotalNetDebtRatioMinimum_6112d8f1-dd9d-4a52-98a2-f54b3c66c449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bc9f2537-b8e9-4836-bd06-76b7e733db53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a247eef4-8c09-461d-be29-7699d049d644" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_bc9f2537-b8e9-4836-bd06-76b7e733db53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6bf513ea-7113-4090-924d-838f34a36023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6bf513ea-7113-4090-924d-838f34a36023" xlink:to="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_873aaeb0-53d2-4a2a-9284-c7a985331a16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_873aaeb0-53d2-4a2a-9284-c7a985331a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_19c3a8e1-df22-4201-9cfe-f0a016a5d089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_873aaeb0-53d2-4a2a-9284-c7a985331a16" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_19c3a8e1-df22-4201-9cfe-f0a016a5d089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralizedDebtObligationsMember_fd11cee5-46a7-4b59-b40c-c39562f3632a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollateralizedDebtObligationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_19c3a8e1-df22-4201-9cfe-f0a016a5d089" xlink:to="loc_us-gaap_CollateralizedDebtObligationsMember_fd11cee5-46a7-4b59-b40c-c39562f3632a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_us-gaap_DebtInstrumentAxis_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9392d29-5513-4a4e-bfda-e1b409c173e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_edef2a2a-ad0f-41a9-8ba3-a08c01a874d1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9392d29-5513-4a4e-bfda-e1b409c173e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_HUDInsuredMortgagesMember_5f152cf9-81ff-4180-9194-14c08d492f42" xlink:href="ensg-20241231.xsd#ensg_HUDInsuredMortgagesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9392d29-5513-4a4e-bfda-e1b409c173e7" xlink:to="loc_ensg_HUDInsuredMortgagesMember_5f152cf9-81ff-4180-9194-14c08d492f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A53PromissoryNoteMember_f21fc064-3971-4434-ba26-f83a163fb104" xlink:href="ensg-20241231.xsd#ensg_A53PromissoryNoteMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a9392d29-5513-4a4e-bfda-e1b409c173e7" xlink:to="loc_ensg_A53PromissoryNoteMember_f21fc064-3971-4434-ba26-f83a163fb104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_52760252-1302-43a9-8786-fd7136101877" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_dei_LegalEntityAxis_52760252-1302-43a9-8786-fd7136101877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c9f6513b-0419-425d-889d-767f9ca98bcc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_52760252-1302-43a9-8786-fd7136101877" xlink:to="loc_dei_EntityDomain_c9f6513b-0419-425d-889d-767f9ca98bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TwentyThreeSubsidiariesMember_0231325f-90f6-4540-b76e-67a629bece63" xlink:href="ensg-20241231.xsd#ensg_TwentyThreeSubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_c9f6513b-0419-425d-889d-767f9ca98bcc" xlink:to="loc_ensg_TwentyThreeSubsidiariesMember_0231325f-90f6-4540-b76e-67a629bece63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3d8a4fc4-3c39-410a-ba81-53c663cabb60" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_srt_RangeAxis_3d8a4fc4-3c39-410a-ba81-53c663cabb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_91dbd22d-b0d8-4be6-8013-8828815730ab" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3d8a4fc4-3c39-410a-ba81-53c663cabb60" xlink:to="loc_srt_RangeMember_91dbd22d-b0d8-4be6-8013-8828815730ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4a97ac2c-c14f-4401-876d-4a3b9bbe9edb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_91dbd22d-b0d8-4be6-8013-8828815730ab" xlink:to="loc_srt_MinimumMember_4a97ac2c-c14f-4401-876d-4a3b9bbe9edb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_1d0f37d2-fac2-4064-a41d-c405bf8d4e81" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_91dbd22d-b0d8-4be6-8013-8828815730ab" xlink:to="loc_srt_MaximumMember_1d0f37d2-fac2-4064-a41d-c405bf8d4e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentFeePeriodAxis_8fd7ae35-6f55-461c-9ce4-edf6578affab" xlink:href="ensg-20241231.xsd#ensg_PrepaymentFeePeriodAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_ensg_PrepaymentFeePeriodAxis_8fd7ae35-6f55-461c-9ce4-edf6578affab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:href="ensg-20241231.xsd#ensg_PrepaymentFeePeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_PrepaymentFeePeriodAxis_8fd7ae35-6f55-461c-9ce4-edf6578affab" xlink:to="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_FirstThreeYearsMember_9c0b25d7-9945-4302-84c8-54471f5b1016" xlink:href="ensg-20241231.xsd#ensg_FirstThreeYearsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:to="loc_ensg_FirstThreeYearsMember_9c0b25d7-9945-4302-84c8-54471f5b1016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InTheFourthYearMember_35bc6954-8418-4282-850b-c97f6b036c89" xlink:href="ensg-20241231.xsd#ensg_InTheFourthYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:to="loc_ensg_InTheFourthYearMember_35bc6954-8418-4282-850b-c97f6b036c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_YearsFiveThroughTenMember_3f304a67-a567-4e75-84fb-90ad60e5e6c9" xlink:href="ensg-20241231.xsd#ensg_YearsFiveThroughTenMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:to="loc_ensg_YearsFiveThroughTenMember_3f304a67-a567-4e75-84fb-90ad60e5e6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AfterYearTenMember_7682a320-0ac2-4a0c-8208-fbb60125c10d" xlink:href="ensg-20241231.xsd#ensg_AfterYearTenMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_PrepaymentFeePeriodDomain_772e1258-c7b9-4f08-bf82-9d4d34e95c8a" xlink:to="loc_ensg_AfterYearTenMember_7682a320-0ac2-4a0c-8208-fbb60125c10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_0b4a2c29-0993-469b-acf1-df6b31ddeb1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_us-gaap_CreditFacilityAxis_0b4a2c29-0993-469b-acf1-df6b31ddeb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_17c93167-05ce-4098-abf1-0b86e073aec8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_0b4a2c29-0993-469b-acf1-df6b31ddeb1d" xlink:to="loc_us-gaap_CreditFacilityDomain_17c93167-05ce-4098-abf1-0b86e073aec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_bf65918d-462c-4e1b-ac1c-d21371d1feef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_17c93167-05ce-4098-abf1-0b86e073aec8" xlink:to="loc_us-gaap_LetterOfCreditMember_bf65918d-462c-4e1b-ac1c-d21371d1feef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_253bff02-c77b-4d75-8384-a1b78bb44221" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfOperatingSubsidiaries_de735198-d955-4297-858d-5cacd22bb35e" xlink:href="ensg-20241231.xsd#ensg_NumberOfOperatingSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_ensg_NumberOfOperatingSubsidiaries_de735198-d955-4297-858d-5cacd22bb35e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_60c0a032-b206-41ec-86c3-644bc2bcef30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_60c0a032-b206-41ec-86c3-644bc2bcef30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f9967fac-fe42-4921-a6d7-69e6af9d0c79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f9967fac-fe42-4921-a6d7-69e6af9d0c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f7d8e8fa-072b-4a38-9ab0-2206ce02bcf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f7d8e8fa-072b-4a38-9ab0-2206ce02bcf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PrepaymentPenalty_9f1b424a-a1ad-4467-a1a9-1fb52b2de950" xlink:href="ensg-20241231.xsd#ensg_PrepaymentPenalty"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_ensg_PrepaymentPenalty_9f1b424a-a1ad-4467-a1a9-1fb52b2de950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ReductionInPrepaymentPenalty_794fd7dd-9f48-4eb3-a6bf-7015f1271e54" xlink:href="ensg-20241231.xsd#ensg_ReductionInPrepaymentPenalty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_ensg_ReductionInPrepaymentPenalty_794fd7dd-9f48-4eb3-a6bf-7015f1271e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_58941b84-1064-4c02-bb2a-57434d0d3d52" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_DebtInstrumentTerm_58941b84-1064-4c02-bb2a-57434d0d3d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4e5c58ee-0b0a-4186-b86a-8100262cdb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4e5c58ee-0b0a-4186-b86a-8100262cdb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_410c81e2-7d77-48a2-9b2d-d684865635a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4aad3d96-c851-4b7b-8be5-bdf0e346d0a8" xlink:to="loc_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_410c81e2-7d77-48a2-9b2d-d684865635a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEBTLongtermDebtArrangementsDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ea37e08a-6507-4222-aea2-b6173b2bad3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f33eed38-b190-4d4a-9654-6cccf099e8fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea37e08a-6507-4222-aea2-b6173b2bad3e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_f33eed38-b190-4d4a-9654-6cccf099e8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d39d3b36-8126-4492-a65c-571a6be82a60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea37e08a-6507-4222-aea2-b6173b2bad3e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_d39d3b36-8126-4492-a65c-571a6be82a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c3b16539-134c-45cd-8250-7bfe7798425c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea37e08a-6507-4222-aea2-b6173b2bad3e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_c3b16539-134c-45cd-8250-7bfe7798425c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3f90671e-a33f-4492-8c53-09580e9ca705" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea37e08a-6507-4222-aea2-b6173b2bad3e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_3f90671e-a33f-4492-8c53-09580e9ca705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3c7ac88c-c174-419f-8712-c800eb162c81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea37e08a-6507-4222-aea2-b6173b2bad3e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_3c7ac88c-c174-419f-8712-c800eb162c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0fc35e65-78f0-4b03-9c15-c696274f7641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea37e08a-6507-4222-aea2-b6173b2bad3e" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0fc35e65-78f0-4b03-9c15-c696274f7641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_64dd8dcc-5d94-48b2-a3a4-a9dad64f0068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea37e08a-6507-4222-aea2-b6173b2bad3e" xlink:to="loc_us-gaap_LongTermDebt_64dd8dcc-5d94-48b2-a3a4-a9dad64f0068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSStockOptionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a127d18b-b87c-465a-a090-ca93ff63e3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a127d18b-b87c-465a-a090-ca93ff63e3fe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_366b8383-ce7f-489d-8c6f-53a7c7c2a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:to="loc_us-gaap_PlanNameAxis_366b8383-ce7f-489d-8c6f-53a7c7c2a02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_946864f1-bf11-472f-96c1-c907e7dd94a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_366b8383-ce7f-489d-8c6f-53a7c7c2a02d" xlink:to="loc_us-gaap_PlanNameDomain_946864f1-bf11-472f-96c1-c907e7dd94a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2022PlanMember_c5a129de-96ad-4d1f-8be7-e5c371bb67fb" xlink:href="ensg-20241231.xsd#ensg_A2022PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_946864f1-bf11-472f-96c1-c907e7dd94a7" xlink:to="loc_ensg_A2022PlanMember_c5a129de-96ad-4d1f-8be7-e5c371bb67fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_b17ce335-bb58-466e-9141-d18c75e9147b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:to="loc_us-gaap_GranteeStatusAxis_b17ce335-bb58-466e-9141-d18c75e9147b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_e95f050a-3416-4cdd-ad10-7e27b591d916" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_b17ce335-bb58-466e-9141-d18c75e9147b" xlink:to="loc_us-gaap_GranteeStatusDomain_e95f050a-3416-4cdd-ad10-7e27b591d916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_925a384d-547e-47fb-a3e1-518abcbe2023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_e95f050a-3416-4cdd-ad10-7e27b591d916" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_925a384d-547e-47fb-a3e1-518abcbe2023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a2729834-95a7-49c7-be55-0275224dd55c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:to="loc_us-gaap_AwardTypeAxis_a2729834-95a7-49c7-be55-0275224dd55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faeba213-7156-4bbe-95e5-6aa5f3409a44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a2729834-95a7-49c7-be55-0275224dd55c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faeba213-7156-4bbe-95e5-6aa5f3409a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3c50a116-f119-435d-940c-637475bc3671" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_faeba213-7156-4bbe-95e5-6aa5f3409a44" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3c50a116-f119-435d-940c-637475bc3671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1c158c7a-7df7-44b6-aa01-8d370c392c18" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfStockIncentivePlans_22203048-58ec-4285-874f-a2cf005690de" xlink:href="ensg-20241231.xsd#ensg_NumberOfStockIncentivePlans"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_NumberOfStockIncentivePlans_22203048-58ec-4285-874f-a2cf005690de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c7661e9-5b2d-462b-952e-1bf38bb657d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_4c7661e9-5b2d-462b-952e-1bf38bb657d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability_a234f230-6129-40eb-8d5f-f329c66f1ac4" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability_a234f230-6129-40eb-8d5f-f329c66f1ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability_cfa8cf02-dae4-404b-8543-81a65e400526" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability_cfa8cf02-dae4-404b-8543-81a65e400526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments_4ee7aa63-8bc8-45f4-9e51-53caf24ba1ce" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments_4ee7aa63-8bc8-45f4-9e51-53caf24ba1ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_fd796b48-59a0-4db8-8141-2b5c8ec345bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1_fd796b48-59a0-4db8-8141-2b5c8ec345bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47c6b1b3-74b5-495b-a269-dcce5139ad24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_47c6b1b3-74b5-495b-a269-dcce5139ad24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ebbaf5bf-2236-4dce-bebc-9cfc0d4aada8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ebbaf5bf-2236-4dce-bebc-9cfc0d4aada8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b90d185a-b327-4d05-883d-b18e090e2089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_b90d185a-b327-4d05-883d-b18e090e2089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_37e430c0-d930-456d-8ffc-dd7ac19ee81b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_37e430c0-d930-456d-8ffc-dd7ac19ee81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate_6d05b250-28fd-485e-87bc-467e33a02253" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate_6d05b250-28fd-485e-87bc-467e33a02253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_94bce7be-c4a4-4fed-bc8a-85bfc62fbc73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_94bce7be-c4a4-4fed-bc8a-85bfc62fbc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_a098f351-84b5-49f2-8c8b-caa26439231c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested_a098f351-84b5-49f2-8c8b-caa26439231c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3d48ab98-0d92-470e-b502-9b12053ac267" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_09e69e92-bbfd-45a0-96c9-e935c009ab62" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3d48ab98-0d92-470e-b502-9b12053ac267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dde948f0-e6d6-432e-bdd3-37e7e07a0639" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_654579d4-8a85-4adb-882d-2b675e1fe147" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dde948f0-e6d6-432e-bdd3-37e7e07a0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_654579d4-8a85-4adb-882d-2b675e1fe147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7ffb9e5c-753e-4f8b-9571-008cb6532db2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dde948f0-e6d6-432e-bdd3-37e7e07a0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_7ffb9e5c-753e-4f8b-9571-008cb6532db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80f55ce4-85f2-4e00-b9aa-e17638cc4b92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dde948f0-e6d6-432e-bdd3-37e7e07a0639" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_80f55ce4-85f2-4e00-b9aa-e17638cc4b92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_a1dfc39d-84c6-4538-bef6-190d24a11888" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dde948f0-e6d6-432e-bdd3-37e7e07a0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_a1dfc39d-84c6-4538-bef6-190d24a11888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ab1f43a3-c613-4f32-a3dd-e4796622d0f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dde948f0-e6d6-432e-bdd3-37e7e07a0639" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ab1f43a3-c613-4f32-a3dd-e4796622d0f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39f7a251-cdd3-4c2c-9cbe-1c330b78218c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a84daa7f-2799-42d3-8196-3d4e7764adbd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39f7a251-cdd3-4c2c-9cbe-1c330b78218c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_a84daa7f-2799-42d3-8196-3d4e7764adbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6f55220f-a5e5-4aac-bcd7-b7f27096fa87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39f7a251-cdd3-4c2c-9cbe-1c330b78218c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_6f55220f-a5e5-4aac-bcd7-b7f27096fa87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bcc13af6-6378-47cc-acf8-35a5f656c4ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_39f7a251-cdd3-4c2c-9cbe-1c330b78218c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bcc13af6-6378-47cc-acf8-35a5f656c4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25de97ac-aa66-4dbd-b41b-c41123f9529e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc68b103-b727-422b-90eb-0b8168b38636" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25de97ac-aa66-4dbd-b41b-c41123f9529e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc68b103-b727-422b-90eb-0b8168b38636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2f05fb0b-6713-49fb-a681-196fba8f8510" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc68b103-b727-422b-90eb-0b8168b38636" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2f05fb0b-6713-49fb-a681-196fba8f8510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b33f26b3-66c5-463a-bbd1-e8aca33f8c31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc68b103-b727-422b-90eb-0b8168b38636" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_b33f26b3-66c5-463a-bbd1-e8aca33f8c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_e14ebd76-8990-41aa-965e-5297beacf8ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc68b103-b727-422b-90eb-0b8168b38636" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_e14ebd76-8990-41aa-965e-5297beacf8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3eb7a41d-b7c3-47a5-8f84-4c588c38a0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc68b103-b727-422b-90eb-0b8168b38636" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3eb7a41d-b7c3-47a5-8f84-4c588c38a0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d89de345-0f06-4b77-897d-be44af2c9900" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_bc68b103-b727-422b-90eb-0b8168b38636" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d89de345-0f06-4b77-897d-be44af2c9900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4ff2e279-9adf-4a89-8ffe-2b5f6706721a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25de97ac-aa66-4dbd-b41b-c41123f9529e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4ff2e279-9adf-4a89-8ffe-2b5f6706721a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_57f5a5c7-b030-47b4-b3ae-301df35b5f45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4ff2e279-9adf-4a89-8ffe-2b5f6706721a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_57f5a5c7-b030-47b4-b3ae-301df35b5f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_609ea4c2-7b41-43ae-937f-5b2a601a6414" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4ff2e279-9adf-4a89-8ffe-2b5f6706721a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_609ea4c2-7b41-43ae-937f-5b2a601a6414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_5048eeab-9dd2-4946-be2a-7d1fd233b5f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4ff2e279-9adf-4a89-8ffe-2b5f6706721a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_5048eeab-9dd2-4946-be2a-7d1fd233b5f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_00ace9f3-09ba-46b1-b7ae-129d063a7cdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4ff2e279-9adf-4a89-8ffe-2b5f6706721a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_00ace9f3-09ba-46b1-b7ae-129d063a7cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ba00a11b-2712-4426-9195-b2ef610a1fa4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_4ff2e279-9adf-4a89-8ffe-2b5f6706721a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ba00a11b-2712-4426-9195-b2ef610a1fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_bb6ffc21-a3a6-4ad6-ada7-28a763aba22f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25de97ac-aa66-4dbd-b41b-c41123f9529e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_bb6ffc21-a3a6-4ad6-ada7-28a763aba22f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0a16f708-34df-4174-8e3c-619bcd27e40e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_25de97ac-aa66-4dbd-b41b-c41123f9529e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0a16f708-34df-4174-8e3c-619bcd27e40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a3d54e45-8114-4c03-b9aa-c9ebdb87110d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_5fa42c5d-a759-45f6-a2b3-508ec0fab99f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a3d54e45-8114-4c03-b9aa-c9ebdb87110d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_5fa42c5d-a759-45f6-a2b3-508ec0fab99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_829ebd26-9e46-478f-ad12-812f20dd8725" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_5fa42c5d-a759-45f6-a2b3-508ec0fab99f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_829ebd26-9e46-478f-ad12-812f20dd8725" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_829ebd26-9e46-478f-ad12-812f20dd8725" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeOneMember_f70593b0-67ff-4e40-a2cf-2ba19453f45c" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeOneMember_f70593b0-67ff-4e40-a2cf-2ba19453f45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeTwoMember_6ceefd46-d2c7-4161-9845-80a42771e0f3" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeTwoMember_6ceefd46-d2c7-4161-9845-80a42771e0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeThreeMember_8dfeb6b0-7661-4319-bc8c-c4adc4d52f22" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeThreeMember_8dfeb6b0-7661-4319-bc8c-c4adc4d52f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeFourMember_6ba3f21e-e9da-41a7-a562-c5b5fc089d12" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeFourMember_6ba3f21e-e9da-41a7-a562-c5b5fc089d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeFiveMember_7ec65dc4-81a5-4f3c-a1de-a47484309950" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeFiveMember_7ec65dc4-81a5-4f3c-a1de-a47484309950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeSixMember_ee2304b2-e52f-4aa1-b9cc-40deead23af4" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeSixMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeSixMember_ee2304b2-e52f-4aa1-b9cc-40deead23af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeSevenMember_271dc412-3d58-494b-84fc-857e79f880fb" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeSevenMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeSevenMember_271dc412-3d58-494b-84fc-857e79f880fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeEightMember_08d9db3d-60a8-4314-9740-8976236a8c34" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeEightMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeEightMember_08d9db3d-60a8-4314-9740-8976236a8c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeNineMember_e55b7835-3a37-420b-a6ce-0b1d79a6eaad" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeNineMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeNineMember_e55b7835-3a37-420b-a6ce-0b1d79a6eaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ExercisePriceRangeTenMember_88a3daae-9d23-46b9-9969-ec804f8035cd" xlink:href="ensg-20241231.xsd#ensg_ExercisePriceRangeTenMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_89879586-626c-403f-805c-d37b853ad009" xlink:to="loc_ensg_ExercisePriceRangeTenMember_88a3daae-9d23-46b9-9969-ec804f8035cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_5fa42c5d-a759-45f6-a2b3-508ec0fab99f" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_51b1a984-99d3-4ef8-93a6-058c5ce58e56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_51b1a984-99d3-4ef8-93a6-058c5ce58e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_204ff60a-831f-47f0-ad99-7c5e511d413a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_204ff60a-831f-47f0-ad99-7c5e511d413a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0ba4c5ba-3731-494d-aa14-414de99cf128" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_0ba4c5ba-3731-494d-aa14-414de99cf128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue_a7913b1e-7b47-4422-9658-3a60f4ec0ab3" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue_a7913b1e-7b47-4422-9658-3a60f4ec0ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_18896f2c-34e2-41ba-83d2-8e0095fb9c68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_18896f2c-34e2-41ba-83d2-8e0095fb9c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d7d2e636-c3b2-4c9f-b220-8326e848e949" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_7042a8e3-b2ad-491a-ae66-14090e80b6c5" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_d7d2e636-c3b2-4c9f-b220-8326e848e949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1cb1cca-a039-418a-a0ff-cf25f8b3a2a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5e2355fc-68dd-4ff8-bfcf-57fbf9c0b15b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1cb1cca-a039-418a-a0ff-cf25f8b3a2a4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_5e2355fc-68dd-4ff8-bfcf-57fbf9c0b15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_56ce8532-2e96-463a-8825-eb2eeef8c4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1cb1cca-a039-418a-a0ff-cf25f8b3a2a4" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_56ce8532-2e96-463a-8825-eb2eeef8c4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_dd6c9528-86a2-4393-9789-571e73570c3a" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a1cb1cca-a039-418a-a0ff-cf25f8b3a2a4" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue_dd6c9528-86a2-4393-9789-571e73570c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7e51a71-e4c4-47db-a784-828e9101b6d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c7e51a71-e4c4-47db-a784-828e9101b6d2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:to="loc_us-gaap_AwardTypeAxis_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7009b67-0093-4473-b189-de33ce7399cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_4d0a88d7-4777-43e3-aa1c-34d1f9cb0e30" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7009b67-0093-4473-b189-de33ce7399cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a82bae5f-fcf5-43d2-ab2c-e9ba821dafc0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e7009b67-0093-4473-b189-de33ce7399cb" xlink:to="loc_us-gaap_RestrictedStockMember_a82bae5f-fcf5-43d2-ab2c-e9ba821dafc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1efb2f16-31d2-4378-bfab-721b8b299205" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:to="loc_srt_RangeAxis_1efb2f16-31d2-4378-bfab-721b8b299205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_946f150c-bca0-48bf-9d98-075561dea98d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1efb2f16-31d2-4378-bfab-721b8b299205" xlink:to="loc_srt_RangeMember_946f150c-bca0-48bf-9d98-075561dea98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7d249a5d-5502-4e13-a9a4-bcfcb5b50421" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_946f150c-bca0-48bf-9d98-075561dea98d" xlink:to="loc_srt_MinimumMember_7d249a5d-5502-4e13-a9a4-bcfcb5b50421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_71a37494-4de5-4a6b-af80-46545ad36325" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_946f150c-bca0-48bf-9d98-075561dea98d" xlink:to="loc_srt_MaximumMember_71a37494-4de5-4a6b-af80-46545ad36325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_87419702-ac53-4a9b-b3ff-763a8a57788a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:to="loc_us-gaap_GranteeStatusAxis_87419702-ac53-4a9b-b3ff-763a8a57788a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_911c3027-efc6-45e2-8ea4-6de53ad5ed81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_87419702-ac53-4a9b-b3ff-763a8a57788a" xlink:to="loc_us-gaap_GranteeStatusDomain_911c3027-efc6-45e2-8ea4-6de53ad5ed81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_4f0fb930-c059-4a7f-8a88-10d80c815f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_911c3027-efc6-45e2-8ea4-6de53ad5ed81" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_4f0fb930-c059-4a7f-8a88-10d80c815f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6753fd65-74c2-440e-959c-c7b24ddb5c03" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7e462e4e-5875-480b-97e9-bcb0ce3691d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_7e462e4e-5875-480b-97e9-bcb0ce3691d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice_dda37e63-17f0-45e0-b1e4-482ec0c71eff" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice_dda37e63-17f0-45e0-b1e4-482ec0c71eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7f61c8ff-2ef7-4415-a0cf-91de40852459" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_7f61c8ff-2ef7-4415-a0cf-91de40852459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b5739262-143c-4480-ba29-c631b24704e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b5739262-143c-4480-ba29-c631b24704e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod_94b37c47-c49e-4bc4-b695-2827a638a26b" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a4454a87-7af6-4283-afb5-b667370f9273" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod_94b37c47-c49e-4bc4-b695-2827a638a26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11251719-2175-427c-99ce-23c6c2ea28d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_631dd9e1-7026-49e9-9fa2-50d147c849f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_11251719-2175-427c-99ce-23c6c2ea28d3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_631dd9e1-7026-49e9-9fa2-50d147c849f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6f629045-f6ec-4315-8b5d-01a701e3dcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_631dd9e1-7026-49e9-9fa2-50d147c849f3" xlink:to="loc_us-gaap_AwardTypeAxis_6f629045-f6ec-4315-8b5d-01a701e3dcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd0ea857-0651-4801-8dc6-7979adec31e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6f629045-f6ec-4315-8b5d-01a701e3dcb8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd0ea857-0651-4801-8dc6-7979adec31e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_eab0d6d8-e0d0-420c-b765-7eb299f1e2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cd0ea857-0651-4801-8dc6-7979adec31e2" xlink:to="loc_us-gaap_RestrictedStockMember_eab0d6d8-e0d0-420c-b765-7eb299f1e2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b59a220-0f29-44ee-b3d5-1f787c19607c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_631dd9e1-7026-49e9-9fa2-50d147c849f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b59a220-0f29-44ee-b3d5-1f787c19607c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b59a220-0f29-44ee-b3d5-1f787c19607c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_36aac8d2-c6f9-46df-9629-1dd26dccc7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_36aac8d2-c6f9-46df-9629-1dd26dccc7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6e9213a-b145-4a42-a1b7-ceb3f3084484" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a6e9213a-b145-4a42-a1b7-ceb3f3084484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94341e63-e60d-41a0-81f5-dde78912f61e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_94341e63-e60d-41a0-81f5-dde78912f61e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1728bb17-4bc2-4fad-b942-61eddb1c59fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1728bb17-4bc2-4fad-b942-61eddb1c59fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638313ed-806b-4150-a447-ec8b980cbe6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2caea1d0-76b0-4149-b5e8-d0d0528b9c1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_638313ed-806b-4150-a447-ec8b980cbe6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5b59a220-0f29-44ee-b3d5-1f787c19607c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_121aa51d-1bee-40ff-a112-d286e6871b02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_121aa51d-1bee-40ff-a112-d286e6871b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a69b2fd8-2034-4105-8018-9ea02bf6bf6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a69b2fd8-2034-4105-8018-9ea02bf6bf6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1e2fc200-ff79-4d1b-b438-2bebf7cc45ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_1e2fc200-ff79-4d1b-b438-2bebf7cc45ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_cecae181-f0c3-4f40-bc42-d6ea2b95fe26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_cecae181-f0c3-4f40-bc42-d6ea2b95fe26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_299c3c27-bbef-4af3-b7e5-8d85893c3e21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d697737e-0880-4085-a918-bccc973dabfd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_299c3c27-bbef-4af3-b7e5-8d85893c3e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2bb972ec-7d23-43e3-a604-ec13d13c5c82" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2bb972ec-7d23-43e3-a604-ec13d13c5c82" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_367a532a-eeef-46e9-a807-48c16cbff9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_367a532a-eeef-46e9-a807-48c16cbff9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_d7eebbc7-c9bb-4e84-a05a-c89a1ed01b37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_367a532a-eeef-46e9-a807-48c16cbff9b7" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_d7eebbc7-c9bb-4e84-a05a-c89a1ed01b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SpinoffMember_cecbc3ea-d24f-4772-9d87-724bca3e71b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SpinoffMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_d7eebbc7-c9bb-4e84-a05a-c89a1ed01b37" xlink:to="loc_us-gaap_SpinoffMember_cecbc3ea-d24f-4772-9d87-724bca3e71b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5704fa8a-4418-4b12-88f4-3960c55a7657" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:to="loc_us-gaap_PlanNameAxis_5704fa8a-4418-4b12-88f4-3960c55a7657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a5651a97-1c5c-432c-afe6-be6807a5b2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5704fa8a-4418-4b12-88f4-3960c55a7657" xlink:to="loc_us-gaap_PlanNameDomain_a5651a97-1c5c-432c-afe6-be6807a5b2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2019LTIPlanMember_7751a7f3-b041-4c8f-bdcd-d90538449026" xlink:href="ensg-20241231.xsd#ensg_A2019LTIPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a5651a97-1c5c-432c-afe6-be6807a5b2a3" xlink:to="loc_ensg_A2019LTIPlanMember_7751a7f3-b041-4c8f-bdcd-d90538449026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1e800265-ce99-491a-a2cf-40a39d292788" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0c8b1cad-2c00-4a07-b067-3954a7650dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0c8b1cad-2c00-4a07-b067-3954a7650dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9132faeb-60fe-4743-9256-7333ff3b4510" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9132faeb-60fe-4743-9256-7333ff3b4510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_60792ec6-1215-4db0-aa92-cbc43023641a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_60792ec6-1215-4db0-aa92-cbc43023641a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a79b5152-db5d-444a-9455-6b2d629528a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f206764e-eed7-46a8-9591-5e4a5bf03f3a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a79b5152-db5d-444a-9455-6b2d629528a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_743d9412-6e93-49bb-9bd0-6ce80b040d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_162aff1d-18ee-4ec7-84f2-f0d2970d5163" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_743d9412-6e93-49bb-9bd0-6ce80b040d5d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_162aff1d-18ee-4ec7-84f2-f0d2970d5163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_636026e4-e61e-46f6-a570-c320453e9699" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_162aff1d-18ee-4ec7-84f2-f0d2970d5163" xlink:to="loc_us-gaap_AwardTypeAxis_636026e4-e61e-46f6-a570-c320453e9699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_636026e4-e61e-46f6-a570-c320453e9699" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_698e7d4e-9539-437e-b2e0-fe6b74a3c26d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:to="loc_us-gaap_EmployeeStockOptionMember_698e7d4e-9539-437e-b2e0-fe6b74a3c26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_685b3a76-1db4-40a8-8e54-61c71519c5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:to="loc_us-gaap_RestrictedStockMember_685b3a76-1db4-40a8-8e54-61c71519c5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OtherStockAwardsMember_97d0b01f-d5a3-42bf-a4b2-2058c8770713" xlink:href="ensg-20241231.xsd#ensg_OtherStockAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_be7d8f59-7370-4aa8-9d04-3ff2d4a6f336" xlink:to="loc_ensg_OtherStockAwardsMember_97d0b01f-d5a3-42bf-a4b2-2058c8770713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_162aff1d-18ee-4ec7-84f2-f0d2970d5163" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_663bc3a5-54d5-4caf-8c1c-9f42448bee2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_663bc3a5-54d5-4caf-8c1c-9f42448bee2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6946fac6-9f95-48ab-a221-35a93eff4089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_6946fac6-9f95-48ab-a221-35a93eff4089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e2e5236d-1c12-44e0-a3ea-c65d19885d7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_e2e5236d-1c12-44e0-a3ea-c65d19885d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards_6b3f2f93-c0d0-46e9-a559-2e219b94e470" xlink:href="ensg-20241231.xsd#ensg_EmployeeServiceShareBasedCompensationNonvestedAwards"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards_6b3f2f93-c0d0-46e9-a559-2e219b94e470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber_dddb3928-d5b8-4341-a127-fa0478bcf23f" xlink:href="ensg-20241231.xsd#ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber_dddb3928-d5b8-4341-a127-fa0478bcf23f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6cb0c2d5-3ec6-48a2-8492-21ac522e699e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_d73143f9-b445-4c19-ba55-a1eb7a08f395" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6cb0c2d5-3ec6-48a2-8492-21ac522e699e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESLesseeNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_94f7db4e-6176-4b06-8232-77e68c9bdb44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_94f7db4e-6176-4b06-8232-77e68c9bdb44" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis_5fc8d43f-36f5-45d6-b829-91213036361e" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_ensg_LeaseArrangementAxis_5fc8d43f-36f5-45d6-b829-91213036361e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementAxis_5fc8d43f-36f5-45d6-b829-91213036361e" xlink:to="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MasterLeaseAgreementsMember_640bab9a-b2ee-41a8-8a84-ef15c7470bd2" xlink:href="ensg-20241231.xsd#ensg_MasterLeaseAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:to="loc_ensg_MasterLeaseAgreementsMember_640bab9a-b2ee-41a8-8a84-ef15c7470bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NewAndAmendedMasterLeaseAgreementMember_cc6249c7-d9d8-409b-9070-193b6179e437" xlink:href="ensg-20241231.xsd#ensg_NewAndAmendedMasterLeaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_MasterLeaseAgreementsMember_640bab9a-b2ee-41a8-8a84-ef15c7470bd2" xlink:to="loc_ensg_NewAndAmendedMasterLeaseAgreementMember_cc6249c7-d9d8-409b-9070-193b6179e437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementMember_b87d7d8c-893e-4d77-88c1-fe80b475e353" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_NewAndAmendedMasterLeaseAgreementMember_cc6249c7-d9d8-409b-9070-193b6179e437" xlink:to="loc_ensg_AmendedMasterLeaseAgreementMember_b87d7d8c-893e-4d77-88c1-fe80b475e353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementOneMember_75c312aa-a226-4151-b1af-f61be05f051a" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_AmendedMasterLeaseAgreementMember_b87d7d8c-893e-4d77-88c1-fe80b475e353" xlink:to="loc_ensg_AmendedMasterLeaseAgreementOneMember_75c312aa-a226-4151-b1af-f61be05f051a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AmendedMasterLeaseAgreementTwoMember_91660fdc-f051-4f36-90b8-2d2c19b36c47" xlink:href="ensg-20241231.xsd#ensg_AmendedMasterLeaseAgreementTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_AmendedMasterLeaseAgreementMember_b87d7d8c-893e-4d77-88c1-fe80b475e353" xlink:to="loc_ensg_AmendedMasterLeaseAgreementTwoMember_91660fdc-f051-4f36-90b8-2d2c19b36c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NewMasterLeaseAgreementMember_64625939-2563-44dd-afb5-61ce9dcf33e6" xlink:href="ensg-20241231.xsd#ensg_NewMasterLeaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_NewAndAmendedMasterLeaseAgreementMember_cc6249c7-d9d8-409b-9070-193b6179e437" xlink:to="loc_ensg_NewMasterLeaseAgreementMember_64625939-2563-44dd-afb5-61ce9dcf33e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_TripleNetLeaseArrangementsMember_c2ba1657-4c68-4a61-9f45-6b940e45b4d0" xlink:href="ensg-20241231.xsd#ensg_TripleNetLeaseArrangementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:to="loc_ensg_TripleNetLeaseArrangementsMember_c2ba1657-4c68-4a61-9f45-6b940e45b4d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_PurchaseOptionMember_e1a54f4e-738a-4cb5-9c8c-03aa64f09542" xlink:href="ensg-20241231.xsd#ensg_PurchaseOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementDomain_5cbe8773-ccbe-484b-8030-fb8713ea7c29" xlink:to="loc_ensg_PurchaseOptionMember_e1a54f4e-738a-4cb5-9c8c-03aa64f09542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_00305b48-af55-4d68-8ad9-d1f4aeb48363" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_srt_CounterpartyNameAxis_00305b48-af55-4d68-8ad9-d1f4aeb48363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4ddf3c5-de09-4357-8f4a-f751c1a30db2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_00305b48-af55-4d68-8ad9-d1f4aeb48363" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4ddf3c5-de09-4357-8f4a-f751c1a30db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CareTrustREITMember_134a411c-b8d0-4867-946b-e14a7abc0bda" xlink:href="ensg-20241231.xsd#ensg_CareTrustREITMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4ddf3c5-de09-4357-8f4a-f751c1a30db2" xlink:to="loc_ensg_CareTrustREITMember_134a411c-b8d0-4867-946b-e14a7abc0bda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_VariousLandlordsMember_522aaa4b-b7b4-4db4-af3c-63cdd6150018" xlink:href="ensg-20241231.xsd#ensg_VariousLandlordsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c4ddf3c5-de09-4357-8f4a-f751c1a30db2" xlink:to="loc_ensg_VariousLandlordsMember_522aaa4b-b7b4-4db4-af3c-63cdd6150018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_054b18b4-0ebb-4ecd-85a4-97146c3fd955" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_054b18b4-0ebb-4ecd-85a4-97146c3fd955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_054b18b4-0ebb-4ecd-85a4-97146c3fd955" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember_1a45af17-7967-489f-b4a5-71ff80011f9b" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:to="loc_ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember_1a45af17-7967-489f-b4a5-71ff80011f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperationMember_f6835328-532d-4491-9acb-64c29e196c61" xlink:href="ensg-20241231.xsd#ensg_OperationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:to="loc_ensg_OperationMember_f6835328-532d-4491-9acb-64c29e196c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_a4e70a0c-1cea-4fd8-83c5-29df8d4c9504" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_73037710-b68d-4f4f-a2cd-f22497587043" xlink:to="loc_ensg_SkilledNursingOperationsMember_a4e70a0c-1cea-4fd8-83c5-29df8d4c9504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f7b551c-5732-48be-88b3-3460182a11ef" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_srt_RangeAxis_6f7b551c-5732-48be-88b3-3460182a11ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f9bb446c-174d-4997-a9bb-700333af5ee8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6f7b551c-5732-48be-88b3-3460182a11ef" xlink:to="loc_srt_RangeMember_f9bb446c-174d-4997-a9bb-700333af5ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dbef945b-1f03-4639-ab2b-de354eb11d5b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f9bb446c-174d-4997-a9bb-700333af5ee8" xlink:to="loc_srt_MinimumMember_dbef945b-1f03-4639-ab2b-de354eb11d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df13aca8-bb92-45c5-8260-eef4590bb718" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f9bb446c-174d-4997-a9bb-700333af5ee8" xlink:to="loc_srt_MaximumMember_df13aca8-bb92-45c5-8260-eef4590bb718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_dbe06a47-209b-4150-a3dc-1cf5f3932a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_AssetAcquisitionAxis_dbe06a47-209b-4150-a3dc-1cf5f3932a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_32d1f263-5999-46de-858e-5dbf436c53af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_dbe06a47-209b-4150-a3dc-1cf5f3932a1e" xlink:to="loc_us-gaap_AssetAcquisitionDomain_32d1f263-5999-46de-858e-5dbf436c53af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember_a638ec94-f0db-4cd3-be27-cf96bdd4887e" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_32d1f263-5999-46de-858e-5dbf436c53af" xlink:to="loc_ensg_A2024AcquiredPropertiesMember_a638ec94-f0db-4cd3-be27-cf96bdd4887e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2025AcquiredPropertiesMember_0372cc36-de4b-416f-b7cd-e03ae2e7b996" xlink:href="ensg-20241231.xsd#ensg_A2025AcquiredPropertiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_32d1f263-5999-46de-858e-5dbf436c53af" xlink:to="loc_ensg_A2025AcquiredPropertiesMember_0372cc36-de4b-416f-b7cd-e03ae2e7b996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d54e29aa-3dea-436a-8245-cac751c3ed5c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_dei_LegalEntityAxis_d54e29aa-3dea-436a-8245-cac751c3ed5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_86e99c5c-911e-4b2d-9e7a-6f024505e12e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d54e29aa-3dea-436a-8245-cac751c3ed5c" xlink:to="loc_dei_EntityDomain_86e99c5c-911e-4b2d-9e7a-6f024505e12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_StandardBearerHealthcareREITIncMember_17139864-c384-46db-b176-6e9653f1fe22" xlink:href="ensg-20241231.xsd#ensg_StandardBearerHealthcareREITIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_86e99c5c-911e-4b2d-9e7a-6f024505e12e" xlink:to="loc_ensg_StandardBearerHealthcareREITIncMember_17139864-c384-46db-b176-6e9653f1fe22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_fcfdc668-81b3-4fad-8479-7dd99ada4b02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_efa363fb-6a1f-412c-b6d4-2d5c185ee0a5" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_fcfdc668-81b3-4fad-8479-7dd99ada4b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_6e3c80ff-410b-4b59-8fae-e7816d0c55e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_fcfdc668-81b3-4fad-8479-7dd99ada4b02" xlink:to="loc_us-gaap_SubsequentEventMember_6e3c80ff-410b-4b59-8fae-e7816d0c55e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6d244fae-95d1-4b13-ad51-69e545b32413" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_8fc65afb-f06e-4c94-9b91-ed2e6fb6cda4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6d244fae-95d1-4b13-ad51-69e545b32413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_599ad1ce-96f5-412d-82e2-5900d6d9ccb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6d244fae-95d1-4b13-ad51-69e545b32413" xlink:to="loc_us-gaap_EquipmentMember_599ad1ce-96f5-412d-82e2-5900d6d9ccb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_10e72bdf-3a28-4b95-bde1-d223ecab295f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_10e72bdf-3a28-4b95-bde1-d223ecab295f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5bd49c5e-8d5f-46c9-ba21-cd3e3d894e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_10e72bdf-3a28-4b95-bde1-d223ecab295f" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5bd49c5e-8d5f-46c9-ba21-cd3e3d894e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CostofSalesandGeneralandAdministrativeExpenseMember_a7675bc6-4a7c-4ad0-b5f6-cc66a6288124" xlink:href="ensg-20241231.xsd#ensg_CostofSalesandGeneralandAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5bd49c5e-8d5f-46c9-ba21-cd3e3d894e4d" xlink:to="loc_ensg_CostofSalesandGeneralandAdministrativeExpenseMember_a7675bc6-4a7c-4ad0-b5f6-cc66a6288124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityAxis_9922cfcc-28e0-4783-986a-c77eb8a0fd07" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_ensg_OperatingEntityAxis_9922cfcc-28e0-4783-986a-c77eb8a0fd07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_OperatingEntityDomain_e00d4ed9-c6ce-4f53-8c7f-5c2c17fee098" xlink:href="ensg-20241231.xsd#ensg_OperatingEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityAxis_9922cfcc-28e0-4783-986a-c77eb8a0fd07" xlink:to="loc_ensg_OperatingEntityDomain_e00d4ed9-c6ce-4f53-8c7f-5c2c17fee098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_5d98c8d1-9196-406a-81d3-d3a91ed50053" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_OperatingEntityDomain_e00d4ed9-c6ce-4f53-8c7f-5c2c17fee098" xlink:to="loc_srt_SubsidiariesMember_5d98c8d1-9196-406a-81d3-d3a91ed50053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_79953966-5f37-4d5d-84d2-1d0237ee684a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_23e2bdb4-3b64-4a43-9682-3a432190fd72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_23e2bdb4-3b64-4a43-9682-3a432190fd72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_NumberOfMasterLeaseAgreements_9b2c5604-4212-4403-a1e6-295567224543" xlink:href="ensg-20241231.xsd#ensg_NumberOfMasterLeaseAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_NumberOfMasterLeaseAgreements_9b2c5604-4212-4403-a1e6-295567224543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_5627902c-1157-492e-9f32-2df0c6479c40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_5627902c-1157-492e-9f32-2df0c6479c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_9260db84-1ac0-4083-8c66-22782312eb9c" xlink:href="ensg-20241231.xsd#ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms_9260db84-1ac0-4083-8c66-22782312eb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a5c7a1b1-dc33-4eb6-9614-3a39ee64fb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a5c7a1b1-dc33-4eb6-9614-3a39ee64fb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseTermExtension_726c838d-166c-4591-9410-b71211bef175" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseTermExtension"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_LesseeOperatingLeaseTermExtension_726c838d-166c-4591-9410-b71211bef175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_1e6e1690-91d8-4718-8921-dcaef98b80c9" xlink:href="ensg-20241231.xsd#ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset_1e6e1690-91d8-4718-8921-dcaef98b80c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_814a11cd-0849-4134-9b16-6143efe5d432" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_814a11cd-0849-4134-9b16-6143efe5d432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionConsiderationTransferred_159bfff9-a932-43e9-bd04-8fc84e18e240" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionConsiderationTransferred"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_AssetAcquisitionConsiderationTransferred_159bfff9-a932-43e9-bd04-8fc84e18e240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseConsumerPriceIndex_7aa6f11e-03b8-4e51-b864-7d5a0900f8cd" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseConsumerPriceIndex"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_LesseeOperatingLeaseConsumerPriceIndex_7aa6f11e-03b8-4e51-b864-7d5a0900f8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_a10c69e6-04e1-49c5-8d09-cb59da3c5627" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_a10c69e6-04e1-49c5-8d09-cb59da3c5627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LesseeOperatingLeaseNumberOfLeases_cbf467d8-f067-4dfe-a085-c9bb1d63a8a3" xlink:href="ensg-20241231.xsd#ensg_LesseeOperatingLeaseNumberOfLeases"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_LesseeOperatingLeaseNumberOfLeases_cbf467d8-f067-4dfe-a085-c9bb1d63a8a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_1095e428-1f8e-4380-9728-80a1625cfb53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_OperatingLeaseExpense_1095e428-1f8e-4380-9728-80a1625cfb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SubsidiariesUnderMasterLeaseArrangement_08aaf78f-8822-40e4-9922-f46c9cb2753d" xlink:href="ensg-20241231.xsd#ensg_SubsidiariesUnderMasterLeaseArrangement"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_ensg_SubsidiariesUnderMasterLeaseArrangement_08aaf78f-8822-40e4-9922-f46c9cb2753d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_e426141b-0b82-4f23-8c9c-a122829f5c60" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_e426141b-0b82-4f23-8c9c-a122829f5c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ee33783c-fc3c-48c0-9db5-854335a95aff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_ee33783c-fc3c-48c0-9db5-854335a95aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6237283f-6ce9-4bd6-b8d1-9bb770bf0171" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_039db602-002f-4f9f-9d1c-b9fe44e0a154" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6237283f-6ce9-4bd6-b8d1-9bb770bf0171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofOperatingLeaseExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dc3e3a15-167f-41f8-8b74-64cfd85c3449" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_9ebd1345-1010-41d6-b888-cfdca7a2959f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dc3e3a15-167f-41f8-8b74-64cfd85c3449" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_9ebd1345-1010-41d6-b888-cfdca7a2959f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9ebd1345-1010-41d6-b888-cfdca7a2959f" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_86d8fa57-2b4a-4377-9e0a-c66b4d64efe6" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_e7017c0d-9d18-4841-ba85-ad12e684088e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:to="loc_us-gaap_CostOfSalesMember_e7017c0d-9d18-4841-ba85-ad12e684088e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cfab102b-8fe5-4c21-ac4a-c8f0455404f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_cfab102b-8fe5-4c21-ac4a-c8f0455404f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_DepreciationAndAmortizationMember_a97f460b-2720-45a2-875e-4f3285f46e1b" xlink:href="ensg-20241231.xsd#ensg_DepreciationAndAmortizationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4f21b2d0-39ec-4733-9740-a0f151536947" xlink:to="loc_ensg_DepreciationAndAmortizationMember_a97f460b-2720-45a2-875e-4f3285f46e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_9ebd1345-1010-41d6-b888-cfdca7a2959f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_dedfad1d-be0d-4dcf-a4f5-6306526d76b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_OperatingLeaseCost_dedfad1d-be0d-4dcf-a4f5-6306526d76b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_4ad41bb9-0148-4473-96ba-30a33232f51d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_VariableLeaseCost_4ad41bb9-0148-4473-96ba-30a33232f51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_9e5f23d1-e9f2-4f12-b6d7-82d8678dc944" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_LeaseCost_9e5f23d1-e9f2-4f12-b6d7-82d8678dc944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_AccruedRentAdjustment_2cb62167-a6b6-4cf1-a0de-3a320b61d023" xlink:href="ensg-20241231.xsd#ensg_AccruedRentAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_ensg_AccruedRentAdjustment_2cb62167-a6b6-4cf1-a0de-3a320b61d023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_554dae8a-eb91-431b-bcc9-789ca30f9ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_bc8091a8-1370-459c-8f99-d35cb82a36da" xlink:to="loc_us-gaap_ShortTermLeaseCost_554dae8a-eb91-431b-bcc9-789ca30f9ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_504a090a-a3eb-4274-85d0-d7d51ebea99e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_504a090a-a3eb-4274-85d0-d7d51ebea99e" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f14e8da0-314a-45f7-a090-ea88a5285740" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f14e8da0-314a-45f7-a090-ea88a5285740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7303c81b-c1ef-412f-8503-dd57a7384f51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7303c81b-c1ef-412f-8503-dd57a7384f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d3728539-0a4c-467c-9142-60c9edfb0ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_d3728539-0a4c-467c-9142-60c9edfb0ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8d4b1c3c-6fb0-4257-bade-e05825c34c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_8d4b1c3c-6fb0-4257-bade-e05825c34c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_34c4faf2-752e-4bad-a7b8-cad89b4cec00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_34c4faf2-752e-4bad-a7b8-cad89b4cec00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7218f2fc-a967-44e2-a8bc-3729b5b7e060" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7218f2fc-a967-44e2-a8bc-3729b5b7e060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_38726ea6-1fbd-42ac-ab49-45fcf7d31ead" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_38726ea6-1fbd-42ac-ab49-45fcf7d31ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7dbe11f2-e2cc-47ee-9d11-b3a761afd3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7dbe11f2-e2cc-47ee-9d11-b3a761afd3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8ee0f153-0551-4be4-85ec-5b3fa1f1b3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_OperatingLeaseLiability_8ee0f153-0551-4be4-85ec-5b3fa1f1b3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_998cc0b0-96f3-4cc6-88ba-e4bbd3e0708e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_998cc0b0-96f3-4cc6-88ba-e4bbd3e0708e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_86d54c68-ba54-4bd7-b805-f22f15be30f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_e9e3d61b-e5e1-4811-85a7-a11a1ade35be" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_86d54c68-ba54-4bd7-b805-f22f15be30f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESLessorNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d9eaccbe-c7dd-403b-bd8c-f6c6aa072387" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d9eaccbe-c7dd-403b-bd8c-f6c6aa072387" xlink:to="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis_9052abd9-4264-46f7-99f0-362f5aa18226" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_ensg_LeaseArrangementAxis_9052abd9-4264-46f7-99f0-362f5aa18226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_29643f6e-c326-46d5-bddf-aec78ed50519" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementAxis_9052abd9-4264-46f7-99f0-362f5aa18226" xlink:to="loc_ensg_LeaseArrangementDomain_29643f6e-c326-46d5-bddf-aec78ed50519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasesToThirdPartyOperatorsMember_74447115-63a3-417e-b0d8-f9b6df384275" xlink:href="ensg-20241231.xsd#ensg_LeasesToThirdPartyOperatorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementDomain_29643f6e-c326-46d5-bddf-aec78ed50519" xlink:to="loc_ensg_LeasesToThirdPartyOperatorsMember_74447115-63a3-417e-b0d8-f9b6df384275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SubleaseToThirdPartyOperatorsMember_36cc4df9-2714-4c9d-b1a3-40ef7e0836f3" xlink:href="ensg-20241231.xsd#ensg_SubleaseToThirdPartyOperatorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementDomain_29643f6e-c326-46d5-bddf-aec78ed50519" xlink:to="loc_ensg_SubleaseToThirdPartyOperatorsMember_36cc4df9-2714-4c9d-b1a3-40ef7e0836f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_37736f9e-8f33-4011-8ee3-d2a432ee1637" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_srt_CounterpartyNameAxis_37736f9e-8f33-4011-8ee3-d2a432ee1637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_86ec0257-3aa7-460b-b564-c23e2d345083" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_37736f9e-8f33-4011-8ee3-d2a432ee1637" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_86ec0257-3aa7-460b-b564-c23e2d345083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThePennantGroupInc.Member_4382270d-dc40-4407-8f65-2ec429d3e402" xlink:href="ensg-20241231.xsd#ensg_ThePennantGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_86ec0257-3aa7-460b-b564-c23e2d345083" xlink:to="loc_ensg_ThePennantGroupInc.Member_4382270d-dc40-4407-8f65-2ec429d3e402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d6034954-5966-458c-9e92-d20265f37301" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_srt_RangeAxis_d6034954-5966-458c-9e92-d20265f37301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c8395550-f5c4-42a9-8486-60d9c11d5265" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d6034954-5966-458c-9e92-d20265f37301" xlink:to="loc_srt_RangeMember_c8395550-f5c4-42a9-8486-60d9c11d5265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_69c63e5b-7af9-4b8d-a8b7-d69c6396c534" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c8395550-f5c4-42a9-8486-60d9c11d5265" xlink:to="loc_srt_MinimumMember_69c63e5b-7af9-4b8d-a8b7-d69c6396c534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8fce12e7-3ccc-4c2c-aa40-72636079bd1a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c8395550-f5c4-42a9-8486-60d9c11d5265" xlink:to="loc_srt_MaximumMember_8fce12e7-3ccc-4c2c-aa40-72636079bd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_515fb11d-7ca4-4ca4-a0e7-da7c50fd3e48" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SeniorLivingOperationsMember_4c7d7ad4-7753-4df3-af75-1136fe9267e3" xlink:href="ensg-20241231.xsd#ensg_SeniorLivingOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:to="loc_ensg_SeniorLivingOperationsMember_4c7d7ad4-7753-4df3-af75-1136fe9267e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SkilledNursingOperationsMember_d45d4093-46a0-4a95-a4e2-5f72748f393a" xlink:href="ensg-20241231.xsd#ensg_SkilledNursingOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:to="loc_ensg_SkilledNursingOperationsMember_d45d4093-46a0-4a95-a4e2-5f72748f393a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_CampusOperationsMember_932e3755-5e7b-4c5c-8c76-55c10f8bfb8b" xlink:href="ensg-20241231.xsd#ensg_CampusOperationsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_edcc3db0-3e1c-4c39-aef1-d1eba4050bcb" xlink:to="loc_ensg_CampusOperationsMember_932e3755-5e7b-4c5c-8c76-55c10f8bfb8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_aea1f6df-fb8a-46ab-82e9-3629069f156d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_us-gaap_AssetAcquisitionAxis_aea1f6df-fb8a-46ab-82e9-3629069f156d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_91de662f-63a0-468f-a181-9fcbeadbc7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_aea1f6df-fb8a-46ab-82e9-3629069f156d" xlink:to="loc_us-gaap_AssetAcquisitionDomain_91de662f-63a0-468f-a181-9fcbeadbc7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2023AcquiredPropertiesMember_d79c5f76-3a6c-4e1d-860a-97e0c1fa65b1" xlink:href="ensg-20241231.xsd#ensg_A2023AcquiredPropertiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_91de662f-63a0-468f-a181-9fcbeadbc7bd" xlink:to="loc_ensg_A2023AcquiredPropertiesMember_d79c5f76-3a6c-4e1d-860a-97e0c1fa65b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_A2024AcquiredPropertiesMember_38908fc4-4b31-4742-9c37-faadb4b9ad7c" xlink:href="ensg-20241231.xsd#ensg_A2024AcquiredPropertiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_91de662f-63a0-468f-a181-9fcbeadbc7bd" xlink:to="loc_ensg_A2024AcquiredPropertiesMember_38908fc4-4b31-4742-9c37-faadb4b9ad7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems_a3767501-2e0d-4e12-a385-9b9621764470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_38e5e92e-5259-42c6-a913-d469e474d9df" xlink:to="loc_us-gaap_LessorLeaseDescriptionLineItems_a3767501-2e0d-4e12-a385-9b9621764470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_078fda41-2b9e-4a67-bfcc-f6f5dbf89513" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_a3767501-2e0d-4e12-a385-9b9621764470" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_078fda41-2b9e-4a67-bfcc-f6f5dbf89513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeaseTermOfContract_ea797b26-d953-4245-b232-32b023bccdac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_a3767501-2e0d-4e12-a385-9b9621764470" xlink:to="loc_us-gaap_LessorOperatingLeaseTermOfContract_ea797b26-d953-4245-b232-32b023bccdac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_1056b569-54d5-4acb-9e90-15b93e3ef168" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_1056b569-54d5-4acb-9e90-15b93e3ef168" xlink:to="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementAxis_a3111e9f-dedf-4441-9f9f-8c6d61efffce" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_ensg_LeaseArrangementAxis_a3111e9f-dedf-4441-9f9f-8c6d61efffce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeaseArrangementDomain_8c22a331-feca-4cb6-a06e-8dcd8ded25bc" xlink:href="ensg-20241231.xsd#ensg_LeaseArrangementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementAxis_a3111e9f-dedf-4441-9f9f-8c6d61efffce" xlink:to="loc_ensg_LeaseArrangementDomain_8c22a331-feca-4cb6-a06e-8dcd8ded25bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_LeasesToThirdPartyOperatorsMember_ff19b46f-3ff9-492d-bf74-625c677f0989" xlink:href="ensg-20241231.xsd#ensg_LeasesToThirdPartyOperatorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ensg_LeaseArrangementDomain_8c22a331-feca-4cb6-a06e-8dcd8ded25bc" xlink:to="loc_ensg_LeasesToThirdPartyOperatorsMember_ff19b46f-3ff9-492d-bf74-625c677f0989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1d215db4-5794-463e-a0dc-cd840e5db26d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_srt_CounterpartyNameAxis_1d215db4-5794-463e-a0dc-cd840e5db26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4737e79c-fb4f-4a7b-8344-f7431cbaabf6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1d215db4-5794-463e-a0dc-cd840e5db26d" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4737e79c-fb4f-4a7b-8344-f7431cbaabf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThePennantGroupInc.Member_2f582bbf-83d6-4a35-9081-8dbd2ba17182" xlink:href="ensg-20241231.xsd#ensg_ThePennantGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4737e79c-fb4f-4a7b-8344-f7431cbaabf6" xlink:to="loc_ensg_ThePennantGroupInc.Member_2f582bbf-83d6-4a35-9081-8dbd2ba17182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_ThirdPartyTenantsMember_1ceec55e-c4f7-4854-9e5d-078a3dc6c8bc" xlink:href="ensg-20241231.xsd#ensg_ThirdPartyTenantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4737e79c-fb4f-4a7b-8344-f7431cbaabf6" xlink:to="loc_ensg_ThirdPartyTenantsMember_1ceec55e-c4f7-4854-9e5d-078a3dc6c8bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_srt_ConsolidationItemsAxis_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_662b0800-0f63-4c8c-b5c3-8213929b4900" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3ed2644f-fa4f-4bb2-aeed-2c00abb091ac" xlink:to="loc_srt_ConsolidationItemsDomain_662b0800-0f63-4c8c-b5c3-8213929b4900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_08c91ac5-6f86-462c-b59f-5751ce798369" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_662b0800-0f63-4c8c-b5c3-8213929b4900" xlink:to="loc_us-gaap_OperatingSegmentsMember_08c91ac5-6f86-462c-b59f-5751ce798369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9abc7da2-4897-49e7-8c25-b0623974d59e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_srt_ProductOrServiceAxis_9abc7da2-4897-49e7-8c25-b0623974d59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e83c3420-f643-49dd-a90f-e92d6561afee" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9abc7da2-4897-49e7-8c25-b0623974d59e" xlink:to="loc_srt_ProductsAndServicesDomain_e83c3420-f643-49dd-a90f-e92d6561afee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_RentalMember_266cfd62-860a-41a8-a065-63ab4a50e8ee" xlink:href="ensg-20241231.xsd#ensg_RentalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e83c3420-f643-49dd-a90f-e92d6561afee" xlink:to="loc_ensg_RentalMember_266cfd62-860a-41a8-a065-63ab4a50e8ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b8642113-1240-445f-8206-54e2ab2dbaf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b8642113-1240-445f-8206-54e2ab2dbaf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_5ee8b5aa-e905-46c2-8288-cf73e2e45e9f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b8642113-1240-445f-8206-54e2ab2dbaf8" xlink:to="loc_us-gaap_SegmentDomain_5ee8b5aa-e905-46c2-8288-cf73e2e45e9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_462d5466-d5b3-4d86-ad9e-a72a3ea4836e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_5ee8b5aa-e905-46c2-8288-cf73e2e45e9f" xlink:to="loc_us-gaap_AllOtherSegmentsMember_462d5466-d5b3-4d86-ad9e-a72a3ea4836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorLeaseDescriptionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionTable_511b2c1e-b954-4e10-bb99-2d5a37141aec" xlink:to="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_dd8821c5-aa74-4697-ad63-82c6aa2d7bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_dd8821c5-aa74-4697-ad63-82c6aa2d7bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_37d3ed80-66f4-41e8-99d5-ca0b8b968c04" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome_dd8821c5-aa74-4697-ad63-82c6aa2d7bbf" xlink:to="loc_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList_37d3ed80-66f4-41e8-99d5-ca0b8b968c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseVariableLeaseIncome_722af248-4611-42e2-94ad-d2480fd78ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseVariableLeaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:to="loc_us-gaap_OperatingLeaseVariableLeaseIncome_722af248-4611-42e2-94ad-d2480fd78ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_62c18ded-1aa6-448d-995b-a1074721d489" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorLeaseDescriptionLineItems_f7b33670-dc73-44fd-916a-7e94ff60b1b1" xlink:to="loc_us-gaap_SubleaseIncome_62c18ded-1aa6-448d-995b-a1074721d489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#LEASESScheduleofAnnualRentalIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_acb1ae92-4891-4ce8-9261-ec48f3bd2fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_8800f94a-7295-473c-a386-e76a5808e42a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_acb1ae92-4891-4ce8-9261-ec48f3bd2fc4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_8800f94a-7295-473c-a386-e76a5808e42a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_a17dfd23-a10d-48e2-9f78-b20c4d53e69d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_acb1ae92-4891-4ce8-9261-ec48f3bd2fc4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_a17dfd23-a10d-48e2-9f78-b20c4d53e69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_509522b1-8f54-460e-817c-3b71dabf9089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_acb1ae92-4891-4ce8-9261-ec48f3bd2fc4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_509522b1-8f54-460e-817c-3b71dabf9089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_d95697cd-b3be-4ed8-85ca-bb942d8bb838" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_acb1ae92-4891-4ce8-9261-ec48f3bd2fc4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_d95697cd-b3be-4ed8-85ca-bb942d8bb838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_e7ca3aa4-8398-4752-8b45-c1e1f73db1cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_acb1ae92-4891-4ce8-9261-ec48f3bd2fc4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears_e7ca3aa4-8398-4752-8b45-c1e1f73db1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_6b84a04f-90d4-42ab-859d-dc64cd346db9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_acb1ae92-4891-4ce8-9261-ec48f3bd2fc4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter_6b84a04f-90d4-42ab-859d-dc64cd346db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_e6ed1be2-4a2b-4047-8452-d59bbde96113" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_acb1ae92-4891-4ce8-9261-ec48f3bd2fc4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_e6ed1be2-4a2b-4047-8452-d59bbde96113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#DEFINEDCONTRIBUTIONPLANSDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_803108c9-afe5-42a7-b8a1-2b8c55fe4aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTable_e72f6752-15c7-46bd-ab24-69f8387d8b88" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_803108c9-afe5-42a7-b8a1-2b8c55fe4aa5" xlink:to="loc_us-gaap_DefinedContributionPlanTable_e72f6752-15c7-46bd-ab24-69f8387d8b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusAxis_92397b4c-1d86-474a-bd9d-4c58015257ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTaxStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_e72f6752-15c7-46bd-ab24-69f8387d8b88" xlink:to="loc_us-gaap_RetirementPlanTaxStatusAxis_92397b4c-1d86-474a-bd9d-4c58015257ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTaxStatusDomain_d132c53f-9f23-486d-b749-5a552e9d0fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetirementPlanTaxStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusAxis_92397b4c-1d86-474a-bd9d-4c58015257ed" xlink:to="loc_us-gaap_RetirementPlanTaxStatusDomain_d132c53f-9f23-486d-b749-5a552e9d0fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_QualifiedPlanMember_decfd80a-5958-460f-8521-2bb8bd29edc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_QualifiedPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_d132c53f-9f23-486d-b749-5a552e9d0fcd" xlink:to="loc_us-gaap_QualifiedPlanMember_decfd80a-5958-460f-8521-2bb8bd29edc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonqualifiedPlanMember_88bf359f-6ce6-4cdd-93cc-7bdf7c3af7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonqualifiedPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTaxStatusDomain_d132c53f-9f23-486d-b749-5a552e9d0fcd" xlink:to="loc_us-gaap_NonqualifiedPlanMember_88bf359f-6ce6-4cdd-93cc-7bdf7c3af7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanTable_e72f6752-15c7-46bd-ab24-69f8387d8b88" xlink:to="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_a3be9bb8-0a74-4ce5-b0e1-4889ab31fc57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_a3be9bb8-0a74-4ce5-b0e1-4889ab31fc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_196810f6-324a-4045-aa8e-aa0197755636" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_196810f6-324a-4045-aa8e-aa0197755636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_bbb1d899-ccd7-4736-b96b-3e9791784404" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_bbb1d899-ccd7-4736-b96b-3e9791784404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestments_d276448a-5fb1-4ba7-8dff-c640c9d27d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_us-gaap_GainLossOnInvestments_d276448a-5fb1-4ba7-8dff-c640c9d27d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_InvestmentExpenseIncome_b59b74a5-ad75-4316-bba2-bc6d213cff6a" xlink:href="ensg-20241231.xsd#ensg_InvestmentExpenseIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedContributionPlanDisclosureLineItems_1f3da5b1-274c-4198-844e-c0edb0f107bc" xlink:to="loc_ensg_InvestmentExpenseIncome_b59b74a5-ad75-4316-bba2-bc6d213cff6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_1f0e2e11-c6fc-4f2f-be27-93403ae3eaa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_5c60d6d6-3157-40ed-971f-407490277428" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_1f0e2e11-c6fc-4f2f-be27-93403ae3eaa0" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_5c60d6d6-3157-40ed-971f-407490277428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_05cf0ccb-b3e5-493f-aa66-e82559ba2258" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_5c60d6d6-3157-40ed-971f-407490277428" xlink:to="loc_srt_ProductOrServiceAxis_05cf0ccb-b3e5-493f-aa66-e82559ba2258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_05cf0ccb-b3e5-493f-aa66-e82559ba2258" xlink:to="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember_f0591cc1-7fa5-4459-b164-18b8b20c5f8d" xlink:href="ensg-20241231.xsd#ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:to="loc_ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember_f0591cc1-7fa5-4459-b164-18b8b20c5f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationInsuranceMember_320743e1-c66f-4887-9c4d-8a5f6fe0c3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WorkersCompensationInsuranceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:to="loc_us-gaap_WorkersCompensationInsuranceMember_320743e1-c66f-4887-9c4d-8a5f6fe0c3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthInsuranceProductLineMember_9c0fcc4c-84fd-4b33-b590-2fe34fd6a333" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HealthInsuranceProductLineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_ad41550c-924b-4ec0-abeb-1882c7e63e5c" xlink:to="loc_us-gaap_HealthInsuranceProductLineMember_9c0fcc4c-84fd-4b33-b590-2fe34fd6a333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable_5c60d6d6-3157-40ed-971f-407490277428" xlink:to="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserve_2b899cdc-907a-4af7-be79-9f26b7f33a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:to="loc_us-gaap_SelfInsuranceReserve_2b899cdc-907a-4af7-be79-9f26b7f33a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_5417098c-e8f7-4112-91c2-111c3abe5526" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_5417098c-e8f7-4112-91c2-111c3abe5526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveNoncurrent_94cc7c9a-0ad5-489a-bf84-857288ffc59c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SelfInsuranceReserveNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems_f75b2f32-0066-4e53-b74d-85778ffc7ad5" xlink:to="loc_us-gaap_SelfInsuranceReserveNoncurrent_94cc7c9a-0ad5-489a-bf84-857288ffc59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_e5c4383a-1c43-4bd5-a1cf-14c962beb137" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_10f5b706-65c8-4dbf-8cb0-b72115874635" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_e5c4383a-1c43-4bd5-a1cf-14c962beb137" xlink:to="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_10f5b706-65c8-4dbf-8cb0-b72115874635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_0eae7c96-e689-42d3-a164-89825a7cc5d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_10f5b706-65c8-4dbf-8cb0-b72115874635" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_0eae7c96-e689-42d3-a164-89825a7cc5d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease_2cda375e-829d-4c3f-b9be-222aafd61d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_10f5b706-65c8-4dbf-8cb0-b72115874635" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease_2cda375e-829d-4c3f-b9be-222aafd61d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_54cdc3e0-7291-475f-a1ae-c072123df424" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_10f5b706-65c8-4dbf-8cb0-b72115874635" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits_54cdc3e0-7291-475f-a1ae-c072123df424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease_fa014368-8398-4d23-870c-5f9ca1b77a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_10f5b706-65c8-4dbf-8cb0-b72115874635" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease_fa014368-8398-4d23-870c-5f9ca1b77a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForFuturePolicyBenefits_8fe046c5-9eec-4a70-bf4a-38e5dd3e9f90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilityForFuturePolicyBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward_10f5b706-65c8-4dbf-8cb0-b72115874635" xlink:to="loc_us-gaap_LiabilityForFuturePolicyBenefits_8fe046c5-9eec-4a70-bf4a-38e5dd3e9f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESNarrativeDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#SELFINSURANCELIABILITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_463c523e-c724-4968-a972-ce1ad0b70f31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimatedInsuranceRecoveries_67a38254-a054-434b-91b8-0aedafb8b61b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EstimatedInsuranceRecoveries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_463c523e-c724-4968-a972-ce1ad0b70f31" xlink:to="loc_us-gaap_EstimatedInsuranceRecoveries_67a38254-a054-434b-91b8-0aedafb8b61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8681c1ef-3ccb-4bde-9d67-3395430939ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8681c1ef-3ccb-4bde-9d67-3395430939ff" xlink:to="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51e2933d-cc55-4080-881f-4a589254d2f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51e2933d-cc55-4080-881f-4a589254d2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_923834b6-ef76-4204-94cd-9941051a0507" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51e2933d-cc55-4080-881f-4a589254d2f6" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_923834b6-ef76-4204-94cd-9941051a0507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_2c63db5a-fb49-4836-9610-58d8eda96b21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_923834b6-ef76-4204-94cd-9941051a0507" xlink:to="loc_us-gaap_AccountsReceivableMember_2c63db5a-fb49-4836-9610-58d8eda96b21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_ba479659-b929-468d-89b9-5d557dfedf3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_923834b6-ef76-4204-94cd-9941051a0507" xlink:to="loc_us-gaap_SalesRevenueNetMember_ba479659-b929-468d-89b9-5d557dfedf3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_a145caa8-c828-42cb-af42-b1ca6ed82dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ba9da6a8-3173-46ca-85f4-4a8d1e58ff3f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_a145caa8-c828-42cb-af42-b1ca6ed82dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c9c44d42-6a2f-4fd9-81c2-128717456cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_a145caa8-c828-42cb-af42-b1ca6ed82dc8" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c9c44d42-6a2f-4fd9-81c2-128717456cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_00b51848-49cf-4eb2-9301-27d7f6ba99f9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_srt_MajorCustomersAxis_00b51848-49cf-4eb2-9301-27d7f6ba99f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_5bfd469a-aea9-4325-ae8d-cc043d5b13a7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_00b51848-49cf-4eb2-9301-27d7f6ba99f9" xlink:to="loc_srt_NameOfMajorCustomerDomain_5bfd469a-aea9-4325-ae8d-cc043d5b13a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_MedicaidAndMedicareMember_7a2ec057-a9fa-4e48-bbfe-00dece542115" xlink:href="ensg-20241231.xsd#ensg_MedicaidAndMedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_5bfd469a-aea9-4325-ae8d-cc043d5b13a7" xlink:to="loc_ensg_MedicaidAndMedicareMember_7a2ec057-a9fa-4e48-bbfe-00dece542115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d33f1030-e852-4c6e-ac2c-6d34134109fa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_srt_ProductOrServiceAxis_d33f1030-e852-4c6e-ac2c-6d34134109fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47bee5c4-0be0-49fb-bb93-d166064b10cc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d33f1030-e852-4c6e-ac2c-6d34134109fa" xlink:to="loc_srt_ProductsAndServicesDomain_47bee5c4-0be0-49fb-bb93-d166064b10cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_b945c8b0-d568-4e01-9f0c-54f2b0178089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47bee5c4-0be0-49fb-bb93-d166064b10cc" xlink:to="loc_us-gaap_ServiceMember_b945c8b0-d568-4e01-9f0c-54f2b0178089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_468f73fd-87f4-4e5c-ac02-bbaef9612e50" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_5a23c7d2-ac46-4e11-91f2-830ceebbc74e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedToOtherParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedToOtherParty_5a23c7d2-ac46-4e11-91f2-830ceebbc74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews_df02d1bc-27cb-4839-a945-e723f100c413" xlink:href="ensg-20241231.xsd#ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:to="loc_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews_df02d1bc-27cb-4839-a945-e723f100c413" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_1f7a7b2e-3d21-44eb-9473-ddb9d0529a43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_39203dc4-3746-4bfb-bf78-425fed4e214a" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_1f7a7b2e-3d21-44eb-9473-ddb9d0529a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails" xlink:type="simple" xlink:href="ensg-20241231.xsd#COMMONSTOCKREPURCHASEPROGRAMDetails"/>
  <link:presentationLink xlink:role="http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_52c6dee6-6593-482f-8b68-7c6e2b90bb58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_d169af50-b19f-4c80-bbb6-9d90b3633d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_52c6dee6-6593-482f-8b68-7c6e2b90bb58" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_d169af50-b19f-4c80-bbb6-9d90b3633d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_b3a4d9d0-b38e-40ba-a95d-babd42187f90" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d169af50-b19f-4c80-bbb6-9d90b3633d3e" xlink:to="loc_srt_ShareRepurchaseProgramAxis_b3a4d9d0-b38e-40ba-a95d-babd42187f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramAxis_b3a4d9d0-b38e-40ba-a95d-babd42187f90" xlink:to="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_May2024RepurchaseProgramMember_a5875a83-d837-4b25-80b4-17c33a2ea453" xlink:href="ensg-20241231.xsd#ensg_May2024RepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:to="loc_ensg_May2024RepurchaseProgramMember_a5875a83-d837-4b25-80b4-17c33a2ea453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_August2023RepurchaseProgramMember_c23122b8-44e1-4d11-bbd2-320f448e8416" xlink:href="ensg-20241231.xsd#ensg_August2023RepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:to="loc_ensg_August2023RepurchaseProgramMember_c23122b8-44e1-4d11-bbd2-320f448e8416" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_July2022RepurchaseProgramMember_9687b096-a197-44cb-bf58-d1e75c102a34" xlink:href="ensg-20241231.xsd#ensg_July2022RepurchaseProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_71a47e7b-eb05-4ad5-8e31-1513ea5d77e9" xlink:to="loc_ensg_July2022RepurchaseProgramMember_9687b096-a197-44cb-bf58-d1e75c102a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_d169af50-b19f-4c80-bbb6-9d90b3633d3e" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_ffac6f54-f50f-4ee6-a119-a23215f49e10" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_ffac6f54-f50f-4ee6-a119-a23215f49e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_976b35de-214a-4131-a20a-a524b29124d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_976b35de-214a-4131-a20a-a524b29124d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_9094e27a-2b49-4c49-a0db-f8dc2a2941c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_9094e27a-2b49-4c49-a0db-f8dc2a2941c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_711b3745-0b61-47f9-b650-9780bba18531" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_32180daf-16da-477e-8c12-1f8a112a5af4" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_711b3745-0b61-47f9-b650-9780bba18531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_Dr.AnnS.BlouinMember" xlink:href="ensg-20241231.xsd#ensg_Dr.AnnS.BlouinMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ensg_Dr.AnnS.BlouinMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ensg_SuzanneD.SnapperMember" xlink:href="ensg-20241231.xsd#ensg_SuzanneD.SnapperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ensg_SuzanneD.SnapperMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ensg-20241231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ensg-20241231_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1#Z17AI9@  34T *@    @ ! $[  (
M   0   (2H=I  0    !   (6IR=  $    @   0TNH<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 %)I='1M86XL
M($QA=7)E;@  !9 #  (    4   0J) $  (    4   0O)*1  (    #-S(
M )*2  (    #-S(  .H<  <   @,   (G      <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BK_P  1" "T 2 # 2(  A$! Q$!_\0
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MEBJTMY,TK[Q#J^ID_;]1N)\G)WN:SF9F^\2?J:2BLFV]S!MO<****1(4444
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MQS7G5,!%ZP=CRZV6PEK3=CXXHKZ/U7X'>&;W<UDUQ9N>@1P5'X$9_6N.U'X
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M0W$UM()+>62)QT:-BI_,5'10,[KPY\6_$F@%8Y;C[?;C_EG<<G_OKK^M>O\
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MX8N6CU*RD\L'Y9HQN1AZY'3\:Y^O(E%Q=FCPY1E%VDK!1112)"BBB@ HHHH
M**** "BBB@ HI0"QP!D^@K3L?#6M:DP6RTRZEST(B('YGBFDWL4HMZ(RZ*]
MTKX,>*]0VFXMX[%3_%.X/'_ <UV&F_L^QC!U;6"<=5MTX/XG%;QPM:6T3IA@
MZ\]HGA]*JLYPBECZ 9KZ7T[X+^$['#36TMTX_BDD./RSBNELO!GAS3P/LVC6
M2L.CF!2WYXKHC@*CW9U1RRJ_B:1\E)87<GW+69OI&35R/PUK4K )IER2?^F9
MKZ^@M+>V&+>".+C'R*!4U;++UUD;K*UUE^!\@?\ "(Z__P! FY_[XJO)X?U>
M)2SZ=<@+U_=FOL>BG_9\?YA_V7'^8\$^$OCR\T>]30=;6464IQ!)(I'E-Z?0
M_P!*][JI-I6GW+;KBRMY6ZY>(&K?3I791IRIQY6[GH8>E*E#DD[A1116YT >
ME05.>E0541!2K]X?6DHJ@)Z*AS1FIY1DU%0YHS1R@345#FC-'* Z>WAN8C'<
MQ)*AZJZA@?P-<-K_ ,'_  QK9:2&!K"=N2]N>I^AR*[?-&:B=&,U:2N9SIPJ
M*TU<\)U/X!:K"2VEZC#<KV1QM;\^E<?J7PR\6:8Q$VD32X[P#S/_ $'-?4V:
M,UR2R^D]M#AGEU&6UT?'L^A:M:Y^TZ9=Q8_OP,/YBJ4D4D+8E1D.,X88K[+>
M"*3_ %D2-_O*#4+:=9,<M9VY/O$O^%8/+>TOP.=Y7VE^!\< $G &35A-.O9&
MQ':3,?01DU]?_P!F6 _Y<K?_ +]+_A3Q9VJGY;:$?2,4?V:_YOP$LK[R_ ^3
MK3P?XBO6 M]%OF!_B^SL!^>*WM/^$'B^_/\ QX+ O<RR!?T-?3"J$&% 4>@%
M.S6D<N@MV:QRRFOB;/"]/^ &I28;4=4@A'=(U)/Y]*ZS3/@5X<M-K7LUS>D?
M>5V"@_E@UZ1FC-;QP5&/0Z88*A'[)CZ=X(\-Z5C[%H]LN.A==_\ Z%FMN*&.
M%-D,:1KZ(H IF:,UTJFH['7&,8_"K$U%0YHS3Y2B:BH<T9HY0)J*AS1FCE F
MHJ'-&:.4":BH<T9HY0)J*AS1FCE F/2H*7-)32L(****H HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>ensg-20241231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ensg-20241231_g2.jpg
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MJS2OJ[OL?/48U\52PM%4Y1]FXN3DK)<JV5][GYZ67[4?[('[<O[3OQ'^*?\
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M/$TL(XUHV?-+OW\TOEY!1117TI[(4444 %%%% !1110 4444 %%%% !1110
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M#_@M3_P5+_88_;X_8;_9B^#7[(MGJ6J:UX#\2>'[SQ.T7A*XM[;P= +$V?\
M9<MQ+&JAY)MH582\;BSSNX3/])] !1110 4444 %%%% !1110 4444 %%%%
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M** "BBB@ HHHH **** "BBB@ HHJ.ZN[6QMI+V^N8X88D+RS2N%5% R22>
M.] $E%?,G[0'_!87_@GG^SH9K'Q1^T-IFN:G#D'1_!P.JS%AU0O!F&-AZ22)
M7QK\:O\ @Z$\/P&6Q_9U_9?O+G.?)U3QIJZP@>F;6V#Y_P"_XKP\;Q)DF ;5
M6NK]E[S^Y7M\SS<1F^6X72=17[+5_A<_66BOY]/BK_P<$?\ !27XD>9#H'Q
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MV4=Q+!-:-)>B*VDN+A[6&&*7!9,*5PR ;J]B\<_L=?\ !1_X'?%3]E3X1?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOPZ_;S;*6'Q0\+\< ZCI/\VB8_F0WT6OFZBOA\DXRXDX>:6#Q$E!?8?O0_\
M 7=+U5GYGGX?'XO"_P .6G;=?<?H1X'^)/@;XD6']H^"_$MM?( #)'&V)(_]
M]&PR_B*W*_.32-9U?P_J$>K:%JEQ9W4)S%<6LQC=#[%3D5[K\)OVXM?T<Q:/
M\5; ZE;#"C4[1 MP@]67A9/J-I_WC7[?PWXQY9CG&CFT/8S?VU=P?K]J/_DR
M[M'T.$SVC4M&NN5]^G^:_$^IJ*R?!GCKPE\0='77O!VNP7ULW#-$WS1G^ZZG
ME#[$ UK5^R4*]'$THU:,E*,M4T[IKNFM&>[&49QYHNZ"BBBM2@HHHH ****
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MB@ KZ*_X)-_ K_AH;_@H/\,_ UU9>=86>OKK.JJRY3[/8J;HJ_\ LNT2Q_\
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MY6_>7:C\DI6MYJY\7?L*?\$6OV@?V[/@M)\<O"OQ#\,^&=*FU6>QT>'7O/\
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M22QJ%) " #I7B-?+XBB\/B)TFT^5M76SL[77D>+5INE5E!N]FUIMH%?T2_\
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MGB/_  4T_P""C'Q"_P""A/QNE\3WKW.F^"]%DD@\&>&GDXMH"<&XE .&N)<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHKA/VFOVA/ G[*OP(\3?'_XD7!72O#>FM<O"C@/=2DA8;>//
M&^21DC7MEQGC-14J4Z--U)NR2NWV2)G.-.#E)V2U9\3_ /!?3_@H^_[-_P )
M!^RI\)=<,7C;QSIS'6+NVDQ)I&CL2CD$?=EG(:->ZH)&^4E"?PNKM?VB_CW\
M0/VG_C;XC^/'Q/U#[1K/B347N;@*3L@3A8X(P>D<<82-1V5!UKBJ_G[B#.:F
M=YC*L_@6D5V7^;W?W=#\KS7,)YCBW4?PK1+R_P"#U"BBBO#/-"BBB@ HHHH
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MT5[-I+>_3U9\3_\ !+#]F/X1^(T\8?MH_M8^'8]0^%?PQLQ&VDW0_=^(=;N
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M@C^Z.0@]"3U; \#KDXESOZ_6^KT7^[C_ .3/OZ+I]_8_*.,N)?[4Q'U3#O\
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M_:2?X*?$U?"'B74-GAOQ',D-T9&^2TN>D<_/ '\#G^Z03]P5^C-?C77Z.?L
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MM4?$=?A!^SY^V;X!\4^*)!(;;0M.UU/M-V$!+^0C[3/M52Q\O=A06Z#-?0%
M'&V'[.OP"TOXVWO[2NF_!3PK;_$/4M+73=0\<PZ!;KJUS9C9BWDNPGFO&/*C
M&TMC$:?W1B#PG^S'^SCX"\6^+_'O@GX#>#])UOX@-N\=:MIWANVAN/$)^?\
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ML<?M,":7XW?LY^%];NYP1)JITX6]\<_]/4&R8?@]?%OQX_X-FOV9/&'G:E\
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M^+UQXIT_X=6VN6^I/H5GAPGVBXMB87N)#(Q?RRP^123EBJ@'W)1110 4444
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M+]YK[373T7XOT04445\<?G@4444 %%%% !1110 4444 %%%% !1110 4444
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _F^_P""I^B/X?\
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M5DT'XH?#W7/#=])%YL=EK^DS6<S)DC<$F521D$9QCBK?@7X*?&7XHZ?>:O\
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M&[+Y?\/^ 4445[1](%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!^"?_  7/_8^;]FK]L.[^(GAG2C#X6^)(DUC3VC3$<-_N'VV >_F,LP'0
M+< #[IKXKK^CG_@J!^QG;?MN?LF:W\-=,M(CXGTO_B:^#KA\ K?Q*V(2QZ+,
MA>(YX!=6/W!7\YFH6%]I5_/I>IV<MO<VTS17%O/&5>*120RLIY!!!!!Z$5^!
M\:Y,\JS>52"_=U;R7D_M+Y/7T:/FLPP_L:]UL]?\R&BBBOCS@"BBB@ HHHH
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M0%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0DXO=!11160@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1K\2P3,&8(VR10ZPL#&$R'=& *;B ?JS17X&>$_^"S/_  <,?'/_ ()GW/\
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MR]OJ&FZA;M%-;2J<,CHP!4@]C6?7Y$TXNSW/"V"BBBD 4444 %%%% !1110
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M:0LQD2TN0S13QHY +()8WVL0"5P2,U[-0 4444 %%%% !1110 4444 %%%%
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M5((((/(K\7S+*<PRBO[+%0<7T?1^:>S_ *N?/UJ%6A+EFK$5%%%><9!1110
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M!<%E&25XYXJI\%_@;\)/V=_ -I\,/@KX"T_P[H=D/W5EI\6-[8 ,DCG+2R'
MR[EF;')-=77[CPQPS#(,-*,YN<YVYOY?DOU>K\CZ'"X*.'IN,G>^_8^1OB3X
M U3X<>*)M U#+Q_?M+G;@31'HWU[$=B#6!7U?\6OAI8?$SPP^FOMCO8,R:?<
MD?<?'W3_ ++=#^![5XO\,_V=?%'BO5'E\56TVF:?;3%)BZXEF93@J@/;MOZ>
MF:G%995IXGDI*Z>WEZ^A\CCLEKTL8H48WC+;R\GZ&!\+_A7K_P 3M7^RV"&&
MRB8?;+YU^6,>@_O,>P_/ KZ<\'^#]"\#:'%X?\/6@BACY9CR\C=W8]R?_K#
M %6-!T'1_#.E0Z)H5A';6T"XCBC'ZD]23W)Y-7*]W X"G@XWWD]W_D?3Y9E=
M++X7>LWN_P!%Y?F%%%%=YZI!J5A#JNG7&EW+R+'<P/%(T4A1@K @D,.0<'@C
MI7YF7'_!I9_P2RO-:B\1W?B;XR2ZC A2"_D^([--&O/"N8-P'S-P#_$?6OTZ
MHH ^0OVO?^"(G[#_ .VO\ ?AG\!OB_9^++>3X0Z/::9X!\<Z)XB,/B#3H(((
M81FZ='69G$$3L9(V^=-Z[22:U_\ @GK_ ,$>/V,_^":VB^*XO@;I/B'6M?\
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M7$,F/K(3[U^CE%>-B^'LDQSO6P\6^]K/[U9_B<\\+AZGQ11^,'Q _P"#:?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
6444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>ensg-20241231_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ensg-20241231_g3.jpg
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<W\7_A-X'^.WPRUK
MX0?$O3I[S0/$%DUIJUI;7\ULT\#$;D\R%E=0<8.&&02#D$BNDHJ9PC4@XR5T
M]&A2C&47%JZ9S_PJ^%?P_P#@A\.M'^$WPK\,6^C>'M!LEM=*TVVW%88U]V)9
MV))9G8EF9BS$DDUT%%%$8QA%1BK);((QC%))62"BBBJ&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[4/P7EOW\,>,]+%]I']J6GD7"IO9&62/)"LKHRG!(XR"1@U^&'_!3?QCH/\
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MBTH1:7KA:0IFV?N#C>G7?'\_'2NH_P""A7[7]C^P-^QEX]_:_P!2\!R^)X?
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M6UO6=5D,\ 81-YJK(=H)49 KZ6_X),?M1?M%_P#!7;_@I=\4/VK]?_:/\4^
M_A=\$-1'ACPO^SQ8ZQ-93WLI2:-=0URU4A6RPF8(VXB:/R\A;;]Z ?0&G_\
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MXF_#;Q<RKX4^(.AZH7QL&G:M#/NSTQL8YK<K^1L$@Y!KMO!/[2W[1OPU*?\
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M-&D>([CXCZ]J.KZ?XGT[1Y(X-,NG@L18RM#(^Z0PW%A%,P#+D?*"/O5^F-%
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MC+_@E+IO[26@OJOB'XH#Q1IWBJ?1IOL\-NL]HZ021AMQ?9;<LO&YN!@9KO\
M]O#_ ((9?%?XZ7?[/W[1'[(W[5D'PU^/'[/_ (.L/#ND>+[G1/M-CJUI;P[
MLD1W&,!GN" 5E1TN9(W1@01^D-% 'Y>_M*_\$,OVV_V\?V _$?P#_;D_X*.I
MXQ^)VH?$:P\8>&==MO"BVVA:')9V<UFFGI:1E T,D=S.SR*B-YC(Q1RC;S1O
M^",7_!1CXP?MT? ;]O']M_\ ;P\%>+-9^#VJR9\,>&/ AT^Q2P"#:+=U*EYY
M92S2-(JJH"!!@8K]0J* /@;X'?\ !%,>$?VNOVO_ (U?&3XGV&O^#/VIM&ET
MF;PYIUC)!=Z=:3QS).'E<LI?;,0K*." W'2OE31/^#:__@I/#^REX@_X)SZS
M_P %9[9?@! ;Z[\(^$].\&+'<W5V\KW%O%>S$>9':"Z83R0)+*C,&VJI(9?V
MDHH \G_82_9TU;]D/]C/X8?LO:]XEM]9O? /@G3]#N]5LX&BBNY+>!8VD16)
M*J2"0#SBO&?^"@W[,O\ P54^+OQ&_M[]A?\ ;8\">$?"&K>#AHGB3P!\0_A]
M%JEHUQYMP7U"&;8[%WBG2)H77RR(%)W9P/KZB@#\C/B-_P &PVK7G_!'#PQ_
MP3#^&?[3UC'KMC\78_'OB7QCK.A2?9;NZ-E<6DD$%O'(6B18Y(0N6.XPLQV^
M9A?H&\_X(^>.?A7_ ,%@M._X*?\ [(GQKTKP?I?BC2O[/^-O@&]TJ62'Q*"
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M4W8[9QG%:5% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9992[' V?*A+1I]@5^,W_!*7]MW]L2[_ &X?V:/ 'CC]N/6?C/HG[1'P O\
MQG\0]!UBWT]H_"&JQ":5#:_9(8VM8@\?V7RF)!;?D9V"/]F: "BBB@ HHHH
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MW"+=K;>>B^]G@%%=/\9_@[\0?V?_ (I:W\&OBKH8TWQ#X>O#:ZI9+<QS".3
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M[]CK]IK]F_XH:[X!_89^,WP2UWP/X2GUKPQXG\=2WOV?7_*BED$;+< Q9/E
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MNHL32CYEM$/_ "RC/K_>;OT''7U6OZ;\./#J.2PCF>91OB'K&+_Y=KN_[_\
MZ3MO<^ORK*EATJU5>]T7;_@_D%0SZCI]K=P6%S?0QSW186T+R@/*5&6V@\M@
M<G'05R_QK^-7@CX#^!KCQSXXO]D2?):6D9'G7DV,K%&.Y/<] ,D\"OS;^+/[
M37Q3^*_Q5B^*]YKLVGW=A,&T."RF(33D!RJQ^I_O,?O'KQ@#]&S?/L-E/+%K
MFF^BZ+N_T[G)Q!Q3@\A<8-<]1V]U/9=6_P!%U]#]4J*\4_8Y_:WT?]HSPO\
MV/KSPVGBO380=1LU^5;I!@?:(A_=)QN7^$GT(KVNO5PN*H8VA&M2=XO^OO/=
MP..PV8X6.(H2O&7]6?9KJ%%%%=!UA1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !117F/[8_P"U'X(_8V_9R\2_M!^.R)8-$LO] L!)
MM?4+USL@ME]WD*@D [5W,1A36=:M3P]*56H[1BFV^R1%2I"E!SF[):L^%/\
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M1PPQ(69V)P% '4DTXQE*225VP2;8NG:=?ZO?PZ7I=G)<7-Q((X((4+-(Q.
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MV*-?XG;' ^I) !(_-+]I#]H_QI^T?XV;Q'XA<VVG6Q9-'TB.0F.TB)_\>=L
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M?B?DN98MXW'3J]&]/1:(****\DX0HHHH **** "BBB@ HHHH **** "BBB@
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MBWEI\NO^7S./HHI41Y'$<:%F8X55&23Z5_*6Y\8+'')-(L,,;.[L JJ,DD]
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MQTVPB+W$\I_)5'5F)P HY)( IWC7QKX7^'?A>\\9^,]8BL--L(C)<W,QX [
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MJB@#\6_V#_\ @CU^W_\ !/\ 9?\ ^"A7@'XF?L]>"_"VM_M"^''_ .%9^&/
MNN62Z,+B>UUECI]HH=19V\$E_!;H)A&H5>/E7=7<>/O^"6/[;FM_\&MFF?\
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MN],\,V-M>>&_"%N(=*TN9+=%DM;-% "V\;ADC  PBKQ75444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'YI_\ !RW\4CHG[/WP
M]^#L%SMD\0^*Y]3F16Y:*RM_+P?;?>(?J@]*_&NOT4_X.3/B =<_:Y\(?#N"
M;=#H'@1)Y%S]R>YNIRP_[]PPG\:_.NOY]XTQ+Q/$=;M&T5\DK_C<^8S"?/BY
M>6@5K^"_'_CSX;ZTGB3X=^-M7T#48_\ 5W^BZE+:SK]'B96'YUD45\M&4H2O
M%V9Q)M/0^NO@K_P7#_X*(_!OR;2[^+5MXQL8<8L?&FF)=EOK.ACN&_&4U]=_
M!7_@YA\%WGDV'[0_[-VHZ>W FU/P?J:72L?46]QY90?]M6-?D517T."XLX@P
M-E3KMKM+WE^-VODT=5/&XJGM+[]3^C#X*_\ !7#_ ()\?'7R;7PU^T?H^DWT
MN!_9WBO?I4BL>B!KD+&[?[CM7T3IFIZ;K5A%JNCZC!=VLZ!X+FVF62.13T*L
MI((]Q7\HU=C\)_VAOCO\"+_^TO@Q\8O$OA>4ON<:'K4ULDA_VT1@KCV8$&OK
ML%XE8B-EBZ"?G%V_!W_-'=3S:2^./W']1]%?A)\%?^#@K]O3X9^39>/[SPYX
M\LTPK_V[I M[G8.RS6AB&?\ :='/KDU]=_!7_@Y+_9K\5>38?'+X->)O"%R^
M ]WI4T>J6BGNS']U*!WPL;GZ]:^MP7''#V,LG4=-]I*WXJZ_$[J>8X6IUMZG
MZ-WUC9:G9R:?J5G%<6\R%)H)XPZ.IZ@J>"/8U\Z_'#_@DA_P3Q^/_G7/C+]F
M30=/OILDZGX61M)G#G^,_92B2-_UT5L]ZZKX*?\ !0O]B?\ :%$,/PH_:4\+
MWUW/CRM,O+_[%>,3V%O<B.4_@M>R]>E?0N.6YK1NU"K'Y27ZF\Z6&Q4+32DO
MDS\J_CA_P; _#;4_.U#]G/\ :3U?2'Y:+3/%^FQWL;'^[Y\'E,@]S&Y^O6OC
MKXX_\$&/^"COP9\Z\TOX66'C:PAR3>^"]62X8CMBWF$5PQ]EC:OZ&:*^>QG
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MNV*]N9;&49^]YT3HH_[[*'\*\CK<^&&OGPI\2O#WBA7VG3=<M+K.>GES(_\
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MQP15F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8634?"VH26$H']XQ3><KM[!HQ].E?7?P5_X+O_\ !/3XN>3::[\0-4\$WTN
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MZ**_)\5BJ^,KNM6=Y/\ K[C\'QN-Q.8XF6(Q$N:4OZLNR71!1117.<@4444
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MQX(U;5/AUX/_ 'OAF[N=7/\ :VG7GF32&\CN54 3%KB?/R>65D9"A7Y:Q?\
M@G[_ ,$)/V&/^"=/Q>O/V@_ABWC3QCX\N--_LZT\7_$GQ&NIWFFVA4(T-MLB
MBCC!10A?87"90,%9E/V;10!X5X#_ ."?'P5\&_MQ>+O^"A.M>(?$OBGXB>)]
M!M]#TR;Q/>P36GA72XN6L]*BB@C-O'(WSR%VD=F+'<-\@;R'X]_\$%OV$_VB
M_P!H'Q'\>/'-UX_M;7QSK6G:O\1?AYHOC.6U\,^+[ZQ.;:XU"R52964\X5T!
M)9B-S,3]IT4 (B)&@CC4*JC"J!@ 4M%% !1110 4444 %%%% !1110 4444
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MZR?$KX ?!KXOQ,OQ#^'FG:A*RX%X8?+N%'M,F''TW8KYT^*'_!*KP]?&2_\
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M **** "BBB@ HHHH **** "BBB@#\</^#F+X=R:9\>?AM\5EM\)K/A*YTHR
M=6L[GS<'WQ>C_(K\SJ_;G_@XX^$[^,/V--!^*%G;[I_!_C&$W#X^Y:74;PO]
M,S"V%?B-7X#QQAGAN(ZKZ32DOFK/\4SYG,8<F+EYZA1117R)PA1110 4444
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MY==K_,?,(_2^#<\ABZ/]DXN7_7MO_P!)_P OFNQW4U3QV'>%J_\ ;K[/^O\
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MU,>#$>>IV9]Z]@@G@NH5N+:9)(W&4=&!##U!'6GUMB,+AL7#EK04EYJYT8K
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M-+N$T'PRE@MG/I=A]G"3Q(I.'=HM1,BN^#O&QMJJM=Q_P3J\:?\ !.7XN?\
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M5C>%H=,6WC$DPN$QYD+HA5S&ZA]K*<889\[UK_@MK_P2=\/>+?#/@;6?V\/
M$&I>+K&TO-$B.I,4,%RBO \\H0QVF]'5@)VC.U@<8(- 'U+17EO[5W[;7[*'
M[#?@.V^)G[67QUT+P/HU]=_9M/N-7G8R7DV-Q2"&-6EF(7DA%;:.3@<U^>/P
M2_X*D>)/VI/^#B_P[\)/V;_VL$\7_ 76_@9)JMKHVB7<<NG27Z)*7D8;=\<Z
MNH#*VUU(VD#I0!^L%%4?$_B?PUX*\.7_ (P\9>(;'2=(TNTDNM3U34[M(+:T
M@C4L\LLCD+&BJ"2S$  $DU\T_!S_ (+7_P#!*?X__%ZU^ _PC_;B\$ZOXJO[
ML6NFZ;]JE@6^G)PL5O--&D-P['A5C=BY("@YH ^I**_.7]L;_@XF_9R_9$_X
M*?\ @S]A'Q+J/A5_"=S87'_"S_']WK\L3>$+Y8IWBM9(5A8,S>7!GYO^7D=-
MO/F?[9'_  5+UWX2?\%^OV9="@_:\@T#]F[QC\ KOQ=XB^TZG%!HFHQ267B"
M:VOI)) ,[OL]D4Y!)5 !EL$ _6:BO&OV0O\ @H5^Q9^WMIFKZK^R%^T1H'CA
M- FCCUJ#3'DCN+(ON\MI()D214?:^U]NUBC $[3CA?B=_P %I?\ @E7\&?C9
M-^SO\3?VY? FD^+K2^^QW^GS:@[16-QG:T-Q<HAM[=U.0RRR*4(PV#0!]/T5
MY=\<OVU_V3?V9]8\)Z%\?OC_ .&O"4_CF.\D\)MK6H"&+48[2))KF1)3^[5(
MXY(V9V8* Z\\U:_9;_:Y_9P_;6^&+?&;]EKXKZ?XR\,)JD^G-J^FQRI&+J';
MYD>)41L@.ISC!# @D'- 'H]%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 >.?MS_ +&7PY_;F^ >H_!GQT%M;O/VKP[K
MB1!I=*OE4A)E'\2G)5TR-R,PR#AA_.E\>O@5\2OV:_BUK7P5^+>@OIVN:'=F
M&YB.2DJ]4FC; WQNI#JW=6'3I7]2%?*'_!5'_@F?X3_;X^%HU;PU':Z;\1_#
MULQ\,ZS(-JW:<L;&X8#)B8DE6Y,;G<.&=6^&XRX76<4/K.&7[Z*_\"7;U73[
MNUO.Q^#]O'GA\2_$_GNHK7\>^ _&7PO\9ZG\//B%X<NM(UO1[Q[74]-O8MDM
MO*IP5(_4$<$$$$@@UD5^&RC*$G&2LT?.--.S"BBBD 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %;7PZ^(?C/X3>.])^)?P\\03Z
M5KFAW\=YIFH6S8>&9#D'T([%3D,"0002*Q:*J,I0DI1=F@3:=T?T8_L(?MB?
M#;_@I1^R\GB2X@M[;7;5$LO&6A1/\VGWP7(EC!R?*DP9(V.>-R$DHU<=X[\%
M:MX \2W'AO5TRT1W0S 86:,_=<?7]"".U?C7^P+^VMX]_83_ &@M.^+WA0RW
M>ERXM/%.A"3":G8,P+ISP)%^_&_\+*,Y4L#_ $ 7DOPY_:^^!^C?%CX4:[;Z
MC::I8"^\/:G&<!U8?-"XZJ<@HRGE'4@\@BOVG(\UCQ-EMI?[Q36O]Y=_GU[/
MR:.S%X=9MA>:/\6'XK^OQ]3Y[HJ2[M+FPNI+&]@:*:&0I+$XPR,#@@CUS4=/
M8^/::=F%%%% !1110 5M_#WP/J?Q"\4V_AS305#G=<38R(8A]YS_ "'J2!WK
M(M+2ZO[J.QLK=Y9IG"111KEG8G  '<YKZB^"WPMM_AIX:$=RJOJ=X ]_,.<'
MM&#Z+D_4Y/ICOP&#>+K:_"M_\CU,JR^6/Q%G\"W_ ,OF=/H6B:;X;T>VT+2+
M<16UK$(XD'H.Y]2>I/<FO _^"NO_ "BI_:4_[(/XM_\ 31=5]#UA?$_X:^!O
MC-\-O$'PA^)WAZ+5_#?BG1;K2=?TJ=V5+RRN(FAFA8H0P#1NRDJ01G@@U]@D
MHJR/T.,5%)+9'X#_ /!*'_@D5^WC_P %/?\ @D+\*_AG\1O^"D,?A+]F;4]4
MU*[3X7>'O ]L^I2_9M?O3+'+>D(SAKN.6=/,:5$+H?+8QJ!Z7_P6._8R_9WU
M?_@K[_P3X_8>U;P&ES\,]/\ #HT!/#DL[[)M-LY4$=O(X(9U9855SG+ MDY.
M:_9/]G+]G#X)?LD?!G1OV>_V=/ %MX7\&^'Q<#1]"LYY9([;S[B2YEPTKNYW
M332.<L>7/; K&^*7[%W[,'QK^//@C]IWXH_".QU?QY\./,_X0KQ%/<SK+I?F
M'+[4218WR>?G5L=L4QGY8?\ !=;X+?!_]G[_ (*$?\$P?A=\"?A=X?\ !OAJ
MR_:(N);/P_X7TB&PLK=Y=>\,RR%(855$W.[,< 9)->4_MR?M%W?_  0:_P""
MVW[0?Q@TF.2S\,_M'? ?4?$'A5(XSY"^+$B<P,Y'5C?V]P3Z#4@>XK]I/CS^
MQ=^S!^T[\1?A[\6OCO\ ".Q\1^(OA3KIUGX?:I=74\;Z-?&6WE\Z,12*KGS+
M2W;#AAF(<=<X'[8W_!-O]A__ (* R>'Y_P!L+]GK2?&\GA87(T":_NKF![03
M^7YRAK>6,LK&*,[6) *\ 9.0#\>_A]J7PG_X)"_\&\/P-UKXV_L@>%?BYXU^
M.'Q,M_%.G:#\1$C_ +'M=6O[>62RO[TRJP(BT^.W78V#OD<[E 8UF^$M*^/W
M@S_@Z#_9@M/V@=%_9ST/Q5<>#M12^TO]FR*ZBLHK5]+UC9'J(N,%KHJQP0H!
MA\K&0 :_;;]H[]BO]E?]KCX%+^S1^T7\$M&\3^!XO(^R:!=(\26;0(4A>WDA
M9)+=T0LBO$RL%9ESAB#Y=^SO_P $6_\ @E[^RAXU\)?$G]GW]D#0/#GB+P/<
M7D_AK7H+Z]GO+>2ZA\B9I)IYW>YS$2H\XR; QV;<G(!^:?\ P3A^%/[#_P /
MO^#D7]K+X<_%'X9?"O1;'1/[*G^&FB:]HFFV\&GWPELFC?38I4"PS[Y4*F$!
M\N".37DG['-C^V+\1O\ @KU^W+I/@>+]E*\\:WGQ&O++5+#]JC3]2N;F;0UO
M;Z*&+2EM74&U%NMLLH;.4%GCCK^SGQH_X))?\$Z?VAOVG](_;-^,'[+FC:O\
M3-#O;*[L?%(O[RWD>>T*&VEGB@F2&Z:/RXPIF1SMC5?NJ ,S]K__ ((Q?\$Q
M?V\_B&OQ:_:I_9*T3Q)XG$,<4VO6NIW^EW=TD:A4$\EA<0-<;5 4>:6PJA1P
M * /*O\ @W;_ &*/'W[!'[#FO? OQU^T-\/OB*&^)VIZAIEY\--=EU'3-)AD
MM[1'L!+*BLLB3Q32-&1\IFY))->+?\% /VL=0\>_\%D8_P!A[]E']BG]G76O
MB]IWPO@O=?\ BW^T9;R/:6^EJ7N5L;5($,S!5N2YV-ES(X90L)>OT>_9F_99
M_9\_8W^$MG\"_P!F/X6:;X/\*6$TDUOI&F!ROFR'+R.\C,\CL0,N[%C@<\"O
M,/VR?^"1_P#P3G_X*!>-M)^)/[7?[+ND>+O$&BVRVUAK+:C>V-SY"N76&5[.
M>$SQJS,1'+O4;VP!N.0#\2_^"95QJ,/_  3J_P""L>A7-[X1>&UAOW2+X=L_
M_".+(T>MJ[Z6')(LF$:>3DD^2L62<5%\8/V'_P!DKPQ_P:"^&_VFM#^ 'AF#
MXBWFH:?JUWXY&EHVK2W$OB%K)P;H@R^5]G;RQ"&$8P#MW<U^Y7PZ_P""7/\
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MHS+[U^*YSP[FF1U+8B%X])+6+^?1^3LSY_$86MAW[RT[]#BJ***\(Y@HHHH
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MP*_8WT_6/V>=6\)!_&7Q**S>9H5S&+Q5MD<3".((L%F0KQN9/M!"D$<?6M%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
D0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>ensg-20241231_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ensg-20241231_g4.jpg
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MA[X[^)M4UQ#KUWXJ\5:=8MH?GS73M'''>GYA*4*DJ/E6V5> <'W']C_]G/\
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MME)<7#$?/';0Q&21B0)6.?F)/KUE_P $#OB_\*/$^NZ/^RG_ ,%&O&/P_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=R&W>6VT[PQ.%$>< LV\9 S^\;U->8_\$6/^"4_@O_@KG^S'<?\ !4']K/\
M:K^+,_QPU[XAW\ND>,?#?C$VLGAY;2=-D,415E568$F,;56)HTC$>W<?TW^'
MW_!*;X;^!?\ @JG\3_\ @J3-\2=1U/5/BA\/(?">J>";S3838V\"1Z;&T@DR
M6DW+ID8*,,?O7Z\ ?+GA?_@U^\*_"SQ?KOA/X!?\%)_CCX"^"GB;7_[4UWX-
M>'-7\JVN"2I> 7(D ,95$CR\+NT:(KNY4-0!XS_P4_\ !?\ P2Z_:S_X*,?$
MSX6>./A/^US^TK\3=,L+*/5/"?P@F,^@_#;99PPH(%:>WCBD9P)GW&:,S2R
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MSX,>'?C&WVF3P_X@MK:,"&(M+*#&7DN)"H9MT5M%YA+@D_-%S_P2P\(^-/\
M@W9\2_\ !8#Q%^U)\2KSXP>+[*YU/Q?=S>*'FL-<L_[>-@=.NXF^:<?NUFWN
MY(G X(4"OVZ_9*_X)C_$'X1>'/B%X?\ VP/V]?B9^T/;_$?PR?#VKZ3XYF6W
MTJVT]TECF2"SB9A')*DS(\@;+* .V:^1-+_X--OAO;_#77_V<M;_ ."C_P :
MM0^$$\MY>^$/AA)>K'IVCZE*K"*\G17\N\:)V\P*L<(9QEL@L& /M/\ X(L?
M\HDOV<?^R.Z#_P"D<=?3M>=?LB?L[:/^R-^R[\/_ -E_P_XDN=8LO /A*QT*
MUU6\A6.6[2VA6(2LB\*6VYP,XSU->BT %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !113+FYM[.WDO+RX2**)"\LLCA510,EB3P !SF@!]%?$W[7
MW_!?/]@/]E>6Y\-Z#XVF^(_B2 E#I'@=DN+>)QVEO&80*,Y!$;2.I'*5^9W[
M4?\ P<F_MU?&J6?1_@C;:/\ "W19"0@TB%;[4F0]GNKA-H/HT44;#UKZ7+N$
M\ZS)*4:?)%]9:?AN_NL?,YEQ=D>6-QE4YY+I'7\=E]]S]\?'?Q&^'OPNT&3Q
M5\3/'>C>'=+B/[W4M=U2*SMTXSS)*RJ/SKY*^.7_  7X_P""9'P2DEL8/C9<
M>,[Z'.ZR\#:3)>@X_NW#^7;-GVE-?SL_$_XQ?%GXV>(W\7_&+XFZ_P"*M4?.
M=0\0ZO->3 'L&E9B![#@5S=?9X/P]P<$GBJKD^T;)?C=_D?$XWQ&QDVUA:*B
MN\FY/[E9+\3]F_BW_P '6_ABW>2T^!'[(E_=J2?*U#Q=XD2W(^MO;QR9_"85
M\\?$3_@YO_X*(>+6>+P;H/P^\*Q?\LVTWP_-<3 ?[374\B$_1 /:OSKHKZ+#
M\*</X=>[03_Q7E^;:/FL1Q;Q#B7[U=K_  VC^23/K3Q=_P %T/\ @JIXS8_V
MA^UIJ5HA/RQZ1H.FV84>FZ&V5C^))KA]6_X*G?\ !1[6FWWG[;?Q*0YS_HGB
MNXMQW[1,OK_G%>!T5Z<,JRRFK0H07I&/^1YD\VS6J[SKS?K*7^9[++_P47_X
M*"S2M*_[='QA!8Y(3XEZHH_ "? _"M;2_P#@J9_P4=TC_CT_;;^);]?^/KQ9
M<S_^C&:O!**T> P,E9TH_P#@*_R,UF&/B[JK+_P)_P"9]:^$_P#@NA_P55\'
ME1I_[6VHW2#&8]6T#3;S</0M-;,WX@@UZ_\ #S_@YP_X*(>$MD/C'P_\/?%4
M0XD?4O#\UO,WT:UGC0'ZH1[5^==%<E7(<EKKW\/#Y12_%6.RCQ!GE!^YB9_.
M3:^YW1^S?PE_X.M_#,YBM/CM^R'?VN,>=J'A+Q(EQN]=MO<1QX_&8U]7_ W_
M (+\?\$R/C:8K.X^-MQX,OYL;;#QSI,EEM_WKA/,ME_&6OYM:*\3%<#9%77[
MM2@_)_I*Y[F%X\S_  [_ 'CC47FK?C&Q_7_X#^(WP]^*?A^/Q;\,?'FC>(]*
MF_U.IZ#JD5Y;O])(F93^!K9K^0OX8?&+XM?!/Q$OBWX._$[7_"NJ)C&H>'M7
MFLY2!V+1,I(]CQ7W5^RY_P ')O[=/P4:WT7XV6FC?%+1HB YU>(6.I!!V2ZM
MUVD_[4L4C'UKY3'^'^/HIRPM1379^Z_U7XH^MP'B'E]9J.+INF^Z]Y?H_P &
M?T%45RGP+^).H?&/X,>%?BUJG@N[\.S^)M M=4;0K^99)[$3Q+((I&4 %@&&
M>!@\$ \5U=? SA*G-QENM#]!A.-2"E'9ZA16-XV^(G@#X::;!K7Q&\<:/H%G
M=7L5G;7>M:E%:Q2W,A(CA5Y64&1B"%4')/0&MA65E#*P((R"#UH<)**DUHQW
M5["T445(PHK\V/\ @X@_X*%?'C]F/3?@O^QS^RU\7-+^'?C3X_>,I-+N_B3J
MTL21>%='@>VCNKPO*0L)S=QL9CRD<,VW#[773_X)!_ SX2>#_CAK'CGX,_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^UW^U#XY_:4\6>8MUXO\13WT5O(^XVML3LM[<'N(H%BB'M&*\VK^S\AX3R[
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M0 4444 %%%% !1110 4444 %%%% !1110 5^?G_!5W_@NG\*_P!B:'4/@E\
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M4\6U&/-*-N:TI.*N^71W2NOO/R''[''[2+?LO']LX?#.7_A6JZO_ &8?$O\
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M$I_ORKZU[=?$4L/AY5IOW8IM^B5SPZ&'JXG$QH07O2:2]6['[M_\$*/V3/\
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MMS*038V9(Z]I)N1&#@9<@4?\$8/^",'C[_@I#X^3XE_$N"]T+X/:%>A=9UE
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M&?Q=KMW\'_B:/ _Q"T[Q;HMO;I<7>1&;JR:!V/E"8A D@W'YCD #?YM^U?\
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MRO,<NE;$TI0]5I\GL_DS HHHKN. **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)(HEWI@A<_+0!^BE%?G!^T3_ ,'$GPX^#W_!*3X/_P#!57P9^S]?:[H'Q/\
M'5MX<U#PS>:^MK<:*V-2%XXD6"07!BETV9$7;&) ZME/NU#HW_!?/X@_##]A
M_P"(_P"WM^W'^P/XI^$_A?3-1TR+X/Z'?ZH'U'QO'?I,UNN'C1;9PL0ED)#!
M(V8@/M&\ _26BOS5^&?_  6__:W^&O[37PA^!G_!3#_@F\_P8T;X^7RV/PU\
M4:;\0+?6!#?2&%8K*^A2-6AD9[B!"2496E&8R!(4_2J@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OAG]H+Q*?%?QE\0:
MJ)=Z)J#6\)SQLBQ$"/8[,_C7VUX@U:+0=!OM=GQLLK.6=\^B(6/\J_/:XGEN
MIWN9W+/(Y9V/<DY)K](\.\,I5Z^(?1**^;N_R1^9^)&*<</0PZZMR?R5E^;&
M4445^J'Y.%2V=[>Z=<I>Z?=RP31G,<L,A5E/J".145%)I-68TVG='IO@K]K7
MXR^$-D%UKB:Q;+_RQU6/S&Q_UT!#Y^I/TKUSP5^W'X U?9;>--#N]'E/#3Q?
MZ1#]3M <?3:?K7RM17SV/X5R/,+N5+EEWC[K^Y:/YIGT>7\6Y[E]E&JY1[2]
MY?>]5\FC] O"OCSP9XWMOM?A+Q/9:@H&6%M.&9/]Y?O+^(%:U?G79WEYI]RE
MY874D$T9S'+#(593Z@CD5Z/X*_:S^,O@_9!<:ZFKVZ_\L=63S&Q_UT!#Y^I/
MTKXO'^'N)A>6#JJ2[2T?WJZ?W(^VP'B+AIVCC*3B^\=5]SLU][/LVN=^)OPA
M^%/QJ\-2>#?C!\-="\4Z3)G?IWB#28;R')[A)58 ^XY%>8^"OVY/ >K;+;QK
MH5WI$IX:>'_2(?J< ./H%/UKUGPKX^\%>.+?[3X2\466H+C++;S@N@_VE^\O
MX@5\=C,IS;*I\U>E*%NO3_P):?B?:8/.,HS:'+0JQG?IU^<7K^!\&?M+?\&V
M7[!/QF^T:O\ !^77OACJTN63^Q+LWNG[SW:UN26 _P!F*6(#TK\]_P!I;_@V
MW_;Z^"_VC5_A(NA?$[28LLAT&[%I?A!W>UN2H)_V8I)37]"5%>E@.+\\P-E[
M3GCVGK^/Q?B>9F'!N0X^[]GR2[PT_#X?P/Y!_B3\)_BC\&O$LG@WXN?#G7?"
M^K1?ZS3?$&E36<X&<9V2JIQ[XQ7/U_7M\3?A%\*OC3X:D\&_%_X;:%XITF7.
M_3O$&DPWD.?4)*K 'W'(KX8_:6_X-L_V"/C-]HU?X0/KOPQU:7+)_8=V;S3R
MY[M:W)9@/]F*6(#TK[3 >(&!JVCBZ;@^Z]Y?HU]S/B,P\.\?1O+"5%-=G[K_
M %3^]'\^%%?H/^TM_P &VW[?/P7^T:O\(QH7Q.TF++(=!NQ::@$'=[6Y*@G_
M &8I)37PS\2OA+\4O@SXED\&_%WX<:[X7U:+/F:;X@TJ:SG SC.R55)'OTK[
M/!9GE^8QOAJJEZ/7YK=?-'Q6-RO,<NE;$TI1]5I\GL_DSGJ***[C@"OV3_X-
M:/V3/(L?'7[:?B;3/FG8>%_"LDB=$&R>]E7/J?LT88?W95]17X[Z#H>K^)]<
MLO#7A_3I;R_U&[CMK&T@7+SS2,$1%'<EB !ZFOZM_P!A_P#9ITC]C_\ 9.\"
M_LZ:2L1?PWH446ISPCY;B_DS+=S#V>=Y6'H"!VKXCCO,OJF5+#Q?O57;_MU:
MO]%\V?=< Y9];S9XF2]VDK_]O/1?A=^J1ZM5/Q#K^B^$] OO%/B34HK+3M-L
MY;J_O)VVI!#&A=Y&/954$D^@JY7Y]?\ !R9^V'_PS-_P3PU'X9>'M5\CQ'\6
M;S_A';)4?$BZ=M\S4)0.ZF+;;M_U]BOR[),KK9WF]# TMZDDO1=7\E=_(_8\
M37CAL/*K+HC\!?V\_P!J36OVT?VP/'_[2^LM*$\3^()9=*MYC\UMI\>(;2$^
MZ6\<2G'4@GO7TI_P1>_X(N^//^"C_CR/XG?$^"^T+X/:%>A=7U= 8YM<F0@F
MQLR1^$DPR(P<#+D +_P1=_X(N^//^"C_ (\C^)_Q/@O="^#VA7H75]70&.;7
M)D(+6-F3^4DPR(P<#+D ?TG_  W^&_@/X/\ @/2?A?\ "_PG9:%X>T*R2TTC
M2-.A$<-M"@P%4#\R3R2222237]!\>\>X;AC!K)<G:]K&*BVMJ44K)+^_;_P'
M=ZGR6595/'5/K.(^%N_^)_Y?F'PV^&W@+X/> M)^%_PO\)V6A>'M"LDM-(TC
M3H1'#;0H,!5 _,DY))))))-6/&GC3PG\.O">H>.O'7B"UTK1]*M7N=1U&]F"
M16\2C+,S'_\ 63P.:3QKXU\)_#GPGJ'COQWXAM=)T?2;5[G4=1OI0D5O$HR6
M8G_]9. .37X;_P#!4C_@J3XM_;;\62?#OX=SW>D_#+2KK-C8,2DNL2J>+JY'
MIWCB/"CDY;[OX]P=P=F?&F9N,6U23O4J/6U^B[R?1?-Z&G%_%^7\(X#GG[U6
M2]R'?S?:*ZOY+4=_P5)_X*E>+/VVO%<GPY^',]UI/PRTJZS96+927695/%U<
MCLO>.(\+]X_-]WX]HHK^P\GR?+\AR^&"P4.6$?O;ZMOJWU9_)N;9MC\[Q\\9
MC)\TY?<ET271+H@HHHKTSS0HHHH **** "BBB@ HHHH **** "BBB@#]>_\
M@W ^)[ZQ\#_B%\(+BZW'0?$MMJ=O&QY6.\@,9 ]@UH3[%_>O%OV1?V#_ !W\
M=/\ @J-_P4C^&OQP^$'B71O _P 7="31M(\2ZMX=N(;*]$ZRJL]K/(@CF:,L
MLJE&."BFLW_@W7\>'0OVN_$_@.>?;#K_ (&EDC3/WY[>Y@9?_(;S&OV<K^.?
M%? K!<;XAI:5%&:^<4G_ .3)G]:>&&->,X-H)O6#E#[I-K\&C\"_^#9S]@3]
MMFX_;HG^+_[>GPU\5Z/8?LQ^ ;CP+\,$\4Z'/:1_:+N^O'<VDDR*+F.*&>^7
MS$SA+NW&=H053_8'^#7_  5"_9__ .""/[5VE?LR_"'XA^#_ (L7OQTNKO1+
M,>'KJQUR?2C'I:7D^G1RHLCR>4DZJ\0+_)((SYBK7] %%?G)^@'\R%Q\ -:^
M,_QI_8Y^(_[./[&_[7M_?>%_B[X:?XS^/OC/:ZI>0-J;W=E)*+>.2214BC-O
M=227"I&BJT0<Y( _1[]FCX(_&?1O^#LS]H;XY:O\(_$]KX)U7X"V-II?C"YT
M&X32[RX$'AI3#%=L@BDDW6\XV*Q.89./D;'ZHT4 ?B!^RO\ !C_@H5\*_C%_
MP5D\>_LX?"#Q?H/CCQ-XG^U?"?5;WP]-;#6'_M#7)&ETZ2=!'<R^1,'C*%AO
MEA/\2Y^#/VC_ (!_%#]I/]B7X<P_#_\ 8Y_;1\7?&_1/&&GWWQN\8_%"UUB]
MTR*X(G@>WM+:61_-=YIHV5Q$)(HHR';]X]?U944 ?SY_\%5Y_BWXX_X.&OB$
MGP6\/?''4]4\._!G2++[9^R/K$5MXALK>3R7E76"\3AMQF($>Y"$^Q,"=N!T
MOA'X+?LT_P#!07_@@G\;?^"<?_!+;X-_$?PW\2?A-XRLM6\;^ /BNL,7B'4M
M:6[W3&XD1A$\TL=E<0JFV(K)9K&T:?*Q^^_VB_\ @A3X ^)_[7_B?]N3]G3]
MLWXQ_ WQ]XXLH;7QK/\ #K784M-66*.-%9XI8F*MB*,G#E<KN"JQ9CZW_P $
MX?\ @ES^SQ_P3,\)^*M.^$.M^*/$WB7Q]K0U?Q_X]\<:L+W5_$%X#(P>>541
M<*TT[ !<[IG9F9F+$ _&W]E;X*?\$U?B[8_"WX%?%_\ X(T_ML:A\4;?4-'L
MO$]CJLNN+X>TG4$:.&XU!I9KY?(M4R\G,*;4)3@<U[C\7O$_[1W_  1[_P"#
M@7XP?MGZW^Q-\4/BU\,_CQX-MK70=2^&/AQ]2N;>^$=C_H[!?D5Q/:2H8F96
M,<D<B[MI4_ME10!^1'_!NG\.?VLM/_X*$_MJ_'?]J?\ 99\3_"Z\^)/B#0]>
MLM)URQE\B/[5-JEW]GBNBBQW+Q1W$2R;.58X95/RCT#_ (.:?^"<_P"TI^V1
M\$/AC^T=^QOH$FN?$KX#^+9=;TGP];@&XOK28V[S&W4D"6:.6RM9!%U=5D"Y
M?:C?IO10!^8?[-O_  7W_:Q_:5\<>!/@=X<_X(O_ !OT?QCJWB'3;#X@ZEXD
MTJ>PT'PS:O/&E]>FYE@#L(X_,=(Y5B)("Y8X#?!/Q[\*_M6_%S]HS]J/X7?\
M%!?V=OVOOB1\4-9UC5-/_9YT3X>W&H0>"H=/E6YCM9BT$L<"VJ*T$CD[U9$<
M2 R&3/\ 1E10!_-[^TK^R+^U=KG_  :;_LY_!'1?V8_B%>>--+^/=Y>ZGX0M
M?!=])JEI;/<>)@D\MJL1ECC8SP8=E /G1X/SKG]*_P#@Z!_83^/'[>?_  3-
M7P?^S=X2NO$7B;P1X]L/%<7AK3QNN=4MX;6\M)H8$R/,E5+PRA!\S"(J@+,J
MG]%Z* /P>_8J^&'_  2Z^.W[2OPAT[0O^"0'[:%GX_TCQ=INH76I>/KO6GT#
MP??02I*]W/<7-^VZ&.6(8#Q(9 H5E!.ROWAHHH **** "BBB@ HHHH ****
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M;ZMOJWU9_)F;9MC\[Q\\9C)\TY?<ET271+H@HHHKTSS@HHHH **** "BBB@
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MX>%I:^(8F4M&(W)#*T@4B,A6C=AM\S<55E_X.3/^"='[17_!1O\ 86T/P?\
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MC48+U]-U*WQN\JY@_=W$39(610,E'P"NUF^CZ "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@#QO\ ;CF:/X/6J _ZS7H5/_?J8_TKY+KZQ_;H4M\(K C^'Q#"3_WXG%?)
MU?M7 J7]@K_%+]#\/X];_P!8'_AC^H4445]D?%A1110 4444 %%%% !1110
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M-V(57BJE27V*4?O<IO\ *Q_3/@WAW3X9JU']JK+[E&*_.X4445^-GZV%%%%
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M[)*6K5TW)*VG6W0\VID5>EB(T*E2"F]U=MQT3LTHMWU^S?KV/IWXR_&#X??
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MX03> OAWX&TWX$^*?C ?AIX=\*VMG<_VY9(TFR/49[DR^7-.\A>64>6-Q)P
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %?*'[5G[/C>!=3?X@^#['_B37DN;N")>+
M*5CZ=HV/3L#QQE:^KZAU+3;#6-/FTK5+2.XMKB)HYX)5RKH1@@CTQ7LY'G6(
MR3&JM#6+TE'NO\UT?Z-GB9]DF'SW NC4TDM8R[/_ "?5?K8_.VBO3OVBOV>]
M2^$.L'6-'CDN/#]W*?LLYY-LQY\IS_)NX'J#7F-?O&!QN&S'#1KT)7B_ZL^S
M74_ <=@<3EN*EA\1&TH_U==T^@4445UG(%%%% !1110 4444 %%%% !1110
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M747Q@\;W>F:H]]X:UA(KMHK2..*,B928[,%DCE'^DGYEV''US^TW_P %9_\
M@GI^QW\(/"'QR_:&_:5TO0M \?Z7#J/@LK87=U>:S:2Q)*D\-G!"]P8]DL9+
MF,*F]0Q4D"@#Z+HKQ_\ 8Q_;Y_9#_P""A'PXN/BK^Q_\;=-\9:18W0M=2^S0
M36US83%=PCGMKA(YH21DJ70!@"5) )IW[9'[>G[(O_!/WX>6WQ3_ &P/C=IO
M@O1KZ[-KITEW!/<3WLP7<8X;>WCDFF(7D[$.T$9QD4 >O45\Y_L,_P#!6;_@
MGW_P4AO]7T3]CO\ :(LO%.JZ%;"YU;19M*O-/O8("X03""\AB>2+<RJ9$#*I
M=02"P%>:>.O^#BG_ ((T_#OPK%XO\2?MLZ3]GEUZ[T<6EIX<U6>\6YMBJS%K
M5+4S)$I8 3,@B<@A'<J0 #[7HKR3Q-^WA^Q]X._90B_;D\2?M!>'K;X3SZ7%
MJ%OXU-PS6LT,C!$"*JF1Y6<^6(54R[\ILW K7Y2_\%#O^"X_PE_:M_:^_8BL
M/^"9W[;NM2Z)JWQ^@TCXH:#H,^H:1)>VLNI:-'%#?6DZ0O-;R))<JI96C;,@
M!R&  /VUHH) &2:^)/'7_!QG_P $8?AU\79_@GXF_;AT3^V+6^-G=W6GZ%J5
MYIT,P8J5-]!;/;$ C!<2%!W88- 'VW17YP?\%M_^"_'@'_@F)H'PTTWX*7WA
M'QGXJ\=7MAJTVF:@;N6V_P"$3N%N!_:MO<6N(I TD(5,.Q(;<$9<&O#?^"ZG
M_!5[1_'G[*O[.'[3O_!/#]L+7-.\'>(/C['I6N^)?#.HWVBI>V\$;?:+>Y$J
MPNT*D999%V$#/(YH _9&BOEC]E__ (+7?\$P?VS/C]<_LP_LW?M7Z1XC\:0K
M.UMI:Z9>VR:B(5+2_9)[B!(;O:JL^(G8E%9QE 6#OVSO^"T__!,O_@G]\18/
MA#^U1^U%I^@^*9;>.>70-/T>_P!4NK2%QN1[A+&";[.&7# 2;692& (.: /J
M6BO!O&__  4[_8.^'O[(MA^WCXE_:/T<_"34YH(;+QIIMI=7T$DLLIA6/R[:
M*297$@9&5D!C96#A2IQ/^RQ_P4E_8H_;9^)WCKX0_LM?'6Q\8ZW\-YH(O%JZ
M98W(MK<RM*B&*Y>)8;E2T,B[H7=05ZX() /<J*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH JZUH
MND^(]*GT/7=/BNK2ZC,<]O,N5=3_ )Z]0>17R%^T'^S=K/PEOGU_0DEO/#\T
MG[N?&7M23PDGMV#=#T.#U^QZBO;*SU*TET_4+6.>"9"DT,R!E=2,$$'@@^E>
M]D.?XO(\1S0U@_BCT?FNS\_O/ S_ (>PF?8?EG[LU\,NJ\GW7E]Q^=E%>[_'
M_P#9&O\ PZTWB_X66DMUI_+W.E+EI;8=28^[I[<L/<=/"""#@BOVW+,TP6;8
M95L/*ZZKJGV:Z?U8_"\TRK&Y1B71Q,;/H^C7=/K^G4****]$\X**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** -SX=^/M=^&?BVU\7^
M'IL36[XDB8_+/&?O1M[$?D<$<@5]&?M$_ [X:?\ !0']FXZ1'/'!=NAN?#^J
M.N9-+OE&-KXYVD_(Z]U.1R%(^5Z]+_9J^.$_PD\6?8=6F=M#U)U2^CY/DMT6
M91ZCH0.J^I KYG/\MQ<IT\RR]N.)HOFBUNTM;>?DMGJGHS[#A3/H9?6>$Q6M
M"IH[_9??T[_)]#\POB)\/O%WPI\<:I\.?'FC2:?J^CW;6U]:RCE77N#T92,,
MK#AE((R"*Q:_5_\ X*K?L+I^T%X$/QU^%FDB3QAX?LR;NVMDRVL6"@L4 'WI
M8QED[LNY.3L _* @@X(K]XX'XOPG&62QQ4+1JQTJ1_EE_P#(RWB_ENF?29EE
M\\OQ+@]8O5/NO\^X445H>$_"?B;QWXDLO!W@W0KG4]4U&X6"QL+.(O)-(>BJ
M!_D $GBOL)SA3@YS=DM6WLEW9P)-NR'>#O!WBCX@^*;#P3X*T.XU+5=3N5M[
M"QM4W/-(QX 'ZDG@ $D@ FOV6_8$_8A\,_L=_#,17RP7OC'68D?Q'JZ#(4]1
M:PD\B)#WZNV6/\*KSW_!.[_@GMX?_9+\++XV\<06^H>/]4ML7UVN'CTN)N3;
M0'U_OR#[Q&!\HY^G:_DSQ3\2O]8JKRO+9?[-%^])?\O&O_;$]OYGKT1]WD>3
M?5(^WK+WWLNW_!_(_FZ_X(W?\$]OVNOV^[O]J_P)\%O^"CVN?!3P'=?%F]TS
MQUX<T'P=%?3>(8YGN@1]I-Q#);CRM\9"DA@YR",BO9_^#D/]@_X(?\$W?^"
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M9GT/X*_#SX5>(M#M].OOB%\0C<V[>=#:02%Y[*!45I+QMA98XDRKS*!]T_\
M!"_Q5^PA\+8/$GP:T?\ ;?\  _Q7_:@\>:G/XF^..M:9K<=Q<ZMJH+&6WM'P
M%GM+,.T:+"2BCS)-J!RJ@'Z-4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &#XY^&7@7XD6/V'QEX
M<M[S"XCF9=LL7^ZZX9?H#CUKPKXA_L+W\!>^^&?B19TY(T_5#M<>RR*,'Z$+
M]:^DZ*]G+<_S7*7;#U'R_P KUC]SV^5F>+F?#^4YNKXBFN;^9:2^];_.Z/@/
MQC\-O'GP_N3;>,/"MY8\X666+,;G_9D&5;\":PZ_16XM[>[@:VNH$EC<8>.1
M0RL/0@]:\_\ &'[+/P5\8%YI/"BZ=.__ "WTF3R"/^ #*?\ CM?=X#Q"H22C
MC*33[QU7W/5?>SX''^'->+<L'64EVEH_O5T_N1\545]$>)_V"[I=TO@SQ]&_
M]V#5+8KCZR1YS_WQ7!:_^R1\<M"):+PO%?QK_P M-/O$?/\ P%BK?I7U>%XF
MR+%KW*\4^TO=_P#2K'R6*X7S_!OW\/)KO'WO_2;GFE%;>K_#7XB: Q76O NK
MVH'5IM.D5?P.W!K%='C8HZE2#@@C!%>S3JTJRO3DFO)W/$J4:M&5JD6GYJPE
M%%%:&8444J(\C!(U+$G@ 9)H 2BMO1_AK\0_$!']B>!=7N@>CP:=(R_B0N!7
M8:!^R1\<M=VO)X7BL(VZ2:A>(F/JJEF'Y5PXC,\NPJ_?5HQ]9+\KG?A\KS+%
MO]S1E+TB_P ['FE%?1'AC]@NZ8K+XS\?1J/XX-+MBV?I))C'_?%>F^#_ -EK
MX*^#F6>+PHNHSKTGU9_/)_X <)_X[7SF,XXR/#)JFW4?]U:?>[?A<^DP7 F>
MXIIU(JFO[SU^Y7_&Q\C>#_AMX\\?W'V?P?X5O+[YL-+%%B-#_M2'"K^)%>T?
M#W]A?4)S'?\ Q,\2K G!;3],^9S[-(PP/P#?6OI&WMK>S@6UM($BC082.-0J
MJ/0 =*?7QF8\=YIBDXX=*E'[Y?>]/N7S/MLMX!RK"-3Q+=67GI'[EK][MY&#
MX&^&/@3X;V7V+P;X;M[/<N))U7=+)_O.V6;Z$X]*WJ**^+JUJM>HZE63E)[M
MN[^\^WHT:.'IJG2BHQ6R2LON04445F:!1110 4444 %%%% 'Y7:]^P%^V)^V
MW_P<567[8/[4OP7N="^!/P%T54^$TNH:I:31ZYJ,6&BN5AAF=T)NII;L.RJ0
MMG;(W/RU]2_\%5OBS_P5)^$_@CP)??\ !+K]GWPQX_UJ_P#&*6_C2V\2S(J6
M>F["0Z[[JWP&?AG!8H /EYR/JRB@#\B?VY?V4/\ @HG^S-_P7/3_ (*T? ;]
MBN']I'P?J/@*'0M.\-0^*[6PO_"EPMO' SP?:0QC)9)9 \<;J1>3JVQF#'I/
M^"(G[ _[8/PM_;C_ &A_^"FG[3G[.=A\$M-^+-N(_#WP:T35X+^6$><D\EU*
M+;]V),QG'"N\ES.?+C!4-^J5% 'YN_LZ_L._M,?MT_&_XH?\%'OVY_!U[X%\
M5ZAX:UCP7^S=\/-9D5Y/A_HTT,MNVJSK&S*NHW+.69E)9$+ $JT:Q_-O_!-K
M_@FY^WYI'Q[_ &,O _Q<_8T?X6Z7^R-#XU_X3;XAR^(--N(/%K:J[_98K%;6
M5I95;<6=I  HFER0V%?]M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>ensg-20241231_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ensg-20241231_g5.jpg
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M'W_@EI_P1T_8Z_;5_8-TKXN_%2S\1VGBC4]2U*V?5]&ULQ^6(KAXXRL3J\?
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MTO\ \$I/V$?VM/&TGQ*^,?P0AF\13A1=ZSI.IW-A-=!0 #,()%65L #>ZEL
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MXG?$:Y^)_B;]G*"/4+VZ-S?V^F:W>V=I<2D[BQ@@F5%R>2$"@]QR<^N?%?\
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MU50Y)1LU%R<K1NU9<NK?:_H73H8^EF$\3-1Y6K63;=E>UE;5^1Z%^R[^V_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45B:3\2_AQKW
MC#4OA[H7Q T2]U_1HT?5]#M-5ADO+%7 *M-"K%X@0RD%@,Y'K6GI6KZ3KMBF
MIZ)JEO>6SDA+BUG61&()!PRD@X((/N* +%%%% !15:?6-)M=1@T>ZU2VCN[I
M6-K:R3J))@HRQ52<M@<G'2K- !16)X&^)?PY^)^GW.K?#3Q_HGB*UL[Q[2[N
M="U6&[C@N% +0NT3,%<!E)4\@,..:VZ "BBB@ HK!\0?%/X8^$O%FD> ?%7Q
M&T'3-=U\N-!T74-8AAN]2*?>%O"[!YL=]@..];DLL5O$T\\JHB*6=W; 4#J2
M>PH =17->,?C+\'_ (=^&;3QI\0/BMX:T+1K^[CM;'5M9UVWM;:YG?=LBCED
M=4=VVMA023M.!P:GN_BG\,;#XA6OPDO_ (C:#!XKOK%KVR\,3:Q"NH7%LNX-
M,EL6\QXQL;+A2!M//!H WJ*** "BL3Q'\2_ASX.\0:3X3\7>/]$TK5=?F:+0
MM,U+588+C49%V[D@C=@TS#<N0@)&X>HK;H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1WW"1]R(QC\W@'UG_@HW_P %R-'_ &,/VHO"W[#_ .SQ^R1XN^/?Q;\1Z/\
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M0S_OI0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45\S_ +;/_!6S]BG]
MA&.?1?BK\21JOBJ*/='X*\,*MWJ).,@2@,([8'@YF="1RH:OR*_;)_X..?VT
MOV@9[KPU\!#!\*?#4FY$_L:07&K3)ZO>.H\H]"/(2-EZ;VZU]#E7"^;YLE*G
M#E@_M2T7RZOY*WF?.9MQ5D^4-PJ3YIK[,=7\^B^;OY'[@_M$_MD_LM?LF:0-
M9_:*^.GA[PJKQF2"TU"]#7=PHZF*VCW33?\  $:OST_:7_X.E?@7X3EGT/\
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MOA?\2'USP=%(#/X#\5,]WIQ3/(@RPDM&ZG,+*">65^E?N[_P3D_X+K_L:_\
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M/F4LC?/=%<N-P6$S'"RP^)@IPDK--73_ *Z/=;HNG5J49J<'9H_K9_X)X_\
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MRW\5]3^"'QX\&OH'BC1Q"=1TM[R"X\L2Q)-&1) [QN#'(K95CUP>017Z=_\
M!-?P)XA_X)N?L<7WQ9\=::VE?$/XS?'?1_AUHD$O$MO8VNJ>1?$=U!,>H(2.
M-T<)ST%=+\<_V"O G[?7_!P9\2_!OQ<^W2>$?"G@K2M=US3]-G,4^I[-.L(H
MK174AD#O+EF4@[8V 92P8<CXDY,QK*:7L(1DTU?F;BX)VUM:\K+3=;G6N&?:
M9;1E!OZQ.44T[<J4E)J^E[VCS/79['XV45^NOQT_X)J?"SXQ?L2_&'XKZO\
M\$V=0_9L\5?"[2&UKPC??\)A)J,7B"PACEEF@G1G9?,$<)!;&[?+&0Y =3QG
MBKX#_P#!,?\ X)R_L5?!36/VM?V7-6^*'C+XW:"-8UG5;+Q'-9S:'9O#;S'[
M,JN$WQ+=1*J\&1TD+2!=JUU4^),+6BE3IRE-RY>5<K?P\U[J7+:W][?0Y:G#
M.+HMRJ5(Q@H\W,^9+XN6UG'FO?\ N[:['S5X_P#^"/?[3_@7]IWX:?LF)XF\
M'ZGXH^*?AK^V_#\MGJDZ6D$ BGE=9Y)H$*NJ6\APJMG@#).*^>_CA\'O&'[/
MOQ@\2_!#X@BT&M^%=9GTS5/L-R)H3-$Y5BCX&Y<CC(!]0#D5^R'[?WP=^$7Q
MW_X+'_LH_"'QGHMQJ_@[5OAH4-I->36TL\$<>H2PEI(&C=&S'&QVE>1CH2*\
M$^!G_!/7]CS3?CW^US^TC^T'X#U#5OA=\ O%.IVV@>!+'5IT.H2K-<-'%).9
M/.945(D&Y_F:8%V(4AN' \12]A&IB6VW!2LHJ[;J."L^;=Z*UDNMSNQW#D/K
M$Z6&2251QYG)V48TU-W7+LM7>[?3E/S!HKZ^\2?%C_@F_P#M%_M&?"_5/A;_
M ,$^?&^@6;W>H0>/?AGX,\22ZB^ON8E_LY+&4E95<R[Q,J1Q_)C9N;)K[)\5
M?\$\O@3\?/V'OC1\0?%__!*S5_V;_$/PY\'W&O>"-8E\87-[)JPM[6>X>&5)
M=O00*C^8C']^"K*RFO4Q.>T\'R>WI2CS6O=PNKRY=N:[UU]U/1W/+PV0U<;[
M3V%6,N6]K*=G:/-OR66FGO..JL?CQ17ZC?!/X!?\$OOV??\ @DK\(O\ @H%^
MU7^S?J7C'Q%K&MZKI3Z7INLW,2:[>-J-_'#]H!E$<:0VUFY&T*"RC<&)K3_8
M]_X)S_!R^_8IF_;T\,_L&ZE\<==^('CB_B\"?#23Q/)8VOAW0X[NYB66=U?,
MSK]G926+YWPX ^=SE4XCPM.,Y2A)*,W33?*E*2;32;DE96O=V5O/0UI<-8NK
M*$8U(MR@JC2YFXQ:33:46[N]K*[OY:GY345]W_\ !;+]@GX5?LGK\)OC3\)/
MA9J'P]M_BAX>N)]=^'&HZHUXWA[4[=;9IHDF9F9E/VH+U(!B)&T,%7X0KU<!
MC:.8X2.(I?#*^_DVGM=;KH['D9A@:V6XN6'J_%&VWFDUO9[/JD^X4445V'&>
MC?LD?LW^,/VNOVD?!_[.?@=66]\4:Q';27*Q[A9VPR]Q<L.ZQ0K)(1W"8[U_
M5K\+_AMX0^#GPWT'X3_#_2EL=#\-Z1;Z;I-HO_+.WAC6- 3W.%&3U)R3UK\J
M/^#7[]B?^Q/"?B7]NKQMI.+C63)H'@DS)]VUC<&\N5S_ 'Y52$,,$>1,.C5^
MNE?C7'.:_7,R6%@_=I:>LGO]VWK<_:N \I^I98\5->_5U7E%;??OZ6"OR<_X
M.H?VZ_\ A57[/VA?L0^!]8\O6_B(ZZEXI$,F'@T6WE_=QG'(\^Y08(ZK:RJ>
M&K]4_%GBKP[X$\*ZGXW\7ZO#I^DZ-I\U]JE_<MMCMK>)#))*Q[*J*S$^@K^1
M_P#X*)?M@^(OV[?VQ/&O[2FMM-'::UJC1>'K&8\V.EP_NK2''0,(E5GQP9&=
MOXC7N^$W#G]L<0_7*JO2P]I>LW\"^6LODNY[N?XSZOA/9Q^*>GRZ_P"1XG11
M17]6'P@4444 %%%% !78_ +X^?%G]F'XN:)\<O@?XRN="\2^'[L7&GW]LWX-
M&ZGB2-U)5XV!5E8@@@UQU%9U:5*O2E3J14HR5FGJFGNFNPXRE"2E%V:/ZK?^
M"3/_  51^%W_  4Z^!G_  DVG16^B^/?#\<</C?PDLV?LTK#"W4&3N>VE()4
MG)0AD8DJ&;ZOK^37_@DWJ7[;NB_MN>%-9_8%\/7>J>-H)O\ 2K$ BPGTXLHN
M$U!LA4M",!F8C#;"A$@2OZP]+DU.73+:76K6""\:!#=PVLYEBCEVC<J.RJ74
M'(#%5)'.!TK^1O$?A3"<+YRHX6:=.HG)0O>4/)K?E_E;WU6ZN_T#)\?4QV&O
M46JTOT?_  >Y/1117YX>N%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !116+\1OB%X.^$O@'6?B?\0M<ATS0_#^F3:AJU_.?E
M@MXD+NQ[G !P!R3@#DTXQE*2BE=L4I1A%RD[)'RW_P %E/\ @I)8?\$]?V:9
M+CP??6\GQ%\8"6Q\%V<@#?9B%'G:@ZG@I"&7 ((:1XU(*[L?S7ZWK6L>)-9N
M_$7B'5+B^O[^YDN;Z]NYC)+<3.Q9Y'9LEF9B22>2237LG_!0O]M?QS^WQ^U#
MKWQ\\6O-!832?9/"VCR/D:7I<;-Y$ YQN()=R.&DD<C ( \1K]XX9R.&2X!*
M2_>2UD_R7HOSNS\!XHSV>=Y@Y1?[J&D5^;]7^5D%%%%?1GS04444 %%%% !7
MWU^U;_P5H^&_CK]J3]F[]H[X":)XDMY/@WX;TZRUZWUBTA@:\:*0?:88O+F?
M=')"9(]S%3A^E? M%<>)P&'Q=2,ZJORJ2\K25G?Y';A<PQ.#IRA2=N9Q?G>+
MNK?,_1#_ (*7_P#!7[X1_M@_M<_!7X@?"WP[XDL?AY\+];M=9OK'4K"""\NK
MUK^*>[=8HYF1CY4$84LX)=I.@.XZ:_\ !:WX4^"O^"NWC+]MOP;\/?$&K?#?
MQUX6M/#VO:+J$,-OJ)M4M;1'FC02M'O66VRJEP&1F!*%LK^;E%<$.'LLA05%
M1?*HRAOTDU)_.ZO<]"?$>:3KRK.2YG.,]NL4XKY6=K'V9^TKXU_X)"I\*_$T
MG[.GC;]HO6_%>L6^WP[I/BS4+1-)TIVD5CYY7][*JIN51F3/&2?O5ZK#_P %
M&/\ @F?^U+^Q]\*?AG_P4'^%'Q%O/&7P5TL:=HB^#)8$M]>M4BAB6&69Y R+
M(EO!YO"LK(6C?YBM?F]15RR7#SIQ4JDVXNZES>\KJS2:MHUN1#/,13J2E&G!
M*2LX\ONNSNFT[ZI['Z7_ !<_X+&_LQ_$W_@I-^S_ /ME:?\ #_Q5I/AOX<>#
M3IWB?18[*WDG@N'AO%,=K^^"S1(;A '8QDJI.T'BL+]GG_@K5^S;X<^/_P"T
MIX6^/GPU\2ZQ\%_VAO$%_>31V$<2:II@FEGV.8_-"Y:.8;MLA9&B0KNP0?SM
MHK/_ %=RU4O9V=N516KNDI<Z:?=2=[FG^LF9^V]I=7YG)Z*S;BH--;6<5:Q^
M@7P9_;B_X)?_ +#'[9?PR^+?['_P:^(FK>'O#D.LP>.?$'B^X@;5-06]ABB@
M:UB5UB7[.%EZB(R"=U)X#5Z+_P /0?\ @G'\'_A_^T1X/^$FK?'/Q?K/QQ\&
M:M;OXA\<26LT5G>W$%S%;6D<?FJRPJUW(SS'<V$4!6K\N**57A_!5I*524V[
M)-N6]I<ROZ-^2Z;)!2XBQU"+C3C!*[:2C\-XJ+MZI:WN^N[9]=_&K]N[X.?$
M/_@C[\(_V"M#T?Q GC3P+XZN]8UF\N;*%=/DMY)M6=1%()3(SXOX>#&HRK\\
M#=WG[*/_  4/_9'\5_L#V/\ P3R_;OL/B'I&D^%_$4NK^"O&OPTGA%U;&1YY
M&AE64]-]S<#[LBLLH&U&C5S\$45T3R;!SHNGJO?=1-/52;;;7WO3L<]/.L;3
MKJIH_<5-IK1Q222?W+7>Y[?^VQXD_8QUCQ!H.E?L9ZG\4=3TW3[*9=;UGXHW
MMO)<7EPS@J8(X/ECC"@CD*22,CC)\0HHKT*%%4*2IIMVZMW9Y]>L\16=1I*_
M1*R"NS_9W^!OC7]ICXY>%?@'\/+;S-8\5ZU#I]HQ4E80[?/,^/X(T#2,>RHQ
MKC*_8+_@U\_8G^UZEXF_;M\;:3\EIYGA[P.9DZR, U[=+GT4I K#@[YU[5Y^
M=YE#*<LJ8E[I67G)[?YORN>CD663S?-*>&6S=Y>45O\ Y+S:/UJ^!/P9\%?L
M[_!KPS\#?AU8_9]%\*Z-!IU@A W.L: &1\=7=LNQ[LS'O76457U;5=,T'2KG
M7-:U"&TL[*W>>[NKB0)'#$BEG=F/"J "23T K^>Y2G5J.4M6W][9_1<(0I04
M8JR6B\DC\QO^#H3]NO\ X4-^R;8?LE>"-9\KQ+\5I&&K^3)B2VT*!E,V<<KY
M\OEPCLR+<#M7\\E?0W_!4S]M;4_V^_VW/&7[0/VF8Z')>?V;X.M9LC[/I%N2
MEN-I^XS_ #3NO:2=Z^>:_LO@/AU<-<-TL/-6J2]^?^*73_MU6C\K]3\ZS7&?
M7<9*:^%:+T7^>X4445]D><%%%% !1110 5]-?\$U?^"5O[2/_!3#XE_\(]\+
M],.D>$M-N%7Q3X[U*W8V6FJ<$QH./M%P5.5A4YY!8HIWCWO_ ((]_P#!!#XJ
M_MZ7>G_'7]H&/4/!_P (ED$EO-L\O4/$P!Y2T##]W >C7+ @](PYW,G]#_P9
M^"WPJ_9Y^&NE?!_X*>!-/\-^&M%MQ#INDZ9#LCC7J6)Y+NQRS.Q+.Q+,2237
MY%QWXG8;(N; Y:U/$;-[QI__ "4O+9?:_E?T&5Y)/%6JUM(=NK_R7]+N><?L
M(?\ !/G]F[_@G?\ "&/X4_L_^$Q%+.$?7_$E\%?4=:G48\VXE &0,G;&H"("
M=JC+$^WT5\[?M]?\%(O@G^PAX/)\1W":WXQOK<OH7A"SN )INH$T[<^1!D8W
MD$M@A%8@X_G*A0SCB7->2FI5J]1^K;[M]$N[LDNR/J,9C<OR7 RKXB2ITH+=
M[>B[M]$M6SZ)HKY@_P""8G_!1GP[^WK\+K@Z];6.D^/- (7Q'H=H6$<D3,1'
M=P!V+&)OND$DHX(/#(6^GZQS7*\=DN85,%C(<M2#LU^37=-:I]4/+,RP6;X&
M&,PLN:G-73_1]FGHUT84445YYWA1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !7Y!_\'-_[>]QH^E:1^P)\.-<V2ZC%%K/Q">WDY$ ;
M=9V38_O,OVAU/.$@/1C7ZF_'WXT^#?V<O@IXI^.WQ!NO*T?PIHEQJ5[A@&D$
M:$K$F>KNVU%'=G [U_*-^T#\</'/[2GQL\3_ !Y^)5]]HUOQ5K$U_?,"2L>\
M_)$F>D<:!8T'944=J^ZX&RA8S'O%U%[M+;SD]ONW];'P7'F</!9>L)3?OU=_
M**W^_;TN<?1117[$?C 4444 %%%% !1110 5^J'[''["'_!"S]J/X@P_LD>!
M?C7\4_$_C^[T22Y'BV)%L;":>*+?.MJCP8 4!F E1@0AQ(W&?RO ). *_77]
MBK]F+Q%_P1M_9GN?VW/B?\&]=\7_ !V\=:/)8?#SX?Z5HMQ=?V%;R!6::],*
MGRF/[LR D,JXA7YGDV?.<2594\+%4ZLHU974%%I<TM-]/ACN]4K;]#Z7AFE&
MIBI.K2C*E&SFY)OECKM9_%+9:-WVZGR7X!_9_P#^"<G[-?[2WQ?_ &??^"B/
MC#XA7O\ PAWB1=,\'ZC\/H85%XD<EP)Y;A9 VQBOV4A0<*3("3@&O</VJO\
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M/KO[3WBV_A^!7P"UV\M/$6OVY$-WXAN%<K9:7;$<?:9MT1<+]S<!E2Z-2_\
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MOZ_*LB5.U7$J[Z1[>O\ D1V=G::=:1:?I]K'!;P1K'!!"@5(T48554<
M=*DJOJNJZ7H6F7&MZWJ5O9V=I TUW=W4RQQ0QJ"6=V8@*H )))P *_)S_@IM
M_P %N]1\9_VA\!?V,-=FLM(.ZWUKQ[ 3'/>CHT=ET,4?8S<.W\&T#<_YAPQP
MIF_%F/\ J^#CHOBF_ABN[??LEJ_O:VXDXGRKA?!>WQ<M7\,5\4GV2[=V]%]R
M/>_^"F?_  66\%_LQ)?_  5_9TNK+Q#\00&AO]1XEL= ;H=_::X':+[J'_6<
MCRV_&KQYX]\:?%#QAJ'C_P"(GB>]UG6M4N#/J&I:A.9)9W/<D]@,  <
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MO6.LH_-=4?5^&'%SR3,_[/Q,OW%9VUVC/9/T>S^3Z,_;"BBBOY//Z@"BBB@
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M%%%% !1110 4444 .BED@E6:%RKHP96!Y!'0U];K_P %W?\ @K JA1^UU>X
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRVE/_P"1CY;M;]@HHHK]E/R0**** "BBB@ HHHH **** "NV_9N^,.I?L_\
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M%*+FU+,Y$,B3+A2[D,CC<PPQ^R: "BBB@ HHHH **** "BBB@ HHHH ****
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MC98FG&HNZ]U_JOP1^BE%?%?A#]J;XU>#]L2>*VU&!?\ EAJR>>#_ ,#.'_\
M'J]3\'_MX:+<;+?QWX+GMFZ-<Z9*)%/OL?!4?\":OD<;P1GF%NZ<547]UZ_<
M[/[KGV.!XZR+%V523IO^\M/O5U]]CZ 9592K*"",$$=:^>/VA_\ @E!_P3X_
M:?\ /N_BC^S%X=34I\E];\/P'2[TO_?:6T,9E;_KIO'J#7K7@_X[?"7QSMC\
M/^-[(S/TM;E_(E)] LF"WX9KKJ^<_P"%'*ZWVJ4_G%_H?2?\)V:T/L58?*2_
M4_(K]H?_ (-5_!.H^?JW[*_[2]_IDAR8=$\<Z>MU$2>WVJV",BCWAD..I/?X
M2_:'_P""'?\ P4I_9T\^^U7]GV[\5Z7!D_VOX#F&JHX'5O)C N5 '.6B4?K7
M],5%?28+CC.\+95&JB_O+7[U;\;GS6.X%R+%W=-.F_[KT^YW_"Q_'AJ^CZOX
M?U.?1=>TNYL;RVD*7-I>0-%+$PZJRL 5/L15:OZV?CA^RK^S9^TKIATKX^?
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M^T9^WC_P1>^,O[$_[,?@";Q;XMT[XF>'?$.GZ%%J-M;.]M*Q2=E>YDC3"_9
MQ&[/S<#FO9?^"_'_  1O_;@_:4\!_L]?&[]A_P"&UY?_ !+\-?#5_A[\1;#3
M->L[.<:7<6 AV-+--&CPCS]1@E"LVY+O^Z":T?\ @W:\=G0?VP?$G@>>8K#K
M_@6=HTS]Z>WN8'7_ ,AM-7[/U_'7BO@5@N-\0TK*HHS7SBD__)DS^L_"_&O&
M<&T$WK!RA]TFU^#1^1__  4%_P""0'[0.F_#7_@GY\ OV2/A2?$^B_L_>/\
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MHFH%PDZJZR(P:-E>-T=$=71E=&564@@&@#^=C]G*VB_X(L>"?@=_P49_:O\
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M2^O_ ("]?P/D;]H?_@@/_P $U?C]Y^H6/P?N/ >IS9/]H^ ;\V2J>V+5Q);
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MY]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEMH[995N#$T;,Z1)YBF+8656"J40K5_X)]?\$1_V6/\ @G[\8-9_:5TOQ_\
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M2>K1%#DDL'/%?E-^UO\ \$Z/VJ/V,;^27XK^ 7N-"\W9;>+-$W7.G39.%S(
M#"Q[)*J,>P(YK^C.&/$/ASBA*G1J>SK/_EW/27_;KVE\G?ND?S_Q)P%Q!PTW
M.K#GI+[<-5_V\MX_-6[-GAE%%%?='Q84444 %%%% !1110 4444 %%%% !11
M10!]#?\ !*#P^_B7_@HC\*].C3<8_$+7>,=H+::<G\HZ_H6K\,/^""_@T^)_
M^"A>DZV(]W_".>&=4U$G'W=T0M,_^36/QK]SZ_E?QNQ"J\54J2^Q2C][E-_E
M8_IGP;H.GPS5J/[55_<HQ7YW"BBBOQL_6PHHHH **** "BBB@ HHHH ****
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M\%^%=;\6^&?^"P/[:'B3P#YG]NZ?\#I[G1?)&7^UQZ?I;0[1Z[PN*A_X(Z_
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M'+(EO<R*9]&U!EW2Z3J"KC#8Y*\[77^)&R.=I'XS_$OX;^,?A#X\U3X:^/\
M1WL-7T>[:WO;9^S#HRG^)6!#*PX96!'!K]7\-^-7Q/ETL+C/=QE#2HGHY):*
M:7GM*VTNR:/N<TP-/#RC6H.]*>L6O/I_EY?,PJL:5JNJ:%J4&L:)J5Q9WEM(
M)+:ZM9FCDB<<AE92"I'J*KT5^DM*2L]CR=C[3_9:_P""S'Q?^&7V;PK^T%IK
M^,]&3"#58V6/5+=?4L<)<8'9]K$\F0U^B/P$_:C^!?[3&@_V[\'_ !]::DT<
M8:[TYSY5Y:9[2PMAU&>-V"I/0FOP;K0\+>+/%'@?7K;Q3X,\17NE:E9R;[6_
MTZZ:&:)O570@BOR/BOP=X=S[FKX'_9JS_E7N-^<-+>L;=VF>_@>(<9A;1J>_
M'SW^_P#S/Z%*Q?B!\.? /Q7\*77@;XF>#=-U[1[U=MUINK6:3PR>AVN" 1U#
M#D'D$&OSE_9;_P""UGC?PM]F\)_M0>'F\06*X0>)-)B2.]B'3,L7$<WU78V,
MGYS7Z#?!SX\_"']H#PPOB[X0>/;#6[/ \X6LF);=CT66)L/$WLX!K^;>(^"N
M)^#JZGBZ;44_=J0NXWZ6DM8OLI6?D?7X7,,!F=-PBT[K6+_5=5]Z/SW_ &R/
M^#>[POKOVOQM^QEXL&CW1W2'P;XAN'DM7/7;;W)R\7H%EW@D\N@K\R/C5\ O
MC-^SIXQD\!?&[X<ZIX<U2/)2#4(,).H.-\4@RDR9_C1F7WK^FVN6^+WP3^$O
MQ\\'3> /C-\/=+\1Z1/R;/4[8.(VQC?&WWHG'9T(8=B*^PX7\8<[RGEH9FOK
M%)==JB_[>VE_V]J_YD?G'$GA/DV:<U;+G["IVW@_EO'_ +=T7\I_,917ZB?M
MD?\ !O7J-G]K\;?L6^+C=1_-(?!7B2Z"RCOMMKLX5O0)-MP!S*37YM?$SX5?
M$GX,^+KGP%\5_ ^I^'M9M#^_T[5K-H9 ,G# ,/F4XX894CD$BOZ'X>XMR'B>
MCSX"LI-;Q>DUZQ>OS5UV9^"9[PMGG#E;DQU)I=)+6+])+3Y.S[HP****^D/G
MPHHHH *ELK*[U*]AT[3[9YI[B58X(8URSNQP% [DD@5%7TS_ ,$AO@ W[0?[
M>'@W3+VP\_2O#,[>(M8RN56.T*O$&'0AK@VZ$'LYKS\VS"CE.65L;5^&G&4G
M\E>WSV1W97@*N:9C1P=/XJDE%?-VO\MS]ROV9?A#;? +]GKP7\&+94SX;\-V
MEC<.G22=(E\Z3_@4F]O^!5W-%%?P3B*]7%8B=:H[RDVV_-N[_$_N&A0IX:A"
MC35HQ22]$K(****Q-0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M^+?VIO 9\"_&#4/L\&RTU4_;K7 X_>$[Q^#A^/3%?:5>/?MF_#EO%GPW7Q98
M0;KO09#*V!RUNV!(/PPK>P5J^KX.S)9?G,8R?NU/=?J]G]^GS9\EQIECS'))
M2@KRI^\O1?$ONU]4CY(HHHK]Q/P@**** "BBB@ HHHH \Z^-G[*'P&_:(\9^
M"/B#\7O!3:KJWPYUL:OX0NEU.Y@%E=B2&3S"L,BK*-]O"=L@9?DQC!(.=\3?
MV)/V8_C%\?O"W[3_ ,1OAA#J/C?P8D2^']9:_N(_($4KRQ;HDD$<I221W4NK
M$$^PKTS6=<T7PYILNM>(=7M;"S@7,]W>W"Q11CU9F( _$U'X?\3>&_%NFKK/
MA7Q!8ZG9NQ5;O3[M)HB1U 9"1D?6N:>%P=2;YH1;;3=TKMK9OS71]#JABL;3
M@N2<DDFE9NR3W2\GU74XC6OV3_@-XA_:5TC]KS5_!+2_$#0M$?2-+UP:G<J(
M;1A,"GD"00L<7$PW,A;Y^O QY=^T!_P2(_8'_:5^)-W\7?B5\%V3Q#J3;M6O
M]$UJZL/MYQ@M,D$BHS'^)PH9OXB:^@+_ ,?>!=*\00>$M4\:Z3;:K<X^S:9<
M:E$EQ+GIMC+;FSCC K6K.I@<OQ$90G3C)-W::3][N_.W7<NGC\QPTXSA5E%I
M633:]WLO*_38\?U']@?]DC5?V8;?]C>]^#5D_P .K/+6.@M=W!-M(97F,T<Y
MD,RR^9)(WF!]WSL,X)%<+\+O^"/?_!/7X/7OAS6O _P%2#5/"WB.'7=)UB76
M[Q[H7L+!HF>0RYD12H(B;,><G;DL3]%^(_%?A?P=IW]K^+O$EAI5IO"?:M2O
M$@CW'HNYR!D^E6-.U73-8TZ+5](U&"ZM)XP\%U;3*\<BGHRLI((]Q2EEV6U*
MD7*E!RBDE[JNDMDM-$NG8J.8YG3IR4:TU&3;?O.S;W;UU;Z]SS_P?^R9\!/
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M@=!G[N>:\H_9:_X+!_ CXR?9O"_QDB3P-K\F$\Z[FWZ9</TRLYQY.>N)0%'
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M&!P00>A![5^BM>'?M2?LV?\ "8PR_$3P'8?\3:-=VH642_\ 'XH'WU'_ #T
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MJGB7XC:AHT-_=3Z>8+C?I]C%(P/VN600LK1YD"0R$ \T ?5=%?A1_P $K?\
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M!+T7TD>WRY)TM6DB5BN"Z([ASNW>.?\ !8S]CO\ X*0?LO\ P3_9H\0_M?\
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M]B#T8'L1P>U4*_5X3A4@I0=T]FMF?D<X3IS<)JS6Z>Z"BBBJ)"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#O?V??C1??!WQDMY.[
MR:1>E8]5MEY^7/$BC^\N2?<$COD=?_P4J_8JTO\ :Y^$\'Q3^%UM#/XQT.Q\
M[29;?'_$WLB-YM<CJW):,_WB5X#DCQ.O?/V/OCP=%OH_A/XKO/\ 1+J3_B33
MR-_J96/^I/\ LL>1Z,<?Q<?*YS0Q^58^GGV5NU>EK)=)QZIKKIH^\?-(^\X1
MSNDD\JQC_=3^%_RR?Z-_<_5GX\S0S6TSV]Q"T<D;%9(W4AE8'!!!Z&FU]]?\
M%?/V$_\ A&-3N/VL/A1H^-.OIQ_PF>GV\?%M<,<"]4#^"0D"3T<AN=[;?@6O
MZ-X7XDP'%>34\PPKTEI*/6,EO%^G3NFGU/3QN#JX'$.E/IL^Z[A116_\,/AA
MXZ^,GCG3_AO\-_#T^J:QJ<PCM;6 ?B78GA$49+,<!0"2:]VM6I8>E*K5DHQB
MFVV[));MOHD<L8RG)1BKMDWPB^$GCSXY_$/3?A?\-M#>_P!7U2<1P1+PL:]6
MD=OX$499F/0"OVD_8V_9&\#?L??"B+P+X;*WFJWA6?Q%K;1X>^N<8X[K$F2$
M3L"2<LS$X/["O["W@?\ 8W\"D!H=3\7ZI O]OZ\$^A^SP9Y6%3]"Y&YOX57W
MFOY"\3_$>?%6(> P$FL)![[.I)?:?]U?93_Q/6R7W^2Y.L##VM5?O'^"[>O?
M[O7X7_X)=?\ !*_XO?L*_MQ?M9?M1_$/XB>&]7TCX_\ Q _M[PSI^BFX-SI\
M'V_4[HI=>;&JA\7R+^[+C*,<]*[7_@MC_P $_P#XE_\ !37]@'Q#^R9\(_&6
MA:#KFK:UIE[;:CXC:86BK;7*2NK&&.1P2JD#"GG&<=:^LZ*_(#Z ^1OV\O\
M@GI\3/VJO^"/NJ_\$ZO!/C;0M/\ %%[X&T#1(-;U4S+8>?I\]C*[L8T:0(XM
M6 (0D;AD=:\L_;4_X(K^+OVLO^")GPX_X)M?\)_X>M/B#\,O#?AB/P]XKN%G
M_LY-4TRUCM)Y 50S"*2!KI%(3<#(A*\$5^AE% 'YT?\ !/7_ ((?>,?V<O\
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M9_\ VF?BOXTT[2/A[X^^"SVNB^,=2NTATY9)+358(U,[D(NZ1[89)P/M<9.
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>ensg-20241231_g6.jpg
<DESCRIPTION>PERFORMANCE GRAPH
<TEXT>
begin 644 ensg-20241231_g6.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !115#Q5XI\/>!_
M#&H^,_%NK0V&EZ38RWFHWUPV([>"-"[R,?0*"3]* +]%?G;\#_CQ^U!\3?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>QK4HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"GQ%'JN@:W;>=87L:E=P#%65E8 HZLK*RD JRD'I734 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&K1WTUGIS2F6>>YFA_=^9(S, JG(61E;&T$\'^S_ *3_ ,% OV"OAM??LH>
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0
M!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP
M_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_
M9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP
M_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
M4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ
M% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_
M]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__
M #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%
M']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]
M^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,
M/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__
M #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[Z
MJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/
M^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!
MJ#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'
M_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^
MJ/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:
M@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0
M:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ
M_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4
M_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
MSXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V
M=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#S
MXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_
M ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V
M=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:
M@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_
MT&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ
M_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A
M,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@
M_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?
M#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X
M3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?
MH4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SX
MP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_
M //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=
MI_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?
MH4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\
M^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I
M_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]
MG:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^
MJN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X
M3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_O
MJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'
M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0
M!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP
M_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_
M9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP
M_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
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MLXE8="L8!% $M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5Q7Q[\2_&WPQX"-S^SW\-]-\3^)KF]BM[:UUG5A9V=JC9WW4[
MX+-&@'*("[9 %=K6/\0=.\:ZOX)U33/AQXEM-'UZ>S=-*U2^L/M4-K,1\KO%
MN7S /3<* /E_3?VL_P!M#X"?M/?#_P"!?[9/@_X=:AHWQ/N+BS\/>(?ATU]&
M;*]B56,4\=VS%U)>-01MX?=D[2M;G[3'[27[8&E?M=:-^RM^RCX5^'=U=7GP
M^D\37MYX]DOD4*EZ;8QHUJW7E#@J<Y;D8 /B'Q9TOX_?LP_MG_"C]H']NGQ7
MIGQ1T"^US_A&O!VI:);_ -F1^$]1O%Q]H-B%83EU4_.9&8+&3PR1@_1O[0O[
M%'BWXO\ [0.F_M'?#7]I;7?A]KVG^#V\.F31]&M;KSK9KEK@Y^T!@,N5R ,_
M(.1DT ==^S;>_MC3V>LR?M?:7\.+.1'A.AGX?W-\ZE,/YQG^UC@@^7MV_P"U
MGM7A7@_]K#]OW]J_3-<^,?[&7P[^&=M\/=-U.ZL_#C>/)KYM0\4?9V*230FW
M98[>-V5E3?T8?,< XK?"/XW_ +3^@_%_XP?L(_'SQ]9^.-6T+X:S>(?"7C6R
MT>.PN+FWDC$7DW$,/[L2!Y4VE>?E8DMN&.T_X(Y7&GW/_!-SX9'360HEGJ"2
M!#TD&I76_/ONR?QH ]#_ &+?VI-(_;!^ 6F_&.Q\/2Z-?-<3V&O:'/)O?3K^
M!]DL); W#HRG .UUR <@>KU\A?\ !'A?-^'7QEU.R_Y!MY^T'XCFTIE^ZT.V
MU 9?]G((^H-?7M !117B6J?M2_&6PU.YL+;]BWQO=1P3O''<Q7-MMF4,0'&6
MZ$#(^M 'MM%>9_"[XY?$;Q[?7=KXE_9N\3>&$MXE>*;5)X66<DX*KL/4=>:[
M3_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_
M .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7
M_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=
M7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z
M%"]_[Z6@#8HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
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M_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
MV**Q_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_
M (275_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK
M'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X
M275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A
M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\
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M^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI: -BBL?\
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M#_AI#/\ V9H\+9N;QPT]W.[EY9Y6  9W=F8X  R    !W=%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_A=^RI\.?A)?7=_X:UWQ-</>1+'*-4\0S7*@ Y&T.?E/TKM/^$'TC_GYO?\
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M!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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MT1C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L45^@GJ&/\ \(/I'_/S>_\
M@6U'_"#Z1_S\WO\ X%M6Q10!C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M6Q1
M0!C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;5L44 8__  @^D?\ /S>_^!;4
M?\(/I'_/S>_^!;5L44 8_P#P@^D?\_-[_P"!;5)9^$M-L;I+N&XNBT;94/<L
M1^(K4HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOR.F,(05HJP4445N4%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_!/3X>^5/XJ\.>)?&<Z<EO$?B%XT+?[EF(!CV;=[YH^O\6XO^#A(4EWJ3O\
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MK8HH Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EK8HH Q_P#A)=7_ .A0O?\
MOI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V**
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M@#'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HH Q_^$EU?_H4+W_OI:/\
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M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\
MH4+W_OI:V** ,?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6MBB@#'_X275_^
MA0O?^^EH_P"$EU?_ *%"]_[Z6MBN(^)/[3'[.GP<$G_"V/COX0\./'G=#K7B
M.VMI,^@1W#$^P!-14JTJ,>:I))=V["<E%7;-_P#X275_^A0O?^^EH_X275_^
MA0O?^^EKY>^)7_!<C_@F[\.3)!;_ !KN?$=S'G-KX:T&ZGS])71(3^#U\_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%<O\0OC=\&?A) ;GXJ?%OPSX:C"[B^OZ];V8QZ_O76O ?B5_P6C_X)
MO?#/S(+G]HJUUJY3.+7PUI=U?;_I+''Y/YN*XL3F.7X/^/6C#UDE^;,YU:5/
MXI)'U-17YK_$O_@Y:_9ST7S(OA-^S[XP\02)D))K5Y;:9$Y]04-PV/JH/M7
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M68G\@.I) &20*\"_8J_X*B?LY_MO^+]?\ ^ 9KK2=9TFZE;3M.U@JDNK6*G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M)_P2M_X*I?MZ?M(_MZ>!/@O\:/CO_;/AG6?[4_M+3?\ A%]+M_.\G2[N>/\
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M/!^E>)Y;&2&+5]2NY9#.UN)0K21QQ2.C''#*O9P:YO\ 87_;L^"?[$/[,O\
MPRI^UQK=WX6\>?#2^U"QDT*72;B275X7NI9[>6T*(5E602;%.0#M#'"L&H ]
M/_X(YZ_KZ_LW>*/@[KNL3WR?#'XH:SX4TR>ZDW/]CMVBDC4GT7SF4#LJ@#
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M#Z1_S\WO_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\
M/S>_^!;4 ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\
MWO\ X%M1_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\
M@6U &Q16/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO
M_@6U'_"#Z1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4
M ;%%8_\ P@^D?\_-[_X%M1_P@^D?\_-[_P"!;4 ;%%8__"#Z1_S\WO\ X%M1
M_P (/I'_ #\WO_@6U &Q16/_ ,(/I'_/S>_^!;4?\(/I'_/S>_\ @6U &Q16
M/_P@^D?\_-[_ .!;4?\ "#Z1_P _-[_X%M0!L45C_P#"#Z1_S\WO_@6U'_"#
MZ1_S\WO_ (%M0!L45C_\(/I'_/S>_P#@6U'_  @^D?\ /S>_^!;4 ;%%8_\
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MK1A_AC*7_I0<N/ENXKT39\0>)/\ @YIT"2;[%\._V.M2OY9#MA;4O%Z0G/\
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M6U?KQ[AL45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
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M)$&://7:2,C\*GHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "O)_VXOVH/\ AC/]ESQ1^TG_ ,(/
M_P ))_PC?V+_ (DO]I_8_M'VB]@M?]=Y4NS;Y^_[ASMQQG(]8KY/_P""X?\
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M\MTN[.X26*10T<L;AE=3T((X(I]?+;'TVX4444 %%%% !1110 4444 %%%%
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M% !1110 4444 %%%% !1110 45SOQ;^)WAGX,?#/7/BIXQN/+TW0M.DN[G!
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M/R#D9- '7?LVWO[8T]GK,G[7VE_#BSD1X3H9^']S?.I3#^<9_M8X(/E[=O\
MM9[5X5X/_:P_;]_:OTS7/C'^QE\._AG;?#W3=3NK/PXWCR:^;4/%'V=BDDT)
MMV6.WC=E94W]&'S' .*WPC^-_P"T_H/Q?^,'["/Q\\?6?CC5M"^&LWB'PEXU
MLM'CL+BYMY(Q%Y-Q##^[$@>5-I7GY6)+;ACM/^".5QI]S_P3<^&1TUD*)9Z@
MD@0])!J5UOS[[LG\: /0_P!BW]J32/VP?@%IOQCL?#TNC7S7$]AKVASR;WTZ
M_@?9+"6P-PZ,IP#M=<@'('J]?(7_  1X7S?AU\9=3LO^0;>?M!^(YM*9?NM#
MMM0&7_9R"/J#7U[0 445XEJG[4OQEL-3N;"V_8M\;W4<$[QQW,5S;;9E#$!Q
MENA R/K0![;17F?PN^.7Q&\>WUW:^)?V;O$WAA+>)7BFU2>%EG)."J[#U'7F
MNT_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q
M_P#A)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (27
M5_\ H4+W_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X2
M75_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_
M^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_
M .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\ H4+W
M_OI: -BBL?\ X275_P#H4+W_ +Z6C_A)=7_Z%"]_[Z6@#8HK'_X275_^A0O?
M^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^E
MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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MW[.I\'?!X_8I-:O(?#4T,<Z?;8#;YNKLEI3]I\CF +[C;NK]4O@=^QW^RO\
MLW"&7X+_ +)6BZ-=P >5JGV%+B^'_;U.7F/_ 'W1^W%\!=7_ &S/V7/%'[-G
MVF]\-_\ "2?8O^)U_9RWGV?[/>P77^I\V+?N\C9]\8W9YQ@\N/R7B3,,#56(
MQ6KC*U.FE&+=G9.3U:;T=^G4SJ8?%U:<N:?39:?B?S7TZ6&6''FQE=PR,CJ*
M]A_:C_9^^$_[/7Q:N?AG\-_CFWC]M*+1:MJ<?A];&VAN@<-#&5N9_/V]&8;0
M&X&[!(\\NK6*[B,4H^A[@U]=PM]%[BG/.$:^8XRHJ&*:O0I.S4DM7[22OR\Z
MTA;;>6CL?C.;^(6 RS.8X2$>>$7:I).]G_=MH[=?N1[Q_P $>?A[X#^*G_!1
MKX=>!/B9X,TOQ#HE\=6-[H^M6$=U:W'EZ1>RIOBD!5]KHC#(."H/:OWZ\)?
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M5-%TBVM0!Z8B5:/[3\-<'_!P%:O_ -?*JA_Z;0?V=XB8O^-CJ-'_ *]TW/\
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MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
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M_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM
M&Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]
M+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM &Q
M16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM &Q16/_PDNK_]"A>_]]+1
M_P )+J__ $*%[_WTM &Q16/_ ,)+J_\ T*%[_P!]+1_PDNK_ /0H7O\ WTM
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M/UU10!PG[-?[//P__98^"^B_ _X:0S_V9H\+9N;QPT]W.[EY9Y6  9W=F8X
M R    !W=%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !16=XI\7^$_ VBR^)/&WBC3M'TZ
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MC&W'\487V&:?!_P1H_X*+_M-3)J/[8O[9GD6TK!VT^35;O67A[D" M%;Q_\
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M[6W_  0F_98\>_#S7-:_9M\&W/A?QFEF\NB6D&ORC3KFX'(CE2<2[%89 V%
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M[NGEZ1?/_P"@P'%4Y_\ @JU^P- S(?CT&*]D\,ZH<_0BVQ6T>$^*I;8"L_\
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M$^[3C\,%?E3ZOS;[O9:(\3A3@_*^$\+*GA_>G+XIOXGV7DEV774****^//K
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M/T1K \2_%?X6^#-W_"8?$K0-)V??_M+68(-OUWL,5\&'_@C_ /M7^/?^2O\
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MM>UKX)275Y>W+W%W<S>*]*+RRNQ9G8_:N2222?>JW_#J+]OO_H@O_ETZ5_\
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M$G7/"FFWI8_,;NQCDS_WT#1_K'P)5_BY)9]XXBHOP:L'UC!/>C_Y,SXBTO\
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M+T:ZL+:W1OH1.YQ]17O/AK_@F3^PSX6VM8_ '3[AUZOJ6H75UN/N)I67]*]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHKPO]I']OKX<?LU?%33?@QJGPG^(GB[Q#J>@G68K'P%X8&I-':"9H
M2[J)58#>N,@$#*Y/(H ]THKS#]FO]J+3?VE[76+K3O@I\1O!HT>2!'3X@^%6
MTMKOS0YS!EV\P+L^;IMW+ZUYQX^_X*B?!_PMXL\0^'? GP:^)_Q!L?!]T]MX
MM\2^ _"8O=-TJ:,9EC>9I4W-&.7V!@ "<G% 'TM17,_!SXP?#OX^?#32/B[\
M*?$4>JZ!K=MYUA>QJ5W ,5965@"CJRLK*0"K*0>E=-0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*
M*?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
MY\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/
M_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_0H_L
M[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^
M_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3_P#G
MQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__
M )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM
M/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU
M5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U!_WU1_PF/AC_ *#4
M'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_ *#4'_?5'_"8^&/^
M@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX8_Z#4'_?5'_"8^&/
M^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\ ?5'_
M  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'_OT* *?_  F/AC_H-0?]
M]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@
MU!_WU1_PF/AC_H-0?]]5<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^
M@U!_WU1_PF/AC_H-0?\ ?57/[.T__GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)C
MX8_Z#4'_ 'U1_P )CX8_Z#4'_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G
M_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT
M* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_
M[]"@"G_PF/AC_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA
M_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T
M_P#Y\8?^_0H I_\ "8^&/^@U!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H
M_L[3_P#GQA_[]"@"G_PF/AC_ *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_O
MT*/[.T__ )\8?^_0H I_\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_
M +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_
M /GQA_[]"C^SM/\ ^?&'_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^
MSM/_ .?&'_OT*/[.T_\ Y\8?^_0H I_\)CX8_P"@U!_WU1_PF/AC_H-0?]]5
M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*
M*?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M& W- '3_ /!,G]H7XC?M"?LW3R_&2[BNO&'@SQ5J'A;Q-?0QA!=W5HR$3%5
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M/@_P?H5IIFE:9:I;:?IUC L4-O"@PJ(B@!5 &,"K]%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 45D>,/B!X%^'MO8W?CWQEI>BQ:GJ<.G:=)JM_'
M;K=7<I(BMXRY&^1\':@R3@X'%:] !1110 445D67Q \"ZEXTOOAQIWC+2Y_$
M&F6D5UJ.B0W\;7=K!)Q'))$#N16QP2 #0!KT444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1161X5^('@7QS<:I:>"_&6EZM+
MH>IR:=K,>FW\<[6-V@!>WF"$^7(N1E&P1GD4 :]%%% !116;XO\ &/A/X?\
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M+XYN-4M/!?C+2]6ET/4Y-.UF/3;^.=K&[0 O;S!"?+D7(RC8(SR* ->BBB@
MHHK-\7^,?"?P_P##5YXS\=>)K#1M(T^'S;_4]3NT@M[=,@;GD<A5&2!R>I%
M&E145A?V.JV,.J:9>17%M<Q++;W$$@=)48 JRL."""""."#4M !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 ><_M':7^TQXC\/6'A3]FGQ)X>\/7>HW;1ZUXJUR
MV:YDTFUV_P"LM;8?)/.6P%$C!!@DYXKQG_@D'XT^)7C/]GGQ:?BG\2];\6:E
MI/Q3UG38M7UZ^>XG:&$0!5!<G8N2Q"#Y5W$  5]65\C?\$;/^2#?$+_LMOB+
M_P!"@H Z_P",/[#GQ4^.7C77O%WB7]NSXI^'8+B4_P#"*:'X!U1-(L])C" *
M)@@+WK;P6+,R'#%1C (R/^"1OQ\^+7[0'[*MSJOQF\1_VYJWAOQA?Z#%XA*
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M3XG:WXMU'1OBUK6EPZOK]\\\[00K;A5!<G8N2S!%^5=QP!7U;7R-_P $<O\
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M_%71/ 'C#P?/\,OB%K@LK/Q0K:;%%%J[6-Q<NR,WE02(ZOYFU&;"'=A2>@-
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M/%/_  2<_8(\:^(KCQ7XH^"M]=ZA=7\E[+</XYUI<3R,79U5;P*A)).%  Z
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MJOB*\MHH+G4HO$VIVADCC4*B[+>YC3A0!PN3CG-:O[/7["O[+7[*OB2^\7?
M?X;3:)J&I6/V.\GE\1:A>"2'>K[=MU<2*OS*IR #QC.*]<HH Y[XK?"SP+\;
MOAUJWPH^)NB'4M!URU-MJ=B+F2'S8\@XWQ,KKR <J0>*U/#GA_1_"7AZP\*^
M'K/[/8:9916EC;[V;RH8T"(NYB2<* ,DDG')J[10 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 5\G_P#!3_\ X*?_ /#M[_A!_P#BQ_\ PF?_  F?
M]I_\S+_9WV/[)]D_Z=IO,W_:O]G;L[[N/=OCG^TQ\!OV9])L-<^//Q0TSPO:
M:G<-!83ZG(RK/(J[F5< \@<U^2__  <#?M7?LZ?M/?\ "I/^% _%O2?%/]A_
MV]_:W]ER,WV7SO[.\K=N ^]Y4F/]PU\OQ5G']FY16EAZL8UH\ME>+>LHW]UW
MZ-]/,X\;7]C0DXRM+3\^QZ%_Q$_?]6/_ /F2_P#[VT?\1/W_ %8__P"9+_\
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M)OV)OBG\;=4^(.@W'PZB\8>%]:\0P1#4+,?;%M);>22-5$@+%F!(X"+@#)R
M?6M%?F_X>_;3\+?M2>)_&/CKXH_\%*9_@SI^G>);K3? ?@[P[<6EO(MK 0J7
MUZ9HG>X,IR?*RJKM.#@\?3'_  3(_:>\7_M3?LYW?B/Q_KMAK.M>&/%E_P"'
M+_Q#I<(CM]9-MY;QWL:+\JB2*:,D+@9R0 #@ '7_ +5?[8GP[_9&L/#<_C?P
M?XKU^[\6:Q_9FAZ1X/T=;V\N;C9NVK$9$+$\ !<L21@5D_!+]MRV^-GQ!MOA
M]'^RA\;_  H;F&60:UXW^'<FG:?%L0MM>=I&"LV,*,<D@5XY_P %;->\3>%_
MB1^SAXB\&>"Y?$>K67Q:CFT[08+V.V>_F6-2L(ED^2,L>-S<#/->[?L]?'']
MH_XH^)KW2/C/^QQJ?PXL+>P\ZUU6]\86&HK<S;U7R0EL=RG:6;<>/E(ZD4 >
MN45\,_"!/VQ/VN?CK\;_ (=G]K+5O!G@KP7\2[RRL)/#UC VJR$JHBMEFD0K
M#;1*F[Y07=I6!( K>_9J_:1_:GE_96^.OAO6KU?''Q)^#7B'6]#T+5%T\*^M
MFWAWVTCPQXWR9W?(O+@*N2Q+$ ^R*X/X9?'0?$KXH>./AF/A;XKT7_A";RUM
M_P"V]<TOR++6/.1VWV<FX^<J;/F.!C>G][CYU_X)W^(F^-2>'/B_HG_!1;Q-
MXUUG^S#+\1?AYK:6 CBN7@96B2T6&.:Q6*X92'4LKB+:"0V:W/@Q^T3\6#\?
M/VK[76]5N]?T_P"'#:;<>$M 95 ASID\[P1[5W?O'C7KGGI0!]545^9GQ.\=
M?M.Q_P#!.6V_X*%VO_!0#Q1'XJU=;6Y/AG3!8QZ1F>\6$Z=;P"$NL\2LV6+.
MQ,3;EZL/9_VOO''[5?P<O_V=/A#\&/C9<MXA\6:Y>:7J^M>+;**3[66M5*RW
M442*KM#YC.$7:&:-0V1F@#[,HKXQFNOVF/V-?VR_A+X(\7?M1Z]\2O"GQ9N-
M1TW6K+Q/86T<EA?P0++'<6QA1?*1F8#RA\H4,#N)4K]>^+]9G\.^$]4\0VMM
MYTMAIT]Q'"?^6C)&S!?Q(Q0!XQ\</^"A_P #_@U\27^"NB>&_&'Q!\:V\(FO
M_"?PV\.MJEY8QD AI\,D<7!!VE]P!!( (S>_9\_;I^&/Q_\ 'UQ\))/ 'CKP
M/XOM]-;4!X8^(/A:33;J:U5U1YHSEXW4,Z#A\_-G& <>+?\ !)4VW@K_ ()Y
M7/[4,'A34?%GC+QIJ6LZ_P"*%TJ))-2UB[CO;B%(5+LN6VQ9520 TKD?>.?3
M/@3^WQH_QF_:*7]G+Q=^S?XZ\!^*1X5EUVS7Q?8VT?F60G6$E?+E9AN<$#C!
M\HYZ"@#Z'HKX,^#UK^VU^V%\;?C3X-M?VNM6\#^#_ ?Q6U.RT>YT33X)=0GD
M#*(K4LX 6U@1 VWK(T[!B0HQW'BGQC\??VR?VR?'O[./PQ^.FJ_#CP+\*;'3
MH_$.I^&+:$ZIK.IWD32HB33*WD11JK@[1DLASD.NP ^NZ*^4/V:?B=\>?@M^
MVUK?["?QS^*USX]TV[\$)XK\#>*M4LXHM02W%Q]GEM+DQ +*0X=@Y&<1^CA5
MZ#_@E[\7OB3\:OV?]=\5?%+Q;<ZSJ%M\1=:L8+JZ"ADMHIP(XQM &%!(% 'T
M?17P9\/OVG_CYJ__  2?^+'QRU'XFW\OBW0];UV'2=<98_.MDBNE6-5PNWY5
M8@9%2_$7PE^W[I_[(\O[<9_;0O[?Q7I/A./Q.G@C3-&MQH L$@6XDM9$=3)-
M(80Q:9FY?(4*,, #[NHKC_V>_BM#\=?@3X.^,T-B+7_A*/#5EJ;VBMD0/-"K
MO&">NUB5SWQ784 >>_![]I;X??&_X@>/?AOX/L]4BO\ X=:Y'I6O/?6R)%).
MZ,P,)5V+KA3RP4Y[5Z%7Q[^P+/+;?M-_M;7,#[7C^(L+(WH1;S$&O-?V2_#W
M[?/[8O[$FF?M#:]^W#K/AN^BTW4#X2L]!TRW_P!-EMKB>,SZG(Z9F+R1M&(T
MVHL:(WS,S"@#]#**^(]2_P""AOQBNO\ @EMX _:)\.6FGGXC_$35+7PMI%Q-
M;C[,FJR7<]JUTT>-N,6TL@3&T,5&"HVGUWX._LM_M/\ PH^(&B>,-:_;G\2>
M,[!BX\8^'_%&C6K6UYNA8*]F8E5K,K-L8*"P*Y!/J >_T444 %%%% !1110
M45Q'QM_:0^!G[-^EV.M_'/XF:;X9M-2N&@L9]2=E6:15W%5P#R!S7B_Q7_X+
M"?L$?#;P!J7C'1_CGIOB>]L[<M9:#H6^2YO9OX8URNU 3U=B%49// /JX+(L
MZS)1>%PTYJ3LG&,FF[VWM;??73J>9C,[R?+W)8G$0@XJ[3DDTM]KW]-->AZ9
M^U]^U]\(OV+?A%=?%?XKZIZQ:-HUNX^U:K=8RL,2G\V<_*B\GL"?L@_M??"+
M]M+X16OQ7^%&J>D6LZ-<./M6E76,M#*H_-7'RNO([@?@5^U_^U]\7?VTOB[=
M?%?XKZI_>BT;1K=S]ETJUSE88E/YLY^9VY/8 _9!_:^^+O[%OQ=M?BO\*-4_
MNQ:SHUPY^RZK:YRT,JC\U<?,C<CN#^X_\03_ .,:_B_[;\6_N;?P_P#[;OY'
MXQ_Q&+_C(OX?^Q_#M[_^/_[7MYG])%%?,'PH_P""PG[!'Q)\ :;XQUCXYZ;X
M8O;RW#7N@Z[OCN;*;^*-L+M< ]'4E6&#QR!ZS\$OVN?V:_VD-4OM$^!GQBT?
MQ-=Z;;K/?P:;(S-#&S;0S94<$\5^(8S(,\R]3>)PM2"CHVX226MM[6WZWLS]
MEPF>Y+CG%8?$PFY;)2BV]+[7OMTL:G[0?QS\%?LT_!O7?CE\1(;Z31O#ULD]
M]'IL"RSN&D2-5169026=1RP'O53]FK]I'X7?M8?"/3_C3\(=2GGTF_>2)H;R
M(1W%K-&VUX9D!.QP<'&2"&5@2""?*O\ @KW_ ,HXOBA_V"[3_P!+[:O)?@R\
MG[ G[8^@Z+*3;_"[]HG3K6XLB>(=(\6K F]/1!=!AC^\[J!A8C7D'JGU=\ O
MVC? /[1UGXKO? -KJ42>#O&U_P"%M5_M*W2,O>VGE^:T>UVW1'S%VL<$\Y45
MR'QB_;^_9_\ @;^TIX3_ &5_'%UJ@\2>,/LPL;BUM$>SM6N)7A@2XD,@:-I'
MC8* K=B< YKSO_@E#+%!X8^/<\\BHB?M+>*F=W. H"VF23V%?/&J_#G2_P!M
M7]F;]HC]KV/7[6+Q+XG\5#4/A=(UVBW$&G^'R5LS""<H\VVX0@=68'/>@#]&
M_B9\2O!'P=\ ZM\4/B3X@ATK0M#LVNM3OYP2L4:^R@EF)P J@EB0 "2!7A?P
MZ_X*9?#GX@>)O#VE77[/'QA\/:-XLU&WLO#?C#Q#X%:'2KV6=PD&)DE=D65F
M78SJ 0P)('-0^(M(LO\ @J9_P3)CT_1_$4.EW7Q!\*VLQNPI,5KJ=M/'(\3!
M>?+6ZMVC; SM!(&>*XWX*?M_?$WX!^(O#'[,W_!0KX)77@C5[MH=(\/^/]+8
M7&@:U*H"1DR+_P >[M\N5Y +981#@ 'JG[17[??PY_9S^,&F_ F\^$GQ&\8^
M)M4\/_VU!IO@#PL-3D2S\YX=[*)588>-LX4@<9(R*=\"?^"A?[/GQU^(A^#4
M<?B3P?XU,!FA\'^/_#\NE7\\8!),:2960@!CM5BV%8XP"1YSXP_Y3=^$_P#L
MWRY_].D]9?\ P6YTC3_#O[,V@_M#:)"EOXP^'_CK2[[POJD2XG1VF"O"K#DH
MWRN5Z$Q*>U 'UG\2/B!X9^%'P^UOXG>-+TV^D>'M*N-1U*91DK##&TCX'=L*
M<#N<#O7#_LC?M??"7]M3X8S_ !4^$":I#96FK2Z;>V6M6J0W5O<1JCE71'<
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M+_;P^,_[1VC_ !O_ &?? O[-'C^U\/S_ !#O=:MKTZK9B>UV?8H&2:2/K(T
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M6_AW#JOQ5^#VG^!-6GNI6/AK3M8BOEMHMV$+S1(L;2$<L$R!ZFNSHH ^7?\
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M_:RM?V[?V0O".G>*+_4_#B:)X_\ A[J>JI8OJMNC*T4T%P^8TF4*BDL< 1#
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MG^&>A_%3P=I7B*33==TZ.[ML^(7+1[A\T;8'#(VY&'9E(KSK_APE_P!76_\
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MVQQ1A$(S@DH,;@YV?7]%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
9110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874403456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 31, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ENSIGN GROUP, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0861263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">29222 Rancho Viejo Road, Suite 127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Juan Capistrano<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">949<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">487-9500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ENSG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Restatement Recovery Analysis</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,196,977<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,455,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Part III of this Form 10-K incorporates information by reference from the Registrant's definitive proxy statement for the Registrant's 2025 Annual Meeting of Stockholders to be filed within 120 days after the close of the fiscal year covered by this annual report.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001125376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868193840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Costa Mesa, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871691968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 464,598<span></span>
</td>
<td class="nump">$ 509,626<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable&#8212;less allowance for doubtful accounts of $8,435 and $9,348 at December&#160;31, 2024 and 2023, respectively</a></td>
<td class="nump">569,897<span></span>
</td>
<td class="nump">485,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments&#8212;current</a></td>
<td class="nump">62,255<span></span>
</td>
<td class="nump">17,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">60,882<span></span>
</td>
<td class="nump">35,036<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">1,157,632<span></span>
</td>
<td class="nump">1,046,930<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,291,354<span></span>
</td>
<td class="nump">1,090,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">1,861,071<span></span>
</td>
<td class="nump">1,756,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceSubsidiaryDepositsAndInvestments', window );">Insurance subsidiary deposits and investments</a></td>
<td class="nump">141,246<span></span>
</td>
<td class="nump">92,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">66,281<span></span>
</td>
<td class="nump">67,124<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_RestrictedAndOtherAssetsNoncurrent', window );">Restricted and other assets</a></td>
<td class="nump">46,499<span></span>
</td>
<td class="nump">40,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">7,292<span></span>
</td>
<td class="nump">6,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">97,981<span></span>
</td>
<td class="nump">76,869<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">TOTAL ASSETS</a></td>
<td class="nump">4,669,356<span></span>
</td>
<td class="nump">4,177,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">98,947<span></span>
</td>
<td class="nump">92,811<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued wages and related liabilities</a></td>
<td class="nump">347,532<span></span>
</td>
<td class="nump">332,568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities&#8212;current</a></td>
<td class="nump">93,475<span></span>
</td>
<td class="nump">82,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserveCurrent', window );">Accrued self-insurance liabilities&#8212;current</a></td>
<td class="nump">67,331<span></span>
</td>
<td class="nump">54,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">132,057<span></span>
</td>
<td class="nump">168,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current maturities of long-term debt</a></td>
<td class="nump">4,086<span></span>
</td>
<td class="nump">3,950<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">743,428<span></span>
</td>
<td class="nump">734,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount', window );">Long-term debt&#8212;less current maturities</a></td>
<td class="nump">141,585<span></span>
</td>
<td class="nump">145,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term lease liabilities&#8212;less current portion</a></td>
<td class="nump">1,735,325<span></span>
</td>
<td class="nump">1,639,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserveNoncurrent', window );">Accrued self-insurance liabilities&#8212;less current portion</a></td>
<td class="nump">144,421<span></span>
</td>
<td class="nump">111,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_DeferredRentAndOtherLongTermLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">64,169<span></span>
</td>
<td class="nump">49,408<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">TOTAL LIABILITIES</a></td>
<td class="nump">2,828,928<span></span>
</td>
<td class="nump">2,680,224<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Notes 14 and 19)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Ensign Group, Inc. stockholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock: $0.001 par value; 150,000 shares authorized; 60,838 and 57,438 shares issued and shares outstanding at December&#160;31, 2024, respectively, and 59,987 and 56,597 shares issued and shares outstanding at December 31, 2023, respectively</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">528,052<span></span>
</td>
<td class="nump">465,707<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,426,762<span></span>
</td>
<td class="nump">1,142,653<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Common stock in treasury, at cost, 3,400 and 3,390 shares at December&#160;31, 2024 and 2023, respectively</a></td>
<td class="num">(117,764)<span></span>
</td>
<td class="num">(116,555)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Ensign Group, Inc. stockholders' equity</a></td>
<td class="nump">1,837,111<span></span>
</td>
<td class="nump">1,491,865<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">3,317<span></span>
</td>
<td class="nump">5,452<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">1,840,428<span></span>
</td>
<td class="nump">1,497,317<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">TOTAL LIABILITIES AND EQUITY</a></td>
<td class="nump">$ 4,669,356<span></span>
</td>
<td class="nump">$ 4,177,541<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_DeferredRentAndOtherLongTermLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rental expense in excess of actual rental payments and other long-term liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_DeferredRentAndOtherLongTermLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceSubsidiaryDepositsAndInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Captive insurance subsidiary cash and equivalents designated to support long-term insurance subsidiary liabilities and debt security investments held to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceSubsidiaryDepositsAndInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Debt, net of Current Maturities and Debt Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RestrictedAndOtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Restricted And Other Assets, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RestrictedAndOtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid after one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874241376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts on accounts receivable</a></td>
<td class="nump">$ 8,435<span></span>
</td>
<td class="nump">$ 9,348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common shares authorized (in shares)</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common shares issued (in shares)</a></td>
<td class="nump">60,838<span></span>
</td>
<td class="nump">59,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common shares outstanding (in shares)</a></td>
<td class="nump">57,438<span></span>
</td>
<td class="nump">56,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Common shares in treasury, at cost (in shares)</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="nump">3,390<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871180672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">$ 4,260,485<span></span>
</td>
<td class="nump">$ 3,729,355<span></span>
</td>
<td class="nump">$ 3,025,468<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of services</a></td>
<td class="nump">3,376,884<span></span>
</td>
<td class="nump">2,941,238<span></span>
</td>
<td class="nump">2,354,434<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_RentCostOfServices', window );">Rent&#8212;cost of services</a></td>
<td class="nump">216,016<span></span>
</td>
<td class="nump">197,358<span></span>
</td>
<td class="nump">153,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative expense</a></td>
<td class="nump">225,143<span></span>
</td>
<td class="nump">263,005<span></span>
</td>
<td class="nump">158,805<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">84,138<span></span>
</td>
<td class="nump">72,387<span></span>
</td>
<td class="nump">62,355<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">TOTAL EXPENSES</a></td>
<td class="nump">3,902,181<span></span>
</td>
<td class="nump">3,473,988<span></span>
</td>
<td class="nump">2,728,643<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">358,304<span></span>
</td>
<td class="nump">255,367<span></span>
</td>
<td class="nump">296,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(8,286)<span></span>
</td>
<td class="num">(8,087)<span></span>
</td>
<td class="num">(8,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">28,749<span></span>
</td>
<td class="nump">19,216<span></span>
</td>
<td class="nump">5,035<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense)</a></td>
<td class="nump">7,327<span></span>
</td>
<td class="nump">6,266<span></span>
</td>
<td class="num">(3,840)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">OTHER INCOME (EXPENSE), NET</a></td>
<td class="nump">27,790<span></span>
</td>
<td class="nump">17,395<span></span>
</td>
<td class="num">(7,736)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">386,094<span></span>
</td>
<td class="nump">272,762<span></span>
</td>
<td class="nump">289,089<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">87,636<span></span>
</td>
<td class="nump">62,912<span></span>
</td>
<td class="nump">64,437<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">NET INCOME</a></td>
<td class="nump">298,458<span></span>
</td>
<td class="nump">209,850<span></span>
</td>
<td class="nump">224,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract', window );"><strong>Less:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME ATTRIBUTABLE TO THE ENSIGN GROUP, INC.</a></td>
<td class="nump">$ 297,973<span></span>
</td>
<td class="nump">$ 209,399<span></span>
</td>
<td class="nump">$ 224,681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET INCOME PER SHARE ATTRIBUTABLE TO THE ENSIGN GROUP INC.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 5.26<span></span>
</td>
<td class="nump">$ 3.76<span></span>
</td>
<td class="nump">$ 4.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 5.12<span></span>
</td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="nump">$ 3.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>WEIGHTED AVERAGE COMMON SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">56,655<span></span>
</td>
<td class="nump">55,708<span></span>
</td>
<td class="nump">54,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">58,240<span></span>
</td>
<td class="nump">57,323<span></span>
</td>
<td class="nump">56,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">$ 4,237,525<span></span>
</td>
<td class="nump">$ 3,708,071<span></span>
</td>
<td class="nump">$ 3,008,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ensg_RentalMember', window );">Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">$ 22,960<span></span>
</td>
<td class="nump">$ 21,284<span></span>
</td>
<td class="nump">$ 16,757<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RentCostOfServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rent cost of services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RentCostOfServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ensg_RentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ensg_RentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378883041568">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Non-Controlling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,190<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 1,021,714<span></span>
</td>
<td class="nump">$ 58<span></span>
</td>
<td class="nump">$ 369,760<span></span>
</td>
<td class="nump">$ 733,992<span></span>
</td>
<td class="num">$ (83,042)<span></span>
</td>
<td class="nump">$ 946<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, balance at beginning of period (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock to employees and directors resulting from the exercise of stock options (in shares)</a></td>
<td class="nump">688<span></span>
</td>
<td class="nump">688<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock to employees and directors resulting from the exercise of stock options</a></td>
<td class="nump">$ 12,677<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">12,676<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of forfeitures</a></td>
<td class="nump">5,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares of common stock used to satisfy tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares of common stock used to satisfy tax withholding obligations</a></td>
<td class="num">(1,702)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,702)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(12,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,334)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Employee stock award compensation</a></td>
<td class="nump">$ 22,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="num">(404)<span></span>
</td>
<td class="num">(404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">$ (29,882)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (29,882)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Acquisition of noncontrolling interest shares</a></td>
<td class="num">(704)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,539)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">835<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Issuance of noncontrolling interests through subsidiary equity plan</a></td>
<td class="nump">6,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Noncontrolling interests attributable to subsidiary equity plan</a></td>
<td class="num">(275)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to the Ensign Group, Inc.</a></td>
<td class="nump">224,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, balance at end of period (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2022</a></td>
<td class="nump">$ 1,248,800<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">415,560<span></span>
</td>
<td class="nump">946,339<span></span>
</td>
<td class="num">$ (114,626)<span></span>
</td>
<td class="nump">1,468<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, balance at end of period (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock to employees and directors resulting from the exercise of stock options (in shares)</a></td>
<td class="nump">759<span></span>
</td>
<td class="nump">759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock to employees and directors resulting from the exercise of stock options</a></td>
<td class="nump">$ 18,369<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">18,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of forfeitures</a></td>
<td class="nump">5,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares of common stock used to satisfy tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares of common stock used to satisfy tax withholding obligations</a></td>
<td class="num">(1,929)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,929)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(13,085)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,085)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Employee stock award compensation</a></td>
<td class="nump">30,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Acquisition of noncontrolling interest shares</a></td>
<td class="num">(256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(256)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Noncontrolling interests attributable to subsidiary equity plan</a></td>
<td class="num">(254)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,787)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,533<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to the Ensign Group, Inc.</a></td>
<td class="nump">$ 209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, balance at end of period (in shares) at Dec. 31, 2023</a></td>
<td class="nump">56,597<span></span>
</td>
<td class="nump">56,597<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2023</a></td>
<td class="nump">$ 1,497,317<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
<td class="nump">465,707<span></span>
</td>
<td class="nump">1,142,653<span></span>
</td>
<td class="num">$ (116,555)<span></span>
</td>
<td class="nump">5,452<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, balance at end of period (in shares) at Dec. 31, 2023</a></td>
<td class="nump">3,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock to employees and directors resulting from the exercise of stock options (in shares)</a></td>
<td class="nump">632<span></span>
</td>
<td class="nump">632<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock to employees and directors resulting from the exercise of stock options</a></td>
<td class="nump">$ 22,286<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">22,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of forfeitures (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Issuance of restricted stock, net of forfeitures</a></td>
<td class="nump">6,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares of common stock used to satisfy tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares of common stock used to satisfy tax withholding obligations</a></td>
<td class="num">(1,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Dividends declared</a></td>
<td class="num">(13,864)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,864)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Employee stock award compensation</a></td>
<td class="nump">36,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Acquisition of noncontrolling interest shares</a></td>
<td class="num">(4,450)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,426)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,024)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Noncontrolling interests attributable to subsidiary equity plan</a></td>
<td class="num">(458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(596)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to the Ensign Group, Inc.</a></td>
<td class="nump">$ 297,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,973<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, balance at end of period (in shares) at Dec. 31, 2024</a></td>
<td class="nump">57,438<span></span>
</td>
<td class="nump">57,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance at end of period at Dec. 31, 2024</a></td>
<td class="nump">$ 1,840,428<span></span>
</td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 528,052<span></span>
</td>
<td class="nump">$ 1,426,762<span></span>
</td>
<td class="num">$ (117,764)<span></span>
</td>
<td class="nump">$ 3,317<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, balance at end of period (in shares) at Dec. 31, 2024</a></td>
<td class="nump">3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -SubTopic 405<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477787/942-405-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866941024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared (in dollars per share)</a></td>
<td class="nump">$ 0.2425<span></span>
</td>
<td class="nump">$ 0.2325<span></span>
</td>
<td class="nump">$ 0.2225<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378867013008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 298,458<span></span>
</td>
<td class="nump">$ 209,850<span></span>
</td>
<td class="nump">$ 224,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">84,138<span></span>
</td>
<td class="nump">72,387<span></span>
</td>
<td class="nump">62,355<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of deferred financing fees</a></td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
<td class="nump">1,036<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NonCashLeaseExpense', window );">Non-cash leasing arrangement</a></td>
<td class="nump">808<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment of long-lived assets</a></td>
<td class="nump">1,849<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost', window );">Write-off of deferred financing fees</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">566<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">635<span></span>
</td>
<td class="num">(27,481)<span></span>
</td>
<td class="num">(6,496)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">1,739<span></span>
</td>
<td class="nump">3,408<span></span>
</td>
<td class="nump">2,390<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">36,226<span></span>
</td>
<td class="nump">30,767<span></span>
</td>
<td class="nump">22,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities', window );">Cash received from insurance proceeds</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">1,396<span></span>
</td>
<td class="nump">1,282<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets1', window );">Loss (gain) on sale of assets</a></td>
<td class="nump">486<span></span>
</td>
<td class="num">(123)<span></span>
</td>
<td class="num">(3,467)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets', window );">Loss (gain) on insurance claims and asset disposals</a></td>
<td class="nump">833<span></span>
</td>
<td class="num">(550)<span></span>
</td>
<td class="num">(627)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossRelatedToLitigationSettlement', window );">Litigation</a></td>
<td class="num">(4,289)<span></span>
</td>
<td class="nump">47,182<span></span>
</td>
<td class="nump">4,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(84,397)<span></span>
</td>
<td class="num">(79,818)<span></span>
</td>
<td class="num">(82,426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="num">(9,227)<span></span>
</td>
<td class="nump">814<span></span>
</td>
<td class="nump">809<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(19,055)<span></span>
</td>
<td class="nump">6,993<span></span>
</td>
<td class="num">(9,141)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct', window );">Deferred employer portion of social security taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(24,155)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue', window );">Cash surrender value of life insurance policy premiums</a></td>
<td class="num">(14,833)<span></span>
</td>
<td class="num">(16,072)<span></span>
</td>
<td class="num">(7,614)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCompensation', window );">Deferred compensation liability</a></td>
<td class="nump">14,986<span></span>
</td>
<td class="nump">16,044<span></span>
</td>
<td class="nump">7,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease obligations</a></td>
<td class="nump">287<span></span>
</td>
<td class="num">(6,564)<span></span>
</td>
<td class="nump">345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">2,835<span></span>
</td>
<td class="nump">15,924<span></span>
</td>
<td class="nump">17,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued wages and related liabilities</a></td>
<td class="nump">19,992<span></span>
</td>
<td class="nump">47,967<span></span>
</td>
<td class="nump">38,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other accrued liabilities</a></td>
<td class="num">(30,670)<span></span>
</td>
<td class="nump">23,828<span></span>
</td>
<td class="nump">3,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInSelfInsuranceReserve', window );">Accrued self-insurance liabilities</a></td>
<td class="nump">44,014<span></span>
</td>
<td class="nump">28,827<span></span>
</td>
<td class="nump">17,785<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Other long-term liabilities</a></td>
<td class="nump">911<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH PROVIDED BY OPERATING ACTIVITIES</a></td>
<td class="nump">347,186<span></span>
</td>
<td class="nump">376,666<span></span>
</td>
<td class="nump">272,513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_PaymentsToAcquirePropertyAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(158,240)<span></span>
</td>
<td class="num">(106,180)<span></span>
</td>
<td class="num">(87,545)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for acquisitions</a></td>
<td class="num">(156,547)<span></span>
</td>
<td class="num">(69,014)<span></span>
</td>
<td class="num">(101,136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities', window );">Cash from insurance proceeds</a></td>
<td class="nump">3,334<span></span>
</td>
<td class="nump">2,029<span></span>
</td>
<td class="nump">1,339<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Cash proceeds from the sale of assets</a></td>
<td class="nump">2,818<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="nump">8,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(105,149)<span></span>
</td>
<td class="num">(29,603)<span></span>
</td>
<td class="num">(21,975)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Maturities of investments</a></td>
<td class="nump">26,397<span></span>
</td>
<td class="nump">18,852<span></span>
</td>
<td class="nump">14,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other restricted assets</a></td>
<td class="num">(2,665)<span></span>
</td>
<td class="nump">970<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED IN INVESTING ACTIVITIES</a></td>
<td class="num">(390,052)<span></span>
</td>
<td class="num">(182,698)<span></span>
</td>
<td class="num">(186,182)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from debt</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Payments on debt</a></td>
<td class="num">(4,350)<span></span>
</td>
<td class="num">(4,033)<span></span>
</td>
<td class="num">(4,106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Issuance of common stock upon exercise of options</a></td>
<td class="nump">22,286<span></span>
</td>
<td class="nump">18,369<span></span>
</td>
<td class="nump">12,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Repurchase of shares of common stock to satisfy tax withholding obligations</a></td>
<td class="num">(1,209)<span></span>
</td>
<td class="num">(1,929)<span></span>
</td>
<td class="num">(1,702)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of shares of common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(29,882)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(13,671)<span></span>
</td>
<td class="num">(12,890)<span></span>
</td>
<td class="num">(12,168)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans', window );">Proceeds from sale of subsidiary shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,693<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Non-controlling interest distribution</a></td>
<td class="num">(543)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="num">(284)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_PurchasesOfNonControllingInterest', window );">Purchase of non-controlling interest</a></td>
<td class="num">(4,450)<span></span>
</td>
<td class="num">(256)<span></span>
</td>
<td class="num">(704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of contingent consideration</a></td>
<td class="num">(625)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments of deferred financing costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="num">(3,197)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED IN FINANCING ACTIVITIES</a></td>
<td class="num">(2,162)<span></span>
</td>
<td class="num">(612)<span></span>
</td>
<td class="num">(32,262)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash and cash equivalents</a></td>
<td class="num">(45,028)<span></span>
</td>
<td class="nump">193,356<span></span>
</td>
<td class="nump">54,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents beginning of period</a></td>
<td class="nump">509,626<span></span>
</td>
<td class="nump">316,270<span></span>
</td>
<td class="nump">262,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash and cash equivalents end of period</a></td>
<td class="nump">464,598<span></span>
</td>
<td class="nump">509,626<span></span>
</td>
<td class="nump">316,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">7,063<span></span>
</td>
<td class="nump">7,025<span></span>
</td>
<td class="nump">7,604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">96,337<span></span>
</td>
<td class="nump">89,730<span></span>
</td>
<td class="nump">70,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Lease liabilities</a></td>
<td class="nump">215,677<span></span>
</td>
<td class="nump">196,942<span></span>
</td>
<td class="nump">151,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash financing and investing activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accrued capital expenditures</a></td>
<td class="nump">7,900<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">4,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Accrued dividends declared</a></td>
<td class="nump">3,589<span></span>
</td>
<td class="nump">3,396<span></span>
</td>
<td class="nump">3,201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new and modified operating lease obligations</a></td>
<td class="nump">$ 232,918<span></span>
</td>
<td class="nump">$ 376,550<span></span>
</td>
<td class="nump">$ 370,753<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (Loss) On Disposal Of Assets And Insurance Claims</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) Due To Deferred Employer Taxes, CARES Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NonCashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NonCashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PaymentsToAcquirePropertyAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments To Acquire Property And Equipment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PaymentsToAcquirePropertyAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Common Stock Associated With Subsidiary Equity Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PurchasesOfNonControllingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchases Of Non-Controlling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PurchasesOfNonControllingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478790/946-405-45-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossRelatedToLitigationSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossRelatedToLitigationSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInSelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the carrying amount of accrued known and estimated losses incurred for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's' compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInSelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The change in cash surrender or contract value during the period which adjusted the amount of premiums paid in determining the expense or income recognized under the contract for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 325<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481551/325-30-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInsuranceSettlementInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21B<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInsuranceSettlementInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromInsuranceSettlementOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow for proceeds from settlement of insurance claim, classified as operating activities. Excludes insurance settlement classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-16<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-21B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromInsuranceSettlementOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4J<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4K<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-2<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WriteOffOfDeferredDebtIssuanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WriteOffOfDeferredDebtIssuanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866496752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Company</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Ensign Group, Inc. (collectively, Ensign or the Company), is a holding company with no direct operating assets, employees or revenue. The Company's independent subsidiaries provide health care services across the post-acute care continuum and engage in the ownership, acquisition, development and leasing of skilled nursing, senior living and other healthcare-related properties and ancillary businesses. As of December&#160;31, 2024, the Company's independent subsidiaries operated 327 facilities and other ancillary operations located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The Company's independent subsidiaries have a collective capacity of approximately 33,500 operational skilled nursing beds and 3,100 senior living units. As of December&#160;31, 2024, the Company's independent subsidiaries operated 231 facilities under long-term lease arrangements and had options to purchase 12 of those 231 facilities. The Company's real estate portfolio consists of 129 owned real estate properties, which includes 96 facilities operated and managed by the Company's independent subsidiaries, 33 operations leased to and operated by third-party operators and the Service Center (defined below) location. Of those 33 third-party operations, one senior living operation is located on the same real estate property as a skilled nursing operation that an independent subsidiary operates. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s wholly-owned independent subsidiaries, collectively referred to as the Service Center, provide specific accounting, payroll, human resources, information technology, legal, risk management and other centralized services to the other independent subsidiaries. The Company also has a wholly-owned captive insurance subsidiary that provides some claims-made coverage to the Company&#8217;s independent subsidiaries for general and professional liabilities, as well as coverage for certain workers&#8217; compensation insurance liabilities.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's captive real estate investment trust (REIT), Standard Bearer Healthcare REIT, Inc. (Standard Bearer), owns and manages its real estate business. The REIT structure provides the Company with an efficient vehicle for future acquisitions of properties that could be operated by Ensign's independent subsidiaries or other third parties. Standard Bearer has elected to be taxed as a REIT for U.S. federal income tax purposes. Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on Standard Bearer. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company's independent subsidiaries are operated by wholly-owned subsidiaries that have their own management, employees and assets. References herein to the consolidated &#8220;Company&#8221; and &#8220;its&#8221; assets and activities in this Annual Report are not meant to imply, nor should it be construed as meaning that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by The Ensign Group, Inc.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868244752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The accompanying consolidated financial statements (the Financial Statements) have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The Company is the sole member or stockholder of various consolidated limited liability companies and corporations established to operate various acquired skilled nursing operations, senior living operations and related ancillary services. All intercompany transactions and balances have been eliminated in consolidation. The Company presents noncontrolling interests within the equity section of its consolidated balance sheets and the amount of consolidated net income that is attributable to The Ensign Group, Inc. and the noncontrolling interests in its consolidated statements of income. The Financial Statements include the accounts of all independent subsidiaries controlled by the Company through its ownership of a majority voting interest. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period statements of income and statements of cash flows have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net income.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the Financial Statements in conformity with GAAP&#160;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company&#8217;s Financial Statements relate to revenue, acquired property and equipment, intangible assets and goodwill, right-of-use assets and lease liabilities, impairment of long-lived assets, as well as general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities. Actual results could differ from those estimates.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Considerations</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist principally of cash and cash equivalents, debt security investments, accounts receivable, insurance subsidiary deposits, deferred compensation investment funds, equity investments, accounts payable and borrowings. The Company believes all of the financial instruments&#8217; recorded values approximate fair values because of their nature or respective short durations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. See Note 5, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's non-financial assets, which includes goodwill, intangible assets, property and equipment and right-of-use assets, are not required to be measured at fair value on a recurring basis. However, on a periodic basis, or whenever events or changes in circumstances indicate that their carrying value may not be recoverable, the Company assesses its long-lived assets for impairment. When impairment has occurred, such long-lived assets are written down to fair value. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue Recognition</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 606).</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's service revenue is derived primarily from providing healthcare services to its patients. Revenue is recognized when services are provided to patients at the amount that reflects the consideration that the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. The healthcare services provided pursuant to skilled patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct. Additionally, there may be ancillary services that are not included in the daily rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rates on a per day basis, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration that is included in the transaction price may be constrained and is included in net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net revenue in the period such variances become known.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company&#8217;s contracts with its patients have an original duration of one year or less, the Company uses the practical expedient applicable to its contracts and does not consider the time value of money. Further, because of the short duration of these contracts, the Company has not disclosed the transaction price for the remaining performance obligations as of the end of each reporting period or when the Company expects to recognize this revenue. In addition, the Company has applied the practical expedient provided by FASB ASC Topic 340, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and all incremental customer contract acquisition costs are expensed as they are incurred because the amortization period would have been one year or less.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rental Revenue Recognition</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's rental revenues are primarily generated by leasing healthcare-related properties through triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Revenue for operating leases is recognized on a straight-line basis over the lease term when collectability of all minimum lease payments is probable in accordance with FASB ASC Topic 842, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 842). The Company has elected the single component practical expedient, which allows a lessor, by class of underlying asset, not to allocate the total consideration to the lease and non-lease components based on their relative stand-alone selling prices where certain criteria are met. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tenant reimbursements related to property taxes and insurance are neither considered lease nor non-lease components under ASC 842. Lessee payments for taxes and insurance paid directly to a third party, on behalf of the Company, are excluded from variable lease payments and rental revenue in the Company&#8217;s consolidated statements of income. Otherwise, tenant reimbursements for taxes and insurance that are paid by the Company directly to a third party are classified as additional rental revenue and expense and recognized by the Company on a gross basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of bank term deposits, money market funds and treasury bill related investments with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of money market funds is determined based on &#8220;Level&#160;1&#8221; inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Subsidiary Deposits and Other Investments &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's captive insurance subsidiary cash and cash equivalents, deposits and investments are designated to support long-term insurance subsidiary liabilities and have been classified as short-term and long-term assets based on the timing of expected future payments of the Company's captive insurance liabilities. The majority of these deposits and investments are currently held in AA, A and BBB rated debt security investments and the remainder is held in a bank account with a high credit quality financial institution. Investments classified as held-to-maturity are financial instruments that the Company has the intent and ability to hold to maturity and are reported net of any related amortization and are not remeasured to fair value on a recurring basis.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's non-qualified deferred compensation plan's (the DCP) contracts insuring the lives of certain employees who are eligible to participate in the DCP are held in a rabbi trust. Cash surrender value of the contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating an investment for its current expected credit losses, the Company reviews factors such as historical experience with defaults, losses, credit ratings, term, market sector and macroeconomic trends, including current conditions and forecasts to the extent they are reasonable and supportable.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from <span style="-sec-ix-hidden:f-501">three</span> to 59 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases skilled nursing facilities, senior living facilities and commercial office space.</span><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease and performs an evaluation to determine whether the lease should be classified as an operating or finance lease at the inception of the lease. As of December&#160;31, 2024, the Company has three financing lease that are not material to the consolidated balance sheet. Rights and obligations of the operating leases are included as right-of-use assets and current and long-term lease liabilities on the Company's consolidated balance sheets. As the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of future lease payments. The Company utilizes a third-party credit specialist to assist in estimating the incremental borrowing rate.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records rent expense for operating leases on a straight-line basis over the term of the lease. The lease term used for straight-line rent expense is calculated from the date the Company is given control of the leased premises through the end of the lease term. Renewals are not assumed in the determination of the lease term unless they are deemed to be reasonably assured at the inception of the lease. The lease term used for this evaluation also provides the basis for establishing depreciable lives for buildings subject to lease and leasehold improvements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's real estate leases generally have initial lease terms of ten years or more and typically include one or more options to renew, with renewal terms that generally extend the lease term for an additional <span style="-sec-ix-hidden:f-507">ten</span> to 15 years. Exercise of the renewal options is generally subject to the satisfaction of certain conditions which vary by contract and generally follow payment terms that are consistent with those in place during the initial term. The Company reassesses the renewal option using a "reasonably certain" threshold, which is understood to be a high threshold. For leases where the Company is reasonably certain to exercise its renewal option, the option periods are included within the lease term and, therefore, the measurement of the right-of-use asset and lease liability. The Company's leases generally contain annual escalation clauses that are either fixed or variable in nature, some of which are dependent upon published indices. The Company recognizes lease expense for leases with an initial term of 12 months or less on a straight-line basis over the lease term. These leases are not recorded on the consolidated balance sheets. Certain of the Company's lease agreements include rental payments that are adjusted periodically for inflation. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company subleases skilled nursing facilities to third-party operators and considers the subleases to be separate contracts as the Company is not relieved of its primary obligation under its operating lease. The rental income from third-parties related to these subleases is presented on a gross basis from the rent expense associated with the Company's lease obligations and is not material to the consolidated statements of income. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the carrying value of long-lived assets that are held and used in the Company&#8217;s independent subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the independent subsidiaries to which the assets relate, utilizing management&#8217;s best estimate, appropriate assumptions and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Goodwill</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Definite-lived intangible assets consist primarily of patient base, facility trade names and customer relationships. Patient base is amortized over a period of <span style="-sec-ix-hidden:f-511">four</span> to eight months, depending on the classification of the patients and the level of occupancy in a new acquisition on the acquisition date. Trade names at independent subsidiaries are amortized over 30 years&#160;and customer relationships are amortized over a period of up to 20 years.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. The Company tests goodwill during the fourth quarter of each year or more often if events or circumstances indicate there may be impairment. The Company performs its analysis for each reporting unit that constitutes a business for which discrete financial information is produced and reviewed by operating segment management and provides services that are distinct from the other components of the operating segment, in accordance with the provisions of FASB ASC Topic 350,&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 350). This guidance provides the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company performs a goodwill impairment test by comparing the carrying value of each reporting unit to its respective fair value. The Company determines the estimated fair value of each reporting unit using a discounted cash flow analysis. The fair value of the reporting unit is the implied fair value of goodwill. In the event a reporting unit's carrying value exceeds its fair value, an impairment loss will be recognized. An impairment loss is measured by the difference between the carrying value of the reporting unit and its fair value. The Company anticipates that the majority of goodwill recognized will be fully deductible for tax purposes as of December&#160;31, 2024. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Insurance</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is partially self-insured for general and professional liability claims up to a base amount per claim (the self-insured retention) with an aggregate, one-time deductible above this limit. Losses beyond these amounts are insured through third-party policies with coverage limits per claim, per location and on an aggregate basis for the Company. The combined self-insured retention is $750 per claim, subject to an additional one-time deductible of $1,500 for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $650 per claim, subject to an additional one-time, deductible of $1,400. For all independent subsidiaries, except those located in Colorado, the third-party coverage above these limits is $1,000 per claim, $3,000 per operation, with a $10,000 aggregate limit and an additional state-specific aggregate where required by state law. In Colorado, the third-party coverage above these limits is $1,000 per claim and $3,000 per operation, which is independent of the aforementioned aggregate limits that apply outside of Colorado. Subsequent to December&#160;31, 2024, the combined self-insured retention is $1,000 per claim ($750 if an enforceable arbitration agreement applies), subject to an additional one-time deductible of $2,950 for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $750 per claim ($650 if an enforceable arbitration agreement applies), subject to an additional one-time, deductible of $4,500.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the self-insured retention and deductible limits for general and professional liabilities and workers' compensation liabilities are self-insured through the captive insurance subsidiary, the related assets and liabilities of which are included in the accompanying consolidated balance sheets. The captive insurance subsidiary is subject to certain statutory requirements as an insurance provider. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy is to accrue amounts equal to the actuarial estimated costs to settle open claims of insureds, as well as an estimate of the cost of insured claims that have been incurred but not reported. The Company develops information about the size of the ultimate claims based on historical experience, current industry information and actuarial analysis, and evaluates the estimates for claim loss exposure on a quarterly basis. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent subsidiaries are self-insured for workers&#8217; compensation liabilities in California. To protect itself against loss exposure in California with this policy, the Company has purchased individual specific excess insurance coverage that insures individual claims that exceed $625 per occurrence. In Texas, the independent subsidiaries have elected non-subscriber status for workers&#8217; compensation claims and the Company has purchased individual stop-loss coverage that insures individual claims that exceed $750 per occurrence. The Company&#8217;s independent subsidiaries in all other states, with the exception of Washington, are under a loss sensitive plan that insures individual claims that exceed $350 per occurrence. In the state of Washington, the Company is self-insured and has purchased individual specific excess insurance coverage that insures individual claims that exceed $500 per occurrence. For all of the self-insured plans and retention, the Company accrues amounts equal to the estimated costs to settle open claims, as well as an estimate of the cost of claims that have been incurred but not reported. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company self-funds medical (including prescription drugs) and dental healthcare benefits to the majority of its employees. The Company is fully liable for all financial and legal aspects of these benefit plans. To protect itself against loss exposure with this policy, the Company has purchased individual stop-loss insurance coverage that insures individual claims that exceed $525 for each covered person.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that adequate provision has been made in the Financial Statements for liabilities that may arise out of patient care, workers&#8217; compensation, healthcare benefits and related services provided to date. The amount of the Company&#8217;s reserves was determined based on an estimation process that uses information obtained from both company-specific and industry data. This estimation process requires the Company to continuously monitor and evaluate the life cycle of the claims. Using data obtained from this monitoring and the Company&#8217;s assumptions about emerging trends, the Company, with the assistance of an independent actuary, develops information about the size of ultimate claims based on the Company&#8217;s historical experience and other available industry information. The most significant assumptions used in the estimation process include determining the trend in costs, the expected cost of claims incurred but not reported and the expected costs to settle or pay damage awards with respect to unpaid claims. The self-insured liabilities are based upon estimates, and while management believes that the estimates of loss are reasonable, the ultimate liability may be in excess of or less than the recorded amounts. Due to the inherent volatility of actuarially determined loss estimates, it is reasonably possible that the Company could experience changes in estimated losses that could be material to net income. If the Company&#8217;s actual liabilities exceed its estimates of losses, its future earnings, cash flows and financial condition would be adversely affected.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#8217;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#8217;s estimates and assumptions, actual results could differ.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer was organized, has operated and intends to continue to operate in a manner to qualify for taxation as a REIT. In order to qualify as a REIT, Standard Bearer must meet certain organizational and operational requirements, including a requirement to distribute to its shareholders, which in this case is the Company, at least 90% of its annual taxable income. As a REIT, Standard Bearer generally will not be subject to federal income tax to the extent it distributes as qualifying dividends, all of its REIT taxable income to its shareholders. If Standard Bearer fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income attributable to The Ensign Group, Inc. in its consolidated statements of income. Net income per share is calculated based on net income attributable to The Ensign Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based payment awards made to employees and directors including employee stock options and restricted stock awards based on estimated fair values, ratably over the requisite service period of the award. Net income has been reduced as a result of the recognition of the fair value of all stock options and restricted stock awards issued, the amount of which is based upon the number of grants and other variables. As stock-based compensation expense recognized in the Company&#8217;s consolidated statements of income was based on awards expected to vest, it has been reduced for estimated forfeitures. The Company estimates forfeitures at the time of grant and, if necessary, revises the estimate in subsequent periods if actual forfeitures differ.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company does not have any components of other comprehensive income recorded within its Financial Statements and, therefore, does not separately present a statement of comprehensive income in its Financial Statements. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except for rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws and a limited number of grandfathered standards, the FASB ASC is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements announced, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company's reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company's financial management and certain standards are under consideration.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Standards Adopted by the Company &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2023, the FASB issued Accounting Standards Update (ASU) 2023-07 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to expand the breadth and frequency of segment disclosures to include additional information about significant segment expenses, the chief operating decision maker (CODM) and other items, and also require the annual disclosures on an interim basis. This guidance was effective for annual periods beginning with the Company's fiscal year 2024, and in interim periods within the Company's fiscal year 2025. The Company adopted the requirements of this ASU in Note 8, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of this Annual Report.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In October 2023, the FASB issued ASU 2023-06</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Codification Amendments in Response to the SEC&#8217;s Disclosure Update and Simplification Initiative," </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which amends U.S. GAAP to include 14 disclosure requirements that are currently required under SEC Regulation S-X or Regulation S-K. Each amendment will be effective on the date on which the SEC removes the related disclosure requirement from SEC Regulation S-X or Regulation S-K. The adoption is not expected to have a material impact on the Company's Financial Statements as these requirements were previously incorporated under the SEC Regulations. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to disclose disaggregated jurisdictional and categorical information for the tax rate reconciliation, income taxes paid and other income tax related amounts. ASU 2023-09 is effective for annual periods beginning with the Company's fiscal year 2025, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to disaggregate key expense categories such as employee compensation, depreciation and intangible asset amortization within its financial statements. ASU 2024-03 is effective for annuals periods beginning with the Company's fiscal year 2027, and interim periods within the Company's fiscal year 2028, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378973875008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE AND ACCOUNTS RECEIVABLE</a></td>
<td class="text">REVENUE AND ACCOUNTS RECEIVABLE<div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's service revenue is derived primarily from providing healthcare services to its patients. Revenue is recognized when services are provided to patients at the amount that reflects the consideration that the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates revenue from contracts with its patients by payors. The Company has determined that disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Payor</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is derived primarily from providing healthcare services to patients and is recognized on the date services are provided at amounts billable to individual patients, adjusted for estimates for variable consideration. For patients under reimbursement arrangements with third-party payors, including Medicaid, Medicare and private insurers, revenue is recorded based on contractually agreed-upon amounts or rates, adjusted for estimates for variable consideration, on a per patient, daily basis or as services are performed.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from the Medicare and Medicaid programs accounted for 70.9%, 72.6% and 73.7% for the years ended December 31, 2024, 2023 and 2022, respectively. Settlements with Medicare and Medicaid payors for retroactive adjustments due to audits and reviews are considered variable consideration and are included in the determination of the estimated transaction price. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and the Company&#8217;s historical settlement activity. Consistent with healthcare industry practices, any changes to these revenue estimates are recorded in the period the change or adjustment becomes known based on the final settlement. The Company recorded adjustments to revenue which were not material to the Company's revenue for the years ended December 31, 2024, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue for the years ended December 31, 2024, 2023 and 2022 is summarized in the following tables:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682,344&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459,449&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183,156&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055,226&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,749&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid &#8212; skilled</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,738&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,663&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicaid and Medicare</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,004,308</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70.9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,690,861</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.6</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,216,194</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789,643&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,129&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525,710&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,574&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,807&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SERVICE REVENUE</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,237,525</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,708,071</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,008,711</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Medicaid payor includes revenue for senior living operations.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Medicaid payor includes revenue related to state relief funding during the year ended December 31, 2023 and 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Private and other also includes revenue from senior living operations and all revenue generated in other an</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">cillary services.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the service revenue above, the Company's rental revenue derived from triple-net lease arrangements with third parties is $22,960, $21,284 and $16,757 for the years ended December 31, 2024, 2023 and 2022.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State relief funding</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received state relief funding through Medicaid programs from various states, including healthcare relief funding under the American Rescue Plan Act (ARPA), increases in the Federal Medical Assistance Percentage (FMAP) under the Families First Coronavirus Response Act (FFCRA) and other state specific relief programs. The funding generally incorporates specific use requirements primarily for direct patient care including labor related expenses that are attributable to the COVID-19 pandemic or are associated with providing patient care. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the expiration of the COVID-19 Public Health Emergency in May 2023, the Company did not receive additional funding during the year ended December 31, 2024. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from these additional payments are recognized in accordance with ASC 606, subject to variable consideration constraints. In certain operations where the Company received additional payments that exceeded expenses incurred related to specific qualifiers, the Company recorded deferred revenue for the excess amount until additional expenses are incurred for recognition. Accordingly, the amount of state relief revenue recognized is limited to the actual related expenses incurred. As of years ended December 31, 2023 and 2022, the Company had $486 and $1,001 in unapplied state relief funds, respectively. During the years ended December 31, 2023 and 2022, the Company received an additional $64,238, and $81,057 in state relief funding and recognized $64,753, and $81,837, respectively, as revenue.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal relief funding </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As part of the Coronavirus Aid, Relief, and Economic Security Act of 2020 (CARES Act), the Company deferred payment of the employer portion of social security taxes related to 2020. For the year ended December 31, 2022, the Company paid $24,155, which was the second and final payment associated with the deferred amount from 2020. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Balance Sheet Impact</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s consolidated balance sheets are contract balances, comprised of billed accounts receivable and unbilled receivables, which are the result of the timing of revenue recognition, billings and cash collections, as well as contract liabilities, which primarily represent payments the Company receives in advance of services provided. The Company had no material contract liabilities and contract assets as of December 31, 2024 and 2023, or activity during the years ended December 31, 2024, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration and doubtful accounts. Accounts receivable as of December&#160;31, 2024 and 2023, is summarized in the following table:</span></div><div style="margin-top:9.75pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.861%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,872&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,285&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,711&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,907&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,056&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,512&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other payors</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,693&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">578,332</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">494,387</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,435)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,348)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ACCOUNTS RECEIVABLE, NET</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">569,897</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">485,039</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378989316848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF NET INCOME PER COMMON SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">COMPUTATION OF NET INCOME PER COMMON SHARE</a></td>
<td class="text">COMPUTATION OF NET INCOME PER COMMON SHARE<div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share is computed by dividing income from operations attributable to stockholders of The Ensign Group, Inc. by the weighted average number of outstanding common shares for the period. The computation of diluted net income per share is similar to the computation of basic net income per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator used in the calculation of basic net income per common share follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NUMERATOR:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,458&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income (loss) attributable to noncontrolling interests </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to The Ensign Group, Inc. </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">297,973</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,399</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">224,681</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DENOMINATOR:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic net income per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,655&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,708&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,887&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.26</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.76</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.09</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator used in the calculation of diluted net income per common share follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.818%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NUMERATOR:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,458&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to The Ensign Group, Inc. </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">297,973</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,399</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">224,681</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DENOMINATOR:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,655&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,708&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,887&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: incremental shares from assumed conversion</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,585&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted weighted average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,240</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57,323</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,871</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.12</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.65</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.95</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> 914, </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,429 and 780 for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378876378528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial assets include held-to-maturity investments carried at amortized cost basis of $138,600 and $59,530, of which $65,831 and $59,530 are designated to support long-term insurance subsidiary liabilities, both as of December&#160;31, 2024 and 2023, respectively. As of December&#160;31, 2024 and 2023, the amortized cost basis of these financial assets are considered to approximate fair value and are derived using Level 2 inputs. The Company believes its amortized cost basis investments that were in an unrealized loss position as of December&#160;31, 2024 and 2023 do not require an allowance for expected credit losses, nor has any event occurred through the filing date of this report that would indicate differently.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's financial assets also include the contracts insuring the lives of certain employees who are eligible to participate in non-qualified deferred compensation plans that are held in a rabbi trust. The cash surrender value of these contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan and are held at fair value. As of December&#160;31, 2024 and 2023, the fair value of the investment funds was $56,049 and $41,216, respectively, which are derived using Level 2 inputs.</span></div>Additionally, the Company has other investments held at historical cost basis, which are not material, for which the fair value is derived using Level 3 inputs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378876324848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STANDARD BEARER<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_StandardBearerTextBlock', window );">STANDARD BEARER</a></td>
<td class="text">STANDARD BEARER<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Standard Bearer's real estate portfolio consists of 124 of the Company's 129 owned real estate properties, of which 92 are operated and managed by the Company's independent subsidiaries and 33 are leased to and operated by third-party operators. Of those 33 operations, one senior living operation is located on the same real estate property as a skilled nursing operation that an independent subsidiary operates. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2024,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Standard Bearer added $131,927 of real estate assets associated with 11 stand-alone skilled nursing operations, three stand-alone senior living operations and three campus operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These new additions for the stand-alone skilled nursing and campus operations are</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operated by </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsidiaries and the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three stand-alone senior living operations are leased to a third-party operator. Refer to Note 7, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operation Expansions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, Standard Bearer added $50,853 of real estate assets associated with four stand-alone skilled nursing operations and one campus operation. Four of the acquisitions were related to exercising purchase options under an existing lease arrangement from CareTrust REIT, Inc. (CareTrust). These locations are currently operated by the Company's independent subsidiaries. The remaining one real estate acquisition was leased back to the Company's independent subsidiaries. Refer to Note 7, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operation Expansions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information. </span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, Standard Bearer added $65,899 of real estate assets associated with three stand-alone skilled nursing facilities and two campus operations. Of these additions, the three skilled nursing facilities and one campus operation acquired are operated by the Company's independent subsidiaries and the other campus operation is leased to a third-party operator. </span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, Standard Bearer added $84,656 of real estate assets associated with ten skilled nursing facilities, three of which were previously operated and managed by the Company's independent subsidiaries. Refer to Note 7, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operation Expansions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the formation of Standard Bearer, certain of the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Standard Bearer and Standard Bearer's independent real estate subsidiaries entered into several agreements that include leasing, management services and debt arrangements between the operations</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All intercompany transactions have been eliminated in consolidation. Refer to Note 8, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information related to these intercompany eliminations as well as Standard Bearer as a reportable segment. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intercompany master lease agreements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's independent subsidiaries and 92 Standard Bearer independent real estate subsidiaries have entered into six triple-net master lease agreements (collectively, the Standard Bearer Master Leases). The lease periods range from 15 to 19 years with three five-year renewal options beyond the initial term, on the same terms and conditions. The rent structure under the Standard Bearer Master Leases includes a fixed component, subject to annual escalation equal to the lesser of (1) the percentage change in the Consumer Price Index (but not less than zero) or (2) 2.5%. In addition to rent, the independent subsidiaries are required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties; (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. Intercompany rental revenue generated from Ensign affiliated operations was $78,110, $66,712, and $57,967 for the years ended December 31, 2024, 2023 and 2022, respectively, which has been eliminated in consolidation.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intercompany management agreement</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer has no employees. The Service Center provides personnel and services to Standard Bearer pursuant to the management agreement between Standard Bearer and the Service Center. The management agreement provides for a base management fee that is equal to 5.0% of total rental revenue and an incentive management fee that is equal to 5.0% of funds from operations (FFO) and is capped at 1.0% of total rental revenue, for a total of 6.0%. Management fee generated between Standard Bearer and the Service Center for the years ended December 31, 2024, 2023 and 2022 was $5,707, $4,948 and $4,367, respectively, which has been eliminated in consolidation. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intercompany debt arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer obtains its funding through various sources including operating cash flows, access to debt arrangements and intercompany loans. The intercompany debt arrangements include mortgage loans and a credit facility to fund acquisitions and working capital needs. The interest rate under the credit facility is a base rate plus a margin ranging from 0.25% to 1.25% per annum or SOFR plus a margin ranging from 1.25% to 2.25% per annum. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as the Department of Housing and Urban Development (HUD) mortgage loans and promissory note are entered into by real estate subsidiaries of Standard Bearer, the interest expense incurred from these debts are included in Standard Bearer's segment income. Refer to Note 14, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information related to these debts. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Instrument Denominated in the Shares of a Subsidiary</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the formation of Standard Bearer in 2022, the Company established the Standard Bearer Healthcare REIT, Inc. 2022 Omnibus Incentive Plan (Standard Bearer Equity Plan). The Company may grant stock options and restricted stock awards under the Standard Bearer Equity Plan to employees and management of Ensign's independent subsidiaries. These awards generally vest over a period of five years or upon the occurrence of certain prescribed events. The value of the stock options and restricted stock awards is tied to the value of the common stock of Standard Bearer, which is determined based on an independent valuation of Standard Bearer. The Company can also call the awards, generally upon employee termination. The Company granted 39 restricted stock awards during the year ended December 31, 2024. During the years ended December&#160;31, 2023 and 2022, the Company did not grant any stock options or restricted shares under the Standard Bearer Equity Plan. During the years ended December 31, 2024, 2023 and 2022, there were no restricted stock awards vested for the periods. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of the awards is recognized as compensation expense over the relevant vesting periods, with a corresponding adjustment to noncontrolling interests. The grant value was determined based on an independent valuation of the subsidiary shares.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2024, the Standard Bearer Equity Plan's share-based compensation expense was not material. There was no expense during the years ended December&#160;31, 2023 and 2022.</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, Standard Bearer sold fully vested common shares from the Standard Bearer Equity Plan to shareholders for cash of $6,544. Also, during the year ended December 31, 2022, Standard Bearer established shareholders of its preferred shares through contributions of cash of $149. These preferred shares were fully vested at the time of the contributions by the shareholders. The value of Standard Bearer common and preferred shares held by the Company are eliminated in consolidation and the value held by other shareholders are classified as noncontrolling interests on the Company's consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_StandardBearerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Standard Bearer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_StandardBearerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866466848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATION EXPANSIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">OPERATION EXPANSIONS</a></td>
<td class="text">OPERATION EXPANSIONS<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expansion focus of the Company's independent subsidiaries is to purchase or lease operations that are complementary to the current operations, accretive to the business, or otherwise advance the Company's strategy. The results of all independent subsidiaries are included in the Financial Statements subsequent to the date of acquisition. Acquisitions are accounted for using the acquisition method of accounting. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the new operations obtained through long-term leases, the Company did not acquire any material assets or assume any liabilities other than the tenant's post-assumption rights and obligations under the long-term lease. The Company also entered into a separate operations transfer agreement with each prior operator as part of each transaction. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's independent subsidiaries also enter into long-term leases that may include options to purchase the facilities. As a result, from time to time, an independent real estate subsidiary may acquire the property of facilities that have previously been operated under third-party leases. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2024 Expansions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, the Company expanded its operations through a combination of long-term leases and real estate purchases</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with the addition of 28 stand-alone skilled nursing operations, including a long-term acute care hospital and</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three campus operations. Of these additions, Standard Bearer acquired the real estate of 14 of these operations, all of which were leased back to the Company's independent subsidiaries.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on the purchase of real estate properties. These new operations added a total of 3,030 operational skilled nursing beds, including 43 long-term acute care beds and 218 operational senior living units to be operated by the Company's independent subsidiaries. The Company also invested in new ancillary services that are complementary to its existing businesses. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, the Company expanded its operations with the addition of seven stand-alone skilled nursing operations. Of these additions, Standard Bearer acquired the real estate of one of these operations, which was leased back to the Company's independent subsidiary.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on the purchase of the real estate property. The new operations added 682 operational skilled nursing beds to be operated by the Company's independent subsidiaries.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2023 Expansions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, the Company expanded its operations through a combination of long-term leases and real estate purchases</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with the addition of 25 stand-alone skilled nursing operations and one campus operation. Of these additions, Standard Bearer acquired the real estate of three of the stand-alone skilled nursing operations and one campus operation, which were leased back to the Company's independent subsidiaries.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information on the purchase of real estate properties. These new operations added a total of 2,483 operational skilled nursing beds and 94 operational senior living units to be operated by the Company's independent subsidiaries. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Expansions</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2022, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company expanded its operations and real estate portfolio through a combination of long-term leases and real estate purchases</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, with the addition of </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> stand-alone skilled nursing operations and </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">one</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> campus operation. Of these additions, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Standard Bearer acquired the real estate of seven</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the stand-alone skilled nursing operations, which were leased back to Ensign's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsidiaries.</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Refer to Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, for additional information on the purchases of real estate properties. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company added </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">five</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> senior living operations that were transferred from The Pennant Group, Inc. (Pennant), </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of which are part of campuses operated by the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsidiaries. These new operations added a total of </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,058</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> operational skilled nursing beds and </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">674</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> operational senior living units to be operated by the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subsidiaries. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also invested in new ancillary services that are complementary to its existing businesses. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the allocation of the purchase price for the operations acquired during the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">years ended December 31, 2024, 2023 and 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,547&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,794&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,527&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,709&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,488&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,070&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture, and fixtures</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assembled occupancy</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,112&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,400&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased asset</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL ACQUISITIONS</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">154,879</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,798</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101,136</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquisition strategy has been focused on identifying both opportunistic and strategic acquisitions within its target markets that offer strong opportunities for return. The operations added by the Company are frequently underperforming financially and can have regulatory and clinical challenges to overcome. Financial information, especially with underperforming operations, is often inadequate, inaccurate or unavailable. Consequently, the Company believes that prior operating results are not a meaningful representation of the Company&#8217;s current operating results or indicative of the integration potential of its newly acquired </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The operations added during the&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">year ended December 31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> were not material to the Company individually or in the aggregate. Accordingly, pro forma financial information is not presented. These additions have been included in the&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> balance sheets of the Company, and the operating results have been included in the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> statements of income of the Company since the date the Company gained effective control.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866490560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENTS</a></td>
<td class="text">BUSINESS SEGMENTS<div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two reportable segments: (1) skilled services, which includes the operation of skilled nursing facilities and rehabilitation therapy services and (2) Standard Bearer, which is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. </span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the skilled services segment includes 286 skilled nursing and 30 campus operations that provide both skilled nursing and rehabilitative care services and senior living services. The Company's Standard Bearer segment consists of 124 owned real estate properties. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also reports an &#8220;All Other&#8221; category that includes results from its senior living operations, which includes 11 stand-alone senior living operations and the senior living operations at 30 campus operations that provide both skilled nursing and rehabilitative care services and senior living services. In addition, the "All Other" category includes mobile diagnostics, medical transportation, other real estate, other ancillary operations and the Service Center. Services included in the &#8220;All Other&#8221; category are insignificant individually, and therefore do not constitute a reportable segment.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s reportable segments are significant operating segments that offer differentiated services. The segment structure reflects the Company's current operational and financial management and provides the best structure to maximize the quality of care and investment strategy provided, while maintaining financial discipline.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment income (loss) is defined as income or loss before provision for income taxes, excluding gain or loss from sale of real estate, real estate insurance recoveries and impairment of long-lived assets. The Company's CODM, who is the Chief Executive Officer, reviews segment income or loss for each operating segment to evaluate performance and allocate capital resources. The CODM uses segment income or loss to analyze actual results as part of operational planning and to decide whether to reinvest profits into the segments or into other parts of the Company, such as through acquisitions, to pay dividends or to recommend a stock repurchase program. The Company's CODM does not review assets by segment in his resource allocation and therefore assets by segment are not disclosed below.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intercompany revenue is eliminated in consolidation, along with corresponding intercompany expenses. Included in segment income for Standard Bearer is expense for intercompany services provided by the Service Center as described in Note 6, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Standard Bearer</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as it is part of the CODM financial information. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth financial information for the segments:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076,825&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076,825&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,086&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,086&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,076,825</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95,086</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,171,911</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,881&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,307)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,260,485</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,513,167&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,152&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,195&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,297&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,302&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518,463</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,335</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">547,798</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,704)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386,094</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All other revenue includes $181,066 of service revenue and $11,815 of rental revenue for the year ended December 31, 2024, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $83,941 and intercompany service revenue of $20,366 for the year ended December 31, 2024.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $104,307 during the year ended December 31, 2024, which are eliminated in consolidation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $20,285 during the year ended December 31, 2024, which is eliminated in consolidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,578,855&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,578,855&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,578,855</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,661,341</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,804&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,790)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,729,355</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,455&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,766&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">464,925</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,065</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">493,990</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221,228)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">272,762</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All Other revenue includes $144,667 of service revenue and $11,137 of rental revenue for the year ended December 31, 2023, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination intercompany rental revenue of $72,339 and intercompany service revenue of $15,451 for the year ended December 31, 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $87,790 during the year ended December 31, 2023, which is eliminated in consolidation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $12,902 during the year ended December 31, 2023, which is eliminated in consolidation.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906,215&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906,215&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,937&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,937&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,906,215</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,937</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,979,152</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,294)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,025,468</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,746&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,707&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">408,732</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,871</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">436,603</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,514)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">289,089</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All Other revenue includes $115,214 of service revenue and $7,396 of rental revenue for the year ended December 31, 2022, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $63,576 and intercompany service revenue of $12,718 for the year ended December 31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment.  Additionally, there are intercompany expenses of $76,294 during the year ended December 31, 2022, which is eliminated in consolidation. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $8,646 during the year ended December 31, 2022, which is eliminated in consolidation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue by major payor source were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,422&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,922&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682,344&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055,226&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055,226&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,738&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,738&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,968,386</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,922</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,004,308</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70.9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789,643&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789,643&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,796&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,778&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,574&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,076,825</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160,700</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,237,525</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429,473&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,976&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459,449&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,749&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,749&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,663&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,663&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,660,885</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,976</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,690,861</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.6</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,129&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,129&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,578,855</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">129,216</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,708,071</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158,309&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,847&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183,156&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,191,347</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,847</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,216,194</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525,710&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525,710&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,807&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,906,215</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">102,496</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,008,711</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all payors generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378876314272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT&#8212; NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT&#8212; NET</a></td>
<td class="text">PROPERTY AND EQUIPMENT - NET<div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,873&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,656&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933,790&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,155&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,603&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,064&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,018&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,383&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,192&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,209&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,563&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,750,842</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,487,013</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459,488)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396,242)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY AND EQUIPMENT, NET</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,291,354</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,090,771</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed the sale of assets for a sale price of $8,607 and recorded a gain of $3,467 within the Company's consolidated statement of income as cost of services during the year ended December 31, 2022. The Company recorded gain and losses related to sale of assets, which were not material during the years ended December 31, 2024 and 2023. Management evaluated its long-lived assets and recorded an impairment charge of</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1,849 within the Company's consolidated statement of income as <span style="-sec-ix-hidden:f-975">cost of services</span> during the year ended December 31, 2024.</span><span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span>The Company determined there was no impairment during the year ended December 31, 2023 and 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378976404976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS &#8212; NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS &#8212; NET</a></td>
<td class="text">INTANGIBLE ASSETS - NET<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="5" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assembled occupancy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,316)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(742)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility trade name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(439)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,582&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,902)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,582&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,692)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,306</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,680)</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,626</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,096</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,873)</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December 31, 2024, 2023 and 2022, amortization expense was $2,019, $1,790 and $1,714, respectively, of which $1,212, $1,202, and $1,160 was related to the amortization of right-of-use assets, respectively. The Company did not record any impairment charge to intangible assets during the years ended December 31, 2024, 2023 and 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated amortization expense for each of the years ending December&#160;31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,626</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other indefinite-lived intangible assets consist of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicaid licenses</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,666</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,302</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>During the year ended December 31, 2024, the Company acquired $364 in Medicare and Medicaid licenses compared to $330 and $245 in the fiscal years 2023 and 2022, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/985-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378880000944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillDisclosureTextBlock', window );">GOODWILL</a></td>
<td class="text">GOODWILL <div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Provided that goodwill corresponds to the acquisition of a business and not merely the acquisition of real estate property, the Company's Standard Bearer segment appropriately does not carry a goodwill balance. The following table represents activity in goodwill by skilled service segment and "all other" category as of December&#160;31, 2024, 2023 and 2022:</span></div><div style="margin-top:3pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,983</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,469</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,400&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,400&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,886</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,983</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76,869</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,886</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,983</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76,869</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,112&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88,626</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,355</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,981</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has evaluated its goodwill and intangible assets and determined there was no impairment during the years ended December 31, 2024, 2023 and 2022. The Company has recognized cumulative goodwill impairment losses of $7,410, since inception in 1999. </span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866499296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">OTHER ACCRUED LIABILITIES</a></td>
<td class="text">OTHER ACCRUED LIABILITIES<div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality assurance fee</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,667&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,035&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refunds payable</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,755&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resident advances</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,818&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,834&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash held in trust for patients</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,370&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,589&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property taxes</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,400&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued litigation (Note 19)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,734&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,458&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ACCRUED LIABILITIES</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132,057</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">168,228</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality assurance fee represents the aggregate of amounts payable to Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Tennessee, Utah, Washington and Wisconsin as a result of a mandated fee based on patient days or licensed beds. Refunds payable includes payables related to overpayments, duplicate payments and credit balances from various payor sources. Resident advances occur when the Company receives payments in advance of services provided. Cash held in trust for patients reflects monies received from or on behalf of patients. Maintaining a trust account for patients is a regulatory requirement and, while the trust assets offset the liabilities, the Company assumes a fiduciary responsibility for these funds. The cash balance related to this liability is included in other current assets in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874237456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the years ended December 31, 2024, 2023 and 2022 is summarized as follows: </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,144&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,092&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,717&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,857&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,216&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87,001</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,393</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,933</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,280)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,158)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,201)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">635</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(27,481)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,496)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;TOTAL</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87,636</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62,912</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,437</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory rate to the effective tax rate for net income for the years ended December 31, 2024, 2023 and 2022, respectively, is comprised as follows: </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes&#160;- net of federal benefit</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL INCOME TAX PROVISION</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.1</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.3</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's effective tax rate was 22.7% for the year ended December 31, 2024, compared to 23.1% for the same period in 2023 and 22.3% in 2022. The lower effective tax rate is due to lower non-deductible expenses included but not limited to tax benefits from stock based compensation.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's deferred tax assets and liabilities as of December&#160;31, 2024 and 2023 are summarized below. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,419&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related reserves</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,023&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,817&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,313&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444,590&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">599,169</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">567,862</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DEFERRED TAX ASSETS</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">599,076</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">567,073</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,253)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,334)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,390)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,113)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset </span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(468,955)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443,222)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DEFERRED TAX LIABILITIES</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(532,795)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(499,949)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET DEFERRED TAX ASSETS</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,281</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,124</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had state credit carryforwards as of December 31, 2024 and 2023 of $597 and $1,192, respectively. These carryforwards almost entirely relate to state limitations on the application of Enterprise Zone employment-related tax credits. Unless the Company uses the Enterprise Zone credits beforehand, the carryforward began to expire in 2023. The remainder of these carryforwards relate to credits against the Texas margin tax and is expected to carryforward until 2027. As of December 31, 2024 and 2023, the valuation allowance of $93 and $789, respectively, was primarily recorded against the Enterprise Zone credits as the Company believes it is more likely than not that some of the benefit of the credits will not be realized. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's operating loss carry forwards for states were not material during the years ended December 31, 2024 and 2023. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2024, 2023 and 2022, the Company did not have any unrecognized tax benefits, net of its state benefits that would affect the Company's effective tax rate. The Company classifies interest and/or penalties on income tax liabilities or refunds as additional income tax expense or income. Such amounts are not material.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal statutes of limitations on the Company's 2020, 2019, and 2018 income tax years lapsed during the third quarter of 2024, 2023, and 2022, respectively. During the fourth quarter of each year, various state statutes of limitations also lapsed. The lapses during the years ended December 31, 2024 and 2023 had no impact on the Company's unrecognized tax benefits.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378973875008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans and promissory note</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,438&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,388&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,086)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,950)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs, net</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,767)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,941)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM DEBT LESS CURRENT MATURITIES</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">141,585</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">145,497</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Facility with a Lending Consortium Arranged by Truist </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a revolving credit facility between the Company and its independent subsidiaries, including Standard Bearer as co-borrowers, and Truist Securities (Truist) (the Credit Facility) with a revolving line of credit of up to $600,000 in aggregate principal amount with a maturity date of April&#160;8, 2027. Borrowings are supported by a lending consortium arranged by Truist. The interest rates applicable to loans under the Credit Facility are, at the Company's option, equal to either a base rate plus a margin ranging from 0.25% to 1.25% per annum or SOFR plus a margin ranging from 1.25% to 2.25% per annum, based on the Consolidated Total Net Debt to Consolidated EBITDA ratio (as defined in the Credit Facility). In addition, there is a commitment fee on the unused portion of the commitments that ranges from 0.20% to 0.40% per annum, depending on the Consolidated Total Net Debt to Consolidated EBITDA ratio. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings made under the Credit Facility are guaranteed, jointly and severally, by certain of the Company&#8217;s wholly-owned subsidiaries, and are secured by a pledge of stock of the Company's material independent subsidiaries as well as a first lien on substantially all of such independent subsidiaries' personal property. The Credit Facility contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. Under the terms of the Credit Facility, the Company must comply with financial maintenance covenants to be tested quarterly, consisting of (i) a maximum consolidated total net debt to consolidated EBITDA ratio (which shall not be greater than 3.75:1.00; provided that if the aggregate consideration for approved acquisitions in a six month period is greater than $50,000, then the ratio can be increased at the election of the Company with notice to the administrative agent to 4.25:1.00 for the first fiscal quarter and the immediately following three fiscal quarters), and (ii) a minimum interest/rent coverage ratio (which cannot be less than 1.50:1.00). As of December&#160;31, 2024, there was no outstanding debt under the Credit Facility. The Company was in compliance with all loan covenants as of December&#160;31, 2024.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mortgage Loans and Promissory Note</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the Company has 23 subsidiaries that have mortgage loans insured with HUD in the aggregate amount of $146,898, which subjects these subsidiaries to HUD oversight and periodic inspections. The mortgage loans bear effective interest rates in a range of 3.1% to 4.2%, including fixed interest rates in a range of 2.4% to 3.3% per annum. In addition to the interest rate, the Company incurs other fees for HUD placement, including, but not limited to audit fees. Amounts borrowed under the mortgage loans may be prepaid, subject to prepayment fees based on the principal balance on the date of prepayment. For the majority of the loans, during the first three years, the prepayment fee is 10.0% and is reduced by 3.0% in the fourth year of the loan and reduced by 1.0%</span><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per year for years five through ten of the loan. There is no prepayment penalty after year ten. The terms for all the mortgage loans are 25 to 35 years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the HUD mortgage loans above, the Company has a promissory note of $1,540 that bears a fixed interest rate of 5.3% per annum and has a term of 12 years. The note, which was assumed as part of an acquisition, is secured by the real property comprising the facility and the rent, issues and profits thereof, as well as all personal property used in the operation of the facility. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future principal payments due under the long-term debt arrangements discussed above are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,227&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,779&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,896&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,553&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148,438</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on Level 2 inputs, the carrying value of the Company's long-term debt is considered to approximate the fair value of such debt for all periods presented based upon the interest rates that the Company believes it can currently obtain for similar debt.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2024, the Company had approximately $27,893 of borrowing capacity under the Credit Facility pledged as collateral to secure outstanding letters of credit, which increased by $21,638 from December&#160;31, 2023. The Company believes that its outstanding letters of credit as of December&#160;31, 2024 do not require an allowance for expected credit losses, nor has any event occurred through the filing date of this report that would indicate differently.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874965200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">OPTIONS AND AWARDS</a></td>
<td class="text">OPTIONS AND AWARDS<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2022 Omnibus Incentive Plan (2022 Plan)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company has one stock incentive plan, the 2022 Omnibus Incentive Plan (the 2022 Plan), pursuant to which grants of the Company's securities may currently be made. Including the shares rolled over from the 2017 Omnibus Incentive Plan, the 2022 Plan provides for the issuance of 3,452 shares of common stock. The number of shares available to be issued under the 2022 Plan will be reduced by (i) one share for each share that relates to an option or stock appreciation right award and (ii) two shares for each share which relates to an award other than a stock option or stock appreciation right award (a full-value award). Non-employee director options, to the extent granted, will vest and become exercisable in three equal annual installments, or the length of the term if less than three years, on the completion of each year of service measured from the grant date. All other options generally vest over five years at 20% per year on the anniversary of the grant date. Options expire ten years from the date of grant. At December&#160;31, 2024, the total number of shares available for issuance under the 2022 Plan was 346.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option-pricing model to recognize the value of stock-based compensation expense for stock option awards. Determining the appropriate fair-value model and calculating the fair value of stock option awards at the grant date requires judgment, including estimating stock price volatility, expected option life, and forfeiture rates. The fair-value of the restricted stock awards at the grant date is based on the market price on the grant date, adjusted for forfeiture rates. The Company develops estimates based on historical data and market information, which can change significantly over time. The Black-Scholes model required the Company to make several key judgments including: </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">The expected option term is calculated by the average of the contractual term of the options and the weighted average vesting period for all options. The calculation of the expected option term is based on the Company's experience due to sufficient history.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">The Company utilizes its own experience to calculate estimated volatility for options granted. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">The dividend yield is based on the Company's historical pattern of dividends as well as expected dividend patterns.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">The risk-free rate is based on the implied yield of U.S.&#160;Treasury notes as of the grant date with a remaining term approximately equal to the expected term.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt">Estimated forfeiture rate of approximately 4.86% per year is based on the Company's historical forfeiture activity of unvested stock options.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 704, 1,008 and 581 stock options during the years ended December 31, 2024, 2023 and 2022, respectively. The Company used the following assumptions for stock options granted during the years ended December 31, 2024, 2023 and 2022:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.428%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.428%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Risk-Free Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Volatility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Dividend Yield</span></td></tr><tr><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5%</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2024, 2023 and 2022, the following represents the exercise price and fair value displayed at grant date for stock option grants:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Fair Value of Options</span></td></tr><tr><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.46&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.37&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average exercise price equaled the weighted average fair value of common stock on the grant date for all options granted during the periods ended December 31, 2024, 2023 and 2022 and therefore, the intrinsic value was $0 at the date of grant.  </span></div><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the years ended December 31, 2024, 2023 and 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Options Vested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Exercise Price of Options Vested</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,038&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.60&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.02&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(688)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,833&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,069&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31. 2023</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,991</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.46&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.92&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.28&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,987</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.84&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.64&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the year ended December 31, 2024:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options Vested</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Black-Scholes Fair Value</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and Exercisable</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year of Grant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.20</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.39</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.93</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.86</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.80</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.41</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.49</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.71</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,557&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.07</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.76</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.84</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.49</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,020&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.47</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.64</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,041&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.79</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.88</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,601&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.83</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.83</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,753&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$119.19</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$146.37</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,987</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136,624</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,895</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options outstanding, vested and expected to vest as of December 31, 2024, 2023 and 2022 is as follows:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,309&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,819&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,593&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,011&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,048&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,243&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,232&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the options</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024, 2023 and 2022, t</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">he aggregate intrinsic value of options that vested </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the years ended December&#160;31, 2024, 2023 and 2022 was</span><span style="color:#ff0090;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$37,700, $31,658, and $27,955, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of options exercised </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">during the years ended December&#160;31, 2024, 2023 and 2022 was $60,358, $56,186, and $47,441, respectively. </span><span style="color:#ff0090;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Awards</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 232, 219</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 233 restricted stock awards during the years ended </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022, </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively. All awards were granted at an issue price of $0 and generally vest over five years. The fair value per share of restricted awards granted during the years ended </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ranged from</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $116.65 to $149.12,</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $89.83 to $98.31 and $73.17 to $94.88, respectively. The fair value per share includes quarterly stock awards to non-employee directors. Included in the restricted stock award grants are </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$6,165</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$5,068</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of annual bonuses that were settled in vested restricted stock awards during the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">years ended December 31, 2024 and 2023, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company's non-vested restricted stock awards as of December&#160;31, 2024 and changes during the years ended December&#160;31, 2024, 2023 and 2022 is presented below:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested Restricted Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at January 1, 2022</span></div></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">549</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.16&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December 31, 2022</span></div></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">487</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">431</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.26&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.97&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.12&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">435</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.71&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2024, the Company granted</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 16</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> quarterly stock awards to non-employee directors for their service on the Company's board of directors. The fair value per share of these stock awards ranged from </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$116.65 to $149.12</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> based on the market price on the grant date. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Term Incentive Plan</span></div><div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 27, 2019, the Board approved the Long-Term Incentive Plan (the 2019 LTI Plan). The 2019 LTI Plan provides that certain employees of the Company who assisted in the consummation of the spin-off of Pennant from the Company in 2019 were granted shares of restricted stock upon successful completion of the spin-off. The 2019 LTI Plan provides for the issuance of 500 shares of Pennant restricted stock. As of December&#160;31, 2024, the 2019 LTI Plan was fully vested. The total stock-based compensation related to the 2019 LTI Plan was $546, $827, and $836 for the years ended December&#160;31, 2024, 2023 and 2022, respectively. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-based compensation expense</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the years ended December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022 was as follows:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,439&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,221&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,361&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to restricted stock awards</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,662&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,845&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,920&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to restricted stock awards to non-employee directors</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36,183</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,754</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,720</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In future periods, the Company expects to recognize approximately</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $84,914 and $38,434 in stock-based compensation expense for unvested options and unvested restricted stock awards, respectively, that were outstanding as of December&#160;31, 2024. Future stock-based compensation expense will be recognized over 3.8 and 3.7 weighted average years for unvested options and restricted stock awards, respectively. There were 2,092 unvested and outstanding options as of December&#160;31, 2024, of which 1,925 shares are expected to vest. The weighted average contractual life for options outstanding, vested and expected to vest as of December&#160;31, 2024 was&#160;6.7 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866504816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases from CareTrust REIT, Inc. (CareTrust) real property associated with 100 independent skilled nursing and senior living facilities used in the Company&#8217;s operations, 99 of which are under nine &#8220;triple-net&#8221; master lease agreements (collectively, the Master Leases), which range in terms from 13 to 20 years. At the Company&#8217;s option, the Master Leases may be extended for two or three five-year renewal terms beyond the initial term, on the same terms and conditions. The extension of the term of any of the Master Leases is subject to the following conditions: (1) no event of default under any of the Master Leases having occurred and continuing; and (2) the tenants providing timely notice of their intent to renew. The term of the Master Leases is subject to termination prior to the expiration of the current term upon default by the tenants in their obligations, if not cured within any applicable cure periods set forth in the Master Leases. If the Company elects to renew the term of a Master Lease, the renewal will be effective to all, but not less than all, of the leased property then subject to the Master Lease. During the year ended December&#160;31, 2024, the Company amended two of the Master Leases by adding three operations and extending the terms to 15 and 20 years, respectively. These amendments increased the lease liabilities and right-of-use assets by $72,503 to reflect the new lease obligations. Additionally, four of the 100 facilities leased from CareTrust include an option to purchase that the Company can exercise starting on December 1, 2024. Subsequent to December&#160;31, 2024, the Company purchased the real estate of the four facilities from CareTrust for $44,575.</span></div><div style="margin-top:10.05pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have the ability to terminate the obligations under a Master Lease prior to its expiration without CareTrust&#8217;s consent. If a Master Lease is terminated prior to its expiration other than with CareTrust&#8217;s consent, the Company may be liable for damages and incur charges such as continued payment of rent through the end of the lease term as well as maintenance and repair costs for the leased property.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rent structure under the Master Leases includes a fixed component, subject to annual escalation equal to the lesser of (1) the percentage change in the Consumer Price Index (but not less than zero) or (2) 2.5%. In addition to rent, the Company is required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The terms and conditions of the one stand-alone lease are substantially the same as those for the master leases described above. Total rent expense under the Master Leases was approximately $69,399, $66,439 and $64,178 for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, under the Master Leases, the Company must maintain compliance with specified financial covenants measured on a quarterly basis, including a portfolio coverage ratio and a minimum rent coverage ratio. The Master Leases also include certain reporting, legal and authorization requirements. The Company is in compliance with requirements of the Master Leases as of December&#160;31, 2024. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities where its independent subsidiaries operate and certain administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from 15 to 20 years. In addition, the Company leases certain of its equipment under non-cancelable operating leases with initial terms ranging from <span style="-sec-ix-hidden:f-1458">three</span> to five years. Most of these leases contain renewal options, certain of which involve rent increases. Total rent expense for continuing operations inclusive of straight-line rent adjustments and rent associated with the Master Leases noted above, was $216,716, $197,856 and $153,174 for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ninety of the Company&#8217;s independent subsidiaries, excluding the subsidiaries that are operated under the Master Leases with CareTrust, are operated under 14 separate master lease arrangements. During the year ended December&#160;31, 2024, the Company amended one of the separate master lease arrangements to add two stand-alone skilled nursing operations operated by the Company's independent subsidiaries and extended the term to 20 years. In addition, the Company entered into one new master lease arrangement to add six stand-alone skilled nursing operations operated by the Company's independent subsidiaries with an initial term of 15 years. The amended and new master lease arrangements increased the lease liabilities and right-of-use assets by $71,616 to reflect the new lease obligations. Under the master leases, a default at a single facility could subject one or more of the other facilities covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of the Company&#8217;s leases, master lease agreements and debt financing instruments. In addition, other potential defaults related to an individual facility may cause a default of an entire master lease portfolio and could trigger cross-default provisions in the Company&#8217;s outstanding debt arrangements and other leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the lease without the consent of the landlord. The components of operating lease expense are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,016&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,358&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,049&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,297&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242,225</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219,512</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">171,272</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Rent- cost of services includes accrued rent expense adju</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">stments of</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> $808, $870 and $493 for the years ended December 31, 2024, 2023 and 2022, respectively. Additionally, rent- cost of services includes other variable lease costs such as consumer price index increases and short-term leases of $14,013, $10,259, $5,878 for the years ended December 31, 2024,  2023, and 2022 respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Cost of services includes variable lease costs, which consists of property taxes and insurance. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Depreciation and amortization is related to the amortization of favorable and direct lease costs.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for all third-party leases as of December&#160;31, 2024 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,909&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,696&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,002&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,994&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,144&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776,571&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL LEASE PAYMENTS</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,792,316</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment </span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963,516)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PRESENT VALUE OF TOTAL LEASE LIABILITIES</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,828,800</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current lease liabilities</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,475)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM OPERATING LEASE LIABILITIES</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,735,325</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the lease commencement date. As of&#160;December&#160;31, 2024 and 2023, the weighted average remaining lease term is&#160;14.5 years and 14.9 years, respectively, and the weighted average discount rate used to determine the operating lease liabilities is&#160;6.3% and 6.5%, respectively. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, the Company expanded its operations through a new master lease with the addition of six standalone skilled nursing operations. The aggregate impact to the carrying value of lease liabilities and right-of-use assets related to the long-term leases is estimated to be approximately $67,572.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its owned real estate properties to third-party operators, of which 32 senior living operations are operated by Pennant. All of these properties are triple-net leases, whereby the respective tenants are responsible for all costs at the properties including: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The initial terms range from 14 to 16 years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024, the Company expanded its operations through a separate master lease arrangement for three stand-alone senior living operations with a third-party operator for an initial lease term of 15 years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company entered into a sublease agreement for three stand-alone skilled nursing operations with a third-party operator with an initial lease term of 18 years. Additionally, during the year, the Company entered into a lease agreement with a third-party operator for one campus operation with an initial lease term of 15 years.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rental income from all third-party sources for the years ended December 31, 2024, 2023 and 2022 is as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennant</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,480&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,048&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,915&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third-party</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,480&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1530"><span style="-sec-ix-hidden:f-1531"><span style="-sec-ix-hidden:f-1532">TOTAL</span></span></span></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,960</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,284</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,757</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Pennant rental income includes variable rent such as property taxes of $1,235, $1,296, and $1,318 during the year ended December 31, 2024, 2023, and 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Other third-party includes rental revenue associated with the Company's subleases to third parties of $4,347 and $3,897 for the years ended December 31, 2024 and 2023. There was no sublease rental revenue for the year ended December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual rental income for all third-party leases as of December&#160;31, 2024 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,664&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,179&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,736&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,535&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,511&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,811&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234,436</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>(1) Annual rental income includes base rents and variable rental income pursuant to existing leases as of December&#160;31, 2024.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases from CareTrust REIT, Inc. (CareTrust) real property associated with 100 independent skilled nursing and senior living facilities used in the Company&#8217;s operations, 99 of which are under nine &#8220;triple-net&#8221; master lease agreements (collectively, the Master Leases), which range in terms from 13 to 20 years. At the Company&#8217;s option, the Master Leases may be extended for two or three five-year renewal terms beyond the initial term, on the same terms and conditions. The extension of the term of any of the Master Leases is subject to the following conditions: (1) no event of default under any of the Master Leases having occurred and continuing; and (2) the tenants providing timely notice of their intent to renew. The term of the Master Leases is subject to termination prior to the expiration of the current term upon default by the tenants in their obligations, if not cured within any applicable cure periods set forth in the Master Leases. If the Company elects to renew the term of a Master Lease, the renewal will be effective to all, but not less than all, of the leased property then subject to the Master Lease. During the year ended December&#160;31, 2024, the Company amended two of the Master Leases by adding three operations and extending the terms to 15 and 20 years, respectively. These amendments increased the lease liabilities and right-of-use assets by $72,503 to reflect the new lease obligations. Additionally, four of the 100 facilities leased from CareTrust include an option to purchase that the Company can exercise starting on December 1, 2024. Subsequent to December&#160;31, 2024, the Company purchased the real estate of the four facilities from CareTrust for $44,575.</span></div><div style="margin-top:10.05pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not have the ability to terminate the obligations under a Master Lease prior to its expiration without CareTrust&#8217;s consent. If a Master Lease is terminated prior to its expiration other than with CareTrust&#8217;s consent, the Company may be liable for damages and incur charges such as continued payment of rent through the end of the lease term as well as maintenance and repair costs for the leased property.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rent structure under the Master Leases includes a fixed component, subject to annual escalation equal to the lesser of (1) the percentage change in the Consumer Price Index (but not less than zero) or (2) 2.5%. In addition to rent, the Company is required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The terms and conditions of the one stand-alone lease are substantially the same as those for the master leases described above. Total rent expense under the Master Leases was approximately $69,399, $66,439 and $64,178 for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Among other things, under the Master Leases, the Company must maintain compliance with specified financial covenants measured on a quarterly basis, including a portfolio coverage ratio and a minimum rent coverage ratio. The Master Leases also include certain reporting, legal and authorization requirements. The Company is in compliance with requirements of the Master Leases as of December&#160;31, 2024. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases facilities where its independent subsidiaries operate and certain administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from 15 to 20 years. In addition, the Company leases certain of its equipment under non-cancelable operating leases with initial terms ranging from <span style="-sec-ix-hidden:f-1458">three</span> to five years. Most of these leases contain renewal options, certain of which involve rent increases. Total rent expense for continuing operations inclusive of straight-line rent adjustments and rent associated with the Master Leases noted above, was $216,716, $197,856 and $153,174 for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ninety of the Company&#8217;s independent subsidiaries, excluding the subsidiaries that are operated under the Master Leases with CareTrust, are operated under 14 separate master lease arrangements. During the year ended December&#160;31, 2024, the Company amended one of the separate master lease arrangements to add two stand-alone skilled nursing operations operated by the Company's independent subsidiaries and extended the term to 20 years. In addition, the Company entered into one new master lease arrangement to add six stand-alone skilled nursing operations operated by the Company's independent subsidiaries with an initial term of 15 years. The amended and new master lease arrangements increased the lease liabilities and right-of-use assets by $71,616 to reflect the new lease obligations. Under the master leases, a default at a single facility could subject one or more of the other facilities covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of the Company&#8217;s leases, master lease agreements and debt financing instruments. In addition, other potential defaults related to an individual facility may cause a default of an entire master lease portfolio and could trigger cross-default provisions in the Company&#8217;s outstanding debt arrangements and other leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the lease without the consent of the landlord. The components of operating lease expense are as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,016&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,358&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,049&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,297&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242,225</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219,512</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">171,272</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Rent- cost of services includes accrued rent expense adju</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">stments of</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> $808, $870 and $493 for the years ended December 31, 2024, 2023 and 2022, respectively. Additionally, rent- cost of services includes other variable lease costs such as consumer price index increases and short-term leases of $14,013, $10,259, $5,878 for the years ended December 31, 2024,  2023, and 2022 respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Cost of services includes variable lease costs, which consists of property taxes and insurance. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Depreciation and amortization is related to the amortization of favorable and direct lease costs.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for all third-party leases as of December&#160;31, 2024 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,909&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,696&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,002&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,994&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,144&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776,571&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL LEASE PAYMENTS</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,792,316</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment </span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963,516)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PRESENT VALUE OF TOTAL LEASE LIABILITIES</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,828,800</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current lease liabilities</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,475)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM OPERATING LEASE LIABILITIES</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,735,325</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the lease commencement date. As of&#160;December&#160;31, 2024 and 2023, the weighted average remaining lease term is&#160;14.5 years and 14.9 years, respectively, and the weighted average discount rate used to determine the operating lease liabilities is&#160;6.3% and 6.5%, respectively. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to December&#160;31, 2024, the Company expanded its operations through a new master lease with the addition of six standalone skilled nursing operations. The aggregate impact to the carrying value of lease liabilities and right-of-use assets related to the long-term leases is estimated to be approximately $67,572.</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lessor Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases its owned real estate properties to third-party operators, of which 32 senior living operations are operated by Pennant. All of these properties are triple-net leases, whereby the respective tenants are responsible for all costs at the properties including: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The initial terms range from 14 to 16 years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2024, the Company expanded its operations through a separate master lease arrangement for three stand-alone senior living operations with a third-party operator for an initial lease term of 15 years. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2023, the Company entered into a sublease agreement for three stand-alone skilled nursing operations with a third-party operator with an initial lease term of 18 years. Additionally, during the year, the Company entered into a lease agreement with a third-party operator for one campus operation with an initial lease term of 15 years.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rental income from all third-party sources for the years ended December 31, 2024, 2023 and 2022 is as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennant</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,480&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,048&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,915&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third-party</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,480&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1530"><span style="-sec-ix-hidden:f-1531"><span style="-sec-ix-hidden:f-1532">TOTAL</span></span></span></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,960</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,284</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,757</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Pennant rental income includes variable rent such as property taxes of $1,235, $1,296, and $1,318 during the year ended December 31, 2024, 2023, and 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Other third-party includes rental revenue associated with the Company's subleases to third parties of $4,347 and $3,897 for the years ended December 31, 2024 and 2023. There was no sublease rental revenue for the year ended December 31, 2022.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual rental income for all third-party leases as of December&#160;31, 2024 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,664&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,179&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,736&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,535&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,511&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,811&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234,436</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>(1) Annual rental income includes base rents and variable rental income pursuant to existing leases as of December&#160;31, 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesOfLessorDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for lessor's operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-30/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesOfLessorDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866457200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEFINED CONTRIBUTION PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">DEFINED CONTRIBUTION PLANS</a></td>
<td class="text">DEFINED CONTRIBUTION PLANS<div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a 401(k) defined contribution plan (the 401(k) Plan), whereby eligible employees may contribute up to 90% of their annual basic earnings, subject to applicable annual Internal Revenue Code limits. Additionally, the 401(k) Plan provides for discretionary matching contributions (as defined in the 401(k) Plan) by the Company. The Company expensed matching contributions to the 401(k) Plan of $3,532, $2,836, and $2,418 during the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a non-qualified deferred compensation plan (DCP), whereby certain highly compensated employees who are otherwise ineligible to participate in the Company's 401(k) plan, may defer the receipt of a portion of their base compensation and, for certain employees, up to&#160;100% of their eligible bonuses. Additionally, the DCP allows for the employee deferrals to be deposited into a rabbi trust and the funds are generally invested in individual variable life insurance contracts owned by the Company that are specifically designed to fund savings plans of this nature. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024 and 2023, the Company accrued $63,051 and $49,201, respectively, as long term deferred compensation in other long term liabilities&#160;on the consolidated balance sheets. Cash surrender value of the contracts is based on investment funds that shadow the investment allocations specified by participants in the deferred compensation plan. Refer to Note 5, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for more information on the funds.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2024 and 2023, the Company recorded gains related to its DCP of $5,157 and $4,634, respectively, which are included in other income (expense), and recorded offsetting expenses of $5,559 and $4,887, which are allocated between cost of services and general and administrative expenses. For the year ended December 31, 2022, the Company recorded a loss related to its DCP of $4,188, which is included in other income (expense), and recorded an offsetting reduction in expense of $4,051, which is allocated between cost of services and general and administrative expenses.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868247376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELF INSURANCE LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock', window );">SELF INSURANCE LIABILITIES</a></td>
<td class="text">SELF INSURANCE LIABILITIES<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company's self-insurance insurance liabilities, on an undiscounted basis, inclusive of anticipated insurance recoveries, as of December 31, 2024 and 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued general liability and professional malpractice liabilities</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,149&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,744&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued workers&#8217; compensation liabilities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,291&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued health benefits</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,312&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SELF-INSURANCE LIABILITIES</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">211,752</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165,910</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current self-insurance liabilities</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,331&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,664&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM SELF-INSURANCE LIABILITIES</span></div></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144,421</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111,246</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents activity in the Company's self-insurance liabilities as of and for the years ended December 31, 2024 and 2023: </span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January&#160;1, 2023</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,682&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year provisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims paid and direct expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135,799)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in long-term insurance losses recoverable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance December&#160;31, 2023</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165,910</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year provisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,631&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims paid and direct expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173,617)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in long-term insurance losses recoverable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance December&#160;31, 2024</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">211,752</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The anticipated insurance recoveries included in the self-insurance liabilities are presented gross rather than net with the corresponding asset of $17,741 and $15,913 as of December 31, 2024 and 2023, respectively, included in Restricted and other assets on the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/944-40/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378989318016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnities</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. The terms of such obligations vary by contract and, in most instances, do not expressly state or include a specific or maximum dollar amount. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Consequently, because no claims have been asserted, no liabilities have been recorded for these obligations on the Company&#8217;s </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> balance sheets for any of the periods presented.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Regulatory Matters</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company and its independent subsidiaries are party to various legal actions and administrative proceedings and are subject to various claims arising in the ordinary course of business. Such claims may be related to, but are not limited to, the Health Insurance Portability and Accountability Act of 1996, alleged Medicare or Medicaid false claims, qui tam or "whistleblower" provisions of the False Claims Act and/or the Anti-Kickback Statute, alleged violations of state and federal wage and hour laws, environmental matters, investigations, examinations, audits, site visits and surveys or other claims in connection with the delivery of healthcare and non-healthcare services. Refer to </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Part I. Item 3. Legal Proceedings</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information on litigation and regulatory matters. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, the Company, on behalf of its independent subsidiaries, received a </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Civil Investigative Demand (CID)</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> from the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. Department of Justice (DOJ) </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indicating that the DOJ is investigating the Company to determine whether claims have been submitted to Medicare and Texas Medicaid for services which were unnecessary or otherwise not consistent with existing reimbursement requirements. The CID covers the period from January 1, 2016, to the present. As a general matter, the Company's </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent subsidiaries</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> maintain policies and procedures to promote compliance with all applicable Medicare and Medicaid requirements, including but not limited to those relating to the presentation of claims for reimbursement for services provided</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company is fully cooperating with the DOJ in response to the CID. </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the Company cannot predict the outcome of the investigation or its potential impact on the consolidated financial statements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, in a four-week medical negligence trial in the State of Arizona, the jury returned a verdict against one of the Company&#8217;s independent subsidiaries. The Company is in the process of appealing the jury verdict. The Company has in the past appealed similar decisions and has, in some circumstances, received decisions in its favor. Although the Company intends to vigorously defend against these claims and in general these types of claims and cases, there can be no assurance that the outcomes of these matters will not have a material adverse effect on operational results and financial condition.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, the Company, on behalf of its independent subsidiaries, received a CID from the DOJ stating that it was investigating to determine whether there had been a violation of the False Claims Act (FCA) and/or the Anti-Kickback Statute (AKS) with respect to the relationships between certain of the Company&#8217;s independent subsidiaries and persons who serve or have served as medical directors. In 2020, the Company was advised that the DOJ declined to intervene in any subsequent action filed in connection with the subject matter of this investigation. Despite the decision of the DOJ to decline to participate in litigation based on the subject matter of its previously issued CID, the involved qui tam relator moved forward with the complaint in 2020. In 2024, the Company mediated with the involved parties and agreed to settle the civil case for $48,000 and recorded the accrual as of December 31, 2023. Following the finalization of the settlement documents and payment of the settlement funds during the year ended December&#160;31, 2024, the qui tam complaint was dismissed and the matter was resolved. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Revenue Recoupments</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's independent subsidiaries are subject to regulatory reviews relating to the provision of Medicare services, billings and potential overpayments as a result of Recovery Audit Contractors (RAC), various Program Safeguard Contractors, and Medicaid Integrity Contractor programs (collectively referred to as Reviews). Reviews vary in claim selection size and processes, ranging from a single episode/claim month to larger, multi-claim batches; and from single rounds of review to reviews of multiple rounds with pass/fail criteria. If an operation has a significant error rate or fails a Review and/or subsequent Reviews, the operation could then be subject to extended review or an extrapolation of the identified error rate to billings in the same time period. The Company anticipates that these Reviews could increase in frequency in the future. As of December&#160;31, 2024 and through the filing date of this report, 18 of the Company's independent subsidiaries had multi-claim Reviews scheduled or in process.  </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company has significant accounts receivable balances, the collectability of which is dependent on the availability of funds from certain governmental programs, primarily Medicare and Medicaid. These receivables represent the only significant concentration of credit risk for the Company. The Company does not believe there are significant credit risks associated with these governmental programs. The Company believes that an appropriate allowance has been recorded for the possibility of these receivables proving uncollectible and continually monitors and adjusts these allowances as necessary. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s receivables from Medicare and Medicaid payor programs accounted for 52.9% and 53.4% of its total accounts receivable as of December&#160;31, 2024 and 2023, respectively. Revenue from reimbursement under the Medicare and Medicaid programs accounted for 70.9%, 72.6% and 73.7% of the Company's revenue for the years ended December&#160;31, 2024, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378876336528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK REPURCHASE PROGRAM<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">COMMON STOCK REPURCHASE PROGRAM</a></td>
<td class="text">COMMON STOCK REPURCHASE PROGRAM<div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 16, 2024, the Board of Directors approved a stock repurchase program pursuant to which the Company may repurchase up to $20,000 of its common stock under the program for a period of approximately 12 months from September&#160;1, 2024. The Company did not purchase any shares pursuant to this stock repurchase program during the year ended December 31, 2024.</span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 29, 2023, the Board of Directors approved a stock repurchase program pursuant to which the Company could repurchase up to $20,000 of its common stock under the program for a period of approximately 12 months from September&#160;1, 2023. The stock repurchase program expired on August 31, 2024 and is no longer in effect. The Company did not purchase any shares pursuant to this stock repurchase program.</span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2022, the Board of Directors approved a stock repurchase program pursuant to which the Company could repurchase up to $20,000 of its common stock under the program for a period of approximately 12 months from August&#160;2, 2022. The stock repurchase program expired on August 2, 2023 and is no longer in effect. The Company did not purchase any shares pursuant to this stock repurchase program. </span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company repurchased 404 shares of its common stock for $29,882 during the year ended December 31, 2022, related to two separate stock repurchase programs that are no longer in effect. </span></div><div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under these repurchase programs, the Company is authorized to repurchase its issued and outstanding common shares from time to time in open-market and privately negotiated transactions, tender offers, pursuant to contractual provisions, and block trades, or otherwise in accordance with federal securities laws. The share repurchase program does not obligate the Company to acquire any specific number of shares. Any such repurchases will depend on the Company's business strategy, prevailing market conditions, the Company's liquidity requirements, contractual restrictions or covenants, compliance with securities laws, and other factors. The amounts involved in any such transaction may be material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477968/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378882496144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 297,973<span></span>
</td>
<td class="nump">$ 209,399<span></span>
</td>
<td class="nump">$ 224,681<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45379062277136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ensg_Dr.AnnS.BlouinMember', window );">Dr. Ann S. Blouin [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on November 12, 2024. Dr. Blouin's 10b5-1 Plan provides for the sale of up to 450 shares of the Company's common stock between February 11, 2025 and November 11, 2025.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Dr. Ann S. Blouin<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">a member of our Board of Directors<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">November 12, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">November 11, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">273 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">450<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ensg_SuzanneD.SnapperMember', window );">Suzanne D. Snapper [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Suzanne D. Snapper, Chief Financial Officer, Executive Vice President, and Director, entered into a Rule 10b5-1 trading arrangement on November 15, 2024. Ms. Snapper's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 10,618 shares of the Company's common stock between February 18, 2025 and July 28, 2025.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Suzanne D. Snapper<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief Financial Officer, Executive Vice President, and Director<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">November 15, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">July 28, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">160 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">10,618<span></span>
</td>
<td class="nump">10,618<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ensg_Dr.AnnS.BlouinMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ensg_Dr.AnnS.BlouinMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ensg_SuzanneD.SnapperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ensg_SuzanneD.SnapperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866771200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871826416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We utilize information technology that enables our operational leaders to access and share with their peers, both clinical and financial performance data in real time. Armed with relevant and current information, our operation leaders and their management teams can share best practices and the latest information, adjust to challenges and opportunities on a timely basis, improve quality of care, mitigate risk and improve both clinical outcomes and financial performance. We have also invested in specialized healthcare technology systems to assist our nursing and support staff. We have installed software and touch-screen interface systems in each operation to enable our clinical staff to monitor and deliver patient care and record patient information more efficiently. We believe these systems have improved the quality of our medical and billing records, while improving the productivity of our staff. Such uses of information systems give rise to cybersecurity risks, including system disruption, security breach, ransomware, theft, espionage and inadvertent release of information. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISK MANAGEMENT AND STRATEGY </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess and identify security risk to the organization by: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">conducting risk assessments to determine the likelihood and magnitude of an attack from unauthorized access, use, disclosure, disruption, modification or destruction of information systems and the related information processes, stored, or transmitted;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">performing penetration testing assessments annually and producing security assessment reports that document the results of the assessment for use and review by information technology (IT) senior leadership, including the Service Center's Chief Information Officer;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">ensuring security controls are assessed for effectiveness, are implemented correctly, operating as intended and producing the desired outcome;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">continuously scanning for vulnerabilities and remediating vulnerabilities within their service level agreements in accordance with the associated risk level; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">reviewing third party and vendor risks to our organization through an internal interdisciplinary Technology Advisory Committee that includes members from our IT, Information Security Office (ISO), legal, compliance, clinical, finance and billing departments. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Monitoring</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a continuous monitoring strategy and program, which includes: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">a set of defined security metrics to be monitored;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">performance of security control assessments on an ongoing basis;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">addressing results of analysis and reporting security status to the executive team;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">monitoring information systems to detect attacks and indicators of potential attacks or compromises;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">identification of unauthorized use of the information system resources;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">deployment of monitoring systems and agents strategically within the information system environment; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">require that third party service providers who store, process or transmit data with access to electronic Protected Health Information (ePHI) undergo an independent third-party audit to achieve system organization controls certification annually. </span></div><div style="margin-bottom:3pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Protection </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented an Information Security Management System Program to secure sensitive data protected by us. This program includes: </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">establishing policies governing data security;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">monitoring data access throughout the organization&#8217;s independent subsidiaries;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">providing continuous security training and awareness;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">establishing controls over devices on the network which are actively tracked, monitored and evaluated for new, missing, or updated software needed to strengthen security on the device, patch known vulnerabilities, or stabilize software or operating system issues;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">protecting sensitive data through encryption techniques; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">designing and implementing systems to include backup and recoverability principles, such as periodic data backups and safeguards in the case of a disaster. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incident Management Plan </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity incident management plan comprises the following six-step process: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The Service Center's Chief Information Officer and Director of Information Security lead its ISO team in the development, documentation, review and testing of security procedures and incident management procedures. Beyond initial creation, procedures are continually re-assessed, updated and tested on an ongoing basis. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The ISO team works with the Executive Team on the identification, assessment, verification and classification of incidents to determine affected stakeholders and appropriate parties for contact. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The Service Center's Chief Information Officer and Director of Information Security are responsible for launching the Incident Response Team (IRT) if necessary and for notification to the Executive Team, who in turn will contact the Board of Directors and the Audit Committee to validate that the response is being addressed appropriately. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The IRT, in consultation with outside experts if needed, is responsible for the following: </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Initial containment by making tactical changes to the computing environment to mitigate active threats based on currently known information. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Analysis to establish the root cause of incidents, identification and evidence collection from all affected machines and log sources, threat intelligence and other information sources. Once all appropriate information has been collected, we perform a careful analysis using forensically-sound tools and methods to prevent any contamination of evidence. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Incident containment by further analyzing additional information and further identifying any additional compromised machines or resources not previously identified. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Incident eradication by re-assessing the root cause of incidents where solutions are then implemented to solve underlying problems and prevent re-occurrence. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Recovery and restoring normal business functionality, which includes the reversal of any damage caused by the incident and responding as necessary. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:13.27pt">Review after closure of each incident and conducting a lessons learned analysis to improve prevention and help to make incident response processes more efficient and effective. Also, the IRT evaluates competency and any additional training requirements needed. A final incident report will then be provided to key stakeholders and IRT members, which includes, but is not limited to the summary of the incident and its impact, a timeline of events, a detailed description of the incident, an evaluation of the organizational response and an assessment of the damages. </span></div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have not experienced a material cybersecurity breach in the past five years and, as a result, there have been no charges related to a breach in the past five years. Moreover, risks from cybersecurity threats have not materially affected our business strategy, results of operations, or financial condition. While we have implemented processes and procedures that we believe are tailored to address and mitigate the cybersecurity threats that our company faces, there can be no assurances that such an incident will not occur despite our efforts, as more fully described in Item 1A. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risk Factors</span>.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text">We utilize information technology that enables our operational leaders to access and share with their peers, both clinical and financial performance data in real time. Armed with relevant and current information, our operation leaders and their management teams can share best practices and the latest information, adjust to challenges and opportunities on a timely basis, improve quality of care, mitigate risk and improve both clinical outcomes and financial performance. We have also invested in specialized healthcare technology systems to assist our nursing and support staff. We have installed software and touch-screen interface systems in each operation to enable our clinical staff to monitor and deliver patient care and record patient information more efficiently. We believe these systems have improved the quality of our medical and billing records, while improving the productivity of our staff. Such uses of information systems give rise to cybersecurity risks, including system disruption, security breach, ransomware, theft, espionage and inadvertent release of information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text">Our Audit Committee receives quarterly reports on our information security and cyber fraud prevention programs from the Service Center's Chief Information Officer and Director of Information Security, who each have over 24 years of experience in IT, including various leadership roles at other large corporations. One of the three members of our Audit Committee is a cybersecurity expert.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Audit Committee receives quarterly reports on our information security and cyber fraud prevention programs from the Service Center's Chief Information Officer and Director of Information Security, who each have over 24 years of experience in IT, including various leadership roles at other large corporations. One of the three members of our Audit Committee is a cybersecurity expert.  </span></div>The ISO has been established by the Service Center's Chief Information Officer, with dedicated cyber security staff focusing on security monitoring, vulnerability management, incident response, risk assessments, employee training, security engineering and management of cyber security policies, standards and regulatory compliance. Like many organizations, we align to a Cyber Security Framework and take a risk-based approach during control assessment and implementation. We align to the National Institute of Standards and Technology (NIST) Special Publication 800-53 Revision 4, a globally recognized cyber security framework of Policies, Standards and Controls is comprised of five categories of defense &#8211; Identify, Protect, Detect, Respond and Recover. We are committed to the protection of our data, systems, network and continually invest in enhancements to mitigate or reduce the impact from a cyber security threat. We conduct periodic tests to maintain readiness and resiliency while regularly reviewing policies in the interest of protecting data security. External companies or agencies may be called upon to provide consulting, guidance, assistance, or some other form of support in response to a cybersecurity incident. The regular training of employees, at least annually, on the ever-present threat of cybersecurity helps maintain data security.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">The Service Center's Chief Information Officer and Director of Information Security are responsible for launching the Incident Response Team (IRT) if necessary and for notification to the Executive Team, who in turn will contact the Board of Directors and the Audit Committee to validate that the response is being addressed appropriately.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity incident management plan comprises the following six-step process: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The Service Center's Chief Information Officer and Director of Information Security lead its ISO team in the development, documentation, review and testing of security procedures and incident management procedures. Beyond initial creation, procedures are continually re-assessed, updated and tested on an ongoing basis. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The ISO team works with the Executive Team on the identification, assessment, verification and classification of incidents to determine affected stakeholders and appropriate parties for contact. </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The Service Center's Chief Information Officer and Director of Information Security are responsible for launching the Incident Response Team (IRT) if necessary and for notification to the Executive Team, who in turn will contact the Board of Directors and the Audit Committee to validate that the response is being addressed appropriately. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt">The IRT, in consultation with outside experts if needed, is responsible for the following: </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Initial containment by making tactical changes to the computing environment to mitigate active threats based on currently known information. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Analysis to establish the root cause of incidents, identification and evidence collection from all affected machines and log sources, threat intelligence and other information sources. Once all appropriate information has been collected, we perform a careful analysis using forensically-sound tools and methods to prevent any contamination of evidence. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Incident containment by further analyzing additional information and further identifying any additional compromised machines or resources not previously identified. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Incident eradication by re-assessing the root cause of incidents where solutions are then implemented to solve underlying problems and prevent re-occurrence. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt">Recovery and restoring normal business functionality, which includes the reversal of any damage caused by the incident and responding as necessary. </span></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:105%">&#8226;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:13.27pt">Review after closure of each incident and conducting a lessons learned analysis to improve prevention and help to make incident response processes more efficient and effective. Also, the IRT evaluates competency and any additional training requirements needed. A final incident report will then be provided to key stakeholders and IRT members, which includes, but is not limited to the summary of the incident and its impact, a timeline of events, a detailed description of the incident, an evaluation of the organizational response and an assessment of the damages. </span></div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We have not experienced a material cybersecurity breach in the past five years and, as a result, there have been no charges related to a breach in the past five years. Moreover, risks from cybersecurity threats have not materially affected our business strategy, results of operations, or financial condition. While we have implemented processes and procedures that we believe are tailored to address and mitigate the cybersecurity threats that our company faces, there can be no assurances that such an incident will not occur despite our efforts, as more fully described in Item 1A. </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Risk Factors</span>.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">Service Center's Chief Information Officer and Director of Information Security<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text">Service Center's Chief Information Officer and Director of Information Security, who each have over 24 years of experience in IT, including various leadership roles at other large corporations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text">The ISO has been established by the Service Center's Chief Information Officer, with dedicated cyber security staff focusing on security monitoring, vulnerability management, incident response, risk assessments, employee training, security engineering and management of cyber security policies, standards and regulatory compliance. Like many organizations, we align to a Cyber Security Framework and take a risk-based approach during control assessment and implementation. We align to the National Institute of Standards and Technology (NIST) Special Publication 800-53 Revision 4, a globally recognized cyber security framework of Policies, Standards and Controls is comprised of five categories of defense &#8211; Identify, Protect, Detect, Respond and Recover. We are committed to the protection of our data, systems, network and continually invest in enhancements to mitigate or reduce the impact from a cyber security threat. We conduct periodic tests to maintain readiness and resiliency while regularly reviewing policies in the interest of protecting data security. External companies or agencies may be called upon to provide consulting, guidance, assistance, or some other form of support in response to a cybersecurity incident. The regular training of employees, at least annually, on the ever-present threat of cybersecurity helps maintain data security.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871224208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span> The accompanying consolidated financial statements (the Financial Statements) have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The Company is the sole member or stockholder of various consolidated limited liability companies and corporations established to operate various acquired skilled nursing operations, senior living operations and related ancillary services. All intercompany transactions and balances have been eliminated in consolidation. The Company presents noncontrolling interests within the equity section of its consolidated balance sheets and the amount of consolidated net income that is attributable to The Ensign Group, Inc. and the noncontrolling interests in its consolidated statements of income. The Financial Statements include the accounts of all independent subsidiaries controlled by the Company through its ownership of a majority voting interest.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts in the prior period statements of income and statements of cash flows have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Estimates and Assumptions</a></td>
<td class="text"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span> The preparation of the Financial Statements in conformity with GAAP&#160;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company&#8217;s Financial Statements relate to revenue, acquired property and equipment, intangible assets and goodwill, right-of-use assets and lease liabilities, impairment of long-lived assets, as well as general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities. Actual results could differ from those estimates<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value Considerations</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Considerations</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist principally of cash and cash equivalents, debt security investments, accounts receivable, insurance subsidiary deposits, deferred compensation investment funds, equity investments, accounts payable and borrowings. The Company believes all of the financial instruments&#8217; recorded values approximate fair values because of their nature or respective short durations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. See Note 5, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for additional information.</span></div>The Company's non-financial assets, which includes goodwill, intangible assets, property and equipment and right-of-use assets, are not required to be measured at fair value on a recurring basis. However, on a periodic basis, or whenever events or changes in circumstances indicate that their carrying value may not be recoverable, the Company assesses its long-lived assets for impairment. When impairment has occurred, such long-lived assets are written down to fair value.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Service Revenue Recognition, Rental Revenue Recognition</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service Revenue Recognition</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 606).</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's service revenue is derived primarily from providing healthcare services to its patients. Revenue is recognized when services are provided to patients at the amount that reflects the consideration that the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. The healthcare services provided pursuant to skilled patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct. Additionally, there may be ancillary services that are not included in the daily rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rates on a per day basis, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration that is included in the transaction price may be constrained and is included in net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net revenue in the period such variances become known.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company&#8217;s contracts with its patients have an original duration of one year or less, the Company uses the practical expedient applicable to its contracts and does not consider the time value of money. Further, because of the short duration of these contracts, the Company has not disclosed the transaction price for the remaining performance obligations as of the end of each reporting period or when the Company expects to recognize this revenue. In addition, the Company has applied the practical expedient provided by FASB ASC Topic 340, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and all incremental customer contract acquisition costs are expensed as they are incurred because the amortization period would have been one year or less.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rental Revenue Recognition</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's rental revenues are primarily generated by leasing healthcare-related properties through triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Revenue for operating leases is recognized on a straight-line basis over the lease term when collectability of all minimum lease payments is probable in accordance with FASB ASC Topic 842, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 842). The Company has elected the single component practical expedient, which allows a lessor, by class of underlying asset, not to allocate the total consideration to the lease and non-lease components based on their relative stand-alone selling prices where certain criteria are met. </span></div>Tenant reimbursements related to property taxes and insurance are neither considered lease nor non-lease components under ASC 842. Lessee payments for taxes and insurance paid directly to a third party, on behalf of the Company, are excluded from variable lease payments and rental revenue in the Company&#8217;s consolidated statements of income. Otherwise, tenant reimbursements for taxes and insurance that are paid by the Company directly to a third party are classified as additional rental revenue and expense and recognized by the Company on a gross basis.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of bank term deposits, money market funds and treasury bill related investments with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of money market funds is determined based on &#8220;Level&#160;1&#8221; inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Insurance Subsidiary Deposits and Other Investments</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Subsidiary Deposits and Other Investments &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's captive insurance subsidiary cash and cash equivalents, deposits and investments are designated to support long-term insurance subsidiary liabilities and have been classified as short-term and long-term assets based on the timing of expected future payments of the Company's captive insurance liabilities. The majority of these deposits and investments are currently held in AA, A and BBB rated debt security investments and the remainder is held in a bank account with a high credit quality financial institution. Investments classified as held-to-maturity are financial instruments that the Company has the intent and ability to hold to maturity and are reported net of any related amortization and are not remeasured to fair value on a recurring basis.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's non-qualified deferred compensation plan's (the DCP) contracts insuring the lives of certain employees who are eligible to participate in the DCP are held in a rabbi trust. Cash surrender value of the contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When evaluating an investment for its current expected credit losses, the Company reviews factors such as historical experience with defaults, losses, credit ratings, term, market sector and macroeconomic trends, including current conditions and forecasts to the extent they are reasonable and supportable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span> Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from <span style="-sec-ix-hidden:f-501">three</span> to 59 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company leases skilled nursing facilities, senior living facilities and commercial office space.</span><span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is a lease and performs an evaluation to determine whether the lease should be classified as an operating or finance lease at the inception of the lease. As of December&#160;31, 2024, the Company has three financing lease that are not material to the consolidated balance sheet. Rights and obligations of the operating leases are included as right-of-use assets and current and long-term lease liabilities on the Company's consolidated balance sheets. As the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of future lease payments. The Company utilizes a third-party credit specialist to assist in estimating the incremental borrowing rate.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records rent expense for operating leases on a straight-line basis over the term of the lease. The lease term used for straight-line rent expense is calculated from the date the Company is given control of the leased premises through the end of the lease term. Renewals are not assumed in the determination of the lease term unless they are deemed to be reasonably assured at the inception of the lease. The lease term used for this evaluation also provides the basis for establishing depreciable lives for buildings subject to lease and leasehold improvements.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's real estate leases generally have initial lease terms of ten years or more and typically include one or more options to renew, with renewal terms that generally extend the lease term for an additional <span style="-sec-ix-hidden:f-507">ten</span> to 15 years. Exercise of the renewal options is generally subject to the satisfaction of certain conditions which vary by contract and generally follow payment terms that are consistent with those in place during the initial term. The Company reassesses the renewal option using a "reasonably certain" threshold, which is understood to be a high threshold. For leases where the Company is reasonably certain to exercise its renewal option, the option periods are included within the lease term and, therefore, the measurement of the right-of-use asset and lease liability. The Company's leases generally contain annual escalation clauses that are either fixed or variable in nature, some of which are dependent upon published indices. The Company recognizes lease expense for leases with an initial term of 12 months or less on a straight-line basis over the lease term. These leases are not recorded on the consolidated balance sheets. Certain of the Company's lease agreements include rental payments that are adjusted periodically for inflation. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. </span></div>The Company subleases skilled nursing facilities to third-party operators and considers the subleases to be separate contracts as the Company is not relieved of its primary obligation under its operating lease. The rental income from third-parties related to these subleases is presented on a gross basis from the rent expense associated with the Company's lease obligations and is not material to the consolidated statements of income.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span>The Company reviews the carrying value of long-lived assets that are held and used in the Company&#8217;s independent subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the independent subsidiaries to which the assets relate, utilizing management&#8217;s best estimate, appropriate assumptions and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Goodwill</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Definite-lived intangible assets consist primarily of patient base, facility trade names and customer relationships. Patient base is amortized over a period of <span style="-sec-ix-hidden:f-511">four</span> to eight months, depending on the classification of the patients and the level of occupancy in a new acquisition on the acquisition date. Trade names at independent subsidiaries are amortized over 30 years&#160;and customer relationships are amortized over a period of up to 20 years.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. </span></div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. The Company tests goodwill during the fourth quarter of each year or more often if events or circumstances indicate there may be impairment. The Company performs its analysis for each reporting unit that constitutes a business for which discrete financial information is produced and reviewed by operating segment management and provides services that are distinct from the other components of the operating segment, in accordance with the provisions of FASB ASC Topic 350,&#160;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other&#160;</span>(ASC 350). This guidance provides the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company performs a goodwill impairment test by comparing the carrying value of each reporting unit to its respective fair value. The Company determines the estimated fair value of each reporting unit using a discounted cash flow analysis. The fair value of the reporting unit is the implied fair value of goodwill. In the event a reporting unit's carrying value exceeds its fair value, an impairment loss will be recognized. An impairment loss is measured by the difference between the carrying value of the reporting unit and its fair value. The Company anticipates that the majority of goodwill recognized will be fully deductible for tax purposes as of December&#160;31, 2024.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReservePolicyTextBlock', window );">Self-Insurance</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Self-Insurance</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; The Company is partially self-insured for general and professional liability claims up to a base amount per claim (the self-insured retention) with an aggregate, one-time deductible above this limit. Losses beyond these amounts are insured through third-party policies with coverage limits per claim, per location and on an aggregate basis for the Company. The combined self-insured retention is $750 per claim, subject to an additional one-time deductible of $1,500 for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $650 per claim, subject to an additional one-time, deductible of $1,400. For all independent subsidiaries, except those located in Colorado, the third-party coverage above these limits is $1,000 per claim, $3,000 per operation, with a $10,000 aggregate limit and an additional state-specific aggregate where required by state law. In Colorado, the third-party coverage above these limits is $1,000 per claim and $3,000 per operation, which is independent of the aforementioned aggregate limits that apply outside of Colorado. Subsequent to December&#160;31, 2024, the combined self-insured retention is $1,000 per claim ($750 if an enforceable arbitration agreement applies), subject to an additional one-time deductible of $2,950 for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $750 per claim ($650 if an enforceable arbitration agreement applies), subject to an additional one-time, deductible of $4,500.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the self-insured retention and deductible limits for general and professional liabilities and workers' compensation liabilities are self-insured through the captive insurance subsidiary, the related assets and liabilities of which are included in the accompanying consolidated balance sheets. The captive insurance subsidiary is subject to certain statutory requirements as an insurance provider. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy is to accrue amounts equal to the actuarial estimated costs to settle open claims of insureds, as well as an estimate of the cost of insured claims that have been incurred but not reported. The Company develops information about the size of the ultimate claims based on historical experience, current industry information and actuarial analysis, and evaluates the estimates for claim loss exposure on a quarterly basis. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent subsidiaries are self-insured for workers&#8217; compensation liabilities in California. To protect itself against loss exposure in California with this policy, the Company has purchased individual specific excess insurance coverage that insures individual claims that exceed $625 per occurrence. In Texas, the independent subsidiaries have elected non-subscriber status for workers&#8217; compensation claims and the Company has purchased individual stop-loss coverage that insures individual claims that exceed $750 per occurrence. The Company&#8217;s independent subsidiaries in all other states, with the exception of Washington, are under a loss sensitive plan that insures individual claims that exceed $350 per occurrence. In the state of Washington, the Company is self-insured and has purchased individual specific excess insurance coverage that insures individual claims that exceed $500 per occurrence. For all of the self-insured plans and retention, the Company accrues amounts equal to the estimated costs to settle open claims, as well as an estimate of the cost of claims that have been incurred but not reported. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company self-funds medical (including prescription drugs) and dental healthcare benefits to the majority of its employees. The Company is fully liable for all financial and legal aspects of these benefit plans. To protect itself against loss exposure with this policy, the Company has purchased individual stop-loss insurance coverage that insures individual claims that exceed $525 for each covered person.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company believes that adequate provision has been made in the Financial Statements for liabilities that may arise out of patient care, workers&#8217; compensation, healthcare benefits and related services provided to date. The amount of the Company&#8217;s reserves was determined based on an estimation process that uses information obtained from both company-specific and industry data. This estimation process requires the Company to continuously monitor and evaluate the life cycle of the claims. Using data obtained from this monitoring and the Company&#8217;s assumptions about emerging trends, the Company, with the assistance of an independent actuary, develops information about the size of ultimate claims based on the Company&#8217;s historical experience and other available industry information. The most significant assumptions used in the estimation process include determining the trend in costs, the expected cost of claims incurred but not reported and the expected costs to settle or pay damage awards with respect to unpaid claims. The self-insured liabilities are based upon estimates, and while management believes that the estimates of loss are reasonable, the ultimate liability may be in excess of or less than the recorded amounts. Due to the inherent volatility of actuarially determined loss estimates, it is reasonably possible that the Company could experience changes in estimated losses that could be material to net income. If the Company&#8217;s actual liabilities exceed its estimates of losses, its future earnings, cash flows and financial condition would be adversely affected.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#8217;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#8217;s estimates and assumptions, actual results could differ.</span></div>Standard Bearer was organized, has operated and intends to continue to operate in a manner to qualify for taxation as a REIT. In order to qualify as a REIT, Standard Bearer must meet certain organizational and operational requirements, including a requirement to distribute to its shareholders, which in this case is the Company, at least 90% of its annual taxable income. As a REIT, Standard Bearer generally will not be subject to federal income tax to the extent it distributes as qualifying dividends, all of its REIT taxable income to its shareholders. If Standard Bearer fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NoncontrollingInterestPolicyTextBlock', window );">Noncontrolling Interest</a></td>
<td class="text"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; </span>The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income attributable to The Ensign Group, Inc. in its consolidated statements of income. Net income per share is calculated based on net income attributable to The Ensign Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all stock-based payment awards made to employees and directors including employee stock options and restricted stock awards based on estimated fair values, ratably over the requisite service period of the award. Net income has been reduced as a result of the recognition of the fair value of all stock options and restricted stock awards issued, the amount of which is based upon the number of grants and other variables. As stock-based compensation expense recognized in the Company&#8217;s consolidated statements of income was based on awards expected to vest, it has been reduced for estimated forfeitures. The Company estimates forfeitures at the time of grant and, if necessary, revises the estimate in subsequent periods if actual forfeitures differ.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;</span> The Company does not have any components of other comprehensive income recorded within its Financial Statements and, therefore, does not separately present a statement of comprehensive income in its Financial Statements.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Except for rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws and a limited number of grandfathered standards, the FASB ASC is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements announced, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company's reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company's financial management and certain standards are under consideration.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Standards Adopted by the Company &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In November 2023, the FASB issued Accounting Standards Update (ASU) 2023-07 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to expand the breadth and frequency of segment disclosures to include additional information about significant segment expenses, the chief operating decision maker (CODM) and other items, and also require the annual disclosures on an interim basis. This guidance was effective for annual periods beginning with the Company's fiscal year 2024, and in interim periods within the Company's fiscal year 2025. The Company adopted the requirements of this ASU in Note 8, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of this Annual Report.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted &#8212;</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In October 2023, the FASB issued ASU 2023-06</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> "Codification Amendments in Response to the SEC&#8217;s Disclosure Update and Simplification Initiative," </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which amends U.S. GAAP to include 14 disclosure requirements that are currently required under SEC Regulation S-X or Regulation S-K. Each amendment will be effective on the date on which the SEC removes the related disclosure requirement from SEC Regulation S-X or Regulation S-K. The adoption is not expected to have a material impact on the Company's Financial Statements as these requirements were previously incorporated under the SEC Regulations. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Improvements to Income Tax Disclosures,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to disclose disaggregated jurisdictional and categorical information for the tax rate reconciliation, income taxes paid and other income tax related amounts. ASU 2023-09 is effective for annual periods beginning with the Company's fiscal year 2025, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.</span></div><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03 "</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses,</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" which requires the Company to disaggregate key expense categories such as employee compensation, depreciation and intangible asset amortization within its financial statements. ASU 2024-03 is effective for annuals periods beginning with the Company's fiscal year 2027, and interim periods within the Company's fiscal year 2028, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NoncontrollingInterestPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NoncontrollingInterestPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 825<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(f)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 12<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 19<br> -Subparagraph (2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReservePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReservePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-15<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866490560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue for the years ended December 31, 2024, 2023 and 2022 is summarized in the following tables:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.312%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682,344&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459,449&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183,156&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055,226&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,749&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid &#8212; skilled</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,738&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,663&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Medicaid and Medicare</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,004,308</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70.9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,690,861</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.6</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,216,194</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789,643&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,129&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525,710&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,574&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,807&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SERVICE REVENUE</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,237,525</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,708,071</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,008,711</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Medicaid payor includes revenue for senior living operations.</span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Medicaid payor includes revenue related to state relief funding during the year ended December 31, 2023 and 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3) Private and other also includes revenue from senior living operations and all revenue generated in other an</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">cillary services.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable</a></td>
<td class="text">Accounts receivable as of December&#160;31, 2024 and 2023, is summarized in the following table:<div style="margin-top:9.75pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.861%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">228,872&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,285&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139,711&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125,907&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,056&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,512&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other payors</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,693&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">578,332</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">494,387</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,435)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,348)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ACCOUNTS RECEIVABLE, NET</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">569,897</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">485,039</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378878498080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock', window );">Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic Net Income Per Common Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator used in the calculation of basic net income per common share follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NUMERATOR:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,458&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income (loss) attributable to noncontrolling interests </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to The Ensign Group, Inc. </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">297,973</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,399</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">224,681</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DENOMINATOR:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic net income per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,655&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,708&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,887&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic net income per common share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.26</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.76</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4.09</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Diluted Net Income Per Common Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the numerator and denominator used in the calculation of diluted net income per common share follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.818%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NUMERATOR:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298,458&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,850&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income (loss) attributable to noncontrolling interests</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to The Ensign Group, Inc. </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">297,973</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">209,399</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">224,681</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DENOMINATOR:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,655&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,708&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,887&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: incremental shares from assumed conversion</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,585&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,615&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,984&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Adjusted weighted average common shares outstanding</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">58,240</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">57,323</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">56,871</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted net income per common share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5.12</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.65</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3.95</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> 914, </span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">1,429 and 780 for the years ended December 31, 2024, 2023 and 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on basic earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866498272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATION EXPANSIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Purchase Price Allocation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the allocation of the purchase price for the operations acquired during the </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">years ended December 31, 2024, 2023 and 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,547&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,794&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,527&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,709&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,488&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,070&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture, and fixtures</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,937&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,618&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assembled occupancy</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,112&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,400&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased asset</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL ACQUISITIONS</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">154,879</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,798</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">101,136</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874182736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Financial Information</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth financial information for the segments:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.603%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076,825&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,076,825&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,086&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,086&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,076,825</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">95,086</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,171,911</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,881&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,307)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,260,485</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,513,167&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,152&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,195&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,297&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,302&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">518,463</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,335</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">547,798</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161,704)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">386,094</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All other revenue includes $181,066 of service revenue and $11,815 of rental revenue for the year ended December 31, 2024, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $83,941 and intercompany service revenue of $20,366 for the year ended December 31, 2024.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $104,307 during the year ended December 31, 2024, which are eliminated in consolidation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $20,285 during the year ended December 31, 2024, which is eliminated in consolidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:59.603%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.366%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,578,855&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,578,855&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,486&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,578,855</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">82,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,661,341</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,804&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87,790)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,729,355</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,075,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,455&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,766&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">464,925</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,065</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">493,990</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(221,228)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">272,762</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All Other revenue includes $144,667 of service revenue and $11,137 of rental revenue for the year ended December 31, 2023, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination intercompany rental revenue of $72,339 and intercompany service revenue of $15,451 for the year ended December 31, 2023.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $87,790 during the year ended December 31, 2023, which is eliminated in consolidation.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $12,902 during the year ended December 31, 2023, which is eliminated in consolidation.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Standard Bearer</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906,215&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906,215&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rental revenue</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,937&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,937&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment revenue</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,906,215</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72,937</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,979,152</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of revenue:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of intercompany revenue</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,294)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL CONSOLIDATED REVENUE </span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,025,468</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less:</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other segment items</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,464,259&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,746&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,707&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment income</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">408,732</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">27,871</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">436,603</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of profit or loss:</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other loss</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147,514)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">INCOME BEFORE PROVISION FOR INCOME TAXES</span></div></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">289,089</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) All Other revenue includes $115,214 of service revenue and $7,396 of rental revenue for the year ended December 31, 2022, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $63,576 and intercompany service revenue of $12,718 for the year ended December 31, 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment.  Additionally, there are intercompany expenses of $76,294 during the year ended December 31, 2022, which is eliminated in consolidation. </span></div>(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $8,646 during the year ended December 31, 2022, which is eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock', window );">Schedule of Service Revenue by Major Payor Source</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service revenue by major payor source were as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.397%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646,422&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,922&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,682,344&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055,226&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,055,226&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,738&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,738&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,968,386</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">35,922</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,004,308</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70.9</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789,643&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">789,643&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,796&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124,778&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">443,574&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,076,825</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">160,700</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,237,525</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,429,473&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,976&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,459,449&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,749&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">985,749&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,663&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245,663&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,660,885</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">29,976</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,690,861</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">72.6</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,129&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,129&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,240&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">351,081&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,578,855</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">129,216</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,708,071</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Service Revenue</span></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158,309&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,847&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,183,156&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.3&#160;</span></td><td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832,160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid-skilled</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200,878&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subtotal</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,191,347</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">24,847</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,216,194</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">73.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525,710&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525,710&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,158&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,649&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">266,807&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SERVICE REVENUE</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,906,215</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">102,496</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,008,711</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">100.0</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. </span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%">(2) Private and other payors also includes revenue from senior living operations and all payors generated in other ancillary services.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%">(3) All Other incorporates intercompany eliminations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45379062629568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT&#8212; NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consists of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.715%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,873&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142,656&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">933,790&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">803,155&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212,603&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">172,064&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396,018&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,383&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,349&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,192&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,209&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,563&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,750,842</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,487,013</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459,488)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396,242)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PROPERTY AND EQUIPMENT, NET</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,291,354</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,090,771</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378880035088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS &#8212; NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.671%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.682%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="5" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible Assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assembled occupancy</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,991&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,316)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">781&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(742)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility trade name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.0</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(462)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">733&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(439)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,582&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,902)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,680&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,582&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,692)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,890&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,306</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(4,680)</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,626</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,096</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(3,873)</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,223</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated amortization expense for each of the years ending December&#160;31 is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.837%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.382%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.381%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">911&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">779&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,626</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock', window );">Schedule of Indefinite-lived Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other indefinite-lived intangible assets consist of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicaid licenses</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,777&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,413&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,666</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,302</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of acquired indefinite-lived intangible asset by major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378876361264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text">The following table represents activity in goodwill by skilled service segment and "all other" category as of December&#160;31, 2024, 2023 and 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:53.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Skilled Services</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">51,486</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,983</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">60,469</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,400&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,400&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,886</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,983</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76,869</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2023</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,886</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8,983</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76,869</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,740&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,112&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">88,626</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">9,355</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">97,981</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1A<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378876382752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Other Accrued Liabilities</a></td>
<td class="text"><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quality assurance fee</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,667&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,035&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refunds payable</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,755&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resident advances</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,818&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,834&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash held in trust for patients</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,370&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,215&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,589&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,396&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property taxes</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,400&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued litigation (Note 19)</span></div></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,734&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,458&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,891&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER ACCRUED LIABILITIES</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">132,057</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">168,228</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866449808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes for the years ended December 31, 2024, 2023 and 2022 is summarized as follows: </span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,144&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,092&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,717&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,857&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,216&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87,001</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">90,393</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">70,933</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,280)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,158)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,201)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,338)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">635</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(27,481)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(6,496)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;TOTAL</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">87,636</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">62,912</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">64,437</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory rate to the effective tax rate for net income for the years ended December 31, 2024, 2023 and 2022, respectively, is comprised as follows: </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes&#160;- net of federal benefit</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible expenses</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL INCOME TAX PROVISION</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.7</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">23.1</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22.3</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's deferred tax assets and liabilities as of December&#160;31, 2024 and 2023 are summarized below. </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,419&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related reserves</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,023&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,714&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,192&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,817&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,864&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liability </span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,313&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">444,590&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">599,169</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">567,862</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(789)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DEFERRED TAX ASSETS</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">599,076</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">567,073</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(197)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(280)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,253)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,334)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,390)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,113)</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use asset </span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(468,955)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(443,222)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL DEFERRED TAX LIABILITIES</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(532,795)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(499,949)</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NET DEFERRED TAX ASSETS</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">66,281</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">67,124</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866493584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt consists of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage loans and promissory note</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,438&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,388&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current maturities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,086)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,950)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: debt issuance costs, net</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,767)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,941)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM DEBT LESS CURRENT MATURITIES</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">141,585</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">145,497</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future principal payments due under the long-term debt arrangements discussed above are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,086&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,227&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,897&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,779&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,896&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,553&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">148,438</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378965947776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Assumptions for Stock Options Granted</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 704, 1,008 and 581 stock options during the years ended December 31, 2024, 2023 and 2022, respectively. The Company used the following assumptions for stock options granted during the years ended December 31, 2024, 2023 and 2022:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.428%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.490%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.428%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Risk-Free Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Volatility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Dividend Yield</span></td></tr><tr><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5%</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.3%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.1%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock', window );">Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2024, 2023 and 2022, the following represents the exercise price and fair value displayed at grant date for stock option grants:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.245%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.687%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Fair Value of Options</span></td></tr><tr><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.46&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.37&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.85&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Schedule of Employee Stock Option Roll Forward</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the years ended December 31, 2024, 2023 and 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.981%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of<br/>Options Vested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Weighted Average Exercise Price of Options Vested</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">January 1, 2022</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,038&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.60&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,183&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.02&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(688)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,833&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,069&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.87&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,008&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(91)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.44&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31. 2023</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,991</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,887&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.58&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">704&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.46&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.92&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(632)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.28&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2024</span></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,987</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.84&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.64&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Stock Options Outstanding, Vested and Related Details</a></td>
<td class="text"><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the year ended December 31, 2024:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.554%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.917%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options Vested</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number Outstanding</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Black-Scholes Fair Value</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remaining Contractual Life (Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vested and Exercisable</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year of Grant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$18.20</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$21.39</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2016</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.93</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.86</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.80</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.41</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">867&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.49</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.71</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,557&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.07</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.76</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,557&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">417&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.84</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.49</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,020&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">301&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.47</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.64</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,041&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.79</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.88</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,601&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.83</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.83</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">951&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,753&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$119.19</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$146.37</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,024&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3,987</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">136,624</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,895</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock', window );">Schedule of Aggregate Intrinsic Value of Options</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options outstanding, vested and expected to vest as of December 31, 2024, 2023 and 2022 is as follows:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.349%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219,309&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,819&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,593&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,011&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,048&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,243&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,232&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Nonvested Restricted Stock Awards</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the status of the Company's non-vested restricted stock awards as of December&#160;31, 2024 and changes during the years ended December&#160;31, 2024, 2023 and 2022 is presented below:</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.954%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-Vested Restricted Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at January 1, 2022</span></div></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">549</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.16&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(269)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.29&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December 31, 2022</span></div></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">487</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.04&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December 31, 2023</span></td><td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">431</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.91&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131.26&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.97&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.12&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nonvested at December&#160;31, 2024</span></div></td><td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">435</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102.71&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the years ended December&#160;31, 2024</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 and 2022 was as follows:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to stock options</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,439&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,221&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,361&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to restricted stock awards</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,662&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,845&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,920&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense related to restricted stock awards to non-employee directors</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,688&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,439&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">36,183</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">30,754</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,720</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378876338000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Operating Lease Expenses</a></td>
<td class="text">The components of operating lease expense are as follows:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.326%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent - cost of services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,016&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,358&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153,049&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,297&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,454&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">700&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">498&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,212&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,202&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">242,225</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">219,512</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">171,272</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Rent- cost of services includes accrued rent expense adju</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">stments of</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> $808, $870 and $493 for the years ended December 31, 2024, 2023 and 2022, respectively. Additionally, rent- cost of services includes other variable lease costs such as consumer price index increases and short-term leases of $14,013, $10,259, $5,878 for the years ended December 31, 2024,  2023, and 2022 respectively.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Cost of services includes variable lease costs, which consists of property taxes and insurance. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt">Depreciation and amortization is related to the amortization of favorable and direct lease costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Lease Payments</a></td>
<td class="text"><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments for all third-party leases as of December&#160;31, 2024 are as follows: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.718%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.352%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,909&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,696&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204,002&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202,994&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199,144&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,776,571&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL LEASE PAYMENTS</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2,792,316</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustment </span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(963,516)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PRESENT VALUE OF TOTAL LEASE LIABILITIES</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,828,800</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current lease liabilities</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93,475)</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM OPERATING LEASE LIABILITIES</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1,735,325</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock', window );">Schedule of Rental Income from Third-Party Sources</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rental income from all third-party sources for the years ended December 31, 2024, 2023 and 2022 is as follows:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.157%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennant</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,480&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,048&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,915&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third-party</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,480&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,236&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,842&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><span style="-sec-ix-hidden:f-1530"><span style="-sec-ix-hidden:f-1531"><span style="-sec-ix-hidden:f-1532">TOTAL</span></span></span></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">22,960</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">21,284</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">16,757</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) Pennant rental income includes variable rent such as property taxes of $1,235, $1,296, and $1,318 during the year ended December 31, 2024, 2023, and 2022.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2) Other third-party includes rental revenue associated with the Company's subleases to third parties of $4,347 and $3,897 for the years ended December 31, 2024 and 2023. There was no sublease rental revenue for the year ended December 31, 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Schedule of Annual Rental Income</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future annual rental income for all third-party leases as of December&#160;31, 2024 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,664&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,179&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,736&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,535&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029</span></td><td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,511&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,811&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL</span></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">234,436</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>(1) Annual rental income includes base rents and variable rental income pursuant to existing leases as of December&#160;31, 2024.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncomeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of components of income from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncomeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378867074944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELF INSURANCE LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock', window );">Schedule of Self-Insurance Insurance Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the Company's self-insurance insurance liabilities, on an undiscounted basis, inclusive of anticipated insurance recoveries, as of December 31, 2024 and 2023: </span></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.999%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued general liability and professional malpractice liabilities</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160,149&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117,744&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued workers&#8217; compensation liabilities</span></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,291&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,352&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued health benefits</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,312&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,814&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TOTAL SELF-INSURANCE LIABILITIES</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">211,752</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165,910</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current self-insurance liabilities</span></div></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,331&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,664&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LONG-TERM SELF-INSURANCE LIABILITIES</span></div></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">144,421</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">111,246</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock', window );">Schedule of Insurance Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents activity in the Company's self-insurance liabilities as of and for the years ended December 31, 2024 and 2023: </span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.011%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.205%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance January&#160;1, 2023</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,682&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year provisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims paid and direct expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(135,799)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in long-term insurance losses recoverable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance December&#160;31, 2023</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"></td><td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">165,910</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year provisions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217,631&#160;</span></td><td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Claims paid and direct expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(173,617)</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in long-term insurance losses recoverable</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;padding:0 1pt"></td><td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance December&#160;31, 2024</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">211,752</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of beginning balance to ending balance for liability for future policy benefit, with separate presentation of expected future net premium and expected future benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-29E<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the present values of future benefits to be paid to or on behalf of policyholders and related expenses less the present value of future net premiums using assumptions such as estimates of expected investment yields, mortality, morbidity, terminations and expenses, applicable at the time the insurance contracts are made and unpaid claim costs relating to insurance contracts including estimates of costs relating to incurred but not reported claims based on the estimated ultimate cost of settling the claims (including effects of inflation and other societal and economic factors), using past experience adjusted for current trends and any other factors that would modify past experience by element such as business segment, country and interest rate range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874250512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>property </div>
<div>facility </div>
<div>bed </div>
<div>unit</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember', window );">Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSkilledNursingBeds', window );">Number of operational skilled nursing beds | bed</a></td>
<td class="nump">33,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSeniorLivingUnits', window );">Number of senior living units | unit</a></td>
<td class="nump">3,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements', window );">Number of facilities under long-term lease arrangements | facility</a></td>
<td class="nump">231<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase', window );">Options to purchase under long-term lease arrangements | facility</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember', window );">Subsidiaries | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_OperatingEntityAxis=ensg_ThirdPartyOperatorsMember', window );">Third Party Operators | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_OperatingEntityAxis=ensg_ThirdPartyOperatorsMember', window );">Third Party Operators | Standard Bearer Healthcare REIT, Inc. | Senior Living Operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfRealEstatePropertiesSharingLocations', window );">Number of senior living operations sharing property with skilled nursing operations</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_RealEstateAndLeaseArrangementsAxis=ensg_CombinedRealEstateAndLeasesMember', window );">Combined Real Estate And Leases | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties | facility</a></td>
<td class="nump">327<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Facilities Under Long-Term Lease Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Facilities Under Long-Term Lease Arrangements, Option To Purchase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfRealEstatePropertiesSharingLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Real Estate Properties Sharing Locations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfRealEstatePropertiesSharingLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfSeniorLivingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operational Assisted Living and Independent Living Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfSeniorLivingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfSkilledNursingBeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of skilled nursing beds available for use at a skilled nursing facility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfSkilledNursingBeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstatePropertiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstatePropertiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_OperatingEntityAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_OperatingEntityAxis=ensg_ThirdPartyOperatorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_OperatingEntityAxis=ensg_ThirdPartyOperatorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RealEstateAndLeaseArrangementsAxis=ensg_CombinedRealEstateAndLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RealEstateAndLeaseArrangementsAxis=ensg_CombinedRealEstateAndLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866425056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">59 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378870364272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Leases (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>lease </div>
<div>option</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfFinancingLeases', window );">Number of financing lease | lease</a></td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LesseeOperatingLeaseNumberOfRenewalOptions', window );">Number of options to renew lease | option</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstatePropertiesLineItems', window );"><strong>Real Estate Properties [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">15 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LesseeOperatingLeaseNumberOfRenewalOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Renewal Options</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LesseeOperatingLeaseNumberOfRenewalOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfFinancingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Financing Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfFinancingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstatePropertiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstatePropertiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874387952">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets and Goodwill (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ensg_AssembledOccupancyAcquiredMember', window );">Assembled occupancy | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Definite-lived intangible asset useful life</a></td>
<td class="text">4 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ensg_AssembledOccupancyAcquiredMember', window );">Assembled occupancy | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Definite-lived intangible asset useful life</a></td>
<td class="text">8 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Definite-lived intangible asset useful life</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Definite-lived intangible asset useful life</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ensg_AssembledOccupancyAcquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ensg_AssembledOccupancyAcquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874432544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-Insurance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Feb. 05, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 211,752<span></span>
</td>
<td class="nump">$ 165,910<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_WorkersCompensationInsuranceMember', window );">Workers' Compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,291<span></span>
</td>
<td class="nump">$ 33,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_WorkersCompensationInsuranceMember', window );">Workers' Compensation | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_WorkersCompensationInsuranceMember', window );">Workers' Compensation | Texas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimMember', window );">Self-Insurance Retention Per Claim | General Liability | WASHINGTON</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimMember', window );">Self-Insurance Retention Per Claim | Parent Company | General Liability | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimMember', window );">Self-Insurance Retention Per Claim | Parent Company | General Liability | California | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimMember', window );">Self-Insurance Retention Per Claim | Parent Company | General Liability | Non-california</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimMember', window );">Self-Insurance Retention Per Claim | Parent Company | General Liability | Non-california | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember', window );">Enforceable Arbitration Agreement | Parent Company | General Liability | California | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember', window );">Enforceable Arbitration Agreement | Parent Company | General Liability | Non-california | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateDeductibleMember', window );">Aggregate Deductible | Parent Company | General Liability | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateDeductibleMember', window );">Aggregate Deductible | Parent Company | General Liability | California | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="nump">2,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateDeductibleMember', window );">Aggregate Deductible | Parent Company | General Liability | Non-california</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateDeductibleMember', window );">Aggregate Deductible | Parent Company | General Liability | Non-california | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_PerOccurenceMember', window );">Per Occurence | Third-Party Payor | General Liability | All States Except Colorado</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_PerOccurenceMember', window );">Per Occurence | Third-Party Payor | General Liability | Colorado</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_PerFacilityMember', window );">Per Facility | Third-Party Payor | General Liability | All States Except Colorado</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_PerFacilityMember', window );">Per Facility | Third-Party Payor | General Liability | Colorado</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateMember', window );">Aggregate | Third-Party Payor | General Liability | All States Except Colorado</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_LossSensitiveLimitPerClaimMember', window );">Loss-Sensitive Limit Per Claim | Workers' Compensation | Other States, Except California, Texas and Washington</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_StopLossInsuranceLimitPerClaimMember', window );">Stop-Loss Insurance Limit Per Claim | Health Liability Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems', window );"><strong>Liability for Claims and Claims Adjustment Expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">Self insurance reserve</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_WorkersCompensationInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_WorkersCompensationInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_GeneralLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_GeneralLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_WA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_WA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PayorAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PayorAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ensg_NonCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ensg_NonCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceCoverageLimitTypeAxis=ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateDeductibleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateDeductibleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_PerOccurenceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceCoverageLimitTypeAxis=ensg_PerOccurenceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PayorAxis=naics_ZZ524292">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PayorAxis=naics_ZZ524292</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ensg_AllStatesExcludingColoradoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ensg_AllStatesExcludingColoradoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_PerFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceCoverageLimitTypeAxis=ensg_PerFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceCoverageLimitTypeAxis=ensg_AggregateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_LossSensitiveLimitPerClaimMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceCoverageLimitTypeAxis=ensg_LossSensitiveLimitPerClaimMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InsuranceCoverageLimitTypeAxis=ensg_StopLossInsuranceLimitPerClaimMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InsuranceCoverageLimitTypeAxis=ensg_StopLossInsuranceLimitPerClaimMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ensg_HealthLiabilityInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ensg_HealthLiabilityInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871388896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 4,260,485,000<span></span>
</td>
<td class="nump">$ 3,729,355,000<span></span>
</td>
<td class="nump">$ 3,025,468,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived', window );">Stat relief funding received</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">64,238,000<span></span>
</td>
<td class="nump">81,057,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_AccruedLiabilitiesStateReliefContractLiabilities', window );">Unapplied state relief funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486,000<span></span>
</td>
<td class="nump">1,001,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized', window );">Stat relief funding recognized as revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,753,000<span></span>
</td>
<td class="nump">81,837,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT', window );">Payment associated with deferred amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,155,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">4,237,525,000<span></span>
</td>
<td class="nump">3,708,071,000<span></span>
</td>
<td class="nump">3,008,711,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Total Medicare and Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 3,004,308,000<span></span>
</td>
<td class="nump">$ 2,690,861,000<span></span>
</td>
<td class="nump">$ 2,216,194,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Total Medicare and Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">70.90%<span></span>
</td>
<td class="nump">72.60%<span></span>
</td>
<td class="nump">73.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ensg_RentalMember', window );">Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 22,960,000<span></span>
</td>
<td class="nump">$ 21,284,000<span></span>
</td>
<td class="nump">$ 16,757,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_AccruedLiabilitiesStateReliefContractLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities, State Relief Contract Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_AccruedLiabilitiesStateReliefContractLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_FamilyFirstCoronavirusResponseActPaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Family First Coronavirus Response Act, Payments Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_FamilyFirstCoronavirusResponseActPaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_MedicareAcceleratedAndAdvancePaymentCARESACT">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Medicare Accelerated And Advance Payment, CARES ACT</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_MedicareAcceleratedAndAdvancePaymentCARESACT</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue Recognition, Family First Coronavirus Response Act, Revenue Recognized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidAndMedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidAndMedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ensg_RentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ensg_RentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378875575568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 4,260,485<span></span>
</td>
<td class="nump">$ 3,729,355<span></span>
</td>
<td class="nump">$ 3,025,468<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">4,237,525<span></span>
</td>
<td class="nump">3,708,071<span></span>
</td>
<td class="nump">3,008,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Total Medicaid and Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,004,308<span></span>
</td>
<td class="nump">2,690,861<span></span>
</td>
<td class="nump">2,216,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,682,344<span></span>
</td>
<td class="nump">1,459,449<span></span>
</td>
<td class="nump">1,183,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">1,055,226<span></span>
</td>
<td class="nump">985,749<span></span>
</td>
<td class="nump">832,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Medicaid &#8212; skilled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">266,738<span></span>
</td>
<td class="nump">245,663<span></span>
</td>
<td class="nump">200,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">789,643<span></span>
</td>
<td class="nump">666,129<span></span>
</td>
<td class="nump">525,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 443,574<span></span>
</td>
<td class="nump">$ 351,081<span></span>
</td>
<td class="nump">$ 266,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Total Medicaid and Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">70.90%<span></span>
</td>
<td class="nump">72.60%<span></span>
</td>
<td class="nump">73.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">39.70%<span></span>
</td>
<td class="nump">39.40%<span></span>
</td>
<td class="nump">39.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">24.90%<span></span>
</td>
<td class="nump">26.60%<span></span>
</td>
<td class="nump">27.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Medicaid &#8212; skilled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">18.60%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">17.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of Revenue</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="nump">9.40%<span></span>
</td>
<td class="nump">8.80%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidAndMedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidAndMedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidSkilledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidSkilledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_ManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_ManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_PrivatePayAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_PrivatePayAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868687296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Accounts Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable, gross</a></td>
<td class="nump">$ 578,332<span></span>
</td>
<td class="nump">$ 494,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">(8,435)<span></span>
</td>
<td class="num">(9,348)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">ACCOUNTS RECEIVABLE, NET</a></td>
<td class="nump">569,897<span></span>
</td>
<td class="nump">485,039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ensg_MedicaidMember', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable, gross</a></td>
<td class="nump">228,872<span></span>
</td>
<td class="nump">178,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ensg_ManagedCareMember', window );">Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable, gross</a></td>
<td class="nump">139,711<span></span>
</td>
<td class="nump">125,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ensg_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable, gross</a></td>
<td class="nump">77,056<span></span>
</td>
<td class="nump">85,512<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=ensg_PrivatePayAndOtherMember', window );">Private and other payors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable, gross</a></td>
<td class="nump">$ 132,693<span></span>
</td>
<td class="nump">$ 104,683<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_ManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_ManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_PrivatePayAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_PrivatePayAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868727408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF NET INCOME PER COMMON SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>NUMERATOR:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">$ 298,458<span></span>
</td>
<td class="nump">$ 209,850<span></span>
</td>
<td class="nump">$ 224,652<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity', window );">Less: net income (loss) attributable to noncontrolling interests</a></td>
<td class="nump">485<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET INCOME ATTRIBUTABLE TO THE ENSIGN GROUP, INC.</a></td>
<td class="nump">$ 297,973<span></span>
</td>
<td class="nump">$ 209,399<span></span>
</td>
<td class="nump">$ 224,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>DENOMINATOR:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding for basic net income per share (in shares)</a></td>
<td class="nump">56,655<span></span>
</td>
<td class="nump">55,708<span></span>
</td>
<td class="nump">54,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Plus: incremental shares from assumed conversion (in shares)</a></td>
<td class="nump">1,585<span></span>
</td>
<td class="nump">1,615<span></span>
</td>
<td class="nump">1,984<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Adjusted weighted average common shares outstanding (in shares)</a></td>
<td class="nump">58,240<span></span>
</td>
<td class="nump">57,323<span></span>
</td>
<td class="nump">56,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in dollars per share)</a></td>
<td class="nump">$ 5.26<span></span>
</td>
<td class="nump">$ 3.76<span></span>
</td>
<td class="nump">$ 4.09<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in dollars per share)</a></td>
<td class="nump">$ 5.12<span></span>
</td>
<td class="nump">$ 3.65<span></span>
</td>
<td class="nump">$ 3.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">914<span></span>
</td>
<td class="nump">1,429<span></span>
</td>
<td class="nump">780<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868247376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Details) - Fair Value, Inputs, Level 2 - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized cost basis of held-to-maturity investments</a></td>
<td class="nump">$ 138,600<span></span>
</td>
<td class="nump">$ 59,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Financial assets, investment funds</a></td>
<td class="nump">56,049<span></span>
</td>
<td class="nump">41,216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Long-Term Insurance Subsidiary Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized cost basis of held-to-maturity investments</a></td>
<td class="nump">$ 65,831<span></span>
</td>
<td class="nump">$ 59,530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=ensg_InsuranceSubsidiaryLongTermInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=ensg_InsuranceSubsidiaryLongTermInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378862389536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STANDARD BEARER (Details)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 05, 2025 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>property </div>
<div>lease </div>
<div>renewal </div>
<div>subsidiary </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>property </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>property </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfLeaseArrangements', window );">Number of master lease arrangements | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">704,000<span></span>
</td>
<td class="nump">1,008,000<span></span>
</td>
<td class="nump">581,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 36,183,000<span></span>
</td>
<td class="nump">$ 30,754,000<span></span>
</td>
<td class="nump">$ 22,720,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock awards granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,000<span></span>
</td>
<td class="nump">219,000<span></span>
</td>
<td class="nump">233,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested in the period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">215,000<span></span>
</td>
<td class="nump">255,000<span></span>
</td>
<td class="nump">269,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,662,000<span></span>
</td>
<td class="nump">$ 11,845,000<span></span>
</td>
<td class="nump">$ 9,920,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ensg_StandardBearerEquityPlanMember', window );">Standard Bearer Equity Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,544,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of preferred shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ensg_StandardBearerEquityPlanMember', window );">Standard Bearer Equity Plan | Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Restricted stock awards granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested in the period (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Revolving credit facility with Truist | Truist | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Revolving credit facility with Truist | Truist | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Revolving credit facility with Truist | Truist | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Revolving credit facility with Truist | Truist | Secured Overnight Financing Rate (SOFR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_StandardBearerMasterLeasesMember', window );">Standard Bearer Master Leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms', window );">Lessee leasing arrangements, operating leases, number of renewal terms | renewal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Operating leases of lessee, contingent rentals, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental revenue | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 78,110,000<span></span>
</td>
<td class="nump">$ 66,712,000<span></span>
</td>
<td class="nump">$ 57,967,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_StandardBearerMasterLeasesMember', window );">Standard Bearer Master Leases | Base Management Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_PropertyManagementFeePercentFeeOfTotalRevenues', window );">Management fees, as a percentage of total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ManagementFeeExpense', window );">Management fees | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,707,000<span></span>
</td>
<td class="nump">4,948,000<span></span>
</td>
<td class="nump">$ 4,367,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_StandardBearerMasterLeasesMember', window );">Standard Bearer Master Leases | Incentive Management Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_PropertyManagementFeePercentFeeOfTotalRevenues', window );">Management fees, as a percentage of total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations', window );">Management fees, as a percentage of funds from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_StandardBearerMasterLeasesMember', window );">Standard Bearer Master Leases | Total Management Fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_PropertyManagementFeePercentFeeOfTotalRevenues', window );">Management fees, as a percentage of total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_StandardBearerMasterLeasesMember', window );">Standard Bearer Master Leases | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Operating leases of lessee, contingent rentals, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_StandardBearerMasterLeasesMember', window );">Standard Bearer Master Leases | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">19 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_CareTrustREITMember', window );">CareTrust REIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Operating leases of lessee, contingent rentals, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember', window );">Senior Living Operations | 2022 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember', window );">Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember', window );">Subsidiaries | Senior Living Operations | 2022 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | 2024 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,927,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfOperatingSubsidiaries', window );">Number of operating subsidiaries | subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | 2025 Acquired Properties | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, purchase price | $</a></td>
<td class="nump">$ 50,853,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | 2023 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | 2022 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,656,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Skilled Nursing Operations | 2024 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Skilled Nursing Operations | 2025 Acquired Properties | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Skilled Nursing Operations | 2023 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Skilled Nursing Operations | 2022 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Campus Operations | 2024 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Campus Operations | 2025 Acquired Properties | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Campus Operations | 2023 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries | 2025 Acquired Properties | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries | 2025 Acquired Properties | Subsequent Event | CareTrust REIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries | Skilled Nursing Operations | 2024 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries | Skilled Nursing Operations | 2025 Acquired Properties | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries | Skilled Nursing Operations | 2023 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries | Skilled Nursing Operations | 2022 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries | Campus Operations | 2023 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Third Party Operators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Third Party Operators | Senior Living Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfRealEstatePropertiesSharingLocations', window );">Number of senior living operations sharing property with skilled nursing operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Third Party Operators | Senior Living Operations | 2024 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Previous Subsidiaries | Skilled Nursing Operations | 2022 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfLeaseArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Lease Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfLeaseArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfOperatingSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of operating subsidiaries entered into mortgage loans that are insured with HUD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfOperatingSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfRealEstatePropertiesSharingLocations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Real Estate Properties Sharing Locations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfRealEstatePropertiesSharingLocations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PropertyManagementFeePercentFeeOfFundsFromOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property Management Fee, Percent Fee of Funds from Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PropertyManagementFeePercentFeeOfFundsFromOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PropertyManagementFeePercentFeeOfTotalRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property Management Fee, Percent Fee of Total Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PropertyManagementFeePercentFeeOfTotalRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ManagementFeeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483326/850-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ManagementFeeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ensg_StandardBearerEquityPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ensg_StandardBearerEquityPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ensg_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ensg_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_StandardBearerMasterLeasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_StandardBearerMasterLeasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceBaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ManagementServiceBaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ManagementServiceIncentiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ManagementServiceIncentiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ensg_ManagementServiceTotalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ensg_ManagementServiceTotalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ensg_CareTrustREITMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ensg_CareTrustREITMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_OperatingEntityAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_CampusOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_CampusOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_OperatingEntityAxis=ensg_ThirdPartyOperatorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_OperatingEntityAxis=ensg_ThirdPartyOperatorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_OperatingEntityAxis=ensg_PreviousSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_OperatingEntityAxis=ensg_PreviousSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378867262608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPERATION EXPANSIONS - Narrative (Details)<br></strong></div></th>
<th class="th">
<div>Feb. 05, 2025 </div>
<div>property </div>
<div>bed</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>property </div>
<div>unit </div>
<div>bed</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>property </div>
<div>unit </div>
<div>bed</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>property </div>
<div>unit </div>
<div>bed</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember', window );">Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSkilledNursingBeds', window );">Number of operational skilled nursing beds | bed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSeniorLivingUnits', window );">Number of senior living units | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember', window );">2024 Acquired Properties | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSkilledNursingBeds', window );">Number of operational skilled nursing beds | bed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfLongTermAcuteCareBeds', window );">Long-term acute care beds included within operational skilled nursing beds | bed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSeniorLivingUnits', window );">Number of senior living units | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember', window );">2024 Acquired Properties | Skilled Nursing Operations | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember', window );">2024 Acquired Properties | Skilled Nursing Operations | Standard Bearer Healthcare REIT, Inc. | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember', window );">2024 Acquired Properties | Campus Operations | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember', window );">2024 Acquired Properties | Skilled Nursing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember', window );">2024 Acquired Properties | Campus Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember', window );">2025 Acquired Properties | Standard Bearer Healthcare REIT, Inc. | Subsidiaries | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSkilledNursingBeds', window );">Number of operational skilled nursing beds | bed</a></td>
<td class="nump">682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember', window );">2025 Acquired Properties | Skilled Nursing Operations | Standard Bearer Healthcare REIT, Inc. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember', window );">2025 Acquired Properties | Skilled Nursing Operations | Standard Bearer Healthcare REIT, Inc. | Subsidiaries | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember', window );">2025 Acquired Properties | Campus Operations | Standard Bearer Healthcare REIT, Inc. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember', window );">2025 Acquired Properties | Skilled Nursing Operations | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember', window );">2023 Acquired Properties | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSkilledNursingBeds', window );">Number of operational skilled nursing beds | bed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,483<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSeniorLivingUnits', window );">Number of senior living units | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember', window );">2023 Acquired Properties | Skilled Nursing Operations | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember', window );">2023 Acquired Properties | Skilled Nursing Operations | Standard Bearer Healthcare REIT, Inc. | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember', window );">2023 Acquired Properties | Campus Operations | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember', window );">2023 Acquired Properties | Campus Operations | Standard Bearer Healthcare REIT, Inc. | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember', window );">2023 Acquired Properties | Skilled Nursing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember', window );">2023 Acquired Properties | Campus Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember', window );">2022 Acquired Properties | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSkilledNursingBeds', window );">Number of operational skilled nursing beds | bed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfSeniorLivingUnits', window );">Number of senior living units | unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">674<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember', window );">2022 Acquired Properties | Skilled Nursing Operations | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember', window );">2022 Acquired Properties | Skilled Nursing Operations | Standard Bearer Healthcare REIT, Inc. | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember', window );">2022 Acquired Properties | Senior Living Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember', window );">2022 Acquired Properties | Senior Living Operations | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember', window );">2022 Acquired Properties | Skilled Nursing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember', window );">2022 Acquired Properties | Campus Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfLongTermAcuteCareBeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Long-Term Acute Care Beds</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfLongTermAcuteCareBeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfSeniorLivingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operational Assisted Living and Independent Living Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfSeniorLivingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfSkilledNursingBeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of skilled nursing beds available for use at a skilled nursing facility</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfSkilledNursingBeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_OperatingEntityAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_CampusOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_CampusOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RealEstateAndLeaseArrangementsAxis=ensg_SkilledNursingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RealEstateAndLeaseArrangementsAxis=ensg_SkilledNursingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RealEstateAndLeaseArrangementsAxis=ensg_CampusOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RealEstateAndLeaseArrangementsAxis=ensg_CampusOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2022AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378863630208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPERATION EXPANSIONS - Purchase Price Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill</a></td>
<td class="nump">$ 21,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_BusinessAndAssetAcquisitionsAxis=ensg_AcquiredPropertiesMember', window );">Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill</a></td>
<td class="nump">21,112<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeasedAssetsAcquiredDuringPeriod', window );">Leased asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Other indefinite-lived intangible assets</a></td>
<td class="nump">364<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet', window );">TOTAL ACQUISITIONS</a></td>
<td class="nump">154,879<span></span>
</td>
<td class="nump">67,798<span></span>
</td>
<td class="nump">101,136<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_BusinessAndAssetAcquisitionsAxis=ensg_AcquiredPropertiesMember', window );">Acquired Properties | Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment</a></td>
<td class="nump">20,547<span></span>
</td>
<td class="nump">7,794<span></span>
</td>
<td class="nump">15,527<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_BusinessAndAssetAcquisitionsAxis=ensg_AcquiredPropertiesMember', window );">Acquired Properties | Building and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment</a></td>
<td class="nump">108,709<span></span>
</td>
<td class="nump">57,488<span></span>
</td>
<td class="nump">65,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_BusinessAndAssetAcquisitionsAxis=ensg_AcquiredPropertiesMember', window );">Acquired Properties | Equipment, furniture, and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment</a></td>
<td class="nump">2,937<span></span>
</td>
<td class="nump">1,840<span></span>
</td>
<td class="nump">1,618<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_BusinessAndAssetAcquisitionsAxis=ensg_AcquiredPropertiesMember', window );">Acquired Properties | Assembled occupancy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Property, plant and equipment</a></td>
<td class="nump">$ 1,210<span></span>
</td>
<td class="nump">$ 346<span></span>
</td>
<td class="nump">$ 367<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination And Asset Acquisition, Assets Acquired And Liabilities Assumed, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeasedAssetsAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Leased Assets, Acquired During Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeasedAssetsAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_BusinessAndAssetAcquisitionsAxis=ensg_AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_BusinessAndAssetAcquisitionsAxis=ensg_AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ensg_AssembledOccupancyAcquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ensg_AssembledOccupancyAcquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874393872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>segment </div>
<div>property</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember', window );">Skilled Services | Skilled Nursing Operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember', window );">Skilled Services | Campus Operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=ensg_StandardBearerSegmentMember', window );">Standard Bearer</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">124<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All Other | Campus Operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All Other | Senior Living Operations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RealEstateAndLeaseArrangementsAxis=ensg_SkilledNursingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RealEstateAndLeaseArrangementsAxis=ensg_SkilledNursingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RealEstateAndLeaseArrangementsAxis=ensg_CampusOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RealEstateAndLeaseArrangementsAxis=ensg_CampusOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ensg_StandardBearerSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ensg_StandardBearerSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_RealEstateAndLeaseArrangementsAxis=ensg_SeniorLivingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_RealEstateAndLeaseArrangementsAxis=ensg_SeniorLivingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871563232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS - Schedule of Segment Financial Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">$ 4,260,485<span></span>
</td>
<td class="nump">$ 3,729,355<span></span>
</td>
<td class="nump">$ 3,025,468<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">84,138<span></span>
</td>
<td class="nump">72,387<span></span>
</td>
<td class="nump">62,355<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="nump">8,286<span></span>
</td>
<td class="nump">8,087<span></span>
</td>
<td class="nump">8,931<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">386,094<span></span>
</td>
<td class="nump">272,762<span></span>
</td>
<td class="nump">289,089<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">4,237,525<span></span>
</td>
<td class="nump">3,708,071<span></span>
</td>
<td class="nump">3,008,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ensg_RentalMember', window );">Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">22,960<span></span>
</td>
<td class="nump">21,284<span></span>
</td>
<td class="nump">16,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">4,171,911<span></span>
</td>
<td class="nump">3,661,341<span></span>
</td>
<td class="nump">2,979,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_SegmentIncomeLoss', window );">Segment income (loss)</a></td>
<td class="nump">547,798<span></span>
</td>
<td class="nump">493,990<span></span>
</td>
<td class="nump">436,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">4,076,825<span></span>
</td>
<td class="nump">3,578,855<span></span>
</td>
<td class="nump">2,906,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">95,086<span></span>
</td>
<td class="nump">82,486<span></span>
</td>
<td class="nump">72,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Skilled Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">4,076,825<span></span>
</td>
<td class="nump">3,578,855<span></span>
</td>
<td class="nump">2,906,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">3,513,167<span></span>
</td>
<td class="nump">3,075,164<span></span>
</td>
<td class="nump">2,464,259<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">45,195<span></span>
</td>
<td class="nump">38,766<span></span>
</td>
<td class="nump">33,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_SegmentIncomeLoss', window );">Segment income (loss)</a></td>
<td class="nump">518,463<span></span>
</td>
<td class="nump">464,925<span></span>
</td>
<td class="nump">408,732<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Skilled Services | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">4,076,825<span></span>
</td>
<td class="nump">3,578,855<span></span>
</td>
<td class="nump">2,906,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Skilled Services | Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Standard Bearer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">95,086<span></span>
</td>
<td class="nump">82,486<span></span>
</td>
<td class="nump">72,937<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">9,152<span></span>
</td>
<td class="nump">8,455<span></span>
</td>
<td class="nump">7,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">29,297<span></span>
</td>
<td class="nump">25,205<span></span>
</td>
<td class="nump">21,613<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="nump">27,302<span></span>
</td>
<td class="nump">19,761<span></span>
</td>
<td class="nump">15,707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_SegmentIncomeLoss', window );">Segment income (loss)</a></td>
<td class="nump">29,335<span></span>
</td>
<td class="nump">29,065<span></span>
</td>
<td class="nump">27,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Standard Bearer | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Standard Bearer | Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">95,086<span></span>
</td>
<td class="nump">82,486<span></span>
</td>
<td class="nump">72,937<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember', window );">Intercompany Elimination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="num">(104,307)<span></span>
</td>
<td class="num">(87,790)<span></span>
</td>
<td class="num">(76,294)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="num">(104,307)<span></span>
</td>
<td class="num">(87,790)<span></span>
</td>
<td class="num">(76,294)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(20,285)<span></span>
</td>
<td class="num">(12,902)<span></span>
</td>
<td class="num">(8,646)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember', window );">Intercompany Elimination | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="num">(20,366)<span></span>
</td>
<td class="num">(15,451)<span></span>
</td>
<td class="num">(12,718)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember', window );">Intercompany Elimination | Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="num">(83,941)<span></span>
</td>
<td class="num">(72,339)<span></span>
</td>
<td class="num">(63,576)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">192,881<span></span>
</td>
<td class="nump">155,804<span></span>
</td>
<td class="nump">122,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_SegmentIncomeLoss', window );">Segment income (loss)</a></td>
<td class="num">(161,704)<span></span>
</td>
<td class="num">(221,228)<span></span>
</td>
<td class="num">(147,514)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">181,066<span></span>
</td>
<td class="nump">144,667<span></span>
</td>
<td class="nump">115,214<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Other | Rental revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">TOTAL REVENUE</a></td>
<td class="nump">$ 11,815<span></span>
</td>
<td class="nump">$ 11,137<span></span>
</td>
<td class="nump">$ 7,396<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_SegmentIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segment Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_SegmentIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ensg_RentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ensg_RentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ensg_StandardBearerSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ensg_StandardBearerSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378861371648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS - Schedule of Service Revenue by Major Payor Source (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">$ 4,260,485<span></span>
</td>
<td class="nump">$ 3,729,355<span></span>
</td>
<td class="nump">$ 3,025,468<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">4,171,911<span></span>
</td>
<td class="nump">3,661,341<span></span>
</td>
<td class="nump">2,979,152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Skilled Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">4,076,825<span></span>
</td>
<td class="nump">3,578,855<span></span>
</td>
<td class="nump">2,906,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">4,237,525<span></span>
</td>
<td class="nump">3,708,071<span></span>
</td>
<td class="nump">3,008,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Total Medicaid and Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">3,004,308<span></span>
</td>
<td class="nump">2,690,861<span></span>
</td>
<td class="nump">2,216,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">1,682,344<span></span>
</td>
<td class="nump">1,459,449<span></span>
</td>
<td class="nump">1,183,156<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">1,055,226<span></span>
</td>
<td class="nump">985,749<span></span>
</td>
<td class="nump">832,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Medicaid-skilled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">266,738<span></span>
</td>
<td class="nump">245,663<span></span>
</td>
<td class="nump">200,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">789,643<span></span>
</td>
<td class="nump">666,129<span></span>
</td>
<td class="nump">525,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">$ 443,574<span></span>
</td>
<td class="nump">$ 351,081<span></span>
</td>
<td class="nump">$ 266,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Total Medicaid and Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">70.90%<span></span>
</td>
<td class="nump">72.60%<span></span>
</td>
<td class="nump">73.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">39.70%<span></span>
</td>
<td class="nump">39.40%<span></span>
</td>
<td class="nump">39.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">24.90%<span></span>
</td>
<td class="nump">26.60%<span></span>
</td>
<td class="nump">27.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Medicaid-skilled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
<td class="nump">6.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">18.60%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">17.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Revenue | Customer Concentration Risk | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="nump">9.40%<span></span>
</td>
<td class="nump">8.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">$ 4,076,825<span></span>
</td>
<td class="nump">$ 3,578,855<span></span>
</td>
<td class="nump">$ 2,906,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Operating Segments | Skilled Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">4,076,825<span></span>
</td>
<td class="nump">3,578,855<span></span>
</td>
<td class="nump">2,906,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Operating Segments | Skilled Services | Total Medicaid and Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">2,968,386<span></span>
</td>
<td class="nump">2,660,885<span></span>
</td>
<td class="nump">2,191,347<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Operating Segments | Skilled Services | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">1,646,422<span></span>
</td>
<td class="nump">1,429,473<span></span>
</td>
<td class="nump">1,158,309<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Operating Segments | Skilled Services | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">1,055,226<span></span>
</td>
<td class="nump">985,749<span></span>
</td>
<td class="nump">832,160<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Operating Segments | Skilled Services | Medicaid-skilled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">266,738<span></span>
</td>
<td class="nump">245,663<span></span>
</td>
<td class="nump">200,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Operating Segments | Skilled Services | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">789,643<span></span>
</td>
<td class="nump">666,129<span></span>
</td>
<td class="nump">525,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | Operating Segments | Skilled Services | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">318,796<span></span>
</td>
<td class="nump">251,841<span></span>
</td>
<td class="nump">189,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">160,700<span></span>
</td>
<td class="nump">129,216<span></span>
</td>
<td class="nump">102,496<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | All Other | Total Medicaid and Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">35,922<span></span>
</td>
<td class="nump">29,976<span></span>
</td>
<td class="nump">24,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | All Other | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">35,922<span></span>
</td>
<td class="nump">29,976<span></span>
</td>
<td class="nump">24,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | All Other | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | All Other | Medicaid-skilled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | All Other | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service revenue | All Other | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems', window );"><strong>Segment Reporting, Revenue Reconciling Item [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total Service Revenue</a></td>
<td class="nump">$ 124,778<span></span>
</td>
<td class="nump">$ 99,240<span></span>
</td>
<td class="nump">$ 77,649<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingRevenueReconcilingItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingRevenueReconcilingItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidAndMedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidAndMedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidSkilledMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidSkilledMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_ManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_ManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_PrivatePayAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_PrivatePayAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=ensg_EliminationsAndReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=ensg_EliminationsAndReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378875094320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT&#8212; NET - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 1,750,842<span></span>
</td>
<td class="nump">$ 1,487,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(459,488)<span></span>
</td>
<td class="num">(396,242)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="nump">1,291,354<span></span>
</td>
<td class="nump">1,090,771<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">162,873<span></span>
</td>
<td class="nump">142,656<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember', window );">Buildings and improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">933,790<span></span>
</td>
<td class="nump">803,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">212,603<span></span>
</td>
<td class="nump">172,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">396,018<span></span>
</td>
<td class="nump">339,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">4,349<span></span>
</td>
<td class="nump">4,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment</a></td>
<td class="nump">$ 41,209<span></span>
</td>
<td class="nump">$ 25,563<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingAndBuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378880117584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT&#8212; NET - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment', window );">Sales price on sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,607,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on sale of assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,467,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long lived assets</a></td>
<td class="nump">$ 1,849,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Cost of services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378867956288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS &#8212; NET - Schedule of Finite Lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 7,306<span></span>
</td>
<td class="nump">$ 6,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(4,680)<span></span>
</td>
<td class="num">(3,873)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,626<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ensg_AssembledOccupancyAcquiredMember', window );">Assembled occupancy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life (Years)</a></td>
<td class="text">4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,991<span></span>
</td>
<td class="nump">781<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,316)<span></span>
</td>
<td class="num">(742)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 675<span></span>
</td>
<td class="nump">39<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Facility trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life (Years)</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 733<span></span>
</td>
<td class="nump">733<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(462)<span></span>
</td>
<td class="num">(439)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 271<span></span>
</td>
<td class="nump">294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted Average Life (Years)</a></td>
<td class="text">18 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 4,582<span></span>
</td>
<td class="nump">4,582<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2,902)<span></span>
</td>
<td class="num">(2,692)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 1,680<span></span>
</td>
<td class="nump">$ 1,890<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ensg_AssembledOccupancyAcquiredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=ensg_AssembledOccupancyAcquiredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868171984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS &#8212; NET - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 2,019,000<span></span>
</td>
<td class="nump">$ 1,790,000<span></span>
</td>
<td class="nump">$ 1,714,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Impairment charge to intangible assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ensg_MedicareAndMedicaidLicensesMember', window );">Medicare and Medicaid licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired', window );">Indefinite-lived intangible assets acquired</a></td>
<td class="nump">364,000<span></span>
</td>
<td class="nump">330,000<span></span>
</td>
<td class="nump">245,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ensg_DepreciationAndAmortizationMember', window );">Depreciation and Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 1,212,000<span></span>
</td>
<td class="nump">$ 1,202,000<span></span>
</td>
<td class="nump">$ 1,160,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefinitelivedIntangibleAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefinitelivedIntangibleAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ensg_MedicareAndMedicaidLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ensg_MedicareAndMedicaidLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ensg_DepreciationAndAmortizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ensg_DepreciationAndAmortizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378861384400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTANGIBLE ASSETS &#8212; NET - Schedule of Estimated Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 911<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 2,626<span></span>
</td>
<td class="nump">$ 2,223<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868707760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INTANGIBLE ASSETS &#8212; NET - Schedule of Indefinite-lived Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite-lived intangibles</a></td>
<td class="nump">$ 4,666<span></span>
</td>
<td class="nump">$ 4,302<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite-lived intangibles</a></td>
<td class="nump">889<span></span>
</td>
<td class="nump">889<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ensg_MedicareAndMedicaidLicensesMember', window );">Medicare and Medicaid licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite-lived intangibles</a></td>
<td class="nump">$ 3,777<span></span>
</td>
<td class="nump">$ 3,413<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ensg_MedicareAndMedicaidLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=ensg_MedicareAndMedicaidLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871364496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL - Schedule of Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 76,869<span></span>
</td>
<td class="nump">$ 76,869<span></span>
</td>
<td class="nump">$ 60,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">21,112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">97,981<span></span>
</td>
<td class="nump">76,869<span></span>
</td>
<td class="nump">76,869<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Skilled Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">67,886<span></span>
</td>
<td class="nump">67,886<span></span>
</td>
<td class="nump">51,486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">20,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">88,626<span></span>
</td>
<td class="nump">67,886<span></span>
</td>
<td class="nump">67,886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember', window );">All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">8,983<span></span>
</td>
<td class="nump">8,983<span></span>
</td>
<td class="nump">8,983<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 9,355<span></span>
</td>
<td class="nump">$ 8,983<span></span>
</td>
<td class="nump">$ 8,983<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=ensg_SkilledServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871337728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss', window );">Cumulative goodwill impairment losses</a></td>
<td class="nump">$ 7,410,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairedAccumulatedImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairedAccumulatedImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874529424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_QualityAssuranceFee', window );">Quality assurance fee</a></td>
<td class="nump">$ 12,667<span></span>
</td>
<td class="nump">$ 14,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ResidentRefundsPayable', window );">Refunds payable</a></td>
<td class="nump">56,755<span></span>
</td>
<td class="nump">51,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Resident advances</a></td>
<td class="nump">18,818<span></span>
</td>
<td class="nump">10,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_CashHeldInTrustForResidents', window );">Cash held in trust for patients</a></td>
<td class="nump">6,370<span></span>
</td>
<td class="nump">6,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">3,589<span></span>
</td>
<td class="nump">3,396<span></span>
</td>
<td class="nump">$ 3,201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent', window );">Property taxes</a></td>
<td class="nump">15,400<span></span>
</td>
<td class="nump">12,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationReserveCurrent', window );">Accrued litigation</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">51,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">18,458<span></span>
</td>
<td class="nump">17,891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">OTHER ACCRUED LIABILITIES</a></td>
<td class="nump">$ 132,057<span></span>
</td>
<td class="nump">$ 168,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_CashHeldInTrustForResidents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash held in trust for residents reflects monies received from, or on behalf of, residents. Maintaining a trust account for residents is a regulatory requirement and, while the trust assets offset the liability, the Company assumes a fiduciary responsibility for these funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_CashHeldInTrustForResidents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_QualityAssuranceFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Quality assurance fee represents amounts payable to California, Utah, Idaho, Washington, Colorado, Iowa, and Nebraska in respect of a mandated fee based on resident days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_QualityAssuranceFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ResidentRefundsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Resident refunds payable includes amounts due to residents for overpayments and duplicate payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ResidentRefundsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 405<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478790/946-405-45-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871411584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 70,144<span></span>
</td>
<td class="nump">$ 73,092<span></span>
</td>
<td class="nump">$ 56,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">16,857<span></span>
</td>
<td class="nump">17,301<span></span>
</td>
<td class="nump">14,216<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense (benefit)</a></td>
<td class="nump">87,001<span></span>
</td>
<td class="nump">90,393<span></span>
</td>
<td class="nump">70,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">582<span></span>
</td>
<td class="num">(22,280)<span></span>
</td>
<td class="num">(5,158)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="nump">53<span></span>
</td>
<td class="num">(5,201)<span></span>
</td>
<td class="num">(1,338)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Total deferred income tax expense (benefit)</a></td>
<td class="nump">635<span></span>
</td>
<td class="num">(27,481)<span></span>
</td>
<td class="num">(6,496)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 87,636<span></span>
</td>
<td class="nump">$ 62,912<span></span>
</td>
<td class="nump">$ 64,437<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378866366944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax expense at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes&#160;- net of federal benefit</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Non-deductible expenses</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent', window );">Equity compensation</a></td>
<td class="num">(3.30%)<span></span>
</td>
<td class="num">(4.20%)<span></span>
</td>
<td class="num">(3.60%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other adjustments</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">TOTAL INCOME TAX PROVISION</a></td>
<td class="nump">22.70%<span></span>
</td>
<td class="nump">23.10%<span></span>
</td>
<td class="nump">22.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.1.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -SubTopic 740<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479176/718-740-35-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378975878864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">22.70%<span></span>
</td>
<td class="nump">23.10%<span></span>
</td>
<td class="nump">22.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">$ 597<span></span>
</td>
<td class="nump">$ 1,192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 93<span></span>
</td>
<td class="nump">$ 789<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868191328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">$ 76,419<span></span>
</td>
<td class="nump">$ 81,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Revenue related reserves</a></td>
<td class="nump">27,023<span></span>
</td>
<td class="nump">23,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">597<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance', window );">Insurance</a></td>
<td class="nump">24,817<span></span>
</td>
<td class="nump">16,864<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">470,313<span></span>
</td>
<td class="nump">444,590<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">599,169<span></span>
</td>
<td class="nump">567,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(789)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">TOTAL DEFERRED TAX ASSETS</a></td>
<td class="nump">599,076<span></span>
</td>
<td class="nump">567,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_DeferredTaxLiabilitiesStateTaxes', window );">State taxes</a></td>
<td class="num">(197)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Depreciation and amortization</a></td>
<td class="num">(57,253)<span></span>
</td>
<td class="num">(52,334)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(6,390)<span></span>
</td>
<td class="num">(4,113)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_DeferredTaxLiabilitiesRightOfUseAsset', window );">Right-of-use asset</a></td>
<td class="num">(468,955)<span></span>
</td>
<td class="num">(443,222)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">TOTAL DEFERRED TAX LIABILITIES</a></td>
<td class="num">(532,795)<span></span>
</td>
<td class="num">(499,949)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">NET DEFERRED TAX ASSETS</a></td>
<td class="nump">$ 66,281<span></span>
</td>
<td class="nump">$ 67,124<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax, Deferred Expense, Reserves And Accruals, Lease Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_DeferredTaxLiabilitiesRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_DeferredTaxLiabilitiesRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_DeferredTaxLiabilitiesStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, State Taxes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_DeferredTaxLiabilitiesStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated losses under self insurance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378867207936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Schedule of Long-term Debt (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: current maturities</a></td>
<td class="num">$ (4,086)<span></span>
</td>
<td class="num">$ (3,950)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: debt issuance costs, net</a></td>
<td class="num">(2,767)<span></span>
</td>
<td class="num">(2,941)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">LONG-TERM DEBT LESS CURRENT MATURITIES</a></td>
<td class="nump">141,585<span></span>
</td>
<td class="nump">145,497<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Mortgage loans and promissory note</a></td>
<td class="nump">$ 148,438<span></span>
</td>
<td class="nump">$ 152,388<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378869817728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Credit Facility with a Lending Consortium Arranged by Truist (Details) - Revolving credit facility with Truist - Truist<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_TotalNetDebtRatioMaximum', window );">Total net debt ratio, maximum</a></td>
<td class="nump">3.75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod', window );">Long-term debt threshold for EBITDA ratio increase election period</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection', window );">Long-term debt, threshold for EBITDA ratio increase election</a></td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection', window );">Total net debt ratio, maximum after increase election</a></td>
<td class="nump">4.25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_TotalNetDebtRatioMinimum', window );">Total net debt ratio, minimum</a></td>
<td class="nump">1.50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding debt</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Line of credit facility, unused capacity, commitment fee percentage</a></td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Line of credit facility, unused capacity, commitment fee percentage</a></td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Base Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="nump">0.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Base Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Secured Overnight Financing Rate (SOFR) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="nump">1.25%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Secured Overnight Financing Rate (SOFR) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Interest rate margin</a></td>
<td class="nump">2.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-Term Debt, Threshold For EBITDA Ratio Increase Election</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long Term Debt Threshold For EBITDA Ratio Increase Election Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_TotalNetDebtRatioMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Net Debt Ratio, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_TotalNetDebtRatioMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_TotalNetDebtRatioMaximumAfterIncreaseElection">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Net Debt Ratio, Maximum After Increase Election</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_TotalNetDebtRatioMaximumAfterIncreaseElection</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_TotalNetDebtRatioMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Net Debt Ratio, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_TotalNetDebtRatioMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=ensg_TruistBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=ensg_TruistBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378863750096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Mortgage Loans and Promissory Notes and Off-Balance Sheet Arrangements (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>subsidiary</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, pledged amount</a></td>
<td class="nump">$ 27,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Letter of credit increase</a></td>
<td class="nump">21,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding debt</a></td>
<td class="nump">$ 148,438<span></span>
</td>
<td class="nump">$ 152,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note | HUD Insured Mortgages | First Three Years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_PrepaymentPenalty', window );">Prepayment penalty</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note | HUD Insured Mortgages | In The Fourth Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ReductionInPrepaymentPenalty', window );">Reduction in prepayment penalty</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note | HUD Insured Mortgages | Years Five Through Ten</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ReductionInPrepaymentPenalty', window );">Reduction in prepayment penalty</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note | HUD Insured Mortgages | After Year Ten</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_PrepaymentPenalty', window );">Prepayment penalty</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note | HUD Insured Mortgages | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="nump">3.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">2.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">25 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note | HUD Insured Mortgages | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Debt instrument, interest rate, effective percentage</a></td>
<td class="nump">4.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">35 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note | HUD Insured Mortgages | Twenty Three Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfOperatingSubsidiaries', window );">Number of operating subsidiaries | subsidiary</a></td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding debt</a></td>
<td class="nump">$ 146,898<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember', window );">Mortgage loans and promissory note | 5.3% Promissory Note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding debt</a></td>
<td class="nump">$ 1,540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt instrument, interest rate, stated percentage</a></td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument, term</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfOperatingSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of operating subsidiaries entered into mortgage loans that are insured with HUD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfOperatingSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PrepaymentPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage that the prepayment penalty percentage is reduced during the first three years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PrepaymentPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ReductionInPrepaymentPenalty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage that the prepayment penalty percentage is reduced during the fourth year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ReductionInPrepaymentPenalty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_CollateralizedDebtObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ensg_HUDInsuredMortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ensg_HUDInsuredMortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PrepaymentFeePeriodAxis=ensg_FirstThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PrepaymentFeePeriodAxis=ensg_FirstThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PrepaymentFeePeriodAxis=ensg_InTheFourthYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PrepaymentFeePeriodAxis=ensg_InTheFourthYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PrepaymentFeePeriodAxis=ensg_YearsFiveThroughTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PrepaymentFeePeriodAxis=ensg_YearsFiveThroughTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_PrepaymentFeePeriodAxis=ensg_AfterYearTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_PrepaymentFeePeriodAxis=ensg_AfterYearTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ensg_TwentyThreeSubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ensg_TwentyThreeSubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=ensg_A53PromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=ensg_A53PromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378977908528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Long-term Debt Arrangements (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 4,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2026</a></td>
<td class="nump">4,227<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2027</a></td>
<td class="nump">3,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2028</a></td>
<td class="nump">3,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2029</a></td>
<td class="nump">3,896<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">128,553<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total long-term debt</a></td>
<td class="nump">$ 148,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378861326480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Stock Options, Narrative (Details)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>plan </div>
<div>installment </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfStockIncentivePlans', window );">Number of stock incentive plans | plan</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate', window );">Forfeiture rate</a></td>
<td class="nump">4.86%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue', window );">Grant date intrinsic value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised in period | $</a></td>
<td class="nump">$ 60,358<span></span>
</td>
<td class="nump">$ 56,186<span></span>
</td>
<td class="nump">$ 47,441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested', window );">Aggregate intrinsic value of options that vested in period | $</a></td>
<td class="nump">$ 37,700<span></span>
</td>
<td class="nump">$ 31,658<span></span>
</td>
<td class="nump">$ 27,955<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ensg_A2022PlanMember', window );">2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares) | shares</a></td>
<td class="nump">3,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability', window );">Conversion to reduce shares availability</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability', window );">Other than options, conversion to reduce shares availability</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares) | shares</a></td>
<td class="nump">346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ensg_A2022PlanMember', window );">2022 Plan | Non-employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments', window );">Number of installments | installment</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1', window );">Award requisite service period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfStockIncentivePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Stock Incentive Plans</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfStockIncentivePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Award, Options, Fair Value, Assumptions Forfeiture Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Conversion To Reduce Shares Availability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Conversion To Reduce Shares Availability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ensg_A2022PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ensg_A2022PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378989314784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Schedule of Assumptions for Stock Options Granted (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Weighted Average Risk-Free Rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">2.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Life</a></td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Weighted Average Volatility</a></td>
<td class="nump">40.50%<span></span>
</td>
<td class="nump">41.30%<span></span>
</td>
<td class="nump">42.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Weighted Average Dividend Yield</a></td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378879949056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">581<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 132.46<span></span>
</td>
<td class="nump">$ 95.05<span></span>
</td>
<td class="nump">$ 85.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted Average Fair Value of Options (in dollars per share)</a></td>
<td class="nump">$ 60.37<span></span>
</td>
<td class="nump">$ 43.85<span></span>
</td>
<td class="nump">$ 37.83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378871229280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Schedule of Employee Stock Option Roll Forward (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period, (in shares)</a></td>
<td class="nump">3,991<span></span>
</td>
<td class="nump">3,833<span></span>
</td>
<td class="nump">4,038<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">704<span></span>
</td>
<td class="nump">1,008<span></span>
</td>
<td class="nump">581<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(91)<span></span>
</td>
<td class="num">(98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(632)<span></span>
</td>
<td class="num">(759)<span></span>
</td>
<td class="num">(688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period, (in shares)</a></td>
<td class="nump">3,987<span></span>
</td>
<td class="nump">3,991<span></span>
</td>
<td class="nump">3,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 62.65<span></span>
</td>
<td class="nump">$ 46.72<span></span>
</td>
<td class="nump">$ 36.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">132.46<span></span>
</td>
<td class="nump">95.05<span></span>
</td>
<td class="nump">85.74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">86.92<span></span>
</td>
<td class="nump">71.44<span></span>
</td>
<td class="nump">59.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">35.28<span></span>
</td>
<td class="nump">24.21<span></span>
</td>
<td class="nump">18.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (in dollars per share)</a></td>
<td class="nump">$ 78.84<span></span>
</td>
<td class="nump">$ 62.65<span></span>
</td>
<td class="nump">$ 46.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of Options Vested (in shares)</a></td>
<td class="nump">1,895<span></span>
</td>
<td class="nump">1,887<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
<td class="nump">2,183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted Average Exercise Price of Options Vested (in dollars per share)</a></td>
<td class="nump">$ 52.64<span></span>
</td>
<td class="nump">$ 39.58<span></span>
</td>
<td class="nump">$ 28.87<span></span>
</td>
<td class="nump">$ 21.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378861176720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Options Outstanding by Exercise Price (Details)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">3,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 136,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">1,895<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeOneMember', window );">2015</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 18.20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 21.39<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeTwoMember', window );">2016</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeThreeMember', window );">2017</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.41<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 867<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeFourMember', window );">2018</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 22.49<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 32.71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 2,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeFiveMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 41.07<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 45.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 6,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeSixMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 44.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 59.49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 8,020<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeSevenMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 73.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 83.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 15,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">251<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeEightMember', window );">2022</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 79.79<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 94.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 18,601<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeNineMember', window );">2023</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 89.83<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 98.83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 41,753<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeTenMember', window );">2024</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Exercise price, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 119.19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Exercise price, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 146.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Number outstanding (in shares)</a></td>
<td class="nump">696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue', window );">Black-Scholes Fair Value | $</a></td>
<td class="nump">$ 42,024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Remaining Contractual Life (Years)</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Stock options vested and exercisable (in shares)</a></td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value determined using a black-scholes model for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeEightMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeEightMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeNineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeNineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeTenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=ensg_ExercisePriceRangeTenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378860878192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Schedule of Aggregate Intrinsic Value of Options (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 219,309<span></span>
</td>
<td class="nump">$ 197,819<span></span>
</td>
<td class="nump">$ 183,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Vested</a></td>
<td class="nump">152,011<span></span>
</td>
<td class="nump">137,048<span></span>
</td>
<td class="nump">136,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue', window );">Expected to vest</a></td>
<td class="nump">$ 63,243<span></span>
</td>
<td class="nump">$ 56,759<span></span>
</td>
<td class="nump">$ 43,232<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874282048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Restricted Stock Awards, Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice', window );">Share-based compensation, restricted awards, exercise price (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 131.26<span></span>
</td>
<td class="nump">$ 92.04<span></span>
</td>
<td class="nump">$ 81.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Annual bonuses settled in vested awards</a></td>
<td class="nump">$ 6,165<span></span>
</td>
<td class="nump">$ 5,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Non-employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 116.65<span></span>
</td>
<td class="nump">$ 89.83<span></span>
</td>
<td class="nump">73.17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Minimum | Non-employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">116.65<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">149.12<span></span>
</td>
<td class="nump">$ 98.31<span></span>
</td>
<td class="nump">$ 94.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock Awards | Maximum | Non-employee Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 149.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Bonuses, Included In Equity Instruments Other Than Options, Grants In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Restricted Awards, Exercise Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45379069904400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Schedule of Nonvested Restricted Stock Awards (Details) - Restricted Stock Awards - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-Vested Restricted Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares)</a></td>
<td class="nump">431<span></span>
</td>
<td class="nump">487<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">232<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="nump">233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(215)<span></span>
</td>
<td class="num">(255)<span></span>
</td>
<td class="num">(269)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares)</a></td>
<td class="nump">435<span></span>
</td>
<td class="nump">431<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 78.91<span></span>
</td>
<td class="nump">$ 64.92<span></span>
</td>
<td class="nump">$ 52.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">131.26<span></span>
</td>
<td class="nump">92.04<span></span>
</td>
<td class="nump">81.57<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">86.97<span></span>
</td>
<td class="nump">64.21<span></span>
</td>
<td class="nump">54.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">83.12<span></span>
</td>
<td class="nump">71.53<span></span>
</td>
<td class="nump">57.29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in dollars per share)</a></td>
<td class="nump">$ 102.71<span></span>
</td>
<td class="nump">$ 78.91<span></span>
</td>
<td class="nump">$ 64.92<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868229600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Long-Term Incentive Plan, Narrative (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 27, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 36,183<span></span>
</td>
<td class="nump">$ 30,754<span></span>
</td>
<td class="nump">$ 22,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_SpinoffMember', window );">Spinoff | 2019 LTI Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Number of shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 546<span></span>
</td>
<td class="nump">$ 827<span></span>
</td>
<td class="nump">$ 836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_SpinoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_SpinoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ensg_A2019LTIPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ensg_A2019LTIPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874945584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - Schedule of Stock-Based Compensation Expense (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense related to stock options</a></td>
<td class="nump">$ 36,183<span></span>
</td>
<td class="nump">$ 30,754<span></span>
</td>
<td class="nump">$ 22,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Share-based compensation, options outstanding, weighted average remaining contractual term</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock-based compensation expense related to stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense related to stock options</a></td>
<td class="nump">$ 22,439<span></span>
</td>
<td class="nump">17,221<span></span>
</td>
<td class="nump">11,361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based compensation, nonvested awards, cost not yet recognized</a></td>
<td class="nump">$ 84,914<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based compensation, nonvested awards, cost not yet recognized, period for recognition</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards', window );">Share-based compensation, nonvested awards (in shares)</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber', window );">Share-based compensation, options expected to vest, number (in shares)</a></td>
<td class="nump">1,925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Stock-based compensation expense related to restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense related to stock options</a></td>
<td class="nump">$ 11,662<span></span>
</td>
<td class="nump">11,845<span></span>
</td>
<td class="nump">9,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based compensation, nonvested awards, cost not yet recognized</a></td>
<td class="nump">$ 38,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based compensation, nonvested awards, cost not yet recognized, period for recognition</a></td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=ensg_OtherStockAwardsMember', window );">Stock-based compensation expense related to restricted stock awards to non-employee directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock-based compensation expense related to stock options</a></td>
<td class="nump">$ 2,082<span></span>
</td>
<td class="nump">$ 1,688<span></span>
</td>
<td class="nump">$ 1,439<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_EmployeeServiceShareBasedCompensationNonvestedAwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Nonvested Awards</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_EmployeeServiceShareBasedCompensationNonvestedAwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>As of the balance sheet date, the number of shares which are expected to vest into stock options outstanding can be converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=ensg_OtherStockAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=ensg_OtherStockAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378861149808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Lessee Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 05, 2025 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>property </div>
<div>agreement </div>
<div>renewal </div>
<div>subsidiary </div>
<div>lease</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase (decrease) in lease liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 287<span></span>
</td>
<td class="num">$ (6,564)<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating lease, weighted average remaining lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 years 6 months<span></span>
</td>
<td class="text">14 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating lease, weighted average discount rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember', window );">Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ensg_CostofSalesandGeneralandAdministrativeExpenseMember', window );">Cost of Sales and General and Administrative Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 216,716<span></span>
</td>
<td class="nump">$ 197,856<span></span>
</td>
<td class="nump">153,174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember', window );">Standard Bearer Healthcare REIT, Inc. | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember', window );">2024 Acquired Properties | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, purchase price | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 131,927<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember', window );">2025 Acquired Properties | Standard Bearer Healthcare REIT, Inc. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, purchase price | $</a></td>
<td class="nump">$ 50,853<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember', window );">2025 Acquired Properties | Standard Bearer Healthcare REIT, Inc. | Subsequent Event | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember', window );">Skilled Nursing Operations | 2024 Acquired Properties | Standard Bearer Healthcare REIT, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember', window );">Skilled Nursing Operations | 2024 Acquired Properties | Standard Bearer Healthcare REIT, Inc. | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember', window );">Skilled Nursing Operations | 2025 Acquired Properties | Standard Bearer Healthcare REIT, Inc. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember', window );">Skilled Nursing Operations | 2025 Acquired Properties | Standard Bearer Healthcare REIT, Inc. | Subsequent Event | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_CareTrustREITMember', window );">CareTrust REIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LesseeOperatingLeaseConsumerPriceIndex', window );">Consumer price index</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Operating leases of lessee, contingent rentals, basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LesseeOperatingLeaseNumberOfLeases', window );">Number of stand-alone leases | lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,399<span></span>
</td>
<td class="nump">$ 66,439<span></span>
</td>
<td class="nump">$ 64,178<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_CareTrustREITMember', window );">CareTrust REIT | 2025 Acquired Properties | Standard Bearer Healthcare REIT, Inc. | Subsequent Event | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_CareTrustREITMember', window );">CareTrust REIT | Skilled Nursing Operations And Senior Living Facilities | 2025 Acquired Properties | Standard Bearer Healthcare REIT, Inc. | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionConsiderationTransferred', window );">Asset acquisition, purchase price | $</a></td>
<td class="nump">$ 44,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_VariousLandlordsMember', window );">Various Landlords</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfMasterLeaseAgreements', window );">Number of master lease agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_SubsidiariesUnderMasterLeaseArrangement', window );">Subsidiaries under master lease arrangement | subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_VariousLandlordsMember', window );">Various Landlords | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_VariousLandlordsMember', window );">Various Landlords | Minimum | Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_VariousLandlordsMember', window );">Various Landlords | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ensg_VariousLandlordsMember', window );">Various Landlords | Maximum | Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_MasterLeaseAgreementsMember', window );">Master Lease Agreements | CareTrust REIT | Skilled Nursing Operations And Senior Living Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_NewAndAmendedMasterLeaseAgreementMember', window );">New And Amended Master Lease Agreement | Various Landlords</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Increase in right-of-use asset | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase (decrease) in lease liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 71,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementMember', window );">Amended Master Lease Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfMasterLeaseAgreements', window );">Number of master lease agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Increase in right-of-use asset | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase (decrease) in lease liability | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementMember', window );">Amended Master Lease Agreement | Operation | 2024 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementMember', window );">Amended Master Lease Agreement | Skilled Nursing Operations | 2024 Acquired Properties | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementMember', window );">Amended Master Lease Agreement | Various Landlords</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfMasterLeaseAgreements', window );">Number of master lease agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Term of operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementOneMember', window );">Amended Master Lease Agreement, One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LesseeOperatingLeaseTermExtension', window );">Lessee, operating lease, term extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementTwoMember', window );">Amended Master Lease Agreement, Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LesseeOperatingLeaseTermExtension', window );">Lessee, operating lease, term extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_NewMasterLeaseAgreementMember', window );">New Master Lease Agreeement | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset', window );">Increase in right-of-use asset | $</a></td>
<td class="nump">67,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase (decrease) in lease liability | $</a></td>
<td class="nump">$ 67,572<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_NewMasterLeaseAgreementMember', window );">New Master Lease Agreeement | Skilled Nursing Operations | 2024 Acquired Properties | Subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_NewMasterLeaseAgreementMember', window );">New Master Lease Agreeement | Skilled Nursing Operations | 2025 Acquired Properties | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_NewMasterLeaseAgreementMember', window );">New Master Lease Agreeement | Various Landlords</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfMasterLeaseAgreements', window );">Number of master lease agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Term of operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_TripleNetLeaseArrangementsMember', window );">Triple Net Lease Arrangements | CareTrust REIT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_NumberOfMasterLeaseAgreements', window );">Number of master lease agreements | agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Extended lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_TripleNetLeaseArrangementsMember', window );">Triple Net Lease Arrangements | CareTrust REIT | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms', window );">Lessee leasing arrangements, operating leases, number of renewal terms | renewal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_TripleNetLeaseArrangementsMember', window );">Triple Net Lease Arrangements | CareTrust REIT | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms', window );">Lessee leasing arrangements, operating leases, number of renewal terms | renewal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_TripleNetLeaseArrangementsMember', window );">Triple Net Lease Arrangements | CareTrust REIT | Skilled Nursing Operations And Senior Living Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_PurchaseOptionMember', window );">Purchase Option | CareTrust REIT | Skilled Nursing Operations And Senior Living Facilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease, Right-Of-Use Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LesseeOperatingLeaseConsumerPriceIndex">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Consumer Price Index</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LesseeOperatingLeaseConsumerPriceIndex</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LesseeOperatingLeaseNumberOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LesseeOperatingLeaseNumberOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LesseeOperatingLeaseTermExtension">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Term, Extension</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LesseeOperatingLeaseTermExtension</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_NumberOfMasterLeaseAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Master Lease agreements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_NumberOfMasterLeaseAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_SubsidiariesUnderMasterLeaseArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Facilities operated under two separate three-facility master lease arrangements. Under these master leases, a breach at a single facility could subject one or more of the other facilities covered by the same master lease to the same default risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_SubsidiariesUnderMasterLeaseArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479908/805-50-55-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480060/805-50-25-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480027/805-50-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_OperatingEntityAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_OperatingEntityAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ensg_CostofSalesandGeneralandAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ensg_CostofSalesandGeneralandAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ensg_StandardBearerHealthcareREITIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2025AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ensg_CareTrustREITMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ensg_CareTrustREITMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ensg_VariousLandlordsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ensg_VariousLandlordsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_MasterLeaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_MasterLeaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_NewAndAmendedMasterLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_NewAndAmendedMasterLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_OperationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_OperationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_AmendedMasterLeaseAgreementTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_NewMasterLeaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_NewMasterLeaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_TripleNetLeaseArrangementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_TripleNetLeaseArrangementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_PurchaseOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_PurchaseOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378870470096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Schedule of Operating Lease Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Cost of service</a></td>
<td class="nump">$ 24,297<span></span>
</td>
<td class="nump">$ 20,454<span></span>
</td>
<td class="nump">$ 16,938<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Lease, cost</a></td>
<td class="nump">242,225<span></span>
</td>
<td class="nump">219,512<span></span>
</td>
<td class="nump">171,272<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_AccruedRentAdjustment', window );">Accrued rent expense adjustments</a></td>
<td class="nump">808<span></span>
</td>
<td class="nump">870<span></span>
</td>
<td class="nump">493<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Rent - cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">216,016<span></span>
</td>
<td class="nump">197,358<span></span>
</td>
<td class="nump">153,049<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">CPI increases and short term-lease cost</a></td>
<td class="nump">14,013<span></span>
</td>
<td class="nump">10,259<span></span>
</td>
<td class="nump">5,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">498<span></span>
</td>
<td class="nump">125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=ensg_DepreciationAndAmortizationMember', window );">Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 1,212<span></span>
</td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">$ 1,160<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_AccruedRentAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustment to deferred rent arising from the difference between rent expense recognized and rental payments made in the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_AccruedRentAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=ensg_DepreciationAndAmortizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=ensg_DepreciationAndAmortizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378879995744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Year</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 204,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">204,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">204,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">202,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">199,144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1,776,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">TOTAL LEASE PAYMENTS</a></td>
<td class="nump">2,792,316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: present value adjustment</a></td>
<td class="num">(963,516)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">PRESENT VALUE OF TOTAL LEASE LIABILITIES</a></td>
<td class="nump">1,828,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current lease liabilities</a></td>
<td class="num">(93,475)<span></span>
</td>
<td class="num">$ (82,526)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">LONG-TERM OPERATING LEASE LIABILITIES</a></td>
<td class="nump">$ 1,735,325<span></span>
</td>
<td class="nump">$ 1,639,326<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378878522208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Lessor Narrative (Details) - property<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Term of operating lease</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators | Senior Living Operations | 2024 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators | Campus Operations | 2023 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Term of operating lease</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Term of operating lease</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators | The Pennant Group, Inc. | Senior Living Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_SubleaseToThirdPartyOperatorsMember', window );">Sublease To Third Party Operators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeaseTermOfContract', window );">Term of operating lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_SubleaseToThirdPartyOperatorsMember', window );">Sublease To Third Party Operators | Skilled Nursing Operations | 2023 Acquired Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of real estate properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SeniorLivingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2024AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_CampusOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_CampusOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=ensg_A2023AcquiredPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ensg_ThePennantGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ensg_ThePennantGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_SubleaseToThirdPartyOperatorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_SubleaseToThirdPartyOperatorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=ensg_SkilledNursingOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378985125920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Schedule of Rental Income from Third-Party Sources (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList', window );">Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">TOTAL REVENUE<span></span>
</td>
<td class="text">TOTAL REVENUE<span></span>
</td>
<td class="text">TOTAL REVENUE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rental revenue | All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="nump">$ 4,347,000<span></span>
</td>
<td class="nump">$ 3,897,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental revenue</a></td>
<td class="nump">22,960,000<span></span>
</td>
<td class="nump">21,284,000<span></span>
</td>
<td class="nump">16,757,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators | Pennant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental revenue</a></td>
<td class="nump">15,480,000<span></span>
</td>
<td class="nump">15,048,000<span></span>
</td>
<td class="nump">14,915,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseVariableLeaseIncome', window );">Operating lease, variable lease income</a></td>
<td class="nump">1,235,000<span></span>
</td>
<td class="nump">1,296,000<span></span>
</td>
<td class="nump">1,318,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember', window );">Leases To Third Party Operators | Other third-party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeaseDescriptionLineItems', window );"><strong>Lessor, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental revenue</a></td>
<td class="nump">$ 7,480,000<span></span>
</td>
<td class="nump">$ 6,236,000<span></span>
</td>
<td class="nump">$ 1,842,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes operating lease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseVariableLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from variable lease payments paid and payable to lessor, excluding amount included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-6A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseVariableLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ensg_RentalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ensg_RentalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_LeaseArrangementAxis=ensg_LeasesToThirdPartyOperatorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ensg_ThePennantGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ensg_ThePennantGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ensg_ThirdPartyTenantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ensg_ThirdPartyTenantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378976347376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Schedule of Annual Rental Income (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 23,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">2026</a></td>
<td class="nump">23,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears', window );">2027</a></td>
<td class="nump">22,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears', window );">2028</a></td>
<td class="nump">22,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears', window );">2029</a></td>
<td class="nump">22,511<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter', window );">Thereafter</a></td>
<td class="nump">119,811<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">TOTAL</a></td>
<td class="nump">$ 234,436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378867691920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEFINED CONTRIBUTION PLANS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability, noncurrent</a></td>
<td class="nump">$ 63,051<span></span>
</td>
<td class="nump">$ 49,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestments', window );">Loss (gain) on deferral investment</a></td>
<td class="num">(5,157)<span></span>
</td>
<td class="num">(4,634)<span></span>
</td>
<td class="nump">$ 4,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_InvestmentExpenseIncome', window );">Offsetting expense (income)</a></td>
<td class="nump">$ 5,559<span></span>
</td>
<td class="nump">4,887<span></span>
</td>
<td class="num">(4,051)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember', window );">Qualified Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum annual contributions per employee</a></td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Expensed matching contributions</a></td>
<td class="nump">$ 3,532<span></span>
</td>
<td class="nump">$ 2,836<span></span>
</td>
<td class="nump">$ 2,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember', window );">Nonqualified Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanDisclosureLineItems', window );"><strong>Defined Contribution Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum annual contributions per employee</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_InvestmentExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment Expense (Income)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_InvestmentExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_QualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTaxStatusAxis=us-gaap_NonqualifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378868667616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SELF INSURANCE LIABILITIES - Schedule of Future Self Insurance Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems', window );"><strong>Liabilities for Guarantees on Long-Duration Contracts [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">TOTAL SELF-INSURANCE LIABILITIES</a></td>
<td class="nump">$ 211,752<span></span>
</td>
<td class="nump">$ 165,910<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserveCurrent', window );">Less: current self-insurance liabilities</a></td>
<td class="nump">67,331<span></span>
</td>
<td class="nump">54,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserveNoncurrent', window );">LONG-TERM SELF-INSURANCE LIABILITIES</a></td>
<td class="nump">144,421<span></span>
</td>
<td class="nump">111,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember', window );">Accrued general liability and professional malpractice liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems', window );"><strong>Liabilities for Guarantees on Long-Duration Contracts [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">TOTAL SELF-INSURANCE LIABILITIES</a></td>
<td class="nump">160,149<span></span>
</td>
<td class="nump">117,744<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_WorkersCompensationInsuranceMember', window );">Accrued workers&#8217; compensation liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems', window );"><strong>Liabilities for Guarantees on Long-Duration Contracts [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">TOTAL SELF-INSURANCE LIABILITIES</a></td>
<td class="nump">37,291<span></span>
</td>
<td class="nump">33,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember', window );">Accrued health benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems', window );"><strong>Liabilities for Guarantees on Long-Duration Contracts [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserve', window );">TOTAL SELF-INSURANCE LIABILITIES</a></td>
<td class="nump">$ 14,312<span></span>
</td>
<td class="nump">$ 14,814<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 944<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479808/944-20-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserveNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid after one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserveNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_WorkersCompensationInsuranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_WorkersCompensationInsuranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_HealthInsuranceProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378876402736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SELF INSURANCE LIABILITIES - Schedule of Insurance Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward', window );"><strong>Movement in Liability for Future Policy Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 165,910<span></span>
</td>
<td class="nump">$ 131,682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease', window );">Current year provisions</a></td>
<td class="nump">217,631<span></span>
</td>
<td class="nump">164,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits', window );">Claims paid and direct expenses</a></td>
<td class="num">(173,617)<span></span>
</td>
<td class="num">(135,799)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease', window );">Change in long-term insurance losses recoverable</a></td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">5,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForFuturePolicyBenefits', window );">Ending balance</a></td>
<td class="nump">$ 211,752<span></span>
</td>
<td class="nump">$ 165,910<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(13)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-29E<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other increase (decrease) in accrued obligations to policyholders pertaining to insured events for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 29E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-29E<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 13I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480046/944-40-55-13I<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued obligations to policy and contract holders for long-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480081/944-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874241376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SELF INSURANCE LIABILITIES - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EstimatedInsuranceRecoveries', window );">Gross insurance recoveries</a></td>
<td class="nump">$ 17,741<span></span>
</td>
<td class="nump">$ 15,913<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EstimatedInsuranceRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EstimatedInsuranceRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378874602592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>subsidiary</div>
</th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty', window );">Litigation settlement, amount awarded to other party | $</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews', window );">Independent subsidiaries with multi-claim reviews scheduled or in process | subsidiary</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer Concentration Risk | Total Medicaid and Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">52.90%<span></span>
</td>
<td class="nump">53.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Customer Concentration Risk | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Customer Concentration Risk | Total Medicaid and Medicare | Service revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration percentage</a></td>
<td class="nump">70.90%<span></span>
</td>
<td class="nump">72.60%<span></span>
</td>
<td class="nump">73.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Facilities under Medicare Probe reviews relating to Medicare services, billings and potential overpayments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ensg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedToOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded to other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedToOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ensg_MedicaidAndMedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ensg_MedicaidAndMedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45378863317792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMON STOCK REPURCHASE PROGRAM (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 16, 2024</div></th>
<th class="th"><div>Aug. 29, 2023</div></th>
<th class="th"><div>Jul. 28, 2022</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">404,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Amount of common stock repurchased</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,882,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=ensg_May2024RepurchaseProgramMember', window );">May 2024 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase program, period in force</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=ensg_August2023RepurchaseProgramMember', window );">August 2023 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase program, period in force</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=ensg_July2022RepurchaseProgramMember', window );">July 2022 Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase program, period in force</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period share may be purchased under authorized share repurchase plan, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=ensg_May2024RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=ensg_May2024RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=ensg_August2023RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=ensg_August2023RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=ensg_July2022RepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=ensg_July2022RepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>123
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MA3R1^5_T4IS;Z3=0F$G%TTTPW$$:L^*3O&Y [ 5<>0<"\"8 OPGPVP<"@DU
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M+W=O<FMS:&5E=',O<VAE970S+GAM;*U9;5/C-A#^*YJ4Z<M,(-:+99N#S.2
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M2NA-RKQ\8%)MS -KDY$UQ>M"&EH0*$)AV -J6\$(H0&<=(>3>G%^%&R;YDO
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MYA4$I34P^RLA],/$=KGFI2;Z"U!+ P04    " !R@$5:/U5Y-]D&  ".'P
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M:=[8FVH+#?:V#4T/H&HQJ%JR5Z/V 6%01N5@Z'@DMO/(?MNWL&EO'G9#=?W
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M# A3H-<7G*MM8#9H_ESA/U!+ P04    " !R@$5:V#>?QT0,  !K/   &
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M-/-G6_5B(N?S=XZV3;-\+^9:WW<*B&Q+@(1QSUA#.\R$#@2&C9'7^%O\\-A
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MK-Z+!D=M+3]6:_OWU. 6/;B7M1.$9^(!1 'J%F6HL[L(B)![Y@-H"7D*6-0
M#CT .*^I7S9^#P!\J#CBN(!DL5W;R4&9@AZ/DYWC-V&2N>JZ]9#A59@MY7*I
M-W?TQERT7JF7XH=HRVH$.;GRP@UU601C[+ ^($,IX38#0#+,$T\9AQJNH6&N
M^296.US:+8IVS"Y[MGL9Z;I5-Q\*C]%SU2\6LI[I27^@[$/!S:S83JV@+'-
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M]?NYE/WK&_T'ML\7G_\?4$L#!!0    ( '* 15JO^*WDW@8  -40   8
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M4=!2-CK<V<UOU,;SFO7E5OOXO]BTLN.!R!L?;-4>A@>5,NE7/K1Y^)X#T_;
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M8Y"44.'0JZSL,YD8(O'E Y_Y$F29B:\2!3"KT/;R5^51,:3CNX%1RC4!C8_
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MQC9%96OCX3T'VMU[<Z^'=[X/GUR%3^Z;C;UV9NE<8X"?.]O!$%5#XW<E/.Y
M6_H-_2[;N.LJ&&57PT:N7>,Z6]=[_-SM>GX7YWK?5/@;3033_W!^_N;^"5%^
MP70;6" ^"(0[LW7;I>M,"Z:L;XL/F[8N\=>5N;9=U0X^7V%=;2O^URZKNNKW
MAGF!HF6;$G[K=FU'///& 1>6=07J6YJ^-6!JX1,7!K;%KT.%:_8?JKJ&?YNA
M\[A*?A"'6!C8@@IHJZOK_!.:K7,U486LK6NPN@:%LBJ</S'G=0T,Z5TGFV5
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M ;*IR=C@%HI^@/E *B&P1;,SU"@S(&Z=674MZ.FF]8EXGICO877F;[8><#O
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M6N4I>8W9.69_26-[D(E9-L#>QNJ%3,TBN!#GA\N*+>"!L4LP-"%:73!^!>I
MG31)/[CT"O_B].A&'^J 5)^=V/5\Y:RAB!H%WO&R9,51R^*Z%W$U/!JY -YM
M*6?;K/,,<QXI2RVS(O-!;C(FUGTLG"NEG!&#]QRR"]3D_CX"H/T!RC<%RB3#
M\]J3_4\V/9_P,K8K)M7 'Z2=,6CD2VSMK'HGNG;883X))6MG#Y*Y4&-,AW7
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MTSCJ6I9N734$#$V<[EO!9/ L93+<R,9V,\RIHR3?=C/[]I-1K[!(7@B%NNC
M*>$&X<&IZ)KV9POS0L]"B"PD#_**6%Q4W,&87!Y(Z,@[P-#F'Q!>J1(D4O\S
M1(2W"#V0QF+]U!QE%W.?P\AE^%J4MWQW7["PX#!"_!)%6=4%>7M%+>5AN$M*
MM7#O%BKM=DM8S/N3JQ,V]XFX/GR<?O])QM5PDB->B1/Z,=EJ '% \'K@ U;F
MZOB_T.!E?_G/$_/**@U\ZE'2^BACK5Z%W-//\6P@C@_4M->BJ5HPG*:82V!W
MHXGL;BDG/.3L:1KHW=7V3P<T>A]KQLX;UV5?LX/1BB 3RD]=<Z26[H^*[:&?
MDJV_@(7+$'RQEE\]GK*6\<G/LY)ZV2G^$!I?2_,+1"Z^K(H$9,/.X[6 IJDU
M5$1$H1B*.O#F[$I*QA%&P;(P%K42DY? ./&V(2X2I:RH_D []D1JH/!KO8^2
M$V"B@TZ%J#/)+3M4NQ))2DR60%AHMGR,K))<93J4'7G:Q[."\?CX]!%LZLNX
M6Y+JB0"$02%F55]T!QF(/<\?W#ZD8;KE+EX!%%+CO"V@3.^MD>@Z/T6872*5
MI!'3WW>5KG9F[_UOVORO%C'X_TP/]NS?3VZFOGCQ0?*%F=@(0%\+2J%WT_-W
M9X:_&OWFT7/^PLWX.']MZ4\6^PCPE-@*7CT]^>K)$=\6H[_T[8Z^?G/9]GV[
MI1\W$&JY#A^ SU<MK$=^P0G"][%^][]02P,$%     @ <H!%6MW"3X)N"P
M#AX  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&ULK5G=;MLX%GX5(I/.
M)H#J6))MR9VV@)LFF #33I!TNE@L]H*6:)M36?204M+LT^]W#B59=IRT4^Q%
M&YDBS^]W_JC7]\9^<2NE*O%U793NS=&JJC:OSLY<ME)KZ09FHTJ\61B[EA5^
MVN69VU@E<SZT+LZBX7!RMI:Z/'K[FM>N[=O7IJX*7:IK*UR]7DO[\$X5YO[-
M47C4+MSHY:JBA;.WKS=RJ6Y5]<?FVN+764<EUVM5.FU*8=7BS=$L?/5N1/MY
MPV>M[EWO69 F<V.^T(^K_,W1D 12A<HJHB#QYTZ=JZ(@0A#CKX;F4<>2#O:?
M6^J7K#MTF4NGSDWQ3YU7JS='Z9'(U4+6175C[G]5C3YCHI>9PO'_XM[O'25'
M(JM=9=;-84BPUJ7_*[\V=N@=2(=/'(B: Q'+[1FQE.]E)=^^MN9>6-H-:O3
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M_(C6@[S_+0I6%3XM&N$JTAH+6BW$ F6:Z.6U90@W(?%$1/0CBHSUV(2R<.:
M_)0.GU+ 9_BBZ'8O54GO?(@U9%'%J6%!OFM+Z4!<H3CDJ"K<E?MTL3]@R+FY
M0]^WGTE*@F"[I^W$?,ZV>E.HEZ6J1*&0Y9YJ602U+-2/(B<<HWQ.)\, #V$0
MI2-6Z!@ 3<;)CZ:K0S[:2ZN*I3[HS6IE3;U<'6@@6$FJM*9V_NQ.P]4K,'LD
M?3M'FLPP]X)JB4SD,MCO&F.'F*';/IG=7,]X_L@LV<ZU*?)2435O@[X0,T=5
M35*AO%8V(W>@X)Q<?IA=G_887<JU+LC&E]JZ"JI;4\H[;2'Y#==:N(?Y7EZ>
MW\Q.>RCT1J%^1B_0I#>JM$;P!:I5S*.-.D/(;>S&<">X/5QS#?VKUK8!0:]C
MAV]SK$.&_F35LR=:;&Z-?/#1I%@ZGEVH$Z=FJ@+@YG75=N(,U-\_7[U_&4Y!
M$Z:@(8-*,6UVSF2:*3$0GYSKZHX6.&J[TR%UU*_K>0':O[+'Q06<"DMD9 5D
MTP<&Y$[@0-.<2W0#O2[VX-"_ET5&7=_KND;)[=!K^JUMJ]),.+KD#MCFC!TV
MPNSV7$R&DP"5F2= TOR)3I)^H2W4?&. Y-$,?OU4=+^B1J0Z%&B'Q&,_8M;&
M0-%W+_Q?6VII^UFWQ=-?&$/PP&-+=:A1RM5"-:=W>Q5BY%Q[3X%_NNA+U;%O
M(.A%\*TY6] /:3,V(-Q4/ 3]>P_@8R>7;"O'UOP.V7NM&XWX+$]5CP'>L@<[
M;J*?RW[](:1OD)5$%AVEDR:=HG"&!("ZE)L-)#R0^MS^%/-^%X]_5X*M[\N^
MH8\G5.W3P N64MN4D&0'4[$?>#H3TMED'&_/IF@;=J0.:%YLC#_H4N<>U9GC
M M0%=2\USFA<ON'MGLM%>U=QJ^ 4S!6<-'$2"@_%R?GLYN*6ED[WPKV%83O\
MM"/6>E.8!QIWC6T3"^<EF@$:!I7\RM6_0S^Q\O<#W\@->Q[84/$Z1H$,T9FV
MLX)T3:V'8KZ!]"-(-Z7MY4D_+3;:-&CGO..E>B<+3B>W_&WC"HQAGJN]:7-_
M<J-<8@J=-X.CI\"WZ]U<ZZ^+FW>.1L0U2@</3@N^?B%I_#SO&JAQTO*W4LV&
M[;IK]9=-A@)HZJ)S2W.E91X%KK^D(')X[[876QGF%O_%PS'D[A5:,.FVDA?(
MH:B_U.6TK+>ESRJ^ Z9;QVTR?!0YW '(_(ZM0SAIKT':&ZG]RT&J,-L9\) H
M7H'V!5S-%N<D\WC8:L(:X48EM!FK]ZO4]W=ELP/>ROR(WC,-)&GOE?*V]WW^
M6B=HVI8EFE5;^KO<[M6Z/]KX_LS?].Y<A?FVWYG:,M:H?X4<WW.!Q61R4\^K
M15UT@#RL[+?M_#TC\JNGQN+.,)CPHA038T3S:I*BJ1[OCGAA//5#% :ZZ3#9
MVC=)D(TQKHZ#<1@=F$^:"ZLPIJD2(R*&S4D:@\T8;.*8&(ZF&$#31/R&8ON*
M!A-SS_CE;F_?3N(D#4;Q^%2<3#%YIZ>'/H($XN/%)V(QF0;I-"$6D&\83\6A
MSSQGO6]TW)31ET@*2[#SG^NZU>YCY\Q_X]MN]U]*/TB[U !*H18X.APDXR-A
M_=='_Z,R&_[B-S=59=;\"(0!&;0![Q?&5.T/8M!] G[[/U!+ P04    " !R
M@$5:_"^;LJ4$  !-#   &0   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6SM
M5]MNXS80_96!6A0)H-J2+-ERFAAP$F\W0'U!+ET411]HB;;84*26I.+D[SND
M;,=);"^*[F-?+-[FS)GAS'!\OI+J41>4&G@NN= 77F%,==9NZZR@)=$M65&!
M.PNI2F)PJI9M72E*<B=4\G84!-UV29CP!N=N;:8&Y[(VG DZ4Z#KLB3JY9)R
MN;KP0F^S<,N6A;$+[<%Y19;TCIJ':J9PUMZBY*RD0C,I0-'%A3<,SRYC>]X=
M^)W1E=X9@[5D+N6CG=SD%UY@"5%.,V,1"'Z>Z!7EW (AC:]K3&^KT@KNCC?H
MGYSM:,N<:'HE^1>6F^+"2SW(Z8+4W-S*U6>ZMB>Q>)GDVOW"JCD;=SS(:FUD
MN19&!B43S9<\K_VP(Y &!P2BM4#D>#>*',MK8LC@7,D5*'L:T>S F>JDD1P3
M]E+NC,)=AG)F<#4=SQ[NA_<WTPE,/\%D= \W$UP<P6QT"S@8X\;=Y^'MZ+QM
M4)^5:F=K[,L&.SJ '48PEL(4&D8BI_E;@#82W;*--FPOHZ.(US1K02?T(0JB
M^ A>9VM]Q^%U#N"-B!),+#7,J(*[@B@*?P[GVB@,EK_V&=S Q?OA; *=Z8ID
M],+##-%4/5%O\-,/83?XY0C9>$LV/H;^'Z_J>V'#)=$L X'U@HE,EA0J])UV
MOF,:<*6J#<UA_@(Y>V(YNG=S<*%D"5A.%+$)J8$8H]B\-F3.*1@)&.S98R%Y
M3I4&N8#[@F+D:+84\*N2=>7#C<#[1V2#.RN7<*B)/"'BDH*HRSE204$L/MH0
MX72CYA*SWQ'4@%7,"2,))O.64]%0=IRL<,ZX,^"0A9J5C!-E"9N/TO.#WO&!
M/F>T,BA%C!/-J9"8TL0@*01& 2RK&E4C-$YXG5-W[M4PDN?,:B+\G5T.<R5K
MGD.!_H YI>*-&]BB46F-PS((E314&/8!J"!Y(\RTKBEZ:(BE-Y,B8YQMC5R3
MLA>)U%'#&U-J:P(3C7<(SVI^W#N[!/"".+X3^@S^H.AC5S< LYXZ#VPRW_YT
M[$\$DX?QZ'9X/[T]@\DK[(\0]5,_3E(["OI^F@1V%,5^-XG@-ZI1P0Z+$RZU
M/OT0CP+-QOJED%(3Q8:BBXR&.$T@3D(XB?JGNVK? QP(8,NNY_=[G36[3K^_
M89>&<#V:3,<WD\:F+^^#?'U-NU=K8_IPV$'21:,32!*_%Z20Q'Z:]O8G\>Y%
MG"&CI!5U\=-I]>PG;@7][QL-!S+M_WCX%_'P-GMWPV+OO<]XC::Z2H.=E<'T
MWQ1&6YL)YGR)X&@EPKN^ZR0\A=!/T,#0[X;VMY_&,,S_QM8$3WXHPD?XI'X4
M!Y#T_ Y>%K)+>VC<MT.@B43L)6PD=A/WZ2>.V+1J'I)=-:N"9078T"%8WW[>
M%CP;EQB#V/-)W!/2P (?>1S;Z%S7\F]80TI9"P-D+I_L683IA[&/+HFCOL/O
MI<'VA7G!>-5 ]P>LWT2LE;%1ZV-6Z8JZ!I6_M/;U"NV=%@]3;>D:6?O<(J.F
MV]NN;GOE8=,BOAYO&NTQ44N&7N-T@:)!JY=XH)KFM9D86;F&<2X-MI]N6&"_
M3Y4]@/L+B8_'>F(5;/]!#/X!4$L#!!0    ( '* 15HG. N]000  +$)   9
M    >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;)U6V6[C-A3]E0LU:%^<>/=D
M4MN LPPZP*0(DDGZ4/2!DJXL8BA2(:DX[M?WD'(4#R9+VQ=;W,X]YV[D?&/L
M-U<R>WJLE':+I/2^/NGW759R)=R1J5ECI3"V$AY#N^Z[VK+(XZ%*]4>#P:Q?
M":F3Y3S.7=GEW#1>2<U7EEQ35<)N3UF9S2(9)D\3UW)=^C#17\YKL>8;]K?U
ME<6HWZ'DLF+MI-%DN5@DJ^')Z23LCQON)&_<WC<%):DQW\+@<[Y(!H$0*\Y\
M0!#X>^ S5BH @<;]#C/I3(:#^]]/Z)^B=FA)A>,SH_Z0N2\7R7%".1>B4?[:
M;'[CG9YIP,N,<O&7-NW>\22AK''>5+O#8%!)W?Z+QYT?]@X<#UXY,-H=&$7>
MK:'(\EQXL9Q;LR$;=@,M?$2I\33(21V"<N,M5B7.^>6GU>=KNEM]N;V@RXO5
MS>WUQ>7%[U]OYGT/\+"EG^V 3EN@T2M PQ%=&NU+1Q<ZY_Q[@#Y8==1&3]1.
M1V\BGG-V1.-ACT:#T>0-O'$G=1SQQJ])%=+2G5 -T[ETF3*NL>SHSU7JO$5V
M_/62Z!9R\C)DJ)@35XN,%PE*PK%]X&3Y\T_#V>#7-PA/.L*3M]#_2VS^%Q!]
M+9G.3%4+O?W%42&UT)D4BH1S[!U)G:DF9RI9Y8?>'*(&&BO]%@L/[#Q*$YLR
M8:WDG(0G41GKY=\89,;Y4"S2D2GH8#@^[LT& Q(ZIX/IQ]YT/.B%A4TILY(.
M9M/>\7BXOTK",FK+R;46'GC>H&O4->!)&;T^]&PKL$  P9BQECJ92S054E*D
M4DDOV?4H-;Z$F& *R<15RK9+J&@.'^,>>HNK.78'M3VBU;O[/=SVFE:L.?[1
ME4%/9M#*<K:M'E'7UCQ*^!3;0V8^Q,P,5EKQ%GQR:IS4:_K"X$8C2*X;].#]
MP%'*2F(9X0IV7J*U'RY?(E ;D, LC%&CT<I5/(&"<%0;)]MV^8X;*#>DC8?S
M[AMI W$2"BT^!@27!?%C<&I@ L721_@0%(VU$NB!.WAK3R;+&AO=4EK3K,OH
MX )1A/(\^"?Z%4(LQQ1H-9A&Y1"1RRQLR6510)7V(83OY+50SG3)'6PA,K$#
MN#:G@MTPK61P*XQG;#WN-^*J5F;+F-R4)H8)OE_+5'&(:"W@^DS6@0XV:Z,/
M[QOXM@CE@8N"H\8,O'"GB>CD6@F]BTE "X46XT)6I*DD;W$!M'(RX4KD.2#0
M79^2I<NW/0$N7E(Y ;UH=+Y#=Z7(T7R"JN=LB '+(A-'H01:JNGV68J./HGG
M7E?0)6WD#VO/^?QORVFO EI1^S1;'1ODS,%TUAM,/K:M8C+LC8:S[\NWM^LI
M[Y;02^VYOW>-5FS7\;& #F<:[=L;M9OMWB.K]AI^WMX^9BZ%72.72'&!HX.C
M#].$;/M : ?>U/%21HO"%1\_2[RIV(8-6"^,\4^#8*![I2W_ 5!+ P04
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MUQ^1U?L7G%)\-PU/L,4K3C2H<VJ!@S25=:P>;<IGJ%]!XQ$VK+(55DLCT48
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M(_%'L'-^3V-L0[ 5?YTIB2/3!#R?6/"U](,V:%_<N?PO4$L#!!0    ( '*
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MKF*YX 5ZLDJALV:"O?0_A,A!A;$E5'O(2F*/U?: ",R*1; 3QP1'J FL2P
MIZG-CCX>K! ]$._TN$))V)?(W&U%;O]XZ=5>R;3RP?)F!"Y<+( %S*'Z8Z(-
M<0OY&\3"?*!W&-K;=1%-6JWVIDB;C6A[Z @X\SEU6"1-T(V35!KV#JY\1=9_
ML#BL(T=UK43<$XHCY=M='98B4A">#U9AV#?JFK OS+:[%J%"*I"R_FL1"4?B
MJNY])?I>ZZM++I#X]&T)<**Z;/@ LVW=?KXZ#U]M=L/#MZ]?P!NRH,MMAJG]
M[G3<":71YL7ITG_# 3,YG?O'I4!B&1J _DP#B?4++;#]J'?V'U!+ P04
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MRZR^*NY^E,UZ/+*7%%FE_V=WIJ^(!BQ95G4Q;P;#@[G*S=_X4Q.'WH#0WC-
M- .$]MM,I+U\&]?Q\>NRN&,E]88U^J&7JD?#.973IHSK$G<5QM7'IS^/SR]&
MXS$;CWYX-[JX'K\^JF&6;AXEC8E38T+L,<$%>U?D]:QBHSR5Z;J!(_C3.25:
MIT[%08MO93)D#K>8L(5[P)[3+=+1]IP]]L9R"AS5[$HNBK)6^93]\^2FJDM
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MT?9P$ YVB+8-X7>$5D\K##@U.;[EV\[G'+=Q4/?XTX[;(D2Q$$9?1?N_+]K
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MFD;8BB5][* T!K0_%T+O%B9 ]_DT_A]02P,$%     @ <H!%6D*YH]N^ P
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M8L,62<W*@C-@,[UCHE^\P@J#-9AYDGH_07(PV*JMZC:!$YJ2K1<B7; Y'-.
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M7"\4S:.5<A7D:AB",I=0[@*SVBA-"=.=0CF!J-\R!U&.@.)Z@3F*,FU-$,/
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M$Q6%\X17D (>H+(83"(#PU#@;=97.F(,Q-6B;86"\UI>:Z&[W9VYQD(K0]O
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MRT2]KB2HWGDB/'?L#.&73X0[FSC^:$J_1KXS#&;0_.X4JK<"QYM-0-H)1H'
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MTH*P2*,UACFHGN08"Z^-_N4KD2L7DO#HO&AM$$#%)Q [ KBZO-\I>H[6TPL
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MCP]F<-@ ATS3TB,DQ/50MY@<H.$SA;<?X8E?</MSRG[ 2I_#7+ 0<J$"^*R
MK7ZS-=%K@A].I3$)D_H&L$_:<<CP<\]YS2BIWSNOD&;DM+WW&=BI@L ,,11@
MG&#SX.S7U@RK-<43XSMQ _Z#XD9W $64&>)R=(.3ZEH[@_?>F(8]6WF7\VX
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MDPY=O_E##EU/8?6593?Z^?M:KG8>I.Y?JK>#VB/QTR3QTS]<XCL.@/<O^'
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M_^CMC:[PA1F8CD6GO &1L=T6:-T8W]7\DV8L\B@D!MY85&:&H_4MC&S @BZ
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M:&5E=',O<VAE970S-"YX;6R55FU/XS@0_BNC[HM LMK$SHO#0J52>CJDA4/
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M,\VP8:9""^#YGG-U6F@'70L^_0-02P,$%     @ <H!%6F[IE7IP P  _ 8
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MBYBR4:0S\Q4*CAE%.C6/$Q6$*M,=\'Z<ID7=T!,TGR6=_ ]02P,$%     @
M<H!%6@X'=BL@ P  >08  !D   !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL
M?55M;]LX#/XKA#<,+2#4MOP2.TL"-&V&#5A[6=O=X7"X#X[-),)L*Y/DIOOW
M1\E)EA[2?+%)B7SXT!(?C[92_=!K1 ,O3=WJL;<V9C/T?5VNL2GTE=Q@2SM+
MJ9K"D*M6OMXH+"J7U-0^#X+4;PK1>I.16YNKR4AVIA8MSA7HKFD*]6N*M=R.
MO=#;+SR(U=K8!7\RVA0K?$3S?3-7Y/D'E$HTV&HA6U"X''O7X7 :VW@7\*?
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M\4#U0M<[1FZ<N"RD(:ERYIK^#:AL .TOI31[QQ8X_&TF_P%02P,$%     @
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M&=#MRV8P-XH6E1V&6Z%IM%KQ0&\92F- ^SM!E=TJYH#N=9S^#U!+ P04
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MW)!NA8;[EAFNX(++)2Z ]TLA]':"#KHK\^A_4$L#!!0    ( '* 15HP\53
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MIC@"W]&76X)X!R?X^*'6JGXOD54O9-4M>_V&K%/A'M",8EVQR_K]>=;N*%3
MY-]KRNMW4-XHE#=*"WK1<B@D9Q+BC")*8KBFN)RSC@Z A2Q1URS4-<O;C?>W
MVET*_,^BM0I9K3NVNW4'Y>U">?L.[2[G;'Z[W6_W;'*91V",Q88D$E&(-5>U
MTM9M%/E@S0W%4SO,5ESIT6B76_T6@3 .^CSF7)T,,Q^+URWX!U!+ P04
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MF$Z'=S_0[00MPNM9. E'P]D]&HY&MP^S^W!VC>:W-^$H_+) )RCD&O,565)
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MGX*\?B+BOCP7^#(MBG19/EQP-N>9?(-X_2I-B_LG\JCAS5G4P_\ 4$L#!!0
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MER*K LKO[]*T>+ZH'M >PYO^#U!+ P04    " !R@$5:,%_MQ]$#  ")$0
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M N3]%9537 ZRW7CU[\OH/U!+ P04    " !R@$5:+GGDZHP$  "8#P  &0
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M%5AT#Z]4(?4@\[MW$=.VX]CUVR%!V:Y62QR!!&5YGBL/'+]T@=_H@FF\@X0
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M_]Q ZTQ8!H#U%:7B.,@V*)OQ[O]02P,$%     @ <H!%6B]IN/3\ @  & D
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M"H(9:?L3?1<\L5[*NRO7>ZPNZ#KK:LB8;08'BG:,:[0H31SYB+'W/4WRP=M
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M?@_%"18G69S"<)WL6WXOL#_X=V:'$/<ZA-XS_/8#<,^3=78H3F&X3IXM9Q=
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MZ8#0@@X(H3H 2A-0&J%H/!VE T*+.D#/-DX):@["GMT7VBW/A@X(E0X(3^H
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M0?WY^SRO?KPSKODO>?%MN\;L_U!+ P04    " !R@$5:V5BV,=@$  !=&@
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M[GLVG^O9RY '8K/?=W#50,5F+#<[IP:;Z2FQF:)B,ZJ;PG*S$VNPF1Z)S13
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MN7K3U;>BKHO%ZL\'G<YTV0J:W^^*HG[YT!Y@^W:UBS\!4$L#!!0    ( '*
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MH;KMNEL_>L".#JV;QBFG?J?\VP7K2X'X.PV>-M"]>12:3;B)&>AX93D4&DA
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M@.T'G_L303?%[/"9"D'3XG"-HQ@S%2#O+RD5KR=J'%F-GR?_ 5!+ P04
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M=)9N*PF3V_ PS1E?!>OVS5E/)36/YCT*-"H+-#+>4\R0LOP?FXN^T*JY*/L
MI.X#CA:S%_"@FXD9>$V?IL9Z:^QE9X'4G<6KU0TU>PUKX-9E S6;C8I5E679
M;B!UNW&,ON50%>5"0Z/!M,W,'G91+;L$I-Z[=R@<:N["87,3W&;E#HT:)_W@
MA$LJUS(]^./ 2UY==MA5W"T.%Z?ID9I>FF<GDU\Q6P8Q!R%92%?CW)%3L^RP
M+QL(ND[/RYZHD#*97JZ(;/E88B"?+R@5SX-D@N+(=?(_4$L#!!0    ( '*
M15H1,Z![BP,  '@.   9    >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;+57
MVV[;.!#]%4)=%"VPC:Z^)+4%V%':-9"D09WL/BSV@9'&-E&)5$DZ3OOU)2E%
MD2U9FP+*BTU2,X=SCL3AS&3'^#>Q 9#H,4NIF%H;*?,SVQ;Q!C(L3E@.5#U9
M,9YAJ:9\;8N< TZ,4Y;:GN,,[0P3:H43LW;#PPG;RI10N.%(;+,,\Q]S2-EN
M:KG6T\)7LMY(O6"'DQRO80GR+K_A:F97* G)@ K"*.*PFEHS]RQRC8.Q^)O
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M&<CW:TK%4T>5S.TW5?P+4$L#!!0    ( '* 15ICB- \< ,  & ,   9
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;*U776_;-A3]*X1:# VP1"+UG=D&
M$BO%^I MJ-.UKXQT;0N51)>D[>S?CZ)D599H(RO\8HO4.8?G7O+2UY,]X]_%
M&D"BU[*HQ-1:2[FYM6V1KJ&DXH9MH%)OEHR75*HA7]EBPX%FFE06-G&<P"YI
M7EFSB9Y[XK,)V\HBK^")([$M2\K_O8>"[:<6M@X3G_/56M83]FRRH2M8@/RR
M>>)J9'<J65Y")7)6(0[+J76';Q.L"1KQ3PY[T7M&=2@OC'VO!Y^RJ>74CJ"
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M'<++RXWZ3@*N >K]FC'Y<J-/XO67U_!_4$L#!!0    ( '* 15I&CL\=[P(
M " )   9    >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;+566V_:,!C]*U96
M39U4FGL('41J@6U(T%5<MH=I#R;Y@*B)G=D.M/]^=I)&0%/42>PE\>4[Q^?8
M_FQW=Y0]\@V 0$]I0GA/VPB1W>@Z#S>08GY-,R"R9T59BH6LLK7.,P8X*D!I
MHEN&X>DICHD6=(NV!Q9T:2Z2F, #0SQ/4\R>[R"ANYYF:B\-TWB]$:I!#[H9
M7L,,Q")[8+*FURQ1G +A,26(P:JGW9HW?5_%%P$_8MCQO3)23I:4/JK**.II
MAA($"81",6#YVT(?DD0121E_*DZM'E(!]\LO[%\*[]++$G/HT^1G'(E-3_,U
M%,$*YXF8TMTWJ/RXBB^D"2^^:%?&>AT-A3D7-*W 4D$:D_*/GZIYV .8SAL
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MW,@G## 5(/M75.JN*NJ6K!]%P5]02P,$%     @ <H!%6JB0&2IA!   +Q0
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M^8UDR^R8W81)R>+L<@$T *Y?4+_/F!K5BAN=07E2<_0_4$L#!!0    ( '*
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MQOG8G9B,^5HE+(,[0>0Z3:EXO(2$;R]Z7N]IX"-;+)4><";C%5W #-3GU9W
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MN2)S3*YL50#A"Q)+S(A:[Y$DF&5DKGCZ1.[:E?>"5@HR\G<"BK)"OD:TS*D
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MD2QW[V(N02Q-@R-)RE>5:JZL;K7KH6+3.ARM3[&W:EJA7S1-8_:9BB7#:E7
M BF]ZR$>.=$T.\U$\=I<_X]<83-AACGVAR"T 7Y?<*YV$_V#KN.,?@)02P,$
M%     @ <H!%6BG\UB K P  W @  !D   !X;"]W;W)K<VAE971S+W-H965T
M.#(N>&ULK5;!;MLX$/V5@791M,!6DB59=E-;@!VUW1[:&'&W.10],-+8(B*)
M6I*VD[_?(25K'=L)4J ^6"0U[Y'OD9S19"?DG2H0-=Q79:VF3J%U<^%Y*BNP
M8LH5#=;T9B5DQ31UY=I3C4266U!5>H'OQU[%>.TD$SNVD,E$;'3):UQ(4)NJ
M8O)ACJ7839V!LQ^XYNM"FP$OF31LC4O4_S0+23VO9\EYA;7BH@:)JZDS&URD
ML8FW =\Y[M1!&XR26R'N3.=S/G5\LR L,=.&@=%CBY=8EH:(EO%OQ^GT4QK@
M87O/_M%J)RVW3.&E*&]XKHNI,W8@QQ7;E/I:[/[&3L_0\&6B5/8?=EVL[T"V
M45I4'9A64/&Z?;+[SH<#P"!^ A!T@. 8$#T!"#M ^%) U $BZTPKQ?J0,LV2
MB10[D"::V$S#FFG1))_79MN76M);3CB=7"V^?;[ZNH39UQ1F-[/K= EO84F'
M*]^4"&(%'^Y19EPA+"3/$%B=PT?&)7QGY08AY:HIV0/FP#1\DJS60,M H/,(
M2RVR.[AJ[/[:=PI>IZ@9+]4;FN5/\$ 53*+:/W@-WPJQ432)FGB:Y)E%>EDG
M9=Y*"9Z0,@C@BZAUH>!#G6/^F, C7WIS@KTY\^!9QA0S%\+!7Q#X071F09<O
MAX=GX.G+X<$S:L)^JT/+%S[!MS0FOYW3)<EAP1[H[FJ82=J7-=KVC]FMTI(N
MXL]SWK?<T7ENDYPN5,,RG#J4?13*+3K)JS\&L?_^G&^_DRS]362//(UZ3Z/G
MV!-[K,G/UW1TVT/\YIQY+4EL24PBWB8CGP[4]M"3TYB![X\?!Z6G0</QH(]Y
M)&'82Q@^*^'&ID;2,-NBI$Q_?..-M%R4)9,*&I2MS+,JVWG&APK"P(WB(Z&G
M8>^&KC\\4GH:-1ZZH_#=P>^\[KC7'?^:[H.T1GFOS5OJ%^3')RN.?3<<':D_
MC8I"=WRL_C0J'+GC\$BQ=Y#W*Y1K6S\59&)3ZS;+]:-]B9[9RG0T/J?2W5;:
M_VG:NO^%R34G&TI<$:7OCFA?9%M+VXX6C:TNMT)3K;+-@CX_4)H >K\20N\[
M9H+^@R;Y#U!+ P04    " !R@$5:@) _L:X$  #W%0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970X,RYX;6RM6-MNVS@0_15"NUBT0*L+=776-N!$ZFX?F@1Q
MVSPS$FT+D40O2=OIWR]UL6Q3C**XSD-T.W/$.3.>&7&\(_29K3#FX"7/"C;1
M5IROKPR#Q2N<(Z:3-2[$DP6A.>+BDBX-MJ88)951GAG0-#TC1VFA3<?5O7LZ
M'9,-S]("WU/ -GF.Z*]KG)'=1+.T_8V'=+GBY0UC.EZC)9YC_F-]3\65T;(D
M:8X+EI("4+R8:#/K*K*\TJ!"_$SQCAV=@]*5)T*>RXNOR40SRQ7A#,>\I$#B
ML,4W.,M*)K&._QI2K7UG:7A\OF?_4CDOG'E"#-^0[#%-^&JB!1I(\ )M,OY
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MEPMZE#YX(W)%ZQIKK>*A8VT(3&%J4#,UV'NL]UO!2[R@-5S0@S;R-T9^6VR
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M "N/_,L;09?%(?@C%8*FQ>6"X(BP7$ ^?Z)4O-_D'=0?7HS_ U!+ P04
M" !R@$5:C=TO1 @$  #N#P  &0   'AL+W=O<FMS:&5E=',O<VAE970X-RYX
M;6RM5UUSHS84_2L:VNGLSC2 Q)=);<\XH=ONPV8S\39Y5D"VF8#D2K*]_?>5
M &.,A9=.XP<#XMPCG7MU+[K3 ^-O8D.(!-_+@HJ9M9%R>^LX(MV0$@N;;0E5
M;U:,EUBJ1[YVQ)83G%5&9>$@UPV=$N?4FD^KL4<^G[*=+')*'CD0N[+$_)\[
M4K##S(+6<> I7V^D'G#FTRU>DR61?VT?N7IR6I8L+PD5.:. D]7,6L#;!/K:
MH$(\Y^0@.O= 2WEE[$T_?,YFEJM71 J22DV!U65/[DE1:":UCK\;4JN=4QMV
M[X_LGRKQ2LPK%N2>%2]Y)C<S:V*!C*SPKI!/[/ G:00%FB]EA:C^P:'!NA9(
M=T*RLC%6*RAS6E_Q]\81'0,8#AB@Q@#U#?P! Z\Q\,8:^(U!Y6JGEE+Y(<$2
MSZ><'0#7:,6F;RIG5M9*?DYUW)>2J[>YLI/SKX_?/G]]6(+%0P(6+XNG9 EN
MP%+MKFQ7$,!6X('1/1&29.!)77B>ZMNE9.D;6!PPSP3XD!")\T)\5)9#F!OP
M,W" V&!.Q/&24_!MPW8"TTQ,':G$Z"4Y:;/PNWKA:&#A$($OC,J- +_3C&3G
M!([R0NL*='3%';K*F)#4!A[\%2 7^88%W8\W]PSFR7AS=$6-UP;6J_B\ 3X5
MMYOGB\#5X3!YNV;SS6RZ^MR*+4[)S%+E11"^)];\EY]@Z/YF\M1[DB7O1';F
M1;_UHG^-?7[:_5B"5[+.*<WI6N?%EO"<9>"#VL7U?OYH\FK-'E;LN@3OY[X'
MI\Z^ZRP#9A*=8Y)+3.#'+>9,6M!*"ZY*^X-CJH7]0$%P,3/R4$^! 0/CG@(3
MCV=6$+8*PJL*FNW] P'AQ<0W" 8]!290T ,E)E X$(6HU1!=U: ^7BN2CY 1
M74X.O9X* P:Y/1$F3&C6,&DU3,8G":'9^/28&-*C'QH3II="B0'32:$S47$K
M*KY:/U^J$X,NF7O"U0D(5/D"U$>6@$\XY^ 9%SMB$A6_9R5]3[+DG<C._ G=
MTTG#_?^U-&-%@;G00_7&,>Z;9J9))^#1Q([[E=4 "WT[[I6OQ  +D T'L@)V
MCE9P=(4=J:LYK*'.4J '[4Z&-LH,P!C9KN^>?OTD,=E,H!V$<><WH!F=-*.Q
M-7FD9&1856C'45^Q :>"B5SCZAO%!IO M]VAR)[.5O#JH:-7M4<*]0Q"/1OV
M/Z8F7*3"Y/7%&7!!9*.A$)Z.// _G'DNR_E(M?Y%3D$7V=%%BE[B#)F<&&#G
MF5QK=3J-4$GXNFHH!4C9CLJZ$6A'VZ9U4;5JO?$[W<Q6#=:)INZ$OV"N*I<
M!5DI2M>.U,&&U\UE_2#9MFJW7IE4S5MUNU$-.>$:H-ZO&)/'!SU!V^+/_P50
M2P,$%     @ <H!%6F&?Y==K P  W0T  !D   !X;"]W;W)K<VAE971S+W-H
M965T.#@N>&ULQ5=M;YLZ%/XK1VR:6JDMKR%9ET1*"].-U'51TVT?KNX'!YR
M!G9FFV:]VH^?;0@+*47M%=+] K8YS^-SSF,?[/&.LN\\P5C SSPC?&(D0FPO
M39-'"<X1OZ!;3.27-64Y$K++-B;?,HQB#<HST[$LW\Q12HSI6(\MV'1,"Y&E
M!"\8\"+/$7N\PAG=30S;V _<I9M$J %S.MZB#5YB\66[8+)GUBQQFF/"4TJ
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M95FY^:%JX#G+OZZZ??$_4$L#!!0    ( '* 15IJD4O%,P0  %T3   9
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M7$&< E,&\OF"4O%RHU[0G*C-?@!02P,$%     @ <H!%6B05"W-Z P  QPP
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M_*<!3$V0UY>4BJ>!VLM6_UUZ_P!02P,$%     @ <H!%6F-#]HU8!   (!T
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M(,P-^OJ2<_5V8C;)\DW1\?]02P,$%     @ <H!%6O4FQP53!   "A8  !D
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M34OU.0&N#ZC]@C'Y&N@6-WR@TO]02P,$%     @ <H!%6L\EU[;M P  Z!
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M&)9>$20024V!U=<*KB%)-)-:QX\-J5'FU,#=ZS?V+[EX)6:*!5RSY"\2R\7
MZ!DHAAG.$OG UE]A(\C7?!%+1/Z)UD5LX!@HRH1DZ0:L5I 26GSCEXT1.P [
M. !P-@"G#O . -P-P'TOP-L O-R90DKN0X@E'O8Y6R.NHQ6;OLC-S-%*/J'Z
MN3]*KNX2A9/#\.;+:'P3HNO[\=/#Z.KY:70_1I/;R_$C.@I!8I*(8W2"GA]#
M=/3I&'U"A**G!<L$IK'HFU(M01.9T2;=59'..9#.=M =HW(AT V-(:X2F&KM
MI0#G3<"5T\H80G2*7/LS<BS':UC0]?OA;@,\?#_<:5'CEH_#S?G<@WPS-1.C
M:V42)],LWQN3!%,4$A$E3&0<T-^W*@:-)*3BGZ9'4*3PFE/H0G(AECB"@:$J
MA0"^ F/X^V]V8/W19%^79&%'9!5KO=):KXU=6PN<*V\CEJJJ*7#N;4+PE"1$
MOGY&E-$H4Q%4-IE:D/LYN2ZFJV'@6K[=-U>[;NU'>>>.58L*6Q?Z'VWP2QO\
M5AMNF1#H:*Y^$8Z1TA_GKN!$[>L5")D>4%]P!CNZ3GS;/ZNI;XCR M>KJ??W
M/;)[O3*HHBHH506MJNYG,P%2$CI'\**?+J C0M63AN,F.<'>$GS?/Z^I"?;4
M>+U>37*X'W3B[;X6%35GI9JS5C5_9C@A,Z+>5;WUFP2TXC^ZQ;LD"SLBJ_C6
M*WWK_?KJV>O2VB[)PH[(*M:>E]:>M[Z2=_B%I%F*,*7JY50U=.NP0$O@"-)E
MPEX!FBPMJ&UK9Y=8I_7MUIK_HU9U1%:QRK:V9RJKU:R;H@3%ZJ FHX4N2A6_
M&H]-UEY)<GW7J7G4$.7TW*!6DYJB5(EMKDGVSDG1;E4U9O3'3PM3.\='MT^G
M;&%7;%7_G*U_SJ^O3IL<7?G;)5O8%5O5W^W1V6X]/OZ_$K7AKM2H^N&N/?^'
MW>KT,&SNM( I\'G>2@ME0D9ET4R5LV6[?IDWJ;7Y*]W&YZWEEJ;X#^ .\SE1
M5B8P4Y36Z9DJ,+QHJXN!9,N\T9PRJ=K6_'(!. :N ]3]&6/R;: 3E']N#/\%
M4$L#!!0    ( '* 15J_#%RGN@,  '8/   9    >&PO=V]R:W-H965T<R]S
M:&5E=#DW+GAM;,5786^;.A3]*Q:;IDUZ*1@()%T2*4W:O4A95S7I>Q^>W@>'
M7!)K@#/;--N_?S90 @G-VB>D?FDPW'M\[O&Q>SW8,_Y=; $D^AE'B1@:6REW
MEZ8I@BW$1%RP'23J2\AX3*0:\HTI=AS(.DN*(].V+,^,"4V,T2![=\=' Y;*
MB"9PQY%(XYCP7U<0L?W0P,;3BWNZV4K]PAP-=F0#"Y /NSNN1F:)LJ8Q)(*R
M!'$(A\887TZPJQ.RB+\H[$7E&>E25HQ]UX/9>FA8FA%$$$@-0=3/(TP@BC22
MXO&C #7*.75B]?D)_28K7A6S(@(F+/J;KN5V:/0,M(:0I)&\9_L_H2BHJ_$"
M%HGL+]H7L9:!@E1(%A?)BD%,D_R7_"R$J"2H0IL3["+!?FF"4R0X6:$YLZRL
M*9%D-.!LC[B.5FCZ(=,FRU;5T$0OXT)R]96J/#E:7,]OT.QV\7 _OIU<H_EL
M?#6;SY:SZP7JH(4RS3J- +$0W:0RY8 6$(5HEHB4DR0 -*=D12,J*0CT<0J2
MT$A\4ID/BRGZ^/X3>H]H@I9;E@J2K,7 E(JRGM@,"GI7.3W[&7I3""Z0@_]
MMF6[#>F3EZ<[]713"56J99=JV1F>\PQ>M5RUA="7E"@=)*BALN2<)9O.5"F3
M&73"$LF52P7Z9ZY@T$Q"+/YMDB"?TVV>4^_C2[$C 0P-M5$%\$<P1A_>8<_Z
MW"1(2V U>9Q2'N<<^FCY;3F>(VVI3J.EFHK/$;L9HCYS'D<VQG[7'IB/U;).
MP[#7[6.K#*L1=DO"[EG"<Q#B4FTSSB&12!TN88>6WHX.B]U$/$?V*HP\WW'P
M$>_3J*[K>6XS[6Y)NWN>]K?;+YWE]?W75VK=/2&#7=>UCSDWA&%LNUXS::\D
M[9TE/0X"GL(:;2 !3J)2WE]('0UHQUFH%D-M'/4I)M%.;QWZ^U4X.^=K]TY+
M8#5Y_%(>_PV.%K]->5H"J\G3*^7IM7ZT]$Y][%G8[1_9O2$,^[[[S![MEX3[
M+[*[[F* BP_O>C;V/Z. Q:H#$_DZ_L;;9R=X[>*U!%;3 EN'+L-Z W<7D[:D
M4%MH=8DJC1ANW>$%9-6[CF_WCP_TIC#'J?R/K5,^=$/X;#=1>GP+)));M%(G
M>TAE<YO7:I/3%EJ][D.;@YVW<//9YNK5$K6$5I?HT%CA\YW5_W*S>]KDN0X^
M;@4;PWKX^+PV*Y<B?2/]2OA&-7<H@E#E61>^ N#Y)2\?2+;+[DDK)M6M*WM4
MQEX#UP'J>\B8?!KHJU=YU1[]!U!+ P04    " !R@$5:U]48(4D#  "G"
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MSH#>+Y6R^XG;H/TV&?\-4$L#!!0    ( '* 15K8^CJR.0(  ! %   9
M>&PO=V]R:W-H965T<R]S:&5E=#DY+GAM;*U4WV_:,!#^5ZRLFEIIPR2!LK$0
MB5_M(C&$H&P/TQY,.(C5Q,YLAW3__6PG1%0*4Q_VDMR=[_M\W]GGH.3B628
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M<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ <H!%6N<^T)"'!P  +4(
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MJWI;@-Y6];8 O:WJ;0%Z6]7; O2VJK<%Z&U5;PO0VZG>#J"W4[T=0&^G>CN
MWJYZ6 +0VZG>#J"W4[T=0&^G>CN WD[U=@"]G>KM 'H[U=L!]/:JMP?H[55O
M#]#;J]X>H+=7O3U ;U\][ ;H[55O#]#;J]X>H+=7O3U ;Z]Z>X#>7O7V +V#
MZAT >@?5.P#T#JIW .@=5.\ T#NHW@&@=ZC^K 3H'53O - [J-X!H'=0O0-
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M\DS[JAU>\L7R+\J;GU!+ 0(4 Q0    ( '* 15H'04UB@0   +$    0
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M965T,RYX;6Q02P$"% ,4    " !R@$5:.TVM6A\#  #@"   &
M    @(&@&@  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @
M<H!%6C]5>3?9!@  CA\  !@              ("!]1T  'AL+W=O<FMS:&5E
M=',O<VAE970U+GAM;%!+ 0(4 Q0    ( '* 15K9IS$  PP  %)P   8
M          " @00E  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M    " !R@$5:QY"SDZ4"  #%!@  &               @($],0  >&PO=V]R
M:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ <H!%6M@WG\=$#   :SP
M !@              ("!&#0  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+
M 0(4 Q0    ( '* 15JO^*WDW@8  -40   8              " @9)   !X
M;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " !R@$5:4QN,C\XC
M  ";=0  &0              @(&F1P  >&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;%!+ 0(4 Q0    ( '* 15K=PD^";@L   X>   9              "
M@:MK  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ <H!%
M6OPOF[*E!   30P  !D              ("!4'<  'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6Q02P$"% ,4    " !R@$5:)S@+O4$$  "Q"0  &0
M        @($L?   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0
M   ( '* 15HM)SM17PL  ,0C   9              " @:2   !X;"]W;W)K
M<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ <H!%6GU]XH[$"   X!L
M !D              ("!.HP  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q0
M2P$"% ,4    " !R@$5:Z?)A4E4,   ^+P  &0              @($UE0
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( '* 15K@#'VS
MX ,  (@(   9              " @<&A  !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&UL4$L! A0#%     @ <H!%6OS:N_XP!   2@D  !D
M ("!V*4  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " !R
M@$5:0KFCV[X#   I"   &0              @($_J@  >&PO=V]R:W-H965T
M<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( '* 15H/M8!*C 0  )D)   9
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M970R-"YX;6Q02P$"% ,4    " !R@$5:0]):-FD%   ##0  &0
M    @(%GX@  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (
M '* 15KL#^XL,@0   L*   9              " @0?H  !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&UL4$L! A0#%     @ <H!%6E:#XK_0"P  $1T  !D
M             ("!<.P  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"
M% ,4    " !R@$5::XR2ZXP$  #9#   &0              @(%W^   >&PO
M=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( '* 15H%,)VN9 (
M (@&   9              " @3K]  !X;"]W;W)K<VAE971S+W-H965T,CDN
M>&UL4$L! A0#%     @ <H!%6G4^^2$R!0  0!P  !D              ("!
MU?\  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " !R@$5:
M/*4S.!$"  #=!   &0              @($^!0$ >&PO=V]R:W-H965T<R]S
M:&5E=#,Q+GAM;%!+ 0(4 Q0    ( '* 15I9_J#HGQ$  %!(   9
M      " @88' 0!X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%
M  @ <H!%6I9@ S,='@  ,6,  !D              ("!7!D! 'AL+W=O<FMS
M:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " !R@$5:__.[;;$$  "J"@
M&0              @(&P-P$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+
M 0(4 Q0    ( '* 15IMCF@:/P0  (X+   9              " @9@\ 0!X
M;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ <H!%6F[IE7IP
M P  _ 8  !D              ("!#D$! 'AL+W=O<FMS:&5E=',O<VAE970S
M-BYX;6Q02P$"% ,4    " !R@$5:L;D9A@8)  "B)   &0
M@(&U1 $ >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( '*
M15H.!W8K( ,  'D&   9              " @?)- 0!X;"]W;W)K<VAE971S
M+W-H965T,S@N>&UL4$L! A0#%     @ <H!%6KR1@+?G P  4 D  !D
M         ("!25$! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4
M    " !R@$5:A^*D$NX"  !A!@  &0              @(%G50$ >&PO=V]R
M:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( '* 15JQ![2W"P,  %$&
M   9              " @8Q8 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL
M4$L! A0#%     @ <H!%6E= )WA*!0  $0P  !D              ("!SEL!
M 'AL+W=O<FMS:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " !R@$5:T+JR
MIT@#   I!P  &0              @(%/80$ >&PO=V]R:W-H965T<R]S:&5E
M=#0S+GAM;%!+ 0(4 Q0    ( '* 15J)LX8[! @   47   9
M  " @<YD 0!X;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @
M<H!%6B8TJIWN!0  /@\  !D              ("!"6T! 'AL+W=O<FMS:&5E
M=',O<VAE970T-2YX;6Q02P$"% ,4    " !R@$5:,/%4P/ #  "L"0  &0
M            @($N<P$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4
M Q0    ( '* 15I"YIQD P0  /82   9              " @55W 0!X;"]W
M;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @ <H!%6IKW."58 @
MZ08  !D              ("!CWL! 'AL+W=O<FMS:&5E=',O<VAE970T."YX
M;6Q02P$"% ,4    " !R@$5:AD8&6^L"  "@"0  &0              @($>
M?@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4 Q0    ( '* 15K4
M]7V'VP(  $4+   9              " @4"! 0!X;"]W;W)K<VAE971S+W-H
M965T-3 N>&UL4$L! A0#%     @ <H!%6L7XTH6("   EUH  !D
M     ("!4H0! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( '* 15HO:;CT_ (  !@)   9              "
M@1:B 0!X;"]W;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ <H!%
M6C.I=@3@%   N20! !D              ("!2:4! 'AL+W=O<FMS:&5E=',O
M<VAE970U-RYX;6Q02P$"% ,4    " !R@$5:!BV:0%H+  !;F@  &0
M        @(%@N@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0
M   ( '* 15K96+8QV 0  %T:   9              " @?'% 0!X;"]W;W)K
M<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ <H!%6IRW6^-? P  ) \
M !D              ("! ,L! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q0
M2P$"% ,4    " !R@$5:Q(6F1'H)  !I30  &0              @(&6S@$
M>&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( '* 15H33>J*
M=@L  !QV   9              " @4?8 0!X;"]W;W)K<VAE971S+W-H965T
M-C(N>&UL4$L! A0#%     @ <H!%6HX(,&%,!   BA8  !D
M ("!].,! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q02P$"% ,4    " !R
M@$5:3\Z4=D$#  !O"@  &0              @(%WZ $ >&PO=V]R:W-H965T
M<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    ( '* 15KN8GHND 0  'X5   9
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M970V.2YX;6Q02P$"% ,4    " !R@$5:^WFJ"Z$"  ##!P  &0
M    @(&B_@$ >&PO=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    (
M '* 15KHA\09A ,  %\-   9              " @7H! @!X;"]W;W)K<VAE
M971S+W-H965T-S$N>&UL4$L! A0#%     @ <H!%6F.(T#QP P  8 P  !D
M             ("!-04" 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"
M% ,4    " !R@$5:S"@]*4T#   ."P  &0              @('<" ( >&PO
M=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+ 0(4 Q0    ( '* 15HU6=D+SP(
M &8(   9              " @6 , @!X;"]W;W)K<VAE971S+W-H965T-S0N
M>&UL4$L! A0#%     @ <H!%6BCR_B4+!   A0T  !D              ("!
M9@\" 'AL+W=O<FMS:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    " !R@$5:
M1H[/'>\"   @"0  &0              @(&H$P( >&PO=V]R:W-H965T<R]S
M:&5E=#<V+GAM;%!+ 0(4 Q0    ( '* 15JHD!DJ800  "\4   9
M      " @<X6 @!X;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%
M  @ <H!%6I@*Q:XD!@  M2D  !D              ("!9AL" 'AL+W=O<FMS
M:&5E=',O<VAE970W."YX;6Q02P$"% ,4    " !R@$5:] "L%'X"  "X!@
M&0              @('!(0( >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+
M 0(4 Q0    ( '* 15IHE3:SE 4  ',>   9              " @78D @!X
M;"]W;W)K<VAE971S+W-H965T.# N>&UL4$L! A0#%     @ <H!%6N1/U.%%
M P  ?0H  !D              ("!02H" 'AL+W=O<FMS:&5E=',O<VAE970X
M,2YX;6Q02P$"% ,4    " !R@$5:*?S6("L#  #<"   &0
M@(&]+0( >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;%!+ 0(4 Q0    ( '*
M15J D#^QK@0  /<5   9              " @1\Q @!X;"]W;W)K<VAE971S
M+W-H965T.#,N>&UL4$L! A0#%     @ <H!%6F: \;FP!P  H#D  !D
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M=#@X+GAM;%!+ 0(4 Q0    ( '* 15I8^F7L$04  *L<   9
M  " @39. @!X;"]W;W)K<VAE971S+W-H965T.#DN>&UL4$L! A0#%     @
M<H!%6O5!P:UZ$0  +]P  !D              ("!?E," 'AL+W=O<FMS:&5E
M=',O<VAE970Y,"YX;6Q02P$"% ,4    " !R@$5::I%+Q3,$  !=$P  &0
M            @($O90( >&PO=V]R:W-H965T<R]S:&5E=#DQ+GAM;%!+ 0(4
M Q0    ( '* 15HD%0MS>@,  ,<,   9              " @9EI @!X;"]W
M;W)K<VAE971S+W-H965T.3(N>&UL4$L! A0#%     @ <H!%6F-#]HU8!
M(!T  !D              ("!2FT" 'AL+W=O<FMS:&5E=',O<VAE970Y,RYX
M;6Q02P$"% ,4    " !R@$5:]2;'!5,$   *%@  &0              @('9
M<0( >&PO=V]R:W-H965T<R]S:&5E=#DT+GAM;%!+ 0(4 Q0    ( '* 15J'
M W_A=P(  *P&   9              " @6-V @!X;"]W;W)K<VAE971S+W-H
M965T.34N>&UL4$L! A0#%     @ <H!%6L\EU[;M P  Z!   !D
M     ("!$7D" 'AL+W=O<FMS:&5E=',O<VAE970Y-BYX;6Q02P$"% ,4
M" !R@$5:OPQ<I[H#  !V#P  &0              @($U?0( >&PO=V]R:W-H
M965T<R]S:&5E=#DW+GAM;%!+ 0(4 Q0    ( '* 15K7U1@A20,  *<(   9
M              " @2:! @!X;"]W;W)K<VAE971S+W-H965T.3@N>&UL4$L!
M A0#%     @ <H!%6MCZ.K(Y @  $ 4  !D              ("!IH0" 'AL
M+W=O<FMS:&5E=',O<VAE970Y.2YX;6Q02P$"% ,4    " !R@$5:NF&KV $$
M   Y$P  &@              @($6AP( >&PO=V]R:W-H965T<R]S:&5E=#$P
M,"YX;6Q02P$"% ,4    " !R@$5:=Z603-8$  "X)@  &@
M@(%/BP( >&PO=V]R:W-H965T<R]S:&5E=#$P,2YX;6Q02P$"% ,4    " !R
M@$5:[B;+PCD#  #R$P  #0              @ %=D ( >&PO<W1Y;&5S+GAM
M;%!+ 0(4 Q0    ( '* 15J7BKL<P    !,"   +              "  <&3
M @!?<F5L<R\N<F5L<U!+ 0(4 Q0    ( '* 15KG/M"0AP<  "U"   /
M          "  :J4 @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !R@$5:
M8\012MT"  !<.P  &@              @ %>G ( >&PO7W)E;',O=V]R:V)O
M;VLN>&UL+G)E;'-02P$"% ,4    " !R@$5:?^!#S%L"  !-.0  $P
M        @ %SGP( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     ;0!M /0=
(  #_H0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>483</ContextCount>
  <ElementCount>486</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>141</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>16</UnitCount>
  <MyReports>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLE</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE</Role>
      <ShortName>COMPUTATION OF NET INCOME PER COMMON SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - STANDARD BEARER</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/STANDARDBEARER</Role>
      <ShortName>STANDARD BEARER</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - OPERATION EXPANSIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPERATIONEXPANSIONS</Role>
      <ShortName>OPERATION EXPANSIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - BUSINESS SEGMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/BUSINESSSEGMENTS</Role>
      <ShortName>BUSINESS SEGMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - PROPERTY AND EQUIPMENT??? NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNET</Role>
      <ShortName>PROPERTY AND EQUIPMENT??? NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - INTANGIBLE ASSETS ??? NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INTANGIBLEASSETSNET</Role>
      <ShortName>INTANGIBLE ASSETS ??? NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - GOODWILL</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/GOODWILL</Role>
      <ShortName>GOODWILL</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - OTHER ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIES</Role>
      <ShortName>OTHER ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - OPTIONS AND AWARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDS</Role>
      <ShortName>OPTIONS AND AWARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - DEFINED CONTRIBUTION PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANS</Role>
      <ShortName>DEFINED CONTRIBUTION PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - SELF INSURANCE LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SELFINSURANCELIABILITIES</Role>
      <ShortName>SELF INSURANCE LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9952175 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9952176 - Disclosure - COMMON STOCK REPURCHASE PROGRAM</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAM</Role>
      <ShortName>COMMON STOCK REPURCHASE PROGRAM</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLETables</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLE</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables</Role>
      <ShortName>COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - OPERATION EXPANSIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPERATIONEXPANSIONSTables</Role>
      <ShortName>OPERATION EXPANSIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/OPERATIONEXPANSIONS</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - BUSINESS SEGMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/BUSINESSSEGMENTSTables</Role>
      <ShortName>BUSINESS SEGMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/BUSINESSSEGMENTS</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - PROPERTY AND EQUIPMENT??? NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT??? NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNET</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - INTANGIBLE ASSETS ??? NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INTANGIBLEASSETSNETTables</Role>
      <ShortName>INTANGIBLE ASSETS ??? NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/INTANGIBLEASSETSNET</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - GOODWILL (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/GOODWILLTables</Role>
      <ShortName>GOODWILL (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/GOODWILL</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESTables</Role>
      <ShortName>OTHER ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIES</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/INCOMETAXES</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/DEBT</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - OPTIONS AND AWARDS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables</Role>
      <ShortName>OPTIONS AND AWARDS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/OPTIONSANDAWARDS</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/LEASES</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - SELF INSURANCE LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESTables</Role>
      <ShortName>SELF INSURANCE LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/SELFINSURANCELIABILITIES</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - DESCRIPTION OF BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESS</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-Insurance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-Insurance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails</Role>
      <ShortName>COMPUTATION OF NET INCOME PER COMMON SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - FAIR VALUE MEASUREMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>56</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - STANDARD BEARER (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/STANDARDBEARERDetails</Role>
      <ShortName>STANDARD BEARER (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/STANDARDBEARER</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - OPERATION EXPANSIONS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails</Role>
      <ShortName>OPERATION EXPANSIONS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - OPERATION EXPANSIONS - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails</Role>
      <ShortName>OPERATION EXPANSIONS - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - BUSINESS SEGMENTS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails</Role>
      <ShortName>BUSINESS SEGMENTS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - BUSINESS SEGMENTS - Schedule of Segment Financial Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails</Role>
      <ShortName>BUSINESS SEGMENTS - Schedule of Segment Financial Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - BUSINESS SEGMENTS - Schedule of Service Revenue by Major Payor Source (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails</Role>
      <ShortName>BUSINESS SEGMENTS - Schedule of Service Revenue by Major Payor Source (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - PROPERTY AND EQUIPMENT??? NET - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT??? NET - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - PROPERTY AND EQUIPMENT??? NET - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT??? NET - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - INTANGIBLE ASSETS ??? NET - Schedule of Finite Lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>INTANGIBLE ASSETS ??? NET - Schedule of Finite Lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - INTANGIBLE ASSETS ??? NET - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails</Role>
      <ShortName>INTANGIBLE ASSETS ??? NET - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - INTANGIBLE ASSETS ??? NET - Schedule of Estimated Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails</Role>
      <ShortName>INTANGIBLE ASSETS ??? NET - Schedule of Estimated Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - INTANGIBLE ASSETS ??? NET - Schedule of Indefinite-lived Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails</Role>
      <ShortName>INTANGIBLE ASSETS ??? NET - Schedule of Indefinite-lived Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - GOODWILL - Schedule of Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails</Role>
      <ShortName>GOODWILL - Schedule of Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - GOODWILL - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/GOODWILLNarrativeDetails</Role>
      <ShortName>GOODWILL - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - OTHER ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails</Role>
      <ShortName>OTHER ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESTables</ParentRole>
      <Position>71</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - INCOME TAXES - Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails</Role>
      <ShortName>INCOME TAXES - Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - INCOME TAXES - Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails</Role>
      <ShortName>INCOME TAXES - Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - INCOME TAXES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>INCOME TAXES - Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - DEBT - Schedule of Long-term Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails</Role>
      <ShortName>DEBT - Schedule of Long-term Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - DEBT - Credit Facility with a Lending Consortium Arranged by Truist (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails</Role>
      <ShortName>DEBT - Credit Facility with a Lending Consortium Arranged by Truist (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - DEBT - Mortgage Loans and Promissory Notes and Off-Balance Sheet Arrangements (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails</Role>
      <ShortName>DEBT - Mortgage Loans and Promissory Notes and Off-Balance Sheet Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - DEBT - Long-term Debt Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails</Role>
      <ShortName>DEBT - Long-term Debt Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - OPTIONS AND AWARDS - Stock Options, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Stock Options, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - OPTIONS AND AWARDS - Schedule of Assumptions for Stock Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Schedule of Assumptions for Stock Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - OPTIONS AND AWARDS - Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - OPTIONS AND AWARDS - Schedule of Employee Stock Option Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Schedule of Employee Stock Option Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - OPTIONS AND AWARDS - Options Outstanding by Exercise Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Options Outstanding by Exercise Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - OPTIONS AND AWARDS - Schedule of Aggregate Intrinsic Value of Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Schedule of Aggregate Intrinsic Value of Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - OPTIONS AND AWARDS - Restricted Stock Awards, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Restricted Stock Awards, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - OPTIONS AND AWARDS - Schedule of Nonvested Restricted Stock Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Schedule of Nonvested Restricted Stock Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - OPTIONS AND AWARDS - Long-Term Incentive Plan, Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Long-Term Incentive Plan, Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - OPTIONS AND AWARDS - Schedule of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails</Role>
      <ShortName>OPTIONS AND AWARDS - Schedule of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - LEASES - Lessee Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails</Role>
      <ShortName>LEASES - Lessee Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - LEASES - Schedule of Operating Lease Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails</Role>
      <ShortName>LEASES - Schedule of Operating Lease Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>9955570 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>LEASES - Schedule of Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>9955571 - Disclosure - LEASES - Lessor Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails</Role>
      <ShortName>LEASES - Lessor Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>9955572 - Disclosure - LEASES - Schedule of Rental Income from Third-Party Sources (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails</Role>
      <ShortName>LEASES - Schedule of Rental Income from Third-Party Sources (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>9955573 - Disclosure - LEASES - Schedule of Annual Rental Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails</Role>
      <ShortName>LEASES - Schedule of Annual Rental Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>9955574 - Disclosure - DEFINED CONTRIBUTION PLANS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails</Role>
      <ShortName>DEFINED CONTRIBUTION PLANS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANS</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>9955575 - Disclosure - SELF INSURANCE LIABILITIES - Schedule of Future Self Insurance Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails</Role>
      <ShortName>SELF INSURANCE LIABILITIES - Schedule of Future Self Insurance Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>9955576 - Disclosure - SELF INSURANCE LIABILITIES - Schedule of Insurance Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails</Role>
      <ShortName>SELF INSURANCE LIABILITIES - Schedule of Insurance Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>9955577 - Disclosure - SELF INSURANCE LIABILITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESNarrativeDetails</Role>
      <ShortName>SELF INSURANCE LIABILITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>9955578 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="ensg-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>9955579 - Disclosure - COMMON STOCK REPURCHASE PROGRAM (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails</Role>
      <ShortName>COMMON STOCK REPURCHASE PROGRAM (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAM</ParentRole>
      <Position>101</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="ensg-20241231.htm">ensg-20241231.htm</File>
    <File>ensg-20241231.xsd</File>
    <File>ensg-20241231_cal.xml</File>
    <File>ensg-20241231_def.xml</File>
    <File>ensg-20241231_lab.xml</File>
    <File>ensg-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>ensg-20241231_g1.jpg</File>
    <File>ensg-20241231_g2.jpg</File>
    <File>ensg-20241231_g3.jpg</File>
    <File>ensg-20241231_g4.jpg</File>
    <File>ensg-20241231_g5.jpg</File>
    <File>ensg-20241231_g6.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="1405">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="15">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="20">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>130
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ensg-20241231.htm": {
   "nsprefix": "ensg",
   "nsuri": "http://www.ensigngroup.net/20241231",
   "dts": {
    "inline": {
     "local": [
      "ensg-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "ensg-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "ensg-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ensg-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ensg-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ensg-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 420,
   "keyCustom": 66,
   "axisStandard": 33,
   "axisCustom": 7,
   "memberStandard": 51,
   "memberCustom": 85,
   "hidden": {
    "total": 14,
    "http://fasb.org/us-gaap/2024": 8,
    "http://xbrl.sec.gov/ecd/2024": 2,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "contextCount": 483,
   "entityCount": 1,
   "segmentCount": 141,
   "elementCount": 895,
   "unitCount": 16,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1405,
    "http://xbrl.sec.gov/dei/2024": 38,
    "http://xbrl.sec.gov/ecd/2024": 20,
    "http://xbrl.sec.gov/cyd/2024": 15,
    "http://fasb.org/srt/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://www.ensigngroup.net/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.ensigngroup.net/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "9952151 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "9952152 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "longName": "9952153 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfGoodsAndServicesSold",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "longName": "9952154 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical",
     "longName": "9952155 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "9952156 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfFinancingCostsAndDiscounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESS",
     "longName": "9952157 - Disclosure - DESCRIPTION OF BUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "longName": "9952158 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLE",
     "longName": "9952159 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE",
     "longName": "9952160 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE",
     "shortName": "COMPUTATION OF NET INCOME PER COMMON SHARE",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTS",
     "longName": "9952161 - Disclosure - FAIR VALUE MEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.ensigngroup.net/role/STANDARDBEARER",
     "longName": "9952162 - Disclosure - STANDARD BEARER",
     "shortName": "STANDARD BEARER",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ensg:StandardBearerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ensg:StandardBearerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.ensigngroup.net/role/OPERATIONEXPANSIONS",
     "longName": "9952163 - Disclosure - OPERATION EXPANSIONS",
     "shortName": "OPERATION EXPANSIONS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.ensigngroup.net/role/BUSINESSSEGMENTS",
     "longName": "9952164 - Disclosure - BUSINESS SEGMENTS",
     "shortName": "BUSINESS SEGMENTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNET",
     "longName": "9952165 - Disclosure - PROPERTY AND EQUIPMENT\u2014 NET",
     "shortName": "PROPERTY AND EQUIPMENT\u2014 NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.ensigngroup.net/role/INTANGIBLEASSETSNET",
     "longName": "9952166 - Disclosure - INTANGIBLE ASSETS \u2014 NET",
     "shortName": "INTANGIBLE ASSETS \u2014 NET",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.ensigngroup.net/role/GOODWILL",
     "longName": "9952167 - Disclosure - GOODWILL",
     "shortName": "GOODWILL",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIES",
     "longName": "9952168 - Disclosure - OTHER ACCRUED LIABILITIES",
     "shortName": "OTHER ACCRUED LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.ensigngroup.net/role/INCOMETAXES",
     "longName": "9952169 - Disclosure - INCOME TAXES",
     "shortName": "INCOME TAXES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.ensigngroup.net/role/DEBT",
     "longName": "9952170 - Disclosure - DEBT",
     "shortName": "DEBT",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDS",
     "longName": "9952171 - Disclosure - OPTIONS AND AWARDS",
     "shortName": "OPTIONS AND AWARDS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.ensigngroup.net/role/LEASES",
     "longName": "9952172 - Disclosure - LEASES",
     "shortName": "LEASES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasesOfLessorDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANS",
     "longName": "9952173 - Disclosure - DEFINED CONTRIBUTION PLANS",
     "shortName": "DEFINED CONTRIBUTION PLANS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIES",
     "longName": "9952174 - Disclosure - SELF INSURANCE LIABILITIES",
     "shortName": "SELF INSURANCE LIABILITIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIES",
     "longName": "9952175 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAM",
     "longName": "9952176 - Disclosure - COMMON STOCK REPURCHASE PROGRAM",
     "shortName": "COMMON STOCK REPURCHASE PROGRAM",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R30": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-477",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-477",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "longName": "9955511 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLETables",
     "longName": "9955512 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE (Tables)",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables",
     "longName": "9955513 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)",
     "shortName": "COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSTables",
     "longName": "9955514 - Disclosure - OPERATION EXPANSIONS (Tables)",
     "shortName": "OPERATION EXPANSIONS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.ensigngroup.net/role/BUSINESSSEGMENTSTables",
     "longName": "9955515 - Disclosure - BUSINESS SEGMENTS (Tables)",
     "shortName": "BUSINESS SEGMENTS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETTables",
     "longName": "9955516 - Disclosure - PROPERTY AND EQUIPMENT\u2014 NET (Tables)",
     "shortName": "PROPERTY AND EQUIPMENT\u2014 NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETTables",
     "longName": "9955517 - Disclosure - INTANGIBLE ASSETS \u2014 NET (Tables)",
     "shortName": "INTANGIBLE ASSETS \u2014 NET (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.ensigngroup.net/role/GOODWILLTables",
     "longName": "9955518 - Disclosure - GOODWILL (Tables)",
     "shortName": "GOODWILL (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESTables",
     "longName": "9955519 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)",
     "shortName": "OTHER ACCRUED LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.ensigngroup.net/role/INCOMETAXESTables",
     "longName": "9955520 - Disclosure - INCOME TAXES (Tables)",
     "shortName": "INCOME TAXES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.ensigngroup.net/role/DEBTTables",
     "longName": "9955521 - Disclosure - DEBT (Tables)",
     "shortName": "DEBT (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables",
     "longName": "9955522 - Disclosure - OPTIONS AND AWARDS (Tables)",
     "shortName": "OPTIONS AND AWARDS (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.ensigngroup.net/role/LEASESTables",
     "longName": "9955523 - Disclosure - LEASES (Tables)",
     "shortName": "LEASES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESTables",
     "longName": "9955524 - Disclosure - SELF INSURANCE LIABILITIES (Tables)",
     "shortName": "SELF INSURANCE LIABILITIES (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
     "longName": "9955525 - Disclosure - DESCRIPTION OF BUSINESS (Details)",
     "shortName": "DESCRIPTION OF BUSINESS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-52",
      "name": "ensg:NumberOfFacilitiesUnderLongTermLeaseArrangements",
      "unitRef": "facility",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails",
     "longName": "9955526 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-56",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-56",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails",
     "longName": "9955527 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Leases (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "ensg:NumberOfFinancingLeases",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "ensg:NumberOfFinancingLeases",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeLeasesPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails",
     "longName": "9955528 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets and Goodwill (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Intangible Assets and Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-58",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-58",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails",
     "longName": "9955529 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-Insurance (Details)",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Self-Insurance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:SelfInsuranceReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-76",
      "name": "us-gaap:SelfInsuranceReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
     "longName": "9955530 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Narrative (Details)",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ensg:FamilyFirstCoronavirusResponseActPaymentsReceived",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails",
     "longName": "9955531 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Disaggregation of Revenue (Details)",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R54": {
     "role": "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails",
     "longName": "9955532 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Accounts Receivable (Details)",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE - Schedule of Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails",
     "longName": "9955533 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Details)",
     "shortName": "COMPUTATION OF NET INCOME PER COMMON SHARE (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails",
     "longName": "9955534 - Disclosure - FAIR VALUE MEASUREMENTS (Details)",
     "shortName": "FAIR VALUE MEASUREMENTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-128",
      "name": "us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
     "longName": "9955535 - Disclosure - STANDARD BEARER (Details)",
     "shortName": "STANDARD BEARER (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ensg:NumberOfLeaseArrangements",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
     "longName": "9955536 - Disclosure - OPERATION EXPANSIONS - Narrative (Details)",
     "shortName": "OPERATION EXPANSIONS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-176",
      "name": "ensg:NumberOfSkilledNursingBeds",
      "unitRef": "bed",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails",
     "longName": "9955537 - Disclosure - OPERATION EXPANSIONS - Purchase Price Allocation (Details)",
     "shortName": "OPERATION EXPANSIONS - Purchase Price Allocation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-200",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
     "longName": "9955538 - Disclosure - BUSINESS SEGMENTS - Narrative (Details)",
     "shortName": "BUSINESS SEGMENTS - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
     "longName": "9955539 - Disclosure - BUSINESS SEGMENTS - Schedule of Segment Financial Information (Details)",
     "shortName": "BUSINESS SEGMENTS - Schedule of Segment Financial Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-216",
      "name": "ensg:SegmentIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
     "longName": "9955540 - Disclosure - BUSINESS SEGMENTS - Schedule of Service Revenue by Major Payor Source (Details)",
     "shortName": "BUSINESS SEGMENTS - Schedule of Service Revenue by Major Payor Source (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-259",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails",
     "longName": "9955541 - Disclosure - PROPERTY AND EQUIPMENT\u2014 NET - Schedule of Property and Equipment, Net (Details)",
     "shortName": "PROPERTY AND EQUIPMENT\u2014 NET - Schedule of Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails",
     "longName": "9955542 - Disclosure - PROPERTY AND EQUIPMENT\u2014 NET - Narrative (Details)",
     "shortName": "PROPERTY AND EQUIPMENT\u2014 NET - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails",
     "longName": "9955543 - Disclosure - INTANGIBLE ASSETS \u2014 NET - Schedule of Finite Lived Intangible Assets (Details)",
     "shortName": "INTANGIBLE ASSETS \u2014 NET - Schedule of Finite Lived Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
     "longName": "9955544 - Disclosure - INTANGIBLE ASSETS \u2014 NET - Narrative (Details)",
     "shortName": "INTANGIBLE ASSETS \u2014 NET - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails",
     "longName": "9955545 - Disclosure - INTANGIBLE ASSETS \u2014 NET - Schedule of Estimated Amortization Expense (Details)",
     "shortName": "INTANGIBLE ASSETS \u2014 NET - Schedule of Estimated Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails",
     "longName": "9955546 - Disclosure - INTANGIBLE ASSETS \u2014 NET - Schedule of Indefinite-lived Intangible Assets (Details)",
     "shortName": "INTANGIBLE ASSETS \u2014 NET - Schedule of Indefinite-lived Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails",
     "longName": "9955547 - Disclosure - GOODWILL - Schedule of Goodwill (Details)",
     "shortName": "GOODWILL - Schedule of Goodwill (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:Goodwill",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.ensigngroup.net/role/GOODWILLNarrativeDetails",
     "longName": "9955548 - Disclosure - GOODWILL - Narrative (Details)",
     "shortName": "GOODWILL - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetImpairment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetImpairment",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetImpairment",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "us-gaap:GoodwillAndIntangibleAssetImpairment",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails",
     "longName": "9955549 - Disclosure - OTHER ACCRUED LIABILITIES (Details)",
     "shortName": "OTHER ACCRUED LIABILITIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "ensg:QualityAssuranceFee",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "ensg:QualityAssuranceFee",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails",
     "longName": "9955550 - Disclosure - INCOME TAXES - Expense (Details)",
     "shortName": "INCOME TAXES - Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails",
     "longName": "9955551 - Disclosure - INCOME TAXES - Tax Rate (Details)",
     "shortName": "INCOME TAXES - Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.ensigngroup.net/role/INCOMETAXESNarrativeDetails",
     "longName": "9955552 - Disclosure - INCOME TAXES - Narrative (Details)",
     "shortName": "INCOME TAXES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R75": {
     "role": "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955553 - Disclosure - INCOME TAXES - Deferred Tax Assets and Liabilities (Details)",
     "shortName": "INCOME TAXES - Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails",
     "longName": "9955554 - Disclosure - DEBT - Schedule of Long-term Debt (Details)",
     "shortName": "DEBT - Schedule of Long-term Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
     "longName": "9955555 - Disclosure - DEBT - Credit Facility with a Lending Consortium Arranged by Truist (Details)",
     "shortName": "DEBT - Credit Facility with a Lending Consortium Arranged by Truist (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-333",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-333",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
     "longName": "9955556 - Disclosure - DEBT - Mortgage Loans and Promissory Notes and Off-Balance Sheet Arrangements (Details)",
     "shortName": "DEBT - Mortgage Loans and Promissory Notes and Off-Balance Sheet Arrangements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LettersOfCreditOutstandingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LettersOfCreditOutstandingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails",
     "longName": "9955557 - Disclosure - DEBT - Long-term Debt Arrangements (Details)",
     "shortName": "DEBT - Long-term Debt Arrangements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails",
     "longName": "9955558 - Disclosure - OPTIONS AND AWARDS - Stock Options, Narrative (Details)",
     "shortName": "OPTIONS AND AWARDS - Stock Options, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "ensg:NumberOfStockIncentivePlans",
      "unitRef": "plan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "ensg:NumberOfStockIncentivePlans",
      "unitRef": "plan",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails",
     "longName": "9955559 - Disclosure - OPTIONS AND AWARDS - Schedule of Assumptions for Stock Options Granted (Details)",
     "shortName": "OPTIONS AND AWARDS - Schedule of Assumptions for Stock Options Granted (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails",
     "longName": "9955560 - Disclosure - OPTIONS AND AWARDS - Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants (Details)",
     "shortName": "OPTIONS AND AWARDS - Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails",
     "longName": "9955561 - Disclosure - OPTIONS AND AWARDS - Schedule of Employee Stock Option Roll Forward (Details)",
     "shortName": "OPTIONS AND AWARDS - Schedule of Employee Stock Option Roll Forward (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-19",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails",
     "longName": "9955562 - Disclosure - OPTIONS AND AWARDS - Options Outstanding by Exercise Price (Details)",
     "shortName": "OPTIONS AND AWARDS - Options Outstanding by Exercise Price (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails",
     "longName": "9955563 - Disclosure - OPTIONS AND AWARDS - Schedule of Aggregate Intrinsic Value of Options (Details)",
     "shortName": "OPTIONS AND AWARDS - Schedule of Aggregate Intrinsic Value of Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
     "longName": "9955564 - Disclosure - OPTIONS AND AWARDS - Restricted Stock Awards, Narrative (Details)",
     "shortName": "OPTIONS AND AWARDS - Restricted Stock Awards, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails",
     "longName": "9955565 - Disclosure - OPTIONS AND AWARDS - Schedule of Nonvested Restricted Stock Awards (Details)",
     "shortName": "OPTIONS AND AWARDS - Schedule of Nonvested Restricted Stock Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-385",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-383",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
     "longName": "9955566 - Disclosure - OPTIONS AND AWARDS - Long-Term Incentive Plan, Narrative (Details)",
     "shortName": "OPTIONS AND AWARDS - Long-Term Incentive Plan, Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-390",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails",
     "longName": "9955567 - Disclosure - OPTIONS AND AWARDS - Schedule of Stock-Based Compensation Expense (Details)",
     "shortName": "OPTIONS AND AWARDS - Schedule of Stock-Based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
     "longName": "9955568 - Disclosure - LEASES - Lessee Narrative (Details)",
     "shortName": "LEASES - Lessee Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails",
     "longName": "9955569 - Disclosure - LEASES - Schedule of Operating Lease Expenses (Details)",
     "shortName": "LEASES - Schedule of Operating Lease Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:VariableLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:VariableLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails",
     "longName": "9955570 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details)",
     "shortName": "LEASES - Schedule of Future Minimum Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
     "longName": "9955571 - Disclosure - LEASES - Lessor Narrative (Details)",
     "shortName": "LEASES - Lessor Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-440",
      "name": "us-gaap:LessorOperatingLeaseTermOfContract",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
     "longName": "9955572 - Disclosure - LEASES - Schedule of Rental Income from Third-Party Sources (Details)",
     "shortName": "LEASES - Schedule of Rental Income from Third-Party Sources (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "c-454",
      "name": "us-gaap:SubleaseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-454",
      "name": "us-gaap:SubleaseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "us-gaap:OperatingLeaseLeaseIncomeTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R95": {
     "role": "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails",
     "longName": "9955573 - Disclosure - LEASES - Schedule of Annual Rental Income (Details)",
     "shortName": "LEASES - Schedule of Annual Rental Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails",
     "longName": "9955574 - Disclosure - DEFINED CONTRIBUTION PLANS (Details)",
     "shortName": "DEFINED CONTRIBUTION PLANS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails",
     "longName": "9955575 - Disclosure - SELF INSURANCE LIABILITIES - Schedule of Future Self Insurance Liabilities (Details)",
     "shortName": "SELF INSURANCE LIABILITIES - Schedule of Future Self Insurance Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:SelfInsuranceReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-461",
      "name": "us-gaap:SelfInsuranceReserve",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails",
     "longName": "9955576 - Disclosure - SELF INSURANCE LIABILITIES - Schedule of Insurance Liabilities (Details)",
     "shortName": "SELF INSURANCE LIABILITIES - Schedule of Insurance Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LiabilityForFuturePolicyBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-30",
      "name": "us-gaap:LiabilityForFuturePolicyBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESNarrativeDetails",
     "longName": "9955577 - Disclosure - SELF INSURANCE LIABILITIES - Narrative (Details)",
     "shortName": "SELF INSURANCE LIABILITIES - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EstimatedInsuranceRecoveries",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:EstimatedInsuranceRecoveries",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
     "longName": "9955578 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-6",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails",
     "longName": "9955579 - Disclosure - COMMON STOCK REPURCHASE PROGRAM (Details)",
     "shortName": "COMMON STOCK REPURCHASE PROGRAM (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "c-13",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-469",
      "name": "srt:StockRepurchaseProgramAuthorizedAmount1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ensg-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "ensg_A2019LTIPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "A2019LTIPlanMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019 LTI Plan",
        "label": "2019 LTI Plan [Member]",
        "documentation": "2019 LTI Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_A2022AcquiredPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "A2022AcquiredPropertiesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Acquired Properties",
        "label": "2022 Acquired Properties [Member]",
        "documentation": "2022 Acquired Properties"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_A2022PlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "A2022PlanMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Plan",
        "label": "2022 Plan [Member]",
        "documentation": "2022 Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_A2023AcquiredPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "A2023AcquiredPropertiesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Acquired Properties",
        "label": "2023 Acquired Properties [Member]",
        "documentation": "2023 Acquired Properties"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_A2024AcquiredPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "A2024AcquiredPropertiesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Acquired Properties",
        "label": "2024 Acquired Properties [Member]",
        "documentation": "2024 Acquired Properties"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_A2025AcquiredPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "A2025AcquiredPropertiesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025 Acquired Properties",
        "label": "2025 Acquired Properties [Member]",
        "documentation": "2025 Acquired Properties"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_A53PromissoryNoteMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "A53PromissoryNoteMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "5.3% Promissory Note",
        "label": "5.3% Promissory Note [Member]",
        "documentation": "5.3% Promissory Note"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r1164"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER ACCRUED LIABILITIES",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r78",
      "r83",
      "r1304"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r75",
      "r968"
     ]
    },
    "us-gaap_AccountsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableGross",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, gross",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r324",
      "r325",
      "r1354"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable\u2014less allowance for doubtful accounts of $8,435 and $9,348 at December\u00a031, 2024 and 2023, respectively",
        "totalLabel": "ACCOUNTS RECEIVABLE, NET",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1161"
     ]
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property taxes",
        "label": "Accrual for Taxes Other than Income Taxes",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r1304",
      "r1352"
     ]
    },
    "ensg_AccruedLiabilitiesStateReliefContractLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AccruedLiabilitiesStateReliefContractLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unapplied state relief funds",
        "label": "Accrued Liabilities, State Relief Contract Liabilities",
        "documentation": "Accrued Liabilities, State Relief Contract Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_AccruedRentAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AccruedRentAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued rent expense adjustments",
        "label": "Accrued Rent Adjustment",
        "documentation": "Adjustment to deferred rent arising from the difference between rent expense recognized and rental payments made in the current period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: accumulated depreciation",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r226",
      "r760"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Life (Years)",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r391",
      "r904"
     ]
    },
    "ensg_AcquiredPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AcquiredPropertiesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired Properties",
        "label": "Acquired Properties [Member]",
        "documentation": "Acquired Properties"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid during the period for:",
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r818",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1320",
      "r1388"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares of common stock used to satisfy tax withholding obligations",
        "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee stock award compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r58",
      "r518"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_AfterYearTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AfterYearTenMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "After Year Ten",
        "label": "After Year Ten [Member]",
        "documentation": "After Year Ten"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_AggregateDeductibleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AggregateDeductibleMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Deductible",
        "label": "Aggregate Deductible [Member]",
        "documentation": "Aggregate Deductible [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_AggregateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AggregateMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate",
        "label": "Aggregate [Member]",
        "documentation": "Blanket Aggregate [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1109"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1022",
      "r1033",
      "r1043",
      "r1076"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1025",
      "r1036",
      "r1046",
      "r1079"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1110"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1037",
      "r1047",
      "r1071",
      "r1080",
      "r1084",
      "r1092"
     ]
    },
    "us-gaap_AllOtherSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllOtherSegmentsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Other",
        "label": "Other Operating Segment [Member]",
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r317",
      "r920",
      "r921"
     ]
    },
    "ensg_AllStatesExcludingCaliforniaTexasAndWashingtonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AllStatesExcludingCaliforniaTexasAndWashingtonMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other States, Except California, Texas and Washington",
        "label": "All States, Excluding California, Texas And Washington [Member]",
        "documentation": "All States, Excluding California, Texas And Washington"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_AllStatesExcludingColoradoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AllStatesExcludingColoradoMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All States Except Colorado",
        "label": "All States, Excluding Colorado [Member]",
        "documentation": "All States Except Colorado [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Stock-based compensation expense related to stock options",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r560"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for doubtful accounts on accounts receivable",
        "negatedTerseLabel": "Less: allowance for doubtful accounts",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r326",
      "r361"
     ]
    },
    "ensg_AmendedMasterLeaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AmendedMasterLeaseAgreementMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended Master Lease Agreement",
        "label": "Amended Master Lease Agreement [Member]",
        "documentation": "Amended Master Lease Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_AmendedMasterLeaseAgreementOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AmendedMasterLeaseAgreementOneMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended Master Lease Agreement, One",
        "label": "Amended Master Lease Agreement, One [Member]",
        "documentation": "Amended Master Lease Agreement, One"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_AmendedMasterLeaseAgreementTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AmendedMasterLeaseAgreementTwoMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended Master Lease Agreement, Two",
        "label": "Amended Master Lease Agreement, Two [Member]",
        "documentation": "Amended Master Lease Agreement, Two"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of deferred financing fees",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r462",
      "r932",
      "r933",
      "r1142",
      "r1332"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r388",
      "r395",
      "r928"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r283"
     ]
    },
    "ensg_AssembledOccupancyAcquiredMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AssembledOccupancyAcquiredMember",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assembled occupancy",
        "verboseLabel": "Assembled occupancy",
        "label": "Assembled Occupancy Acquired [Member]",
        "documentation": "Assembled occupancy acquired [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Axis]",
        "label": "Asset Acquisition [Axis]",
        "documentation": "Information by asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r1315"
     ]
    },
    "us-gaap_AssetAcquisitionConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset acquisition, purchase price",
        "label": "Asset Acquisition, Consideration Transferred",
        "documentation": "Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer."
       }
      }
     },
     "auth_ref": [
      "r950",
      "r1316",
      "r1317",
      "r1318"
     ]
    },
    "us-gaap_AssetAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetAcquisitionDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Acquisition [Domain]",
        "label": "Asset Acquisition [Domain]",
        "documentation": "Asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r1315"
     ]
    },
    "us-gaap_AssetImpairmentCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetImpairmentCharges",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long-lived assets",
        "label": "Asset Impairment Charges",
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r41"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ASSETS",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r161",
      "r229",
      "r253",
      "r287",
      "r294",
      "r312",
      "r316",
      "r358",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r604",
      "r608",
      "r640",
      "r753",
      "r845",
      "r920",
      "r921",
      "r968",
      "r1000",
      "r1210",
      "r1211",
      "r1343"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r234",
      "r253",
      "r358",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r604",
      "r608",
      "r640",
      "r968",
      "r1210",
      "r1211",
      "r1343"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.ensigngroup.net/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1006",
      "r1029"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.ensigngroup.net/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1006",
      "r1029"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.ensigngroup.net/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1006",
      "r1029"
     ]
    },
    "ensg_August2023RepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "August2023RepurchaseProgramMember",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "August 2023 Repurchase Program",
        "label": "August 2023 Repurchase Program [Member]",
        "documentation": "August 2023 Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1087"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1088"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1086"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1085"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1084"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1084"
     ]
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_BuildingAndBuildingImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingAndBuildingImprovementsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails",
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Building and improvements",
        "terseLabel": "Buildings and improvements",
        "label": "Building and Building Improvements [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r598"
     ]
    },
    "ensg_BusinessAndAssetAcquisitionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "BusinessAndAssetAcquisitionsAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business And Asset Acquisitions [Axis]",
        "label": "Business And Asset Acquisitions [Axis]",
        "documentation": "Business And Asset Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_BusinessAndAssetAcquisitionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "BusinessAndAssetAcquisitionsDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business And Asset Acquisitions [Domain]",
        "label": "Business And Asset Acquisitions [Domain]",
        "documentation": "Business And Asset Acquisitions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL ACQUISITIONS",
        "label": "Business Combination And Asset Acquisition, Assets Acquired And Liabilities Assumed, Net",
        "documentation": "Business Combination And Asset Acquisition, Assets Acquired And Liabilities Assumed, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATION EXPANSIONS",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r599"
     ]
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CA",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "California",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_CO": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CO",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Colorado",
        "label": "COLORADO"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_CampusOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "CampusOperationsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Campus Operations",
        "label": "Campus Operations [Member]",
        "documentation": "Campus Operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued capital expenditures",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r24",
      "r25"
     ]
    },
    "ensg_CareTrustREITMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "CareTrustREITMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CareTrust REIT",
        "label": "CareTrust REIT [Member]",
        "documentation": "CareTrust REIT [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r224",
      "r909"
     ]
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Financial assets, investment funds",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1322",
      "r1323"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r21"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents beginning of period",
        "periodEndLabel": "Cash and cash equivalents end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r112",
      "r250"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (decrease) increase in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r112"
     ]
    },
    "ensg_CashHeldInTrustForResidents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "CashHeldInTrustForResidents",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash held in trust for patients",
        "label": "Cash Held In Trust For Residents",
        "documentation": "Cash held in trust for residents reflects monies received from, or on behalf of, residents. Maintaining a trust account for residents is a regulatory requirement and, while the trust assets offset the liability, the Company assumes a fiduciary responsibility for these funds."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1059"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfTreasuryStockTable",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Treasury Stock [Table]",
        "label": "Class of Treasury Stock [Table]",
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48",
      "r49",
      "r50"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "us-gaap_CollateralizedDebtObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollateralizedDebtObligationsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loans and promissory note",
        "label": "Collateralized Debt Obligations [Member]",
        "documentation": "Securities collateralized by a pool of assets."
       }
      }
     },
     "auth_ref": [
      "r953",
      "r956",
      "r958",
      "r1166",
      "r1167",
      "r1240"
     ]
    },
    "ensg_CombinedRealEstateAndLeasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "CombinedRealEstateAndLeasesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Combined Real Estate And Leases",
        "label": "Combined Real Estate And Leases [Member]",
        "documentation": "Combined Real Estate And Leases"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies (Notes 14 and 19)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r151",
      "r754",
      "r832"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMMITMENTS AND CONTINGENCIES",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r421",
      "r422",
      "r891",
      "r1199",
      "r1204"
     ]
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r989",
      "r990",
      "r991",
      "r993",
      "r994",
      "r995",
      "r996",
      "r1149",
      "r1150",
      "r1152",
      "r1320",
      "r1386",
      "r1388"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r833"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares outstanding (in shares)",
        "periodStartLabel": "Common stock, balance at beginning of period (in shares)",
        "periodEndLabel": "Common stock, balance at end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r89",
      "r833",
      "r851",
      "r1388",
      "r1389"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock: $0.001 par value; 150,000 shares authorized; 60,838 and 57,438 shares issued and shares outstanding at December\u00a031, 2024, respectively, and 59,987 and 56,597 shares issued and shares outstanding at December 31, 2023, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r755",
      "r968"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1068"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1067"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1066"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DEFINED CONTRIBUTION PLANS",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132"
     ]
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Benefits [Abstract]",
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Income",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r70",
      "r71",
      "r323",
      "r890"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r70",
      "r71",
      "r323",
      "r804",
      "r890"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r70",
      "r71",
      "r323",
      "r890",
      "r1119"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "% of Revenue",
        "terseLabel": "Revenue %",
        "netLabel": "Concentration percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r70",
      "r71",
      "r323"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r30",
      "r31",
      "r32",
      "r70",
      "r145",
      "r890"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r70",
      "r71",
      "r323",
      "r890"
     ]
    },
    "srt_ConsolidationEliminationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationEliminationsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intercompany Elimination",
        "label": "Consolidation, Eliminations [Member]",
        "documentation": "Eliminating entries used in consolidating a parent entity and its subsidiaries."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Axis]",
        "label": "Consolidation Items [Axis]",
        "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r178",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r257",
      "r287",
      "r296",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r920",
      "r921",
      "r1129",
      "r1130",
      "r1210",
      "r1211"
     ]
    },
    "srt_ConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ConsolidationItemsDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidation Items [Domain]",
        "label": "Consolidation Items [Domain]",
        "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments."
       }
      }
     },
     "auth_ref": [
      "r159",
      "r178",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r257",
      "r287",
      "r296",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318",
      "r429",
      "r430",
      "r431",
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r438",
      "r920",
      "r921",
      "r1129",
      "r1130",
      "r1210",
      "r1211"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Resident advances",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r486",
      "r505"
     ]
    },
    "us-gaap_CorporateNonSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateNonSegmentMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other",
        "label": "Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]",
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r311",
      "r312",
      "r313",
      "r314",
      "r317",
      "r1157"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of services",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r98",
      "r99",
      "r713"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent - cost of services",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_CostofSalesandGeneralandAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "CostofSalesandGeneralandAdministrativeExpenseMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of Sales and General and Administrative Expense",
        "label": "Cost of Sales and General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing cost of services and general and administrative expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL EXPENSES",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpensesAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expense:",
        "label": "Costs and Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]",
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r255",
      "r256",
      "r444",
      "r472",
      "r678",
      "r696",
      "r752",
      "r910",
      "r912"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover page.",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r1208"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r1208",
      "r1209"
     ]
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current:",
        "label": "Current Federal, State and Local, Tax Expense (Benefit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1121",
      "r1146",
      "r1314"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current income tax expense (benefit)",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r1146"
     ]
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1121",
      "r1146",
      "r1314"
     ]
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r117",
      "r323"
     ]
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1192",
      "r1194",
      "r1197",
      "r1198"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1103"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1103"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1016",
      "r1105"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1016",
      "r1105"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1018",
      "r1107"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1016",
      "r1105"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1098"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1099"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1099"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1097"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1097"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1097"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1011",
      "r1100"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1102"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1102"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1103"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1017",
      "r1106"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1015",
      "r1104"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1101"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DEBT",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r251",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r427",
      "r428",
      "r440",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r456",
      "r463",
      "r464",
      "r466",
      "r648"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r77",
      "r78",
      "r147",
      "r150",
      "r257",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r452",
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r965",
      "r1144",
      "r1200",
      "r1201",
      "r1202",
      "r1331",
      "r1333"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate margin",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loans and promissory note",
        "verboseLabel": "Outstanding debt",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r150",
      "r467"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, interest rate, effective percentage",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r469",
      "r648",
      "r649",
      "r965"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, interest rate, stated percentage",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r442"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r257",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r452",
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r965",
      "r1144",
      "r1331",
      "r1333"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r257",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r452",
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r965",
      "r1144",
      "r1200",
      "r1201",
      "r1202",
      "r1331",
      "r1333"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r44",
      "r45",
      "r73",
      "r126",
      "r127",
      "r257",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r447",
      "r452",
      "r453",
      "r454",
      "r455",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r465",
      "r929",
      "r930",
      "r931",
      "r932",
      "r933",
      "r965",
      "r1144",
      "r1331",
      "r1333"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, term",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortized cost basis of held-to-maturity investments",
        "label": "Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of investment in debt security measured at amortized cost (held-to-maturity)."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r343",
      "r345",
      "r748"
     ]
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation liability, noncurrent",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails": {
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1146",
      "r1313",
      "r1314"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred income tax expense (benefit)",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1305"
     ]
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred:",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: debt issuance costs, net",
        "label": "Debt Issuance Costs, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r1213",
      "r1330",
      "r1331",
      "r1333"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r566"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r175",
      "r1146"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "TOTAL DEFERRED TAX LIABILITIES",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r86",
      "r148",
      "r578"
     ]
    },
    "ensg_DeferredRentAndOtherLongTermLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "DeferredRentAndOtherLongTermLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other long-term liabilities",
        "label": "Deferred rent and other long-term liabilities",
        "documentation": "Rental expense in excess of actual rental payments and other long-term liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails": {
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1146",
      "r1313",
      "r1314"
     ]
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET DEFERRED TAX ASSETS",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1308"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL DEFERRED TAX ASSETS",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1308"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.ensigngroup.net/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1311"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r1311"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue related reserves",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r1311"
     ]
    },
    "ensg_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liability",
        "label": "Deferred Tax Assets, Tax, Deferred Expense, Reserves And Accruals, Lease Liability",
        "documentation": "Deferred Tax Assets, Tax, Deferred Expense, Reserves And Accruals, Lease Liability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Self Insurance",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated losses under self insurance."
       }
      }
     },
     "auth_ref": [
      "r1311"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails",
      "http://www.ensigngroup.net/role/INCOMETAXESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance",
        "negatedLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses."
       }
      }
     },
     "auth_ref": [
      "r1311"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Depreciation and amortization",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r1311"
     ]
    },
    "ensg_DeferredTaxLiabilitiesRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "DeferredTaxLiabilitiesRightOfUseAsset",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Right-of-use asset",
        "label": "Deferred Tax Liabilities, Right-Of-Use Asset",
        "documentation": "Deferred Tax Liabilities, Right-Of-Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_DeferredTaxLiabilitiesStateTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "DeferredTaxLiabilitiesStateTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "State taxes",
        "label": "Deferred Tax Liabilities, State Taxes",
        "documentation": "Deferred Tax Liabilities, State Taxes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expensed matching contributions",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_DefinedContributionPlanDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanDisclosureLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plan Disclosure [Line Items]",
        "label": "Defined Contribution Plan Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum annual contributions per employee",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanTable",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined Contribution Plan [Table]",
        "label": "Defined Contribution Plan [Table]",
        "documentation": "Disclosure of information about defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans."
       }
      }
     },
     "auth_ref": [
      "r514"
     ]
    },
    "ensg_DepreciationAndAmortizationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "DepreciationAndAmortizationMember",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and Amortization",
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation And Amortization [Member]",
        "documentation": "Depreciation And Amortization [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization",
        "netLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r287",
      "r299",
      "r316",
      "r920",
      "r921"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r935",
      "r936",
      "r937",
      "r938",
      "r939",
      "r940",
      "r941"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1216"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPTIONS AND AWARDS",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r521",
      "r552",
      "r553",
      "r555",
      "r946"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Dividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Dividends",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends declared",
        "label": "Dividends",
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r128"
     ]
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued dividends declared",
        "terseLabel": "Dividends payable",
        "label": "Dividends Payable",
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r83",
      "r149",
      "r997",
      "r1352"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1006",
      "r1029"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Restatement Recovery Analysis",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1006",
      "r1029",
      "r1072"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents Incorporated by Reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r1003"
     ]
    },
    "ensg_Dr.AnnS.BlouinMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "Dr.AnnS.BlouinMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dr. Ann S. Blouin [Member]",
        "documentation": "Dr. Ann S. Blouin"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1061"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NET INCOME PER SHARE ATTRIBUTABLE TO THE ENSIGN GROUP INC.",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic net income per common share (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r273",
      "r275",
      "r280",
      "r281",
      "r282",
      "r286",
      "r596",
      "r602",
      "r619",
      "r620",
      "r749",
      "r768",
      "r913"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted net income per common share (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r275",
      "r280",
      "r281",
      "r282",
      "r286",
      "r596",
      "r602",
      "r619",
      "r620",
      "r749",
      "r768",
      "r913"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "COMPUTATION OF NET INCOME PER COMMON SHARE",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r272",
      "r283",
      "r284",
      "r285"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESNarrativeDetails",
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL INCOME TAX PROVISION",
        "terseLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r568",
      "r949"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense at statutory rate",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss)."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r568",
      "r587",
      "r949"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-deductible expenses",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r572",
      "r1147",
      "r1306"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other adjustments",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r949",
      "r1147",
      "r1306",
      "r1307"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity compensation",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-Based Payment Arrangement, Percent",
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1115",
      "r1306",
      "r1307"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "calculation": {
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails": {
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State income taxes\u00a0- net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r949",
      "r1147",
      "r1306"
     ]
    },
    "ensg_EliminationsAndReconcilingItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "EliminationsAndReconcilingItemsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "All Other",
        "label": "Eliminations And Reconciling Items [Member]",
        "documentation": "Eliminations And Reconciling Items"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued wages and related liabilities",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_EmployeeServiceShareBasedCompensationNonvestedAwards": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwards",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation, nonvested awards (in shares)",
        "label": "Employee Service Share-based Compensation, Nonvested Awards",
        "documentation": "Employee Service Share-based Compensation, Nonvested Awards"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation, nonvested awards, cost not yet recognized",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation, nonvested awards, cost not yet recognized, period for recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r554"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options",
        "verboseLabel": "Stock-based compensation expense related to stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1112"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1002"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1113"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1055"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1108"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1108"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1108"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EQUITY",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityClassOfTreasuryStockLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r218",
      "r238",
      "r239",
      "r240",
      "r258",
      "r259",
      "r260",
      "r262",
      "r267",
      "r269",
      "r271",
      "r289",
      "r359",
      "r360",
      "r404",
      "r484",
      "r585",
      "r586",
      "r593",
      "r594",
      "r595",
      "r597",
      "r601",
      "r602",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r618",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r650",
      "r653",
      "r677",
      "r766",
      "r797",
      "r798",
      "r799",
      "r818",
      "r871"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1065"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1022",
      "r1033",
      "r1043",
      "r1076"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r1019",
      "r1030",
      "r1040",
      "r1073"
     ]
    },
    "us-gaap_EstimatedInsuranceRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EstimatedInsuranceRecoveries",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Gross insurance recoveries",
        "label": "Estimated Insurance Recoveries",
        "documentation": "Carrying amount as of the balance sheet date of amounts expected to be recovered under the terms of insurance contracts."
       }
      }
     },
     "auth_ref": [
      "r1133"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ensg_ExercisePriceRangeEightMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeEightMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022",
        "label": "Exercise Price Range Eight [Member]",
        "documentation": "Exercise Price Range Eight [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeFiveMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2019",
        "label": "Exercise Price Range Five [Member]",
        "documentation": "Exercise Price Range Five [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeFourMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2018",
        "label": "Exercise Price Range Four [Member]",
        "documentation": "Exercise Price Range Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeNineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeNineMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Exercise Price Range Nine [Member]",
        "documentation": "Exercise Price Range Nine [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeOneMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2015",
        "label": "Exercise Price Range One [Member]",
        "documentation": "Exercise Price Range One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeSevenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeSevenMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021",
        "label": "Exercise Price Range Seven [Member]",
        "documentation": "Exercise Price Range Seven [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeSixMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2020",
        "label": "Exercise Price Range Six [Member]",
        "documentation": "Exercise Price Range Six [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeTenMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Exercise Price Range Ten [Member]",
        "documentation": "Exercise Price Range Ten [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeThreeMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2017",
        "label": "Exercise Price Range Three [Member]",
        "documentation": "Exercise Price Range Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ExercisePriceRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ExercisePriceRangeTwoMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2016",
        "label": "Exercise Price Range Two [Member]",
        "documentation": "Exercise Price Range Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByBalanceSheetGroupingTable",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r69"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r631",
      "r632",
      "r634",
      "r683",
      "r684",
      "r685",
      "r930",
      "r931",
      "r942",
      "r943",
      "r944",
      "r953",
      "r958"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE MEASUREMENTS",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r627",
      "r629",
      "r630",
      "r631",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r746",
      "r953",
      "r959"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r508",
      "r513",
      "r622",
      "r623",
      "r632",
      "r684",
      "r930",
      "r931",
      "r942",
      "r943",
      "r944",
      "r953"
     ]
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r454",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r631",
      "r632",
      "r634",
      "r683",
      "r684",
      "r685",
      "r930",
      "r931",
      "r942",
      "r943",
      "r944",
      "r953",
      "r958"
     ]
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Considerations",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ensg_FamilyFirstCoronavirusResponseActPaymentsReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "FamilyFirstCoronavirusResponseActPaymentsReceived",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stat relief funding received",
        "label": "Family First Coronavirus Response Act, Payments Received",
        "documentation": "Family First Coronavirus Response Act, Payments Received"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r362",
      "r363",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r465",
      "r482",
      "r616",
      "r639",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r767",
      "r926",
      "r953",
      "r956",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r969",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1321",
      "r1324",
      "r1325",
      "r1326",
      "r1327",
      "r1328"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Definite-lived intangible asset useful life",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r371",
      "r394",
      "r928"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1195",
      "r1390"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r904",
      "r928"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r904",
      "r928"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r904",
      "r928"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r904",
      "r928"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r904",
      "r928"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r389",
      "r390",
      "r391",
      "r393",
      "r394",
      "r398",
      "r399",
      "r714",
      "r715",
      "r904"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r394",
      "r715",
      "r928"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r394",
      "r398",
      "r399",
      "r402",
      "r714",
      "r904",
      "r928"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r389",
      "r390",
      "r391",
      "r393",
      "r394",
      "r398",
      "r399",
      "r904"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofEstimatedAmortizationExpenseDetails",
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r1194"
     ]
    },
    "ensg_FirstThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "FirstThreeYearsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Three Years",
        "label": "First Three Years [Member]",
        "documentation": "First Three Years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1037",
      "r1047",
      "r1080"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1037",
      "r1047",
      "r1080"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1037",
      "r1047",
      "r1080"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1037",
      "r1047",
      "r1080"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1037",
      "r1047",
      "r1080"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1060"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails",
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Equipment, furniture, and fixtures",
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfAssets1",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Loss (gain) on sale of assets",
        "label": "Gain (Loss) on Disposition of Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee."
       }
      }
     },
     "auth_ref": [
      "r1142"
     ]
    },
    "ensg_GainLossOnInsuranceClaimsAndDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "GainLossOnInsuranceClaimsAndDispositionOfAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss (gain) on insurance claims and asset disposals",
        "label": "Gain (Loss) On Insurance Claims And Disposition Of Assets",
        "documentation": "Gain (Loss) On Disposal Of Assets And Insurance Claims"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnInvestments",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss (gain) on deferral investment",
        "label": "Gain (Loss) on Investments",
        "documentation": "Amount of realized and unrealized gain (loss) on investment."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r105",
      "r1114"
     ]
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sale of assets",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_GainLossRelatedToLitigationSettlement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossRelatedToLitigationSettlement",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Litigation",
        "label": "Gain (Loss) from Litigation Settlement",
        "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process."
       }
      }
     },
     "auth_ref": [
      "r920",
      "r1205"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative expense",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r855"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative expense",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ensg_GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued general liability and professional malpractice liabilities",
        "label": "General Liability And Professional Malpractice Liability Insurance [Member]",
        "documentation": "General Liability And Professional Malpractice Liability Insurance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralLiabilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralLiabilityMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General Liability",
        "label": "General Liability [Member]",
        "documentation": "Type of business insurance which provides insurance coverage for a wide variety of liability exposures including, but not limited to, contractual liability, product liability and personal injury liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "periodStartLabel": "Goodwill, beginning balance",
        "periodEndLabel": "Goodwill, ending balance",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r227",
      "r373",
      "r747",
      "r921",
      "r927",
      "r955",
      "r968",
      "r1176",
      "r1183"
     ]
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAcquiredDuringPeriod",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails": {
       "parentTag": "ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Goodwill",
        "terseLabel": "Additions",
        "label": "Goodwill, Acquired During Period",
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r927"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILLNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and intangible asset impairment",
        "label": "Goodwill and Intangible Asset Impairment",
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets and Goodwill",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1174",
      "r1186"
     ]
    },
    "us-gaap_GoodwillDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILL"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "GOODWILL",
        "label": "Goodwill Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r374",
      "r384",
      "r927"
     ]
    },
    "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairedAccumulatedImpairmentLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILLNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative goodwill impairment losses",
        "label": "Goodwill, Impaired, Accumulated Impairment Loss",
        "documentation": "Amount of accumulated impairment loss for asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r375",
      "r382",
      "r927"
     ]
    },
    "us-gaap_GoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Line Items]",
        "label": "Goodwill [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r927"
     ]
    },
    "us-gaap_GoodwillRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillRollForward",
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill [Roll Forward]",
        "label": "Goodwill [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Axis]",
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r519",
      "r522",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Domain]",
        "label": "Grantee Status [Domain]",
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r519",
      "r522",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "ensg_HUDInsuredMortgagesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "HUDInsuredMortgagesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HUD Insured Mortgages",
        "label": "HUD Insured Mortgages [Member]",
        "documentation": "HUD Insured Mortgages"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HealthInsuranceProductLineMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HealthInsuranceProductLineMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued health benefits",
        "label": "Health Insurance Product Line [Member]",
        "documentation": "Product line consisting of insurance against loss by illness or injury."
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "ensg_HealthLiabilityInsuranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "HealthLiabilityInsuranceMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Health Liability Insurance",
        "label": "Health Liability Insurance [Member]",
        "documentation": "Health Liability Insurance [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1006",
      "r1029"
     ]
    },
    "us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use."
       }
      }
     },
     "auth_ref": [
      "r405"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment charge to intangible assets",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r388",
      "r401"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of long lived assets",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r41",
      "r121",
      "r954"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r122"
     ]
    },
    "ensg_InTheFourthYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "InTheFourthYearMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "In The Fourth Year",
        "label": "In The Fourth Year [Member]",
        "documentation": "In The Fourth Year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Less: net income (loss) attributable to noncontrolling interests",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of income (loss) from continuing operations attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r142",
      "r267"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before provision for income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r156",
      "r160",
      "r750",
      "r762",
      "r915",
      "r920",
      "r1154",
      "r1156",
      "r1158",
      "r1159",
      "r1160"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net income",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r160",
      "r253",
      "r261",
      "r267",
      "r358",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r596",
      "r602",
      "r620",
      "r640",
      "r762",
      "r915",
      "r1154",
      "r1156",
      "r1158",
      "r1159",
      "r1160",
      "r1210"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r406",
      "r413",
      "r416",
      "r626",
      "r628",
      "r633",
      "r792",
      "r796",
      "r856",
      "r904",
      "r957",
      "r1356"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r413",
      "r416",
      "r626",
      "r628",
      "r633",
      "r792",
      "r796",
      "r856",
      "r904",
      "r957",
      "r1356"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INCOME TAXES",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r254",
      "r562",
      "r568",
      "r573",
      "r574",
      "r575",
      "r576",
      "r582",
      "r588",
      "r590",
      "r591",
      "r592",
      "r815",
      "r949"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 1.0
      },
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/INCOMETAXESExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r176",
      "r270",
      "r271",
      "r287",
      "r302",
      "r316",
      "r567",
      "r568",
      "r589",
      "r770",
      "r949"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r563",
      "r564",
      "r576",
      "r577",
      "r581",
      "r583",
      "r811"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes",
        "label": "Income Taxes Paid",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r114",
      "r1143",
      "r1309",
      "r1310"
     ]
    },
    "ensg_IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Deferred employer portion of social security taxes",
        "label": "Increase (Decrease) Due To Deferred Employer Taxes, CARES Act",
        "documentation": "Increase (Decrease) Due To Deferred Employer Taxes, CARES Act"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation liability",
        "label": "Increase (Decrease) in Deferred Compensation",
        "documentation": "The increase (decrease) during the reporting period in the obligation created by employee agreements whereby earned compensation will be paid in the future."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued wages and related liabilities",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in operating assets and liabilities",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease obligations",
        "verboseLabel": "Increase (decrease) in lease liability",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1120",
      "r1141"
     ]
    },
    "ensg_IncreaseDecreaseInOperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Increase in right-of-use asset",
        "label": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset",
        "documentation": "Increase (Decrease) In Operating Lease, Right-Of-Use Asset"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherDeferredLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherDeferredLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "label": "Increase (Decrease) in Other Deferred Liability",
        "documentation": "Amount of increase (decrease) in deferred obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued liabilities",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid income taxes",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_IncreaseDecreaseInSelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInSelfInsuranceReserve",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued self-insurance liabilities",
        "label": "Increase (Decrease) in Self Insurance Reserve",
        "documentation": "The increase (decrease) during the period in the carrying amount of accrued known and estimated losses incurred for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's' compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r1141"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plus: incremental shares from assumed conversion (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r276",
      "r277",
      "r278",
      "r282",
      "r520"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]",
        "label": "Indefinite-Lived Intangible Assets [Axis]",
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r392",
      "r397",
      "r928"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]",
        "label": "Indefinite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r397",
      "r402",
      "r928"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other indefinite-lived intangibles",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r397",
      "r928"
     ]
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r392",
      "r397",
      "r928"
     ]
    },
    "us-gaap_IndefinitelivedIntangibleAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IndefinitelivedIntangibleAssetsAcquired",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails": {
       "parentTag": "ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other indefinite-lived intangible assets",
        "terseLabel": "Indefinite-lived intangible assets acquired",
        "label": "Indefinite-Lived Intangible Assets Acquired",
        "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition."
       }
      }
     },
     "auth_ref": [
      "r392",
      "r1196"
     ]
    },
    "ensg_IndependentOperatingSubsidiariesUnderMedicareProbeReviews": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "IndependentOperatingSubsidiariesUnderMedicareProbeReviews",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Independent subsidiaries with multi-claim reviews scheduled or in process",
        "label": "Independent Operating Subsidiaries Under Medicare Probe Reviews",
        "documentation": "Facilities under Medicare Probe reviews relating to Medicare services, billings and potential overpayments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1037",
      "r1047",
      "r1071",
      "r1080",
      "r1084",
      "r1092"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1096"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1096"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1096"
     ]
    },
    "us-gaap_InsuranceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InsuranceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_InsuranceCoverageLimitTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "InsuranceCoverageLimitTypeAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance Coverage Limit Type [Axis]",
        "label": "Insurance Coverage Limit Type [Axis]",
        "documentation": "Insurance Coverage Limit Type [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_InsuranceCoverageLimitTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "InsuranceCoverageLimitTypeDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance Coverage Limit Type [Domain]",
        "label": "Insurance Coverage Limit Type [Domain]",
        "documentation": "Insurance Coverage Limit Type [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_InsuranceSubsidiaryDepositsAndInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "InsuranceSubsidiaryDepositsAndInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance subsidiary deposits and investments",
        "label": "Insurance Subsidiary Deposits And Investments",
        "documentation": "Captive insurance subsidiary cash and equivalents designated to support long-term insurance subsidiary liabilities and debt security investments held to maturity."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_InsuranceSubsidiaryLongTermInvestmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "InsuranceSubsidiaryLongTermInvestmentsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Insurance Subsidiary Liabilities",
        "label": "Insurance Subsidiary Long-Term Investments [Member]",
        "documentation": "Long-Term Insurance Subsidiary Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INTANGIBLE ASSETS \u2014 NET",
        "label": "Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for all or part of the information related to intangible assets."
       }
      }
     },
     "auth_ref": [
      "r386",
      "r400",
      "r403",
      "r903",
      "r904"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r1194",
      "r1196"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "terseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r298",
      "r1138"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r244",
      "r248",
      "r249"
     ]
    },
    "ensg_InvestmentExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "InvestmentExpenseIncome",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offsetting expense (income)",
        "label": "Investment Expense (Income)",
        "documentation": "Investment Expense (Income)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InvestmentIncomeInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Investment Income, Interest",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r297",
      "r316",
      "r920",
      "r1137"
     ]
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insurance Subsidiary Deposits and Other Investments",
        "label": "Investment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment in financial asset."
       }
      }
     },
     "auth_ref": [
      "r769",
      "r807",
      "r808",
      "r809",
      "r810",
      "r878",
      "r879"
     ]
    },
    "ensg_July2022RepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "July2022RepurchaseProgramMember",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "July 2022 Repurchase Program",
        "label": "July 2022 Repurchase Program [Member]",
        "documentation": "July 2022 Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LandMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails",
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Land",
        "terseLabel": "Land",
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r1217"
     ]
    },
    "ensg_LeaseArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LeaseArrangementAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Arrangement [Axis]",
        "label": "Lease Arrangement [Axis]",
        "documentation": "Information by group of related lease arrangements."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_LeaseArrangementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LeaseArrangementDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease Arrangement [Domain]",
        "label": "Lease Arrangement [Domain]",
        "documentation": "Lease Arrangement"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Lease, cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r967"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Lease Expenses",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1336"
     ]
    },
    "ensg_LeasedAssetsAcquiredDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LeasedAssetsAcquiredDuringPeriod",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails": {
       "parentTag": "ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leased asset",
        "label": "Leased Assets, Acquired During Period",
        "documentation": "Leased Assets, Acquired During Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r669"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_LeasesToThirdPartyOperatorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LeasesToThirdPartyOperatorsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases To Third Party Operators",
        "label": "Leases To Third Party Operators [Member]",
        "documentation": "Leases To Third Party Operators"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r670"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r670"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r657"
     ]
    },
    "ensg_LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee leasing arrangements, operating leases, number of renewal terms",
        "label": "Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms",
        "documentation": "Lessee Leasing Arrangements, Operating Leases, Number Of Renewal Terms"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_LesseeOperatingLeaseConsumerPriceIndex": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LesseeOperatingLeaseConsumerPriceIndex",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consumer price index",
        "label": "Lessee, Operating Lease, Consumer Price Index",
        "documentation": "Lessee, Operating Lease, Consumer Price Index"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseDiscountRate",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating leases of lessee, contingent rentals, basis spread on variable rate",
        "label": "Lessee, Operating Lease, Discount Rate",
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Lease Payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1337"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LEASE PAYMENTS",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: present value adjustment",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r668"
     ]
    },
    "ensg_LesseeOperatingLeaseNumberOfLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LesseeOperatingLeaseNumberOfLeases",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of stand-alone leases",
        "label": "Lessee, Operating Lease, Number Of Leases",
        "documentation": "Lessee, Operating Lease, Number Of Leases"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_LesseeOperatingLeaseNumberOfRenewalOptions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LesseeOperatingLeaseNumberOfRenewalOptions",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options to renew lease",
        "label": "Lessee, Operating Lease, Number Of Renewal Options",
        "documentation": "Lessee, Operating Lease, Number Of Renewal Options"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extended lease term",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1335"
     ]
    },
    "ensg_LesseeOperatingLeaseTermExtension": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LesseeOperatingLeaseTermExtension",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, operating lease, term extension",
        "label": "Lessee, Operating Lease, Term, Extension",
        "documentation": "Lessee, Operating Lease, Term, Extension"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease term",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1335"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r652"
     ]
    },
    "us-gaap_LessorLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorLeaseDescriptionLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessor, Lease, Description [Line Items]",
        "label": "Lessor, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_LessorLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorLeaseDescriptionTable",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessor, Lease, Description [Table]",
        "label": "Lessor, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessor's leases."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL",
        "label": "Lessor, Operating Lease, Payment to be Received",
        "documentation": "Amount of lease payments to be received by lessor for operating lease."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFiveYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFiveYears",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Five",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Four",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Annual Rental Income",
        "label": "Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease."
       }
      }
     },
     "auth_ref": [
      "r1338"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThereafter",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessor, Operating Lease, Payment to be Received, after Year Five",
        "documentation": "Amount of lease payment to be received by lessor for operating lease after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Three",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofAnnualRentalIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "us-gaap_LessorOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LessorOperatingLeaseTermOfContract",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of operating lease",
        "label": "Lessor, Operating Lease, Term of Contract",
        "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1339"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LettersOfCreditOutstandingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letters of credit outstanding, pledged amount",
        "label": "Letters of Credit Outstanding, Amount",
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r77",
      "r78",
      "r79",
      "r82",
      "r83",
      "r84",
      "r87",
      "r253",
      "r358",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r605",
      "r608",
      "r609",
      "r640",
      "r831",
      "r914",
      "r1000",
      "r1210",
      "r1343",
      "r1344"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "TOTAL LIABILITIES AND EQUITY",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r95",
      "r153",
      "r758",
      "r968",
      "r1145",
      "r1172",
      "r1329"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES AND EQUITY",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r223",
      "r253",
      "r358",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r605",
      "r608",
      "r609",
      "r640",
      "r968",
      "r1210",
      "r1343",
      "r1344"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesForGuaranteesOnLongDurationContractsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesForGuaranteesOnLongDurationContractsLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities for Guarantees on Long-Duration Contracts [Line Items]",
        "label": "Liabilities for Guarantees on Long-Duration Contracts [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "label": "Liability for Claims and Claims Adjustment Expense [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpenseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpenseTable",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for Claims and Claims Adjustment Expense [Table]",
        "label": "Liability for Claims and Claims Adjustment Expense [Table]",
        "documentation": "Disclosure of information about the liability for claims and claims adjustment expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefitActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefitActivityTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Insurance Liabilities",
        "label": "Liability for Future Policy Benefit, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of beginning balance to ending balance for liability for future policy benefit, with separate presentation of expected future net premium and expected future benefit."
       }
      }
     },
     "auth_ref": [
      "r793",
      "r800",
      "r981"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitByProductSegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefitByProductSegmentTable",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability for Future Policy Benefit, by Product Segment [Table]",
        "label": "Liability for Future Policy Benefit, by Product Segment [Table]",
        "documentation": "Reflects the carrying amount of and other relevant, pertinent information about the liability as of the balance sheet date for future benefits to be paid to or on behalf of policyholders and related expenses less the present value of future net premiums by major product line segment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilityForFuturePolicyBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Liability for Future Policy Benefit, before Reinsurance",
        "documentation": "Amount, before effect of reinsurance, of present value of future benefit to be paid to or on behalf of policyholder and related expense less present value of future net premium receivable under insurance contract."
       }
      }
     },
     "auth_ref": [
      "r793",
      "r794",
      "r800",
      "r981",
      "r1351"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SELF INSURANCE LIABILITIES",
        "label": "Liability for Future Policy Benefits and Unpaid Claims Disclosure [Text Block]",
        "documentation": "The entire disclosure for liabilities related to future policy benefits and unpaid claims and claim adjustments."
       }
      }
     },
     "auth_ref": [
      "r788",
      "r789"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in long-term insurance losses recoverable",
        "label": "Liability for Future Policy Benefits, Other Increase (Decrease)",
        "documentation": "Amount of other increase (decrease) in accrued obligations to policyholders pertaining to insured events for the period."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsPaymentForBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefitsPaymentForBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Claims paid and direct expenses",
        "label": "Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment",
        "documentation": "Amount of cash outflow to policyholder from benefit payment for expected future policy benefit and expense component of liability for future policy benefit."
       }
      }
     },
     "auth_ref": [
      "r980",
      "r981",
      "r1140",
      "r1366",
      "r1383"
     ]
    },
    "us-gaap_LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current year provisions",
        "label": "Liability for Future Policy Benefits, Period Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in accrued obligations to policy and contract holders for long-duration insurance contracts."
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "us-gaap_LifeInsuranceCorporateOrBankOwnedChangeInValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LifeInsuranceCorporateOrBankOwnedChangeInValue",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Cash surrender value of life insurance policy premiums",
        "label": "Life Insurance, Corporate or Bank Owned, Change in Value",
        "documentation": "The change in cash surrender or contract value during the period which adjusted the amount of premiums paid in determining the expense or income recognized under the contract for the period."
       }
      }
     },
     "auth_ref": [
      "r1173"
     ]
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lender Name [Axis]",
        "label": "Lender Name [Axis]",
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r81",
      "r1144",
      "r1208",
      "r1209"
     ]
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of credit increase",
        "label": "Line of Credit Facility, Increase (Decrease), Net",
        "documentation": "Amount of increase (decrease) of the credit facility."
       }
      }
     },
     "auth_ref": [
      "r1144"
     ]
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLenderDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility, Lender [Domain]",
        "label": "Line of Credit Facility, Lender [Domain]",
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r81",
      "r1144",
      "r1208"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, maximum borrowing capacity",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r81"
     ]
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, unused capacity, commitment fee percentage",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationReserveCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued litigation",
        "label": "Estimated Litigation Liability, Current",
        "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r1205"
     ]
    },
    "us-gaap_LitigationSettlementAmountAwardedToOtherParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationSettlementAmountAwardedToOtherParty",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation settlement, amount awarded to other party",
        "label": "Litigation Settlement, Amount Awarded to Other Party",
        "documentation": "Amount awarded to other party in judgment or settlement of litigation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total long-term debt",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r150",
      "r453",
      "r468",
      "r930",
      "r931",
      "r965",
      "r1353"
     ]
    },
    "us-gaap_LongTermDebtCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current maturities of long-term debt",
        "negatedTerseLabel": "Less: current maturities",
        "label": "Long-Term Debt, Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r257",
      "r1214"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r257",
      "r458"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Long-Term Debt, Maturity, Year Five",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r257",
      "r458"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r257",
      "r458"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r257",
      "r458"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTLongtermDebtArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r257",
      "r458"
     ]
    },
    "ensg_LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt\u2014less current maturities",
        "label": "Long Term Debt, net of Current Maturities and Debt Discount",
        "documentation": "Long Term Debt, net of Current Maturities and Debt Discount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "LONG-TERM DEBT LESS CURRENT MATURITIES",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r231"
     ]
    },
    "ensg_LongTermDebtThresholdForEBITDARatioIncreaseElection": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LongTermDebtThresholdForEBITDARatioIncreaseElection",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt, threshold for EBITDA ratio increase election",
        "label": "Long-Term Debt, Threshold For EBITDA Ratio Increase Election",
        "documentation": "Long-Term Debt, Threshold For EBITDA Ratio Increase Election"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term debt threshold for EBITDA ratio increase election period",
        "label": "Long Term Debt Threshold For EBITDA Ratio Increase Election Period",
        "documentation": "Long Term Debt Threshold For EBITDA Ratio Increase Election Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r1200",
      "r1201",
      "r1202"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/DEBTScheduleofLongtermDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r43",
      "r1200",
      "r1201",
      "r1202"
     ]
    },
    "ensg_LossSensitiveLimitPerClaimMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "LossSensitiveLimitPerClaimMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss-Sensitive Limit Per Claim",
        "label": "Loss-Sensitive Limit Per Claim [Member]",
        "documentation": "Loss-Sensitive limit per claim [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r937",
      "r979",
      "r986",
      "r1216",
      "r1355",
      "r1357",
      "r1358",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1384",
      "r1385"
     ]
    },
    "ensg_ManagedCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ManagedCareMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Managed care",
        "verboseLabel": "Managed care",
        "netLabel": "Managed care",
        "label": "Managed Care [Member]",
        "documentation": "Revenue from managed care payors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManagementFeeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ManagementFeeExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fees",
        "label": "Management Fee Expense",
        "documentation": "Amount of expense for investment management fee, including, but not limited to, expense in connection with research, selection, supervision, and custody of investment."
       }
      }
     },
     "auth_ref": [
      "r72",
      "r855",
      "r998",
      "r1387"
     ]
    },
    "us-gaap_ManagementServiceBaseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ManagementServiceBaseMember",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Management Fee",
        "label": "Management Service, Base [Member]",
        "documentation": "Contractually stipulated right to receive base compensation for operating and managing business."
       }
      }
     },
     "auth_ref": [
      "r1217"
     ]
    },
    "us-gaap_ManagementServiceIncentiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ManagementServiceIncentiveMember",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Incentive Management Fee",
        "label": "Management Service, Incentive [Member]",
        "documentation": "Contractually stipulated right to receive incentive compensation for operating and managing business."
       }
      }
     },
     "auth_ref": [
      "r1217"
     ]
    },
    "ensg_ManagementServiceTotalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ManagementServiceTotalMember",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Management Fee",
        "label": "Management Service, Total [Member]",
        "documentation": "Management Service, Total"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_MasterLeaseAgreementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "MasterLeaseAgreementsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Master Lease Agreements",
        "label": "Master Lease Agreements [Member]",
        "documentation": "Master Lease Agreements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MaterialReconcilingItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MaterialReconcilingItemsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "All Other",
        "label": "Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]",
        "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r314",
      "r317",
      "r920",
      "r921"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r181",
      "r183",
      "r184",
      "r186",
      "r216",
      "r217",
      "r423",
      "r424",
      "r425",
      "r426",
      "r515",
      "r561",
      "r625",
      "r712",
      "r791",
      "r795",
      "r803",
      "r823",
      "r824",
      "r876",
      "r880",
      "r882",
      "r883",
      "r885",
      "r901",
      "r902",
      "r925",
      "r934",
      "r945",
      "r958",
      "r959",
      "r963",
      "r964",
      "r982",
      "r1212",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350"
     ]
    },
    "ensg_May2024RepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "May2024RepurchaseProgramMember",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "May 2024 Repurchase Program",
        "label": "May 2024 Repurchase Program [Member]",
        "documentation": "May 2024 Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ensg_MedicaidAndMedicareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "MedicaidAndMedicareMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Medicare and Medicaid",
        "verboseLabel": "Total Medicaid and Medicare",
        "label": "Medicaid And Medicare [Member]",
        "documentation": "Total revenue from Medicaid and Medicare [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_MedicaidMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "MedicaidMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medicaid",
        "label": "Medicaid [Member]",
        "documentation": "Revenue from Medicaid for custodial services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_MedicaidSkilledMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "MedicaidSkilledMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medicaid \u2014 skilled",
        "verboseLabel": "Medicaid-skilled",
        "label": "Medicaid-skilled [Member]",
        "documentation": "Revenue from Medicaid for skilled services [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_MedicareAcceleratedAndAdvancePaymentCARESACT": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "MedicareAcceleratedAndAdvancePaymentCARESACT",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payment associated with deferred amount",
        "label": "Medicare Accelerated And Advance Payment, CARES ACT",
        "documentation": "Medicare Accelerated And Advance Payment, CARES ACT"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_MedicareAndMedicaidLicensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "MedicareAndMedicaidLicensesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medicare and Medicaid licenses",
        "label": "Medicare And Medicaid Licenses [Member]",
        "documentation": "Medicare licenses for home health and hospice segment and all other segment."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_MedicareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "MedicareMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medicare",
        "verboseLabel": "Medicare",
        "netLabel": "Medicare",
        "label": "Medicare [Member]",
        "documentation": "Revenue from Medicare [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r181",
      "r183",
      "r184",
      "r186",
      "r216",
      "r217",
      "r423",
      "r424",
      "r425",
      "r426",
      "r515",
      "r561",
      "r625",
      "r712",
      "r791",
      "r795",
      "r803",
      "r823",
      "r824",
      "r876",
      "r880",
      "r882",
      "r883",
      "r885",
      "r901",
      "r902",
      "r925",
      "r934",
      "r945",
      "r958",
      "r959",
      "r963",
      "r982",
      "r1212",
      "r1345",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350"
     ]
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r152",
      "r253",
      "r358",
      "r429",
      "r432",
      "r433",
      "r434",
      "r438",
      "r439",
      "r640",
      "r757",
      "r835"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Noncontrolling interests attributable to subsidiary equity plan",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisition of noncontrolling interest shares",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)."
       }
      }
     },
     "auth_ref": [
      "r65",
      "r128",
      "r143"
     ]
    },
    "us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Less:",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1083"
     ]
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate, Type of Property [Axis]",
        "label": "Real Estate, Type of Property [Axis]",
        "documentation": "Information by type of real estate property."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r889",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900"
     ]
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate [Domain]",
        "label": "Real Estate [Domain]",
        "documentation": "Land and any structures permanently fixed to it."
       }
      }
     },
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900"
     ]
    },
    "us-gaap_MovementInLiabilityForFuturePolicyBenefitsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MovementInLiabilityForFuturePolicyBenefitsRollForward",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in Liability for Future Policy Benefits [Roll Forward]",
        "label": "Movement in Liability for Future Policy Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r937",
      "r979",
      "r986",
      "r1216",
      "r1355",
      "r1357",
      "r1358",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1384",
      "r1385"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH USED IN INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r247"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET CASH PROVIDED BY OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r115"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCOME ATTRIBUTABLE TO THE ENSIGN GROUP, INC.",
        "verboseLabel": "Net income attributable to the Ensign Group, Inc.",
        "terseLabel": "Net Income (Loss)",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r115",
      "r157",
      "r221",
      "r235",
      "r236",
      "r240",
      "r253",
      "r261",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r270",
      "r271",
      "r279",
      "r358",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r596",
      "r602",
      "r620",
      "r640",
      "r765",
      "r853",
      "r869",
      "r870",
      "r998",
      "r1210"
     ]
    },
    "us-gaap_NetIncomeLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NUMERATOR:",
        "label": "Net Income (Loss) Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net income (loss) attributable to noncontrolling interests",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r144",
      "r235",
      "r236",
      "r267",
      "r270",
      "r271",
      "r764",
      "r1136"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NewAndAmendedMasterLeaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NewAndAmendedMasterLeaseAgreementMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New And Amended Master Lease Agreement",
        "label": "New And Amended Master Lease Agreement [Member]",
        "documentation": "New And Amended Master Lease Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NewMasterLeaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NewMasterLeaseAgreementMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Master Lease Agreeement",
        "label": "New Master Lease Agreement [Member]",
        "documentation": "New Master Lease Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NonCaliforniaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NonCaliforniaMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-california",
        "label": "Non-California [Member]",
        "documentation": "Non-California [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NonCashLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NonCashLeaseExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash leasing arrangement",
        "label": "Non-Cash Lease Expense",
        "documentation": "Non-Cash Lease Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1026",
      "r1037",
      "r1047",
      "r1071",
      "r1080"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of noncontrolling interests through subsidiary equity plan",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r46",
      "r143"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Controlling Interest",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r484",
      "r1149",
      "r1150",
      "r1151",
      "r1152",
      "r1388"
     ]
    },
    "ensg_NoncontrollingInterestPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NoncontrollingInterestPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncontrolling Interest",
        "label": "Noncontrolling Interest [Policy Text Block]",
        "documentation": "Noncontrolling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "OTHER INCOME (EXPENSE), NET",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "us-gaap_NonqualifiedPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonqualifiedPlanMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonqualified Plan",
        "label": "Nonqualified Plan [Member]",
        "documentation": "Plan without tax-exempt status in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1117",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277"
     ]
    },
    "ensg_NumberOfFacilitiesUnderLongTermLeaseArrangements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfFacilitiesUnderLongTermLeaseArrangements",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of facilities under long-term lease arrangements",
        "label": "Number Of Facilities Under Long-Term Lease Arrangements",
        "documentation": "Number Of Facilities Under Long-Term Lease Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options to purchase under long-term lease arrangements",
        "label": "Number Of Facilities Under Long-Term Lease Arrangements, Option To Purchase",
        "documentation": "Number Of Facilities Under Long-Term Lease Arrangements, Option To Purchase"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfFinancingLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfFinancingLeases",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of financing lease",
        "label": "Number Of Financing Leases",
        "documentation": "Number Of Financing Leases"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfLeaseArrangements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfLeaseArrangements",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of master lease arrangements",
        "label": "Number Of Lease Arrangements",
        "documentation": "Number Of Lease Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfLongTermAcuteCareBeds": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfLongTermAcuteCareBeds",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term acute care beds included within operational skilled nursing beds",
        "label": "Number Of Long-Term Acute Care Beds",
        "documentation": "Number Of Long-Term Acute Care Beds"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfMasterLeaseAgreements": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfMasterLeaseAgreements",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of master lease agreements",
        "label": "Number Of Master Lease Agreements",
        "documentation": "Master Lease agreements"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfOperatingSubsidiaries": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfOperatingSubsidiaries",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating subsidiaries",
        "label": "Number Of Operating Subsidiaries",
        "documentation": "Number Of operating subsidiaries entered into mortgage loans that are insured with HUD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfRealEstateProperties": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfRealEstateProperties",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of real estate properties",
        "verboseLabel": "Number of real estate properties acquired",
        "label": "Number of Real Estate Properties",
        "documentation": "The number of real estate properties owned as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfRealEstatePropertiesSharingLocations": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfRealEstatePropertiesSharingLocations",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of senior living operations sharing property with skilled nursing operations",
        "label": "Number Of Real Estate Properties Sharing Locations",
        "documentation": "Number Of Real Estate Properties Sharing Locations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r916",
      "r924",
      "r1155"
     ]
    },
    "ensg_NumberOfSeniorLivingUnits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfSeniorLivingUnits",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of senior living units",
        "label": "Number Of Senior Living Units",
        "documentation": "Operational Assisted Living and Independent Living Units"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfSkilledNursingBeds": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfSkilledNursingBeds",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operational skilled nursing beds",
        "label": "Number Of Skilled Nursing Beds",
        "documentation": "Number of skilled nursing beds available for use at a skilled nursing facility"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_NumberOfStockIncentivePlans": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "NumberOfStockIncentivePlans",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of stock incentive plans",
        "label": "Number Of Stock Incentive Plans",
        "documentation": "Number Of Stock Incentive Plans"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_OperatingEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "OperatingEntityAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Entity [Axis]",
        "label": "Operating Entity [Axis]",
        "documentation": "Operating Entity [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_OperatingEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "OperatingEntityDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Entity [Domain]",
        "label": "Operating Entity [Domain]",
        "documentation": "[Domain] for Operating Entity [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r915",
      "r1154",
      "r1156",
      "r1158",
      "r1159",
      "r1160"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r660",
      "r967"
     ]
    },
    "us-gaap_OperatingLeaseExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent expense",
        "label": "Operating Lease, Expense",
        "documentation": "Amount of operating lease expense. Excludes sublease income."
       }
      }
     },
     "auth_ref": [
      "r1334"
     ]
    },
    "us-gaap_OperatingLeaseIncomeComprehensiveIncomeExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseIncomeComprehensiveIncomeExtensibleList",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Operating Lease, Lease Income, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes operating lease income."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLeaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rental revenue",
        "label": "Operating Lease, Lease Income",
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r672",
      "r675"
     ]
    },
    "us-gaap_OperatingLeaseLeaseIncomeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLeaseIncomeTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Rental Income from Third-Party Sources",
        "label": "Operating Lease, Lease Income [Table Text Block]",
        "documentation": "Tabular disclosure of components of income from operating lease."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r675"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "PRESENT VALUE OF TOTAL LEASE LIABILITIES",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities\u2014current",
        "negatedLabel": "Less: current lease liabilities",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term lease liabilities\u2014less current portion",
        "verboseLabel": "LONG-TERM OPERATING LEASE LIABILITIES",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r655"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r664"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r654"
     ]
    },
    "us-gaap_OperatingLeaseVariableLeaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseVariableLeaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, variable lease income",
        "label": "Operating Lease, Variable Lease Income",
        "documentation": "Amount of operating lease income from variable lease payments paid and payable to lessor, excluding amount included in measurement of lease receivable."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r676"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, weighted average discount rate, percent",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r667",
      "r967"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease, weighted average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r666",
      "r967"
     ]
    },
    "us-gaap_OperatingLeasesOfLessorDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasesOfLessorDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASES"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LEASES",
        "label": "Lessor, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for lessor's operating leases."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Segments",
        "label": "Operating Segments [Member]",
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r317",
      "r920",
      "r921"
     ]
    },
    "ensg_OperationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "OperationMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operation",
        "label": "Operation [Member]",
        "documentation": "Operation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "DESCRIPTION OF BUSINESS",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r141",
      "r805",
      "r806"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "OTHER ACCRUED LIABILITIES",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_OtherNoncashInvestingAndFinancingItemsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashInvestingAndFinancingItemsAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash financing and investing activity",
        "label": "Other Noncash Investing and Financing Items [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income (expense)",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense):",
        "label": "Other Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1063"
     ]
    },
    "ensg_OtherStockAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "OtherStockAwardsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense related to restricted stock awards to non-employee directors",
        "label": "Other Stock Awards [Member]",
        "documentation": "Stock awards [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1024",
      "r1035",
      "r1045",
      "r1078"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1027",
      "r1038",
      "r1048",
      "r1081"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1027",
      "r1038",
      "r1048",
      "r1081"
     ]
    },
    "srt_ParentCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ParentCompanyMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parent Company",
        "label": "Parent Company [Member]",
        "documentation": "Registrant with controlling financial interest in one or more subsidiaries. Controlling interest in subsidiary includes, but is not limited to, primary beneficiary of variable interest entity (VIE). Controlling interest in subsidiary excludes broker-dealer with controlling financial interest in subsidiary but control is likely to be temporary."
       }
      }
     },
     "auth_ref": [
      "r178",
      "r257"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payment of contingent consideration",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other restricted assets",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1116",
      "r1139"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of shares of common stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_PaymentsOfDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDividends",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid",
        "label": "Payments of Dividends",
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests."
       }
      }
     },
     "auth_ref": [
      "r110"
     ]
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments of deferred financing costs",
        "label": "Payments of Financing Costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Repurchase of shares of common stock to satisfy tax withholding obligations",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r243"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cash payments for acquisitions",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r600"
     ]
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments",
        "label": "Payments to Acquire Investments",
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ensg_PaymentsToAcquirePropertyAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PaymentsToAcquirePropertyAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of property and equipment",
        "label": "Payments To Acquire Property And Equipment",
        "documentation": "Payments To Acquire Property And Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToMinorityShareholders",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-controlling interest distribution",
        "label": "Payments to Noncontrolling Interests",
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ensg_PayorAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PayorAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payor [Axis]",
        "label": "Payor [Axis]",
        "documentation": "Payor [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_PayorDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PayorDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payor [Domain]",
        "label": "Payor [Domain]",
        "documentation": "Payor [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1064"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "ensg_PerFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PerFacilityMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Per Facility",
        "label": "Per Facility [Member]",
        "documentation": "Per Facility [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_PerOccurenceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PerOccurenceMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Per Occurence",
        "label": "Per Occurence [Member]",
        "documentation": "Per Occurence [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282",
      "r1283",
      "r1284",
      "r1285",
      "r1286",
      "r1287",
      "r1288",
      "r1289",
      "r1290",
      "r1291",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1055"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1111"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1135"
     ]
    },
    "ensg_PrepaymentFeePeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PrepaymentFeePeriodAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment Fee, Period [Axis]",
        "label": "Prepayment Fee, Period [Axis]",
        "documentation": "Prepayment Fee, Period"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_PrepaymentFeePeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PrepaymentFeePeriodDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment Fee, Period [Domain]",
        "label": "Prepayment Fee, Period [Domain]",
        "documentation": "Prepayment Fee, Period [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_PrepaymentPenalty": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PrepaymentPenalty",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepayment penalty",
        "label": "Prepayment Penalty",
        "documentation": "Percentage that the prepayment penalty percentage is reduced during the first three years."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_PreviousSubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PreviousSubsidiariesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Previous Subsidiaries",
        "label": "Previous Subsidiaries [Member]",
        "documentation": "Previous Subsidiaries"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassifications",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r1132"
     ]
    },
    "ensg_PrivatePayAndOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PrivatePayAndOtherMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Private and other",
        "terseLabel": "Private and other payors",
        "label": "Private Pay And Other [Member]",
        "documentation": "Revenue from self-pay and Other payors [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromInsuranceSettlementInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromInsuranceSettlementInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash from insurance proceeds",
        "label": "Proceeds from Insurance Settlement, Investing Activities",
        "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as investing activities. Excludes insurance settlement classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r16"
     ]
    },
    "us-gaap_ProceedsFromInsuranceSettlementOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromInsuranceSettlementOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash received from insurance proceeds",
        "label": "Proceeds from Insurance Settlement, Operating Activities",
        "documentation": "Amount of cash inflow for proceeds from settlement of insurance claim, classified as operating activities. Excludes insurance settlement classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r246",
      "r905"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of preferred shares",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r812"
     ]
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturities of investments",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "ensg_ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Proceeds from sale of subsidiary shares",
        "label": "Proceeds From Sale Of Common Stock Associated With Subsidiary Equity Plans",
        "documentation": "Proceeds From Sale Of Common Stock Associated With Subsidiary Equity Plans"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash proceeds from the sale of assets",
        "label": "Proceeds from Sale of Productive Assets",
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales price on sale of assets",
        "label": "Proceeds from Sale of Property, Plant, and Equipment",
        "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock upon exercise of options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r13"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails",
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r215",
      "r319",
      "r713",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r790",
      "r907",
      "r935",
      "r978",
      "r982",
      "r983",
      "r987",
      "r988",
      "r1131",
      "r1206",
      "r1207",
      "r1216",
      "r1355",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1384",
      "r1385"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails",
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r189",
      "r190",
      "r191",
      "r192",
      "r193",
      "r215",
      "r319",
      "r713",
      "r782",
      "r783",
      "r784",
      "r785",
      "r786",
      "r787",
      "r790",
      "r907",
      "r935",
      "r978",
      "r982",
      "r983",
      "r987",
      "r988",
      "r1131",
      "r1206",
      "r1207",
      "r1216",
      "r1355",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1384",
      "r1385"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "NET INCOME",
        "terseLabel": "Net income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r235",
      "r236",
      "r245",
      "r253",
      "r261",
      "r267",
      "r270",
      "r271",
      "r358",
      "r429",
      "r430",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r439",
      "r596",
      "r602",
      "r603",
      "r606",
      "r607",
      "r620",
      "r640",
      "r750",
      "r763",
      "r817",
      "r853",
      "r869",
      "r870",
      "r951",
      "r952",
      "r999",
      "r1136",
      "r1210"
     ]
    },
    "ensg_PropertyManagementFeePercentFeeOfFundsFromOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PropertyManagementFeePercentFeeOfFundsFromOperations",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fees, as a percentage of funds from operations",
        "label": "Property Management Fee, Percent Fee of Funds from Operations",
        "documentation": "Property Management Fee, Percent Fee of Funds from Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_PropertyManagementFeePercentFeeOfTotalRevenues": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PropertyManagementFeePercentFeeOfTotalRevenues",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fees, as a percentage of total revenues",
        "label": "Property Management Fee, Percent Fee of Total Revenues",
        "documentation": "Property Management Fee, Percent Fee of Total Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAdditions",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails": {
       "parentTag": "ensg_BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, plant and equipment",
        "label": "Property, Plant and Equipment, Additions",
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails",
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r669"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNET"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PROPERTY AND EQUIPMENT\u2014 NET",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r119",
      "r170",
      "r173",
      "r174"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r225",
      "r761"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r669"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "PROPERTY AND EQUIPMENT, NET",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r669",
      "r751",
      "r761",
      "r968"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r170",
      "r173",
      "r759"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails",
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r669"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for doubtful accounts",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r242",
      "r364"
     ]
    },
    "ensg_PurchaseOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PurchaseOptionMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase Option",
        "label": "Purchase Option [Member]",
        "documentation": "Purchase Option"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_PurchasesOfNonControllingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "PurchasesOfNonControllingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of non-controlling interest",
        "label": "Purchases Of Non-Controlling Interest",
        "documentation": "Purchases Of Non-Controlling Interest"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "us-gaap_QualifiedPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "QualifiedPlanMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Qualified Plan",
        "label": "Qualified Plan [Member]",
        "documentation": "Plan with tax-exempt status designed and operated in accordance with applicable tax provision of designated taxing authority. Taxing authority includes, but is not limited to, U.S. Internal Revenue Service (IRS). Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1117",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277"
     ]
    },
    "ensg_QualityAssuranceFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "QualityAssuranceFee",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Quality assurance fee",
        "label": "Quality Assurance Fee",
        "documentation": "Quality assurance fee represents amounts payable to California, Utah, Idaho, Washington, Colorado, Iowa, and Nebraska in respect of a mandated fee based on resident days"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r181",
      "r183",
      "r184",
      "r186",
      "r216",
      "r217",
      "r423",
      "r424",
      "r425",
      "r426",
      "r507",
      "r515",
      "r547",
      "r548",
      "r549",
      "r561",
      "r625",
      "r686",
      "r695",
      "r712",
      "r791",
      "r795",
      "r803",
      "r823",
      "r824",
      "r876",
      "r880",
      "r882",
      "r883",
      "r885",
      "r901",
      "r902",
      "r925",
      "r934",
      "r945",
      "r958",
      "r959",
      "r963",
      "r964",
      "r982",
      "r991",
      "r1203",
      "r1212",
      "r1325",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r181",
      "r183",
      "r184",
      "r186",
      "r216",
      "r217",
      "r423",
      "r424",
      "r425",
      "r426",
      "r507",
      "r515",
      "r547",
      "r548",
      "r549",
      "r561",
      "r625",
      "r686",
      "r695",
      "r712",
      "r791",
      "r795",
      "r803",
      "r823",
      "r824",
      "r876",
      "r880",
      "r882",
      "r883",
      "r885",
      "r901",
      "r902",
      "r925",
      "r934",
      "r945",
      "r958",
      "r959",
      "r963",
      "r964",
      "r982",
      "r991",
      "r1203",
      "r1212",
      "r1325",
      "r1346",
      "r1347",
      "r1348",
      "r1349",
      "r1350"
     ]
    },
    "ensg_RealEstateAndLeaseArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "RealEstateAndLeaseArrangementsAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate And Lease Arrangements [Axis]",
        "label": "Real Estate And Lease Arrangements [Axis]",
        "documentation": "Real Estate And Lease Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_RealEstateAndLeaseArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "RealEstateAndLeaseArrangementsDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate And Lease Arrangements [Domain]",
        "label": "Real Estate And Lease Arrangements [Domain]",
        "documentation": "Real Estate And Lease Arrangements [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealEstatePropertiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RealEstatePropertiesLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Properties [Line Items]",
        "label": "Real Estate Properties [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table]",
        "documentation": "Disclosure of information about identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40"
     ]
    },
    "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Service Revenue by Major Payor Source",
        "label": "Reconciliation of Revenue from Segments to Consolidated [Table Text Block]",
        "documentation": "Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1019",
      "r1030",
      "r1040",
      "r1073"
     ]
    },
    "ensg_ReductionInPrepaymentPenalty": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ReductionInPrepaymentPenalty",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reduction in prepayment penalty",
        "label": "Reduction In Prepayment Penalty",
        "documentation": "Percentage that the prepayment penalty percentage is reduced during the fourth year."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_RentCostOfServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "RentCostOfServices",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rent\u2014cost of services",
        "label": "Rent Cost Of Services",
        "documentation": "Rent cost of services"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_RentalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "RentalMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rental revenue",
        "label": "Rental [Member]",
        "documentation": "Rental"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Payments on debt",
        "label": "Repayments of Long-Term Debt",
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r813"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]",
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r213",
      "r214",
      "r255",
      "r256",
      "r444",
      "r472",
      "r678",
      "r696",
      "r752",
      "r911",
      "r912"
     ]
    },
    "ensg_ResidentRefundsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ResidentRefundsPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails": {
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Refunds payable",
        "label": "Resident Refunds Payable",
        "documentation": "Resident refunds payable includes amounts due to residents for overpayments and duplicate payments"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1020",
      "r1031",
      "r1041",
      "r1074"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1021",
      "r1032",
      "r1042",
      "r1075"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1028",
      "r1039",
      "r1049",
      "r1082"
     ]
    },
    "ensg_RestrictedAndOtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "RestrictedAndOtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted and other assets",
        "label": "Restricted And Other Assets, Noncurrent",
        "documentation": "Restricted And Other Assets, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Awards",
        "verboseLabel": "Stock-based compensation expense related to restricted stock awards",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r27"
     ]
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestructuringCostAndReserveAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restructuring Type [Axis]",
        "label": "Restructuring Type [Axis]",
        "documentation": "Information by type of restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r415",
      "r418",
      "r419"
     ]
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r128",
      "r756",
      "r801",
      "r802",
      "r814",
      "r834",
      "r968"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r258",
      "r259",
      "r260",
      "r262",
      "r267",
      "r269",
      "r271",
      "r359",
      "r360",
      "r404",
      "r585",
      "r586",
      "r593",
      "r594",
      "r595",
      "r597",
      "r601",
      "r602",
      "r610",
      "r612",
      "r613",
      "r615",
      "r618",
      "r650",
      "r653",
      "r797",
      "r799",
      "r818",
      "r1388"
     ]
    },
    "us-gaap_RetirementPlanTaxStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanTaxStatusAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Tax Status [Axis]",
        "label": "Retirement Plan Tax Status [Axis]",
        "documentation": "Information by tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1117",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277"
     ]
    },
    "us-gaap_RetirementPlanTaxStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetirementPlanTaxStatusDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DEFINEDCONTRIBUTIONPLANSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement Plan Tax Status [Domain]",
        "label": "Retirement Plan Tax Status [Domain]",
        "documentation": "Tax status of plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans."
       }
      }
     },
     "auth_ref": [
      "r1117",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232",
      "r1233",
      "r1234",
      "r1235",
      "r1236",
      "r1237",
      "r1238",
      "r1239",
      "r1240",
      "r1241",
      "r1242",
      "r1243",
      "r1244",
      "r1245",
      "r1246",
      "r1247",
      "r1248",
      "r1249",
      "r1250",
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1261",
      "r1262",
      "r1263",
      "r1264",
      "r1265",
      "r1266",
      "r1267",
      "r1268",
      "r1269",
      "r1270",
      "r1271",
      "r1272",
      "r1273",
      "r1274",
      "r1275",
      "r1276",
      "r1277"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer [Abstract]",
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "TOTAL REVENUE",
        "netLabel": "Revenue",
        "verboseLabel": "Total Service Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r287",
      "r295",
      "r296",
      "r310",
      "r316",
      "r319",
      "r321",
      "r323",
      "r503",
      "r504",
      "r713"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service Revenue Recognition, Rental Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r906"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLE"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REVENUE AND ACCOUNTS RECEIVABLE",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r506"
     ]
    },
    "ensg_RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stat relief funding recognized as revenue",
        "label": "Revenue Recognition, Family First Coronavirus Response Act, Revenue Recognized",
        "documentation": "Revenue Recognition, Family First Coronavirus Response Act, Revenue Recognized"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevolvingCreditFacilityMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revolving credit facility with Truist",
        "label": "Revolving Credit Facility [Member]",
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new and modified operating lease obligations",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r665",
      "r967"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1091"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r323",
      "r1118"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r96",
      "r325",
      "r1164"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Receivable",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r96"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OTHERACCRUEDLIABILITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Accrued Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Indefinite-lived Intangible Assets",
        "label": "Schedule of Acquired Indefinite-Lived Intangible Assets by Major Class [Table Text Block]",
        "documentation": "Tabular disclosure of acquired indefinite-lived intangible asset by major class."
       }
      }
     },
     "auth_ref": [
      "r1191"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSPurchasePriceAllocationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Disclosure of information about business combination. Includes, but is not limited to, recognized asset and liability."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r60",
      "r598"
     ]
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Employee Stock Option Roll Forward",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1312"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r44",
      "r45",
      "r73",
      "r126",
      "r127",
      "r930",
      "r932",
      "r1148",
      "r1331"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1308"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Basic Net Income Per Common Share",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table Text Block]",
        "documentation": "Tabular disclosure of the effect of income (loss) on basic earnings per share."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r1153"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of the Numerator and Denominator Used in the Calculation of Diluted Net Income Per Common Share",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]",
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r28",
      "r1153"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/INCOMETAXESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r569",
      "r949",
      "r1306"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock-Based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETNarrativeDetails",
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r394",
      "r398",
      "r399",
      "r402",
      "r714",
      "r904",
      "r928"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r928",
      "r1193"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTable",
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill [Table]",
        "label": "Goodwill [Table]",
        "documentation": "Disclosure of information about goodwill, including, but not limited to, change from acquisition, sale, impairment, and other reason."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r385",
      "r927"
     ]
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfGoodwillTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/GOODWILLTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Goodwill",
        "label": "Schedule of Goodwill [Table Text Block]",
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule."
       }
      }
     },
     "auth_ref": [
      "r927",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1180",
      "r1181",
      "r1182",
      "r1183",
      "r1184",
      "r1185"
     ]
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "label": "Intangible Asset, Indefinite-Lived [Table]",
        "documentation": "Disclosure of information about indefinite-lived intangible asset. Excludes finite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r387",
      "r397",
      "r402",
      "r928"
     ]
    },
    "us-gaap_ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Self-Insurance Insurance Liabilities",
        "label": "Schedule of Liability for Future Policy Benefits, by Product Segment [Table Text Block]",
        "documentation": "The entire disclosure for the present values of future benefits to be paid to or on behalf of policyholders and related expenses less the present value of future net premiums using assumptions such as estimates of expected investment yields, mortality, morbidity, terminations and expenses, applicable at the time the insurance contracts are made and unpaid claim costs relating to insurance contracts including estimates of costs relating to incurred but not reported claims based on the estimated ultimate cost of settling the claims (including effects of inflation and other societal and economic factors), using past experience adjusted for current trends and any other factors that would modify past experience by element such as business segment, country and interest rate range."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturities of Long-term Debt",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Nonvested Restricted Stock Awards",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.ensigngroup.net/role/PROPERTYANDEQUIPMENTNETScheduleofPropertyandEquipmentNetDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule of Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r669"
     ]
    },
    "us-gaap_ScheduleOfRealEstatePropertiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRealEstatePropertiesTable",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Real Estate Properties [Table]",
        "label": "Real Estate Property, Ownership [Table]",
        "documentation": "Disclosure of information about real estate property by ownership of property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Purchase Price Allocation",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r38"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Financial Information",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r38"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r519",
      "r522",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement by range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Outstanding, Vested and Related Details",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assumptions for Stock Options Granted",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Estimated Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r928",
      "r1195"
     ]
    },
    "us-gaap_SecuredOvernightFinancingRateSofrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SecuredOvernightFinancingRateSofrMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "documentation": "Interest rate at which bank can borrow U.S. dollar overnight while posting U.S. Treasury bond as collateral."
       }
      }
     },
     "auth_ref": [
      "r1319"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1001"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r1004"
     ]
    },
    "us-gaap_SegmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Domain]",
        "label": "Segments [Domain]",
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r287",
      "r291",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318",
      "r323",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r402",
      "r417",
      "r420",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r917",
      "r920",
      "r921",
      "r927",
      "r985",
      "r1355",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1384",
      "r1385"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r182",
      "r185",
      "r187",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r321",
      "r322",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r820",
      "r821",
      "r822",
      "r877",
      "r881",
      "r884",
      "r886",
      "r889",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r908",
      "r936",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r984",
      "r991",
      "r1216",
      "r1355",
      "r1357",
      "r1358",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1384",
      "r1385"
     ]
    },
    "ensg_SegmentIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SegmentIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Segment income (loss)",
        "label": "Segment Income (Loss)",
        "documentation": "Segment Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BUSINESS SEGMENTS",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r287",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r306",
      "r308",
      "r309",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r323",
      "r916",
      "r918",
      "r919",
      "r920",
      "r922",
      "r923",
      "r924"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r287",
      "r308",
      "r309",
      "r316",
      "r920"
     ]
    },
    "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingRevenueReconcilingItemLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "label": "Segment Reporting, Revenue Reconciling Item [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SelfInsuranceReserve": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SelfInsuranceReserve",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Self insurance reserve",
        "totalLabel": "TOTAL SELF-INSURANCE LIABILITIES",
        "label": "Self Insurance Reserve",
        "documentation": "Carrying amount (including both current and noncurrent portions) of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_SelfInsuranceReserveCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SelfInsuranceReserveCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails": {
       "parentTag": "us-gaap_SelfInsuranceReserve",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued self-insurance liabilities\u2014current",
        "verboseLabel": "Less: current self-insurance liabilities",
        "label": "Self Insurance Reserve, Current",
        "documentation": "Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid within one year (or the normal operating cycle, if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SelfInsuranceReserveNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SelfInsuranceReserveNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails": {
       "parentTag": "us-gaap_SelfInsuranceReserve",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued self-insurance liabilities\u2014less current portion",
        "verboseLabel": "LONG-TERM SELF-INSURANCE LIABILITIES",
        "label": "Self Insurance Reserve, Noncurrent",
        "documentation": "Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid after one year (or the normal operating cycle, if longer)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SelfInsuranceReservePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SelfInsuranceReservePolicyTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Self-Insurance",
        "label": "Self Insurance Reserve [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for self-insurance reserves, including, but not limited to incurred but not reported reserves (IBNR)."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Enforceable Arbitration Agreement",
        "label": "Self-Insurance Retention Per Claim, Enforceable Arbitration Agreement [Member]",
        "documentation": "Self-Insurance Retention Per Claim, Enforceable Arbitration Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_SelfInsuranceRetentionPerClaimMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SelfInsuranceRetentionPerClaimMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Self-Insurance Retention Per Claim",
        "label": "Self-Insurance Retention Per Claim [Member]",
        "documentation": "Self-insurance retention per claim [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_SeniorLivingOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SeniorLivingOperationsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Living Operations",
        "label": "Senior Living Operations [Member]",
        "documentation": "Senior Living Operation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ServiceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ServiceMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLENarrativeDetails",
      "http://www.ensigngroup.net/role/REVENUEANDACCOUNTSRECEIVABLEScheduleofDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Service revenue",
        "label": "Service [Member]",
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service."
       }
      }
     },
     "auth_ref": [
      "r935"
     ]
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ensg_ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeiture rate",
        "label": "Share-Based Compensation Arrangement By Share-Based Award, Options, Fair Value, Assumptions Forfeiture Rate",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Award, Options, Fair Value, Assumptions Forfeiture Rate"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Annual bonuses settled in vested awards",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Bonuses, Included In Equity Instruments Other Than Options, Grants In Period",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Annual Bonuses, Included In Equity Instruments Other Than Options, Grants In Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award requisite service period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period",
        "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r946"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock awards granted (in shares)",
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r537"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested at beginning of period (in shares)",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r535"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Vested Restricted Awards",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested at beginning of period (in dollars per share)",
        "periodEndLabel": "Nonvested at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r534",
      "r535"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Vested in the period (in shares)",
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Dividend Yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r548"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Risk-Free Rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r549"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r519",
      "r522",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of installments",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Installments",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Installments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares authorized (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r948"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares available for grant (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion to reduce shares availability",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Conversion To Reduce Shares Availability",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Conversion To Reduce Shares Availability"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price of Options Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intrinsic value of options exercised in period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r541"
     ]
    },
    "ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation, options expected to vest, number (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expected To Vest, Number",
        "documentation": "As of the balance sheet date, the number of shares which are expected to vest into stock options outstanding can be converted under the option plan."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected to vest",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Expected To Vest, Outstanding, Aggregate Intrinsic Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": [
      "r1284"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either forfeited or expired."
       }
      }
     },
     "auth_ref": [
      "r1284"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant date intrinsic value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value",
        "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Options granted (in shares)",
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r530"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Fair Value of Options (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r540"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period, (in shares)",
        "periodEndLabel": "Balance at end of period, (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r527"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Options Outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period (in dollars per share)",
        "periodEndLabel": "Balance at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r526",
      "r527"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Aggregate Intrinsic Value of Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable [Table Text Block]",
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Options Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r542"
     ]
    },
    "ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other than options, conversion to reduce shares availability",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Conversion To Reduce Shares Availability",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Other Than Options, Conversion To Reduce Shares Availability"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation, restricted awards, exercise price (in dollars per share)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Restricted Awards, Exercise Price",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Restricted Awards, Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofNonvestedRestrictedStockAwardsDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r522",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r531"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofExercisePriceandFairValueDisplayedatGrantDateforStockOptionGrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price (in dollars per share)",
        "verboseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r530"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r516",
      "r525",
      "r544",
      "r545",
      "r546",
      "r547",
      "r550",
      "r556",
      "r557",
      "r558",
      "r559"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Range [Axis]",
        "label": "Exercise Price Range [Axis]",
        "documentation": "Information by range of option prices pertaining to options granted."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price Range [Domain]",
        "label": "Exercise Price Range [Domain]",
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "ensg_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Black-Scholes Fair Value",
        "label": "Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range, Fair Value",
        "documentation": "Fair value determined using a black-scholes model for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, lower range limit (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options vested and exercisable (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number outstanding (in shares)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r134"
     ]
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price, upper range limit (in dollars per share)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSRestrictedStockAwardsNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-employee Directors",
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r522",
      "r523",
      "r524",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550"
     ]
    },
    "srt_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r1215"
     ]
    },
    "srt_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r1215"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting rights, percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1278"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate intrinsic value of options that vested in period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested",
        "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSStockOptionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r947"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAssumptionsforStockOptionsGrantedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected Life",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofAggregateIntrinsicValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofStockBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation, options outstanding, weighted average remaining contractual term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSOptionsOutstandingbyExercisePriceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining Contractual Life (Years)",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares of common stock used to satisfy tax withholding obligations (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments\u2014current",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r1134"
     ]
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CPI increases and short term-lease cost",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r661",
      "r967"
     ]
    },
    "ensg_SkilledNursingOperationsAndSeniorLivingFacilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SkilledNursingOperationsAndSeniorLivingFacilitiesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Skilled Nursing Operations And Senior Living Facilities",
        "label": "Skilled Nursing Operations And Senior Living Facilities [Member]",
        "documentation": "Skilled Nursing Operations And Senior Living Facilities"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_SkilledNursingOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SkilledNursingOperationsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Skilled Nursing Operations",
        "label": "Skilled Nursing Operations [Member]",
        "documentation": "Skilled Nursing Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_SkilledServicesSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SkilledServicesSegmentMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Skilled Services",
        "label": "Skilled Services Segment [Member]",
        "documentation": "Skilled Services Segment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SpinoffMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SpinoffMember",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Spinoff",
        "label": "Spinoff [Member]",
        "documentation": "Creation of an independent entity from an existing entity through divestiture, for example, but not limited to, sale or distribution of new shares."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_StandardBearerEquityPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "StandardBearerEquityPlanMember",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard Bearer Equity Plan",
        "label": "Standard Bearer Equity Plan [Member]",
        "documentation": "Standard Bearer Equity Plan"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_StandardBearerHealthcareREITIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "StandardBearerHealthcareREITIncMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard Bearer Healthcare REIT, Inc.",
        "label": "Standard Bearer Healthcare REIT, Inc. [Member]",
        "documentation": "Standard Bearer Healthcare REIT, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_StandardBearerMasterLeasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "StandardBearerMasterLeasesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard Bearer Master Leases",
        "label": "Standard Bearer Master Leases [Member]",
        "documentation": "Standard Bearer Master Leases"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_StandardBearerSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "StandardBearerSegmentMember",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Standard Bearer",
        "label": "Standard Bearer Segment [Member]",
        "documentation": "Standard Bearer Segment"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_StandardBearerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "StandardBearerTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/STANDARDBEARER"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "STANDARD BEARER",
        "label": "Standard Bearer [Text Block]",
        "documentation": "Standard Bearer"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementBusinessSegmentsAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSNarrativeDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofSegmentFinancialInformationDetails",
      "http://www.ensigngroup.net/role/BUSINESSSEGMENTSScheduleofServiceRevenuebyMajorPayorSourceDetails",
      "http://www.ensigngroup.net/role/GOODWILLScheduleofGoodwillDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segments [Axis]",
        "label": "Segments [Axis]",
        "documentation": "Information by business segments."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160",
      "r161",
      "r220",
      "r287",
      "r291",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r314",
      "r316",
      "r317",
      "r318",
      "r323",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r402",
      "r407",
      "r417",
      "r420",
      "r771",
      "r772",
      "r773",
      "r774",
      "r775",
      "r776",
      "r777",
      "r778",
      "r779",
      "r780",
      "r781",
      "r917",
      "r920",
      "r921",
      "r927",
      "r985",
      "r1355",
      "r1357",
      "r1358",
      "r1359",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1384",
      "r1385"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r89",
      "r93",
      "r94",
      "r218",
      "r238",
      "r239",
      "r240",
      "r258",
      "r259",
      "r260",
      "r262",
      "r267",
      "r269",
      "r271",
      "r289",
      "r359",
      "r360",
      "r404",
      "r484",
      "r585",
      "r586",
      "r593",
      "r594",
      "r595",
      "r597",
      "r601",
      "r602",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r618",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r650",
      "r653",
      "r677",
      "r766",
      "r797",
      "r798",
      "r799",
      "r818",
      "r871"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r182",
      "r185",
      "r187",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r321",
      "r322",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r734",
      "r735",
      "r736",
      "r737",
      "r738",
      "r739",
      "r740",
      "r741",
      "r742",
      "r743",
      "r744",
      "r745",
      "r820",
      "r821",
      "r822",
      "r877",
      "r881",
      "r884",
      "r886",
      "r889",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r908",
      "r936",
      "r970",
      "r971",
      "r972",
      "r973",
      "r974",
      "r975",
      "r976",
      "r977",
      "r984",
      "r991",
      "r1216",
      "r1355",
      "r1357",
      "r1358",
      "r1360",
      "r1361",
      "r1362",
      "r1363",
      "r1364",
      "r1365",
      "r1366",
      "r1367",
      "r1368",
      "r1369",
      "r1370",
      "r1371",
      "r1372",
      "r1373",
      "r1374",
      "r1375",
      "r1376",
      "r1377",
      "r1378",
      "r1379",
      "r1380",
      "r1381",
      "r1382",
      "r1384",
      "r1385"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r289",
      "r653",
      "r713",
      "r807",
      "r819",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r833",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r852",
      "r854",
      "r855",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r871",
      "r992"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r259",
      "r260",
      "r289",
      "r324",
      "r653",
      "r713",
      "r807",
      "r819",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r833",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r846",
      "r847",
      "r848",
      "r849",
      "r850",
      "r852",
      "r854",
      "r855",
      "r857",
      "r858",
      "r859",
      "r860",
      "r861",
      "r862",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r871",
      "r992"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1023",
      "r1034",
      "r1044",
      "r1077"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of restricted stock, net of forfeitures (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r88",
      "r89",
      "r128"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSScheduleofEmployeeStockOptionRollForwardDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock to employees and directors resulting from the exercise of stock options (in shares)",
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r88",
      "r89",
      "r128",
      "r531"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of restricted stock, net of forfeitures",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r128"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock to employees and directors resulting from the exercise of stock options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r89",
      "r93",
      "r94",
      "r128"
     ]
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized amount",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1215"
     ]
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, period in force",
        "label": "Share Repurchase Program, Period in Force",
        "documentation": "Period share may be purchased under authorized share repurchase plan, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total Ensign Group, Inc. stockholders' equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r93",
      "r94",
      "r118",
      "r835",
      "r851",
      "r872",
      "r873",
      "r968",
      "r1000",
      "r1145",
      "r1172",
      "r1329",
      "r1388"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Ensign Group, Inc. stockholders' equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r64",
      "r66",
      "r218",
      "r219",
      "r239",
      "r258",
      "r259",
      "r260",
      "r262",
      "r267",
      "r269",
      "r359",
      "r360",
      "r404",
      "r484",
      "r585",
      "r586",
      "r593",
      "r594",
      "r595",
      "r597",
      "r601",
      "r602",
      "r610",
      "r611",
      "r612",
      "r613",
      "r614",
      "r615",
      "r618",
      "r641",
      "r642",
      "r646",
      "r651",
      "r677",
      "r798",
      "r799",
      "r816",
      "r835",
      "r851",
      "r872",
      "r873",
      "r887",
      "r999",
      "r1145",
      "r1172",
      "r1329",
      "r1388"
     ]
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAM"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "COMMON STOCK REPURCHASE PROGRAM",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r252",
      "r470",
      "r471",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r483",
      "r484",
      "r617",
      "r874",
      "r875",
      "r888"
     ]
    },
    "ensg_StopLossInsuranceLimitPerClaimMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "StopLossInsuranceLimitPerClaimMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stop-Loss Insurance Limit Per Claim",
        "label": "Stop-Loss Insurance Limit Per Claim [Member]",
        "documentation": "Stop-Loss Insurance limit per claim[Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r663",
      "r967"
     ]
    },
    "ensg_SubleaseToThirdPartyOperatorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SubleaseToThirdPartyOperatorsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease To Third Party Operators",
        "label": "Sublease To Third Party Operators [Member]",
        "documentation": "Sublease To Third Party Operators"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r647",
      "r679"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r647",
      "r679"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r647",
      "r679"
     ]
    },
    "srt_SubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SubsidiariesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails",
      "http://www.ensigngroup.net/role/OPERATIONEXPANSIONSNarrativeDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Subsidiaries",
        "label": "Subsidiaries [Member]",
        "documentation": "Entity in which controlling financial interest is held. Includes, but is not limited to, variable interest entity (VIE) consolidated by primary beneficiary. Excludes entity in which broker-dealer holds controlling financial interest but control is likely to be temporary."
       }
      }
     },
     "auth_ref": [
      "r1263",
      "r1340",
      "r1341",
      "r1342"
     ]
    },
    "ensg_SubsidiariesUnderMasterLeaseArrangement": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SubsidiariesUnderMasterLeaseArrangement",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiaries under master lease arrangement",
        "label": "Subsidiaries Under Master Lease Arrangement",
        "documentation": "Facilities operated under two separate three-facility master lease arrangements. Under these master leases, a breach at a single facility could subject one or more of the other facilities covered by the same master lease to the same default risk."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_SuzanneD.SnapperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "SuzanneD.SnapperMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Suzanne D. Snapper [Member]",
        "documentation": "Suzanne D. Snapper"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_TX": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "TX",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Texas",
        "label": "TEXAS"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "ensg_ThePennantGroupInc.Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ThePennantGroupInc.Member",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLessorNarrativeDetails",
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "The Pennant Group, Inc.",
        "verboseLabel": "Pennant",
        "label": "The Pennant Group, Inc. [Member]",
        "documentation": "The Pennant Group, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ThirdPartyOperatorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ThirdPartyOperatorsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third Party Operators",
        "label": "Third Party Operators [Member]",
        "documentation": "Third Party Operators"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_ThirdPartyTenantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "ThirdPartyTenantsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofRentalIncomefromThirdPartySourcesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other third-party",
        "label": "Third Party Tenants [Member]",
        "documentation": "Third Party Tenants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_TotalNetDebtRatioMaximum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "TotalNetDebtRatioMaximum",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total net debt ratio, maximum",
        "label": "Total Net Debt Ratio, Maximum",
        "documentation": "Total Net Debt Ratio, Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_TotalNetDebtRatioMaximumAfterIncreaseElection": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "TotalNetDebtRatioMaximumAfterIncreaseElection",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total net debt ratio, maximum after increase election",
        "label": "Total Net Debt Ratio, Maximum After Increase Election",
        "documentation": "Total Net Debt Ratio, Maximum After Increase Election"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_TotalNetDebtRatioMinimum": {
     "xbrltype": "pureItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "TotalNetDebtRatioMinimum",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total net debt ratio, minimum",
        "label": "Total Net Debt Ratio, Minimum",
        "documentation": "Total Net Debt Ratio, Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1062"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r162",
      "r163",
      "r164",
      "r1162",
      "r1163",
      "r1165"
     ]
    },
    "us-gaap_TradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeNamesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofFiniteLivedIntangibleAssetsDetails",
      "http://www.ensigngroup.net/role/INTANGIBLEASSETSNETScheduleofIndefinitelivedIntangibleAssetsDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESIntangibleAssetsandGoodwillDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade name",
        "verboseLabel": "Facility trade name",
        "label": "Trade Names [Member]",
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r1187",
      "r1188",
      "r1189",
      "r1190",
      "r1191",
      "r1192",
      "r1194",
      "r1196",
      "r1197",
      "r1198"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1090"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.ensigngroup.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/FAIRVALUEMEASUREMENTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r465",
      "r482",
      "r616",
      "r639",
      "r680",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r767",
      "r953",
      "r956",
      "r958",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r969",
      "r1122",
      "r1123",
      "r1124",
      "r1125",
      "r1126",
      "r1127",
      "r1128",
      "r1168",
      "r1169",
      "r1170",
      "r1171",
      "r1321",
      "r1324",
      "r1325",
      "r1326",
      "r1327",
      "r1328"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1092"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1093"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common shares in treasury, at cost (in shares)",
        "periodStartLabel": "Treasury stock, balance at beginning of period (in shares)",
        "periodEndLabel": "Treasury stock, balance at end of period (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common stock in treasury, at cost, 3,400 and 3,390 shares at December\u00a031, 2024 and 2023, respectively",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r50",
      "r93"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of common stock (in shares)",
        "verboseLabel": "Repurchase of common stock (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r89",
      "r128"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.ensigngroup.net/role/COMMONSTOCKREPURCHASEPROGRAMDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repurchase of common stock",
        "terseLabel": "Amount of common stock repurchased",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r47",
      "r128"
     ]
    },
    "ensg_TripleNetLeaseArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "TripleNetLeaseArrangementsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Triple Net Lease Arrangements",
        "label": "Triple Net Lease Arrangements [Member]",
        "documentation": "Triple Net Lease Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_TruistBankMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "TruistBankMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Truist",
        "label": "Truist Bank [Member]",
        "documentation": "Truist Bank [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ensg_TwentyThreeSubsidiariesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "TwentyThreeSubsidiariesMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Twenty Three Subsidiaries",
        "label": "Twenty Three Subsidiaries [Member]",
        "documentation": "Twenty Three Subsidiaries"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfRestructuringDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/OPTIONSANDAWARDSLongTermIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Type of Restructuring [Domain]",
        "label": "Type of Restructuring [Domain]",
        "documentation": "Identification of the types of restructuring costs."
       }
      }
     },
     "auth_ref": [
      "r414",
      "r415",
      "r418",
      "r419"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1089"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimates and Assumptions",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r35",
      "r168",
      "r169",
      "r171",
      "r172"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESScheduleofOperatingLeaseExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of service",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r662",
      "r967"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTCreditFacilitywithaLendingConsortiumArrangedbyTruistDetails",
      "http://www.ensigngroup.net/role/STANDARDBEARERDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "ensg_VariousLandlordsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "VariousLandlordsMember",
     "presentation": [
      "http://www.ensigngroup.net/role/LEASESLesseeNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Various Landlords",
        "label": "Various Landlords [Member]",
        "documentation": "Various Landlords[Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1058"
     ]
    },
    "stpr_WA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "WA",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WASHINGTON",
        "label": "WASHINGTON"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Adjusted weighted average common shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r274",
      "r282"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "WEIGHTED AVERAGE COMMON SHARES OUTSTANDING",
        "verboseLabel": "DENOMINATOR:",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/COMPUTATIONOFNETINCOMEPERCOMMONSHAREDetails",
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in shares)",
        "terseLabel": "Weighted average shares outstanding for basic net income per share (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r273",
      "r282"
     ]
    },
    "us-gaap_WorkersCompensationInsuranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WorkersCompensationInsuranceMember",
     "presentation": [
      "http://www.ensigngroup.net/role/SELFINSURANCELIABILITIESScheduleofFutureSelfInsuranceLiabilitiesDetails",
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Workers' Compensation",
        "verboseLabel": "Accrued workers\u2019 compensation liabilities",
        "label": "Workers' Compensation Insurance [Member]",
        "documentation": "Contract providing insurance coverage for employer's liability related to injury, disability, or death."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WriteOffOfDeferredDebtIssuanceCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WriteOffOfDeferredDebtIssuanceCost",
     "crdr": "debit",
     "calculation": {
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://www.ensigngroup.net/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Write-off of deferred financing fees",
        "label": "Deferred Debt Issuance Cost, Writeoff",
        "documentation": "Write-off of amounts previously capitalized as debt issuance cost in an extinguishment of debt."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ensg_YearsFiveThroughTenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.ensigngroup.net/20241231",
     "localname": "YearsFiveThroughTenMember",
     "presentation": [
      "http://www.ensigngroup.net/role/DEBTMortgageLoansandPromissoryNotesandOffBalanceSheetArrangementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Years Five Through Ten",
        "label": "Years Five Through Ten [Member]",
        "documentation": "Years Five Through Ten"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "naics_ZZ524292": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/naics/2024",
     "localname": "ZZ524292",
     "presentation": [
      "http://www.ensigngroup.net/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSelfInsuranceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Third-Party Payor",
        "label": "524292 Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(f)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "SubTopic": "405",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477787/942-405-45-2"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21B",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21B"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "825",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-1"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(2)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-4"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-2"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-2"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479328/805-10-50-3"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-24"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-11"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-12"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "850",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480091/360-10-S99-2"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/505/tableOfContent"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/710/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/805/tableOfContent"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-23"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-15"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-6"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479808/944-20-55-15"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(A)",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(B)",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)(C)",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "a",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(1)(iii)",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-21B"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-6A"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26A"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-4"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.b.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4.d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479823/420-10-S99-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-16"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.1.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479907/805-20-50-5"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479581/805-30-50-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-6"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-30/tableOfContent"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479016/842-30-45-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-12"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-5"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column J))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-16(Column K))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-1"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/944-40/tableOfContent"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-3"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(f)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477968/946-235-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "12",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-12"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "19",
   "Subparagraph": "(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-19"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-6"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/985-20/tableOfContent"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-16"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479908/805-50-55-1"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4J"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4K"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13I"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29E"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "405",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478790/946-405-45-2"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "SubTopic": "740",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479176/718-740-35-2"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "SubTopic": "20",
   "Topic": "715",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(ii)",
   "Publisher": "SEC"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "a",
   "Subparagraph": "(4)(iii)",
   "Publisher": "SEC"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483504/205-10-50-1"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "325",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481551/325-30-35-2"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1A"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(10)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(8)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(k)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(n)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(q)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-2"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-3"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-6"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-8"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480123/805-50-15-3"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480060/805-50-25-1"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-1"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480027/805-50-30-2"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480682/815-20-25-6A"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r1331": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1332": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1333": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1334": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1335": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1336": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1337": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1338": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-12"
  },
  "r1339": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479773/842-30-50-3"
  },
  "r1340": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1341": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-1"
  },
  "r1342": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r1343": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1344": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1345": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1346": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1347": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1348": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1349": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1350": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1351": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(13)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1352": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1353": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1354": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1355": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1356": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1357": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1358": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1359": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1360": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1361": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1362": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1363": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1364": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1365": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1366": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1367": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1368": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1369": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1370": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1371": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1372": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1373": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1374": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1375": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1376": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1377": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1378": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1379": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1380": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1381": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1382": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1383": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r1384": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1385": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1386": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1387": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1388": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1389": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1390": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>131
<FILENAME>0001125376-25-000021-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001125376-25-000021-xbrl.zip
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M?G,Q]:RX(U=0<U8Q]:R(DRL$.+N8>E;DR14LFV5,/2L"Y1*O/."8>E9\D$O
M\$!CZEGQ0*[@PH./J6?%!;D"[-Y$3#TK3BAP,WUCF5G ,QG5IZH7Z)V^?)@!
M#I01&S8*E% GI9@5%[P)-' O!G*A$%_*@[D$/=\ #[XA99@K8%=K%LPK!^02
M.7Y[,?6LV".7@/*;BZEGQ1VY@IJSBJEG19Q<(<#9Q=2S(D^N8-DL8^I9$2B7
M>.4!Q]0SXH-F+@'# XVI9\4#N8(+#SZFGA47Y JP>Q,Q]:PX04O<["O[PY-G
MH1]X(R[3+NE7;@N+B>>N>LO$N]H;JSW[(NTQH(R*,C2UA @S979Z45J>=ES[
MEL.Z6<+!&^BQI2Y\GU>NTQ)Y?(;KY*N%4"%BWZ2(U1)(S939"Q&[>Z[3$B%^
M5K%'@J&0M(6D?0'/:PF[Z\#SA<#=/?-I&5)XEOF $0KSMA"Z+^?[EI8A%%WX
MOA"\NV= +>,WJQF0N6S [;-"X!8"]V7\KF6D*FM^+P3M[ADO7X&Q&RGN8:XW
M; *L0-=0%_*VD+<O8/M\A<CVR_:%V-T]_VD9+"L8(CN&R&- J4A0R;GVS:C"
M22N?<:Q"Y^:;Z_(822H I4+$OHC9\QBY*M"DG'/=<3[C1D6"2B%I7\[S.0M5
M%0DJA\1\.8L;%0DJA=#="M_G*VQ5)*@<' /F*X!4)*@4 O=U_*YEP"IK?B\$
M[>X9+U^!L2)!I9"W6V'[?(7(B@250^,_+8-E!4-DQQ!Y#"@5"2HYU[X9E0LZ
MR6<<J]"Y^>:Z/$:2"D"I$+$O8O8\1JX*-"GO7)?/N%&1H%)(VI?S?,Y"546"
MRB$Q7\[B1D6"2B%TM\+W^0I;%0DJ!\> ^0H@%0DJA<!]';]K&;#*FM\+0;M[
MQLM78*Q(4"GD[3;8OIVO$%F1H')H_*=EL*Q@B.P80KN 4KSL0!2823"Y<9@;
M .'/_PS%F%3)Y&XRGJ/1%^8^AWF^@$#"!3) V\6J-?&3EZVY=N$4/=>\OLTU
MUP[.?]&:?PH%].H.H%W\\7(TEMX]7\<^U&@+: =PYXX<6]T=VN&N+Y-(G/E\
MZ#EV/O>$=MAC3HBPU9V@'2#V(B(D#_/#_=H!0AHO_!8YOE[5#I)XT<)?A-(5
M02@Y-+P0C_@I-Z*_7M7.+<\'#;:Z#P[#$T8L)9"A15"*"S\= !%RM!,.PS?.
M@ I;W0O:>LL7 B0,_R+NN7WIP@0'HN?PCN_SP/\T43BVP_PT?H@/1]#(OK:L
M<,Q<:]*Q@'3RV22YUR)ZV=1$KE>U=:WUIMVN!)JVKG5NR+%5R::MD[T1.>(?
MW4EF\RLVVH6=I84PT]8=UXY<N]HPVOKE+Z) '.6^Y8X**0[%^$#W3DU;QUYG
MRNUH&]6T]? O70N6-4G4^>)9M+PIM?^9CR6WA/K:M3LC3P;B/_3G@>X<;:$
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MK84PT!8G?RH.]X4'0*8X+'B@E-$6=<;JF'@,/[UA,:T<O\^/5-06B-WO\NK
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MR('O[ZSHG3<\Y5#V=T;VVDG>4)I#V=]9T3MOV,_.O:8=7=YX4D Y^[D8[J1
M9_9S'\A) ;CL)Z9U\L8QE+W51,BI#WZB+>:B3Q6+ _<6LN(\;=&?@O,.&W=L
M:XM#+:^74VM_N;M<HV3.VJ\A_@FM()1X*Y#G!QW7AN^XO)]CM.Y8N%Z_OTMK
MI]8N5T_*YO%6K)VVMHC3FZ&L%AM<6R#J;;)!1OAS6UM\ZFVR048P93LOZ!GQ
MP74PC-)NZ>F!5G!MYP5HRX(F68G+O&!R6= D*]F5-_AN+^FU.\)*V]IA8>2*
M1[<6?/&8ZU^[MYPYYS#)@'_FOB4%+3'2X;I_(SV8[\REG-WOPG&X?15*'TR
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M2P94LCOV"*2('R#,<<_/'[%@_(&&/$WMX+E\DB\C[\C4#JS))_DR<J3,O(%
M&ZI??=24J1VTDV'"U<$264NL:">AEQRG^Z7S%MU!.@B'JX6Q+V$+8,'7AY'>
M0&*AJ1T4]QQG7?&'0J9M0& M<;I<RK0=<5XAS[;)[MI!FFMP50><E@.VUK3
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M-'^N-[YVF*VNFG^KJYX[L/# X1<=PI0-[:#"@BDRCX,V"@!/8Z;(*-#:*%#
M#9@B?N,=1]8XT+R^AG9 8L$2&:N.YAL"]?+&$ADICJ9VB*-6WIX.@KR9.R0N
M.Q)E)5BU ^WT)5%6@DX[6$LI(-?W'&$3,'H9\)$_FQ&5'$[KJFZWHO5NI&>'
M5G MNUS>"RNM]6[A'<S96L)7G!+[*?2%RWT_GL7L)#N.HRY(76^.>17CVB%\
M!0-FPX!9*2GMT,2" ;-AP*Q4L';(9;S^MSP0DNB$M=[NV"/2+9PCTC]"YN![
M;&QSH#I*.QA16PIE)<2U0_6TI5!&4JZE'<BV$86N//?/PQ=T+>U@KV?,DNCX
MX!?!>GA3QZ3C8FY)'RP*^#78*\P92V8%\*.DR:7KA^#Z6SLX6[BC],>6=DA7
M7JFRS=24EG;@UFJJQ%+L=T]^Y](_\T9XNE;Y%OG;#EI"5IHN_%8Y7DNHYNF%
M5W=>)6L=-?XB=G'CZZ[X74N 0LMEWRJW:^>6JW-;?WCR+/0#;P3R)*5SOW);
M6$S8H&O51_G<4J]M()]Y0$(W4&G*M\+_OJS0>SRFA<8[',4G[EK#$9/?YV C
MR\( MG_++2[N6<\YT'(M+>U@B8)#->70C&"9EG:P#%6P'.(5F'P<W3<,RFD@
MV2C-J6R"6W6AR8Y-AFJS7&MM17<=:P>V:+;N\^([O?)/B^^9IJ_:',=:@BT:
M$RD+'7NL)?;R+)$ZX0"T'4KS_0HQT#,G9;.]'2&F)<"BU]+/*_GTXC^MY&>:
MOFZ+:(G':$RGK$29EO#-LW3Z6^B@PC'W*\C,<O6X;)YL1Y!I">#HM/#S <KT
MTC\=H)QI^KKML7.\9W,Y4:MF(2>T@Q6X99]>NK:X%W;(G!2+?I:5CNMV*Y\<
M+Q2[C\EF0P[M?&A=R)&)%CW1SK7.C!P[BG><:.<7KUSA;O@?YKK\<Z7KLC%,
M\C ET(EV/K ^!,E&!FGG&6=(D-=+H??B\51RWP,KE_OJSR%G-HT'IO3Q%_@7
M+;W@5OVX7S49[[6;C8;-3FJ\WVZUVAQ6TNRW^O^+-N3T-WXP<8 $(^&6AUP,
MAL%IHUUICH,/#\(.AJ>U:O7'HYF6.)XR<\3 /?T#G%/1G\!S?\S<C[_TY'OH
M6GU6;UAX3^K7&(?@,OIQ_-SR'$^>_E"E?S[T8?KE/AL)9W+ZTQG\K"?%3R6?
MN7[9AX7JJP:^^ \_K=5AS/3G@YK&,?S>$2Z/IU4S<29&\4_Q3_'/&__GV]7E
MW?EGHWO7N3OOSDHLC615]_SLV^WEW>5YU^A<?3;._W7VU\[5;^?&V?77KY?=
M[N7U509#KZTU]-^9/Q3N(/#<DO&Y<E8QS&JST<Y@N.9:P_W?I_[)8-2MM49]
M<7W[U?@%+ '7<Z_"$71B&9'!<,O[:(75C@R7H85E<W'ZV;-"M%@PZ^"(;(4^
M-/@(YOK?R9Z8]O+1V&C. 28'Q UZG@2KI QS=]C8YZ?QAP^V\,<.FX#%0S.A
M'WT8,3D RZ/G!8$W.D6SXQYK[EG,B5Y"[U./(XNDW:Z<-.MHE 1@_ 1V_.+(
M7JG RKQ?_+Y9J3?,I4^JE=K2[U?UU#8KC>;)DUV]IY&IT<'\<2E_/:H?Q8W'
MS+9A<YR:XT<#M]/"FLXO@IK_MKBK/<=<C7GF4B;?QGP%?CS8U;=\[,G@R.A[
M<L0"L$=A;F#4PQP\I\<<QPMZWF/,?N"T_>6']G&C]6&> Q,&#.P7+*/#^PN<
MM-M%7-BAM(B=JZMOG2_&[?G-]>V=<?/MMONM<W5GW%T;(-OO0( ;M;IQ?6O4
MFN_LGXWK"^/NK^=&2NPG(K]S=H>/:^UZHS*S-,^P6KSI8&5YQ+%KM*).W],.
MW:?8>W9-E=3SI!$,N=$7/A#7F' F#;H&] 6B\(:\K7/EY\[P[*D-WY1'T,40
M?U:VV:2,KRIS-V;>QB:;Y"R4$EYX08/^-W2T[DNG[P.'^C.WR G]RP^U5O4#
M>I&SNZ9DH(<Y_VUE,W&^1UI>W\8C*W1(H4/0-I'P-BK+NT2/G/;%([=AA(Z?
M&##-2(,T#E2#W-UVKKJ7I"JRTR+Q.E5QE5:KD9<N)PFE/:YIK$&"A-D,!;L9
M?>F-$F&YMQ&IA;*YY:FTW-,0U)G$5LC<*.GW_^^]+\+11R/PM%IZXTVLNGIQ
M90ZV383"2BLPTKJ!-SYM+=,_^S4DSKS12-#13; +P9!P0S233C<P"<\)OK^
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M*]8(!N%"ZX"[1H^#7(/O1%_ .O0FQH,G;1AX"$O(?.,O/YR89O4#5E?$Z&P
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MD!304CQ?>(C>$7)4:[?;I54^[3OUW<]/^"U/HQ*QO^!_%X21N*'TR5'PN2M
M%3OB/KZX0/*ALEW5A5>QJ3]C"BM9B'$JQT'H)C98X77O5*P,>QMYT ^B[&S@
M>K#D5F3U(N8+8A&-,A\E(YD'/Y=H%9H*AD0@RD\4O++D$[1G&@A[ #/ \<%+
ML@B,1"\&5(FR[AY<8SA%?M+F-?@&T:R4/(:QE9F%-@4UC6(LX2CQ6ZA[?WH3
M8FHLL]$T,?/.2-"3#W#A*7A^PC$J0T3_S"V.-J<R->NUDF%6S09-2GDF9%:.
MH9=' I_!,VPW*\<_QBL2.: JUH!?S!$7PP:)#X*,)4%Q"0H4S/4@$(F'=TC@
M[-2[DX[3BS>=U#SS)$[AU&><<DC\L++.AFTOW:];DS3S:,=R27-]<W[;P=2"
MM63,)D/>_/3=&L[ BDG<X[KSA]7V1"[D) H#X-DG=HR'\3A$)C86<+15IX!&
MM.7KYO'"?B*H<Z:[] Z[5L A_G#ZM1I;#!V:]5KJ612T<SQW4$;D-!9>4F)L
M9WK9%B'*7AR[](QQ**TAMJR9RH3$*.-LU\I?G=FV(*7ZGB,\<J' (Z8%K9EM
M0T%3J[;X3/Z#;;1;3]CGG)O'9F,7Y,_"*4@1*B'@%+2QXRA=O9Y*Y5 D5, =
M"L$49@P.@;3+J-$FT?<4T24G8@'J^,DW< [@.[N"*8@!NI_R6'U)=RI2B5#&
M+(\F3]-H!8)_%,$?\66DGZA(]/P&F'9%1L4#N2OIF6Y=NN]35"H'\$_0AQU4
MN@RCKE@N()"A%=#M37D6H6@ H)\:1QR/D!W\B>NYDQ'F&) 1R8RCOL,&1XC.
MP&<_ BZ/(KG9QYI:$;(Z\!@%"GT>$$9.[!0#G9CZH\+6L>-,MM%LF!S$[@BV
M"ZRL38'L*$-'\58LARFSJ@\;(1*&L,%L52&,1"NB1WVPW]#6,%S0<P[T0.,:
M Z.B@4;B?0'A52E2G+)(@J>18B7U@ZC_9/C)7!$6YL@L\1L?$G5"TR+UF[(*
M$U4S-;EHL^'6=%+0;VI%R+@+"2&C30S\AM:@+4%_N;C8V !-?/@K0JZ13+U0
M.#9:RZ!AEN'MWSE-XSN/RZ4!B=0H4L.%E1I%YBU9Z"AR2A3TYP2UDUP@93,.
ME25/*Z(<#C(+0Y -*(^PN[FT$?QA3](*1S:]DB9RP%SQ'^H-1N/'.Q!['7F$
MS0"W\='8>P"]269X/QKYE#\4X0+6[^-:C#!!0J$MD6"?4"=Q0#.1;-"3-?2
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M?U7R'D)NJ&%2-@\!!'YD4/<X5J<W;#ZB).=82,>BDR19K,\755Z$::E$R 3
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MY0$-CTN[\A,V=&^N8YH;Y\B<?OINM'VN8AQUQ=5)#&;P+JG>%'';!6P3D#7
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M-_[Q]&B3_(7BJ9<%EYJ8G=%QS4^VL,E (@?ZS],%-ZUARLRX\=QO T#LW*[
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M-"HZBKU48CN-PU+I_B JTMLK9XIGW]U8W[>8G)%;.HX'ICGJ>THT2*U@>M7
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M<@W/I[B!!46IY+(@;R(:&$<_S>7 U&0DH9#R5?")WM/QZ22--2_/S@91UM/
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M4 !V[6)F5!VI%B)ZNAYV@/"3019 7[QNG#T:F64&,?PFN.NI&'=89M657Z4
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MK,8=U9TJ6H9M?Z:5U/,6+"S]X(F _:VY> >C$I%U;57)P*^\(JYZQXHOF?>
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MZD6U]:_FU%7XWMLG=]24S3"]F%]9M6\B_G5YU;Y)JQ9.3KNH-5[/Z8XZC.G
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M@C0T.UT _9A+]::U;_@)'W1)#]=Y]?D-A'T%3U!#0T=7?+ZAELJ[67Z0'DN
M@GIRD_I]ABP#F*T9UQ)=]KL^]/J2NEEY)ZU84TQKE;Q1%A ,UGFU[I')O?J
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M-M,M[)YZOD*ZF\:B*7PCR\PGV&A$^!;?Z0#OP0N3:GNC$+>HN,22W(!%/-G
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M2;TWG;Q(ZQ!C;-I2H],3@ 65VQ5(-1=J6$?6XLT]5C".PW?&M+W9PK'E6%N
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MAL8K^)FZ@R+/QXTP9^69EMO';59&66A>.IB!9OD8FJ?R(',S4F&1P,D>"NU
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MBL0$"XL;Y+)N8LB1)0=0+0R?>[:9E2. X=F52/N7#'(=*L+8PGYYSYQ(S@7
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MH[09>#MRX%Q?PLL5W"TB'HZ@K7B<<71 #\UV^Z60UB%OD2(Q&5_=M.HL3!5
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MG50HW1KWKD(Z&]?"R=J%LX\1KA<FV%1.RN5*>/IS*WT+U_< :^LGD2<Y72B
MF2V1B+B1 Y4V1^SU?;O<?!%/5I\Y:%MG0,+?5@@(=1>&OYGV,)CKA&#?%_G#
M+_P2#"Z1UV'_X![0,-$-DT$CN^>N2GK3"NX/%\:E^M?!:"YZI]"/W R1O=YV
M@THP-K]HZOC'9JY5>/ 352%Z7840\J51X1]R2_MS2].<O] M@W@H*&9/! GN
MDBN:]YQ(&@"F4-,\9H ,=M2/-4SN5-N3T1VFPHE;B:O(9UAL(ZAU"V_L;A\'
M#Y/8]01S"MNO$L2JT4 R050M5]&)D RN$KB+I81X&'824@196^_H3/+SR&FY
MG+F4-4CU@QU(^XA2T[ZTE!W6_$ FF^B/0DS:2WKHX?'H^6+T<]F&(_I5H;6J
M-!Q7Y4M72]8O'FMAJZ9YK;/E&R##K-6KQ+L8;F:4>3=]><I@6F;15S3775-"
M4E(+QB6\C63%EFU]Q:8>0'JL:)G7'LYWB0@E&Y#J<6G;X4TL-JMP._5[Q@_
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M/N!.L:S+$E6:,+HC>2G#]73CR[ SE&1*.BG&Q+Y5M30:A+TP,HEGW13,Z Q
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M6YCAD6;QWVMX'!0]Z^6+5\GP)5A(T! ^"G=@Q0A!]%CS-\DEE7:!G\(O5>V
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M#<7<5(./SW2&)A:_G"7N&;I$.F.K2KI4PLS05]-;FB<T[C@M9DD1+S NUO-
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M.7NPD)*0_J8?X\CT$4*#7EX=XVJVR H/[5GZ3_;#L@;"XNO"0;L"K:S_2'Z
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M+]?5E?RGO4F__M_I$:LT1=_5%UW5OZ[D7]?5.OWW55K'5^D277+SY6(_U7N
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MV_*^IM,V_:K"F?9^#([2I?Y87W%Y\ZS_,>03?J>14JQ$*$-:/TMFI:4B ?!
M$@.IWJ?D*#N3'=]K"VLX+[OR72?V0*%&:UW$(V;9"%62RW[[PP\_+I%H3*Z8
M)>.J;)B6JA F_3U&&DU&?-40UX]NJV:7/*7ZMA5$DZ/J'7$IVDK)O]NNE:@@
M,]5R &*65CGGO]]X+M&R,<A+8NPD21D8T)FH&[/HSESV/G,:'1"K(UW<+IZ>
M_\=G_VYIKAGJW>1O'-&ZD6QW5*$H*#+,%S?Z7V,7CITY^Q,=.??#W=__\^ZG
M"8/1RSUD3M*4_*?%*^;PQ[XR-O5ESH>K%NKB+9/:(%T1_1H*&POZQ7HP,I&C
M.$CBYDR\4>68..@5J4IS2AU!M*O-(<2R]6=,"UW$;CPQ!=[E].K2G&G^U<QR
M'"DCS3;]S#5CO4W7SX,\S!_)W-_UJ'KNO9K/K5?S!7A$0!-[(9[B7ZQL^W5D
M@;.62NZ"#LPI<-[[<6MGCH2=>E5-8%MHAX-FMH@G"_+>+/_$&[/,AN!".H3"
MA03*O>?EM-L9IX?*GR7[_03JC-1H_ RO1F;UM#>;,SW3&.CW91TS!?O_==S7
MRB!E0V =4BQ!M6DY:MN2E!;7?MB*FN\/RD0NKG>Z^,\I(EO\L*WV_EH?]8O_
MJM(#)*."A^N'XSJ2Q\NK@H$%; >'3GAWZS4)HO* &)B'N$L-]=PJ\0PV/$@:
MH?*B'7R\S&NHC[41T#N>2>)(\#MA0+Z3:K7V(\N?EQB3='F.A[RF?P$G7'(_
M!DOR6/6V_VA<)+P"X,C3+523_ZBW4N$9TS*_I$_M!?>=&R_E[N3S882#96")
M&[G.B_\?9_BYU]WQ &R]1PQ?L:*I4"FQ+DT614Z7]S0-9R@MFF+-Q"7CD-V=
MZ"FB,UWAE[IB,N5T>7*4C7\V5*$$87WS*&-X/^*S&5QHWJD"S"?QN+3'[RU-
M1AZ@06F-QRU\420D^YG2'@@5)=VN^<G.%[:6?9QF]I(Z/"0U",]5>H;R9*J,
M>>AOT\D_=)B9=7>\Q*E>K"&FK3J1>A ',=:1T0R=:\G,*\Q<%'<CN-9'=>PT
MZP-9K5JWW>WH68 5TNQ)9[AT^2K&U!%,MCG5?:'GSV#A?/&EI1Z!#2A8[E!/
MA2DU,4"63OW"9-RCQPM'J6LOA&2]N%']IG+XZL5M]FAZJX.2_"#TZ"/#R5*M
MR6G<@>O(DRR  +5'=DC[DZ@%BDOHQ5L+;!(=8:JBK_?MS=[+RS2#-W>B,F[8
M?.N8?#*J1HIL -O<B':+ND\O0_3ZZ!7HT-G=35G">ZN0?1$KJO[O'2/G6^<@
MTV#Z">$0>+APA)]:;?]9.TBQ7<$IMJXCPEBMT-!?-9M!*7=U/U:K8P/9*FVE
M=MJ(] ?A2F";SS!H?M;:MO572Y7\;7;,N5E#F 65N^8-(E7T?O0#^?OP%+7*
M?,:'R$G6L_1:H 8INIW](1%/IPU<L,58'),)L,3$('!.8_TWS<6?K>MM U;&
M3($EQTJ%-CU2HV0]R(7)2E="EY8NOH4:SW#T^(8T_?@IRWO )*9I7FS9$1Y$
MT":'$MP=1KDX&"2NHZ+HT8AQ)U;" =KI9%D2^$2%&-F.I*X"^T_7$ 6J/)1T
M-PPL:\P:Q/9^R,P4KU!J"DD0-=Y*,ND_C?QH/\ =+J=8.EFM1B-$B$UZ/>N
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M5 4"[SZ)B,^L"PJ'3+Y<Z$J+>%OC^ZW8$??N/6XH*Q^WZ32J02B]S.A6.P/
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MZ(6Z6/\>?E'='QK5YW5E!)V;K[[_+QE\"\%A;SO/TC>%A^#6'CE"W6MD:H(
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M[14'^]"N7DOXXV)XB@+[P%,*\XSA]6!^ A6H0*QNF5_H5JE"LIS]65N9XT,
MRB#AS#) [69!&FJ OC "2>!64[C'G*84*UJ>_LBYJ2U5^GS)T8/DJKX$*]H]
MW@<F#=>?33"\2[?%AVNV?FK![KZ,KPXPYG"5J]8E)7,D(@>>,T\_4CSUS5AF
M-<+D7N4,M6&/*>02&7DL,ZQH2L_"RC7HL4BY"A36C)$R!9W:&HNJDX%S2* =
MW'U=OZ8 +[AXZC.@724S>>:B9/&EXBN4;XNV#] 814#TV ^19[FL)>UQ2"LO
MVJ:0.Y E;!G@QUK_;UOK?_)8ZW^L];\G!O?GFF)>I@MB'5Q,2Q66]*05760&
M1^M;SQ<+N/CSQ9>9-,T8%*TS :8["P2J?WH+1#S&.CY-,OWK9DV>>?4#"CF;
M@I4Q7/60;/25G*R1XIC4I?H'>E#6=AP^E=G2W',-!,KK^B)-# RIQ#%Z-23B
M:CDT2%(Q.E>6LX=*.#P03DH5;.X40]_>S1[N=[K\7G4@!=(E92C06(>V/F!7
MD;$9<B8'(?%5R-FHZ&<=2:!Q\&ZVQ]5P1':E.'Y=.-32-E(^R22=LW>%(\7[
MQ-M,TD)^S\)-FSAG#S;&\YR&.(VRT*0\$N>P6FQ&JR!DNH3:O;HF=U^]U\"N
M]%E%7E.650J(&I <:/Z.4V@07'6#%:&-_1SE<06I@^*J$A#OL&'")]Q1 :P\
MW*MND"E/ 3V$"#-F4XLUB,](RK?47@AF!B4U?!@'5>FF+(PK;TKL'CM?_-1J
M?H9^4AU]>YJH?;Z8(X[[9H>NC#H./+.1X=-24N80C!Q;&45S]O\%XC1!:0CD
MQJ!$3F\B7GJRF9>T!+XZH1T\/DN0XQWW)(=5![#2ZDJ5#82^85]O&DK"Z!E$
MO:PL/AD#P@<21[W%C# ;B#SK4$R0G!Q%#"V9H-FY\G#"TYJGHUP!$1DV3*L0
MQ%@'Q6E[!NR@^ 2^*/Q&(Y63G(DY"EU!W4N<F$,9AS'A4=8"-Q@"P.2C'B7_
M?:8SG[G/DGW(JI:T+ZG+!!5MN6EPQ^,]<V3E\6'N992GD?S.5A,<>7+.%U_/
MO&9NY4,E,GA#QEHBK?\"5H'B,K+903"(WD?/;H0!H"MKSEH=NRY\'9EEG"FT
M3RKLLU#IGWU[G?NNY]R%R,!-OEH=CCP?>>@E>]>W^WV])="KEC%09H(3!H0/
M_];KPV7N1IO!Q(18Q5'UH:/![J6\:JYO9V^-O8%GN0-\$F9]QC;ATFF'_TTI
M_7<G[!1&PZ3>\MW@.H]=9=8K<AU6TU!*))K>$?BP4%*-]16I-+NJ%Y:.78_=
M3H=C+M&B&3"O2"^![7:2= B,L+K(35UIM3HFV[>Z75K-T;ISF0<.*H%&R3]D
M"NH@)1=!JSDC*-4&J4_T5R6D,><O%A# N:.7]\:/I9S1EN5B4P4_/0@5^,2&
M@RG(/)!Z"#LM?HN*830D@/>-B [O.OEA]]_'D^:K8V>B-")"=DJ#;*E[H,*?
MR_/=\4+2H[>[@#PU%]RVW5^>B?V1J,@B39D48/2&.D9:7F-SGH9T@:?_P4I;
M&C7I71R3M8RHT-)SB+!'M3M(EV*P(.B&"FE(("'7\\5LHB1C0_JZ3GMQW1LX
M4,UM-()^/"A%2M[<&O\A9\?[>PE/BP*G#>7D()^:2<\CXC5*O?;X4IRY<MX$
M>U3F#L,;1=:@"#H879?Z%,LLY@?@QC*% @.!7/FRB]?)_7?03>2IL2SI&74"
M-8#V('G;BE',$"1)"G/^QT=#2<AG=8-TA_]S%,KNAF0LWG*=#RLYD:T>$0=<
M:4[\LAFG'H8*< *S(/LBOE;2%$FOL*/+R51:>[SP;/DH#0LGK_!1Y%W +<X7
MS]*!SRP!SS@_V2>>5EPC_?P3\PA!G3O3[20C/,TW&+>HU</U3)@Q\W8LC0/,
M]#BKU^AY%!L296;G!2B4D4%L+V4$5EKE'BL>GVR1*+QH.UZUDR3TYJLOVP);
MG,R..$3+WRB,.='PT!_)9_0!QY(O]R[,-PX#XMSF:EVL_ZA;$4O/(S09P4R!
MQ&FNZA=-_X,(%^\;=(\&3HY\"+N*T4]&JKDX#K9WX-=!4"F+QHD*K79%K-6Y
MSS'FTK$@IB,HCP$[DFXAW,"HM,*;%X3 ^>);;)G"[-V1YD0^:5R\]5--C]BK
M:AU0CK,+RL6JV8F2T0D6)'$X4VB7^SH< T7+=IKIBT"= L5Y([A,.;-E.)#!
M3_%*6E<A+)P^I.'CV,M3?!A 6D?/DVM'FW LV84&'(5PFB02AOV@__2+4TZU
M7N-\3$?N1SH\!=Q>Z75V.<[:S'%T!2BSY-P[[_CH7#(]O*AXA4?P/*.UQBT&
M0KOI$ 50'VC6UTXDFE,&MQH3E0TXS6Y7KQN&[^GO=@B!^A1*9*%!;RB#)LEL
M'[?; E7U5;KP)6('@WST<IP/"HU&E),?F\&]Z*CH$&S95CE9QQ&2+RA(:-%W
MUHE.%C/@6X3;PZO'MXK*2HZ!N&;@^I OIEVQ3J<_$O+IWX  >\AHJ$R7*%V&
MW@LZ#5FM'2"Y^$:Y"PMN?+-WF$=P)-,P*0\I,.5'F20;M@S47DYRR]YHX"Y-
M=]H3PE]<6"8G>;:B'GJCH])3&H9Y:;X25U@4-V5TMRR]IIPTHA:)K*7H"X+Z
MCHY@,P#"Y^R^(8>D+X#?WS2J7KJKZT$D!&4A(]3<:LZ&,$+![(K[F_;86G52
MQ2K_'32>C\7]F>+^T\?B_F-Q__UQZPHB,C(R)7L)K6BIA\7T5$R2>TG?S5 D
M[<MIMKDPL9 U0*Q_&9N^&].M=VF"Y WM0PJN+%A&*H$JN3$,M?)G/NIS-L-[
MA\RY-.9^ZE1V4M"#Q;6V0O]")&)'W"=< 5L#?C(!KJ=)=F';F[VK H1RGWB+
M2F8^ IZ6(JX&LU!4LUQ'',8U$VJLU(HD=[4O;[!DZ7:=\]7J-E'>%EVJRK05
M.+4 L+42!:X7GZSM>!'/B%S,A=["L!-\:S]==>(*N:MP#.>4[-VIA4E=)J<_
M1N49'HBC[%U4;]W7EY7FR!BE!)F#R!OI3=3CS1 @[$2J\]3-)ZZV?/-)A"/"
M6^$4YR=)#&V-477Q]#(.Y*4?Q<>#\_^040P(+^E Q<8O<61DCKRJ;A*(P:\-
M'KMW@"W+/$Y(RIS4G2D 0QW)I#TJ+0U=OOG(C$FEHUNKT/$4W@*AR$A%T*^N
M:I&#P,(*WR%P>Y2>M@ C4(09?< XE%/@-XUGJ W:]9% "P_FH2N-%H@/,)0U
M^QVOR9;@-G64)/O9.0TF5U;.,."EFIUN[,X-7PHJV2ZEMQ-XB5CX(@27S7H0
MI(DI&\<FRO9BZTWE=E7+!H\Q'6:L2NL&[-:VNB68A)$+U2OTH7+&KM;@-BP*
MQ^<265)%V^5$*4$@F\>&]D^?+YZ)E=AGEI-P?P'7W/%=I!6LR%N$ANWB.*3K
M_0W5^*'WJ6R4NC\]X1Z<$^!/H6T<%11MH81FCF+16VP=[>4,"B]'2!CAOMS+
MK"[JGM*'U-IQ7%_B34AOG=!;Q!B3+8-$\5NB%KF<0L4\6;7&+S^7XV4M?2_F
MH.H++VE<_O.XS3.UT0,*T&P"^96)@D:M/%IR"XPBD3P[7'";<NB*%"^2S\CP
M?L@)7LS5NBU2X AH&^.E5?3H=<WBAFKJRCE*_(!Z4N+OP#"Q5-1VE]6^^9NN
M/DHOL+RL0JK:(<<,IU&"+V=I@X+_X+Q!_Y1 ^7T\H9]%9=PTGE!->7*^5*OW
M?FBG_&=6$_K1C=#OP;7^CR)X?\?Q^%VD8V1'NC"M:F.Q\>J83NJ5]/942]W$
M&DV\^NY%  8)5#+9!.53"QK;:@C.VLV9]9J*"6\[X753M_ N0W#*#D@RO]J_
M+FT"J.*<=8CE:Q(SU8L7Z77.7J63=_'_JFWZD8_^BA^C";\$[ 2O4E"X5?;R
M$H36PPU@:GN5\Y:!2B_>X:0TMI.58'%501RY4?G8F7S,C>%596XG_8<%<4W-
M3C77[7-@U7 4&?Q1\(KOZ@Z=1A)UUA?I*$M.3\%V^APSR?B.,)VRJF$@>H4@
MNY?R49_+)O$A(GX7]3:(!VY/CZTU8#E\[%;/YPU;\:[JLFO;G $+8)%OEG!N
MJZY$<G6KK0C"P+!_:>(2:=K3,Q>T+ 5_2R[.$JN<EK/6^-/.VCIQ@&P#;6IM
MNR$K7LT-J@WYI!Y?2&WSP9!P8&< Y!?2UT5C0'SE+<1/#."MCE5OE(JK+8GY
MTK1AO_EU$(QN-LFW(T))='*XTM)T!(2BR0AYSD+W<W'IB/GP5T_#(\-ATGD"
M(3Q*UIF2F"1(BQFCE^T-9=&S2OI2T_>BBH[^ VYCU'J&LL3;4'LF.IGE,\('
M+FH*/_GKR&$?U,/SR^@E@%F6+<ST02$ SX=P_9F<8<BL!JZ#1($[1EJR_,&_
M<;M@ 336;+"R2@2^9Q7Z*Q1F?"9A&P@\&U]H2;19HQQIT\](@3"]UP@OQ#23
M_(%?Z5=M9[DD<9:E&]-EL!38]W"=)";?B&RR@A"QD.;#*BD#4&:]9.B\'Z/R
MR*ECS*!*'SPA^^:-'%G#%6I)KQG8J0&*](SF2Q\/4,2S(Z4X*TB"FN\@<<SI
MYU-2[J=WW!?(IV+)VAD4//I-6B%GIQ[HE1C#< G@6&HY*H.."4D)[9P87R79
M^9[4'+=8Q,V>!.GHO?!M3,Q,W,&PMY/C]!Y&*^O:P*-A8S'-T73CD00A8P5,
M.F&MZP"O'5OXMS@BF.&5+ V"VXL4H\ V'5)TK8J;>IRGJ%@RJ<T*C6!OL#RB
M'Q+A6$!@K1H]IL+0&<.43+%P.JZ-< WD6\BQ;D&-AR388=LJ.@!N I<-+/]A
M[:(?8D)P@-L '7LE)DG'DNT:<0VPZ-?)@]F[1"EPY.X,'+N]K(:':V_2&/_7
M,:V"--"?V<*X;GH=:)WL,SB=A$76;]+(@A)LU37 &'#T=>$)V^^^0>^7G/$Z
MOC932R2#X*#',][X3\6,F$,5L.*$_H^OQ63]$0R;VBME:\2VX, &,*V!&$50
MKTRHC:Q#2<<9J4UTL_U(RZ;(TL;%+M?&?'ER."$*\E7\N<D(P-K%A$2^:C4Q
M'=K;,3',;@?92.8A %Q,&NWDA'Z_3[/YY--_#_C4:!:%>3)+Y$XLH'J/C)N<
M-M:*-;7K 6E?AF7<>4*I\][32=K?;?[B"(!P*9?9Q#;D+I6Q897L;O8^, F4
M6G]=GSC0%.$:!2^R$^4):V4VL^K=^V80'I$1BHSX[!$9\8B,>'].SU=UBB9-
M'%J/T&J_;X]HX8=_U P:".-XRD<::E8X5"4;<K9+ODH@(-O5PU6[3B^@"BR;
MKJZEW0N9#AZ,$T?QV&?)F,(%O"_=="%"\WOGR)7O/SMTS9:",FEJQ9>WV]Z9
M?Y!DQOE"?+=\@>FHU'P=36'AG<8OHWDJ]-M<)0]2#H$<7=A1[VTLB^]70ZO3
M\(?\%N+'?Y7B;M+$O3A2MV#Q"D'HM\&3&%RACNT[>4SWFZ[]&W"+66KGTZ>?
M9R&(_ EZ 7%F_3)X(CLWM=1LO&."VU!'A(TM@41]@>80<X>"2&S.H61 RMA'
MH@C3_)(T+\4<+W]PRXZ%]2>T1HVV&,C1*RJZ5D5C/*^094!NI=:5<=FXWT9(
MSU!T5AUINQER7[DLO*B[KD4??/F1L>.!HOY=_H63]V?7YZ*FAZ-<W%M5] #!
M@:8FHA-&:OAK)3U$$\60R[IK$KJOD76!*\+LKP()(%0"(X<79&,0*3TW6]-C
M+M+#TP R8!)T[Q-_(XUAAL QG]26F8W3U#]B'7 NC21]663$M_:3.*CWC:HX
M8S/D#D&ONI9'<140:Y$# S<UKAXZ 4>(P=146IQ?'!7W'1*0: .->)8Y_N&K
M'[YE;O).HTU.M,OC'MAV)1:=-6/8S:31$!1 OCW-C/;_2019/KP:E9 4BA$-
M/EI1&8^='FKO-$H#KLXN53X+[BC])$9E:-KCNF<T@6Z;)N ._'G=:#%[(%<%
M4?80K!%+3LA2T9+I)_C["[4ESDTR9R@]7M.V(;Y&A,J5C'19N=U%5NZ,J$9/
M%D-L.RN^_>J5)N/^@)=IB%!<U_7.DD_RD4 3KMEC'X@"G&?F*<NN)#N#1@!,
M@X(YPJ%WM\'#L&06 ?;M@7]5"T-NO*RN3GP+-))Y +I7D<[DT@2?[-(J$H#[
M]0SF;XQKT7C2+>B#-5P_X-#VSM8T/+&[R$J=*Y'3Z?H!JJ^; B>!Q7]1;[5_
M47*)K;1F5%MIW[FZ[87*?1]1+B8LN#"B1/PB"U@*<*EW0A]4HISY1V\>R C(
MN07=D/@6*U8I@3!)UDI@-+:Y'&D22;UU]5RV$#S,-D($Q"R3YD(*JI\=K<&]
M_GFL;*E;8+D=XD ]Z:;%WVF*<^E,31'V>%_6]UV3MDND8$I^K;!UO"'&]2&7
M[R+$[+05F;>2!/1]NVT8#\P*Y<S3X^*[#N?]\+%099^S)M=<\\SL?19!,X9K
M34[V8G-EOH\A.3</:YI10WL@#:Z##@%ZM4>IQDKEZF:&$2+IV/:L>_+@H)4<
M=QFKG4L!3E'0%L60M"T%N7H<VEU[(7U9NH23R8CR=B- ,0((T++#BXR$9:=/
MQ;!IQRMI@7C.#E>0%_ZO?TK]Y,#BP=FVWFBF\YZ+GSWY[/0B>?=\V5LN$O%P
MGO[QBW\^<.J+8H#^X_SSI_+N"C913AF&JV="*G/F6%1I\ZOA[P7"]=NEK[EB
MG>4&AL5P>Z#;I5I]RH=0]U\\SN%O/8=6I* X:*EM(7!D/8 Q'7&2E?B^7Z6I
M1+>SH '2[#Y.T6\^109XC^W477N\V)8]2B.H@WB]UDF=CN_,,H\C  E!9?IA
MFLQK6##(R7(_SN1O.Y,VKBEP;<%O)[J\[2%2FDL&7L4]77.EK! /N:DH2D(F
MI[3=-:O("B]&L[IYG,5_U"P.\L%:F4ENI+.OU,TII'*.;)1GF@4J-%^D7SQ.
MS3]F:N +^T\A?D$?I3)2$\[#H@^^HA1\JA$T!$:6K.M,7UQ];E(D/-@LS<N1
M1G-09RMB 4"=Q=\71HZE;@+S^5.HDCS(SFH)Z5=;4N: RU/HH4&,0EM8<)PJ
MPU<IMK$/TB0I]-B<<88E56L=ND9L(<F=V\B(D;ZO11>?;LMO(H>,>[.R4(1=
M(13.894PH<'6"SAGWQLOS;SCFR.O9:S$9>&NX#O/:U7&3Q@)7=2^DL^:@(@*
M1\YXYOY>#WA1*]VG(;^1<*]N9,"NFHN&O>B@&NKC*H[K 9T J"-N%@?(G5Q;
M/W8/(4) IZ3P=V(6XF2%N<FQD+/%E3CUS-MD3:#(>^4H32J24B]>=]5-M24F
M7HVD-W*2B)<LD>IHL+?3^&+:CIT:@[^D7V1;5]>&:U<Y@:FO8B.J'&=$5Y6(
M7;)LY9,V=[4&<2V%Q3V/0S\9[D:Q9$ 72DF60'],<9X^LR_GBV<9?AOIW )1
MP>@6)JK.A^I=4YTBZ8VUW\.@89409<LV$R1R^P#I+1[H5M=9>D>5K%>JL2-U
M>]-]M_IMEEAV$H 9>^MPE!FFTOA2TZ *J\-"/E5]\(PW,[ 3'C^>@)074SZ,
M$5^D*$1=B]"[R7ONA!ZA$SQ#(.%"[T-U>S:T9^OJMF1C*%+YCRBWWQ+E]H='
ME-LCRNT].6M_1K]@\O'$#!ZTA^V4E[*<=:E(!%0Z/,6Y++WL684D=Y;@>%K#
M9=26!?!#T[Z)=?8D9NR5&37!_=2R)0V^8W+%1.K/D"[\1I22]7L#SZXRDJ9[
M/N^KRL.LQ><<I-+/7(!0Z*Y<YN.MO#H<'YDWWU@=77JU"O<O9.?EP)L==H%7
M;[?N)6$6%'\$C9;D54.C4MO@^CNO]%/]IDJ/]U7&)>VK01OB)F</B1D,8R2%
M5,%+1=<[^E_J-,&[R=^JY(NB"MJ'H.72.[1E-%=%U?%B!/UV^C^G-;0$@,E%
MX-R<*7 (&WW=:1:/C6JYW#%/(/^;5=PZZ[$;1; 06:AR%HG+F7?53J*WKM=]
MP-7.[XM]&/=!;_S7;3\3=V*N"[D-(]!0 OV'4<,$W$AQ5V]AE,*N "O)K&FP
MCV0&_INK-JW.,VDLE0CZD#/6^* #EVY#>J>=3FQ7-[L+(>15@J61G17#( @/
MT-AHVR1V17)LMVR,U5X_&)K@_:HZU2VLK:@ H(](<TMV=Y![=T1Z]AE4)UNP
M1T^SO+U9$D/&%7W!NCT-00IY3B7V.D.5("U-E:_0A):C7>?NX0W9!;4^5:-,
MN!LV/N YTUQNDMVX76U=D,X.FK_V&8);/"?!?26_ >(0X54Z*'SB0MA\TVAV
ME.3JZCU:404 *H(+//:J?0%8JT2)K9/TB%BT]E",%:^(F%'0>"*'JZWC=C[X
M%+#?V?-^H<"92^BQ"5L'=]*QO4LVH+01X0TCFGYF,JS'T)C][$S#2- % (UX
M0?LCOPL'GG/O71R-*T@;WNT,'9DK"+T:8;4DQBR"QFAW*#WAZ#ON#U6S]JE^
M65 ?+1=7[4T-5)"3$6)J2KUM6E-@F"#WP#%@R5?VAF,7-78/DS"BO 48*[=W
M!86$G"[1?ZD^D,&'^=K(IIA)&N<21^%YFI]?Z'DIM=HPXM37OO/EO,'1W<[8
M625L@(&,O,5\/NV8BT,V>9JX"J,E+>\+CZ*:C,L"3%MIC>64 JT%9C/F*E2U
M.-^#@GEIZOJ142MR%O?3%D$XP^7#C:O]P>8='3WLH,)[#RV5"X1<\KW'[<E#
MUET<%*R<"+#6?2.FL:&Q(?)RWW**S57?56^:W7$7-F'>>;!:+?QIA#N, DQG
M4SG>0$$6_0)4%70UL8GEP:X*B]A">$B+.8IXC?0M&<Z1N<:!5GYHM*Q,\U'M
M$]>0E;NTO?@(Y+7[*2)VA9E6*M'"X[#%6'@>VAU$V^(?-RG%F[U=R@0(<,1/
MY)9DW5'/KG1TX$_A-B<?8*E:.]'QDK?++P4/HJ%VDQY'+L-!B]@Q?4FX+@\U
MN5XXG\;Y =DT(CPQ&F.Y9'D""&\>M0ZC9M=%K4''^IZ0XQV4NM[3X$N<IJSZ
M+AZHY&3*E/#)#@5:$JD^(#R[/FYE!9C^6H!'K--2HVQ H%JUV@1D"YF2T?Q#
M8U*$(-!](''<]W>-M(A5:9/9LZ[Y6SIDE@43DJQ+I'.,H=@K8KOJ%Z$_]G83
MG@O6HA4++\Z#5"R"I68N,KYEH])9.KLS\FLJ*KF,Y:<BS0-&I*7"I-2!0D8/
M9)BZ]*P.Y8O&4=[%@:QRV^)P*H%%<=]UO;/5G:[$Y]ND(YS$#.6ZRRZER9"[
M)0K<T*[-JY='YI+J4>6#H<MI)"WGPE?CPE4!F!<<?]=*Y"#^!*BV1M!YC9ET
M'I<A^3$+CC]??)O,(?L&TG.LR/.]>/KDW^_=Y, TY^475YVFS#AS2E/4'WLD
ME5U.DYK&8BGYE $LT%DQ#ZX7G%[,!'39^JI']<J4X)'G5%@(NSNEB[@"!?>F
M08-QG1[D*GGTK[D>=L=UOQ7.0>;@/ \<_?NL^-1)CYLF+,-RBR276@4UHLM)
M,>,?A;KY.VL7GWWZI__V_S@K9RY9/#)SXD'>.R_WL6BJ1=//'XNFCT73]\0]
M*S4L[CHPI\!A.211(WK[P[%_R],QE]^NCIV<CF#X3[[+OEJWZIIMMFTK'S$R
M@9'7$PC9F[X['IPPWG*=)JYZGZLPU_N7M32L^9:A6H:[W.=^C( P:%AV006C
MF2B54][RVN[ Y#]#_&W?-_U@(6$RK 0A:5_I+0E.VK4TM%;=KEK5QT&\DG0Y
M4.R/&K\NTT=[B[A//XFEAS6]Z()R>? CVT:4I &@)SP;;ZA#<>I*'<C1[AQX
MP$?1$BMK@LZ?)!V\F=.R'0HUJR:K,VJ4:896J'.BHQMCZ[Q WG%!: YOAX!?
M27\K;69M=A K4JJ"2GZYF7O4J,9FDA#U=;5"U06=SAVW<.1/U90:7NC"*\"9
M[;_92]FJGFG^L^JW%(PK1$3\R'@)LZIA([,)&Q\Y9Z6\I4KC A2VDOI 'MV;
M^,\7K\2%U@_9YNQVY5Z)@(ZWV#EH.X((O0K>2.-U/W3M;3%:]UX'#Q*G<QG[
MN<D-:AW I8!]5-VY2Q1!UJTX!#ZMF9%@)2PZ@ZFO?.AIG&KE 7J5^].3,0'Z
MWH69(%2>HM$C "C.O$"N8W;+I^667@[Q=/K5WXR0V,>V,1O>WZ&6:X>;[5?*
MW*M!>B YG9_K0M;<Z_2%G!"+F.]VU&IM53YRW=0WKCJ283799F#NE?>>+??R
M22E*$&T<A-3V2JN?Y<SS(YTOO@E2N<O Y.E:DJ>H(4M26:@'5:)RQ+HFGD[!
M6NDG&0Q@='YACI5+5\G[(1"PV0@!+8J5QBV/NB&H_XGSZCR1*Y^]6K4[Z[E&
M5I>,W*86LLS9:'FI+P6M=/:--$CTBV>!BD%5Y>K5$3L&3DA,#SSJ7LP)3D1E
MD%D V+:^;'IEB+5DC\S#-\^_?+5XA@)J^D_RQIH=E@QHK ].58)SQD5061Z3
MW#'\N#6;^L0]/.,DRS^15%3]WTQU"FV>YJJEZ)Z7>HKMH[Y.X.+>)2\P^8OP
M'"=WD9<79OVHD_03):[ .*"[%A1W!\/)H1:RK0T)ET43R4%++**PJMO77]62
M(\3N_4$O(O3_UEGP5;UK5[)^5U8[_+&FM4^K0')WM\M)BE.,=]=7=HO>5ONR
M\-A"FO6;;ZAM *D/UA"-^IXDX4JS[:T\Y6B'0GE<#N1NJNO7A?L[G7&0%&&'
M5\,5#_MV9CK.%P6;;WKL'^*@EWL] R'T4$.%B3P)[E07BT,-4[(ZFY9$NVGL
M98"-W>TO<A;#:<^&/K\YA*F$FB6:Q:72Z!-ELH8NFI_#7LG%8EQ:"8N_#N4Q
MK!<Y#:BXM8PJUE [%#R7:GAF$L%0JH%S:,6<>G_=="UL2PI:TT7@2:>_;M*T
MX_4I8&*O0.R+P%/S;_S])27?-:_5KY=#"<VY!^9U0TU.BA* YV!-.)=65-(K
MI!_=*S_N,[XR@*SJW/_[(3M^7RILX49 I6;)8LUGN"KE!MG0$P F]\3&Z9>_
M:$V;#>Q5W[<KZH)07(*&$/6?3&J2S1:_%75B]4$!LM(:$W\%2;Y,*FA"[JZT
MJ6V/,<LPZWKF6"($#VV6KSA1(ED\#*?T&5[\JWH%FMO_\=^?_/'3+SY[LC06
MN;L\.5\]3S][8B[J9T__%!<8G2  !F6&=6:3,R4F=\>8]ELU9X &,-LE2RT9
M@L.V/MO7@_[6(NQ=7:EH^Y+V*M/5=;!"NE9=.% .B^K6HVD6QT9-4-X3^O&4
ME&<Q5&^H/^-@#0*G)!^R#R) *5"B=>X_(<Z?)Q.5*:USC81</$;Y*"GJE+V#
MKG6#&4K)40^\X!HX>&2\[6:N6JU67= ]3==."VF-&A8%85R;,%\K>";O6QGD
MG[4?OI94&)>IBY0YBM)&$6>0F2SU%_$5*$5"EJNFP<VYKJ(S8EUO*G.O!&>5
M59>YA+'B<L;,_QZD3'4U7VCR3MO \7&!#8J:), 4KC!J79_RH,GQS :7.0*^
M@#45QOHV'S4#W=;U15 NC<V(OZ7]!6P''1&"66R!W34<.E,W3@ZJ"73T@]PJ
M;&F[-9L2!\T4IFJS-"56Z ,^^E]4S?;(%G_GX0MX)J?"XT!=UUVVCU'@>U<G
M>YNY4&PE19RC6/,S6'-9"$MQP(=+ME6CV\+^FJ^B8SU>6[JR[-J,]D;+JFO[
M_FST02[R\N;!W[,;%L?,N!JA><8[\\KTI0C&%V6OD7L97&KQ\%4_[ $ E)Y\
MK@"EYY(J'18O3$V%0F IJNF4C:XZ5"N+C0XRC/_VQT\_/?]TL1/R#VU@N[R4
M+NH!XL5[0?P83A5PI).^B=9(V)&"+=QLM=\A:[@1;Z_=?Q)U2*SMYZP_:%S=
MHW=*=N@FC?'M&7GCK5$P+A6DJGP=;EOQ3JR)T)GJR]#OF_;H])Y_[2[2K'W%
MC@E\X.-O_OK5)RHZ',9'T;OIZ__VY ]_//^SC:(M;?7->T,2C?18TD4!\^F1
M:22=N\!Z4PR7]9PT(R'[U_V#T:MA3S&?\/3S,[GR9Y^?H6OSL4G\-\4[_/$1
M[_"(=WA/K'W1M(R27K"CR4\60G%)#>U;I0<I3=?8M,/CE,3_&],._;<GYY_[
ML5#=8?>S@3+[A'LF8__D*9O'SQ>6!L$9,'ZZ9F2=DUW4/AD<!W6P[K?!7[3O
MA@S(VUK4AQI*%2 9/8+_[>GY?RPN=)X%.T$6^;'K%GWVNU?#SX0E[-=%-D\C
M#2U5WE&+HO_@1YQ_;WF7(YOQ',Z1&KZ8([U9!T/&B;2J]#10U58N??XFN)F:
M[F3_YL-=2=J(*.7YNX,;N"4A[SL-=H!AJ?MA&8W2?FTAOX9"A1 "S4.T>&/'
M5R7]HILD2[$"K86DM%>J9V#1%/-%D4(M5X.3 4I/WV^\HR=2G0TU&B9-EMN9
MT=$@QH4)U4%[LI*.%)\RX)<_F658Y\(^;8-=BN&6W<15?T6I/GT#E=,>]SRM
M5L>T1%9H![X8#*;DK[*T5L[%;5-OU\(Z/X *P0GT6ZG+-7LTMMFTY9'@)SCT
M^J&J%^Z/T2=F7Y?EOG3)#;BZ($4URXM=N?ZJ)#=(I7<R6$!.QK\JO'G!#N%/
M66>>(YE)-5Q7WM.<>,19EJC+9%6FG!Q>OGSHBCLO4.M4VBOYK[*DST&'$-%-
M(4JVF==CT6'VH.4\$XE0U+:<SIL,IX*J%.2*'G&[/U/3LY0?<(?&.GTMWS'.
MP^7%%3,=3'$LHZ.RDL,%V<R>]#[F'DD:;*_@2<MAU!D5<L**]'6Z(-I7)&,C
M,WV13!#68=LM+:6VJBC*H9G%\J;BCV%VICG4):5:O?E0)6 &MODA0YJA1-SQ
MPH<0"%XK_ZAE\$>H0)'4DFSIBF6%X@T:?3\6Q4#I4(4LT_XD_(\%[<MCE:8B
M#5GZLNKI ,ISK9'_))^ZM^2^A.PIT$R.26N,AYP;3:U>M\UZ\4MR++B$A:9@
MK?K1N<Z1)Q'2NZ$()P\D-#(5*1^VVTQ^% ZVO%K]19K=+ADY>NGKHW5GW48Q
M,+D_OHV3;'/<;B0S.\Z]XI![77/5A(-V1&#J@S!'63HC ))KNW/"%6 (J-ZX
MCMY2#L><K2/AA[?#Z6#!\[*K#BIYA-Q67V6>#1]9)OV3.Y&VJU (;*WH4B2;
MJJW9&Q8 <"3Z0BMM@@)Y?^7WG1H '7[IY>D<&$[/J[*20M>4[*J]!.PJ?5K9
M#(A(V<?!6H+'@E\AFX4J#7,K77%1UNL1%G9><BE%:GMXQB[48JF9(.(5V_#+
M-//$)\^X-?.\BMQQR":GXT=*?YVH@GGWO9O&O$&Q@V.=4/:JFT3=E2QSE-#E
MW(3O[8,1"3Z )A*-S%(:Q.R>,.5S;_I@C_4OPV)@,5D<[>4XP$^KI@57S:@N
M,8TKQ8 W;VJ"8_86V(5-E3OJY9A1&Q_79.=,1/(LDZN'2UTWW4#RHE"9LLLV
MF[DFUJ7K;56K([13I=^_RXZU$8=E=C!PBS%Q;+QF4R8SEGA0R*D0;DR&QDE7
MJ6P9"FS7ZGKD!E.6I[OI:T4M':6I/5]\7SJR. ]R^6DSBLG<Z0]= 'Y05PSY
M<8DR>+./3VP$LP!]5IK2N+N DJOITMIB\**,T6"&YG^9:0Y Q=276/5EZ:B7
M3<4T(?>E*I;T6!SO M:$^K95.+5B .>IZ]XM9"XJHF0D8N#FI5^Z;N\P\)'$
MU[R5^8@2MZM?Q[ KFT9],GL&N9#L"FLO[VI^5#G"TVP<5VSDWF[I%FH+=813
MVW*2'@:A4C3^1-N:!"BRH6$KA!'I%%;2,TDCTW2D9X4GYI^2NUVDJ1:,J"FG
M4D"$1URO71@N=KE#"E&W6Y@FA(SXMA+>_=USP?SI)E>+\=V96O"^N,ED+RG\
M8/R^5N&"-Z5C)>%J<J.-E&V*,=B?Z&?7-3@O,9>#@#[M/#GP1ST%108'!"DR
MY"%19PM&PW/S[<Q\Q2G)/$\2&B&0(_)0.$HC86.6SM*>.1F:09;@'=F[]Q]=
M\&QQI25+(^_0673V Z4^ ,M!O0=5>7,=.0[>[OW?0F7C=W$^7N&=Y(R"VH@&
MLN;P0I8)A/75MM8@R#T]%T?F!HYC$Y'@S_+0JJ&S(7<+%V"4I$E4>\V[(@#I
M0W^H)H04%C]HYDF/5'4Q_# +*J]+>/9X9*[??#ML5Z:J;NTQE6,^:M^Q(= I
M0):GX$$<#1>>CD3H@IY>&V$/!?4VM1ZLH",![J+6MD=O< )%OF![1X.W0 F7
MG%K6T%FPJF:O2D=&+4S_5@*3^H(ENYK3J?WVB)"'4P7_TV,5_$%6P3^ ,Y&4
MS:&CSR3B<KP9>9#,I2QCJ]#K(O32L)Z;6P,'4;5W9_+JDA\3T]=K=^>[Y (^
MW,#_;HBZ]SI\]ME,&@^9N*9;GZ&U2>UW.G+.>9F7,=CAU,#M"YH;6SU"/=TG
M4<2FW38MICP'*@,S_BA) R>!'OQ,EZ==6M>:8-6)-T7IP+2N%_)3T9- X:BT
M@)(GXA(^9G)Q6>VH]!+9<6\[(\]V$M?"W1!,>6Z6)KXVQ07B7@S]7-95<Y1H
MY3Q(]F2I-8[9^YIDM@K-]#G,8-+^YJI&-UWR@K;#%4KRW@T0(:&7#;GE4'6Q
MCMGZC5"Y"W99>3:D(KEN,KC7D^^6V=/R1H&FOM%VE&/>H4;]2]T8451)_ELK
M*9:;D:YY+4V[JSH&/WB\D$:FG' ]=(VRGBD)1!SU/8)?YN<A/HZJL7?(/MS4
MW[.].%-"\"6"7,H)7HR>!Y=-Y,ZNN3X.2LJV6#> ZVQNU;',QCEL:F,Y7R7O
MF1.0 W=-2UVG;W&R#_)%B!%QO06UKVR%F/?27F'F'P!-\H>^N"T[_\(QL,SE
MMLF!P'80;,QX*CBO,)4(KE+P6;.)+P<%2N"97M!?2Z'VWDQW<<N<DR:J8OC!
MT5-6M*OFH-5_DS)5!ES7,E6#MCQ18V<_@?CUS.A8;@5"#?U JMS*H^ID4RYJ
MT3+BEF'ZBZ_B@FSE?9)/W@X-N/YR>(X@GLTS9MFU+\8V(<*U[3;D[*QU\@A3
M>!1_&'1W-L7Q.3;.33U>).Q<#"OEQZ]?_H0X(ZS'=%EY&!G<Y6A525-*5_Z6
MI<*87N0B'<V;\K+CVQ?5_G5L:E)"5^0:#VR\0Q0K:C#>/GZ&9J96,D6R0KVF
MD6+/:WELG<%-DP9WZ:U+-RDVAD7%L7B)@EJLY>7N7780W-2681:8E*X&3'8R
MO.OV?/&#MXM'=CZTZ.;NW-"8RWFP)RXZSUM)NF^OR9.D$UB?G#Q).R*03'%R
M6VXZQK]Y!F/AJ&0L"BG:X/T),^_8^^.K*^?&OC \76&6BJ?D/M.LF[%1>V)L
M88P3X5G#A;,A_!7R(O_BQ]!+'Z:>><MUD=1%%FC._LN:$0]HOF5V?B)"17/:
M/^L-:6'B4+$01R6Y"O!,G)<X'6/)S>N#&@ ZR#/#LBS=/5(^@GEU<YB.7*%'
M-GC7=JMTR6G?2D4>C19=ONB,[X<ON?,G=:<(O>$#:K^7^>.H%YDNHXV?C#10
M8DK3T903,?+Y;>&^Q4%VDI+6S<KB8V.A2%&AF$7=F_GCYLQ^DF6S/ LU)PGM
M%]QLI4"1RR[CW)SF"GO(.9J^4Q8FS9?\9!G9PK:UWKP_'@Z0Q%)E%4_0ZL2N
MRQS=*,W7<204": L')D;&-(?12G/\(NC\N1RAJ?.AR#2U$6^5B>JZS]!:EZI
MK70&1W">^3U7(:"2;*WHR0HN()F1-!=_0^U)"=;6H>V&RK+Q%QO%JI1+RW";
M2O#%99]IT..NF4I9*LD4FAGKQ6U[++L9;>\B;+&UHUV_("'#EN$F*.Q_=](K
M?:NFQB=/W^<<2XC&G23:(93IG*VOQ?"$9:#56&,NL" ,*WE"88 N5TUB"SN8
M*2/ 6;'P/4?.;U?'.#&@O_\9]M,,"_A)?#R&X"H0/9&SZ=5W+[BT_]ZY 1#H
M3;I^%'/*>B7MNMYR7\1X3OE:8 TI!F8A #(@85HM]_\6L[HLR(:^E@_L&63]
M[V;U^J):\8H_UL! W)*"R)UM'M[;ZB:4!;G-X6>>F=^]IF'ULX5V>=6H4$AU
M'*XX,7R.)EF\9)$ .DA[_;K:UI9@4D-0& ^\&G)2LMH\'5)O:\=7% ->#O3=
M?)UE8?9^6=@/P+:\U$1-O:D[&6*+0<Q?$2HU2/+T& @J\THX.V9QMY#, #BS
M5\WTA/B3*&ZBL9^$B]P*AO<1FB+-0#%8_\!MSL^(AL;23JV2OZ78D?$21TQ=
MO*NV1_ CT>C5;2]9CKWZ0-QS<S&Q8X_;W2XD97SS*S.JROHH]WZ072Z?QX4J
M@7A59LQ[N%N9!YC,OAD$33DR+.1"B!R5*@!%+V/\Q].O#8M@"<E=P+-.GF/^
MEF/5AWHA*-9P0-C"=!5[V!$EN)(4FTOL 2%W;+8D]\H9HMQC,7XF"X@%M;RT
M;'CT*)?98LWDG(I+>B)AZ5<Q*3KIQBB^;KO59 OJ#FA6YT*:SB%U<S+7G/B5
M/E)QB.8JRNYRGAA: ??1])*H=(1?:1PE/?ML2J!;./"^9)%^2;<&Q:DN :?I
MC?(5/'(R7\=O\!:/E>]?7?G^C\?*]V/E^[WTG*P=4Z0C0P'4,[4*?[J78,7Q
MFIZN+$C^1NAC4V >,@:O6@F!_BS<+K;142IOIHGN _>K)FAJ3<$0(W7E8WOG
M)$AD<3""*!&I;#B@N<'&<G>! A)M*54GQ0%E@1-W@*!5I0[NZAVZ,*S*=%U;
MJL["LHG>[4ZF21Y0ZGQE82#4](H"7/,6_/#^AD[*)H4)*96K6#>("OJ^83EW
M6E*2U]"UW3N!/&K_'5O&^F/MD5_3&RMKH1!?7;K4KIP\*#*4?2'A,8NC/[\W
M8NT^()A#\3@3X11YH4UVGF*SVN1*,Y_R>B. U/I9-+66+9&6#YM:@F4I!D5G
MR[JZ9.]NN72P,T=%UOR$ B.6E)]C=:-M\)2G=_]9]G?\ESU#CA%X5Z[C1<&B
M=[]FAZ,GB\KL;+Z">(%6BR37L,O^:C0B:$JDB?OQU%J!;-Q?/FETR&0$"K^V
M;N9Y&/W(U%'=,\R/7'V^5Z"K9/U&^+V4 )'4GS1$ZY].&V.UXY:7F&#C9WI'
M2JPX BKO!A,?>'QW4"S*,Y=D4+(EK5TN?$?+DZRH<R< QBN^_WY @^>-5EV=
MZFEH5Z^OVBW"2T=SK!OQ'=?:O5O?R.KN0:(_N44> D)"('0G;>?H)1=&R*ZY
M;K;U)3IKD?%WUFI]!K&,,ESR*!\R1]U/43O0Z6B]##R#<[YNQ;%WC@4@<AKU
MQW*CL<(%T.&'AOPL.4A-2DKES@BJC*$'N2$@'#R&Y2[NM&W2-];RG8(%8628
MBU+S3",D:C'"&BJ79QNSS;EB*7(]%K7P_FI)U'%("(Y *<4 _O7\U?GBIPY]
M)L6J!/58^N.9Y#:+,_6!H J!UWBK\:29K[<4O8GLGG8FG%W4[*MN<%K.S\(P
MG849Q<TZ(_$7ZV0?^\$4?;?M!9@SY>A=R>%J!:)E024SVDZC+K5(0IK5I:SG
M2Y/--*UL&8,\Y--/GSY9*L&SILXM;X O$XD)QG?@D])1] /:H5^F"7X3;E1=
MM$5%(9V_<G1(49+7&%5V%?(Z8ME!6=('>H$:@-;6TW_@Q4@*,6_18!H@9]J)
M0_&?C8@<XQS71J-9\X*Y"Q-PQU@#>25M9LF7I(U9ELRE"K$". LWIF0P2YRY
M@7CV.39B)DH3,;MZEV4QL,_  /31GR_^FCL]DG_3I4,STPZG8W>=NR8P+WC_
M4.T.-L3-EY5+?;SRYS_JHR=BS#:" 9WRLJ($,[--C-J>1A/4"#ZU+0>ED"A^
M!]NYG!K/J@A!0L^@I9$[PUW0Q3N]N=USR2Y\L:5A/KQUQ7=VV8M3@3V;^#HL
MO>7\/B^^)#Z'@FTSO3^F4^E,,7[F>\?5<NC< Y%DX$YJ]S+.\@ B,D/G%K&,
M*M7%7G_-0[HJV'SYJ& NFI("G^JX:;O<</.6I:=/W]/(_9X,BGBZQ2H<U?I5
M3(Z^<J[V6[]U'_L5D>0.*N6J_ 5C0+!.!+@A?CWGFK:G,>.FUDM]LAK1] D\
MP\P[.5MS?+29OLIQ&($XQ0>&.7C_VJE.=;ALNKVV).O5?WO('$+@3EG:UQD"
MR(2%5+1[:^WEH$].U;]G(?[N'OE7D !A53H2$&05R&QI#UVRV/7N+1LYW]NM
MQZ@W=$+8>^5Z$O@)X<T!JT8MHMMD[W>][B=-^3#;@^]]*ZIQJ/WP7\VZH&\'
M[DS7:KHKL<.JP.(0-F5Y!X5 .CVF-%:&7\A/O^:AJ1<:5?)*C!HS66D6AB/5
M<;0]NYQYO9(<%1?']64]*/,,OJ$D.MBYY:T.HG[ QQ<1KOKF0U\FKX 5HF)K
M+"%;NK,J6"NQ!'2\UL#DDTX]@"G&?VU&K4>>K6::I)P5Q2BE^5+ Y<UIOGW?
ML:-DTV:ZGHQ%"I85*[HD)93YO4#NO)/:N* %5]NJV;FJD<TYN+;3!P<!UQF.
M9#]TS<5QJ+UH#D(UL@:)H>[%%Y4#3A@_&%-D:R0?8LDWC@/>01'R77O953L=
MYMU.FH#$B>!"7T>LD UV\F>@1J6^JVUS>;FC^/2!5*L4,@R\1650(1)%RG0N
M-O<W. L>RY]:_OSS8_GSH9<_WU>O2?.8&M*)EX3\@+KC&S'4,'6 RZA6I<8P
M'W_[_/O^$],P4P/IR?%>0<B!VX%PCV #8Q;G6[V1N1Q_#Q[O]S]R7X)M;K@]
M$Z(U'KWQ9:,0TA8:8(,TCG9U.):7>CBX#Y85DU"AHJ1?W85R@4S(^>*GVT.0
M,DTS*K_6B8S'"^%7C, U6V:>W^*9$,2BBN!W95ZC*E>$=9&=+[[3V%]NNZ-*
MH%21;MHS-"U3O7>[';_.2HN;1L"W@X*6UU&48 [\9G)>\@WUA6Z]&75<]1R-
MW.PKII?8KQ15EQ8*.I74(P#Q"QOGA$_PZ!AZ[_7M6V\6:0+^SCDG 7K4<=(A
MXKQ9_Y)XQ;+W0G29)O/04_$Q$R$>63K!&\N#-GWV(, Y+NE-?D<KP)(]9#T@
M[4+Q8528<LD-*:\3R9'$.[Z;K0N]08$[F%PB;!+++3S6"[@!)WC $R>'>Y*R
M[8^]]>4AH$V_9Y,>FF50:!4_2E.&DJ5NDQ=7M+68S_0A%Y&>9V[<P,";NP#5
M0KR+X$JL8A\S4>FQ<$X+IJ\(E7;>92?&\^']33R'7SU2'S:X94YWYS3,HXM*
M[K'%(\B69AX!$W[@+KQLM./FN2!0P'M$^D[YQ$775NN S,<UXU(!IQVTL]?6
M/N#];UB+(^6H@I3 F^>*6SOQ "[7%<&FUN^)M8$I%HU ,)N-91?E\</..%^,
MMT[ZP$=]6;^4'!^[IE#EMLSQA2MJD$H]?,-['>!Y4VB9_$IC@NQ<(24!HAXN
MH' C0XJ>+N>+9P@VF646)"\R[2:I88E(;< ")#6%LV?LC==MOE2XR;K%TQ7M
M]22(,-;IR?6763;W CE &.FU,B4"!B$WD>&=D!.:GD4W3?:@<I93V<D6@]R=
M/Q=D?2PWI.N?F5))) K[@&TW<V\&S>ZK32TTTVME+]ZCY4CKK!%5/'32SZ+-
MZ$'X+S)?NX_,S<"K%7#"DLUS97.Q#*=OLBW)O;M[E/^5:N!?JW3DG;:U"13C
MR<&R;;NM;DK0X<QTE;-L96TE6'1/=;[3PIG!TU36MZ'^/G,;(;QH^M"]L9Y5
M@<UK!*B?Z75,(C:K%/'F3+E5D[O$9WR+Q8L'&EUB9#C@-P*1U;'5S*L<__A%
M+_E=@4WAHU/K+.UM'[+CJ-C/:B%H+HHTL&40YY1H Y;D?FA9<JK@73H&19#X
M]#X9LB;]L<^''V<^M]='!N9<^PS%\//%7QJ6S!NB'M#X,=6H*&[NQY7PY @:
M#@].1"1.%L85L5/I?7=2_Y4,[;UK;YVV]"HJKQI;'!O^ZUI30U1V6;RMX7:)
M;F<U2G&W<.D,*#FTR1LZ$\CC>CE_F5O+YHNT)VH:-WL-TIF+RH_G<AS: Q>H
MO&GO(>I]Y1PQAIU"%S%??WM+[(K_)*/EJ'';@&&,]@6%@0]NV9 W;L&O@/2Q
M5\4^63<]4W%D<H&?-]YAD7WX5^UK4\X0%BHY[]8Z4)- 9EM?HM=Z#4BVM?MK
M;R!J26*L_,(>K^H94P*?-6.2(8]S+X:OEX.@Q&QRZ'"P(AY!H=1V>AO/4YX9
M W#@))I2J1=:3 A63M"!7VE7M?L*OQR[IE\WCD>/V=5IRT=YEH_'1T[[^-*$
M2BMM$O)9 ?N[C/&CQW5ETF>(*C]A'<S).A2?!3L)'8 37YF9N _Y+'YN"$?L
M=!GN9(R0$JPM%OJR%9]1B!_],Y"@Y(>2.<K?31_ZH=Y+MD8;A".(N[^JNCI^
MIH!36[=GOAB;#T#5)@\C$?#_9>];F-M&KC7_"LI);NPMB,.'GG8R51I9GBCQ
M6%Y)CBNUM;4%$DT*8Q!@\)#,^?5[7MUH@"!%691$BKA5-R.#>'2?/GWZO#],
M_2://;D,71,-I3PI?1&LSR%,GM=*"[?9-=K8(TPOF7#B#Z^<-%_LZYOJEA&%
M5O"C-.=NDG'.]?CRQK^FUK$EO0#U=\&X5J8-@WAFK< ]>D$4Y1,&Z#X9>$6_
M+Y')AOG*^;58O12:CG^XQT':3'*J+1_![$W2I0T,9G>[)->MOBN=P)8&=K2[
MCAE)4BJU[JOL5E&7<GMT#@5(Y[]*4$-THSL3\; &1'%@QE",*W;+O&_*^.#(
MB ?&L\$I*YK^NJ4II2;4OV=K.XX=%Y4Q-3*IP%_A6Q!&3BMD]KX"G:V0@KH_
M@I& Y6UG1S;+<C0GC_</B,XAJ)G27]5F/@G N+IH2V]JXA?:ZJ:"QVSTV7W.
M'LD[Q^ Q6IONN;:"W3Z?)[<F1V._W>1H;&6.QAIJE&=#YU**DIU?0'8H;B0B
M:6Q4BDP]*PA.EY(7L>NJBPGR-08*Y3]K%YBTP$,D/<EZQ)@*0;A-=)$&U\JB
M%"%MPL[=QN?"0,/2/+F[8[=U\ S9DY6E*&)SXI$PA1<9(7)56C:;;(Z9O$=4
M)&[1%8&W\8).)0H'=+:7MBA>J5E'G<E*#MSE^:;^0P%C2"+X//.3]L7=S5"V
MRHCO@',/SQR"B[):@&N 8WI"M.P*5*.7S?"E<BQ*&Z>#,\'L#E3@,"4#U8)R
M=:MDTON<A81?P*[1F2.U_)P[C,^6!\"EL&SWLX-+#\+P?N&D+)4V4!HE(T(1
MUE;9:*>*CSML]LI$,*TTI,)\=MHK[/L;:H]Y&*BA!$AU0.(D]LOXN%C?A1:+
M5>^;%EQ [IA$[1!6F/0"F,-_I"';JX5,4M6(\%J18TP \($,=R&'WR%+:@7
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M\T,6G*_'D8\/E8IK:SW<Q:32TQTK#VG-6>K4R 0K(*F*\9:SR PH7F?O+U4
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M\V/Q IPG%\J#O0MR??H1NUE-K^+J71=J%&!-1)3-RXH?>F%:I,7WBC1A AQ
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M>3\-_  1IN*A8(L0+(6%IE:+G^8^!4;:&;X7OI,&64Y3<_D[\^:=:G@]'VF
MMV8$0 ![227.J[F@&TX%=.,5W42?JHSY1SXVB][RRG6NXUL%.Y(GY(UANQM8
M-;A3WE&%3W@%E ZG<-\@'D7 +PS 5HR)R0SC# O:M^X'ZL7WUH.H!?[?7]T-
MUMG;WWWU@$TC';-7*GMHUYQE:NST6HQY-ON_SL?37X\_.I\OSD].3]^???KU
M<CX<FL"7H20^*LO:-84990+ <,91L'(<CA^!%J4!.6(8/34J)7W\0Q*/G2P8
M,P(B_)< 1>FHA/T,UQ!(,?$8Y1#D$^,JCN &VH'_S8-$.7F*3P=,V.'401E)
M,'LC+XC2K"0Y!Z$7C-,62!R5*NOMDR0 ?H*)&6S0U\$;9P![%]Y1$J<DDT&J
MLW1@V0YC'GM3IZ_TF/S*B R.),BC! Z"!#\(_VNDKT'$),S&29QF.S"R*!W"
M-U1T$R1QA*"/, SX.2; RC#P^AK'DP0V7>4).C 7%N](8 0DS%.E82"]R018
M0Q .U3B@Z;P.8+X6=*3YNC=*E,)OPTU "C-ANEXE/%"[F E\SH(:Q4<&O&!Z
M831Y2S.Q!T[R7 ]$XV86@C;R?P)JE"\B$13<2NC1Y1? 6)$2]2<O4<!:\A#N
MP''8T[_/DA,HI*(']'1O8&XQ,*M>(CS@BYF[=.%U<%.,H?BV<QMDUPPL2;"A
M"=SNPT<'1&BS^O<<8YK#34"Y5&.%V@O1I\-9E(K(R_)$,U"0. S0 H]=!Q-\
M9\Y;R@&:CVGAZ=5Q'\2Q\-,-:C=P]NHMAX,FAAH#KSM('R\:(!7\V(GBS%'?
M@3?3%#8D;[LX,3L33M>)&@1 ![PZ]KX'XWP,SX6AE\@IWG)^5;#3O#"$A>5+
MJ9 FJ^S\@1?A]XA('E "]L44]SK( U8"LB"T/TFKAXJ'EX+0@UM:"(:= H%)
M*KGPIH&'NRV*]4I?>S<*+JO(/./BKS:UBUM0KTA0GQG&>K V'1%B%-B@[X5(
M+R>]5BKCQ?.BJ=XCL*9![*-4@\<C'.,+.T4_ M5&!=SNA1KE(0J=J?.;EP$3
M-F<KT,B[9=&0,'6(?48QZ+L1"K;?E ^'0,*8S_P/L&3AI!HEWIC!G ?Q>!*J
M[W0'2,K?0=S@9D_43:!NZ6J )S5P64:OQYT 3P3$F22Q2 R$=0.!#:1NO#"G
M3<8_)+A[*F#&+,A@C^(&M<8PS$D@\73D9)P[+H9D)J.+)0BJ_[B9/=+W#>^
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M[@S2+*$=C%)AH!3JX_)S4CH,JHJUF!#B$(H1I1VU3Q"5"5M!?1#8F+;KRHF
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MKZZ]<'C75"TEU!-ORUE!3UC?]VI,OO^3L_=OBL#'E]9E"W["G4%,#%_Y)Q(
MI-?K]^?_?(,,\T\ORB5M '3N79(% R]CU5H42KB7X^3FDZ)XH[,.G<:P<IK7
M5<&K5=<US&@<9&*JE)R'E.90N!!14S$&E%8<,4P710HM (]-(7(8W0;D**?
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M-F1C.TQ',>(BV&89!]KA7PAPZ960,IK2- &;30Q9%D9]D/W#@(W9R22D=TQ
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M/QZ9!"2:L]4DI@]\AEIC<PDAYY+5(@Y%^F5QY%NA$@??FSU( <<WHHJ(GV6
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M1-MI9 \F3M1/(],YXZI2$=F[ W78:!-1+-().%E882:F(R]YUW"!]59>"?:
MXTW+ 7S7984Y+(U53ASX*^O=:K>>J^&[#9X]7+??E37OP5^N1IEWIZV1TZ:M
M/!2&!S*<KB86AJ (-7TM>(:>/]$H7.+^)Z41_(%L(*W)\F_MZ,'+(GH>/^9
M:&$XN"S%>.MP,6M^61 Q3J1&+>/!2W,0+HC(EQD=8)Q@*BO0TU/Q-7%3U :N
M$_+SZ/SQ 9 ^F47T-54L^56MO(>E>3D9:*;(0!,9:+79R189:/4WAC9T;;Z,
M3B))(I.$8TA9DKQ5:)(DYZ?)\()UK4261DHHTC\<5.*TK!WC;S2C*?;HHZ@W
MLL-<>+BZ(.WI#^51X>EW4SR-<S##&6Z/ITDJ3*ZK4L%+1P[(/B><$)KB-W)L
MM$GFM!VI%#E3>C!,T"+S;%;>SZRAK&.2=4-@7_XK6$Z!C*ER=/S,XI-T';S(
M?Y)N'[X6.&!<T5IK^"?A#:B!2[Z!Q;3HBRWCT)CYTIB;PC:L] N97+2L]99M
MP)L9P;,,\T6F.04C&KF3]1AC%()#=\9HJ]%TK7OTH;#W,U8ZTE2RY)S\-@Q]
M>Y& ]H"?O6.?O:<;HAF.3T&,>[GZ<OMP=__T3K)A>6AA($6N[RN;VUR6!G&#
M^*+TP)=-%D)\+.TKYU92&;"P7*EUS'N87Q40).W@@I=9(#]IEYOL@7,3[TQ8
MP!=+HU;DS/RCS7&,3- Z@T:9GN_0BGSNG-/],-O.7>8)N7AL4O&K6>/TQ10E
M>-7*"5,E?[@X$GOB1+#LK$J:!M8>3_[A$IT<YM[QI)_5P0PX/VR1^P-\G"3D
M).'$5&6 J*?=\C$;)W-$A^/ (G2=:"<AB_:XH+GDE..3%P/GHPNZF/6%0\I"
M8'0L#$Z$-1M P.6XO-R;BWH6,U00BS6EY3SY]MAX^X1@Q:!MT5VQTB"YH%5V
M\@:;/;G2?IC/2H-MT'D!08"=%6CRKK(*381")A5UD5*:]OI&#0)WT:1O-@F)
M>8U)JQPG7.""W<;GW5%)@ITIBS.VG&@AQ;/5UXF(IROS\$&7)QUC\"X?&DD?
MH7B@;1B#)+$HF?Q ,9LXQ?GXWT4&AS%<PX(%+*%[:HW2D1XOV%;-G6<"6TF\
M"6@U7AM!HHG*E)GHRY)P$CR!2%JF.:J&%_'I%9($QELH3L36-=7L\%G>3($K
MPI78UZ6&/;-S(^+BU@.TN^]KR%M9,'F5E5;93,C,:<Y"1+U.?&:9+IB/G@)Q
MX4.;(:!\D6@++[ C+>0RM'%X##5[8[[C$'X?+9: CV=<G#'08@(K.W2RPN-9
M67(6!C\#/V>J.!:#(K?(M5R:DY2*RR2-,I6F)V@.5@A0/E@TB??1R:TX6LF:
MA>0F^<O[9-"JXU$PT8?>KR83+ VKI1]DEQ>1,Z7#HF=\%#?_,K^LP*4?5W\W
M3,7L:867.HKZ]C0SJ7>^J](6,;=@H)9ML>+O^J"[U1,;%Z5O?%7)6/6CCOO-
MWF6N?+)@#C>+2!]W\#0+%)?[(W^"P2O=T8E@'XE-ID-P<W55SLV@K@MPCS3D
M?66N]IC^;ZNYV75%K];1NLOSQ-?/TC[$/.ZF@TLO(OWE\RNJZ]K)#0>@A$,2
M3/J.BD*H@, P:6XM>5'KY#CF7#&)Y:9ZA[FQU-QD@TO6DAVV@77K14BUT7\5
M G0KYC:U"*_NT2,&-QG<G_#=-GIP5P&XD3Z/)/Z*]WY?T9^HH%%J099K-3SI
M$G.TA8;O2&?!6[F'2-'VPS(^#K?O['X#_&0M-JP/#+EC=I?2A Z]>;RZ%1 .
MIU2WE2@-I<^&DZ'6U^2^H6TFPV-26_-LHF) /I84?C;4&-(V^)A<&)4R<2$%
M3)W1R"6G%KJ&K&G&;C)W-T+GV]S-S] *V: ZC,^CV#H@4/H;87QDF5$LK\AH
M3(BVLQ%[<H'R.2UD/FBQEE')CB[(;$5P7NM*07 :A1Z^ !P/]9W47D%7F:YJ
MSJ%7JMS5>N\.8W06L]51C<ZE3Y:(SK9@S0"Y.E!W,-0.A*&V&&J?#]FUH,72
MKD&LH<FZWCNE55<FM]IGU8'.4'5MG<XXLFRI%^_4Z2X!. &X6@&N';[7[;I>
M.0URQ;1W[;5-VF+3JW)'-0]Y!""\L1-A;J"6'-TTQQ5+([$G%[,?MNR+U5Z!
MUJ 8NB:;/5V$T(\)8M/8#& 1/Z\ Q(\;RQFO<_T?&F36Z<*LJ[V([/4/FM>Q
ME]50)CV%49<YNNR51!&;8]2=3^[>+W5# U&[Z-&SID%/@^1OM\7RMT$B5NMT
MA UZ3 #3[F?:^QK8H;PJ;C7U["C)RJ=,IF>QQH__]X_'I[N/JS-UZBY:*EHS
M^^.O+JFAQ0C<-77Y ' YM^@H!DA7Z\MFWSAQC^G.HBW'V1!R\%CK?DM:GXY]
ML3S9<M;3C9ZLJYWZL=XY.8R:&3_22ON"6OY<7_KBCDOYKOWFX?IG#,H@J['<
MBW?2 ^']#<*DPXV-Q4TV(;AXWIXMTS'%"IR0M>N-L$E;VCX/F_A:P5S"F:ZL
M#4<Z_75MMX/M!QO@32>&D9:#T=+$#6SLBT>ZV2XBO/%<,BR6-_]P_A?)9,,L
MT :0BYX#15$W^ES/M<V-<"4+)Q:_8MM#!D'@Z6^.Z^)H52"AI,D*? N;G+L.
M;9@_MG "++RV*E75$Y#='""1?ZIU&^;M!Y,^U8B 9^N92*X/BZE50Z>2%UU,
MK^-!9\GU$KV.F]<A^")['=>OV]>&9D^9#OV@>)+6_BN=VD"?K#0'.TB[)]'=
MJ0'QI'9V=SIA#N;E=8JJV+>D2J.H-N))-)W:EE)$SZDMH:4?FXF671+1ONKD
M[:O.(!KK?'HG6F&=0Q"M]<6V;H5U]JJ8.K35JAC<_[)PW$3CK%IAYN(:9VGF
M0.[V!J)Q5L/IL^EDV#'E0:\D">WTU'8IUMB:W@XD#&\DZ<OZ0:!K9@6+TJ(Z
M\%1W(+HX'!? O<T-9!HDDXY5I%1X/*UU3WF*DD^C9X*LO?*I]L4C53L/:P.Y
MWQ75W(W$G6K*FEK2&/+T*+IL8^YV- );[O?R#MZM$XE-XIQ!7S;TD[94;9'9
M5A7(AB:;ZN8FS0V20.VH+V?8V.W/C;7I[95KK3$7!EU9U0\:@A2FWJEPU]=D
M?;"Y/_6EFWI-$:/+I>9-.9IJK2TH:P-A"AX;QIT2Z=4@ =6@<_'B>CN6G=P4
MN=.Z(_'#%F0WX"QR3<%UUP3)FR8LGEY]BV/XQO)$PTE?UW6Y9YCU(_V6'/TW
M2$.OBR(OBJ+3FJ.;IFCL(HSL)51/D!#<E*1BRG9:3^GW:DJZE4?*-86(V]6"
M3 R3:\4PN0;$X]:GI5#A=6*<B,%T[1":39H]=_'AP<,-B6N0O*P7([;U+H&$
M&MQ5KVS7LY@58BYC.Y(HCC^TL:$I% U"SG''/0J7:]L@IIA'5VN9W"#.WF/D
MG'#"#C,;KD'B\P+L3C&$KFWCE_:84"<&,)T5<V6#[\Z GN:<JI]S<DDN"ZX1
M@O%@*4H-S?MI;2Z<V9%U4ZM?0I#(A:L]3S2=]+6>W#=J2/HB%ZX>CND#.#%\
MKAM&C[!)(;SIQ;$SQ=0U5]O[^S-5Q55]X@F::LB=LNX$358OE3V:YN%.-?NR
M7M:M3LC'^GHU#PT[2A1^33O]FG['D+N=0?V,NU8HGAIEKR>7.0IZ&QJ=GV^M
M)RASJ DNSTP/#1];N,@5Y@<KM A'3#!<,\'PPVG&%FX+@77SDIS1W]^4#[32
M=?7--M.9EN"]_=RN"LWB*\^'8;I/5V4)1X( @J8SBZ,&J;'L"7TM0OA0*"I7
MM 0='/::IIST'#0=VS7V7==_1:ZC8B>40A)AW[5H(HU(9#DN'6S :1'N"D@8
MNT"QV)H-V!'^_4*\F%!>!LAXR-@R_1< R\'KR/J8,T(+FD#0 :?+TG#.GY[!
MI]B<+?*,4F!EZA< ".R!B(S6\_H28)LRNJNK*6:G5WCI?'.M3*6K&6)-8DT'
M6].@O_G;AQF9M3G(U*^2'5@\U02DRO$:OFPUM$Q:&5%5YV90YAZ.9I%1OF[T
M6%6COHFCRZH2S",?S_Q8/;1_$$>IU3"-P(BQ@I'T"W C"01(]P?IK>M*7\&V
M$\ \ ##O7&<*;G$^05' <V=X9L>Z-4;)5@SG/OG@#Z>N6@5JV901TM1CAJKM
M]MISSE!UQUVYTS?D@7;0VJSCAOW+"A8$X5X"X9H]N;-K^U%!M?7 X>51K6IJ
M\J"D98,@6T&V-2/;*[73E?5.?^M.+H)DZX' RR/9KJP9'7GG&8-')=RVS&QB
MOB7O3QC*>)3MQB-ZC(^A'CZ_298\$E5.JZN:,5KGXNRJ-*K+O=Y UHW-LWY.
M7*&]E?QL*V:,GMPOF9XIT'(&ANEILE8VAEG@I3GVH<#)$97+H*_)G=Z91K2<
MH]7$*6V?1YZSQ&=47KE^&*Z0_ZX;WY4^:]\MK"KQ]M2!W"UK#U"GAF%[K>7B
MT:V9S6H/)["]G[70 WP;YH&B20+5]44UKS\6G'T9Z-8'H+:U'1O.'17=HNUQ
M8^YJ2W24MC@N[&U\F&#HOOZN>+[9S[<L7G%%6T2?/()4+4[!2X)6CX(:U"6F
MN-+\GL4OAF3L!P1+-%^<$ LXL1:+QS8BZWNVQWII;&,_8.W**^+CXN/BX\W\
M^$D^6*LTC</V.3D 8,YN%:R9^#HPY(YYV&''U8,7>[BQ![$8CNWF;FXZL5RT
MGG05H&N@+296"SI.7H!MFLJ@I^]0?SW0](/5RVY7R;VAAK>[[;?%FL2:-M1?
M#P:B_OI0]==Z8TK#1/VUJ+]N-$Q%_;6HOZXQ,$7]M:B_/DO]=>/"'%M6HS0G
M6K$VH;\_D >]DE2FTQ=%":)J+E$--+E;5NDL*$I0U!95R+V>/.AL'ELH2$J0
MU#:G]X.^W#<[:X_O!34):MK&CNIC2O@Y[:BV9*&=L4:W2=E'NJRJNFSJFVL+
M3R>I&@[.GBYWM<WULP*654FSWY<[):)0 /,P=HJ 8V5YV>T9LE$RITP4D=:X
MB+0M12==HRN;90T,SU!*)'"4*_#L& )%=4;1E::ILM93MW/A!7Y.A9]*I90"
M1^<5<WU-[NLE]8]G+'-L3-3B5\OQL'8NM%PZ](L7SN%L(<<+X\#R;"(%Q/9A
MQ0X)I7'@3^'?&.D((RLZ9#Q#W'9)?HVVN>>(J#8[3;5978K-Q#?$-\0WB@[/
M+K<6J^TE5]2(-;0:EEPUM;*J&2,I564PT Y4PM+3BS^R?0E+KW^H-1UNK*%8
M4U/7I,(#QN97%0]FUS<,9J^?[R5NVUYB'_(NT6VJ,7<)5#7F+H&JQMPE4-68
MNP2J&G.70%5C[A*H:LQ= E6-N6MSOZ+$53>P5Y$?.EB??1,0UXJ<%[((CKU]
MDWN*A]8ZBT>L8>B[<;3^D:*N1\<Y15N)DM)ZZ8&Z=+2=^7.21BYFUC.Y'@;$
M^G9MC6&1-Y;[:LU#A&.VR9/C)2_OLBAMA5W_-PXC9SPOWK:F&<9VVQXDNZ8O
MNG$BN-LNB53W<776F3[-XL8C8OL![0+ "%2:!&3\]S=_<XBM]\<=S2)#L]?M
MCJR!2L:F89A$U7K:V!C_1]/>_/Q$@\+^6/KI1ZO9._D WP V".E&"@AS(PVQ
M!3C>"-YPH_5IF.V4O/0U#J0H5Z/O>#8P34A&TG N_=#35465X(,N0$>6_$!2
MNXKV5@9Q-9U9 =P5^5(T(=(<.P>1XLY!BO0T6;P8_I)^[-4*I5G@3*T MB2-
M I!4'GX7 )"]W;?M&(!BSY%@-*7_EJ;"=!7U+4M]\6$7(>]$$_).-/C<HS4E
MTB?+=EP0;80ET#P% "XJZ; *:'%1AD6%,V*CM'3GN,%XAN][=:))LAA\8F3A
M4I,- -GP]R(0'(")'=&,'?NOV&&?"17I=C2B?[5<?/.ZU3X0%*?P\EM\&&&;
M6?H"+7ET(9*TOJKT%TAZG0 0E_$3(BAF0"0^YA QM.2IM;CUW5*;NP.+O@65
M5F?;PKY#$L\E7[NEM7OX^:=A\.//6SR79UD-E<;AF79+<#PP:CCHH66%Q13+
M%.D@P*PG7C9N'*7<V'==_Q4%!;734+R1$(L<*!,N<WW"Q2A OI$Y,NC8#Z8T
MOV]*HL"Q0^1P&Z3,LQ^ A(P#^FHN<,,U$K=+7X@\?G-JDBBFSVU(XN0]-'<\
M,>YU%-W8[B1O[;D<R&]CNZZ'QS]\KN6B3*6K&35;TT QS<W-5/=I-*FI5?*7
MZ]3/:DT3R;:UMJK>0+(%/<I0J9RJUUL[P*4+<%5-B_XPL;QG(N!5%5YOI0*(
M'2UQYQ! %Y^J_*FR&HFR;L3U4)G%A/OT]>GVL_3I]L/]Y_NG/Z6'N\<_/C\]
MWJSE_(SML\N^3\NRU;UD5G#Z$?V8@$9^HHD?P]M'2]7O.]7_;TCX[2O]WMDI
M8TTK@#6>\6&F*-8G_;XB.':=A%*_M/N*&^[*G;XA#\KZ&.R]_6-7_E91(&65
MOU6IM3[8JVWCUSVK?%HK1IHN+<R^;/8W-RMK K6U6"2HNK)+(X!#X.>T&WV[
M1URK[E;9EY@&[_RQ-,X<HD;).2+Q1NM-]PV6>XW&LU8$A%;6@?I8\UEW"1@7
M4EO= =S;+"T$'"O"L2_ > CMU5$V]P=OJX(Z2D_!S'$O?\4UWG]C4,UW-IUF
M6]-9'*[3: =9DU&I\+L@71,1<*TK!>?70RLD^((W/U]EFI45]_BIH(1KWWRJ
MJ@M:X@WLO?]CNPDMZQEV&'TEL'->IA+(J2]R5%79W&+\>/BIL0'3, _[UHYB
MRY5FH/4Q27!DS=<W_VJ72VW*75W=/>(O/)EJ8![(/;,CFZ9HH'\0:'8[\D!,
MR3B, % &PL6NHI9KK+Z^IH4YX$!CNH7U3"3>JEGZ"K]9K.Q%&I+17HJM+4;;
MH*,<](B[Z=:<,//+X-4?E%&,((R+) Q-V>4 7-!%^^GB$N5%N\("23KDU/F.
M]7]>'/#:XXL)#VAF6?[(42(#]1-M[7/\]-8>KEX*!J_ BSG*#$&!O!,@3U6,
MUB'O*)-%FAF366,[K"FHV"$(LPI%P^R/>_W6!&FZ V7'=+^#0:A1S'=$GJOF
ML^W/US6GR%Y'T8XP'$(0GB"\W8T%07."YHY"<[JB"9K;PKH]?V?2NMZUN6.J
MZ#U5US9/M5R4Z#U5_\8[HO=4<[K=B-Y3HO?4V5O2B-Y3HO>4^)1ZGMY3U" _
M)?4^WOYVM[[_U$%6LEKR5[2474O^M-*2/]$R2[3,.D!B:7MZW;2U998N=]2!
M;'1*BL":W#)K6ZYM*(4VG! U>:#ILJYN3NH1]";H[4"%KV9/U@:[%([7B]HJ
MYR WK_N7(9I_-3X'633_2N5-21\$4:-\7  +.%8]%:"%EP*638!EC165: (F
MFH U,G/HL.W#12>CFJ!-8*?NFE"@Z()15&-+IF$N]^5V S-DLZ/)G8YHLWUD
M,/<[7=D8B&;;AXE;]&5=%1VW#V(#ED2,VZJAVE1Y*KJ!;0FP@:KL&%INIS4G
M+/TR>/7-:H6@@C NC#"TBVP&+>BBG"[.U6&_QD97P^PJT0U,5\O(6'0#:ZCC
M!ZAM:1_H2\'@54=16]=0ZH*0I[<.>:(;6)GM<,QN8"UK1U+>>^GH$&H4\QV1
MYT2#'$:1JN@&)@CO/-W .J(SDZ"YD]*<)FA.= ,[R%VB&UCIJVK9>*N6BQ+=
MP.K?"NF W< :W-E']-D2?;;.WC=*]-D2?;;$I]1*?;8:TT[KZ>'VR^/]T_W7
M+_=??FUT7RU]B[Y:M1$@]$VB?99HGR7:9^URK-.7U>Y!TV_KU5YF6YYM*'TV
MG R[?4T>=#9GP AJ$]1VH&2KKJSKNU1;UXO8*N?K-J]S5K^L(D1TSJJ]:2DZ
M9R7*K61"N2CG/2I\!1AKTNM)P/*2\DI%WRS1-ZM9.38';2$NNO[4 VL".777
M@P)%%XRB&MLQ#7.W+[=KEBKKNB%W^B63%X2;O3>8.YIL#(2W?9 8M"[KYF:*
M%:"LVMQA<[^\MBJH-A5HBJ99VYZ0&,J.8>5V&G/"T"^E&+V,8@1A7"1A"+H0
M=%%XKG:1S=3:%1403;.TLLY*HFE68QV_3DD_-('!FF-0+5$Q H$U1V"O)%&O
ML0@4S;-$\ZS#>5@#9<?#B<OL[7%$GA/]9"I2I" \07CG33<0M"=H3]!>':S=
M\S>MJNM=FYMI):TI#$#):H)NVNWJ;3[!F=->9_&(-00ZBZ/UCZP4WY^.FF@7
MF(&VE$:<^7.2=NJ86<_D>A@0Z]NU-89%WECNJS4/$8Z9O4P=+WEYEW6AJ;#K
M1:^R@FUKFF%LM^U!:7.!U;8+?5R==:9/,R$S(K;/3LH9@4J3@(S__N9O#K'U
M_KBC661H]KK=D350R=@T#).H6D\;&^/_:-J;GY]HES=_+/WTH]7LG7R ;P ;
MA'0C!80I^MTM_5['UG*U7)2I:(/MWG2*-:FZ*?K=I<I(]+L3_>Z."2[1[T[T
MNSL2O$2_NQ9_JBW][A[N/MQ]>?K\IW3[X?_[X_[A[F.C>]YU1<\[T?-.]+R[
MI)YWO8[<Z^PX2;$)C:&VY=F&TF?#R5#K#^2^N4N*K: V06W;4YLJ]]7-A7)-
MH+8#^GWU0<Z7WUJ<@B[ZP"5VQXYM=D4=<$41M[FEIP!C13 ><1#UO@&7%DIS
MT2Y-M$MK9#;5?AG-HMV3:)<FD+.<E=T>Y.ROX.J#EE:[9Y?<-TPU5=DPA%MV
M7+?7,&3=K)U3T4A8&EI/UHS:^;G"06N(L!=MMK8$V$ M:2XGVFP)&SY/,=UJ
ME96","[5?Q"@NE!72S1CT@:**9HQM=(UT?LE>N^2,-ALA^CB-BR:_8AF/X<[
M%]M9QUUF[P'1]^+H$5BSI$^B(+Q3$-YQ%$H](;V-RRM ?4);YOPM4^IZU^96
M+J)/1%U;,M1R4:)/1/U+^46?"-$GXIC@$GTB1)^((\%+](EH\:?:TB<B[0KQ
MX?/7Q[N/36P.T1/-(41S"-$<XI*:0^PZ1K@)Q=/;\FM#:;/A)*C+9E=K?*&^
MH+4FT-J5+NO&X%V#Z>R #EY]T")B^@>,Z0O '1QP#3/J+[?&39,[@Q);0M2W
M[5E&V)>U^O7,:"0HK]2>K':-=>:(J&P3E6VBLNU0@0Y-5+:)RK9MX&5VRB9I
M"\*X['(M 2KAT@N7OJ9W"< =)3$TUU^/3OI;315E/SG>".S2FVMU<+@6?(,R
MV:,QO^K=00_=JWSU?0XPIJ*B?/_Y ^T * 5D%I 01[1)5M(6=BY%$RN2_/&8
M!*$$,GHBA?PP-JE"LCP\F/4</Y!<YP5_28YI%>F!G=/2>\CW&?%">GCK6A&\
M(/*W>)<TL5X(^ G$DRS7]6WZ!KP]P*%TF"Y(3\H)_#N<$1NS"22?>1CT+<]3
MV)@BY3,'FD8Q6ETHYM&:$NE30B( \MB-,@2$*,HV%I[%@3VQ0D#2+$#< N;_
MK^7%5C!GIJLJ2UI'4YN.'KTNZ'D*X'TTM0:)?Q<\C0-_6H@CQ%V2F,LNZ.R*
MIC0;>=VZ(.^!8*3$G4NW]E^Q$P R4@1>T9\89L-WV^#3]R3@NS >AN2O&.\L
M9D&]Z2S8JPL64YQ]<'U$0 &N))M=\I- F#2* V185&-SS(,G*WGPB*0NW$<0
M@7A?E&-U?PPZ$31A1((I&3F@)"7;"LA"F\\"_SFPIOBT)6$@:29-?)#E(8E0
M4<K2Z\2Q)Y*#B6>V&V?TZBV0UE?X2R"A[GWV@[DB/<'OX9K<+.G5"D'G\Y=0
M>5*L-<:H$/B.P[5;1E6/!$IOM_WIS J<$$ &)#X#*(;KI4\)E6K]E$A__FD8
M_/CS 5YT O=5VY07A\@+"&7\'[KF0.E(\%$7:$1&*:#JBOE6YD!D=E@)Q>D,
MU<E;:5;B>KP3(#C+#OPPI/)H9LWA3=%\1A*B0DK-O>LWH%7;<D;I.X".?]#T
ME85W%0T6SNX.2.YNPU2ZN9O[2@?NG5J>]0RK7+E?A4T9^;</%.,MI3,P4EZ0
M=7+O[R\M1C/@]MVI3E-ZAZ*[[*M.17E9<MA,#2 % )Y38%=0:2. +%CPPSFL
M,_!18&5/"("U 5]V2CU^'*R^.)66X%Y\C5$6>#3P1!V"Q>L6'  ? PB]13(?
M=/ O5:7L,H.$*+YXAW38,O*%+%GH+#%1EDK?!5A<V.,U"F-&@"F=\T/OD)+;
MTC,YDDVVCZ?C&W0S+URDD;A.N68^"\D\I+*)(C:K#!PF&A*1I9H]1<\QFU$H
ML0H1PG7CXG4+FJ!*: DE"2;DA"*S$.<.)ELW?"B;K,"H;P3+?\9?R!BH%Q"*
M3FT4$.\9%L@V"DN.//">)\XLE%X=\*!?@!E\<+ASF/:#9\MS_I>1M@Q:.9QA
MMCA; SJ\+NY_&GL47')V@_"10CD'E*]JBDK%H.,A^^5A$ZZ0&]TTD+&!?+)A
M\WB/CO)/^C=!#@3;(>8>/0'VE6"SXRC!=/+<S)_%+C-T*"92.0Z/Y58!/)5>
MNQV]6.S<D'B![[KHQJ=?I."V;-N/X4<T#"S)!4[ M0(R\$.P3J04_P6$!NBB
M]+4$T.9@G?!B48IT[TEHRD64ZE9T4DZB_# PE4%"HHQ"!PLXT^U%RQHS?6,U
MT@HS35^*GDC.4T?$1F:CDI8C&*'N^=[U6EH&R^^5QELB&NH)([H D+S1Q/)R
M<G?Y4462?LE&@?#2QD\MP)9"A04!4/:NUY]-DF@@ % G,<I X!7ZWTM"3N\N
MR;B^HK^5B[R7U3/?,?W?^V/O+ZNXN>28@@/QDA.J2$K11"XV#M?1;I[:#^JR
M5=W;BD&;LU]'!"T53K/KC$BM!V*RV!YE8K?(KD7C>YV5J:+<I;9VF%W<B$Q!
M)T1(8I2\K"$/S?H@]&Q0)'YJ03@YFXK;41D+'(5<WJ_;9/:C'\ABJFR)F<CM
M<H08I8_G1YF8*_PXCD'FVA9(%KPOC$ 3,MN?OG7L!&$D_17#KVP23=:W';N^
MCX["X21$]\1C=C9[:#F942NN7QM_ @%V%D[-*5YK!A+H.XBEB, 2?]#ZJM)/
M]? ^+BUE^Q6!IZL+AP,L,/)]AI(=N%$:DN@53R-X%$W*!BH* Z3=A!TC@K"#
M#6RRZ)-"88RSK=9)IKU'WN;G2O'.)9W%(]80O*,X6O_(2D7DB3EDH.=AD/US
M$BR"C\_D>@BH^G9MC6&1-Y;["GH%3P*S(@'D 7]YE_4$J+#K1>>8@FUKFF'L
M&#*D+RJJ^%RMA>WCZJPS?9I)R1$>HU$R9T>LTB0@X[^_^9M#;+T_[F@6&9J]
M;G=D#50R-@W#)*K6T\;&^#^:]N;G)]IS!T3X3S]:S=[)!_@&^H-T(P6$V30%
M] \GC/P \VS<N0Q"CIVC,NT#/]%3V0!,,9N@E_F*BC@U'U _)?XG7LE:=:#=
M-RD*^A1&BPFX981^&-PXQW9F:,3P#W&G;/%!'IEAD6"@)F9;YFT6ZNV2"+;$
M0L>;5P$R7>UGCT1P(<F-\#:$,;S%<ZPD@L#-&=0&4Q__L*(X8"?8Z&D&:)0@
M*"?62)H H%<A)B>_%UK!!=<2FR!UOL!40XRQE?+C'NJ>4K,IQ@6!P3W.;"9U
M7.$IN.Q9U'*@9SYH=5W'LTS@C*(#$6]'B<N^'O4YI#.D@G&:8(#ZTO1-3.N^
MH"JD1C./R\!O_&]#JL+CF<^V@>9HXIZ/\W2S6&F"C&2;6UJ#9^4\-"_&ONLR
M3YMU)0-V< %6S*JV:;>0K+N4ID$@9Z!K;Z$IDEK?%"=@ X$]CX@%2K&!#M@9
M2RY7@D(-48,6N8U\QHPG_"I_)[+AJ6<\:H>8\7A*%*9=,1K14TXSE6YONYYK
MZUYE*&:W;IW2Q)K$FL2:SK*F$JFR3S^^;J]R5]CZ-YGK'+B#X5F:+Y3FO-!=
M%M><I'LQV]38+9>W<M1^>*T"6^X41("M*MBR.7X":I6)S8\L][)D;*N:9XI.
MMEM"JTHCVXL"B" ?03Z"? 3Y"/*I/[3T(DMM^>A[0X_LM<D15:&X[OF#H$@L
M3BQ.+$XL;N_^\MU!]676HU'KF@#:/^\_?[[[*'WYX^'Q_LNOTNV_[AYN?[V3
M/M[>?_Y3>KC[U]V7/^ZDA]NGNT=I&Q]^/]C7 V+%KG^24RHZG%]&A_-^KZ^8
M^TTH/6E#X(-)Y&W-VH;2;=/)4U.53DD/_C90H1"K+1.KG9[25X58;2O=-IP\
MC7Z_E#S;0(5"K+9+K ZZAF)TA%AM*]TVG3R-GC(08K6UY-E6L=HWP!S8<3!$
M.PEZVW!>6PAZZWW7E*!U7>GVMR3H'4*X6Q/TKG'E1H2.,]T*+F2@3J_74]0=
MW?P3R\;VS8?IZ3W%[)UAU,Z^,&X%Y6N&TA&4?R[@#Q1ULQM<3QBW@O+-CM+;
M,0913ZPT"/B&JBN]S89=/6'<"LH':T??UJJN->57LK?KCA7=5+3-9E!5M^)D
M[LRN WQJX^NPAM2\?8(8( >"&4R27>W!XTT*.U0(Z3)'O/7,7IFR;1WJVLZG
M/;VOZ <]06LPLEN"TZ[95;JZX-,V\:FA]97!ME:=X--:X[2K=95>R9C=MJ&N
M_7S:4;H'/3IM$[*W=?=JCNQ>OZ?H)=G(AW!YSW6LR*!?W['NM-=&VK20MR>\
MD*-&0Q\HACAP.5?8&3SAS54R]81Q*RB_ U)W1Q5;3ZPT"/@]4U>ZFVW6>L*X
M#93?!YFO"YE_)N!W];)<\WK"N V4;W3[BC9H$^6WX:C1T'2EOVWP6!PU'J(B
MWQ&GC-C!QS048UL'O*W1EK;@M-\KS=5N&^I:SZ?]KJ()/FT7G_9412TQR=J&
MNK;SJ=XQ%5-D [2+3TU-Z8ML@%;QJ69VE?Z.[G#[D=VR4T:MKREJBT\9:^EE
M_\Z'(M,Q<#2YEPX[6S\(H5WQ-JT_4#11U'(FX!N:8F[6V/6$<2LHOVN4NC6"
M\H\%?+U?5C]=3QBW@?)UO:N8XES]3,#O]LN.4NH)XS90OC;H[!R>; I6FG>Z
M6,$,JNOIXMK1D4<Y?:0CJ,^7=YD,BU[.OV3#ZK>+2NP/N+9T7CHX7.K)Y-V.
MKG3VRY<_"+.=*-*UWUK7=X"\6+YI.7OH TU12\J^!!<(M2+4RK([!;;C?@D'
ME\U0%\XW;6</K%*LU)CXLKE J!6A5G+>BFZ4=E80:D6HE0M5*UVC_.Q,<(%0
M*T*M+)ECYD Q2AJ!"+6R#4,=.AS?%H8Z.%QJRE#]P?91Y2,<X>QV[O1C9 U=
MDIR@P!_)FC/O^6\<1LYX?BBX#LK JB%8K]1WTM.$2($5D5"R B(-K9",)-\#
M,>!%@65'L>6Z<\EZ#@@97<<SN&)- <A1*/D!>TZ6R'?;C1%,4@0O(["1*7VA
M/Y9>K,#!S>/[0@?@;$4.O .P1 )Z-S]D@O_:_K/GT*MA9'DC*QC)TB?'LSS;
ML5SIUK;QL_B11WXYE'[QX3_2U:?;QU_>%=_QP1\Y8\ ,?>_5[>,'V+ _<VS)
MZ!@T%Q"^%>'778>,I3&L"Y\?Q4&RFSFQ@H3BLIA92VY'1IE$ '0CZ2.QR70(
M,-156<K.O3\A]2CYD\$J=/WS3\, N:+R<XS5'-BS%]UHFM(#57$RT4-W^34.
MI&1HLC2RX,4)NT32HS4ETB?+=EP@7/P)".HI@(]1.D82REQT/#L@E+V&<ZFG
MJ&_I[5WXBPST%\Z('3DOQ)W+P"O3&7QM)$5^2H/K\*Y0!D[>+3FXKBAPAC&5
M.<D;NDHG^9SV5O)()$VMX!O\!_@=_Y,^'TU@6T-BX\;(>,S6!)>EKW;DXW?Q
MF_1-F1^ZRQO ZY843IQQ!"MX12:= $CA;LN.G6@NS8 A :.A(NU*"[J14L*>
M1-6E_9#.0%46: WKF4A) 3"GJP6=#!3]+<@BBL5$3CG381R$9 I+3^\$$>S'
MF-",2LB9,6$'. OCV<REMX( 3;\RL^;TZ5G@/P?6E%'M7R#G$3'.%'Y^(?D;
MX%4HQ_TX9,M@C]@3RWNFZUV\>^I\5Z1/H!G(=VL*WY:E5RKZ02JS;4Q@T_!T
MAF S3X^L.7T=_\BK$TT2NN&:)HSMB62!6(?5COW <RQ%N@>5!$H:-RUG)?>'
MK_^Z_RC- #\^*()QX$^15CMP#<3V\X12,ET?J!X"A+M&%R2W+^"7@(6^<@DP
M10L$!H6-XOM"MO\A(1Y7FO!5^AH_0P]9(9,N^YHQ.VBV@*HX !/CO)#@8RXJ
M6]QU CLB^3/4MA3"]*L <C^8^?C;:''K\G9A[4A'N=<A$*610Z9\48A?#[!O
MLQ<Y09[2$@ ITFV(@B%V(T!=1*&0J'L4IK @!@%8(7X+][,,A,0Z@._2UR%\
MZ;N**2@/-!TICKX5Q*+G1R"37+@!H<5$K!/ZGB*MET$@))\=CYJ&9MY5.*DD
MH6^Z<0"VCIV3+?U"V?([%C9(CT!2-K(J_%_ZG<#? 3D 6$#L(T_T^<(3?1Y)
M\.+@O0<U(BJLOU@V_I^_#315>W^DQ6RVKOY-I!AH"MDQ28<"F<: . 5RBP.2
ML$8B,N&?.;$<9F0*&@GX+J20&:%DLI)F-5Z8""!Y@U2B<,FU0476A#PW0A2M
MD['ONOXK%:9HE  7@\D!TA'$.]5;.>)<!@\W%1:2P^.*8CAG)3S@L2&EW^QL
M /1WMR3@.69GY:.A %37FH7D)OG+^Y$3SEQK?N-X%$3TH?<<?]PSQ::,2WXD
M_2"[_/[5&443=(>5#G6)DVQ&_F5^&>R\?"B%_:Z92K?7*[S4 0.TZ/=UKS(4
MLUM\9=V;UO_>T[=[DUB36)-84ZW65")52O*NFU Y6AQU3#?3[2UW&%@;:=RP
M6U2 )#CN?DV,GE2P'__$<,/=2K@A!X'VX]4L:1S1+)QF(U7SM7O6M]MS8<U*
MN^"6B^8)N%6&VZW]5^PPP*TOL1=@6R$W+,2Y,$&[)174'(,8;CHJP;<.7'H%
M<%T61 0!"0(2!"0(2!!00\"E%YELR0+XS3J-,A^?N$K>(3XE/M7"3Q6Z2=U!
M3?VD%4'"6M3=/7RX^_)T^^N=]/63]/C/^\^?[SY*7_YX>+S_\JOT</>ONR]_
MW&WC'.XJ76OC.29Y5X=OC5\ A+IW3^DH!QT76DP&VR6XGA8";X]JE)0U"FX@
MQ6A*2<6T((SM"*/M,D8URRA&R!@A8Y:TTBXC P1A7*R,T54A8X2,V6ZLNE)2
M^B4(0\B8G%92E<W#?(6,$3)FJ5'U1=HQ+<@N^,WRK&<"R]\S3M0D8NWL:D(=
MIS] ^[IW X3/T;7^@EITJUUEQ[Y+@H8K0E@K@;"@X?TA7#+75-#PGA#6!0T?
M&<(#9<=&18*&*T-X\\'=D6<;-,&(_THGLO'2SPNQXDUA !T7P(,2[2QTQ[Z!
M66'^'!? /6']')N":S49L'T4W"TYNA$4O+>2*VG[+BAX/P#W2XZ2CFR];WWN
MT*==7FJ9X/JXZ*AS61F=Q>#H=13MQ$V.-M1CMN]DM!CJXF1T2RI5ZTBE@A@O
M->.C&)#Z0.G6CTJ%+!6RM/Y4*HA1R-*<SSY0S/I1J9"E0I;F[%)3Z=>/2@4Q
M"EFZ)$N-^E&ID*5"EM8_$M5*8FQ[R?[O@?."(P.P3;=/LSIHD^[U30!;J0S6
M'25L.\+JZ'+Y")T^FBP>U^&M)$6NH>AI.[_MG-K85(2V!F\EU7L-14_[^4WH
MMR;BS3A;GQC!;_O9);7K""7XK>[V9(D#F@PJ\GR/K,>FN$O<5797"\I2DKF"
M%U*1TM5$+=B1(:R*?.@CETSH2D?0\%$A7%;U+&AX?SF\8_LB0<,5F]#I1\[J
M%S1<!F%!P\=NBW>:RI2UTPX;=)19?'#[]/7I]O-R'_8#G&/N#[':4&8QX.B0
MXOKE$QP=+8U*1#@B4U<+XPDV.&=:C:#V4U&[T :U9 .A#6K"'X(-A#:X'&H7
MVJ"6;""T04WX0["!T :70^U"&]22#80VJ E_"#80VN <!5H_1M;0)?#?D?/R
M\T_P1[*6S ;^&X>1,Y[SQ?[\TS# ,Q/^IN7GDB'0!JQHYH=.Y/@  N):D?-"
MWK\ZHVC"5Y-]BH.^LWC$&@*8XVC](RM#LD]W*D6G80^Z>1AD_YRD,[%GUC.Y
M'@;$^G9MC6&1-Y;[:LU#E 29O4P=+WEYETWCKK#K/%J6MJUIAK'=M@?)KNF+
M;IP([K9+B*J/J[/.]&G&8R-B^X%%28;FXTF3@(S__N9O#K'U_KBC661H]KK=
MD350R=@T#).H6D\;&^/_:-J;GY^0^B5_+/WTH]7LG7R ;P ;A'0C!8191D-4
M#BP)1 "#:\U"<I/\Y7V2^NAX= _TH?=3*W@& N8\C-2[).SH!]GE!6$K'4;<
M_-R5?YE?5N#2CZN_:Z;2[?4*+W44M?#W=:\R%+-;?&7=F];_WM.W>Y-8DUB3
M6%.MUE0B55J0XEUL :>;Z?8J.R,;=LLLL>/NEQE(&W4J-=#^)%8@W7DC,I(^
M$IM,AR20=%5NVUBX$KR:>W=<J!-.'ZTID3Y9MN,ZT?RHO4_:!;>G )ZFCA4L
M5L"M,MQN[;]BAP%N?6,/ ;85<O/!\;DP0;M_:YLZ85#K:-VC$GSKP*57 -=E
M0400D" @04""@ 0!-01<>I')MGRP W X!7&5O$-\2GRJA9\J=).Z@YKZ2<6G
MS+_?/7RX^_)T^^N=]/73<E69]/'VS\>+ZA/*6FL$1/0%Q?2/76MEFY>"40P!
MT;!Y2XI1S]8BL:6$T7898Y;U^!,B1HB8/,&4C,85="$D3$XG&?5K_]I24FH)
MQ6AEG:0$80@9LVSW"C-&R)AM*$93] N4,2U(+/C-\JQG LO?,TK4)&+MEAG=
MHFG:WA#>+ Y$X[^]_<82>2M(^+A=_P4%GRM4)BBX\GF'*DCXJ!#6!0T?'<*;
M^XP?N?MJ$RSXKW3^8_C-<5UR*3,4#-%^_LCMYTMF5 C=L6]O]!+E+"AX;P!O
MULV"@O<&L'!!C]MZ7LC@8RLY(8//"N C6^];'SJH2K]W=BN_.+'UD=GWTM3Y
M?EG)G,7@T %5]6OEU9YCT;T[UEW8L>A:*AW4CTH%,5YJND<Q(+5:4JF0I4*6
MYJBT4T>-+XA1R-(<E0X4LWY4*F2ID*4YN[2O=.M'I8(8A2S-R5)3R-(6DV]+
MJ%3O"%EZ(F)L>[7^[X'S8D5$LKR1Y-.LCIDU]X/US?]:J0S69K/5KB;E""T^
MFBP?UQ83E>3J-!0_K><X;=<DJZ9BM#V(*SG7;BA^6L]QG;)*7<%QM43<H"13
MIZGH$0PG&*Z>B#NK45GBAR9SBN@@I;7H%'>)N\KN:D%U"NM Z%Q*84JOOVN3
M09%36AG"FQL@B;3H?8NK=FXQ)6BX(H0%#1\;PCN'BP4-5Y3#W2.7YEX\#?=$
MBX1C0[@L<'.: I6#S/ZN9=7*T]>GV\_+;=@/<)RY/\1J0YF-FE5_=+0T*A_A
MB$Q=+8XGV."<V36"VD]%[4(;U)(-A#:H"7\(-A#:X'*H76B#6K*!T 8UX0_!
M!D(;7 ZU"VU02S80VJ F_"'80&B#<]1I_1A90Y? ?T?.R\\_P1_)6C(;^&\<
M1LYXSA?[\T_# ,],^)O*GV.P<+P1\:(;3<-9TX??-WW3C1/![?9F2-!)UA_\
M,)+\L?1(@A?')J%TD/W4$S3K^(("XFE"I+'ONOXKT+!$B4$*213"CT$TD2(?
M( H"BT$K3* %%R4_3ML9+RZ$Y'D*>Z$W1/#J&:S*'X42;!&(/X);KT;P-2O
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M+65*_WB7H$P/.%H:N-K53,ZT,LCU<'*\, YH$2>?+! N@B5QR&V';/^V8UL
M9^,,9AITLA/X5LZZ8RX&G8(DO@/:!;GN]"D6-K11+&QDEVFCN.B(O4H&M$,D
M"JVTV)^_+*DE;K0D6"1E'4,2G*..>+&C<D&P9,[2[L4AUL;S=BVYM@XS.F2
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ME$J*^;L9*5(9%LFOU;1V,1%ILYI+1+I6H( T?S!QAU@J!=Y2&/=8K\XU('V
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MF@+WB>[GP%5,08AL[^#D=QS^BP#'<31^,@+>BM8ILCTPP7 <=4S'\W0SKK4
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MW0.@ D,"0P)# D-EP!"OHMRP.2LO1:EG*DI!1X6E(ZY.FTU4U+)QHP[=B?2
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MZYJQ6LE+XX?=1N].T%Z=H[U1:5:O%559'M<N38DO49MJ3@&;]C"7AT]%X%>
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MTZ7?76^JQ=&;9U[<THZ&QD1%+1;6)V&=2Q)<$;4K(J8ID"V0?9;(SK,;)A7
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MYRQPC2[]V+$>G3%-1>2_5FK/X,@1H;3U&J7=G8NR/V.'&D:U>JT4=7U W'O
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MFOJXXBY\HZT)Y-\S9XK+%T6Y02X#Y^C(QGOK#4$:#+S6$.#KD_L(Y"W7;L<
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M4"=1UM%*/9AB^]F:FX[@HD]G_O 9/WCB2_?HD0;>?72>+"!H8.DM=]<AYL$
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M>B7UJ8&U(Y9*KI1ZY.K0:"F(?M$TB9&7EA*L:9I24>C#N:4/#^W.X".X;R&
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M'#Y9XFNX3QCT1V^"\ + _HPI/Q8M4G2T,S 5+$S7@3],;_(49JU9Z&>'5_+
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M8J($"/75^5(B>(%:*)*O%;TKRW<79YR#CE$5QDE(6<>)59%'#;8B4=X7 UM
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MNG'AO=]<F"A(HJ\@#9P)$-M=N',/,-IGVYW\&0F:(9=YY, <!>(S?!<#H;1
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M+U(-0PDXLWZ*FG_7@<%T9#7_AKO',[F=)?$@V'(N>ADB'LBHAHV[Y2$O1O1
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MK78Z$;!F'BF+-=[=^I<8GN$&I+DUL(&%.V!7'8)0 $M2&*C_JT 1Y&0,\T.
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M,LC_20HN]L#7J86)9K$M5OY\\J+TLD=V/H9S__/<!&/(^V3:+^;*1YM>Y?;
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M++*E#UKI@E_>EM )3#M<(HQ-]+\"$M?P(DVU+VS"YF,X\'9+UXRFT=&U,5
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M0(%I4LD*[#0(4(VQM^\V$A%Y?[:<C)$!F7\:#09OYWW;V*&%/0!_IQ"2"LW
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M,\. LQQ7*(?;\ QX9&DS2T4V0*DDD1$Y=7/J/B9S02WW/F)W>J::<B'A9,K
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MA# )Q"<OL)>P%-@I9&]W_H;B8#7Q-R'X ;_ (< A_@0IO%H[[&S'@3$>IJ_
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MG!">'-QES+\* ;J$T3K(SU:G"2'99 +^^E<V\*QT)1W/BLZUT!QK DC2U2R
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MA/H)DZ7R$8R>&<VM0TMO]!\PL]QHFG [>X0-0_4[6C)@^">0(##1>&W+<W3
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M+C!+^E-"YPR:R?7&&[<?$*ZC#^.%_^KYXX#,UM:M=7J!^Z< 7#Q_VO9'H)B
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MZUDP4F7"'*9S_CG"#X%@,8[5'^W"(JJ+=5"]#U^]XAR#.:>BHB1+Q0_CF-/
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M>=B=%>'(DIK/YX90L ));X1,;$?87>%A]Z-N6XPAXZF* 1+8[IJ\V+V52VP
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MQ/# L:+U:CO-*YQ4XS/5/=,:C'V#N=(?ONYX&,I/6I, 5WCN.9M,Q_8;P]0
M!YYJ.VY5ZO%;#7@&:83I!BG7'5T)7W8$<<V=I#IV+,O7QU]LRR>O, =;S\KM
M'<CI,VYAYF-%3I']Q9)TY+(I/FKL)$?Q4*B!*8N56G.><Q0+-< :U0E"4I^#
MB">4D"O"99XWYNQ'))BLX!([!)ZE!37#)FB!J:;.L.QD^ %/"?'1!%CP8]I6
M0.+RKWWGXC(SV!$T'&K"<Z>V:^++/SELK.,RH^YG?T[VN1.]TVK1+7K?M<>^
MEWW+7.N./2?'P<\9D,=^CL(&3%,0SN=]A^F_SO4AK/*3/G[5WUS,&(R?"!R'
M>#K8&MA"+FO;R69SZG&WLU.JBJINI;7:MA^UN'7<CHI="'6V$MMLYP]M\N/3
M#_1J#B,00+9#_(JGU4HC!X7IGTPV4%O#FJ*SOM:HUPV]+;.AUFQJ3%8:RK Y
M_)<"FCZUV$0)@%.%4 ;^]4)?U%!U@[WM#8@[!AEWAL[_C$-.\+7E15!;::JT
M1AR_OMH4FF]=J7O[V/MZ*WU]N/MY7Y%ZMU>1U,Q1XY5*_=HVJ'_WLDU9J8#B
M]NZI^R@]W4D(M*N[V\>[[[WKSE/W6KKIW79NKWJ=[]+C$WSPHWO[]"B=2Q^N
MN*[!C(\I:).2&I^^V62&QQ)-(]=]_.>,4A1HMTJM?EY?,C-MOF7P8,0,?\SN
MAK>VQ?7)*(I$>2$_P3IP.ZB?@6J>U?\70\E'WO^W([G^!%;Z%F3KNY[N^6[P
MET@>^8M+CH$EFG>R\V\R5D.:[V"$%E)FU'JU'$#3E::P D8QJCX;VZ^GT#VX
M">I+H[6=3K:-:KM1N$;$6A5$W1[;ZQ:[BR"PI7.>NRS%,M9F<M4V;K5X'+ (
MO*62<)=*Y Z1T&$JH<=4(I=IGIZ+V];Q=XD&0:MU3_J;#J(/&#7GB\H2%2]6
MP'Z:XR74]JY2?Y?ZZ\)CXV,G4GURK;/+1GVU_+I=E]R6+=;*%FN[+][.#LJI
M!PK*A62Z7CRN#12L5.6\4]S+MFL+4>AK,DU]@5PKI.C:TNCF N<HM[3T'.6R
M^\6A&&@26XXKJZ&-:4!RM3&?Y5%VO-JH/^51HO^'XV&4'/R+&&5;!D;9G%?Q
M/Y8\\H1X9!)/UN.1"MJ*U5I.3;/DD9<WMC-D9LDF#\<FPQ-8R"FQI'(>NTM&
M>4J,4F"*#_B['I>L Y=L594]]^5[EZ[FV<2UTMF\U-E\L(KU%9S-[<;99;T]
M;V*5SN:%SN;C]R>_6Y=Q_2A=QNWFV66S7M6*U?#S&!3YU;W"QR> MN0R+G S
MD78KO9G(,<B"4S0!&D?L3VZ?76I*M58O66SI3U[#47(P+KJ"/QD#;RD=*4LW
MR2GQR"WXD[4:J:%*SFE7)8\L_<D'9Y,K^9,UC+S-=W@J&>4I,<I-_<D:]I^0
MJXT]9[H<%9=<PY6LODL;?DM.Y(.QU16<R)J*XVKF=8;2B5PZD0^]]/6<R(>2
M3)LYD;4ZR*5V52N6]I[9-:18 FMC[W+6G,#C$UE;<CL7N%.WUDCOU+W>),@#
MB)6E4RE/?'1IMM%QJ/C@%CS86A.G ,O5E(2HPXPP?<^<?V6G]WL@I?QNGH,Q
M]^7><(UBBJM[P_<\X;=DW<?&NK?A6&^?7;:;52UG,4O)N7?LBG\/Q'1$S'LU
M'SWVYI[WK9;LNS 8=USL>T-W/X  >+>:UBJ^D+S[N//*T^=X+$\N7V*;BSY,
M\^;Y\7EGMA10.%C=S_* 0KTF8T!AM7[5APTH[!SM#B2X-A96A=$&,QNJK+2U
M0Q/[-H,:ARK?VBBH4:\IH W6E&HK9U1CM^(WV?9R9JS6^YD2>IULQYC5O+P2
M[PAY5.-$VZW"!BGJ-14P?][56ZS._'GGA>"$ L06TY'@E2\T,="::2C:MW%@
MB#V,3QE9-*@.[G99\OVQ$6/%FRF1S:*/=Z)6O5;?P8BQ]O&.L:K7&IDCQHI%
MPGV$3D"%(*]^,2^8Y<D_(X8N&;#AZC$/^/YN6\_G3\R9X,@B.'0<BWD_UJUE
M6PJ4>&RR?12=F^\LJ>,_PW(DI84"6M:X@/Y"?%6?3AW[!4X</\J"B?0!O\5;
MI>]//?KH(V?"B<\D?)1I!/-8!J SZ:8E!6Q_MEFT]#JR)=UU3;+ZQ;PH('EJ
M-$U<(6@U/04@V\,A_GW/+ OQCWAY_&%P/RTF,9"6R_F9\:5<-/A3>('K#P;,
M=8?^&%X,RV1IKUVX4R' :.BM;O&)MWG5#JVV([6#V]1W0_K6[?C>R'8 <]+U
MB^;99:.6,NXV@F$ ^UE85J7.@H[>'-N2X'O5 7)^,#Z7&1S$G@W$RQ]YSMG0
M(+9?B0;,(*;:&4_,-[I)DQ=#O3,>VP-\83KXN[_Q5Y8*2NK9.J^K5?*N4-G9
M"C$ I<R'GRK+9PC.KW))^]P-5JFAJW4>CB'1Y6X*/SL![XCEUV,6F3 .T.36
MUIQZT!6L^Y$KYQF,B!\P_'8W?& #^]E"'L-UI2O;]=SYB0AUN7;T$Q&6'0"@
M6@"+$&$CJX:1SHF3%H6<G0(7<PE1QRB%/93"R6]SH'VA5,H"3+PF\8 RQP9<
M?76S!T'DPK1U9I<<RQ")FKQTPD.*5SE8-TTI.M15*VU1EJMR.]](BNS/U?;B
MB10'6=36)F[(54UN[&'BQN9H(3>.;&3%_Z(;M3OG1MW'C(K#1\V*RC_2HF4Y
M G0%1;5$ #W[!%;:Z1)"?A_0RBY +*$U#RWEO?&L%=3[T!W!/4HV=Q8?"YO;
M;:528<XQ=\3_/<]6F4_#VY(3+-^D\;J,C1>42EW-V^NK0$57Y?2ATZ"0+3EA
M\U(()KJT*DK>YCLE(92$L"-"V)*?/R\A8-Z+7%&;12*$$]-O,P;Y'HNF>X)U
M%[FK?'9%O90'5&DVBU(N4?;@2D..)?V$=H4<#4*.=GT^2:P<$K=W'%A2 K(K
M'&B>76H5+:4+WS%V3]MAU=3.I'AV=NZ2>JM2RA>.B+4#27GLL5"IM4LA7V3<
M.)"0;X.0KS3;[5+&'QX%#B3CL80_O[-WUUTMMEB46<CVJD]W3YWOQV*CK^C@
MWU'E=F'.;-UHU1;@<FC^EK.2/86_'2:6I=3.+M5F16[/-RDI*]0WJ5#?QI*R
M8Q(GRTE*AA$QC,/$]A09.$:MTFK,#Q\J'L<H&4/)&$Z/,1PFUJDHE!;32O&&
MEHQA_:X;NRWJ*'+'CIXE#7WL=88M$DS;<).].=!)//!<[AP6Q4J\(O@WH*C'
MQF\':=N1L_YP2=..E6K8PJXT5#?K/F$E:OQ[K&.[M;W_95Y4X9:?O-6SRW:]
MHLGS<G^-NLME/;L*M.\ZZ#OM2EU-V;=I29D%OT$, ^O>_* [G,BR)8"%'V:$
M-I+EGA5>EDX%XK;ON1X\ OO9Z N*EZO2#:>?I8M\-<=CJ9^H^K.!?TD+2R\I
M_W)/Q\8+,F]L1WR$U\F)LP2"'7PR? ?K"V.GUX#3J[9G&2P=P)+-U8N_N29N
MKC6WN5?1XT/2>9,/47.9B8DK(2!5N0,N$0;F;A*0P>8 *L]KP34_&?,H3\I4
MZ@@F"(LX;84P6M@@ +YZ'9F#T7:!LG;;!-'UI4O2D1E/-K9\#OH3Y@4:A3\T
M):4/CFBL@&V+F'@52F*$).^',(>$N'N\W=?'TM@<<LX8@#@&]HH4.X[99R\\
M"RR4%6I?OI)QW$M_.:S[&;"^BQ8_TU[G@4UTTX+/KZ+-8XL2917JULXNFRG4
M3<1<G0EOPS6X2=/R=:YQK]$.8(GR*-0<M0G/F-HN<:E/%*$'_A"5[/XY60TO
M5.Q:=(O>!W7:][)OF2L3VG-MO(QIRPGHQG[B.O&$3#906\.:HK.^UJC7#;TM
MLZ'6;&I,5AK*L#G\EZ("]8B[1DX4%WIFYWV'Z;_.]2'L[9,^?M7?7+0+XD<&
MYR765->J6"V=!:QD7;6:=;Y'4;FM*E5%5;=2][OM1RTND=YS0D[^1AWM_'TZ
M^/'I!WHUAQ&()MLAAL:C;=+(01;^IQ6(3SF[?"*<!VF!S!<[H_WU0E_DBMA@
M;WL#XHY!QJ7G_,\XY)8F5&VU['.-IC3UU0+,W[I2]_:Q]_56^OIP]_.^(O5N
MKZHK1)SGG+"IU*]M@_IW+Q&5E7QIMW=/W4?IZ4Y"H%W=W3[>?>]==YZZU])-
M[[9S>]7K?)<>G^"#']W;IT?I7/IPQ9419GQ,09L4!]BRSB-K.;<6W+?ZW9OC
MXU(/+]<ZFM7%%NF<VGHW94CIUO-W!HJI>S?\SES7=JY-=S"V7;#[4UH7J3(W
M0^AL.E[P(3Y\IJ-1KJ7@FQF;65#:ZVMIKZ_-O_Y[M_/8?9SSB\[]'3_3&1TX
MMN?SC%TK9PONJJ7?5:.[CJW?TU/,<3JFT^%-"*_ K'ERL+_B0[?W5,'6B56@
MWN#3CQ)HJF-L& A'Z[UAPT-[8%).[JOI+3!Y@SOFC=Y$7]C>[<TL*@5M_Q[@
MQ5TPJSQVSY]EH@D]WYM4I:;:*:W_$-Y31D"7W%_F> R+MGS'):\9F)8NLTRP
M0,?F"WXRU ?FV,272+X;=704,/NO/[45N?49;$^.XF#T5=;9O+;MS:MGE]I\
M9EKDDT#[W <8.-FKU9\=1E;N[')Q6DCZ<LE#$:SUAP[6ND,DWPD>Y<[;MY8_
M>06[ Z">NI'ZV278R6Q^*PAZI?;9<\SIF)U;S*,/Y,_2A-[+L5D*-^%*']"<
MB;M-F<27*'&V]+$B8$/F/1TT6.2"'A:R/1SFL +C0P/_;AA8_"M8^FHC/B4H
M-/0]>]ERYKH(;V<Y36R*D>%WD#I>!F'@<:6 &\[I#5W+L&[>] W=/IG(Z#"+
MO:(S*@7RV:C(MXWO@TW'_#;NC$2*R(O>@I#)CZFMLTOOU4ZAN76VI11F6VW8
M%M@**12X! EKJR!A;&FI&!BN+%R/=G8Y!!(^1[2;PT4!3T&Y??9F6[P)L(G>
M<_%%)6CZ[,+RQ*7(^&$#!KFB1"]VPDPWUCN7VA?"[R@LQ4=)E#9=R?7[_P8F
M$_1SY;WY4)!$3_\D?9 _2I8ML1>40=@$G@UU?^P)CISY^)%.(LD>#'S'$8Y0
MH8C YY_I[P_*1[%6[&KKBIZ^-.' G #C@_=ZYB#H*6\Z !FT@7FT%( GFM:*
MG2[=(EQG6EQ!FCHH-L6^V>^IZ23Z'=.:\47X:.I3'.RZ_Y98,9>PL#*[#\I2
M(%3-(:X<GR)T#+@, :5/IV.PDM"B'\1"PB#%/<0GT$6$Q$YLHRKUDEV;V3B*
M&0,4DL>=N)>SL@#1@@ 9&PZY:,%'Z.-Q1>K['JUX#%B/,3J+?RR@0=+)B!0H
M^,R:Q9WX6ZO2XCD5:=V)@[T!EM.UZTAZ=6^2OE[+XI]I: @XP\WG_-H6MO'?
M1-O*N2TYDW]&.J,(:: @#,Z8LZ7EHKZ1(AGFY7PW8&4KB/DZ*LZ-_)%1;+:]
M];6HV2I'2A@2%3Y$=J[PF=; X6064AQH]7H_T.<IQ(FVT+D]//?Q7EBP1[B5
M*VD!6V,O3%KHB84 L=*_/2L)E>]B46^Y W'U>KX4L,RETHDM6^<# NMN^!/(
M'"&5?[6@S[:42J.6EE2>,E##8<,Q\4,X/F3*_ AC8@&T3H,+5>"M;VM87M@S
M?(^\ !3HH>T[F3RN &9SO95A-L<,82&\9AP%0&YCWP JLH32CT<X]9W!"$^-
MLE3B4FF@8YH)<P8F#;;1'8]T&ROJ&1IFJSSZ?9?]X0LU9161%[S6$,(:)#6C
MS:\-:>S;OD=,:6=A2NP89N"/]E,^OB4O&=% 5-X9_.&;/$0+MJ)K&D)H/8'9
MX0X9*J+Y&0$H\?5ZI=&:3R"H9OIQ$_ZT:JVQ@DM-J1[6HV;8<$RH!(+FS@CO
M!*./Z\[\BQA7"\R A,H3J=<FB*B8>HVZL VZ9H@(H>F-4T< #*3KSCP,M/CP
M]4;FHVV<&,1U5_+J9;XB27S"L$=1.^;9'(8^T9^%Q 4VX3L24*>#G[@^.J/<
MR)\J37D>!1]O@A0_<FS_><2M"LM(*-!<18?;7QFHX3KZ%,B<H9DE/(-IB@.U
M!MBP/^PT/Z-[KXAQ1?;@$J!PT-. TOHX_J38;IQ#PSE(0_.WR/FS+3K F.VA
M6Y9/#!/H5J0#_H$?"+,$#1IX)IP#FK'X"8 1PT^4S#,*G6>$$3CW!BZ^IUE+
M/5C7;^G#O&64R;4LD9\TR[A6\/HD59=@);006D>2:1$\SO_#'#N-'3? -L'O
MY@=VHW<'3>[-=C#'>=.V@/$;V[>\!Z#9<)'G2FR5V'^R.L]2_PP<P")S*9#*
MSAS- D-P<'J#PU.J@ B3[@ONLP M2S(G0<8.IV=/_TTJP8O))VP!0(A9".4\
MPIHXT:'X^A!C+_PAPBT#:&I/6$3H&+SZ^)G C OPO;@"SQ\BYNP!LV4X^DAW
MWG =E/0-S UY;#KQ!T_!;_J^"\3E$B\R?$HN$PN:NP<6HPIH %HYQ&Y"\ 'N
MPQ,L-@C9\U9?7.<O%GK VT*6)UQ"#7$+(QXPMSJ*_0#T+.01"#8Q4DE(H_V
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M:2FUY:4R!ZE!"!%M7BFB2@+L7FA(@,Q8GV(Q;\:[8P_I"X=-=-.*GA(6,=@
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MB"90Z.!X^8"CPF6_ >.LX"_=-P!'*I(+X)1P_1X_58#C"WMS<:-<^1;G8N+
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MVZ#^W<LV9:5\CMN[I^ZC]'0G(="N[FX?[[[WKCM/W6OIIG?;N;WJX2BE)_B
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MP8_^?W3+8M)U57JT].F4.7DY2<:K9K@8JI6914]1G=0_X /I'A":9K)RUUS
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MUPLCJ1[\1QS'8/KI $DRO$(]"V%.?LA1S![&JXT=W]]H#I:!9RQ8B(<%X3M
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M,*YB%,NB<7U2NPI2 <8?GT>*VN[ES<X4;K;8XN0<!YY<TV'3\VT9..[8*J!
MC&)9A()P3VH??(Y^;]@M@.#"+6<!!%D"@G!W*9V<,\LW"Q@0HUA68 #U)>UO
M] VC 7SV%%TM5EUS(G?.S6J?>#^8WL.GY2R.D</@F*8GR2F#Q9ESN\^<J\:?
M.7<S=J<_X</T9_:?_P-02P,$%     @ <X!%6HZ<5B(:'   6U ! !$   !E
M;G-G+3(P,C0Q,C,Q+GAS9.U=;7?;MI+^WE^!]9ZSVSVGBFTE3I-LDWMHO3C:
M*TNZDIRTGWH@$I)P2Q$J2-I6?_T"("E2? .AEQ@IU0^-+&%F,/,,@ $P '[Y
MQ_/*!H^(NI@X'R^N7UU= .28Q,+.XN/%P[3;>'?QCT\__/#+?S0:O]Z.^Z!-
M3'^%' ^T*((>LL 3]I; 6R+PE= _\",$(QMZ<T)7C<8G0=8BZPW%BZ4'FE?-
MFZA8]"O]\'X.K>;5##;>SM[?--[,;JS&.W@]:UR9UMNK-[-WS3?6VY\6']XU
MW\*KYL^SQEOTKMEX<V-=-V9OK'>-FS=O;TSSS?7K=\@23)_=#ZZY1"L(F&J.
M^^'9_7BQ]+SUA\O+IZ>G5T^O7Q&ZN&Q>75U?_GK?GXBB%V%9&SM_[)1^GE$[
M*O_ZDO\\@RZ*BB/'7>P49U_@A;.@Q%^_<I#'J)IOKINOKR,"S@Z7",".ZT''
MW JP/-KP-FOD7N<3L=\O^>]<T%7CZKK1O,Z0RBF;C:O7C=U*6MZ6+%G#F\O@
MQPL /8_BF>^A+H.ZC>;0MQF)[_SI0QO/,;*8']F(>\I.@<3/'J0+Y W@"KEK
M:*)J=OST P <8;Q:$^H!)T,]A^Y,U-:E =D%"+RA3TSH"2?G)=U(L4SY2V1[
M+O^KP?]Z]>Q:%Y?5I?IN8P'A6DERDB:0'GZC4H,R7\JK1BX)_ZL1T37X5XWK
M)O.,O>L0-QBU.D1T!]8AMWD4@2*C%'^[AU9CV]:4JQ%2*E4CO^U6Q"(BX"#<
MJ ATD?EJ01XOS8W5@/.&Z\^JM(<$5= 48G*5AK##RT)81714G'_86R8R+169
M47'^86^9#L2FJR(U)@@^[BW9]=941?"VO/B4(Q8Z#O$$!_Y-^-UZC9TY";Y@
M7_'NX4/41XS1/!JX,L-W.-A?OW___E+\RL8X00RI28F-R@M?KBE9(^IAY":'
M?L%@2='\XP4/ !K1X/3[FJ)7K"91D8R W8Z._\PD()>-D4+??JQ0Q(*W]8\7
M+H/"1H&)=-;?0G-5_1D)=O#?0GL;SE2U9R3(_NX5-Z&MJC@C,7U['Z_GY%/V
M.\#6QXL683.7"\"_>QCW2B-((38H'S&,6,8^^.E*_'<-&O$\IP$$U2^7Z;(I
M+KZ+K*'S27Q.M^J0."Q20IBR2V6ZW6:42Q9^&=FOQ*J&;V&OY_ YG*B)@H$S
MI%);-W=M+1B !(<:V;TU'$R&_5[;F';:MT;?&+0ZD\^=SG2BXN&%/$J0>/_^
MIGE]P[U^PFR'(K=/L (A+Q P.X,RG8P@95HMD8=9/8^!T"Y#*5S-ZG"!'W=X
M_T]-X9M,V?_O.X/I9-CM#5K#^\Z>L.4PDL+UN@RNF"$8=D' \@Q2=S(=MO[Y
M>=AO=\:3SK\>>M/?C@!8#E,I>&^J@Y=D_]\@$'"&,L?JQ^@_521(0;XY#.1S
M)YN!I&5,/G?[PZ_[!C#YO*1 OJT.).<*!-L:P=7N3%KCWFC:&PZ&W=N'26_0
MF:A E$\OA>5G'NECU[2)ZU/$_XCY<"PB3C5"8O)P?V^,?V.=5^]NT.OV6L9@
M:K1:PX?!M#>X&S&G;?4Z*M!49"C%ZET:JY"QZ/QBUB#F#2+F-8)OW/G2&3QT
MC$$[M,-DW&EU>E^,V[Y*:%G*1@K5^S14(3O ^$7X3$#,L4;XL#!Z],#Z>]%1
M#3K3(+ >=<;LGWLV*'PVQFI3@ KL9'B]O4KCE6#+FQ=C',X  &,- MY ,*\1
M=%VC-_YB]!_84&U,'L;!B*V 53Z]%)SK-#B<#Q",0))3C9!@ 1/KF,;MVP[S
MP+'*6+1+*+5],S/FA Q P*%&-A^REB\ZA,ZO(V,P81]4?#^/6FK]UVGK;[F
MF$V-((BBT4GG3K7OR9!*C?\F;?R(!8AXU,CRHS%WO>EOK/'SF?6(Z\\&104
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MVVO\-)D-YS4F/QI_)@-6L]ZS@>9*D2U7X%5.%)(7#R'Q HS<+>$Q!&'*6A[
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M_?#TW%7\SZ$]N2])2&F >5<OAO!,2!VOI;#.>,N,9WNBYY/:<ZOKF[?X\,
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MJK&]Y_K;=X"7RPXYJ9PU>7 Y)#+&I%%CO9JK,BNB^)"D;GWLL1' 7C6P[XY
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M?QV>MB@I>NC+FM4*K86VZ;T]4ONK9[W$,98AO;$H:Z68!T[>)KF@-7?N0X:
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M!I6"EXVUP7TX=E6#]WWG9:E5$ F5X@$D]_1><NO!NY2!%PJT,6H*A5J[=H_
MZ5-J9&=&W%9CK<30S#S>!^A:I68Q+')F$="5"$HK2?&PL*"3-#YP9V-S6_@X
MHCYE,O;"CBV%L:9%6_V\_A+)HO[U#_\/4$L#!!0    ( '. 15J6T%UA<*P
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M<ENB-]S2XD>+EE(^0>"%%%HPYHQF(0;=6#?6P-F]0O3!X+@?\?=P1/!Z])6
MU??A8MH+J*=DDN3Y2^%M#.2Q<@2OT=$V5GPN6M ;TUXMEF,Y4)UH(/B=[RBG
MT44E2M)@A:S[74$(/@G(PB6;"[>T^>UT)SE(Y6A(0@^[R1I@I+HBH@&6L(#R
M7) AI#@0*,V8-H*LHL;:\7TI1AO1]^!A7IO$B]N1P>B<0%[:S./1]&<LXPE>
M_-['\"=.C_\D>=#X@U&8?)M;8C2[&JE$,A_.YW>Y(IK,;);<@<$L26!>0HRN
M  MD7Q<6O>:^^5;4VW2>O<G[5*CN38L)\N5;]3..B)_9:<3@HR-$Y-31@LOJ
M)9XK&5!EG;)'+GWKR[(54 Y$>[83<0_')N\F8T(Q=^F31Q:#H54Y523)1'"6
M1T I"$D,0?/8F.SKT9\]OX\4Y'U*S;:4_CH8C2>#V;?%XO)Z]!9GUXO72:&E
M:SH>#G)-$SJF56PVN'$F:$4B2SQ$X);6'X5D:$7:ML$SE7,NPFK=VM#="O"S
M5YS=T75?U^S6)O%-J$>SV600SV<U(/CC>,5.)S%F;86!Z((F45E:[U((8'PD
MD\WZG%-S4WE3D+O7J1TJP5W+NE<&>SBYN07X-!;!?/ "F-06E$P6HM0,DN3>
MU.A"5VR?ZO3LEY_'B_,^MVY;;H_#9$2J-GV'DP^?P^3:=W2.91L3 \ZX F51
M02@R@T[>22=,"KGUO=TJ+,^>\29"OD^^;TW^SV$Z2.3?DPN45(92"@-%:PMX
MI6I\JC8\*;36M+[#6PID][2WX>D!\C<7<@]+^EU0+P?#<]KG3FT625LCH)B<
M"%80X)"<Y"A,R2['S$7KL_@54 Z4_<<(NH>S]W]B+4. ^>@K3L(G?'M>17-2
MYA"G)^>SFJ,_CR]>R$#$G$PJU> 1-:R$&W#!*"B(UE@9N0BM=_U-,3[[;:)7
M4I8L(EN'?'<%?+'DR4!&+"\:N.8!5!0:HH\1A)?.JH09<VL_9". N]>??@E_
MI'9M3E8/^],*L)>KYSW,Y(\QIEWT-1K&@RHL0 Q2@[9H,&6:2-[1\K0*XO>I
M74T(6[G__?M/=X1)Z_#O/52<^/#QY,7_^OO)FY?'[S\<_W^_O?[XOV]#VZ[Z
MQ)*G]UN)XJ'I]%>5PC)II"(7MSBDW5'( "XK!Y:YP-!+*51O%1S>]%25@CL=
M@K8:: +DP&LR#*-(!8K&4"*1;U+S%-:G4I5B$SX?J$JQB1CW797BWA2._W4^
MF'U[,3[[,A[1E]-YZK9/QLN "-DR,O&C2>!92,"LUL8J0SY%;\J^#- 3J5NQ
M$=&K=&9K@??A4]_&=)DIW 74)D4L-O&LEP':;3&+'HB[ZV WD_K.5$)B#C*2
M9VB8*@1N'GJ@/4@CM!3&^L";'[+L3A565+C8ER9L(NQ>$F//SL:C#[-Q^OTR
MZ3_8@-9;!]G5NCU80^H4)T<+G4%;"P(TMQ?N@=C#X=KVY-Q+A]E&LCTDP!_E
M/!=B&+X+@_QZ]")\&5S7>L@A.Y>*J>GXM.VQ0%--6@%],Z+FAO/FB1%K 1V"
M"K23>"_5-68T/\R+$^!+5&3AQ.A%!E^3-Q5/'+S, G0)(@CIC4BIL1XL1W((
M"M! QCT<KG^<8)B>3[[-UZ:+9>H26)&1&>]H/\L^@)+&T I5'"@C>8PEDS7<
M>NU?">80^&\CZ7X"UY<$<BSVJ1Q$L3&#M+(F@1JL=P3T)1KG2[*>B=9+P#H\
MAZ (S>3=3ZAO55-\B1?_?WUAM'P>#^GYTPM9O"?@K\:3/\(DG]HBC0PZ N,A
M@[*9@>>!@R'S)E@97&2M%XD-(3Z)F[9MSI[ZI*27TDI7IN[]D_3,&->:&7":
M5VQ:0!0N@U;*JT@;(7>M@XC7X=F];O1*YFJG8SLF^JBL>&_6))F+,F'O:H$(
MXJ!+L&%]=1+*2,:R)+-9%0D>0X&4!;>.%6]4:WUJ@_RP-6\/[.[&-+YXCTZ5
MSBD7(4&C4J!R5!"B5R ",S+*G%&WC@Y8">:P-:D-!ST8S7- KZ?3<\POSR=5
ML7$R&%]>'L]_>/)EGO5U_"=.TF"*^31R3S,U%IBH871*(SAI,B$VTM%Z[%WN
M5 9\T\5J(Y2'K4X]L]:#0;X"\3_"\!R7 Y:)RU0$ Z,3 39(.WLH%D3A(N=$
M=BAO'0R],<CO4LL:<=9#FM_:U^(];<630:J1,?77CJIXWN+LI)"H"@YFYW4U
MCL7$[+V )$,]OTP%''T+8HX!"SKDS?/"M@;]72IA3YSVD*BX[BWJA#\SDWFR
M B2+-6Q+6UJYR?TF\\#HPDHHKGVPRW:8OTN5[(?1'M(9+]Z=>GU#H#Z&/VN5
MZRHHF@E]8Y$P@;D>%N)H>E'C,)GLC:.EG5Z;FCSA#016-,BH8A$BB(S-5\9'
MX#QPS>N;N1ZRW8[R?YU?E$*BY7I8,SL_CKM"%S((%44!0<8#*!T\N%J)M7#$
MR(USMGEEABW@'K;N[8K''G+N7@Z^#C*.\O34FX0\Y02IV+KR9@W.U?)L/"<6
M#4.;36.%NAK\L-7C<3+N(T/FAJ)^'*\(5YCK:;RKI^^11#(=S/"R,/C%OOX>
MT_C3!57S+?Y4*?)DJH,32RRTH&KZA)R#EHC,1*T,:WU:V_><#ELWGY1&+%'Y
MK:\A;ATO7A@)1XF03\@G1Q0,2Y90A"'!18L04TR FK,H5.*H6VOK&CB'K6BM
M>%BB(VVO >9JNX!6BUS_BK//8YJ\1Q5IAF!#IHU:R@+1U'86+BJ52XP&6Q^Z
M=<'U'6E-"V:6J,_6%P5W:[<L!%.KQ+W'C&<79X&GEGN/)1AR9AD'%7* VF =
M7/5!C$\B(&NL01VA';82]<'/$CW:^B)@^1WI0E(5[8?S.!WD09A\N[QSG4[/
M:_?Z4QVX3K5!2T M03DGP:F:Y^T8$]IZ@;EU'[3'HSUL;=L1BTL4<.M+@LU+
M06'R/&MR5XT)CEX9&\!GY\ C4S;FPKEI'COX](MY[53=>N5LB98U+T]X<SE^
M6?L,U1G4!7G5#/Y^(<?3E*W$5 /M0LJU#AE-I 0+G%XA[17/*K0VWUMA/VR=
MW O#2U2U;77#TV1"R1@M:,-$C0B.X+U*P'V]EV",&=[ZMFG/I>;VMI!M).LE
MS&]]-+\VLA)K7X(4#3@WKY%5'$1?(\5).;W2: C>WF)<]Q:I:9*7R*L;YD.M
M(:4%.,,\N)P9F='HR()Y!I&:+:,(1?!>".LA)EZK>EL+KB:1:B]8[97NV\=,
M/!!%V+I&R<OC#R_>OW[W\?7)VY-7/__VX?7;XP\?7M8\J.'T]OO9K2K)VN>U
MJ4/2'7*CRB/O,0R/IS5EX-VD-C&HI5O?7"4.E*!2TK2]>98TJ%3O(*-4@"(G
MZ7A!)5I;,6L!;;V:I,^8SX=X4I8-<U%TP63CG2 G&XNN"VBVX&W6P)W*W"IZ
M;9H?O': M:O*)>WTX=XE>&/9[[NRR653VL54CD;Y335#CB:3,/HT'^(B3Y^[
MP*/TH7:#J;E:$LEQ5K3U%&NCJOL/8P^M/!W'VEO9DM;4COL3<?M&SNO@7>;K
M=0&XO++)HW1A'^5+>N&JNQYL(>B]:(3V+K.$O!ZGL9J2A[4JN@#!$R/\2H>0
MGK@FK*A>\C0481/YME8 LFQC3;6_#W21=<]]/<M*"C*O[>0,2Q"$0O).:K"K
MRC;&THG]!X?:G5_>$S?CW@3;,/MTCNZJ$^V\!<*WN9('D8MAA78]@Q84&@=.
M,P1.%A/Z)&1BH1/12QY^D+O]MD)LF(BW#,^E!G=!M-%^OG28/6S@6XM_#9=;
MR*[U"KT<6?$A)LXT%,83*.\41%EJ.!#M4]$QX6VW/7F';*[;A'= YB8B:TCB
M=#([O;JI'%RM_BHFG[5,D%5 4 4U!,LS;2Q%Z,R+0=:I<!0]_H;;3E]=N^S+
M1][Q+MN BW$S0;;>1C]^'DSRNS"9?;N8YG@RO2Y.8EUV!;2O$?&!,;(@/ /-
M/'<L&)$[OI\KAWBV/#:47,/7-./@] U^(B/A>@'"X$(ARQ\"JY8!EP9<9 :,
MP*0$2T65=;D!4TQ_^33^^A,]^N(5I0_7;^>2 0_-2MI6I@V3T2N46YK;!4>'
M JX/<[P_*VEK\8\;RJ[QJWH+#V.!.Q[K?;;(M IA@1KN6K4TIHC6H%)/G,,5
MME%O%&XBLM86[8=ZWQHF^6<,$YS\G9:<V>=$']\?O_[X>I06I=Y$2C%'3_-*
M[F)?=R(*VE_0""6E+5%VVD$[#;>[W70[*L:]RK&A?52MM5_'D]FG\ G?C,-H
M>C*ZWEQ>XC1-!O-PT8_TG)-RN=M<*CAC3%@103BR]I4.$KRP#+++7(A"&X[J
M5$CY =/X<>@.;8_>$4\-ZWVL1?PVG"W$\JU"7NQ8':!N4J[]L:JU'-YNS8)=
M,=Y%P1K2U=AEWQ2RX(QKI)<M&D5N"^::>U-JF<OL2PS*"M\IK>4Y:-8*8^49
M*-8F+#4W>W T&$_>#+Z2$WWI38]'"Z\7@\CD+Y.OJP1M_:)$B$4Z(%,O%:NK
M0:"[63MK1MF=D=,[-^,^!-M#C<]%QZQEF_9IR+0I1UX@2QW(-".C+](L08N,
MT5EK,VN>;;(&S^[C8ON+X&DF]]9'AE?]VGX?#(>8WYY/IK4['^;IJ;68,^<<
M9!"UR60F5=7.@RC(I8L8D^WF\:P>XQ H;BG&UFO\%:P;2])O).+I:<Z)^^03
M.5^6W# ?%'CE+23A@F JJ2C-9N3>'>+PN-U*B*UO5Q>H7H4T& [J5'\;T6/?
MC$>?/N+D[%X P:F-FL6:1(LZUOKDS$$D#PP$N>,FB9"]C1LQWG7D@U.$7D3>
M\'#Y46 O*AM^'+\[GZ3/]+-39I#L7C)]$@82TSQC%FVU67)*C*%.=K,5XK%(
MOEO]V8J2AB<<M\ ODTW-1*!%\4U]PD7*-6,RL2+(=<HUS8=K<%YHL*66'V0D
MM]+MNG&340].3YJ+>F4!TM;I(Q]^^_77H_?_^^35A]>_O'W]ZO6+H[<?CUZ\
M./GM[<?7;W]Y=_+F]8O7QQ\63E<8Y9KE\Z4J_18Y)ML/VB81I?'D&V6K+,9[
M-PRCV=&-0:\5E@<MM*S]F'G-?^/:DI>J"Q17O.,Q1^E;=PQ\&%6[O)658UV<
M5D>3,"K4P)@0M6B@)V-.9/+,-><U!="$UI7WNF+;509+8QU9G<;2D(I]Y[+4
MHZ7W=<N>'QPFS-%%J\#J:&E?3H)VZ!"A&,FL"1I9MTKQ#QR[7@VX_^N?EE2.
MMQ5IXT/W.8C+@[LN,!I>V=P8>O?7,8\4_EWZMI!<CT3&4 MEV @RR'JNRPS$
M7#OIL!)34(*Q;MWA]TW@FEN/MOQM(K#6MUXDJ;/SLX4B^:QS(B VQ C*Q  1
M+;G3SGD,R!%SI^8M#]UIW1QTMW<4CQ;[N(7,6H=;A#]O ,DI:V]]J@6X7.W&
MD2%XV@U"0*-H'T@F="JN\!!Y-P=]AN0]6F8]M/I:N;7_-L5R/GPS*'A:B]MR
M@Q*,2Y[L06<ARNB AZB4]*B#:]U0J0.LW1\%]&PZMZ9BY:N^GY. BT2TWGW_
MV\/LTMM?,\&=5*,00K%@I08I:YL:1 ^.#  (.FET)C ?6Q=QV7LUBFQL0F4"
M>&]KU2(DK\/H!"[Q8DVBA=G9WASZ)UZ-8A-]>$PUBDUD_[0\^)+(-&(2Z[)9
M0&F9P2=:17WFBG;U5(1J860^(0^^$8M+G?=-I-FCS]<%QN$Y[QL)?X7S]QC)
M]4BDC,9X*9! D#&LQ$6HC(7$L6C/I4^^4X6A?1/8R7EOP=\F NO5>==:"V&B
M)'.7*=IQM (?<VT.ZX7%0,L*MF#NB3CO&XE]I?.^B<QZ==Y%Q%",H^4_UE::
M0M>&2DP")B=D$4P7WBDR\'DX[X\F[]$RZRONZ]5@%$:IWA?/_8]3:6RV/FM0
MD=81E;* 2%MYK2.#5D>9Y5UO_:&8CML#/+4K^,>8N<T$V$/X[AN<3A&O<I_G
MH&KHR$EY4>M?AC0[I2U#%J0I8S(U=-UPB"5SL-%Y+;ACQ;3N9_$PJD/0BYXX
M:/WJ+X-W'5 RPC_"\+*)[:FS:+VV'+(LI-%"U-X:W->[.:VYD;34N4ZK0?<Q
M#T$1^A1SPRC1=?IZB;"J[6E.F)(K-=P\D)4I8PTJXPJ8XYFEK(SVK<M?/P#I
M$)2D#^FO#!'=SZ'MZ]&,C*9!'.(1S7$V#:/\RWB<_Q@,A[V?Y'88>Y?'NYN*
MHM&9[ZLZ*WPS^(KY+H)K[?61=J&H/$239+5;R(G(*8+,D2O!T0JYKAK!8][O
M+KC:G0"O&>WB&$MRH[DD[SEJ6GN5JR5Y4))7%9 ;P4MQ[1OY=D:WJ_/@YKJR
M^EBX*2'[/AWN(+^?O_T:_FL\>3$,TXOZG(DV==HE#/" -#]>.(3('#!5G#"R
M&,];-Q+8 -[^3YS;*LAX-T3U<,&^!NHUT)J>>IF2V@7N)L?8;?1K&=3='GOW
M3GUW%6O&VQ-0-\UB\=X(P(B![%Y?ZO6/ .W1)XXQZ=BZ"]B34+,5A_-/7<LV
MH:OUJ4.%=4;P\DE*YU_"*'U;-/1<'&4S&4PP'$2N 5%2!/"Q&/*)R:Q@/)K,
M\D.N0:>1=N\\]LK3N"\A]W Z^7$2\KR:PJ+8@=#2>^D%".$T;>/2@Y<6P:N<
M2TI<%=XI&GZC/CFW,1RF.C21> \[S(OSZ6Q\AI/W.+Q(3_L\^+* QK)B0L@(
MFCN:)],T3QL+^1:YQJ@&Q[%U"-(:.(>M%ZUX:'@<>?MJ.Z-5F<F:%A+J2I5X
M7:D<>!:=<27X;%O45'M"43:]^#R/%VH?S"ZBECO .+Q@FXV$OR)8XS&2ZS/E
M24=AF'=0#*LK$"FC9\9#$CXAI[^74HN:X$\CV*8%?YL(K-=@FZ!*S3*H:3_9
M@PK1@#>LMHJQ3GCR29@ZH&";C<2^,MAF$YGUFRG#O([2%8B9=FDEZB=N',C@
MDB-C(&?>R>U^'L$VCR;OT3+;Z<G*C?P,%*1BD2PMG\A%4\)R"+5:D$*CT/EH
MF=K=J? ^<V5ZOXIH3L<32Y?Y@,/R>C0]GX11PM[O6I>.MLO;U8>GV^@^]<T@
MQ%J9Y]NKN3LV.)L>C?+EA_Q?Y%/5BZ3C/[_07/!:4RTW(4B3P7!EH*9:D4K9
M!#DJGI)"6T3K4XY' =TZD&2#02]<&G)??6#, BI574U!;S/W ;2R26AF;,IL
MCY+9Z?UK_[IU+_2D5[[V?2\[/Q&]6A5>C+_BI!9W'9P-9K6(ZT7')I4+BRF!
ML4S3?#Q"8"* *\P6M"'[U.W0>?TX^SI<Z)G@<3^";GWUL!K:HFM:!W ;=9Q[
M:,0]-)]KR4\WWK<0[LXU@,M@L2@)Y."1+<DY>0>Z1+ V!Z:UDC9UZQFZ'^;7
M-:K;&_&;R+1]Z?(;!N%[)-NO"OD=7JR"B\PU%#QY6< 8VC]IN\P0DJO%=Z,W
M-J>ZM78BO<MH.^Y^UI:=<9^B;5VP>CW XU$93Q+6S>YH$@>SB^+K1Y\F.+<Z
M%JUN&6<^A0 H"^$O!2'ZQ "+3#I8XYSK5MJT 9@=:TY[?KMK3WMRFH<Q?"(P
MG^;M(?)YFM5C@\4Q%6,:&1(JRSD9XC9 K,5T)%="ZA*,LQWC%U8-<3!+2!LA
MMJ:6E+"&34R0IKQHU2D-S:-H,G^Y!V6,H!F2<:RS1&.<E";R3IS>?_;!D+FE
MV%I7/2<XE]63ORW0&#1"!%M[\290]28[)%'O;8KQ65B3/>M*XNU''Q*'6PBM
M=6'RJ^7ANB,*&:=<@9&H" M-*V1N(5IKHLC9N+O'9P^MK =&WS8":UT%_,UX
M.OU0_9+9X.O%#.^8#L)PKJ4W4+ >6-EZ@$^K.MB CB6%(IANC8,>&NE@Z&TJ
MTI45OA_=&W/\I0*\FOXR@+H>'27R*EEQM<8@2G"^U*3Y3'ZF0IM9MZSR+J,=
M#._-17N?>[/=7AN^C2?S4P13LC:6_ ':&6H"9+7;@@\5!6J1>8D=7^JK1WX'
M1Z:/$U]S@ZFBN%35+C@V.@B]\? ]G'D^4L#W.-I".LV=E!MX8@B.:XS@LBFU
MU(0D*(I#LIXAKRV&6+=#BMY96G<^V9BD3832.,+J72 G:/9B?/8EC!9VM*-%
MW^H<(=3P7!6<!)]";6ML;<G1D+O;(HQUR= [W@8?S<&XG0 ;GB2.PB!-3__/
M_]%""2].0XGSL'DP(97:D]K1W&B7+05-9-X7E=:%RRT:ML^?>L'C_.,UB;?'
M>V;<;2&LUJ_@9%Q/E$XF'W#R=9 NJZ392)9PSK4YJP45?2VK&ZL!AI&;'"-]
MT>(=7#+V85LQ323>\/3@!IXZWTM$TTO-[@*J8=3Y2B"[CT'?GJ/[A#<2<#_O
M_Q)PIKB2BZMQ?#&3<:$T1,P*T,C@BK VY!:AZCMF?4W@^HY(WT2N/<35_H(C
M<KJ'5^O=HD"?,UXEVL6B=:;ZW H\HQTI&5V"#<6)V+KH_'(DNPV;;D33N+F,
M>\@E_>=X\CM.IM5:I+=A?E%X=5!R=0_AK"4C!%B*$N@K ;3+<7"BD.VHF).R
MM18\C.H0-**Q[%L[R7_',)Q]OM+7N] <\JC1DWTJK+KLVZ[)4G6N("9$Z]6=
M>D<K_.;UXSQGHEN+L7$RX8=:B*V:L+_@^-,D?/D\2&$XW^"T0^V5R:!#09IQ
M4> "*:#A+(7(+1>J4T#Q ]O\2@"';_"WD7W#:Z<YJ(M0X9N0%DG2'4 UM/I7
M MF]U=^(J'%?4FYL^J\&9WR)?EXWD1M-"U69'RD*("7G7"?F:8=Z?M2O,?UW
MR?PFPFW)^.S+Y/3%T2FM4DDS5%!2K:&-48/GD8/Q(F#(VH?<Y6"N/NZ"V_KI
M!J\7P^QV*V\D[/'C)=4Z)//M>/0B# =E/!D-PE4-]6@L0P8R)7'1NR!HQLA>
MY$7*F(JWMI,5MN3ASYFO)@)K'O8X',X7E>GQGVEXG@>C3R_&P_$DY/$E.%\T
MX\%%<%AC,EU,X(O*P&JA?,=*D7<[+ZZ*T7E@I&=/;5-1MK2KY^O$R:EP*'G@
MD<9+EM0LJFK1.Y N!331A"#657ONMJ*>/&<:'R.IEJ?<=?B/_WF:ZV#&S6.[
MZLT8.0HNF0!!)J%$1L;\NI8;G8CZ^)_/GJ@-)=4Z'F[)ZWZUL'_$/T/UT_X9
MII_I![/Q:%%IPB5ME RU.2CY[9J4*CI!2[V3V8@42BGQL:OI@Z,_9\9W(_*&
M,71S%?WGT:D1.I=H"RWUF;QQ;CP$C@&*3E&;K$V06[_,_WS^=NR&DFH8\'95
MK^L\3O%?Y_4TY6OM8;_(HRLY9<]RAF2J=298 *<U>5;>%"PERQPZ73)O4D)\
M.93#/H)JR4/#]W@-K,7M: =@/95F7@EJ/T68FU#WL#IL(?<>+BI7 Q16<N0&
M0>=<S]%9K<BI#/B0A'#*,>=:%U'>L4(\4"YYM_JPB;C[UX-%R4WO,L,0(+$8
M065IP:-5-5!<D>'!+&_>8F<ID-V7>FI$U'KZ'R'E'FZL[^2^3G'R%4^ED&B%
M1[ JD2E4@^Z<)=]$Z!2TLZEPV;H"SC(<NR=^]^5NMI;_SHI\O3_^Q_';WXZ/
MWKZ\K'7UX?WQB^/7_SCZ^<WQVS"I:=%?MRGKM='SVQ3R>OR4&I7N>CF8ALL\
M.<)?>[#1RG!^0[6<R#2_B\*"N?;DRQ 86:/*JDCKC<^D)8W?Q(<P;;OBK'C^
MA?4=:H:G00T&<\VU3@BQANEF57C)C''!6K=]6H=G5V6VFNK!W26FF<#W73QK
M900A1E,KC6N05C.2CC7DNA='6ZKQ,D01<[=F8<\HF+H=J0_%36\BW)U%SG8!
M]1W%36_$4:<0VL<(>&?L2V80LV,$B==B*\%!Y"("%E>$8T4FVR*@ZHG'3;<G
M?1.Y]N&&7J"Y=(QLM$Y%<K(-_0.J=H3QD3Y9YY745BG5+3A^(R?D!H"G$BJY
M$2GWO(O'2K1UM,5[VO?#\!)(=(Z1Y>) 6$932DY "#7LQTO& D?G=7K(7;CW
MU.?,UW8BZN%5?#$F=W1T6>OJ_6#Z^\_??L91^GP6)K_/%Q]R=[FHK5A2JOBB
M3N %TV!SX9Q\7E=4ZX;M#V$Z&%.L%Q(:1F6LQK= MW@5.N#KZ7KA(6S[N65H
MR^B#ZM* CIVL+7=P:D6+I(L%8LVL5C9K"%DKX-QY9"5&G>U!J,L#=Q#[U99-
M6.C#& Q#G%XNI6]Q<5H>; E&F@A)UO-W%@1X601@H*6U7MP;W;H=VU(@NS^:
M;LO773MQ:V'W<#6Q1/VOKN&LM=$+;Z$X1J9LT1FB4P&82-I*%;Q4_2\15W"^
M!\OC4:)O&&&X$MJ-V[DNT'9E;^P[H*$9A0^IQI;RWX6!<0-B$L60!T:8<B"(
M/D0(BEX2GTH,C+N8?'CNJK&Y6=&[9FPB]CXTXK*SZ#V(5^'M1NLD#'!7\U "
MY_42OH! (2UBRDQUJHCTB"ZO*R ] 0/CL?2MZ.K:0O8-K8R+;FRU@^TEOHO6
MY[SH*(I*P+@)A$80&A,5D/8'%ZQ1F75:'QYL8W=WY(.Q(1H(MG$B;FU/?%)N
M85J4P>P JN$UTDH@N[]&VI:A<5_B;7R)M!J<$#E(J1A@#%C])0?.60^B!.ZS
M1A="BX:5.^9\S2723BC?1*JM$P)_Q3Q(89"/1OGBX^3JYD.@QA(Y!*?#1>7P
M*+B$6!O/AZR487?NDE9<.*P<8K>W#XWD/VXNO%T< [RCS:U>E7Q"7NM]<!2"
M@='*T@9%NAN#<D"VBD&;+1DFK;N3KL.S>ZNMU\BA9J+O02TN)_J*)$(P"6.:
M_7,P^[QX':[2K&H#5?HW?PQ_GMK$R&SA$81SK'HWC'1:";)N9'8NZ&)<Z]/#
M1\ \,"7JFZC6N\BK<#88?GLUF$QG+\:3\2A\'4S.I^]Q^F4\FN)1FKT+WVH4
M&WTK86W6>UJ<,R6Q5(L.\5K CM9<;R/8&*WS6D04W3JR;#ST@:C*#N3>ND+Y
M44J3<\R+@/$!3N?IG>]Q.,"RT/,;/SV56FE7HRU,5A$4SPJ<D048"P&M<]JK
MCL4(-ASYD'2D5ZDW/*R^C.>83YO4=?SI0N0/JOCMO_)_2<=U*"%5NURD+&I6
M*H)'Y2$G%@O-)XG4K2Y<"S2'I$H[9Z=U$O_"2J=W H=(-AI6V_TH?ZV9))=K
MY8NC]\<?CEY\/)7<)UN# WUP-2C)D*,7> %Z%\B,RR;9NQD]:QV@;J,>DKKT
M)NV5^;Z[S-_YD#YC/A_BN-R6X'@AP9[R>CJ/VW^^S^-$L*L\(!%8Y%8A,%[U
MEOX!LH<CT(;F$CE:S+.#R@,J](IX)AP8*S0HD6AA%1@@165Y,FA0K2L]<;!Y
M0)OHP49Y0)L(_,GF 07-@U!2DSAB L5,A!B%A)!R]M(+&T2GTZ!#R0/:B-2'
M\H V$>[.,D&Z@/J.\H VXJA32LAC!+P[]AT+*@8&PO&:C>\3..L0BK/*F<B8
M\2VN<)YX'E /I&\@U][S@(1A3-+F!FA%J$&N-+W:'L*G)+FPM<(D;VP*/,D\
MH(U(69L'M(E$=Q/7>3NLF3168^(:(L?J53L-H5XX!>5"\L4G:5HG@3_+W)+'
M;.^]D+"/W)(N^/X[M^31C&Z:+? 8.O:16T(KG(I"&<BLUFKQKMY:(@?A'8\8
ME0BF]POC9Y%;TJNV;,+"SG)+HC0QALC!AEKY#RV'H(T%24@)DF<I?*^Y)1OQ
MU2FW9!-A[SBWA$NAA<0,5FK2_)(,.,<<<*M*X:)PO%LV_+O++6EL>3Q*]#O.
M+>D"[;]S2S:D<(,,@L?(?\>Y)5J8*'B1M0HP!R61750!CB:+S&7F0K<NF/B<
M<DOZTHQ-Q+Z'W!*5?(P1'2"&1'LG(V\[!$E+IRM%UAJ/YKO.+=F(O@US2S:1
M_0YR2S %:1,'B4G6@CT,G/(<N([%.^]U,BV.*Y]);LEC+R>V%.SN<DLZ@/I^
M<DLV8:A;;LDCQ+NSW)*$-3-*:<"<%"B.Y#P[6XOY*%KL# _:=TI/?UJ<;YA;
MTISR3:2ZN]P2P3 'KQCH7-O7>5K":)X:G&=>"71<I6[1OT\^MV0C^7?++=E$
M>*U+DBU0+6P%;9.+08.-F6R%*$E?BS& PAJCG$_L;NG9!WC<-7DM1;V,O4?(
MJ9^W\&I*":M'8120H1A U=8X,>=,1B1+;EZ17W1KU[>O]ZU?RAXEI]:!\HO9
M??A],!SB0HE0**TU&>8T@]J)6UOR!64&+9B.PEN4X<' PM6//Q0"MY%:ZVCV
M7\,H?,+\XL;D:F-6K.4-!?VA/!GP+B<&+&0RYJ,K],-N'-Y]]//?\+825NM5
M\]UD\#7,:I0R:>C)[#-.%NM"\IXG]+24<P\*C2!0*H 4W(I<4G),=V)PU0C/
MGL@FHNOA>OPQ274LUWA1;R )P4'EFAJ,B% "BA ]MS*V#JLXC.S';8)N^R9J
MUPG7(?%<BDE@7#4@F$7PI41 +8V4IJ3<_C3S>25<;Z,MS42_<@O93U;)44KC
M\ZO4S7K\UWM"R>HA=YE+TG'BC=)(%J.]'<^P1A"^&8?1C:&O==3&0#:_H5U0
M1:S[80$G1 8;4I$F%.MLZW22KMBVCNVXE/U)N37B?#@:]M5@%$:)%MSKH2^/
MH[-GQNL$F#@9:+(H"!(EE"1,L#(D%9MW.WL<U%TEH_2B3?>B0W9 UU/(5UER
M0.JB3JA8!F$L>7/1QFI"JMIB74?ZVV28'E:IL9UPO?ZF:!.9[^RVH NH[^:F
M:".&.ET;/$:\.^,^AJR0NPQ!9PO*,09.AP(F!F=<DCZG%JULGO1-47O*-Y%J
M7S=%BR+:-)3G*H"-,H(*BM72F63$J\)48%RJO$GF_>ZO%1I*>LVMPB9B:GX1
M=.^T3LH8C4 //-8>+D['>L>10/*DLC.&\ZX7"T_U://QO&TEK)XOA)Q"IH4G
MGUCX4ANG)O":#-,4$UKD*<FTR;7"X9#V>#&UO@]:>:)JO2C>\0*\U*:W(03P
MQ13PW'D>7!+1E$[</?7#Z$>SV$1T/81-WS_D^&4RGM*^GK)SOF3(S)&:\<0A
M)&=HRKR(XH*0L763AA50=G],N!/GN87@>SA /AH.QW_4NCBOQJ3SYW%6SH?W
MH;XXGTS(J3[-'@5CD8/1]2;%64&B\($0*Y_HQ<BJ>7[O1@ /57=Z(ZF'&.O[
MP-[B;(&M..^C2 (TJU?C444((9$1PC19CBEQZUK7BEF'YU#UI14%*PV*UE<3
MKXY>O__'T9O?CG\]/OKPVWOZW]N/'[:X=UC[O#:7"MTA-[HQ>!4&DW^$X3G^
M'(9U,?CP&7'V2P4U&'VZ/) +PWF1Q7F%L_"ESFMZK5):<:8+K0DL!S(]D/YP
MV7!(DIO$E6$ZMSXVWQ;SMHO1]?C?EB&X.+/DKJ@BD&QJ+1BHZLIZ)"-/."Z*
M-<:PTGI1ZH)K5W<'.]6KNTM5<X+V?8&P9&)7'_\^P DA^_SM#7[%X?P\3?M2
M6T!G($%Q4%9*\#(QT-%:6N<CR:YU FLW9/NZ>&BO$*LUKA4Q/5A15]!^Q3 ]
MG\QU<WH?[R(OJP/8GA)>-P*ZGQ38/AA?I52]T;5W';/6!%]#\D34%I26#IQT
M#C17@7O-)/K67:2?@&X]D$/[Y%1K$Y;Z5*G7HR_GL^E< N+RY$LS3X8"E\"]
M\K6^=X$@3 "MHE4^,E9$IY3*QRC0?3B[=_UZ)'*5RFS)0@_G35?VY.O1E,RP
M*H/Y&\*29H9' 5+S BI83C:DCU"4L3+J%&X4>VZE',NA'*[ATT#T/81'?YR$
MT;34^^5%&3V:[4E9@G9:,]&GRW]T^=9TF4M/AE#+>>S)3FJA(.,GQFX/FUS3
M.2E14#EI(6&A.0E=:SOFVE>3NVQE0M>\S]'3U]2'K*ZGKJB;D-KZFIW0G$_F
MV\=YG [R($R^O1G3_H&3L]>CKSB=S8$N;B.MCM*Z !R+(<,T*(@.,]2P^"02
MTG_=\L(V&77WIM?^R!WO@ID>[+27&&<?,)U/YKUY_H[#_''\:YC5K[\=G8TG
ML]I3Y<5X.CLJ,YS<O*!Z,<$\F+VI=YO"*R1CA4,J@N:04P&'HH"L3>>8UTKK
MYIT!&N#>HVNPCR/8G5/=1QY4F'ZF=[O^[_A?YX.O87C+N7HYF-:S7W*Z3H,3
M*C@G('.-H)(1$# 6R(;V"Z=4BJJU%]H9W'>F>/V0MK-TJ@\?:T+1^Y<_'Q^]
M/WZ_Q67E\@>UN:7L ++1]>2'BWN3]_BE+AFC3Z]'93PY"Y>H+]7%<*^T)75!
MQE3U7SE$(QV@-:$D*ZS YG5;.^!JE\BT9K2?OUW^\,*5IW<ERR03%%MS#Y$L
M5I>"!%3).F^*LJIUBN\C8.[J$K*Y]JQ.7NJ'HGW?.V8<G+[!3V%X/)K5C7O>
M;2(S;3*MF#YF"8H'#UX*!LRRG+4S/+BX1L6FF/[R:?SU)WKTA7;1AVNE6C+@
M_I.5>N)VW$;&#5V]"N4"Q:+E1 <<'4Z^'N;\YJB[/:?:6OSCAK+KDTNE(M-2
M(91<DVRL\A"9DI!3*":CCY&M"]1Y"ARN.,'IC<)-1-;ZQ(7,XU$.D_PSA@E.
M_HYA./M<(_C?'[_^^'J4+AWZ[%E0 0ND3%Z](ML8@B77WC'ME457%/</68K=
MA]N=*[$=%>->Y=@Z^^CD2VTG2OO*#?5%907G\YP 1KX)\07.908Z^9II(YW4
MW9I%+WGXH6^H383:.NOE#IY+K>Z":/G^VHWN?6RH;<2_ALLM9-=ZD5Z.3"?#
MLO6$# ,M)CZH>ALN(!7-!#.,MI]NR8,[9'/%UKHK,C<16>/4[*MS\P$NCLF9
M#"DIVF*D]::6V2,TBF8H E<9>>;1=HJ??" G^_[(.ZY;V("+<3-!MMY6/WX>
M3/*[,)E]NYCF>+) E373R(P&RY4FCS\9B)RT.&5NDF5<D*78Z?U<.<2SY;&A
MY-H7,<2O@_'Y=(F:H5&!-(WT*@=2LR(X!.DX%%V$L&AT5+$3H:O'>-Z,-I)=
M0Z-H7@F"K+]/X1/.TY5.1N_)-C^>UEN!ESA-D\'\5J#>G)Z4=Y,Q">1RZQ$Z
M&AZ5!>.CK3:A!6>\!B.X<BF;HD6+U?EQZ [=N-X1;PV3E-<BKDG:"Y W6I)T
M@=JP(,^&\/90IF<'C'=1L(9T-;8B-X4<:!UW]<"AF%++ <=(RV[PP$,(!2WG
M2G4*37T.FK6N&-#35JQ-6&I^ (BCP7CR9O"U1A5=F /CT95A':1W5AC@%G.M
MF"0@"EF QV1S"8$%WRW$:MTHNZV7T2LWXSX$V]ICN:SU_O9\,ET&+2OAO4\9
MO-5^7KH?HF$U3HQ'S8.7.G:K;;-^G$-EO9UP6[_I+\+9E_/I/4C))6:%4J =
MHT4NL@"D?QYR2EX$\L+"W4K+*_A>_OP#Y;F!,'O(1ZC5O6='Z5_G@^F%D.<-
MDG*)-F1.[G,]'0E6@[.ULRX+R?%47#:MXU:6X3ATEZ49!_?UXM&=XU9A6O0V
MZX"JIXR3Y8CVDSNR/6,/J, 6XNZCR,UR=)*L$%8X@VAK>3VO$ )J Q)]D60$
M&U%:!Y?N4@D>2,O8E0YL(N76!L!1)6 .:8+Y<C.\<8AN6-(^)'#,DVD233WU
M(TN%=BT>HI(EE&['U6N'V4/5H@9$C'N18FO#OB+3JY&AER&9 !9U[1=A"T3'
M%,CB3+(^^9A-9WY7#G,8_+:18A_OKUR)+!5MM,L.,-9RCZEP")8L6W(K,K*H
M3?:I,[\KASD,?MM(L77P1D4F5B(+*I +038I,ZG42S$+L28(8G+!,!6B=]W\
MM+7#' :_;:380PG3>C.&_SHG1^/X:_4VOEWVK/?9:-2E0"B)@W+(P)%K"K32
MD,<19<&U49./"JA?#N5[<=-:,'%?070/"G+Y0G0!UI.SMA+4?ORU)M0]K Y;
MR+T'KVTU0"6$*BDJ<%+3DB:C !>8 YV8TB+5,*G6Q8UVK! /^&Z[U8=-Q-V_
M'EQN:SXJ;0(KD&C-([/%<_#T)TVZ6&EI(<30N@3V4B"[-Q\:$;6>_D=(N:%S
M5P^V7]2BN#CY4L.EZEGV16DNQH) &X'5P$A5,^Y]9@E4,>23<"\XEPUN=Y>-
M?>AF0A.9W]<!LXT.T%3/)^ESF.+1IPE>)#7?@;B(X.H LF%@26=@NP\IV9[#
M\:X(:!PJTAUL$-HQZ27X4"$R3_ND,K4(#2NE(#=*M8ATV[.6K D/V9.2;"+W
M]I?!$_PX.9_.:H+255!"-$'$VJ2%U60V62"J:"!EJV,TDD7>+=ICR<-W>PW<
M$P?CA@)L??C[!NML)Y,P^H371:6D2<RE!"'% "H3-&>* .,+:3;7/-P-_UK!
MZ+*G'[H)T$:L]WFV37E>E)?K &FC%*_EX^PAQVM[!M;QN87X6B_)*Z I*4I4
MF8,QN7:L<YKV(1\@D0?CG,XL*_?D&%V7Y[430C>16K\YU;^&*>T[<YC3*S\R
M*".K"VDM;36Z7A*Z@A Y#X8ECDKD3I0^--*.TTE:<+$ZJ7I+039VR-_725X<
M,QFM;''U(L&0":&=HOT_%[!:!L^T2(ZUB+&^&O#0]]W'2_<^Q6YKBA>:U@%&
M2X_Z>NC=^\R/%/Y=^K:07&M7^ 8<I;6U(AB(*,BM8\*1P5\"2"Q9F< DD\W>
MUCX)7./.MN5O$X&USG8A29V=GRVN;J/G6#,2N4^TXK/(()H:G(463>2TB=QU
M3Q^7RW)ST!V[K8\5^[B%S!IOD+^&/V\ <3I@$%R#P5JZWP4++C-#]IV5*@8=
M^%V3YW'DW1ST&9+W:)DU?O/>3<;Y/,U.)A<5AR]6$UN"C;HP L (CZBQ3[HX
ML*IDJ5F17K=X 9>-_3W8/%O+_+X.^ 8Z<%UW&A=5I+N :F@,K02R>]-H>X[N
M$]Y(P/VL $O I5B*,:4 K66UK[0JX&EG@2Q++H0NH.K42/=IL;[&GMH1Z9O(
MM8? @E_#*%RX[9>X?B9'>U'0W20;H[!@F') +K<@#QX#?1*9L*$+OM-%\P;A
M!6O@['9?;T38N!]I]U"/_!ZTUZ-$7PR^+O E$80P1@%&)^HUAP?G?0)I,@J/
M(<:TKC1K$VVX@^D@56(;N;<^T[P'[N-X%H970;5,9V\S%"/K6JARS9,78&4(
M,AJ50^AV1+UNE.=,<5L1]I X>M$-X55(@^&B])I@K):J)/62Y'BH('.-A#>0
ME6>6_J,?MNYJ=A_%H=O]C>2_Y&W?OBW%+4B+$B@=0/44A+P,SW[BC[<E:RWW
M6PBZ!Z-P*3;+(^TWB8&K5<&4)VWW.2K0H<0:-<-H0WJVY#\0:[P+[C>1;P^<
MO\>OXV&M6G(;W**"A=$,+5D=+-6PJ,P"Q&(99*]<P> R-H\V7PMH]Q''VW,V
M[DO@/7@#;P8CV@67J#UZ%75 VNZT0E+[I"$P[B$%-/6202C7VCY8A>5[L1*:
M<+%DQ=AZR5@&[$UMS#-95%'N + GN^$A;/NQ(=I0V4$_MJ:AAQWF09R6Y^0T
MO22&J>KI"E^C@2+$' W/CA7/.MTT/'DU><#:V(^6;"+]UN<,'R?G@^GLYS#Z
M?;']!7*WO4AD4V6L5]@&?"%8%CD*G9T3\<YI\ZHJRG>>O'O#H:W@QZVDUH/1
M\(\P&=3=[GV879R6RR02UE9[BMD$RI#FNDAX7 RHR#3RFG=*,=C@A;Z+X7LQ
M$K:2_9+7>>NSI9N %LG]'2#U9 [<1[,? V [FM9POH6(>]CJER"K]1F0^0A&
MB:K<B9 YKVJJA&-.)T9+WC,E_8'MO&_.-Y%L#US7*ZR*YG(/,CPQFZ, 8W2M
MA1@Y1.LU6)-28CK0%ZU/"FXCV/T.ORTGXV8"[6%3G_=9QGSR%2>CP:?/L\L6
MNZ-/%>*'<9DLPI98D%%C!.U]H1GK#-X;LCUL"3%C8*GY]6!':,]>(?J@H(>%
MX-TPC*[R*$-MI5PC([BWM?]Q"1 35AN7A8+H+).LL3K<'/][,?L>+?,E_&]=
MYF@!9I%DV0%.3^;>;23[,?4>3\T*CK<0:X]O^Z+*:3%"^VQ 2F/(]>2QEO R
M$#"C=(RC]_H9DOR :=<7QYM(L]\\MMKF?O:MPEN$H]0@<C0,BJKA*%KRVON4
MK!.>LO/>.UVZ%:1;/\[N-^UM*%B=OK:5_'HPYX[^(&A7M9)"X3QPH2'I2!9#
MRF0QU(!SG[QF0IM2NL5V;_#6W@+PO6S3CY?ZDK=[Z[K@'SZ39E8O([\8GWTA
M684+F5]E<$YIZE>_\RY\F^?KUBE<SV.4[VY+'2;55Z&Z'N:SIYKDC]>3NS[#
M4^&XCV)H?<S-&V.M1P0=D@.E> !G;"9MD[7\:]$:S7>KMP^547_::KL)M;U$
MUDQGDT&:8?XP&Z?%70U:5[+/C'9_0]N)B;6D-!D96'*)+,GB1*=\BHTB:I8
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M>!C@,7VU96T1QS]Q\NGS)>87WW >/N'?+[!<G;^>%#RC?4T*$0OX0CZ'BCI
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MY-T>] F2M[/,1KI\7@+\93:?S_ZL[VSA*_WF\OL9#_5:E6FB0RI07'C::9*
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M^A,O*PA4TZKZ=!]G-:1D67(UYQRE%XYL^>B@EFXFR0D+)3!E74Q%R-))^X9
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M$*-P%'/,4\!:!?B!B992B()5*I"K+W?/@?ULDE6#+<UHM# >)Y1W]V#TF7G
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MYAU/^3__MK[UOM_[K>_[UGK]9NUU][GGW+///GN?NW]W<*.X*>""AJJZ*D!
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M=@QJU1\FYXO!DA0BWF.'Y>SVH/M?<$",+X0AZJ,1PJYEUI5FC;T<!U >F>"
M3 74R0X.F%4[%EVSQ3[^<ZP"?2"\>9MR)1GU0R%E8O:X(;!"30=QI6\7TIQ_
M[+XQ/TR21=SSHDBH 3%;BTDO+(Z5K5NV9PWTV:W=_?AB%G3>$0B,,GK+LZ/V
MC!OT;MLLBQ!0AK$_-6J+6+M,HBKX(8N486 1>N%8?7K!HGR9AD>Y5#^@$X%9
M,;_3C4AC2]R&5-TZ:1^:_'WO?[#3'4SD+?>PE34RO:Z%RW_%KJ%V,'>0!NF\
M\9?.1X-+"SB0._;#,2H^%4-YIFEW?>0BYU&F\N4K.MF5]1#F/_6HUZ=J;(&"
M($4N1YY%@V)E8LE^^'#R15T5AN3W)<ODGGP9X*4M82->FL1U<%8]S.\N4N#B
M$#N-[^:+-C^2(I&PZH()^<]OF8BO9"SH%ZQ12RN!/G3T?(W*EL !L2.NFS33
M;071I=U[$QR#LZ#ZQ&A2T#>'PV;C?@@UZ1U_!<.QM1_*T6)3)S1^FRN:M->/
M3=D9N7Q*Y9M$:"P2]I[JLB17LO5]O9Q*<+!6/(#]7"U<$Z440U-4RX\#K#$L
MV;78:HO#6 O,0^BK+06-V=F^B+1;U565$;,A7?4,H;Z;SA\OO<0!D7%/H-LM
M7C,UQ4)2$<7["1+/!2NK$R0Q#<HER["39MV:#'Y^_Y1>&YNCUHRBW.PW3HW=
MEYU=LI%7Z.AU58!_$(,XLQZ9U@N?.'& I3KV;I'MM$@0#L J>$05++!^-#J<
M28GRYTJ$[:DJ,(R-'_-M)G40+?ZDBWMV_^;"+EHZB,RGV)"SK4&9S>07]FYQ
MUMV3YX]>#Z7WVZ:.N$XY1]85/"VC(S<OJQSX+D\5M+AN6 6=5O')P/KC,_*[
M$Y;!U"(D73CZ;8=E@K/6&\_CY5F-1JD>^AY+M8L:]_JCU#[7\=5:S;!=%3H!
M6PJ#:=ITLM 4&Q8$]NG7-M@;2KQS[UU[*4><=G<H_.@=X?T=&8Q#C)J>XE:%
MXA,:DZ'0N=+W2 %T[V-\'J3N% IF_UTN%)(79B.[+57H[Q 83W)OY"?,O+KH
M7&):&@X2SK3\LNAH@]06U.A^J:)NDB'O4S(5B\YSKOG\_>C&J'M%,!>J /&^
M87BY]\='=^KYAM>W&O4,!!'<%G;#7@73)_S&$>U%2QOWKJS4^AZW0Q8,WJFL
MD%IUH9^_-_WBI2B=W80:"B+UL=EW-X&TO4H/9F4 !3.?.,8.!@$.NK6R\"*J
M13^A_ $HZPC]:\^<@84,>6*?G=HY2:-,\P#&S<"W&A/7P7M;\T09[RMR#TQF
M#CXBRG\X[U^'1.7H.C.Z-RA8-YATZ)H_/!;;]!<#C59S*W2R5-&\%V6Z?8L%
MWHT(+-<<'4181]XIQG8=Q?(A=[HL@N\+)!.Z[;VVQ:; T6O0O<"@RWK#!K%+
M],;<FSS#Y>^'$;!A:=FM(W[DP&/U=W,C [+>+2!*DU"I<S_6PG6%HD$=%"N2
M.(#TP%^S?53RE5WYE_EOQ]MF[02ZQ]KM!N!.S(P]2&C4Q^S>X"BEB."Z$B+B
MQ@1"_F$]M<04"NF<9+K$^49U$?9,_#BX)Y"35;>U)I*!-#M:OR1?FL)QQEMV
M^KF^Q<5'FVBIO:"WAJ2&0[D!""H* )I<UGS[0&U:1(KZ)&,ODG2SBQOT1;IL
M'+D4RY+H%3E&Q4OF1!>:'YH[FFFF=6V80ZY4D&8!V000 @]T5>#Q9FSDO*]U
M5>@__OTY(,V[KI^>1&QPD_XT0>*3@C9^#1% Z'5-H@6RD<"_E5Q; [W>%@-/
MGBE#\_W('06(YOWEY^6SA=L$T&<_$NSA_#S5-FB&=\L6S &\#UJ5/7FGV;*B
M42>4#%WWL9]=SB$J*NV9;%$*[[ WA^E:^V.W9/*BLJCG_!48MGN^MV=<Z-89
M<W)"-TI_0W4;\HZT_63ZMN"5RPW:Z11K[BSW6=9T3-WJ+A0IZRNTPR38'$3.
MU'X@&5X?\=[G%4)U%N. ]TXSJ%],$-%C"L1F*0ZHY!SM.]++V*I8Z12:@QYH
M->CB &62/!P0K(.%P$$16.'PRYXE^>_:^S@E$7;*KX4',HPK5EB$?FA"HYM$
M*Z4=.WY8J'/I(607*W$ OB"JP?/R/HAA=YR>''J@N6.S]S\/R\20-O;_E#1Z
MN01B/98)N.L\6_,:OL85TGRPQ%<?(]$Z?K6<*5!*KSJ5_;$BS9QO6;)A 30T
MS06C4?"!6P]_5+5"D *9 /ZHN@]D%D>$G(9@0)\OV>S]-K@B8K#<X%YY^P.Y
ME'SB8J'H)S/M3VV>Y2PK*A.&\)DG0S#.LSK4Y@1[@?#.VSL38I#>XI;5_A2T
MMIGZY41#CR". 5Z7N.5KW>V9=!1)NS&R/"*\JQ0Y15<%#U^X'>9\K56QKHZL
M5-$S,Z@"/!7M2H\R(NY?K.IX8?Y&^#Q%:69&9UXOI1>_'J57;#QR^BI6_$!Q
MR'UOC$_AJ>YZ*64?:EQ>Z02E65,C,PLFPB:EEM-;-41;([/8YE"FV4U!@TT*
M*^YP%J>8JKKT,"7S\!FR,B.]@[29GML,+PSCI?L,(@#HQ]KYV-RW@S_2K57E
MS#-TOSDP>@G5[:U?=ET1#D:DN;-DM(F2VYL]'<_6^)#YF%GBH,QQ_BA&=6\M
MZMXWK2L*WK40T]KY9/5C@;ET>_Z-F_MIFK/8-':CVU_XDO=\SU_:6KD75K39
MU3J2&\5;_?K^DRZM=AS WN.+9N@2OFOO*;T0@X%6.BTK@C?/%[O[EY@K^H4^
MRX0^;K-2Y^Z<S_/R4M!D37%BZ)V;7)U/S!,QHQ#(CN,\?77^O>@INT(J0S1]
M89'MJC'(C&X#CSL2=1L+;<UT=L16SV?7]F:Q)E_=$#_+FM%^."!44=1.D7.,
M>")&=G7SC54H_UB=4?=@YC.W\S1H3[TV@X+AQ=6<&+0F>N3EWIO7GE1/P:\[
M.#941 *ZIC#(\>8POMC)S?%]G5X6*2B89D\KD'SZ)]U2.O^7Y]OJ-28&)_-]
MW>&?D;N+,YPF]K7KTYL&*VC)P!BK@<RB/HV0NAE/XE-BF7M:#JJ4?)S;<$ X
MC:TK?X2'784S9T^KH(SRR?3:?26FV*>H+$R5=21?9$X280X5?@U<#7(SHBU+
MG/%.1N\WPZ)^JMLU&IU\=W;8=#56"_)AYY,B6E_6/\QIEV]G8VN6M;BF/*R*
M YJ*>&*FXW*2F-FT*5ZWT(]O];%Z)^. 2>?>5ZF[O[]+B/ZE*O^#:)!HD_(]
MID,V.F4O>Y<2EV6X7_5SBHPX7O%KGPZ/PHSZFDH6%Y3(%<]NRQ1'\XO$Y=KW
M6E \FEO$:%<<T,Z8)9'X1\DYVS.CMDC>BN  VXD<5)7CA5C?K<&,'T+6H:78
M3PTNGM_'Y&V0^]+-MO6W,Z#WDL]/<)$>#C9O]/DYGY#"<<#/3CQ;M!A<\9+$
M]K5Z'>N0HC%4/@6Z&^G%U76P&@5V<) 1>UBC@\78^A?NCA$^[J:#Q]B[JBM[
M@;7 291)1/JD0]QQ*"04<\DC^$&Y6, G!S_,TX:[5C/?SLNM,!*41S[D3YX8
MJ"KI:&#>P %MD\2;=%^5>1OG4S-X6UUE#L,+J6,=1QS'/_2ZH9I*^_R>+D@'
M;9J$_A7&SW M%7I#*VD,T[%8?X A2B#:Y#MMZR85["@VK$&N#40EKSS]PM;?
MIO[MFB2A-_N4&Y3E5TI<DKE&71AI(3?DDQFE=EF]!+*)(LG)R[:-AX&'-D3V
MB;J%X<IWZ@:)&;H^[P?EM[]OC=,D-7_8P4@--P%?<Z-_,>:^X;<KN <Z6L$!
MZ/M.MQF,UXKF#+I6E*<'-XN%R@:QEWRJ-?F[!_+2C$K,8F9WRFQ^?%SN568;
M:HB37B[+99E+Y 5%LNH52 =HM/E=N<5=F%LD@3]<CRD$\H#T$'R\TR<[?RSM
MF;7PQ"R6I$R6'_C/H)4(G;._/5)@R^$(\M0 /^^H>:]W<+?7 ;E33Q.<SE\[
M#I\<'](I6>?>F*GKD=A#E$<4#569V.Y>$-!92)F4-AU8]/A ?-\"MH%,'^]<
MWMT;F]"4\[L9BEJRT%EJI@C@SG_6E2_R(18E1Z<VCUP6J:RGY"%WM*6Z[N<4
M3;$4:\&_*5'&?.][&_?\FB@^\R!.^6R"QDGU7X-^@O:'A5Y_4026$RRKM%0O
MNWZ[ '?NR_/_QC#$2LW;5  #CXM/KFZSB4X9A0MW5NV,2!74U3N!#M:I/7\A
M@AL@><%[6NRC3HLP<QSPB]$Q"+D4P^(RSG]/;"=KHXU6V8FX;JTZ3#H\F\-B
M7J]?Q0'^7ZO<@LRKZ+([>:VT'06%UB3YV8^_+JPWD$_[#XNX9XUU?)\4IQJ&
M-9,W@+C7L5T&>\K!YFD,K_*TUN,2<K1^TKO83HT\Z;JX)Z,:R(,#5O1S#N2F
M=AZ=A*GNV4N<"-5E%XSJ80UTAA9Q@*#T@2+#@2+-X5,5?NC69YLJD89+T_70
M@]W^1S,XP(O3+/&NH(L9CUZ.EA.],G5:58,E1XBD[F=!9#(@2Z6K8N= ;Z!O
M;C81_56'WN)GC<6"\3Z>YWY[0NM9:EK$YM7T<S[EA0!Z#)QH52]E5T:W/0MZ
MLF8<@1F?>_)DOO7#8;")?H#OQE<-#5,+C>N+Q0U8FS<^2$U?[DO(S.IXA1O(
M+=2!'1LA-MCTQ3P(!S!H1\WNAZ<KH?.7:5$_Q6[3?"H*=$!M7]SMAFZSEZBX
M7$,P-W"ZHV1WUQ KN8\0SR#]2UB)C?5"TM$J?Z,^I;[7^$_)432W8>K;>$B,
M@]X!+*;N2GE'?*9/FKF.JGZ<-IKZ!KZ8G_M#_JFHZV$F0::9?-E((?%0>H-+
M7[J<K(6'-RY'TFJ2/7E0_=:..G(1(QX^6Q#>VL.89>_ML.SR[NHQ:* R85;T
MR;?K1[ <A6CC]A5C817^O;C><@/0N)JOBBO-IG?+XJOF2O4]RH0[FILY+?U7
M?U9I8S^=U]DN6%M"@$'# IC*V%_(K8D,U'UV%-2FLN[5\C4<H/&^^20S]Z%J
M6@[9X537U56LDJ%;6[^%7:?Q5_F@_K6=IZ%ZQE/G<T=Z9,,_9C!./M\J"/G,
MGGX31GN8<.]MUDR/_]V^B5VSE^[826B2I7 @9*,D=:!["1-Z+5"GT*=>:>!S
MU3K:[BF")C6O6?A'+;7F;'CHZB<S'<7=<-B-YB*&[:B.+=:.U86A6/NJ'N%
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MG(X,E[0I2(0-&LCD2+H%0QC.V_6P9LKZ^\ ?BG]MC<]:+LL*/J9V&<<!+3B
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MB+_Z] Q!X5_"!EV^;,@)P F+<<0O[#2ISL<F3S]6CJVT!W'TVP?^UAM2\C^
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M$YGR<4)WI[)?&\EQ)L^B8_TE#"Z,2T;WA94-! X_L]%]^NBXCI=J5'WT OD
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M;MN^,*U4#?5W)*+(-FG)Q\\ _Y[^; $+E)ROC373JP42@"7QB*EQ2]RG\=T
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MTGZFJ4PL8IXCHN;3$N<4FRF-72AQG\?4:@1M0\O2?=\B+S%OK.A%-C01\W0
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M-Q6)ZT2>6WBU)*E;=S$%-V/_"(GU@>Z=7Q_>OG"=FFIATKP0M8_*I5N5?JQ
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MW2 XE<*CF3 .6%?(L4,].-6HP*6H]-[OD@U'R69?C7ZR78;<8<C QM]H=%U
M*OPXF5;(=?G:<JE:>>3%(DPM+,92O:'#_5W*VS)CK14P@L@EL_^0UQK0R%%L
M'0AKS!0/X6@A!3.?EF1K.:)RZ%OAI>/$?7Q,S?2<08Q<94P<'L)SSN[V'6S=
M+DF'G$8U K3*Z ' *%&D>D3S&T7:/+X /'MAYE)LVGE[6<@C",>KLO*SS& L
M' <H<O: :!3KX3(\B3!I\3TFVEV@SA-^>]I]?-KR\T5.J_/W.U[+GQ ] 1&Q
MLT8Z)X9GQYL:91S?\585@^LL3(70IHA+$MT&-6B5D(]4UU9<SB(<U6X*Q7_
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MW(A-ZQQ#[-*Z0BO*;#BE>;QQD7@*J"VF9[(/\XC.RG%/MR"^2+)4.V9[S4C
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M@3^KK-:\P.R)@&6/E,QQFS-*0G01]A%,'[0.&_.&X4@W8LBUNYD.TC7TG9Q
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MBA2COGBZ[+WSQ=H^F%^CZOE>[3LWHE;.X+K%4Y!52([,.F_7TK^@2C"?\/C
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MSD>.H8E5U"=S2;&\+D"<*]HL:]1\W&Z66KE<$G&Q\^&Y2''MNV$O.I[+=O
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MD9[RUYX F4N)TM6O*U!7-B]C6I0GW E8*N\0HS?"N:CF )1R#:[6II._H5@
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MQ>V;\?#P+=9V' <#&5Z@B)9'H)?04G0B"I]E<+J"]+'K!?(,/!MRTL]F%OC
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ML[W,\>TBZ'2DHH!]^;\MEL]_E_\N_UW^N_S?"^IHXO\"4$L#!!0    ( '.
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M12^=HT?7'_%$\0/YJ $(%_MP)HAL2TG"P[ CY%I*?" >G2*I;IK[Q>FRHT_
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MD5[S>@AVOW::7D^6X1R*VS3L1MBDWDP]^2J5T;?P!4KCGV0<[Z1ZAU>1_V*
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MY3[)B$\,B+\)?4'_PC=W_F-MB=1G3^N%%I_?IT\<..?RGUMR-+UJ5,4>HQC
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M:Y:1M^A"^-FQ4B3VN9'R#C2!"1)""-$\B+\H;1OR@U%<@W^=GA\M+?%[MSJ
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MX:&4 V(VV8?B^89VC[),<#+GN#[#?W'-14/.^/*R@,^%Z0^#;A;Z[D\X:7*
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MS9!68_^-(HUS,^=>.='+G$(B BM,L9HG3!QF,\4?5@A*RA*K&,?U2>)X"$U
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M%UTO"SWM^?)+ _(K"79U*3LOI_R!T:?%O23AP*IWP>>\/EA+IYI?+BN,-.A
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MK>4?GY4(K(ZDP^A<N1V6.*T<,,]B72BS1#73R_G)YB0T_TR&_(:@1Z,3=?)
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MZM9<YPM^=8D<$Q5$1/(O?QY=HI[/\EY;@WA<BRJ1WPN0!_G!WF)KA4G("N:
MPVD]GHBA!\"-UD=/GKPAA=6)AVRRX6FE Y>V97#:OF]O_W3S,W YB'SJGY,B
MBFM?B9[/;+H#.Q&VV]R-N'A&=7R'VD!A)XD1-0K=2%JH:&4Y^5M#HX2*4X]9
MY8S$+3;QBC\SD>]8S,?*=SPJG56J'\G]NP_"?*5#Q)+;YW6S'JGQS;_&EI[K
M]F=9K]6%'__A9R+_)98VWDNEM,W GB.?K(]YW@7$*%<L1DA;JF( @B/ -/?P
M'4_3CN3&;WX"/X]?21>?^<L'/M9\ABQ/%V4IZB-M@!^%LXL8&P,WIH2JN'3=
MCB3;Z[1?F]),O5YY.C6#MZ\A]9G&>/,^"!!^YH/@ /3(;[/@2L7-X7Y>(A6?
ML/X%YT+5,OU12ZOZ4S?UY?8*]T&'B9 )").#G<:-&-T'57LMD#S#B.;Q,&ZF
MU/*?>!\,D$DP3NI[I?TI4;3S!"$_/>C)U3NWI1XF-OB*E.^#7N#)5WP ^8.S
M)$9SNO"?41'Z_.43 (SXX@%EODG[Z^!*:..[*/%!>_67HNKJ<1^ECWP;-6U>
MQRR6<Z->Z1_DB;G#B$)('<16X#JL7SV4KD@MK[L$7-0^*(R0TY!KMP_R=,?E
M/1X4^[%F^0^_T%<T5#[C_K7+T0B;#I9-(5A/'H<ZH@!Y\XZ5_G$P(3%XJ--0
M_^L0LJI<'T:1;_<LF7:OC;ZLJ3UQ)D&WQ8@#YO@TZY\6Z]>,'"-0L%7$OSDJ
MCL+%:+[!#4Q._O+@V/;FLT \,?P8_LJ0',5@E=\FV,HT,:-J,#^!H[?QF4Z_
M5&#J6*)$&_QY8^PLGLYK2^5GY+.@#W*2'DSIQ:%(7G"_<O=Q;#LL-ELU::Z&
MW)^X7G;+JT*+2_:.L[,^P9Y-]DWRKW9&L1'HS)EKD;K#BA];/YX"W1GXKYW7
M@M1 U]'[H20<)6NJTKC#(-QO54OD.^-HB& 8.UW@S*]1)HL.BCQTW&E6\*ST
M8T[16:RFR@J%VZ Z(C$CV$W33=<N2Z9RTP,64?[QSW\4V"D@((6#J[[O_7(X
M0[:*WY: W(YEF%$SPV0;!_9!]927;62MK0,<5K&B"YC.8%ZY0[K8*99)#_9!
M_U#*TSS$*(REO@G6VT5ZSNDI88Z_<?JL/M\V\MI S*BU_(;/I!>DC.4)H#/S
M9MKFBFW4!$:V2QQE8;F9:^1(Q![QSX(W='T7\]GP8&\.[-\C]JIEM_.B",B4
M/_6&7\+5C8XE$TNM-7>SK4[+./Z5-/TB RJ1Y@M>4]H=?<=7J/[VY.^$O4DP
M9&'45K%"2SB[BC;KTZ%1G^<:']M1PGAH 3O**I</.U-42K.DJ\/&%F:%L%@B
MY,43JU5<T!WG[2FM\Z6&YBKZ(?=>-1RJ?&9*H@UBG7LTQ+4](V/DHAJ==XI'
MH)IA6QZM-5JZJ_U2C'*D"XHE7A!B-;^K40D:BY_'OKQ<*O>0J6W(!&PN%YZ7
MKIL^7#&Y"1. 6S!BH&[[H.AFYQ'<<[QU)4J>Q(0X^7^5^ F2M5B[#0YE:.5_
MU3@G^7T^0,*ZMG@*.C 5_L?0\P)!O.K"IQ6SGUJ0>^NUXQ=+0Q_0O;)%O.;<
MY.-3!Q+J]69*)"ZQO_^ 6Y%OQT1 CC6KMO=0P(3YW(\W>IX'.VZL"83=?..[
M-96P.T2,I?.5MN$Z35E6#>%U_?+R[X?<"N/Y#O0EY8?JJ$_?=C O.Y^F.%VQ
M43$+[U\+1<@OC,6"7 #;'IX1R[G"YH7BR3&*EN 25@#JM#XN3)#/\B.:QV9:
M:5O\S34U@7A$^>S$WZP$[[3BLOQ78%JV8!BWX8TOO@B/KD[BTS=E$N:N#CS@
M*C/$01HL>=W_: ;N=='T#V&K]D'/TV.E6\9=D&0^O57/;$#-93RH9?WXTMKY
MA^21%X]#!>LN,92*,)-/?XX&J\KN0H:"-6>C/J W,#]8-&YRZ?]:O/I?O*!O
MS0%%:B3\ FO>"@-UQ6^HNWE*865.S+ .\5TZ_!>NWY(*HPM7M:P34,!9G80
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M"&:O6_WK@XGM(^M5G-1!#)@#S-B&YW1U EIT*>4=4(,=<\Y[@T*,7ZNS+ P
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MA)#M^D0KO]\R$!_UZNM[(- ]W2673(I)C0S')>FHU N_Q58-%2DXHD]T?6<
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M*[8I^>9PG]]USH*-B:ZWCZ%T$0.J)B-O"PDHLY3L'%5JM/EP-H3K[QZ()^F
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MKU5FHP?7)W.I-QDHB"<RNAYY< _D#8G)"8BB*WIH9[@LB=T*;+T7IR[3_&)
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M]-T7N\!5T(X+4I9(P!3NHB\=.AT0]A9UJ[IT.PNCPS1@]B'!^P\6 JBC\'#
MIASP)E<YB5^K,S;K/_?*Q[53DU9X9AN]+%)CZ(%'<\!-R%O=T<T1!"-=EZ%/
MX_YCN643W8\"SOSU_7W(A2),?MT0M^.N\X4 K<[V*D>LH>0#9'Z@LZZ7EAN-
M ^">3&%:!<T"V8:!5METF7\>:Q4^6T'&.>2J8";2&24V:D_JRKNED35":1_^
MHF.,C5A2J17:(-]><[:0W.$+X:O]LV%'$Z,[N]^3G.),3T11/=--H?G>$J*H
M>1+&ZY^L0+ H/CPXD&ZMENUNWO[2T85BAY?O6G_6F$VUZ;*)1LB26]HB/N2L
M)>E\2-T#50XI\!B-I,+2T=EYYUZ^G],>=I-Z,>?7N?^Z?4WZ_Z^VMFPB454<
MI&":F24_H$,S!$J<&W+%=62'Q<35'GLO^*>BB<2Z0I/64_"7[W[39*=I:==?
MO"<)/^KY@QY2GZ0QN9L8[PQO>8PB?5&)8J)1JN+<<KE%)T?6JWXY1:;N1YFY
M7WGL.(NJL:'SHZA<C)P<G -+V1A"*Z93L2Z4VD0XH?MD^L&R^]%2%_C7).#=
M)] 5O9]%C;NUE\UL4\(#]D!/*Q TR=KJ&6OKT>S70!-->;_(*/*>^C3/\E$F
M'URFV4W$>X=N5U%:,\S_*++=!]S:'?S< DNKVXVG22!9A*XI:<NNI\21U,M1
MSZ?^WM$;ZK,.*)S&N(;?Q#V*FC7ACW,J^RMV_'9#_*W(TQ?-CCU/?/KV 8CM
M;8GCGTESMCL[,+N/+>7C-_TWDG$1 PZQ;B99U=LHU(YPD!'O17)_BC]AG?L/
MM3$BYHTR=UY24F,G%_^']G>GGGY\&P0"*8T*.4X6I5<;L0BM^/3?'(KY_Q2^
M>;BD>"EG-+K1O:;D0BA,DY0SM2R<KL]1J'SPR.YX#-SV/Q[$C#4L3W>_V -Y
MV1PKVOC]_5'!5'VVC.YVXDUMLY0O/Y[,"P\\;_=X^' >?54+.FO)O-/#EU.;
M.?"4'L&"%PM,K)2\GQH<3$1+A=V]M >RYWY?<ZCOZ-9-O ]DF^R8"M0PN5\,
MOZF=/<RH]'Z./-1:@:^20U2;!WW> [4J;]U-()>1X[C'0[,DU2_-[6@_LF*+
MSB)#Q(+1^PTMDI^B '.(+X;]%R^!YE\\W_IX#Q0LVQTPL-G>N >*@NV!_(MN
MJ3#5Z"II#[]G.XZD1@%.8HR:=Y^]OAKJRQ?)8DB+NZ\-:X[L0IKI-L,LPVL*
M-VUBWE5*22' E?/K=_,+%;M_3JH&37'0Q34HC?,OPTJH^>2*5TR9DC\-NGIS
M]9LBX>B)CPIQ!Q[,A);(K\CO.L%4V]50\3O!^'7@K#GAQ_LNX!GM)NQQ7*BU
M>#MYD@GZKHW+AQRC!L2AR $E=$%LF[]$ONQ/N@NQRX23^TG'#[&JW9NR$D^\
M6W'O6I0DY+&?0]<\WC$"U!F*-4[XRJHISDWZ@ )PG<:)Z :S_4Y8(02L#N)_
M*2WS;CDG_'EH%8*A4A3\D)3EK<<*Z,"D8\?# H<B$U;3K<CG9(ZW.2NUL0S@
MXG_93?@_XW_&_XS_&?_- =Z;_%]02P,$%     @ <X!%6DY(A$N?Q   A=P
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MK:&N&THEBQDU<T2'[J7UB9ZQ*FBF_BOWX(H8J1(;&!6BB27D=6@RRUF*C/O
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MJ._H[12D-/8K;AW*RK2!!+&^%5/LSU#Q+'YIRA)MZP"4,,S,,3WT%H>#)!R
MB."==.ICTEJ45^0*.KN5?$ELN=&T[<<F@5ES "+D^]#>,NL[Q%DS8$HSZN-
M-WU>'?_/WYD@0W"P.QWTZQPH,]/"@1^J/H3(45O-L%WDS4N58[97&I2/-%];
MMO>HN;=>GC$8I?N^\3W1WF,R]1F>'T.>_Y#4!V[4Z0I-!#?H,.2<B> GL&/W
M$B9-C=[[3V>\NVYS+EW[LHSS2*_#&2[QFE,.E5>1MVSWWF,ICJ&/B_FPOEA
M,W=CJ9HUC.0=9Z@^J%[#F:S)2">2Q:?Y1&CO&H5/IG%#C57@!?Z'NN6VKQ=7
MHNZ& @I?D^A>R.G])+)=-7+L?E/BS]R>Z>D6@_*DLHV6"0.!,-/4J>:=?D*9
M;[^8S5!/98\@=@[*XJU"(PR9E1NH(#1N@H:>1FH#!1<T%N59$_79II4.MCWZ
M=?:F'UC7E3,-<.\)ANY'JX-\F]-M=RNKC??6(]_GIB])3AR I*UN_Z3I5N9Z
MK[B422EO.?V\UC*FTH$LJO@,$6VSI_:0H SI>))Y%1$U%VH'C-8 5S[;H40
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M5E]WXQ)EK,+/OO_FR.?QE0<+Q:AO# ?VND%9"\6'[T$!39'>+5E\@.<).GA
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MV62WIG<>^K92 T*"X<,LIR5*,?.5:?&^0QSL,MM-&.LL?&EIA2&)9S.21.O
M 8B?I<&X!)B\14C7456?(L412EA#7%)JZ-O&%I-EA>MM@PK73PXN-$OYS3J7
M*3THJ$)U-<-XHT(!I8Y<MD]OLFC95 5_'.Q91O)$OT#)//.]35I=\Y.NUEN7
M;2UC_$Z  W_#YK=8O(64&=I7:E-/: 9>&.6/DD&<!+HH5189UI2FWM'#=;*Y
MM<YA)SX]S=Z1C,WR":J0%J\*=<&!S \QXW?Q\U@67Q]Q:Q[2#Q;\.^UIQ8(H
MOP4)0M%;TFB\_'&@'Q^0U<,ZT=B8QNNM=>IUOZ==,G]B\)B[Q4]Q0M:.Q2A#
MO*?;7/\ %!^-L&/SZD.J--F&JK&SQ).Z\2$*(KTP0DK*[[E9SUHTY+G2FMP1
M,+ Y';SY([F3D,"!#<'ZH@$52"_XB:<<D$ \ ,USTG:!//K%>88598A"0Y<!
M/V\WC=<T[-GXY)VH3_[72JE23W%0]M1KX3GT"WTLH#]/;,?V>*!H$=/L2"L]
M ,E@1)Y(#,?&$442Q3VK[T=G5-I6*[052C%:^Y/GO_#7=A_K=S_Q\99( _OT
M5/!VLL[< &MP,_X 5!8^,X%9@=6I;I!+68/XNBTVV\RA>EA*S=.GVCB)FL?Y
M9YS;$GQRR%IOKC^I3NW.F7\EN&1F?U\+).E@\?^@76YN;JIORMS>)BJD*.F<
MJCOK;,&IG&P*XCGWFF<,)H&<P5-@D%D1FFO.2L]]D?1R((-DS7>Q#'X\D[2H
M>OQMVQU1M:_GQ1J>E45D_RFDLWNVKB%LDVM_I=\8BW?>_P D<.\&'Z_^4Q>Z
MHZ]9T1K1,/[7F(6LB-O^S=8G.]5#ZI;%2K ; 4 (:QVLEQ<>;95C=,QI)7/U
M..IX+CYR;V  )=8AS]#^YDMU[1T]_FOQ^#@)TCZ)67#4-+FW9#JDJ9'QM<,6
M8.LA;H"=NKX(\4SWH^:&-^%?]^4VZRB&6<J_SK+(/7^B1XH#[%$F$ G6&<0-
M8(YD1$7UZR2W'(!2,%9?HT1$UW8\+Q_:D''QYOE(<#6"^<53]GBXBC2JLLBR
MRL "RZIW"6'9;X])*"EI'6J&--_0Z646 $T'(!YWP'OA1P,@1E> +52J?IXT
M]2!=:E)<#PV5RV.H2.T,]$*!<U@6_TG2-+Q-]C7#G%(-VQYIP(N,A)\&DPTF
MMT]"+G'BL,:_T"4]E H1XDSK>0C5$U;@_Z?:Z@A56)D^A3L "97^41JM,?V[
M[?8;&^1[^$@&+8D<4.EV$G+JOF5\^5R"?,&;1A=(LLJG!^XL_D+V>?+3!0]6
MR$U4=>%(5C*I-34<WW"Y [LB1;CG6B%8=:J\AE_4\T7&'WG?G;O356WK(_N?
M83_C3F$I#BA [=1X YI^#^'%_<P:FGR_)*.3CP+AGQYGQV\E6^4M*++,(,'8
MY- 9EGG;C4@(*^T.FJND 2XHF%VHQCY'DY$V[961VE*EP^ [ .7MHI^P#[:
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M?>3%Y#?NN.&PLW2RN#HROM*,.SP?+(OJ\NDP8*@"/!149XO'UL8$ 9IZ &K
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M,/5H)[+[7_U](J$/+#1I4W5RB"M\?U)<YQ]6K^O<"'HIIVFP6G=IRFJ^Y[-
M&=J>4%&[.)V'Z@)7SCYF@SPL!;:NY(I]/UK36!=UOU8W,5/#@PVJ26VL1']>
MH.!9_-]W"N->L4%P/G3\65;FK">8=Q%=\\;C2K[W=6&9!(\?D5NIQ1O5N+D
M_/&=JKBZ=XCCGXZNF \M;:JC/!9R9::;NOFL911*"6KA8FP0Q]/TG\<;H(G3
MV#$!ED0M:S\UA()I;2A*)FO&AW0:U3@0A!1?/#)'']FP!F?XM?8OXR^4;&6Q
M09&)^'M0P!L*'&^J)?Z;EA-S8H-:3KXIA3\/:[N]N3KU(?S5"[/EFK?>!J>^
MX&N \M2L3V>AC1G,CQ3<R[(BFTS:F4G5^5_[G4(]F\)8/,T<EH:&@;'<X22.
MW;KN.'C$/QP\P^*?)5377PX>_.3?$&$WAU>+XXGQDX8[F@M!@SXE"-_\]+U)
MP-,^+RC<91?';]TYDBUURI0DW_H/S874 7R)FI&3N_M1XD@-2LZ_:*[C_R/-
MI?8OFJM)"L%'W/P?@,P0]C"BM84@P%!'3\&E?&@-=LF%-_X3')RD8J)08(3]
M-2H^R<#(I]!+TO8OS;6^H[FL.)KK^RY8#(QBTP>HP./POFB1+LH J;#W9QJE
MV[RAMS#?_4Q0O0TUZ+[^<8/.0W1\:-,];H939)V^UM25W@[U=UZ3A:9EN+%&
MK/':0REJB/A=AES&6M]DB<*R4=#:WXH+QAF9(:K?#JW!Q2D =RE?9Q8N W<+
M)]Q_#GV0;AA_BVBHDSG/U>,/_OB7H)/^88R^]7M$!_9LFM)\,Z]['W-IPW<#
M7L(4^-TSIM,Y^V)KZF3JS,NFWPWR#0H_4'D<I?TV-.\_''+@>IWNH.!(3$[^
M$2F7UWS]K&"8).LIGLAQ\U4 LQQZ1X 7:3>H*>;BI^KV!O&"Z\N@.B7ES/K:
MWJY'BXJBC(5A#B?<.=!L HUJ.@44T>[^K#[@")1<90W]N!U,A#D=N/S.T'6O
M6GB9,<J>3#OWP4\L785O\T7(-WS+>M9Z=0%G_Z*R27:(U7(%!R]\0,,TFGRC
MF;F)83:BFGX8BS*2T-91_[=+BF\!=++N$Y2$U[4%E-9@;UGIIKE?RKY,5H!$
MPW&EP]:CM:HSFF,?VWM#R3G@YA/F](^J.@TY1FQ0>HK.$,^XB@>+QW588-K_
MF]:E6P6C\1]]X7?PW[Y0]>)/IUND60KO>9F68ND^MA7X$?*4@D]D')UR@M4@
M+-MJ;D3L2J>KMWQ0HG</65;LKE9=J_RZ3;_28+YT=M4I-/],DJ?\\:_A1M)Q
MZUANU$\.GT8>K>3[Y&UX>P*Q6NVP60-=>'5T;4/I#\P>0]D4O;K:8GO=I3"?
M/C3 $$CN9ABW#%;Y/W\)0\PWS;KCA1??S4*4&+* )?5#JR5Q)0'&KPT6^7/=
M(SB'S*\H]27 Y)28[4V!NM\/A[,X+IP,A)?>JZ'FQH?F?T5XY;-!EYZ$39_S
M7Q]%52_(BE/[(AM]?6GX_4!6][4K=Z.J_YX#Z@DOL.ANG7W7>@9W]5JM*U99
M'2J\="*TR2K[0GJ4PS?F609Y@R$0 =V!"CR-#^CB0 5QJ>,3I=,V0RW2I$&W
M ;4V45;N\%Z"=7@ZT;00%;:3 _<=7MJB."U)XEL0@="GHU<<[\ %)G?N$?XX
M.I[6Q0:Y*RN<9O):N>9RQ:_U\&=4S6*\%H 5(-?U5G/]0<C*R*IYHS8# O[,
M,FJ21RH#6,J#MDJ$+IG06O:@5;(*NJ#=)^C%0=)\O6]=MDZR0/M-^XT%JCZ)
MIP63B))$[V7< GQ> 45FJ?I5*X)>)R8OI)R-2G/@6CXC2L$OJ7/0\Q>K&2:!
M^E'"D,UV!=Q*S-,M%YWRPXI6#$=__D[G8K[8F4GX&ZZV _Q.IN(6S9NNJTQ)
M>B95(B8&\<\XNOH:;X3>69M9&AU0WX%1[8<<&.7P!YW'"'5XR\$5GP ;85;/
M]<L^)-Q3*"_D.%**JI;+#]139ITI'64'D;VZ;9(V/Q\\WD'1(LY4PG/YM+K7
M#A/X;<U_+*PYX;(@JE)I,V<"RYX6'M\N@UAZK'I .0[ __,_2W779CH7JD<2
MLX2APP!A&J(JSMH'YY.<X^U9>4 R\%QOR!'#V(@S.K,EHC(+*AO_*__#%"O]
M&27Y(NM'H87K=2]-^]?0((YP(^!&M%@2^:S]]-< WG7  "/(N()E"5F8Y9Q8
M\#H651$/G5C=_97'O>XA/?I5?]4GW0O]2U4NLAVJ3N;Z@1$_1_?P)IO$B5J=
M(W)DUD/>7'S.2>!K9K3.&\6PWEJ6^>\J:,$J0\8 SV7)S_\J96.9!;?N@!+S
ML-7N&71A5@=4$.IE_N<VW3ZF2@+ZGIB]Q]G[P2'^EQ=#]H;*3220+LAVX),-
MW>R'#(Q*7'Q&IQFU(;7#FOZA0?KIH87!:LMMJV:WS2!O\!YXXI+ F$!?$T5@
M48OD:SW]V#*.X2)MR?#HJ:V(JA@7J+YDPP8]%.N\ (L799XA[35F9K=BI'9*
MQ=#T %TK.D'[DR3$--;?=4QB\>=WQB0;])J7WLG:]VD':'<NWX[LK&!<!;*Y
MEZ,H8><_\97,SQUXX)-Z=*?B"[I?4>)0Y..,(US_H3WZK_8Y_VU[@3\72+6M
M\%U(68I8*N4C*>3)XK\DI(T>O>.9,=N)S,IG35.EVCSO/$MW2O\*Q!04U+S!
M;T&92B'%;RQ3&\UM2S0?O%YA@[C6!*()_(W<E+#/-RQ;5J(FA2N_-QKF.2J\
M22[P^AY+JHG:N_LM.%-I9\04[[Z$QKLD6$RNZ*"!_Q1&\,:?&R9IWIMGD_+#
M3R2I(I[?S7FQ#F:]LY0 ^EJP!QG*;Q&SG9 CU?U5X2K_KKF.=VN=G(-BC6 Q
M4(H-#E"!Q7$4"%;4C$(@?6K?P=G+#;UIJ1R<+>;@;("^)H(,#5G1[=U$BQ&7
M#_8  UK^\=XI(<56"S[K+K^W-;._$^+K\)HD:7PN:L,1*;@R0S<.0BN\Q5-L
M\#N#XWTQG+''2&7MDW^/G9/];V/_.X;#/U(G1.QILA:I=[<.POXEL'FE]\,]
M5,@_!38%.4)[7M;S/P7ST'15I/<G9@[4<X6;X?LAA*LU]VAMP\=+K/6:CS7C
MIIS5CBJP!$3OB]CIO314<Y4-5"GI\&HO_U,"_3PFX%HN?HAW<*)0+"L\*P3V
ME&G^B^ X'WQM_D;X5PNXOU#WGA\UMC^B;1\O[SLR6+TVS!#"34DQX,S'+&G@
MS>I"[Z>!=?BBSZJ3FGQE< TW9C-+;PH-R* Y*J]V&M.!XW :>]QH+8OW),7>
M&<\&/8FA^0/=I+( LGS]_0]>J>/AR>2 ,R<SN0O4L"%=*>=,5 &PUN?!;BV5
M7V>QHF<N:[(F?%$QFP==$HM>3*_[WQ\M<%/@4&:.?K/>+GR-5T(3.3NY.@%;
MH[382M=CM< JT0E*'/(ZIMK68%!!<#2C=Z-Y;_-ESCP[^K7<H]:=)SJ)+^K(
MHY9&+(O_$5 Q!1W)9NU7H%] 3)$RFM'"2(M!I!RU[QJFM6D7Y7<VKOH,?WH:
M;[O$D2<2-U<A ]6'QKPZ!/:/HB:L8"]N>##$-6F_ 1ZZ(^,8L)^CXW=N[G71
M;-$40 90I1^"(Y"F!<BK'X;EJQI3'&Y=K$^:T"&:/? #JPNK?'%07;PK":VV
M9XAW3NDVK^Q<+00%%.T7ESAV.3?,4D>P0:T/(9E!I MYB.(CF&NZ.CJ;J=UA
M,TY+%;6/-79O11'"GL!2>[X^0J5;P79Q2+,6QT76RAYA-D)V(1]0>>*A;H1#
M0 AY>'%[6!!H)4$20V@+O2;3QQI.C-WP2]*A7TQU=![;4BLHC<5K^1U>M8S#
M4EQWTC0"BT%DV"[&SN<88M'-Q]P!%THJF2>N;%T5*N2$M*D<.BVCX15YMHKV
MO3.'+)]R03C6[% =3\#2$?"[=?L6:$T(0Q1/>T3A6>IE@PY.[63N66T>4Z9M
M$ZK-7.VY)\X6)9:M2_'+67I<O"AT]8F%JL2MY3PD0,5K?NB%NL$ O7QKH)LN
MPO!C-D&]\;_F+:-E00 4+9:\9]LCZ>A/C>K>>W5)+LI'3GRF7,$8QD4_NP>O
MCJS;<QL$O>J)ZP8+H)L_8ZLQ+;W6)' [?&R8M3]9LX40@96N+C'4;\XUK  2
MX>^<_Y0A(IQ,FZH<K))=Y6:>(6L=AK[8WU%V*5IJYKS%#F",\I'&K.,\.QS=
M#,'?'&.#,-!#!J=)P 9>MB-7&6,>>;G&DYS]U1XQ8KYE/98J5_DV="K1SM3W
M%=<R-H90I?L9%@_1I9JV6D;A)9&J9.@AQ+$E=:1;GN=#YJ>AR1C]##[1\9-G
MPD(4SX#L03.Z,C93%;AV-*"C2FYG@SKA@++ETA]JJAT04HHP66MK.MD?Q$?@
M!2+4,T8O]KLNJ"L4+#Q^*A?P9?R@_:L_KB5L$,^5G3(G:#,T$KT/>ILP N_8
M1(E384L"4UZ!9HW&11/:XH(.YW]6F.T)>",+UO&AW_Q6H)N>HFFJO6L[U:O<
MLW9S4](VJ<+G]- ;R)"O:$O5L]DW&SRJV(?5L$S"AQ6&Y!#] *I'5@OPIY80
M.SG/&'=6MPV["\!8#&T(2#@!6):)8@1BNJ&FOG:DPG=9U%7GHLKYIL-?N/9.
M,"OPQ'=L$,56\_'V;!M.@K%3E*#M?8/#S_%1NN)+98B%=K20KW;Q1K;4D27_
ML+NWO[C[A,?VR\<I3+XX^F#U.\]<H>A6,_TB9X^W80]".&]8&2*P\UD*I 0=
M"O-IV+FP2L8)\> :I7>FJ:964M7MNGB2O(.\^%[EP)%D\7NWS\V/6'Z\-K=S
M%THL] #T%AL4RW%.M4N=="Z@B 2-6N\UO1)/9,6@W_$,(N$RVU=^+L0DBHVT
MM"D\>]8LYWX$\J.1:ST]CC$$</0[-YY9QI)D#<#VH?:BFZ] B=E]%#<38 M9
M ^5'6KUAG*O]N4>W_["=JNK<]=.>=SSJ'N]7D+AA]>*+D A3Y?_LZ%*3!/-5
MXV6D/36C3?)MQD/%5S\I+ZF5:A?WT?2U@.$QUR-#K[\'2BT%(^]5?D@/Z7M]
MU(U1LC9*#O4K"LL<__!E.@<3<-4,UV^@WZILCXL-%XK;^HCO F<"R7'^K=];
MR\NZ&&D9,QT<2-G.V]*SJ0FI;0CZZOIG,Z!9V^-D]X$H1\NW<LE65F8%0R\&
MO"9DLXFXT>$IS2<Z1D'EBA7W\*N=MIB>>^CA<Q=FYRW[/SUHAM6"'YT.3Y_4
M_KZ\'FK);P#[(\B\^ETZ7 =;ABPS1M*@40$&+<LV]7<G(0OT=,Q,YGHH6FRV
M/ORY=[UIU:?IS4_V7?GK?"U-!A2/Q*6F89*F\(@W[UX'IZL2J<QI>C?P^,;0
MUK!':&C1>.%TU. S"XF>@-:C=M;S^W[;YW.4Q@>@F\A\YNQ37#*&8U0,I?[[
MLS5I@DG+BN+I!]^E+*F#)\NQXYB:SXCXZ)S\A (RO=-V4__TYH?%T5F4(N,H
M8$TM:;V.T)WB:77A:S][)9-0A(@TBUZ5SB4IV('H2<:AF B\G^6N^3'U1I\\
MES]"N9((=/_1[9>@J3D1IL]/I.K4"C>"3%B""%&-TU_5=:LW$AL$:!DKFF1N
M9+"6<F]E\9I]X7$GG"5COQ> ]8K\=BIA5+I*I2/DS_"L.([(V=/FZ.8:V'O+
M#OA.2(UG>KCI\'S_="I=:''R#[TON+I>X=&.5+G-U8\W_#M81J!M YH[+/_8
M'$RXZD7EET"I"B^48$B84\HK+.UVBC7L>YKHGYMZ>(//(V%7$;1</*8=R'7_
M3ZJ&)<]0 O(I/G^IFMG6G)"6[2K8@C;A+U6SUS\GY=W+L"G1ON&-):HN2;P%
MEPB13&W&B[.D/%V5^^]^8^JW25[1?38[*/_N,]C_"R[Z+WG61]L'].X\'-<"
M_D"05T 7,R88KKTZ^_'&>/I-Z$B<PZ-U7-5GQ./')9[D/W60A4E8/NP!1.X$
M905LLMIB8^V";6"#;%CK:(B(_1ST+YTTAB) N5D<G20G*?Z7JI'9NWC#>Q=/
M2'6]ROZ_91REKPWW!"_2= !(M]S+< '\RP&873S$/9O,K^)SYO,WK4K;ZZ;X
MRW0#,8^,F9--DN\R\H=G:F':2#M=U9Z /T["EZTV;B!S^WY_>_A7<%"59LGB
M]V2F&L2#95"C*,4!B-<O!*RE\E*.X+U<FFU?,5W[5LSF79@5+&G[8$P)@'6N
MI S'K/^!:VY(U2V5^AYQ;ER[U'Q()$0A%O0PBU7&!G&\T$C1I9WC(W=6=K.^
M95UN@[4^%+'R?M "<8K?TE(?;QV9#75XN)O'&TC2[VDJ3E,S@'VR'6--W,#_
M0(YL.G.EA\-U$)F:P2EX9N,Z+(KPSK3$%BJXL*WY9)UO101(O1[7?77@WG0#
MOC&GID"P(VK2Q##-1LCR54G:UL;.A36H7VA*#X%BR6]*RHBIALFUH<7@4)),
MI0WR4D,P0>O:\X/SM\?\"!LTU=7%5-6RG)GU$]JUQ?*?Q.U7[=%R- ,+!.G]
M:HE&+(.;V<@&>5OL7 /RW@!--U]0/VXI#$0X!I:$8GI]BSIC?8]"_L"E+_L/
M1H0-]V,IQBO L14,E)C/,L"00]H S:J_2V%A]N?<LIW_3A !_TCW:#(.A;#V
M?9SJ XYS0%@.P%(A_SC+8C_T_?#,L.)Y/H>1U*W_E1XR8X/X65*  )$->K2.
MC6*#^!C_^^"=Y=_QP._(L,XZO\/-I1E*/J,=*NIEQ<:J\G@\G,$34KSJ:&=K
M$&192H:(K;"46+ 7_S'0R-#\;P.-=@9>4Y;[&6<IN7E3.!E$Q/#E'^LE]O6#
M05(C$<9PH80/6F VR-'@H)>!SQ1L/^/,3CN\#! ];/9C/?NO=G_.[[1+OXUF
MWB$>M$!)<2#O.I18#%%GUC <E5KQ,0\F_D /5)64_OIU4EFC0B57H]RT"$$V
M./Y[NFEEZM\31=?_2A2AXO^*#4KZH\6G&7*/9K&?[,S'8]"ZHZHE6^JFZ.;K
M:&*QJQJSIM%>J14;HS7A]=?0(PXUUUW<;0U<G).Z)_4P?)N8WDV4X>LX5FO7
M*A)_M)L4T7PA_1!];'YLGF"'5IP9J8'J_U.:*/;XZ[CU/NW_*K#.#&.#(N]#
ME)HJ*%"R> M??%FG$56]I@@N)6NG_^7 '8&;/Y_0Q3=Q8LQD]$T.S#,".>0A
M']U\B27)N \8D5VD/K-!XH'R/ZHP0O.3,G717]>O5K[K\S&(E<O,5ZLL-M$[
M_N8#FCB!EI7AHWVD0CGSOG>6#7I<F*+=1\B=G-D+8T2O23)?XJ:PHA15#O.+
M3D\3<6_RY^RBWUW8G[F'W5RU(CT5-R*?0_[HX/=B/N,!G0>T/<P:/ZC?4Y8F
M:Q++C[3/_X7J0>VJHVBV[J%>C3$L0'M^;&H,T4FY$J?A%B>QDM%SA:2QU!'\
M1-22Q@.<YE"(\TPLAZQ'0*N#T^BG.)@3P]FL\>)X&8WR=?.3I(42F8#PXYV%
MA;^W P->?UD--3M;TL;'2-G7]Z($]IU;=*MK>Q?CBS,2]+-)B^'%3$+)L;Y!
M*_!+8>AP$CJ^21*=P(( ?3[O7,^-9D^,F!VO33*3MXG3@@?)9_ FORZY*/W[
M$=04[XZ)@$JLPP%]+5HT,,WQI51#7$00[%&-3A8L02-0ZDG_BL8>64GK _;W
M(I3E)^!ZOTJOWDK%)%=LYQN#4$=07SF.>.=>*%[6272SHT$870]YA(J*G,((
M([!+L/T;3@0!BWNG8UC?A^6] O\H&<GT-%ULGCKN $\79IAC(Z&>'/M$BT"]
MH+\R2#U0#I]SPXZ9MA.DUBT/>VT2I!K=J.>''3X-'*L[AI"=[!]U!/>&9'F.
M.%^4CSO^)9@Y-;QQUQB$AJ IMJ$L=6"*=5 2>(+E;C2D=EH/&>A3/"Y5TCT6
M,:7&OF0IU5"#C+2@"*J>;\?M/6'/GM"%=P<3 YL. >IT;8Y-&:&)$6@I-/$E
MFF(.CT0?8NA2E4BZ":75<"F B]S0*AX;I.[EMWG%3][DD$%_YUU_WC>_XKK<
M*ZJ\5BOH*[1XSH84X31$+Z')Z+%46B#S ^HD@Y^ZF:265TTMY6B@ZE_7!^P<
M\A-%<Y5OWRZ+S5<Z:*]:IU+A#JGE2#T2I[LSJP],N=*W'RBY"EPH _+;)A6H
MM*K3:#"PV2GY_M,0PPAQ($$VU/;0_3+M19#S<N9(9F:\H$ '8<2)6,00MB<O
M85H(CV$[I6J)T)J./*H)X=J/Q49+MW?=Y9HQ53E&DGI^I_>F^TROJEMK*IUX
M,ZB@)SU<QW"E0I=D.(^P8X*/42=0(]N$10OJ!?)P*Q0CRU]3_3U(,QHB'7YY
M9A(P=6,E-:.,_0T+WMYVMSO9)1W_T<N:SGD#J(OHY@;T0;2/.I3%*TSW9H0P
MB]F@NUAAAD8CD$KF%W"M[ _JED#&LH9TBD-HB/(XM1!-D9!#:MEG[/3N6J]B
MSG%^/(NS^&Q05=%2,N4"";,D0Y>:$_+!"C5Q 34N<#/*1MU>\G:_F]^:5)#\
M?O<D)U7'/2XN=N?JP]\2WJQ?XYD!+W+T&?<FLQ3M!9-&"!-#8J!$SEN16D<?
MGI\\.G /<F3>5;Z_Z/UWI);W6D?&\)L9!Z[W2="3_6?LCEWB2]?CIUAVXGE9
M0WAQJ&??*(84PA 1IP4S<4WRR&L_@Q*M+9FY@98QM9)/9'EC+-/\W*I?5 EU
M[AY]725T1G\H6?K2@>@K;)")S36>M3#Z9=87?'5P/<<VLEG?T'L"82,8LNAL
MHC8>$Y+1@'VBCA0/5RSVNK<IJ[C?H*;D4+K>K[Z],L^Y9DTCU\K1ESDO< [\
MRW*J<VEVISH6QL/JG11JH(H_;3PT-28@VDXJ,_"K'U(G53=691T6ENM)NT[Y
M*HCL.:;RZ(,*]L?#XUR4,)H*P&$6>QJ )?IEQM&!*DU GF<ISV.**=<^ZI<7
M5(S87KD1SM6\^?URRJ?Q37'=I8;#T[$W#2[=X15]+ER)1WC^GV6V]7"C6K9G
M=9L%A%SW=C#UFK';\RV:S-PF:5P%^E[\3!4@$0:"4M?"? ]MMCUF@VB7@7G\
M+0HK)<GRS&8V0P1-Q"8 3VW[SA0)3$?0QS(8H-=QJLM]C__I9U+ZEY=;2)IJ
M?@71#M^N.[PL4=[8$Z!R5ED[ZX.DKWY^?Z,HW8'A3@G^HC@\;%<+V[I5HI3E
MSP:Y[!+8JMBV+^=(@VF*1EGE6,<H]V2J,JGH$?,UN/CS0<ACIP68FA4,BB$Y
M8TY\S%&0",%PJ"8_N%=K[KVT8^[TSVOOIF7[-S.FWFUIHQXAK,D\$<@'<!IV
M'_#F*\--+7TMX@]K-7R:<:XLCK%0W=!046?^437S:+K6\W0EE;_3+3!NU!!!
MHE&J<K_!^=,^=]F@=,G*T"+PQL!1-DA';O0O87+LGX1);3?#N/7JCX[K_N%3
M[^@Y6?016O@#@C!$"*D*_" 5&TA1PTA-4>1$1>>5 >1./GZ_7D?PY=)=F])Q
MJP1NU/CDOB$=)P2A=?BA35%T72W4,V;^/A?F%?\&[@8%VP;E N8%JA"F[7;V
M4Q)W(NZ[F-(OH>XRSN$2.^Y*--EJ> \62@7]X>#CW_F6#LN_\RULD >.M7N#
M(?#D+TH_S(&QOAU*S^?S%Z7_$JC_(;0H8R=-4<'%?%$8*W"9L?E7_0)L;);8
M.7H:_<3T/)!3T)Y^(<\EWO#<D>6?M0I&T,5V^8)M^_6CQ@\=#FKVG=!Q'<@U
M+,)-45%*F1CB> PX9'%+85(2!18@HB%L$.7\3OTUIATJC&XV7:R&8K#[@P@'
M1QG*56S0DP@VR)(JBSF=7TV!:[3K?'TU^ZUGWC]"W?(T<X^5L;]'YM"]-;&2
M08QZBID2&O:)#4J>>/;[^2EIJ;RKSL.^-4/92YN::[R,=.9;-NBV@"RZV0]/
M+&Y([(O'P:NP(PO$G62XEO^[EG8P;,C-7S'?U]W21/@07+OUB9,ME\9]Z T?
M:$N3"(7PF 'U)<'VS=5L!^>X1_F6J;OQ/DUQQ'S4$FI/,M<2,I//*L48X)[9
M%,>V:A+TZCI@7;U4,_3#48UA>)ALDBJ?](UKV-:PZLDQS?-%K>AH%A< )1HJ
MD= M;- _%23M^5\%27]%W =9.M3:)TU2@+D5=19C<,&G8&[4XN^*WKQCM4]-
MS$]"NXOE=Z5X4O&)##G*6,M9# 891E9U43+I]W6=M1J$W]TO<NAXE[O25I#\
MHU,6J)V/EUCAB6]9&LQ:Y TV2*") [\%#*U^OUJO[3"AE/G58O+R[X,3_7(M
M!Z\Z4)?NP_?.('TRJ\6&Y%>NY_\<_MG]%]D$:[4S8!F4)*[<X#1'S0 9!L&S
M'/>[6IS%RY$]W)>H\*5Z<A=$%FF8NV &>!2Z^+T?^/4\PR'-4CQ$;J#17U8P
M(( 0\IOW.&[1 *O4O2K==%A-Y(Q7Y]]E28Z,S&SW7XP5L('[*>1 QGC&Q8R+
M#4<X_F/ @/C?W7 TCP&.]<5A6W:.[L40FXX-1A>ZZ?59*6+OVZ )[9?I RQ>
M>XX^ J,^PR@6Z#AEBEP[/UD C"!/SA]G&)%6N)H/8']=GI= #1GTFPI]M?E]
MOK0OR?G($6RO)J!87KZMM+1&25_5'85UBMEMT=(8KZ%*N#P\D;H2!3U@L(N^
M!]!LAW #(7ESH]@XM*</WXK0_%G7M /"\\-RQH/?+1X<.^XU?H17HNL(Z*S]
MZDJ2M@@B5< V_)U9^$#&%K8?=< N@#2_3K>%KR2@OS"-F)_P<,V16=9^/%UW
M'E_-LZ2)<QF=DPQJLTNO>7CW?=:F]:>,D#0O7XF[ JK<P5N9MK8RF6DVR:N$
MQ63.) \BQ9BO..)-@)?5A95&W\'$$[B0YE2A+RX,G3H 2R)Y^9 /9YJ;R 5<
M4+TD$OO%+O&7[YJNJ!T,.*/%VO^#;HQN-N%(65^!9C:HLBG3JP31_1DOZ&M@
MZ4$J6?CURN+V\:7RLM^/9=T=GN0O\4[UW+W^=N'E>]PW J ,_ZLB5V2'+A!?
MP]Z?7EF"<W!KJP80+OF#EEPZ2JG43%JJ#NOUAB]9B.+<5TFV/DZ>7\_;F'UD
MNI%^J4HR;)A/6-$+)$U 99@AS4,_BFY6A"@BT$1".Y8;\;%#5O'GNOM0^7K?
MWE;O6;/*->3;PGJMWL/6JD]W'^]JNY/SZLW*>Y0APXV"6URB:'9@JP224DA5
MEKL!2ROJWO<U3QNL?>[Z*O3D[>IPNN/[>)R,3[<<W:3E,#/P7EA 2;Q#8)1
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M$A;CJDRWC,/?L93%1^.<-)K$J=*5S@XG68OV(.WOF,VV^@TKV _&?G(,W\V
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M=12 '3XRL#:,G$Q@QBUMYLS5H]\[KJ>=H:74]@;Z]+IPBUBY/O[\O_ML2+@
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M65T+.:7IIDK]=]W$WJ0>OX,YPT_40/VH1U$T -P]!B>:!R!D>$2+/4\8Y#X
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MB%7TGWQ3%I^ P$E_HYXKU6'(G@.R^D>@FQ1!V&N$1!Z,M!O'UA(&$&H$BDA
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MKSXXR]A(<?<LA_ :P2P5?BWC5[9,]=730G!)@[1FVD<ZQQCBS+\.1T=8\+/
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MMT?H+&/_JJSFDA[@*M*:>_A]7MWJQ@'?KA?/[?MW+T'70)! 7BL:UQV=8W_
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M6-G_??EWD?\T]00C/3TC*S,3,^M_\SC^ #E]\H3+B0IZNO.0$Z?IZ$_3'0]
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M]F=<1%-67$?1^5KZ1G=^B82]N=EO4!;8?1/.&#0G"-9$$!K43F5T"HQ+VY.
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M5LTF)B][@Y)S4I8<7F9;?'#12W8WT]$B[8,Y%MM*X9XEJ0/!Y,MAXA_;@>9
MPH'I5- WM'>T81R;6[/O82BB!O&QT%7O3Z.X$J+"JKMQF9-R>H_&\I>L0C%H
M!NH)4\OV(A'F+TW*G#8U!Z<)]2^"PDJ*#/0?/K0:S;54K#D5#&O:I?"$@J6V
M0=O7G<A/>@'(%HG/-&W+!2UHK=1MG/'+J9;(J'&S_WZCAGY,C/$93&.MPS-[
M?>IH2%(I1N:;16)C=@E?9W==:*3R%ZRM[*333$.6JZ7W!=_Y"STMW;BW\2,P
M@N%$+ IT=CW#,80?J8#$XE@I=XC]>.$WP5))>+."<)7TMBR-AMB8K:GO)I?N
MR"85[C;;B(7".I$S1=R@&XQI,VC>=S01Y SM,L$1ET1AYIQ;>S]#\=5-";Z?
M.2PR/'H&3R>=[;7P<(FWL#0Z_0Y@0SN9"Z[R 8)-HC).(,R7Y.80:6*$B3LP
M;PLXNZEXLCRA?VA0E%#MG"52<U*]ER'0D7E;"9Q02HT!(09*Q)RHMZK6:]5&
MO# YU-JQE%OM:&<:=)J/?YSK8Z78R:HW>2:,MY6>V:_\^33,F4VUF?N:81I1
M.U(IY^#?1K%IG*\E?>FPU7:4Y7]/"L*:>RR8=X8Z+$UX(!^!E?ZR=G XP9/&
M!JVD?8+5MPZF_"/A#+OR?U7:6B/UW]4@QT0R/\GSIF5>661(>,#KH7_NP?E;
M:.S-/_#YQZ2SU&R8JYSFSC#I$0!S?FU:<<Y4SU+)Y'%XT.L?,M_-=L5N[;V_
M?#6<56:FNO/<6*" $\MDK<1"9G;VH0MZ/N5O ]7L51VS#6/\PXKIA0=C[LA$
M*I>%/M^.Z L+?5[(_Y3_*?]3_J?\_UIL\\T',/&"!\DJ"O$=_ .GN _@7TL,
MI_>U3*T%%&2M/DA/7:]Q.J=WB?'I9\-:[]_V/9GOYMZ6%_OD'.1\-C))LINY
MX<+"S%X:'752%_]4]C\N:54^HUS@:'!*=/-N2^K.;ULL=D0S09)5<?#NJQ9F
M*1'I<0BOM=2SG@L4#0!=_GT#=TH;51R6./.9N"V_$R1G+=2VW':;[?HVSV4;
MNJQL[:?]J;X/GK)>+'[**L,\ .6EG05,!O,-GR*LB$+7IE06$6U?@ASU;..$
MNHW*E\X0.ID+1$CTJ7_;9>L=!J8FI(O/YX2&?+BMF1'!"@GF&P\;7E7H/8;$
M(P6:B.4#G(E+@E^:?,EMVW[!_IZ.K<TM[84'?HD:;L&&(=BYV\9:9LQ,Y9T@
M91[JQ_/5]9D<0YYCV45E>NI]%Q3836NN=\0.-NR<4G0XLR=ZI;YAQ4C(7%L0
MLO0?S]/KM0V)"BL3T5W72@'SP2785^5:&WA>\9>F<1.K.+84 _V%]G,I<\J?
MU.2OGS!8V9#YSR;^=Y6:8PAO6&=?T<FO/XB<*=KFY=Z""/&#66S95@AA^&_X
M20L@WUM#2TRU^-TXJ\PZ9\(QA&"#!B1S^Z!7$(YDMS#5%?QGH$OGR5%GE)9_
MO5UJ9'4?PO\8PJR ZE6AR'1Y<8>1!\J0O[]VR=;''4,^M+\>7G4J9,]4'Y"9
MZA]_1WF'B_CR9W,]3U4 ^_8\"VG-AIQ3_DN.[]"J#FS;TR LCVR\3&C=:EZ-
M^,#Y,?B4V><Y]+M^>:VC6048121E)3L]MG5+!?F+<W2">(H777&&&9I7=UU;
M?.".S5THCN^P<2+W[,/O(D5BD9.H+/-9K QQ;8S&,3KUXT6*(>E4OL36%XHI
M-_3C[VK*9@G(-I8W45&Y/-) )DF/:%H:?I@_/) SRQ!);RB*TGRTPB&>N@_[
MXX49O3&<W.;CX +[8U?W66I3A.]P</D8 F@<0V@LNW@6\58BF+F2OV3G]B0[
MO\A)QL+.RB]^/(8\1?)MHSDPRVUH@DE @H=Z$ ;;?W-*ZA']-;R._('9G+GK
MA8%+4/S9M"<KM2\\[_*MQZ-'Y6@V6K^(3(;/0^+.0S4N',X=#26N(8417H 6
M,<V<-@,8$N']3I>:L6>_ Z&.K=U7=4*O;\F\K9.^G75A[(+'DR^OI$2].NO.
M%2=*W_P_Q)[F!ENNPW"!+)@=U>N+\@9)AQ8I$L#AQX30\WA<GZYLZ]?:X(5T
M'RPJN]C!A//%.][^M:6:#$E518%6^K9\6L$F<7@Y8 MD*Z*@[U9A"V,KN8,P
M^HV$9<QSU G_?;9",W]5_=8BF5J87BRETBY$Z5E7LG"T *S_ W,IJA?D@\LE
MV-TT\"T'S4+1(O.%O?TS-0QOX:A\XX7BA-[J\0KPKU5 Y+W+<])65#Q\,3^2
MEF<Z_\M0%(2-3-.(R*ECB!MLOH T2(1N7R$.W_M&$2*XXOW[OF\*;N_/FO,U
MU]PQV!;V^X08062=4/[YO2HY0V8=C)0:AJ1!?=_S[^[S+<H5PC"IGS!3#8W&
MN.A !\Z(\L9;3%U(_;9Q\*1P].WP"Q=+)[MUPSM/<U27']+I,&_%D\_0P%1I
MRJ7P!-!8'<FP,.854CUSHK8Y,<=D@GW.R<[8[ZC1SL< Z&5Y<3$D^_Z5.G5)
M*X;D+\QSFG"*<'M5&*J_AXU:<@SQ4@ DX0-U\;A&S( <4D>I'RJHHL!E]YUX
M*4!R;=TL1?NCF+MA9)_A]^=#,+6GD9XT5K5C"./'K\<05TYL4A_N/4CIB&2)
ML,Y5W"#F]*]CR )/F$GO;-]W6]MT<9FN8H$D(TNIS/M7J\]R?'Z3"WMQ#*&3
M!7V=B^)'N>^>0([@6J2>HY9?:]8-^$M/F4\V[S[3]-_>7HSM*7G P.JW]>X\
M5^^#DY+J<]4#Y1ZZ]]!5QQ"_ "@<U2L,7@3_AAR)\ ;$5\VY$,)  B%NME_3
M +/B+]#,-"7OW-S4\H=I[;8'I[/ Q7M74G<?[9RKA3R&$HPYL3Q]L.8TRADU
MTA:PAT^+%94FS.3BH=%@$K!P1E'T3M=/[^^Q6^?,YEA"'O-6$6\]:Q.G>U_^
M; =%N&D.7 2=7DUC^0V"=]$NZGL*)V%AB,8+1+JO+MZ<F>KKV'W^9B8XQ<$N
M?54_CL5:*ZPG6%]]+C&!-W6^_\H?&"#)^5SW"@(!LILZVG=XTVPRRL-<B*+=
M!"01KNU2M-Z$=1IE"/7[2JB.>:]!.JV]G5,N7#DQ:)(]YO\=Z3$)<Y[ QJ\.
M4P31*[5J*[E](BB+6204^96_1W9:6XJ:?J6K<\J2+<E.(A47D"<_U&$C=HV*
MO8F*^<*\N;NE T;N.;!)-@T;7>__MZ$I&\5/X_H]Z\301?2,H5RK, @6<O3Y
M/&<P#AG@>OE@\8)!*GU;2V#Z"_,4"LBAHU_0E&F?CU33B!A2(:B_*L(-Y+:>
M=C.OZY.&:>>F:U=[GGE\=PT/:CSI];*JD<$[+O#IP M.&X(OC6VJ@H8#^Z?_
M,GJ.AZ0-5&"X]N'1]COM9TKP:#993;-L_$4YV)>F6O+\@[<Y/UNJ1)[%(+=X
MB(])Q4#V*GJ!GL92^3B0*+Z*VDXAZI&2&XB7.X"RY4BDS-XRCF5!CCPHU/PB
M1H_M<H1[RMT<._> #!7(;>:MT.T)_,1<R;^])4?(C_ZK=;'(R[-(L4WDZ?9V
M@E32?@!_64NZIQ_C?KU0DA*;3J_49[$<(R!=CP6"E4>$@Q:G!&$8D7.ZVM27
M, \H(+4+,K:4(YL^@7R%I")%PA7V?!Z#K=83,H$\U-<#(])<?ZZU+V?)6['-
M)M&^P3B[(H)!AX-Y$A4>%K?0*]B5C\PE/->OA!N^'75N2O?;;95XQ^_GIZAX
M-DI1QQ<LSBZH!;8!'.$Z6!TN>FZ'$GA(J=1TY"4 <P]H)O)1] CY<'K@_I):
MHM6[NA^M"??2L],#SFM-??JSZ&G@N-GT-"*7(E!>;>^+>X\9,GW4'YH>03R&
M6!2);$;7[X^KQ!FZ1LG\I6&D8,M?S>/1/#1!Y#!4L M&#%V9*5^)]$)^>5*.
MW:^UG"X)*W6$F=OQ&4,TJZOE?XX6=@D>H4A_0#MD$2?!8Q3"MQ58)\J0<H'U
M%;GK"]>BC4UE5F8'>*>"]G@M3<Z]Z)N9I.WGO51B@L0Z*;*<@SIM6,('R^^9
ME"V4MIK0%WB51E;]@814ZCQ3%ZA;LZ&Q=!;3/F((%@')\-/[*$"6D\(KLPKM
MY\2^@T._+X1YO]-VP5YXEU\E?K>UV;O$ZTV15IVF0D/CC1.R,JSK@=!),W3)
M",%SN4N0.5:V&7X:$ZLMWW+DW[VX7A!9)>1PO[YDU'!"N0 B;R@[@,>@TP!9
MS^U>,@.JUQ9Y\AY%A<!,X>Y?Y<@CWU]RLK7W(HP1-K>.B@H5[QE(I6Z$0<>[
MHT?L2O1SSNMIMLP]M+NJ^R_S6[R)%"WP?0,LWMI!&)ZP'H=O7VKE7;ZI4%T>
MUJG'EG#?^[SUD,U?_I.9HO%XQ% ZF >>P#7P>)GZ$N4;\^7?KBU^.&WB&,)!
M$P[+Z2/CW00I(;ZK5\Z@-3J:IUX,]YS_PAS\,F=.E/O7VZO9A%P*KQ+8UXFM
MJ\S#NX"4PI8[^78_WK?S-XUK? 7^O.?\UWR['U-2$6'XW.!OX=9AC^@\7!K"
M/4-^NJ+U0#T1%#UJ"<P3 TC!MZ/!NJ5.+=<]X_,0Z%\^Z.,4&B?L.DTA8-+S
M0(%AV_L./_WS;R^\& L6KO_CEJ'UOI3IV1^ZO6$*;[DE%1T\ :ADDIQFCR'N
MN_%+YPFM4;LHKP2XZ1>*%9YA6N%UNGD"_M7(P_0;J8)>/X(7!"$U3(HL,&_:
M5^B?MH,/*+):P015BLB'T"*;4\2!NDBPA68C1WI8&P!7O$!S 0S+2HKHEI0[
M$](1)=E%=)H-BPJPTG4+D[B_"[> /Z%]T3U)+)NEB&P2U(95E[BF);[*'4,\
MR1_?J<1,_5"MAZ7CZ9K+V.K-')E8/MM%ZD-"<6? -K&BP&U"E,(7I9"Y4;T:
MVN'$B5X8@_QZ,X F\AL21=X5N+LK"XV/S@]+/ (K9$[]1[/QTJWO= 9V0FW
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MFW3M1C>971I]-YS_;E)^AO_*S.32> F9/U,G"7.O)+0!,HG#P^*0[@GQ=OP
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M[2B_M.%&E<@>SFOC>P)KS1FCZD.0)ME7XV\LMKFY%GME>RX_\ISUV-QYA6F
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M9_CO9?_U7]8Q&9_,98,#'U;UK#TO*KHIG@0Z5JC"'[+/ )T@T9D*FS2,K/T
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M9P0B6^J=APJB&H._62M96VU+GA04(ZI*Z%U2N2#_N.'"!=2RUJ[$81]'5P5
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MB1%6UWJA +\#'UQ//WGI=<H;,<?R_:CD.&RY?_RQ[Y2B:&H<<)D98$"(8:0
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M2%7%G;FV+O5&ZYMB5,QI5KE-##&8HLHT%Z:R?,@-2-2%'7X=%41B;R@CV9_
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M&HOK\#PO*O@+]GH$C017H2XBAC&D>YB)AMUR6@Q"&-&..@,AR-0-:?*X^PM
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MFG*V_N[<M<G0M@3K!=<<7%/41+U"Z;[2;S%5+%P$*!EJFQ9%>;:54_^8=BN
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MQ.11#.5OUB'4^3W^Q6"% KW5O+U)G?9EVE,4BP6>]?<,N/S)@$N'H*M^>(%
M;3H?F/UN:UX,3#E.HTS:0=4AM'0Y<<[91 "'^=IE(![OBKOD8*[[4/B)XZG@
MMS($Q.E?R(A]-T,[7#3E](MEA+]U1Z>'P-@^7)(X%PE$IA<YK'E *D]D(Z;C
M^[%Z_Q!7/EILN/P'1NO24HZ I1*H)H074%5)-A-?II92OB[O/?2C[7Z]7&"P
M,L"O(O'3IPW^",Y %:()$I=-OHY)A$;3CX7$<?2.>\[VGO;KR[AE(J0 XKP2
M(E$0&W)<!;W4=X;$$ZF<==G7/42UGV[;;X"80+O!,B@Y" A)^M@K%BXEAI7*
M:9Q4A)*WIB&*+WHSA77X+:; @O]O+T9"N1BS_4JD *D,MXJ(-HE3.D.]@PWL
M<)7[_@75I4H/+R2VT%GE9X9F$8",75)QU!ZB6860\>B!-#C ]\X09%\1V8[Q
M6=V'MJ_=*6Q[G"]?:@@)^8A?<#AP::KE1G&._*"/6.S)M,$#CI(<12#6_Y4=
M$#4% =HW1#.$A&I-]^_]NI)H4A@?([^IM[3[QZ*,/D$_IPIM"PD-5B:)Y>>V
M]P"K$HY9X+T_R&WTV:/KZ%.E01KL#;/HE634+'+QW![7KOHBKU'%5(-(+?4,
MPP:N9.K_3_&S;'@?6&2#P08KM/,--[^Y7\W_T:JRA=1)TRO8$\5J_.[X,F#S
M:U(,# Y/$2NK=RPZ!/6/O(@O$E3B39W-BOJZ+E.'WH*;.@=[405,R:)5M"P8
M"%,AW:RA<E7=(FN,I3:B5UO4Q93)7P@,?])T)<R[.WE^C6GK\P</\B.R&D":
M-P W0P2GJ?&(6;U7LJ&CZI_8]E8:]^U69.?E 5G3-8;+Q![2ED@?P'/<]&P4
MQ+XX!,V&.'F!NW/Q*I09GCK.'-*X3?*, OL.[,9L]/Y5",VB5_+[CM0!>OX0
M-!^BUK'_X*#DXA/8*JA<_3+6K:.<WKCK,CD#<3IJRK,N2E$-1;74DG-@3H1/
M+S'CJ@LMPC-:.(Y,6^7?[$U_N:-5L4L,U_&H5M5QVA>(>Z#]4+WH;.GWP#?8
MO4SAT:Z6@#I,:J=E!W37\8/*A6"+61U5MG]5:5<]O[O.Q[W3NWB=LXA;B]E7
M<9=J03#E)"DINK\B"^ GWII[4?X.0&[5.!Z4/KTQZ<P^X)6N@6*,1!B@\3Y6
MC?^<YR%XVLVJ(4S)O/KZS0!!['66^,?V;XN*6)_J,8MQP8WHW0BB!0J)9V[L
M)2"C<^O]"$O$=Y0[<R^R7V1H&KUE2Q+U[SKS!22L X^E]S+(&7)ME_)HN5"I
M&2_2ZB>)#.V/K#RGA6 I>2:Q^6!J[DKC/OI?YB7BZGO T"0W&+:3,G(A (QZ
M0AVT&"]?^VG9R''-IM0_=:OAB,!<AX^#B5K]XW-S"!S5B:)FIT?<;$U\\6%,
MFRU)KQ;^ZQHR?4*=LVU+YA"4<A>[$+"N0SD%'SP$E?YKH"606@B5(W$YB1]+
ML<401)Y=<)#/CXE$E;$)&^X"V0/M DTI(B:BWNWK5*!%NZ98Z8AO]U*L1:U_
MKGM2DZI8 >G7Y9:Q:+(RM"WSPI\:UUG\J$Q)(OS [M$(-1?>U=%"D@X?YP[H
MM69O"+<8E9WRZE.5_^(Y-4FW<46/(2?$Z5QTP( $7K>[24NDWLGD' 7[1K8$
M)]7C'J]C>3&]<B6F>9\R0#H"^WZ4N_ N1 7+6OYL.8$G_A#$N<O%'N LF.K=
M+C9*Y)F-\.WQC@];?Z8;!")!!VP4.\ZIM5TS8C$?41U*28)>+>R3*UF<4==N
M2F,\V5MO*SNTK+S*LKV\+)&V^/&!3NBKK?]G$6*69315Q(.X7D*_0#4!RA4;
M3Z*RG[@);B7L-0[<3-+_2@E-OXB8%CCHAYY"-!W3Y#>8D1^SII_^W.U9#@RU
M*=6&>5]K$0GTM[I(4VJ2Y=E;73^@RY'DKUDB11RDA7(<OV+66[\=@K8<^U</
M0=Q$^6--8_J*1=_^'8+6R?.8DPP.@0[7'/ZO3!P@\4Q\;HXK@&D,U5MP!H7*
MWA^_T#$5;?\6L5D9"U?<J@S=)6DWL\WA(VLQ899:'A-"^CY_#35=^V<(I@0H
M4_>Y#W_^]H3;GHDP/W,^_BMV39TISFPKWWYB] N&S1TC@HH%PM_XWG"=?3B8
M@SC#4!ON!Q6,=1TG_O?M.%C:\$0+#"##PU!R/EN8+!&S-C*#YEJUPK9J>&_]
MUIH5N;0X)>$\<B%:,L+UI^W&2P/IK^VJV$+X;TS5OW#*4WB[*F1=;]8^;PG+
M:S4E'2MWU)XRP\?=NE_\E?.3KA-I6E?NZ-=(S&-[,40KR+ZZZ5@YO?LR8KE%
M#YT <46^A_ AGD)%X8,HXCU,!$Y@_@/5GB09QICKMXHS\=-<ACI"I[[.:3K5
MOW>C[YQL! M_>58V^:_!,/%%=,7C$(.A1W&8UB'HS=!I'LEFYZ"K8AG*/T8#
MDE(M!!XT6RQO?$=]<QE"_ R@"D+)GV@,3'YQ5,[N- G:C&=?!O/4>]H7KF@*
M9G+()@_#6SS);1%ZR25GE1PDOR0TBC-=^'GR1"B&%$ >HB7"CP>6@(]376C9
MZF!"L;.CA:V\.=8^VE>74K)D?3U_K?>UKDF@(E'Z32.+*Z+<E"JX2O8%. CK
M<5X$Z/CF&L]-CS>O%)J*@H8<1@V,_H1.8F/@;7@NA!L>YS,KM"["$TEGH?*1
M,.\54<)X2Z#=*^;&I*BUL470![F";]5)?%4SPOX?2$=0X19+#&KT>)>[=AF^
M59@O,_5]O9NU,R>[9-.D:S/K^PWIKE?)C:6F>[YFRH:=N7"WKDO5<K>L]OQM
M3<<AIZAF@!-!/K(,9DV"M,H)MC0/6$K.9XK7#L\:\;X QN4SK>W-)^OTE3U;
MA/^@(S'/H<"E>[@\!C#) 5YD!5JNKZU%,UP%0-Y*FOMSDZ6B0>@!1\-5Q;</
ME[9NP^K22!59%_8<"?K[%N0^X (IA/R,X8#84UEHZ0S_CR<*9Y=-0 ,VU=>!
MR/O$]I*]6Q\LO9(3F:[K=!ICXZK/F-_S,U%#3W3/Y*W9$UWH[ Z4BSAX5^8Y
MXG?D#WS@HJD7WS*=/Q-R9>)J5AXM(D@\-IF34%(J/?U!RL#SZVA:A-\GBV^$
M,P6PQH[/T^X!7Y(J/ >>4PH/>%/FTT+925]R5GQ"7D#]E*UXW;<P%K5KZRNA
M+42O69?U$\5'=]2-4K";),0Z!W'"@G@U@; D];?^6+:M[O3Y09=7[G>Q#Z):
MBAS5:R;7>#*.W?\Z6[=N1)Z@?;B)B'XW$Y]/N1<HA6_[OF8E>A+*.Q$37B-]
M_*1(HZ7!C*[^,_TSG0)$:+@?1A!PH7,P45P#DWYKNI W4$35D RA3F%$94?>
MLB?WP&K]U<M@0!S]F^'Y62 Q,YE5*'Z(JRDG</H^29XJB7T8B&J%2]9$:-QI
M)S&.\("#]7>G=*X_#*^O2\*-A_,)UESH5IMA7<N@X8:9M4]299::92@]P<C9
M^UD93,(UU+G0_\&WQ#"S366[S8W=I)#L370,P]IAU]X365K?-6&$,:Z'()9
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MZ+;+F!2&FE6_2-U"Z;V953?FT*U=1,(Q1#@BB+)G(]W1/_YYQG0=0A DZG5
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MR,-*>#N#=-4SMNMQ)A/ @J8/!M,BNC=%5H[WZP;869A4.)O[:82EGKRMA[C
M!3>A<@):LV@D_@Q,B<&HKGD-4XT*6QR>MQD\>5?=+^L \"JIB76%87>RB)\)
MJ>&-'-3K?S7Y *FASD&82HY6WMB%]KES^J=N\(Y\%OFT)Y&YNQ\09W/[IZ6B
M>L'GO56U;BIO -7) Q&.R@W42%!W]GITXT=#UV4&#)Y+QK!.TW\LN7Z+ID,A
M.6__1\T,_U<_V?7EE<-7%GXVOG&*",2I?'OU8:6%&?R,RT#G)B[@CINB,TR4
M%$F88K@=45:182Z<]M&F"EWFAZ"4GTHRTXOGP'Z*/198<!5/L_8<D@DI[$JN
MVY7C$IX\OY];M;*Z6;V)?#I=N:4!WV\)JO>)+5&TWIO+:;" 9AZ"(K7WM]^7
M!3F.%RU+;AA-([.7MR9(*T>U*Q?[P_];;!Y8!M'T$"Z&:-+PJI!G@=DP#DM<
M8.&3=\WI4GFO\EQQZD)GWY<V8&IB>KEN6@7?[+W8X2'5/OF#2?GYQO'&.XQO
M7UZ^X8871;CQQ(!+6[&7B.ER9U?DF0-='@ZW5BN=?8M)<UQ_T3?XX['!??6O
M-ZYTU:6]<]B 3 20"X$TBM*JE615!H43J)[%A^V*J#@.^X%9)CC&=R9RG@J(
M#74_,TMXOZWPU5OE7^-1V*D#O0\"5O=A -IU$GY]';+644 ]#005NIVV6J;S
MC3SO_8@=[!2M=5AKNQ_N\KXDHXJ9[QJ[=0I8Z--0&! 1FZ^[]7"OF.V2Q-P+
M%R7?V8H!ZY&5T$;;ASG*WO4>A@.O]H+RA%C<\KJ^5CX,7MF<[M:>AX333]/>
M:%YEG&)E36FJ/RU;\]J$$46OMW!%:%0H&!OM8FQNE+,US3I;M7V\KRRCJ^_!
M3]M&IZUV/-8+D(2V]0M1&;-]&T*5 Y+GILP]:':K+>L>H:'>"[DU'M;O/>^6
M=*3XGXIP5D\TT/ @X'%>T!&$>QQ3*Y3C/YJ#<E.U"5XQ=C<L;](>=8C)$"4K
M*[^G2'E6"WG GYD%"7.\N2X##R5\%K%>QO.Y8RI<J*?ER;: "$63W@<N-]MK
M<[-/YP*W50??$^),D5A/#/FB(W*&06[34@RN10G]ZU3L3FAS O+-IK]<^M'U
M( Q[\TN%IV* K!W9!#N2$;23Z1 6+EK0E_W1X5+35IOVXW3_6"\/V\*)N[!N
MBF4G19WJS!!MV@/#CIG)L9-_VT$(B&@4:Y)^O>:W[F^K9)R^8AUB()S^.%$C
M-R=Q[]]D73KNID0XAYTU10D*;-L"3!0/> >X5#Y&T?0T8&V:*'((BJ@Z,!M.
MY<:%K%Q)?64-;KB4WNEO'_3A^VW)/CB!,5@4["G@\PUF7DUD+"T@T1&CJ:3C
MD=.F%*ENE@U(R=GQW+HS4<P9(>7Q\LQQ"[F,\;&7-U"'(.8P6I*F))6Y#,BG
M/*'" 7N7&4^/6?^?U:.:)P:+L&)B@T]O& C4MK%3P_;;[FH%G(A0?]WZ(VUA
ML#C#\(LDW.VQ3V+LQVQAG1(+Z6R#RJYD<F/*9>&/KHX)^<H3*3<_GE\0$C:\
M89JFX_[98%O)<[VX/ZWQ."R8J+?F1$*W(2HB?\N_ADO\I0KEP\X/P*2S@%O;
M+5@KC\#"CMXKFH]/-5TN-)5P+]\?.O_<J<\RUYC!?1@[KP 7#.0@M&?,(G@#
M%^=<PJD>I+GV  SN$"18XEL<C-M8-/VLYC#4^DKMYC5KIH43OVW'VX6>H3,"
M.680'=")_O9,%=HO^.5 Z\?$UG1$Q"Z2A]XGQDDZ48>S<5V7X-.A5;\Z_?I9
M3;IQ'0?GM]@M06DT'V-]_>&]>/[G#%4>[_)D(6N3O%IB^L/%A$@"Z';(Z=5I
M 56_QFK%9B/1^E>3YQ"NB1OG3EF[_Q(/$_C.L7KFBJUT9R^;4F>V@8^!M"1_
MNDEOQ>=!MH;Y]12U%6!2TG'%N^^ZS4&^4K?@G)#4D/NR3D7E9]N+Z(,&!M&9
M!O_?+_.7<A.%!5T='7V?_EEY^3@^3&P8)\.%+*:?I!H2^]?!Q"Z&.4:W%HJ$
M4+*?CJ;WQG4M>*U_>:[@,'GNENHMUG8=^&/X%*9T,PKCL!GK$VA3A-4\.V(T
M"4#-/KCTO5-OGG_UKUW??/>$-4A98!?]5MVEA HAZ>3%P%1\%J:L#&JT*&7R
MNKJBP[%O-5:74;$(]D8A1--MC'-GO=(/@;=&X=N^$U-9_P9V^>UX?@GC6N*6
M%L_\$5_TADU71ZIK[T9-S;SBNIP ?68KD9I"?U4?\,!E9?RJO9A4-[S8[!!4
M\= *\@^YOP/W#[4$8G1\(0*-0H%#,^A6#0L"HE5.LJ@R5&RI*8!MP;JV%CRK
M^U#8NO:GQFHF>N6R8OXSF?;B2Y=T#6Z.YN<5N)%=MW.%[Y@HF+LR_.Z__Y&[
M88O_C<%9SP6L3<R" ?U&;N!@VR#@Y8NBD?INZZ]J1AQ.X'@%74(FJSJ63<=G
M]N<G&S^V^ZU:)GP#[08,B/G[ZW'&I7RM\9(?-/VCH(^9\D,0._T"#=6,J7@1
MG\D[@F)5++R]Y9947>BB8#U_" H)CC=X!75SK9V.F366PML1-] >"(> 4XFC
MY"Z"4[2CAK"H :=&$WHQI0%"]CNJP.S*,^YE+H1AH_JI"YI>I32P[]T8LSG8
M"/MR"8*_@Z:/P(7:X"P+0-]S70.(DP;M2\D,3:P,V9\6++[\4]W(/"/KO4UW
M+9Z*FH&O8&/H(T<NS%'P-KE[,!T<B^*YH%K65C;4=M9<KE+VZ<F34J#]:#6)
M-W]=-A;3MY#C'G0.%J+XG/1XO3PI48)X"R-UNJ_N,SSM)4VA_$N0RNK[VP]^
M3[<WUE765C96Q9.[_JEDI3&UW301MM7_\U2/F7<:@R*-NYQ^:>?<4.\265"5
MZ(\!'"L2-YVQNJ%7YI(7/^D9YCB8?YY21#1HH':.LO R$42]8C 93,NB:I-2
M+8%WGK,_4DT$X1P):_>4!(TN>56H=R=^,WXC;JZ[G[SPQ^8-U'- Y^6BY3^7
MUC/XXKD5G^$RBS(K2:=O9;93M56=G5O/JR\TT2R8N/5MZVP;K#<V\$[P]T?U
M!CHU;O_75]R6.?9_I>(#W>3/@*)T,^J<XG3R<]VX@G+CO&3P%;DO]1 B7^ A
MR!&I#76QT" 9$=IC2(^:4NUX1S_*?/2J_,614OV)J4IK9TGOI?XF5*?%<K+L
M7I,)M"4ET<Z69K'@-[S?)_UG+M.ICY<NX1>SO=( 7G3Y"UR,'B)%AE7V'V?P
MY^;,BQ77IL:['NJLM91?VLAY^F[R; ]Z:GDX_,FEIBF-1QO(W^Z/,B[],K8L
M/AMZEN%&%KW^GY41?9N6"5>T@XF1WO;Z;THA8=UB^2_J9_R3]?92I5?8Q,*"
M: *]L<WW.^QS[_QGO$O)JJ_O#.E3[,G+9Z*O#L;4TNLT4 EK4.(CU%AB"SD?
M@ JUFX8+/I@,[+CS<]N3ZP<+Q;GE1(\P.*C=J#TDL9OZ%#V?E-WZ3^54X:46
M6<Y3H;)D>;(&0**E^H&;H8)VL[B 0]![N=8X>L$=;WOI :0L?:"#Q EK8W">
M@/_P,IFQTK1\.O\2,.!GE' (8O,,KX=9VM;\K@7YQILK>VW\T6(0QT]V&*[
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M/E(8"SJ D17J2N/.WHZ7>W+\5,(O1S_T%5HE9"::?I56A)EYC^*&S'R&$E%
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M-(-,X.ELDCEP!B^JC&0X:Y_O VG?8/>'=D-OV W*R5\8S/I;?+.]W,C9J<+
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M^< B'-B;@;1!(CFW F.:RRL+$-VT3]M?._*=*!CB%; [Y5OT ;4ZKAS&_J"
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MHBFE?]<E@.$/JUV7=N^V<U<F.=)P-GT4C^)1/(I!F/W_30!02P,$%     @
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M"6F2!I&EB 7<PIA.J0Z,T#+K&I#\A?JE:&ST^,7%K_L\/WT"+#LQI$T$>,2
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M?,VE%,FF*+9"5*X$/^[H5#00_]IQ?86,'26B*Y2U%'IW43_'1OF[$/'V4_+
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MBKM!X80 C-$%H+U%,W[L6V>T9_9Q_8X/J&[T3(=EQ &^5UHX8*[4F5:)54T
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MG_'R";ZVW=/0GB$K9RC)IM1[0\H8AAC+)RT/@VJE9TWD"T*I$X83=QZBXXJ
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M585Q=%]A$M^>'@!8DE5#?B\/I#X+ON%CPE&!3K:./-?C%K%BG@XA$U/=AAW
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MB/$"9;"J'I5?%'XY'K.!M!4BU%EON916GZ5GXY3_KN[B_">%WOJ,Y1Y+5I1
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MM"D-@G6@!U,LB/?:%Y8L_E+YF>LT3.^>RI&EA"=&7"#1<@DEO#!/I>91[;@
MX=8%6 DNE;WT=>E=>9CULV U?1L-!:F!485>I \<F&(/E6;KMY>.+*69[[H:
MBIO@?UC6=62M7YEUF,C:(43K_$3/'N,-<A_RAE8J\62Y8_M#5X=2G@Q/ ^(K
M ^$X*=81*,!C&14U"GS1W'M[=J$X;+^,2\L;!4M[?[#@Q;X[7" )9[%Q8*A
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M?@QOLMA[*:$])"]1M$1!QOVF5G=?<(^!K4&4A9&/'Z<;653SH<B!%4IWN&+
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M9JD1(-7)QD1]#?JK8C'E$2X0P__H#86%\,,WIW*DLCE"I@QYL,F2L52,7$^
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M0Z,=P$XRXHQ2: ,L\<3)!MS&-"^9>E(1)\.UT.'D6%;!#V;[3JTY,.+SF60
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MXDZK\D@H1:3%GTSQK^\(^S5\@RBPK9%E&L\Q4,^O3C.UGZN)5XIIM @FU;S
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M?F:P8E^1 3:C3>E]G?CR<G:NVYK6<Y]\]X&DX:&A8[\=OIW^>BKCG.U3_&5
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M_5QO''O!/@O[(\PV=/]<DO8+4P:N?QMT;UZ.CP5PU!A,C'>8-\#3'G\]P=,
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M=V,%S\;"#"8>$!^\B=LS)5EV-=K5MZ118 FF#KT.?0@&(V-8)#)QA2:2R-&
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MNG=UN%\*T.9E,U983LR"#L-I:$==L")9.KQZU?)4-)KFU9J4V(,G/6N(,7G
MHWPLVI/99=VYSVWB\86==@F6TO^V(Y0(C^+5$.<'O7[&[<Z/J/@Y(D5)5)HT
M 6\.I#&A?!7/<(1-I] *,C:@ZD >594!6\$YW\(:9-,LV$JFA]72+9QVM2UE
MN#_13!#3<] V_:,F)S  0"D%7=DI! E%"N:>I51 *> 1>K#!6^/<+G'1,DG-
MK9R4>=+3@KFV7*\[L5@9-,"/-X[L5\?Q\=> "FK*Z.699@ADRO%MR0LSTFV1
MIGA#&Q#R>S3[$*+"E=N(4D5\^!.L#U%$JC&$WI>(-^5=AJ>^GO@A$>I8G?'E
ML]K;?3+V'NEO3FCF6K%[(<JCR!!JL5WGO$93R!^Z9Q?< I")>?A)\LW%<<L
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M;B'A1IC?L#?PDZ)2$[CH7 ]W=+W?TY*96ZW7F_:XJ3D3IEGB+DLZ7FM]FON
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MJKZ"TH\Z]]J]]M%ZM0>(8KL*9_E:]PS''0J&WF![1[BT3OWA]VU7^2S"\63
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MP1S2#<"^1<?IJ]CB(EG>.E,GW/TN;S5@GI'RI@59I[A8O &OEZ 8AM+E')J
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MQ')TYU'_L3]H:>NR.>0I1DUUW^IA(\_E.V/]&CV=L>N3RW.EH9)TH7LENIG
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M!1GXP\Y5B/"(]]:&)#WB$86KMJN72XXUN[)JT:Q(P('MB-S1S'W%B7C-T6W
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MWC\-'SV-I;X0\&0IDC% $\M)\F0XD=<Q!P6$K>A]PU19=BR<>[-JLG0%KLS
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MA2+P$BBUN#I?B6(8\"@.A) _,OW>'<.T1M8/+?%U.@58D3<P18Z@I6'"N</
M;/L?%M_F7/@(#@;&ESL\[,RL4W Q,Z;T)!TTFXXL,9V!I"?+EBFD>8N%"OM2
MXP7#)?O$I3(LUUE@J<]C&L4"(AQAU;PY@VD2(^G)>IY/LHC&J7X2RP$B8Y\
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M XD][&^=0NS[>[O/3Y_W@>?W.&<WB^YD>L->F_& ^2CU?1C'*8.("_E)XCB
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M7Q9/)7XY7];/1:DFW[792OX,AYB1  N($D(A4N9$AI '?4:HER&?"*;5L\Z
MYMCN;J.WRK5R>VWY. -XQ4F7<ZFGMDS@'-90(X%DIHR:5PUL*/_['I\U$^X2
M("U$'E(U<KD--2/_M%8Q)I0FT286HO>*P^96B\R@!^G)4J5H;A;K[/)[OL#S
M^GV6!4$LY#\P"C&"*" IQ+[ D%'I9:I4H2S,M!."ABB-K ]6I%7;IM=U+<)K
M2]T@XV40KN&=[Q0$L_V^EO^FZ7[5RW_O5GZ#1!]7.%B6HW#Y>WG3$P?U,Z[E
M?_B>UT(EZ/>7Y97\G$B6Y7>#M5/3U#U"$JB?P3O'Y9\<)0?I #.8$S2XP'2I
M0#IR;&4 :=UPXKQUI4[OFFD+72N[+$@\0D(* \$Q1''J0TQ0".-,S4SWXBQ)
MC$[K#E*:Q."YLQDD<1B<)$YYBC,!?<K2MMX01RR#04"\).1AA@F>O?&2%)/"
MLTG1#*"NNIIN%@'S=N2XW-UM^S_E[#9@%F[!U/-;G0!D80L.#65OV7#8TE!;
M6-<#U'?H?)]1Z(?$/3C4_. -EGD+R[)L2@CE+7C^17X[5:^C6_F\YM(IO6HW
M1-<&<]6DF[#0IUG$H&!$#3B@!*9!QB%.D>]'H1=28C3@P(:)L?,>6I;^;)CG
M8(.FGC88&R,S1=%Q SIVSD##4'/BV;#4AK8ZKL!/'5]_'*5;^BG(N,JXL&%A
MVHR,$T#:R=@X92W;P=1*SGR>=\5V#_R-+Y9<%>%]X4]-,$T->%E4Q3QG34RM
MR2 @?BBB+(IAJ#Q5Y/D,$A$0&(0\\9B/?!YH%;&<QL;H#NTF4VVM7,-66R77
M,];.#UJS9I?+8?D@]'3<^/":NLKC(&LQ0/L48)S-U;9B8N)QVZ< M3N%^Z35
M+")P7_A<W"RJ9:E.OA]X+4E(RO>\O)CC_*5S'_PPB*GP(\B8)[6:0 E,(^Y#
MDJ49"R(J*-;O_:)#<6R'5;( 5SR %1-- 7[#AD%02@M!C>"<:UP,';&CD!SW
MP2RQ,0C<N<;(+H#78)6OL"I76*F>&E0/*[.XG(G<@_$YK86FB].9R+45KS.Z
MT<X"O.55Q?F'\NBN%^][?Z!ZN>2?^;?Z\2N?O_%?BD7]7,VHCS(/21O02[T$
MHBA5&7(!AWY&>9@&A*61446,+2,C*U'Y<D5FIIPUHGK&W!0XF2G5EB,5Q/K8
M)Z%GZTR9<H0W@_W.P#\X+L'=XG &FK$==RHFCBPY:S8FM>5.!>NC-7?R>A;V
MW+F06UF]1X^\#_[B)"$)YE(!^6DF]9&7P8S%'N09R7S.TS@-J+;UMKO^R&JF
M(=CN#$G2P/;8@X2&%7::?&;J85LT&_MJCXP&UM1ILMK93IJ/T\P\.BS(H#&T
MY[;I3)_#/&\9.@.761Y'"L&IZC#5=WGY]B =R0^.9_W,R_4@Z&KF"49B+V(P
MY#R R.<IQ*FG-(J@G'*$4[W>+*<P,;*>:<@!O*9G>/9F ZOFL=S(8)DIK14W
M?9LG%7=7#(%MCJ35TR"ZP533>9,ZS2H]!1M7!WPV+$Q[]G<"2#O'@J>L9=EV
M0/4V?I3W-A7U?A:'OO!\2$GH0Q2F,4Q3^1/Q0Y]Z)&9>9C;K?'/UL6V9IJ&W
M(F;786 +"#WE82V>H2FC+9EY,X%]$KCJ(K"U]K3M _:)M=,W8.]%I]8H[\_U
M;GY;K=,[?UW(M3=._YL1E)_>K[Y)'9ZK=-"<\@>5J+'NI..G(@UQAN6.)$3N
M3=^#F/@$QBP4U/=]'*6)73GS6"Q/F1D%-B;9GH'?>*5.;M0!=I>5#RYYC?.Y
MH>$QP6/5TS0_UL,RC'[KI2&=@9X[T+ '&OY&;70Y':K.2[)'8_@[56^/_0 .
M%WJ/3MDBT'115'4AON YKZ0.^RM?J-0,^=,Y>\D7N<K!4%9BEYO1)[RFW*,"
M(YBJ[IX(80XS%F;0BV.>X@1%"=//Z+=@8.P4+LF1.K-O>&HT>\=5.\]QBZ\^
M5<D@V&.#N$;$:V0<S12Q#80V@3,;+ TB:R-C:CL&(V\FAHNV0X3$M%*95,W'
MCN(VSY8KK^X55Y4ZK*#=PZAX^29U1_L\GC:>!]Y^'OS(*VT6U#L!P\&HG\VZ
MTX4%3Y!Z*VYXRCH67X.K>2[7;6NQSQ=L%0]8/#4#B7K]'X5QR!F".,LRB$C*
M(<:I@)' "1,)"D,?Z>7TZQ,UV5=6R?WG\WD;ZC)0/WIP:2AOYQ 8!@,WR(/S
MQI59,=".++-1SGKH&*ACYRC9*>#C:#E2G4;R#BI+O96F4X]&DFTI1+,[+5-&
MUJ.:KXORKTLL/<B:\^INH?JR7B[+AOR%:C6-:5W=KN8<1BBDW/,2*.WB "(O
M#6&F$HB%ES&<4IR$L581_*F,C&P@;XXR%T4)UHP!:7LTG8M[WL"*N1,F4%H_
M#[V(QQ0HF^GC$0$V3STY$1U7J2>V;$R;>G(B6#NI)Z>N9Z< _U[F-;\3XDY<
M<L'+DK-+3NJ;JEJJ/#UED\X80JF?I$1:?AF2JLY#,//\%*8HB7SA9PR%1BWM
MCY,<6:DU#,!"".4JL8Z'WLF2'W;!3:<$::"HIZ#<8F.FBGJ*0)$$/4V@B)Z!
MAC$)F3MMHR^J([VB07!2#:(/P$==87"GG5;X)5\4DL9[/UCC9O&9U^WY\6U1
M57=BLZ+A:E$W:FM=^XDB/T&(J]Z""42I_ ES/X$B4!7S"1?,,VHX>1(W8QM(
MO*H,*T!/ U=/CTP&F9F*D4ST22@_*3[^",[KNLS)LF[.8^H"'!P\-$)5J!.0
M'"FGTWB95&\Y@>VC2G.SJ&7GQ[)XY67]KHY?:NEI7OUKF;^J8(%D899Z/&4I
MYS!*.(7(%P%,?9%!@1F.(X02/S6R?H:(C:RK>M)-))CW=,_ @FNV-=,"S M2
M' 2)#WF42G.1B1AFF;09428R(M$2.$YF=5'C^<2 K4CJ _9P=W_U\/@/</[Y
M$ES]/[_>W/]R]?GQ#'R^>G0(F)Y&=P6#F<+NJ9Z!AF[SYERMWYS/ V^.>;])
M#0E=]90<(C5MWT@-H7=Z0^K<8Z8*&<]G-U24YTN6RZ<DO\J\:F.EUW/\-(N)
MY_L\S"!)4PX1"5.(@RR%<J_30/XND3_H*,%A,B.KOYN+ZP?0408;I(&BK;>?
MC\ TO)/="6^VA^WDUMZ^>F+MV;@5IW]Z*MY^E@NT>U;^L-ZJ1Y:=9)/JB=9O
M3\VK3PY4SU!,Y68,! P)5S-( @;3-$ PPIY'O)C'*8I-OK ;:X_\07V\>SR_
M!;<WYY]N;F\>;ZZ^6$>'S0.^D\1P1PG&CA=?_6XA4XTHJ.,0QDSN#I_&1%JC
M 96&/(LCF''*((LY\5$6B$3$IT0E1OYZ2<<8;GK&N=%PXH.HV(431CR?EK:,
M,C<UXP+C!0-&]N^_K\NNZX6?N ?W9T%NI.E^>E]?TF7Q-@GT7?YUEPBIWH&_
M\_SI6;K^YV^\Q$]\*T52FJ<\3IB/(4N8W-H\P! C+X!)%%**,DY8+(RRV*?A
M>^QCCHXTZ&A_3(4NQ"K/O4MM_RE? "9W&"ZKIC-&,^#ACX;9[1,]<SW%]0,^
M23-]N)GGOBG"9K([(._[IT(H0?I,^&J5"J^$.0-'W@Z'^?#3/@)72?$3<3UM
M9ORTCV(G/7YB\I;M3IM9-DU6_CTN[\JF>2'[#<^7_)ZW4S=F/HH#'F,/"AYG
M$(D@A#B*4XB9QUD:4(\F1B=<&C1'_EA<;$SP.0.ON 1OBKJ33X(.HGKJW#%.
M9JJX@^A+"Y&DKP:YMQR AH6F\U;#A,/.I?H2NVI4JD%QVKZD^A#LM"$UN'6<
M&LT-[58=4F]M_TON\Y G',,8^6H2-/-@BI0Y2Z*,(2]+8H^Y+,74YFQDS;,Y
M:[:U8LB@M5.MS1VR:^Z<.G[VU*>H:99^CV=C:'CN/)9A([0:M$+''&?K",*)
MJBGU^?JABB:-X32MC30G8-F;@OYKF9=<3=W-:WZ;OW%VLZ@EZ5RN?5Y5O*X^
M&)>_5EPLY[>YX+,HS((DB-6H1QY!% 8!)#[%,$1^EI&$D2C1:JOJ@IFIHP>*
M)OA)-3:J#.V_DR#74ZA3 6FF0WNN0,L6;/@":\9 R]D>9[SEKL'<85\.!R"Y
M:N-Q"BO3=OUP -I.DQ 7:]IVR7\KYF_YXNE"TL_K:TR;WH9=A5:4$B)B$L$T
M4%W#2!S#C$D;-,&(^R&5\(5&\XT&J8VLP%:T 6V( ]%1;R;2@L=RF9N>G@R#
MIZ>IG$%BIHK6:+1T04]XA$$]6B(ZZS@_1&OBQO(:8N_VC]>YR;"^E[+98\FD
M177U[35O"T<NI>.KU:CAP+TC;]8U,:"H:9:>'I)S>">Z$-%L\SV6N!E_O1FS
MUY58OX[TB%@#&3CRUFZO4;;>8@<7G*9X](@XJU+18]?9?2<_\_H"5\_W9?&6
M,\X^O<LOL/Q(WRS>>*5: Y^KEGK;F?F4$YJ%B$(O"6.(5 HL#F,.D1]&V$^0
M'T=&'T]S%L:.$4MN@)@77ZMVN$G><P+PBA7#6@@+F/4^L^."9[;]5=5#@UW/
MC0J5_*08DA#^$:QX FNF1JEWL,?$T<?:@H%)O^#V 'W\K)^PDDT+<8ETV#L5
M77:P7+JS2Q$6(I&Z1]KS!$N]%*52+XE8VO@!P2F+D@3ISX(9)#6R_E&DP<JG
M7A,W:;\]B-01N\&I_&8JY)#H5BW(!S$PZ4;N"@N[YAS&KX-ABW(=Z8:[E0^N
M,&'C<AU)MGN8:]UA76U%.6>5&I'5EZPVY5UOB@B9\_NR*VIMSNUFB$H]Y?NI
MRN:2QA1+FV$(!*8AQG'J8R$-+<,"+!/Z(^NTGIO.HNJ+K@NA!HQW]=C-F;MA
M1;HIRGI6U8C8F>G#;=AN-F#;8 :LN&D/[9V6*MG@X*YZR8CZU 5--M#LJ7&R
M6L9.)QV8^-)-,9U1)F@28M4%#:N21H9ARK$/ RP0"C%A/ Q,5- PN9$U3D,3
MS->)]O_GOZ>!'_S?M*5NIF:. !?%3/K$/(&$>$0!ET LX@SZB4\XDE)@RF<+
M_J2R,B:#+FNAVR1K %Y5_1ET4('Y1RB=@J>GDMV]2V8:>&A"UL615\E8W^H)
MZ4B]'B$VJ3;5$_RC\M2\RR*JK$J^FK/YYV(N;WFH%^<OM79<>>_=(ZN[ABC8
MH*HF92[+!3A_*9:ZZFY =HU8\\EB&T:;+24VBS0/"F47:]Z_Y'31YD&1MN+-
MPU=:1'!N%K14>_62M_^_66SOX0=U&GPG?JW:X^&9:B^81>I+RD4(D1='$"O/
MR(])'+$TY$@D!GU9#<F;O+M6'5I[?D"^ *6B#0L!E_+/6)$WB'68XJH1 1H1
M*[-]O@+IIYX5%4O>'5W9, 3O!)0LM1DG(P)H$#X:$4B[@-((@)J%G"P1&0Q"
MF:XY75C*4MJM0)7M&A8J^O-2!;_N1'=$+ZW]9GR#ZL[XR,N7AMQF$N.,)30@
M&!&8<<XA$CQ0C7#4 (4L]#B.21!H316VHCZR5=6RH^(M8L406"J.P%SU+)5+
MOG3N$=[@RD#Q&,.MH;K'!-'P2+#%[TZ -2^@8:;M^:K8:=7-5H[UF/@9:.XQ
M<;13W:[Q--/;MG@,*F[C1:?3W+;R;JENZT7,W=:K?]7OYU]+5IVS_[I>K,=D
M:?JM!VX?.R6JZ830ED]4VT,YKXNB7A0F:5*'$#CNO3H0WDPU:L@-?G<ZN4M#
M3"N']M":DWFT1X3:=&F/76IC,/&OO^!*OOGM5GXJ>;.1NW-FGH0ASC($8\0R
MB!!#D# OA0GW8R:BC#-?JZ78<5)CFT+\*VB)]Q\81;ZA;_*Y'@1+Q[9Q!8&A
M(;-7^B;#T2(U81@%$PO%%1J6YLA!5%Q9'#KR#9L7@RM,:$OH2+)M.&C=83EK
MO6^EV+UROM10@L=":JE(0.1CHEH@QC **8JBR(L("HW&J&^O/X$)\:JOB Z!
MH'<0=8)HY@;"JYZ&,9].OE\(5X/'/ZP^[4SQ_:+MC L_<)GCULI_+8NJFG&!
M*(D#5>FNSH>3-%%3P5/(&4FC, HE@,1)<^6&W/BI/'O:*SMJ%-SBI;<3W:%@
MMC&/- MNJ$_0+GA+RK$;!K?$?HR6P5N":S<-WK[+L@N&RL%1:3J<72[+?/%T
MS\N\8.V\VXT!MWT+'\YF**->3,( !FG,I/U/,4P]0: (.8DQP6F$/+T3+'LF
MQC_'VDA,HQL==E1'0_[R.B_>>3>DD^4EI_*%KX!<;CEOCAN:W+;Z68WI[%IS
MJ=&>S?U%U[A-M>=ITP--V[29/[$DBW 0H1BF?I1 Q.,$9F&"((J"P(M9(N(L
MZI-Y'@WZE(SSV+:S?!YM2M(Z<I."K*?AQWW5S;3^"!WJY)Z0D+<R.>P88@V:
MJ]8@Y@Q,VP/$&J"=9A_V*]E]@)KY1XNJ+AMG_78U%I @'F(F(IC%-(,HB$-(
M8B^$*/5"D4;,"\P*V@_0&=FR; =RK<B>,%_Q$$YZ:L>!]&:ZQ4IP8\5P1"Q'
MN_\0E4FW^!%1/^[C8Y>;'\5\QB^<R5U/EVJ:]9T0.97[P>)0YNA"8X=]%7VP
M8@#T'-B<SAP'Y?@YC5,\#&/ 1Z$8X<!&6UZKHYOCJT]VB*,MZ.9QCOY-WZ>S
M]]VRKFKI]TC38*B5ZT,QGXNB5#?..$_CF,0(QAF53@>G F(NW0_AX40%9G&0
M::73?#\11M9(MAV=?Y0'K.GZ_-"/[?NY3AMR'6WN/4IW@>_W8'Z0EM\6 OR/
MZOYM_X!<-P(_@1.[S]U?BX)]S>?S\\5.H[;[8I[3][6E1C."4190F F,(4)1
M"--4".C[))4_Q'%L]IG2)SWRYV6G;6$3M^S9,_NZ&."I]U48!R4S;=[ST."R
MI\ECRPCXO?N_4XO8'@='RM. \*1*SQR0C\K*8@4[)2.U75[=B7-*59F6"IHU
MRW_<$$F(D,@"#](D(Q#%&89I*(UAFE(>^FF8X<QHCI4>V9&52\.$.MZXEQ?U
MZ39F.D43/CU]XAX4,UVRPF/-P30*Q$QP1\I#D^BDBL,,B(]*P_!NB^S*/D]:
MA>@>Y7.H5"GB=5%>?;IYO#Q_4!NH+XZYFG/:I,RE& 641AC2#,<0L="#)/,I
MQ$D4AVG(U,&K=LZE!0,C*Y';5>4)DSR=@;KG"D@K$+1\@:9#(,C[4B_>L6:0
MI&B#_)'XW01XFNF?=='$90/EBB%PO8:RX0FLJN:NIH'2( MT9$CM<D-'@=8L
M>_0$7 9S2FW6G2[3] 2IM_)/3UG'SC+\X.3VE3.7^7PI?]N>JF[XQ+,T2KV,
M9!3Z4<(@"F,!LS1,(,LHQ5$H6$*TF@%;TA_[-+0E:Y^680JGLJII$$0P]'"H
MNB@&,..Q_':&$<Y8$GA)1$SF+8\)I_E,YK;"1N+YM0\:XBYHV&<L-0R!8LW1
M=-#K6>LC FKVV=R)NZ[K9%LNML.T'8/NK'=+(!R9\:;4)[7G+:'Y:-C;+F-^
M4O[+XC6_S"OZF+]P]7E1H=+?\%S-DM<](Q]88F0=_<OG^QN@2,^+:EERT'#0
MF.%;YQS-)#;]<_(A2(Z?D#M"PTPCF  !?E>\.#H?UY#6ZF1\:-W)SL0UA-L\
M#=>YW$'3GLLE?RPNN[:$5VUZ;_F(O_'JXOSAZLLYK6<DR0@+XQ@2+Q$0T2R!
M:4P$],(0>;&(.">I7D,\2PXL<F<-K;.^Y6:7WUR"UZ)LWG&5O%S0',^!?,N6
M:LPXJ!5K)W2CT4!<P_,>"45G37TD/^"Q "MD>Y9 P],9:+A2S>/'1?*$UCYN
M$777W>=T9$]K\*./BU&/'XUEOU^;'WV9!SO]&"QS0DU+V]^M:GL2S*B@ 2/2
MF\8Q22#"J@\LC3-(O80G@DEU3KF)([A+8F1?KVT->+6H\J>%JL=:OIZI(-.?
MVJJ2CI/_JRE>J]\M:AVVX=)SWDX#P4R[MNN?@?.Z+G.RK-4\256+<X_=]BL]
M+)/+4H)M M.7"NP5<&\IP/XK;5/]VSTO]WI["MN61J8^Y6G(*0P1\B 2C$.<
MAAGT?6E;!6F2Q@DUV9O[R4RR/UG_.9+F4=OQT+"Q\ &(]/;CZ8*;[<G5QU<2
M7.5*.*X5'9;)68+_7B(3Y_</";J;WC]XM85+]*#,LOEJFB07(1<41H$J\:21
M#TGJ1S +D J9LI1DB?9QX^;*(P<O6E*@Y&]\H1V>V)%>P_&PE<EL@W7B6+1C
MV9+'P/RWE<O.L&^I.;+0][$^:'MOW3"=5;V/SRU[>>\%EI;P:G1WGPNU3J>)
M$AK&@GG0#Y( HH3Z$'M!!D62<;G#LSCSC(Z:!FB-O.LW!][;934.X:1I"[N1
MWDP_[!,<_-[,6A\GQTA#2E=F\@"E:>WEXR+O&,X:M]CMYPO%\Z)N9V4^Y-4_
M'^4ZE\4+SA<SSQ<$$\]3[<2E&9U(%Y>D",'$#W" LXAGD=&HDP%:(^_G+<I
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M\]7\C1!FTMV6!F*8H5 $L4C#V6O3LO!++675LQ"G%,%DHWT41'NO*1:E,\X
M53_P-;. \*=\T:3^2HNI7=]P^,>4CUOX)$9>E$""?0I1DGB0!,B#$8LI\U(6
MLIATC_MJP?[_\+![,1P\:G64^C_A(>NY'C_J8S.S%A1?9Z!Y9AOLJ92_GG/0
M7J*>Z(=?;M^Q$@GT,K756,V=FV*!M5P.Y]]\AZ?A:K3.E*Q/.[7G.SR4G8%
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M]L19JP^)GK$OW1C&?,@98Q"%@L$,)1AF2>:%E(1!9)>(ZX:]D<V#S<S0#1Z
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MFS3+3XUIEEO-JY_HY[E6'I7:O_^#@^Q*W_T!.NYEW_-! K?$O4+<O)'N1_2
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MR;M WE6?E&&5'[;]RKL\F*.N+N^CA4- ^J_?/Y<)=E)\FR^6S_1Y4\R1)FE
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MJ-CYCBYL!>ZNC<0-KYR1V4L$J\VPSG*WSX@9.'N[V=CC_.V6Z]UFZ"XMK^G
M4'9GF$01B8+ ]W :I $F&4WUYL"DJ-$@26F:>8%,[$C,&^58O;$=LI6+DIV(
M:A0V.L!F[FFT[*:M.P(7TXW/#=WX1F9W$[;1I(YFZVD9@T[51C,/YVGSQ1^M
M'5W97Z6XG57K@/9>4BSF"4G3&$?$5YBD2F)*B(^]($Y)&HM$^?X@1+M=6];S
M0J$4*#]Z4S'HVV"YU_DH^G[H1#3+]F*5R?H#MMFC_;_39<SQ<;YW#ESG=GV
MA(UW?)S#-1US5="!G?(XX>2+]B7K #Q/$I&F#(>!V0Q'W,?4"PE6:4@#E<HX
M9E9UDJV2>O[(!9Z? C@8&S%I_K1T:BGPD.Q4JIH1[$)#V0@!@(6R*RC<2"@O
M@ 1&1VEC9B,;9>, PY%1VMBQQT5I=8/;WN)VQN<O<DQ_/<RG.7_;'E,S+^!1
MDE#LBYAB0FB*F3EVR!11,E->Z/L)9*E_3E#/3JD2:ZBQH33D9Y&Q6_9V82_,
M-6U-O4*54/3W^N]>CO';+.QH8796S*#KI#9C#Y<MK=<[,,=*N?A],5^]EA'\
M1?%EMGTG;<EDSP_1\SPTDE$I&M6RK_0W8KZ<S2%-K9H@:%DR=&<];%8V&=YQ
M?HVEC6[<M WC#D=7VV[<'H.MQ>6.$3GY7#;,JBHR.,\HRPC!"36Y<"GS<,:H
M_F@&:1AZ:13$=G7<)T?O.W.FDE6X%KCL 6$9$'(U#QB4L;8,'@,Y94%7<8B]
ML8>-!9PRZV@_?O(BQV[<LBBDW*<Q,0S=IAO$H^E3&*N <Z;GDT\9Q\2/3-YT
M&&,1)A&-_5AD*@1UX6X1V/-DVS+I3(WDPF2G3$N5KI!^1N8W)B2X,%NPJ?Y.
M,%KD!2I>%Y(*<XKSDRYRPSN!%M:M(*VAMIN[70((F\Y?:YR.V(C6XM%C)RTB
MH99VU:&[3=RPG;DMC3_JR&U[GT,,;=LW=EZ%Z+[F+_ERK$<:_<J+B>!1Q),T
MQ#Q(37(<,6?67H8%,VS#Q)=)9+5?M9#5^Y9UT[.XEHY*\<C(1W\W&D""3"VX
M643:ND,#NJ$=$@A O*T[0-PB;A<! XNYV9G:&'5K&6*XN)N=+7N1-\M;7#;S
M\SK.:[UUGP\2Q7^X.4^6U&"%S>[;P0#@7OOFOLN8\RFE'3?/\T&#S*<4W]\8
M'_X2_@*/%V*T6-S.Q!U]L68'W+NIYQ?9B+!_D_?-:7^;G2V!O='C!35L(;N)
M!%=(2\U_YF)%IZC12-";?M(@I[=]?Z3!WOB3!NR^]:<O<%B)/BSD:W70_"!G
M=+I\F\B()DIF%$>^QS 148BSC%-,22RES_R$IU8-R$\/W[?'W\A#KY5 P*+J
M& N+!>5%%@(_"5OC'CHP#K!(O,A(MW7A@UP8DF>S'ES^H,NR$N;UZ.F:S+/U
M9;FIGA$K+@425>V'N4?EB\+<O9 2O4FZ*/ZCH]7D64P:%Y#'=PVW9CRK\=XR
M\?Q5'3.)?'K;[%>\V$\#D@681[&/B2]\S$Q[%1DSFB8)(2*P^BX#9/;NB!I(
M,Z[@NSX(FG;AKXXQ D; YK-G_#7_639]GCWG)A!84CUWMN-S,+-O-I$=B1^#
M3^08 FM&D1.WPMR#D/GD9K;,]=@K-LWYE^F<+B<9R91>;?@X2V*)B?0$3CT:
MX"PF?BHSG@J/VSB"DZ/W/.4K>:@2B$J)=G/[-!3-L_AB V'S%6*;]11MM*%A
MN:[OJ^:A_L=V^IT>;9")UFC(>DHU7^1^Z#1?[,>HZ[S18CS_)!\EE\;)FA2K
MOYG%SX1F2E"/<$PHU7\$,L2I[RO,4YIZ/F<^3\"G4" ->IZ$^G6P3-QTQ]#N
M^]HK,L"O;:G*B?.F=>+^<HZ81&N-KI#1ITQ[[/8,R@F.#@^E8/('/Z5R@N?4
ML97;0(ZT2DI)OM0C;K+$S.&8:2TPX_DTWQ(9'N6]W_SB6E=]PR<YDRI?UCN^
M21!E+&6*XH2:;,TDC7%*?(IIX"59)HAB+ ;1,76M8=_KB*I\AN\H N1KZOR1
MV'F\=P4:N)Y9JXJVF:;EH3O:5_>J_$5=J(Q^J]7[R]7I\J?=P&9M0H=,4WVA
MVQ5#5>?Z#<MLU1>\1XQ8O0ER<^#CA?Y$K!9O)6G&=4E34Y5$IIP($L4A5E&4
M8B)BO2L+],HQ"B55O@AD%O!UY?S8WAV?DV<UV?<KZ,=PYWJ]R\.3S]"RUN;*
M]#O@\T+/W/"*>%X9L FOPLRK6QZ8WW_6WTYSU/0__X<?>_\K]*^0F07EI?H?
MX95A[WFM'N[4,C;;^A3L7.]%H#J>YE02*T:=*U0)O>JZ1+/-L(Z<UUDQ@_J@
M-F,/74GK]8Z[RGPF[]7U0HI\^84:I[1\^SY;&6]$7_5_+]^,K+SD _@BY392
M/R$9C7T6,)PRX6$2^0FF69C@Q(MCQ>.,13&(<-]9DYZ7:$:ODM6KU RI6K4K
MM"J50[S6[JKD_:KT0TK*G>,*X";5^9%8;E:' !JX::TQKI1"7S885WJAZPW&
M6]60U@T]M&,,W[U>BD]7NUAG/8;=S5X*U]&N]N(!X5DA9>5U<3V=%W(\_S9[
MS4WV9]DK#URK9#%4SQZKT@"5*IAUSSC7FY[E''V[>[@MTX[U+U;Z?K/AT6K9
M)YO8H-3L@WH ".9I;+&I>T]V6X$(M-XIB\5F_,%R6P#&[F:\0&YSR(/YICT+
MI[FH4P"C.),\CF,LA6END:8I3K,DP;[/(Y60. E3*W*@$V/W/-'7P@"I(0>V
MM\S6RRR"S<RU'!="@@.K -DN[M:YI;H\RI]RMI(5X^O&9#5?(+[2&U61TRDJ
MY.)GSHT/ZI:'X+2MC2DL![<,E[]R6M>]Y)4SE[CM@SZ;S$0Y$\4#?3..YGJU
M,.5,HYFXT]I6_S$1/@E4HCUN$I,0$Q69+8\Y6DL"&B>"I['R843&-F(A+Z43
M=_&(\X5AT15K99"0?$H7#52Y[A@F:1*(*).8<^IC$GH*IYRF6*1)YB6FMPAL
MV]@U@@YN>*,">JUTZ $VNZU=UV# //@6AX<6',![,HAA'6V_K$0.NM."@'"X
MJ0+=Z^9"2YXJ/=I\?1Y9!;WK Y4-6[#'&4MC/\&IC Q)J\<P4SS3:ZZ8QT&2
MJ,P#<2C;B>W9!52<=WEUOO2;K&3_!4BP; F@G2OH'A:8,Z@0V55@??SV6ZW#
M7WIA8X;9W9&OL!0ZJ+>  7'H+X!WPR,N7PP[W:BX5P^+Q=\6-S-QKV[^M7P;
M_:EW?K\O9DMQ.RM_4WR9BC^*Y>SY>JZ]U^>%_L?/A?C; E:%UHVTGIW(PR+7
M^X R'T=KN,.":4*C=:9 ';]8$[/F,S2:O:&=.\L$>GWKM(QJ2+E$H]?7J5XH
MFVC&'[(H9Z*Q+J_:(M2M$\HZ03V@&<,^(-310VR/&0W__&#>[J,\NH[+"+N%
MW2F>U9$*@X6\NH5L-RK6\<B.K3%H\4,O&LU?YK7^2:<FV6Q#-KJ-H$ZXYZDH
MXA%.DM#TRN *9TFBEWV,\9!D,E,4N%FVEMW[COE+/J,S;F(UU!0R%%<[U/Q(
MK33LP-8:UJC:+?YZ00KF$8WL,ENB_,>.%E>[WG&K28?].*#&=]6@PUKNL!T[
MH' <M?  #^!P_O;\O+Q9+$P&U.AE:7W4MG=7WZ=JS\^+,A4):9'SF9ROB@/2
M]!=#%P,X3=NWV>+@S-E<X!G9A9;"SL-.&N5V]+4_U'"G7"=-V#O0.GV%"R-W
MW4ONJ3HC.)T\J/=MYFLD1;7DG' J6<)-(QSN2TQBHC 3'L6ATLJ1U".17<FE
MLP8]3\TJ09>5";J[J=17:+;6 ]%J]6TZ651)?I;M*]Q1MSA;ZQM+V+Q?:X-J
M== NKM=[N&YTJG<U?6,)(17O&5-'LO$>L 6RD%^ 2S,[N<O  [*67V#W/IOY
M)0/!"V:_ZL<Y??BAO[]WJS)*0AA/0D(2S))081)%,68D]#&//#]-:"!#W^KD
M[-3@/3OH4APJY:%*H'VU[!$.S7[U4NM@+A-@&*A4]IP%3I6R1X,-5BA[SHS=
M.MFSUS@>Y)?-\J08TU\ER4!A-BE5[Y7I=/ZGX42;)))$),@HSE(_T>LAD>$L
M40D.8DI%&&8!#1GH#+I=9L\3;",0T;5$X"&T!6R9BF3, HDSWPLQ2>) +R-Y
MBDFF/.*3)*)I"&NOV!5PES1;' 0ZN[!-Q^\1S)6MA9=5<*,ZK+4%9]0*#OQ0
MW][<KL[T+20.>Z1O#\'1B3[@5H>-9IT4]&B2!,0_5E5L<^*30)(TS' :^MH%
M1&F*F2\$S@3//)'ZBBA[MMJ3(OJ.XM2Y3B;? =7G](ANI$,V,J<1LMCU76PW
M,)Q3F_Q8UJUN!%YL*6!/=K'%;INNK2QSHB;6#JY\]G21%^;TK$S$-.1A(E?Z
M]]*PTS*Y_%/*V?Y+LI!\_CS+_]O$$F:B)CM'-7U6@5ZH*!/*S5!U/HVI ,KG
MHBL2LD80&W=HI^\<;@O6J/G>'JOYRHOBRG?SY=_D\K/43N,EGYF"4FAAA\58
M[QV#UHHAK1G:JN84CSZ/%2A*W0E,'<>NCQ'JH9L-!(-+0]WG!;Q' +S5W#-A
M\?;['-8P3RM6Y"+7KEX6WV?ZIF^TT )*GI0= H=)S+/8]XFG5S5Z=T.4QS'C
MDN&4!)$2A$F6!M:K&DNA?8?$=[1 *Z.&_D(9/:H6'OKSM]$$L!"P!=1B$=0#
M3#!/L8=0J0&J5*@(DW89/GI "+!XZ@$IM^5478QI\*K2 K7OK%ZMY9]S5,A7
M:GY6\:_B=9WTV=>N^(\:=;UBTK_9O4QO/"EB"TGY#T/%0)%9J4WEIO8:\?EJ
M*E"Q8O^0?(E,\&VNW^_YHDRW,BNP>9E]JK8*\SI)BKV5OR_HR[Y(LT#<_$*O
M%.EJND1ZB?C/KE9OP*?8N)ZS'6NX%1[0NKTU'_1>M[C@/NG*O:H+L;YH.]8=
MM\;SZ_FLF$]S41&.K-<\?D(%BS.)&>,$$_TT<,:3$#,O(TH*D62>5:/CRU7I
M^Z/!?TBQFI:S:'U.M2Y8TQ/G&_V'GF8/]$W_^52. 0N47? ([.)GPP +^\SL
MZV20W2L!W'1[T_YG5[->ZH^[PZFC>-P%B@P:IKL<L,/H70<CNOG!VQE?E.VM
M9/7W[6S#'WA-7_,EG6X*36CJA2KF/O;].,/$3QG.PC#!OHQ2O32. YF"F+KM
M1??LYZY_E+V^\QG:%J=4B9QE:$<_%%:O&\"MEVVQM7-H_2 &<V!K'=!O:RW^
M8I#;\HO6FO12S0,'H+ONS;:"A^[G# 3D1(=GZ C=44L="O\R7SR40=([N9PP
M/]*;;9%B$85Z&QY&!#,2*YRJ)%.$A$EDE^#@JD#?21!R:;8;6RJIO-;E<GJH
M1ECM7$V?8,$<SM=S9% G/-$5TJKT2_UD T*/C$^-XM^=Z,D&'!M^)ZMQW-S0
MD^0K+>M>[_]G^?./95V[,7LV5)Q/<[4N0HM"QI,T3K3C(2DFC 28I3S!W/-9
M(J*$!:'5T290;M];NDH+M%$#;?2H.'!_>[K_\FB9"PN%U,[S]  4,!)HAU&'
MM76.IG?6JMM.ZL!-O$%0'+?WAMWN<)IP-Y]=TVFNYEH"K=]PGT=4$1;A4 I?
M.XW,-/J.0^QG2<99P(2?6BU9S@GHV3MHB9AO1 +"W*>PL CZ7V@A;%H;X[;2
M7&BE3ED)"-Q?:*U;D/[0ZJKA?5<44@TF-4:L3]TW7'2Z0>N]2'33=4ZM<L=S
MO9T"%K4=W-:S!S"M9TMQE]6R'=K:X@LN,Q/F!MPLA';;/66+:\_=O;&&[+Q[
MRHB#_KLG+W'XF);CW)D3?[9\-$_D&_V5OZQ>)DF0L5 &%&<L)9CX(<.9H"GV
M@IA[RL]$3#+K+^HY*3U/JNIUF\DE$EHP,L&5^15ZJ60#OC]G0;+XU'9A.FRB
M55;?E;DUVNK'RNIOW5D-^/1V8;W;]]<-!=A7N,VZQD_QV9N'^QZWZ;_W46Z]
MV"4QZ&3M5OG38K1:_I@O3)YG>1A=\NW?OYK?F\:(Q<TON>!Y(1\6.9>/YAQA
M4PD_\7R2J#@F. M9@(GG,\SB+,$A56D2)W&44:N#XAYU[-GS?9I2_D_\Q'_H
M^XL=H@=(!DT_S\;"9;X_XL"XQ4Y?HOT2TDIGM%6Z3K4IU4:5WF6SVN(*K55'
MI>ZH5/[J0STZ2*[4NS]"U]0J#??/DA)%;!-35V6&.D6LG%5%/:M>YD(#;RB#
M7U>+UWEATK$4$A4-A[FA;F+S.E]J/7(ZG;ZAO"A693Y!E:\U7RV+)9V)\NKR
MG9A7[T1=)5\50^W_ZM6 5)Z/5LE5"_FO5;XHB:RT+B_5JMHTD-7;S;(A]WP]
MVB8K7H_W4KZ-95)/5XE5O3[RYCRL?D0/F+;5*W;[65[]BKJDI^K7ZN2AX(N\
M%%IFWDPRY8=1I+<?OD@Y)B(PC*6!P%% J?)XJ$))X-U33\KJ_>"Q:@E:-P+=
MD5YG&0'[DC>A9GG8V T6P'-%=Q@<.Z V&MAIK]/3DMZAJVFCR:?[ES;?XC:Q
MS_8R-YW,JY#HQ).,A$%B9K1,, E$ABE3/@Y"R87T:2 9J#VRA<R^@WFU!E?E
MVFY9?JPW6EPAHT=[0-@93[NIWS%*0!<PGSWCKZ8E+AKKG^=F1506SW88)W<P
MM"-78"-Q4)< @.#0-4!N=3G+*ZDF[M63G.7: ^4_]8KU^RQ?%I,DB$0L,J*]
M@A>8SND,Z_\'V&<1BSQEJ ^D'6UELR#(2^[$45E)-EN#HI2-IJ5PO0/(067.
MYZ&R.?#KPGS@L5]E][U)82_MKJ2B[YW9#3D"[,)^MRUEG=4WG]&I\7%YR2A5
M8V$^#+=ZJ:W7X<(4*EM!!#PI;+.\^;SP[-T#GAJV6;!_=MAZM7.^]OQ%/NF'
M7U;!&+:<DN/A5UY,LC#)(B\FF)5UBWY(<!;[$@O%94(E]4,&3= ^)ZOGE4O=
M&F C&JUEH[\;Z<#52A-F=JN4CI  QO,VUFNG72.REGR%/M&IX?1H \0EQ;K-
MU.YRJL]*&CJ)NLWD$UG3K;>X$E:QY99#=]LF)?5Y3+T8!\3TFN)!B#.5I>9
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M#_!!((<YK]V \G[UT4[A]*>WO<!SJ?L5JK6_0D9_5!IPA79,0#M/\O'C/$G
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M7+=^54_-;6^<HB2M&_^@LWI3>&<VA<52BO^2^?,/_7?=2?EW/?3R,UW*#<G
MXWPZ_3)?F%$G,2><<THP#P*"B?05SCCEF$N/!;&A@2=6SO.#VM>SOUZKLNE:
M72J#C#8[A"' E>/'0M!V5?JQM'[GX#%KC"/6?8UW;$85B>E26[V-,FX,OT)V
M[UDOI>X?],%VM6S_8-8-NR7X8,:?VVY\4#4OHQ]YT\-]61EZGS*C_^V3G$F5
MUSJN6U=\EM7?$Q[$&0U5B$60FG33D&+J$1]3)9G)Q9>Q!%'W.VG1]WGI#_-
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M"<4L#U069W$1AJ!\PXNQN60LLAC06C@\=IZV+Z%AIGU-]0JMZ:*6,+KK;[T
M]G9MY//DHO:2FM2OM!'ZT!FT>@9FW^IJ-6M\PW65G>!:)9-(VZZ,:(5-$UQD
M-,"*,:HDC7C&$AN%/5AW]'.WWI?K5<F;T"4SU:#-<0YV47.(1;]V7B A\)SJ
M*IRU(IX1I4_G]",[^J;_MM6UP]4F4:LS(JPUZ-RO7?,0]8',U* ?I+GQ-%5Y
MD<18)5SO=J$9WQ*2"/.<:5E2FD0BA248GJ0S8>;@0<K;.@\=N >>P\MN^_.
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M&^M[LM42588#-#=, 8*% "PMHJCC( 1U/0P/)TH-.M2^*-2QTMU.67IB4+@
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MR.?KG-!#:=JSP;#(1^<!BT?@28XWBU53!_?CUFQUI2IYXSVTD>590 J6%"3
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M[OKS5_W35YAV6Z)GI^C^,8'I_)H^VF$ ;3GPW(O+36I/ML"2Z*1F 0;$H84
M/@WOTM6-@O^H%V5S,T#C9B%,WL@L%DP&E!58VX 8DTP?A"C),AQ'D2Q$F+!
M6.WW?41&-@0=6=32;<?#:,I-QIA]SZZS"/6KOR^Y8<KN)#*H@]>03$Y=O,XN
M.EDGKR&Q=KMY#7[6U?NN:RFWHUV-<[">[_KZEX70Y$S45HJ;'UQ_]/K)_&U&
M(ZEH(5.]>Y-$^^4!QWG*8ARE+ S30E >,H?+3B=FIKD)-:S]!WK6GS#?].]-
MTB?;=(B%^O$NF-MZ^&-!Z.C[&W:N=N= &XZN-N.@7Z_0+E>H90NU?/D\&EP
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M"!\[]\157+<V#1TQDQ0WPDE]CRR>'(9#%"9U!WI$?/VQ[[O430NO%J8K;^M
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M< B\3?D#D)YX\A\<E+?3 !W6<$TH_?1<M1W40,FDZ[O&M@4[B99KDM!\THV
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M"%,E<^VP!3*6 >7"KJ>[';F1C<*:/MJ=97!N)J4T/  T:A@X"^/A%0Z8.1E
MPL7(#$,",#M>H7$S1*XO"\P\60O::["&5YG.A%E+M&?4[.]RW,X>=*F:W];G
MSZN'966<J5],#*,YQ+E^,O_>G."L1ZLU \)NS2;@\R;-(I8J% D/,<]- 6-
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M[\>@L7#O?0@,T\,#LCI-MS\F-&2\O0?AW?QTR ,'CK<?D*E_OOVQFR<<<#_
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MD1_D0JIR-0MYK$1"!9:,99B0.,/:3A18L2()::RB* 2U>8$0']E8-"Q G08
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MFJ1S%X5SN-DY2<)BX:;J]D'831XV](%A(+KM@\:G48*EM.%:))PC.'9S!$L
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M+6!BTS5T ,C<6X$^3O[K[MEXJY]_O;N-[C]>?_AX_W'R\<ZQ:=H9R.R,LG!
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MV-1DS[G6?(PKP&B1 <&4E(QE<4&<6@B>(SBT[C-]+K3]VS 0=1R8GIN&!\\
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M.\AX;AI;>?8\*]8ON:FU2F^0IJ;[H_I$_[DLNY94;3X#91I$0C&(L82F8XT
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MS\.0<)!1QE"<IBS%3J'KCO0'5EROI:3NL/1O79WDWPU;4<N7H[_,%76[<^N
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M!UMTEUJ$\@[&I4O8XG$/25ZOT=239]3J.?4R<5NVGRKK&#Q^PRU(LK)9>T4
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MT7#MC8S"06GJ4\80*' EZQ67HAE!KU"]V+A@FQOSAY0T Z:MY+SBPGP+IC<
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MX\%XUWT9HBEU;UF#X+EQVF=(0G(T\)T$0]!W-+@L+3SCR=>VEE^GJN\LRD[
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M@7V'3"OCZ$F\JS-A-6 'WHO:X98_GBZX&1=>\DF:+N:E#J3V.9>J"TO+W7A
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M50AE04&_X8$:\GX:<]^8PSV>2;/IO'2GCU=ACNYDFGX=AK3S;3@;.$UEUE$
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MWRB>?)2:*?#&262M1KT<G -E/9JTVL88JKL5;R6RWZC;.P+HL1?2J31;@^O
M9T:LLPP(EQH$#QH\EP0"IU:5;'F3:[?\>D! O_V]*JN]S5G;P'%[TSKXIE'*
M76\S0Z+V@0 E5(#028#+/((,UG##5'"Q]F7V*EK64TKD!X%+%8XWH%$>K^.#
MFPW#P OT38.(D',F(% )@A6B%&M(18-(6JO:-]O/$M+S$(LJ,GX%.&]G>(.H
MV1N.KO P'^@R)E@K5J9(!5R&8V 2->"9RM%$'VGU24PK2.FY[^Y[(&<3IC>
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M;39H<$JDTFV+J:R5T=7[3JQ/7<\M4)J#:T=R;<#\?+JRFS $\CT-OR[F8NE
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M1=,](XF7BPJL*,IT2EK6:5&/9YZ2P1TG8NTF()O2VF0 NS.$OH= VU"7=S$
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MU88I 7JR=(C9*+)QT6"G"6Q/*?[VHL/<-C=3_-'R&\&;U<XC[R9@Y*B%EMR
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M;8!-.S!?9O)C<PV[S]*/6L*PL>NOSSZ>?SI[_?E"<A]M3?WSZ&KJC^'T%2]
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M,Q$1.!A=7Z2=%20ZC\2A\I&.A*2:%X,?1."P-NYY<->;PDYX3?M2>TM][M'
MO<O++4O%>1]$%*!9S8X**@!BI.B!:0H78^36M6Z2LX^>80ON!C)U1ZKC>'LW
M6^)EKX]KK]___N&OG\\^OWG_[OVO[\X_OWE'WSG_</Z1_O/[^W>?_G+V\?R$
MA[1#/K[5H]G1+#5Z(#O'^90\NL6'//_TM;:ANWZO0&YTJO&#E'1$NN A:/3@
M38R))1$>7)*=O(-WT7*JI:*-\&8:*51Z2V?_34LJJ:.0C&(:P3DHY@1M!Z=
MEU(HU&$YW.]B>#*#CQ(RK!O61/_W;='I A^!TW7#P?9M;S*](E&]_Y[7.0P+
M^A/KU)@/L_E*7\OE?!*NEJO :/9N1A\P71)5M,*7-U.B+"^6%PQ9DI8YL$77
MNB,E 0,7D 4F$SDS5H7&L.N'DV%QVP!BL]'I>Q3YH4_+81_?Y_3'ES\O(D^D
MBH# 3>W\7=M2!*8$<"5\+(7BK-@ZK:H%W<.&)D-@NK$N1X'@.W*\",+&VO\$
M8A+5J?89O T&L*CB43"4K'4BRQT"AHT]VF/J>.DVBRR.A\;?\^3+U]IBF?"&
M7_*[JWK1_;ZL7)_%^ZOE8HG35;+K5E(.)8\8:D@6-R\B6-!6)H531I30?$+R
MH30.:[1Z<2![5=,H;%17#E_A8A(O'"\RAL!KMFT=%ZV)41](M-9&'GCPK/EQ
M>A"!P_J"_:+E2&@>KKAQQ#SS7#O.X^7KV;=OL^F:K;M.PNI[Q%Y.F_;T9_,Y
M3K^L_M[B J-)6A0);M4LD_%ZF9D+I."=5BPFVSQO]'2JAS6ASXK?9U;Q"$"]
M0[R_3"ZOZ+L/I'SA1#2."5E[Z+%:(\P!C8\@C2NI_M"+UG?7!Y(XK$LY!G/;
M1'DC\$?O>T_K4X-(=T70CO*9G'*%Y%D[33Q1)*:-+2FHT"GS^82[U^['>F\X
MZ\6S/%W@HW ?[[.QV0\7@64A.")$"KT(_H%,LV<,)-<Q>2R\\-:I+3M(&;8O
MV+-@YQBACP(]9]/E)%7B)S_RIQROYJMI:NM*SYS65T7?OE\M-V6 #X3YK;XT
M7K"4.3*I(6"H_1T3 Y>\ ,:C0:5#-K)Y)DL+PH<M)N\%F<^OT!%/E_KU[,W'
MOYV]_>OY[^=GG_[ZD?[S[O.G$YZ%]WY>JW?@[D0W>OC]%2?SO^'E%5FQ1;R<
M+:YJ$+#%8O!664F^DXZY]I)6".3:.R /BC'EO19"-M[:^^@YU=Y=?_:KGZ_P
MLN;E?/J:\_*WJ@+:!^LD1NZ*(A] 0]2"/,=:W> S;4?AN"C6&,-*:[>_"UW#
M7JTT0\E]B]5<)2,(-&_Q=/WE7R84M\SCUY]O\X]\N:K%TKXPXV4B[U)Q( E*
M\#(RT,':(DU@NGDO\FZ4C01JS1"Q&W*MU#,FT/V>L6[/U17-0_XV10+6&O2U
M]9$(VH+2TH&3SH'F"KG73&:?^L)>%P)' \%F"-D%PN;J&A,6WTS)V5RL)"8V
MQ22:><49E\"]\G54<P$4!D&K8"ED8JR(3@VJCT'>0W)&@K/V(-@%MQ,U,@9P
MK:M/\/+-E/R/J]6M=-V-+&IF. 4L4G.*F]#R&K4$*,I8&73$6Y-W6P'K<5*&
M?47H__QLH( 1X.CS'*>+4@OCMR/C:D),>82[19T\L'C\1YN]J43)RDD+,1?B
M7>@Z%2YQ$BIWR<J8G6N='M"2_H'-8 M S4:BW:&KWHGZJ_EJUU^%Q21-</[S
M[8RV?9Y_>S/]D1?+%6/;RDZK@[0.@>="D9M%!;4%#=3N7E'$3/]VZ_QZR*K#
M@FTX8,R>0TLC,*PW!] CQ\^U,#^1RE<.SVO\OLI ?'M=_J+)'=&%>V )-:A,
MO[AD.$3)#;G:AOSJUJD#I](\[ O9,X;,SZ#2$4#XEQR6-_?G?\F7Z?/L=US6
MW_\\^U:SOO\KI]>SQ?*LT**WJ_Q>$[&3Y2HE4GB52=[$9!&T;5,LX+(H($VV
MB7FMM&X^(+X!W2,)B9X%:??[\#ZWVD< ]=>X^$I'8?W/^3^O)C_P\DX0>G/?
M>X%.*'1.0.(Z@XI& .90(!ERS9Q2,:C6D7MGXL82<@T VGX4..KFJI\^U^:B
M'W]Y=7[V\?SC"4]ZCW]0J[>\#F0V>L3[E+]48'W,WZN1NI5R)0RFD+4#]":
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MD[]XT!R]U*';2)']ZPPW5>;Y$--.T$-CYC5^^WZU>,!"=)%9H11HQ\@8!X9
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MRLCJA%M+]E+7QPI7,@3.T;#(LQ*I$Q:>6FE$J#A&C[O+TDX4ZM!.:A7*^H+
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M7FO@AB+/$=[T(?5Q@V@[?*-D[M$HP!(\J$2G*2IMP?MLDV<,]?T!6T?!:,C
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MRX!YY,,';OS[;*]/I\IU9+C8;!SM;#9&"(JO:L-%:Q6@"[4@VC+F9"@V=)N
M\.C'#_A$<+*Z]NC^"-D-?+-VNZ7Y-K+6R8:"K#:^ST#A=&TMEA&XSBXIP:47
MG>:\/G%Y]G#E\8#B&#W.F@EU%$6BE8?\SRL2W/D/^N5ZFAN37#(7ZLCBFNJ.
M@63B56TR4E 9ZVQDS9MI/$[*P+V_GS-YNX4R1I"__0@;FYT6LC6N>$>,Z )*
M*UUKNC+(Y$IP)#AAGP%58\CB;J+JI^%SA-S'!Z"-;?69>\84V=:L0F4"P2=N
MH93Z[.ZBEM+U"YXQ)'HW4O)^Z!PA\1' YA$+_?:Z=#5F)3 R!@(3)[ML+ 05
M$G#GG$VA:!5;FYY]] P\8> Y3[5F:AD!Q/8.RM/%*%9[LNE2JZ-=T. 9R2S4
MZIRHC578NK'!>&<6MM/Z(;,*#U'!>&85WGT#?943^0$IVIR=!L.=I5#5DQ_
M61VIG+3TO(X7.FQ@T\,UADT;;HZ/EA(=^J[F>N#4;/JESL4XBU?+_+IVB:F<
M.*5C-B)#2IZ,<;(&G'<<F"LNB^1,*=U&Y.Q=9MBLJG[A<;I<QX*0VT^>?YU.
MEHL+J1Q+P2C@N0ZL$_622]?1ALHZ0]:QQ(X#E'8N,>SS8,^&XR1Y-CQ2GJ43
MR8>K>?R*"SI!)S%O^E'50I^F?4F>6*3'+B6'L#=,SQ+D4;%86Y$2:H%<%PG>
M>@;1<.G0.6%EZ[[-(^]98B./4OH,;M7%V_L$:&D;L\ <DTEG:SM=2_]/SY+#
M$79RSY)#E#?T"7K-TD/AK>N-LD1CZ[. DTJ2PY@CA&0I\ VQ:.F*S[E;WMY3
M*[VP]B0'*7G6E\3'#)_-A5Q*/'&T&;Q*Y$]&94A04D#ME%;H6UK=?V$[ D"#
M/[2VU6I7O!PAXJ$1L[/RV0FI<T +W'*RTXXA1::N_M;Q%"GTL-CM#7Y<K4EZ
MT>&LM4!'<*FX38']<(G3)0FJ=B;^OFY=?/TNQ%FR-FH.!5VA8]P)")QYX$F&
MVE?#&M:ZDU8'LEY8Y?DQ)U=?2AHS[FX]*C%NH[(H@4?!ZGC##!@=;2IC!&<L
M2-5\R&0'LH;UF)I#H2O4CM3+"*#V%J=I8YP9&J_KF":&S($*0@*F2'N2.6N,
M-DZ;UDTI;U8?*7".5>S]V;?'27D4B4BOKDAT=2+Y-&V_?//M^WSV8UVYO6&+
M#FX>8B0WP3 .JBA!%AP#((;DR)74H;DYZD38L =AW[AJKYM10.[7J_ETLKR:
MUU8!OT[^J%]=%PN9DJ0Q&9+WQ(NKS8@*.:;),^U24$7KUD,1=E,S[$M,W^!J
MI(7A7W-K?/.-W,ST/L:K[SB-/[<!RK;#E2(/,R=9\V<LJ#J)!XW0X*,MPBJF
M,]X;3+HKSGMBI6$?:/H"3'LAC\(*[7W/,C);E;@!0]$)*'0)@J]\L2BST<5I
MUWKNZ,E92^/IM'%*O-=,+2/POG?NR+.4UL*[""*7R&RNF>^)#N]Z/\>"@>R]
M=M*AT>G9XKQKJL;QT'(Z KK&=\>I8P0 ^VTV2_^:7%YN;?$O5_/K@:47EAOA
M3"R0LJNU><5!R+0+163>!!]%]JU]J7WTC#CMZ110-5/!X7#R:SA-\_)T)VK5
MLFM]5;QXE!6%7(=0NP'8Y$&148?@R$7DD=O"3 [:=FMN]]1*(\Y_.@8G[:4[
M KOS9IIRF5#XD"\G/^JLOB5.O]190G=9O B\UEY%#T75VQ"G+ 1+7%J!WFDO
M@A*ZL0GJ2-J(<ZE.L49]*&;X"*]CZL4=%FL;P@F&R>6D/E#1SZZ^Y?0N+R^R
M1F6]IY!6U"XGGA6RR5: *5(I9D70L9LA:TG5L,7<_1B]P;1VO(&<+?&RUUS
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MJ1K+(.TA;J2.4\V8P?;;O#;+#SR9%#$#"\933*L4>$-\!;08&$LH9*<^:RV
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M)S6N_N[!8VKN0I&2 [>AMK/2 DBT J#QUD?,T6/K@N@]MSIN<[*AL'@,OG4
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M)YN(6=2*H4R>/$A-%S0J!S$; S*J2-ZETM:W#@4]M(^1!R\>R-LGH;('H3L
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M_?NS;3X(#7LHGUO)@<PNJ))4G11 M. LT-WE..CZ*"I3B-%L-6;S=.LF][D
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MY/KHW;OV/<QIE\[N@.D!^_P< (]>S*U[5NI]0L1'"''C&KQ-"#[1)J'34H!
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M$Q$_+RZ6YQ_?O/V\T9M<JJ X3Q!=S:9RQH)7)@)R%6R(B<6\G8O\P,?' \-
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MVZ^-K*>7];65D[-I:";U>N7S="[=5=OX#'OVM/"+%%*GO#X TS(DU_Z'++S
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M!0PVPV#!%8*K\Q/H'*)S"";#,XG9PJT:?=0Y;P0YAE$$@#L$4)?;*( @QF4
M7[OP:6$Y^I31L)RMN"KCK FMX(K>=Z+;S@]T W@ON$GIPM=%K&_'83,1"5L8
MOS^R>>FS-MB\!"!W!J2A9,S*8#,]'%'@%P _SFX'^3 DBB%1L!B2155%J+\@
M@UD*( DD@ROSMO9+YQ!& YUY(68[/D']R:N$@SY!8,,$7K+5A4D0\##$"PK\
MO?0&AAXB+" (#$G@?/!OOG@4\/T!^'9X "/H>[F-ZZW1Z2QZNQ8T!9,3F"@$
MB.V#.&:%J-O?T@E;ZX%@<PA.E9T(*7GS' I@B/EZ(-@&@D7B72MF12.,R6"*
M$$2&5N9M<7-#4N.40MA#T!> /I.,L*\7YA! /@YE!M&5\S0N-A7BJ,+O&C,=
ML'*&).PC<-P1CB1I0H8L_%/XI^ O!'_B1ALE*/I<&%M.WI\FE'(VPX@ICDH#
MCJWCF)$1LARNT5E6*.%FU0L?,,([!8X!<%1D9M%;5BD\4WBF8*]=]A@'-GU+
M)00'!H,-,_C)2E*(@P@+"/I:IZ\\D^(J-]5T(>)SA]R% A"W2A=KYW3VD#;/
MOO4-*)\WO=M]P-\+*$1<BGAM?"FY-H[*J)->R(D'.V/E JCZ<KE_Y2B6['^F
M8G)R[#\6%:MSOWGMB\^U%>5#ZAN6_FE-^&@J4C?RU^[ZHE=SU8^BN\Q"L2T#
MBV[/DI$9"K5XB(>YJQ4Z.8[+^M45KJJW^CDRBP)R&O)>;)C&>W3CV/1)3FEF
M-Z[B+[%Z2SNKS3?R5O)NM%?_S*6G@/N++T>IL+FD65^HZLE5F8[6B_-M[TYK
M*AO;/'EY/YWN_)[J%WI]Y3JY4R4MB%I+V^]V#O</MB9W.[VM:0&*[1UTNKWM
MR:O%PL]LZKW[[#7#AGKT^YKCT:3BY@8C+MLE.A>2[TS_H;\' '<'H"() A\8
M;\%Y:."O.?Y\Q55SC>O)*X23EX!?D_AY_J2KSL,N_VYA"#'Y!PA;AM ZR=&%
M3["P@P@F P## %@NL(+Y X$@L'T".243#<H]$#" & @%@8$(G(<TW)@<!(:K
M0GW5.JU6R6ZHU$RL#R#Y<EO:8H_;Z815@4"C#RCU@1Q/J3G? 12^W+8U&%%.
MQF"*$".C8*]]]AQ3$?VMD(+ 'X9FP&  !KD,=P__$_XG^ O$G_%-2TB)R7F8
M0" 8 D&1C"GEYD;>G[Q$Z ""O&;(RQ3/,#4/XP<$ R$H3"(7E@\1[1'1'BP&
M9+%:(+.Z4!M1[1'$%T & U+Z1I65%WZOM1NMC-& 2\3S!9EAR<0Y3/!:@6)P
M93R*LY2EQ/ I?%5@&!!#_Y:/KL:",8\(%('B(T!Q%KV7\\$<F,-5?2Z$Y\\[
MI-AB 1 ;!W%RV_-9:V 1>$1'$32V2Z/P%_4O?2$Q<@,@ 61H9092^[IX&WF#
MH1NL_09_(?@3-KK0I5V$181%!)&AB=0DV2:LDMLE<5=L)J(Z!@9$KDHU/Z9I
M\;XJ3SGV0LQVK!)8?+D-;.!;UM1[7^;VW#1,:VRG$4&\ 6)S(!99+*@\$BT7
MAIPVB[/L81+7A9IX]V'%=\",!EALBD4Q6>L&P2)N3C*R4G3;KX9%!(6[I% E
M_E;60[=AZ 9#-V R))-#WZ9 (V@$C<&5\30:2L$B6 2+H97Q+%HG7%$MLKS4
MMUBBVXA0&^"P50Z7*TE@$V$3P6) %G.NCGF *=RJ$8*^ ;U&T#.*770F,N$X
M!74;\ER/.'JGK*]$],'H(M^U0,\?O5,C?M<*[-W+GG44?1&)TT;@5&[L$H8=
M#,BB\RW,E;NA!H89 5 Q*@,,G^VBK2>O$_Q2,-@<@U/80 S'@+T0['GN,%&/
M20F@&%P9CZ*U=PPA6,2Z[L<!8%R.6&0/:?/L6]_ Z*FJ3FO;:(#?$4\*,O[H
M>,Z/*_AR*7_E*);L?Z9B<G+L/Q85JW._>>V+S[45Y7*QOF%)3DSX:"I2-_+7
M[OJB5W/5CZ*[S$*Q5ZQPV[-D9(9"+1[B8>YJA4Z.X[)^=86KZJU^CLRB@)R&
MO!<;IO$>W3@V?9)3FMF-J_A+K-[2SFKSC;R5O!OMU3]S2;GE_N++42IL+FG6
M%ZIZ<E6FH_7B?-N[TYK*QC9/7MY/ISN_I_KU75^Y3NY420NBUM+VNYW#_8.M
MR=U.;VM:@&)[!YUN;WOR:K'P)FM3-;.N/'.!QCC=%^,JC\R7?/;-:C#+[^W.
MS?E#^%$ "  ;5>:7?[V.WBGO'N9&6,2JV%#GJ]9IM0 60;AW,SW*_R +#._!
ML%QOIA(!%W2[1HC>!#/8''\W-SH5$OS! P5Z+:-GQM4Q,)A=Q^PZ: Q.8QEL
M&R@"1: 8&D6.SK6PS9VJ\.05.A>2[VQ @F,*_G;$GW^WKTY,P!["'H+'L#Q>
MESL!KU@);:(S,?$5QSC-']F6^UD;;,L%B[MD<6C(XK@)@ @0@X+H,[IHH"=8
MOH:Y0R 8#L%W62Y\LWK+(YIX[Y06<XE@$2R"Q799//,E8S4I& 2#X1@\)RGU
M%$[I=_8/$3\-,.X6QC(8T4 X++#!+ : #*Z,!])2 ;.(=:8 KV7P)EK943E&
M _C@DX+$@"1.&=XHO%&@&%R97WS%-E:YP2PBM#80;!%!09E6:?2%I(191'QM
M@!@,1)MH7YM9&>T!6X$?DNH#.5Z>T@A[" QWB*$VVHU@"-$_!(S!E?FE7%>Z
MYIG"'J)[" +;)'"J/'P#G66%*F?Q=S\K]N0UPJ0%.&R<0T-#K6[D#+L/L>D)
M+(9EL4C&F+/ .AK %P0^"^S@C(+!D.,--)2^?9'Q-X3P4#@$#00&(G ^1W'%
M9B(2QAS%QB9#(](A+V9PRB$L+\1LQV<, ,*7V\#>D1F1:>X%_^0%PCP]X&L.
M/NNB<[:$F7K,U /'T,I4.%Z*R6T+ X_@$3R&XS$9Z6C@^SOE<6$8+44@&B#8
M.H+BYH8WCZ '>Y@@!':-8B?)"3BA#^]C*HR*V9B&E[D#PY?;Q-Y)+XWCZ%28
MZ)Q3 +A^\#CE<]NW<;+O)S5AZS)6SF)O(6#<'8SCD3;JOK<]PI)B>R\0; -!
M*6QTH85R#.\4'4,0V#J!583\:B"FYN_46IT([Z6"P#^PB'3@O=+R7 $ "2"?
MPK;5)Z\/W%&PUQQ[5J2BR-9'', ?^ -_;?%7!L:79<BGE"1L'_;Q@L$@#)[[
M?SC461EY#0R"P4?%8*R=T]E#VCS[5EA3>D'2.ZO?U_"@W@Y'<GY<S)?+^2M'
ML63_,Q63DV/_L:A8G?O-:U]\KJTH)X'[ALLE+!,^FHK4C?RUN[[HU5SUH^@N
MLU#L%2O<]BP9F:%0BX=XF+M:H9/CN*Q?7>&J>JN?([,H(*<A[\6&:;Q'-XY-
MG^249G;C*OX2J[>TL]I\(V\E[T9[]<]<4FZYO_ARE J;2YKUA:J>7)7I:+TX
MW_;NM*:RL<V3E_?3Z<[OJ7Z!UU>NDSM5TH*HM;3];N=P_V!K<K?3VYH6H-C>
M0:?;VYZ\6BQ<RG5CI;2AC.!08EKAL;F4S[Z5+1B43+X8W]Q (;IU8# $@U<4
M"Z7!'_8<@;MVN5/1+R(CK&N! PH(PT'HR)=GT0V$ PH&PS!8AT;#QG>L;0%[
M+;.GE<80*&P?^ O#W]>1<$ZPB:K83,#PFQ@B2C8P;!##KPP,@2$P#(2AD%(X
M#(C"'06 +;<QFJKHG"G54XN=[P@."B)#*_->&.^*X@2S;\ATJ9/Q++K6.:;J
M >$3GHM^\E)AL@(8/O4>T),7"A "PJ<^#OCDA0*$@+ Y"(5W/GV?)WI/4MH[
M/4-$"EUJA1"%0+ 1!/4L17A0#)*"Q>#*O-=&\2PZHS%CD!26$/2U39\IU\M\
M%!)'* $^P-<N?-8*B0E"X ?\@N!7E#O$+3J & 0%>X'8N_P[J&OSK03H7G+3
M^D?TEAH^C/+)JX1Q3\#8$HR>0*FGZ/H]M*NDT;-K .#+;5HE@%<Y&0,",?@"
M^MJFSY :^S]'IQ-6!:;^8 -!84 *T25$EQ T!J>153):70H#( $D@ P'9"&E
MKXM6<$_#;RH!B"^WC7T@,]4ZO6,5/WWG267/7B@81O#8"H^.H^N18<:B4=A%
M<!B2P^GMC#X@Q!HVP-<>?)RA7[A=G@M6BOQE,6\!]':/GON=?4='K75Q@"#F
M[D%?"_3)DCVYUK$YM58GPKNCF*K ,80 L2T019;!!&(4!A@&Q5#+E%7TCH;>
M)EZQ$MI$9V+BZPX<<3(H@ P%Y&\TOAM>#3"V-GH,!%]PVYHC>"G2X=W%W0AQ
MN!3J7$B^8Q&!(3#<)8;_R61L=&'TT% &.P@$@6#+"%I'&*=!QQ L!F?Q1K!,
MHW-=*$="8>D,)B[ 8?L<EHNY=8Y]OQB> 8"! /05Q39#[*9X]##&VCF=/:3-
MLV^('PPE+'UC_+'I12CYPT;UQR5\N:2_<A1+]C]3,3DY]A^+BM6YW[SVQ>?:
M"B>TZAO?X)V8\-%4I&[DK]WU1:_FJA]%=YF%8J]8X;9GR<@,A5H\Q,/<U0J=
M',=E_>H*5]5;_1R910$Y#7DO-DSC/;IQ;/HD?6NR&U?QEUB]I9W5YAMY*WDW
MVJM_YI)RR_W%EZ-4V%S2K"]4]>2J3$?KQ?FV=Z<UE8UMGKR\GTYW?D_U*[R^
M<IW<J9(61*VE[7<[A_L'6Y.[G=[6M #%]@XZW=[VY-5BX5TNS)4W56N1G>!B
MPL5\O"[FLV]F<R*_"&\#HHN/?\=8"W9* +M6L+.VZK>MO-?+7R]Y1+&0PE'I
MN )'X @<V\"162$$/IQ2X/@8E)GC^)&-5M@V@;EX4!B00JR'@4\*_,+C=\'&
M:N4K]3NG54O#C@F "!!; _$+2<GH'Z)_""*#*_-AEMLBP_G86"@*!D,I\[$L
M=!D!?\TBPBF%202.+>-H_*U$YVR;&PQ\\B)AM!0 -@B@I-(:EG^SZ"?"*(+)
MT,J43/J*,HYIPJ@IV&N=O4PK#)CB& H0&)A (24,X':=<(PV$&P.02/L_8.D
M(!#=0=#8,HUNRK?&$#2"1M 8D,;I6"@;7>5F&7 &DQ88GP%^K>#W%J<T_0&9
M<$P,4&P<Q:IE27'CHG-.RRI%U\:7EVN#;<#W*C:@? [ENDY>I@E;E[%R%B.I
M '2'@!JWLEM_V7/\] GV$IU'$-DZD?Y[8K3%,4Z8V !_8?C;#%\#0XBUIJ"O
M)?J6>Q%A^D ?Z&N5/BFC0;DOWV!Y&WJ#(#*X,IZ^V&@]AC>*DPS!7Q#^;ORM
MP!C"& +&T,IX^N0LNI!4+JX!D2 21#X&(B73#49LL- &( 8%,2-LQH!1!(O!
ME?FH,TY)XJ#?!S2Z8*7(7Q9C-N!O]_SEO+(9"F.FV)L/^EJD[[\+01F,'XP?
M\ N 7Q%' ^&:BXS[Y!7"KD. UPAXK#A#IP]3]0 P$(#*^8J6@;O?,B6C:*#5
MA'R+2[CTM;3-A2-9[@=F!Y.X)MV95L-84]/K')X_G;^PI*E_JX'/^_ATR6@Y
M<P\+"=\4IK$E]&:FR# YB,E!H!A:F4]9QFD9CB8:^$211%=,SDF<>?AMI9KS
M&P#D"VYF!D%,81I!8GAEYB1J8YL;'WSR&N'<0_#7E#)_HV0<O1=*80,^QFA
M7]OTG5Y>;@;]:V1QUI-7"B$2&Q#UU(C?M?IGR(RU<SI[2)QGWR+_QC<W;):G
M87R_7P81=[9-ZL>E?/ZT;S/#KQS%DOW/5$Q.COW'HF)U[C>O??&YMJ)\X?8-
M2__FG?#15*1NY*_=]46OYJH?17>9A6*O6.&V9\G(#(5:/,3#W-4*G1S'9?WJ
M"E?56_T<F44!.0UY+S9,XSVZ<6SZ)'V'R6Y<Q5]B]99V5IMOY*WDW6BO_IE+
M;]&XO_ARE J;2YKUA:J>7)7I:+TXW_;NM*:RL<V3E_?3Z<[OJ7Z+UU>NDSM5
MTH*HM;3];N=P_V!K<K?3VYH6H-C>0:?;VYZ\6BR\S;G%\O>QW"^XC)$/9Q-K
MUM#I:P_#RVL,M6"C!- +@%ZA1,ZF/J0)J]*^MV?V61L$L ".NQM5E_)V:GEM
M(AYK8C 3#QA;AE%I.R(LBP&,@#&T,K]RN3XT&ACF,8@$D2 RM#(-K@!Y\MH@
MM RX:XR[TN25^WO?DY06BT2#!< "A"^W<?TJ.>.U,7F,EV*%*,AKH5FI\A=T
M =$%!(NAE?E5&RO^^>6>SUZ?>Z<,!]YO,"1A$4'ACB@TL]PMM^]>L9F(A&$2
M-_9+Z#(,EDH8T9T 8D,!Q"CZ6[EZ.;H:"RDY!8$X 08(MHW@%W:$<1E@" Q#
M8ICPC6"9HF^X3:)+G8QGT;7.,3\! !L <%P.O%LK4IQAC[EZ8!@0PT]6DH(E
MQ$0AV&N=O7-MC, QV9@M!)#!E:F O)!,EK!RYB&AWGH<V1 ZAH"P(0BU4*[A
MB; GKQ2L(H!L"\BO9$?UJ4VPBUNE0B ,8-@DAE.M&S[[Z\G+!*,(&MNG$=;P
M'HW>J;1 )Q'X-8*?==&[+!<&AU# &P6  0!T(\JB2S%9\[%@ V$#@6!+"'(:
MLW/W1V,#@N@1 L=V<1RR2J-JM!1  D@ &1S(;'XVT^06R&4 ?2")+1?@L5T>
MR^_*5Q7]Q>\$$3&\ >).091__NGP=>_-472MG8U^H5ET8?304 8><:X,2&R3
M1$JB@7#8 H4N(W@,KHSG4<Y\0815-N 1/ 97YDSX5C:2Z#!NE^@#.9[2#.XI
M\&L"OW%T5>3EV>VW4=M X)VX;4:QB\Y$)ARGV)P/_G;'7W6DS%M98$H1_BB
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M ^.LWS\D&<[Z!:%M*E-^OUD_[1!,PE4%B&TKH^/;53;1A2DWCSO!B(Z!\53
M& !&XYW5Z(NWBWQW^0V0!)) LGTD/8/OM4%<;_ ('L,K4_%XNU<#R\.Q/!P,
M!F'P@LQX&;839A%F$4@^*B1O(P("1VPA!H6M47@EY 3A$A'9!C0^ AK9J.@W
M&F-)'%;A@+]VE?'8S5<\@SVP!_;:9\^0, *[%!^0"4?/ ,'&$$R8U*0,Z08
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M>>MH864=W%+ &+"9,<MH(!QBX3R@$D[4 (!- CAB0C#&!T2Z8*5(.0 ( )L
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M!0!L$L"IUG?W88 _\ ?^VN!/EF[6!=-XOCK$>Z09&,16*%#8+H5ZBA!MF*H
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M5MKP9%/Y::"/PR*Z$%0O'Z.37TQ_,IYYXP F0_#' ^_:HX6V4^_"GP7>U!O
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M,@\AOWG(MVOY37%8?,M\ 5!+ P04    " !S@$5:?6[OB>PJ  #0(P$ $P
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M/4-HBO3#%P-:BY,H5G<JM?R&'']5P>Q(2S#9Z?VDGNE\!/HRVM% F,#LTMP
M/[_+000F1+5+]WBW3W_+/FD%1Q$$RPANJ/?IWU[V8#3X_V@O0P.@A$-$[GCV
M/01[A[8)?2:9ML^L!OC);N.^Z,;]3@XY"99/?;AFL%KS: Z6U--S!IV$01Q0
MB4Q; 1*-"R8R8X*D2$-+(3)B*FM="(..1+^DH/4BM$JMW],],E$):%ZE5=LX
M/L'?+!P">HB/AEHE_BO>C8?JY*?L1(ZNV-C>K#Y^VW(A,5(#-O5.&?3F>SV]
MU^WH%@4Z(D#Q+KL\W39(VC+8>LY.6ZV%_P6->\=$OZ"6\F^'7OKEFDAC3*!4
MW7N8 H.<1:"CM$I+]I9)'ROP+,+;]SO)^<@JS^*^'WFUYUEQ;&*0_7,*&";1
MC<C8E;]Y7TKHC&>("\/@W&$*D!F"G,6JM*@0C&6J#"/I?. X4J3197:GPD>Z
M1\ ]4L03?SY[#H_0@".P2$$94;$C'UC]_7<@75%<8>[>V>4?GX$P\0*#8M-6
M\X"[W?XHNS_&[8]SBZ-[7F5Q6H%NDBB#0 !4Z.'=Y"S'RR3Y>> ;TF*\8N.9
MD)M1/5CF6A3.$8$/$J:<BEE3LL*EL*J6(3(Z'X%#$K53V-@>/@,E;S[+"$ZD
M)0<Y,/"\$$^0S4#('0R, LV(&BOKJ70O(T8)AQ+4-QZP3)H#Q86B,(0?&P<P
M,)"E8.M<O,'=;I;MUN)ZNCOI\<'MDI>+L55X<28QH"Q ^1BQ:]"/#F8X$ZA+
MVN]'B@-E% :!W76 )V'%%O[@6!D'WWQ FD(JJ)X0DB0G[ (L# :O4+'!Q^)&
M*#A@&0Z%;^_@>9_I?-]4;&-[@AN';P8'1\CLHZNSZYO+BYOHYK<?__/L]#:Z
MO8QN?SZ_60U"?:KRQEH&T<V*,-RF38<'0,?;\J@+%=ZC.QS8HWF#Y\,_YD(G
M^./[!A0=[VS T5>];#V^UXSTFDE>I<F"Y=*Q##T64<!L"3(D>*#,J%!JB*SD
MP/%$( J'(#3XL/NC&#U\(!CLP-2&$L<!YM+2?<#9!)O1A-+T[,R"Q19MB0>3
M-7*2PX0)ZP_: OD"' 8*!S"O?0IQCM&UA+%XG2O2,?9G<Z)/+158HY_B7A=Y
MUC]S)+N_Z;-<GP633R6;;U4) O9/*Z6M7FB<[DC3J<-X#L"!$GS901Q$)P08
MF_20OOONLN I> X?="2Z8-KA9.0GA.!PX@@=R8ZAM_1/Y!2U&IUYSZW%Y'1
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M@!PF"(# @Z=A6[]&#GU:'PJWP=O IGWB58,$F1UW##GPF96V;-'?SP[G][#
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MFB\.@.M*D@%W[T+2(@:-Z&PK,%=OE)>/>S9:J" ;0WU!-<8DNOS,A*K0M;:
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MV[-S6G<XK0\/=E[KEM?ZG\,\F<-_)N4T_>%_ 5!+ P04    " !S@$5:I>S
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MA)PXD"K(QCK%A>LE#,50T\)&R*4(X) !>NH6]X!N1S$8@":,?M\8&7W<%%]
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M=>=3>(H"4;O[ISQ"^Z6?\8\2]L,?0_P/4$L#!!0    ( '. 15J==] @)0@
M $HR   3    96YS9W$T,C R-&5X,S$R+FAT;>U;;6\;N1'^WE_!.NC%!E:R
M7BU;=@SDSDYK%+@6.:/7;P6UG)58<\D]DBM9]^L[0ZY>+,F);"<^14T^.-KE
M<#C#>?C,D)0N1CY7EQ<CX.+R3Q=_KM78E4G+'+1GJ07N0;#223UDOPIP=ZQ6
MJZ1^,L74RN'(LU:CU66_&GLGQSRV>^D57,[T7!S'YXOC,,C%P(CIY8608R;%
MNP/9&)PTLHYH0ZL+G5Z[=]8[;36[T$O/&F=<I*?_:1Y@5Q2/?9R?*GAWD$M=
M&P&-W^^TZKUNX<\G4OA1O]EH_.4@B%Y>9$9[',]B__@QJEE3YN'>U[B20]T/
M+AW$KK/FU"AC^V\:X=\YM=0RGDLU[;^]E3DX]C-,V$>3<_TV<5R[F@,KLRCH
MY.^ -J%YX7$23>ZA'B4US%QHMLCHZW__[>;'FUO6;M9;[*')GS=V@Y_S.?AZ
MCG0V.G*3L%_*W[G6P*[J[!?-BP)LPE*P7F93YD?<__"F>WJ^E9/_+1WU^J2;
M<U1P.T1@>%/TS]#2@@N!T*TIR'R_?8)OUO7&5U(+1&J_UCPMOG[T-T]:LSYS
MZ_5'?SA3S4:]2]-PPT9\#,S"6,($><"/I&/LO=8E5^PC%,9Z9C3[8&S.FHW:
MWYG)V.T(V+5V.,'LK]:41<)N=%K':)^=[V746CL7M1^YPUAA7/(IN]-FHD ,
M(8G!LS%HPJ )VB##XPA<:L;UE)7:VQ+0 ^3\0/\83<YR?+(2XYWQ%%]99G+I
MF3=1;DU 0PK.<3LED9S? 8Z[I-/A.X'&X) JY X<@P12:3%7H)C&[FB) ,LF
M(YF.F"OISZ+_!"Q42LB!7#J%287RTT3Z$3KH"DB#@:07:4<:@6Z.L9M@@^GR
M-.PO*-O?#BB!95)CV E!BS GB$@4QV:[U"YUAE3#O40]4J>J%*@3H;04TP1A
M**V:L@*10" F<"NU0&D%$+<R-"X$(4EQ0A*E0@&$ID'\A.%<L"?E;L0R929N
MAEL+0^F\Y3@0IY?1;K0R68*?FQFS9NW^(K"S<PB\?1"NMZY"5U63$(&8+)/X
M&$)XP[B% !8,OAPHH* R0(0.E'0C$B>Q',F3")2>A72I,J[$?D2KUJB(FL*:
M% 2^=NP002( 41>1<'V?CK@> GN/C/6Q5.!^>-,\:9PWV[S6[!["4>C?[(KX
M%!]Q0+ Z0C8.0N2V!.4(+;+H:<-E#X;+<#AR>17E*$%%02C?GH7<;F>WD7O(
MCW8%NB?ULR;-PQ50/85!#,GP\SA+*$^GO'3;=Z&$.0!$2S523,&FM*@ 66PL
M7>!&E (=]% -OV#596:VH'B 7Y6#%^A)*M:F1HD,B[8XHZ0(FTQ7#IP4DEM)
M#LA8*81<H4E3Z2A[AS7K0JH/3&H<H$&XO0R="HZX3TO%*0&@6\&(116 /6)-
ML5P*X:<!D"!R-/8'\7Q.WGED#W8(V>W..K)7J>U19EL#^-8]M\<YKHVQ% 1?
M[HSFE *X0^A3B4J8YE;,\(6(EWP@E?13*@PV#4NK+4 QH"PNE >B2R5NR#3W
ME4,+%45I"\2["R5-FAHK@BFA[!V"QDI%(>RQ!0I:3R2")7V$-JX[603"WUMP
MISL$[DC;UV.NRL!M%'G(,JP[Y1@CY3;4CUB0;,'2\7%S,1E0C!V185TL60>F
M](^/O4T>X7-IH'H\^_RFB@UFE7Y8F!#G .T)T*,!]A-^8H?@5W%KC.\Z3FBS
M7U6"H64%AD_@4JH!3)J6EG"PE' ?Z,N-\_@FI=U8AC:ABM]*S-2H]'!-.$,0
M(Y^MR%5FXOX+PJD$'5B$0ZAHRU&T9,3=O"(A)@R@!Q&21?"^(O(I4_(.5'5$
ML2*?O&!"7@;Q7=_2=;_Y+5TXS12S99$LJ(J8<QFF"]8BN#VA+%DK>=$HC@6O
M-];-:X#P I7EN?0>8&,N&!BL+ZA%2+0I=#]$&"/U.J)V_)\*[MEZ@]]*B2:'
M%5;J-)Q8''W?HKUBKG^OL(3#N9*(-]HGT[8[E8  J;+V?*LT 7Y':3@6<B$1
MAV(TG*W.SIN>!+MJ5Q,/+#9P'!?8T<&<XC9 M"I>41C1AI5E$JL AR6 *W/$
M"DY/<*-*(1O/Y/8\P^_>[ND])O+,(ITD" $(W(<@"L?B%=J2F!FE'ALU!DJ/
MF@^KTWU;T27DA3)3P-;)R$2.Y ^PC-A[8:50?^1>\M.7>2^"QRY=AUYA-.)]
MYP<86*QIIO'@K9N$N_.9E3YL,BO;!K@*P=;01,4+!_W9AW/,7X7BT[[48:#0
MZ;Q:6 /CO<G[=!D^IB2(-50U76&:8O/BGKS>B'?E'F?*B]G(57,]-!U[L=[6
MJG<:IX^V-NK-9[6UZMU>[XMK;=1/6^V]M_53T6KWZF?M[A=7VZWW>L]U\]6G
MH%UO=4^^N-J3>K>Q'0J.PQ*+RPQ7LBNX?G?0/#U8H;I^@X5J8JYP+MM>$VT5
M]R2\S(E$E*L+/Y="*'C]G!F8)=+<G(6_._7=J3_8J6T7XFZYM_9UL6UB=C9W
MJJHEJNH W6+AVH7-3-Q-IQ^+::=W[L+?#=\Q8]]Q_"SW(C1V$\?M51S3]O'%
M('XECS<']&>>QPW!9UP_V3_7U]?LUUJR?ZB;_]^IY]NDV5OZEOK2LMQZ<>X8
M,(/&OO0X6KJ%VS^-)&3LP_S4YA_QS#QAU_>0EG1KR/Z%+]@_+3A)YRSA(/"J
M.I=FA]7M,GT#=*YC^=Q]T;YT)5T)'.T9A!Y;]L?AF.:)YU\K/V\HC O?4.S'
M+]B,8>T'#XMD$0J]QJ(+'V#&*/WC798FE6Y P#Y^C/;@;_PMQW'X#<G_ %!+
M P04    " !S@$5:1/3GO: %   '*@  $P   &5N<V=Q-#(P,C1E>#,R,2YH
M=&WM6FUOVS80_KY?<7.Q-@%L19+M^+4!7,=9@PU)$;MH]VF@12KF*I$J2<7Q
M?OV.E.V\IVF:+'::(#!L\>[X/!3OCB_7G9@TV>E.&*$[OW1_K51@5T9YRH2!
M2#%B&(5<<W$,GRC37Z!2F4OU9393_'AB(/3#.GR2Z@L_(46[X29A.PL[W:WB
M=W?+==(=2SK;Z5)^ IR^+?&@VJK3P&\%8UJKQ7[4'!,2^_B]%C=JV[3V=U!"
M510O=+29)>QM*>6B,F&V_W8M]!KUS'2FG)I)._#]WTI.=*<;2V&P/X7ZQ=?"
MS!5CAIV:"DGXL6@[2J5"==$<R42J]BO?_75L2R4F*4]F[3<CGC(-!VP*1S(E
MXDU9$Z$KFBD>%X*:_\L0$\)S/Z<%Y ;:2;A@"PI!:$$//K_??[<_@FKH!1<1
MKQY6N O "-\^4T^$L#\X&NWO[?=[H_W# _CP\6CXL7<P@M'AZD,/FO#1&WI]
M#UZ_"K8;G:!:]\NK#[LWA-[NX8?18'>]AGLXZ+LYTO*WX7 /1N\',.P=O>L=
M#(:5P\]_#OZ"7G]D6T+?#[^;S34!: 7'X$YOZ9]<&Q[/'AUB[5J(^P(B*02+
M#)<"IMQ,P$P8](3(20)'+)/*@(QAA \'0B-@^%W)/"O#OH@\V+#"?9EF1,PV
M 2WL295"X%?^@%@J9RI#8)("$Q2SWBZ+6#IFRKJ@WZD&99OH:F4@&F*>H, 2
MP9!%N>*&(U4B* Q.HPD1QZZSE&MMT>*_E:283V'"%$.8#D^!>A,AEN$=46H&
M1QY\P$=EZ$\XB]$8&C?\A,%A'/.(*<OP'),RX#/[4LJ0Y4KG!-^+D7 Y@D 1
M0A [H3*S2?V\]+ 8TX*I]8)Y'T.BQD0P73D\3=@,>I$;7^L%96PG3C>=P1<A
MIS@@Q^SUJWJS _>82M_O(X:,$[80&$M%F:K@1$Q(IEE[\:5#N<X2,FMSX::3
M4^JD1!WCZF$LC9%IVZX<3NP01B29=^+Z*YKGBXI6RVOX#;NN,(C3T$7'1:OO
M!;9IR]"K;:%7;]9O;+U-\[:V .%L/[A5WZM7J_?$X]_85@N\L'&_(;C-[+97
M;3379 C"EM>LW@_L;6:#P&O5PSN9W7+SMIB[Z!T:0\?;4K6T4,@(I;C&;X?9
M*03H$.<\+F'Q%0<I?./_3P-N:5]$J66PF#/_<5)&9D_$*'AX,JO\AH+Z6K(:
M+=,UQ'F2S)!0FB4VZ2\7 HI]S;EB=M.K;::<YU5,OAL$EQP*@OH&W5QFU[-E
MPW+),$^Q0:M:@XV@ODCBC69JU1M-B?J;FYAG6QV[UK@PQ@_KXRFG-&$//=;-
MQW%QWS(J_9CH-=/R@NQ+"%WA$!J^A- U8&5#*!>XVTJ)BXNXG3,$I2@^!7,N
MOA*N,,!FBFD;2LNVF20)H!IVC)L];,@PMNJRTXJY("*RS]$@Y<ZTW8BA5)X4
MD5CBUL[UJ2_MG[QOA] @7*T8^L1._D+JA=0+J9\Q9+26I.8'+O,C%*0%6B:<
MP@+B>I&N-3K:?5X\@GN9NVM.[_IW-I^[N%9=\XE[0-+BQ+6@_HT!V'Y^ W#!
M6U_RS;.@M_[O;&2+'>[CE_?=R2U+'1Z!J;/8Y@:[C.[ _:8[*[L;V^4*MVQ2
MP4:F.&[7,MROL:6D+"0W%^/T=-/QTO75,YF5=XTD8>U9TWN>@;+UPZ0>,X;<
MRFR/C55.U*Q@6'>7[/6?R@.WW*WTN6OOVZ[$5R#0%Z4^8.LK& 6I^#$7&,K=
ML1K7,%7<&"80(C'N)F1Q*T)A/#M7EW"AYL!6)\"$:!@S5,V4/.&V!,/(\T=U
M+HM,>9*@%!J=GQRBT<LR<:X$UY,S W<IT%# C;:HXQCR#)]8V$P;[VHYPUUJ
M%B[5)F92NW/)MF()L0GO2K7BV>K<[:G],Q4RQB5Z;FY6^8[*HPN?12'FEBL
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MP'5:+!1PHZW620)%CD^LVDP;[V(SPG4Z#BZV""R>V(5R=-95[ZD[Z/(W6;Z
M'P-YKF\PE]H=G7842XDMSQ<Z"4\V#<XL_HD(F>#.H3!7BWQ'^]&9S[))<L,U
M9_X'4$L! A0#%     @ <H!%6AIOOAQ.?00 2"HS !$              ( !
M     &5N<V<M,C R-#$R,S$N:'1M4$L! A0#%     @ <X!%6HZ<5B(:'
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M,#(T,3(S,5]G,2YJ<&=02P$"% ,4    " !S@$5:L!@B@DVY  "AS@  %
M            @ &NC@4 96YS9RTR,#(T,3(S,5]G,BYJ<&=02P$"% ,4
M" !S@$5:7MT_(V^Z  "]SP  %               @ $M2 8 96YS9RTR,#(T
M,3(S,5]G,RYJ<&=02P$"% ,4    " !S@$5:3DB$2Y_$  "%W   %
M        @ '. @< 96YS9RTR,#(T,3(S,5]G-"YJ<&=02P$"% ,4    " !S
M@$5:<5)51>C&  !MW   %               @ &?QP< 96YS9RTR,#(T,3(S
M,5]G-2YJ<&=02P$"% ,4    " !S@$5:=XN4E(P8 0 )M $ %
M    @ &YC@@ 96YS9RTR,#(T,3(S,5]G-BYJ<&=02P$"% ,4    " !S@$5:
M(__> )>4 0!-8P\ %0              @ %WIPD 96YS9RTR,#(T,3(S,5]L
M86(N>&UL4$L! A0#%     @ <X!%6F U%M9!#P$ I$H, !4
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M;G-G<30R,#(T97@Q.3(N:'1M4$L! A0#%     @ <X!%6ING:$3A!P  $S$
M !,              ( !%\L, &5N<V=Q-#(P,C1E>#,Q,2YH=&U02P$"% ,4
M    " !S@$5:G7?0("4(  !*,@  $P              @ $ITPP 96YS9W$T
M,C R-&5X,S$R+FAT;5!+ 0(4 Q0    ( '. 15I$].>]H 4   <J   3
M          "  7_;# !E;G-G<30R,#(T97@S,C$N:'1M4$L! A0#%     @
M<X!%6D![;)?*!0  HRD  !,              ( !4.$, &5N<V=Q-#(P,C1E
>>#,R,BYH=&U02P4&     !0 %  >!0  2^<,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>ensg-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:ensg="http://www.ensigngroup.net/20241231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:naics="http://xbrl.sec.gov/naics/2024"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ensg-20241231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <instant>2025-01-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CombinedRealEstateAndLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">ensg:ThirdPartyOperatorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">ensg:ThirdPartyOperatorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateDeductibleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateDeductibleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:AllStatesExcludingColoradoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:PerOccurenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:AllStatesExcludingColoradoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:PerFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:AllStatesExcludingColoradoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CO</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:PerOccurenceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CO</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:PerFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">naics:ZZ524292</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateDeductibleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimEnforceableArbitrationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:NonCaliforniaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:AggregateDeductibleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PayorAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">ensg:AllStatesExcludingCaliforniaTexasAndWashingtonMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:LossSensitiveLimitPerClaimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:GeneralLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:WA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:SelfInsuranceRetentionPerClaimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:HealthLiabilityInsuranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:InsuranceCoverageLimitTypeAxis">ensg:StopLossInsuranceLimitPerClaimMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ensg:InsuranceSubsidiaryLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">ensg:InsuranceSubsidiaryLongTermInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">ensg:ThirdPartyOperatorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">ensg:PreviousSubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceBaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceIncentiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:ManagementServiceTotalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceBaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManagementServiceBaseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:StandardBearerMasterLeasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:StandardBearerEquityPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2022AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:BusinessAndAssetAcquisitionsAxis">ensg:AcquiredPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:RealEstateAndLeaseArrangementsAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:StandardBearerSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidSkilledMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:PrivatePayAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">ensg:EliminationsAndReconcilingItemsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingAndBuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">ensg:AssembledOccupancyAcquiredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:DepreciationAndAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:DepreciationAndAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:DepreciationAndAmortizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">ensg:MedicareAndMedicaidLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">ensg:SkilledServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">ensg:TruistBankMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:TwentyThreeSubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PrepaymentFeePeriodAxis">ensg:FirstThreeYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PrepaymentFeePeriodAxis">ensg:InTheFourthYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PrepaymentFeePeriodAxis">ensg:YearsFiveThroughTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:PrepaymentFeePeriodAxis">ensg:AfterYearTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:HUDInsuredMortgagesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:A53PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">ensg:A53PromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:CollateralizedDebtObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-349">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2022PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-352">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-354">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-355">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-356">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-357">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-358">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-359">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-360">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeFiveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-361">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-362">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeSixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-364">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeSevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-365">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-366">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeEightMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-367">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-368">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeNineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-369">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-370">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">ensg:ExercisePriceRangeTenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-371">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-372">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-373">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-374">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-376">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-377">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-378">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-379">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-380">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-381">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-382">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-383">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-384">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-385">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-386">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-387">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-388">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-389">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2019LTIPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-27</instant>
        </period>
    </context>
    <context id="c-391">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2019LTIPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-392">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2019LTIPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ensg:A2019LTIPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:SpinoffMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-394">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ensg:OtherStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ensg:OtherStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-396">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">ensg:OtherStockAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-397">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-398">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:MasterLeaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:TripleNetLeaseArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-400">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:TripleNetLeaseArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:TripleNetLeaseArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-402">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:TripleNetLeaseArrangementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-403">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-404">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:OperationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-405">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-406">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-407">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-408">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:PurchaseOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-409">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-410">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsAndSeniorLivingFacilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ensg:StandardBearerHealthcareREITIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-411">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-412">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-413">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:CareTrustREITMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-418">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-419">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:CostofSalesandGeneralandAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-420">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:CostofSalesandGeneralandAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-421">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">ensg:CostofSalesandGeneralandAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-422">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-423">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:AmendedMasterLeaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-425">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewMasterLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-426">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewMasterLeaseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:OperatingEntityAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:VariousLandlordsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewAndAmendedMasterLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-429">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-431">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-432">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-433">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-434">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2025AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewMasterLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-05</instant>
        </period>
    </context>
    <context id="c-435">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:NewMasterLeaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-02-05</endDate>
        </period>
    </context>
    <context id="c-436">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThePennantGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-438">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-439">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SeniorLivingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2024AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-441">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:SkilledNursingOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:SubleaseToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-442">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:SubleaseToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-443">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">ensg:CampusOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">ensg:A2023AcquiredPropertiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-444">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-445">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThePennantGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-446">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThePennantGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-447">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThePennantGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-448">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThirdPartyTenantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThirdPartyTenantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-450">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ensg:ThirdPartyTenantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-451">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-452">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ensg:LeaseArrangementAxis">ensg:LeasesToThirdPartyOperatorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-454">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-455">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:RentalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-457">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-458">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:QualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-460">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTaxStatusAxis">us-gaap:NonqualifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-461">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-462">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ensg:GeneralLiabilityAndProfessionalMalpracticeLiabilityInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-463">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-464">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:WorkersCompensationInsuranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-465">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-466">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:HealthInsuranceProductLineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-467">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-468">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ensg:MedicaidAndMedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-469">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:May2024RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-05-16</instant>
        </period>
    </context>
    <context id="c-470">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:May2024RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-05-16</startDate>
            <endDate>2024-05-16</endDate>
        </period>
    </context>
    <context id="c-471">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:May2024RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-472">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:August2023RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-29</instant>
        </period>
    </context>
    <context id="c-473">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:August2023RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-29</startDate>
            <endDate>2023-08-29</endDate>
        </period>
    </context>
    <context id="c-474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:August2023RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-475">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:July2022RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-28</instant>
        </period>
    </context>
    <context id="c-476">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">ensg:July2022RepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-28</startDate>
            <endDate>2022-07-28</endDate>
        </period>
    </context>
    <context id="c-477">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-478">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:Dr.AnnS.BlouinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:Dr.AnnS.BlouinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-480">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:Dr.AnnS.BlouinMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-481">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:SuzanneD.SnapperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-482">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:SuzanneD.SnapperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001125376</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ensg:SuzanneD.SnapperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="facility">
        <measure>ensg:facility</measure>
    </unit>
    <unit id="bed">
        <measure>ensg:bed</measure>
    </unit>
    <unit id="unit">
        <measure>ensg:unit</measure>
    </unit>
    <unit id="property">
        <measure>ensg:property</measure>
    </unit>
    <unit id="lease">
        <measure>ensg:lease</measure>
    </unit>
    <unit id="option">
        <measure>ensg:option</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="subsidiary">
        <measure>ensg:subsidiary</measure>
    </unit>
    <unit id="renewal">
        <measure>ensg:renewal</measure>
    </unit>
    <unit id="segment">
        <measure>ensg:segment</measure>
    </unit>
    <unit id="plan">
        <measure>ensg:plan</measure>
    </unit>
    <unit id="installment">
        <measure>ensg:installment</measure>
    </unit>
    <unit id="agreement">
        <measure>ensg:agreement</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-32">0001125376</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-33">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-34">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-35">false</dei:AmendmentFlag>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-55" id="f-501">P3Y0M0D</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-55" id="f-507">P10Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-57" id="f-511">P4M0D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-1" id="f-975">http://fasb.org/us-gaap/2024#CostOfGoodsAndServicesSold</us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-417" id="f-1458">P3Y0M</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList contextRef="c-13" id="f-1530">http://fasb.org/us-gaap/2024#RevenueFromContractWithCustomerExcludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList contextRef="c-1" id="f-1531">http://fasb.org/us-gaap/2024#RevenueFromContractWithCustomerExcludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList contextRef="c-12" id="f-1532">http://fasb.org/us-gaap/2024#RevenueFromContractWithCustomerExcludingAssessedTax</us-gaap:OperatingLeaseIncomeComprehensiveIncomeExtensibleList>
    <ecd:TrdArrDuration contextRef="c-478" id="f-1627">P273D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-481" id="f-1628">P160D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-3">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">001-33757</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">ENSIGN GROUP, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">33-0861263</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">29222 Rancho Viejo Road, Suite 127</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">San Juan Capistrano</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">92675</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">949</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">487-9500</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">ENSG</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-26">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-27">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-3" id="f-29" unitRef="usd">4196977000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-30" unitRef="shares">57455374</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-31">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Part III of this Form 10-K incorporates information by reference from the Registrant's definitive proxy statement for the Registrant's 2025 Annual Meeting of Stockholders to be filed within 120 days after the close of the fiscal year covered by this annual report.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-36">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We utilize information technology that enables our operational leaders to access and share with their peers, both clinical and financial performance data in real time. Armed with relevant and current information, our operation leaders and their management teams can share best practices and the latest information, adjust to challenges and opportunities on a timely basis, improve quality of care, mitigate risk and improve both clinical outcomes and financial performance. We have also invested in specialized healthcare technology systems to assist our nursing and support staff. We have installed software and touch-screen interface systems in each operation to enable our clinical staff to monitor and deliver patient care and record patient information more efficiently. We believe these systems have improved the quality of our medical and billing records, while improving the productivity of our staff. Such uses of information systems give rise to cybersecurity risks, including system disruption, security breach, ransomware, theft, espionage and inadvertent release of information. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;RISK MANAGEMENT AND STRATEGY &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Risk Management &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We assess and identify security risk to the organization by: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;conducting risk assessments to determine the likelihood and magnitude of an attack from unauthorized access, use, disclosure, disruption, modification or destruction of information systems and the related information processes, stored, or transmitted;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;performing penetration testing assessments annually and producing security assessment reports that document the results of the assessment for use and review by information technology (IT) senior leadership, including the Service Center's Chief Information Officer;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;ensuring security controls are assessed for effectiveness, are implemented correctly, operating as intended and producing the desired outcome;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;continuously scanning for vulnerabilities and remediating vulnerabilities within their service level agreements in accordance with the associated risk level; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;reviewing third party and vendor risks to our organization through an internal interdisciplinary Technology Advisory Committee that includes members from our IT, Information Security Office (ISO), legal, compliance, clinical, finance and billing departments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Monitoring&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established a continuous monitoring strategy and program, which includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;a set of defined security metrics to be monitored;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;performance of security control assessments on an ongoing basis;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;addressing results of analysis and reporting security status to the executive team;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;monitoring information systems to detect attacks and indicators of potential attacks or compromises;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;identification of unauthorized use of the information system resources;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;deployment of monitoring systems and agents strategically within the information system environment; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;require that third party service providers who store, process or transmit data with access to electronic Protected Health Information (ePHI) undergo an independent third-party audit to achieve system organization controls certification annually. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Data Protection &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have implemented an Information Security Management System Program to secure sensitive data protected by us. This program includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;establishing policies governing data security;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;monitoring data access throughout the organization&#x2019;s independent subsidiaries;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;providing continuous security training and awareness;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;establishing controls over devices on the network which are actively tracked, monitored and evaluated for new, missing, or updated software needed to strengthen security on the device, patch known vulnerabilities, or stabilize software or operating system issues;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;protecting sensitive data through encryption techniques; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;designing and implementing systems to include backup and recoverability principles, such as periodic data backups and safeguards in the case of a disaster. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Incident Management Plan &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity incident management plan comprises the following six-step process: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;The Service Center's Chief Information Officer and Director of Information Security lead its ISO team in the development, documentation, review and testing of security procedures and incident management procedures. Beyond initial creation, procedures are continually re-assessed, updated and tested on an ongoing basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;The ISO team works with the Executive Team on the identification, assessment, verification and classification of incidents to determine affected stakeholders and appropriate parties for contact. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;The Service Center's Chief Information Officer and Director of Information Security are responsible for launching the Incident Response Team (IRT) if necessary and for notification to the Executive Team, who in turn will contact the Board of Directors and the Audit Committee to validate that the response is being addressed appropriately. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;The IRT, in consultation with outside experts if needed, is responsible for the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Initial containment by making tactical changes to the computing environment to mitigate active threats based on currently known information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Analysis to establish the root cause of incidents, identification and evidence collection from all affected machines and log sources, threat intelligence and other information sources. Once all appropriate information has been collected, we perform a careful analysis using forensically-sound tools and methods to prevent any contamination of evidence. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Incident containment by further analyzing additional information and further identifying any additional compromised machines or resources not previously identified. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Incident eradication by re-assessing the root cause of incidents where solutions are then implemented to solve underlying problems and prevent re-occurrence. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Recovery and restoring normal business functionality, which includes the reversal of any damage caused by the incident and responding as necessary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:105%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:13.27pt"&gt;Review after closure of each incident and conducting a lessons learned analysis to improve prevention and help to make incident response processes more efficient and effective. Also, the IRT evaluates competency and any additional training requirements needed. A final incident report will then be provided to key stakeholders and IRT members, which includes, but is not limited to the summary of the incident and its impact, a timeline of events, a detailed description of the incident, an evaluation of the organizational response and an assessment of the damages. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We have not experienced a material cybersecurity breach in the past five years and, as a result, there have been no charges related to a breach in the past five years. Moreover, risks from cybersecurity threats have not materially affected our business strategy, results of operations, or financial condition. While we have implemented processes and procedures that we believe are tailored to address and mitigate the cybersecurity threats that our company faces, there can be no assurances that such an incident will not occur despite our efforts, as more fully described in Item 1A. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Risk Factors&lt;/span&gt;.</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-37">We utilize information technology that enables our operational leaders to access and share with their peers, both clinical and financial performance data in real time. Armed with relevant and current information, our operation leaders and their management teams can share best practices and the latest information, adjust to challenges and opportunities on a timely basis, improve quality of care, mitigate risk and improve both clinical outcomes and financial performance. We have also invested in specialized healthcare technology systems to assist our nursing and support staff. We have installed software and touch-screen interface systems in each operation to enable our clinical staff to monitor and deliver patient care and record patient information more efficiently. We believe these systems have improved the quality of our medical and billing records, while improving the productivity of our staff. Such uses of information systems give rise to cybersecurity risks, including system disruption, security breach, ransomware, theft, espionage and inadvertent release of information.</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-38">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-39">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-40">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-41">&lt;div style="margin-bottom:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity incident management plan comprises the following six-step process: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;The Service Center's Chief Information Officer and Director of Information Security lead its ISO team in the development, documentation, review and testing of security procedures and incident management procedures. Beyond initial creation, procedures are continually re-assessed, updated and tested on an ongoing basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;The ISO team works with the Executive Team on the identification, assessment, verification and classification of incidents to determine affected stakeholders and appropriate parties for contact. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;The Service Center's Chief Information Officer and Director of Information Security are responsible for launching the Incident Response Team (IRT) if necessary and for notification to the Executive Team, who in turn will contact the Board of Directors and the Audit Committee to validate that the response is being addressed appropriately. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.02pt"&gt;The IRT, in consultation with outside experts if needed, is responsible for the following: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Initial containment by making tactical changes to the computing environment to mitigate active threats based on currently known information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Analysis to establish the root cause of incidents, identification and evidence collection from all affected machines and log sources, threat intelligence and other information sources. Once all appropriate information has been collected, we perform a careful analysis using forensically-sound tools and methods to prevent any contamination of evidence. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Incident containment by further analyzing additional information and further identifying any additional compromised machines or resources not previously identified. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Incident eradication by re-assessing the root cause of incidents where solutions are then implemented to solve underlying problems and prevent re-occurrence. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:110%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:110%;padding-left:13.27pt"&gt;Recovery and restoring normal business functionality, which includes the reversal of any damage caused by the incident and responding as necessary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:105%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:105%;padding-left:13.27pt"&gt;Review after closure of each incident and conducting a lessons learned analysis to improve prevention and help to make incident response processes more efficient and effective. Also, the IRT evaluates competency and any additional training requirements needed. A final incident report will then be provided to key stakeholders and IRT members, which includes, but is not limited to the summary of the incident and its impact, a timeline of events, a detailed description of the incident, an evaluation of the organizational response and an assessment of the damages. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;We have not experienced a material cybersecurity breach in the past five years and, as a result, there have been no charges related to a breach in the past five years. Moreover, risks from cybersecurity threats have not materially affected our business strategy, results of operations, or financial condition. While we have implemented processes and procedures that we believe are tailored to address and mitigate the cybersecurity threats that our company faces, there can be no assurances that such an incident will not occur despite our efforts, as more fully described in Item 1A. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Risk Factors&lt;/span&gt;.</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-42">The Service Center's Chief Information Officer and Director of Information Security are responsible for launching the Incident Response Team (IRT) if necessary and for notification to the Executive Team, who in turn will contact the Board of Directors and the Audit Committee to validate that the response is being addressed appropriately.</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-43">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-44">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Audit Committee receives quarterly reports on our information security and cyber fraud prevention programs from the Service Center's Chief Information Officer and Director of Information Security, who each have over 24 years of experience in IT, including various leadership roles at other large corporations. One of the three members of our Audit Committee is a cybersecurity expert.  &lt;/span&gt;&lt;/div&gt;The ISO has been established by the Service Center's Chief Information Officer, with dedicated cyber security staff focusing on security monitoring, vulnerability management, incident response, risk assessments, employee training, security engineering and management of cyber security policies, standards and regulatory compliance. Like many organizations, we align to a Cyber Security Framework and take a risk-based approach during control assessment and implementation. We align to the National Institute of Standards and Technology (NIST) Special Publication 800-53 Revision 4, a globally recognized cyber security framework of Policies, Standards and Controls is comprised of five categories of defense &#x2013; Identify, Protect, Detect, Respond and Recover. We are committed to the protection of our data, systems, network and continually invest in enhancements to mitigate or reduce the impact from a cyber security threat. We conduct periodic tests to maintain readiness and resiliency while regularly reviewing policies in the interest of protecting data security. External companies or agencies may be called upon to provide consulting, guidance, assistance, or some other form of support in response to a cybersecurity incident. The regular training of employees, at least annually, on the ever-present threat of cybersecurity helps maintain data security.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-45">Our Audit Committee receives quarterly reports on our information security and cyber fraud prevention programs from the Service Center's Chief Information Officer and Director of Information Security, who each have over 24 years of experience in IT, including various leadership roles at other large corporations. One of the three members of our Audit Committee is a cybersecurity expert.</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-46">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-47">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-48">Service Center's Chief Information Officer and Director of Information Security, who each have over 24 years of experience in IT, including various leadership roles at other large corporations.</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-49">Service Center's Chief Information Officer and Director of Information Security</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-50">The ISO has been established by the Service Center's Chief Information Officer, with dedicated cyber security staff focusing on security monitoring, vulnerability management, incident response, risk assessments, employee training, security engineering and management of cyber security policies, standards and regulatory compliance. Like many organizations, we align to a Cyber Security Framework and take a risk-based approach during control assessment and implementation. We align to the National Institute of Standards and Technology (NIST) Special Publication 800-53 Revision 4, a globally recognized cyber security framework of Policies, Standards and Controls is comprised of five categories of defense &#x2013; Identify, Protect, Detect, Respond and Recover. We are committed to the protection of our data, systems, network and continually invest in enhancements to mitigate or reduce the impact from a cyber security threat. We conduct periodic tests to maintain readiness and resiliency while regularly reviewing policies in the interest of protecting data security. External companies or agencies may be called upon to provide consulting, guidance, assistance, or some other form of support in response to a cybersecurity incident. The regular training of employees, at least annually, on the ever-present threat of cybersecurity helps maintain data security.</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <dei:AuditorName contextRef="c-1" id="f-51">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-52">Costa Mesa, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">464598000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-3" id="f-54" unitRef="usd">509626000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">8435000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-5" decimals="-3" id="f-56" unitRef="usd">9348000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">569897000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="-3" id="f-58" unitRef="usd">485039000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ShortTermInvestments contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">62255000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-5" decimals="-3" id="f-60" unitRef="usd">17229000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">60882000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-3" id="f-62" unitRef="usd">35036000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">1157632000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-3" id="f-64" unitRef="usd">1046930000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">1291354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-66" unitRef="usd">1090771000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">1861071000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-3" id="f-68" unitRef="usd">1756430000</us-gaap:OperatingLeaseRightOfUseAsset>
    <ensg:InsuranceSubsidiaryDepositsAndInvestments contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">141246000</ensg:InsuranceSubsidiaryDepositsAndInvestments>
    <ensg:InsuranceSubsidiaryDepositsAndInvestments contextRef="c-5" decimals="-3" id="f-70" unitRef="usd">92687000</ensg:InsuranceSubsidiaryDepositsAndInvestments>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">66281000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-5" decimals="-3" id="f-72" unitRef="usd">67124000</us-gaap:DeferredIncomeTaxAssetsNet>
    <ensg:RestrictedAndOtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">46499000</ensg:RestrictedAndOtherAssetsNoncurrent>
    <ensg:RestrictedAndOtherAssetsNoncurrent contextRef="c-5" decimals="-3" id="f-74" unitRef="usd">40205000</ensg:RestrictedAndOtherAssetsNoncurrent>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">7292000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-3" id="f-76" unitRef="usd">6525000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">97981000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-78" unitRef="usd">76869000</us-gaap:Goodwill>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-79" unitRef="usd">4669356000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-5" decimals="-3" id="f-80" unitRef="usd">4177541000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-81" unitRef="usd">98947000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-5" decimals="-3" id="f-82" unitRef="usd">92811000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-83" unitRef="usd">347532000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-84" unitRef="usd">332568000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-85" unitRef="usd">93475000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-3" id="f-86" unitRef="usd">82526000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:SelfInsuranceReserveCurrent contextRef="c-4" decimals="-3" id="f-87" unitRef="usd">67331000</us-gaap:SelfInsuranceReserveCurrent>
    <us-gaap:SelfInsuranceReserveCurrent contextRef="c-5" decimals="-3" id="f-88" unitRef="usd">54664000</us-gaap:SelfInsuranceReserveCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">132057000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-90" unitRef="usd">168228000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">4086000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-5" decimals="-3" id="f-92" unitRef="usd">3950000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">743428000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-94" unitRef="usd">734747000</us-gaap:LiabilitiesCurrent>
    <ensg:LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount contextRef="c-4" decimals="-3" id="f-95" unitRef="usd">141585000</ensg:LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount>
    <ensg:LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount contextRef="c-5" decimals="-3" id="f-96" unitRef="usd">145497000</ensg:LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-97" unitRef="usd">1735325000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">1639326000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:SelfInsuranceReserveNoncurrent contextRef="c-4" decimals="-3" id="f-99" unitRef="usd">144421000</us-gaap:SelfInsuranceReserveNoncurrent>
    <us-gaap:SelfInsuranceReserveNoncurrent contextRef="c-5" decimals="-3" id="f-100" unitRef="usd">111246000</us-gaap:SelfInsuranceReserveNoncurrent>
    <ensg:DeferredRentAndOtherLongTermLiabilities contextRef="c-4" decimals="-3" id="f-101" unitRef="usd">64169000</ensg:DeferredRentAndOtherLongTermLiabilities>
    <ensg:DeferredRentAndOtherLongTermLiabilities contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">49408000</ensg:DeferredRentAndOtherLongTermLiabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-103" unitRef="usd">2828928000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-5" decimals="-3" id="f-104" unitRef="usd">2680224000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-105" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-106" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-107"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-108"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="-3" id="f-109" unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="-3" id="f-110" unitRef="shares">150000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-3" id="f-111" unitRef="shares">60838000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-3" id="f-112" unitRef="shares">57438000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="-3" id="f-113" unitRef="shares">59987000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="-3" id="f-114" unitRef="shares">56597000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-115" unitRef="usd">61000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-5" decimals="-3" id="f-116" unitRef="usd">60000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-117" unitRef="usd">528052000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">465707000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-119" unitRef="usd">1426762000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-3" id="f-120" unitRef="usd">1142653000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="c-4" decimals="-3" id="f-121" unitRef="shares">3400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="-3" id="f-122" unitRef="shares">3390000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-4" decimals="-3" id="f-123" unitRef="usd">117764000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-5" decimals="-3" id="f-124" unitRef="usd">116555000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-125" unitRef="usd">1837111000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-3" id="f-126" unitRef="usd">1491865000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-3" id="f-127" unitRef="usd">3317000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-5" decimals="-3" id="f-128" unitRef="usd">5452000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-129" unitRef="usd">1840428000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-130" unitRef="usd">1497317000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-131" unitRef="usd">4669356000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-3" id="f-132" unitRef="usd">4177541000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-133" unitRef="usd">4237525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-134" unitRef="usd">3708071000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-3" id="f-135" unitRef="usd">3008711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-3" id="f-136" unitRef="usd">22960000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-137" unitRef="usd">21284000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-138" unitRef="usd">16757000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">4260485000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-140" unitRef="usd">3729355000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-3" id="f-141" unitRef="usd">3025468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-142" unitRef="usd">3376884000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-12" decimals="-3" id="f-143" unitRef="usd">2941238000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-13" decimals="-3" id="f-144" unitRef="usd">2354434000</us-gaap:CostOfGoodsAndServicesSold>
    <ensg:RentCostOfServices contextRef="c-1" decimals="-3" id="f-145" unitRef="usd">216016000</ensg:RentCostOfServices>
    <ensg:RentCostOfServices contextRef="c-12" decimals="-3" id="f-146" unitRef="usd">197358000</ensg:RentCostOfServices>
    <ensg:RentCostOfServices contextRef="c-13" decimals="-3" id="f-147" unitRef="usd">153049000</ensg:RentCostOfServices>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-148" unitRef="usd">225143000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-12" decimals="-3" id="f-149" unitRef="usd">263005000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-13" decimals="-3" id="f-150" unitRef="usd">158805000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">84138000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-12" decimals="-3" id="f-152" unitRef="usd">72387000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-13" decimals="-3" id="f-153" unitRef="usd">62355000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-154" unitRef="usd">3902181000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-12" decimals="-3" id="f-155" unitRef="usd">3473988000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-13" decimals="-3" id="f-156" unitRef="usd">2728643000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-157" unitRef="usd">358304000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-12" decimals="-3" id="f-158" unitRef="usd">255367000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-13" decimals="-3" id="f-159" unitRef="usd">296825000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-160" unitRef="usd">8286000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-12" decimals="-3" id="f-161" unitRef="usd">8087000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-13" decimals="-3" id="f-162" unitRef="usd">8931000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InvestmentIncomeInterest contextRef="c-1" decimals="-3" id="f-163" unitRef="usd">28749000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-12" decimals="-3" id="f-164" unitRef="usd">19216000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c-13" decimals="-3" id="f-165" unitRef="usd">5035000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-166" unitRef="usd">7327000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-12" decimals="-3" id="f-167" unitRef="usd">6266000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-13" decimals="-3" id="f-168" unitRef="usd">-3840000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-169" unitRef="usd">27790000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-12" decimals="-3" id="f-170" unitRef="usd">17395000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-13" decimals="-3" id="f-171" unitRef="usd">-7736000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-172" unitRef="usd">386094000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-173" unitRef="usd">272762000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-174" unitRef="usd">289089000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-175" unitRef="usd">87636000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-176" unitRef="usd">62912000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-177" unitRef="usd">64437000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-178" unitRef="usd">298458000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-12" decimals="-3" id="f-179" unitRef="usd">209850000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-13" decimals="-3" id="f-180" unitRef="usd">224652000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-181" unitRef="usd">485000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-182" unitRef="usd">451000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-183" unitRef="usd">-29000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-184" unitRef="usd">297973000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-3" id="f-185" unitRef="usd">209399000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-186" unitRef="usd">224681000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-187"
      unitRef="usdPerShare">5.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-12"
      decimals="2"
      id="f-188"
      unitRef="usdPerShare">3.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-13"
      decimals="2"
      id="f-189"
      unitRef="usdPerShare">4.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-190"
      unitRef="usdPerShare">5.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-12"
      decimals="2"
      id="f-191"
      unitRef="usdPerShare">3.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-13"
      decimals="2"
      id="f-192"
      unitRef="usdPerShare">3.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-193" unitRef="shares">56655000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-12" decimals="-3" id="f-194" unitRef="shares">55708000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-13" decimals="-3" id="f-195" unitRef="shares">54887000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-196" unitRef="shares">58240000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-12" decimals="-3" id="f-197" unitRef="shares">57323000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-13" decimals="-3" id="f-198" unitRef="shares">56871000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-14" decimals="-3" id="f-199" unitRef="shares">55190000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-200" unitRef="usd">58000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-201" unitRef="usd">369760000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-16" decimals="-3" id="f-202" unitRef="usd">733992000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-17" decimals="-3" id="f-203" unitRef="shares">2944000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-204" unitRef="usd">-83042000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-18" decimals="-3" id="f-205" unitRef="usd">946000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-19" decimals="-3" id="f-206" unitRef="usd">1021714000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-20" decimals="-3" id="f-207" unitRef="shares">688000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-20" decimals="-3" id="f-208" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-21" decimals="-3" id="f-209" unitRef="usd">12676000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-13" decimals="-3" id="f-210" unitRef="usd">12677000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-20" decimals="-3" id="f-211" unitRef="shares">207000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-21" decimals="-3" id="f-212" unitRef="usd">5241000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-13" decimals="-3" id="f-213" unitRef="usd">5241000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-20" decimals="-3" id="f-214" unitRef="shares">20000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-22" decimals="-3" id="f-215" unitRef="shares">20000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-22" decimals="-3" id="f-216" unitRef="usd">1702000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-13" decimals="-3" id="f-217" unitRef="usd">1702000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-13"
      decimals="INF"
      id="f-218"
      unitRef="usdPerShare">0.2225</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends contextRef="c-23" decimals="-3" id="f-219" unitRef="usd">12334000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-13" decimals="-3" id="f-220" unitRef="usd">12334000</us-gaap:Dividends>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-21" decimals="-3" id="f-221" unitRef="usd">22720000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-13" decimals="-3" id="f-222" unitRef="usd">22720000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-20" decimals="-3" id="f-223" unitRef="shares">404000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-22" decimals="-3" id="f-224" unitRef="shares">404000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-22" decimals="-3" id="f-225" unitRef="usd">29882000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-13" decimals="-3" id="f-226" unitRef="usd">29882000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-21" decimals="-3" id="f-227" unitRef="usd">1539000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-24" decimals="-3" id="f-228" unitRef="usd">-835000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-13" decimals="-3" id="f-229" unitRef="usd">704000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c-21" decimals="-3" id="f-230" unitRef="usd">6693000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance contextRef="c-13" decimals="-3" id="f-231" unitRef="usd">6693000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-24" decimals="-3" id="f-232" unitRef="usd">-29000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-233" unitRef="usd">-29000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-21" decimals="-3" id="f-234" unitRef="usd">-9000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-24" decimals="-3" id="f-235" unitRef="usd">284000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-13" decimals="-3" id="f-236" unitRef="usd">275000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLoss contextRef="c-23" decimals="-3" id="f-237" unitRef="usd">224681000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-238" unitRef="usd">224681000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-25" decimals="-3" id="f-239" unitRef="shares">55661000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-25" decimals="-3" id="f-240" unitRef="usd">59000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-26" decimals="-3" id="f-241" unitRef="usd">415560000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-242" unitRef="usd">946339000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-28" decimals="-3" id="f-243" unitRef="shares">3368000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-244" unitRef="usd">-114626000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-3" id="f-245" unitRef="usd">1468000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-3" id="f-246" unitRef="usd">1248800000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-31" decimals="-3" id="f-247" unitRef="shares">759000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-31" decimals="-3" id="f-248" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-32" decimals="-3" id="f-249" unitRef="usd">18368000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-12" decimals="-3" id="f-250" unitRef="usd">18369000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-31" decimals="-3" id="f-251" unitRef="shares">199000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-32" decimals="-3" id="f-252" unitRef="usd">5068000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-12" decimals="-3" id="f-253" unitRef="usd">5068000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-31" decimals="-3" id="f-254" unitRef="shares">22000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-33" decimals="-3" id="f-255" unitRef="shares">22000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-33" decimals="-3" id="f-256" unitRef="usd">1929000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-12" decimals="-3" id="f-257" unitRef="usd">1929000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-12"
      decimals="INF"
      id="f-258"
      unitRef="usdPerShare">0.2325</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends contextRef="c-34" decimals="-3" id="f-259" unitRef="usd">13085000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-12" decimals="-3" id="f-260" unitRef="usd">13085000</us-gaap:Dividends>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-32" decimals="-3" id="f-261" unitRef="usd">30754000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-12" decimals="-3" id="f-262" unitRef="usd">30754000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-32" decimals="-3" id="f-263" unitRef="usd">256000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-12" decimals="-3" id="f-264" unitRef="usd">256000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-35" decimals="-3" id="f-265" unitRef="usd">451000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-266" unitRef="usd">451000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-32" decimals="-3" id="f-267" unitRef="usd">3787000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-35" decimals="-3" id="f-268" unitRef="usd">-3533000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-12" decimals="-3" id="f-269" unitRef="usd">254000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLoss contextRef="c-34" decimals="-3" id="f-270" unitRef="usd">209399000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-3" id="f-271" unitRef="usd">209399000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-36" decimals="-3" id="f-272" unitRef="shares">56597000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-36" decimals="-3" id="f-273" unitRef="usd">60000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-37" decimals="-3" id="f-274" unitRef="usd">465707000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-3" id="f-275" unitRef="usd">1142653000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-39" decimals="-3" id="f-276" unitRef="shares">3390000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-39" decimals="-3" id="f-277" unitRef="usd">-116555000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-40" decimals="-3" id="f-278" unitRef="usd">5452000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-279" unitRef="usd">1497317000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-41" decimals="-3" id="f-280" unitRef="shares">632000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-41" decimals="-3" id="f-281" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-42" decimals="-3" id="f-282" unitRef="usd">22285000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-283" unitRef="usd">22286000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-41" decimals="-3" id="f-284" unitRef="shares">219000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-42" decimals="-3" id="f-285" unitRef="usd">6165000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures contextRef="c-1" decimals="-3" id="f-286" unitRef="usd">6165000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-41" decimals="-3" id="f-287" unitRef="shares">10000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation contextRef="c-43" decimals="-3" id="f-288" unitRef="shares">10000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-43" decimals="-3" id="f-289" unitRef="usd">1209000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-290" unitRef="usd">1209000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-1"
      decimals="INF"
      id="f-291"
      unitRef="usdPerShare">0.2425</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:Dividends contextRef="c-44" decimals="-3" id="f-292" unitRef="usd">13864000</us-gaap:Dividends>
    <us-gaap:Dividends contextRef="c-1" decimals="-3" id="f-293" unitRef="usd">13864000</us-gaap:Dividends>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-42" decimals="-3" id="f-294" unitRef="usd">36183000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-295" unitRef="usd">36183000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-42" decimals="-3" id="f-296" unitRef="usd">2426000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-45" decimals="-3" id="f-297" unitRef="usd">2024000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-1" decimals="-3" id="f-298" unitRef="usd">4450000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-45" decimals="-3" id="f-299" unitRef="usd">485000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-300" unitRef="usd">485000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-42" decimals="-3" id="f-301" unitRef="usd">-138000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-45" decimals="-3" id="f-302" unitRef="usd">596000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders contextRef="c-1" decimals="-3" id="f-303" unitRef="usd">458000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NetIncomeLoss contextRef="c-44" decimals="-3" id="f-304" unitRef="usd">297973000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-305" unitRef="usd">297973000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-46" decimals="-3" id="f-306" unitRef="shares">57438000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-46" decimals="-3" id="f-307" unitRef="usd">61000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-47" decimals="-3" id="f-308" unitRef="usd">528052000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-48" decimals="-3" id="f-309" unitRef="usd">1426762000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TreasuryStockCommonShares contextRef="c-49" decimals="-3" id="f-310" unitRef="shares">3400000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-3" id="f-311" unitRef="usd">-117764000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-3" id="f-312" unitRef="usd">3317000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-313" unitRef="usd">1840428000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-314" unitRef="usd">298458000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-12" decimals="-3" id="f-315" unitRef="usd">209850000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-13" decimals="-3" id="f-316" unitRef="usd">224652000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-317" unitRef="usd">84138000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-12" decimals="-3" id="f-318" unitRef="usd">72387000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-13" decimals="-3" id="f-319" unitRef="usd">62355000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-1" decimals="-3" id="f-320" unitRef="usd">1061000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-12" decimals="-3" id="f-321" unitRef="usd">1067000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-13" decimals="-3" id="f-322" unitRef="usd">1036000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <ensg:NonCashLeaseExpense contextRef="c-1" decimals="-3" id="f-323" unitRef="usd">808000</ensg:NonCashLeaseExpense>
    <ensg:NonCashLeaseExpense contextRef="c-12" decimals="-3" id="f-324" unitRef="usd">870000</ensg:NonCashLeaseExpense>
    <ensg:NonCashLeaseExpense contextRef="c-13" decimals="-3" id="f-325" unitRef="usd">493000</ensg:NonCashLeaseExpense>
    <us-gaap:AssetImpairmentCharges contextRef="c-1" decimals="-3" id="f-326" unitRef="usd">1849000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-12" decimals="-3" id="f-327" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges contextRef="c-13" decimals="-3" id="f-328" unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="c-1" decimals="-3" id="f-329" unitRef="usd">200000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="c-12" decimals="-3" id="f-330" unitRef="usd">0</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:WriteOffOfDeferredDebtIssuanceCost contextRef="c-13" decimals="-3" id="f-331" unitRef="usd">566000</us-gaap:WriteOffOfDeferredDebtIssuanceCost>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-332" unitRef="usd">635000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-333" unitRef="usd">-27481000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-334" unitRef="usd">-6496000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">1739000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-12" decimals="-3" id="f-336" unitRef="usd">3408000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-13" decimals="-3" id="f-337" unitRef="usd">2390000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-338" unitRef="usd">36226000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-12" decimals="-3" id="f-339" unitRef="usd">30767000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-13" decimals="-3" id="f-340" unitRef="usd">22720000</us-gaap:ShareBasedCompensation>
    <us-gaap:ProceedsFromInsuranceSettlementOperatingActivities contextRef="c-1" decimals="-3" id="f-341" unitRef="usd">199000</us-gaap:ProceedsFromInsuranceSettlementOperatingActivities>
    <us-gaap:ProceedsFromInsuranceSettlementOperatingActivities contextRef="c-12" decimals="-3" id="f-342" unitRef="usd">1396000</us-gaap:ProceedsFromInsuranceSettlementOperatingActivities>
    <us-gaap:ProceedsFromInsuranceSettlementOperatingActivities contextRef="c-13" decimals="-3" id="f-343" unitRef="usd">1282000</us-gaap:ProceedsFromInsuranceSettlementOperatingActivities>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-1" decimals="-3" id="f-344" unitRef="usd">-486000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-12" decimals="-3" id="f-345" unitRef="usd">123000</us-gaap:GainLossOnDispositionOfAssets1>
    <us-gaap:GainLossOnDispositionOfAssets1 contextRef="c-13" decimals="-3" id="f-346" unitRef="usd">3467000</us-gaap:GainLossOnDispositionOfAssets1>
    <ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets contextRef="c-1" decimals="-3" id="f-347" unitRef="usd">-833000</ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets>
    <ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets contextRef="c-12" decimals="-3" id="f-348" unitRef="usd">550000</ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets>
    <ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets contextRef="c-13" decimals="-3" id="f-349" unitRef="usd">627000</ensg:GainLossOnInsuranceClaimsAndDispositionOfAssets>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-1" decimals="-3" id="f-350" unitRef="usd">4289000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-12" decimals="-3" id="f-351" unitRef="usd">-47182000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:GainLossRelatedToLitigationSettlement contextRef="c-13" decimals="-3" id="f-352" unitRef="usd">-4553000</us-gaap:GainLossRelatedToLitigationSettlement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-353" unitRef="usd">84397000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-12" decimals="-3" id="f-354" unitRef="usd">79818000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-13" decimals="-3" id="f-355" unitRef="usd">82426000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="c-1" decimals="-3" id="f-356" unitRef="usd">9227000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="c-12" decimals="-3" id="f-357" unitRef="usd">-814000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes contextRef="c-13" decimals="-3" id="f-358" unitRef="usd">-809000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-359" unitRef="usd">19055000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-12" decimals="-3" id="f-360" unitRef="usd">-6993000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-13" decimals="-3" id="f-361" unitRef="usd">9141000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct contextRef="c-1" decimals="-3" id="f-362" unitRef="usd">0</ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct>
    <ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct contextRef="c-12" decimals="-3" id="f-363" unitRef="usd">0</ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct>
    <ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct contextRef="c-13" decimals="-3" id="f-364" unitRef="usd">24155000</ensg:IncreaseDecreaseDueToDeferredEmployerTaxesCARESAct>
    <us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue contextRef="c-1" decimals="-3" id="f-365" unitRef="usd">14833000</us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue>
    <us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue contextRef="c-12" decimals="-3" id="f-366" unitRef="usd">16072000</us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue>
    <us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue contextRef="c-13" decimals="-3" id="f-367" unitRef="usd">7614000</us-gaap:LifeInsuranceCorporateOrBankOwnedChangeInValue>
    <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="c-1" decimals="-3" id="f-368" unitRef="usd">14986000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="c-12" decimals="-3" id="f-369" unitRef="usd">16044000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInDeferredCompensation contextRef="c-13" decimals="-3" id="f-370" unitRef="usd">7637000</us-gaap:IncreaseDecreaseInDeferredCompensation>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-371" unitRef="usd">287000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-12" decimals="-3" id="f-372" unitRef="usd">-6564000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-13" decimals="-3" id="f-373" unitRef="usd">345000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-374" unitRef="usd">2835000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-12" decimals="-3" id="f-375" unitRef="usd">15924000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-13" decimals="-3" id="f-376" unitRef="usd">17870000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-3" id="f-377" unitRef="usd">19992000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-12" decimals="-3" id="f-378" unitRef="usd">47967000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-13" decimals="-3" id="f-379" unitRef="usd">38982000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-380" unitRef="usd">-30670000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-12" decimals="-3" id="f-381" unitRef="usd">23828000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-13" decimals="-3" id="f-382" unitRef="usd">3010000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInSelfInsuranceReserve contextRef="c-1" decimals="-3" id="f-383" unitRef="usd">44014000</us-gaap:IncreaseDecreaseInSelfInsuranceReserve>
    <us-gaap:IncreaseDecreaseInSelfInsuranceReserve contextRef="c-12" decimals="-3" id="f-384" unitRef="usd">28827000</us-gaap:IncreaseDecreaseInSelfInsuranceReserve>
    <us-gaap:IncreaseDecreaseInSelfInsuranceReserve contextRef="c-13" decimals="-3" id="f-385" unitRef="usd">17785000</us-gaap:IncreaseDecreaseInSelfInsuranceReserve>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-1" decimals="-3" id="f-386" unitRef="usd">911000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-12" decimals="-3" id="f-387" unitRef="usd">-50000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-13" decimals="-3" id="f-388" unitRef="usd">-46000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-389" unitRef="usd">347186000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-12" decimals="-3" id="f-390" unitRef="usd">376666000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-13" decimals="-3" id="f-391" unitRef="usd">272513000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <ensg:PaymentsToAcquirePropertyAndEquipment contextRef="c-1" decimals="-3" id="f-392" unitRef="usd">158240000</ensg:PaymentsToAcquirePropertyAndEquipment>
    <ensg:PaymentsToAcquirePropertyAndEquipment contextRef="c-12" decimals="-3" id="f-393" unitRef="usd">106180000</ensg:PaymentsToAcquirePropertyAndEquipment>
    <ensg:PaymentsToAcquirePropertyAndEquipment contextRef="c-13" decimals="-3" id="f-394" unitRef="usd">87545000</ensg:PaymentsToAcquirePropertyAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-1" decimals="-3" id="f-395" unitRef="usd">156547000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-12" decimals="-3" id="f-396" unitRef="usd">69014000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-13" decimals="-3" id="f-397" unitRef="usd">101136000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:ProceedsFromInsuranceSettlementInvestingActivities contextRef="c-1" decimals="-3" id="f-398" unitRef="usd">3334000</us-gaap:ProceedsFromInsuranceSettlementInvestingActivities>
    <us-gaap:ProceedsFromInsuranceSettlementInvestingActivities contextRef="c-12" decimals="-3" id="f-399" unitRef="usd">2029000</us-gaap:ProceedsFromInsuranceSettlementInvestingActivities>
    <us-gaap:ProceedsFromInsuranceSettlementInvestingActivities contextRef="c-13" decimals="-3" id="f-400" unitRef="usd">1339000</us-gaap:ProceedsFromInsuranceSettlementInvestingActivities>
    <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c-1" decimals="-3" id="f-401" unitRef="usd">2818000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c-12" decimals="-3" id="f-402" unitRef="usd">248000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets contextRef="c-13" decimals="-3" id="f-403" unitRef="usd">8630000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-1" decimals="-3" id="f-404" unitRef="usd">105149000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-12" decimals="-3" id="f-405" unitRef="usd">29603000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-13" decimals="-3" id="f-406" unitRef="usd">21975000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="c-1" decimals="-3" id="f-407" unitRef="usd">26397000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="c-12" decimals="-3" id="f-408" unitRef="usd">18852000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments contextRef="c-13" decimals="-3" id="f-409" unitRef="usd">14356000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-3" id="f-410" unitRef="usd">2665000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-12" decimals="-3" id="f-411" unitRef="usd">-970000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-13" decimals="-3" id="f-412" unitRef="usd">-149000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-413" unitRef="usd">-390052000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-12" decimals="-3" id="f-414" unitRef="usd">-182698000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-13" decimals="-3" id="f-415" unitRef="usd">-186182000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-1" decimals="-3" id="f-416" unitRef="usd">400000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-12" decimals="-3" id="f-417" unitRef="usd">150000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-13" decimals="-3" id="f-418" unitRef="usd">411000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-1" decimals="-3" id="f-419" unitRef="usd">4350000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-12" decimals="-3" id="f-420" unitRef="usd">4033000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt contextRef="c-13" decimals="-3" id="f-421" unitRef="usd">4106000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-422" unitRef="usd">22286000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-12" decimals="-3" id="f-423" unitRef="usd">18369000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-13" decimals="-3" id="f-424" unitRef="usd">12677000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-425" unitRef="usd">1209000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-12" decimals="-3" id="f-426" unitRef="usd">1929000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-13" decimals="-3" id="f-427" unitRef="usd">1702000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-428" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-12" decimals="-3" id="f-429" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-13" decimals="-3" id="f-430" unitRef="usd">29882000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends contextRef="c-1" decimals="-3" id="f-431" unitRef="usd">13671000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-12" decimals="-3" id="f-432" unitRef="usd">12890000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends contextRef="c-13" decimals="-3" id="f-433" unitRef="usd">12168000</us-gaap:PaymentsOfDividends>
    <ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans contextRef="c-1" decimals="-3" id="f-434" unitRef="usd">0</ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans>
    <ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans contextRef="c-12" decimals="-3" id="f-435" unitRef="usd">0</ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans>
    <ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans contextRef="c-13" decimals="-3" id="f-436" unitRef="usd">6693000</ensg:ProceedsFromSaleOfCommonStockAssociatedWithSubsidiaryEquityPlans>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-1" decimals="-3" id="f-437" unitRef="usd">543000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-12" decimals="-3" id="f-438" unitRef="usd">4000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-13" decimals="-3" id="f-439" unitRef="usd">284000</us-gaap:PaymentsToMinorityShareholders>
    <ensg:PurchasesOfNonControllingInterest contextRef="c-1" decimals="-3" id="f-440" unitRef="usd">4450000</ensg:PurchasesOfNonControllingInterest>
    <ensg:PurchasesOfNonControllingInterest contextRef="c-12" decimals="-3" id="f-441" unitRef="usd">256000</ensg:PurchasesOfNonControllingInterest>
    <ensg:PurchasesOfNonControllingInterest contextRef="c-13" decimals="-3" id="f-442" unitRef="usd">704000</ensg:PurchasesOfNonControllingInterest>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-1" decimals="-3" id="f-443" unitRef="usd">625000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-12" decimals="-3" id="f-444" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities contextRef="c-13" decimals="-3" id="f-445" unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-1" decimals="-3" id="f-446" unitRef="usd">0</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-12" decimals="-3" id="f-447" unitRef="usd">19000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-13" decimals="-3" id="f-448" unitRef="usd">3197000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-449" unitRef="usd">-2162000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-12" decimals="-3" id="f-450" unitRef="usd">-612000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-13" decimals="-3" id="f-451" unitRef="usd">-32262000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-452" unitRef="usd">-45028000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-12" decimals="-3" id="f-453" unitRef="usd">193356000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-13" decimals="-3" id="f-454" unitRef="usd">54069000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-5" decimals="-3" id="f-455" unitRef="usd">509626000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-30" decimals="-3" id="f-456" unitRef="usd">316270000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-19" decimals="-3" id="f-457" unitRef="usd">262201000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-4" decimals="-3" id="f-458" unitRef="usd">464598000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-5" decimals="-3" id="f-459" unitRef="usd">509626000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations contextRef="c-30" decimals="-3" id="f-460" unitRef="usd">316270000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-461" unitRef="usd">7063000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-12" decimals="-3" id="f-462" unitRef="usd">7025000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-13" decimals="-3" id="f-463" unitRef="usd">7604000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-3" id="f-464" unitRef="usd">96337000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-12" decimals="-3" id="f-465" unitRef="usd">89730000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-13" decimals="-3" id="f-466" unitRef="usd">70055000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-467" unitRef="usd">215677000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-12" decimals="-3" id="f-468" unitRef="usd">196942000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-13" decimals="-3" id="f-469" unitRef="usd">151870000</us-gaap:OperatingLeasePayments>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-470" unitRef="usd">7900000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-12" decimals="-3" id="f-471" unitRef="usd">4600000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-13" decimals="-3" id="f-472" unitRef="usd">4800000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-4" decimals="-3" id="f-473" unitRef="usd">3589000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-474" unitRef="usd">3396000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-30" decimals="-3" id="f-475" unitRef="usd">3201000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-476" unitRef="usd">232918000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-12" decimals="-3" id="f-477" unitRef="usd">376550000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-13" decimals="-3" id="f-478" unitRef="usd">370753000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-479">DESCRIPTION OF BUSINESS&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;The Company&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Ensign Group, Inc. (collectively, Ensign or the Company), is a holding company with no direct operating assets, employees or revenue. The Company's independent subsidiaries provide health care services across the post-acute care continuum and engage in the ownership, acquisition, development and leasing of skilled nursing, senior living and other healthcare-related properties and ancillary businesses. As of December&#160;31, 2024, the Company's independent subsidiaries operated 327 facilities and other ancillary operations located in Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington and Wisconsin. The Company's independent subsidiaries have a collective capacity of approximately 33,500 operational skilled nursing beds and 3,100 senior living units. As of December&#160;31, 2024, the Company's independent subsidiaries operated 231 facilities under long-term lease arrangements and had options to purchase 12 of those 231 facilities. The Company's real estate portfolio consists of 129 owned real estate properties, which includes 96 facilities operated and managed by the Company's independent subsidiaries, 33 operations leased to and operated by third-party operators and the Service Center (defined below) location. Of those 33 third-party operations, one senior living operation is located on the same real estate property as a skilled nursing operation that an independent subsidiary operates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s wholly-owned independent subsidiaries, collectively referred to as the Service Center, provide specific accounting, payroll, human resources, information technology, legal, risk management and other centralized services to the other independent subsidiaries. The Company also has a wholly-owned captive insurance subsidiary that provides some claims-made coverage to the Company&#x2019;s independent subsidiaries for general and professional liabilities, as well as coverage for certain workers&#x2019; compensation insurance liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's captive real estate investment trust (REIT), Standard Bearer Healthcare REIT, Inc. (Standard Bearer), owns and manages its real estate business. The REIT structure provides the Company with an efficient vehicle for future acquisitions of properties that could be operated by Ensign's independent subsidiaries or other third parties. Standard Bearer has elected to be taxed as a REIT for U.S. federal income tax purposes. Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standard Bearer &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information on Standard Bearer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the Company's independent subsidiaries are operated by wholly-owned subsidiaries that have their own management, employees and assets. References herein to the consolidated &#x201c;Company&#x201d; and &#x201c;its&#x201d; assets and activities in this Annual Report are not meant to imply, nor should it be construed as meaning that The Ensign Group, Inc. has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by The Ensign Group, Inc.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-51"
      decimals="INF"
      id="f-480"
      unitRef="facility">327</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfSkilledNursingBeds contextRef="c-52" decimals="-2" id="f-481" unitRef="bed">33500</ensg:NumberOfSkilledNursingBeds>
    <ensg:NumberOfSeniorLivingUnits contextRef="c-52" decimals="-2" id="f-482" unitRef="unit">3100</ensg:NumberOfSeniorLivingUnits>
    <ensg:NumberOfFacilitiesUnderLongTermLeaseArrangements
      contextRef="c-52"
      decimals="INF"
      id="f-483"
      unitRef="facility">231</ensg:NumberOfFacilitiesUnderLongTermLeaseArrangements>
    <ensg:NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase
      contextRef="c-52"
      decimals="INF"
      id="f-484"
      unitRef="facility">12</ensg:NumberOfFacilitiesUnderLongTermLeaseArrangementsOptionToPurchase>
    <ensg:NumberOfFacilitiesUnderLongTermLeaseArrangements
      contextRef="c-52"
      decimals="INF"
      id="f-485"
      unitRef="facility">231</ensg:NumberOfFacilitiesUnderLongTermLeaseArrangements>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-4"
      decimals="INF"
      id="f-486"
      unitRef="property">129</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-52"
      decimals="INF"
      id="f-487"
      unitRef="property">96</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-53"
      decimals="INF"
      id="f-488"
      unitRef="property">33</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-53"
      decimals="INF"
      id="f-489"
      unitRef="property">33</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfRealEstatePropertiesSharingLocations
      contextRef="c-54"
      decimals="INF"
      id="f-490"
      unitRef="property">1</ensg:NumberOfRealEstatePropertiesSharingLocations>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-491">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The accompanying consolidated financial statements (the Financial Statements) have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The Company is the sole member or stockholder of various consolidated limited liability companies and corporations established to operate various acquired skilled nursing operations, senior living operations and related ancillary services. All intercompany transactions and balances have been eliminated in consolidation. The Company presents noncontrolling interests within the equity section of its consolidated balance sheets and the amount of consolidated net income that is attributable to The Ensign Group, Inc. and the noncontrolling interests in its consolidated statements of income. The Financial Statements include the accounts of all independent subsidiaries controlled by the Company through its ownership of a majority voting interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period statements of income and statements of cash flows have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Estimates and Assumptions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of the Financial Statements in conformity with GAAP&#160;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company&#x2019;s Financial Statements relate to revenue, acquired property and equipment, intangible assets and goodwill, right-of-use assets and lease liabilities, impairment of long-lived assets, as well as general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Considerations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments consist principally of cash and cash equivalents, debt security investments, accounts receivable, insurance subsidiary deposits, deferred compensation investment funds, equity investments, accounts payable and borrowings. The Company believes all of the financial instruments&#x2019; recorded values approximate fair values because of their nature or respective short durations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. See Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's non-financial assets, which includes goodwill, intangible assets, property and equipment and right-of-use assets, are not required to be measured at fair value on a recurring basis. However, on a periodic basis, or whenever events or changes in circumstances indicate that their carrying value may not be recoverable, the Company assesses its long-lived assets for impairment. When impairment has occurred, such long-lived assets are written down to fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Service Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 606).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's service revenue is derived primarily from providing healthcare services to its patients. Revenue is recognized when services are provided to patients at the amount that reflects the consideration that the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. The healthcare services provided pursuant to skilled patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct. Additionally, there may be ancillary services that are not included in the daily rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rates on a per day basis, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration that is included in the transaction price may be constrained and is included in net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#x2019;s estimates, the Company adjusts these estimates, which would affect net revenue in the period such variances become known.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company&#x2019;s contracts with its patients have an original duration of one year or less, the Company uses the practical expedient applicable to its contracts and does not consider the time value of money. Further, because of the short duration of these contracts, the Company has not disclosed the transaction price for the remaining performance obligations as of the end of each reporting period or when the Company expects to recognize this revenue. In addition, the Company has applied the practical expedient provided by FASB ASC Topic 340, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and all incremental customer contract acquisition costs are expensed as they are incurred because the amortization period would have been one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Rental Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's rental revenues are primarily generated by leasing healthcare-related properties through triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Revenue for operating leases is recognized on a straight-line basis over the lease term when collectability of all minimum lease payments is probable in accordance with FASB ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 842). The Company has elected the single component practical expedient, which allows a lessor, by class of underlying asset, not to allocate the total consideration to the lease and non-lease components based on their relative stand-alone selling prices where certain criteria are met. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tenant reimbursements related to property taxes and insurance are neither considered lease nor non-lease components under ASC 842. Lessee payments for taxes and insurance paid directly to a third party, on behalf of the Company, are excluded from variable lease payments and rental revenue in the Company&#x2019;s consolidated statements of income. Otherwise, tenant reimbursements for taxes and insurance that are paid by the Company directly to a third party are classified as additional rental revenue and expense and recognized by the Company on a gross basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of bank term deposits, money market funds and treasury bill related investments with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of money market funds is determined based on &#x201c;Level&#160;1&#x201d; inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Insurance Subsidiary Deposits and Other Investments &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's captive insurance subsidiary cash and cash equivalents, deposits and investments are designated to support long-term insurance subsidiary liabilities and have been classified as short-term and long-term assets based on the timing of expected future payments of the Company's captive insurance liabilities. The majority of these deposits and investments are currently held in AA, A and BBB rated debt security investments and the remainder is held in a bank account with a high credit quality financial institution. Investments classified as held-to-maturity are financial instruments that the Company has the intent and ability to hold to maturity and are reported net of any related amortization and are not remeasured to fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's non-qualified deferred compensation plan's (the DCP) contracts insuring the lives of certain employees who are eligible to participate in the DCP are held in a rabbi trust. Cash surrender value of the contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating an investment for its current expected credit losses, the Company reviews factors such as historical experience with defaults, losses, credit ratings, term, market sector and macroeconomic trends, including current conditions and forecasts to the extent they are reasonable and supportable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from &lt;span style="-sec-ix-hidden:f-501"&gt;three&lt;/span&gt; to 59 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company leases skilled nursing facilities, senior living facilities and commercial office space.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease and performs an evaluation to determine whether the lease should be classified as an operating or finance lease at the inception of the lease. As of December&#160;31, 2024, the Company has three financing lease that are not material to the consolidated balance sheet. Rights and obligations of the operating leases are included as right-of-use assets and current and long-term lease liabilities on the Company's consolidated balance sheets. As the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of future lease payments. The Company utilizes a third-party credit specialist to assist in estimating the incremental borrowing rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records rent expense for operating leases on a straight-line basis over the term of the lease. The lease term used for straight-line rent expense is calculated from the date the Company is given control of the leased premises through the end of the lease term. Renewals are not assumed in the determination of the lease term unless they are deemed to be reasonably assured at the inception of the lease. The lease term used for this evaluation also provides the basis for establishing depreciable lives for buildings subject to lease and leasehold improvements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's real estate leases generally have initial lease terms of ten years or more and typically include one or more options to renew, with renewal terms that generally extend the lease term for an additional &lt;span style="-sec-ix-hidden:f-507"&gt;ten&lt;/span&gt; to 15 years. Exercise of the renewal options is generally subject to the satisfaction of certain conditions which vary by contract and generally follow payment terms that are consistent with those in place during the initial term. The Company reassesses the renewal option using a "reasonably certain" threshold, which is understood to be a high threshold. For leases where the Company is reasonably certain to exercise its renewal option, the option periods are included within the lease term and, therefore, the measurement of the right-of-use asset and lease liability. The Company's leases generally contain annual escalation clauses that are either fixed or variable in nature, some of which are dependent upon published indices. The Company recognizes lease expense for leases with an initial term of 12 months or less on a straight-line basis over the lease term. These leases are not recorded on the consolidated balance sheets. Certain of the Company's lease agreements include rental payments that are adjusted periodically for inflation. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company subleases skilled nursing facilities to third-party operators and considers the subleases to be separate contracts as the Company is not relieved of its primary obligation under its operating lease. The rental income from third-parties related to these subleases is presented on a gross basis from the rent expense associated with the Company's lease obligations and is not material to the consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the carrying value of long-lived assets that are held and used in the Company&#x2019;s independent subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the independent subsidiaries to which the assets relate, utilizing management&#x2019;s best estimate, appropriate assumptions and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Definite-lived intangible assets consist primarily of patient base, facility trade names and customer relationships. Patient base is amortized over a period of &lt;span style="-sec-ix-hidden:f-511"&gt;four&lt;/span&gt; to eight months, depending on the classification of the patients and the level of occupancy in a new acquisition on the acquisition date. Trade names at independent subsidiaries are amortized over 30 years&#160;and customer relationships are amortized over a period of up to 20 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. The Company tests goodwill during the fourth quarter of each year or more often if events or circumstances indicate there may be impairment. The Company performs its analysis for each reporting unit that constitutes a business for which discrete financial information is produced and reviewed by operating segment management and provides services that are distinct from the other components of the operating segment, in accordance with the provisions of FASB ASC Topic 350,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 350). This guidance provides the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company performs a goodwill impairment test by comparing the carrying value of each reporting unit to its respective fair value. The Company determines the estimated fair value of each reporting unit using a discounted cash flow analysis. The fair value of the reporting unit is the implied fair value of goodwill. In the event a reporting unit's carrying value exceeds its fair value, an impairment loss will be recognized. An impairment loss is measured by the difference between the carrying value of the reporting unit and its fair value. The Company anticipates that the majority of goodwill recognized will be fully deductible for tax purposes as of December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Self-Insurance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company is partially self-insured for general and professional liability claims up to a base amount per claim (the self-insured retention) with an aggregate, one-time deductible above this limit. Losses beyond these amounts are insured through third-party policies with coverage limits per claim, per location and on an aggregate basis for the Company. The combined self-insured retention is $750 per claim, subject to an additional one-time deductible of $1,500 for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $650 per claim, subject to an additional one-time, deductible of $1,400. For all independent subsidiaries, except those located in Colorado, the third-party coverage above these limits is $1,000 per claim, $3,000 per operation, with a $10,000 aggregate limit and an additional state-specific aggregate where required by state law. In Colorado, the third-party coverage above these limits is $1,000 per claim and $3,000 per operation, which is independent of the aforementioned aggregate limits that apply outside of Colorado. Subsequent to December&#160;31, 2024, the combined self-insured retention is $1,000 per claim ($750 if an enforceable arbitration agreement applies), subject to an additional one-time deductible of $2,950 for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $750 per claim ($650 if an enforceable arbitration agreement applies), subject to an additional one-time, deductible of $4,500.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the self-insured retention and deductible limits for general and professional liabilities and workers' compensation liabilities are self-insured through the captive insurance subsidiary, the related assets and liabilities of which are included in the accompanying consolidated balance sheets. The captive insurance subsidiary is subject to certain statutory requirements as an insurance provider. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy is to accrue amounts equal to the actuarial estimated costs to settle open claims of insureds, as well as an estimate of the cost of insured claims that have been incurred but not reported. The Company develops information about the size of the ultimate claims based on historical experience, current industry information and actuarial analysis, and evaluates the estimates for claim loss exposure on a quarterly basis. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s independent subsidiaries are self-insured for workers&#x2019; compensation liabilities in California. To protect itself against loss exposure in California with this policy, the Company has purchased individual specific excess insurance coverage that insures individual claims that exceed $625 per occurrence. In Texas, the independent subsidiaries have elected non-subscriber status for workers&#x2019; compensation claims and the Company has purchased individual stop-loss coverage that insures individual claims that exceed $750 per occurrence. The Company&#x2019;s independent subsidiaries in all other states, with the exception of Washington, are under a loss sensitive plan that insures individual claims that exceed $350 per occurrence. In the state of Washington, the Company is self-insured and has purchased individual specific excess insurance coverage that insures individual claims that exceed $500 per occurrence. For all of the self-insured plans and retention, the Company accrues amounts equal to the estimated costs to settle open claims, as well as an estimate of the cost of claims that have been incurred but not reported. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company self-funds medical (including prescription drugs) and dental healthcare benefits to the majority of its employees. The Company is fully liable for all financial and legal aspects of these benefit plans. To protect itself against loss exposure with this policy, the Company has purchased individual stop-loss insurance coverage that insures individual claims that exceed $525 for each covered person.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that adequate provision has been made in the Financial Statements for liabilities that may arise out of patient care, workers&#x2019; compensation, healthcare benefits and related services provided to date. The amount of the Company&#x2019;s reserves was determined based on an estimation process that uses information obtained from both company-specific and industry data. This estimation process requires the Company to continuously monitor and evaluate the life cycle of the claims. Using data obtained from this monitoring and the Company&#x2019;s assumptions about emerging trends, the Company, with the assistance of an independent actuary, develops information about the size of ultimate claims based on the Company&#x2019;s historical experience and other available industry information. The most significant assumptions used in the estimation process include determining the trend in costs, the expected cost of claims incurred but not reported and the expected costs to settle or pay damage awards with respect to unpaid claims. The self-insured liabilities are based upon estimates, and while management believes that the estimates of loss are reasonable, the ultimate liability may be in excess of or less than the recorded amounts. Due to the inherent volatility of actuarially determined loss estimates, it is reasonably possible that the Company could experience changes in estimated losses that could be material to net income. If the Company&#x2019;s actual liabilities exceed its estimates of losses, its future earnings, cash flows and financial condition would be adversely affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#x2019;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#x2019;s estimates and assumptions, actual results could differ.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Standard Bearer was organized, has operated and intends to continue to operate in a manner to qualify for taxation as a REIT. In order to qualify as a REIT, Standard Bearer must meet certain organizational and operational requirements, including a requirement to distribute to its shareholders, which in this case is the Company, at least 90% of its annual taxable income. As a REIT, Standard Bearer generally will not be subject to federal income tax to the extent it distributes as qualifying dividends, all of its REIT taxable income to its shareholders. If Standard Bearer fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Noncontrolling Interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income attributable to The Ensign Group, Inc. in its consolidated statements of income. Net income per share is calculated based on net income attributable to The Ensign Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures and recognizes compensation expense for all stock-based payment awards made to employees and directors including employee stock options and restricted stock awards based on estimated fair values, ratably over the requisite service period of the award. Net income has been reduced as a result of the recognition of the fair value of all stock options and restricted stock awards issued, the amount of which is based upon the number of grants and other variables. As stock-based compensation expense recognized in the Company&#x2019;s consolidated statements of income was based on awards expected to vest, it has been reduced for estimated forfeitures. The Company estimates forfeitures at the time of grant and, if necessary, revises the estimate in subsequent periods if actual forfeitures differ.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company does not have any components of other comprehensive income recorded within its Financial Statements and, therefore, does not separately present a statement of comprehensive income in its Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Except for rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws and a limited number of grandfathered standards, the FASB ASC is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements announced, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company's reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company's financial management and certain standards are under consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Standards Adopted by the Company &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In November 2023, the FASB issued Accounting Standards Update (ASU) 2023-07 "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" which requires the Company to expand the breadth and frequency of segment disclosures to include additional information about significant segment expenses, the chief operating decision maker (CODM) and other items, and also require the annual disclosures on an interim basis. This guidance was effective for annual periods beginning with the Company's fiscal year 2024, and in interim periods within the Company's fiscal year 2025. The Company adopted the requirements of this ASU in Note 8, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Segments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of this Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In October 2023, the FASB issued ASU 2023-06&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; "Codification Amendments in Response to the SEC&#x2019;s Disclosure Update and Simplification Initiative," &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which amends U.S. GAAP to include 14 disclosure requirements that are currently required under SEC Regulation S-X or Regulation S-K. Each amendment will be effective on the date on which the SEC removes the related disclosure requirement from SEC Regulation S-X or Regulation S-K. The adoption is not expected to have a material impact on the Company's Financial Statements as these requirements were previously incorporated under the SEC Regulations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09 "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" which requires the Company to disclose disaggregated jurisdictional and categorical information for the tax rate reconciliation, income taxes paid and other income tax related amounts. ASU 2023-09 is effective for annual periods beginning with the Company's fiscal year 2025, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03 "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" which requires the Company to disaggregate key expense categories such as employee compensation, depreciation and intangible asset amortization within its financial statements. ASU 2024-03 is effective for annuals periods beginning with the Company's fiscal year 2027, and interim periods within the Company's fiscal year 2028, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-492">&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt; The accompanying consolidated financial statements (the Financial Statements) have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). The Company is the sole member or stockholder of various consolidated limited liability companies and corporations established to operate various acquired skilled nursing operations, senior living operations and related ancillary services. All intercompany transactions and balances have been eliminated in consolidation. The Company presents noncontrolling interests within the equity section of its consolidated balance sheets and the amount of consolidated net income that is attributable to The Ensign Group, Inc. and the noncontrolling interests in its consolidated statements of income. The Financial Statements include the accounts of all independent subsidiaries controlled by the Company through its ownership of a majority voting interest.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c-1" id="f-493">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain amounts in the prior period statements of income and statements of cash flows have been reclassified to conform to the presentation of the current period financial statements. These reclassifications had no effect on the previously reported net income.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-494">&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Estimates and Assumptions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt; The preparation of the Financial Statements in conformity with GAAP&#160;requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company&#x2019;s Financial Statements relate to revenue, acquired property and equipment, intangible assets and goodwill, right-of-use assets and lease liabilities, impairment of long-lived assets, as well as general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities. Actual results could differ from those estimates</us-gaap:UseOfEstimates>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="c-1" id="f-495">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Considerations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments consist principally of cash and cash equivalents, debt security investments, accounts receivable, insurance subsidiary deposits, deferred compensation investment funds, equity investments, accounts payable and borrowings. The Company believes all of the financial instruments&#x2019; recorded values approximate fair values because of their nature or respective short durations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. See Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information.&lt;/span&gt;&lt;/div&gt;The Company's non-financial assets, which includes goodwill, intangible assets, property and equipment and right-of-use assets, are not required to be measured at fair value on a recurring basis. However, on a periodic basis, or whenever events or changes in circumstances indicate that their carrying value may not be recoverable, the Company assesses its long-lived assets for impairment. When impairment has occurred, such long-lived assets are written down to fair value.</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-496">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Service Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 606).&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's service revenue is derived primarily from providing healthcare services to its patients. Revenue is recognized when services are provided to patients at the amount that reflects the consideration that the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. The healthcare services provided pursuant to skilled patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct. Additionally, there may be ancillary services that are not included in the daily rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rates on a per day basis, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration that is included in the transaction price may be constrained and is included in net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#x2019;s estimates, the Company adjusts these estimates, which would affect net revenue in the period such variances become known.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company&#x2019;s contracts with its patients have an original duration of one year or less, the Company uses the practical expedient applicable to its contracts and does not consider the time value of money. Further, because of the short duration of these contracts, the Company has not disclosed the transaction price for the remaining performance obligations as of the end of each reporting period or when the Company expects to recognize this revenue. In addition, the Company has applied the practical expedient provided by FASB ASC Topic 340, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, and all incremental customer contract acquisition costs are expensed as they are incurred because the amortization period would have been one year or less.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Rental Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's rental revenues are primarily generated by leasing healthcare-related properties through triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property. Revenue for operating leases is recognized on a straight-line basis over the lease term when collectability of all minimum lease payments is probable in accordance with FASB ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 842). The Company has elected the single component practical expedient, which allows a lessor, by class of underlying asset, not to allocate the total consideration to the lease and non-lease components based on their relative stand-alone selling prices where certain criteria are met. &lt;/span&gt;&lt;/div&gt;Tenant reimbursements related to property taxes and insurance are neither considered lease nor non-lease components under ASC 842. Lessee payments for taxes and insurance paid directly to a third party, on behalf of the Company, are excluded from variable lease payments and rental revenue in the Company&#x2019;s consolidated statements of income. Otherwise, tenant reimbursements for taxes and insurance that are paid by the Company directly to a third party are classified as additional rental revenue and expense and recognized by the Company on a gross basis.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c-1" id="f-497">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration.&lt;/span&gt;&lt;/div&gt;</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-498">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of bank term deposits, money market funds and treasury bill related investments with original maturities of three months or less at time of purchase and therefore approximate fair value. The fair value of money market funds is determined based on &#x201c;Level&#160;1&#x201d; inputs, which consist of unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets. The Company places its cash and short-term investments with high credit quality financial institutions.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock contextRef="c-1" id="f-499">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Insurance Subsidiary Deposits and Other Investments &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's captive insurance subsidiary cash and cash equivalents, deposits and investments are designated to support long-term insurance subsidiary liabilities and have been classified as short-term and long-term assets based on the timing of expected future payments of the Company's captive insurance liabilities. The majority of these deposits and investments are currently held in AA, A and BBB rated debt security investments and the remainder is held in a bank account with a high credit quality financial institution. Investments classified as held-to-maturity are financial instruments that the Company has the intent and ability to hold to maturity and are reported net of any related amortization and are not remeasured to fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's non-qualified deferred compensation plan's (the DCP) contracts insuring the lives of certain employees who are eligible to participate in the DCP are held in a rabbi trust. Cash surrender value of the contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When evaluating an investment for its current expected credit losses, the Company reviews factors such as historical experience with defaults, losses, credit ratings, term, market sector and macroeconomic trends, including current conditions and forecasts to the extent they are reasonable and supportable.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-500">&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt; Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from &lt;span style="-sec-ix-hidden:f-501"&gt;three&lt;/span&gt; to 59 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-56" id="f-502">P59Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-503">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company leases skilled nursing facilities, senior living facilities and commercial office space.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is a lease and performs an evaluation to determine whether the lease should be classified as an operating or finance lease at the inception of the lease. As of December&#160;31, 2024, the Company has three financing lease that are not material to the consolidated balance sheet. Rights and obligations of the operating leases are included as right-of-use assets and current and long-term lease liabilities on the Company's consolidated balance sheets. As the Company's leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at lease commencement date in determining the present value of future lease payments. The Company utilizes a third-party credit specialist to assist in estimating the incremental borrowing rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records rent expense for operating leases on a straight-line basis over the term of the lease. The lease term used for straight-line rent expense is calculated from the date the Company is given control of the leased premises through the end of the lease term. Renewals are not assumed in the determination of the lease term unless they are deemed to be reasonably assured at the inception of the lease. The lease term used for this evaluation also provides the basis for establishing depreciable lives for buildings subject to lease and leasehold improvements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's real estate leases generally have initial lease terms of ten years or more and typically include one or more options to renew, with renewal terms that generally extend the lease term for an additional &lt;span style="-sec-ix-hidden:f-507"&gt;ten&lt;/span&gt; to 15 years. Exercise of the renewal options is generally subject to the satisfaction of certain conditions which vary by contract and generally follow payment terms that are consistent with those in place during the initial term. The Company reassesses the renewal option using a "reasonably certain" threshold, which is understood to be a high threshold. For leases where the Company is reasonably certain to exercise its renewal option, the option periods are included within the lease term and, therefore, the measurement of the right-of-use asset and lease liability. The Company's leases generally contain annual escalation clauses that are either fixed or variable in nature, some of which are dependent upon published indices. The Company recognizes lease expense for leases with an initial term of 12 months or less on a straight-line basis over the lease term. These leases are not recorded on the consolidated balance sheets. Certain of the Company's lease agreements include rental payments that are adjusted periodically for inflation. The lease agreements do not contain any material residual value guarantees or material restrictive covenants. &lt;/span&gt;&lt;/div&gt;The Company subleases skilled nursing facilities to third-party operators and considers the subleases to be separate contracts as the Company is not relieved of its primary obligation under its operating lease. The rental income from third-parties related to these subleases is presented on a gross basis from the rent expense associated with the Company's lease obligations and is not material to the consolidated statements of income.</us-gaap:LesseeLeasesPolicyTextBlock>
    <ensg:NumberOfFinancingLeases contextRef="c-4" decimals="INF" id="f-504" unitRef="lease">3</ensg:NumberOfFinancingLeases>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-55" id="f-505">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <ensg:LesseeOperatingLeaseNumberOfRenewalOptions contextRef="c-1" decimals="INF" id="f-506" unitRef="option">1</ensg:LesseeOperatingLeaseNumberOfRenewalOptions>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-56" id="f-508">P15Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-509">&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014; &lt;/span&gt;The Company reviews the carrying value of long-lived assets that are held and used in the Company&#x2019;s independent subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the independent subsidiaries to which the assets relate, utilizing management&#x2019;s best estimate, appropriate assumptions and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c-1" id="f-510">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Goodwill&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Definite-lived intangible assets consist primarily of patient base, facility trade names and customer relationships. Patient base is amortized over a period of &lt;span style="-sec-ix-hidden:f-511"&gt;four&lt;/span&gt; to eight months, depending on the classification of the patients and the level of occupancy in a new acquisition on the acquisition date. Trade names at independent subsidiaries are amortized over 30 years&#160;and customer relationships are amortized over a period of up to 20 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations. The Company tests goodwill during the fourth quarter of each year or more often if events or circumstances indicate there may be impairment. The Company performs its analysis for each reporting unit that constitutes a business for which discrete financial information is produced and reviewed by operating segment management and provides services that are distinct from the other components of the operating segment, in accordance with the provisions of FASB ASC Topic 350,&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other&#160;&lt;/span&gt;(ASC 350). This guidance provides the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. If, based on a review of qualitative factors, it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company performs a goodwill impairment test by comparing the carrying value of each reporting unit to its respective fair value. The Company determines the estimated fair value of each reporting unit using a discounted cash flow analysis. The fair value of the reporting unit is the implied fair value of goodwill. In the event a reporting unit's carrying value exceeds its fair value, an impairment loss will be recognized. An impairment loss is measured by the difference between the carrying value of the reporting unit and its fair value. The Company anticipates that the majority of goodwill recognized will be fully deductible for tax purposes as of December&#160;31, 2024.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-58" id="f-512">P8M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-59" id="f-513">P30Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-60" id="f-514">P20Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:SelfInsuranceReservePolicyTextBlock contextRef="c-1" id="f-515">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Self-Insurance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company is partially self-insured for general and professional liability claims up to a base amount per claim (the self-insured retention) with an aggregate, one-time deductible above this limit. Losses beyond these amounts are insured through third-party policies with coverage limits per claim, per location and on an aggregate basis for the Company. The combined self-insured retention is $750 per claim, subject to an additional one-time deductible of $1,500 for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $650 per claim, subject to an additional one-time, deductible of $1,400. For all independent subsidiaries, except those located in Colorado, the third-party coverage above these limits is $1,000 per claim, $3,000 per operation, with a $10,000 aggregate limit and an additional state-specific aggregate where required by state law. In Colorado, the third-party coverage above these limits is $1,000 per claim and $3,000 per operation, which is independent of the aforementioned aggregate limits that apply outside of Colorado. Subsequent to December&#160;31, 2024, the combined self-insured retention is $1,000 per claim ($750 if an enforceable arbitration agreement applies), subject to an additional one-time deductible of $2,950 for the Company's independent subsidiaries in California. For the independent subsidiaries not in California, the self-insured claim is $750 per claim ($650 if an enforceable arbitration agreement applies), subject to an additional one-time, deductible of $4,500.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the self-insured retention and deductible limits for general and professional liabilities and workers' compensation liabilities are self-insured through the captive insurance subsidiary, the related assets and liabilities of which are included in the accompanying consolidated balance sheets. The captive insurance subsidiary is subject to certain statutory requirements as an insurance provider. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy is to accrue amounts equal to the actuarial estimated costs to settle open claims of insureds, as well as an estimate of the cost of insured claims that have been incurred but not reported. The Company develops information about the size of the ultimate claims based on historical experience, current industry information and actuarial analysis, and evaluates the estimates for claim loss exposure on a quarterly basis. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s independent subsidiaries are self-insured for workers&#x2019; compensation liabilities in California. To protect itself against loss exposure in California with this policy, the Company has purchased individual specific excess insurance coverage that insures individual claims that exceed $625 per occurrence. In Texas, the independent subsidiaries have elected non-subscriber status for workers&#x2019; compensation claims and the Company has purchased individual stop-loss coverage that insures individual claims that exceed $750 per occurrence. The Company&#x2019;s independent subsidiaries in all other states, with the exception of Washington, are under a loss sensitive plan that insures individual claims that exceed $350 per occurrence. In the state of Washington, the Company is self-insured and has purchased individual specific excess insurance coverage that insures individual claims that exceed $500 per occurrence. For all of the self-insured plans and retention, the Company accrues amounts equal to the estimated costs to settle open claims, as well as an estimate of the cost of claims that have been incurred but not reported. The Company uses actuarial valuations to estimate the liability based on historical experience and industry information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company self-funds medical (including prescription drugs) and dental healthcare benefits to the majority of its employees. The Company is fully liable for all financial and legal aspects of these benefit plans. To protect itself against loss exposure with this policy, the Company has purchased individual stop-loss insurance coverage that insures individual claims that exceed $525 for each covered person.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company believes that adequate provision has been made in the Financial Statements for liabilities that may arise out of patient care, workers&#x2019; compensation, healthcare benefits and related services provided to date. The amount of the Company&#x2019;s reserves was determined based on an estimation process that uses information obtained from both company-specific and industry data. This estimation process requires the Company to continuously monitor and evaluate the life cycle of the claims. Using data obtained from this monitoring and the Company&#x2019;s assumptions about emerging trends, the Company, with the assistance of an independent actuary, develops information about the size of ultimate claims based on the Company&#x2019;s historical experience and other available industry information. The most significant assumptions used in the estimation process include determining the trend in costs, the expected cost of claims incurred but not reported and the expected costs to settle or pay damage awards with respect to unpaid claims. The self-insured liabilities are based upon estimates, and while management believes that the estimates of loss are reasonable, the ultimate liability may be in excess of or less than the recorded amounts. Due to the inherent volatility of actuarially determined loss estimates, it is reasonably possible that the Company could experience changes in estimated losses that could be material to net income. If the Company&#x2019;s actual liabilities exceed its estimates of losses, its future earnings, cash flows and financial condition would be adversely affected.&lt;/span&gt;&lt;/div&gt;</us-gaap:SelfInsuranceReservePolicyTextBlock>
    <us-gaap:SelfInsuranceReserve contextRef="c-61" decimals="-3" id="f-516" unitRef="usd">750000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-62" decimals="-3" id="f-517" unitRef="usd">1500000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-63" decimals="-3" id="f-518" unitRef="usd">650000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-64" decimals="-3" id="f-519" unitRef="usd">1400000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-65" decimals="-3" id="f-520" unitRef="usd">1000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-66" decimals="-3" id="f-521" unitRef="usd">3000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-67" decimals="-3" id="f-522" unitRef="usd">10000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-68" decimals="-3" id="f-523" unitRef="usd">1000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-69" decimals="-3" id="f-524" unitRef="usd">3000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-70" decimals="-3" id="f-525" unitRef="usd">1000000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-71" decimals="-3" id="f-526" unitRef="usd">750000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-72" decimals="-3" id="f-527" unitRef="usd">2950000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-73" decimals="-3" id="f-528" unitRef="usd">750000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-74" decimals="-3" id="f-529" unitRef="usd">650000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-75" decimals="-3" id="f-530" unitRef="usd">4500000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-76" decimals="-3" id="f-531" unitRef="usd">625000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-77" decimals="-3" id="f-532" unitRef="usd">750000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-78" decimals="-3" id="f-533" unitRef="usd">350000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-79" decimals="-3" id="f-534" unitRef="usd">500000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-80" decimals="-3" id="f-535" unitRef="usd">525000</us-gaap:SelfInsuranceReserve>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-536">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#x2019;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#x2019;s estimates and assumptions, actual results could differ.&lt;/span&gt;&lt;/div&gt;Standard Bearer was organized, has operated and intends to continue to operate in a manner to qualify for taxation as a REIT. In order to qualify as a REIT, Standard Bearer must meet certain organizational and operational requirements, including a requirement to distribute to its shareholders, which in this case is the Company, at least 90% of its annual taxable income. As a REIT, Standard Bearer generally will not be subject to federal income tax to the extent it distributes as qualifying dividends, all of its REIT taxable income to its shareholders. If Standard Bearer fails to qualify as a REIT in any taxable year, it will be subject to federal income tax on its taxable income at regular corporate income tax rates and generally will not be permitted to qualify for treatment as a REIT for federal income tax purposes for the four taxable years following the year during which qualification is lost unless the Internal Revenue Service grants the Company relief under certain statutory provisions.</us-gaap:IncomeTaxPolicyTextBlock>
    <ensg:NoncontrollingInterestPolicyTextBlock contextRef="c-1" id="f-537">&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Noncontrolling Interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014; &lt;/span&gt;The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income attributable to The Ensign Group, Inc. in its consolidated statements of income. Net income per share is calculated based on net income attributable to The Ensign Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest.</ensg:NoncontrollingInterestPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-538">&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures and recognizes compensation expense for all stock-based payment awards made to employees and directors including employee stock options and restricted stock awards based on estimated fair values, ratably over the requisite service period of the award. Net income has been reduced as a result of the recognition of the fair value of all stock options and restricted stock awards issued, the amount of which is based upon the number of grants and other variables. As stock-based compensation expense recognized in the Company&#x2019;s consolidated statements of income was based on awards expected to vest, it has been reduced for estimated forfeitures. The Company estimates forfeitures at the time of grant and, if necessary, revises the estimate in subsequent periods if actual forfeitures differ.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-539">&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt; The Company does not have any components of other comprehensive income recorded within its Financial Statements and, therefore, does not separately present a statement of comprehensive income in its Financial Statements.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-540">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Except for rules and interpretive releases of the Securities and Exchange Commission (SEC) under authority of federal securities laws and a limited number of grandfathered standards, the FASB ASC is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements announced, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company's reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company's financial management and certain standards are under consideration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Standards Adopted by the Company &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In November 2023, the FASB issued Accounting Standards Update (ASU) 2023-07 "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" which requires the Company to expand the breadth and frequency of segment disclosures to include additional information about significant segment expenses, the chief operating decision maker (CODM) and other items, and also require the annual disclosures on an interim basis. This guidance was effective for annual periods beginning with the Company's fiscal year 2024, and in interim periods within the Company's fiscal year 2025. The Company adopted the requirements of this ASU in Note 8, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Segments &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of this Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In October 2023, the FASB issued ASU 2023-06&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; "Codification Amendments in Response to the SEC&#x2019;s Disclosure Update and Simplification Initiative," &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;which amends U.S. GAAP to include 14 disclosure requirements that are currently required under SEC Regulation S-X or Regulation S-K. Each amendment will be effective on the date on which the SEC removes the related disclosure requirement from SEC Regulation S-X or Regulation S-K. The adoption is not expected to have a material impact on the Company's Financial Statements as these requirements were previously incorporated under the SEC Regulations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09 "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Improvements to Income Tax Disclosures,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" which requires the Company to disclose disaggregated jurisdictional and categorical information for the tax rate reconciliation, income taxes paid and other income tax related amounts. ASU 2023-09 is effective for annual periods beginning with the Company's fiscal year 2025, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03 "&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;" which requires the Company to disaggregate key expense categories such as employee compensation, depreciation and intangible asset amortization within its financial statements. ASU 2024-03 is effective for annuals periods beginning with the Company's fiscal year 2027, and interim periods within the Company's fiscal year 2028, with early adoption permitted. The Company is currently evaluating the impact of this ASU on its Notes to the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-541">REVENUE AND ACCOUNTS RECEIVABLE&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's service revenue is derived primarily from providing healthcare services to its patients. Revenue is recognized when services are provided to patients at the amount that reflects the consideration that the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disaggregates revenue from contracts with its patients by payors. The Company has determined that disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue by Payor&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue is derived primarily from providing healthcare services to patients and is recognized on the date services are provided at amounts billable to individual patients, adjusted for estimates for variable consideration. For patients under reimbursement arrangements with third-party payors, including Medicaid, Medicare and private insurers, revenue is recorded based on contractually agreed-upon amounts or rates, adjusted for estimates for variable consideration, on a per patient, daily basis or as services are performed.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from the Medicare and Medicaid programs accounted for 70.9%, 72.6% and 73.7% for the years ended December 31, 2024, 2023 and 2022, respectively. Settlements with Medicare and Medicaid payors for retroactive adjustments due to audits and reviews are considered variable consideration and are included in the determination of the estimated transaction price. These settlements are estimated based on the terms of the payment agreement with the payor, correspondence from the payor and the Company&#x2019;s historical settlement activity. Consistent with healthcare industry practices, any changes to these revenue estimates are recorded in the period the change or adjustment becomes known based on the final settlement. The Company recorded adjustments to revenue which were not material to the Company's revenue for the years ended December 31, 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service revenue for the years ended December 31, 2024, 2023 and 2022 is summarized in the following tables:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.312%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid &#x2014; skilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicaid and Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,004,308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,690,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,216,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;SERVICE REVENUE&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,237,525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,708,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,008,711&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Medicaid payor includes revenue for senior living operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Medicaid payor includes revenue related to state relief funding during the year ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3) Private and other also includes revenue from senior living operations and all revenue generated in other an&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;cillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the service revenue above, the Company's rental revenue derived from triple-net lease arrangements with third parties is $22,960, $21,284 and $16,757 for the years ended December 31, 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;State relief funding&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received state relief funding through Medicaid programs from various states, including healthcare relief funding under the American Rescue Plan Act (ARPA), increases in the Federal Medical Assistance Percentage (FMAP) under the Families First Coronavirus Response Act (FFCRA) and other state specific relief programs. The funding generally incorporates specific use requirements primarily for direct patient care including labor related expenses that are attributable to the COVID-19 pandemic or are associated with providing patient care. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to the expiration of the COVID-19 Public Health Emergency in May 2023, the Company did not receive additional funding during the year ended December 31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from these additional payments are recognized in accordance with ASC 606, subject to variable consideration constraints. In certain operations where the Company received additional payments that exceeded expenses incurred related to specific qualifiers, the Company recorded deferred revenue for the excess amount until additional expenses are incurred for recognition. Accordingly, the amount of state relief revenue recognized is limited to the actual related expenses incurred. As of years ended December 31, 2023 and 2022, the Company had $486 and $1,001 in unapplied state relief funds, respectively. During the years ended December 31, 2023 and 2022, the Company received an additional $64,238, and $81,057 in state relief funding and recognized $64,753, and $81,837, respectively, as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Federal relief funding &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As part of the Coronavirus Aid, Relief, and Economic Security Act of 2020 (CARES Act), the Company deferred payment of the employer portion of social security taxes related to 2020. For the year ended December 31, 2022, the Company paid $24,155, which was the second and final payment associated with the deferred amount from 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Balance Sheet Impact&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the Company&#x2019;s consolidated balance sheets are contract balances, comprised of billed accounts receivable and unbilled receivables, which are the result of the timing of revenue recognition, billings and cash collections, as well as contract liabilities, which primarily represent payments the Company receives in advance of services provided. The Company had no material contract liabilities and contract assets as of December 31, 2024 and 2023, or activity during the years ended December 31, 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration and doubtful accounts. Accounts receivable as of December&#160;31, 2024 and 2023, is summarized in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9.75pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.861%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other payors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;578,332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;494,387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,435)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ACCOUNTS RECEIVABLE, NET&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;569,897&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;485,039&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-81" decimals="3" id="f-542" unitRef="number">0.709</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-82" decimals="3" id="f-543" unitRef="number">0.726</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-83" decimals="3" id="f-544" unitRef="number">0.737</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-545">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service revenue for the years ended December 31, 2024, 2023 and 2022 is summarized in the following tables:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.086%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.312%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;% of Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid &#x2014; skilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Medicaid and Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,004,308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,690,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,216,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;SERVICE REVENUE&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,237,525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,708,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,008,711&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Medicaid payor includes revenue for senior living operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Medicaid payor includes revenue related to state relief funding during the year ended December 31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3) Private and other also includes revenue from senior living operations and all revenue generated in other an&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;cillary services.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-84" decimals="-3" id="f-546" unitRef="usd">1682344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-85" decimals="3" id="f-547" unitRef="number">0.397</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-86" decimals="-3" id="f-548" unitRef="usd">1459449000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-87" decimals="3" id="f-549" unitRef="number">0.394</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-88" decimals="-3" id="f-550" unitRef="usd">1183156000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-89" decimals="3" id="f-551" unitRef="number">0.393</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-90" decimals="-3" id="f-552" unitRef="usd">1055226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-91" decimals="3" id="f-553" unitRef="number">0.249</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-92" decimals="-3" id="f-554" unitRef="usd">985749000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-93" decimals="3" id="f-555" unitRef="number">0.266</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-94" decimals="-3" id="f-556" unitRef="usd">832160000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-95" decimals="3" id="f-557" unitRef="number">0.277</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-96" decimals="-3" id="f-558" unitRef="usd">266738000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-97" decimals="3" id="f-559" unitRef="number">0.063</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-98" decimals="-3" id="f-560" unitRef="usd">245663000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-99" decimals="3" id="f-561" unitRef="number">0.066</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-100" decimals="-3" id="f-562" unitRef="usd">200878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-101" decimals="3" id="f-563" unitRef="number">0.067</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-102" decimals="-3" id="f-564" unitRef="usd">3004308000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-81" decimals="3" id="f-565" unitRef="number">0.709</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-103" decimals="-3" id="f-566" unitRef="usd">2690861000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-82" decimals="3" id="f-567" unitRef="number">0.726</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-104" decimals="-3" id="f-568" unitRef="usd">2216194000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-83" decimals="3" id="f-569" unitRef="number">0.737</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-105" decimals="-3" id="f-570" unitRef="usd">789643000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-106" decimals="3" id="f-571" unitRef="number">0.186</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-107" decimals="-3" id="f-572" unitRef="usd">666129000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-108" decimals="3" id="f-573" unitRef="number">0.180</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-109" decimals="-3" id="f-574" unitRef="usd">525710000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-110" decimals="3" id="f-575" unitRef="number">0.175</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-111" decimals="-3" id="f-576" unitRef="usd">443574000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-112" decimals="3" id="f-577" unitRef="number">0.105</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-3" id="f-578" unitRef="usd">351081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-114" decimals="3" id="f-579" unitRef="number">0.094</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-580" unitRef="usd">266807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-116" decimals="3" id="f-581" unitRef="number">0.088</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-582" unitRef="usd">4237525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-117" decimals="3" id="f-583" unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-584" unitRef="usd">3708071000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-118" decimals="3" id="f-585" unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-3" id="f-586" unitRef="usd">3008711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-119" decimals="3" id="f-587" unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-9" decimals="-3" id="f-588" unitRef="usd">22960000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-10" decimals="-3" id="f-589" unitRef="usd">21284000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-11" decimals="-3" id="f-590" unitRef="usd">16757000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <ensg:FamilyFirstCoronavirusResponseActPaymentsReceived contextRef="c-1" decimals="INF" id="f-591" unitRef="usd">0</ensg:FamilyFirstCoronavirusResponseActPaymentsReceived>
    <ensg:AccruedLiabilitiesStateReliefContractLiabilities contextRef="c-5" decimals="-3" id="f-592" unitRef="usd">486000</ensg:AccruedLiabilitiesStateReliefContractLiabilities>
    <ensg:AccruedLiabilitiesStateReliefContractLiabilities contextRef="c-30" decimals="-3" id="f-593" unitRef="usd">1001000</ensg:AccruedLiabilitiesStateReliefContractLiabilities>
    <ensg:FamilyFirstCoronavirusResponseActPaymentsReceived contextRef="c-12" decimals="-3" id="f-594" unitRef="usd">64238000</ensg:FamilyFirstCoronavirusResponseActPaymentsReceived>
    <ensg:FamilyFirstCoronavirusResponseActPaymentsReceived contextRef="c-13" decimals="-3" id="f-595" unitRef="usd">81057000</ensg:FamilyFirstCoronavirusResponseActPaymentsReceived>
    <ensg:RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized contextRef="c-12" decimals="-3" id="f-596" unitRef="usd">64753000</ensg:RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized>
    <ensg:RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized contextRef="c-13" decimals="-3" id="f-597" unitRef="usd">81837000</ensg:RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized>
    <ensg:MedicareAcceleratedAndAdvancePaymentCARESACT contextRef="c-13" decimals="-3" id="f-598" unitRef="usd">24155000</ensg:MedicareAcceleratedAndAdvancePaymentCARESACT>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-599">Accounts receivable as of December&#160;31, 2024 and 2023, is summarized in the following table:&lt;div style="margin-top:9.75pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.861%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;228,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other payors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;578,332&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;494,387&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,435)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ACCOUNTS RECEIVABLE, NET&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;569,897&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;485,039&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross contextRef="c-120" decimals="-3" id="f-600" unitRef="usd">228872000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-121" decimals="-3" id="f-601" unitRef="usd">178285000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-122" decimals="-3" id="f-602" unitRef="usd">139711000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-123" decimals="-3" id="f-603" unitRef="usd">125907000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-124" decimals="-3" id="f-604" unitRef="usd">77056000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-125" decimals="-3" id="f-605" unitRef="usd">85512000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-126" decimals="-3" id="f-606" unitRef="usd">132693000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-127" decimals="-3" id="f-607" unitRef="usd">104683000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-4" decimals="-3" id="f-608" unitRef="usd">578332000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-5" decimals="-3" id="f-609" unitRef="usd">494387000</us-gaap:AccountsReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-4" decimals="-3" id="f-610" unitRef="usd">8435000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent contextRef="c-5" decimals="-3" id="f-611" unitRef="usd">9348000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-4" decimals="-3" id="f-612" unitRef="usd">569897000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="-3" id="f-613" unitRef="usd">485039000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-614">COMPUTATION OF NET INCOME PER COMMON SHARE&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share is computed by dividing income from operations attributable to stockholders of The Ensign Group, Inc. by the weighted average number of outstanding common shares for the period. The computation of diluted net income per share is similar to the computation of basic net income per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerator and denominator used in the calculation of basic net income per common share follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.207%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NUMERATOR:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: net income (loss) attributable to noncontrolling interests &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to The Ensign Group, Inc. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;297,973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209,399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;224,681&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DENOMINATOR:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for basic net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.76&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerator and denominator used in the calculation of diluted net income per common share follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.818%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NUMERATOR:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: net income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to The Ensign Group, Inc. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;297,973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209,399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;224,681&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DENOMINATOR:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: incremental shares from assumed conversion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjusted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;58,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;57,323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; 914, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,429 and 780 for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock contextRef="c-1" id="f-615">&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerator and denominator used in the calculation of basic net income per common share follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.841%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.207%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NUMERATOR:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: net income (loss) attributable to noncontrolling interests &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to The Ensign Group, Inc. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;297,973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209,399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;224,681&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DENOMINATOR:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for basic net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.26&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.76&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4.09&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicByCommonClassTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-616" unitRef="usd">298458000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-617" unitRef="usd">209850000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-618" unitRef="usd">224652000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-1" decimals="-3" id="f-619" unitRef="usd">485000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-12" decimals="-3" id="f-620" unitRef="usd">451000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-13" decimals="-3" id="f-621" unitRef="usd">-29000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-622" unitRef="usd">297973000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-3" id="f-623" unitRef="usd">209399000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-624" unitRef="usd">224681000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-625" unitRef="shares">56655000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-12" decimals="-3" id="f-626" unitRef="shares">55708000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-13" decimals="-3" id="f-627" unitRef="shares">54887000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-628"
      unitRef="usdPerShare">5.26</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-12"
      decimals="2"
      id="f-629"
      unitRef="usdPerShare">3.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-13"
      decimals="2"
      id="f-630"
      unitRef="usdPerShare">4.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock contextRef="c-1" id="f-631">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the numerator and denominator used in the calculation of diluted net income per common share follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.818%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NUMERATOR:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: net income (loss) attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to The Ensign Group, Inc. &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;297,973&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;209,399&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;224,681&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;DENOMINATOR:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: incremental shares from assumed conversion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Adjusted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;58,240&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;57,323&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;56,871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted net income per common share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;5.12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.65&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3.95&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; 914, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;1,429 and 780 for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-632" unitRef="usd">298458000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-633" unitRef="usd">209850000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-634" unitRef="usd">224652000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-1" decimals="-3" id="f-635" unitRef="usd">485000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-12" decimals="-3" id="f-636" unitRef="usd">451000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity contextRef="c-13" decimals="-3" id="f-637" unitRef="usd">-29000</us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-638" unitRef="usd">297973000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-12" decimals="-3" id="f-639" unitRef="usd">209399000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-13" decimals="-3" id="f-640" unitRef="usd">224681000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-641" unitRef="shares">56655000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-12" decimals="-3" id="f-642" unitRef="shares">55708000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-13" decimals="-3" id="f-643" unitRef="shares">54887000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-1" decimals="-3" id="f-644" unitRef="shares">1585000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-12" decimals="-3" id="f-645" unitRef="shares">1615000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-13" decimals="-3" id="f-646" unitRef="shares">1984000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-647" unitRef="shares">58240000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-12" decimals="-3" id="f-648" unitRef="shares">57323000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-13" decimals="-3" id="f-649" unitRef="shares">56871000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-650"
      unitRef="usdPerShare">5.12</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-12"
      decimals="2"
      id="f-651"
      unitRef="usdPerShare">3.65</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-13"
      decimals="2"
      id="f-652"
      unitRef="usdPerShare">3.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-1" decimals="-3" id="f-653" unitRef="shares">914000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-12" decimals="-3" id="f-654" unitRef="shares">1429000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-13" decimals="-3" id="f-655" unitRef="shares">780000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-656">FAIR VALUE MEASUREMENTS&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's financial assets include held-to-maturity investments carried at amortized cost basis of $138,600 and $59,530, of which $65,831 and $59,530 are designated to support long-term insurance subsidiary liabilities, both as of December&#160;31, 2024 and 2023, respectively. As of December&#160;31, 2024 and 2023, the amortized cost basis of these financial assets are considered to approximate fair value and are derived using Level 2 inputs. The Company believes its amortized cost basis investments that were in an unrealized loss position as of December&#160;31, 2024 and 2023 do not require an allowance for expected credit losses, nor has any event occurred through the filing date of this report that would indicate differently.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's financial assets also include the contracts insuring the lives of certain employees who are eligible to participate in non-qualified deferred compensation plans that are held in a rabbi trust. The cash surrender value of these contracts is based on funds that shadow the investment allocations specified by participants in the deferred compensation plan and are held at fair value. As of December&#160;31, 2024 and 2023, the fair value of the investment funds was $56,049 and $41,216, respectively, which are derived using Level 2 inputs.&lt;/span&gt;&lt;/div&gt;Additionally, the Company has other investments held at historical cost basis, which are not material, for which the fair value is derived using Level 3 inputs.</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c-128" decimals="-3" id="f-657" unitRef="usd">138600000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c-129" decimals="-3" id="f-658" unitRef="usd">59530000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c-130" decimals="-3" id="f-659" unitRef="usd">65831000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss contextRef="c-131" decimals="-3" id="f-660" unitRef="usd">59530000</us-gaap:DebtSecuritiesHeldToMaturityAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-128" decimals="-3" id="f-661" unitRef="usd">56049000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="c-129" decimals="-3" id="f-662" unitRef="usd">41216000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <ensg:StandardBearerTextBlock contextRef="c-1" id="f-663">STANDARD BEARER&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Standard Bearer's real estate portfolio consists of 124 of the Company's 129 owned real estate properties, of which 92 are operated and managed by the Company's independent subsidiaries and 33 are leased to and operated by third-party operators. Of those 33 operations, one senior living operation is located on the same real estate property as a skilled nursing operation that an independent subsidiary operates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;year ended December 31, 2024,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Standard Bearer added $131,927 of real estate assets associated with 11 stand-alone skilled nursing operations, three stand-alone senior living operations and three campus operations&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. These new additions for the stand-alone skilled nursing and campus operations are&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;operated by &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the Company's &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;independent&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; subsidiaries and the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three stand-alone senior living operations are leased to a third-party operator. Refer to Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operation Expansions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2024, Standard Bearer added $50,853 of real estate assets associated with four stand-alone skilled nursing operations and one campus operation. Four of the acquisitions were related to exercising purchase options under an existing lease arrangement from CareTrust REIT, Inc. (CareTrust). These locations are currently operated by the Company's independent subsidiaries. The remaining one real estate acquisition was leased back to the Company's independent subsidiaries. Refer to Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operation Expansions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, Standard Bearer added $65,899 of real estate assets associated with three stand-alone skilled nursing facilities and two campus operations. Of these additions, the three skilled nursing facilities and one campus operation acquired are operated by the Company's independent subsidiaries and the other campus operation is leased to a third-party operator. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, Standard Bearer added $84,656 of real estate assets associated with ten skilled nursing facilities, three of which were previously operated and managed by the Company's independent subsidiaries. Refer to Note 7, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operation Expansions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the formation of Standard Bearer, certain of the Company's &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;independent subsidiaries&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Standard Bearer and Standard Bearer's independent real estate subsidiaries entered into several agreements that include leasing, management services and debt arrangements between the operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. All intercompany transactions have been eliminated in consolidation. Refer to Note 8, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Segments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information related to these intercompany eliminations as well as Standard Bearer as a reportable segment. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intercompany master lease agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company's independent subsidiaries and 92 Standard Bearer independent real estate subsidiaries have entered into six triple-net master lease agreements (collectively, the Standard Bearer Master Leases). The lease periods range from 15 to 19 years with three five-year renewal options beyond the initial term, on the same terms and conditions. The rent structure under the Standard Bearer Master Leases includes a fixed component, subject to annual escalation equal to the lesser of (1) the percentage change in the Consumer Price Index (but not less than zero) or (2) 2.5%. In addition to rent, the independent subsidiaries are required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties; (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. Intercompany rental revenue generated from Ensign affiliated operations was $78,110, $66,712, and $57,967 for the years ended December 31, 2024, 2023 and 2022, respectively, which has been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intercompany management agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Standard Bearer has no employees. The Service Center provides personnel and services to Standard Bearer pursuant to the management agreement between Standard Bearer and the Service Center. The management agreement provides for a base management fee that is equal to 5.0% of total rental revenue and an incentive management fee that is equal to 5.0% of funds from operations (FFO) and is capped at 1.0% of total rental revenue, for a total of 6.0%. Management fee generated between Standard Bearer and the Service Center for the years ended December 31, 2024, 2023 and 2022 was $5,707, $4,948 and $4,367, respectively, which has been eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intercompany debt arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Standard Bearer obtains its funding through various sources including operating cash flows, access to debt arrangements and intercompany loans. The intercompany debt arrangements include mortgage loans and a credit facility to fund acquisitions and working capital needs. The interest rate under the credit facility is a base rate plus a margin ranging from 0.25% to 1.25% per annum or SOFR plus a margin ranging from 1.25% to 2.25% per annum. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as the Department of Housing and Urban Development (HUD) mortgage loans and promissory note are entered into by real estate subsidiaries of Standard Bearer, the interest expense incurred from these debts are included in Standard Bearer's segment income. Refer to Note 14, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information related to these debts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Instrument Denominated in the Shares of a Subsidiary&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the formation of Standard Bearer in 2022, the Company established the Standard Bearer Healthcare REIT, Inc. 2022 Omnibus Incentive Plan (Standard Bearer Equity Plan). The Company may grant stock options and restricted stock awards under the Standard Bearer Equity Plan to employees and management of Ensign's independent subsidiaries. These awards generally vest over a period of five years or upon the occurrence of certain prescribed events. The value of the stock options and restricted stock awards is tied to the value of the common stock of Standard Bearer, which is determined based on an independent valuation of Standard Bearer. The Company can also call the awards, generally upon employee termination. The Company granted 39 restricted stock awards during the year ended December 31, 2024. During the years ended December&#160;31, 2023 and 2022, the Company did not grant any stock options or restricted shares under the Standard Bearer Equity Plan. During the years ended December 31, 2024, 2023 and 2022, there were no restricted stock awards vested for the periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair value of the awards is recognized as compensation expense over the relevant vesting periods, with a corresponding adjustment to noncontrolling interests. The grant value was determined based on an independent valuation of the subsidiary shares.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;year ended December 31, 2024, the Standard Bearer Equity Plan's share-based compensation expense was not material. There was no expense during the years ended December&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, Standard Bearer sold fully vested common shares from the Standard Bearer Equity Plan to shareholders for cash of $6,544. Also, during the year ended December 31, 2022, Standard Bearer established shareholders of its preferred shares through contributions of cash of $149. These preferred shares were fully vested at the time of the contributions by the shareholders. The value of Standard Bearer common and preferred shares held by the Company are eliminated in consolidation and the value held by other shareholders are classified as noncontrolling interests on the Company's consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</ensg:StandardBearerTextBlock>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-132"
      decimals="INF"
      id="f-664"
      unitRef="property">124</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-4"
      decimals="INF"
      id="f-665"
      unitRef="property">129</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-133"
      decimals="INF"
      id="f-666"
      unitRef="property">92</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-53"
      decimals="INF"
      id="f-667"
      unitRef="property">33</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-53"
      decimals="INF"
      id="f-668"
      unitRef="property">33</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfRealEstatePropertiesSharingLocations
      contextRef="c-54"
      decimals="INF"
      id="f-669"
      unitRef="property">1</ensg:NumberOfRealEstatePropertiesSharingLocations>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-134" decimals="-3" id="f-670" unitRef="usd">131927000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-135"
      decimals="INF"
      id="f-671"
      unitRef="property">11</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-136"
      decimals="INF"
      id="f-672"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-137"
      decimals="INF"
      id="f-673"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfOperatingSubsidiaries
      contextRef="c-138"
      decimals="INF"
      id="f-674"
      unitRef="subsidiary">14</ensg:NumberOfOperatingSubsidiaries>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-136"
      decimals="INF"
      id="f-675"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-139" decimals="-3" id="f-676" unitRef="usd">50853000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-140"
      decimals="INF"
      id="f-677"
      unitRef="property">4</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-141"
      decimals="INF"
      id="f-678"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-142"
      decimals="INF"
      id="f-679"
      unitRef="property">4</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-143"
      decimals="INF"
      id="f-680"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-144" decimals="-3" id="f-681" unitRef="usd">65899000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-145"
      decimals="INF"
      id="f-682"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-146"
      decimals="INF"
      id="f-683"
      unitRef="property">2</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-147"
      decimals="INF"
      id="f-684"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-148"
      decimals="INF"
      id="f-685"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-149" decimals="-3" id="f-686" unitRef="usd">84656000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-150"
      decimals="INF"
      id="f-687"
      unitRef="property">10</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-151"
      decimals="INF"
      id="f-688"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-133"
      decimals="INF"
      id="f-689"
      unitRef="property">92</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfLeaseArrangements contextRef="c-1" decimals="INF" id="f-690" unitRef="lease">6</ensg:NumberOfLeaseArrangements>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-152" id="f-691">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-153" id="f-692">P19Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms
      contextRef="c-154"
      decimals="INF"
      id="f-693"
      unitRef="renewal">3</ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-154" id="f-694">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="c-152"
      decimals="INF"
      id="f-695"
      unitRef="number">0</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c-154" decimals="3" id="f-696" unitRef="number">0.025</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-155" decimals="-3" id="f-697" unitRef="usd">78110000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-156" decimals="-3" id="f-698" unitRef="usd">66712000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-157" decimals="-3" id="f-699" unitRef="usd">57967000</us-gaap:OperatingLeaseLeaseIncome>
    <ensg:PropertyManagementFeePercentFeeOfTotalRevenues contextRef="c-158" decimals="3" id="f-700" unitRef="number">0.050</ensg:PropertyManagementFeePercentFeeOfTotalRevenues>
    <ensg:PropertyManagementFeePercentFeeOfFundsFromOperations contextRef="c-159" decimals="3" id="f-701" unitRef="number">0.050</ensg:PropertyManagementFeePercentFeeOfFundsFromOperations>
    <ensg:PropertyManagementFeePercentFeeOfTotalRevenues contextRef="c-159" decimals="3" id="f-702" unitRef="number">0.010</ensg:PropertyManagementFeePercentFeeOfTotalRevenues>
    <ensg:PropertyManagementFeePercentFeeOfTotalRevenues contextRef="c-160" decimals="3" id="f-703" unitRef="number">0.060</ensg:PropertyManagementFeePercentFeeOfTotalRevenues>
    <us-gaap:ManagementFeeExpense contextRef="c-158" decimals="-3" id="f-704" unitRef="usd">5707000</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c-161" decimals="-3" id="f-705" unitRef="usd">4948000</us-gaap:ManagementFeeExpense>
    <us-gaap:ManagementFeeExpense contextRef="c-162" decimals="-3" id="f-706" unitRef="usd">4367000</us-gaap:ManagementFeeExpense>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-163"
      decimals="INF"
      id="f-707"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-164"
      decimals="INF"
      id="f-708"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-165"
      decimals="INF"
      id="f-709"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-166"
      decimals="INF"
      id="f-710"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-167" id="f-711">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-168"
      decimals="-3"
      id="f-712"
      unitRef="shares">39000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-169"
      decimals="INF"
      id="f-713"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-170"
      decimals="INF"
      id="f-714"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-171"
      decimals="INF"
      id="f-715"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-172"
      decimals="INF"
      id="f-716"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-168"
      decimals="INF"
      id="f-717"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-170"
      decimals="INF"
      id="f-718"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-171"
      decimals="INF"
      id="f-719"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-169" decimals="INF" id="f-720" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-172" decimals="INF" id="f-721" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-172" decimals="-3" id="f-722" unitRef="usd">6544000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="c-172" decimals="-3" id="f-723" unitRef="usd">149000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-724">OPERATION EXPANSIONS&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expansion focus of the Company's independent subsidiaries is to purchase or lease operations that are complementary to the current operations, accretive to the business, or otherwise advance the Company's strategy. The results of all independent subsidiaries are included in the Financial Statements subsequent to the date of acquisition. Acquisitions are accounted for using the acquisition method of accounting. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the new operations obtained through long-term leases, the Company did not acquire any material assets or assume any liabilities other than the tenant's post-assumption rights and obligations under the long-term lease. The Company also entered into a separate operations transfer agreement with each prior operator as part of each transaction. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's independent subsidiaries also enter into long-term leases that may include options to purchase the facilities. As a result, from time to time, an independent real estate subsidiary may acquire the property of facilities that have previously been operated under third-party leases. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2024 Expansions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2024, the Company expanded its operations through a combination of long-term leases and real estate purchases&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; with the addition of 28 stand-alone skilled nursing operations, including a long-term acute care hospital and&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three campus operations. Of these additions, Standard Bearer acquired the real estate of 14 of these operations, all of which were leased back to the Company's independent subsidiaries.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standard Bearer, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information on the purchase of real estate properties. These new operations added a total of 3,030 operational skilled nursing beds, including 43 long-term acute care beds and 218 operational senior living units to be operated by the Company's independent subsidiaries. The Company also invested in new ancillary services that are complementary to its existing businesses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2024, the Company expanded its operations with the addition of seven stand-alone skilled nursing operations. Of these additions, Standard Bearer acquired the real estate of one of these operations, which was leased back to the Company's independent subsidiary.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standard Bearer, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information on the purchase of the real estate property. The new operations added 682 operational skilled nursing beds to be operated by the Company's independent subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2023 Expansions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2023, the Company expanded its operations through a combination of long-term leases and real estate purchases&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; with the addition of 25 stand-alone skilled nursing operations and one campus operation. Of these additions, Standard Bearer acquired the real estate of three of the stand-alone skilled nursing operations and one campus operation, which were leased back to the Company's independent subsidiaries.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standard Bearer, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information on the purchase of real estate properties. These new operations added a total of 2,483 operational skilled nursing beds and 94 operational senior living units to be operated by the Company's independent subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#3d6702;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2022 Expansions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2022, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company expanded its operations and real estate portfolio through a combination of long-term leases and real estate purchases&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, with the addition of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; stand-alone skilled nursing operations and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;one&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; campus operation. Of these additions, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Standard Bearer acquired the real estate of seven&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of the stand-alone skilled nursing operations, which were leased back to Ensign's &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;independent&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; subsidiaries.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Refer to Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standard Bearer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, for additional information on the purchases of real estate properties. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company added &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;five&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; senior living operations that were transferred from The Pennant Group, Inc. (Pennant), &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of which are part of campuses operated by the Company's &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;independent&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; subsidiaries. These new operations added a total of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,058&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; operational skilled nursing beds and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;674&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; operational senior living units to be operated by the Company's &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;independent&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; subsidiaries. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also invested in new ancillary services that are complementary to its existing businesses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the allocation of the purchase price for the operations acquired during the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;years ended December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture, and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assembled occupancy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL ACQUISITIONS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;154,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,798&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101,136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s acquisition strategy has been focused on identifying both opportunistic and strategic acquisitions within its target markets that offer strong opportunities for return. The operations added by the Company are frequently underperforming financially and can have regulatory and clinical challenges to overcome. Financial information, especially with underperforming operations, is often inadequate, inaccurate or unavailable. Consequently, the Company believes that prior operating results are not a meaningful representation of the Company&#x2019;s current operating results or indicative of the integration potential of its newly acquired &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;independent subsidiaries&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The operations added during the&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;year ended December 31, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; were not material to the Company individually or in the aggregate. Accordingly, pro forma financial information is not presented. These additions have been included in the&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; balance sheets of the Company, and the operating results have been included in the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; statements of income of the Company since the date the Company gained effective control.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-173"
      decimals="INF"
      id="f-725"
      unitRef="property">28</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-174"
      decimals="INF"
      id="f-726"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-175"
      decimals="INF"
      id="f-727"
      unitRef="property">14</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfSkilledNursingBeds contextRef="c-176" decimals="INF" id="f-728" unitRef="bed">3030</ensg:NumberOfSkilledNursingBeds>
    <ensg:NumberOfLongTermAcuteCareBeds contextRef="c-176" decimals="INF" id="f-729" unitRef="bed">43</ensg:NumberOfLongTermAcuteCareBeds>
    <ensg:NumberOfSeniorLivingUnits contextRef="c-176" decimals="INF" id="f-730" unitRef="unit">218</ensg:NumberOfSeniorLivingUnits>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-177"
      decimals="INF"
      id="f-731"
      unitRef="property">7</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-178"
      decimals="INF"
      id="f-732"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfSkilledNursingBeds contextRef="c-143" decimals="INF" id="f-733" unitRef="bed">682</ensg:NumberOfSkilledNursingBeds>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-179"
      decimals="INF"
      id="f-734"
      unitRef="property">25</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-180"
      decimals="INF"
      id="f-735"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-147"
      decimals="INF"
      id="f-736"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-148"
      decimals="INF"
      id="f-737"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfSkilledNursingBeds contextRef="c-181" decimals="INF" id="f-738" unitRef="bed">2483</ensg:NumberOfSkilledNursingBeds>
    <ensg:NumberOfSeniorLivingUnits contextRef="c-181" decimals="INF" id="f-739" unitRef="unit">94</ensg:NumberOfSeniorLivingUnits>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-182"
      decimals="INF"
      id="f-740"
      unitRef="property">23</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-183"
      decimals="INF"
      id="f-741"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-184"
      decimals="INF"
      id="f-742"
      unitRef="property">7</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-185"
      decimals="INF"
      id="f-743"
      unitRef="property">5</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-186"
      decimals="INF"
      id="f-744"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfSkilledNursingBeds contextRef="c-187" decimals="INF" id="f-745" unitRef="bed">3058</ensg:NumberOfSkilledNursingBeds>
    <ensg:NumberOfSeniorLivingUnits contextRef="c-187" decimals="INF" id="f-746" unitRef="unit">674</ensg:NumberOfSeniorLivingUnits>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c-1" id="f-747">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the allocation of the purchase price for the operations acquired during the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;years ended December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.449%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture, and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assembled occupancy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL ACQUISITIONS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;154,879&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,798&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;101,136&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-188" decimals="-3" id="f-748" unitRef="usd">20547000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-189" decimals="-3" id="f-749" unitRef="usd">7794000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-190" decimals="-3" id="f-750" unitRef="usd">15527000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-191" decimals="-3" id="f-751" unitRef="usd">108709000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-192" decimals="-3" id="f-752" unitRef="usd">57488000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-193" decimals="-3" id="f-753" unitRef="usd">65070000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-194" decimals="-3" id="f-754" unitRef="usd">2937000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-195" decimals="-3" id="f-755" unitRef="usd">1840000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-196" decimals="-3" id="f-756" unitRef="usd">1618000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-197" decimals="-3" id="f-757" unitRef="usd">1210000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-198" decimals="-3" id="f-758" unitRef="usd">346000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions contextRef="c-199" decimals="-3" id="f-759" unitRef="usd">367000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-200" decimals="-3" id="f-760" unitRef="usd">21112000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-201" decimals="-3" id="f-761" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-202" decimals="-3" id="f-762" unitRef="usd">16400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <ensg:LeasedAssetsAcquiredDuringPeriod contextRef="c-200" decimals="-3" id="f-763" unitRef="usd">0</ensg:LeasedAssetsAcquiredDuringPeriod>
    <ensg:LeasedAssetsAcquiredDuringPeriod contextRef="c-201" decimals="-3" id="f-764" unitRef="usd">0</ensg:LeasedAssetsAcquiredDuringPeriod>
    <ensg:LeasedAssetsAcquiredDuringPeriod contextRef="c-202" decimals="-3" id="f-765" unitRef="usd">1909000</ensg:LeasedAssetsAcquiredDuringPeriod>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-200" decimals="-3" id="f-766" unitRef="usd">364000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-201" decimals="-3" id="f-767" unitRef="usd">330000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-202" decimals="-3" id="f-768" unitRef="usd">245000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c-200" decimals="-3" id="f-769" unitRef="usd">154879000</ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c-201" decimals="-3" id="f-770" unitRef="usd">67798000</ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c-202" decimals="-3" id="f-771" unitRef="usd">101136000</ensg:BusinessCombinationAndAssetAcquisitionAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-772">BUSINESS SEGMENTS&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two reportable segments: (1) skilled services, which includes the operation of skilled nursing facilities and rehabilitation therapy services and (2) Standard Bearer, which is comprised of selected real estate properties owned by Standard Bearer and leased to skilled nursing and senior living operators. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the skilled services segment includes 286 skilled nursing and 30 campus operations that provide both skilled nursing and rehabilitative care services and senior living services. The Company's Standard Bearer segment consists of 124 owned real estate properties. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also reports an &#x201c;All Other&#x201d; category that includes results from its senior living operations, which includes 11 stand-alone senior living operations and the senior living operations at 30 campus operations that provide both skilled nursing and rehabilitative care services and senior living services. In addition, the "All Other" category includes mobile diagnostics, medical transportation, other real estate, other ancillary operations and the Service Center. Services included in the &#x201c;All Other&#x201d; category are insignificant individually, and therefore do not constitute a reportable segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s reportable segments are significant operating segments that offer differentiated services. The segment structure reflects the Company's current operational and financial management and provides the best structure to maximize the quality of care and investment strategy provided, while maintaining financial discipline.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment income (loss) is defined as income or loss before provision for income taxes, excluding gain or loss from sale of real estate, real estate insurance recoveries and impairment of long-lived assets. The Company's CODM, who is the Chief Executive Officer, reviews segment income or loss for each operating segment to evaluate performance and allocate capital resources. The CODM uses segment income or loss to analyze actual results as part of operational planning and to decide whether to reinvest profits into the segments or into other parts of the Company, such as through acquisitions, to pay dividends or to recommend a stock repurchase program. The Company's CODM does not review assets by segment in his resource allocation and therefore assets by segment are not disclosed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intercompany revenue is eliminated in consolidation, along with corresponding intercompany expenses. Included in segment income for Standard Bearer is expense for intercompany services provided by the Service Center as described in Note 6, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Standard Bearer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as it is part of the CODM financial information. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth financial information for the segments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Standard Bearer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,076,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,076,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,076,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95,086&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,171,911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of revenue:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intercompany revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL CONSOLIDATED REVENUE &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,260,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,513,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,335&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;547,798&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of profit or loss:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;INCOME BEFORE PROVISION FOR INCOME TAXES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;386,094&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) All other revenue includes $181,066 of service revenue and $11,815 of rental revenue for the year ended December 31, 2024, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $83,941 and intercompany service revenue of $20,366 for the year ended December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $104,307 during the year ended December 31, 2024, which are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $20,285 during the year ended December 31, 2024, which is eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.363%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.363%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.366%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Standard Bearer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,578,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,578,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,578,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82,486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,661,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of revenue:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intercompany revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL CONSOLIDATED REVENUE &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,729,355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;464,925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;493,990&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of profit or loss:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;INCOME BEFORE PROVISION FOR INCOME TAXES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;272,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) All Other revenue includes $144,667 of service revenue and $11,137 of rental revenue for the year ended December 31, 2023, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3) Elimination of intercompany revenue includes the elimination intercompany rental revenue of $72,339 and intercompany service revenue of $15,451 for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $87,790 during the year ended December 31, 2023, which is eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $12,902 during the year ended December 31, 2023, which is eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Standard Bearer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,906,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,937&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,979,152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of revenue:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intercompany revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL CONSOLIDATED REVENUE &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,025,468&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;408,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;436,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of profit or loss:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;INCOME BEFORE PROVISION FOR INCOME TAXES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;289,089&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) All Other revenue includes $115,214 of service revenue and $7,396 of rental revenue for the year ended December 31, 2022, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $63,576 and intercompany service revenue of $12,718 for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment.  Additionally, there are intercompany expenses of $76,294 during the year ended December 31, 2022, which is eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $8,646 during the year ended December 31, 2022, which is eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service revenue by major payor source were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid-skilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,968,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,004,308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL SERVICE REVENUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,076,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;160,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,237,525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(1) Medicaid payor includes revenue generated from senior living operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(3) All Other incorporates intercompany eliminations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid-skilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,660,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,976&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,690,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL SERVICE REVENUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,578,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;129,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,708,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(3) All Other incorporates intercompany eliminations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid-skilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,191,347&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,847&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,216,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL SERVICE REVENUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,906,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;102,496&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,008,711&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Private and other payors also includes revenue from senior living operations and all payors generated in other ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(3) All Other incorporates intercompany eliminations.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-773"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-203"
      decimals="INF"
      id="f-774"
      unitRef="property">286</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-204"
      decimals="INF"
      id="f-775"
      unitRef="property">30</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-205"
      decimals="INF"
      id="f-776"
      unitRef="property">124</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-206"
      decimals="INF"
      id="f-777"
      unitRef="property">11</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-207"
      decimals="INF"
      id="f-778"
      unitRef="property">30</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="c-1" id="f-779">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth financial information for the segments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.426%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Standard Bearer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,076,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,076,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,076,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;95,086&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,171,911&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of revenue:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192,881&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intercompany revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,307)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL CONSOLIDATED REVENUE &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,260,485&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,513,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;518,463&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,335&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;547,798&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of profit or loss:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161,704)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;INCOME BEFORE PROVISION FOR INCOME TAXES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;386,094&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) All other revenue includes $181,066 of service revenue and $11,815 of rental revenue for the year ended December 31, 2024, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $83,941 and intercompany service revenue of $20,366 for the year ended December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $104,307 during the year ended December 31, 2024, which are eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $20,285 during the year ended December 31, 2024, which is eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.603%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.363%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.363%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.386%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.366%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Standard Bearer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,578,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,578,855&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,578,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;82,486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,661,341&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of revenue:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intercompany revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87,790)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL CONSOLIDATED REVENUE &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,729,355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,075,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;464,925&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,065&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;493,990&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of profit or loss:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(221,228)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;INCOME BEFORE PROVISION FOR INCOME TAXES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;272,762&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) All Other revenue includes $144,667 of service revenue and $11,137 of rental revenue for the year ended December 31, 2023, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3) Elimination of intercompany revenue includes the elimination intercompany rental revenue of $72,339 and intercompany service revenue of $15,451 for the year ended December 31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment. Additionally, there are intercompany expenses of $87,790 during the year ended December 31, 2023, which is eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $12,902 during the year ended December 31, 2023, which is eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.332%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Standard Bearer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rental revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,906,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72,937&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,979,152&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of revenue:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Elimination of intercompany revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76,294)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL CONSOLIDATED REVENUE &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,025,468&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other segment items&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,464,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Segment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;408,732&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;27,871&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;436,603&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Reconciliation of profit or loss:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other loss&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(147,514)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;INCOME BEFORE PROVISION FOR INCOME TAXES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;289,089&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(1) Skilled services service revenue does not include intercompany service revenue generated by ancillary operations provided to the Company's independent subsidiaries and management service revenue generated by the Service Center with Standard Bearer. Intercompany service revenue is eliminated in "Elimination of intercompany revenue". &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) All Other revenue includes $115,214 of service revenue and $7,396 of rental revenue for the year ended December 31, 2022, both of which include intercompany revenue that is eliminated in "Elimination of intercompany revenue".&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(3) Elimination of intercompany revenue includes the elimination of intercompany rental revenue of $63,576 and intercompany service revenue of $12,718 for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(4) Other segment items includes cost of services and rent expense for the skilled services segment and cost of services, rent expense and general and administrative expenses for the Standard Bearer segment.  Additionally, there are intercompany expenses of $76,294 during the year ended December 31, 2022, which is eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;(5) Included in interest expense in Standard Bearer is interest from intercompany debt arrangements between Standard Bearer and The Ensign Group, Inc. of $8,646 during the year ended December 31, 2022, which is eliminated in consolidation.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-208" decimals="-3" id="f-780" unitRef="usd">4076825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-209" decimals="-3" id="f-781" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-210" decimals="-3" id="f-782" unitRef="usd">4076825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-211" decimals="-3" id="f-783" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-212" decimals="-3" id="f-784" unitRef="usd">95086000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-213" decimals="-3" id="f-785" unitRef="usd">95086000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-214" decimals="-3" id="f-786" unitRef="usd">4076825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-215" decimals="-3" id="f-787" unitRef="usd">95086000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-216" decimals="-3" id="f-788" unitRef="usd">4171911000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-217" decimals="-3" id="f-789" unitRef="usd">192881000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-218" decimals="-3" id="f-790" unitRef="usd">-104307000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-791" unitRef="usd">4260485000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-214" decimals="-3" id="f-792" unitRef="usd">3513167000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-215" decimals="-3" id="f-793" unitRef="usd">9152000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-214" decimals="-3" id="f-794" unitRef="usd">45195000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-215" decimals="-3" id="f-795" unitRef="usd">29297000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpenseNonoperating contextRef="c-214" decimals="-3" id="f-796" unitRef="usd">0</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-215" decimals="-3" id="f-797" unitRef="usd">27302000</us-gaap:InterestExpenseNonoperating>
    <ensg:SegmentIncomeLoss contextRef="c-214" decimals="-3" id="f-798" unitRef="usd">518463000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-215" decimals="-3" id="f-799" unitRef="usd">29335000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-216" decimals="-3" id="f-800" unitRef="usd">547798000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-217" decimals="-3" id="f-801" unitRef="usd">-161704000</ensg:SegmentIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-802" unitRef="usd">386094000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-219" decimals="-3" id="f-803" unitRef="usd">181066000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-220" decimals="-3" id="f-804" unitRef="usd">11815000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-221" decimals="-3" id="f-805" unitRef="usd">-83941000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-222" decimals="-3" id="f-806" unitRef="usd">-20366000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-218" decimals="-3" id="f-807" unitRef="usd">-104307000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:InterestExpenseNonoperating contextRef="c-218" decimals="-3" id="f-808" unitRef="usd">-20285000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-223" decimals="-3" id="f-809" unitRef="usd">3578855000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-224" decimals="-3" id="f-810" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-225" decimals="-3" id="f-811" unitRef="usd">3578855000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-226" decimals="-3" id="f-812" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-227" decimals="-3" id="f-813" unitRef="usd">82486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-228" decimals="-3" id="f-814" unitRef="usd">82486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-229" decimals="-3" id="f-815" unitRef="usd">3578855000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-230" decimals="-3" id="f-816" unitRef="usd">82486000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-231" decimals="-3" id="f-817" unitRef="usd">3661341000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-232" decimals="-3" id="f-818" unitRef="usd">155804000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-233" decimals="-3" id="f-819" unitRef="usd">-87790000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-12" decimals="-3" id="f-820" unitRef="usd">3729355000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-229" decimals="-3" id="f-821" unitRef="usd">3075164000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-230" decimals="-3" id="f-822" unitRef="usd">8455000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-229" decimals="-3" id="f-823" unitRef="usd">38766000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-230" decimals="-3" id="f-824" unitRef="usd">25205000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpenseNonoperating contextRef="c-229" decimals="-3" id="f-825" unitRef="usd">0</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-230" decimals="-3" id="f-826" unitRef="usd">19761000</us-gaap:InterestExpenseNonoperating>
    <ensg:SegmentIncomeLoss contextRef="c-229" decimals="-3" id="f-827" unitRef="usd">464925000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-230" decimals="-3" id="f-828" unitRef="usd">29065000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-231" decimals="-3" id="f-829" unitRef="usd">493990000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-232" decimals="-3" id="f-830" unitRef="usd">-221228000</ensg:SegmentIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-831" unitRef="usd">272762000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-234" decimals="-3" id="f-832" unitRef="usd">144667000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-235" decimals="-3" id="f-833" unitRef="usd">11137000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-236" decimals="-3" id="f-834" unitRef="usd">-72339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-237" decimals="-3" id="f-835" unitRef="usd">-15451000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-233" decimals="-3" id="f-836" unitRef="usd">-87790000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:InterestExpenseNonoperating contextRef="c-233" decimals="-3" id="f-837" unitRef="usd">-12902000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-238" decimals="-3" id="f-838" unitRef="usd">2906215000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-239" decimals="-3" id="f-839" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-240" decimals="-3" id="f-840" unitRef="usd">2906215000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-241" decimals="-3" id="f-841" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-242" decimals="-3" id="f-842" unitRef="usd">72937000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-243" decimals="-3" id="f-843" unitRef="usd">72937000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-244" decimals="-3" id="f-844" unitRef="usd">2906215000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-245" decimals="-3" id="f-845" unitRef="usd">72937000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-246" decimals="-3" id="f-846" unitRef="usd">2979152000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-247" decimals="-3" id="f-847" unitRef="usd">122610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-248" decimals="-3" id="f-848" unitRef="usd">-76294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-13" decimals="-3" id="f-849" unitRef="usd">3025468000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-244" decimals="-3" id="f-850" unitRef="usd">2464259000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-245" decimals="-3" id="f-851" unitRef="usd">7746000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-244" decimals="-3" id="f-852" unitRef="usd">33224000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-245" decimals="-3" id="f-853" unitRef="usd">21613000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpenseNonoperating contextRef="c-244" decimals="-3" id="f-854" unitRef="usd">0</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-245" decimals="-3" id="f-855" unitRef="usd">15707000</us-gaap:InterestExpenseNonoperating>
    <ensg:SegmentIncomeLoss contextRef="c-244" decimals="-3" id="f-856" unitRef="usd">408732000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-245" decimals="-3" id="f-857" unitRef="usd">27871000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-246" decimals="-3" id="f-858" unitRef="usd">436603000</ensg:SegmentIncomeLoss>
    <ensg:SegmentIncomeLoss contextRef="c-247" decimals="-3" id="f-859" unitRef="usd">-147514000</ensg:SegmentIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-860" unitRef="usd">289089000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-249" decimals="-3" id="f-861" unitRef="usd">115214000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-250" decimals="-3" id="f-862" unitRef="usd">7396000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-251" decimals="-3" id="f-863" unitRef="usd">-63576000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-252" decimals="-3" id="f-864" unitRef="usd">-12718000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-248" decimals="-3" id="f-865" unitRef="usd">-76294000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:InterestExpenseNonoperating contextRef="c-248" decimals="-3" id="f-866" unitRef="usd">-8646000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock contextRef="c-1" id="f-867">&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Service revenue by major payor source were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646,422&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,682,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,055,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid-skilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,968,386&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;35,922&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,004,308&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70.9&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;789,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;318,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;443,574&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL SERVICE REVENUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,076,825&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;160,700&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,237,525&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(1) Medicaid payor includes revenue generated from senior living operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(3) All Other incorporates intercompany eliminations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,429,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,459,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;985,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid-skilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,660,885&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;29,976&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,690,861&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;72.6&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;351,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL SERVICE REVENUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,578,855&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;129,216&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,708,071&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Private and other payors also includes revenue from senior living operations and all revenue generated in other ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(3) All Other incorporates intercompany eliminations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.742%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.355%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Service Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,183,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;832,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid-skilled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;200,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,191,347&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;24,847&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,216,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;73.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;189,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;266,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL SERVICE REVENUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,906,215&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;102,496&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,008,711&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;100.0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(1) Medicaid payor includes revenue generated from senior living operations and revenue related to state relief funding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:120%"&gt;(2) Private and other payors also includes revenue from senior living operations and all payors generated in other ancillary services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8.5pt;font-weight:400;line-height:80%"&gt;(3) All Other incorporates intercompany eliminations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-253" decimals="-3" id="f-868" unitRef="usd">1646422000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-254" decimals="-3" id="f-869" unitRef="usd">35922000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-84" decimals="-3" id="f-870" unitRef="usd">1682344000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-85" decimals="3" id="f-871" unitRef="number">0.397</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-255" decimals="-3" id="f-872" unitRef="usd">1055226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-256" decimals="-3" id="f-873" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-90" decimals="-3" id="f-874" unitRef="usd">1055226000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-91" decimals="3" id="f-875" unitRef="number">0.249</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-257" decimals="-3" id="f-876" unitRef="usd">266738000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-258" decimals="-3" id="f-877" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-96" decimals="-3" id="f-878" unitRef="usd">266738000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-97" decimals="3" id="f-879" unitRef="number">0.063</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-259" decimals="-3" id="f-880" unitRef="usd">2968386000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-260" decimals="-3" id="f-881" unitRef="usd">35922000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-102" decimals="-3" id="f-882" unitRef="usd">3004308000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-81" decimals="3" id="f-883" unitRef="number">0.709</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-261" decimals="-3" id="f-884" unitRef="usd">789643000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-262" decimals="-3" id="f-885" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-105" decimals="-3" id="f-886" unitRef="usd">789643000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-106" decimals="3" id="f-887" unitRef="number">0.186</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-263" decimals="-3" id="f-888" unitRef="usd">318796000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-264" decimals="-3" id="f-889" unitRef="usd">124778000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-111" decimals="-3" id="f-890" unitRef="usd">443574000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-112" decimals="3" id="f-891" unitRef="number">0.105</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-208" decimals="-3" id="f-892" unitRef="usd">4076825000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-265" decimals="-3" id="f-893" unitRef="usd">160700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-894" unitRef="usd">4237525000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-117" decimals="3" id="f-895" unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-266" decimals="-3" id="f-896" unitRef="usd">1429473000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-267" decimals="-3" id="f-897" unitRef="usd">29976000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-86" decimals="-3" id="f-898" unitRef="usd">1459449000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-87" decimals="3" id="f-899" unitRef="number">0.394</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-268" decimals="-3" id="f-900" unitRef="usd">985749000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-269" decimals="-3" id="f-901" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-92" decimals="-3" id="f-902" unitRef="usd">985749000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-93" decimals="3" id="f-903" unitRef="number">0.266</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-270" decimals="-3" id="f-904" unitRef="usd">245663000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-271" decimals="-3" id="f-905" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-98" decimals="-3" id="f-906" unitRef="usd">245663000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-99" decimals="3" id="f-907" unitRef="number">0.066</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-272" decimals="-3" id="f-908" unitRef="usd">2660885000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-273" decimals="-3" id="f-909" unitRef="usd">29976000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-103" decimals="-3" id="f-910" unitRef="usd">2690861000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-82" decimals="3" id="f-911" unitRef="number">0.726</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-274" decimals="-3" id="f-912" unitRef="usd">666129000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-275" decimals="-3" id="f-913" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-107" decimals="-3" id="f-914" unitRef="usd">666129000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-108" decimals="3" id="f-915" unitRef="number">0.180</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-276" decimals="-3" id="f-916" unitRef="usd">251841000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-277" decimals="-3" id="f-917" unitRef="usd">99240000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-3" id="f-918" unitRef="usd">351081000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-114" decimals="3" id="f-919" unitRef="number">0.094</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-223" decimals="-3" id="f-920" unitRef="usd">3578855000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-278" decimals="-3" id="f-921" unitRef="usd">129216000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-922" unitRef="usd">3708071000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-118" decimals="3" id="f-923" unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-279" decimals="-3" id="f-924" unitRef="usd">1158309000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-280" decimals="-3" id="f-925" unitRef="usd">24847000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-88" decimals="-3" id="f-926" unitRef="usd">1183156000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-89" decimals="3" id="f-927" unitRef="number">0.393</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-281" decimals="-3" id="f-928" unitRef="usd">832160000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-282" decimals="-3" id="f-929" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-94" decimals="-3" id="f-930" unitRef="usd">832160000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-95" decimals="3" id="f-931" unitRef="number">0.277</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-283" decimals="-3" id="f-932" unitRef="usd">200878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-284" decimals="-3" id="f-933" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-100" decimals="-3" id="f-934" unitRef="usd">200878000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-101" decimals="3" id="f-935" unitRef="number">0.067</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-285" decimals="-3" id="f-936" unitRef="usd">2191347000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-286" decimals="-3" id="f-937" unitRef="usd">24847000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-104" decimals="-3" id="f-938" unitRef="usd">2216194000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-83" decimals="3" id="f-939" unitRef="number">0.737</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-287" decimals="-3" id="f-940" unitRef="usd">525710000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-288" decimals="-3" id="f-941" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-109" decimals="-3" id="f-942" unitRef="usd">525710000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-110" decimals="3" id="f-943" unitRef="number">0.175</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-289" decimals="-3" id="f-944" unitRef="usd">189158000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-290" decimals="-3" id="f-945" unitRef="usd">77649000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-946" unitRef="usd">266807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-116" decimals="3" id="f-947" unitRef="number">0.088</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-238" decimals="-3" id="f-948" unitRef="usd">2906215000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-291" decimals="-3" id="f-949" unitRef="usd">102496000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-3" id="f-950" unitRef="usd">3008711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-119" decimals="3" id="f-951" unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-952">PROPERTY AND EQUIPMENT - NET&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consists of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,750,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,487,013&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(396,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,291,354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,090,771&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company completed the sale of assets for a sale price of $8,607 and recorded a gain of $3,467 within the Company's consolidated statement of income as cost of services during the year ended December 31, 2022. The Company recorded gain and losses related to sale of assets, which were not material during the years ended December 31, 2024 and 2023. Management evaluated its long-lived assets and recorded an impairment charge of&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1,849 within the Company's consolidated statement of income as &lt;span style="-sec-ix-hidden:f-975"&gt;cost of services&lt;/span&gt; during the year ended December 31, 2024.&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;The Company determined there was no impairment during the year ended December 31, 2023 and 2022.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-953">&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consists of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:63.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.715%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;933,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;803,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;172,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396,018&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,750,842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,487,013&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(396,242)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PROPERTY AND EQUIPMENT, NET&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,291,354&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,090,771&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-292" decimals="-3" id="f-954" unitRef="usd">162873000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-293" decimals="-3" id="f-955" unitRef="usd">142656000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-294" decimals="-3" id="f-956" unitRef="usd">933790000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-295" decimals="-3" id="f-957" unitRef="usd">803155000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-296" decimals="-3" id="f-958" unitRef="usd">212603000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-297" decimals="-3" id="f-959" unitRef="usd">172064000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-298" decimals="-3" id="f-960" unitRef="usd">396018000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-299" decimals="-3" id="f-961" unitRef="usd">339383000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-300" decimals="-3" id="f-962" unitRef="usd">4349000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-301" decimals="-3" id="f-963" unitRef="usd">4192000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-302" decimals="-3" id="f-964" unitRef="usd">41209000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-303" decimals="-3" id="f-965" unitRef="usd">25563000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-966" unitRef="usd">1750842000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-5" decimals="-3" id="f-967" unitRef="usd">1487013000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-968" unitRef="usd">459488000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-969" unitRef="usd">396242000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-970" unitRef="usd">1291354000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-5" decimals="-3" id="f-971" unitRef="usd">1090771000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment contextRef="c-13" decimals="-3" id="f-972" unitRef="usd">8607000</us-gaap:ProceedsFromSaleOfPropertyPlantAndEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-13" decimals="-3" id="f-973" unitRef="usd">3467000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="-3" id="f-974" unitRef="usd">1849000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-13" decimals="INF" id="f-976" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-12" decimals="INF" id="f-977" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:IntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-978">INTANGIBLE ASSETS - NET&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.806%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="5" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assembled occupancy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(742)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(439)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,626&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,096&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,873)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December 31, 2024, 2023 and 2022, amortization expense was $2,019, $1,790 and $1,714, respectively, of which $1,212, $1,202, and $1,160 was related to the amortization of right-of-use assets, respectively. The Company did not record any impairment charge to intangible assets during the years ended December 31, 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated amortization expense for each of the years ending December&#160;31 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.837%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,626&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other indefinite-lived intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.590%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicaid licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,666&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,302&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;During the year ended December 31, 2024, the Company acquired $364 in Medicare and Medicaid licenses compared to $330 and $245 in the fiscal years 2023 and 2022, respectively.</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-979">&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.806%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="5" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assembled occupancy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,316)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(742)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(439)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,692)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,306&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(4,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,626&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,096&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(3,873)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,223&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-304" id="f-980">P0Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-305" decimals="-3" id="f-981" unitRef="usd">1991000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-305" decimals="-3" id="f-982" unitRef="usd">1316000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-305" decimals="-3" id="f-983" unitRef="usd">675000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-306" decimals="-3" id="f-984" unitRef="usd">781000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-306" decimals="-3" id="f-985" unitRef="usd">742000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-306" decimals="-3" id="f-986" unitRef="usd">39000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-307" id="f-987">P30Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-59" decimals="-3" id="f-988" unitRef="usd">733000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-59" decimals="-3" id="f-989" unitRef="usd">462000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-59" decimals="-3" id="f-990" unitRef="usd">271000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-308" decimals="-3" id="f-991" unitRef="usd">733000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-308" decimals="-3" id="f-992" unitRef="usd">439000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-308" decimals="-3" id="f-993" unitRef="usd">294000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife contextRef="c-309" id="f-994">P18Y4M24D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-60" decimals="-3" id="f-995" unitRef="usd">4582000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-60" decimals="-3" id="f-996" unitRef="usd">2902000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-60" decimals="-3" id="f-997" unitRef="usd">1680000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-310" decimals="-3" id="f-998" unitRef="usd">4582000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-310" decimals="-3" id="f-999" unitRef="usd">2692000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-310" decimals="-3" id="f-1000" unitRef="usd">1890000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-3" id="f-1001" unitRef="usd">7306000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-1002" unitRef="usd">4680000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-1003" unitRef="usd">2626000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-5" decimals="-3" id="f-1004" unitRef="usd">6096000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-3" id="f-1005" unitRef="usd">3873000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-3" id="f-1006" unitRef="usd">2223000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-1007" unitRef="usd">2019000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-12" decimals="-3" id="f-1008" unitRef="usd">1790000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-13" decimals="-3" id="f-1009" unitRef="usd">1714000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OperatingLeaseCost contextRef="c-311" decimals="-3" id="f-1010" unitRef="usd">1212000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-312" decimals="-3" id="f-1011" unitRef="usd">1202000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-313" decimals="-3" id="f-1012" unitRef="usd">1160000</us-gaap:OperatingLeaseCost>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-13" decimals="INF" id="f-1013" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-1" decimals="INF" id="f-1014" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-12" decimals="INF" id="f-1015" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-1016">&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated amortization expense for each of the years ending December&#160;31 is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.837%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.382%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,626&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1017" unitRef="usd">911000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-4" decimals="-3" id="f-1018" unitRef="usd">234000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-4" decimals="-3" id="f-1019" unitRef="usd">234000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-4" decimals="-3" id="f-1020" unitRef="usd">234000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-4" decimals="-3" id="f-1021" unitRef="usd">234000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-4" decimals="-3" id="f-1022" unitRef="usd">779000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-1023" unitRef="usd">2626000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock contextRef="c-1" id="f-1024">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other indefinite-lived intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.590%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicaid licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,777&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;text-indent:4.5pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,666&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,302&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAcquiredIndefiniteLivedIntangibleAssetsByMajorClassTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-314" decimals="-3" id="f-1025" unitRef="usd">889000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-315" decimals="-3" id="f-1026" unitRef="usd">889000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-316" decimals="-3" id="f-1027" unitRef="usd">3777000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-317" decimals="-3" id="f-1028" unitRef="usd">3413000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-4" decimals="-3" id="f-1029" unitRef="usd">4666000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="c-5" decimals="-3" id="f-1030" unitRef="usd">4302000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-318" decimals="-3" id="f-1031" unitRef="usd">364000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-319" decimals="-3" id="f-1032" unitRef="usd">330000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:IndefinitelivedIntangibleAssetsAcquired contextRef="c-320" decimals="-3" id="f-1033" unitRef="usd">245000</us-gaap:IndefinitelivedIntangibleAssetsAcquired>
    <us-gaap:GoodwillDisclosureTextBlock contextRef="c-1" id="f-1034">GOODWILL &lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Provided that goodwill corresponds to the acquisition of a business and not merely the acquisition of real estate property, the Company's Standard Bearer segment appropriately does not carry a goodwill balance. The following table represents activity in goodwill by skilled service segment and "all other" category as of December&#160;31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51,486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,983&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;60,469&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,886&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,983&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,886&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,983&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;88,626&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,981&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management has evaluated its goodwill and intangible assets and determined there was no impairment during the years ended December 31, 2024, 2023 and 2022. The Company has recognized cumulative goodwill impairment losses of $7,410, since inception in 1999. &lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock contextRef="c-1" id="f-1035">The following table represents activity in goodwill by skilled service segment and "all other" category as of December&#160;31, 2024, 2023 and 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:53.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.524%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Skilled Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;51,486&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,983&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;60,469&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,886&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,983&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,886&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;8,983&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76,869&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;88,626&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;9,355&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;97,981&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill contextRef="c-321" decimals="-3" id="f-1036" unitRef="usd">51486000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-322" decimals="-3" id="f-1037" unitRef="usd">8983000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-19" decimals="-3" id="f-1038" unitRef="usd">60469000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-244" decimals="-3" id="f-1039" unitRef="usd">16400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-323" decimals="-3" id="f-1040" unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-13" decimals="-3" id="f-1041" unitRef="usd">16400000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill contextRef="c-324" decimals="-3" id="f-1042" unitRef="usd">67886000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-325" decimals="-3" id="f-1043" unitRef="usd">8983000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-30" decimals="-3" id="f-1044" unitRef="usd">76869000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-326" decimals="-3" id="f-1045" unitRef="usd">67886000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-327" decimals="-3" id="f-1046" unitRef="usd">8983000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-5" decimals="-3" id="f-1047" unitRef="usd">76869000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-214" decimals="-3" id="f-1048" unitRef="usd">20740000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-328" decimals="-3" id="f-1049" unitRef="usd">372000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod contextRef="c-1" decimals="-3" id="f-1050" unitRef="usd">21112000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill contextRef="c-329" decimals="-3" id="f-1051" unitRef="usd">88626000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-330" decimals="-3" id="f-1052" unitRef="usd">9355000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-1053" unitRef="usd">97981000</us-gaap:Goodwill>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-12" decimals="INF" id="f-1054" unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-1" decimals="INF" id="f-1055" unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment contextRef="c-13" decimals="INF" id="f-1056" unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillImpairedAccumulatedImpairmentLoss contextRef="c-4" decimals="-3" id="f-1057" unitRef="usd">7410000</us-gaap:GoodwillImpairedAccumulatedImpairmentLoss>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-1058">OTHER ACCRUED LIABILITIES&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.590%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quality assurance fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Refunds payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Resident advances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash held in trust for patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued litigation (Note 19)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OTHER ACCRUED LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132,057&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;168,228&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Quality assurance fee represents the aggregate of amounts payable to Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, Tennessee, Utah, Washington and Wisconsin as a result of a mandated fee based on patient days or licensed beds. Refunds payable includes payables related to overpayments, duplicate payments and credit balances from various payor sources. Resident advances occur when the Company receives payments in advance of services provided. Cash held in trust for patients reflects monies received from or on behalf of patients. Maintaining a trust account for patients is a regulatory requirement and, while the trust assets offset the liabilities, the Company assumes a fiduciary responsibility for these funds. The cash balance related to this liability is included in other current assets in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-1059">&lt;div style="text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.590%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Quality assurance fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Refunds payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Resident advances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash held in trust for patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued litigation (Note 19)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;OTHER ACCRUED LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;132,057&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;168,228&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <ensg:QualityAssuranceFee contextRef="c-4" decimals="-3" id="f-1060" unitRef="usd">12667000</ensg:QualityAssuranceFee>
    <ensg:QualityAssuranceFee contextRef="c-5" decimals="-3" id="f-1061" unitRef="usd">14035000</ensg:QualityAssuranceFee>
    <ensg:ResidentRefundsPayable contextRef="c-4" decimals="-3" id="f-1062" unitRef="usd">56755000</ensg:ResidentRefundsPayable>
    <ensg:ResidentRefundsPayable contextRef="c-5" decimals="-3" id="f-1063" unitRef="usd">51248000</ensg:ResidentRefundsPayable>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-1064" unitRef="usd">18818000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-3" id="f-1065" unitRef="usd">10834000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <ensg:CashHeldInTrustForResidents contextRef="c-4" decimals="-3" id="f-1066" unitRef="usd">6370000</ensg:CashHeldInTrustForResidents>
    <ensg:CashHeldInTrustForResidents contextRef="c-5" decimals="-3" id="f-1067" unitRef="usd">6215000</ensg:CashHeldInTrustForResidents>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-4" decimals="-3" id="f-1068" unitRef="usd">3589000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-1069" unitRef="usd">3396000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent contextRef="c-4" decimals="-3" id="f-1070" unitRef="usd">15400000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent contextRef="c-5" decimals="-3" id="f-1071" unitRef="usd">12875000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent>
    <us-gaap:LitigationReserveCurrent contextRef="c-4" decimals="-3" id="f-1072" unitRef="usd">0</us-gaap:LitigationReserveCurrent>
    <us-gaap:LitigationReserveCurrent contextRef="c-5" decimals="-3" id="f-1073" unitRef="usd">51734000</us-gaap:LitigationReserveCurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-1074" unitRef="usd">18458000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-3" id="f-1075" unitRef="usd">17891000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-1076" unitRef="usd">132057000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-3" id="f-1077" unitRef="usd">168228000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1078">INCOME TAXES&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes for the years ended December 31, 2024, 2023 and 2022 is summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87,001&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90,393&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,933&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;635&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(27,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87,636&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;62,912&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64,437&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the federal statutory rate to the effective tax rate for net income for the years ended December 31, 2024, 2023 and 2022, respectively, is comprised as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes&#160;- net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL INCOME TAX PROVISION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's effective tax rate was 22.7% for the year ended December 31, 2024, compared to 23.1% for the same period in 2023 and 22.3% in 2022. The lower effective tax rate is due to lower non-deductible expenses included but not limited to tax benefits from stock based compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's deferred tax assets and liabilities as of December&#160;31, 2024 and 2023 are summarized below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;599,169&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;567,862&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL DEFERRED TAX ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;599,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;567,073&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(468,955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443,222)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL DEFERRED TAX LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(532,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(499,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NET DEFERRED TAX ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had state credit carryforwards as of December 31, 2024 and 2023 of $597 and $1,192, respectively. These carryforwards almost entirely relate to state limitations on the application of Enterprise Zone employment-related tax credits. Unless the Company uses the Enterprise Zone credits beforehand, the carryforward began to expire in 2023. The remainder of these carryforwards relate to credits against the Texas margin tax and is expected to carryforward until 2027. As of December 31, 2024 and 2023, the valuation allowance of $93 and $789, respectively, was primarily recorded against the Enterprise Zone credits as the Company believes it is more likely than not that some of the benefit of the credits will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's operating loss carry forwards for states were not material during the years ended December 31, 2024 and 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2024, 2023 and 2022, the Company did not have any unrecognized tax benefits, net of its state benefits that would affect the Company's effective tax rate. The Company classifies interest and/or penalties on income tax liabilities or refunds as additional income tax expense or income. Such amounts are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The federal statutes of limitations on the Company's 2020, 2019, and 2018 income tax years lapsed during the third quarter of 2024, 2023, and 2022, respectively. During the fourth quarter of each year, various state statutes of limitations also lapsed. The lapses during the years ended December 31, 2024 and 2023 had no impact on the Company's unrecognized tax benefits.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1079">&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes for the years ended December 31, 2024, 2023 and 2022 is summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87,001&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;90,393&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;70,933&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,280)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,158)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,201)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;635&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(27,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(6,496)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;87,636&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;62,912&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;64,437&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1080" unitRef="usd">70144000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-1081" unitRef="usd">73092000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-1082" unitRef="usd">56717000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1083" unitRef="usd">16857000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-1084" unitRef="usd">17301000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-1085" unitRef="usd">14216000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1086" unitRef="usd">87001000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-1087" unitRef="usd">90393000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-1088" unitRef="usd">70933000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1089" unitRef="usd">582000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-1090" unitRef="usd">-22280000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-1091" unitRef="usd">-5158000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1092" unitRef="usd">53000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-1093" unitRef="usd">-5201000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-1094" unitRef="usd">-1338000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1095" unitRef="usd">635000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-1096" unitRef="usd">-27481000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-1097" unitRef="usd">-6496000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1098" unitRef="usd">87636000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-12" decimals="-3" id="f-1099" unitRef="usd">62912000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-13" decimals="-3" id="f-1100" unitRef="usd">64437000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1101">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the federal statutory rate to the effective tax rate for net income for the years ended December 31, 2024, 2023 and 2022, respectively, is comprised as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes&#160;- net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL INCOME TAX PROVISION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22.7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;23.1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22.3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="3" id="f-1102" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-12" decimals="3" id="f-1103" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate contextRef="c-13" decimals="3" id="f-1104" unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="3" id="f-1105" unitRef="number">0.035</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-12" decimals="3" id="f-1106" unitRef="number">0.035</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes contextRef="c-13" decimals="3" id="f-1107" unitRef="number">0.035</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="c-1" decimals="3" id="f-1108" unitRef="number">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="c-12" decimals="3" id="f-1109" unitRef="number">0.034</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense contextRef="c-13" decimals="3" id="f-1110" unitRef="number">0.020</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent contextRef="c-1" decimals="3" id="f-1111" unitRef="number">-0.033</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent contextRef="c-12" decimals="3" id="f-1112" unitRef="number">-0.042</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent contextRef="c-13" decimals="3" id="f-1113" unitRef="number">-0.036</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-1" decimals="3" id="f-1114" unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-12" decimals="3" id="f-1115" unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments contextRef="c-13" decimals="3" id="f-1116" unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1117" unitRef="number">0.227</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-12" decimals="3" id="f-1118" unitRef="number">0.231</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-13" decimals="3" id="f-1119" unitRef="number">0.223</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1120" unitRef="number">0.227</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-12" decimals="3" id="f-1121" unitRef="number">0.231</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-13" decimals="3" id="f-1122" unitRef="number">0.223</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1123">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's deferred tax assets and liabilities as of December&#160;31, 2024 and 2023 are summarized below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liability &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;444,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;599,169&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;567,862&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(789)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL DEFERRED TAX ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;599,076&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;567,073&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(280)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,334)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,113)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right-of-use asset &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(468,955)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(443,222)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL DEFERRED TAX LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(532,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(499,949)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;NET DEFERRED TAX ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;66,281&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;67,124&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-4" decimals="-3" id="f-1124" unitRef="usd">76419000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-5" decimals="-3" id="f-1125" unitRef="usd">81502000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-4" decimals="-3" id="f-1126" unitRef="usd">27023000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-5" decimals="-3" id="f-1127" unitRef="usd">23714000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-4" decimals="-3" id="f-1128" unitRef="usd">597000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="-3" id="f-1129" unitRef="usd">1192000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance contextRef="c-4" decimals="-3" id="f-1130" unitRef="usd">24817000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance contextRef="c-5" decimals="-3" id="f-1131" unitRef="usd">16864000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance>
    <ensg:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability contextRef="c-4" decimals="-3" id="f-1132" unitRef="usd">470313000</ensg:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability>
    <ensg:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability contextRef="c-5" decimals="-3" id="f-1133" unitRef="usd">444590000</ensg:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLeaseLiability>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-4" decimals="-3" id="f-1134" unitRef="usd">599169000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-3" id="f-1135" unitRef="usd">567862000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-1136" unitRef="usd">93000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-1137" unitRef="usd">789000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-4" decimals="-3" id="f-1138" unitRef="usd">599076000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-5" decimals="-3" id="f-1139" unitRef="usd">567073000</us-gaap:DeferredTaxAssetsNet>
    <ensg:DeferredTaxLiabilitiesStateTaxes contextRef="c-4" decimals="-3" id="f-1140" unitRef="usd">197000</ensg:DeferredTaxLiabilitiesStateTaxes>
    <ensg:DeferredTaxLiabilitiesStateTaxes contextRef="c-5" decimals="-3" id="f-1141" unitRef="usd">280000</ensg:DeferredTaxLiabilitiesStateTaxes>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-1142" unitRef="usd">57253000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-5" decimals="-3" id="f-1143" unitRef="usd">52334000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses contextRef="c-4" decimals="-3" id="f-1144" unitRef="usd">6390000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses contextRef="c-5" decimals="-3" id="f-1145" unitRef="usd">4113000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <ensg:DeferredTaxLiabilitiesRightOfUseAsset contextRef="c-4" decimals="-3" id="f-1146" unitRef="usd">468955000</ensg:DeferredTaxLiabilitiesRightOfUseAsset>
    <ensg:DeferredTaxLiabilitiesRightOfUseAsset contextRef="c-5" decimals="-3" id="f-1147" unitRef="usd">443222000</ensg:DeferredTaxLiabilitiesRightOfUseAsset>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-4" decimals="-3" id="f-1148" unitRef="usd">532795000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="-3" id="f-1149" unitRef="usd">499949000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-4" decimals="-3" id="f-1150" unitRef="usd">66281000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-5" decimals="-3" id="f-1151" unitRef="usd">67124000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-4" decimals="-3" id="f-1152" unitRef="usd">597000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="-3" id="f-1153" unitRef="usd">1192000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-4" decimals="-3" id="f-1154" unitRef="usd">93000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-3" id="f-1155" unitRef="usd">789000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-1156">DEBT&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.590%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans and promissory note&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,086)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: debt issuance costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LONG-TERM DEBT LESS CURRENT MATURITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;141,585&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;145,497&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Facility with a Lending Consortium Arranged by Truist &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a revolving credit facility between the Company and its independent subsidiaries, including Standard Bearer as co-borrowers, and Truist Securities (Truist) (the Credit Facility) with a revolving line of credit of up to $600,000 in aggregate principal amount with a maturity date of April&#160;8, 2027. Borrowings are supported by a lending consortium arranged by Truist. The interest rates applicable to loans under the Credit Facility are, at the Company's option, equal to either a base rate plus a margin ranging from 0.25% to 1.25% per annum or SOFR plus a margin ranging from 1.25% to 2.25% per annum, based on the Consolidated Total Net Debt to Consolidated EBITDA ratio (as defined in the Credit Facility). In addition, there is a commitment fee on the unused portion of the commitments that ranges from 0.20% to 0.40% per annum, depending on the Consolidated Total Net Debt to Consolidated EBITDA ratio. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Borrowings made under the Credit Facility are guaranteed, jointly and severally, by certain of the Company&#x2019;s wholly-owned subsidiaries, and are secured by a pledge of stock of the Company's material independent subsidiaries as well as a first lien on substantially all of such independent subsidiaries' personal property. The Credit Facility contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. Under the terms of the Credit Facility, the Company must comply with financial maintenance covenants to be tested quarterly, consisting of (i) a maximum consolidated total net debt to consolidated EBITDA ratio (which shall not be greater than 3.75:1.00; provided that if the aggregate consideration for approved acquisitions in a six month period is greater than $50,000, then the ratio can be increased at the election of the Company with notice to the administrative agent to 4.25:1.00 for the first fiscal quarter and the immediately following three fiscal quarters), and (ii) a minimum interest/rent coverage ratio (which cannot be less than 1.50:1.00). As of December&#160;31, 2024, there was no outstanding debt under the Credit Facility. The Company was in compliance with all loan covenants as of December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Mortgage Loans and Promissory Note&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the Company has 23 subsidiaries that have mortgage loans insured with HUD in the aggregate amount of $146,898, which subjects these subsidiaries to HUD oversight and periodic inspections. The mortgage loans bear effective interest rates in a range of 3.1% to 4.2%, including fixed interest rates in a range of 2.4% to 3.3% per annum. In addition to the interest rate, the Company incurs other fees for HUD placement, including, but not limited to audit fees. Amounts borrowed under the mortgage loans may be prepaid, subject to prepayment fees based on the principal balance on the date of prepayment. For the majority of the loans, during the first three years, the prepayment fee is 10.0% and is reduced by 3.0% in the fourth year of the loan and reduced by 1.0%&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;per year for years five through ten of the loan. There is no prepayment penalty after year ten. The terms for all the mortgage loans are 25 to 35 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the HUD mortgage loans above, the Company has a promissory note of $1,540 that bears a fixed interest rate of 5.3% per annum and has a term of 12 years. The note, which was assumed as part of an acquisition, is secured by the real property comprising the facility and the rent, issues and profits thereof, as well as all personal property used in the operation of the facility. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future principal payments due under the long-term debt arrangements discussed above are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.013%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;148,438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on Level 2 inputs, the carrying value of the Company's long-term debt is considered to approximate the fair value of such debt for all periods presented based upon the interest rates that the Company believes it can currently obtain for similar debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Off-Balance Sheet Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2024, the Company had approximately $27,893 of borrowing capacity under the Credit Facility pledged as collateral to secure outstanding letters of credit, which increased by $21,638 from December&#160;31, 2023. The Company believes that its outstanding letters of credit as of December&#160;31, 2024 do not require an allowance for expected credit losses, nor has any event occurred through the filing date of this report that would indicate differently.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-1157">&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.590%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage loans and promissory note&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,086)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,950)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: debt issuance costs, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,767)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,941)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LONG-TERM DEBT LESS CURRENT MATURITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;141,585&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;145,497&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-331" decimals="-3" id="f-1158" unitRef="usd">148438000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-332" decimals="-3" id="f-1159" unitRef="usd">152388000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent contextRef="c-4" decimals="-3" id="f-1160" unitRef="usd">4086000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent contextRef="c-5" decimals="-3" id="f-1161" unitRef="usd">3950000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-4" decimals="-3" id="f-1162" unitRef="usd">2767000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-5" decimals="-3" id="f-1163" unitRef="usd">2941000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-4" decimals="-3" id="f-1164" unitRef="usd">141585000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-5" decimals="-3" id="f-1165" unitRef="usd">145497000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-333" decimals="INF" id="f-1166" unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-163"
      decimals="INF"
      id="f-1167"
      unitRef="number">0.0025</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-164"
      decimals="INF"
      id="f-1168"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-165"
      decimals="INF"
      id="f-1169"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-166"
      decimals="INF"
      id="f-1170"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-334"
      decimals="INF"
      id="f-1171"
      unitRef="number">0.0020</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-335"
      decimals="INF"
      id="f-1172"
      unitRef="number">0.0040</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <ensg:TotalNetDebtRatioMaximum
      contextRef="c-333"
      decimals="INF"
      id="f-1173"
      unitRef="number">3.75</ensg:TotalNetDebtRatioMaximum>
    <ensg:LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod contextRef="c-333" id="f-1174">P6M</ensg:LongTermDebtThresholdForEBITDARatioIncreaseElectionPeriod>
    <ensg:LongTermDebtThresholdForEBITDARatioIncreaseElection contextRef="c-333" decimals="-6" id="f-1175" unitRef="usd">50000000</ensg:LongTermDebtThresholdForEBITDARatioIncreaseElection>
    <ensg:TotalNetDebtRatioMaximumAfterIncreaseElection
      contextRef="c-333"
      decimals="INF"
      id="f-1176"
      unitRef="number">4.25</ensg:TotalNetDebtRatioMaximumAfterIncreaseElection>
    <ensg:TotalNetDebtRatioMinimum
      contextRef="c-333"
      decimals="INF"
      id="f-1177"
      unitRef="number">1.50</ensg:TotalNetDebtRatioMinimum>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-333" decimals="INF" id="f-1178" unitRef="usd">0</us-gaap:DebtInstrumentCarryingAmount>
    <ensg:NumberOfOperatingSubsidiaries
      contextRef="c-336"
      decimals="INF"
      id="f-1179"
      unitRef="subsidiary">23</ensg:NumberOfOperatingSubsidiaries>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-336" decimals="-3" id="f-1180" unitRef="usd">146898000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-337"
      decimals="3"
      id="f-1181"
      unitRef="number">0.031</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-338"
      decimals="3"
      id="f-1182"
      unitRef="number">0.042</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-337"
      decimals="INF"
      id="f-1183"
      unitRef="number">0.024</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-338"
      decimals="INF"
      id="f-1184"
      unitRef="number">0.033</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <ensg:PrepaymentPenalty
      contextRef="c-339"
      decimals="3"
      id="f-1185"
      unitRef="number">0.100</ensg:PrepaymentPenalty>
    <ensg:ReductionInPrepaymentPenalty
      contextRef="c-340"
      decimals="3"
      id="f-1186"
      unitRef="number">0.030</ensg:ReductionInPrepaymentPenalty>
    <ensg:ReductionInPrepaymentPenalty
      contextRef="c-341"
      decimals="3"
      id="f-1187"
      unitRef="number">0.010</ensg:ReductionInPrepaymentPenalty>
    <ensg:PrepaymentPenalty
      contextRef="c-342"
      decimals="INF"
      id="f-1188"
      unitRef="number">0</ensg:PrepaymentPenalty>
    <us-gaap:DebtInstrumentTerm contextRef="c-343" id="f-1189">P25Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-344" id="f-1190">P35Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-345" decimals="-3" id="f-1191" unitRef="usd">1540000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-345"
      decimals="INF"
      id="f-1192"
      unitRef="number">0.053</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm contextRef="c-346" id="f-1193">P12Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-1194">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future principal payments due under the long-term debt arrangements discussed above are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:87.057%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.013%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #3d6702;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #3d6702;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;148,438&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1195" unitRef="usd">4086000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-4" decimals="-3" id="f-1196" unitRef="usd">4227000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-4" decimals="-3" id="f-1197" unitRef="usd">3897000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-4" decimals="-3" id="f-1198" unitRef="usd">3779000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive contextRef="c-4" decimals="-3" id="f-1199" unitRef="usd">3896000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive contextRef="c-4" decimals="-3" id="f-1200" unitRef="usd">128553000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="-3" id="f-1201" unitRef="usd">148438000</us-gaap:LongTermDebt>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c-4" decimals="-3" id="f-1202" unitRef="usd">27893000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet contextRef="c-347" decimals="-3" id="f-1203" unitRef="usd">21638000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-1204">OPTIONS AND AWARDS&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2022 Omnibus Incentive Plan (2022 Plan)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company has one stock incentive plan, the 2022 Omnibus Incentive Plan (the 2022 Plan), pursuant to which grants of the Company's securities may currently be made. Including the shares rolled over from the 2017 Omnibus Incentive Plan, the 2022 Plan provides for the issuance of 3,452 shares of common stock. The number of shares available to be issued under the 2022 Plan will be reduced by (i) one share for each share that relates to an option or stock appreciation right award and (ii) two shares for each share which relates to an award other than a stock option or stock appreciation right award (a full-value award). Non-employee director options, to the extent granted, will vest and become exercisable in three equal annual installments, or the length of the term if less than three years, on the completion of each year of service measured from the grant date. All other options generally vest over five years at 20% per year on the anniversary of the grant date. Options expire ten years from the date of grant. At December&#160;31, 2024, the total number of shares available for issuance under the 2022 Plan was 346.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes option-pricing model to recognize the value of stock-based compensation expense for stock option awards. Determining the appropriate fair-value model and calculating the fair value of stock option awards at the grant date requires judgment, including estimating stock price volatility, expected option life, and forfeiture rates. The fair-value of the restricted stock awards at the grant date is based on the market price on the grant date, adjusted for forfeiture rates. The Company develops estimates based on historical data and market information, which can change significantly over time. The Black-Scholes model required the Company to make several key judgments including: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt"&gt;The expected option term is calculated by the average of the contractual term of the options and the weighted average vesting period for all options. The calculation of the expected option term is based on the Company's experience due to sufficient history.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt"&gt;The Company utilizes its own experience to calculate estimated volatility for options granted. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt"&gt;The dividend yield is based on the Company's historical pattern of dividends as well as expected dividend patterns.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt"&gt;The risk-free rate is based on the implied yield of U.S.&#160;Treasury notes as of the grant date with a remaining term approximately equal to the expected term.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.02pt"&gt;Estimated forfeiture rate of approximately 4.86% per year is based on the Company's historical forfeiture activity of unvested stock options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 704, 1,008 and 581 stock options during the years ended December 31, 2024, 2023 and 2022, respectively. The Company used the following assumptions for stock options granted during the years ended December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Dividend Yield&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2024, 2023 and 2022, the following represents the exercise price and fair value displayed at grant date for stock option grants:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.245%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Fair Value of Options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average exercise price equaled the weighted average fair value of common stock on the grant date for all options granted during the periods ended December 31, 2024, 2023 and 2022 and therefore, the intrinsic value was $0 at the date of grant.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the employee stock option activity during the years ended December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of&lt;br/&gt;Options Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Exercise Price of Options Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(688)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31. 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,991&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the employee stock option activity during the year ended December 31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.455%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Black-Scholes Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vested and Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year of Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.71&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.88&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$119.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$146.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136,624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,895&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options outstanding, vested and expected to vest as of December 31, 2024, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the options&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. At &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2024, 2023 and 2022, t&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;he aggregate intrinsic value of options that vested &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;during the years ended December&#160;31, 2024, 2023 and 2022 was&lt;/span&gt;&lt;span style="color:#ff0090;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$37,700, $31,658, and $27,955, respectively. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of options exercised &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;during the years ended December&#160;31, 2024, 2023 and 2022 was $60,358, $56,186, and $47,441, respectively. &lt;/span&gt;&lt;span style="color:#ff0090;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 232, 219&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 233 restricted stock awards during the years ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 and 2022, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;respectively. All awards were granted at an issue price of $0 and generally vest over five years. The fair value per share of restricted awards granted during the years ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 and 2022&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ranged from&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $116.65 to $149.12,&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $89.83 to $98.31 and $73.17 to $94.88, respectively. The fair value per share includes quarterly stock awards to non-employee directors. Included in the restricted stock award grants are &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$6,165&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$5,068&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of annual bonuses that were settled in vested restricted stock awards during the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;years ended December 31, 2024 and 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of the Company's non-vested restricted stock awards as of December&#160;31, 2024 and changes during the years ended December&#160;31, 2024, 2023 and 2022 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.954%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Vested Restricted Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested at January 1, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;549&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;487&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;431&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested at December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;435&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2024, the Company granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 16&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; quarterly stock awards to non-employee directors for their service on the Company's board of directors. The fair value per share of these stock awards ranged from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$116.65 to $149.12&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; based on the market price on the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Term Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 27, 2019, the Board approved the Long-Term Incentive Plan (the 2019 LTI Plan). The 2019 LTI Plan provides that certain employees of the Company who assisted in the consummation of the spin-off of Pennant from the Company in 2019 were granted shares of restricted stock upon successful completion of the spin-off. The 2019 LTI Plan provides for the issuance of 500 shares of Pennant restricted stock. As of December&#160;31, 2024, the 2019 LTI Plan was fully vested. The total stock-based compensation related to the 2019 LTI Plan was $546, $827, and $836 for the years ended December&#160;31, 2024, 2023 and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the years ended December&#160;31, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.915%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense related to stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense related to restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense related to restricted stock awards to non-employee directors&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,754&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,720&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In future periods, the Company expects to recognize approximately&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $84,914 and $38,434 in stock-based compensation expense for unvested options and unvested restricted stock awards, respectively, that were outstanding as of December&#160;31, 2024. Future stock-based compensation expense will be recognized over 3.8 and 3.7 weighted average years for unvested options and restricted stock awards, respectively. There were 2,092 unvested and outstanding options as of December&#160;31, 2024, of which 1,925 shares are expected to vest. The weighted average contractual life for options outstanding, vested and expected to vest as of December&#160;31, 2024 was&#160;6.7 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <ensg:NumberOfStockIncentivePlans contextRef="c-4" decimals="INF" id="f-1205" unitRef="plan">1</ensg:NumberOfStockIncentivePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-348"
      decimals="-3"
      id="f-1206"
      unitRef="shares">3452000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability
      contextRef="c-349"
      decimals="INF"
      id="f-1207"
      unitRef="number">1</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsConversionToReduceSharesAvailability>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability
      contextRef="c-349"
      decimals="INF"
      id="f-1208"
      unitRef="number">2</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsConversionToReduceSharesAvailability>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments
      contextRef="c-350"
      decimals="INF"
      id="f-1209"
      unitRef="installment">3</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfInstallments>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 contextRef="c-350" id="f-1210">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-349" id="f-1211">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-349"
      decimals="2"
      id="f-1212"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-349" id="f-1213">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-348"
      decimals="-3"
      id="f-1214"
      unitRef="shares">346000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <ensg:ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate contextRef="c-4" decimals="4" id="f-1215" unitRef="number">0.0486</ensg:ShareBasedCompensationArrangementByShareBasedAwardOptionsFairValueAssumptionsForfeitureRate>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1216">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 704, 1,008 and 581 stock options during the years ended December 31, 2024, 2023 and 2022, respectively. The Company used the following assumptions for stock options granted during the years ended December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.490%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.428%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Risk-Free Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Dividend Yield&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-3" id="f-1217" unitRef="shares">704000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-12"
      decimals="-3"
      id="f-1218"
      unitRef="shares">1008000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-13"
      decimals="-3"
      id="f-1219"
      unitRef="shares">581000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-3" id="f-1220" unitRef="shares">704000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-1" decimals="3" id="f-1221" unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-1" id="f-1222">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c-1" decimals="3" id="f-1223" unitRef="number">0.405</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-1" decimals="3" id="f-1224" unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-12"
      decimals="-3"
      id="f-1225"
      unitRef="shares">1008000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-12" decimals="3" id="f-1226" unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-12" id="f-1227">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c-12" decimals="3" id="f-1228" unitRef="number">0.413</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-12" decimals="3" id="f-1229" unitRef="number">0.002</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-13"
      decimals="-3"
      id="f-1230"
      unitRef="shares">581000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="c-13" decimals="3" id="f-1231" unitRef="number">0.028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-13" id="f-1232">P6Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate contextRef="c-13" decimals="3" id="f-1233" unitRef="number">0.421</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="c-13" decimals="3" id="f-1234" unitRef="number">0.003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock contextRef="c-1" id="f-1235">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2024, 2023 and 2022, the following represents the exercise price and fair value displayed at grant date for stock option grants:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.245%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.198%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.687%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Fair Value of Options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-3" id="f-1236" unitRef="shares">704000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1237"
      unitRef="usdPerShare">132.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-1238"
      unitRef="usdPerShare">60.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-12"
      decimals="-3"
      id="f-1239"
      unitRef="shares">1008000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-12"
      decimals="2"
      id="f-1240"
      unitRef="usdPerShare">95.05</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-12"
      decimals="2"
      id="f-1241"
      unitRef="usdPerShare">43.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-13"
      decimals="-3"
      id="f-1242"
      unitRef="shares">581000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-13"
      decimals="2"
      id="f-1243"
      unitRef="usdPerShare">85.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-13"
      decimals="2"
      id="f-1244"
      unitRef="usdPerShare">37.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="c-13"
      decimals="INF"
      id="f-1245"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="c-1"
      decimals="INF"
      id="f-1246"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
      contextRef="c-12"
      decimals="INF"
      id="f-1247"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock contextRef="c-1" id="f-1248">&lt;div style="margin-top:12pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the employee stock option activity during the years ended December 31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.297%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.958%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.981%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Number of&lt;br/&gt;Options Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Weighted Average Exercise Price of Options Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;January 1, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,038&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(688)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,833&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(91)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31. 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,991&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,895&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-19"
      decimals="-3"
      id="f-1249"
      unitRef="shares">4038000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-19"
      decimals="2"
      id="f-1250"
      unitRef="usdPerShare">36.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-19"
      decimals="-3"
      id="f-1251"
      unitRef="shares">2183000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-19"
      decimals="2"
      id="f-1252"
      unitRef="usdPerShare">21.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-13"
      decimals="-3"
      id="f-1253"
      unitRef="shares">581000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-13"
      decimals="2"
      id="f-1254"
      unitRef="usdPerShare">85.74</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c-13"
      decimals="-3"
      id="f-1255"
      unitRef="shares">98000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-13"
      decimals="2"
      id="f-1256"
      unitRef="usdPerShare">59.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-13"
      decimals="-3"
      id="f-1257"
      unitRef="shares">688000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-13"
      decimals="2"
      id="f-1258"
      unitRef="usdPerShare">18.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-30"
      decimals="-3"
      id="f-1259"
      unitRef="shares">3833000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-30"
      decimals="2"
      id="f-1260"
      unitRef="usdPerShare">46.72</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-30"
      decimals="-3"
      id="f-1261"
      unitRef="shares">2069000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-30"
      decimals="2"
      id="f-1262"
      unitRef="usdPerShare">28.87</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-12"
      decimals="-3"
      id="f-1263"
      unitRef="shares">1008000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-12"
      decimals="2"
      id="f-1264"
      unitRef="usdPerShare">95.05</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="c-12"
      decimals="-3"
      id="f-1265"
      unitRef="shares">91000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-12"
      decimals="2"
      id="f-1266"
      unitRef="usdPerShare">71.44</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-12"
      decimals="-3"
      id="f-1267"
      unitRef="shares">759000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-12"
      decimals="2"
      id="f-1268"
      unitRef="usdPerShare">24.21</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-5" decimals="-3" id="f-1269" unitRef="shares">3991000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-1270"
      unitRef="usdPerShare">62.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c-5" decimals="-3" id="f-1271" unitRef="shares">1887000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-5"
      decimals="2"
      id="f-1272"
      unitRef="usdPerShare">39.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="c-1" decimals="-3" id="f-1273" unitRef="shares">704000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1274"
      unitRef="usdPerShare">132.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod contextRef="c-1" decimals="-3" id="f-1275" unitRef="shares">76000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1276"
      unitRef="usdPerShare">86.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="-3" id="f-1277" unitRef="shares">632000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-1278"
      unitRef="usdPerShare">35.28</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-4" decimals="-3" id="f-1279" unitRef="shares">3987000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1280"
      unitRef="usdPerShare">78.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="c-4" decimals="-3" id="f-1281" unitRef="shares">1895000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-4"
      decimals="2"
      id="f-1282"
      unitRef="usdPerShare">52.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock contextRef="c-1" id="f-1283">&lt;div style="margin-top:12pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the employee stock option activity during the year ended December 31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:29.455%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.554%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:5.917%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.891%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options Vested&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Black-Scholes Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Vested and Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year of Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$18.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$21.39&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2016&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.80&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.41&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32.71&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.49&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.47&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.88&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.83&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$119.19&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$146.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;3,987&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;136,624&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,895&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-351"
      decimals="INF"
      id="f-1284"
      unitRef="usdPerShare">18.20</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-351"
      decimals="INF"
      id="f-1285"
      unitRef="usdPerShare">21.39</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-352"
      decimals="-3"
      id="f-1286"
      unitRef="shares">69000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-352" decimals="-3" id="f-1287" unitRef="usd">537000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-351" id="f-1288">P1Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-352"
      decimals="-3"
      id="f-1289"
      unitRef="shares">69000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-353"
      decimals="INF"
      id="f-1290"
      unitRef="usdPerShare">15.93</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-353"
      decimals="INF"
      id="f-1291"
      unitRef="usdPerShare">16.86</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-354"
      decimals="-3"
      id="f-1292"
      unitRef="shares">112000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-354" decimals="-3" id="f-1293" unitRef="usd">667000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-353" id="f-1294">P2Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-354"
      decimals="-3"
      id="f-1295"
      unitRef="shares">112000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-355"
      decimals="INF"
      id="f-1296"
      unitRef="usdPerShare">15.80</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-355"
      decimals="INF"
      id="f-1297"
      unitRef="usdPerShare">19.41</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-356"
      decimals="-3"
      id="f-1298"
      unitRef="shares">148000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-356" decimals="-3" id="f-1299" unitRef="usd">867000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-355" id="f-1300">P3Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-356"
      decimals="-3"
      id="f-1301"
      unitRef="shares">148000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-357"
      decimals="INF"
      id="f-1302"
      unitRef="usdPerShare">22.49</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-357"
      decimals="INF"
      id="f-1303"
      unitRef="usdPerShare">32.71</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-358"
      decimals="-3"
      id="f-1304"
      unitRef="shares">241000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-358" decimals="-3" id="f-1305" unitRef="usd">2557000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-357" id="f-1306">P4Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-358"
      decimals="-3"
      id="f-1307"
      unitRef="shares">241000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-359"
      decimals="INF"
      id="f-1308"
      unitRef="usdPerShare">41.07</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-359"
      decimals="INF"
      id="f-1309"
      unitRef="usdPerShare">45.76</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-360"
      decimals="-3"
      id="f-1310"
      unitRef="shares">417000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-360" decimals="-3" id="f-1311" unitRef="usd">6557000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-359" id="f-1312">P5Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-360"
      decimals="-3"
      id="f-1313"
      unitRef="shares">417000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-361"
      decimals="INF"
      id="f-1314"
      unitRef="usdPerShare">44.84</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-361"
      decimals="INF"
      id="f-1315"
      unitRef="usdPerShare">59.49</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-362"
      decimals="-3"
      id="f-1316"
      unitRef="shares">406000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-362" decimals="-3" id="f-1317" unitRef="usd">8020000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-361" id="f-1318">P6Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-362"
      decimals="-3"
      id="f-1319"
      unitRef="shares">301000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-363"
      decimals="INF"
      id="f-1320"
      unitRef="usdPerShare">73.47</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-363"
      decimals="INF"
      id="f-1321"
      unitRef="usdPerShare">83.64</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-364"
      decimals="-3"
      id="f-1322"
      unitRef="shares">458000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-364" decimals="-3" id="f-1323" unitRef="usd">15041000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-363" id="f-1324">P7Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-364"
      decimals="-3"
      id="f-1325"
      unitRef="shares">251000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-365"
      decimals="INF"
      id="f-1326"
      unitRef="usdPerShare">79.79</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-365"
      decimals="INF"
      id="f-1327"
      unitRef="usdPerShare">94.88</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-366"
      decimals="-3"
      id="f-1328"
      unitRef="shares">489000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-366" decimals="-3" id="f-1329" unitRef="usd">18601000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-365" id="f-1330">P8Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-366"
      decimals="-3"
      id="f-1331"
      unitRef="shares">176000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-367"
      decimals="INF"
      id="f-1332"
      unitRef="usdPerShare">89.83</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-367"
      decimals="INF"
      id="f-1333"
      unitRef="usdPerShare">98.83</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-368"
      decimals="-3"
      id="f-1334"
      unitRef="shares">951000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-368" decimals="-3" id="f-1335" unitRef="usd">41753000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-367" id="f-1336">P9Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-368"
      decimals="-3"
      id="f-1337"
      unitRef="shares">180000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="c-369"
      decimals="INF"
      id="f-1338"
      unitRef="usdPerShare">119.19</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="c-369"
      decimals="INF"
      id="f-1339"
      unitRef="usdPerShare">146.37</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="c-370"
      decimals="-3"
      id="f-1340"
      unitRef="shares">696000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-370" decimals="-3" id="f-1341" unitRef="usd">42024000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2 contextRef="c-369" id="f-1342">P10Y</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="c-370"
      decimals="-3"
      id="f-1343"
      unitRef="shares">0</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions contextRef="c-4" decimals="-3" id="f-1344" unitRef="shares">3987000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue contextRef="c-4" decimals="-3" id="f-1345" unitRef="usd">136624000</ensg:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions contextRef="c-4" decimals="-3" id="f-1346" unitRef="shares">1895000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock contextRef="c-1" id="f-1347">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options outstanding, vested and expected to vest as of December 31, 2024, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:38.519%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.349%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;136,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-4" decimals="-3" id="f-1348" unitRef="usd">219309000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-5" decimals="-3" id="f-1349" unitRef="usd">197819000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-30" decimals="-3" id="f-1350" unitRef="usd">183593000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-4" decimals="-3" id="f-1351" unitRef="usd">152011000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-5" decimals="-3" id="f-1352" unitRef="usd">137048000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-30" decimals="-3" id="f-1353" unitRef="usd">136000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-4" decimals="-3" id="f-1354" unitRef="usd">63243000</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-5" decimals="-3" id="f-1355" unitRef="usd">56759000</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue contextRef="c-30" decimals="-3" id="f-1356" unitRef="usd">43232000</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="c-371" decimals="-3" id="f-1357" unitRef="usd">37700000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="c-372" decimals="-3" id="f-1358" unitRef="usd">31658000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested contextRef="c-373" decimals="-3" id="f-1359" unitRef="usd">27955000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-3" id="f-1360" unitRef="usd">60358000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-12" decimals="-3" id="f-1361" unitRef="usd">56186000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-13" decimals="-3" id="f-1362" unitRef="usd">47441000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-374"
      decimals="-3"
      id="f-1363"
      unitRef="shares">232000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-375"
      decimals="-3"
      id="f-1364"
      unitRef="shares">219000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-376"
      decimals="-3"
      id="f-1365"
      unitRef="shares">233000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice
      contextRef="c-1"
      decimals="0"
      id="f-1366"
      unitRef="usdPerShare">0</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardRestrictedAwardsExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-374" id="f-1367">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-377"
      decimals="2"
      id="f-1368"
      unitRef="usdPerShare">116.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-378"
      decimals="2"
      id="f-1369"
      unitRef="usdPerShare">149.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-379"
      decimals="2"
      id="f-1370"
      unitRef="usdPerShare">89.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-380"
      decimals="2"
      id="f-1371"
      unitRef="usdPerShare">98.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-381"
      decimals="2"
      id="f-1372"
      unitRef="usdPerShare">73.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-382"
      decimals="2"
      id="f-1373"
      unitRef="usdPerShare">94.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-374" decimals="-3" id="f-1374" unitRef="usd">6165000</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-375" decimals="-3" id="f-1375" unitRef="usd">5068000</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardAnnualBonusesIncludedInEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock contextRef="c-1" id="f-1376">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the status of the Company's non-vested restricted stock awards as of December&#160;31, 2024 and changes during the years ended December&#160;31, 2024, 2023 and 2022 is presented below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.954%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-Vested Restricted Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested at January 1, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;549&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(269)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;487&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(255)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;431&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nonvested at December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;435&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-383"
      decimals="-3"
      id="f-1377"
      unitRef="shares">549000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-383"
      decimals="2"
      id="f-1378"
      unitRef="usdPerShare">52.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-376"
      decimals="-3"
      id="f-1379"
      unitRef="shares">233000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-376"
      decimals="2"
      id="f-1380"
      unitRef="usdPerShare">81.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-376"
      decimals="-3"
      id="f-1381"
      unitRef="shares">269000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-376"
      decimals="2"
      id="f-1382"
      unitRef="usdPerShare">54.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-376"
      decimals="-3"
      id="f-1383"
      unitRef="shares">26000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-376"
      decimals="2"
      id="f-1384"
      unitRef="usdPerShare">57.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-384"
      decimals="-3"
      id="f-1385"
      unitRef="shares">487000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-384"
      decimals="2"
      id="f-1386"
      unitRef="usdPerShare">64.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-375"
      decimals="-3"
      id="f-1387"
      unitRef="shares">219000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-375"
      decimals="2"
      id="f-1388"
      unitRef="usdPerShare">92.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-375"
      decimals="-3"
      id="f-1389"
      unitRef="shares">255000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-375"
      decimals="2"
      id="f-1390"
      unitRef="usdPerShare">64.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-375"
      decimals="-3"
      id="f-1391"
      unitRef="shares">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-375"
      decimals="2"
      id="f-1392"
      unitRef="usdPerShare">71.53</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-385"
      decimals="-3"
      id="f-1393"
      unitRef="shares">431000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-385"
      decimals="2"
      id="f-1394"
      unitRef="usdPerShare">78.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-374"
      decimals="-3"
      id="f-1395"
      unitRef="shares">232000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-374"
      decimals="2"
      id="f-1396"
      unitRef="usdPerShare">131.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-374"
      decimals="-3"
      id="f-1397"
      unitRef="shares">215000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-374"
      decimals="2"
      id="f-1398"
      unitRef="usdPerShare">86.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-374"
      decimals="-3"
      id="f-1399"
      unitRef="shares">13000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-374"
      decimals="2"
      id="f-1400"
      unitRef="usdPerShare">83.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-386"
      decimals="-3"
      id="f-1401"
      unitRef="shares">435000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-386"
      decimals="2"
      id="f-1402"
      unitRef="usdPerShare">102.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-387"
      decimals="-3"
      id="f-1403"
      unitRef="shares">16000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-388"
      decimals="2"
      id="f-1404"
      unitRef="usdPerShare">116.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-389"
      decimals="2"
      id="f-1405"
      unitRef="usdPerShare">149.12</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-390"
      decimals="-3"
      id="f-1406"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-391" decimals="-3" id="f-1407" unitRef="usd">546000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-392" decimals="-3" id="f-1408" unitRef="usd">827000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-393" decimals="-3" id="f-1409" unitRef="usd">836000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-1410">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the years ended December&#160;31, 2024&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 and 2022 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.915%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense related to stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense related to restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense related to restricted stock awards to non-employee directors&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;36,183&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;30,754&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,720&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-371" decimals="-3" id="f-1411" unitRef="usd">22439000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-372" decimals="-3" id="f-1412" unitRef="usd">17221000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-373" decimals="-3" id="f-1413" unitRef="usd">11361000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-374" decimals="-3" id="f-1414" unitRef="usd">11662000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-375" decimals="-3" id="f-1415" unitRef="usd">11845000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-376" decimals="-3" id="f-1416" unitRef="usd">9920000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-394" decimals="-3" id="f-1417" unitRef="usd">2082000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-395" decimals="-3" id="f-1418" unitRef="usd">1688000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-396" decimals="-3" id="f-1419" unitRef="usd">1439000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-1420" unitRef="usd">36183000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-12" decimals="-3" id="f-1421" unitRef="usd">30754000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-13" decimals="-3" id="f-1422" unitRef="usd">22720000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-397" decimals="-3" id="f-1423" unitRef="usd">84914000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-386" decimals="-3" id="f-1424" unitRef="usd">38434000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-371" id="f-1425">P3Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-374" id="f-1426">P3Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <ensg:EmployeeServiceShareBasedCompensationNonvestedAwards
      contextRef="c-397"
      decimals="-3"
      id="f-1427"
      unitRef="shares">2092000</ensg:EmployeeServiceShareBasedCompensationNonvestedAwards>
    <ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber
      contextRef="c-397"
      decimals="-3"
      id="f-1428"
      unitRef="shares">1925000</ensg:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-1429">P6Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:OperatingLeasesOfLessorDisclosureTextBlock contextRef="c-1" id="f-1431">LEASES&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases from CareTrust REIT, Inc. (CareTrust) real property associated with 100 independent skilled nursing and senior living facilities used in the Company&#x2019;s operations, 99 of which are under nine &#x201c;triple-net&#x201d; master lease agreements (collectively, the Master Leases), which range in terms from 13 to 20 years. At the Company&#x2019;s option, the Master Leases may be extended for two or three five-year renewal terms beyond the initial term, on the same terms and conditions. The extension of the term of any of the Master Leases is subject to the following conditions: (1) no event of default under any of the Master Leases having occurred and continuing; and (2) the tenants providing timely notice of their intent to renew. The term of the Master Leases is subject to termination prior to the expiration of the current term upon default by the tenants in their obligations, if not cured within any applicable cure periods set forth in the Master Leases. If the Company elects to renew the term of a Master Lease, the renewal will be effective to all, but not less than all, of the leased property then subject to the Master Lease. During the year ended December&#160;31, 2024, the Company amended two of the Master Leases by adding three operations and extending the terms to 15 and 20 years, respectively. These amendments increased the lease liabilities and right-of-use assets by $72,503 to reflect the new lease obligations. Additionally, four of the 100 facilities leased from CareTrust include an option to purchase that the Company can exercise starting on December 1, 2024. Subsequent to December&#160;31, 2024, the Company purchased the real estate of the four facilities from CareTrust for $44,575.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10.05pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have the ability to terminate the obligations under a Master Lease prior to its expiration without CareTrust&#x2019;s consent. If a Master Lease is terminated prior to its expiration other than with CareTrust&#x2019;s consent, the Company may be liable for damages and incur charges such as continued payment of rent through the end of the lease term as well as maintenance and repair costs for the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rent structure under the Master Leases includes a fixed component, subject to annual escalation equal to the lesser of (1) the percentage change in the Consumer Price Index (but not less than zero) or (2) 2.5%. In addition to rent, the Company is required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The terms and conditions of the one stand-alone lease are substantially the same as those for the master leases described above. Total rent expense under the Master Leases was approximately $69,399, $66,439 and $64,178 for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Among other things, under the Master Leases, the Company must maintain compliance with specified financial covenants measured on a quarterly basis, including a portfolio coverage ratio and a minimum rent coverage ratio. The Master Leases also include certain reporting, legal and authorization requirements. The Company is in compliance with requirements of the Master Leases as of December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities where its independent subsidiaries operate and certain administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from 15 to 20 years. In addition, the Company leases certain of its equipment under non-cancelable operating leases with initial terms ranging from &lt;span style="-sec-ix-hidden:f-1458"&gt;three&lt;/span&gt; to five years. Most of these leases contain renewal options, certain of which involve rent increases. Total rent expense for continuing operations inclusive of straight-line rent adjustments and rent associated with the Master Leases noted above, was $216,716, $197,856 and $153,174 for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ninety of the Company&#x2019;s independent subsidiaries, excluding the subsidiaries that are operated under the Master Leases with CareTrust, are operated under 14 separate master lease arrangements. During the year ended December&#160;31, 2024, the Company amended one of the separate master lease arrangements to add two stand-alone skilled nursing operations operated by the Company's independent subsidiaries and extended the term to 20 years. In addition, the Company entered into one new master lease arrangement to add six stand-alone skilled nursing operations operated by the Company's independent subsidiaries with an initial term of 15 years. The amended and new master lease arrangements increased the lease liabilities and right-of-use assets by $71,616 to reflect the new lease obligations. Under the master leases, a default at a single facility could subject one or more of the other facilities covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of the Company&#x2019;s leases, master lease agreements and debt financing instruments. In addition, other potential defaults related to an individual facility may cause a default of an entire master lease portfolio and could trigger cross-default provisions in the Company&#x2019;s outstanding debt arrangements and other leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the lease without the consent of the landlord. The components of operating lease expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rent - cost of services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242,225&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;171,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Rent- cost of services includes accrued rent expense adju&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;stments of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; $808, $870 and $493 for the years ended December 31, 2024, 2023 and 2022, respectively. Additionally, rent- cost of services includes other variable lease costs such as consumer price index increases and short-term leases of $14,013, $10,259, $5,878 for the years ended December 31, 2024,  2023, and 2022 respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Cost of services includes variable lease costs, which consists of property taxes and insurance. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Depreciation and amortization is related to the amortization of favorable and direct lease costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for all third-party leases as of December&#160;31, 2024 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.352%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL LEASE PAYMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,792,316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PRESENT VALUE OF TOTAL LEASE LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,828,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LONG-TERM OPERATING LEASE LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,735,325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the lease commencement date. As of&#160;December&#160;31, 2024 and 2023, the weighted average remaining lease term is&#160;14.5 years and 14.9 years, respectively, and the weighted average discount rate used to determine the operating lease liabilities is&#160;6.3% and 6.5%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2024, the Company expanded its operations through a new master lease with the addition of six standalone skilled nursing operations. The aggregate impact to the carrying value of lease liabilities and right-of-use assets related to the long-term leases is estimated to be approximately $67,572.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases its owned real estate properties to third-party operators, of which 32 senior living operations are operated by Pennant. All of these properties are triple-net leases, whereby the respective tenants are responsible for all costs at the properties including: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The initial terms range from 14 to 16 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2024, the Company expanded its operations through a separate master lease arrangement for three stand-alone senior living operations with a third-party operator for an initial lease term of 15 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2023, the Company entered into a sublease agreement for three stand-alone skilled nursing operations with a third-party operator with an initial lease term of 18 years. Additionally, during the year, the Company entered into a lease agreement with a third-party operator for one campus operation with an initial lease term of 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total rental income from all third-party sources for the years ended December 31, 2024, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pennant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other third-party&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1530"&gt;&lt;span style="-sec-ix-hidden:f-1531"&gt;&lt;span style="-sec-ix-hidden:f-1532"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,960&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,284&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,757&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Pennant rental income includes variable rent such as property taxes of $1,235, $1,296, and $1,318 during the year ended December 31, 2024, 2023, and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Other third-party includes rental revenue associated with the Company's subleases to third parties of $4,347 and $3,897 for the years ended December 31, 2024 and 2023. There was no sublease rental revenue for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future annual rental income for all third-party leases as of December&#160;31, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;234,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Annual rental income includes base rents and variable rental income pursuant to existing leases as of December&#160;31, 2024.</us-gaap:OperatingLeasesOfLessorDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-1430">LEASES&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases from CareTrust REIT, Inc. (CareTrust) real property associated with 100 independent skilled nursing and senior living facilities used in the Company&#x2019;s operations, 99 of which are under nine &#x201c;triple-net&#x201d; master lease agreements (collectively, the Master Leases), which range in terms from 13 to 20 years. At the Company&#x2019;s option, the Master Leases may be extended for two or three five-year renewal terms beyond the initial term, on the same terms and conditions. The extension of the term of any of the Master Leases is subject to the following conditions: (1) no event of default under any of the Master Leases having occurred and continuing; and (2) the tenants providing timely notice of their intent to renew. The term of the Master Leases is subject to termination prior to the expiration of the current term upon default by the tenants in their obligations, if not cured within any applicable cure periods set forth in the Master Leases. If the Company elects to renew the term of a Master Lease, the renewal will be effective to all, but not less than all, of the leased property then subject to the Master Lease. During the year ended December&#160;31, 2024, the Company amended two of the Master Leases by adding three operations and extending the terms to 15 and 20 years, respectively. These amendments increased the lease liabilities and right-of-use assets by $72,503 to reflect the new lease obligations. Additionally, four of the 100 facilities leased from CareTrust include an option to purchase that the Company can exercise starting on December 1, 2024. Subsequent to December&#160;31, 2024, the Company purchased the real estate of the four facilities from CareTrust for $44,575.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10.05pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not have the ability to terminate the obligations under a Master Lease prior to its expiration without CareTrust&#x2019;s consent. If a Master Lease is terminated prior to its expiration other than with CareTrust&#x2019;s consent, the Company may be liable for damages and incur charges such as continued payment of rent through the end of the lease term as well as maintenance and repair costs for the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rent structure under the Master Leases includes a fixed component, subject to annual escalation equal to the lesser of (1) the percentage change in the Consumer Price Index (but not less than zero) or (2) 2.5%. In addition to rent, the Company is required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The terms and conditions of the one stand-alone lease are substantially the same as those for the master leases described above. Total rent expense under the Master Leases was approximately $69,399, $66,439 and $64,178 for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Among other things, under the Master Leases, the Company must maintain compliance with specified financial covenants measured on a quarterly basis, including a portfolio coverage ratio and a minimum rent coverage ratio. The Master Leases also include certain reporting, legal and authorization requirements. The Company is in compliance with requirements of the Master Leases as of December&#160;31, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases facilities where its independent subsidiaries operate and certain administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from 15 to 20 years. In addition, the Company leases certain of its equipment under non-cancelable operating leases with initial terms ranging from &lt;span style="-sec-ix-hidden:f-1458"&gt;three&lt;/span&gt; to five years. Most of these leases contain renewal options, certain of which involve rent increases. Total rent expense for continuing operations inclusive of straight-line rent adjustments and rent associated with the Master Leases noted above, was $216,716, $197,856 and $153,174 for the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ninety of the Company&#x2019;s independent subsidiaries, excluding the subsidiaries that are operated under the Master Leases with CareTrust, are operated under 14 separate master lease arrangements. During the year ended December&#160;31, 2024, the Company amended one of the separate master lease arrangements to add two stand-alone skilled nursing operations operated by the Company's independent subsidiaries and extended the term to 20 years. In addition, the Company entered into one new master lease arrangement to add six stand-alone skilled nursing operations operated by the Company's independent subsidiaries with an initial term of 15 years. The amended and new master lease arrangements increased the lease liabilities and right-of-use assets by $71,616 to reflect the new lease obligations. Under the master leases, a default at a single facility could subject one or more of the other facilities covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of the Company&#x2019;s leases, master lease agreements and debt financing instruments. In addition, other potential defaults related to an individual facility may cause a default of an entire master lease portfolio and could trigger cross-default provisions in the Company&#x2019;s outstanding debt arrangements and other leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the lease without the consent of the landlord. The components of operating lease expense are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rent - cost of services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242,225&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;171,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Rent- cost of services includes accrued rent expense adju&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;stments of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; $808, $870 and $493 for the years ended December 31, 2024, 2023 and 2022, respectively. Additionally, rent- cost of services includes other variable lease costs such as consumer price index increases and short-term leases of $14,013, $10,259, $5,878 for the years ended December 31, 2024,  2023, and 2022 respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Cost of services includes variable lease costs, which consists of property taxes and insurance. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Depreciation and amortization is related to the amortization of favorable and direct lease costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for all third-party leases as of December&#160;31, 2024 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.352%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL LEASE PAYMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,792,316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PRESENT VALUE OF TOTAL LEASE LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,828,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LONG-TERM OPERATING LEASE LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,735,325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at the lease commencement date. As of&#160;December&#160;31, 2024 and 2023, the weighted average remaining lease term is&#160;14.5 years and 14.9 years, respectively, and the weighted average discount rate used to determine the operating lease liabilities is&#160;6.3% and 6.5%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to December&#160;31, 2024, the Company expanded its operations through a new master lease with the addition of six standalone skilled nursing operations. The aggregate impact to the carrying value of lease liabilities and right-of-use assets related to the long-term leases is estimated to be approximately $67,572.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Lessor Activities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases its owned real estate properties to third-party operators, of which 32 senior living operations are operated by Pennant. All of these properties are triple-net leases, whereby the respective tenants are responsible for all costs at the properties including: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all facility maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties. The initial terms range from 14 to 16 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2024, the Company expanded its operations through a separate master lease arrangement for three stand-alone senior living operations with a third-party operator for an initial lease term of 15 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2023, the Company entered into a sublease agreement for three stand-alone skilled nursing operations with a third-party operator with an initial lease term of 18 years. Additionally, during the year, the Company entered into a lease agreement with a third-party operator for one campus operation with an initial lease term of 15 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total rental income from all third-party sources for the years ended December 31, 2024, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pennant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other third-party&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1530"&gt;&lt;span style="-sec-ix-hidden:f-1531"&gt;&lt;span style="-sec-ix-hidden:f-1532"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,960&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,284&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,757&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Pennant rental income includes variable rent such as property taxes of $1,235, $1,296, and $1,318 during the year ended December 31, 2024, 2023, and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Other third-party includes rental revenue associated with the Company's subleases to third parties of $4,347 and $3,897 for the years ended December 31, 2024 and 2023. There was no sublease rental revenue for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future annual rental income for all third-party leases as of December&#160;31, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;234,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Annual rental income includes base rents and variable rental income pursuant to existing leases as of December&#160;31, 2024.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-398"
      decimals="INF"
      id="f-1432"
      unitRef="property">100</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-399"
      decimals="INF"
      id="f-1433"
      unitRef="property">99</us-gaap:NumberOfRealEstateProperties>
    <ensg:NumberOfMasterLeaseAgreements
      contextRef="c-400"
      decimals="INF"
      id="f-1434"
      unitRef="agreement">9</ensg:NumberOfMasterLeaseAgreements>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-401" id="f-1435">P13Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-402" id="f-1436">P20Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms
      contextRef="c-401"
      decimals="INF"
      id="f-1437"
      unitRef="renewal">2</ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms>
    <ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms
      contextRef="c-402"
      decimals="INF"
      id="f-1438"
      unitRef="renewal">3</ensg:LesseeLeasingArrangementsOperatingLeasesNumberOfRenewalTerms>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-400" id="f-1439">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <ensg:NumberOfMasterLeaseAgreements
      contextRef="c-403"
      decimals="INF"
      id="f-1440"
      unitRef="agreement">2</ensg:NumberOfMasterLeaseAgreements>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-404"
      decimals="INF"
      id="f-1441"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <ensg:LesseeOperatingLeaseTermExtension contextRef="c-405" id="f-1442">P15Y</ensg:LesseeOperatingLeaseTermExtension>
    <ensg:LesseeOperatingLeaseTermExtension contextRef="c-406" id="f-1443">P20Y</ensg:LesseeOperatingLeaseTermExtension>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-407" decimals="-3" id="f-1444" unitRef="usd">72503000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset contextRef="c-407" decimals="-3" id="f-1445" unitRef="usd">72503000</ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-408"
      decimals="INF"
      id="f-1446"
      unitRef="property">4</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-398"
      decimals="INF"
      id="f-1447"
      unitRef="property">100</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-409"
      decimals="INF"
      id="f-1448"
      unitRef="property">4</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:AssetAcquisitionConsiderationTransferred contextRef="c-410" decimals="-3" id="f-1449" unitRef="usd">44575000</us-gaap:AssetAcquisitionConsiderationTransferred>
    <ensg:LesseeOperatingLeaseConsumerPriceIndex
      contextRef="c-411"
      decimals="INF"
      id="f-1450"
      unitRef="number">0</ensg:LesseeOperatingLeaseConsumerPriceIndex>
    <us-gaap:LesseeOperatingLeaseDiscountRate
      contextRef="c-411"
      decimals="3"
      id="f-1451"
      unitRef="number">0.025</us-gaap:LesseeOperatingLeaseDiscountRate>
    <ensg:LesseeOperatingLeaseNumberOfLeases
      contextRef="c-412"
      decimals="INF"
      id="f-1452"
      unitRef="lease">1</ensg:LesseeOperatingLeaseNumberOfLeases>
    <us-gaap:OperatingLeaseExpense contextRef="c-412" decimals="-3" id="f-1453" unitRef="usd">69399000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-413" decimals="-3" id="f-1454" unitRef="usd">66439000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-414" decimals="-3" id="f-1455" unitRef="usd">64178000</us-gaap:OperatingLeaseExpense>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-415" id="f-1456">P15Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-416" id="f-1457">P20Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-418" id="f-1459">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseExpense contextRef="c-419" decimals="-3" id="f-1460" unitRef="usd">216716000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-420" decimals="-3" id="f-1461" unitRef="usd">197856000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense contextRef="c-421" decimals="-3" id="f-1462" unitRef="usd">153174000</us-gaap:OperatingLeaseExpense>
    <ensg:SubsidiariesUnderMasterLeaseArrangement
      contextRef="c-422"
      decimals="INF"
      id="f-1463"
      unitRef="subsidiary">90</ensg:SubsidiariesUnderMasterLeaseArrangement>
    <ensg:NumberOfMasterLeaseAgreements
      contextRef="c-422"
      decimals="INF"
      id="f-1464"
      unitRef="agreement">14</ensg:NumberOfMasterLeaseAgreements>
    <ensg:NumberOfMasterLeaseAgreements
      contextRef="c-423"
      decimals="INF"
      id="f-1465"
      unitRef="agreement">1</ensg:NumberOfMasterLeaseAgreements>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-424"
      decimals="INF"
      id="f-1466"
      unitRef="property">2</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-423" id="f-1467">P20Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <ensg:NumberOfMasterLeaseAgreements
      contextRef="c-425"
      decimals="INF"
      id="f-1468"
      unitRef="agreement">1</ensg:NumberOfMasterLeaseAgreements>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-426"
      decimals="INF"
      id="f-1469"
      unitRef="property">6</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-425" id="f-1470">P15Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-427" decimals="-3" id="f-1471" unitRef="usd">71616000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset contextRef="c-427" decimals="-3" id="f-1472" unitRef="usd">71616000</ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1473">The components of operating lease expense are as follows:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rent - cost of services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;242,225&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;219,512&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;171,272&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Rent- cost of services includes accrued rent expense adju&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;stments of&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; $808, $870 and $493 for the years ended December 31, 2024, 2023 and 2022, respectively. Additionally, rent- cost of services includes other variable lease costs such as consumer price index increases and short-term leases of $14,013, $10,259, $5,878 for the years ended December 31, 2024,  2023, and 2022 respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Cost of services includes variable lease costs, which consists of property taxes and insurance. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.11pt"&gt;Depreciation and amortization is related to the amortization of favorable and direct lease costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-428" decimals="-3" id="f-1474" unitRef="usd">216016000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-429" decimals="-3" id="f-1475" unitRef="usd">197358000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-430" decimals="-3" id="f-1476" unitRef="usd">153049000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-1477" unitRef="usd">24297000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-12" decimals="-3" id="f-1478" unitRef="usd">20454000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-13" decimals="-3" id="f-1479" unitRef="usd">16938000</us-gaap:VariableLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-431" decimals="-3" id="f-1480" unitRef="usd">700000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-432" decimals="-3" id="f-1481" unitRef="usd">498000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-433" decimals="-3" id="f-1482" unitRef="usd">125000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-311" decimals="-3" id="f-1483" unitRef="usd">1212000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-312" decimals="-3" id="f-1484" unitRef="usd">1202000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-313" decimals="-3" id="f-1485" unitRef="usd">1160000</us-gaap:OperatingLeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-1486" unitRef="usd">242225000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-12" decimals="-3" id="f-1487" unitRef="usd">219512000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-13" decimals="-3" id="f-1488" unitRef="usd">171272000</us-gaap:LeaseCost>
    <ensg:AccruedRentAdjustment contextRef="c-1" decimals="-3" id="f-1489" unitRef="usd">808000</ensg:AccruedRentAdjustment>
    <ensg:AccruedRentAdjustment contextRef="c-12" decimals="-3" id="f-1490" unitRef="usd">870000</ensg:AccruedRentAdjustment>
    <ensg:AccruedRentAdjustment contextRef="c-13" decimals="-3" id="f-1491" unitRef="usd">493000</ensg:AccruedRentAdjustment>
    <us-gaap:ShortTermLeaseCost contextRef="c-428" decimals="-3" id="f-1492" unitRef="usd">14013000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-429" decimals="-3" id="f-1493" unitRef="usd">10259000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-430" decimals="-3" id="f-1494" unitRef="usd">5878000</us-gaap:ShortTermLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-1495">&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments for all third-party leases as of December&#160;31, 2024 are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.718%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.352%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;202,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199,144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,776,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL LEASE PAYMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2,792,316&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustment &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(963,516)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;PRESENT VALUE OF TOTAL LEASE LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,828,800&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(93,475)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LONG-TERM OPERATING LEASE LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;1,735,325&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1496" unitRef="usd">204909000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-4" decimals="-3" id="f-1497" unitRef="usd">204696000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-4" decimals="-3" id="f-1498" unitRef="usd">204002000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-4" decimals="-3" id="f-1499" unitRef="usd">202994000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-4" decimals="-3" id="f-1500" unitRef="usd">199144000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-4" decimals="-3" id="f-1501" unitRef="usd">1776571000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-4" decimals="-3" id="f-1502" unitRef="usd">2792316000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-4" decimals="-3" id="f-1503" unitRef="usd">963516000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-1504" unitRef="usd">1828800000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-1505" unitRef="usd">93475000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-1506" unitRef="usd">1735325000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-4" id="f-1507">P14Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-1508">P14Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-4" decimals="3" id="f-1509" unitRef="number">0.063</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="3" id="f-1510" unitRef="number">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-434"
      decimals="INF"
      id="f-1511"
      unitRef="property">6</us-gaap:NumberOfRealEstateProperties>
    <ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset contextRef="c-435" decimals="-3" id="f-1512" unitRef="usd">67572000</ensg:IncreaseDecreaseInOperatingLeaseRightOfUseAsset>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-435" decimals="-3" id="f-1513" unitRef="usd">67572000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-436"
      decimals="INF"
      id="f-1514"
      unitRef="property">32</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-437" id="f-1515">P14Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-438" id="f-1516">P16Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-439"
      decimals="INF"
      id="f-1517"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-440" id="f-1518">P15Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-441"
      decimals="INF"
      id="f-1519"
      unitRef="property">3</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-442" id="f-1520">P18Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-443"
      decimals="INF"
      id="f-1521"
      unitRef="property">1</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:LessorOperatingLeaseTermOfContract contextRef="c-444" id="f-1522">P15Y</us-gaap:LessorOperatingLeaseTermOfContract>
    <us-gaap:OperatingLeaseLeaseIncomeTableTextBlock contextRef="c-1" id="f-1523">&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total rental income from all third-party sources for the years ended December 31, 2024, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:60.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.623%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pennant&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other third-party&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-1530"&gt;&lt;span style="-sec-ix-hidden:f-1531"&gt;&lt;span style="-sec-ix-hidden:f-1532"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;22,960&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;21,284&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;16,757&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1) Pennant rental income includes variable rent such as property taxes of $1,235, $1,296, and $1,318 during the year ended December 31, 2024, 2023, and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2) Other third-party includes rental revenue associated with the Company's subleases to third parties of $4,347 and $3,897 for the years ended December 31, 2024 and 2023. There was no sublease rental revenue for the year ended December 31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:OperatingLeaseLeaseIncomeTableTextBlock>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-445" decimals="-3" id="f-1524" unitRef="usd">15480000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-446" decimals="-3" id="f-1525" unitRef="usd">15048000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-447" decimals="-3" id="f-1526" unitRef="usd">14915000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-448" decimals="-3" id="f-1527" unitRef="usd">7480000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-449" decimals="-3" id="f-1528" unitRef="usd">6236000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-450" decimals="-3" id="f-1529" unitRef="usd">1842000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-451" decimals="-3" id="f-1533" unitRef="usd">22960000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-452" decimals="-3" id="f-1534" unitRef="usd">21284000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-453" decimals="-3" id="f-1535" unitRef="usd">16757000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseVariableLeaseIncome contextRef="c-445" decimals="-3" id="f-1536" unitRef="usd">1235000</us-gaap:OperatingLeaseVariableLeaseIncome>
    <us-gaap:OperatingLeaseVariableLeaseIncome contextRef="c-446" decimals="-3" id="f-1537" unitRef="usd">1296000</us-gaap:OperatingLeaseVariableLeaseIncome>
    <us-gaap:OperatingLeaseVariableLeaseIncome contextRef="c-447" decimals="-3" id="f-1538" unitRef="usd">1318000</us-gaap:OperatingLeaseVariableLeaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-454" decimals="-3" id="f-1539" unitRef="usd">4347000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-455" decimals="-3" id="f-1540" unitRef="usd">3897000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-456" decimals="INF" id="f-1541" unitRef="usd">0</us-gaap:SubleaseIncome>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock contextRef="c-1" id="f-1542">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future annual rental income for all third-party leases as of December&#160;31, 2024 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #edfee2;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #edfee2;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,811&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;234,436&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;(1) Annual rental income includes base rents and variable rental income pursuant to existing leases as of December&#160;31, 2024.</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths contextRef="c-4" decimals="-3" id="f-1543" unitRef="usd">23664000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears contextRef="c-4" decimals="-3" id="f-1544" unitRef="usd">23179000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears contextRef="c-4" decimals="-3" id="f-1545" unitRef="usd">22736000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears contextRef="c-4" decimals="-3" id="f-1546" unitRef="usd">22535000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears contextRef="c-4" decimals="-3" id="f-1547" unitRef="usd">22511000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFiveYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThereafter contextRef="c-4" decimals="-3" id="f-1548" unitRef="usd">119811000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThereafter>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived contextRef="c-4" decimals="-3" id="f-1549" unitRef="usd">234436000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="c-1" id="f-1550">DEFINED CONTRIBUTION PLANS&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a 401(k) defined contribution plan (the 401(k) Plan), whereby eligible employees may contribute up to 90% of their annual basic earnings, subject to applicable annual Internal Revenue Code limits. Additionally, the 401(k) Plan provides for discretionary matching contributions (as defined in the 401(k) Plan) by the Company. The Company expensed matching contributions to the 401(k) Plan of $3,532, $2,836, and $2,418 during the years ended December 31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a non-qualified deferred compensation plan (DCP), whereby certain highly compensated employees who are otherwise ineligible to participate in the Company's 401(k) plan, may defer the receipt of a portion of their base compensation and, for certain employees, up to&#160;100% of their eligible bonuses. Additionally, the DCP allows for the employee deferrals to be deposited into a rabbi trust and the funds are generally invested in individual variable life insurance contracts owned by the Company that are specifically designed to fund savings plans of this nature. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024 and 2023, the Company accrued $63,051 and $49,201, respectively, as long term deferred compensation in other long term liabilities&#160;on the consolidated balance sheets. Cash surrender value of the contracts is based on investment funds that shadow the investment allocations specified by participants in the deferred compensation plan. Refer to Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for more information on the funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December 31, 2024 and 2023, the Company recorded gains related to its DCP of $5,157 and $4,634, respectively, which are included in other income (expense), and recorded offsetting expenses of $5,559 and $4,887, which are allocated between cost of services and general and administrative expenses. For the year ended December 31, 2022, the Company recorded a loss related to its DCP of $4,188, which is included in other income (expense), and recorded an offsetting reduction in expense of $4,051, which is allocated between cost of services and general and administrative expenses.&lt;/span&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="c-457"
      decimals="INF"
      id="f-1551"
      unitRef="number">0.90</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-457" decimals="-3" id="f-1552" unitRef="usd">3532000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-458" decimals="-3" id="f-1553" unitRef="usd">2836000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-459" decimals="-3" id="f-1554" unitRef="usd">2418000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="c-460"
      decimals="INF"
      id="f-1555"
      unitRef="number">1</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="c-4" decimals="-3" id="f-1556" unitRef="usd">63051000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent contextRef="c-5" decimals="-3" id="f-1557" unitRef="usd">49201000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:GainLossOnInvestments contextRef="c-1" decimals="-3" id="f-1558" unitRef="usd">5157000</us-gaap:GainLossOnInvestments>
    <us-gaap:GainLossOnInvestments contextRef="c-12" decimals="-3" id="f-1559" unitRef="usd">4634000</us-gaap:GainLossOnInvestments>
    <ensg:InvestmentExpenseIncome contextRef="c-1" decimals="-3" id="f-1560" unitRef="usd">5559000</ensg:InvestmentExpenseIncome>
    <ensg:InvestmentExpenseIncome contextRef="c-12" decimals="-3" id="f-1561" unitRef="usd">4887000</ensg:InvestmentExpenseIncome>
    <us-gaap:GainLossOnInvestments contextRef="c-13" decimals="-3" id="f-1562" unitRef="usd">-4188000</us-gaap:GainLossOnInvestments>
    <ensg:InvestmentExpenseIncome contextRef="c-13" decimals="-3" id="f-1563" unitRef="usd">-4051000</ensg:InvestmentExpenseIncome>
    <us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock contextRef="c-1" id="f-1564">SELF INSURANCE LIABILITIES&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company's self-insurance insurance liabilities, on an undiscounted basis, inclusive of anticipated insurance recoveries, as of December 31, 2024 and 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued general liability and professional malpractice liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued workers&#x2019; compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued health benefits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL SELF-INSURANCE LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;211,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current self-insurance liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LONG-TERM SELF-INSURANCE LIABILITIES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;144,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;111,246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents activity in the Company's self-insurance liabilities as of and for the years ended December 31, 2024 and 2023: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance January&#160;1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims paid and direct expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in long-term insurance losses recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims paid and direct expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in long-term insurance losses recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;211,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The anticipated insurance recoveries included in the self-insurance liabilities are presented gross rather than net with the corresponding asset of $17,741 and $15,913 as of December 31, 2024 and 2023, respectively, included in Restricted and other assets on the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitsAndUnpaidClaimsDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock contextRef="c-1" id="f-1565">&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the Company's self-insurance insurance liabilities, on an undiscounted basis, inclusive of anticipated insurance recoveries, as of December 31, 2024 and 2023: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.999%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.911%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued general liability and professional malpractice liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;117,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued workers&#x2019; compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued health benefits&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;TOTAL SELF-INSURANCE LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;211,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current self-insurance liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LONG-TERM SELF-INSURANCE LIABILITIES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;144,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;111,246&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForFuturePolicyBenefitsByProductSegmentTextBlock>
    <us-gaap:SelfInsuranceReserve contextRef="c-461" decimals="-3" id="f-1566" unitRef="usd">160149000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-462" decimals="-3" id="f-1567" unitRef="usd">117744000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-463" decimals="-3" id="f-1568" unitRef="usd">37291000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-464" decimals="-3" id="f-1569" unitRef="usd">33352000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-465" decimals="-3" id="f-1570" unitRef="usd">14312000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-466" decimals="-3" id="f-1571" unitRef="usd">14814000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-4" decimals="-3" id="f-1572" unitRef="usd">211752000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserve contextRef="c-5" decimals="-3" id="f-1573" unitRef="usd">165910000</us-gaap:SelfInsuranceReserve>
    <us-gaap:SelfInsuranceReserveCurrent contextRef="c-4" decimals="-3" id="f-1574" unitRef="usd">67331000</us-gaap:SelfInsuranceReserveCurrent>
    <us-gaap:SelfInsuranceReserveCurrent contextRef="c-5" decimals="-3" id="f-1575" unitRef="usd">54664000</us-gaap:SelfInsuranceReserveCurrent>
    <us-gaap:SelfInsuranceReserveNoncurrent contextRef="c-4" decimals="-3" id="f-1576" unitRef="usd">144421000</us-gaap:SelfInsuranceReserveNoncurrent>
    <us-gaap:SelfInsuranceReserveNoncurrent contextRef="c-5" decimals="-3" id="f-1577" unitRef="usd">111246000</us-gaap:SelfInsuranceReserveNoncurrent>
    <us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock contextRef="c-1" id="f-1578">&lt;div style="margin-top:10pt;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents activity in the Company's self-insurance liabilities as of and for the years ended December 31, 2024 and 2023: &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:1pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.205%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance January&#160;1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims paid and direct expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(135,799)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in long-term insurance losses recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance December&#160;31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;165,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Claims paid and direct expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(173,617)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in long-term insurance losses recoverable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#e4e9df;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance December&#160;31, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;211,752&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#e4e9df;border-bottom:1pt solid #566b39;border-top:1pt solid #566b39;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LiabilityForFuturePolicyBenefitActivityTableTextBlock>
    <us-gaap:LiabilityForFuturePolicyBenefits contextRef="c-30" decimals="-3" id="f-1579" unitRef="usd">131682000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease contextRef="c-12" decimals="-3" id="f-1580" unitRef="usd">164627000</us-gaap:LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits contextRef="c-12" decimals="-3" id="f-1581" unitRef="usd">135799000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease contextRef="c-12" decimals="-3" id="f-1582" unitRef="usd">5400000</us-gaap:LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease>
    <us-gaap:LiabilityForFuturePolicyBenefits contextRef="c-5" decimals="-3" id="f-1583" unitRef="usd">165910000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease contextRef="c-1" decimals="-3" id="f-1584" unitRef="usd">217631000</us-gaap:LiabilityForFuturePolicyBenefitsPeriodIncreaseDecrease>
    <us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits contextRef="c-1" decimals="-3" id="f-1585" unitRef="usd">173617000</us-gaap:LiabilityForFuturePolicyBenefitsPaymentForBenefits>
    <us-gaap:LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease contextRef="c-1" decimals="-3" id="f-1586" unitRef="usd">1828000</us-gaap:LiabilityForFuturePolicyBenefitsOtherIncreaseDecrease>
    <us-gaap:LiabilityForFuturePolicyBenefits contextRef="c-4" decimals="-3" id="f-1587" unitRef="usd">211752000</us-gaap:LiabilityForFuturePolicyBenefits>
    <us-gaap:EstimatedInsuranceRecoveries contextRef="c-4" decimals="-3" id="f-1588" unitRef="usd">17741000</us-gaap:EstimatedInsuranceRecoveries>
    <us-gaap:EstimatedInsuranceRecoveries contextRef="c-5" decimals="-3" id="f-1589" unitRef="usd">15913000</us-gaap:EstimatedInsuranceRecoveries>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1590">COMMITMENTS AND CONTINGENCIES&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. The terms of such obligations vary by contract and, in most instances, do not expressly state or include a specific or maximum dollar amount. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Consequently, because no claims have been asserted, no liabilities have been recorded for these obligations on the Company&#x2019;s &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"&gt;consolidated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; balance sheets for any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation and Regulatory Matters&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company and its independent subsidiaries are party to various legal actions and administrative proceedings and are subject to various claims arising in the ordinary course of business. Such claims may be related to, but are not limited to, the Health Insurance Portability and Accountability Act of 1996, alleged Medicare or Medicaid false claims, qui tam or "whistleblower" provisions of the False Claims Act and/or the Anti-Kickback Statute, alleged violations of state and federal wage and hour laws, environmental matters, investigations, examinations, audits, site visits and surveys or other claims in connection with the delivery of healthcare and non-healthcare services. Refer to &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Part I. Item 3. Legal Proceedings&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for additional information on litigation and regulatory matters. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2024, the Company, on behalf of its independent subsidiaries, received a &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Civil Investigative Demand (CID)&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; from the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. Department of Justice (DOJ) &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;indicating that the DOJ is investigating the Company to determine whether claims have been submitted to Medicare and Texas Medicaid for services which were unnecessary or otherwise not consistent with existing reimbursement requirements. The CID covers the period from January 1, 2016, to the present. As a general matter, the Company's &lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;independent subsidiaries&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; maintain policies and procedures to promote compliance with all applicable Medicare and Medicaid requirements, including but not limited to those relating to the presentation of claims for reimbursement for services provided&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company is fully cooperating with the DOJ in response to the CID. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;However, the Company cannot predict the outcome of the investigation or its potential impact on the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2023, in a four-week medical negligence trial in the State of Arizona, the jury returned a verdict against one of the Company&#x2019;s independent subsidiaries. The Company is in the process of appealing the jury verdict. The Company has in the past appealed similar decisions and has, in some circumstances, received decisions in its favor. Although the Company intends to vigorously defend against these claims and in general these types of claims and cases, there can be no assurance that the outcomes of these matters will not have a material adverse effect on operational results and financial condition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2018, the Company, on behalf of its independent subsidiaries, received a CID from the DOJ stating that it was investigating to determine whether there had been a violation of the False Claims Act (FCA) and/or the Anti-Kickback Statute (AKS) with respect to the relationships between certain of the Company&#x2019;s independent subsidiaries and persons who serve or have served as medical directors. In 2020, the Company was advised that the DOJ declined to intervene in any subsequent action filed in connection with the subject matter of this investigation. Despite the decision of the DOJ to decline to participate in litigation based on the subject matter of its previously issued CID, the involved qui tam relator moved forward with the complaint in 2020. In 2024, the Company mediated with the involved parties and agreed to settle the civil case for $48,000 and recorded the accrual as of December 31, 2023. Following the finalization of the settlement documents and payment of the settlement funds during the year ended December&#160;31, 2024, the qui tam complaint was dismissed and the matter was resolved. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medicare Revenue Recoupments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company's independent subsidiaries are subject to regulatory reviews relating to the provision of Medicare services, billings and potential overpayments as a result of Recovery Audit Contractors (RAC), various Program Safeguard Contractors, and Medicaid Integrity Contractor programs (collectively referred to as Reviews). Reviews vary in claim selection size and processes, ranging from a single episode/claim month to larger, multi-claim batches; and from single rounds of review to reviews of multiple rounds with pass/fail criteria. If an operation has a significant error rate or fails a Review and/or subsequent Reviews, the operation could then be subject to extended review or an extrapolation of the identified error rate to billings in the same time period. The Company anticipates that these Reviews could increase in frequency in the future. As of December&#160;31, 2024 and through the filing date of this report, 18 of the Company's independent subsidiaries had multi-claim Reviews scheduled or in process.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#226600;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; The Company has significant accounts receivable balances, the collectability of which is dependent on the availability of funds from certain governmental programs, primarily Medicare and Medicaid. These receivables represent the only significant concentration of credit risk for the Company. The Company does not believe there are significant credit risks associated with these governmental programs. The Company believes that an appropriate allowance has been recorded for the possibility of these receivables proving uncollectible and continually monitors and adjusts these allowances as necessary. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s receivables from Medicare and Medicaid payor programs accounted for 52.9% and 53.4% of its total accounts receivable as of December&#160;31, 2024 and 2023, respectively. Revenue from reimbursement under the Medicare and Medicaid programs accounted for 70.9%, 72.6% and 73.7% of the Company's revenue for the years ended December&#160;31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LitigationSettlementAmountAwardedToOtherParty contextRef="c-1" decimals="-6" id="f-1591" unitRef="usd">48000000</us-gaap:LitigationSettlementAmountAwardedToOtherParty>
    <ensg:IndependentOperatingSubsidiariesUnderMedicareProbeReviews
      contextRef="c-4"
      decimals="INF"
      id="f-1592"
      unitRef="subsidiary">18</ensg:IndependentOperatingSubsidiariesUnderMedicareProbeReviews>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-467"
      decimals="3"
      id="f-1593"
      unitRef="number">0.529</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="c-468"
      decimals="3"
      id="f-1594"
      unitRef="number">0.534</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-81" decimals="3" id="f-1595" unitRef="number">0.709</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-82" decimals="3" id="f-1596" unitRef="number">0.726</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-83" decimals="3" id="f-1597" unitRef="number">0.737</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-1598">COMMON STOCK REPURCHASE PROGRAM&lt;div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 16, 2024, the Board of Directors approved a stock repurchase program pursuant to which the Company may repurchase up to $20,000 of its common stock under the program for a period of approximately 12 months from September&#160;1, 2024. The Company did not purchase any shares pursuant to this stock repurchase program during the year ended December 31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 29, 2023, the Board of Directors approved a stock repurchase program pursuant to which the Company could repurchase up to $20,000 of its common stock under the program for a period of approximately 12 months from September&#160;1, 2023. The stock repurchase program expired on August 31, 2024 and is no longer in effect. The Company did not purchase any shares pursuant to this stock repurchase program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 28, 2022, the Board of Directors approved a stock repurchase program pursuant to which the Company could repurchase up to $20,000 of its common stock under the program for a period of approximately 12 months from August&#160;2, 2022. The stock repurchase program expired on August 2, 2023 and is no longer in effect. The Company did not purchase any shares pursuant to this stock repurchase program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company repurchased 404 shares of its common stock for $29,882 during the year ended December 31, 2022, related to two separate stock repurchase programs that are no longer in effect. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9.75pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under these repurchase programs, the Company is authorized to repurchase its issued and outstanding common shares from time to time in open-market and privately negotiated transactions, tender offers, pursuant to contractual provisions, and block trades, or otherwise in accordance with federal securities laws. The share repurchase program does not obligate the Company to acquire any specific number of shares. Any such repurchases will depend on the Company's business strategy, prevailing market conditions, the Company's liquidity requirements, contractual restrictions or covenants, compliance with securities laws, and other factors. The amounts involved in any such transaction may be material.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-469" decimals="INF" id="f-1599" unitRef="usd">20000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="c-470" id="f-1600">P12M</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-471"
      decimals="INF"
      id="f-1601"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-472" decimals="INF" id="f-1602" unitRef="usd">20000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="c-473" id="f-1603">P12M</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-474"
      decimals="INF"
      id="f-1604"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-475" decimals="INF" id="f-1605" unitRef="usd">20000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1 contextRef="c-476" id="f-1606">P12M</us-gaap:StockRepurchaseProgramPeriodInForce1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-476"
      decimals="INF"
      id="f-1607"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-13"
      decimals="-3"
      id="f-1608"
      unitRef="shares">404000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-13" decimals="-3" id="f-1609" unitRef="usd">29882000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-477" id="f-1610">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-477" id="f-1611">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-477" id="f-1612">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-479" id="f-1614">Dr. Ann S. Blouin, a member of our Board of Directors, entered into a Rule 10b5-1 trading arrangement on November 12, 2024. Dr. Blouin's 10b5-1 Plan provides for the sale of up to 450 shares of the Company's common stock between February 11, 2025 and November 11, 2025.</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndName contextRef="c-478" id="f-1613">Dr. Ann S. Blouin</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-478" id="f-1615">a member of our Board of Directors</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-478" id="f-1616">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-478" id="f-1617">November 12, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-480"
      decimals="INF"
      id="f-1618"
      unitRef="shares">450</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrExpirationDate contextRef="c-478" id="f-1619">November 11, 2025</ecd:TrdArrExpirationDate>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-482" id="f-1621">Suzanne D. Snapper, Chief Financial Officer, Executive Vice President, and Director, entered into a Rule 10b5-1 trading arrangement on November 15, 2024. Ms. Snapper's 10b5-1 Plan provides for the potential exercise of vested stock options and the associated sale of up to 10,618 shares of the Company's common stock between February 18, 2025 and July 28, 2025.</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndName contextRef="c-481" id="f-1620">Suzanne D. Snapper</ecd:TrdArrIndName>
    <ecd:TrdArrIndTitle contextRef="c-481" id="f-1622">Chief Financial Officer, Executive Vice President, and Director</ecd:TrdArrIndTitle>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-481" id="f-1623">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-481" id="f-1624">November 15, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-483"
      decimals="INF"
      id="f-1625"
      unitRef="shares">10618</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:TrdArrExpirationDate contextRef="c-481" id="f-1626">July 28, 2025</ecd:TrdArrExpirationDate>
    <dei:AuditorFirmId contextRef="c-1" id="f-1629">34</dei:AuditorFirmId>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-1630">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
